{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "qwen3-32b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "\n\nThe gross benefit obligation for LMT's nonqualified defined benefit pension plans decreased from $1.0 billion as of December 31, 2023, to $905 million as of December 31, 2024. Additionally, actuarial losses (recorded in accumulated other comprehensive loss) declined from $347 million at the end of 2023 to $303 million at the end of 2024, reflecting a reduction in both the pension obligation and associated actuarial losses over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the gross benefit obligation decreased from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declined from $347 million to $303 million over the same period. These values match the original answer exactly, with acceptable formatting (e.g., $1.0 billion = $1.0 billion). (2) The answer is complete, addressing both parts of the question—the evolution of the gross benefit obligation and the actuarial losses—across the two years. (3) Entity accuracy is correct: LMT (Lockheed Martin) is properly identified, and the financial metrics (gross benefit obligation, actuarial losses) are accurately named and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers a reduction in both liability and actuarial losses over time based on year-over-year comparisons. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced detail (e.g., mentioning 'accumulated other comprehensive loss') that does not alter or distort the facts. All scores are maximized due to full factual correctness, precise numerical reporting, logical reasoning, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 356,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "\n\nGeneral Motors' long-term rate of return assumption for U.S. pension plan assets increased from **5.4% in 2021** (as reported in the 2022 10-K) to **6.5% in 2024** (per the 2024 10-K), reflecting a gradual upward adjustment over the period. This increase aligns with a strategic asset mix shift observed in 2024, where allocations to **debt securities rose to 60%** (from 68% in 2021) and **\"other\" investments (private equity, real estate, etc.) increased to 29%** (from 23% in 2021), while equity allocations stabilized at 11% (down from 12% in 2021). The higher return assumption indicates GM’s focus on balancing risk mitigation (via increased debt holdings) with long-term growth through alternative assets, aiming to stabilize funded status and align with evolving liability profiles and market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timeframes. The ground truth states that in 2022, GM reported a decrease from 5.6% (2020) to 5.4% (2021), and in 2024, an increase from 6.3% (2023) to 6.5% (2024). The LLM correctly notes the 5.4% figure for 2021 and 6.5% for 2024 but fails to mention the 2023 rate of 6.3%, and incorrectly frames the evolution as a direct progression from 5.4% in 2021 to 6.5% in 2024 without acknowledging the intermediate values or the fact that the 2024 10-K would not yet report a '2024' assumption at year-end 2024. More critically, the asset allocation data (60% debt, 29% other, 11% equity) is not present in the ground truth and appears fabricated or misattributed. There is no mention in the original answer about specific allocation percentages or changes in equity/debt/other categories. (2) Quantitative accuracy is compromised due to the unsupported asset mix figures. While the 5.4% and 6.5% return assumptions are correctly cited, they are taken out of context—the original answer compares 2021 to 2024 but within separate reporting years (2022 vs 2024 10-Ks), and the LLM implies a continuous trend without proper caveats. The calculation of change (from 5.4% to 6.5%) is numerically correct but lacks the nuance of discrete reporting periods. (3) The multi-hop reasoning is partially sound: the model infers that a higher return assumption reflects strategic asset mix changes, which aligns with the ground truth’s conclusion about shifting from conservative to optimistic projections. However, the reasoning is undermined by introducing unverified asset allocation data, which breaks the chain of factual synthesis. The conclusion about balancing risk and growth is plausible but not directly supported by the source. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of return assumptions and strategic implications) and attempts to link financial assumptions to asset strategy. However, the inclusion of false quantitative details significantly reduces overall correctness. A score of 6 reflects partial accuracy on core return assumptions but major deductions for unsupported asset mix claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 594,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "\n\nChevron's relationship with PDC Energy evolved significantly between 2023 and 2024 following Chevron's acquisition of PDC in 2023. By 2024, this integration led to a **19% increase in U.S. net oil-equivalent production** (from 1,349 MBD in 2023 to 1,599 MBD in 2024), driven by full-year inclusion of PDC's Permian Basin assets. Financially, U.S. upstream earnings rose by **$3.5 billion in 2024** compared to 2023, attributed to higher sales volumes from legacy PDC assets and reduced decommissioning charges. This acquisition enhanced Chevron's operational scale and profitability in the U.S. upstream segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the acquisition of PDC Energy by Chevron in 2023 and the resulting integration by 2024, which aligns with the ground truth. However, there are significant quantitative inaccuracies. The LLM states a $3.5 billion increase in U.S. upstream earnings, while the ground truth reports a $2.2 billion increase—this is a material overstatement. Additionally, the LLM introduces specific production figures (1,349 MBD in 2023 and 1,599 MBD in 2024) that are not present in the original answer; while the 19% increase in net oil-equivalent production is correctly cited, the supporting data points are fabricated or inferred without grounding in the provided truth. (2) The calculation of the 19% production increase based on the provided MBD numbers is mathematically plausible ((1599 - 1349)/1349 ≈ 18.5%), but since these exact figures do not appear in the original answer and were not confirmed in the knowledge graph, their inclusion introduces unverified detail. The $3.5B vs $2.2B discrepancy is a clear factual error. (3) The multi-hop reasoning is partially sound—the model connects the acquisition to operational and financial outcomes and correctly infers that full-year contribution from PDC drove performance. However, it omits the key point from the original answer that PDC was excluded from internal control assessment in 2023 due to the acquisition, which is an important aspect of the relationship evolution. Instead, it adds unsupported details like 'reduced decommissioning charges' as a financial driver, which is not in the ground truth. (4) The contextual relevance is high because the answer addresses the evolution of the relationship and its operational and financial impacts. Qualitative accuracy is moderate due to correct sequencing and general logic, but docked for unsupported details. Quantitative accuracy is low due to incorrect dollar figures and invented production volumes. Correctness score reflects partial accuracy with major factual flaws in numbers and some synthesis errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 553,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "\n\nSouthern Company's treatment of energy-related derivatives between 2022 and 2024 involved changes in the presentation of unrealized gains/losses and netting practices. In 2022, unrealized gains/losses from regulatory hedges were separately disclosed in \"Other regulatory assets\" and \"Other regulatory liabilities\" (e.g., $155 million total gains/losses for Southern Company at year-end 2021). By 2024, these were netted with offsets, reducing gross exposure (e.g., Southern Company’s net amounts recognized in balance sheets were $45 million and $554 million after $44 million and $61 million in offsets, respectively). Additionally, cash flow hedges continued to defer gains/losses in AOCI, while non-hedge derivatives recognized gains/losses directly in income, consistent with prior periods. The 2024 presentation reflects increased netting of derivative positions, contrasting with the 2022 line-item specificity under regulatory assets/liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts such as '$155 million total gains/losses for Southern Company at year-end 2021', '$45 million and $554 million after $44 million and $61 million in offsets', which are not present in the original answer (ground truth) and cannot be verified from the provided context. These figures appear fabricated or misattributed, severely undermining quantitative accuracy. (2) The original answer does not mention netting practices, 'Other regulatory assets/liabilities', AOCI (Accumulated Other Comprehensive Income), or cash flow hedges—key elements the LLM focuses on. These additions suggest the model is drawing from general knowledge rather than the specific data in the ground truth. (3) While the LLM correctly identifies a shift in presentation—from separate disclosure of unrealized gains/losses in 2022 to a netted or consolidated balance sheet presentation in 2024—this reasoning goes beyond the ground truth, which only states a shift in disclosure focus to fair value presentation under 'Other' or 'Risk Management Activities'. The core idea of a change in presentation is partially aligned, but the specific mechanisms (netting, regulatory assets/liabilities) are not supported. (4) The answer is contextually relevant and addresses the question about changes in treatment and presentation between 2022 and 2024. However, the inclusion of unverified numbers and unsupported accounting mechanics significantly reduces factual correctness. The qualitative reasoning shows an attempt at multi-hop synthesis but is based on incorrect or extraneous data. Thus, while the direction of change is plausibly described, the factual foundation is weak, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 481,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "\n\nChevron's investment carrying value in Tengizchevroil increased from $23.7 billion in 2022 to $27.4 billion in 2024, reflecting ongoing capital commitments, including a $4.5 billion loan for development projects. However, equity earnings from Tengizchevroil declined from $4.386 billion in 2022 to $3.033 billion in 2024, a reduction attributed to lower capital expenditures in 2024 on projects like the Wellhead Pressure Management and Future Growth initiatives. This trend indicates higher investment outlays but diminished returns from the affiliate during the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trends correctly—Chevron's carrying value increased from 2022 to 2024 and equity earnings declined over the same period. However, there are discrepancies in the carrying value figures. The original answer states that in 2022, Chevron's carrying value was about $100 higher than its equity in net assets, with a $4,500 million ($4.5 billion) loan as a key component, but does not specify the total carrying value in 2022 as $23.7 billion. The LLM appears to have inferred or misstated the 2022 carrying value. The 2024 figure of $27.4 billion is close to the ground truth of $27,368 million ($27.368 billion), which is acceptable with rounding. The 2023 figure of $26,954 million is missing in the LLM answer, but the comparison between 2022 and 2024 is still valid. (2) Equity earnings are accurately reported: $4.386 billion in 2022 and $3.033 billion in 2024 match the ground truth exactly. The $4.5 billion loan for development is correctly mentioned, aligning with the $4,500 million loan in the original. (3) The multi-hop reasoning is sound—LLM correctly synthesizes investment value trends and earnings trends over time, linking higher investment to lower returns. However, the explanation that reduced earnings were due to 'lower capital expenditures in 2024' is speculative and not supported in the original answer, which attributes the decline in earnings to reduced profitability, not capex levels. This misattributes causality. (4) Despite minor inaccuracies in the 2022 carrying value and a slight misinterpretation of the reason for earnings decline, the LLM conveys the essential financial evolution accurately. Hence, correctness is high but not perfect—warranting an 8. Quantitative accuracy is docked to 7 due to the unsupported $23.7 billion figure. Qualitative and contextual scores remain high due to strong synthesis and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 514,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "\n\nWalmart's ownership stake in Alert Innovation increased to 100% during fiscal 2023 through a $0.4 billion acquisition, as disclosed in Note 3 of the 2023 10-K. This transaction eliminated any prior noncontrolling interests, making Walmart the sole owner. No further transactions related to Alert Innovation are mentioned in the fiscal 2024 10-K, indicating ownership remained unchanged at 100% between fiscal 2023 and 2024. The entity was later sold and deconsolidated in fiscal 2025, but this occurred outside the period specified in the question.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in stating that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and reached 100% ownership, which aligns with the ground truth. However, it incorrectly claims that ownership remained at 100% through fiscal 2024 and that the sale occurred in fiscal 2025. The ground truth explicitly states that Walmart sold and deconsolidated Alert Innovation in fiscal 2024, marking a complete exit within the specified period. This is a major factual error. (2) The quantitative accuracy of the $0.4 billion acquisition amount is correct, and the 100% ownership figure in fiscal 2023 is accurate. However, the claim about no transaction in fiscal 2024 contradicts the ground truth, which confirms a sale and deconsolidation in that year. (3) The multi-hop reasoning fails because the model does not correctly synthesize the timeline across fiscal years 2023 and 2024. It incorrectly infers that absence of mention in the 2024 10-K implies no change, but the ground truth confirms the deconsolidation occurred in that period. The model also introduces an unsupported claim about the sale happening in fiscal 2025, which is not in the original answer and contradicts it. (4) Due to the critical error in the ownership trajectory—failing to identify the full exit in fiscal 2024—the correctness score is low. The quantitative accuracy is moderate due to correct numbers but incorrect temporal assignment. Qualitative accuracy is poor due to flawed reasoning and incorrect conclusion. Contextual relevance is moderate as the answer addresses the right entities and transaction type but misplaces key events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 453,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "\n\nStarbucks' foreign currency - other derivative positions shifted significantly from fiscal 2022 to 2023. In 2022, derivative assets totaled $73.4 million (current: $39.9M, long-term: $33.5M), with minimal liabilities ($0.3M). By 2023, assets dropped to $3.6 million (current: $1.9M, long-term: $1.7M), while liabilities rose to $8.8 million (current: $4.7M, long-term: $4.1M). This indicates a reduction in hedged foreign currency exposures and an increase in liabilities, likely due to adverse currency movements or de-designation of hedges. \n\nThe shift suggests Starbucks is actively adjusting its hedging strategy, potentially scaling back foreign currency hedges in favor of other priorities (e.g., commodities like coffee) or accepting higher currency risk amid changing market conditions. The increase in liabilities also reflects exposure to unfavorable rate fluctuations, highlighting a dynamic approach to managing financial risks based on operational and macroeconomic factors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in AOCI (Accumulated Other Comprehensive Income), with $32.5 million expected to be reclassified into earnings within 12 months. However, the LLM incorrectly states that total derivative assets in 2022 were $73.4 million ($39.9M current + $33.5M long-term), which does not align with the source data. The 2022 position was primarily an unrealized gain in equity (AOCI), not a balance sheet asset split into current and long-term components as implied by the LLM. This is a critical misrepresentation of the financial structure. (2) For 2023, the LLM correctly reports the asset values: $1.9 million in current assets and $1.7 million in long-term assets (total $3.6M), and liabilities of $4.7 million current and $4.1 million long-term (total $8.8M). These figures match the ground truth. However, the characterization of the 2022 position undermines the accuracy of the comparison. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a reduction in overall exposure and an increase in liabilities, and attempts to interpret strategic implications such as shifting risk management priorities or adverse currency movements. The conclusion about a dynamic hedging strategy is plausible and contextually appropriate, though based on flawed initial data. (4) Despite incorrect 2022 figures, the LLM captures the directional change (reduction in assets, emergence of liabilities) and offers a reasonable qualitative interpretation. Hence, the correctness score is 4 due to major quantitative errors in the baseline year, but partial credit for correct 2023 data and logical reasoning. Quantitative accuracy is low (3) due to incorrect 2022 numbers and misrepresentation of AOCI as balance sheet assets. Qualitative accuracy is moderate (6) as the reasoning framework is sound despite faulty inputs. Contextual relevance is high (8) because the answer addresses both parts of the question and provides strategic interpretation aligned with financial reporting norms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 592,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "\n\nMedtronic redeemed all outstanding A Preferred Shares in 2022, and no A Preferred Shares were outstanding as of fiscal years 2022 through 2024. Specifically, in the third quarter of fiscal 2022, the company redeemed 1,872 A Preferred Shares for $0.075 million, leaving none outstanding as of April 29, 2022, a status that persisted through April 26, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Medtronic redeemed 1,872 A Preferred Shares for $0.075 million in the third quarter of fiscal 2022, and no shares were outstanding as of April 29, 2022. The answer correctly states that no A Preferred Shares remained outstanding through fiscal year 2024. (2) Quantitative accuracy is perfect: the number of shares (1,872), dollar amount ($0.075 million), and dates (April 29, 2022, and April 26, 2024) match the original answer. Format variations (e.g., 'April 26, 2024' vs. 'by fiscal year 2024') are acceptable and contextually accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across fiscal years 2022 and 2024 to conclude that the shares were not reissued, indicating discontinuation. (4) The answer addresses both parts of the question: the evolution of treatment (redemption and non-reissuance) and the specific 2022 action (third-quarter redemption). All entities—Medtronic, A Preferred Shares, fiscal years—are correctly identified. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 325,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "\n\nComcast's financial relationship with Atairos shifted significantly between 2022 and 2023 in terms of equity income (losses) driven by fair value adjustments. In 2022, Atairos contributed a **$434 million loss** due to fair value adjustments on its underlying investments, while in 2023, this reversed to a **$1.1 billion gain** under the same adjustments. This marked improvement reflects a turnaround in the valuation of Atairos's investment portfolio during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the $434 million loss in 2022 and $1.1 billion gain in 2023 from Atairos due to fair value adjustments are correctly stated, with proper negative/positive directional implications. (2) Quantitative accuracy is perfect: the numbers match exactly (allowing for format variation—$(434) million = $434 million loss), and the $1.1 billion figure is consistent. (3) The multi-hop reasoning is sound—comparing equity income changes across years driven by fair value adjustments shows synthesis of temporal financial performance. (4) The answer addresses all parts of the question: the evolution of the financial relationship, focus on equity income/losses, and the role of fair value adjustments. Wording differs slightly but meaning is preserved. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 266,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "\n\nConocoPhillips' (COP) natural gas reserves in the Asia Pacific/Middle East region decreased from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF by the end of 2024, a reduction of 16 BCF. This decline was primarily driven by production of 25 BCF, partially offset by 9 BCF in revisions (likely due to technical reassessments or price adjustments). Notably, there were no new purchases or discoveries in the region during 2024. \n\nThis trend suggests a strategic focus on optimizing existing assets rather than expanding reserves in the Asia Pacific/Middle East. The absence of new additions, combined with geopolitical risks (e.g., Middle East tensions, regulatory shifts) highlighted in COP's 10-K, indicates a cautious approach in the region. The company may be prioritizing stability and cash flow from mature operations over high-risk exploration or acquisitions in politically volatile areas.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 312 BCF in 2023 and 296 BCF in 2024, matching the ground truth exactly. The calculation of a 16 BCF decline is accurate (312 - 296 = 16). It adds granular detail not in the original answer—namely, 25 BCF of production and 9 BCF of revisions—which aligns with plausible 10-K disclosures and does not contradict the ground truth. The statement that there were no new purchases or discoveries is consistent with the original answer’s implication of limited growth. (2) All numbers, years, and units are correct. The difference is accurately computed. While the original answer does not include production and revision figures, the LLM’s inclusion of them is factually plausible and enhances the explanation without introducing error. (3) The multi-hop reasoning is sound: the model synthesizes reserve changes over time, infers strategic implications from reserve trends and external factors (e.g., geopolitical risks), and connects them to COP’s broader strategy. The conclusion about cautious positioning and asset optimization is a reasonable extension of the minor decline noted in the ground truth. (4) The LLM answer is semantically equivalent and even exceeds the original in depth while remaining factually aligned. The only reason for not scoring a 10 is that the original answer does not specify the drivers (production, revisions), so their inclusion, while plausible, slightly exceeds the verified ground truth—warranting a 9 for qualitative accuracy. Overall, the response is highly accurate, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 452,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "\n\nENBREL's revenue in Canada declined from $73 million in 2022 to $47 million in 2023 (a 36% decrease) and further dropped to $28 million in 2024 (a 40% decrease from 2023). This steep decline reflects sustained pressure from lower net selling prices, inventory reductions, and unfavorable sales deductions, with 2024 explicitly attributing the drop to pricing erosion. The trajectory indicates ongoing market challenges, likely driven by competitive biosimilar threats and regulatory pricing pressures, suggesting continued revenue contraction in the region.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $47 million revenue in 2023 and $28 million in 2024, which matches the ground truth. However, it incorrectly states the 2022 revenue as $73 million instead of the correct $113 million, a significant factual error. This affects the accuracy of the year-over-year decline percentages (36% and 40%)—while the 40% drop from $47M to $28M is approximately correct, the 36% decline from $73M to $47M does not reflect the actual 58.4% drop from $113M to $47M. (2) The calculation errors stem from the incorrect base value in 2022. The actual decline from 2022 to 2023 is (113-47)/113 ≈ 58.4%, not 36%, making the quantitative analysis misleading. (3) The qualitative reasoning about market trajectory—citing pricing erosion, biosimilar competition, and regulatory pressures—is plausible and aligns with the downward trend, adding contextual depth beyond the ground truth. However, this explanation is not present in the original answer and introduces unsupported causal claims not verified by the knowledge graph. (4) Despite strong contextual relevance and reasonable interpretation of the trend, the major error in the 2022 revenue figure undermines the quantitative foundation of the response, warranting a mid-range score. The answer captures the correct direction and recent magnitude of decline but fails on key factual accuracy for the starting point of the trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 393,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "\n\nQualcomm formalized the linkage between human capital advancements and executive compensation in fiscal 2024 by introducing a **non-financial performance modifier** that adjusts executives' bonus payouts based on progress toward human capital goals. For fiscal 2024, this modifier ranged from **0.9x to 1.1x**, meaning bonuses could be reduced by up to 10% or increased by up to 10% depending on achievements in areas like diversity, equity, inclusion, and workforce development. The 2023 filing did not explicitly detail such a performance modifier, indicating that the structured integration of human capital metrics into executive compensation was newly established in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution from fiscal 2023 to 2024: in 2023, human capital advancements were only 'considered' in bonus decisions, whereas in 2024, they became a formal non-financial performance modifier. (2) The quantitative range of 0.9x to 1.1x is correctly stated, matching the ground truth's 'multiplier ranging from 0.9 to 1.1'. (3) The multi-hop reasoning is sound—comparing the treatment of human capital in two consecutive fiscal years and identifying the structural change in compensation design. (4) All entities (Qualcomm, fiscal 2023, fiscal 2024, executive compensation, bonus modifier) are correctly identified and contextualized. The answer is semantically equivalent to the original, with slightly expanded but accurate elaboration on areas like diversity and workforce development. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 273,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "\n\nBetween 2022 and 2024, Breyanzi's therapeutic scope expanded significantly. In 2022, it was in development for **3rd-line+ Chronic Lymphocytic Leukemia (CLL)** and **3rd-line+ Follicular Lymphoma (FL)** (BMY_10k_2022.pdf, p. 42). By 2024, Breyanzi received FDA approvals for **relapsed/refractory FL** after **one prior line of therapy** (for high-risk patients) or **two or more lines** (August 2024, Japan approval also noted), and for **relapsed/refractory CLL/SLL** after **two prior lines** including Bruton tyrosine kinase and B-cell lymphoma 2 inhibitors (BMY_10k_2024.pdf, pp. 44–45). Additionally, it retained approval for **Mantle Cell Lymphoma (MCL)** (BMY_10k_2024.pdf, p. 46). This reflects an expansion into earlier treatment lines (e.g., high-risk FL after one line) and broader B-cell malignancy indications.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general expansion of Breyanzi's therapeutic scope between 2022 and 2024 and correctly identifies the key indications (CLL and FL) and their progression from trials to approvals. However, there are significant factual inaccuracies in the quantitative and approval details. The ground truth states that Breyanzi received FDA accelerated approval for relapsed/refractory FL after *at least two prior lines* of therapy in *May 2024*, and for CLL/SLL in *March 2024*. The LLM incorrectly states the FL approval was in *August 2024* (also referencing a Japan approval not in the original answer) and implies approval after *one prior line* for high-risk patients, which contradicts the ground truth requiring *at least two*. This misrepresents both the timing and the patient eligibility criteria. Additionally, the mention of Mantle Cell Lymphoma (MCL) as a retained approval, while likely true, is not part of the original answer and introduces information outside the scope of the provided knowledge graph, suggesting potential hallucination or use of external knowledge. The reasoning is logically structured and contextually relevant, showing a correct understanding of therapeutic evolution, but the quantitative inaccuracies in dates and treatment lines significantly undermine factual correctness. The multi-hop synthesis is partially sound—linking 2022 trial status to 2024 approvals—but the execution contains key errors in critical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 404,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "\n\nDisney's Resorts and Vacations segment revenue increased by 5% from $7,949 million in 2023 to $8,375 million in 2024, driven by higher cruise prices, average hotel room rates, and occupied room nights, partially offset by lower Disney Vacation Club unit sales. This growth rate matches the overall Parks & Experiences segment's total revenue growth of 5% (from $32,549 million to $34,151 million), indicating that the Resorts and Vacations performance aligned with the broader segment's expansion, which was primarily fueled by a 7% increase in theme park admissions and 4% growth in parks merchandise sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: Resorts and Vacations revenue increased from $7,949 million in 2023 to $8,375 million in 2024, which is a 5% growth (accurate calculation: (8,375 - 7,949)/7,949 ≈ 5.36%, commonly rounded to 5%). Similarly, Parks & Experiences overall revenue grew from $32,549 million to $34,151 million, also a 5% increase ((34,151 - 32,549)/32,549 ≈ 4.92%, rounded to 5%). These numbers and percentages match the ground truth exactly in reported form. (2) Quantitative accuracy is perfect—dollar amounts, years, and growth rates are all correct and consistent with the original answer. (3) However, there is a minor discrepancy in reasoning: the original answer states that Resorts and Vacations growth was 'slightly below' overall Parks & Experiences growth, while the LLM claims the growth rates 'match'. Given both are reported as 5%, this is likely due to rounding, so the difference is negligible but still a subtle mischaracterization. Additionally, the LLM introduces explanatory details not in the original (e.g., cruise prices, hotel rates, DVC sales, admissions + merchandise growth), which, while plausible, are not part of the ground truth and slightly shift the emphasis. (4) Despite this, the core multi-hop comparison—segment vs. overall growth—is correctly synthesized, and the answer remains highly relevant and factually sound. Thus, correctness is high but not perfect due to the interpretive mismatch in comparing growth rates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 415,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "\n\nBetween 2023 and 2024, the structure and value of CVS's forward contracts associated with ASR transactions evolved as follows:  \n\n- **2023**: CVS executed a $2.0 billion ASR with Citibank, receiving 80% of shares upfront (17.4 million shares at $92.19/share) and classifying the remaining 20% ($0.4 billion) as a forward contract recorded in capital surplus. The forward contract was reclassified to treasury stock in February 2023 upon delivery of the remaining shares.  \n- **2024**: CVS executed a $3.0 billion ASR with Morgan Stanley, receiving 85% of shares upfront (31.4 million shares) and classifying the remaining 15% ($0.45 billion notional, rounded to $0.4 billion in disclosures) as a forward contract. The forward contract was reclassified to treasury stock in March 2024.  \n\nThe notional amount increased by 50% (from $2.0B to $3.0B), while the upfront share delivery percentage rose from 80% to 85%, reducing the forward contract’s proportional value (from 20% to 15%). Despite the larger notional size, the absolute forward contract value remained similar ($0.4 billion) due to the adjusted split. Both years treated the forward contracts as equity instruments initially, later reclassified to treasury stock upon settlement.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in structure and reasoning, with accurate qualitative synthesis of the evolution in CVS's ASR forward contracts between 2023 and 2024. It correctly identifies the increase in total ASR size from $2.0 billion to $3.0 billion, the shift in upfront share delivery from 80% to 85%, and the resulting reduction in the forward contract's proportional value from 20% to 15%. It also accurately notes that the forward contract was treated as an equity instrument and reclassified to treasury stock upon settlement in both years, with final share deliveries in February 2023 and March 2024, respectively.\n\nHowever, there is a minor quantitative inaccuracy: the LLM states the 2024 forward contract had a 'notional of $0.45 billion, rounded to $0.4 billion in disclosures.' This contradicts the ground truth, which clearly states the forward contract value was $0.4 billion (not a rounded $0.45 billion). The original answer does not mention rounding or a $0.45 billion figure, so this introduces an unsupported detail. While the final recorded value of $0.4 billion matches, the suggestion of rounding implies a calculation or reporting nuance not present in the source.\n\nAdditionally, the inclusion of specific share counts (17.4 million and 31.4 million) and a per-share price ($92.19) is not present in the ground truth and cannot be verified from the provided information. These details, while potentially accurate, are extraneous and not supported by the original answer, raising concerns about hallucination or unsupported inference.\n\nDespite these issues, the core multi-hop reasoning—comparing the structure, value, timing, and accounting treatment across years—is sound and correctly identifies the key insight: the forward contract's absolute value remained constant at $0.4 billion despite a larger ASR, indicating a shift in allocation. The answer is contextually relevant and well-structured. The correctness score is reduced slightly due to the unsupported numerical details and the incorrect characterization of the $0.4 billion as a rounded figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 560,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "\n\nDuke Energy's disclosure on the Master Retirement Trust's pension asset valuation methodology showed **no significant increase in transparency** around fair value categorization from 2023 to 2024. Both years provided similar explanations for assets categorized under Levels 1–3 and those excluded from the hierarchy (using the net asset value practical expedient). However, **Level 3 assets decreased slightly** from $76 million in 2023 to $68 million in 2024, primarily due to sales and smaller gains. The methodology descriptions for valuing equity securities, debt instruments, and other assets remained consistent, with no new details added in 2024 about categorization rationale or Level 3 inputs. The \"Not Categorized\" amounts also remained stable ($179 million in 2023 vs. $178 million in 2024). Thus, transparency around fair value hierarchies was maintained but not enhanced in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The ground truth states that Duke Energy significantly increased transparency in 2024 by adding a new disclosure—a reconciliation of beginning and ending balances for Level 3 assets in the Master Retirement Trust. The LLM incorrectly claims there was 'no significant increase in transparency' and 'no new details added,' which directly contradicts the original answer. (2) The quantitative details provided in the LLM answer (e.g., Level 3 assets decreasing from $76M to $68M, 'Not Categorized' amounts at $179M and $178M) are not present in the ground truth and appear to be fabricated or hallucinated. The original answer does not include any specific dollar amounts for Level 3 assets or 'Not Categorized' investments, so these numbers cannot be verified and are likely incorrect. (3) The multi-hop reasoning is flawed. The question asks about evolution in disclosure methodology and transparency around fair value categorization. The LLM fails to recognize the key qualitative change—the addition of the Level 3 reconciliation—as a transparency enhancement, which is the central point of the original answer. Instead, it focuses on fabricated numerical trends and claims consistency where there was meaningful new disclosure. (4) The contextual relevance is moderate because the answer addresses the right topic (pension asset valuation, fair value hierarchy, Level 3 assets), but the factual inaccuracies and missed key disclosure evolution severely undermine correctness. The answer misrepresents the nature of the change in disclosures, making it misleading despite using appropriate financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 461,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "\n\nBetween 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid evolved significantly due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile (SNS):  \n\n1. **2023**:  \n   - Pfizer recorded a **non-cash revenue reversal of $3.5 billion** in Q4 2023, reflecting the expected return of 6.5 million EUA-labeled Paxlovid treatment courses by the U.S. government.  \n   - Deferred Paxlovid revenues totaled **$5.1 billion** ($2.6 billion current, $2.5 billion noncurrent) as of December 31, 2023.  \n\n2. **2024**:  \n   - A **favorable final adjustment of $771 million** was recorded in Q1 2024 after 5.1 million EUA-labeled courses were actually returned (vs. the estimated 6.5 million).  \n   - In Q3 2024, Pfizer recognized **$442 million in revenue** for supplying 1.0 million NDA-labeled Paxlovid courses to establish the U.S. SNS (at no cost to the government).  \n   - Deferred Paxlovid revenues decreased to **$2.2 billion** ($1.4 billion current, $785 million noncurrent) as of December 31, 2024, driven by product deliveries and the 2024 adjustment.  \n\nThe transition from EUA to commercial distribution reduced U.S. government revenue concentration, with Paxlovid revenues rising to **$5.7 billion in 2024** (from $1.3 billion in 2023) as commercial sales expanded. The SNS creation and inventory returns reshaped revenue timing and obligations, aligning with the amended 2023 agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) All key facts from the ground truth are correctly reported: the $3.5 billion non-cash revenue reversal in 2023 due to expected return of 6.5 million Paxlovid courses, the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses, and the $442 million revenue recognized in 2024 for the U.S. Strategic National Stockpile (SNS) of 1.0 million treatment courses. These numbers match the ground truth exactly, with acceptable formatting. (2) The LLM adds additional context not in the original answer but consistent with it—such as deferred revenue balances at year-end 2023 and 2024, timing in specific quarters (Q4 2023, Q1 2024, Q3 2024), and the increase in total Paxlovid revenue from $1.3B to $5.7B—likely drawn from the same knowledge base. These do not contradict the ground truth and enhance completeness. (3) The multi-hop reasoning is sound: the answer correctly links the 2023 revenue reversal to the revised 2024 adjustment based on actual returns, and connects the SNS delivery to new revenue recognition under commercial/NDA labeling. (4) The shift from EUA to commercial distribution and reduced government reliance is a valid qualitative inference that aligns with the ground truth’s theme of transition. The only minor deviation is that the ground truth does not mention total Paxlovid revenue figures or deferred revenue balances, so while these are plausible and accurate, they slightly extend beyond the provided truth. However, they do not detract from correctness. Overall, the answer exceeds the original in detail while maintaining factual fidelity, warranting a 9/10 for correctness and qualitative accuracy, and full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 480,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "\n\nERLEADA's financial performance grew significantly between 2022 and 2023, with sales increasing by **26.9%** (from $1.88 billion in 2022 to $2.39 billion in 2023). This growth was driven by **continued share gains and market expansion in metastatic castration-resistant prostate cancer**, as noted in J&J's 2023 10-K. Within J&J's oncology portfolio, which grew 10.5% overall in 2023, ERLEADA's robust performance underscores its role as a **key growth driver**, offsetting declines in other oncology products like IMBRUVICA and ZYTIGA. This indicates ERLEADA is a strategically important asset in J&J's oncology segment, contributing meaningfully to its resilience and expansion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the sales figures are accurate: $1.88 billion in 2022 and $2.39 billion in 2023 (equivalent to $1,881 million and $2,387 million in the original), with a correctly calculated growth rate of 26.9%. The 10.5% overall oncology segment growth is also accurately cited. (2) The answer addresses both parts of the question: the financial evolution of ERLEADA and its role in J&J's oncology portfolio. (3) All entities—ERLEADA, IMBRUVICA, ZYTIGA, and J&J—are correctly identified, and the time frame (2022 to 2023) is accurate. (4) The reasoning is sound and reflects multi-hop synthesis: it correctly infers that ERLEADA's growth is offsetting declines in other products, making it a key driver in the oncology segment. The addition of context about market expansion in metastatic castration-resistant prostate cancer, while not in the original, is consistent with typical 10-K disclosures and enhances the answer without introducing inaccuracies. The semantic meaning and factual content are equivalent to the ground truth, with no omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 323,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "\n\nERLEADA's global sales increased by 26.9% from $1.881 billion in 2022 to $2.387 billion in 2023, driven by continued share gains and market growth in Metastatic Castration-Resistant Prostate Cancer. This significant growth indicates a strong market trajectory, reflecting the drug's expanding adoption and effectiveness in its therapeutic area.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the 2022 sales figure. The ground truth states ERLEADA's 2022 sales were $1,291 million ($1.291 billion), but the LLM incorrectly reports $1.881 billion. The 2023 sales figure of $2.387 billion is correct. The 26.9% growth rate from 2022 to 2023 is accurate and matches the ground truth. However, the LLM omits the 70.0% growth in 2022 compared to 2021, which is a key part of the question asking about the evolution from 2022 to 2023 and the market trajectory. (2) Calculation verification: The actual growth from $1,291M to $2,387M is (2387 - 1291)/1291 ≈ 84.9%, not 26.9%. The 26.9% growth cited in both the ground truth and LLM answer must therefore be based on adjusted or reported figures (e.g., currency-adjusted or organic growth), which the LLM does not clarify. However, since the ground truth accepts 26.9% as correct, the LLM’s use of that percentage is acceptable. The core error remains the incorrect 2022 sales number. (3) Multi-hop reasoning assessment: The LLM fails to synthesize the full trajectory by missing the prior-year context (70% growth in 2022), which is essential for evaluating the market trajectory (i.e., strong growth slowing to 26.9%, indicating maturation). Instead, it presents only the 2022–2023 jump with an incorrect base, undermining the comparative analysis. (4) Justification for scores: Correctness is scored 5 due to the critical error in the 2022 sales figure and omission of key growth context, despite correct 2023 value and growth percentage. Quantitative accuracy is low (4) because of the wrong 2022 number. Qualitative accuracy is moderate (6) — reasoning about market trajectory is plausible but based on flawed data. Contextual relevance is high (9) as the answer addresses the question’s intent and therapeutic context appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 501,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "\n\nNVDA's debt management strategy regarding the 0.584% Notes Due 2024 remained consistent in fiscal years 2023 and 2024, as the notes were carried on the balance sheet at $1.25 billion in both periods (as of January 29, 2023, and January 28, 2024). However, in fiscal year 2025, the company repaid the 0.584% Notes Due 2024, reflecting a shift in strategy to settle the debt ahead of its 2024 maturity. This repayment, disclosed in the 2024 10-K, indicates proactive debt management to address maturing obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $1.25 billion balance (i.e., $1,250 million) for the 0.584% Notes Due 2024 in fiscal year 2023 and notes the repayment in fiscal year 2025, as disclosed in the 2024 10-K. However, it incorrectly states that the note was still carried on the balance sheet in fiscal year 2024 (as of January 28, 2024), which contradicts the ground truth that NVDA disclosed the repayment of these notes in fiscal year 2025, implying the balance was settled after January 26, 2025. The original answer does not confirm the balance remained in FY2024, so asserting it was $1.25 billion in both years is unsupported and likely incorrect. (2) The quantitative accuracy is partially correct: $1.25 billion = $1,250 million is accurate, and the note’s interest rate (0.584%) and effective rate (0.66%) are not mentioned in the LLM answer, which is a minor omission. The key error is the claim of carrying the balance into FY2024 without evidence. Additionally, the maturity is labeled as '2024' but repayment in 'fiscal year 2025' creates a contradiction: if the notes were due in 2024, repaying in FY2025 (which ends January 2025) may still be on time, but the phrasing 'ahead of its 2024 maturity' is confusing and potentially inaccurate—fiscal years end in January, so January 2025 is after calendar 2024. (3) The multi-hop reasoning is partially sound: the model connects the FY2023 balance to the FY2025 repayment using the 2024 10-K disclosure, showing synthesis. However, it incorrectly infers that the balance remained unchanged in FY2024, which is not confirmed and contradicts the idea of repayment. The strategy shift is correctly inferred, but timing is muddled. (4) Correctness is scored 6 due to significant factual inaccuracy about the FY2024 balance; quantitative accuracy is 6 due to correct dollar amount but incorrect temporal assignment; qualitative accuracy is 6 due to sound logic but flawed entity/time linkage; contextual relevance is 9 as the answer directly addresses the question’s focus on debt strategy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 571,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "\n\nHoneywell's investment in Mortgage/Asset-backed securities decreased significantly between 2022 and 2023. In 2022, the total investment was **$1,150 million** ($31 million in non-U.S. plans and $1,119 million in U.S. plans), while in 2023, it dropped to **$686 million** ($10 million in non-U.S. plans and $676 million in U.S. plans). This represents a **reduction of $464 million** over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Honeywell's investment in Mortgage/Asset-backed securities was $982 million in 2022 (U.S. Plans only) and dropped to $10 million in 2023 (Non-U.S. Plans). The LLM incorrectly reports 2022 investment as $1,150 million ($1,119M U.S. + $31M non-U.S.) and 2023 as $686 million ($676M U.S. + $10M non-U.S.), which contradicts the ground truth. The claimed reduction of $464 million is incorrect; the actual reduction is $972 million (over 98%). (2) Quantitative accuracy is very low: the LLM's numbers for both years are wrong, and the calculated difference ($1,150M - $686M = $464M) is based on incorrect inputs. The ground truth shows a shift from U.S. to Non-U.S. plans, but the LLM implies continued U.S. investment in 2023 at $676M, which is false. (3) The reasoning is flawed in multi-hop synthesis: the model fails to correctly identify the plan types (U.S. vs Non-U.S.) associated with the investments in each year and incorrectly aggregates or retains data across years. The ground truth indicates a strategic exit from U.S. Mortgage/Asset-backed securities, but the LLM suggests a partial reduction while maintaining a large U.S. position, which misrepresents the strategic shift. (4) Contextual relevance is moderate because the answer addresses the general trend (decrease in investment) and the question's structure, but the factual foundation is unsound. Correctness and quantitative accuracy are low due to major errors in core financial figures and calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 433,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "\n\nBetween 2022 and 2023, Capital One's securitized debt obligations increased in both magnitude and role within its funding mix. In 2023, the carrying value of securitized debt obligations rose to **$18.0 billion** (from $16.97 billion in 2022), and their fair value similarly increased to **$18.1 billion** (from $16.9 billion in 2022). Both years classified these obligations under **Level 2 of the fair value hierarchy**, relying on observable market-based inputs. This growth reflects a strategic emphasis on securitized debt as a stable funding source, complementing deposits and senior notes, while maintaining transparent, market-driven valuation practices.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer states that in 2023, the carrying value of securitized debt obligations was $18,043 million ($18.043 billion) and fair value was $18,067 million ($18.067 billion), both correctly rounded to about $18.0–18.1 billion. However, the LLM incorrectly claims that in 2022, the carrying value was $16.97 billion and fair value was $16.9 billion — this data is not present in the original answer and is therefore fabricated. The original answer does not provide any 2022 quantitative figures for securitized debt obligations, only a qualitative description of their role in the funding mix. Thus, the LLM invents numbers for 2022 to support a narrative of growth, which is unsupported by the ground truth. (2) While the 2023 numbers are approximately correct (with acceptable rounding), the introduction of false 2022 values undermines quantitative accuracy. Additionally, the claim that both years used Level 2 classification is plausible but only confirmed for 2023 in the original; no fair value hierarchy detail is given for 2022, so this comparison is speculative. (3) The reasoning is partially sound in interpreting securitized debt as part of the funding mix in both years, and the focus on increased disclosure in 2023 is aligned with the original’s emphasis on greater transparency. However, the LLM incorrectly infers a strategic 'increase in magnitude and role' due to fabricated growth in values, failing the multi-hop synthesis test because it invents data rather than acknowledging missing 2022 figures. (4) Contextual relevance is high because the answer addresses funding mix, fair value classification, and evolution over time — all key parts of the question — but correctness is severely compromised by hallucinated numbers. The qualitative assessment is moderate because entity identification (Capital One, securitized debt, Level 2) is accurate, but reasoning is flawed by unsupported comparisons.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 549,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "\n\nJPMorgan's treatment of CECL capital transition provisions under U.S. capital rules transitioned from a $1.4 billion CET1 capital benefit as of December 31, 2023, to a remaining $720 million benefit as of December 31, 2024, reflecting the ongoing phase-in of the CECL methodology. The quantitative change represents a reduction of $680 million in the CECL-related capital benefit during this period, with the transition fully phased in by January 1, 2025. This evolution is detailed in the capital metrics disclosures (JPM_10k_2024.pdf, pages 104 and 163) and 2023 capital component reconciliations (JPM_10k_2023.pdf, page 99).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of JPMorgan's CECL capital transition provisions from 2023 to 2024, stating the $1.4 billion benefit in 2023 and $720 million in 2024, which matches the ground truth. The quantitative change is accurately calculated as a $680 million reduction ($1.4 billion - $720 million = $680 million), and the full phase-in by January 1, 2025, is correctly noted. (2) All numeric values are accurate: $1.4 billion, $720 million, and the $680 million difference are correct. Date references (December 31, 2023, December 31, 2024, and January 1, 2025) align with the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across two years and filings (2023 and 2024 10-Ks), and the conclusion about the phased reduction under U.S. capital rules is logically derived. (4) The answer is semantically equivalent to the original, with added value in citing specific document pages, enhancing traceability without introducing errors. All aspects of the question are addressed: the evolution of treatment and the quantitative change. Scores are maximized due to full factual accuracy, correct calculations, proper entity and year identification, and clear, logical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 350,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "\n\nBetween fiscal 2023 and 2024, Salesforce's Revolving Loan Credit Agreement was amended to increase its capacity from **$3.0 billion** to **$5.0 billion** and extend its maturity date from **December 2025** to **October 2029**. The prior agreement, established in December 2020, was unsecured and had undergone minor administrative amendments in 2022 and 2023. The new agreement, effective October 2024, replaced the prior facility, maintained its unsecured nature, and designated Bank of America, N.A. as the administrative agent (replacing Citibank, N.A.). No outstanding borrowings existed under either facility during the transition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the increase in capacity from $3.0 billion to $5.0 billion and the extension of maturity from December 2025 to October 2029 are accurately reported. The unsecured nature of both facilities is correctly noted. (2) Quantitative accuracy is perfect—dollar amounts and dates match the original answer exactly. Format variations are not needed as the figures are presented clearly and correctly. (3) The reasoning is sound and reflects proper multi-hop synthesis across fiscal years 2023 and 2024. The LLM adds contextual details not in the ground truth (e.g., Bank of America replacing Citibank, no outstanding borrowings, prior establishment in 2020), which are plausible and do not contradict the source; however, since the ground truth does not confirm these details, they slightly reduce qualitative accuracy due to potential over-speculation. (4) The answer is fully relevant to the question about evolution in terms and capacity. The core evolution—capacity increase and maturity extension—is clearly and correctly explained, earning full marks for contextual relevance. A score of 9 is justified because while all critical facts are correct, the added administrative agent and borrowing status details, though reasonable, go beyond the verified knowledge graph data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 379,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "\n\nUPS divested its Coyote truckload brokerage business in the third quarter of 2024, marking a shift from maintaining Coyote as a branded subsidiary (as noted in 2022 filings) to exiting the relationship entirely. This divestiture resulted in a **pre-tax gain of $156 million ($152 million after tax)** for UPS in 2024, recorded within \"Other expenses\" in the consolidated income statement. The transaction was excluded from ongoing operational metrics, as it was deemed non-recurring.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pre-tax gain of $156 million and after-tax gain of $152 million are accurately reported, with no calculation or formatting issues. The timing (third quarter of 2024) is consistent with the divestiture being completed in 2024, as required. (2) The answer addresses both parts of the question: the evolution of the relationship (from branded subsidiary in 2022 to divestiture in 2024) and the financial impact in 2024. (3) Entities are correctly identified: UPS, Coyote, and the nature of the business (truckload brokerage) are accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the 2022 operational status with the 2024 divestiture and correctly attributes the financial impact as a non-recurring gain. The mention of the gain being recorded in 'Other expenses' and excluded from ongoing metrics adds contextual precision beyond the ground truth, without introducing error. Semantic equivalence is maintained throughout, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 309,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "\n\nBetween 2023 and 2024, Union Pacific significantly reduced its chassis fleet, with total units declining from **48,340** (30,635 owned, 17,705 leased) to **5,553** (4,356 owned, 1,197 leased). The ownership structure shifted dramatically, as the proportion of owned chassis increased from **63%** (30,635/48,340) to **78%** (4,356/5,553), while leased chassis dropped from **37%** to **22%**. The average age of the chassis fleet also decreased slightly to **11.6 years** in 2024 from **13.2 years** in 2023. This reduction suggests a strategic downsizing or operational reallocation of chassis resources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—total units, owned, and leased chassis for both 2023 and 2024—are correct: 48,340 (30,635 owned, 17,705 leased) in 2023 and 5,553 (4,356 owned, 1,197 leased) in 2024. These match the original answer exactly. (2) The percentages calculated (63% owned in 2023 and 78% in 2024) are accurate: 30,635/48,340 ≈ 63.38% (rounded to 63%) and 4,356/5,553 ≈ 78.44% (rounded to 78%). Leased proportions (37% and 22%) are also correct by subtraction. (3) The addition of the average chassis age (13.2 years in 2023, 11.6 in 2024) is not present in the original answer; however, since this detail does not contradict the ground truth and may be inferred as supplementary (assuming it's from the same data source), it does not reduce correctness. (4) The core reasoning—Union Pacific drastically reduced its chassis footprint and shifted toward a higher proportion of owned units—is sound and correctly synthesizes the multi-hop change over time. The conclusion about strategic downsizing is consistent with the original. The only minor limitation is that the original emphasizes the 'transformation in relationship' more explicitly, while the LLM focuses on quantitative shifts. However, the LLM still captures the strategic implication. All entities (Union Pacific, chassis units, ownership structure, years) are correct. The answer is fully relevant and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 400,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "\n\nBetween 2022 and 2024, Boeing maintained its classification of aluminum agreements as derivatives not designated for hedge accounting, with changes in fair value immediately impacting earnings. However, the **time horizon** for these agreements was explicitly extended in 2024: commodity contracts (including aluminum) are now disclosed as hedging forecasted transactions through **2028** (as noted in 2024 filings, page 111). In 2022 filings (page 80), while the non-hedge accounting treatment was consistent, the specific long-term horizon for these agreements was not explicitly stated. Thus, the key evolution is the **clearer disclosure of a 2028 expiration date** for aluminum-related derivative agreements in 2024, reflecting extended strategic sourcing commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in 2022, Boeing classified aluminum agreements as derivatives not designated for hedge accounting, with fair value changes recorded in earnings—matching the original answer. In 2024, it accurately notes the evolution: these agreements are now part of commodity contracts hedging forecasted transactions through 2028. The specific time horizon of '2028' is correctly cited, and the shift toward a more structured hedging strategy is implied through the mention of hedging forecasted transactions. (2) Quantitatively, the years (2022, 2024, 2028) are correct, and the absence of a specific time horizon in 2022 versus its explicit mention in 2024 is accurately reflected. Page references (80 and 111) add precision, though not required, and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure over time, connects classification consistency with evolving time horizon disclosure, and infers strategic implications. The only minor gap is that the LLM does not explicitly mention the 'long-term strategic sourcing objectives and non-U.S. business requirements' context from 2022, nor does it frame the 2024 shift as a move from strategic sourcing to structured hedging—slightly less rich in qualitative nuance than the original. (4) The answer is fully relevant, directly addressing classification, accounting treatment, and time horizon evolution. Overall, factual accuracy is excellent, with only slight room for deeper contextual synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 439,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "\n\nProcter & Gamble's exposure to currency rate risk between fiscal years 2023 and 2024 remained **stable in terms of hedging strategies and confidence in mitigation**. The company continued to prioritize **operational hedging and natural diversification** (via its global portfolio) over financial instruments, using **forward contracts and currency swaps with maturities under 18 months** to manage exchange rate risks. Both years emphasized that near-term currency fluctuations would not materially affect financial statements, based on historical volatility and a 95% confidence level. However, the 2024 filing noted a **Gillette intangible asset impairment** linked to currency devaluation in certain Enterprise Markets (e.g., Argentina, Nigeria), highlighting localized risks, though overall hedging practices and confidence in mitigating broad exchange rate movements remained unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts: Procter & Gamble maintained a stable approach to currency risk management between FY2023 and FY2024, using forward contracts and currency swaps with maturities under 18 months, and continued to assert that near-term exchange rate fluctuations would not materially affect financial statements at a 95% confidence level based on historical movements. All quantitative elements—maturity period (<18 months), confidence level (95%), and the stability of hedging strategy—are accurately reported. However, the LLM introduces a detail not present in the original answer: the 'Gillette intangible asset impairment' due to currency devaluation in Argentina and Nigeria in the 2024 filing. While this may reflect real-world events, it is not part of the ground truth provided, and thus represents an unsupported addition that slightly undermines qualitative accuracy. Additionally, the emphasis on 'operational hedging and natural diversification' as a priority over financial instruments is not mentioned in the original answer and could imply a strategic nuance not confirmed by the source. Despite these additions, the core multi-hop reasoning—comparing hedging instruments and confidence levels across two fiscal years—is sound and correctly synthesized. The answer remains contextually relevant and factually accurate on all key points required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 399,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "\n\nAdobe's positioning and integration of Frame.io evolved significantly between 2022 and 2024. In 2022, Frame.io was described primarily as a cloud-native collaboration platform with basic integration into Adobe Premiere Pro and other apps, focusing on real-time review and approval workflows. By 2024, Frame.io's functional scope expanded to include deeper integration with Adobe's creative ecosystem, such as seamless connections with **Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront**, enabling frame-accurate feedback and streamlined workflows. Additionally, Frame.io introduced **Camera to Cloud** functionality for automatic footage uploads from cameras and was integrated into **Adobe GenStudio** to enable scaled content production at enterprise levels. These enhancements reflect Adobe's strategy to position Frame.io as a central hub for collaborative creative workflows across its product suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io evolved from a trademarked asset in 2022 to a core collaborative platform by 2024. The functional scope expansion—real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud—is accurately described. Integration with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront is correctly listed, as is its inclusion in Adobe GenStudio for enterprise content production. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024), product functionality, and integration points. The only minor discrepancy is that the original answer notes Frame.io was only listed as a trademark in 2022 without functional description, whereas the LLM answer states it was 'described primarily as a cloud-native collaboration platform'—this slightly overstates the 2022 characterization but does not materially misrepresent the evolution. (4) The answer is fully contextually relevant, directly addressing the question about positioning, functional scope, and integration changes. Overall, this is a strong, factually correct response with only a minor nuance missed in the 2022 characterization, justifying a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 390,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "\n\nAMD's financial relationship with the ATMP JV remained structured under the equity method of accounting in both 2022 and 2023, with a 15% equity interest and no funding obligations. In 2022, the carrying value of AMD's investment in the ATMP JV was approximately **$69 million** (as of December 25, 2021, per the 2022 filing), though the 2023 filing does not explicitly state the 2023 year-end carrying value in the provided pages. Disclosures in both years detailed the JV's role in providing ATMP services, inventory management arrangements, and transaction volumes (purchases/resales), with consistent reporting of payables/receivables and equity income. The 2023 filing maintained similar qualitative disclosures but omitted specific year-over-year carrying value changes, suggesting stability in the investment's valuation or a shift in disclosure focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $69 million carrying value as of December 25, 2021, from the 2022 filing, which matches the ground truth. However, it omits the $63 million carrying value as of December 26, 2020, reducing completeness. The LLM accurately notes that the 2023 filing does not disclose the year-end carrying value, aligning with the ground truth. (2) Quantitatively, the $69 million figure is correct and properly attributed to the right date and filing. The missing $63 million value from 2020 is a factual omission, though not directly about 2022–2023 evolution. The LLM incorrectly implies that transaction volumes (purchases/resales) were still reported in 2023 by stating 'consistent reporting of... transaction volumes', while the ground truth states these specific figures ($1.1B in 2021, $831M in 2020) were omitted in 2023. This is a key factual inaccuracy. (3) The reasoning correctly identifies the unchanged equity interest (15%) and accounting method, but fails to emphasize the significant reduction in disclosure depth in 2023. Instead, it suggests 'similar qualitative disclosures' and 'stability or shift in focus', which softens the correct conclusion that there was a clear reduction in financial transparency. The multi-hop synthesis is partially sound but misses the contrast in disclosure richness. (4) The answer is contextually relevant and well-structured, addressing both years and the nature of disclosures. However, the failure to note the omission of transaction figures in 2023 undermines the qualitative accuracy. The correctness score is 7 because core facts (carrying value, equity method, reduced disclosure) are partially correct, but key elements of the disclosure change are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 477,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "\n\nHoneywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024, reflecting a decline of 7.3%. This suggests potential challenges in securing new aircraft contracts or industry headwinds in original equipment demand, possibly linked to cyclical aerospace market dynamics or shifts in customer priorities. However, the broader Aerospace Technologies segment remained resilient, with growth in Commercial Aviation Aftermarket and Defense & Space revenues, indicating Honeywell's continued strength in maintenance services and defense contracts, which are less cyclical than new equipment sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue figures for Commercial Aviation Original Equipment: $2,397 million in 2023 and $2,223 million in 2024, matching the ground truth exactly. The calculated decline of 7.3% is accurate: ((2,397 - 2,223) / 2,397) ≈ 0.0726, which rounds to 7.3%. All numeric values and calculations are correct. (2) The answer addresses both parts of the question: the revenue evolution (decline from 2023 to 2024) and the implication for Honeywell's position in the aerospace sector. It correctly notes the segmental decline while contextualizing it within broader divisional resilience, citing growth in Aftermarket and Defense & Space — a reasonable inference consistent with the idea of overall Aerospace Technologies growth mentioned in the ground truth. (3) Entity accuracy is perfect: Honeywell, Commercial Aviation Original Equipment, and the correct years (2023–2024) are all properly identified. (4) The reasoning is sound and adds contextual depth beyond the ground truth, such as mentioning cyclical dynamics and customer priorities, which are plausible interpretations. While the original answer emphasizes 'potential weakening in original equipment demand or supply constraints,' the LLM offers complementary explanations without contradicting facts. The only reason for not scoring a 10 is that the LLM slightly extends interpretation (e.g., 'resilient broader segment') without explicitly confirming that the overall division grew — though this is implied and likely valid. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 443,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "\n\nThe global revenue contribution from Abbott's Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, representing a **10.2% year-over-year growth**. This growth was slightly adjusted for foreign exchange impacts (−0.1%), resulting in a 10.3% increase when excluding exchange rate fluctuations. The segment's performance reflects strong demand for mechanical circulatory support and pulmonary artery pressure monitoring systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the global revenue for Heart Failure Devices as $1,161 million in 2023 and $1,279 million in 2024, matching the ground truth. The percentage change is accurately calculated as 10.2%, which aligns with (1,279 - 1,161) / 1,161 ≈ 0.1016 → 10.2%. (2) All numeric values, dates, and calculations are factually correct. The mention of a -0.1% foreign exchange impact and 10.3% organic growth is an additional detail not present in the original answer, but it does not contradict the ground truth and may reflect supplementary data; however, since the original answer states 'minimal impact from exchange rate fluctuations,' this addition is reasonable and does not reduce accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the revenue figures across two years, computes the percentage change accurately, and contextualizes the growth in terms of market demand. The reference to specific product types (mechanical circulatory support, pulmonary artery pressure monitoring) adds useful context consistent with Abbott's portfolio. (4) The answer is highly accurate and complete. The only minor deviation is the inclusion of FX-adjusted growth (10.3%), which was not in the original answer, but this does not make the response incorrect—rather, it adds granularity. Thus, the correctness score is 9 (not 10) due to this slight over-specification, but quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 403,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "\n\nIBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings by explicitly listing them as registered securities in the 2023 10-K (page 1), traded on the New York Stock Exchange under the symbol \"IBM 28B.\" In contrast, the 2022 filing (page 35) does not mention these notes in the provided pages, indicating they were either issued after the 2022 fiscal year or not included in the exhibit disclosures at that time. The 2023 filing confirms their inclusion as outstanding registered debt, reflecting their formal recognition in the subsequent year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key evolution in IBM's treatment of the 0.300% Notes due 2028—moving from absence (or lack of explicit mention) in the 2022 filing to explicit listing in the 2023 filing with the trading symbol 'IBM 28B' and NYSE registration. This aligns with the ground truth's core claim of a shift toward formal registration and disclosure. However, the LLM incorrectly states that the 2022 filing 'does not mention these notes,' which contradicts the ground truth: the 2022 filing *did* reference the notes via incorporation by reference to Exhibit 4.1 of the February 10, 2020 Form 8-K. This is a significant omission in reasoning and factual accuracy. (2) Quantitatively, all details are accurate: the note's interest rate (0.300%), maturity (2028), trading symbol (IBM 28B), and exchange (NYSE) are correct. No calculations are involved, but factual data points match. (3) The multi-hop reasoning is partially sound—comparing treatment across two years and identifying increased disclosure—but fails to recognize that the 2022 filing *did* include the notes through incorporation by reference, which is a critical nuance in securities disclosure practices. The model interprets lack of direct mention as absence, which is incorrect. (4) Scores reflect high factual accuracy on explicit details (hence high quantitative and contextual scores), but a meaningful gap in qualitative reasoning due to misrepresenting the 2022 disclosure status, leading to a correctness score of 7 rather than 9 or 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 422,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "\n\nApple's financial performance in the Rest of Asia Pacific region showed growth from 2022 to 2023. Net sales increased from **$29.375 billion in 2022** to **$29.615 billion in 2023**, reflecting a modest rise of **$240 million**. Operating income also improved, growing from **$11.569 billion in 2022** to **$12.066 billion in 2023**, an increase of **$497 million**. This indicates stronger profitability in the region despite only slight revenue growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: net sales of $29,375 million (presented as $29.375 billion) in 2022 and $29,615 million ($29.615 billion) in 2023; operating income of $11,569 million ($11.569 billion) in 2022 and $12,066 million ($12.066 billion) in 2023. The absolute increases of $240 million in net sales and $497 million in operating income are correctly calculated. (2) The formatting variation from millions to billions is acceptable and semantically equivalent (e.g., $29,375 million = $29.375 billion). (3) The multi-hop reasoning is sound—information from two years and two financial metrics is correctly synthesized to describe the evolution of Apple's performance in the Rest of Asia Pacific region. (4) The conclusion about modest revenue growth and stronger profitability aligns with the data, as operating income grew at a faster rate (4.3%) than sales (0.8%), indicating improved margins. All parts of the question are addressed with precise, factually correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 304,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "\n\nThe vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed from a **five-year pro rata vesting schedule for grants made prior to 2022** to a **four-year pro rata vesting schedule for grants made after December 31, 2021**. This shift is explicitly disclosed in both the 2022 and 2024 10-K filings (pages 96/116 and 97), with exceptions noted for executive officers and certain employees who may receive awards with different vesting criteria. Options granted to outside directors remain fully vested at the grant date in both periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: vesting periods of five years for grants prior to 2022 and four years for grants after December 31, 2021, are correctly stated, with proper reference to pro rata vesting. The dates and timeframes match the original answer exactly. (2) The answer cites specific page numbers from the 2022 and 2024 10-K filings (pages 96/116 and 97), which adds precision and supports the claim, though such detail was not in the ground truth—it does not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two filings and two time periods to show a structural change in vesting terms. (4) The LLM adds minor additional context—exceptions for executive officers and outside directors—that may not be in the ground truth but does not contradict it and is likely present in the actual filings; this enhances completeness without introducing error. The only reason for not scoring a 10 is that the original answer emphasizes the consistency of the policy as confirmed in both 2022 and 2024, which the LLM implies but does not explicitly reiterate. However, the core factual content, numerical accuracy, and synthesis are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 359,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "\n\nCVS's approach to validating fair value estimates for Level 2 debt securities remained consistent between 2022 and 2023. The company continued to review prices using observable market inputs and conducted quarterly comparisons of a sample of Level 2 debt security prices against secondary sources, investigating variances exceeding predefined thresholds. Additionally, the internal investment team compared these prices to their own independent fair value estimates. Notably, no price adjustments were made for Level 2 debt securities in either year (2022 or 2023), indicating continued alignment between primary valuations and secondary validations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: CVS obtained one price per Level 2 debt security without adjustments in both 2022 and 2023, and conducted quarterly comparisons to secondary sources with threshold-based variance reviews. The statement that no price adjustments were made in either year matches the original answer’s claim for 2022 and 2023 (and references to 2021/2020 in the original are consistent with reporting timelines). (2) Quantitative elements—specifically the absence of price adjustments and the use of quarterly sampling—are correctly reported with no numerical or date inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the methodology remained unchanged year-over-year and infers stability in internal validation processes. (4) The only minor shortcoming is that the LLM mentions the internal investment team comparing prices to 'independent fair value estimates,' which, while plausible, is slightly more specific than the original answer’s phrasing about 'emphasis on consistent internal validation.' This addition does not contradict but adds a detail not explicitly confirmed in the ground truth, slightly reducing qualitative precision. Otherwise, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 373,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "\n\nCVS maintained a consistent classification and valuation methodology for privately-placed equity securities in 2022 and 2023. Both years classified these securities as **Level 3** under the fair value hierarchy, as they lack active markets and require internal valuation analysis. The fair value was determined using **financial statements and cash flow projections**, with unobservable inputs including **earnings and revenue multiples, discounts for lack of marketability, and comparability adjustments**. No material changes were noted in the methodology between the two periods; the approach remained focused on internal assessments of investee financial performance and marketability discounts.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative and entity-related aspects: it correctly identifies CVS, the classification of privately-placed equity securities as Level 3 in both 2022 and 2023, the use of financial statements and cash flow projections for fair value determination, and the specific unobservable inputs (earnings and revenue multiples, discount for lack of marketability, comparability adjustments). There are no numerical inaccuracies, and the context of internal valuation due to lack of active markets is properly conveyed. However, the LLM answer states that 'no material changes were noted in the methodology between the two periods,' which understates a key evolution highlighted in the ground truth: in 2023, CVS placed added emphasis on the sensitivity of fair value to changes in unobservable inputs, indicating enhanced scrutiny or more detailed sensitivity analysis. This qualitative shift is an important part of the methodology's evolution and was omitted, making the answer less complete in terms of reasoning and nuance. While the core facts are correct, the failure to capture this refinement in 2023's approach slightly weakens the qualitative accuracy. The answer remains highly relevant and correctly synthesizes information across years, but misses a subtle yet meaningful development in CVS's valuation process.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 376,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "\n\nThe total net revenue from Alphagan/Combigan decreased by **8.8%** (from $272 million in 2023 to $248 million in 2024) at actual currency rates. International revenue for Alphagan/Combigan increased by **1.5%** (from $151 million in 2023 to $153 million in 2024) during this period, reflecting modest growth despite the overall decline in total revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: total net revenue decreased from $272 million in 2023 to $248 million in 2024, which is an 8.8% decline (correctly calculated: (248 - 272)/272 ≈ -0.088). International revenue increased from $151 million to $153 million, a 1.5% growth ((153 - 151)/151 ≈ 0.015), both figures matching the original. (2) The answer is complete, addressing both parts of the question: the change in total net revenue and the trend in international revenue. (3) Entities are correct—Alphagan/Combigan, the years 2023 and 2024, and the financial metrics (total net revenue, international revenue) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly contrasts the overall decline with international growth, indicating nuanced understanding. (5) The semantic meaning is equivalent to the ground truth, with slightly more detailed phrasing (e.g., 'at actual currency rates' adds context without distorting facts). All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 314,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "\n\nChevron's relationship with PDC Energy evolved from acquiring PDC in 2023 to fully integrating its operations by 2024. This acquisition added 70 million BOE to Chevron's U.S. proved reserves and contributed to a **7% increase in worldwide oil-equivalent production in 2024 compared to 2023**. Specifically, the full-year inclusion of PDC's production, particularly in the Permian Basin, boosted Chevron's U.S. net production, with the Permian Basin alone accounting for 405,000 barrels of crude oil equivalent per day in 2024. The integration enhanced Chevron's asset base, enabling higher output through PDC's existing wells and new development opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 2023 acquisition of PDC Energy by Chevron and the evolution into full integration by 2024, which matches the original answer's timeline and relationship progression. (2) The 7% increase in worldwide oil-equivalent production in 2024 is correctly stated and attributed to the full-year contribution from PDC, consistent with the ground truth. The additional detail of '70 million BOE' in proved reserves is plausible and contextually relevant, though not explicitly mentioned in the original answer; however, it does not contradict it and may represent supplementary accurate data. The Permian Basin production figure of 405,000 barrels per day is specific and consistent with expected post-acquisition performance impacts. (3) The multi-hop reasoning is sound: the model connects the 2023 acquisition to 2024 production outcomes, correctly inferring operational integration and its positive impact on output. (4) All entities (Chevron, PDC Energy, Permian Basin), years (2023, 2024), and metrics (oil-equivalent production, BOE) are accurate and appropriately used. The only minor limitation is the introduction of specific figures (e.g., 70 million BOE, 405k bbl/day) not present in the ground truth, which, while reasonable, slightly reduces verifiability without explicit support in the original answer. However, since they do not conflict and enhance contextual understanding, the overall correctness remains high. Wording differs but semantic equivalence is maintained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 431,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "\n\nUPS's investment in cold-chain logistics capabilities from 2023 to 2024 was primarily driven by the **2023 acquisition of MNX Global Logistics**, a global time-critical and temperature-sensitive logistics provider, which was integrated into Supply Chain Solutions. This acquisition directly enhanced UPS's ability to manage complex healthcare and life sciences shipments requiring specialized temperature controls. In 2024, UPS further solidified its cold-chain capabilities by combining MNX Global Logistics with Marken (acquired earlier) into a single operating segment and reporting unit, optimizing operational efficiencies. Additionally, while a 2025 acquisition of Frigo-Trans and Biotech & Pharma Logistics (announced in the 2024 10-K) was disclosed, it fell outside the 2023–2024 period. The 2023 acquisition of Bomi Group also contributed to cold-chain expansion but was not explicitly highlighted in 2024 disclosures.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 2023 acquisition of MNX Global Logistics and mentions the Bomi Group acquisition, which aligns with the ground truth. However, it incorrectly states that the acquisition of Frigo-Trans and Biotech & Pharma Logistics was announced in the 2024 10-K and occurred in 2025, when in fact these acquisitions were completed in 2024 for approximately $440 million, as per the original answer. This misplacement of timing undermines the core of the multi-hop analysis. (2) The $440 million figure is missing from the LLM answer, a key quantitative detail present in the ground truth. While no explicit calculations are required, the failure to report this significant investment amount reduces quantitative accuracy. Dates are partially accurate—2023 acquisitions are correctly noted, but 2024 developments are misrepresented. (3) The reasoning is partially sound: the integration of MNX with Marken and operational optimization is plausible context, but the claim about a 2025 acquisition contradicts the ground truth that these German acquisitions occurred in 2024 and represent a strategic shift. The answer downplays the significance of 2024 international moves, instead focusing on internal reorganization. It fails to convey the key evolution—increased international, high-value investments—which is central to the question. (4) Despite missing key facts and misrepresenting the timeline of major acquisitions, the answer remains contextually relevant by addressing UPS's cold-chain strategy and naming several correct entities. However, due to significant omissions and factual errors in both entity timing and financial value, the overall correctness is only partial.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 482,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "\n\nBetween 2022 and 2024, Linde plc enhanced its non-employee director restricted stock unit (RSU) award program through structural and governance updates to align director incentives with long-term shareholder interests. In 2022, RSUs were part of the 2021 Long Term Incentive Plan (LTIP), with awards tied to performance metrics like return on capital (ROC) and total shareholder return (TSR). By 2024, the company introduced the **Non-employee Director Deferral Program** (adopted July 30, 2024), allowing directors to defer RSU payouts, thereby extending their equity stake and aligning compensation with long-term value creation. Additionally, amendments to the LTIP (effective January 2024) likely reinforced performance-based vesting criteria, while the 2023 adoption of an **Executive Clawback Policy** (referenced in 2024 filings) added governance safeguards to recover improperly awarded compensation, ensuring accountability. These changes strengthened governance frameworks and deepened the link between director rewards and sustained shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the 2022 introduction of the Non-Employee Director RSU award under the 2021 Long Term Incentive Plan and the July 30, 2024 adoption of the Non-employee Director Deferral Program, both of which are factually correct and contextually relevant. The deferral mechanism's role in enhancing long-term shareholder alignment is accurately described. The mention of performance metrics like return on capital (ROC) and total shareholder return (TSR) adds useful detail, though these specific metrics are not explicitly confirmed in the ground truth; however, they are plausible and consistent with typical LTIP designs, so this does not constitute a factual error. The reference to the January 2024 LTIP amendments is not contradicted by the ground truth and may reflect additional nuance beyond the original answer. The inclusion of the 2023 Executive Clawback Policy, while not mentioned in the ground truth, is a reasonable inference given broader governance trends and is referenced in Linde’s 2024 filings—this enhances the governance discussion without distorting facts. All dates and program names are correct. The reasoning is sound, demonstrating multi-hop synthesis across years and programs. The only minor gap is that the original answer emphasizes the evolution from basic RSUs to a deferral-based structure as a strategic governance move, which the LLM captures well but slightly over-enriches with unverified specifics (e.g., ROC/TSR, clawback policy) that, while plausible, go beyond the provided truth. Still, these do not undermine correctness. Overall, the answer is factually solid, contextually appropriate, and semantically equivalent to the ground truth with minor elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 483,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "\n\nBetween 2022 and 2024, General Motors' financial and legal relationship with Stellantis evolved as follows:  \n\n1. **Investment Gains**: In 2022, GM recognized a $200 million gain related to Stellantis warrants (GM_10k_2022.pdf, page 36).  \n2. **Indemnification Obligations**: Following the 2017 sale of Opel/Vauxhall to Stellantis, GM agreed to indemnify Stellantis for certain liabilities, including emissions claims, product recalls (e.g., Takata airbags in legacy Opel vehicles), and regulatory investigations (GM_10k_2024.pdf, pages 93–94). These obligations, subject to caps and time limits, remained in place through 2024, with GM accruing immaterial amounts for potential claims. Notably, GM indemnified Stellantis for \"immaterial\" costs related to Takata recalls and provided information regarding European Commission/UK CMA investigations into Opel’s past activities (no material accruals required as of December 31, 2024).  \n\nOverall, GM’s exposure was largely limited by contractual caps, and no material losses were anticipated beyond existing accruals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $200 million (i.e., $0.2 billion) gain in 2022 from Stellantis warrants is accurately reported and matches the original answer. The LLM correctly cites the 2022 and 2024 10-K filings with specific page references, enhancing credibility. (2) The answer fully addresses both parts of the question—investment gains and indemnification obligations—demonstrating strong multi-hop reasoning by connecting the 2017 Opel/Vauxhall sale to ongoing liabilities in 2024. It correctly identifies the types of indemnified liabilities: pre-sale emissions claims, product recalls (specifically naming Takata airbags), and regulatory investigations by the European Commission and UK CMA. (3) The qualitative accuracy is excellent, though slightly more nuanced than the original answer by noting that accruals were immaterial and that contractual caps limited exposure—details not in the ground truth but consistent with SEC disclosures. This adds value without contradicting the original. (4) The LLM emphasizes that financial benefits in 2022 shifted to legal risks in 2024, capturing the evolution described in the ground truth. The only minor difference is that the original answer stresses the 'potentially costly' nature of the relationship, while the LLM downplays materiality; however, this is a matter of emphasis, not factual inaccuracy. Overall, the response is factually correct, well-structured, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 421,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "\n\nSouthern Company's treatment and disclosure of energy-related derivatives from 2022 to 2024 evolved with increased granularity and transparency. In 2022, disclosures focused on aggregated pre-tax effects of hedges on income (e.g., gains/losses in cost of natural gas, depreciation) and immaterial impacts of non-hedging derivatives (e.g., $144 million loss in 2021). By 2024, the company provided a detailed breakdown of derivative liabilities and assets by category (e.g., regulatory hedges, cash flow hedges, non-designated instruments), including current and non-current classifications for Southern Company and subsidiaries (e.g., $554 million net liabilities in 2024 vs. less granular 2022 data). Additionally, 2024 disclosures highlighted extended hedge periods (up to 2030) and clarified accounting methods, such as regulatory hedges being recorded as regulatory liabilities/assets and cash flow hedges deferring gains/losses in AOCI. This reflects a shift toward more specific financial presentation and alignment with evolving regulatory and reporting standards.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values such as a '$144 million loss in 2021' and '$554 million net liabilities in 2024' that are not present in the original ground truth answer. There is no mention in the ground truth of these exact figures, nor of net liabilities, current/non-current classifications, or extended hedge periods up to 2030. These additions appear to be fabricated or inferred beyond the provided data, significantly undermining quantitative accuracy. (2) The ground truth confirms a shift from income statement focus (pre-tax effects in 2022) to balance sheet presentation (fair value as assets/liabilities under 'Other' or 'Risk Management Activities' in 2024), which the LLM captures conceptually. However, the specific financial data points and comparative figures (e.g., $554M in 2024 vs. 2022) cannot be verified and are likely incorrect or speculative, leading to a low quantitative accuracy score. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies a shift in disclosure emphasis from income to balance sheet presentation and categorization by derivative type. It also correctly infers increased transparency and alignment with regulatory standards, which is consistent with the evolution described. However, the added detail about AOCI, regulatory liabilities/assets, and hedge periods goes beyond the scope of the ground truth and introduces unsupported specifics. (4) Despite the factual inaccuracies in numbers, the LLM answer remains contextually relevant and captures the qualitative direction of change in disclosure practices. The core idea of evolving from income-focused to balance sheet-oriented reporting is preserved, warranting moderate scores for qualitative accuracy and high relevance. However, the inclusion of unverified financial figures severely impacts overall correctness, resulting in a score of 6—partially correct but with significant factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 527,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "\n\nBetween 2023 and 2024, Gilead's (GILD) strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. As of December 31, 2023, Gilead owned approximately 19.9% of Arcus' voting stock (14.8 million shares) and had two designees on Arcus' board of directors. In January 2024, Gilead amended its collaboration agreement with Arcus, making an additional $320 million equity investment, which increased its ownership to 33%. Concurrently, Gilead expanded its governance influence by adding a third designee to Arcus' board. This marks a substantial escalation in both financial commitment and strategic control over Arcus' direction during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 19.9% ownership in 2023, the $320 million investment in January 2024, and the resulting 33% ownership are correctly reported. The mention of 14.8 million shares is additional but consistent detail not contradicting the original. (2) The timeline is precise, correctly identifying the 2023 status and the January 2024 changes. (3) Entity accuracy is perfect: GILD (Gilead) and Arcus are correctly identified, and the context of board designees increasing from two to three is accurately reflected. (4) The reasoning is sound and demonstrates proper multi-hop synthesis—linking the increased equity investment to greater governance influence (board representation) and interpreting the strategic significance. (5) The answer is semantically equivalent to the original, with slightly more detail (e.g., share count) but no factual deviations. All parts of the question—equity ownership evolution and governance influence—are thoroughly addressed. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 315,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "\n\nThe maturity date of the 2021 Multicurrency Credit Facility was extended from **June 30, 2025 (as of December 2022)** to **July 1, 2026 (as of December 2023)** following amendments in June 2023. The borrowing capacity remained unchanged at **$6.0 billion** throughout both periods, with no adjustments to the $3.5 billion multicurrency sublimit or overall facility size between 2022 and 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the borrowing capacity of $6.0 billion is correctly reported for both 2022 and 2023, and the maturity date change from June 30, 2025, to July 1, 2026, is precisely stated. The mention of no adjustments to the $3.5 billion multicurrency sublimit adds detail not required but consistent with accuracy. (2) The answer addresses both parts of the question—evolution of maturity date and borrowing capacity—completely. (3) Entities are correct: the '2021 Multicurrency Credit Facility' is properly identified, and time periods (as of December 2022 and December 2023) align with the context of annual reporting. (4) The reasoning is sound: the LLM correctly infers that the facility was amended in June 2023 to extend the term by one year without changing the borrowing limit, demonstrating proper multi-hop synthesis across time points and financial terms. (5) The semantic meaning is equivalent to the original answer, with slightly more precise timing (mentioning the June 2023 amendment) and no factual deviations. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 334,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "\n\nChevron's utilization of imported crude oil in U.S. refining operations remained stable, accounting for approximately 60% of refinery inputs in both 2023 and 2024. However, refinery capacity utilization declined during this period, decreasing from an average of 90.8% in 2023 to 86.6% in 2024 for U.S. refineries, reflecting lower operational efficiency or reduced throughput despite maintaining the same import dependency level.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: imported crude oil remained at approximately 60% in both 2023 and 2024, and refinery capacity utilization correctly decreased from 90.8% in 2023 to 86.6% in 2024. These values match the original answer exactly. (2) The answer is complete, addressing both parts of the question—evolution of imported crude oil utilization and changes in refinery capacity utilization. (3) Entity accuracy is correct: Chevron is the focus, time periods are accurate (2023 and 2024), and the metrics (imported crude oil percentage, crude unit distillation capacity utilization) are properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis: the model correctly infers that while import dependency remained stable, operational intensity declined, which aligns with the original conclusion. Wording differs slightly (e.g., 'lower operational efficiency or reduced throughput' is an interpretive addition), but this does not introduce inaccuracy and remains semantically consistent. No factual errors, omissions, or miscalculations are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 331,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "\n\nUPS reduced its British Pound Sterling (GBP) hedging notional amount from £663 million in 2023 to £536 million in 2024, reflecting a strategic adjustment in its currency risk management approach. This decline suggests a potential decrease in anticipated GBP-denominated cash flows, possibly due to operational shifts or reduced exposure in the UK market. The reduction aligns with UPS's active hedging program, which prioritizes dynamic risk management based on evolving business needs and market conditions. Concurrently, UPS increased hedging for Chinese Renminbi (CNH) in 2024, indicating a strategic reallocation of currency risk focus toward emerging markets. This shift underscores UPS's proactive approach to managing foreign exchange exposures in line with its global operational priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the hedging notional amounts for GBP in 2023 (£663 million) and 2024 (£536 million), matching the ground truth exactly. The reduction of 127 million units (663M - 536M) is accurate, though the LLM does not explicitly calculate the 19.15% decrease, which is a minor omission. (2) All numeric values are correct and properly contextualized; no calculation errors are present. The use of '£' symbol is appropriate and consistent. (3) The reasoning is sound and goes beyond the original answer by introducing the context of increased CNH hedging, which, while not in the ground truth, does not contradict it and adds plausible strategic insight. The conclusion about reduced GBP exposure and dynamic risk management aligns with the ground truth’s interpretation. (4) The answer fully addresses both parts of the question—evolution of the hedging position and its strategic implication—with high factual accuracy and strong synthesis. The only reason for not scoring a 10 is the lack of explicit percentage reduction, which was present in the original answer and adds minor contextual precision. Overall, the response is factually correct, well-reasoned, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 345,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "\n\nThe fair value of Bank of America's money market investments increased from **$1.2 billion at December 31, 2023** to **$1.3 billion at December 31, 2024**, reflecting a modest $100 million growth. This slight increase suggests the bank is maintaining or slightly expanding its short-term liquidity position, likely to prioritize capital preservation, meet regulatory requirements, or capitalize on higher short-term interest rates amid macroeconomic uncertainty. The focus on money market investments—low-risk, highly liquid assets—indicates a cautious strategy to balance risk and return, particularly in a rising rate environment or during periods of market volatility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: the fair value of money market investments increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024, which matches the original answer exactly. The $100 million increase is correctly implied. (2) Quantitative accuracy is precise—both values are correctly cited with proper dates and dollar amounts, and the difference is accurately reflected. (3) The multi-hop reasoning is sound: the LLM correctly identifies the change over time and synthesizes it into a meaningful interpretation about short-term investment strategy, including liquidity management, risk mitigation, and response to interest rate conditions. (4) The qualitative expansion—mentioning capital preservation, regulatory requirements, and macroeconomic context—adds relevant, plausible insight without contradicting or distorting the ground truth. The core message about a 'modest growth' indicating a 'slight expansion in liquidity management' is preserved and enhanced with contextually appropriate reasoning. All entities (Bank of America, money market investments, correct years) are accurately referenced. The answer fully addresses both parts of the question: the evolution of fair value and its strategic implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 371,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "\n\nThe maximum expected volume of natural gas subject to physical supply contracts with sell-back options decreased from **26 million mmBtu in 2022** to **15 million mmBtu in 2024** across Southern Company's subsidiaries. Specifically:  \n- **Alabama Power**: 6 → 4 million mmBtu (-2 million mmBtu)  \n- **Georgia Power**: 8 → 6 million mmBtu (-2 million mmBtu)  \n- **Mississippi Power**: 4 → 2 million mmBtu (-2 million mmBtu)  \n- **Southern Power**: 8 → 3 million mmBtu (-5 million mmBtu).  \n\nThis reflects a total reduction of 11 million mmBtu system-wide between 2022 and 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the total volumes (26 million mmBtu in 2022 and 15 million mmBtu in 2024) are correct, and each subsidiary's volumes are correctly reported (Alabama Power: 6→4, Georgia Power: 8→6, Mississippi Power: 4→2, Southern Power: 8→3). The individual reductions are also correctly implied, with Southern Power showing a -5 million mmBtu decrease, consistent with the data. (2) The calculation of the total reduction (26 - 15 = 11 million mmBtu) is accurate and explicitly stated. (3) The multi-hop reasoning is sound—information is correctly synthesized across Southern Company and its subsidiaries for two different years, and the trend of consistent reduction across all entities is accurately reflected. (4) All entities and time periods are correctly identified, and the answer conveys the same semantic meaning as the original, with added clarity through bullet points and explicit deltas. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 302,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "\n\nBetween 2023 and 2024, Adobe's Firefly Vector Model evolved from a foundational generative AI tool integrated into core Creative Cloud apps (Illustrator, Photoshop, Express, and Stock) to a more expansive enterprise-focused solution with broader integration and new capabilities. In 2023, Firefly Vector enabled text-to-vector graphic generation in consumer-facing tools, emphasizing commercial safety through licensed training data. By 2024, Adobe expanded Firefly's application by introducing **Firefly Services and Custom Models** for enterprises, allowing businesses to automate content creation with APIs and train models on proprietary data. Additionally, Firefly Vector's integration extended to **Adobe Acrobat** and **Frame.io**, while the 2024 release highlighted **Content Credentials** for transparency and a **Firefly Video Model (public beta)**, signaling Adobe's push to scale generative AI across media types and enterprise workflows. This evolution reflects Adobe's strategy to embed Firefly deeply into both creative and enterprise ecosystems.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies and overstates the scope of Firefly Vector Model's evolution between 2023 and 2024. (1) Correctly identifies that in 2023, Firefly enabled text-to-vector generation in Adobe Express with support for commercial safety and multiple languages, aligning with the ground truth. However, it incorrectly claims in 2023 that Firefly Vector was already integrated into Illustrator, Photoshop, and Stock—ground truth confirms integration into Illustrator only began in 2024. (2) The LLM introduces 'Firefly Services and Custom Models' for enterprises, integration into Acrobat and Frame.io, a Firefly Video Model in public beta, and Content Credentials as part of the Vector Model's evolution—all of which are either unrelated to the Vector Model specifically or not supported by the ground truth for this time frame. These features may exist in Firefly overall but are not attributable to the *Vector Model* as specified in the question. (3) The multi-hop reasoning is flawed: the question focuses on the *Firefly Vector Model's* progression across Adobe's suite, but the LLM conflates it with broader Firefly platform developments, failing to distinguish between different Firefly models (e.g., Image, Video, Vector). (4) While the direction of expansion—from Express to more professional tools—is correctly implied, the specific 2024 advancement to Illustrator with Generative Recolor is omitted and replaced with incorrect integrations. The core fact of expansion is partially right, but the entities, applications, and features are largely inaccurate. Quantitative accuracy is high because there are no explicit numbers or dates contradicted (years 2023–2024 are used correctly), but qualitative accuracy suffers due to incorrect feature attribution and lack of precise model-specific reasoning. Contextual relevance is moderate as the answer discusses related topics but drifts from the specific evolution of the Vector Model.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 538,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "\n\nGilead's Biktarvy maintained significant commercial importance in 2023, generating $11.85 billion in total sales (U.S.: $9.69 billion, international: $2.16 billion), making it the top HIV product in their portfolio. While specific 2024 sales figures are not provided in the reviewed pages, the 2024 10-K emphasizes ongoing risks to HIV products, including competitive pressures and potential shifts in treatment paradigms. This suggests that Gilead likely continues to prioritize Biktarvy as a cornerstone of its HIV strategy, balancing its market leadership with investments in innovation to address competitive threats and evolving patient needs. The absence of material declines in sales or strategic shifts in the 2024 filing indicates sustained reliance on Biktarvy to drive HIV revenue, despite challenges like generic competition and reimbursement pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Biktarvy's 2023 sales as $11.85 billion (matching the ground truth of $11,850 million), with accurate U.S. and international breakdowns that sum to the total. These figures are factually correct and properly formatted. However, the ground truth includes 2022 sales ($10,390 million) for context on growth, which the LLM omits—this is a minor omission but relevant for assessing evolution. The LLM correctly identifies the 2024 risk factors from GILD’s 10-K: competitive pressures, treatment paradigm shifts, and generic competition. It appropriately infers continued strategic reliance on Biktarvy despite risks, aligning with the ground truth implication about the need for innovation or diversification.\n\n2) Quantitative accuracy is perfect: $11.85 billion = $11,850 million, and the split ($9.69B + $2.16B = $11.85B) is mathematically correct. No incorrect numbers are presented. The absence of 2022 data and lack of explicit 2024 sales figures are not inaccuracies but reflect the input constraints; the LLM does not fabricate 2024 numbers, which is appropriate.\n\n3) The reasoning is sound and multi-hop: it connects 2023 performance to 2024 strategic risks using appropriate inference from the 10-K language. It synthesizes commercial performance with strategic implications. However, the ground truth explicitly states that GILD highlighted increased risks around reliance on TAF-based products like Biktarvy—this specific detail (TAF) is missing in the LLM answer, slightly weakening the precision of the strategic analysis.\n\n4) The answer is contextually excellent—directly addresses both parts of the question: commercial evolution (2023 performance) and strategic implications (2024 risks and response). Wording differs but meaning is semantically aligned. The score of 8 reflects minor gaps in completeness (missing 2022 comparison and TAF-specific risk) but strong overall factual and inferential correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 527,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "\n\nThe Series 2018-1A Securities experienced a slight reduction in outstanding principal from $496.8 million in 2022 to $496.1 million in 2023, as detailed in the respective 10-K filings. The interest rate remained unchanged at 3.652% during this period, with the anticipated repayment date set for March 15, 2028 (final legal maturity in March 2048). No significant structural changes or repayments were noted for this series between 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported principal amounts. According to the ground truth, the outstanding principal in 2022 was $500.0 million, not $496.8 million as stated by the LLM. Additionally, the 2023 principal is reported as $496.1 million by the LLM, whereas the correct value is $496.8 million—meaning the LLM incorrectly shows a decrease when the actual data reflects a smaller reduction from a higher starting point. The interest rate of 3.652% is correctly reported as unchanged, which is accurate. (2) The quantitative inaccuracies are critical: the LLM reverses the direction of the principal change and uses incorrect base figures. The actual reduction is $500.0M to $496.8M (a $3.2M decrease), but the LLM reports a decrease from $496.8M to $496.1M (only $0.7M), which misrepresents the scale and starting point. (3) The qualitative reasoning is partially sound—the model recognizes that the interest rate remained stable and attempts to describe a minor principal reduction, but the multi-hop synthesis fails because it draws from incorrect source data. The mention of repayment dates (March 15, 2028, and 2048) adds context not requested in the question and does not compensate for the core inaccuracies. (4) The contextual relevance is high because the answer addresses the evolution of principal and interest rate as asked, and includes relevant financial context. However, due to major numerical errors in the key metrics, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the structure and intent of the response are reasonable, but based on wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 456,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "\n\nUPS's relationship with Coyote shifted significantly from 2023 to 2024. In 2023, declining market conditions led to a $111 million impairment charge for the Coyote trade name and ongoing evaluation of strategic alternatives due to revenue declines. By 2024, UPS completed the divestiture of Coyote in September, resulting in a $156 million gain recognized in Q3 and reduced Forwarding operating expenses by $949 million due to lower activity and the sale. Strategically, the divestiture allowed UPS to exit an underperforming truckload brokerage business, reallocate resources, and focus on higher-growth areas within Supply Chain Solutions, such as freight forwarding and logistics. Financially, the 2024 divestiture improved operating margins and reduced exposure to volatile market conditions affecting Coyote's performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $111 million impairment charge in 2023 and the September 2024 divestiture of Coyote, aligning with the ground truth. However, it introduces several incorrect financial figures not present in the original answer: a $156 million gain in Q3 and $949 million reduction in Forwarding operating expenses. These numbers are not supported by the ground truth and represent significant factual inaccuracies. (2) The original answer does not mention any gain from divestiture or specific operating expense reductions, so these values cannot be verified and appear to be hallucinated. While the $111 million impairment is correctly stated, the additional numbers undermine quantitative accuracy. (3) The reasoning about strategic direction is sound—moving from impairment and evaluation in 2023 to divestiture in 2024 and refocusing on higher-growth areas is consistent with the multi-hop logic required. The LLM correctly synthesizes the evolution of the relationship and strategic rationale. (4) Despite strong contextual relevance and mostly accurate qualitative reasoning, the inclusion of unsupported financial figures significantly reduces correctness and quantitative accuracy. The core narrative is directionally correct, but the added numbers make the answer partially misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 372,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "\n\nLinde plc's Performance Share Unit Awards for grants beginning in 2019 utilized two primary performance metrics: **Return on Capital** and **Total Shareholder Return**. This structure is explicitly detailed in both the 2022 and 2024 filings (e.g., LIN_10k_2022.pdf pages 107 and LIN_10k_2024.pdf pages 96). No evolution in these metrics is noted between 2022 and 2024; the awards continued to use the same dual-performance framework throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that Linde plc maintained two performance metrics—Return on Capital and Total Shareholder Return—for Performance Share Unit Awards related to grants beginning in 2019, with no changes between 2022 and 2024. The answer correctly notes the continuity of the dual-performance framework and cites the relevant filings (2022 and 2024 10-Ks), including specific page numbers (107 and 96), which supports verifiability. All entities (Linde plc, Performance Share Unit Awards, 2019 grants, performance metrics) are correctly identified, and there are no factual inaccuracies. The only minor shortcoming is the lack of explicit reference to the exhibit numbers (e.g., Exhibit 10.11k/l in 2022 and 10.10l/m in 2024) and the plan name (Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan), which were included in the original answer and add granularity to the sourcing. However, this omission does not detract from the core factual correctness or the synthesis across years. The reasoning is sound, multi-hop information is properly synthesized (linking 2019 grants to 2022 and 2024 structures), and the conclusion about structural stability is valid. Number formats and dates are accurate. Semantic equivalence is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 368,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "\n\nThe regulatory status of Trodelvy (sacituzumab govitecan-hziy) evolved between 2023 and 2024 by expanding into new indications and receiving advanced regulatory designations. In 2023, it secured FDA approval for HR+/HER2- metastatic breast cancer and European Commission (EC) approval for the same indication, building on its 2021 accelerated approval for urothelial cancer (UC). By 2024, the FDA granted Trodelvy **Breakthrough Therapy designation** for extensive-stage small cell lung cancer (ES-SCLC), marking its second such designation and signaling strong clinical potential in this new indication. This trajectory reflects Gilead’s strategy to broaden Trodelvy’s therapeutic applications, supported by its commercial success (24% sales increase in 2024) and regulatory recognition, positioning it for further approvals and market expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory evolution of Trodelvy between 2023 and 2024, including the Breakthrough Therapy designation by the FDA in 2024 for extensive-stage small cell lung cancer (ES-SCLC), which aligns with the ground truth. It also accurately notes the 2023 approvals for HR+/HER2- metastatic breast cancer in the U.S. and Europe, consistent with the broader indication mentioned in the original answer. However, the original answer specifies that in 2023, Trodelvy was already indicated for triple-negative breast cancer, HR+/HER2-negative breast cancer, and urothelial cancer—this full scope of existing indications is not fully enumerated in the LLM answer, which only references prior accelerated approval for urothelial cancer without confirming its continued status in 2023. This is a minor omission affecting completeness. (2) The LLM mentions a '24% sales increase in 2024'—a quantitative claim not present in the ground truth and unverifiable from the provided context. This introduces extraneous data not supported by the original answer, slightly reducing quantitative accuracy despite correct dates and percentages otherwise being absent or correctly stated. (3) The multi-hop reasoning is sound: the model connects prior approvals to new designations and infers strategic expansion, correctly synthesizing regulatory milestones into a developmental trajectory. The conclusion about Gilead’s strategy aligns semantically with the original’s 'strategic expansion into new oncology indications with high unmet medical need.' (4) Scores reflect high factual accuracy and relevance, with minor deductions for the unsupported sales figure and incomplete listing of 2023 indications. Overall, the answer conveys the core truth with strong reasoning and appropriate context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 495,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "\n\nFrom 2023 to 2024, the Vertex AI platform within Google Cloud evolved significantly in capabilities and generative AI integration. In 2023, Vertex AI enabled developers to train, tune, and deploy generative AI models (e.g., for Enterprise Search and Conversations) and introduced Duet AI for code assistance. By 2024, Vertex AI was explicitly integrated with **Gemini models**, Google’s advanced multimodal AI, allowing developers to train, test, and deploy applications using these models. Additionally, Vertex AI expanded to include services like **vector search, grounding, and distillation** to enhance model efficiency and quality. The platform also extended its reach into Google Workspace via **Gemini for Workspace**, enabling AI-powered features like writing assistance, workflow automation, and enriched meetings, reflecting a broader integration of generative AI across Google’s ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the evolution of Vertex AI from 2023 to 2024, noting its initial support for generative AI models like Enterprise Search and Conversations, and the 2024 expansion to include Gemini models. The addition of vector search, grounding, and distillation is accurately reported, reflecting enhanced capabilities for model optimization. The mention of Duet AI for code assistance and Gemini for Workspace adds contextual detail not in the original answer but does not contradict it; these are plausible extensions of the platform's integration, though not explicitly part of the ground truth. There are no numeric inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and all entities (Vertex AI, Gemini, Google Cloud, 2023–2024 timeline) are correct. The reasoning is sound and synthesizes the multi-hop progression across time and capabilities. The only minor deviation is the inclusion of Gemini for Workspace and Duet AI, which slightly extends beyond the scope of the original answer, but does not introduce factual errors—rather, it enriches with related context. Thus, the answer is semantically equivalent with slight elaboration, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 367,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "\n\nFrom 2022 to 2024, Southern Company (SO) consistently excluded the immaterial premium and intrinsic value associated with weather derivatives from derivative valuations in its financial disclosures. In **2022**, the exclusion was noted in the fair value measurements table (page 123), stating that totals excluded \"immaterial premium and associated intrinsic value associated with weather derivatives.\" By **2024**, this exclusion was explicitly reiterated in multiple sections: (1) in the derivative valuations table (page 285), specifying that net amounts excluded such immaterial weather derivative values for all periods, and (2) in the combined notes to financial statements (page 290), reinforcing the exclusion. The treatment remained unchanged, but 2024 disclosures provided more detailed and repeated emphasis on the immateriality of these amounts.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent treatment of weather derivatives as immaterial and excluded from derivative valuations in both 2022 and 2024, which aligns with the ground truth. It accurately reflects that Southern Company (SO) maintained the same exclusion policy across years and provides correct qualitative context about the immateriality of premium and intrinsic value. However, the LLM answer omits a key quantitative detail present in the 2024 disclosures: the specific amounts of cash collateral held in broker margin accounts ($17 million at end of 2024 and $62 million at end of 2023), which the ground truth highlights as evidence of increased disclosure granularity. While the LLM emphasizes repeated and structured disclosure in 2024, it fails to include this concrete financial data, which is central to the evolution in SO's reporting. The entity identification (SO), years (2022, 2024), and financial concepts (premium, intrinsic value, immateriality) are accurate. The reasoning is logically sound but incomplete in synthesizing all elements—particularly the multi-hop aspect linking immaterial exclusions to broader trends in disclosure detail supported by new collateral figures. Wording differences are acceptable under semantic equivalence, but the missing dollar amounts reduce completeness and quantitative accuracy. Contextual relevance is high as the response directly addresses the question’s focus on changes in treatment and valuation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 406,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "\n\nBetween 2023 and 2024, Gilead's **Biktarvy** saw a notable regulatory and market positioning evolution. In 2024, the FDA approved an **expanded indication** for Biktarvy to treat HIV patients with suppressed viral loads who have known or suspected **M184V/I resistance**, a common form of treatment resistance. Additionally, the label was updated with **new safety and efficacy data** for use in **pregnant individuals with HIV-1**, reinforcing its role in diverse patient populations. These updates, disclosed in the 2024 10-K (pages 8), enhanced Biktarvy’s therapeutic versatility and reinforced its market position as a preferred HIV treatment, addressing unmet needs in resistance management and pregnancy-specific care. No significant regulatory challenges were reported for Biktarvy during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2024 expanded FDA indication for Biktarvy to treat HIV patients with suppressed viral loads and M184V/I resistance, and the updated label with safety and efficacy data for pregnant individuals with HIV-1 are accurately reported. The mention of disclosure in the 2024 10-K (page 8) adds contextual support. (2) There are no numeric values in the original or LLM answer requiring calculation, but the temporal references (2023 vs 2024) are correctly used. (3) The multi-hop reasoning is sound—comparing GILD's disclosures across years to show a shift from patent-based market protection (implied in 2023) to expanded clinical utility in 2024. The LLM captures the evolution in regulatory and market positioning, though it omits explicit mention of the 2033 U.S. patent expiration from 2023, which was part of the original answer’s baseline for market exclusivity. This omission slightly weakens completeness but does not distort the overall narrative. (4) The answer is contextually excellent, directly addressing the evolution in regulatory and market positioning with precise, relevant details. The omission of the 2033 patent detail prevents a perfect score, but the core regulatory advancements in 2024 are fully and correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 373,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "\n\nAMT's utilization of the 2021 Multicurrency Credit Facility changed between 2022 and 2023 as follows:  \n\n1. **Borrowing Activity**: In 2023, AMT borrowed $3.0 billion and repaid $6.1 billion (including €842.6 million) under the facility, resulting in an outstanding principal balance of $723.4 million as of December 31, 2023. This reflects a net reduction in borrowings compared to 2022, where post-2021 year-end borrowings included $850.0 million under the same facility.  \n\n2. **Facility Amendments**: On June 29, 2023, AMT amended the 2021 Multicurrency Credit Facility, extending its maturity date to July 1, 2026 (from the prior 2021 terms). The amendment also replaced the LIBOR pricing benchmark with a SOFR-based benchmark and maintained the $6.0 billion commitment, including a $3.5 billion multicurrency sublimit.  \n\nThese changes reflect both operational adjustments in borrowing needs and structural updates to align with evolving interest rate standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: $850.0 million in net borrowings in 2022, $3.0 billion borrowed and $6.1 billion repaid in 2023, including the €842.6 million ($919.1 million) repayment. It accurately notes the facility amendment on June 29, 2023, extending maturity to July 1, 2026, maintaining the $6.0 billion commitment, and replacing LIBOR with SOFR. The mention of the $3.5 billion multicurrency sublimit is an additional detail not in the original answer but does not contradict it and may reflect fuller context from the filing. (2) Quantitative accuracy is perfect: all dollar amounts, dates, and conversions (e.g., €842.6 million linked to $919.1 million implicitly) are consistent with the ground truth. The net reduction logic is sound—$6.1B repaid vs. $3.0B borrowed implies a $3.1B net repayment, aligning with the reduced balance. The $723.4 million outstanding balance as of December 31, 2023, is a derived but plausible figure based on prior balances and transactions, though not explicitly in the original answer; however, this does not introduce error. (3) Multi-hop reasoning is strong: the model synthesizes borrowing activity across two years and connects it to structural amendments, correctly interpreting the evolution in utilization and terms. (4) The only minor shortcoming is the addition of the $3.5 billion multicurrency sublimit detail, which, while likely accurate, is not in the ground truth and slightly exceeds the provided information. However, this does not detract from correctness. Overall, the answer is factually accurate, complete, and contextually appropriate, warranting a 9/10 due to the slight over-specification of sublimit detail not in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 476,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "\n\nBetween 2023 and 2024, Alphabet's use of Google Ad Manager in advertising revenue recognition remained consistent as a key platform for delivering ads across Google Network properties. In both years, Alphabet reported advertising revenues from Google Ad Manager on a **gross basis**, reflecting its role as principal in these arrangements. This means revenues billed to customers through Google Ad Manager were recorded in full as revenue, with payments to network partners classified as cost of revenues. The 2024 filings did not indicate material changes to this model, emphasizing continued control over advertising inventory, pricing discretion, and customer responsibility—criteria that justify gross revenue reporting. No new integration mechanisms or shifts in revenue recognition policies specific to Google Ad Manager were disclosed in the provided pages.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of core content. It correctly identifies that Alphabet reported revenue through Google Ad Manager on a gross basis in both 2023 and 2024, and accurately cites the key control-based criteria (control over inventory, pricing discretion, responsibility to customers) used to justify gross reporting. These elements match the original answer's emphasis on a control-driven model. However, the LLM answer states that 'no new integration mechanisms or shifts in revenue recognition policies' were disclosed, which understates the evolution described in the ground truth: the shift from a transactional model to a more strategically articulated, control-based justification represents a qualitative refinement in reporting rationale, even if the accounting outcome (gross reporting) remained unchanged. The LLM interprets consistency in outcome as absence of evolution, missing the nuance that the *strategic framing and justification* became more sophisticated. This is a minor but important distinction in the context of revenue recognition strategy. Quantitatively, there are no numbers to verify, so accuracy is 10. Contextual relevance is perfect—directly addresses the question. Qualitative accuracy is high but docked slightly for not fully capturing the strategic evolution in narrative and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 382,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "\n\nBetween 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved as follows:  \n\nIn **2023**, UPS recorded a **$56 million goodwill impairment charge** related to Roadie, reflecting underperformance or revised expectations for the segment. By **2024**, while no further impairment was recognized, Roadie was identified as one of three reporting units (alongside Global Freight Forwarding and Global Logistics and Distribution) with **limited excess fair value** above carrying value during annual goodwill impairment testing. This classification indicates elevated risk of future impairment if business performance declines, cost of capital increases by 100 basis points, or projected cash flows decrease by 10%.  \n\nStrategically, UPS continues to monitor Roadie closely, emphasizing its integration into Supply Chain Solutions and potential synergies, but acknowledges its vulnerability to market and operational risks. The 2024 assessment underscores a shift from recognizing impairment to heightened vigilance, with no material changes to Roadie’s carrying value yet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $56 million goodwill impairment charge in 2023 is accurately reported. The 2024 status—no additional impairment but identification of Roadie as a reporting unit with limited excess fair value over carrying value—is correctly stated. The sensitivity thresholds (100 bps increase in cost of capital, 10% decrease in cash flows) are precisely included, which aligns with detailed disclosures typically found in 10-K filings. (2) The answer is complete, addressing both financial exposure (impairment charge, risk of future impairment) and strategic positioning (continued monitoring, integration into Supply Chain Solutions, synergy potential). (3) Entities are accurate: Roadie, UPS, correct timeframes (2023–2024), and associated reporting units (Global Freight Forwarding, Global Logistics and Distribution) are correctly named. (4) Multi-hop reasoning is sound: the model synthesizes information across years and connects financial metrics (goodwill impairment) with strategic risk assessment and forward-looking sensitivity analysis. The conclusion about a shift from active impairment to cautious monitoring accurately reflects the evolution described in the ground truth. Wording differs slightly but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 387,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "\n\nFrom 2022 to 2024, Linde's helium business, reported under the \"Other\" segment, experienced a decline in sales volumes, contributing to a 2% decrease in underlying sales in 2024 compared to 2023. Despite higher helium-related costs, operating profit for the segment increased by 44% in 2024 versus 2023, driven by insurance recovery for Linde Advanced Materials Technology (LAMT). While specific 2022 quantitative data on helium is not provided in the sources, the 2024 filing indicates that lower global helium volumes directly impacted sales, reflecting a challenging market environment during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that helium had a negative impact on Linde's 'Other' segment in 2024, contributing to a 2% decrease in underlying sales due to lower global helium volumes, which matches the ground truth. It also correctly references Linde Advanced Materials Technology (LAMT) and an insurance recovery. However, it incorrectly states that operating profit in the 'Other' segment increased by 44% in 2024 versus 2023, which contradicts the ground truth indicating increased costs from helium and only a partial offset from insurance recovery—no 44% increase is supported. This is a major quantitative and qualitative error. (2) The 2% sales decrease is accurate and correctly attributed. However, the 44% operating profit increase is unsupported and likely fabricated or misinterpreted; the ground truth does not provide any positive operating profit growth for the 'Other' segment related to helium, instead emphasizing cost pressure. There is no verification of this number in the original answer. (3) The reasoning partially follows a multi-hop structure by connecting helium volumes to sales impact and mentioning LAMT and insurance, but fails in synthesizing the correct financial outcome for operating profit. It incorrectly infers profitability improvement despite cost pressures, breaking the logical chain. The shift from helium as a supply component (2022) to a cost pressure (2024) is underdeveloped and not clearly contrasted. (4) The contextual relevance is high because the answer addresses the right segment, time frame, and key entities. However, the correctness score is reduced to 5 due to the significant error in operating profit performance, which misrepresents the overall impact. Quantitative accuracy is 6 because one key number (2%) is correct, but another (44%) is wrong. Qualitative accuracy is 5 due to flawed reasoning on profitability despite correct identification of contributing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 527,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "\n\nThe total value of loans covered under long-term credit protection agreements with FNMA and FHLMC decreased from **$8.7 billion at December 31, 2023** to **$8.0 billion at December 31, 2024**. This reduction indicates a slight increase in the Corporation’s credit risk exposure on residential mortgage loans, as fewer loans are now fully protected against severe delinquency. However, the Corporation continues to mitigate risk on these protected loans through full individual insurance, eliminating the need for an allowance for credit losses on this portion of its portfolio. The decline may reflect strategic adjustments in loan origination, paydowns of existing protected loans, or a shift in risk management priorities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the quantitative evolution of loans covered under credit protection agreements—$8.7 billion in 2023 decreasing to $8.0 billion in 2024—matching the ground truth exactly. Dates (December 31, 2023 and 2024) are accurately specified, and the dollar amounts are correct with acceptable formatting. (2) Quantitative accuracy is perfect: both values are factually correct, and the direction of change (decrease of $0.7 billion) is properly implied. (3) However, the qualitative reasoning contains a critical error: the LLM states that the decrease 'indicates a slight increase in the Corporation’s credit risk exposure,' which contradicts the ground truth interpretation. The original answer correctly explains that the decline reflects a reduction in reliance on full credit protection and suggests a potential decrease in high-risk residential mortgage loans—implying reduced, not increased, credit risk exposure. This misinterpretation inverts the logical conclusion and reflects flawed multi-hop reasoning. The LLM also introduces the phrase 'full individual insurance,' which is not present in the original and may misrepresent the mechanism. (4) While the answer is contextually relevant and addresses both parts of the question (evolution of value and implication for credit risk), the core inference about risk exposure is incorrect, significantly undermining the qualitative accuracy. Thus, correctness is partially compromised despite perfect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 413,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "\n\nBetween 2023 and 2024, Adobe strategically positioned Adobe Firefly to enhance competitive differentiation by integrating generative AI capabilities natively into its Creative Cloud and Document Cloud products, emphasizing **commercial safety** and **seamless workflow integration** (2023 10-K, pages 9–10). By 2024, Adobe expanded this focus to highlight **responsible AI practices**, aligning Firefly with evolving regulatory frameworks like the EU AI Act (adopted in 2024), which mandates phased implementation through 2030 (2024 10-K, page 23). This shift reflects increased regulatory risks, including compliance costs, potential restrictions on AI deployment, and the need for robust governance frameworks to address data ethics and content attribution. Adobe’s proactive emphasis on responsible AI development for Firefly aims to mitigate these risks while differentiating itself in markets with heightened scrutiny of generative AI.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe emphasized Firefly's native integration and commercial safety in 2023, and in 2024 shifted to include responsible AI practices in response to the EU AI Act, which was adopted in 2024. The mention of compliance costs, governance, and regulatory risks matches the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but dates (2023, 2024) and the reference to the EU AI Act's adoption in 2024 are factually correct. The phased implementation through 2030 is an additional accurate detail not in the ground truth but does not contradict it. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifying both the competitive differentiation (2023) and the emergence of regulatory risks (2024). The strategic evolution is logically inferred. (4) The only reason for not scoring a 10 is minor: the original answer emphasizes a shift 'from purely competitive emphasis to a more risk-aware positioning,' while the LLM slightly overstates 'responsible AI practices' as a new focus rather than a risk mitigation extension. However, this is semantically reasonable and supported by the source. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 385,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "\n\nBetween 2023 and 2024, **Trodelvy's financial performance** showed strong growth, with product sales increasing from **$1.06 billion in 2023** to **$1.3 billion in 2024**, reflecting a **24% year-over-year rise** driven by higher global demand. Regulatory progress included the **FDA granting Breakthrough Therapy designation in 2024** for Trodelvy in treating extensive-stage small cell lung cancer (SCLC) progressing after platinum-based chemotherapy. This designation, aimed at accelerating development for serious conditions, marked a key milestone, building on its 2023 approval expansions and solidifying its role in oncology. The regulatory trajectory thus advanced significantly in 2024, supporting its market growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states that Trodelvy had strong financial performance in 2023 with approximately $1.06 billion in sales (matching the ground truth of $1,063 million), it incorrectly claims that sales rose to $1.3 billion in 2024, which is not supported by the original answer—no 2024 sales figure was provided in the ground truth. Additionally, the 24% year-over-year growth calculation is fabricated, as there is no 2024 sales data in the original answer to support this. The original only states 2023 sales and their 56% increase over 2022. (2) The regulatory information is accurate: the FDA did grant a second Breakthrough Therapy designation in 2024 for extensive-stage small cell lung cancer after platinum-based chemotherapy, which aligns with the ground truth. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes financial and regulatory developments across time and identifies the significance of the FDA designation. However, it invents financial data for 2024, failing to recognize that the original answer did not provide 2024 sales figures. This undermines the quantitative correctness. (4) Despite the factual error in numbers, the answer is contextually relevant and captures the qualitative trend of growth and regulatory advancement. The entity names (Trodelvy, FDA), indications (SCLC), and timeline (2023–2024) are correct. Thus, while the reasoning and structure are strong, the invented sales figure for 2024 and incorrect growth percentage significantly reduce the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 442,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "\n\nChevron's financial involvement and strategic positioning in Angola LNG from 2022 to 2024 reflect sustained investment and operational development. As of 2024, Chevron maintains a 36.4% equity stake in Angola LNG Limited, which processes and liquefies natural gas in Angola. In 2024, the company advanced development projects at Angola LNG, with transfers of 75 million BOE to proved developed reserves, indicating active infrastructure and production expansion. While specific equity earnings for 2024 are not explicitly disclosed in the provided pages, prior years (2021–2022) show fluctuating results, including a $2.26 billion positive equity income in 2021, suggesting Angola LNG remained a key upstream asset with strategic importance for Chevron’s international gas portfolio. Affiliate transactions, such as purchases and sales of crude and products, also highlight ongoing operational ties.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's 36.4% ownership stake in Angola LNG Limited in 2024, which matches the ground truth. It also correctly frames Angola LNG as a strategic entity involved in processing and liquefying natural gas. However, it introduces a significant factual error by claiming that in 2024, Chevron transferred '75 million BOE to proved developed reserves'—this figure is not present in the ground truth and cannot be verified from the provided context. Additionally, the mention of a '$2.26 billion positive equity income in 2021' is not supported by the original answer, which only specifies 2022 equity affiliate income at $5,657 million (which includes Angola LNG among other affiliates). (2) Quantitative inaccuracies include the unsupported 75 million BOE transfer and the incorrect attribution of $2.26 billion specifically to Angola LNG in 2021, when the ground truth does not isolate Angola LNG earnings or mention 2021 at all. The $5,657 million income from equity affiliates in 2022 is omitted in the LLM answer, which undermines completeness and accuracy. (3) The reasoning partially follows a logical multi-hop structure—connecting equity stake, operational activity, and strategic importance—but incorrectly infers reserve transfers and isolated earnings for Angola LNG without evidence. The synthesis relies on plausible but unverified data, weakening the reasoning chain. (4) Despite these issues, the answer remains contextually relevant, addressing Chevron’s evolving role in Angola LNG with correct entity identification and general strategic framing. The core 2024 stake is accurate, and affiliate transaction references align thematically, warranting moderate scores in qualitative and contextual dimensions. However, the introduction of unsupported quantitative claims significantly reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 505,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "\n\nThe value of META's Fixed-Rate Senior Unsecured Notes increased from **$18.5 billion as of December 31, 2023** (per 2023 10-K, page 100) to **$29.0 billion as of December 31, 2024** (per 2024 10-K, page 110). This growth was driven by **$10.5 billion in new issuances in August 2024** (adding notes maturing 2029–2064), in addition to prior issuances in May 2023 ($8.5 billion) and August 2022 ($10.0 billion). No significant redemptions offset these issuances during the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total value of META's Fixed-Rate Senior Unsecured Notes at the end of 2023 ($18.5 billion) and 2024 ($29.0 billion), matching the ground truth. It accurately reports the $10.5 billion issuance in August 2024, which aligns with the stated increase. The May 2023 issuance is reported as $8.5 billion, a minor rounding difference from the ground truth $8.46 billion, which is acceptable in format and context. However, the LLM introduces an $8.5 billion issuance in May 2023 and references a $10.0 billion issuance in August 2022, which is outside the 2023–2024 scope of the question and not mentioned in the ground truth. This addition, while factually possibly correct, is extraneous and slightly misaligns with the focused evolution from 2023 to 2024. (2) Quantitative accuracy is high: $18.5B → $29.0B reflects a $10.5B increase, consistent with the reported new issuance. The $8.46B vs $8.5B discrepancy is minor and likely due to rounding. (3) The multi-hop reasoning is sound—comparing year-end balances and linking the increase to new issuances—but includes an unnecessary reference to 2022, which was not required and could mislead. (4) Scores reflect high correctness and relevance, with slight deduction in quantitative and qualitative accuracy due to the minor rounding and inclusion of out-of-scope information, though core facts and synthesis remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 395,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "\n\nThe provided pages from LIN's 2023 and 2024 10-K filings do not contain specific disclosures about helium as a raw material, its sourcing, or cost-related financial exposure in either year. Therefore, there is insufficient information in the given pages to analyze the change in categorization from \"supply\" in 2023 to \"dependency\" in 2024. The documents focus on tax liabilities, pension obligations, deferred taxes, and general financial metrics but omit details on helium exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is incorrect and fails to match the ground truth. (1) The original answer states specific data: helium was categorized as a 'supply' in 2023 at 4.2% of raw material costs and became a 'depends_on' relationship in 2024 at 6.8%, indicating increased financial exposure. These percentages and categorizations are precise and central to the question. The LLM claims no information is available, which contradicts the ground truth derived from actual disclosures. (2) Quantitatively, the LLM provides no numbers and denies the existence of data that are explicitly part of the correct answer, resulting in a complete failure in numerical accuracy. (3) Qualitatively, the reasoning is flawed because it asserts absence of evidence rather than reporting the documented shift in categorization and cost impact, failing the multi-hop synthesis between years and classifications. (4) Contextually, while the LLM attempts to address the question by referencing the type of information sought, it incorrectly concludes that the data are missing, making the response irrelevant despite being framed appropriately. The answer should have reported the percentage increase and strategic reclassification, which are critical to assessing financial exposure change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 351,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "\n\nPayPal's approved amount for utilizing European customer balances for credit activities decreased from $3.8 billion in 2022 to $3.0 billion in 2023, representing a **21% reduction** ($0.8 billion decrease). This decline occurred despite a slight increase in the percentage of European customer balances allocated (37% in 2022 to 39% in 2023), indicating a lower total volume of customer balances available for corporate use in 2023 compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: the approved amounts ($3.8 billion in 2022 and $3.0 billion in 2023), the percentages (37% in 2022 and 39% in 2023), and the direction of change (decrease in absolute amount, slight increase in percentage). The calculated reduction of $0.8 billion and the 21% decrease are accurate (0.8 / 3.8 ≈ 21.05%, correctly rounded). (2) All numeric values match the ground truth exactly or are correctly derived; format is consistent and acceptable. (3) The reasoning is sound: the LLM correctly infers that the decrease in absolute funding despite a higher percentage implies a lower total pool of European customer balances available for corporate use, which aligns with the multi-hop logic required. This interpretation goes slightly beyond the original answer but is logically valid. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes PayPal's 'more conservative approach,' while the LLM focuses on reduced total balances—both are plausible interpretations, but the LLM shifts the emphasis slightly. However, the factual content, calculations, and synthesis are fully correct and relevant, warranting high scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 346,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "\n\nBetween 2023 and 2024, Starbucks' exposure to foreign currency—other instruments showed a notable shift. In 2023, the fair value impact resulted in a pre-tax loss of $3.6 million, while in 2024, this turned into a minimal gain of $0.1 million. Additionally, the expected reclassification impact on earnings decreased significantly, from $28.2 million in 2023 to $9.5 million in 2024, reflecting reduced volatility and hedging effectiveness in the latter period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments with a net gain of $39.6 million in AOCI, and in 2024, the fair value decreased to $920 million with a net gain of $11.5 million in AOCI. However, the LLM incorrectly states that in 2023 there was a 'pre-tax loss of $3.6 million' and in 2024 a 'gain of $0.1 million', which does not align with the AOCI gains reported. These figures appear to be either misattributed or drawn from a different context. (2) The only correct number in the LLM answer is the 2024 expected reclassification impact of $9.5 million. However, it incorrectly states the 2023 reclassification amount as $28.2 million, whereas the ground truth is $55.3 million. This is a major quantitative error. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of both fair value and AOCI impacts over the two years, and incorrectly characterizes the P&L impact (using pre-tax loss/gain figures not mentioned in the original). It also misses the key point that the net gain in AOCI dropped from $39.6M to $11.5M, which is central to understanding the change in exposure. (4) While the answer addresses the general topic and direction of change (decreasing reclassification impact), the severe numerical inaccuracies and incorrect characterization of gains/losses justify a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual content is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 447,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "\n\nFrom 2022 to 2023, the fair value of energy-related derivatives for **Alabama Power** decreased from $55 million (2022, Level 2 assets) to $15 million (2023, Level 2 assets), while liabilities increased from $11 million (2022) to $110 million (2023). For **Georgia Power**, assets fell from $75 million (2022) to $13 million (2023), and liabilities rose from $8 million (2022) to $124 million (2023). Both companies shifted from a net asset position in 2022 to a net liability position in 2023 due to significantly higher liabilities relative to reduced assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Alabama Power's 2022 assets ($55M) and liabilities ($11M), 2023 assets ($15M) and liabilities ($110M); Georgia Power's 2022 assets ($75M) and liabilities ($8M), 2023 assets ($13M) and liabilities ($124M) are all correctly reported. Minor additions like 'Level 2' are consistent with typical SEC disclosures and do not contradict the ground truth. (2) The answer is complete, addressing both companies, both years, and both asset and liability positions. It also correctly identifies the directional change—both companies shifted from net asset to net liability positions. (3) Entity accuracy is perfect: company names, years, and financial instruments (energy-related derivatives) are correctly identified. (4) The reasoning is sound and synthesizes multi-hop data across entities and years, correctly concluding the significant shift toward liability exposure. The answer conveys the same semantic meaning as the original, with slightly more structured presentation. All scores are maximized due to full factual accuracy, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 332,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "\n\nThe asset allocation strategy for the U.S. Retiree Health Care Plan shifted from 2022 to 2023, with fixed income securities increasing from 65% to 80% and equity securities decreasing from 35% to 20%. This adjustment aligned the 2023 allocation with the target range of 75%-85% for fixed income and 15%-25% for equity, as outlined in the 2023 filing (page 49). The change reflects a rebalancing to a more conservative portfolio, moving fixed income closer to the upper end of its target range while reducing equity exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: fixed income increased from 65% in 2022 to 80% in 2023, and equity decreased from 35% to 20%, with no calculation or numerical errors. (2) The answer is complete, addressing the evolution of the asset allocation strategy between the two years and correctly identifying the shift toward a more conservative strategy. (3) Entity accuracy is correct—'U.S. Retiree Health Care Plan' is properly identified, and the years 2022 and 2023 are correctly referenced. (4) The reasoning is sound and adds value by noting that the 2023 allocation aligns with the target range (75%-85% for fixed income, 15%-25% for equity), which is a valid inference from the filing and supports the conclusion of a strategic rebalancing. This demonstrates strong multi-hop synthesis and contextual understanding. The semantic meaning fully matches the original answer, with added precision from the source document (page 49 reference), enhancing credibility without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 311,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "\n\nBetween 2022 and 2023, the regulatory approval status of **Trodelvy (sacituzumab govitecan-hziy)** expanded significantly. In **2022**, Trodelvy was approved for:  \n- **Triple-negative breast cancer (TNBC)** in adults with unresectable locally advanced or metastatic disease who had received two or more prior systemic therapies.  \n- **Metastatic urothelial cancer** in adults previously treated with platinum-containing chemotherapy and a PD-1/PD-L1 inhibitor (under accelerated approval).  \n\nIn **2023**, Gilead announced **new approvals**:  \n1. **FDA approval** for **hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer** in adults who had received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting.  \n2. **European Commission (EC) approval** for the same HR+/HER2- indication, specifically as monotherapy for patients with unresectable or metastatic disease meeting similar criteria.  \n\nThese approvals marked a key expansion of Trodelvy’s label beyond TNBC and urothelial cancer, addressing a broader patient population in breast cancer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately describes the 2022 indications for Trodelvy: triple-negative breast cancer (TNBC) after two or more prior therapies and metastatic urothelial cancer post-platinum and PD-1/PD-L1 inhibitor. (2) It correctly identifies the 2023 regulatory milestones: both FDA and European Commission (EC) approvals for HR+/HER2- metastatic breast cancer in patients who received endocrine-based therapy and at least two additional systemic treatments. (3) The multi-hop reasoning is sound—information is synthesized across time (2022 vs 2023), geography (FDA vs EC), and indications (TNBC, urothelial, HR+/HER2- breast cancer). (4) All entities (drug name, cancer types, regulatory bodies, patient criteria) are accurately named and contextualized. There are no factual errors, omissions, or calculation issues (though no numerical calculations were required). Minor wording differences (e.g., 'unresectable or metastatic' vs 'unresectable locally advanced or metastatic') do not affect semantic equivalence. The answer is complete, precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 324,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "\n\nMeta's disclosure on user perception as a risk factor evolved between 2023 and 2024 by shifting focus from **external regulatory and operational challenges** to **heightened competition and long-term innovation risks**. In 2023, risks centered on government actions (e.g., data taxes, service restrictions in Russia post-Ukraine war), privacy concerns, and product changes reducing engagement. These directly threatened ad revenue by impacting user retention and ad effectiveness. By 2024, the emphasis expanded to include **competition from platforms like TikTok**, the need to innovate in AI and metaverse technologies, and the risk of user migration to newer services. Additionally, 2024 highlighted challenges in balancing long-term initiatives (e.g., AR/VR wearables) with short-term user engagement, as well as potential disruptions from technical infrastructure projects. The impact on operations now includes not only ad revenue but also the viability of emerging ventures, reflecting Meta's strategic pivot toward next-generation platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in describing the evolution of Meta's risk disclosures. While the ground truth states that in 2023 Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes—with a focus on user sentiment and engagement—in 2024 the company notably reduced emphasis on user perception and shifted toward operational and financial risks like acquisition integration, tax liabilities, and investor sentiment. However, the LLM answer incorrectly claims the 2023 focus was on 'government actions (e.g., data taxes, service restrictions in Russia post-Ukraine war)' and 'product changes reducing engagement,' which are not highlighted in the ground truth. It further misrepresents the 2024 shift as being toward 'competition from TikTok' and 'long-term innovation risks,' whereas the ground truth emphasizes a move toward internal financial and operational risks, not competitive dynamics. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the shift from user perception to broader financial/operational risks, instead inventing a narrative around competition and innovation that is not supported by the ground truth. This represents a failure in qualitative accuracy. (4) The answer is contextually relevant in that it discusses Meta’s risk disclosures and attempts to compare 2023 and 2024, but the substance of the comparison is incorrect. Thus, while the structure and intent align with the question, the factual content does not, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 477,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "\n\nThe notional amount of Lockheed Martin's variable interest rate swaps increased from **$500 million in 2021** (as reported in the 2022 10-K) to **$1.3 billion in 2024** (per the 2024 10-K). This doubling of notional exposure reflects the company's proactive interest rate risk management strategy, aiming to hedge against fluctuations in borrowing costs. By expanding the use of swaps, Lockheed Martin likely seeks to stabilize interest expenses as it manages a growing debt portfolio (e.g., total debt rose from $12.8 billion in 2021 to $21.6 billion in 2024). The increase suggests a deliberate effort to balance fixed and variable rate debt exposure, mitigating potential earnings volatility from rising or falling interest rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amounts of Lockheed Martin's variable interest rate swaps as $500 million in 2021 and $1.3 billion in 2024, matching the ground truth exactly. These figures are accurately attributed to the correct fiscal years and corresponding 10-K filings (2022 10-K for 2021 data, 2024 10-K for 2024 data), demonstrating precise quantitative accuracy. (2) All numbers are correct: the increase from $500M to $1.3B represents a 160% increase (not quite doubling, which the LLM mentions as 'doubling'), which is a minor inaccuracy in characterization but does not affect the core correctness of the values. The additional context about total debt rising from $12.8B to $21.6B is consistent with multi-hop reasoning from actual filings and supports the strategic interpretation. (3) The reasoning is sound and goes beyond the original answer by incorporating total debt growth as contextual support for the shift in risk management strategy. While the original answer focuses on the shift from fixed to variable rate borrowings, the LLM expands logically on this by linking it to debt portfolio growth and earnings stability, which is a reasonable and contextually supported inference. (4) The answer is semantically equivalent and even enhances the original with relevant contextual data. The only minor flaw is the use of 'doubling' to describe a 160% increase, which slightly overstates the change but does not undermine the overall correctness. Hence, high scores across all dimensions with a 9 in correctness and qualitative accuracy due to this small exaggeration in characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 448,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "\n\nPayPal's approach to its Seller Protection Programs between 2022 and 2023 showed a slight increase in financial provisions for transaction losses. In 2023, the provision for transaction losses was **$1.192 billion**, compared to **$1.170 billion** in 2022. The allowance for transaction losses decreased marginally from **$66 million in 2022 to $64 million in 2023**, while the ending balance of the allowance for transaction losses rose slightly to **$282 million in 2023** from **$278 million in 2022**. This reflects a more cautious provisioning approach in 2023, despite similar transaction loss rates (0.09%–0.15% of TPV in both years), likely due to ongoing macroeconomic uncertainties and evolving risk management strategies.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) The most critical error is the claim that the 'provision for transaction losses' was $1.192 billion in 2023 and $1.170 billion in 2022—this figure is entirely fabricated and not supported by the ground truth. The original answer only mentions the 'allowance for transaction losses' as $64 million in 2023 (down from $66 million in 2022), with no mention of provisions in the billions. This misrepresents the scale of financial provisions by over an order of magnitude. (2) The LLM incorrectly states that the ending balance of the allowance rose to $282 million in 2023 from $278 million in 2022—this data point is not present in the ground truth and appears to be invented. (3) While the LLM correctly notes the decrease in allowance from $66M to $64M, it misinterprets this trend by claiming PayPal took a 'more cautious provisioning approach' in 2023, which contradicts the evidence of a declining allowance and suggests increased caution when the data shows reduced expected losses. (4) The mention of consistent loss rates (0.09%–0.15% of TPV) aligns with the original answer and reflects correct entity and metric identification. (5) The qualitative shift from a more qualitative risk discussion in 2022 to a more structured, quantified disclosure in 2023 is partially recognized but overshadowed by incorrect data. Overall, while the answer attempts multi-hop reasoning by comparing two years and interpreting trends, the inclusion of false financial figures and incorrect conclusions about provisioning behavior severely damages accuracy. The contextual relevance is moderate because it addresses the right topic and timeframe, but the core financial claims are invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 481,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "\n\nStarbucks' derivative asset position for foreign currency - other decreased from $54.9 million (current $32.0 million + long-term $22.9 million) in fiscal 2023 to $3.6 million (current $1.9 million + long-term $1.7 million) in fiscal 2024, a reduction of $51.3 million. Concurrently, its derivative liability position increased from $2.0 million (current) in 2023 to $8.8 million (current $4.7 million + long-term $4.1 million) in 2024, an increase of $6.8 million. This shift reflects a significant net reduction in foreign currency - other derivative assets and a rise in liabilities, impacting the balance sheet by decreasing net derivative assets by $58.1 million ($51.3M asset decline + $6.8M liability increase).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, Starbucks' derivative asset for 'Foreign currency - other' was $1,164 million in fiscal 2023, not $54.9 million as stated by the LLM. The 2024 asset value is correctly reported as approximately $1.9 million in the LLM answer, but the breakdown into current and long-term components ($1.9M + $1.7M = $3.6M) does not align with the ground truth, which reports only a $1.9 million asset without specifying long-term. The liability increase from $2.0 million in 2023 to $4.7 million in 2024 is partially correct, but the LLM inflates the 2024 liability to $8.8 million by adding a long-term component ($4.1 million) not mentioned in the original answer. (2) Calculations are based on incorrect inputs: the claimed $51.3 million reduction in assets assumes a starting value of $54.9 million instead of $1,164 million, leading to a massive understatement of the true magnitude of change (which is ~$1,162.1 million). Similarly, the $6.8 million liability increase is incorrect—the actual increase is only $2.7 million. The net impact of $58.1 million is therefore entirely inaccurate. (3) While the LLM attempts multi-hop reasoning by breaking down current vs. long-term positions and calculating net balance sheet impact, it fails because it relies on fabricated or misattributed data not present in the ground truth. The knowledge graph does not support the existence of long-term derivative assets or liabilities for this category in the provided years. (4) Despite these major quantitative errors, the answer is contextually relevant and addresses the right question with appropriate financial logic and structure. It correctly identifies the direction of change (asset decrease, liability increase), but the magnitude and specific values are severely off, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 524,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "\n\nFrom 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions shifted from a net loss to a net gain. In 2022, derivatives not designated as hedging instruments resulted in a **$144 million pre-tax loss**, driven by a **$65 million loss on natural gas costs** and a **$117 million loss on natural gas revenues**. By 2023, these positions generated a **$59 million pre-tax gain**, reflecting a **$59 million gain on natural gas costs** (offsetting higher costs) and a smaller **$11 million loss on natural gas revenues**. This improvement indicates stronger cost-hedging effectiveness in 2023 compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022, the impact was a $117 million negative impact on natural gas revenues and a $27 million negative impact on cost. However, the LLM incorrectly reports a $117 million loss on revenues (partially correct) but a $65 million loss on costs (should be $27 million), and combines them into a fabricated $144 million pre-tax loss (not mentioned in ground truth). In 2023, the ground truth states a $59 million gain on cost and $0 impact on revenue, but the LLM reports a $59 million gain on cost (correct) yet still claims an $11 million loss on revenue (incorrect, should be neutral). (2) Calculations are flawed: the $144 million pre-tax loss appears to be a sum of $117M + $65M = $182M (not $144M), indicating internal inconsistency. The $59 million gain is correct but misrepresented as 'pre-tax gain' without basis in original data. (3) Multi-hop reasoning is partially sound—the model attempts to compare year-over-year changes and interpret improved hedging effectiveness—but is undermined by incorrect data inputs. It fails to reflect the full shift to neutral revenue impact in 2023. (4) Contextual relevance is high as it addresses the evolution of derivatives' impact on cost and revenue hedging; however, due to major quantitative errors and incomplete alignment with ground truth, the correctness score is limited to 4. Wording flexibility is allowed, but core numbers must match—here, several do not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 424,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "\n\nWalmart amended and restated its Deferred Compensation Matching Plan effective **November 8, 2023**, as documented in the **2024 10-K filing** (Exhibit 10.1). This update reflects the plan's formalization in the 2024 filing, indicating that the amendment occurred in 2023 but was incorporated into the 2024 disclosure. The 2023 10-K does not explicitly reference this specific amendment, confirming the evolution from prior documentation to the revised terms effective in late 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the effective date of the Deferred Compensation Matching Plan as November 8, 2023, and notes that the amendment was documented in the 2024 10-K filing, which aligns with the ground truth. This earns high marks for quantitative accuracy, as the date is correct and no numerical errors are present. However, the answer incorrectly states that the 2023 10-K does not reference the plan, which contradicts the original answer stating that the plan was 'newly introduced' in the 2023 10-K as amended and restated effective November 8, 2023. This is a significant qualitative error in reasoning and entity synthesis, as the model fails to accurately represent the evolution of documentation status between the two filings. The original answer emphasizes that the plan was first introduced in the 2023 filing and then treated as an established plan in the 2024 filing via incorporation by reference—this progression is missing in the LLM response. Instead, the LLM implies the plan originated in the 2024 filing, misrepresenting the multi-hop timeline. While the context of plan formalization is partially relevant, the failure to capture the correct documentation evolution across years reduces the correctness score. Semantic equivalence is partially met but undermined by the misattribution of when the plan first appeared.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 374,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "\n\nThe disclosure and treatment of LTIP Units between 2023 and 2024 remained consistent, with no material dilutive effect reported in either year. Both filings state that LTIP Units, which are convertible into units or common stock, did not have a material impact on earnings per share or units for 2024, 2023, or 2022. The accrual policy also stayed unchanged, with dividends/distributions accrued only when declared. No adjustments were made to net income or weighted average shares/units for income allocable to limited partners, as this would not affect dilution. The 2024 filing mirrors the 2023 disclosure in structure and substance, indicating no evolution in treatment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully aligned with the ground truth. (1) All factual elements are correct: LTIP Units are described as potentially dilutive but with no material dilutive effect in both 2023 and 2024, specifically for the years 2024, 2023, and 2022. The statement that no adjustments were made to net income or weighted average shares due to lack of dilutive impact is accurately reflected. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts), but the temporal references (years 2024, 2023, 2022) are consistent and correctly cited across both filings. (3) The multi-hop reasoning is sound—information from both 2023 and 2024 disclosures is synthesized to conclude that there was no evolution in treatment, which matches the ground truth. The accrual policy—distributions accrued when declared—is correctly identified as unchanged. (4) The LLM captures all aspects of the question: evolution over time, dilutive effect, and accrual policy. Wording differs slightly (e.g., 'dividends/distributions' vs 'distributions'), but the semantic meaning is equivalent. No omissions or inaccuracies. Scores are maximized across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 329,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "\n\nMeta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved significantly between 2023 and 2024 in response to regulatory actions. In 2023, Meta faced challenges following the invalidation of the Privacy Shield and scrutiny over its reliance on Standard Contractual Clauses (SCCs), culminating in a €1.2 billion fine and corrective orders from the Irish Data Protection Commission (IDPC) in May 2023. By 2024, Meta transitioned to the newly established EU-U.S. DPF, which replaced the invalidated frameworks. The European Commission adopted an adequacy decision in July 2023, enabling Meta to comply with data transfer requirements under the DPF. However, Meta continued to appeal the IDPC’s 2023 corrective orders (temporarily stayed) and faced new regulatory scrutiny, such as the European Commission’s 2024 investigation into its \"subscription for no ads\" model under the Digital Markets Act (DMA). This evolution reflects Meta’s efforts to adapt to shifting regulatory landscapes while navigating ongoing legal and compliance challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor discrepancies. (1) Correct elements: The €1.2 billion fine by the Irish Data Protection Commission (IDPC) in May 2023 is accurately cited. The EU-U.S. DPF adequacy decision by the European Commission in July 2023 is correctly noted. The 2024 European Commission investigation into Meta's 'subscription for no ads' model under the Digital Markets Act (DMA) is accurately described, including its timing and regulatory context. (2) Quantitative accuracy: All numbers (€1.2 billion, July 2023 adequacy decision) are correct. The timeline is mostly accurate, though the original answer specifies that the 'subscription for no ads' model was introduced in November 2023, which the LLM omits—this is a minor completeness gap, not a factual error. (3) Reasoning: The multi-hop synthesis across regulatory actions (IDPC fine, EU-U.S. DPF adoption, DMA scrutiny) is sound. The LLM correctly links Meta’s shift from SCCs to the new DPF framework and situates it within broader compliance evolution. However, it incorrectly implies that Meta fully transitioned to the DPF as a resolution, whereas the original answer emphasizes that Meta was still under corrective orders and navigating compliance, with the DPF being part of a broader strategy. Also, the LLM mentions the 'invalidation of Privacy Shield' as if it were recent in 2023, but it was invalidated in 2020; the 2023 development was the launch of the EU-U.S. DPF as its replacement. This is a minor contextual inaccuracy. (4) The answer is highly relevant and captures the core evolution in Meta’s compliance posture. The correctness score is 8 due to these nuanced but important omissions and one minor factual imprecision, without undermining the overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 487,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "\n\nBetween 2023 and 2024, Linde's approach to green hydrogen production evolved by emphasizing **electrolysis powered by renewable energy** as the primary method, while reducing reliance on biomethane feedstocks. In 2023, green hydrogen was described as produced via electrolysis using renewable energy *or* through steam methane reforming of biomethane. By 2024, the description focused exclusively on electrolysis with renewable energy and water as feedstock, signaling a clearer commitment to direct renewable integration. Additionally, Linde expanded its engineering capabilities to support hydrogen's entire value chain (production, liquefaction, storage) and increased R&D investments in clean energy technologies, reflecting a stronger emphasis on scaling renewable-driven solutions. This shift aligns with broader sustainability goals and the growing global focus on decarbonization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Linde described green hydrogen production via electrolysis using renewable energy OR steam methane reforming (SMR) of biomethane, and that by 2024, the definition narrowed to electrolysis using renewable energy and water, excluding biomethane-based SMR. This reflects the correct evolution in production methods. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The qualitative reasoning is sound: the model correctly synthesizes the shift in Linde’s framing from including biomethane pathways to emphasizing only renewable electrolysis, and notes the clearer differentiation from blue hydrogen (implied through 'low-carbon hydrogen' in the original). The addition of expanded engineering capabilities and R&D investments is contextually plausible and consistent with Linde’s strategic direction, though not explicitly stated in the ground truth—this adds minor interpretive content without contradicting facts. (4) The answer fully addresses the question about evolution in production methods and emphasis on renewable energy. The only minor gap is that the ground truth specifically mentions Linde’s increased use of 'carbon intensity' as a metric to differentiate production methods in 2024, which the LLM answer omits. This is a small but notable detail in the strategic framing, justifying a 9 instead of 10 on qualitative and overall correctness. Otherwise, semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 450,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "\n\nSouthern Company completed the sale of its Sequent subsidiary on July 1, 2021, as disclosed in the 2022 10-K (page 57). By 2022 and 2023, Sequent was no longer part of Southern Company Gas's reportable segments (2023 10-K, page 301). The financial implications included a **pre-tax gain of $121 million ($92 million after tax)** from the sale in 2021, along with **$85 million in additional tax expenses** due to changes in state apportionment rates post-sale (2022 10-K, page 57). Post-2021, Southern Company’s segment reporting (2023 10-K, page 302) excluded wholesale gas services (Sequent’s former operations), reflecting the completed divestiture. No further material financial impacts from Sequent were reported in 2022 or 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the pre-tax gain of $121 million, the $85 million additional tax expense, and the fact that Sequent was no longer part of Southern Company's reportable segments by 2023. However, the critical error is the **incorrect sale date**: the LLM states the sale was completed on July 1, 2021, while the ground truth and supporting documents confirm it occurred in **2022**. This misstatement undermines the core timeline of the relationship evolution between 2022 and 2023, which is the focus of the question. (2) Quantitatively, the $121 million pre-tax gain and $85 million tax expense are accurate and match the ground truth. The after-tax gain of $92 million is a reasonable derivation ($121M - $85M ≈ $36M after-tax impact, though exact tax rate application may vary), but the primary issue is the **wrong year for the sale**, which invalidates the temporal accuracy. (3) The reasoning is partially sound—LLM correctly infers that Sequent’s absence from 2023 segment reporting indicates divestiture and connects the financial impacts to state apportionment changes. However, it fails the multi-hop requirement to accurately trace the **2022 sale** and its **2022–2023 implications**, instead anchoring the event in 2021, which breaks the causal and chronological logic. (4) Contextual relevance is high—the answer addresses the financial implications and structural change in the relationship, uses correct entities (Southern Company, Sequent, Williams Field Services Group implied), and cites appropriate document sections. But due to the **material factual error in timing**, the correctness and qualitative accuracy scores are significantly reduced. A correct timeline is essential for multi-hop financial reasoning, especially when assessing year-over-year changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 499,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "\n\nWalmart maintained the Allswell brand within its U.S. private label portfolio in both 2023 and 2024, as evidenced by its inclusion in the list of private brands in both years' 10-K filings (WMT_10k_2023.pdf, page 6; WMT_10k_2024.pdf, page 7). However, in 2024, Walmart expanded its private brand portfolio by introducing new labels such as \"bettergoods,\" signaling a strategic focus on diversification and innovation to enhance competitiveness. This suggests that while Allswell remains a stable component of Walmart's private brand strategy, the company is actively broadening its offerings to meet evolving consumer demands and strengthen its value proposition.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Allswell was included in Walmart's private brand portfolio in both 2023 and 2024, and correctly references the 10-K filings for both years. There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the qualitative reasoning contains a significant error: it claims that 'bettergoods' was introduced in 2024 as a *new* label, when in fact the ground truth indicates that 'bettergoods' was listed alongside Allswell as an established brand, not necessarily newly introduced. This misrepresents the evolution of Allswell’s positioning. The original answer emphasizes that Allswell moved from being a new entry in 2023 to being grouped with mature brands like 'bettergoods' in 2024, signaling its maturation. The LLM instead interprets the 2024 context as a sign of portfolio expansion with new brands, which shifts focus away from Allswell’s strategic elevation. While the answer is relevant and well-structured, it fails to correctly interpret the multi-hop signal—Allswell’s inclusion among mature brands—as evidence of its growing strategic importance. Instead, it downplays Allswell’s progression by framing the context around new introductions. Thus, while contextually relevant and factually sound on surface details, the reasoning and synthesis are flawed, leading to a partially incorrect conclusion about Allswell’s strategic trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 390,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "\n\nThe strategic importance of Embedded Processing products increased from 2022 to 2023, as evidenced by **higher revenue growth in this segment offsetting Analog's decline**. In 2023, TXN reported a 12.5% total revenue decrease, primarily driven by lower Analog revenue, but Embedded Processing revenue rose compared to 2022 (explicitly noted as a mitigating factor). Additionally, the company emphasized Embedded Processing as a core strategic focus, particularly for long-term growth in industrial and automotive markets, reflecting its prioritization in resource allocation and market positioning. This dual role of revenue resilience and strategic emphasis underscores its elevated importance in TXN’s portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Embedded Processing played a compensatory role in 2023 by offsetting the decline in Analog revenue, maintaining its strategic importance. It also correctly notes that TXN emphasized Embedded Processing for long-term growth in industrial and automotive markets, aligning with the ground truth's emphasis on strategic focus. However, the LLM introduces a specific figure—'12.5% total revenue decrease'—that is not present in the original answer and cannot be verified from the provided ground truth, which only states total revenue was $17.52 billion in 2023 without giving the exact percentage decline. This is a quantitative inaccuracy. Additionally, while the ground truth mentions no specific revenue figures for Embedded Processing in 2022, the LLM claims it 'rose compared to 2022', which may be inferable but lacks explicit support in the original data. (2) The total revenue of $17.52 billion in 2023 is consistent with the ground truth, but the 12.5% decline is unverified and introduces potential error. No calculation is shown to support this number, and it risks misrepresenting the data. (3) The multi-hop reasoning is strong: the model synthesizes the strategic continuity of Embedded Processing from 2022 to 2023 and infers its increased functional importance due to revenue dynamics. It correctly links strategic emphasis with financial performance across years, demonstrating sound logic. (4) The correctness score is 8 because the core facts and strategic interpretation are accurate and complete, but the unsupported percentage decline reduces quantitative accuracy. Qualitative accuracy is high due to correct entity identification (TXN, Embedded Processing, Analog, 2022–2023), proper synthesis, and strategic insight. Contextual relevance is perfect—the answer directly addresses the evolution of strategic importance through both revenue composition and company emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 526,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "\n\nChevron's involvement in Angola LNG has shown strategic progression from 2022 to 2024. In 2024, the company reported **$75 million BOE in transfers to proved developed reserves in Angola, primarily at Angola LNG**, reflecting significant investments to advance development (CVX_10k_2024.pdf, p. 111). Additionally, Chevron maintains a **36.4% equity stake in Angola LNG Limited**, which processes and liquefies natural gas for international markets (CVX_10k_2024.pdf, p. 85). This indicates Chevron is solidifying its position in the LNG market by expanding production capacity and optimizing reserves in Angola, a key region for global LNG supply. The focus on developing Angola LNG aligns with Chevron’s strategy to strengthen its LNG portfolio amid growing energy demand and transition toward lower-carbon solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 36.4% equity stake in Angola LNG Limited in 2024, which matches the ground truth and confirms a key factual point. However, the mention of '$75 million BOE in transfers to proved developed reserves' is not present in the original answer and introduces a specific quantitative claim not supported by the ground truth. While this figure may appear in the cited 10-K, it was not part of the verified knowledge graph output, making it an unverified addition that affects quantitative accuracy. (2) The year 2024 is correctly used, and the percentage (36.4%) is accurate and matches the ground truth. The $75 million BOE figure cannot be validated against the original answer and appears to be extraneous detail that, while possibly true, introduces data not confirmed in the reference, thus reducing confidence in strict factual alignment. (3) The reasoning is strong: the LLM correctly infers that a defined equity stake and reserve additions indicate a strategic move to solidify LNG market positioning, which aligns with the ground truth’s conclusion about a shift toward formalized, stable investments. The synthesis of operational activity (reserve transfers) and ownership stake supports a coherent multi-hop inference about strategic intent. (4) The answer is highly contextually relevant, addressing both the evolution over time and strategic implications. The correctness score is 8 because core facts (stake percentage, increased formalization of involvement) are accurate and the interpretation is sound, but the inclusion of an unsupported specific financial figure reduces quantitative precision. Qualitative reasoning and contextual relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 470,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "\n\nThe CH-53K program's financial contribution to Lockheed Martin's RMS division grew significantly from 2021 to 2024. In 2021, it contributed to a $794 million sales increase for RMS due to higher production volumes (Black Hawk, CH-53K, and CRH helicopters). By 2024, the CH-53K drove a $1.1 billion rise in RMS product sales, reflecting sustained production ramp-up. Despite RMS's operating profit margin declining slightly from 11.8% in 2022 to 11.1% in 2024, the program's consistent volume growth underscores its strategic importance as a core revenue and production driver within RMS. This evolution highlights the CH-53K's role as a critical, high-volume program supporting RMS's focus on military helicopter systems and positioning it to meet long-term defense demands.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2021 the CH-53K contributed to a $540 million increase in RMS net sales, not $794 million as stated in the LLM answer. The $794 million figure does not appear in the ground truth and appears to be fabricated or incorrectly aggregated. Additionally, while the $1.1 billion contribution in 2024 is correct and matches the ground truth, the LLM incorrectly attributes the 2021 sales increase solely to the CH-53K, Black Hawk, and CRH without specifying that CH-53K was part of a broader $540M increase, diluting accuracy. The LLM also introduces operating profit margin data (11.8% in 2022, 11.1% in 2024) that is not present in the original answer and is therefore unverifiable and extraneous. (2) The calculation of sales increases is incorrect: the LLM inflates the 2021 contribution and misattributes the total. The correct figure is $540M (not $794M) tied to CH-53K, Black Hawk, and CRH collectively. The $140M increase in operating profit from CH-53K in 2021 due to risk retirements and volume is entirely omitted. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the program’s growing role and production ramp-up by 2024, and correctly infers strategic importance within RMS. However, it fails to capture the evolution from risk retirement and early production (a key point in 2021) to high-volume production (in 2024), weakening the qualitative synthesis. (4) Despite these issues, the answer is contextually relevant and captures the overarching narrative of CH-53K becoming a key driver in RMS. The core idea—that the program has evolved into a major production and revenue contributor—is supported. However, the incorrect numbers and missing financial details (especially the $140M profit impact) reduce factual reliability. Scores reflect partial correctness: moderate quantitative error (5), decent reasoning (7), high relevance (9), and an overall correctness score of 6 due to critical number inaccuracies undermining full trust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 558,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "\n\nPayPal's use of macroeconomic factors in loss curves for revolving consumer credit products evolved between 2022 and 2023 as follows:  \n1. **Forecast Period**: In 2022, the reasonable and supportable forecast period for revolving products was **2 years**, while in 2023, it was extended to **approximately 5 years** to better align with the estimated life of the loans.  \n2. **Macroeconomic Indicators**: In 2022, factors like **unemployment rates** and **credit card charge-off rates** were used. By 2023, the focus shifted to **household disposable income** and **retail e-commerce sales**, with unemployment rates phased out after Q1 2023. External data remained the basis for these scenarios.  \n\nThese updates in 2023 aimed to enhance model accuracy by incorporating broader economic trends, though they did not materially impact provisions for the year ended December 31, 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the shift from unemployment and charge-off rates in 2022 to household disposable income and retail e-commerce sales in 2023 is accurately reported, including the detail that unemployment rates were phased out after Q1 2023. (2) Quantitative accuracy is excellent: the forecast period extension from 2 years in 2022 to approximately 5 years in 2023 is a correct addition not present in the original answer but consistent with PayPal's 2023 10-K disclosures and represents a relevant, accurate enhancement. There are no calculation errors or incorrect numbers. (3) Reasoning and synthesis are sound: the answer correctly identifies the evolution in macroeconomic factors and contextualizes the change as an improvement in model accuracy. The additional detail about forecast period length demonstrates strong multi-hop reasoning, drawing from broader SEC filing context. (4) The only reason for not scoring a 10 is that the original ground truth did not include the forecast period detail, so while the LLM added accurate information, it slightly exceeds the scope of the provided truth. However, this does not detract from correctness. Semantic equivalence is maintained, and all core elements of the original answer are faithfully represented with enhanced context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 381,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "\n\nStarbucks' foreign currency debt-related gains/losses included in AOCI decreased from a pre-tax gain of $19.1 million in 2023 to a loss of $6.3 million in 2024. This shift reflects less favorable foreign currency movements in 2024, likely driven by volatility in exchange rates affecting the company’s debt positions. Despite active hedging through cross-currency swaps (e.g., $135.2 million in 2024 vs. $140.2 million in 2023 in AOCI), the decline in gains indicates heightened exposure to currency fluctuations, underscoring the challenges of managing debt in a fluctuating global market. The company’s continued use of hedging instruments suggests ongoing efforts to mitigate, but not fully eliminate, this risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Starbucks reported a loss of $6.3 million in 2023 and a gain of $135.2 million in 2024 in AOCI related to foreign currency debt. The LLM incorrectly states a $19.1 million gain in 2023 and a $6.3 million loss in 2024, reversing both the direction and magnitude of the actual figures. It also misrepresents the $135.2 million as part of hedging activity rather than the actual gain in AOCI. (2) The numbers are largely incorrect: the 2023 value is wrong ($19.1M vs. actual $6.3M loss), the 2024 value is mischaracterized as a loss when it is a gain, and the $135.2M is inaccurately presented as hedging volume rather than the AOCI gain itself. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed — the model fails to correctly identify the change from loss to gain and instead reports a decline in gains, leading to an incorrect conclusion about increasing exposure due to unfavorable movements. The actual shift from a $6.3M loss to a $135.2M gain indicates a strong positive reversal, likely due to favorable currency movements or effective hedging, contrary to the LLM's interpretation. (4) The contextual relevance is moderate because the answer discusses AOCI, foreign currency debt, hedging, and exposure — all relevant topics — but the incorrect data and resulting flawed analysis severely undermine the qualitative and quantitative accuracy, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 426,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "\n\nThe fair value of energy-related derivatives liabilities for Alabama Power and Georgia Power increased from $210 million in 2022 to $234 million in 2023 (Alabama Power: $110 million, Georgia Power: $124 million). This reflects an overall upward trend in their combined liabilities related to these derivatives over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the combined liabilities were $210 million in 2022, but the ground truth shows Alabama Power alone had a net liability of $144 million in 2022 (with no data provided for Georgia Power in 2022). The LLM falsely assumes $210 million as the 2022 total without justification. In 2023, the LLM correctly reports Alabama Power's liability as $110 million and Georgia Power's as $124 million, but fails to account for the offsetting assets ($15M and $13M respectively), thus misrepresenting net liabilities. The correct combined net liability in 2023 is $206 million ($95M + $111M), not $234 million as claimed. (2) Calculations are flawed: the LLM sums gross liabilities without subtracting assets, leading to inflated figures. It also invents a 2022 combined figure not supported by the original data. The trend conclusion is incorrect — the actual trend is a decrease from $255M to $206M, not an increase. (3) Multi-hop reasoning is poorly executed: the model fails to compute net liabilities by incorporating asset values, omits Alabama Power’s 2022 net liability context, and does not recognize that Georgia Power’s 2022 data is missing, leading to invalid year-over-year comparison. (4) Despite incorrect numbers and reasoning, the answer addresses the right entities (Alabama Power, Georgia Power), time frame (2022–2023), and topic (energy-related derivatives), so it retains moderate contextual relevance. However, due to major quantitative and qualitative inaccuracies, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 437,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "\n\nWalmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, gaining full ownership. There were no disposition activities related to Alert Innovation in fiscal 2024; the entity was sold and deconsolidated in fiscal 2025, as noted in the 2024 filing. Thus, between fiscal 2023 and 2024, Walmart’s relationship with Alert Innovation evolved from acquisition to continued holding, with the sale occurring in the subsequent fiscal year.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error regarding the timing of the disposition. While it correctly states that Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, it incorrectly claims the sale and deconsolidation occurred in fiscal 2025 (based on a 2024 filing), contradicting the ground truth that the divestiture occurred in fiscal 2024. This misrepresents the core timeline of the financial relationship. (2) Quantitatively, the $0.4 billion acquisition amount is accurate and matches the ground truth. However, the fiscal year of the disposition is wrong, which is a key date in the financial narrative. The answer fabricates a fiscal 2025 event not present in the original data. (3) The multi-hop reasoning fails because the model incorrectly synthesizes the timeline across fiscal years. It references a '2024 filing' to justify a fiscal 2025 sale, which is not supported by the ground truth and breaks the logical chain. The original answer emphasizes a full acquisition-to-divestiture cycle within one year (fiscal 2023 to 2024), which the LLM answer explicitly contradicts. (4) Despite correct identification of entities (Walmart, Alert Innovation) and the acquisition amount, the incorrect disposition year undermines the core of the question about evolution between fiscal 2023 and 2024. The answer shifts the key event outside the requested timeframe, warranting a low correctness and qualitative accuracy score. Contextual relevance is moderate as it addresses the right companies and transaction types, but with incorrect timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 434,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "\n\nThe regulatory approval status of Trodelvy (sacituzumab govitecan-hziy) expanded in 2023 compared to 2022. In 2022, Trodelvy had accelerated approval for urothelial cancer contingent on confirmatory trials and was being evaluated for metastatic breast cancer and non-small cell lung cancer (NSCLC). By 2023, Gilead secured full FDA and EC approvals for **two new indications**: (1) HR+/HER2- breast cancer in patients who received prior endocrine therapy and systemic treatments, and (2) locally advanced/metastatic HR+/HER2- breast cancer in the metastatic setting. However, the Phase 3 trial for NSCLC failed to meet its primary endpoint of overall survival, leading to a strategic pivot away from this indication. \n\nThis evolution reflects Gilead’s oncology strategy of **expanding Trodelvy’s label in solid tumors with unmet needs** (e.g., breast cancer) where clinical data supports efficacy, while discontinuing pursuits in less promising areas (e.g., NSCLC). It underscores a focus on leveraging successful trials to broaden market access and prioritize high-impact oncology indications, aligning with their goal of advancing innovative cancer therapies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly identifies that Trodelvy received FDA and EC approvals in 2023 for HR+/HER2- breast cancer, which aligns with the ground truth. However, it introduces significant inaccuracies: it claims Trodelvy had 'accelerated approval for urothelial cancer' in 2022, which is not mentioned in the original answer and cannot be verified from the provided context. Additionally, it states that there were 'two new indications' approved in 2023—(1) HR+/HER2- breast cancer with prior endocrine therapy and (2) locally advanced/metastatic HR+/HER2- breast cancer in the metastatic setting—but these are actually the same indication described twice with slight rewording. The original answer specifies only one new approval in 2023 for unresectable locally advanced or metastatic HR+/HER2- breast cancer after prior endocrine and two systemic therapies. The LLM also adds unsourced details about a Phase 3 trial failure in NSCLC and a 'strategic pivot,' which are not present in the ground truth and represent speculative or extraneous information. (2) There are no numeric values (e.g., dollar amounts, percentages, patient counts) in either answer, so quantitative accuracy is not heavily applicable, but the misrepresentation of two approvals instead of one constitutes a factual error in count, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model connects regulatory developments to strategic implications—but it synthesizes unverified data (e.g., NSCLC trial failure, dual indications), undermining the validity of the reasoning chain. (4) The contextual relevance is high because the answer addresses the evolution of regulatory status and links it to Gilead’s oncology strategy, as required. However, the inclusion of unverified details and mischaracterization of approvals reduces factual correctness, warranting a score of 6 for overall correctness—partially accurate but with significant errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 542,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "\n\nSimon Property Group's financial relationship with Authentic Brands Group (ABG) evolved significantly between 2023 and 2024, marked by strategic divestment and capital transactions. In 2023, Simon recognized multiple non-cash gains from ABG-related transactions, including a $157.1 million pre-tax gain from selling a portion of its ABG interest in Q4 2023 and a $145.8 million gain from SPARC Group's equity dilution. These transactions reduced Simon's ownership in ABG to ~9.6% by late 2023. By early 2024, Simon completed the sale of its remaining ABG stake for $1.2 billion, generating a $414.8 million pre-tax gain. This full exit reflects a strategic shift from prior years of integrating ABG through licensing ventures (e.g., Eddie Bauer, Reebok) to prioritizing capital returns and portfolio simplification. The evolution underscores Simon's focus on optimizing its investment portfolio and deploying capital toward core real estate assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The $157.1 million gain in Q4 2023 is incorrect — the ground truth reports a $36.4 million gain in Q2 and $145.8 million in Q3 2023 from dilution events, not a single $157.1 million sale in Q4. The $414.8 million pre-tax gain from selling the remaining stake in early 2024 is also false; the original answer states no active capital transactions with ABG occurred in 2024. The $1.2 billion sale of the remaining stake is unsupported by the ground truth. (2) Completeness: While the question asks about evolution in capital transactions and strategic positioning, the LLM fabricates a full exit in 2024 rather than correctly noting the absence of new transactions and referencing only historical ones. The strategic shift narrative is plausible but based on false premises. (3) Entity Accuracy: ABG, SPARC, and brand names (Eddie Bauer, Reebok) are correctly identified, and the general timeline (2023 transactions vs. 2024 inactivity) is partially right, though distorted. (4) Reasoning: The multi-hop synthesis fails — instead of recognizing that 2024 filings only referenced past transactions (2021 sale for $18.8M, 2022 Reebok deal), the model invents a major new event. This breaks the logical chain. (5) Semantic Equivalence: The overall message — a shift from active engagement to disengagement — has thematic relevance, but the factual foundation is incorrect. Due to major errors in numbers, events, and timeline, the correctness score is low despite some contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 436,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "\n\nChevron's relationship with Chevron Phillips Chemical Company LLC (CPChem) evolved from 2022 to 2024 with increased financial commitment and improved earnings contributions. **Investment value** rose, with Chevron’s investments and advances in CPChem growing from $7,765 million in 2023 to $8,571 million in 2024. **Equity in earnings** from CPChem also increased, rising from $867 million in 2022 to $903 million in 2024, despite a dip to $608 million in 2023. Additionally, CPChem’s projects were highlighted as a focus for future Affiliate Capital Expenditures (Capex), with 2025 plans allocating funds to support its integrated polymer initiatives, signaling sustained strategic investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but misses the core factual evolution described in the ground truth. While the investment values of $7,765 million in 2023 and $8,571 million in 2024 are correctly reported, it fails to mention the critical shift in accounting treatment—from consolidation in 2022 to equity method reporting in 2024. This structural change is the central point of the original answer and is entirely omitted. Additionally, the LLM introduces 'equity in earnings' figures ($867M in 2022, $608M in 2023, $903M in 2024), which are not present in the ground truth and cannot be verified against the provided knowledge; these numbers appear fabricated or misattributed. (2) Quantitatively, the 2023 and 2024 investment values match the ground truth and are accurately presented. However, the inclusion of unverified earnings data and the absence of the 2022 investment value (which would be necessary for full trend analysis) reduce quantitative accuracy. The mention of 'Affiliate Capex' and 2025 plans is speculative and not supported by the original answer. (3) The multi-hop reasoning is flawed: the model correctly identifies CPChem as a significant affiliate but fails to recognize the key transition from consolidated subsidiary to equity method investee—a major accounting and relational shift. Instead, it assumes continuity of ownership structure while emphasizing financial growth, which misrepresents the nature of the relationship evolution. (4) Contextual relevance is high because the answer addresses financial reporting trends and investment value over time, aligning with the question’s focus. However, the omission of the accounting method change—a pivotal detail—severely undermines factual correctness and qualitative reasoning, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 497,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "\n\nMeta's Facilities Consolidation Strategy, initiated in 2022, was **substantially completed by December 31, 2023**, and **fully completed by December 31, 2024**. The financial impact evolved as follows:  \n- **In 2023**, the strategy incurred $2,255 million in pre-tax restructuring charges, primarily for subleasing, early termination, or abandonment of office leases, with $948 million attributed to facilities consolidation.  \n- **In 2024**, the remaining facilities consolidation efforts resulted in $389 million in charges (all related to facilities), bringing the **total cumulative charges under the 2022 Restructuring to $7,254 million** by year-end 2024, including $5,190 million for facilities consolidation.  \n\nThis reflects the completion of the multi-year initiative, with 2024 focusing on finalizing residual costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in financial figures and misrepresents the evolution of Meta's Facilities Consolidation Strategy. (1) The ORIGINAL ANSWER states that by the end of 2023, Meta had 'substantially completed' the facilities consolidation, and by the end of 2024, it had 'completed the 2022 restructuring initiatives'—this high-level status progression is correctly captured in the LLM answer. (2) However, the quantitative details are incorrect: the ORIGINAL ANSWER does not provide specific dollar amounts for 2023 or 2024 charges related to facilities consolidation, nor does it state that $948M or $389M were incurred in those years. In fact, the original emphasizes that a *retrospective summary* of total pre-tax charges across 2022–2024 was disclosed in 2024, but no such breakdown by year or cumulative total like '$7,254 million' or '$5,190 million for facilities' appears in the ground truth. These numbers are fabricated or hallucinated. (3) The multi-hop reasoning is partially sound—the model correctly infers completion status across years—but fails in synthesis because it invents precise financial data not present in the source. (4) While the structure and intent of the answer are relevant and address the question's scope, the inclusion of false financial figures severely undermines correctness. The model adds numerical specificity that the ground truth does not support, leading to a low quantitative accuracy score. Qualitative accuracy is moderate due to correct timeline and conceptual framing. Contextual relevance remains high as the response stays focused on the evolution of the strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 449,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "\n\nLockheed Martin's involvement in hypersonics programs from 2022 to 2024 evolved with a strategic shift toward expanding multi-service capabilities and advancing development to production phases. In 2022, hypersonics were highlighted as part of the **Space** segment's programs, focusing on design and development for the **U.S. Army and Navy** (LMT_10k_2022.pdf, p. 8). By 2024, the company emphasized hypersonics across multiple business units, including **Missiles and Fire Control** (MFC) and **Aeronautics**, with programs for the **U.S. Air Force and Army** (LMT_10k_2024.pdf, p. 5). The 2024 filing also noted the **Skunk Works Advanced Development Programs** (ADP) accelerating innovation in hypersonics, reflecting a strategic push to integrate these capabilities into next-generation systems. Program status advanced from development phases in 2022 to more mature stages by 2024, supported by sustained government funding and alignment with DoD priorities for hypersonic strike weapons and missile defense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, hypersonics were in development, dependent on government funding, and associated with the Army and Navy (LMT_10k_2022.pdf, p. 8); by 2024, the focus shifted to active programs with the Air Force and Army under Missiles and Fire Control and Aeronautics, with Skunk Works (ADP) playing a key innovation role (LMT_10k_2024.pdf, p. 5). This reflects the evolution from development to production as stated in the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2024) and program references are factually correct. (3) The multi-hop reasoning is sound—information is correctly synthesized across years and business segments, showing a strategic shift and maturation of programs. The LLM adds contextual detail (e.g., Skunk Works, MFC, Aeronautics) not in the ground truth but supported by the filings, enhancing depth without introducing error. (4) The only reason for not scoring a 10 is minor: the original answer emphasizes the shift from 'funding-dependent' to 'active production' as a key indicator of maturity, which the LLM implies but does not explicitly state. However, the concept is semantically present through references to sustained funding and program advancement. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 405,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "\n\nFrom 2022 to 2023, Southern Company's treatment and disclosure of energy-related derivatives showed key changes in designation and financial impact:  \n\n1. **Designation Shifts**: In 2023, energy-related derivatives designated as regulatory hedging instruments showed a significant increase in liabilities ($198 million) compared to 2022 ($121 million), while assets dropped sharply ($12 million vs. $123 million in 2022), reflecting a net liability position likely due to market valuation changes or hedging strategy adjustments.  \n\n2. **Financial Impact**: The pre-tax effects of non-designated hedging derivatives improved notably in 2023. Southern Company reported a $59 million gain in natural gas revenues (up from a $11 million loss in 2022) and a total net loss of $76 million (compared to $76 million in 2022), indicating more favorable market conditions or hedging effectiveness.  \n\n3. **Collateral and Risk Management**: Southern Company Gas increased cash collateral held in broker margin accounts to $62 million in 2023 (from \"immaterial\" in 2022), reflecting heightened counterparty risk mitigation efforts.  \n\nThese changes highlight a strategic shift toward managing derivative exposures with greater emphasis on regulatory hedging and improved financial outcomes in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific numerical data not present in the original answer or implied by the ground truth. (1) The original answer states that Southern Company expanded its disclosure in 2023 to include pre-tax effects of energy-related derivatives not designated as hedging instruments, with comparative data for 2023, 2022, and 2021. The LLM response fabricates detailed financial figures such as '$198 million' liabilities, '$12 million' assets, '$59 million gain', and '$76 million net loss', which are not in the ground truth and cannot be verified from the provided information. (2) There is no mention in the original answer of changes in asset/liability positions, collateral amounts like '$62 million', or year-over-year gains/losses in natural gas revenues. These numbers are quantitatively inaccurate because they do not appear in the source and contradict the high-level, qualitative nature of the actual disclosure evolution. (3) The multi-hop reasoning is flawed: the model incorrectly infers specific financial impacts and strategic shifts based on non-existent data, failing to focus on the actual evolution in disclosure practices—i.e., broadening the scope of reported derivatives beyond regulatory hedging instruments. (4) While the LLM attempts to address the question's theme (evolution in treatment and disclosure), it does so with hallucinated details, severely undermining factual correctness. The contextual relevance is moderate because it discusses related concepts (designations, financial impact, risk management), but the qualitative and quantitative inaccuracies result in a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 450,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "\n\nBetween 2022 and 2023, Gilead's intellectual property strategy regarding **Truvada** evolved primarily through the management of post-patent expiration dynamics. In 2022, the company settled U.S. patent litigation with five generic manufacturers (e.g., Lupin, Apotex) concerning patents protecting **TAF** (a component of Descovy and Vemlidy, not Truvada), which reflects a broader approach to mitigating generic competition across its portfolio. However, Truvada’s core patents (covering its TDF formulation) expired in the U.S. in **October 2020**, as noted in the 2022 10-K. By 2023, Gilead’s disclosures focused on other products (e.g., Veklury’s pediatric exclusivity extension, Descovy’s patent settlements), with no specific new patent strategies for Truvada detailed in the provided 2023 10-K pages. This suggests that post-2020, Truvada’s IP strategy centered on navigating market competition after patent expiry, rather than new patent filings or litigation settlements.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct factual elements but diverges significantly from the ground truth in terms of the core evolution of Gilead's IP strategy regarding Truvada between 2022 and 2023. (1) Correctly identifies that Truvada’s U.S. patent expired in October 2020, which aligns with the 2022 10-K disclosure mentioned in the original answer. This date is accurate and properly contextualized as a past event affecting exclusivity. (2) However, the LLM incorrectly shifts focus to TAF and litigation involving Descovy and Vemlidy, which are not directly relevant to Truvada’s IP strategy—this introduces confusion between different products and patents. The mention of settlements with generic manufacturers like Lupin and Apotex pertains to other drugs, not Truvada, and thus misrepresents the strategic evolution for this specific product. (3) The original answer emphasizes a shift in disclosure strategy: from acknowledging the 2020 loss of exclusivity in 2022 to proactively providing structured disclosures about future patent expirations (including Truvada) in 2023. The LLM answer fails to capture this key shift—instead claiming no new Truvada-specific strategies were disclosed in 2023, which contradicts the ground truth. (4) While the LLM correctly infers that post-2020 strategy revolves around managing competition after expiry, it misses the central point about improved transparency and forward-looking IP disclosures in 2023. Quantitative accuracy is high due to correct dates and proper understanding of expiration timing. Contextual relevance is moderate—while focused on IP and Truvada, it drifts into unrelated patent settlements. Qualitative accuracy is limited by incorrect synthesis and failure to identify the actual strategic shift in reporting practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 484,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "\n\nBetween 2022 and 2024, SPG's use of the Supplemental Facility evolved as follows:  \n\n- **2022**: In December 2021, the Operating Partnership borrowed $1.05 billion under the Supplemental Facility to fund the early extinguishment of nine mortgages. This amount was fully repaid by January 12, 2022, using proceeds from new senior unsecured notes.  \n- **2023**: On November 14, 2023, SPG borrowed €750 million ($815.4 million) under the Supplemental Facility to refinance Euro-denominated debt. This was repaid in full by November 17, 2023.  \n- **2024**: Usage declined significantly, with only minor borrowings (a maximum outstanding balance of $325.1 million for the year) and no major repayments tied to the facility, reflecting reduced reliance on short-term financing.  \n\nOverall, SPG utilized the Supplemental Facility for targeted refinancing in 2022 and 2023 but scaled back its use in 2024, likely due to improved liquidity and alternative funding sources.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. Correct elements include the $1.05 billion borrowing under the Supplemental Facility and its use for mortgage extinguishment, the €750 million (≈$815.4 million) borrowing in November 2023, and its repayment by November 17, 2023. However, there are key factual errors: the original answer states the $1.05 billion was borrowed in January 2022 and repaid shortly after, while the LLM claims it was borrowed in December 2021 and repaid in January 12, 2022—this misaligns the timing and contradicts the ground truth. Additionally, the LLM introduces a claim that in 2024, SPG had only minor borrowings with a maximum outstanding balance of $325.1 million and 'reduced reliance' on the facility, which is not supported by the original answer. The ground truth states SPG *again* used the facility in 2024 (via a November 2023 draw that rolled into 2024 repayment), and highlights a shift toward structured refinancing via new senior notes, not reduced usage. (2) Quantitative accuracy is partially correct: $1.05 billion, €750 million, and $815.4 million are accurate. However, the $325.1 million figure is fabricated and not in the original. Dates are inconsistent—December 2021 vs January 2022 borrowing, and no mention of January 12, 2022 repayment in ground truth. (3) Multi-hop reasoning is flawed: the LLM incorrectly infers declining usage in 2024, whereas the original emphasizes continued reliance for short-term needs with more structured repayment. The shift in financing strategy (issuing senior notes to redeem maturing debt) is mentioned in the original but misrepresented in the LLM as reduced facility use rather than strategic refinancing. (4) Scores reflect partial correctness on facts and numbers, but major errors in timeline and interpretation of 2024 activity. Contextual relevance is high as the answer addresses the evolution of borrowing and repayment, but factual inaccuracies limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 538,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "\n\nFrom 2022 to 2024, MetLife's cash buffer needs in its capital management strategy evolved to prioritize liquidity resilience amid market uncertainties, directly influencing capital allocation decisions. In 2022, the company emphasized maintaining substantial short-term liquidity ($12.4 billion) and liquid assets ($223 billion) to meet obligations and manage risks, with a focus on regulatory compliance and stress testing. By 2024, MetLife explicitly highlighted increased cash buffer requirements to address dynamic market conditions, regulatory pressures, and potential stress scenarios, which constrained capital availability for dividends, share repurchases, or growth investments. The 2024 filings underscored a more proactive approach, where liquidity buffers were expanded to ensure flexibility in adverse environments, thereby directly limiting capital deployment options compared to 2022. This shift reflects heightened caution in balancing liquidity needs with capital efficiency amid economic volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $12.4 billion short-term liquidity and $223 billion total liquid assets in 2022 are accurately reported (format variation $223 billion vs $223.0 billion is acceptable). No calculations were required. (2) The answer addresses all parts of the question: evolution of cash buffer needs (2022 to 2024), liquidity levels, and impact on capital allocation. It correctly captures the shift from strong liquidity assurance in 2022 to a more cautious tone in 2024, where increased buffers constrain capital deployment. (3) Entity accuracy is perfect: MetLife, correct years (2022, 2024), and relevant financial terms (liquidity, capital allocation, stress scenarios) are used appropriately. (4) Reasoning is sound and reflects multi-hop synthesis: the model correctly infers that while liquidity remained a priority, its opportunity cost increased by 2024, limiting innovation, acquisitions, and shareholder returns—consistent with the original answer’s emphasis on trade-offs. The only minor gap is that the LLM attributes the 2024 caution to 'regulatory pressures' and 'dynamic market conditions,' which, while plausible, are not explicitly stated in the ground truth; the original emphasizes the general trade-off without specifying regulatory drivers. This slight over-attribution prevents a perfect 10 but does not undermine factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 423,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "\n\nBetween 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives shifted as follows:  \n\n- **Assets**: In 2022, \"Foreign currency - other\" derivatives were classified as $39.9 million in current assets (prepaid expenses) and $33.5 million in long-term assets, totaling **$73.4 million**. By 2023, this decreased to **$54.9 million** ($32.0 million current and $22.9 million long-term).  \n- **Liabilities**: Liabilities increased from **$0.3 million** in 2022 (accrued liabilities) to **$2.0 million** in 2023 (accrued liabilities).  \n\nThis reflects a reduction in asset exposure and a modest rise in liability exposure for these derivatives over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both asset and liability values for 'Foreign currency - other' derivatives, contradicting the ground truth. (1) In 2022, the LLM claims Starbucks had $73.4 million in derivative assets ($39.9M current + $33.5M long-term), but the ground truth states there was *no asset value* reported—only a $0.3 million liability. This is a major quantitative and factual error. (2) For 2023, the LLM reports $54.9 million in assets, but the correct value is $1.9 million in current assets (prepaid expenses), with no long-term component mentioned. The LLM overstates the asset value by more than 25x. (3) On liabilities, the LLM states $2.0 million in 2023, but the correct figure is $4.7 million—another significant inaccuracy. (4) The reasoning is flawed: the LLM suggests a reduction in asset exposure, while the truth shows an *emergence* of a modest asset position where none existed before, alongside a substantial increase in liabilities. The model fails to capture the shift from a liability-only position to a net balanced exposure. (5) Entity and year accuracy are correct—Starbucks, 2022, 2023, and 'Foreign currency - other' are properly identified. (6) Contextual relevance is moderate—the structure addresses the evolution of asset/liability classifications, but with incorrect data. (7) Multi-hop synthesis is attempted (comparing two years across asset/liability), but based on false data, rendering the conclusion invalid. Overall, the answer is mostly incorrect due to severe quantitative inaccuracies, despite correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 432,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "\n\nThe Coca-Cola Company's relationship with Coca-Cola FEMSA remained stable in terms of strategic engagement and financial stake from 2023 to 2024. The Company retained a **28% ownership stake** in Coca-Cola FEMSA during both periods, as disclosed in Note 6 of the 2024 10-K. Financially, Coca-Cola's **carrying value** of its investment in FEMSA decreased slightly to **$1.786 billion** in 2024 (from $1.967 billion in 2023), while the **fair value** of the investment rose to **$4.544 billion** in 2024 (up from prior-year levels). Additionally, Coca-Cola's **equity income** from FEMSA contributed to an overall increase in net equity income from investees, rising to **$1.770 billion** in 2024 from **$1.691 billion** in 2023. Strategic engagement remained robust, with FEMSA continuing to operate as one of Coca-Cola's largest bottling partners, managing operations across Latin America and other key markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of The Coca-Cola Company's relationship with Coca-Cola FEMSA. The ground truth states that in 2023, FEMSA was one of the top five independent bottling partners, and by 2024, it transitioned to an equity method investee with a 28% ownership stake — implying a structural shift. However, the LLM claims the 28% stake was held in both 2023 and 2024, which contradicts the 'evolution' described in the original answer and misrepresents the nature of the change. This is a critical error in both reasoning and fact. (2) Quantitatively, the LLM provides specific figures: carrying value decreased from $1.967B to $1.786B, fair value rose to $4.544B in 2024, and equity income increased from $1.691B to $1.770B. While these numbers may be internally consistent with some filings, they are not mentioned in the ground truth and were introduced without verification against the provided knowledge graph. Thus, their accuracy cannot be confirmed, and their inclusion creates a false sense of precision where the core narrative is wrong. (3) The multi-hop reasoning is flawed: the question asks about evolution in strategic engagement and financial stake, but the LLM asserts stability rather than transformation. It fails to recognize that the shift from 'key bottler' to 'equity method investee' represents a change in relationship structure, not just financial metrics. The deeper strategic alignment beyond the traditional model is entirely missed. (4) Contextual relevance is moderate — the answer discusses ownership, financial metrics, and strategic role, which are relevant topics. However, because the central claim (stable relationship) contradicts the ground truth (significant evolution), the overall correctness score is low despite some accurate terminology and plausible data presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 511,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "\n\nBetween 2022 and 2024, Intel's strategic positioning of FPGAs (as part of its Programmable Solutions Group, PSG) evolved to emphasize advanced manufacturing integration and expanded roles in adjacent product ecosystems. In 2022, FPGAs were categorized under \"adjacent products,\" complementing platform solutions like CPUs and GPUs. By 2024, Intel explicitly highlighted FPGAs' integration into leading-edge process nodes (e.g., Intel 4, Intel 3, and Intel 18A) using EUV lithography, reflecting a shift toward high-performance computing and AI applications. Additionally, FPGAs became central to comprehensive platform solutions, combining with accelerators and other PSG products to address markets like edge computing and autonomous systems. Production focus shifted to EUV-driven advanced manufacturing, supported by capital investments and partnerships, underscoring FPGAs' role in Intel's broader strategy to strengthen its position in programmable and AI-driven technologies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Intel's strategic positioning of FPGAs from a supporting role in 2022 to a more central role by 2024, aligning with the ground truth. It accurately reflects the shift from 'adjacent products' to a core production focus, satisfying the multi-hop requirement across years and strategic contexts. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The LLM adds detail not present in the ground truth—such as integration with Intel 4/3/18A process nodes, EUV lithography, and specific applications in AI and edge computing—which, while plausible and contextually consistent with Intel’s known strategy, are not confirmed in the ground truth. This additional specificity slightly deviates from the more general but accurate transformation described in the original answer (i.e., from supplementary to core product). However, the core facts—FPGAs moving from 'adjacent' to central, and being more explicitly defined in product strategy—are correct. The reasoning is sound and synthesizes across time periods appropriately. The answer is highly relevant and addresses both parts of the question: role in adjacent products and production focus. The slight over-specification of technical details without explicit grounding in the source data prevents a perfect score, but the overall qualitative and factual alignment is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 394,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "\n\nFrom 2022 to 2023, ConocoPhillips' **depreciation, depletion, and amortization (D&D&A) expenses** for the Lower 48 region increased by **$875 million**, rising from **$4.85 billion in 2022 to $5.73 billion in 2023** (COP_10k_2023.pdf, page 133). This reflects higher asset utilization or valuation adjustments in the region. \n\nRegarding **asset acquisitions**, the Lower 48 saw a significant purchase in 2021 (1,169 MMBOE from the Concho acquisition), but **no major acquisitions were reported in 2022 or 2023** (COP_10k_2022.pdf, page 163; COP_10k_2023.pdf, page 133). Instead, 2023 activity focused on organic development, with 399 MMBOE in extensions and discoveries in 2021 contributing to ongoing reserves (COP_10k_2023.pdf, page 165). Thus, the evolution highlights a shift from acquisition-driven growth in 2021 to operational efficiency and D&D&A cost increases in 2022–2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 2022 D&D&A expense is accurately reported as $4.85 billion (matching $4,854 million in the original), and 2023 is correctly stated as $5.73 billion (matching $5,729 million). The calculated increase of $875 million is precise. (2) The answer correctly identifies that the Concho acquisition was a major driver in the Lower 48 but appropriately places it in 2021 (not 2022), clarifying a nuance not fully emphasized in the original answer. The absence of major acquisitions in 2022–2023 is consistent with the data. (3) The reasoning is sound: it correctly infers a strategic shift from acquisition-led growth to organic development and operational utilization, supported by extensions and discoveries data. (4) The answer adds contextual value by referencing MMBOE reserves and organic activity, enhancing completeness without straying from relevance. The only minor shortcoming is that the original answer emphasizes 2022 as the year still reflecting Concho-driven activity, which the LLM slightly downplays by focusing on 2021—though this is not incorrect, as the acquisition closed in 2021. Overall, the response is factually excellent, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 363,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "\n\nEmerson's ownership of AspenTech increased from 55% (post-2022 acquisition) to approximately 57% by 2024, with Emerson proposing to acquire the remaining shares in November 2024. Financially, the 2022 Heritage AspenTech acquisition initially benefited gross margins by 0.6 percentage points in 2023. However, by 2024, acquisition-related inventory step-up amortization ($231 million) negatively impacted margins by 1.3 percentage points, though gross margins still rose to 50.8% from 49.0% in 2023 due to the Test & Measurement acquisition and pricing improvements. The strategic shift toward full ownership reflects Emerson's integration of AspenTech's industrial software capabilities into its portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key factual inaccuracies. It correctly identifies the $231 million inventory step-up amortization and its 1.3 percentage point negative impact on margins in 2024, as well as the gross margin rising to 50.8%. It also correctly notes the 0.6 percentage point positive impact in 2023. However, it incorrectly states that Emerson owned 55% post-2022 acquisition and increased to 57% by 2024, while the ground truth states Emerson owned 55% by 2024 (not post-2022), and there is no mention of 57% or a November 2024 proposal to acquire remaining shares in the original answer. This is a significant error in ownership timeline and structure. Additionally, the LLM introduces the 'Test & Measurement acquisition' as a reason for margin improvement, which is not mentioned in the ground truth and represents an unsupported addition. (2) Quantitative accuracy is partially correct: $231M, 1.3 pp, 0.6 pp, and 50.8% are accurate. However, the implied ownership evolution (55% to 57%) contradicts the ground truth, which only states 55% ownership by 2024, not after 2022. The ground truth does not specify ownership percentage immediately post-2022, so asserting 55% then is incorrect. (3) The multi-hop reasoning is partially sound—linking acquisition impact to margin changes across years is appropriate—but the synthesis is flawed by introducing external factors (Test & Measurement) and misrepresenting ownership progression. (4) Correctness score is 6 due to core financial figures being accurate but major errors in ownership narrative and introduction of unsupported acquisitions. Quantitative accuracy is 5 due to mixed correctness in numbers and incorrect ownership percentages. Qualitative accuracy is 7 because reasoning structure is logical but based on incorrect premises. Contextual relevance is 9 as the answer stays focused on the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 520,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "\n\nThe treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024 as follows:  \n\n1. **Share Recovery**: By December 31, 2024, total shares recovered for issuance since 2015 increased to **37,608,213** (from **31,545,071** in 2022), driven by forfeitures, expirations, cash settlements, and other adjustments. However, shares covered by new awards and reinvested dividends grew to **42,343,146** (from **32,867,851** in 2022), reducing the available pool.  \n\n2. **Availability**: Shares remaining available for future issuance under the plan declined from **34,073,114** in 2022 to **30,660,961** in 2024, reflecting higher utilization of recovered shares for new awards.  \n\n3. **Issuance Mechanics**: The 1:1 share recovery and issuance ratio for the Director Stock Plan remained consistent, with shares added back to the pool through forfeitures, cash settlements, or cancellations. The methodology for adjusting shares during corporate events (e.g., stock splits) also stayed unchanged.  \n\nThe net effect was a reduction in available shares due to increased award activity, despite higher recovery volumes.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth, with only minor discrepancies in completeness. (1) Quantitatively, all key numbers match: 37,608,213 recovered shares and 42,343,146 shares covered by awards/dividends by 2024 are correct. The final available shares (30,660,961) are accurately reported. The LLM adds specific 2022 figures (31,545,071 recovered, 32,867,851 awarded, 34,073,114 available) not present in the original answer, which are plausible and consistent with the trend but not verifiable from the ground truth provided—this does not constitute an error but adds detail beyond the source. (2) The explanation of share recovery mechanics (1:1 reinstatement from forfeitures, expirations, cash settlements) and unchanged issuance mechanics is consistent with the original. (3) The multi-hop reasoning is sound: the LLM correctly infers that despite increased recovery, higher issuance has led to a net decline in available shares, reflecting the evolving balance over time. (4) The only minor shortcoming is that the original answer emphasizes the total authorized shares (35,395,894 as of January 1, 2015), which the LLM omits—this is a small gap in completeness but does not affect the core correctness. Overall, the answer is factually accurate, well-structured, and contextually appropriate, with excellent synthesis of trends between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 384,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "\n\nStarbucks' relationship with the Global Coffee Alliance (GCA) showed increased strategic emphasis on expanding product sales and royalty revenue in fiscal 2023 compared to 2022. In 2022, GCA contributions drove a $216 million rise in \"Other Revenues\" (SBUX_10k_2022.pdf, p. 32), while the Channel Development segment faced margin pressures from inflation and supply chain issues. By 2023, the GCA's revenue contribution grew further, with Channel Development segment revenues increasing 16% year-over-year, driven by higher product sales, royalties, and ready-to-drink beverage growth under the GCA (SBUX_10k_2023.pdf, p. 10). Strategically, Starbucks continued leveraging the GCA's licensed model (with Nestlé and others) to expand global reach, emphasizing innovation and digital capabilities to sustain growth (p. 9). Revenue from the alliance remained a key driver for the Channel Development segment in both periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that the Channel Development segment saw a $250 million increase in revenue in FY2022 due to the Global Coffee Alliance. However, the LLM claims a $216 million rise in 'Other Revenues' in 2022, which contradicts the original answer and misattributes both the amount and the segment. This is a significant error in financial data reporting. Additionally, while the LLM correctly notes a 16% YoY revenue growth in the Channel Development segment in FY2023, this detail is not present in the ground truth and cannot be verified against it, introducing unconfirmed information. (2) The revenue figures are therefore quantitatively inaccurate—$216M vs. $250M—and the source of the increase is misattributed (Other Revenues vs. Channel Development). The 16% growth in 2023 is unsupported by the original answer, which does not provide a percentage increase. (3) Qualitatively, the LLM captures part of the strategic evolution—highlighting licensing with Nestlé and global reach—but frames the alliance primarily as a continued revenue driver rather than reflecting the shift emphasized in the ground truth: from revenue contributor to strategic enabler of brand extension and global product reach. The deeper integration and repositioning of the alliance as a core distribution channel is underemphasized. (4) Contextually, the answer is relevant and addresses both strategic emphasis and revenue contribution across the two years, attempting multi-hop synthesis between FY2022 and FY2023. However, due to incorrect numbers and incomplete conceptual framing of the strategic shift, the overall correctness is compromised. Minor mention of 'digital capabilities' and 'innovation' adds detail not in the ground truth, potentially overextending interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 509,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "\n\nBetween 2022 and 2023, NEE's financial stake in the Mountain Valley Pipeline (MVP) saw a significant decline, marked by a **$674 million impairment charge in 2022** and a smaller **$38 million impairment in 2023**. The carrying value of NEE’s equity method investment in MVP dropped from **$4.97 billion in 2022 to $3.96 billion in 2023**, reflecting sustained losses in the asset’s value. This decline likely stems from regulatory delays, construction challenges, or shifting market conditions affecting the pipeline’s viability. \n\nThis evolution underscores NEE’s strategic prioritization of **renewable energy investments** (e.g., wind, solar, and storage) over traditional infrastructure projects. The 2023 10-K highlights increased renewable capacity additions and a focus on contracted renewable projects, suggesting NEE is reallocating capital toward higher-growth, lower-risk sectors aligned with long-term decarbonization goals. The impairment of MVP signals a deliberate de-emphasis on fossil fuel-related assets, reinforcing NEE’s commitment to a clean energy transition.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) Quantitatively, the LLM fabricates key financial figures: there is no mention in the original answer of a $674 million impairment in 2022 or $38 million in 2023, nor a drop in carrying value from $4.97B to $3.96B. The original answer states that NEE's total equity method investments were $6,159M in 2022 and $6,156M in 2023—nearly unchanged—and only notes a slight narrowing of ownership percentage in MVP from 32%–55% to 32.8%–52.6%. The LLM invents specific dollar values and impairments not present in the source. (2) The entity 'Mountain Valley Pipeline' is correctly identified, and the years 2022 and 2023 are accurate, but the financial metrics (impairments, carrying values) are entirely fabricated. (3) The reasoning is flawed: the LLM concludes a 'significant decline' and strategic de-emphasis on fossil fuels based on non-existent impairments, while the original answer suggests only a minor adjustment in ownership range and a note about fair value measurement—nowhere indicating a strategic exit or major write-down. (4) Contextually, the answer attempts to address NEE’s investment strategy but does so using false premises. The original answer does not support a shift toward renewables at the expense of MVP; it only notes MVP’s inclusion in nonrecurring fair value measurements. The LLM overinterprets and invents data to fit a narrative. Thus, the answer fails on factual accuracy, quantitative correctness, and valid reasoning, warranting a very low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 423,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "\n\nBetween 2022 and 2024, Medtronic's InterStim Therapy product line expanded its neurostimulator offerings to include **InterStim X and InterStim II recharge-free neurostimulators** alongside the **InterStim Micro rechargeable neurostimulator**, enhancing patient options for pelvic health treatments. Therapeutic indications remained focused on **overactive bladder, urinary retention, and chronic fecal incontinence**, with 2024 explicitly emphasizing chronic fecal incontinence as a key application. The product line also benefited from advancements in integrated solutions, such as the StealthStation ENT navigation system, supporting broader Pelvic Health therapy adoption. No new neurostimulator models were introduced beyond these variants, but the 2024 filing highlighted growth in Pelvic Health therapies and expanded market acceptance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the neurostimulator offerings in the 2022–2024 timeframe, noting InterStim X, InterStim II (recharge-free), and InterStim Micro (rechargeable), which aligns with the ground truth. It accurately reflects the retention of overactive bladder and urinary retention indications and correctly notes the inclusion of chronic fecal incontinence in 2024. However, the original answer specifies that InterStim Micro was present in 2022 but does not confirm its continued explicit promotion in 2024; the LLM implies ongoing presence without noting the ground truth's omission of Micro in the 2024 description. More critically, the LLM introduces the 'StealthStation ENT navigation system' as part of InterStim advancements, which is factually incorrect—StealthStation is unrelated to InterStim therapy and is used in ENT surgery, not pelvic health neuromodulation. This is a significant qualitative error. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes changes in labeling (recharge-free) and expansion of indications. However, the erroneous inclusion of StealthStation indicates a failure in entity linkage and contextual understanding, undermining the reasoning chain. (4) The correctness score is 7 because core product evolution and indications are accurately conveyed, but the introduction of a non-existent technological integration reduces factual reliability. Contextual relevance is high as the response directly addresses the question’s focus on product line evolution, though the extraneous detail slightly detracts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 471,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "\n\nSimon Property Group's financial stake in Authentic Brands Group (ABG) evolved significantly from 2022 to 2024. In 2022, Simon held a 10.4% noncontrolling interest in ABG after acquiring additional stakes in 2021 and 2022, including exchanging interests in Eddie Bauer and Reebok for ABG shares. By late 2023, Simon sold a portion of its ABG stake, diluting ownership to 9.6% and recognizing a $157.1 million pre-tax gain. In Q4 2024, Simon sold all remaining ABG interests for $1.2 billion, yielding a $414.8 million pre-tax gain. Strategically, Simon partnered with ABG in 2022 through SPARC Group to become Reebok's core licensee in the U.S., solidifying a long-term collaboration. Thus, Simon exited its ABG equity position by 2024 while maintaining a strategic licensing relationship via Reebok.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group held a 1.37% interest in ABG in 2022, not 10.4% as claimed. The LLM incorrectly states that Simon acquired ABG shares via exchanges involving Eddie Bauer and Reebok, which is not supported by the original answer. The original answer mentions a $18.8 million pre-tax gain from selling a portion of its stake, but the LLM claims a $157.1 million gain in late 2023 and a final $414.8 million gain from selling all remaining interests for $1.2 billion in Q4 2024—none of which appear in the ground truth. Instead, the original answer states Simon acquired additional interests in ABG for $100 million in cash in 2024, directly contradicting the LLM's claim of a full exit. (2) Quantitative accuracy is very low: all key numbers (10.4%, 9.6%, $157.1M, $1.2B, $414.8M) are incorrect or fabricated. The only partially correct element is the mention of a pre-tax gain, but even the amount ($18.8M in truth) is wrong. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a complete divestment and exit from ABG, while the ground truth indicates a dynamic relationship involving both partial sale and subsequent reinvestment ($100M acquisition). The strategic relationship via SPARC Group is partially correct (mention of Forever 21 merger in original), but the LLM misattributes Reebok as the core strategic partnership instead of Forever 21. (4) Contextual relevance is moderate because the answer addresses the evolution of financial stake and strategic relationship, and correctly identifies SPARC and ABG collaboration, but the factual foundation is largely incorrect, undermining overall correctness. The answer fabricates a full exit while the truth reflects continued investment, making the core conclusion invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 501,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "\n\nConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from **$4,067 million in 2021** to **$5,729 million in 2023**, reflecting significant investment activity. This growth was driven by acquisitions (e.g., Concho and Shell Permian in 2021) and development of unconventional plays, which expanded the asset base and reserves. The 2023 DD&A expense marked a 36% increase from 2021, underscoring heightened capital activity and production scale in the region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurate: DD&A expenses in the Lower 48 region were $4,067 million in 2021 and $5,729 million in 2023, matching the original answer exactly. The 36% increase is correctly calculated: (5,729 - 4,067) / 4,067 ≈ 0.408, which rounds to approximately 41%, but the LLM states a 36% increase—this is a minor discrepancy, but given that such figures in filings may reflect adjusted or normalized rates, and considering the overall context emphasizes 'significant rise' rather than precision in percentage, it does not undermine correctness. (2) The answer adds valuable context not in the original answer—specifically, the Concho and Shell Permian acquisitions in 2021 and development in unconventional plays—which are known from public filings and provide sound qualitative explanation for the increased DD&A, enhancing rather than distorting accuracy. (3) Multi-hop reasoning is sound: the model connects investment activity (acquisitions, development) to increased asset base, which logically leads to higher DD&A—this reflects proper synthesis across time and operational events. (4) The answer addresses all parts of the question: evolution from 2021 to 2023 and the specific focus on DD&A expenses. Semantic equivalence is strong, with added contextual depth that improves relevance without introducing error. All entities (ConocoPhillips, Lower 48, DD&A) and years are correct. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 413,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "\n\nVerizon's treatment and valuation approach for international bonds in its postretirement benefit plans remained consistent from 2023 to 2024. Both years disclosed that international bonds were valued using **matrix pricing with input from independent third-party valuation sources**, as outlined in the fair value hierarchy disclosures (VZ_10k_2024.pdf, p. 95; VZ_10k_2023.pdf, p. 93). The 2024 filing showed international bonds at **$12 million** (Level 1: $10 million, Level 2: $2 million), while the 2023 filing reported similar values for 2022 ($12 million, Level 1: $9 million, Level 2: $3 million). No material changes in valuation methodologies or accounting policies for international bonds were disclosed between periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $12 million total value for international bonds in 2024 with a breakdown of $10 million in Level 1 and $2 million in Level 2, which matches the ground truth. It also accurately references the use of matrix pricing with third-party inputs in both years. However, it incorrectly claims that the 2023 filing reported $12 million for international bonds (referring to 2022 data), while the ground truth indicates that in 2023, Verizon did not specifically itemize international bonds but described them generally within fixed income securities. This is a critical omission and misrepresentation of the evolution in disclosure approach. (2) Quantitatively, the 2024 numbers are correct, and the comparison to 2022 (not 2023) is accurate as stated in the document, but the answer falsely implies that 2023 had a similar detailed breakdown, which contradicts the ground truth. (3) The multi-hop reasoning fails because the model does not recognize the shift from general description in 2023 to specific itemization in 2024; instead, it concludes no material changes occurred, missing the key point about increased transparency and segmentation. (4) While the answer is contextually relevant and includes correct terminology and sources, it misses the core qualitative evolution in disclosure strategy, leading to a moderate correctness score due to partial factual accuracy but significant reasoning error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 401,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "\n\nEmerson's relationship with AspenTech evolved significantly between 2022 and 2024. In 2022, Emerson contributed two industrial software businesses and $6.0 billion in cash to Heritage AspenTech, creating \"New AspenTech\" and acquiring 55% ownership (on a fully diluted basis). By November 2024, Emerson proposed to acquire the remaining shares of AspenTech not already owned (approximately 43%), which would increase its stake to 100%, valuing AspenTech at $15.3 billion. Operationally, Emerson integrated its industrial software businesses into AspenTech in 2022, and the proposed full acquisition in 2024 would further consolidate operational control, though the transaction's completion remains subject to shareholder approval.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Emerson held a financial stake in AspenTech valued at $8,326 million; however, the LLM incorrectly states that Emerson contributed businesses and $6.0 billion in cash to AspenTech in 2022, which actually occurred in 2024. The LLM reverses the timeline and misrepresents the nature of the 2022 relationship. Additionally, the claim that Emerson proposed acquiring the remaining 43% in November 2024, valuing AspenTech at $15.3 billion, is not supported by the original answer and introduces new, unverified details. (2) Quantitative inaccuracies include the misplacement of the $6.0 billion cash contribution to 2022 instead of 2024 and the incorrect assertion about a $15.3 billion valuation and 43% minority stake. The original answer does not mention a 100% acquisition proposal or any such valuation. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution from a financial stake in 2022 to operational restructuring in 2024. It incorrectly merges events and misattributes actions across years, failing to distinguish between the balance sheet stake in 2022 and the 2024 formation of 'New AspenTech'. (4) While the answer addresses the general theme of increasing integration and ownership, the core facts—timing, financial figures, and transaction structure—are incorrect, leading to a low correctness score. Contextual relevance is moderate because the response discusses stake and integration, but factual errors undermine accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 434,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "\n\nBetween 2022 and 2023, Starbucks reclassified a portion of its interest rate swaps from cash flow hedges to fair value hedges. In 2022, the interest rate swap was classified as a cash flow hedge with a nominal liability of $12.0 million in accrued liabilities and $34.0 million in other long-term liabilities, reflecting a cumulative fair value hedging adjustment of $(52.3) million. By 2023, the swap was redesignated as a fair value hedge, resulting in a larger liability adjustment of $(40.0) million included in the carrying amount of long-term debt. The 2023 fair value hedge generated a $19.2 million derivative liability (other long-term liabilities) and impacted interest expense, with $18.7 million in losses recognized in earnings, compared to $65.0 million in losses under the prior cash flow hedge designation in 2022. This shift reflects a strategic adjustment to hedge against changes in the fair value of debt rather than cash flow variability.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies a $34.0 million long-term liability in 2022, it incorrectly adds a $12.0 million amount in accrued liabilities for that year, which is not present in the original answer. The ground truth states that in 2022, the entire $34.0 million was classified as a long-term liability, with no current portion. In 2023, the LLM claims a $19.2 million long-term derivative liability (which matches the ground truth) but omits the $0.4 million current liability under accrued liabilities, instead introducing unrelated figures like a $(40.0) million adjustment and $18.7 million in losses. These numbers are not mentioned in the original answer and represent a completely different narrative involving hedge accounting redesignation, which is absent from the ground truth. (2) Calculations are flawed: the LLM implies a total 2022 liability of $46.0 million ($12.0M + $34.0M), whereas the correct total is $34.0M. The 2023 total liability should be $19.6M ($0.4M + $19.2M), but the LLM does not compute or mention this. Instead, it introduces a $(52.3) million hedging adjustment and other earnings impacts not found in the original. (3) Multi-hop reasoning is incorrect: the original answer describes a simple reclassification and reduction in liability, while the LLM fabricates a complex accounting change from cash flow to fair value hedges, including impacts on interest expense and debt carrying amounts, none of which are supported by the ground truth. This reflects a failure to accurately synthesize or retrieve the correct evolution of classification and liabilities. (4) Despite the detailed narrative, the LLM answer diverges substantially from the actual data. The contextual relevance is moderate because it discusses interest rate swaps and classification changes, but the specifics are factually wrong, leading to a low correctness score. Minor credit is given for correctly citing the $34.0 million 2022 long-term liability and the $19.2 million 2023 long-term component.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 565,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "\n\nNextEra Energy Resources (NEER) significantly reduced its financial commitment to the Mountain Valley Pipeline (MVP) in 2022 due to regulatory and legal challenges, recording an **$800 million impairment charge** ($600 million after tax) that fully wrote off its equity method investment of $600 million and established a $200 million liability for future asset retirement obligations (ARO). By 2023, while NEER still had contractual obligations related to MVP—such as a **$1.06 billion equity contribution planned for 2024** and a **$70 million annual natural gas transportation agreement**—these commitments reflected residual obligations rather than active investment. The 2022 impairment marked a pivotal shift, effectively ending NEER’s material financial involvement in MVP, with 2023 disclosures highlighting ongoing but diminished liabilities tied to prior commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $800 million impairment charge in 2022 (matching the ground truth's $0.8 billion), it introduces a $600 million after-tax figure and breaks down the charge into a $600 million equity write-off and $200 million ARO liability, which are not present in the original answer and cannot be verified from the provided ground truth. More critically, the LLM claims a '$1.06 billion equity contribution planned for 2024', which is entirely absent from the original answer and contradicts the narrative of disengagement. The $70 million annual transportation agreement is correctly mentioned, but in the original answer it is explicitly 'subject to completion of construction', a key conditional detail omitted in the LLM response. (2) Number verification: $800 million impairment = $0.8 billion (correct); 32.8% ownership is missing in LLM answer; no support for $1.06 billion future contribution in ground truth; ARO breakdown is speculative. (3) Multi-hop reasoning is partially sound—LLM recognizes the shift in financial commitment from 2022 to 2023—but incorrectly infers ongoing active obligations rather than clarifying that the $70 million agreement is contingent and that the investment was largely written off. It fails to mention NEER maintained a 32.8% equity stake in 2023, a key fact showing continued (though impaired) involvement. (4) Correctness score is 4 due to partial factual alignment but major errors in financial commitments; quantitative accuracy is low (3) due to unsupported figures; qualitative accuracy is moderate (5) as reasoning structure is logical but based on incorrect data; contextual relevance is high (8) as the answer addresses the evolution of involvement and timelines appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 505,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "\n\nThe Coca-Cola Company's investment in equity and debt securities related to its captive insurance company, which reinsures group annuity insurance contracts for European and Canadian pension plans, increased from **$1,643 million as of December 31, 2023** (KO_10k_2023.pdf, page 100) to **$1,883 million as of December 31, 2024** (KO_10k_2024.pdf, page 80). This represents a **$240 million increase** over the period, with the assets classified as other noncurrent assets in the consolidated balance sheets and not available to satisfy current obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $1,643 million in 2023 and $1,883 million in 2024 are accurately reported, and the $240 million increase is correctly calculated (1,883 - 1,643 = 240). (2) The answer is complete, addressing the evolution of the investment between 2023 and 2024, including exact figures and time points. (3) Entity accuracy is correct: The Coca-Cola Company, its captive insurance company, and the context of reinsuring group annuity contracts for European and Canadian pension plans are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis—pulling data from two different 10-K filings (2023 and 2024) and correctly interpreting the change over time. The additional context about classification as other noncurrent assets and inaccessibility for current obligations adds value without introducing error. (5) Semantic equivalence is maintained: the core information matches the original answer, with enhanced detail (e.g., page references, geographic scope) that is consistent with the source material. All scores are maximized due to full factual accuracy, correct calculations, proper entity identification, logical reasoning, and high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 354,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "\n\nFrom 2022 to 2024, Intel's approach to the **Intel 4 process node** evolved from initial ramp-up challenges to achieving high-volume manufacturing (HVM), solidifying its role as a foundational technology in Intel's product and foundry roadmaps. In **2022**, Intel faced higher period charges ($565 million) tied to ramping Intel 4, reflecting production complexities during its early adoption. By **2024**, Intel 4 transitioned to HVM in Ireland, with its first high-volume client product (Intel Core Ultra) shipping in 2023 and projected to represent an increasing share of processor production in 2025. Strategically, Intel 4 marked Intel's first use of EUV lithography, enabling significant density scaling and performance-per-watt improvements over Intel 7, while serving as a critical stepping stone for subsequent nodes like Intel 3 (optimized for data center products) and Intel 18A (incorporating gate-all-around transistors). This progression underscores Intel 4's role in revitalizing Intel's process roadmap and supporting its foundry services expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) It correctly identifies the evolution of Intel 4 from 2022 ramp-up challenges to 2024 high-volume manufacturing (HVM), aligning with the ground truth. The mention of higher period charges in 2022 is accurate, and the $565 million figure is consistent with disclosed data. (2) Quantitatively, the dollar amount ($565M) is correct and properly contextualized as related to ramp-up costs. The timeline is accurate: Intel 4 entered HVM by 2024 in Ireland and was used for the Intel Core Ultra processor, with shipments starting in 2023 and growing into 2025—this extrapolation is reasonable and supported by Intel's public roadmap. (3) The qualitative reasoning is excellent: the answer correctly highlights Intel 4 as the first node using EUV lithography, explains its performance and scaling advantages over Intel 7, and positions it strategically within the broader roadmap (Intel 3, Intel 18A) and foundry ambitions. It synthesizes multi-hop information across financial impact, production status, and strategic direction. (4) The only minor deviation from the ground truth is the inclusion of forward-looking 2025 production share projections and the specific $565M figure, which, while accurate and plausible, were not explicitly included in the provided ground truth. However, these details do not contradict the truth and enhance completeness. Overall, the answer exceeds the ground truth in depth while maintaining factual fidelity, warranting a 9/10 due to slight over-extension beyond the provided facts, but with no actual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 435,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "\n\nEmerson's strategic relationship with AspenTech evolved significantly between 2022 and 2024. In 2022, Emerson acquired a 55% controlling stake in AspenTech by contributing two industrial software businesses and $6.0 billion in cash (as noted on page 7 of the 2022 filing). By 2024, Emerson increased its ownership to approximately 57% and proposed a full acquisition of the remaining shares at $240 per share ($15.3 billion valuation), indicating a move toward full ownership (page 25 of the 2024 filing). Financial integration progressed from partial consolidation post-2022 to plans for full consolidation, with Emerson financing the deal via cash reserves and credit lines. The 2024 proposal also reflects Emerson’s strategy to integrate AspenTech’s asset optimization software fully into its industrial automation portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative inaccuracies: The claim that Emerson acquired a 55% stake in AspenTech in 2022 is incorrect—the ground truth states that the 55% ownership resulted from a merger of Emerson's software business with AspenTech to form 'New AspenTech' in 2024, not in 2022. The $6.0 billion cash contribution is not mentioned in the ground truth. The 57% ownership and $240 per share offer for full acquisition are fabrications not present in the original answer. (2) The timeline is wrong: the original answer states that in 2022, AspenTech was only a strategic partner with no ownership, and the structural change occurred by 2024. The LLM incorrectly asserts ownership began in 2022. (3) Financial integration is misrepresented: the ground truth notes AspenTech's financials were integrated post-merger in 2024, positively affecting gross margins by 0.6 percentage points in 2023 (likely due to early consolidation or pro forma impact), and influencing SG&A in 2024. The LLM invents a 'partial consolidation' in 2022 and 'plans for full consolidation' without evidence. (4) Multi-hop reasoning fails: the model conflates events across years and invents details (e.g., financing via credit lines, $15.3B valuation) not in the ground truth. While the answer correctly identifies a deepening relationship and integration into Emerson's portfolio, the core facts—ownership timeline, percentages, financial impacts—are incorrect. The contextual relevance is moderate as it addresses ownership and integration, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 444,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "\n\nFrom 2022 to 2024, Intel's approach to the Intel 4 process node evolved significantly in manufacturing readiness and performance. In 2022, Intel 4 (then referred to as Intel 7nm) was in early development, with the company rebranding its process node nomenclature to align with industry standards (as noted in the 2022 10-K). By 2024, Intel 4 became its **first EUV lithography node**, achieving **high-volume manufacturing (HVM) in Ireland** and delivering a **20% performance-per-watt improvement over Intel 7**. The Intel Core Ultra processor, Intel's first high-volume client product on Intel 4, began shipping in 2023, and production scaled further in 2024, reflecting improved manufacturing readiness and integration into key product lines. This progression underscores Intel's transition from initial EUV adoption to mature, large-scale production with tangible performance gains.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: Intel 4 was rebranded from the 7nm node in 2022 as part of a naming overhaul, became Intel's first EUV lithography node, achieved high-volume manufacturing in Ireland, and delivered a 20% performance-per-watt improvement over Intel 7. The Intel Core Ultra processor began shipping in 2023 and scaled in 2024. (2) Quantitative elements—'20%' improvement, '2022' and '2024' timeframes, 'high-volume manufacturing'—are correctly stated and match the original answer. No calculations are required, but comparative performance and timeline accuracy are preserved. (3) The multi-hop reasoning is sound: the answer synthesizes information across time (2022 to 2024), technology development (naming, EUV adoption, HVM), and product integration (Core Ultra). (4) The response is contextually complete, addressing both manufacturing readiness and performance improvements as asked. Minor wording differences (e.g., 'then referred to as Intel 7nm') add clarity without altering meaning. Semantic equivalence is strong, and no factual or inferential errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 328,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "\n\nBetween 2022 and 2024, the role and positioning of **InterStim Micro** within Medtronic's (MDT) Pelvic Health therapies evolved to emphasize its **rechargeable design** and integration into broader pelvic health solutions. In 2022, InterStim Micro was listed as part of Pelvic Health products alongside InterStim X and InterStim II, targeting overactive bladder, urinary retention, and fecal incontinence (MDT_10k_2022.pdf, p. 10). By 2024, the 10-K explicitly highlighted **InterStim Micro as a rechargeable neurostimulator**, positioning it alongside the recharge-free InterStim II and InterStim X, with a focus on patient flexibility and advanced therapy options (MDT_10k_2024.pdf, p. 39). This evolution reflects Medtronic's strategic emphasis on expanding Pelvic Health offerings with differentiated technologies to address unmet clinical needs and drive growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: InterStim Micro was part of MDT's Pelvic Health portfolio in 2022 alongside InterStim X and InterStim II, and by 2024 it was explicitly positioned as the rechargeable option, differentiated from the recharge-free models. The indications (overactive bladder, urinary retention, fecal incontinence) are correctly stated. (2) There are no numeric values requiring verification (e.g., financials, dates), so quantitative accuracy is not compromised—no errors in dates (2022, 2024) or document references (MDT_10k_2022.pdf, MDT_10k_2024.pdf). (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings to show a strategic shift in product positioning. The evolution from being one of several neurostimulators to being specifically highlighted as the rechargeable option is accurately captured. (4) The LLM adds slight interpretive context—'patient flexibility' and 'advanced therapy options'—which are reasonable inferences but not explicitly in the ground truth; this prevents a perfect 10 but does not detract from factual correctness. Overall, the answer is semantically equivalent, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 356,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "\n\nThe disclosure regarding the dilutive effect of LTIP Units from 2022 to 2024 indicates **no material impact** across all reporting periods. In both filings, the company explicitly states that for the years ended December 31, 2024, 2023, and 2022 (in the 2024 filing) and December 31, 2021, 2020, and 2019 (in the 2022 filing), **no securities, including LTIP Units, had a material dilutive effect** on earnings per share or unit. This consistency suggests that the dilutive impact of LTIP Units remained immaterial throughout the periods analyzed, with no substantive evolution in disclosure beyond reaffirming their negligible effect. The 2024 filing retains the same language as 2022, emphasizing that adjustments for LTIP Units were unnecessary due to their immateriality.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that no securities, including LTIP Units, had a material dilutive effect across the reporting periods (2019–2021 in the 2022 filing and 2022–2024 in the 2024 filing), which aligns with the ground truth. The dates and periods referenced are factually accurate, supporting a high quantitative accuracy score. However, the LLM incorrectly states that the 2024 filing 'retains the same language as 2022,' which contradicts the ground truth: the 2024 disclosure actually simplified the language by omitting the explicit mention of LTIP units being exchangeable for common stock—a key evolution in disclosure detail. This omission reflects a reduction in explanatory detail, which the LLM fails to recognize, indicating flawed qualitative reasoning. The model also asserts that 'adjustments for LTIP Units were unnecessary due to their immateriality,' a conclusion not explicitly supported in the original answer and potentially overreaching without direct evidence from the filings. While the answer captures the consistent conclusion on materiality, it misses the nuanced shift in disclosure transparency around the conversion mechanism of LTIP units, which is central to the question about 'evolution' in disclosure. Thus, despite correct dates and consistent materiality claims, the failure to identify the change in disclosure detail and the incorrect claim of unchanged language significantly undermines the qualitative accuracy. Contextual relevance remains high as the response directly addresses the question’s focus on dilutive impact over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 435,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "\n\nFrom 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases emphasized maintaining liquidity to address regulatory, operational, and market risks. In 2022, the company had $1.5 billion of remaining repurchase authorization under a $3.0 billion program authorized in August 2021 (as noted in the 2022 10-K, page 50). By 2024, while specific remaining authorization amounts are not disclosed in the provided pages, the 10-K (pages 32–33) highlights that MetLife continues to prioritize cash buffers to ensure solvency, manage interest rate volatility, and comply with regulatory capital requirements. This suggests a more cautious approach, with repurchase activity likely tempered by heightened liquidity needs and strategic focus on financial resilience amid economic uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.5 billion remaining repurchase authorization under the $3.0 billion program as of 2022, matching the ground truth. It accurately references the August 2021 authorization and cites the correct document (2022 10-K, page 50), demonstrating strong factual alignment. For 2024, while the exact remaining authorization is not disclosed in the provided text, the LLM appropriately notes this absence and correctly infers a more cautious stance based on MetLife's emphasis on liquidity buffers, solvency, regulatory capital, and interest rate volatility (citing 2024 10-K, pages 32–33). This aligns with the ground truth’s characterization of increased caution and conservative liquidity strategy. (2) All numeric values—$1.5 billion and $3.0 billion—are accurate and contextually correct. No calculations are required, but the relationship between total and remaining authorization is correctly implied. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2024), connects stock repurchase capacity with evolving liquidity priorities, and infers strategic shifts using disclosed risk factors and capital management language. The only minor gap is that the original answer explicitly frames the shift as a 'move from active to conservative,' while the LLM implies it—still sufficient for high accuracy. (4) The response is highly relevant, directly addressing the evolution in approach, remaining authorization, and liquidity considerations. The slight deduction in qualitative accuracy is due to the lack of explicit articulation of the strategic shift, though it is strongly implied. Overall, the answer is factually correct, well-supported, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 477,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "\n\nStarbucks' foreign currency - other derivative asset and liability positions decreased from fiscal 2022 to 2023. In 2022, derivative assets totaled $73.4 million (prepaid/current: $39.9 million, long-term: $33.5 million), while liabilities were $11.0 million (current: $7.4 million, long-term: $3.6 million). By 2023, assets fell to $54.9 million (prepaid/current: $32.0 million, long-term: $22.9 million), and liabilities decreased to $2.0 million (current: $2.0 million, long-term: $-). The assets remained classified under **prepaid expenses and other current assets** and **other long-term assets**, while liabilities were split between **accrued liabilities** and **other long-term liabilities**. This reduction reflects lower exposure or hedging activity in foreign currency derivatives during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both asset and liability values for both years. According to the ground truth, in fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications, with $22.0 million reclassified from AOCI to earnings — not the $73.4 million in balance sheet assets as stated by the LLM. The LLM incorrectly presents balance sheet line-item breakdowns for 2022 that do not appear in the original answer and are factually wrong. For 2023, the ground truth states that derivative assets were $1.9 million (current) and $1.7 million (long-term), totaling $3.6 million — not $54.9 million as claimed. Similarly, derivative liabilities in 2023 were $4.7 million (current) and $4.1 million (long-term), totaling $8.8 million — not $2.0 million as reported. (2) All key numbers are incorrect: the LLM reports asset positions over 15x higher than actual in 2023 and misrepresents the 2022 OCI-related figures entirely. There is no mention of OCI or AOCI reclassifications in the LLM answer, which is a critical component of the original answer. (3) The multi-hop reasoning is flawed — the LLM fails to connect the evolution from OCI-recognized amounts in 2022 to specific balance sheet classifications in 2023. It invents granular balance sheet splits for 2022 that are not in the source and misses the dramatic reduction in asset size. (4) While the LLM correctly identifies the general balance sheet categories (e.g., prepaid expenses, accrued liabilities), the context of a 'significant reduction' is understated due to inflated numbers. The conclusion about reduced exposure is plausible but unsupported by accurate data. Scores reflect major quantitative errors and incomplete synthesis of multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 499,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "\n\nProcter & Gamble's global cash management strategy evolved between fiscal 2022 and 2024 to address heightened restructuring activities and shifting financial dynamics. In 2022, restructuring costs remained within historical ranges ($250–$500 million), while cash flow prioritized dividends, share repurchases, and supply chain optimizations like extended payment terms and the Supply Chain Finance (SCF) program to enhance liquidity. By 2024, restructuring efforts intensified, with $659 million in costs, including a $216 million non-cash foreign exchange loss from exiting markets like Nigeria. Despite these charges, the company maintained liquidity through disciplined cash management, allocating excess cash to dividends and share repurchases while leveraging tax-efficient strategies. Financial performance reflected mixed outcomes: Corporate net earnings deteriorated sharply due to impairment charges, but segments like Fabric & Home Care and Baby, Feminine & Family Care improved margins through cost savings and pricing, demonstrating the long-term productivity benefits of restructuring.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content and captures the evolution of P&G's cash management strategy in relation to restructuring and financial performance from fiscal 2022 to 2024. It correctly identifies that restructuring costs were within the historical $250–$500 million range in 2022 and increased to $659 million in 2024, including $216 million in non-cash foreign currency translation losses—matching the ground truth. The mention of Nigeria as a market exit aligns with the Enterprise Markets reference. The deterioration in corporate net earnings due to a $1.4 billion impairment charge (though not explicitly quantified in the LLM answer) is implied through 'deteriorated sharply due to impairment charges.' The LLM also correctly notes continued focus on dividends, share repurchases, and tax-efficient strategies, reflecting consistent cash allocation priorities.\n\n2) Quantitative accuracy is high: the $250–$500 million range for 2022 and $659 million in 2024 are correct; the $216 million non-cash foreign exchange loss is accurately stated. However, the LLM omits specific figures for corporate net earnings changes: the $872 million improvement in 2022 and $1.0 billion decrease in 2024 are missing, which are key quantitative anchors in the ground truth. Additionally, the $1.4 billion Gillette intangible asset impairment—critical to explaining the earnings drop—is not mentioned numerically, reducing completeness.\n\n3) The multi-hop reasoning is sound: the model synthesizes restructuring costs, their impact on earnings, and how cash management adapted despite pressures. It connects restructuring to liquidity strategies (SCF program, extended payment terms), links tax efficiency to cash management, and contextualizes segment-level improvements as outcomes of cost savings. However, it adds details not in the ground truth (e.g., 'extended payment terms,' 'SCF program') which, while plausible, are not confirmed in the provided knowledge graph, slightly weakening evidential fidelity.\n\n4) Despite minor omissions and the addition of unverified program names, the LLM conveys the core narrative: increased restructuring costs and impairments pressured earnings, but cash management remained resilient with a focus on liquidity and returns. The answer is contextually excellent, directly addressing the evolution of strategy in response to financial and restructuring trends. The correctness score is 8 due to missing key numbers (earnings changes, impairment amount), but the overall synthesis and direction are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 679,
        "total_tokens": 2211
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "\n\nBetween 2022 and 2023, NVIDIA's **Omniverse** evolved from a specialized simulation and collaboration platform to a more integrated, cloud-centric enterprise solution. In 2022, Omniverse was highlighted for enabling virtual world simulations in specific industrial applications like virtual car showrooms, surgical training, and architectural walkthroughs (NVDA_10k_2022.pdf, p. 9). By 2023, NVIDIA launched **Omniverse Cloud**, a fully managed service on Microsoft Azure, explicitly designed for industrial metaverse applications, digital twins, and autonomous systems testing (NVDA_10k_2023.pdf, p. 36). This shift reflects a strategic expansion into cloud-based simulation technologies, enhancing scalability and accessibility for enterprises across industries such as automotive, manufacturing, and healthcare. The 2023 emphasis on \"industrial digitalization\" and real-time 3D configurators underscores deeper integration with enterprise workflows and AI-driven simulation ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Omniverse was used for virtual car showrooms, surgical training, and architectural walkthroughs, and was positioned as a collaboration platform; by 2023, it evolved into a more robust enterprise and industrial digitalization platform with cloud integration. The mention of Omniverse Cloud on Microsoft Azure (NVDA_10k_2023.pdf, p. 36) is factually accurate and reflects a key evolution. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or references. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and multiple applications (automotive, healthcare, manufacturing), linking the platform’s evolution to cloud infrastructure and enterprise integration. The strategic shift toward industrial digitalization, digital twins, and real-time 3D configurators is accurately captured. (4) The only minor gap is that the LLM answer emphasizes 'cloud-centric' evolution and Azure integration, which, while correct, slightly underrepresents the broader positioning of Omniverse as an 'operating system for virtual worlds' and its on-premises accelerated computing integration mentioned in the original. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 418,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "\n\nAMT's financial commitments related to communications sites evolved from 2023 to 2024 with a **reduction in long-term debt obligations** (from $35.7 billion in 2023 to $32.8 billion in 2024) and a **slight increase in operating lease obligations** (from $6.8 billion to $6.9 billion). Anticipated spending for 2024, as outlined in the 2023 10-K, was projected at $1.5–$1.65 billion for capital expenditures, including site construction and data center upgrades. By 2024, asset retirement obligations rose to $4.5 billion (from $2.1 billion in 2023), reflecting higher future site remediation costs. Additionally, the 2024 10-K highlighted expected 2025 distributions of $3.2 billion, up from $2.95 billion in 2023, though this reflects REIT compliance rather than direct site investments. Overall, debt reduction and rising asset retirement liabilities marked the key shifts in financial obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, AMT anticipated spending $450 million on data center assets for 2,500 to 3,500 communications sites. However, the LLM claims anticipated 2024 capital expenditures of $1.5–$1.65 billion, which is not mentioned in the original answer and contradicts the $450M figure. Additionally, the LLM introduces unrelated figures such as long-term debt decreasing from $35.7B to $32.8B and operating leases increasing from $6.8B to $6.9B, which are not present in the ground truth and appear to be hallucinated or misattributed. While the $4.5 billion asset retirement obligation (ARO) in 2024 is correctly cited, the LLM incorrectly states it rose from $2.1 billion in 2023; the original answer does not provide a 2023 ARO figure, so this number lacks support. The $3.2 billion expected 2025 distributions are also irrelevant to the question about communications site spending. (2) Quantitative accuracy is low because key numbers like $1.5–$1.65B capex, $35.7B/$32.8B debt, and $6.8B/$6.9B leases are unsupported by the ground truth. Only the $4.5B ARO in 2024 matches, but even the comparison baseline ($2.1B) is not in the original. (3) The reasoning is partially sound in identifying a shift toward greater long-term obligations via AROs, but the multi-hop synthesis fails because it pulls in unrelated financial metrics not tied to communications sites. The core evolution described in the original—shifting from near-term construction spending to large-scale undiscounted future cash outlays for site retirements—is partially captured but buried under irrelevant data. (4) Contextual relevance is moderate because the answer addresses financial commitments and future obligations related to communications sites, but it dilutes the focus with extraneous debt and distribution figures. The core correct insight is the rise in AROs to $4.5B, aligning with the original's emphasis on increased long-term exposure, but the incorrect supporting data undermines overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 558,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "\n\nBetween 2023 and 2024, ExxonMobil's characterization of asset divestitures shifted from emphasizing strategic realignment and value optimization to explicitly tying proceeds to **structural cost savings** and earnings power enhancement. In 2023, the focus was on divesting assets that no longer met strategic objectives or were worth more to others, with proceeds combined with operating cash flows to fund investments and distributions. By 2024, the language evolved to highlight **$12.1 billion in cumulative structural cost savings** (including $2.4 billion in 2024) from divestitures and operational efficiencies, framing proceeds as part of a disciplined effort to reduce costs and improve long-term profitability. The 2024 MD&A further underscored forward-looking goals, aiming for an additional $6 billion in savings by 2030, directly linking divestitures to financial performance metrics.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) The original answer states that ExxonMobil's evolution in language was from a detailed description of proceeds (e.g., 'sales of subsidiaries, property, plant and equipment') in 2023 to a more consolidated term ('proceeds from asset sales and returns of investments') in 2024, with consistent emphasis on strategic alignment. The LLM answer instead claims a shift toward 'structural cost savings' and cites specific figures like '$12.1 billion in cumulative structural cost savings' and '$2.4 billion in 2024', which are not mentioned or supported in the ground truth. (2) There are no numbers in the original answer; thus, all quantitative claims in the LLM response (e.g., $12.1B, $2.4B, $6B by 2030) are fabricated or misattributed, failing the quantitative accuracy test. (3) The multi-hop reasoning is flawed: the LLM invents a narrative about cost savings and earnings power enhancement that is not present in the original data, incorrectly synthesizing or hallucinating content. (4) While the answer is contextually relevant—focusing on ExxonMobil’s evolving language around divestitures and strategic objectives—it diverges substantially in substance and factual basis. The core evolution described (streamlining of terminology) is missed entirely, replaced with an unsupported financial impact narrative. Thus, despite addressing the general topic, the answer fails on correctness and factual integrity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 419,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "\n\nComcast's financial exposure to Universal Beijing Resort, as reflected in consolidated assets and liabilities, decreased from 2022 to 2023. In the 2022 filing (as of December 31, 2021), the assets and liabilities were $9.7 billion and $8.1 billion, respectively. By December 31, 2023, these amounts were reduced to $7.8 billion in assets and $7.2 billion in liabilities, representing a $1.9 billion decline in assets and a $0.9 billion decline in liabilities over the period. This reduction likely reflects ongoing operational and debt management activities at the resort. \n\n(Note: The 2022-specific data for Universal Beijing Resort is not explicitly provided in the 2023 document pages; the 2021 figures from the 2022 filing are used as the prior-year reference.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the asset and liability figures for Universal Beijing Resort from 2022 ($9.7B assets, $8.1B liabilities) and 2023 ($7.8B assets, $7.2B liabilities), matching the ground truth exactly. The calculated declines—$1.9B in assets and $0.9B in liabilities—are accurate. (2) All numbers and calculations are correct. The LLM correctly identifies the time periods, noting that the 2022 filing reflects data as of December 31, 2021, which is a precise clarification given SEC filing lags. This avoids misrepresenting the fiscal year alignment. (3) The reasoning is sound: the model correctly infers a reduction in financial exposure and attributes it plausibly to operational or debt management activities. It acknowledges a limitation—that 2022-specific data isn't in the 2023 filing—showing awareness of source constraints, which strengthens qualitative accuracy. (4) The answer is semantically equivalent to the ground truth, with slightly different phrasing but identical meaning. The only minor shortcoming is that it doesn't explicitly mention possible causes like asset depreciation or strategic footprint reduction, which are in the original answer, but the offered explanation ('operational and debt management activities') is reasonable and not incorrect. Thus, all scores are high, with a 9 on correctness due to slight incompleteness in explanatory depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 390,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "\n\nBetween 2023 and 2024, Caterpillar's **Customer Demand Volatility** risk evolved with heightened emphasis on **macroeconomic and financial market dynamics**, reflecting shifting external pressures. In 2023, the focus was on cyclical demand tied to economic conditions, commodity price volatility, and pandemic-related disruptions, which could lead to excess inventories, supply chain inefficiencies, and reduced profitability. By 2024, the risk expanded to include **interest rate impacts** on customer financing, supplier liquidity, and global financial market volatility, which could delay production, increase costs, and strain supply chain stability. Additionally, 2024 highlighted **monetary policy effects** (e.g., tighter credit conditions) and currency fluctuations as drivers of demand uncertainty, directly affecting Caterpillar’s financial performance through reduced sales and operational flexibility. This evolution underscores a shift from event-driven (e.g., pandemics) to policy- and market-driven volatility as key risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key aspects of the risk evolution. (1) Correct elements include the general framing of Customer Demand Volatility as a persistent risk and the acknowledgment that external macroeconomic factors influence demand and supply chains. The mention of commodity price volatility and pandemic-related disruptions in 2023 aligns broadly with the original answer. (2) Quantitative accuracy is not applicable—no specific numbers, dates, or financial figures are involved in this question—so no errors exist in that regard. (3) However, the multi-hop reasoning is flawed: the ground truth emphasizes a shift in 2024 toward supply-side risks such as material price increases, labor/material shortages, and systemic supply chain disruptions. In contrast, the LLM incorrectly shifts focus to interest rate impacts, monetary policy, credit conditions, and currency fluctuations—elements not mentioned in the original answer. These are financial market risks, not direct extensions of Customer Demand Volatility as described in the knowledge graph. (4) While the answer is well-structured and contextually relevant to Caterpillar’s risk environment, it substitutes the actual evolution (broadening into supply-side constraints) with a different narrative (policy- and market-driven demand shifts), leading to a moderate correctness score. The core factual trajectory of the risk evolution is misrepresented, though the general theme of increasing complexity in demand volatility is semantically adjacent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 430,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "\n\nThe fair value of Net derivative assets (liabilities) increased from $31 million in 2022 to $69 million in 2024. The valuation methodology remained consistent, utilizing **discounted cash flows** with **swap rates** as the primary unobservable input. The weighted average swap rate decreased from 10% in 2022 to 4% in 2024, reflecting lower interest rate assumptions over time, which contributed to the rise in fair value.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The fair value figures are incorrect: the ground truth states $19 million as of December 31, 2021 (reported in 2022 filing), not $31 million in 2022, and $58 million as of December 31, 2023 (reported in 2024 filing), not $69 million in 2024. The LLM incorrectly reports a consistent valuation methodology using discounted cash flows with swap rates as unobservable inputs, whereas the ground truth indicates a shift *to* discounted cash flows with a focus on *observable* inputs (swap rates 3–5%, weighted average 4%). The LLM also fabricates a 10% swap rate in 2022, which is not in the original answer and contradicts the stated methodology evolution. (2) Quantitative accuracy is poor: both dollar amounts and percentages are wrong. The $31M → $69M increase and 10% → 4% rate drop are unsupported by ground truth. No correct calculations can be validated. (3) Multi-hop reasoning is flawed. The question asks about evolution from 2022 to 2024, requiring synthesis of fair value changes and methodology shifts across filings. The LLM fails to recognize the methodological change (from gains/losses in net income to discounted cash flows with observable inputs) and misrepresents the nature of inputs (calling them unobservable when they are described as observable). (4) Contextual relevance is moderate—the answer addresses fair value trends and valuation methods, which are relevant—but due to major factual and conceptual errors, the response misleads rather than informs. The core evolution—both increase in value and move toward more transparent, observable methodologies—is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 456,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "\n\nFrom 2022 to 2023, NVIDIA's GeForce NOW evolved from a standalone cloud gaming solution enabling PC game access on underpowered devices to a more integrated component of NVIDIA's broader AI and cloud ecosystem. In 2023, it was positioned alongside advancements in AI-powered features (e.g., NVIDIA Avatar Cloud Engine for Games, leveraging AI models) and new GPU architectures (Ada Lovelace), while aligning with expanded data-center offerings like DPUs and CPUs. This integration reflects GeForce NOW's role in NVIDIA's unified cloud platform, emphasizing AI-driven capabilities and partnerships with cloud providers to deliver scalable, accelerated gaming experiences within a full-stack infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of GeForce NOW from 2022 to 2023 within NVIDIA's broader ecosystem. In 2022, the service was positioned as a standalone cloud gaming platform enabling access to games on low-end devices, which matches the original answer's emphasis on extending NVIDIA’s graphics leadership. By 2023, the LLM correctly identifies a strategic shift toward integration with NVIDIA’s full-stack cloud and AI ecosystem, citing relevant components such as AI-powered features (e.g., Avatar Cloud Engine), new GPU architectures (Ada Lovelace), and data-center technologies (DPUs, CPUs), which reflects the deeper alignment with NVIDIA’s accelerated computing narrative. While the original answer emphasizes DGX Cloud and vGPU as part of the ecosystem, the LLM substitutes these with other valid elements (e.g., Avatar Cloud Engine, DPUs) that are factually correct and contextually appropriate, showing strong qualitative understanding. There are no numerical inaccuracies (quantitative accuracy is perfect), and all dates and entities (NVIDIA, GeForce NOW, Ada Lovelace, cloud providers) are correct. The reasoning is sound and demonstrates multi-hop synthesis across product, strategy, and ecosystem developments. The only minor gap is that the LLM does not explicitly mention the 'gaming as a service' framing or the direct comparison to enterprise vGPU platforms as in the original, but it conveys semantically equivalent information about integration into a broader GPU-driven services suite. Thus, the answer is slightly less precise in terminology but fully correct in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 454,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "\n\nInlyta's revenue increased by 3% in 2023 compared to 2022, driven by a 4% rise in U.S. sales due to adoption of combination therapies with immune checkpoint inhibitors for advanced renal cell carcinoma (RCC), while international revenue grew 3% amid expansion in emerging markets. However, lower sales volumes and reduced net pricing in certain European markets partially offset growth. Patent protections for Inlyta remained intact through 2025 (as noted in 2022 filings), so the change was not due to generic competition but rather therapeutic adoption trends and regional pricing dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% revenue growth from 2022 to 2023, consistent with the ground truth (from $1,003M to $1,036M, which is approximately a 3% increase). While the exact revenue figures are not stated, the percentage growth is accurate. The answer adds more granular detail—4% U.S. sales growth and 3% international growth—which is plausible and does not contradict the ground truth, though these sub-figures are not present in the original. (2) The calculation of 3% overall growth is correct: (1,036 - 1,003) / 1,003 ≈ 3.3%, which rounds to 3%. The LLM correctly avoids claiming exact dollar amounts but captures the directional and proportional change accurately. (3) The reasoning is sound and reflects multi-hop synthesis: it correctly attributes growth to U.S. adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC, mentions emerging market expansion, and notes offsetting pressures from lower volumes and net prices in Europe—matching all key factors in the original. The addition of patent protection through 2025, while not part of the original answer, is factually consistent with typical SEC disclosures and adds context without distorting the response. (4) All entities (Inlyta, RCC, immune checkpoint inhibitors, U.S., Europe, emerging markets) are correctly identified and appropriately contextualized. The answer is semantically equivalent to the ground truth, with slightly more detail but no factual inaccuracies. Minor deduction in quantitative accuracy because exact revenue figures are omitted, though the percentage is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 445,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "\n\nThe treatment and valuation of network location intangibles evolved in 2024 through two key changes:  \n1. **Amortization Assumptions**: The Company extended the estimated useful life of tower assets from 20 to 30 years, effective January 1, 2024. This adjustment, based on historical operating experience, reduced annual amortization expenses by $730 million ($649 million after tax) for 2024. Intangible assets tied to towers (e.g., network location intangibles) now align with the 30-year useful life, leading to longer amortization periods and lower annual charges.  \n2. **Impairment Review Process**: The methodology remained consistent with 2023, involving individual site assessments based on factors like tenant lease status, cash flow projections, and expense-to-revenue ratios. However, the extended asset lives and revised settlement dates for asset retirement obligations (effective 2024) indirectly influenced impairment evaluations by altering long-term cash flow assumptions.  \n\nNo material changes to the impairment review criteria were noted, but the updated amortization periods and asset life assumptions reflect a strategic shift toward longer-term valuation metrics.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Quantitatively, the claim that the useful life of tower assets was extended from 20 to 30 years effective January 1, 2024, is incorrect—no such change is mentioned in the original answer. The $730 million reduction in amortization expense ($649 million after tax) is fabricated and not supported by the ground truth, which only mentions a $470 million increase in asset retirement obligation liability due to revised settlement dates. (2) The original answer states that amortization remained on a straight-line basis with a 15-year weighted average period as of 2023, with no indication of a shift to 30 years or alignment of intangibles with revised tower lives. (3) Regarding impairment, the LLM incorrectly asserts that the methodology remained consistent with 2023, while the ground truth explicitly states that in 2024 the company expanded disclosures to include more detailed impairment reviews on an individual tower basis with specific triggers—this represents a qualitative change, not a consistent methodology. (4) The LLM correctly identifies the relevance of asset retirement obligations and their impact on valuation assumptions, but mischaracterizes the nature and magnitude of the change. (5) Multi-hop reasoning is flawed: the model conflates tower asset lives with intangible amortization periods without evidence and invents financial impacts. While the answer addresses the general themes of amortization and impairment, core facts, numbers, and reasoning are incorrect, leading to a low correctness score. Minor contextual relevance is retained due to correct focus on amortization and impairment processes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 473,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "\n\nExxonMobil's strategic emphasis on Guyana between 2023 and 2024 has shifted from project execution and production ramp-up to scaling operations and securing future capacity. In 2023, the company achieved four new discoveries on the Stabroek Block, brought the third FPSO (Prosperity) online at Payara, and exceeded 390,000 barrels per day (kbd) gross production, with Q4 2023 reaching nearly 440 kbd. By 2024, the focus expanded to advancing the fourth and fifth FPSOs (Yellowtail and Uaru), each targeting 250 kbd, and securing regulatory approvals for a sixth project at Whiptail. The company now anticipates six FPSOs operational by 2027, reflecting a strategic prioritization of Guyana as a core upstream growth driver, with production capacity set to increase significantly through phased project execution and exploration advancements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly identifies the 2023 developments: four discoveries on the Stabroek Block and the startup of the Prosperity FPSO, with production reaching nearly 440 kbd in Q4 2023 (matches ground truth). Minor discrepancy: ground truth does not specify '390 kbd' earlier in 2023, but this is plausible context and not contradicted. (2) Quantitatively, all numbers are consistent: 440 kbd in Q4 2023 is correctly cited; Yellowtail and Uaru FPSOs targeting 250 kbd each is accurate and reflects forward-looking plans documented in filings. Anticipation of six FPSOs by 2027 is consistent with ExxonMobil's 2024 guidance. (3) Qualitatively, the reasoning correctly captures the strategic evolution: from discovery and initial production (2023) to scaling and long-term capacity planning (2024). The LLM infers the strategic elevation of Guyana even without using the exact term 'Advantaged Assets'—it conveys the same meaning by calling it a 'core upstream growth driver' and detailing FPSO expansion. (4) Contextual relevance is excellent: directly addresses both upstream growth portfolio and production capacity evolution. The only reason for not scoring 10 is that the LLM omits the explicit reclassification of Guyana under 'Advantaged Assets' in 2024 earnings drivers, a key qualitative signal from the ground truth. However, the substance of that reclassification is effectively conveyed through operational and strategic emphasis. Overall, the answer demonstrates strong multi-hop synthesis across time, projects, and strategic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 439,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "\n\nBetween 2022 and 2023, the X1 platform expanded its integration with third-party streaming services, incorporating additional platforms such as **Disney+**, **Netflix**, and **Peacock** (including its ad-supported tier), alongside Comcast’s own services like Xumo Play and Sky-branded content. This evolution, highlighted in CMCSA_10k_2023.pdf (pages 5–6) and CMCSA_10k_2022.pdf (pages 7–8), reflects Comcast’s strategy to combat cord-cutting by offering a unified, flexible viewing experience that combines linear TV, on-demand content, and third-party streaming within a single interface. By bundling these services and earning commission revenue from third-party DTC (direct-to-consumer) sales, Comcast aims to retain customers who might otherwise subscribe to standalone streaming platforms, thereby stabilizing or increasing average revenue per user (ARPU) through cross-selling and reduced churn.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and strategic interpretation. (1) It accurately identifies the integration of Disney+, Netflix, and Peacock (including premium/ad-supported tiers) on the X1 platform in 2022–2023, and correctly notes Comcast's commission revenue from third-party DTC sales. However, it omits the specific 2023 addition of Xumo Play, NBC, and Sky through NOW TV service targeted at broadband customers—a key detail in the evolution. Instead, it groups Xumo Play and Sky-branded content as if they were integrated directly into X1, which slightly misrepresents the structure (NOW TV/Xumo Play is a separate streaming service, not an X1 feature). (2) There are no numerical values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable—score reflects no factual inaccuracies in timeframes or metrics. (3) The multi-hop reasoning is sound: the model correctly infers that deeper streaming integration combats cord-cutting and supports ARPU growth via bundling and commissions. The logic connecting integration to reduced churn and revenue stabilization is consistent with the original answer. (4) Contextual relevance is high—the response directly addresses both parts of the question: evolution of integration and strategic implications. The omission of NOW TV’s role and slight conflation of Xumo/Sky with X1 integration prevents a perfect score, but core facts and strategic analysis remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 416,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "\n\nBetween 2023 and 2024, Caterpillar's distribution network for FG Wilson electric power generation systems expanded slightly in terms of distributors while narrowing geographic coverage. In 2023, FG Wilson systems were distributed through **108 distributors covering 158 countries**, whereas in 2024, the network grew to **110 distributors but covered 109 countries**. This suggests a consolidation or strategic realignment of distributor partnerships, reducing the number of countries served but increasing the number of distributors per region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content and reasoning. (1) Quantitatively, it reverses the data: it claims that in 2023 there were 108 distributors covering 158 countries, and in 2024 there were 110 distributors covering 109 countries. The ground truth states the opposite — in 2023: 110 distributors, 109 countries; in 2024: 108 distributors, 158 countries. This inversion of numbers leads to a completely wrong conclusion. (2) The calculations and comparisons are therefore invalid. The model incorrectly suggests distributor count increased and geographic coverage decreased, when in fact distributor count decreased slightly and geographic coverage expanded significantly. (3) The multi-hop reasoning is flawed — the model fails to correctly synthesize the evolution of the distribution network over time, drawing an opposite and unsupported conclusion about strategic realignment toward more distributors per region, which contradicts the actual trend of network optimization with fewer distributors covering more countries. (4) While the answer addresses the question's topic and attempts to interpret strategic implications, the severe factual inaccuracies in core data points result in a near-total failure of correctness. Contextual relevance is low but not zero because the structure and intent align with the question. Scores reflect catastrophic failure in quantitative and qualitative accuracy, with minimal credit for attempting the right type of analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 411,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "\n\nCapital One's exposure to securitized debt obligations increased between 2022 and 2024. As of December 31, 2023 (from the 2024 filing), the carrying value of securitized debt obligations was **$18,043 million**, with a fair value of **$18,067 million**. For comparison, the 2022 filing (COF_10k_2022.pdf, page 179) indicates that as of December 31, 2021, the carrying value of securitized debt obligations in consolidated VIEs was **$15,203 million**. While 2022-specific data is not explicitly provided in the pages, the trend shows a notable increase in both carrying value and fair value from 2021 to 2023, reflecting higher exposure over this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical error in temporal alignment that affects quantitative accuracy. It correctly identifies the 2024 (as of Dec 31, 2023) carrying value ($18,043 million) and fair value ($18,067 million) from the 2024 filing, which matches the ground truth. However, it incorrectly uses 2021 data ($15,203 million as of Dec 31, 2021) from the 2022 filing to represent 2022 exposure, which is not valid—no actual 2022 year-end data is provided. The question asks for changes between 2022 and 2024, but the LLM substitutes 2021 for 2022 without justification, undermining the comparison. While the trend inference may be directionally correct, this is an unsupported substitution. The qualitative reasoning about increased exposure and stable valuation is reasonable but based on flawed data pairing. The entity (Capital One), metric (securitized debt obligations), and fair value hierarchy (Level 2) are correctly identified, and the contextual relevance is high. However, the lack of actual 2022 carrying/fair values prevents a valid multi-hop comparison, leading to a deduction in quantitative accuracy. Semantic equivalence with the original answer is partial—core 2024 facts are correct, but the change over time is not accurately represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 356,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "\n\nBetween 2023 and 2024, McDonald's maintained a **$4.0 billion committed line of credit agreement** as part of its financing strategy, but its use of **uncommitted foreign currency lines of credit** decreased significantly. In 2023, subsidiaries had **$122.0 million** in borrowings under uncommitted foreign currency lines, whereas in 2024, this dropped to **$7 million**, indicating reduced reliance on such flexible but less predictable credit facilities. \n\nThe Company also terminated its 2022 borrowing authority in late 2024 and replaced it with a new **$15.0 billion borrowing program** effective January 1, 2025. This shift reflects a strategic adjustment to align with evolving financing needs, particularly as bond issuances declined in 2024 (leading to higher cash used for financing activities). The continued access to committed credit lines and commercial paper borrowings underscores McDonald's focus on maintaining liquidity and managing short-term funding needs amid fluctuating capital market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth, undermining its correctness. (1) Quantitative Accuracy: The $4.0 billion committed line of credit, $122.0 million and $7 million uncommitted foreign currency borrowings, and the $15.0 billion borrowing program effective January 1, 2025, are all absent from the original answer and cannot be verified against the provided ground truth. These specific figures and the termination of a 2022 borrowing authority are not mentioned, suggesting fabrication or hallucination. (2) Completeness: While the question asks about the evolution of line of credit use in relation to financing activities and cash flow, the LLM fails to mention key data from the ground truth—namely, the cash used for financing activities ($4.4B in 2023, $7.5B in 2024) and the cash and equivalents balance ($4.6B in 2023, $1.1B in 2024), which are central to understanding liquidity trends. (3) Entity Accuracy: The companies and years are correct, but specific financial instruments and programs (e.g., $15B program) are incorrectly introduced. (4) Reasoning: The LLM attempts multi-hop reasoning by linking reduced bond issuance to increased financing outflows and credit reliance, which aligns conceptually with the ground truth. However, the reasoning is built on incorrect data, weakening its validity. (5) Semantic Equivalence: The general theme of increased reliance on credit facilities in 2024 is partially consistent, but the absence of core financial figures and introduction of unsupported details result in a materially divergent answer. The ground truth emphasizes a shift from surplus liquidity in 2023 to a cash-constrained 2024 due to timing of debt issuances, which the LLM does not capture. Thus, while contextually relevant and attempting appropriate reasoning, the answer is factually unsound on key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 514,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "\n\nBetween 2022 and 2024, the **Worldwide Business Conduct Manual** evolved from a foundational governance tool to a more integrated component of Procter & Gamble’s (P&G) internal control framework. In 2022, the manual was highlighted as a key element in reinforcing integrity and compliance, aligning employee actions with P&G’s Purpose, Values, and Principles (PVPs) while supporting written policies, segregation of duties, and oversight by governance bodies like the Audit Committee. By 2024, the manual’s role expanded to explicitly include **annual Control Self-Assessment Programs** for critical financial reporting areas, demonstrating a proactive approach to identifying and addressing control deficiencies. This evolution reflects P&G’s commitment to **continuous governance improvement**, embedding ethical standards into structured risk management processes and ensuring alignment with dynamic regulatory and operational challenges. The sustained emphasis on the manual underscores P&G’s prioritization of a robust, principles-driven governance culture.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces information not present in the ground truth, affecting factual accuracy. (1) Correct elements: The general evolution of the Worldwide Business Conduct Manual from reinforcing integrity to a more integrated role in internal controls is consistent with the original answer. The mention of governance bodies and alignment with ethical principles (PVPs) corresponds to the 2022 description. (2) Quantitative accuracy: There are no numeric values, dates, or calculations in the question or ground truth, so this dimension is neutral; no errors here. (3) Multi-hop reasoning: The LLM claims that by 2024, the manual explicitly included 'annual Control Self-Assessment Programs for critical financial reporting areas'—this detail is not present in the ground truth. Instead, the actual evolution emphasized ties to governance frameworks like the Global Leadership Council and Disclosure Committee, which the LLM omits. This represents a significant factual deviation. (4) The answer captures the directional shift toward stronger integration of governance and controls, which is contextually relevant and reasonably interprets P&G’s governance priorities. However, because it fabricates a specific program (Control Self-Assessment Programs) not in the source and misses the actual structural governance additions (Disclosure Committee, Global Leadership Council oversight), the qualitative accuracy is reduced. The core idea of increased integration is valid, but the supporting evidence is incorrect, leading to a score of 6—partially correct with significant factual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 440,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "\n\nExxon's strategic positioning in Guyana strengthened between 2023 and 2024, as evidenced by increased long-lived asset investments and explicit inclusion in earnings driver definitions. In 2024, Guyana was explicitly categorized as an \"Advantaged Asset\" within the earnings driver framework (page 37 of 2024 10-K), highlighting its role in driving volume growth through high-return projects. Long-lived assets in Guyana rose from $6.766 billion in 2023 to $9.689 billion in 2024 (page 115 of 2024 vs. page 115 of 2023 10-K), reflecting expanded capital deployment. This aligns with Exxon's focus on \"advantaged projects\" and integration of high-value assets, underscoring Guyana's strategic importance as a core growth driver in its resource portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2023 long-lived asset value for Guyana. The original answer (ground truth) states $9,689 million in 2023, while the LLM claims $6.766 billion in 2023 and $9.689 billion in 2024. This reverses the correct trend: the ground truth shows $9,689 million in 2023, with no indication of a prior lower value. The LLM incorrectly implies growth from $6.766B to $9.689B, introducing a false calculation and misrepresenting the data. This is a major quantitative inaccuracy. (2) The 2024 figure of $9.689 billion matches the ground truth, though the unit shift from million to billion is semantically acceptable if accurate, but here it compounds confusion. The claim of an increase is unsupported by the provided truth. (3) Qualitatively, the LLM correctly identifies the strategic evolution: Guyana’s inclusion in 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver in 2024 is accurately noted and reflects proper multi-hop reasoning between asset disclosures and strategic framing. The conceptual shift from quantitative significance to strategic emphasis is well captured. (4) Contextually, the answer is highly relevant, citing correct document locations (page numbers) and using appropriate terminology. However, the core numerical error undermines factual correctness, especially as the question hinges on year-over-year evolution supported by asset values. Despite strong qualitative synthesis, the incorrect financial data reduces the correctness score significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 426,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "\n\nCapital One's reliance on securitized debt obligations as a funding source decreased from 2022 to 2024. As of December 31, 2021 (the latest data in the 2022 filing), securitized debt obligations totaled **$14.994 billion**, while by December 31, 2024, this amount declined to **$14.264 billion**. Despite this slight absolute reduction, total borrowings (including deposits, senior notes, and other liabilities) more than doubled from **$61.009 billion in 2021 to $125.132 billion in 2024**, indicating a significant decline in the proportion of funding derived from securitized debt obligations over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific dollar value for securitized debt obligations was disclosed in 2022, but the LLM claims a figure of $14.994 billion as of December 31, 2021 (from the 2022 filing), which contradicts the original answer and misrepresents the disclosed data. While the 2024 carrying value of $14,264 million is correctly stated (equivalent to $14.264 billion), the use of 2021 data to represent 2022 is misleading and incorrect in context. (2) The calculation of total borrowings increasing from $61.009 billion in 2021 to $125.132 billion in 2024 is not supported by the original answer and introduces unsourced data, making the proportional decline argument baseless. There is no mention in the ground truth of total borrowings or their composition over time, so this analysis is fabricated. (3) The multi-hop reasoning is flawed: the original answer emphasizes increased transparency and continued use of securitized debt, while the LLM concludes decreased reliance based on unsupported comparisons. The model fails to recognize that the absence of a disclosed figure in 2022 does not imply a known value from prior years, nor does it justify trend analysis. (4) The contextual relevance is moderate because the answer addresses the topic of securitized debt obligations and attempts to compare across years, but the incorrect data and reasoning severely undermine accuracy. The conclusion of decreased reliance is directly contradicted by the ground truth, which highlights continued strategic use and improved disclosure. Thus, despite some correct formatting and partial topic alignment, the answer is largely factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 470,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "\n\nBetween fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from a **3D design collaboration and simulation tool** (2022) to a **cloud-based industrial metaverse solution** (2023). In 2022, Omniverse was positioned as software enabling real-time 3D design and virtual world creation for artists and industries. By 2023, NVIDIA introduced **Omniverse Cloud**, a fully managed service on Microsoft Azure, explicitly targeting enterprise adoption for industrial metaverse applications like digital twins, real-time 3D configurators, and autonomous system testing. This shift to a cloud-deployed, scalable solution (on-premises and cloud) expanded its accessibility and utility, aligning with growing demand for digitalization in manufacturing, automotive, and other industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of NVIDIA's Omniverse platform between fiscal years 2022 and 2023. It correctly identifies the shift from a 3D design collaboration tool in 2022 to a more enterprise-focused, cloud-based industrial metaverse platform in 2023. The introduction of Omniverse Cloud on Microsoft Azure is factually correct and aligns with the strategic expansion into enterprise digital twin and simulation applications. While the original answer emphasizes the platform's evolution into a 'development platform and operating system' with a subscription model for enterprises and free access for individuals, the LLM answer omits the detail about the free tier for individual users. However, it compensates by correctly highlighting the cloud deployment model, scalability, and industrial use cases such as digital twins and real-time 3D configurators. All entities (NVIDIA, Omniverse, Microsoft Azure), timeframes (fiscal years 2022–2023), and technological developments are accurately represented. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information across positioning, target users, deployment model, and enterprise adoption. The omission of the free individual tier is minor in context and does not detract from the overall correctness. Semantic equivalence is maintained, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 399,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "\n\nBetween 2022 and 2023, the net amounts due under Pfizer's agreements with Viatris decreased significantly. As of December 31, 2022, Pfizer owed Viatris **$94 million**, while by December 31, 2023, this amount had reduced to **$33 million**. This reduction reflects the completion of transitional services and the winding down of interim agreements (such as Transition Services Agreements and Manufacturing and Supply Agreements) established post-separation. The decline aligns with the termination of most post-combination operational support services by year-end 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts ($94 million as of December 31, 2022, and $33 million as of December 31, 2023) are accurately reported with correct dates. The reduction from $94M to $33M is correctly characterized as a significant decrease. (2) The answer is complete, addressing the evolution of Pfizer's financial relationship with Viatris over the specified period and focusing on net amounts due under their agreements. (3) Entity accuracy is correct: Pfizer and Viatris are properly identified, and the context of post-separation transitional agreements (e.g., Transition Services Agreements, Manufacturing and Supply Agreements) is accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the decline in net amounts is logically tied to the winding down of transitional services, with an added detail about the termination of most support services by end of 2023, which enhances the explanation without contradicting the ground truth. The semantic meaning and factual content are equivalent to the original answer, with slightly more contextual elaboration. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 341,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "\n\nExxonMobil's strategic emphasis on Guyana evolved from active project development in 2023 to a classification as a core \"Advantaged Asset\" in 2024, reflecting its role in driving high-return growth. In 2023, the company completed 12.6 net exploratory/development wells, initiated the Payara project with the Prosperity FPSO, advanced Yellowtail, and funded Uaru (as noted on page 20 of the 2023 filing). By 2024, Guyana was explicitly designated as part of the \"Advantaged Volume Growth\" earnings driver (page 37 of the 2024 filing), signaling its integration into the company’s prioritized, high-value projects. This classification underscores a shift toward leveraging Guyana’s low-cost, high-margin production to enhance capital productivity, aligning with broader strategic goals of disciplined investment in advantaged assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the number of net exploratory and development wells (12.6) is accurately reported and matches the original answer. The years (2023 and 2024) and project names (Payara, Yellowtail, Uaru) are correct. (2) The answer correctly identifies the strategic reclassification in 2024, noting Guyana's inclusion in the 'Advantaged Volume Growth' earnings driver, which aligns with the ground truth. The reference to page 37 of the 2024 filing adds precision, and the mention of page 20 of the 2023 filing corroborates the operational details. (3) The multi-hop reasoning is sound: the answer synthesizes operational activity in 2023 with strategic classification in 2024, correctly inferring a shift from development to strategic prioritization. (4) The LLM enhances the original answer with additional context (e.g., FPSO name 'Prosperity', emphasis on capital productivity and low-cost production) without introducing inaccuracies. All entities, metrics, and timeframes are correct, and the semantic meaning fully aligns with the ground truth. Minor additions improve clarity without deviating from facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 336,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "\n\nThe weighted-average interest rate for senior notes with maturities greater than 10 years remained unchanged at **3.8%** from 2022 to 2023. The face value increased slightly from **$52.8 billion in 2022** to **$53.4 billion in 2023**, as reported in Note 6 of the 2023 10-K (page 82).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, in 2022 the weighted-average interest rate was 3.67%, not 3.8%, and the face value was $54.536 billion, not $52.8 billion. The 2023 face value of $53.4 billion is correct, but the interest rate is inaccurately stated as unchanged at 3.8%—the ground truth shows a change from 3.67% to 3.8%, meaning the rate did increase slightly. (2) The numbers are not quantitatively accurate: the 2022 face value is off by over $1.7 billion, and the interest rate misrepresents a small increase as no change. The 2023 values are partially correct (face value matches), but the rate should reflect an increase. (3) The reasoning is partially sound in that it attempts to compare year-over-year changes, but it fails in multi-hop synthesis by not correctly retrieving or calculating the change in interest rate. The claim of 'unchanged' rate contradicts the ground truth evolution from 3.67% to 3.8%. (4) Contextual relevance is high—the answer addresses the right metric, time frame, and debt category, and cites a relevant note and page. However, due to key numerical errors and incorrect conclusion about rate stability, the overall correctness is significantly compromised. Minor format flexibility is allowed, but directional changes and magnitudes must be accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 385,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "\n\nBetween 2023 and 2024, Alabama Power and Georgia Power adjusted their nuclear decommissioning trusts' domestic equity allocations and valuation methodologies as follows:  \n\n- **Alabama Power**: Increased Level 1 (quoted prices in active markets) domestic equity investments from $396 million (2023) to $443 million (2024), while Level 2 (observable inputs) rose from $169 million to $208 million.  \n- **Georgia Power**: Elevated Level 1 domestic equity from $255 million (2023) to $321 million (2024), with Level 2 remaining at $1 million in both years.  \n\nThese shifts reflect a strategic reallocation toward higher transparency (Level 1) and expanded observable inputs (Level 2) for Alabama Power, whereas Georgia Power primarily increased Level 1 holdings without significant Level 2 changes. Valuation methodologies remained consistent, adhering to fair value hierarchy standards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All dollar amounts for both Alabama Power and Georgia Power in both years are accurate—$396M to $443M (Level 1) and $169M to $208M (Level 2) for Alabama Power; $255M to $321M (Level 1) and $1M in both years for Georgia Power. Totals are implied correctly ($565M to $651M and $256M to $322M). (2) Completeness: The answer addresses both companies, both years, both Level 1 and Level 2 allocations, and the shift in investment strategy. It also touches on valuation methodologies, noting consistency with fair value hierarchy standards, which aligns with the original answer’s implication of continued use of transparent, market-based inputs. (3) Entity accuracy: Company names, years (2023–2024), financial metrics (domestic equity, Level 1/Level 2), and trust context are all correctly identified. (4) Reasoning: The multi-hop synthesis across two companies and two years is sound. The conclusion about a strategic shift toward Level 1 (more transparent, liquid) investments is logically supported and consistent with the original answer. (5) Semantic equivalence: While the LLM uses slightly different phrasing (e.g., 'strategic reallocation toward higher transparency' vs. 'strategic shift toward higher allocations... through more actively traded instruments'), the meaning is equivalent and accurately reflects the trend. No factual, numerical, or interpretive errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 409,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "\n\nNVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 by solidifying its role as the foundational programming model across its full-stack computing platform, enabling accelerated computing for AI, HPC, and graphics workloads. In 2022, CUDA was highlighted as a key enabler for diverse markets (Gaming, Data Center, Professional Visualization, Automotive) through its programmable architecture and ecosystem of developers. By 2023, CUDA's integration expanded to support new hardware innovations like DPUs and CPUs (e.g., Grace CPU), and it became central to NVIDIA's cloud offerings, such as the DGX Cloud platform. Additionally, CUDA's role in AI-driven solutions deepened across end markets, including autonomous vehicles (via DRIVE software stacks) and enterprise AI, reflecting its broader adoption as a unified foundation for cross-industry innovation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of CUDA's evolving strategic role from 2022 to 2023. It accurately captures the progression of CUDA from a key enabler in multiple markets (Gaming, Data Center, Automotive, etc.) in 2022 to a more central, full-stack foundation in 2023. The mention of CUDA supporting new hardware like DPUs and Grace CPU, as well as integration with DGX Cloud and domain-specific stacks like DRIVE, reflects accurate qualitative understanding and contextual relevance. However, the original answer emphasizes a specific strategic shift toward CUDA enabling 'hundreds of domain-specific software libraries, SDKs, and APIs' in verticals like healthcare, telecom, and manufacturing—details not explicitly mentioned in the LLM response. While the LLM references AI-driven solutions and enterprise AI, it does not clearly articulate the expansion into domain-specific software ecosystems as a core strategic evolution, which is a key differentiator in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and all entities (NVIDIA, CUDA, DGX, DRIVE, Grace CPU) are correctly identified. The reasoning is sound and multi-hop synthesis is appropriate, though slightly less comprehensive than the original. Thus, the answer is strong but misses a nuanced yet important aspect of the strategic evolution, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 411,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "\n\nFrom 2022 to 2023, Pfizer's financial obligations and contractual relationships with Viatris evolved as follows:  \n\n1. **Transitional Service Agreements (TSAs):** Services under the TSAs, which involved Pfizer providing transitional support to Viatris (e.g., billing, collections, and manufacturing), were **largely completed by December 31, 2023**. In 2022, these services were still ongoing, but by 2023, they were no longer material to operations.  \n\n2. **Net Amounts Owed:** The net amounts due to Viatris decreased significantly from **$94 million as of December 31, 2022**, to **$33 million as of December 31, 2023**. This reduction reflects the winding down of post-separation obligations and the completion of TSA-related activities.  \n\nThese changes indicate a substantial reduction in Pfizer's financial exposure and contractual obligations to Viatris by the end of 2023 compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the dollar amounts ($94 million in 2022 and $33 million in 2023) are accurately reported, and the timeline (largely completed by end of 2022, fully completed by December 31, 2023) aligns with the original answer. (2) The answer is complete, addressing both transitional service agreements and net amounts owed, as required by the question. (3) Entities—Pfizer, Viatris, TSAs, MSAs (implied under TSAs), and the timeframes 2022 and 2023—are correctly identified and contextualized. (4) The reasoning is sound: the reduction in net amounts and completion of services are logically tied to the winding down of post-spin-off obligations from the 2020 Upjohn Business separation. The LLM correctly synthesizes multi-hop information across years and agreement types, and the semantic meaning is equivalent to the ground truth, despite slightly different phrasing. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 290,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "\n\nFrom 2022 to 2023, Duke Energy's exposure to retail deregulation pressures and environmental compliance costs remained interconnected but evolved with specific regulatory developments. **Retail deregulation risks** persisted, with the company highlighting uncertainties around stranded costs (e.g., generation assets and power purchase obligations) and potential erosion of exclusive service rights, though no major legislative changes were enacted during this period. However, in 2023, Duke Energy emphasized the need for supportive policies to fund transmission upgrades for renewables, linking deregulation pressures to infrastructure demands. \n\n**Environmental compliance costs** saw heightened focus in 2023 due to new EPA actions, such as the January 2022 CCR Rule interpretation, which increased closure and remediation obligations for coal ash management. The company also noted rising risks from state-level carbon reduction mandates and the need to retire carbon-intensive assets earlier than planned to meet its 2050 net-zero goal. While compliance costs for existing regulations were generally recoverable through regulatory mechanisms, Duke Energy warned of potential material impacts from future rules, particularly as clean energy transitions require significant capital expenditures. \n\nOverall, the interplay between deregulation and environmental compliance intensified in 2023, driven by regulatory shifts and the accelerating clean energy transition, though core risks around cost recovery and legislative uncertainty remained consistent with 2022 disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and reasoning. (1) It accurately captures the ongoing relationship between retail deregulation pressures and environmental compliance costs at Duke Energy from 2022 to 2023. The mention of stranded costs, power purchase obligations, and erosion of service rights reflects the 2022 risk environment, while the 2023 emphasis on EPA rules (e.g., CCR Rule), state-level carbon mandates, and early retirements matches the original answer's focus on increasing regulatory pressure. (2) There are no specific numbers, dollar amounts, or dates that conflict with the ground truth; the reference to the January 2022 CCR Rule interpretation is factually accurate and contextually relevant, even though the original answer does not include it—this represents additional but correct detail, not an error. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how deregulation limits cost recovery mechanisms while environmental compliance costs rise due to federal and state regulations. It also appropriately links deregulation to infrastructure and clean energy transition challenges, which is a nuanced extension of the original answer. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention PURPA or qualifying facilities (QFs), which are key elements in the 2022 cost recovery concern per the original answer. Additionally, while the LLM discusses transmission and clean energy investments, it slightly shifts focus from the core issue in the original answer—deregulation undermining the ability to pass on environmental compliance costs—toward broader transition challenges. However, the central theme of compounding pressures is preserved. Overall, the answer is factually accurate, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 508,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "\n\nThe retail share of Skoal oral tobacco products decreased by 1.7 percentage points (from 9.3% in 2023 to 7.6% in 2024). This decline occurred despite a pricing strategy in 2023 that included multiple list price increases on Skoal brands, such as a $0.09 per can hike in January 2023 and a $0.10 per can increase in April 2023. The contrast lies in the fact that while Altria actively raised Skoal prices in 2023, these efforts failed to offset retail share losses, likely due to competitive pressures from growing oral nicotine pouch categories (e.g., on!) and shifting consumer preferences.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in retail share from 9.3% in 2023 to 7.6% in 2024, accurately calculating the 1.7 percentage point decline. However, the pricing details for 2023 are factually incorrect. The ground truth states that the price increases announced in 2023 were for a $0.11 per can increase effective January 23, 2024, and references earlier increases in 2022 ($0.09, $0.09, $0.08), not in 2023. The LLM incorrectly reports a $0.09 increase in January 2023 and $0.10 in April 2023, which are not supported by the original data. (2) Quantitative accuracy is compromised due to these incorrect dollar amounts and dates. While the share numbers are correct, the pricing figures are not, and the timeline of increases is misrepresented. (3) The qualitative reasoning is sound in noting the contrast between price increases and declining retail share, and the mention of competitive pressures from nicotine pouches adds relevant context, even if not in the original answer. The multi-hop synthesis between market share and pricing strategy is logically structured, but based on incorrect pricing data. (4) The answer is contextually relevant and addresses both parts of the question—change in retail share and contrast with pricing strategy—but the factual inaccuracies in the pricing details reduce correctness. The core insight (price hikes amid declining share) is preserved, but with flawed supporting data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 399,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "\n\nAmgen's investment in 'Other short-term interest-bearing securities' decreased slightly from $138 million as of December 31, 2023, to $135 million as of December 31, 2024, representing a minor reduction of $3 million. This category remains a small portion of Amgen's total short-term investments, which are predominantly held in money market mutual funds and U.S. Treasury bills. The stable, low-allocation to 'Other short-term interest-bearing securities' aligns with Amgen's conservative investment strategy, emphasizing safety of principal, liquidity, and minimal risk. The slight decline suggests no significant strategic shift but reflects routine portfolio management within their overarching focus on preserving capital and maintaining ready access to funds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Amgen's investment decreased from $138 million in 2023 to $135 million in 2024, while the ground truth confirms the amount remained unchanged at $138 million in both years. This is a critical factual error affecting the core of the response. (2) The quantitative inaccuracy is significant—there is no $3 million decrease as claimed; the calculation of a 'minor reduction' is therefore baseless. All other numerical references (e.g., characterization as a small portion) are speculative but not directly contradicted. (3) The reasoning about Amgen’s conservative investment strategy and emphasis on liquidity and safety is plausible and contextually sound, but it is built upon incorrect data. The multi-hop synthesis fails because the premise (a decline) is false, leading to an invalid conclusion about 'routine portfolio management' reflecting a slight decline. (4) While the answer addresses both parts of the question (evolution and strategic implication), the factual foundation is flawed. The contextual relevance is fair because the general discussion aligns with typical interpretations of short-term investment behavior, but the qualitative accuracy is low due to incorrect entity-state representation. Correctness score is low due to the central error in financial data, which undermines the answer’s validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 382,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "\n\nFrom 2022 to 2024, General Dynamics' involvement in Abrams Main Battle Tank Upgrades expanded in scope and value. In 2022, the company secured a $360 million contract for upgrades, mission control units, and technical support (as reported in 2021 awards). By 2024, the contract scope broadened to include engineering, logistics support, and sustainment technical services, with a $350 million award (listed in 2024) and additional $285 million for producing SEPv3-configured Abrams tanks for Romania. The 2024 contracts also emphasized international production and modernization, reflecting a more comprehensive lifecycle support approach compared to 2022, with higher potential total value due to multi-year options and expanded service offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: the $360 million 2022 contract, the $350 million 2024 contract for upgrades and support, and the $285 million contract for Romania SEPv3 production. These match the ground truth exactly in amount and context. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers are reported accurately with acceptable formatting. While the total combined value of $635 million (350 + 285) is not explicitly summed, the mention of both contracts conveys the increased total value compared to 2022’s $360 million, which is sufficient for semantic equivalence. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across time (2022 to 2024), distinguishes between upgrade, support, and new production contracts, and infers a broader scope in 2024. It accurately notes the evolution from primarily upgrades to include production (Romania SEPv3) and expanded lifecycle support. The mention of 'international production' and 'lifecycle support' adds insightful context not explicitly stated but logically derived. (4) Minor deduction in qualitative accuracy because the LLM references the 2022 contract as 'reported in 2021 awards,' which slightly misaligns with the ground truth framing (the contract was received in 2022). However, this does not materially distort the timeline. Overall, the answer is factually correct, comprehensive, and contextually precise, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 415,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "\n\nFrom 2023 to 2024, AIG's financial relationship with Corebridge transitioned from structured borrowing arrangements to post-divestiture income recognition. In 2023, Corebridge maintained significant debt (e.g., $9.4 billion in notes, bonds, and a $1.5 billion DDTL facility) with AIG providing guarantees and collateral agreements requiring Corebridge to reimburse AIG for any payments under these guarantees. By 2024, AIG deconsolidated Corebridge, recognizing a **$4.75 billion after-tax loss on disposal**, which included fair valuation of retained investments (e.g., 294.2 million shares at $28.90 per share, valued at $8.5 billion). Income recognition shifted to equity method accounting, reflecting Corebridge’s stock price changes: **$601 million equity method income in 2024** (sum of dividends and fair value adjustments post-June 9, 2024 deconsolidation). Borrowing arrangements in 2023 involved active debt management, while 2024 focused on resolving residual obligations and recognizing gains/losses from the sale of Corebridge shares.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in AIG's financial relationship with Corebridge from borrowing arrangements in 2023 to equity method income recognition in 2024, which aligns with the ground truth. However, there are significant quantitative inaccuracies that reduce confidence in the factual precision. The ground truth states that Corebridge had borrowing ability through February 25, 2025, but the LLM does not mention this specific date or borrowing continuation, instead focusing on 2023 debt figures ($9.4B notes/bonds, $1.5B DDTL) and guarantees, which are not in the original answer and cannot be verified against the provided ground truth. These specific dollar amounts and facilities are likely from external data not reflected in the knowledge graph used for the ground truth. The $4.75 billion after-tax loss on disposal and $601 million equity method income are not mentioned in the original answer, making them unverifiable; the ground truth only confirms that AIG began recognizing equity method income tied to stock price changes and dividends since June 9, 2024, without specifying amounts. The 294.2 million shares at $28.90 and $8.5 billion valuation also do not appear in the original, suggesting fabrication or use of external data. While the qualitative shift—from debt-based to equity-based income—is correctly identified and logically synthesized, the inclusion of unsupported numerical details reduces quantitative accuracy. The reasoning is sound in structure and addresses the multi-hop nature (change over time, two financial aspects: borrowing and income), but relies on potentially incorrect data. Contextually, the answer is highly relevant and well-structured. Thus, correctness is partially compromised by unsupported numbers, warranting a 7; quantitative accuracy is penalized (6), qualitative reasoning is strong (8), and relevance is perfect (10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 509,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "\n\nBetween 2022 and 2024, Tesla's approach to Solar Roof evolved from addressing production bottlenecks and supplier dependencies to prioritizing vertical integration and internal manufacturing capabilities. In 2022, challenges included reliance on external suppliers for components and collaboration with real estate developers to improve installation efficiency (2022 10-K, pages 6, 102). By 2024, Tesla acknowledged ongoing production delays and supply chain risks for Solar Roof, emphasizing the need to develop proprietary battery cells and reduce reliance on limited suppliers like Panasonic and CATL (2024 10-K, pages 17–18). Strategically, Tesla shifted toward controlling more of its supply chain, investing in automation, and scaling internal production to mitigate external dependencies, reflecting a move toward vertical integration to ensure cost efficiency and scalability.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies despite including plausible details. The ground truth states that in 2022, Tesla was selling the Solar Roof and improving installation efficiency through collaboration with real estate developers—this part is correctly reflected. However, the LLM incorrectly claims that by 2024, Tesla emphasized developing proprietary battery cells and reducing reliance on suppliers like Panasonic and CATL. This is not supported by the ground truth, which makes no mention of battery cells or specific suppliers (Panasonic, CATL) in the context of Solar Roof. The 2024 10-K reference to production ramp challenges, bottlenecks, and supplier risks is partially correct but misdirected—the ground truth does not tie these issues to battery cells or name specific suppliers for Solar Roof. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not violated—score is 10. (3) The multi-hop reasoning is partially sound: the model identifies a shift from installation efficiency (2022) to production and supply chain challenges (2024), which aligns with the ground truth. However, it introduces unsupported strategic shifts toward vertical integration and proprietary battery development that are not mentioned in the original answer, indicating flawed synthesis. (4) Contextual relevance is high because the answer addresses the evolution of Tesla's Solar Roof strategy across the two years and focuses on production and dependencies. However, the introduction of unverified details (battery cells, specific suppliers) undermines qualitative accuracy. The core shift in emphasis is captured, but with significant factual overreach, warranting a correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 483,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "\n\nSkoal's retail share in the U.S. oral tobacco market declined from **9.3% in 2023 to 7.6% in 2024**, a **1.7 percentage point decrease**. This decline aligns with broader shifts in the category, as oral nicotine pouches (e.g., on!) gained market share at the expense of moist smokeless tobacco (MST) products like Skoal. The weakening competitive positioning of Skoal reflects both industry-wide adoption of nicotine pouches and internal strategic focus on newer product lines (e.g., on!), which captured 19.2% of the nicotine pouch category in 2024 but saw a **2.6 share point decline** year-over-year. The results highlight Skoal's struggle to retain relevance amid evolving consumer preferences and product innovation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: Skoal's retail share decreased from 9.3% in 2023 to 7.6% in 2024, a 1.7 percentage point drop, which matches the ground truth. This core quantitative information is accurate. However, the LLM introduces additional data not present in the original answer—specifically, that on! captured 19.2% of the nicotine pouch category in 2024 and had a 2.6 share point decline year-over-year—which is not supported by the provided ground truth and appears to be hallucinated or inferred beyond available information. (2) The calculation of the 1.7 percentage point decrease is correct (9.3% - 7.6% = 1.7%). The years and percentages are accurately cited. However, the unsupported claim about on!'s 2.6 share point decline and its 19.2% category share undermines quantitative accuracy. (3) The reasoning about Skoal’s weakening competitive positioning due to shifts toward nicotine pouches is logically sound and consistent with the contrast to on!’s growth (6.8% to 8.3% in overall oral tobacco market share). However, the model incorrectly frames on!’s performance as declining (‘2.6 share point decline’), which contradicts the ground truth that on! grew from 6.8% to 8.3%—a 1.5 point increase. This misrepresents a key comparative dynamic and breaks the multi-hop logic. (4) The answer is contextually relevant and addresses both parts of the question—change in share and competitive positioning—with good structure and flow. Despite the hallucinated metrics and incorrect inference about on!, the main conclusion about Skoal’s weakening position is valid. The score is reduced due to significant qualitative inaccuracy in the comparative analysis, even though the primary facts about Skoal are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 477,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "\n\nThe risk associated with the concentration of device share among premium-tier companies has intensified for Qualcomm between 2023 and 2024, exacerbating potential impacts on pricing power and revenue stability. In 2024, the company highlighted heightened vertical integration by key customers, such as Apple’s continued development of in-house modems and Chinese OEMs advancing self-sufficiency under policies like \"Made in China 2025,\" which directly reduces demand for Qualcomm’s premium-tier integrated circuits. Additionally, slowing growth in the premium-tier smartphone segment—driven by market maturity and shifting consumer demand—increases reliance on innovation cycles and new product launches, creating revenue volatility. Geopolitical tensions, particularly U.S.-China dynamics, further amplify risks to revenue stability by disrupting access to critical markets and customers. Compared to 2023 disclosures, 2024 emphasizes a more pronounced shift in customer behavior and market conditions, with concentrated purchasing power among a few OEMs potentially driving down prices and margins, thereby weakening Qualcomm’s pricing authority and exposing its financial performance to greater fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. It correctly identifies the persistence and intensification of the risk related to device share concentration among premium-tier companies from 2023 to 2024. The core elements—pricing pressure due to concentrated customer power, revenue instability due to product launch timing, and the growing threat of vertical integration (e.g., Apple and Chinese OEMs)—are all present and correctly emphasized. The mention of 'Made in China 2025' and geopolitical tensions adds contextual depth that, while not explicitly in the original answer, is semantically consistent with the broader risk environment and does not introduce inaccuracies. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative reasoning is strong, demonstrating correct multi-hop synthesis: linking customer concentration to pricing power, integrating trends in self-sufficiency, and connecting market dynamics to revenue volatility. The only minor gap is that the original answer specifically highlights Chinese OEMs as key revenue sources and notes the shift in emphasis in 2024 filings toward revenue fluctuation due to product cycles—details the LLM touches on but could have made more explicit. However, the overall meaning and risk assessment are preserved. Contextual relevance is excellent, as all points directly address the evolution of risk and its impact on Qualcomm. Thus, the answer earns a 9/10 for correctness—very close to perfect, with only slight room for more precise alignment on emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 442,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "\n\nAmgen's allocation to money market mutual funds increased slightly between 2023 and 2024. As of December 31, 2023, the fair value of money market mutual funds was **$10,266 million**, while as of December 31, 2024, it rose to **$10,354 million**. This reflects a modest growth in short-term liquidity holdings, consistent with Amgen's strategy to prioritize safety of principal, liquidity, and low-risk investments. The increase occurred alongside a broader rise in total available-for-sale investments, which grew from $10,404 million in 2023 to $11,486 million in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Amgen's allocation to money market mutual funds increased from $10,266 million in 2023 to $10,354 million in 2024. The ground truth explicitly states that the allocation remained unchanged at $10,266 million in both years. This fundamental error invalidates the core of the response. (2) The quantitative inaccuracies are severe: the reported 2024 value of $10,354 million is false, and the claim of an increase is unsupported. Additionally, the LLM invents a total available-for-sale investment figure of $11,486 million in 2024, which is not in the ground truth and cannot be verified, but contradicts the implication of stability. Even if totals were relevant, they are misrepresented. (3) The multi-hop reasoning is flawed—the question asks about evolution in allocation, and the correct inference from unchanged values is no change in strategy. The LLM incorrectly infers a shift in strategy due to a non-existent increase, demonstrating faulty logic. (4) While the answer addresses the general topic of short-term liquidity and references Amgen’s strategy appropriately, the complete divergence on key facts—especially dollar amounts and trends—results in a very low correctness score. Contextual relevance is partially maintained due to correct mention of money market funds and liquidity strategy, but factual accuracy is critically compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 394,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "\n\nGeneral Dynamics' U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) increased from **$295 million in 2022** to **$315 million in 2023** and further to **$333 million in 2024**, reflecting a gradual rise in participation over the period. This growth indicates an expansion in the company's utilization of the CCF program to defer taxes on eligible maritime vessel-related earnings. \n\n*Sources: GD_10k_2024.pdf (page 68) for 2024 and 2023 figures; GD_10k_2022.pdf (page 67) for 2022 figure (implied as $295 million based on prior-year context).*",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the pledged amounts as $295 million in 2022 (referring to the balance as of December 31, 2021), $315 million in 2023 (as of December 31, 2022), and $333 million in 2024 (as of December 31, 2023). The original answer also references the $333 million figure for December 31, 2024, which appears to be a forward-looking or projected value; however, based on standard 10-K reporting timelines, the 2024 filing would report up to December 31, 2023. The LLM correctly interprets the data available in the filings and aligns with the trend. (2) All numeric values match the ground truth exactly and are correctly attributed to the respective years. The formatting ($295 million, etc.) is consistent and acceptable. (3) The multi-hop reasoning is sound: the model synthesizes data from the 2022 and 2024 10-K filings, correctly identifying the evolution over time and interpreting the increasing trend as growing participation in the CCF program. (4) The only minor discrepancy is the original answer’s mention of a $333 million pledge 'on December 31, 2024', which is likely a typo or misstatement since financial reports typically do not include future-dated balances; the LLM correctly uses the $333 million figure as of December 31, 2023, per the 2024 10-K. This suggests the LLM is more factually accurate than the ground truth in that detail. Thus, the answer is fully correct in context, earning a 9 due to potential ambiguity in the ground truth, but with excellent quantitative and qualitative performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 428,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "\n\nAIG's financial relationship with Corebridge evolved significantly between 2023 and 2024 following the 2022 IPO and deconsolidation. **Tax implications** were marked by Corebridge's separation from AIG’s consolidated U.S. federal tax group, leaving Corebridge’s net operating losses and tax credits unused prior to deconsolidation to remain with Corebridge. In 2024, AIG recognized a **$4.754 billion after-tax loss on the disposal of Corebridge**, driven by a $8.5 billion retained investment (valued at Corebridge’s stock price) and a $378 million unsettled receivable, with tax expenses of $545 million offsetting a pre-tax gain. \n\n**Investment income** shifted from consolidated reporting to equity method accounting post-deconsolidation. In 2023, AIG recorded a $439 million gain on Corebridge’s stock price changes, while 2024 showed **$601 million in equity method income** (reflecting dividends and stock price fluctuations). However, the 2024 loss on disposal overshadowed this income, driven by reclassification adjustments and fair value declines. The deconsolidation also reduced AIG’s deferred tax assets related to Corebridge, though the overall valuation allowance remained largely unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite capturing some high-level qualitative shifts. (1) The original answer states that AIG began reporting under the equity method in 2024 with '$X' in income (placeholder), but the LLM asserts a specific figure of '$601 million in equity method income' and '$439 million gain in 2023'—these numbers are not present in the ground truth and cannot be verified as correct. (2) The claim of a '$4.754 billion after-tax loss on disposal' in 2024, driven by an '$8.5 billion retained investment' and '$545 million tax expenses', is entirely absent from the original answer and introduces unsupported specifics. The original mentions no such loss or disposal event in 2024. (3) The date of Corebridge's IPO is correctly implied as post-2022 (original: September 19, 2022), and the tax deconsolidation due to ownership dropping below 80% is correctly noted, aligning with the original. (4) The shift from consolidated reporting to equity method accounting is conceptually correct and addresses the multi-hop evolution. However, the LLM fabricates precise financial figures and a major loss event not present in the ground truth, undermining factual reliability. (5) While the answer correctly identifies tax implications such as retention of NOLs and tax credits by Corebridge, it incorrectly implies AIG recognized a large tax expense in 2024, which is not supported. (6) Contextually, the response is well-structured and relevant, addressing tax implications and investment income as required. However, the introduction of unverified numbers and a major financial event (disposal loss) constitutes serious factual errors. Thus, while the directional reasoning is partially sound, the quantitative inaccuracies severely reduce correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 494,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "\n\nTesla's approach to Solar Roof production and supply chain management evolved from 2022 to 2024 by shifting from initial scaling challenges to structured operational strategies. In 2022, Tesla focused on improving Solar Roof installation efficiency through collaborations with real estate developers and onboarding new installers to reduce costs and time (TSLA_10k_2022.pdf, p. 34). By 2024, the company expanded its strategy to include localized procurement, partnerships with education institutions for skilled labor development (e.g., FlexLearn, Tesla START programs), and addressing supply chain constraints by diversifying supplier bases and emphasizing responsible sourcing (TSLA_10k_2024.pdf, pp. 13, 17). Despite ongoing challenges like component shortages and single-source supplier risks, Tesla prioritized scaling Solar Roof through training programs and supply chain resilience initiatives, reflecting a more integrated approach to operational and human capital management.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately reflecting Tesla's shift from installation-focused efforts in 2022 to broader supply chain and production scalability concerns by 2024. It correctly identifies 2022 initiatives such as collaborating with real estate developers and onboarding new installers (supported by TSLA_10k_2022.pdf, p. 34), which aligns with the ground truth. The 2024 focus on supply chain risks like component shortages and single-source dependencies is also valid and contextually appropriate. However, the LLM introduces specific details not present in the ground truth, such as 'localized procurement,' 'FlexLearn,' 'Tesla START programs,' and 'partnerships with education institutions.' While these may be plausible initiatives, they are not mentioned in the original answer derived from the knowledge graph and represent an overextension beyond the provided evidence. Additionally, the ground truth emphasizes a shift from localized installer development to systemic supply chain risks, whereas the LLM frames it as an expansion that includes human capital programs, slightly misrepresenting the nature of the strategic evolution. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and the answer remains contextually relevant and well-structured. The qualitative accuracy is reduced due to the addition of unverified specifics and slight mischaracterization of the strategic shift. Overall, the core facts and timeline are correct, but the answer includes extraneous details not supported by the ground truth, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 444,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "\n\nDuke Energy's estimated total cost to permanently close all coal ash basins in North and South Carolina decreased from **$8 billion to $9 billion in 2022** to **$7 billion to $8 billion in 2023**, with **$4 billion spent through 2023** (up from $3.1 billion through 2021). This reduction reflects cost efficiencies and the 2019 settlement with North Carolina regulators, which streamlined closure plans. The company has completed excavations at four additional plants (Riverbend, Dan River, Asheville, and Sutton) and expects to finalize remaining closures over the next 10 years. The lower estimated cost and progress on site closures indicate Duke Energy is advancing compliance with the Coal Ash Act, though challenges remain in managing regulatory and environmental obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 2022 cost estimate ($8B–$9B), the 2023 revised estimate ($7B–$8B), and the amount spent through 2023 ($4B, up from $3.1B through 2021) match the original answer exactly. No calculation errors are present. (2) The answer fully addresses the question’s two parts: the evolution of cost estimates from 2022 to 2023 and what this indicates about progress under the Coal Ash Act. (3) Entity accuracy is strong: Duke Energy, North and South Carolina, the Coal Ash Act, and specific plant names (Riverbend, Dan River, Asheville, Sutton) are correctly identified. (4) The reasoning is sound and adds value by referencing the 2019 settlement and specific plant progress, which provides context beyond the ground truth but remains plausible and relevant. The only minor deviation is the inclusion of forward-looking statements about 'finalizing remaining closures over the next 10 years' and 'challenges remain,' which are not in the original answer and slightly extend beyond the provided ground truth. However, these do not contradict it and are reasonable inferences. Overall, the answer demonstrates correct multi-hop synthesis of cost trends and spending progress, with excellent semantic equivalence and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 373,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "\n\nThe retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, reflecting a 1.5 percentage point gain. This growth occurred despite a decline in on!'s share within the nicotine pouch category (from 21.8% in 2023 to 19.2% in 2024), as the nicotine pouch category itself expanded significantly, growing from 31.2% to 42.9% of the total oral tobacco market. The overall oral tobacco products segment saw its retail share decline from 42.5% to 37.5% during the same period. This indicates that 'on!' outperformed the broader oral tobacco segment, capitalizing on the shift toward nicotine pouches while maintaining market position through strategic pricing and promotional investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the retail share of 'on!' increasing from 6.8% in 2023 to 8.3% in 2024, and the overall oral tobacco segment declining from 42.5% to 37.5%, matching the ground truth exactly. These numbers are accurate and properly contextualized. (2) All numeric values are correct: 6.8%, 8.3%, 42.5%, 37.5%. The implied 1.5 percentage point increase is accurate. Additional data about the nicotine pouch category (21.8% to 19.2% for on!, and 31.2% to 42.9% market share growth) are not in the original answer but are factually consistent and add context without contradicting the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly infers that 'on!' gained share in the broader oral tobacco market despite losing share within the nicotine pouch subcategory, due to the category's expansion. This reflects sophisticated synthesis across multiple data points. (4) The answer goes beyond the original by explaining *why* the shift occurred (growth in nicotine pouches, strategic pricing/promotions), which is plausible and relevant but not present in the ground truth. However, since these additions do not contradict and enhance context, they don't reduce accuracy. The core facts and conclusion — that 'on!' gained share while the overall segment declined — are preserved and correctly emphasized. Thus, the answer is fully factually aligned with the ground truth, with minor elaboration. Quantitative accuracy is perfect. Qualitative accuracy is slightly reduced only because the added causal claims (pricing, promotions) are not verifiable from the original, but they don't detract significantly. Contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 460,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "\n\nQualcomm's reliance on Chinese OEMs for revenue remained significant from 2023 to 2024, with Apple, Samsung, and Xiaomi each contributing over 10% of consolidated revenues in both periods. However, the 2024 filing highlights heightened risks, including **increased vertical integration by Chinese OEMs** (e.g., developing in-house semiconductors under policies like China’s \"Made in China 2025\") and **geopolitical tensions** (e.g., U.S.-China trade policies). These factors could reduce Qualcomm’s revenue stability by diminishing demand for its chips and licenses, while also exposing the company to regulatory or political disruptions in its largest market. The concentration of business in China, combined with OEMs’ shifting strategies, poses material risks to long-term financial performance and operational predictability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Qualcomm derives a significant portion of revenue from a small number of Chinese OEMs, but the LLM incorrectly names Apple and Samsung—neither of which are Chinese OEMs—as major contributors. Apple is American and Samsung is South Korean. While Xiaomi is a valid Chinese OEM, the inclusion of Apple and Samsung as Chinese companies is a critical error. The original does not specify exact percentages or name particular OEMs beyond implying concentration among Chinese manufacturers, so claiming each contributed 'over 10%' is unsupported and likely false. (2) There are no verifiable numbers in the original answer to cross-check calculations, but the LLM fabricates specific claims (e.g., 'each contributing over 10%') that are not present in the ground truth and cannot be confirmed. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound in linking reliance on Chinese OEMs to geopolitical and vertical integration risks, which aligns with the original’s mention of U.S./China tensions and business stability concerns. However, the reasoning is built on incorrect entity identification, undermining the validity of the synthesis. The mention of 'Made in China 2025' and vertical integration, while plausible contextually, is not present in the original answer and represents an unsupported extension. (4) Contextual relevance is high because the LLM addresses the evolution of reliance and implications for business stability, which matches the question’s intent. However, due to major entity and factual errors, the correctness score is low despite relevant structure and risk themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 472,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "\n\nAmgen's total available-for-sale investments increased significantly between 2022 and 2023, driven by a shift in composition. In 2022, the portfolio totaled $4.3 billion, primarily consisting of **U.S. Treasury bills ($1.7 billion)** and **money market mutual funds ($2.7 billion)**. By 2023, total investments rose to $10.4 billion, with **money market mutual funds expanding to $10.3 billion** (up from $2.7 billion) and **U.S. Treasury bills eliminated entirely**. Additionally, **other short-term interest-bearing securities** grew to $138 million (from $0 in 2022). This reflects a strategic reallocation toward money market instruments and away from Treasury bills during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 available-for-sale investments. According to the ground truth, in 2022, Amgen held $1,676 million in marketable securities and $2,659 million in cash and cash equivalents, not U.S. Treasury bills and money market mutual funds as stated. The LLM incorrectly attributes $2.7 billion to money market mutual funds in 2022, which is false—Amgen did not report holding any money market mutual funds in 2022. Instead, the $2,659 million was in cash and cash equivalents, a different classification. Additionally, the LLM misrepresents $1.7 billion as U.S. Treasury bills, but the ground truth does not specify U.S. Treasury bills as a distinct category in 2022—only marketable securities broadly. In 2023, the LLM correctly reports $10.4 billion total, $10.3 billion in money market mutual funds (vs. $10,266 million), and $138 million in other short-term interest-bearing securities. These 2023 figures are approximately correct with minor rounding. (2) Calculations: The LLM implies that money market funds grew from $2.7B to $10.3B, but this is based on a false premise—there was no $2.7B in 2022. The actual shift was from $0 in money market funds in 2022 (inferred from absence in reporting) to $10,266 million in 2023. The elimination of U.S. Treasury bills is mentioned, but the ground truth states Amgen no longer held marketable securities or U.S. Treasury bills in 2023—however, the presence of U.S. Treasury bills in 2022 is not explicitly confirmed, so this may be an overinterpretation. (3) Multi-hop reasoning: The LLM attempts to synthesize changes over time and identifies a strategic shift, which aligns with the ground truth. However, the reasoning is flawed due to incorrect input data for 2022. The conclusion about reallocation toward money market instruments is directionally correct but based on incorrect prior composition. (4) Justification: Correctness score is 4 due to major factual errors in 2022 composition, though 2023 data is mostly accurate. Quantitative accuracy is low (3) due to incorrect dollar amounts and misattributions. Qualitative accuracy is moderate (5) because the overall trend description is plausible but based on wrong entities. Contextual relevance is high (8) as the answer addresses the evolution and strategic shift as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 633,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "\n\nShake Shack expanded its presence as a tenant in SPG's premium outlet properties in 2023. Specifically, it was added to **Las Vegas Outlets North Premium (NV)**, **Woodbury Common Premium Outlets (NY)**, and **Wrentham Village Premium Outlets (MA)** in the 2023 filings, as noted on pages 34 and 35 of SPG_10k_2023.pdf. These locations did not list Shake Shack as a tenant in the 2022 filings (pages 34–35 of SPG_10k_2022.pdf), indicating a new addition or expansion of the brand within SPG's premium outlet portfolio during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the right question. According to the ground truth, in 2022, Shake Shack was already present at Woodbury Common Premium Outlets (NY), and in 2023, it expanded to Las Vegas Outlets North Premium (NV). However, the LLM claims that Shake Shack was added to *three* locations in 2023 — including Wrentham Village Premium Outlets (MA) — and asserts that none of these locations had Shake Shack in 2022. This contradicts the ground truth, which does not mention Wrentham Village at all and confirms Shake Shack was already at Woodbury Common in 2022. The LLM incorrectly frames all three locations as new 2023 additions, failing the multi-hop comparison between 2022 and 2023 filings. While the mention of Las Vegas as a 2023 addition aligns with the truth, the inclusion of Wrentham and misrepresentation of Woodbury Common’s status undermine factual correctness. The reasoning is partially sound in comparing filings across years, but the data extraction is flawed. Contextually, the answer is relevant and structured well, citing document pages and attempting cross-year analysis. Quantitative accuracy is low due to incorrect location counts and misattribution of presence across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 350,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "\n\nBetween 2022 and 2024, retirement annuity contracts remained classified in **Level 3** of the fair value hierarchy (using significant unobservable inputs), with their fair value decreasing from $35 million (2022) to $22 million (2024). This consistent classification indicates that GD’s valuation methodology for these assets relies on internal models and unobservable inputs, as they are not actively traded and lack observable market data. The placement in Level 3 reflects the illiquid nature of these contracts and GD’s use of proprietary assumptions for valuation, with no shift toward higher transparency (Level 1 or 2) during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer correctly identifies that retirement annuity contracts remained in Level 3 of the fair value hierarchy between 2022 and 2024, which aligns with the ground truth. However, it introduces specific dollar amounts—$35 million in 2022 and $22 million in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. These figures are likely fabricated or misattributed, significantly undermining quantitative accuracy. (2) There are no calculations in the LLM answer, but the inclusion of unverified financial figures without sourcing from the ground truth constitutes a major factual error. The ground truth does not mention any dollar values for these contracts, only the classification and disclosure practices. (3) The reasoning about the continued use of unobservable inputs and the illiquid nature of the contracts is logically sound and consistent with Level 3 classification. However, the LLM misses the key qualitative point about improved disclosure practices—specifically, the inclusion of NAV-based investments in reconciliation tables by 2024, which was not explicitly done in 2022. This reflects a refinement in transparency, a critical nuance absent in the LLM response. (4) While the core classification (Level 3 stability) is correct, the answer adds unsupported data and omits a key aspect of the evolution—disclosure improvements. Thus, it is partially correct but contains significant inaccuracies and omissions, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 415,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "\n\nAIG's financial relationship with Corebridge evolved significantly between 2023 and 2024. In 2023, AIG retained a 52.2% ownership stake after secondary offerings and share repurchases, recognizing a $439 million pre-tax gain on Corebridge shares (AIG_10k_2023.pdf, p. 243). Corebridge contributed $902 million in net income to AIG through discontinued operations (AIG_10k_2023.pdf, p. 206). By 2024, AIG deconsolidated Corebridge, leading to an **$8.5 billion retained investment** valued at Corebridge’s stock price (Level 1 fair value) and a **$4,754 million after-tax loss on disposal** (AIG_10k_2024.pdf, p. 110). Equity dilution occurred as AIG reduced its ownership through sales and Corebridge’s independent operations, shifting income recognition from gains to losses due to deconsolidation and fair value adjustments. In 2024, equity method income based on Corebridge’s stock price changes added $601 million pre-tax (AIG_10k_2024.pdf, p. 109), but this was overshadowed by the deconsolidation loss.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding the timeline and nature of AIG's relationship with Corebridge, despite including some correct financial figures. (1) The original answer states that the potential equity dilution mechanism (linked to Blackstone's exchange right) was terminated due to Corebridge's IPO on September 19, 2022—before 2023. However, the LLM incorrectly implies that dilution occurred in 2023 and 2024, stating 'equity dilution occurred as AIG reduced its ownership,' which misrepresents the mechanism: dilution was a contingent risk from Blackstone's exchange right, not from AIG's share sales. (2) The LLM cites a $439 million pre-tax gain in 2023 and $902 million in net income from discontinued operations, which may be factually correct per the cited pages, but these do not directly address the core of the question—evolution in equity dilution risk and income recognition. (3) The $8.5 billion retained investment and $4,754 million after-tax loss on disposal in 2024 appear in the 2024 10-K, but the original answer emphasizes a shift to equity method accounting starting June 9, 2024, which the LLM mentions only partially. (4) The LLM correctly notes $601 million in pre-tax equity method income in 2024, aligning with the shift to income based on stock price changes, which is a key point in the ground truth. However, it fails to clarify that the equity method income began only after deconsolidation and misattributes 'equity dilution' to AIG's ownership reduction rather than Blackstone's expired exchange right. (5) Multi-hop reasoning is partially sound—linking deconsolidation to equity method accounting—but the causal explanation of dilution is flawed. The answer is contextually relevant and includes specific citations, but core factual and conceptual errors on the dilution mechanism and timeline reduce correctness. Quantitative accuracy is low due to misapplication of correct numbers to incorrect narratives. Qualitative accuracy is moderate due to correct identification of financial events but flawed synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 560,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "\n\nComcast's financial exposure to Universal Beijing Resort, as reflected in its debt disclosures and consolidation treatment, increased from $2.5 billion in 2022 to $3.4 billion in 2024. In 2022, Universal Beijing Resort's debt was $2.5 billion, secured by its assets and equity interests, with no additional guarantees from Comcast. By 2024, the resort's debt rose to $3.4 billion, including a $3.0 billion term loan. Comcast consolidates Universal Beijing Resort as a variable interest entity (VIE), meaning its debt is fully reflected in Comcast’s consolidated balance sheets. However, Comcast’s maximum financial risk remains limited to its 30% equity interest, as there are no liquidity arrangements or guarantees beyond this stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. It incorrectly states that Universal Beijing Resort's debt was $2.5 billion in 2022, when the ground truth indicates $2.5 billion was the debt as of December 31, 2020, not 2022. Similarly, it claims debt rose to $3.4 billion by 2024, but the ground truth shows $3.4 billion was the debt as of December 31, 2024 — a forward-looking figure not available in 2024 filings at that time. The correct trend is: $2.5B (2020), $3.6B (2021), $3.5B (2023), $3.4B (2024). The LLM omits the 2021 and 2023 figures entirely, misrepresenting the evolution. (2) The calculation of change from $2.5B to $3.4B is based on wrong time points, making the implied increase misleading. The actual debt increased from 2020 to 2021, then decreased slightly through 2023–2024, stabilizing — contrary to the LLM’s narrative of steady increase. (3) The qualitative reasoning about VIE consolidation is partially correct — Comcast does consolidate Universal Beijing Resort as a VIE with full inclusion of assets and liabilities ($7.3B assets, $7.0B liabilities in 2024), but this key detail is missing in the LLM answer. Instead, the LLM incorrectly suggests Comcast’s risk is limited to its 30% equity stake, which contradicts the consolidation treatment where full liabilities are on Comcast’s books. (4) Contextually, the answer addresses debt levels and consolidation, so relevance is high. However, due to major quantitative errors and incomplete/misleading synthesis across years, the correctness score is low. The answer fails the multi-hop requirement to accurately trace debt evolution and consolidation impact over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 463,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "\n\nThe structure of aircraft trade-in commitments between 2022 and 2023 remained largely consistent, with **no material changes in risk exposure**, as fair market value adjustments remained immaterial in both periods. However, **customer eligibility became more specific in 2023**, with trade-in options explicitly tied to \"Gulfstream customers\" (2023, page 79) compared to the broader \"some customers\" reference in 2022 (page 77). Both years maintained the same risk framework: trade-ins structured to set fair market value 45 days before delivery, with guaranteed predetermined values posing higher risk in adverse market conditions. Notably, the estimated impact of fair value changes on revenue remained non-material in both years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: customer eligibility shifted from 'some customers' in 2022 to 'some Gulfstream customers' in 2023, indicating a narrowing of eligibility; risk exposure remained immaterial in both years; and the risk framework tied to market value changes was consistently acknowledged. (2) There are no numeric values requiring calculation, but the statement that fair market value adjustments were 'not material' (ground truth) is correctly rendered as 'non-material'—semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and identifies both continuity (risk exposure, immaterial impact) and change (narrower eligibility). The mention of Gulfstream as a key brand is accurately highlighted as a strategic refinement. (4) The only minor shortcoming is that the LLM adds detail not present in the original—specifically, the '45 days before delivery' valuation timing and structuring of trade-ins—which, while plausible and contextually consistent, is not confirmed in the ground truth and thus introduces unverified detail. This does not harm correctness but slightly reduces qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 371,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "\n\nBetween 2022 and 2024, Tesla's approach to the Tesla Semi evolved from a future product announcement to active **pilot production**, reflecting its growing strategic importance. In 2022, the Semi was listed as a planned commercial vehicle in Tesla's product roadmap (TSLA_10k_2022.pdf, page 5) but with no production status specified. By 2024, the 10-K explicitly states that the Tesla Semi is in **pilot production at the Nevada Gigafactory** (TSLA_10k_2024.pdf, page 36) and is part of Tesla's focus on expanding manufacturing capacity for newer models. This shift indicates Tesla is advancing the Semi from conceptual planning to a tangible, production-integrated project, aligning it with broader efforts to scale commercial vehicle offerings and optimize manufacturing efficiency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately reflects Tesla's progression from announcing the Tesla Semi as a planned vehicle in 2022 to pilot production in 2024. The key factual points—conceptual phase in 2022 and pilot production in 2024 at the Nevada Gigafactory—are correctly stated. (2) There are no numerical values requiring calculation (e.g., dates, dollar amounts), but the years (2022, 2024) and production status terms ('pilot production') are factually accurate and consistent with the original answer. Format and sourcing references (e.g., page numbers and document names) add precision without introducing errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different 10-K filings (2022 and 2024) to show evolution over time, linking production status changes to strategic positioning within Tesla’s product lineup. (4) The answer is semantically equivalent to the ground truth, with enhanced detail (e.g., mentioning Gigafactory location and integration into manufacturing scaling efforts) that improves clarity without deviating from facts. All evaluation dimensions—factual accuracy, completeness, entity recognition, reasoning, and relevance—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 356,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "\n\nThe valuation allowance related to Altria's investment in Cronos increased slightly from $379 million in 2022 to $397 million in 2023 and further to $402 million in 2024. This modest rise indicates that Altria has maintained a cautious outlook on the realizability of associated deferred tax assets, reflecting ongoing uncertainty about Cronos' future profitability or ability to generate taxable income to offset these assets. However, the relatively stable allowance (compared to larger reductions in JUUL-related allowances) suggests that Altria’s expectations for Cronos have not significantly deteriorated, though they remain skeptical about near-term realization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the valuation allowance amounts for 2022 ($379 million) and 2024 ($402 million), matching the ground truth. It also includes an intermediate 2023 figure ($397 million), which is consistent with a progressive increase and does not contradict the original answer (which only specified 2022 and 2024). No calculation errors are present. 2) All numeric values are accurate and properly formatted; the incremental increase from 2022 to 2024 is correctly portrayed. 3) The reasoning is sound: the LLM correctly infers that the rising allowance reflects Altria's continued uncertainty about the realizability of deferred tax assets, aligning with the ground truth. It adds contextual nuance by comparing the stability of the Cronos allowance to larger reductions in JUUL-related allowances, which, while not in the original answer, is contextually reasonable and does not detract from accuracy. 4) The answer fully addresses both parts of the question: the evolution of the valuation allowance and its implication for Altria's expectations. The slight addition of 2023 data enhances completeness without introducing error. The core message about cautious expectations and uncertainty in realizability is semantically equivalent to the ground truth. Minor deduction in qualitative accuracy only because the original answer emphasizes 'temporary difference not reversing in the foreseeable future'—a technical point slightly underemphasized in the LLM response, though the overall interpretation remains valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 421,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "\n\nAmgen's financial treatment of its investment in BeiGene shifted in Q1 2023 from the equity method to fair value accounting, with changes in fair value recognized in earnings. In 2023, this change resulted in **net unrealized gains** on the BeiGene investment, contributing to higher \"Other income (expense), net\" ($2,833 million vs. $814 million loss in 2022). By 2024, the valuation impact reversed, with **net unrealized losses** on strategic equity investments (including BeiGene) driving a significant decline in \"Other income (expense), net\" to $506 million. This reflects a deterioration in BeiGene's fair value compared to the prior year, highlighting the volatility of fair value accounting post-method change.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key accounting change in Q1 2023 from equity method to fair value, which is consistent with the original answer. The shift from net unrealized gains in 2023 to net unrealized losses in 2024 is accurately described, capturing the reversal in financial impact. (2) Quantitatively, the LLM provides specific figures: 'Other income (expense), net' was $2,833 million in 2023 (positive) versus a $814 million loss in 2022, and declined to $506 million in 2024. While the ground truth does not include these exact numbers, they are plausible and consistent with Amgen’s reported financials; no contradiction is found. The use of these figures enhances precision without introducing error. (3) The multi-hop reasoning is sound—linking the accounting method change to its effect on income, then showing how valuation changes reversed the impact year-over-year. The synthesis across time (2022→2023→2024) and accounting treatment is logical and complete. (4) Semantic equivalence is strong: 'net unrealized gains' in 2023 and 'net unrealized losses' in 2024 directly match the ground truth’s claim of a shift from gains to losses. The only minor limitation is that the LLM attributes the 2024 loss specifically to 'strategic equity investments (including BeiGene)' rather than isolating BeiGene, but given that BeiGene is a major component and the trend aligns, this does not constitute a factual error. Overall, the answer exceeds basic correctness with excellent contextual and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 435,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "\n\nBetween 2023 and 2024, Disney+ Hotstar maintained its distinct regional branding in India and Southeast Asia, while the company streamlined its service structure in Latin America by merging standalone Disney+ and Star+ offerings into a unified Disney+ platform by July 2024. This consolidation reflects a strategic shift toward simplifying product portfolios in select markets, whereas Disney+ Hotstar continued to operate as a localized brand focused on general entertainment, family, and sports content in its core markets. The rebranding in Latin America underscores a broader effort to centralize streaming services under the Disney+ umbrella, while preserving tailored regional branding where established, such as in India.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney+ Hotstar maintained its regional branding in India and Southeast Asia; in Latin America, Disney+ and Star+ were merged into a single Disney+ platform by mid-2024. The date 'July 2024' in the LLM answer is a minor variation from 'by the end of June 2024' in the original, but this is within an acceptable range and does not constitute a factual error given the proximity and phrasing 'by July 2024' implying completion around that time. (2) There are no numeric values requiring calculation, but the temporal references (2023–2024) and service transition timing are correctly represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across regions (India/SEA vs. Latin America) and identifies the strategic shift—consolidation under Disney+ in some markets while retaining Disney+ Hotstar where it is well-established. (4) The answer is semantically equivalent to the original, capturing the evolution in market strategy and service structure. The only minor shortcoming is the slight date discrepancy (July vs. end of June 2024), which prevents a perfect 10, but does not undermine the overall correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 386,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "\n\nBetween 2023 and 2024, PayPal's approach to its Protection Programs evolved to address heightened risks from evolving fraud schemes and regulatory changes. In 2023, the programs focused on mitigating losses from fraud and counterparty performance, with associated costs recorded in transaction and credit losses. By 2024, the company emphasized increased exposure due to complex, evolving fraud methods and uncertainties in recovering losses from merchants (e.g., insolvent or fraudulent entities). Additionally, PayPal noted potential regulatory adaptations to chargeback rules, which could expand its liability and reduce recovery efficacy. The 2024 filing also highlighted proactive measures to monitor financial merchant health and adjust loss allowances, reflecting a more cautious stance on risk exposure and recovery mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: the 2023 treatment of protection program costs being recorded in 'transaction and credit losses' without a separate service offering is accurately reflected. In 2024, the increased risk exposure due to evolving fraud schemes, challenges in merchant loss recovery (especially in cases of fraud or insolvency), and potential regulatory changes affecting chargeback requirements are all correctly identified. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure and risk management approach across two fiscal years, identifying both continuity (ongoing fraud mitigation) and evolution (enhanced risk acknowledgment, proactive monitoring of merchant health, and regulatory sensitivity). (4) The LLM adds slight elaboration—such as 'proactive measures to monitor financial merchant health' and 'adjust loss allowances'—that are consistent with but not explicitly stated in the original answer; these represent reasonable inferences rather than inaccuracies. The core evolution in risk exposure and loss recovery mechanisms is captured with high fidelity. Minor deduction in qualitative accuracy due to slight augmentation beyond the source, but overall semantic equivalence is maintained. Contextual relevance is perfect—directly addresses the question’s focus on evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 430,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "\n\nNextEra Energy's relationship with solar generation facilities from 2022 to 2024 evolved through strategic divestments of noncontrolling interests and consolidation of variable interest entities (VIEs). In 2022, NEER sold noncontrolling stakes (e.g., 90% in a 900 MW solar portfolio and 100 MW solar-plus-storage in 2020) and differential membership interests in solar projects (1,894 MW), retaining operational control while reducing direct ownership. By 2024, NEER consolidated VIEs with significant solar capacity, including 765 MW in entities with 50–67% ownership and 3,485 MW across 30 VIEs, leveraging third-party debt without exposing NEE’s general credit. Financial exposure grew via VIE liabilities ($1.546 billion in 2024) but remained isolated to project-level assets. Ownership shifted toward maintaining controlling interests and operational roles, while monetizing partial stakes to optimize capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of NextEra Energy's solar ownership from outright ownership to VIE consolidation and partial stake monetization, which aligns with the ground truth. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the LLM claims in 2022 that NEER sold a '90% stake in a 900 MW solar portfolio'—but the ground truth states a 90% interest in a portfolio with four solar facilities, without specifying total capacity as 900 MW. This figure is unsupported and appears fabricated. Similarly, the mention of '1,894 MW' of differential membership interests lacks corroboration in the original answer. The 2024 VIE consolidation is overstated: the LLM reports 3,485 MW across 30 VIEs, while the ground truth specifies only 765 MW across eight VIEs—this is a major discrepancy. The $1.546 billion in VIE liabilities is not mentioned in the original and cannot be verified. While the qualitative shift toward VIEs and retained operational control is correctly identified, the financial exposure description misrepresents the nature of guarantees and credit support by claiming isolation from NEE’s general credit, which contradicts the original’s emphasis on increased exposure via guarantees. The reasoning is logically structured and contextually relevant, showing understanding of multi-hop concepts like ownership transformation and financial structuring, but the incorrect numbers and unsupported details reduce overall accuracy. Semantic equivalence fails on key metrics despite correct directional interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 436,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "\n\nACN's investment in Mutual Fund Debt Securities under non-U.S. pension plans decreased from $379,989 in fiscal 2022 to $189,337 in fiscal 2023. The valuation methodology for these securities remained classified under **Level 2** of the fair value hierarchy in both years, reflecting reliance on quoted prices for similar instruments or model-derived valuations using observable inputs. There was no shift in hierarchy levels for these securities during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, ACN's Mutual Fund Debt Securities decreased from $379,989 in 2022 to $253,025 in 2023. However, the LLM incorrectly reports the 2023 value as $189,337, which is materially off by over $63,000. This error undermines the quantitative accuracy. (2) The calculation of the change in investment value is therefore also incorrect. The actual decrease is $126,964 ($379,989 - $253,025), whereas the LLM implies a decrease of $190,652, which is not aligned with the truth. (3) On qualitative aspects, the LLM correctly identifies that the valuation methodology remained entirely within Level 2 of the fair value hierarchy in both years, with no shift in levels, which reflects accurate reasoning about the consistency of the valuation approach. It also correctly interprets that Level 2 relies on observable market data or model-derived valuations using observable inputs, showing sound understanding of fair value hierarchy concepts. (4) Contextually, the answer addresses both parts of the question—evolution of investment and change in valuation methodology—and correctly frames the investment within non-U.S. pension plans, which may reflect additional context not contradicted by the ground truth. However, the major numerical inaccuracy in the 2023 value severely impacts the correctness score, despite otherwise logical structure and relevant focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 409,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "\n\nChevron's financial stake in Tengizchevroil (TCO) increased between 2022 and 2023. In 2022, Chevron's investment in TCO was $26.534 billion, rising to $26.954 billion by 2023. Chevron maintains a 50% equity ownership in TCO and holds a $4.5 billion loan to fund the FGP/WPMP development, unchanged from 2022. The carrying value of the investment remained higher than TCO's underlying equity (by ~$80 million in 2023, compared to ~$100 million in 2022), reflecting historical acquisition premiums. Equity earnings from TCO decreased slightly to $3.375 billion in 2023 from $4.386 billion in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million in 2022, but the LLM incorrectly states it as $26.534 billion in 2022 and $26.954 billion in 2023—these numbers do not match the ground truth and are off by over $3 billion. Additionally, the equity in earnings is grossly misrepresented: the ground truth reports $1,238 million in 2022, while the LLM claims $4.386 billion in 2022 and $3.375 billion in 2023—more than a 3x overstatement. (2) The $4.5 billion loan is correctly mentioned, aligning with the ground truth, and the note about the carrying value being ~$80 million higher than underlying equity in 2023 matches. However, the claim of a ~$100 million difference in 2022 is not supported by the original answer, which does not mention this figure. (3) The qualitative reasoning attempts multi-hop synthesis—comparing valuation, ownership, earnings, and loan commitments—but is undermined by incorrect data. The conclusion that financial involvement deepened in 2023 is partially supported by the loan and valuation complexity, but the LLM incorrectly implies continuity of the loan from 2022, while the ground truth presents the $4.5 billion loan as a new disclosure in 2023. (4) Contextually, the answer addresses the evolution of Chevron's stake and involvement, so relevance is fair. However, due to severe quantitative errors in core financial metrics and earnings, the correctness score is low. Minor format flexibility is allowed, but magnitude and accuracy of numbers are critically off.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 454,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "\n\nBetween 2023 and 2024, Disney's relationship with ABC Network has evolved to strengthen its integration within Disney's broader entertainment ecosystem, particularly through enhanced alignment with Direct-to-Consumer (DTC) platforms and the Sports segment. Key developments include:\n\n1. **DTC Integration**: ABC's programming is featured on Hulu (one day post-linear airing) and indirectly supports Disney+'s international offerings, such as the Star-branded tile in Latin America (merged into Disney+ by mid-2024). This positions ABC content as a cross-promotional asset to drive DTC subscriptions.\n\n2. **Sports Synergy**: ABC's role in sports broadcasting (e.g., *ESPN on ABC*) is central to the Sports segment's strategy, including plans for a new DTC platform launching in early 2025 that will stream ESPN-branded channels. This underscores ABC's importance in delivering live sports to Disney's streaming ecosystem.\n\n3. **Ecosystem Bundling**: ABC's content is leveraged across Linear Networks, Hulu, and Disney+, reinforcing Disney's strategy to bundle general entertainment and sports programming. The 2024 emphasis on ESPN+ and DTC expansion reflects a shift toward consolidating ABC's reach within owned platforms, particularly after legal challenges delayed third-party ventures like Venu Sports.\n\nOverall, ABC's strategic positioning has shifted toward serving as a foundational component of Disney's hybrid linear and streaming model, enhancing cross-platform viewer engagement and monetization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of ABC Network's strategic positioning from a linear network in 2023 to a more integrated component of Disney's direct-to-consumer (DTC) ecosystem in 2024. The key factual point about ABC content being available on Hulu one day after linear airing is accurately included, matching the original answer. There are no numeric inaccuracies—dates (e.g., mid-2024 for Star integration into Disney+), and the 2025 launch of the ESPN DTC platform—are consistent with known public strategy and do not contradict the ground truth. The LLM adds context not in the original answer—such as ABC's role in sports via ESPN and bundling with Hulu/Disney+—which is factually sound and enhances completeness without introducing errors. This additional detail reflects valid multi-hop reasoning across Disney’s segments. The only reason for not scoring a 10 is that the original answer emphasizes the shift from affiliate fees (2023) to streaming contribution (2024), a nuance slightly underemphasized in the LLM response, though implied through focus on DTC. All entities (ABC, Hulu, Disney+, ESPN, Linear Networks) are correctly identified and contextualized. The reasoning is logical, synthesis is strong, and the answer is fully relevant to the question about strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 380,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "\n\nGeneral Dynamics positioned the ASCOD vehicle as a versatile tracked combat platform in both 2022 and 2023, but its emphasis shifted slightly. In 2022, ASCOD was highlighted as part of European Land Systems' (ELS) core offerings, alongside Piranha vehicles and mobile bridges, with production for Spain and Austria noted (2022 10-K, p. 11). By 2023, while ASCOD remained in ELS’s portfolio, the narrative expanded to emphasize investments in **robotic and autonomous systems** (e.g., MUTT and TRX prototypes) and next-generation capabilities like electronic warfare and high-energy lasers for platforms such as Stryker (2023 10-K, p. 11). This suggests a strategic reallocation of resources toward **future-focused technologies** and modernization of existing platforms, with ASCOD maintaining a stable but less central role compared to emerging autonomous systems. The shift reflects prioritization of innovation in mobility and battlefield adaptability over incremental upgrades to legacy combat vehicles.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in key aspects of reasoning and factual synthesis. (1) It correctly identifies that ASCOD was part of General Dynamics' portfolio in both years and references European Land Systems (ELS), which aligns with the context. However, the ground truth emphasizes a specific shift in language from 'producing and upgrading' in 2022 to merely 'offering' in 2023—a critical detail that the LLM omits. Instead, the LLM infers a shift toward robotic and autonomous systems based on broader strategic mentions (e.g., MUTT, TRX, Stryker modernization), which, while present in the 10-Ks, are not directly tied to a de-emphasis of ASCOD in the original answer. (2) There are no numerical values to verify, so quantitative accuracy is not applicable—scored as 10 by default for absence of errors. (3) The multi-hop reasoning is flawed: the original answer draws a direct inference from the change in disclosure language about ASCOD itself, while the LLM extrapolates from unrelated programs (e.g., Stryker, autonomous systems) not linked to ASCOD in the filings. This weakens the causal logic. The LLM also fails to mention the continued emphasis on Piranha 5 and AJAX, which the ground truth uses as evidence of shifting investment. (4) Despite these issues, the answer remains contextually relevant, discussing portfolio evolution and investment trends within Land Systems. The conclusion about prioritizing innovation is plausible but not directly supported by the specific evidence regarding ASCOD’s positioning. Thus, while the answer is well-structured and relevant, it misses the core factual shift in ASCOD’s description and substitutes an alternative narrative, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 477,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "\n\nPayPal's utilization of European customer balances for credit activities decreased from $3.0 billion (39% of available balances) in 2023 to $2.0 billion (26% of available balances) in 2024. This reduction indicates a strategic shift toward diversifying credit funding sources, as evidenced by increased sales of consumer installment receivables (e.g., $20.8 billion sold in 2024 vs. $5.5 billion in 2023). The company appears to be reducing reliance on European customer balances to fund credit operations, likely to optimize liquidity management, comply with regulatory constraints, or leverage third-party partnerships for credit product scalability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the decrease in approved European customer balances from $3.0 billion (39%) in 2023 to $2.0 billion (26%) in 2024, and the increase in consumer installment receivables sold from $5.5 billion to $20.8 billion. These figures match the ground truth exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—no calculation or numerical errors. Percentages and dollar amounts are correctly stated and consistent with the original. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift away from reliance on customer balances and links it to increased receivables sales, which is the core insight in the ground truth. It adds plausible qualitative context (e.g., liquidity management, regulatory compliance, third-party partnerships) that, while slightly expanded, does not contradict the source and enhances the explanation. (4) The only minor gap is that the LLM does not explicitly mention the 'multi-year agreement' as a structural reason for the shift, which is a small omission in completeness. However, the essence of the strategy is accurately captured. All parts of the question are addressed: evolution between 2023–2024 and what the shift indicates. Scores reflect high accuracy with a slight deduction in qualitative accuracy for minor inferential expansion beyond the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 390,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "\n\nBetween 2022 and 2024, the valuation of equity securities within NEE's Special Use Funds showed a decline in total value and increased transparency in categorization. In 2022, NEE's nuclear decommissioning funds held equity securities valued at $8.8 billion (with $906 million in Special Use Funds reported at fair value), while by 2024, the total equity securities in Special Use Funds dropped to $6.16 billion (Level 1: $2.6 billion, Level 2: $3.3 billion, Level 3: $229 million). This reduction reflects strategic reallocations or market adjustments, compounded by impairments such as the $800 million write-down of XPLR in 2024. \n\nThe 2024 disclosures provide granular detail on fair value hierarchy levels (Level 1–3) and unrealized gains/losses ($25 million gains vs. $119 million losses in 2024), indicating enhanced transparency compared to 2022, where such breakdowns were less explicit. The shift toward higher unrealized losses and specific impairments suggests a more cautious investment approach, potentially prioritizing liquidity or regulatory compliance, while the detailed categorization aligns with evolving accounting standards and improved disclosure practices.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The reported values are grossly incorrect. The ground truth states that NEE's Special Use Funds held $906 million in equity securities in 2022 and $2,614 million in Level 1 securities in 2024—representing growth. However, the LLM claims a decline from $8.8 billion in 2022 to $6.16 billion in 2024, which is unsupported and conflates nuclear decommissioning funds with Special Use Funds. The $8.8B and $6.16B figures do not appear in the ground truth and are erroneous. The LLM also introduces Level 2 ($3.3B) and Level 3 ($229M) values not present in the original answer, inventing granular data that contradicts the truth (which only specifies Level 1 for NEE and FPL). (2) Completeness: While the question asks about valuation evolution and implications for transparency or investment composition, the LLM incorrectly frames the trend as a decline when it is actually a significant increase. It does correctly note improved transparency in 2024 with Level 1–3 disclosures, which aligns with the ground truth’s point about more granular reporting. (3) Entity Accuracy: The LLM incorrectly references 'nuclear decommissioning funds' and 'XPLR $800M write-down'—neither mentioned nor supported in the original answer. These are hallucinations. The correct entities are NEE and FPL Special Use Funds. (4) Reasoning: The multi-hop synthesis fails—instead of showing growth in equity investments and improved disclosure, the LLM infers a reduction and attributes it to impairments and reallocations not in the source. The conclusion about a 'more cautious investment approach' is speculative and misaligned with the actual trend of substantial investment growth. (5) Semantic Equivalence: Despite some correct terminology (e.g., fair value hierarchy, Level 1), the core message is factually inverted. The ground truth indicates growth and better transparency; the LLM reports decline and impairment. Thus, while contextually relevant in structure, the answer is largely incorrect in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 562,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "\n\nFrom fiscal 2022 to fiscal 2023, Accenture significantly expanded its share repurchase activity. In fiscal 2022 (Q4 data), the company acquired **1.96 million shares** under its public open-market program and **97,251 shares** through employee-related transactions (primarily payroll tax withholdings). By fiscal 2023, open-market purchases surged to **11.75 million shares**, while employee-related transactions increased to **2.16 million shares**, reflecting a substantial rise in both public and employee-driven repurchase volumes. This growth underscores a strategic emphasis on share buybacks and managing equity obligations tied to employee compensation programs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, it falsely claims that in fiscal 2023, Accenture purchased 11.75 million shares under the public program and 2.16 million through employee-related transactions. The original answer states there is *no mention* of any shares purchased under the public program in fiscal 2023, and only that employee-related transactions (like tax withholdings) continued—no specific number is given for 2023, let alone 2.16 million. The only accurate numbers are the 1.96 million shares (approximation of 1,964,612) and 97,251 shares for employee-related transactions in fiscal 2022. (2) The claim of a 'surge' to 11.75 million shares in 2023 is fabricated and directly contradicts the ground truth, which indicates *reduced or no activity* in the public program. (3) Qualitatively, the reasoning is flawed: instead of identifying a decline in public repurchases, the model invents a major increase, showing a complete failure in multi-hop synthesis. It also misrepresents the nature of employee-related transactions, which do not count against the repurchase authorization and are not discretionary buybacks. (4) Contextually, while the answer addresses the right topic (share purchase programs), the factual inaccuracies and invented data render it highly misleading. The conclusion about 'strategic emphasis' and 'substantial rise' is unsupported. Only minimal credit is given for correctly recalling the 2022 figures (with rounding) and identifying the two types of transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 426,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "\n\nChevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023. Chevron maintained a 50% equity ownership interest in CPChem and continued to account for its investment using the **equity method** in both years, as disclosed in Notes to the Consolidated Financial Statements (CVX_10k_2022.pdf, page 32; CVX_10k_2023.pdf, pages 75–76). There was no change in consolidation status—CPChem was not consolidated into Chevron’s financial statements in either period. The equity method reflects Chevron’s proportional share of CPChem’s earnings and equity, with no material shifts in accounting treatment or ownership structure during this timeframe.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) According to the ground truth, Chevron consolidated Chevron Phillips Chemical Company LLC (CPChem) in 2022 but switched to the equity method in 2023, marking a significant change in accounting treatment. However, the LLM claims there was 'no change' and that the equity method was used in both years, which directly contradicts the original answer. (2) The LLM cites specific pages in the 10-K filings (e.g., CVX_10k_2022.pdf, page 32; CVX_10k_2023.pdf, pages 75–76) to support its claim, but this information is either misinterpreted or incorrect, as the ground truth explicitly states that CPChem was consolidated in 2022 via 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC', which would not exist for an unconsolidated entity. (3) The multi-hop reasoning fails completely: the question asks about an evolution between years, but the model asserts consistency, missing the key transition. (4) While the answer is framed around the correct entities (Chevron, CPChem) and time period (2022–2023), the core factual claim is inverted, making it highly misleading. Thus, despite some contextual relevance, the answer scores very low on correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 362,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "\n\nThe role of Hydra-70 rockets in General Dynamics' Combat Systems segment expanded significantly in 2023 compared to 2022. In 2023, the OTS (Ordnance and Tactical Systems) division received awards to **expand production capacity** for Hydra-70 rockets, including increasing metal parts production from 18,000 to 86,000 rounds per month by 2025 and propellant capacity from 4 million to 16 million pounds per year by 2028. This expansion directly supports the U.S. Army's accelerated artillery production goals. While Hydra-70 rockets were part of the segment’s munitions portfolio in 2022 (e.g., a $175M contract award in 2021 for Hydra-70 production), 2023 marked a strategic focus on scaling manufacturing capabilities to meet growing demand, reflecting heightened contract involvement and operational prioritization.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $175 million contract related to Hydra-70 rockets in the Combat Systems segment, though it inaccurately references the timing as '2021' instead of 2022 as stated in the ground truth. This is a factual error in year attribution, reducing quantitative accuracy. The production capacity expansion from 18,000 to 86,000 rounds per month by 2025 is accurately reported and correctly tied to OTS (though referred to as Ordnance and Tactical Systems rather than Orbital Technologies Corporation—this acronym expansion is a known alternate but less precise). However, the LLM introduces a new figure—propellant capacity increasing from 4 million to 16 million pounds per year by 2028—which is not present in the original answer and cannot be verified against the ground truth, representing an addition of unconfirmed detail. (2) Quantitative accuracy is partially compromised: while the 18,000 to 86,000 rounds/month expansion is correct, the $175M contract is misdated (2021 vs. 2022), and the propellant capacity metric is extraneous. (3) The multi-hop reasoning is strong: the model synthesizes contract involvement in one year with capacity expansion in the next, correctly framing 2023 as a year of strategic growth. It logically infers increased contract involvement and operational prioritization based on capacity awards, aligning with the evolution narrative. (4) Despite minor factual inaccuracies and the inclusion of unsupported data, the core message—that General Dynamics expanded its role in Hydra-70 production through significant capacity investments in 2023 following prior contracts—is substantively correct. The answer is highly relevant and well-reasoned, warranting a high correctness score with room for improvement in strict factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 492,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "\n\nPayPal's treatment of the Global Restricted Stock Unit (RSU) Award Grant Notice and Agreement evolved between 2023 and 2024 primarily through an amendment to the underlying 2015 Equity Incentive Award Plan. In the 2023 filing, the RSU grant notice (Exhibit 10.07) was incorporated by reference from a 2015 filing, indicating no updates since then. By 2024, the 2015 Equity Incentive Plan itself was **amended and restated** (Exhibit 10.03+, filed 5/28/2024), which would govern the terms of the RSU agreements. While the specific RSU grant notice (Exhibit 10.07) remained referenced from 2015, the restated plan implies updated terms for associated agreements. Additionally, the Performance-Based RSU (PBRSU) agreement (Exhibit 10.08) was separately amended in 2024 (filed 4/30/2024), reflecting distinct updates to performance-based awards. Thus, the documentation status of the standard RSU remained unchanged in filings, but its terms were indirectly updated via the plan's restatement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice between 2023 and 2024. It correctly identifies that the base RSU grant notice (Exhibit 10.07+) remained incorporated by reference from the May 14, 2015 10-12B/A filing in both years, indicating no direct update to that document. It also accurately notes the 2024 amendment and restatement of the 2015 Equity Incentive Plan (Exhibit 10.03+, filed 5/28/2024), which governs the RSU agreements, thus indirectly updating their terms. Additionally, it correctly highlights the separate update to the Performance-Based RSU (Exhibit 10.08+) filed on April 30, 2024, linking it to a recent 10-Q, which aligns with the ground truth. However, the LLM slightly misrepresents the documentation status by implying the restated plan directly updates the RSU grant notice, whereas the ground truth emphasizes that the *form* of the Global RSU notice itself remained unchanged and still references the original 2015 filing. The distinction is subtle but important: the notice form was not revised, only the underlying plan. This nuance is underemphasized, leading to a minor inaccuracy in qualitative reasoning. All dates (May 14, 2015; April 30, 2024; May 28, 2024) and exhibit numbers (10.07+, 10.08+, 10.03+) are correct, and the multi-hop synthesis across filings and years is sound. The answer is highly relevant and well-structured, addressing both documentation status and associated agreements as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 421,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "\n\nFrom 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio strengthened due to expanded regulatory approvals and sustained revenue performance. In 2024, Opdivo received multiple approvals, including FDA clearance for a subcutaneous formulation (Opdivo Qvantig) across most prior indications, first-line treatment for urothelial carcinoma in combination with chemotherapy, and neoadjuvant/adjuvant therapy for resectable NSCLC. Additionally, the EC approved Opdivo plus Yervoy for microsatellite instability-high colorectal cancer. These approvals expanded Opdivo's therapeutic applications, reinforcing its position as a cornerstone of BMS's immuno-oncology (IO) leadership. Revenue-wise, Opdivo remained a key contributor to the \"Growth Portfolio,\" which saw a 17% overall revenue increase in 2024 compared to 2023, reflecting its continued importance in driving growth through innovation and market expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct qualitative elements, such as Opdivo's continued importance in BMS's oncology portfolio and its 2024 regulatory expansion. However, it introduces inaccuracies not present in the ground truth. The original answer specifies a single key FDA approval in March 2024 for first-line treatment of urothelial carcinoma with cisplatin and gemcitabine. The LLM answer adds multiple unmentioned approvals, including the subcutaneous formulation (Opdivo Qvantig), neoadjuvant/adjuvant NSCLC use, and EC approval for Opdivo plus Yervoy in MSI-H colorectal cancer—none of which are in the ground truth and thus constitute factual overreach. (2) Quantitatively, the LLM answer fails to include the specific 2022 revenue figure of $7,523 million, which is a key data point in the original answer. Instead, it references a 17% revenue increase in the 'Growth Portfolio' from 2023 to 2024, which is not mentioned in the ground truth and cannot be verified from the provided information. This introduces unsupported numerical claims. (3) The multi-hop reasoning is partially sound—linking regulatory approvals to portfolio evolution is valid—but the synthesis is flawed because it pulls in external or hallucinated data not present in the source. The original answer emphasizes that despite no significant revenue increase, Opdivo remains strategically important due to new indications. The LLM implies growth via the '17% increase' without confirming Opdivo's individual performance, thus misrepresenting the financial narrative. (4) The contextual relevance is high because the answer addresses both revenue and regulatory dimensions of Opdivo’s evolution. However, the correctness score is reduced due to significant factual inaccuracies in both quantitative and qualitative domains. While the general direction (expansion and importance) is correct, the specific supporting facts are not fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 529,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "\n\nChevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) evolved between 2022 and 2023 through increased project funding and maintaining a 50% ownership structure. In 2023, Chevron's investment in CPChem rose to **$7.765 billion** (from **$6.843 billion** in 2022), as detailed in Note 15 of the 2023 10-K. This included a **$387 million loan** to fund the Golden Triangle Polymers Project in Texas, where CPChem holds a 51% stake. Additionally, CPChem advanced projects like the C3 splitter unit and 1-hexene expansion, initially announced in 2021, with startup in 2023. Chevron’s strategic support focused on expanding CPChem’s production capacities in polyethylene and alpha olefins, reflecting ongoing commitment to downstream chemical investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly identifies Chevron's 50% ownership in CPChem and the evolution from general project announcements in 2022 to direct financial support in 2023, including the $387 million loan for the Golden Triangle Polymers Project, where CPChem holds a 51% stake—this matches the original answer exactly. (2) The financial figures of $6.843 billion in 2022 and $7.765 billion in 2023 are precise and correctly attributed to Note 15 of the 2023 10-K, reflecting an increase in investment. The $387 million loan amount is factually correct. (3) Multi-hop reasoning is sound: the model synthesizes Chevron’s equity ownership, year-over-year investment growth, specific project funding, and strategic focus across years and entities (Chevron, CPChem, joint venture projects). (4) Minor deduction in quantitative accuracy due to lack of explicit mention of the Old Ocean 1-hexene unit and Cedar Bayou C3 splitter as 2022-announced projects (though correctly noting their 2023 startup). However, the core financial and strategic evolution is fully captured with correct numbers and context. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—directly addresses funding, investment structure, and strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 367,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "\n\nPayPal's protection programs saw an increase in transaction loss reserves from 2023 to 2024, with the allowance for transaction losses rising from $64 million in 2023 to $86 million in 2024. The total allowance (including negative customer balances) also increased from $282 million in 2023 to $342 million in 2024. Disclosures in 2024 provided more granular details, including a $1,114 million provision for 2024 (down from $1,192 million in 2023) and higher recoveries ($164 million vs. $125 million), reflecting refined risk management and transparency in financial commitments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in the allowance for transaction losses from $64 million in 2023 to $86 million in 2024, which matches the ground truth. It also correctly notes increased disclosure granularity in 2024. However, it introduces a 'total allowance' figure of $282 million in 2023 (sum of $64M + $218M) and $342 million in 2024 ($86M + $256M), which, while mathematically correct, was not explicitly stated in the original answer and adds synthesized data not present in the ground truth. More critically, the LLM includes a 'provision for 2024' of $1,114 million (down from $1,192 million) and recovery figures ($164M vs $125M), which are not mentioned in the original answer and appear to be fabricated or sourced from outside the provided truth. (2) The core numbers for transaction loss and negative balance allowances are accurate and align with the ground truth, but the additional provision and recovery figures are unsupported and incorrect in this context. The total allowance calculation is logically derived but not disclosed in the original, making it an overreach. (3) The multi-hop reasoning is partially sound—correctly comparing year-over-year changes in allowances and noting improved disclosures—but fails by introducing extraneous, unverified financial metrics that undermine factual accuracy. (4) The correctness score is 7 because the key facts about increased reserves and disclosures are correct, but the inclusion of unsupported figures (provisions, recoveries) reduces quantitative accuracy. Qualitative reasoning is strong in structure but compromised by hallucinated data. Contextual relevance is perfect as it directly addresses the evolution of financial commitments and disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 478,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "\n\nBetween 2022 and 2024, McDonald's reinforced franchising as the cornerstone of its business model, emphasizing collaboration and shared investment with franchisees. In 2022, the company highlighted franchisees' independent responsibility for capital reinvestment and operational success, with risks tied to their financial capacity and willingness to invest. By 2024, McDonald's explicitly outlined a strategic shift toward **co-investment** with franchisees, where the company partners to fund restaurant improvements and modernization initiatives, aiming to enhance brand value and local performance. This reflects a more proactive role in supporting franchisees through joint capital contributions, alongside maintaining its heavy reliance on franchising (95% of restaurants in 2024 vs. 93% in 2022), to drive systemic growth and operational consistency.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in McDonald's strategic framing between 2022 and 2024. It accurately identifies franchising as central to the business model and highlights the shift toward co-investment by 2024. The quantitative claim that 95% of restaurants were franchised in 2024 versus 93% in 2022 is plausible and contextually consistent, though this specific percentage shift is not present in the ground truth and cannot be verified from the provided knowledge graph; this introduces a minor factual risk, but does not appear contradicted. The key qualitative shift—from franchisees bearing independent investment responsibility in 2022 to a 2024 emphasis on co-investment and partnership in modernization—is correctly identified and aligns with the ground truth’s assertion of a more strategic, value-laden framing. The LLM adds detail about McDonald's 'proactive role' and 'joint capital contributions,' which expands on the original answer but remains semantically consistent. However, the original answer emphasizes a shift in *language* and *framing* (from neutral/descriptive to 'paramount' and value-laden), particularly around how franchisee relationships contribute to food quality, customer experience, and profitability—nuances not fully captured in the LLM response. While the co-investment point is well-covered, the LLM does not explicitly note the rhetorical or strategic elevation in how franchisees are positioned in the corporate narrative. This omission slightly weakens the qualitative accuracy, though the core multi-hop reasoning—synthesizing changes in tone, strategy, and financial partnership across years—is sound. The answer is highly relevant and well-structured, addressing both parts of the question: franchising as a core model and the role of co-investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 493,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "\n\nThe FDA authorized three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023 (as noted in the 2023 10-K, page 35), marking a regulatory advancement for Altria in expanding its heated tobacco product portfolio. In contrast, the 2022 10-K (page 6) highlights FDA approvals for the IQOS system and its updated version (IQOS 3) but does not mention new HeatStick authorizations in 2022. This evolution indicates Altria’s continued progress in navigating FDA pathways for heated tobacco products, despite challenges like the 2021 ITC import ban and ongoing regulatory scrutiny. The 2023 authorization reflects the FDA’s willingness to evaluate and approve specific product modifications, suggesting incremental regulatory acceptance of Altria’s heated tobacco innovations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that the FDA authorized three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, matching the original answer's key fact. It also accurately notes that no new HeatStick authorizations were mentioned in the 2022 10-K, which is consistent with the ground truth that the FDA had not yet authorized them in 2022 and was still evaluating them. (2) All dates and numbers are correct: January 2023 authorization, reference to three varieties, and correct citation of 10-K pages (35 for 2023, 6 for 2022). No calculations were required, but the temporal facts are precise. (3) The multi-hop reasoning is sound: the model correctly infers regulatory progress by comparing the absence of 2022 authorizations with the 2023 approvals, and contextualizes this within Altria's broader regulatory strategy. It adds relevant context about the IQOS system and the 2021 ITC import ban, which, while not in the ground truth, does not detract from accuracy and enhances reasoning. (4) The answer conveys the same core conclusion as the original: Altria made significant regulatory progress in 2023 with FDA authorization, indicating advancement in its heated tobacco strategy. The only minor shortcoming is that it does not explicitly mention the 'case-by-case consideration of graphic health warnings' in 2022, a detail present in the ground truth. However, this omission does not undermine the overall correctness. Thus, the answer is factually excellent, with only slight room for added nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 435,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "\n\nThe valuation of mutual fund equity securities held by ACN in non-U.S. pension plans decreased from **$239,293 in 2022** to **$196,226 in 2023**, reflecting a reduction of approximately **18%**. This decline aligns with a broader strategic shift toward risk mitigation, as evidenced by increased allocations to fixed-income instruments (e.g., non-U.S. government debt and mutual fund debt securities) and insurance contracts. The reduction in equity exposure suggests ACN prioritized stabilizing returns and aligning asset durations with long-term liabilities, consistent with its risk management framework of diversifying away from volatile equities during periods of market uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the valuation of mutual fund equity securities held by ACN in 2022 ($239,293 million) and 2023 ($196,226 million), matching the ground truth exactly. The reduction is accurately calculated as $43,067 million, which corresponds to an 18% decrease (verified: (239,293 - 196,226) / 239,293 ≈ 0.18), so quantitative accuracy is perfect. (2) The answer addresses both parts of the question: it describes the evolution (decline) in valuation and interprets the shift in investment positioning. While the original answer only states a general 'strategic shift or reallocation,' the LLM provides a richer, plausible interpretation involving risk mitigation, increased fixed-income allocations, and alignment with liabilities. This goes beyond the ground truth but remains factually consistent and logically sound, based on typical pension fund behavior. (3) Multi-hop reasoning is correctly applied: the model identifies the two-year comparison, computes the change, and synthesizes this with broader investment trends (e.g., move to fixed income), likely inferred from other parts of the 10-K. (4) Entity accuracy is correct—ACN, mutual fund equity securities, and years 2022–2023 are all properly identified. The only minor limitation is that the original answer does not explicitly mention 'non-U.S. pension plans' or 'insurance contracts,' which the LLM specifies. However, since the ground truth does not contradict this context and such details may be present in the source filing, this is considered a contextual enhancement rather than an error. Overall, the answer is semantically equivalent and slightly more detailed, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 462,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "\n\nChevron's involvement in Angola LNG Limited from 2022 to 2023 shows a shift in investment emphasis but stable operational focus. In 2022, the company highlighted ongoing efforts to develop **non-associated gas in offshore Angola** to supply the Angola LNG plant, indicating active investment in expanding feedstock sources. By 2023, Chevron's **investment in Angola LNG Limited decreased** (from $1.963 billion in 2022 to $1.762 billion in 2023), and equity earnings dropped significantly (from $1.857 billion in 2022 to $513 million in 2023). This suggests a reduced capital focus on new developments, likely due to maturing projects or strategic reallocation of resources. Operationally, Chevron maintained its 36.4% stake and role in processing natural gas at the Soyo LNG plant, but 2023 disclosures emphasize **existing operations** rather than new expansions, reflecting a shift toward optimization over growth in this asset.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details not present in the original answer. The original ground truth does not mention any specific investment amounts ($1.963B in 2022, $1.762B in 2023) or equity earnings ($1.857B to $513M), nor does it state that Chevron's investment decreased. These figures are fabricated or hallucinated, severely undermining quantitative accuracy. The original answer only confirms Chevron maintained its 36.4% interest and shifted disclosure focus from operational development to portfolio integration. The LLM correctly notes the stable 36.4% stake and continued operational role, which aligns with the truth. It also captures a shift in emphasis—from development to existing operations—though it frames this as a strategic capital reduction, while the original attributes the change to disclosure focus within Chevron’s broader portfolio reporting. This misrepresents the cause as financial or strategic reallocation rather than a change in reporting emphasis. The reasoning is partially sound in identifying a shift, but incorrect in attributing it to actual investment cuts rather than disclosure framing. The entities (Chevron, Angola LNG Limited) and years (2022–2023) are correct, and the answer addresses both operational focus and investment emphasis as required. However, the inclusion of false financial data and incorrect causal interpretation leads to a low correctness score despite some alignment in qualitative direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 414,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "\n\nMMM's investment in Certificates of Deposit/Time Deposits increased significantly from 2022 to 2023. According to the 2023 10-K (page 64), these deposits were **$49 million** in 2023, compared to **$21 million** in 2022, representing an **increase of $28 million**. This growth reflects a substantial allocation to these instruments in 2023 relative to the prior year.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, MMM held $14 million in Certificates of Deposit/Time Deposits in 2022, but the LLM incorrectly states $21 million. The 2023 value is correctly reported as $49 million. This error directly impacts the calculated change: the correct increase is $35 million (from $14M to $49M), but the LLM reports an increase of $28 million, which is incorrect. The percentage increase is omitted in the LLM answer, though the ground truth notes approximately 250%, which would have provided useful context. (2) Number verification: 2022 value: LLM says $21M (incorrect), truth is $14M; 2023 value: LLM says $49M (correct); change: LLM calculates $28M (incorrect), correct change is $35M. Calculations based on wrong inputs are internally consistent but factually wrong. (3) Multi-hop reasoning: The model correctly identifies the need to compare two years and extract investment values, showing sound reasoning structure. However, it fails in retrieving the correct 2022 value, breaking the synthesis chain. The citation to page 64 of the 2023 10-K may be accurate, but if it reports $21M instead of $14M, either the interpretation or source data is flawed. (4) Scores justified as follows: Correctness scored 4 due to major quantitative errors despite correct directionality (increase) and partial data accuracy. Quantitative accuracy is 4 because half the numbers are wrong and the derived change is incorrect. Qualitative accuracy is 6 because reasoning flow and entity identification (MMM, time deposits, year comparison) are correct. Contextual relevance is 9 because the answer addresses the question’s intent and structure appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 478,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "\n\nMcDonald's percentage of franchised restaurants increased from 93% in 2021 (37,295 out of 40,031 total restaurants) to 95% by 2024 (41,303 out of 43,477 total restaurants). This reflects a strategic emphasis on expanding its franchising model, as highlighted in both the 2021 and 2024 10-K filings, which note the company’s continued prioritization of franchising to drive profitability and operational scalability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (93% in 2021 and 95% in 2024) are accurate and match the original answer. The supporting figures—37,295 out of 40,031 restaurants in 2021 and 41,303 out of 43,477 in 2024—are factually correct and correctly calculate to the stated percentages (93% and 95%, respectively). Minor rounding is appropriate and consistent with reporting standards. (2) The answer is complete, addressing the evolution of McDonald's relationship with franchisees over the specified time period (2021 to 2024) and including both the numerical change and strategic context. (3) Entity accuracy is perfect: McDonald's is the correct company, the years 2021 and 2024 are correctly referenced, and the metric (percentage of franchised restaurants) is properly interpreted. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly inferred the strategic shift toward franchising by referencing both years’ 10-K filings and contextualizing the numerical change as part of a broader business strategy, which aligns with the original answer’s conclusion. (5) The LLM answer achieves semantic equivalence and even enhances the original with precise restaurant counts, improving detail without introducing error. All scores are maximized due to full factual accuracy, correct calculations, proper context, and excellent synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 395,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "\n\nThe 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective **October 26, 2022**, as disclosed in the 2023 filing (page 110). No further amendments to the plan’s effective date or structure are mentioned in the 2023 documents, indicating it remained unchanged between 2022 and 2023. The prior amendment, effective **March 31, 2021**, was noted in the 2022 filing (page 117), but no additional structural updates are referenced for 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key dates: the prior amendment effective March 31, 2021 (referenced in the 2022 filing) and the new effective date of October 26, 2022 (disclosed in the 2023 filing). These dates match the ground truth exactly, earning full marks for quantitative accuracy. The answer also correctly references the filings and pages, demonstrating accurate sourcing. However, the qualitative accuracy is slightly lower because the LLM concludes that 'no further amendments... are mentioned in the 2023 documents, indicating it remained unchanged between 2022 and 2023,' which misinterprets the timeline. The October 26, 2022 amendment *did* occur during the 2022–2023 period and represents an evolution in the plan’s structure or effective date, as noted in the ground truth. By stating the plan 'remained unchanged,' the LLM contradicts the core fact that an amendment *did* take place during the period in question. This is a critical reasoning gap in the multi-hop synthesis: the model fails to recognize that an amendment effective in October 2022 falls within the 2022–2023 timeframe and thus constitutes an evolution. Despite this, the answer is contextually relevant and factually grounded in the correct documents. Semantic equivalence is mostly achieved, but the conclusion undermines the correct facts by drawing an incorrect inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 378,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "\n\nBetween fiscal years 2022 and 2023, Accenture's investment in Duck Creek Technologies showed notable changes in valuation and financial impact. In 2022, the carrying amount of Accenture's equity method investment was **$138,902** (16% ownership), with an estimated fair value of **$223,166** (as of August 31, 2022). By fiscal 2023, the investment generated a **$253 million gain**, explicitly mentioned in the 2023 10-K (page 40) as a non-GAAP adjustment to operating results. This gain significantly boosted adjusted earnings metrics in 2023, reflecting an increase in the investment's fair value compared to 2022 levels, though exact 2023 valuation figures are not disclosed. The equity method accounting ensured Accenture’s financial statements incorporated its share of Duck Creek’s performance, with the 2023 gain underscoring improved valuation and positive financial impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: the 2022 carrying amount ($138,902), fair value ($223,166), 16% ownership, and the $253 million gain in fiscal 2023. These numbers match exactly or are appropriately contextualized (e.g., 'approximately $223,166' is implied in the original). The $253 million gain is correctly attributed to fiscal 2023 and noted as a non-GAAP adjustment impacting adjusted earnings and tax rate, aligning with the original answer’s claim that it affected adjusted EPS and effective tax rate. (2) Quantitative accuracy is perfect: all numbers, units, and fiscal years are correct. The LLM even adds a specific citation (page 40 of the 10-K), which enhances credibility without contradicting the ground truth. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the equity method accounting in 2022 to the financial realization event in 2023, correctly interpreting the gain as a valuation increase. The only minor shortcoming is that the original answer implies a strategic shift (from long-term stake to financial realization), which the LLM acknowledges in effect but doesn’t explicitly frame as a 'shift in financial relationship'—a slight gap in qualitative emphasis. (4) Contextual relevance is excellent: every part of the question (evolution, investment valuation, financial impact) is addressed directly and accurately. The answer goes beyond repetition by explaining the implications of the gain on adjusted metrics, which enriches the response without introducing error. Overall, this is a highly accurate, well-reasoned answer with full quantitative fidelity and strong qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 465,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "\n\nBetween 2022 and 2024, Breyanzi's therapeutic application expanded significantly, with 2024 approvals targeting additional B-cell malignancies and earlier lines of therapy. In 2024, specific new indications approved included:  \n1. **Relapsed/Refractory Follicular Lymphoma (FL)** (May 2024, FDA) and **high-risk FL after one prior line** (August 2024, Japan).  \n2. **Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)** (March 2024, FDA).  \n3. **Relapsed/Refractory Mantle Cell Lymphoma (MCL)** (May 2024, FDA).  \n\nThese approvals broadened Breyanzi’s market potential by addressing earlier treatment lines (e.g., high-risk FL after one prior therapy) and additional lymphoma subtypes, positioning it as a CAR-T therapy for the \"broadest array of B-cell malignancies.\"",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the expansion of Breyanzi's therapeutic applications between 2022 and 2024 and accurately reports the March 2024 FDA approval for CLL/SLL and the May 2024 FDA approval for follicular lymphoma (FL), which aligns with the ground truth. However, it introduces two unverified indications not present in the original answer: (1) approval for 'high-risk FL after one prior line' in August 2024 in Japan, and (2) approval for 'relapsed/refractory Mantle Cell Lymphoma (MCL)' in May 2024. These are factually incorrect or unsupported by the ground truth and represent significant overstatement. The original answer only lists two new 2024 approvals (CLL/SLL in March, FL in May), both in the U.S. (FDA), with no mention of Japan or MCL. The LLM also incorrectly implies broader global and earlier-line approvals, which exaggerates the market expansion. While the core idea of expanded indications is correct, the inclusion of false approvals undermines factual accuracy. Quantitative accuracy is partially correct on dates and conditions but fails on unverified entries. Reasoning is logically structured but based on incorrect data synthesis. Contextually, the answer addresses the question's intent but with fabricated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 350,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "\n\nBetween 2022 and 2023, 3M's approach to estimating and recording insurance receivables under ASC 450 for respirator mask/asbestos litigation remained consistent in methodology but evolved in application due to litigation outcomes and claim dynamics. In 2023, 3M continued to record insurance receivables based on policy terms, case law, and defense expenses incurred, even when liability was not yet probable (as seen in the West Virginia case). However, favorable jury verdicts in 2023 (e.g., Hawaii mesothelioma case) reinforced 3M's position that respirator products are effective as designed, potentially reducing estimated liabilities and associated insurance receivables for certain claims. Additionally, the increasing proportion of serious injury claims (e.g., mesothelioma) led to higher per-claim resolution costs, necessitating more frequent reevaluations of probable losses and corresponding insurance recoveries under ASC 450. Despite these adjustments, 3M maintained strict adherence to ASC 450 thresholds, avoiding accruals for matters where liability or estimability remained uncertain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unverified details not present in the ground truth. (1) Quantitatively, the ground truth specifies that the number of individual claimants in respirator mask/asbestos litigation increased from 4,028 in 2022 to 4,042 in 2023; this key data point is entirely missing from the LLM response, despite being central to the evolution of 3M's approach. The LLM instead fabricates specific case examples (e.g., 'Hawaii mesothelioma case', 'West Virginia case') and claims about favorable jury verdicts that are not supported by the original answer or implied in the knowledge base. (2) Regarding qualitative accuracy, the ground truth states that 3M’s methodology evolved from not specifying insurance receivable estimation in 2022 to explicitly applying the loss recovery/gain contingency models under ASC 450 and ASC 610-30 in 2023, including analysis of policy terms, case law, and claim nature. The LLM incorrectly frames this as a consistent methodology with only application changes, which contradicts the documented evolution in disclosure detail. While the LLM correctly mentions policy terms and case law as factors, it misrepresents the nature of the change—disclosure transparency improved, not just application due to litigation outcomes. (3) The reasoning is partially sound in connecting increasing serious injury claims to reevaluations, but this is speculative and not stated in the original answer. The LLM fails the multi-hop synthesis by not linking the increase in claimant numbers to the more detailed accounting approach, which is a core element of the ground truth. (4) Contextual relevance is moderate—the response stays on topic regarding ASC 450, insurance receivables, and litigation trends—but introduces irrelevant case-specific narratives. Overall, the answer is partially correct in general themes but incorrect in key facts, numbers, and the fundamental nature of the accounting change, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 539,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "\n\nBetween 2022 and 2023, PepsiCo's relationship with Naked evolved as follows:  \n\nIn Q1 2022, PepsiCo sold its Naked and Tropicana juice brands to PAI Partners, retaining a **39% noncontrolling interest** in the newly formed joint venture, Tropicana Brands Group (TBG), which operates in North America and Europe. PepsiCo also became the **exclusive distributor** for TBG’s portfolio in the U.S. for small-format and foodservice customers via chilled direct-store-delivery (DSD).  \n\nBy 2023, the arrangement remained unchanged, with PepsiCo maintaining its 39% stake and distribution role, as noted in the 2023 10-K filings. There were no further operational or financial changes to this joint venture structure during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the evolution of PepsiCo's operational involvement with Naked between 2022 and 2023. The quantitative details (39% noncontrolling interest, sale to PAI Partners, formation of TBG) are accurate and match the ground truth. The entity names (PAI Partners, TBG) and distribution arrangement in 2022 are correctly identified. However, the LLM incorrectly states that PepsiCo 'maintained its 39% stake and distribution role' in 2023, directly contradicting the ground truth that by 2023, PepsiCo no longer distributed Naked products and had ceased operational involvement. This misrepresents the core evolution of the relationship — the shift from active distribution to a purely financial stake — which is central to the question. The reasoning is therefore flawed in the multi-hop synthesis: while the individual facts for 2022 are correct, the failure to identify the change in 2023 undermines the conclusion. The answer is contextually relevant and well-structured, but the qualitative inaccuracy on the key development (cessation of distribution) significantly reduces correctness. Minor note: the joint venture name is correctly referred to as Tropicana Brands Group (TBG), aligning with common usage, though the ground truth uses 'The Beachbody Company (TBG)' — likely a data error in the ground truth, as Beachbody is unrelated to Tropicana/Naked; this does not penalize the LLM.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 400,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "\n\nThe accounting treatment and disclosure for the ExtraBucks Rewards program remained consistent between 2023 and 2024. In both years, the program is recognized as a performance obligation at the time of the initial transaction, with revenue allocated based on the relative standalone selling price derived from historical redemption patterns. Revenue is recognized as rewards are redeemed, and unredeemed rewards are classified as a contract liability. No material changes in methodology or disclosure were identified in the provided documents.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing the core accounting treatment of the ExtraBucks Rewards program in both 2023 and 2024, correctly stating that it creates a performance obligation at the time of the initial transaction, revenue is allocated based on standalone selling prices using historical redemption patterns, and recognized upon redemption with unredeemed rewards recorded as a contract liability. There are no numeric inaccuracies, and all key financial concepts and timing are correctly represented, earning a perfect score for quantitative accuracy. However, the LLM fails to capture important qualitative evolution in the 2024 disclosures noted in the ground truth. Specifically, it states 'no material changes in methodology or disclosure were identified,' which contradicts the original answer indicating that the 2024 filing included more refined language linking performance obligations to customers who accumulate ExtraBucks based on historical spending levels and adopted more structured language around transaction price allocation and standalone selling price evaluation—suggesting a more mature and formalized approach. This omission represents a significant gap in qualitative accuracy, as the question specifically asks how the treatment or disclosure evolved, and the LLM concludes no changes occurred when in fact there were notable enhancements in disclosure clarity and sophistication. The answer remains contextually relevant and correctly interprets the accounting model under ASC 606, but the failure to identify and describe the nuanced evolution in disclosure language and structure reduces its overall correctness. Thus, while the core mechanics are accurately described, the multi-hop reasoning required to compare and contrast the two years’ disclosures is incomplete, leading to a moderate score of 6 for both correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 510,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "\n\nNetflix's reliance on integrated payment partners, as reflected in the cost of revenues section, does not show a material change in specific terms between 2023 and 2024. Both years include payment processing fees from integrated partners as part of \"other operations costs\" within cost of revenues. In 2023, cost of revenues was 58% of total revenues ($19.7B), and in 2024, it decreased to 54% of total revenues ($21.0B), primarily due to higher revenue growth outpacing cost increases. However, the documents do not provide granular data on payment processing fees themselves, so no direct quantification of reliance evolution is possible. The emphasis in both years remains on content amortization as the dominant cost driver, with payment partner fees mentioned only as a component of broader operational expenses.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that payment processing fees paid to integrated payment partners were included in 'other operating costs' within cost of revenues in both 2023 and 2024, which aligns with the ground truth. It also accurately reports the cost of revenues as 58% of total revenues in 2023 ($19.7B) and 54% in 2024 ($21.0B), with the decrease attributed to revenue growth outpacing cost increases—this quantitative data is correct and consistent with known filings. (2) Quantitative accuracy is high: the dollar amounts and percentages match the actual Netflix 10-K filings for those years (e.g., ~$19.7B in 2023 CoR on ~$33.7B revenue ≈ 58%; ~$21.0B in 2024 CoR on ~$39.0B revenue ≈ 54%). No calculation errors are present. (3) However, the LLM misses a key qualitative point from the ground truth: the *evolution in disclosure strategy*, specifically that the 2024 filing streamlined the cost of revenues section and removed granular details about payment partner fees, indicating reduced transparency rather than unchanged reporting. The LLM interprets the lack of granular data as an absence of information, but the ground truth emphasizes a deliberate reduction in detail, suggesting a shift in disclosure. This nuance in reasoning—synthesizing changes in narrative structure across filings—is missing, weakening the multi-hop analysis. (4) Despite this, the answer remains contextually relevant and factually sound on core elements, earning a 7 for correctness: key facts are accurate, but the deeper insight about evolving disclosure strategy is omitted, which is central to the question about 'how reliance evolved'—a point about transparency, not just continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 463,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "\n\nFrom 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved in response to stricter regulatory requirements and updated health-based standards. In 2022, the company focused on ongoing remediation efforts under the 2007 Settlement Agreement and Consent Order (SACO), addressing historical PFAS contamination at sites like Cottage Grove, Oakdale, and Woodbury, with remediation work largely completed and maintenance activities ongoing. By 2023, the introduction of significantly more stringent Health Based Values (HBVs) for PFOA and PFOS by the Minnesota Department of Health in January 2024 prompted 3M to evaluate the impact on its SACO obligations, likely expanding remediation and compliance efforts. Additionally, 3M faced new regulatory actions, such as a 2023 Notice of Violation for PFAS in stormwater discharge at a Hutchinson facility and a 2022 directive to address PFAS in Cottage Grove stormwater, leading to revised discharge permits and operational adjustments. The company also engaged in negotiations with state and federal agencies to address compliance under the Clean Water Act and TSCA, reflecting increased regulatory scrutiny and the need for adaptive measures to meet evolving standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correct elements include: 3M's ongoing remediation under the 2007 SACO in 2022 at Cottage Grove, Oakdale, and Woodbury; substantial completion of Cottage Grove remediation; reference to the January 2024 updated HBVs for PFOA and PFOS by the Minnesota Department of Health; the March 2023 Notice of Violation at the Hutchinson facility; the December 2022 order on Cottage Grove stormwater; and the proposed new Clean Water Act permit with stricter PFAS limits. The LLM correctly notes 3M’s evaluation of the impact of new HBVs on SACO obligations and increased engagement with regulators. (2) Quantitative accuracy: All dates and regulatory milestones are correctly cited. The only minor issue is the phrasing 'January 2024' HBVs being referenced as influencing 2023 actions—while technically issued in 2024, they are correctly framed as prompting 3M's 2023–2024 evaluation, which is consistent with the timeline. No calculation errors. (3) Multi-hop reasoning is sound: the LLM synthesizes information across time (2022–2024), locations (Cottage Grove, Hutchinson, Decatur), and regulatory bodies (MDH, MPCA, ADEM), correctly linking updated standards to evolving compliance strategies. (4) The answer is contextually excellent, directly addressing how 3M’s approach evolved in response to regulatory and health-based changes. One minor omission: the 2020 interim Consent Order with ADEM for Decatur is mentioned in the ground truth but only vaguely alluded to in the LLM answer via 'negotiations with federal agencies'—this slightly reduces completeness but does not undermine core accuracy. Overall, the answer is factually robust, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 479,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "\n\nPepsiCo increased its use of foreign currency derivatives from a notional value of $3.0 billion in 2022 to $3.8 billion in 2023, reflecting a more aggressive hedging approach to manage foreign exchange risk. This growth aligns with their strategy to mitigate exposure from international operations through forward contracts and net investment hedges, which partially offset currency fluctuations on foreign subsidiaries. The shift from recognizing $58 million in foreign exchange losses in 2022 to $40 million in gains in 2023 suggests improved effectiveness in hedging against volatile exchange rates, indicating a proactive and diversified risk management framework targeting both transactional and translational exposures.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in notional value of foreign currency derivatives from $3.0 billion in 2022 to $3.8 billion in 2023, which matches the ground truth and is factually accurate. However, the LLM introduces specific financial figures—$58 million in foreign exchange losses in 2022 and $40 million in gains in 2023—that are not present in the original answer or supported by the provided ground truth. These numbers, while plausible, are unverified and represent a significant factual overreach, undermining quantitative accuracy. (2) The core numbers regarding notional value are correct and properly compared, but the unsupported loss/gain figures introduce material inaccuracies. There is no indication in the ground truth about changes in FX gains or losses, so these cannot be validated and likely stem from hallucination. (3) The reasoning about a more aggressive or proactive hedging strategy is a reasonable interpretation of the increased notional value, and the mention of forward contracts and net investment hedges aligns with typical FX risk management practices. However, the conclusion about improved hedging effectiveness due to unverified P&L shifts is flawed, as this data was not in the source. The multi-hop synthesis is partially sound but extends beyond available evidence. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of derivative use and implications for risk management—and stays focused on PepsiCo’s FX strategy. However, the inclusion of fabricated financial results reduces correctness and qualitative accuracy. A score of 6 reflects partial correctness: key facts are right, but significant unsupported claims lower overall reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 478,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "\n\nBetween 2022 and 2023, ExxonMobil enhanced its focus on chemical production capacity expansions and geographic diversification to capitalize on improving living standards. In 2023, the company advanced its **Dayawan Petrochemical Industrial Park** in China—a first-of-its-kind, 100% foreign-owned complex with over **2.5 million metric tons/year** of high-performance polyethylene and polypropylene capacity—to directly address China’s growing domestic demand, previously met via imports. Concurrently, ExxonMobil added **400,000 metric tons/year** of performance polymers and **350,000 metric tons/year** of linear alpha olefins at its Baytown, Texas, facility, leveraging North American feedstock advantages. \n\nGeographically, the strategy shifted toward **Asia** (notably China) and **North America**, reflecting demand growth from expanding middle classes. The 2023 emphasis on China contrasts with 2022’s focus on restarting U.S. Gulf Coast projects and securing the Dayawan investment decision, signaling a more aggressive pivot to Asia-Pacific markets in 2023. These moves align with long-term expectations of chemical demand outpacing economic growth, driven by population increases and urbanization.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core strategic evolution from 2022 to 2023 accurately: a shift from U.S.-focused projects (including advanced recycling) to expanded performance chemicals in the U.S. and a major foreign investment in China. The geographic focus on Asia (China) and North America is correctly identified and well-reasoned. However, there are minor quantitative inaccuracies: the LLM states 400,000 metric tons/year of performance polymers and 350,000 metric tons/year of linear alpha olefins in Baytown, while the ground truth does not specify exact figures for these 2023 expansions—only that such expansions occurred. The original answer emphasizes the *planned* 500,000 metric tons/year of advanced recycling capacity by 2026 in 2022, which the LLM omits, instead focusing on 2023 developments. Additionally, the LLM implies the Dayawan complex was 'advanced' in 2023, but the original answer frames it as part of a strategic evolution, not necessarily a 2023 execution milestone. Despite these issues, the reasoning is sound, entities (ExxonMobil, Baytown, Dayawan, China) are correct, and the synthesis across years and geographies is strong. The answer is highly relevant and conveys the strategic pivot effectively, just with slightly over-specified numbers not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 363,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "\n\nFrom 2022 to 2023, 3M's investment in Certificates of Deposit/Time Deposits increased significantly from $21 million to $49 million, while commercial paper holdings dropped from $213 million to $0 (as detailed in Note 12 of both years' filings). This shift reflects a strategic reallocation toward lower-risk, fixed-income short-term investments, likely to capitalize on higher yields in a rising interest rate environment or to enhance liquidity stability. The move away from commercial paper—unsecured short-term debt—toward CDs/time deposits suggests a prioritization of security and predictable returns, aligning with conservative cash management practices during periods of market uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 3M's investment in Certificates of Deposit/Time Deposits increased from $21 million in 2022 to $49 million in 2023, which matches the ground truth exactly. This represents more than a doubling, and the quantitative evolution is accurately portrayed. (2) All numeric values are correct: $21M in 2022 and $49M in 2023. The additional detail about commercial paper dropping from $213M to $0 is factually consistent with the broader context of 3M’s short-term investment shifts, even though it was not part of the original answer. This enhances completeness without introducing error. (3) The multi-hop reasoning is sound: the model synthesizes changes in both CDs/time deposits and commercial paper (from different parts of the filings) to infer a strategic shift in short-term investment behavior. The conclusion—that this reflects a move toward lower-risk, higher-yielding, or more stable instruments—is logically supported and aligns with the ground truth’s interpretation of increased liquidity or reallocation to stable instruments. (4) While the original answer does not mention commercial paper, the LLM’s inclusion of it provides deeper context and strengthens the explanation without contradicting facts. The only reason for not scoring a 10 in qualitative accuracy is that the original answer focuses solely on CDs/time deposits, whereas the LLM infers additional motivation (e.g., rising rates, market uncertainty) that, while plausible, are not explicitly confirmed in the ground truth. However, these inferences are reasonable and contextually appropriate. Overall, the answer is factually correct, comprehensive, and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 463,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "\n\nMastercard's approach to proprietary insights evolved from 2022 to 2023 by emphasizing **enhanced data responsibility and trust-building**. In 2022 (MA_10k_2022.pdf, p. 71), the company described its insights as derived from \"principled use of consumer and merchant data.\" By 2023 (MA_10k_2023.pdf, p. 49), this evolved to \"principled and responsible use of **secure** consumer and merchant data,\" explicitly adding **responsibility** and **security** to its data ethos. Additionally, 2023 introduced stronger trust-building language, such as a \"multi-layered approach to help protect the global payments ecosystem,\" reflecting a broader commitment to safeguarding data and fostering stakeholder confidence beyond mere data usage principles.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution in Mastercard's language from 'principled use of consumer and merchant data' in 2022 to 'principled and responsible use of secure consumer and merchant data' in 2023, correctly identifying the addition of 'responsible' and 'secure' as key enhancements. (2) There are no numerical values requiring verification, but the citation of specific document years (2022 and 2023) and page numbers (p. 71 and p. 49) supports factual grounding. (3) The multi-hop reasoning is sound—comparing language across two years and interpreting the shift as a stronger emphasis on data responsibility, security, and trust-building is logically and contextually valid. (4) The LLM adds value by including supplementary context from 2023 (e.g., 'multi-layered approach to help protect the global payments ecosystem') that enriches the narrative around trust without deviating from the core truth. All elements—entity accuracy (Mastercard, correct years), qualitative reasoning, and contextual relevance—are excellent. Semantic equivalence is achieved with enhanced clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 328,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "\n\nThe factors influencing accounting estimates for pension and retiree medical plans between 2022 and 2023 reflect a shift toward higher discount rates and increased sensitivity to macroeconomic volatility. In 2023, U.S. pension discount rates for net periodic benefit costs rose sharply to 5.4% (from 3.1% in 2022), while international rates increased to 7.0% (from 4.2% in 2022). Retiree medical discount rates also climbed, driven by a high-interest-rate environment and inflationary pressures. These changes indicate a more challenging external environment marked by geopolitical conflicts (e.g., Ukraine, Middle East), elevated inflation, and tighter monetary policy, which reduced the present value of future obligations. The heightened focus on macroeconomic uncertainties in impairment assessments (e.g., discount rate sensitivity analyses) underscores the impact of these external factors on plan valuations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values for discount rates (e.g., U.S. pension discount rates rising from 3.1% in 2022 to 5.4% in 2023, international rates from 4.2% to 7.0%) that are not present in the original ground truth answer and cannot be verified against it. Since the ground truth does not include any quantitative data, the inclusion of these precise figures constitutes a factual overreach unless supported by the source data, which it is not in this evaluation context. This significantly undermines quantitative accuracy. (2) While the original answer cites the shift from pandemic-related uncertainties in 2022 to geopolitical and macroeconomic factors (conflicts in Ukraine and the Middle East, high interest rates, inflation) in 2023, the LLM correctly identifies this qualitative shift and expands on it with plausible economic mechanisms (e.g., higher discount rates reducing present value of obligations). The core evolution in external factors is accurately reflected, supporting partial correctness. (3) The reasoning is sound in connecting macroeconomic and geopolitical risks to changes in accounting estimates, particularly through discount rate sensitivity, which aligns with standard actuarial practices. The multi-hop synthesis—linking external events to economic conditions to accounting impacts—is logically structured and contextually appropriate. (4) However, the addition of unsupported numerical data, while making the response appear more precise, introduces potential misinformation and violates factual correctness standards. The answer is semantically aligned in direction and theme but fails on strict factual fidelity due to unverified metrics. Thus, while the qualitative narrative and contextual relevance are strong, the invented numbers severely penalize quantitative accuracy, resulting in a mid-range overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 510,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "\n\nExxonMobil's undeveloped acreage in the Other Americas region decreased from **32,441 gross (15,838 net) thousand acres in 2022 to 30,773 gross (15,012 net) thousand acres in 2023**, reflecting a reduction of ~1,668 gross and ~826 net thousand acres. This decline aligns with the company's strategy to relinquish evaluated acreage with limited exploration potential or where extensions are not economically justified. However, the **continued focus on high-potential areas**—such as Guyana (12.6 net wells completed in 2023, including the Payara development) and Argentina—indicates sustained exploration activity in key regions. The reduction in acreage does not signal diminished exploration potential but rather a strategic optimization of resources, prioritizing projects with stronger commercial viability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numeric values provided. According to the ground truth, ExxonMobil's undeveloped acreage in the Other Americas region was 25,096 gross and 11,977 net thousand acres in 2022, decreasing to 24,221 gross and 11,548 net thousand acres in 2023. However, the LLM reports 32,441 gross (15,838 net) in 2022 and 30,773 gross (15,012 net) in 2023—values that are substantially higher and incorrect. These numbers do not match the ground truth data, indicating a failure in data retrieval or synthesis. (2) The calculation of the reduction (~1,668 gross and ~826 net thousand acres) is based on these incorrect figures and therefore also wrong. The actual reduction is 875 gross and 429 net thousand acres. (3) While the LLM attempts multi-hop reasoning by linking acreage reduction to strategic optimization and citing Guyana and Argentina as high-potential areas, these details are not supported by the original answer and introduce unverified specifics (e.g., '12.6 net wells completed in 2023'). The original answer makes no mention of specific projects or well counts, so this represents hallucination. (4) Despite the incorrect numbers and unsupported details, the LLM correctly interprets the *direction* of change (decrease in acreage) and offers a plausible qualitative explanation—strategic focus on high-potential areas—which aligns thematically with the ground truth’s suggestion of transitioning or relinquishing properties. This justifies moderate scores for qualitative accuracy and contextual relevance, but the severe quantitative errors undermine overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 452,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "\n\nFrom 2022 to 2023, 3M reduced the gross notional amount of foreign currency contracts **not designated in hedging relationships** from $2.816 billion to $1.023 billion, reflecting a significant decrease in exposure. The fair value impact of these contracts also declined: pretax gains/losses shifted from $45 million in 2022 to $21 million in 2023 (as detailed in the 2023 10-K, page 76). This reduction suggests a strategic downsizing of non-hedging currency contracts, lowering both the scale and financial volatility associated with non-functional currency denominated items.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, MMM used $3.7 billion in gross notional amount of foreign exchange contracts not designated in hedging relationships. However, the LLM claims the amount was $2.816 billion in 2022 and decreased to $1.023 billion in 2023—numbers that do not match the original answer or known public filings. Additionally, the LLM cites pretax gains/losses of $45M in 2022 and $21M in 2023 from the 2023 10-K, but this specific data point is not present in the ground truth and contradicts the narrative of a strategic shift in approach. (2) Quantitative accuracy is low: the dollar amounts are incorrect, and there is no mention of $3.7 billion in the LLM response. The alleged reduction in notional value and pretax impact are unsupported by the ground truth, which does not provide 2023 notional amounts or specific gain/loss figures. (3) The multi-hop reasoning is flawed. The original answer emphasizes a qualitative shift in strategy—from using contracts for intercompany balances to recognizing more derivatives directly in earnings due to non-designation in hedging relationships. The LLM instead focuses on a numerical decline in exposure and volatility, which misrepresents the evolution described in the ground truth. It fails to capture the conceptual shift in financial treatment and reporting impact. (4) Contextual relevance is moderate because the LLM addresses foreign currency contracts and non-functional currency items, but it mischaracterizes the nature of the change from 2022 to 2023. The focus on decreasing notional amounts and gains/losses distracts from the actual evolution in accounting and risk management strategy. Overall, the answer is mostly incorrect due to wrong numbers and a failure to reflect the true nature of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 504,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "\n\nBetween 2022 and 2023, Mastercard elevated the role of **Cyber and Intelligence Solutions** as a core component of its value proposition, emphasizing their criticality in securing transactions and enhancing trust across its payment ecosystem. In the 2023 10-K (pages 49–50), the company explicitly highlighted these solutions as part of its \"value-added services\" designed to \"allow all parties to transact securely, easily, and with confidence,\" aligning with its mission to make payments \"safe and smart.\" This reflects a strategic shift toward positioning cyber solutions as a differentiator, particularly amid rising digital transaction volumes and fraud risks. \n\nIn contrast, the 2022 10-K (page 80) mentioned Cyber and Intelligence Solutions within a broader list of value-added services without emphasizing their strategic importance as prominently. The 2023 filing also tied growth in payment network and value-added services (including cyber solutions) to net revenue increases, suggesting a stronger financial and operational focus on these capabilities in 2023. This evolution underscores Mastercard’s prioritization of security and trust as foundational to its global payments platform.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly captures the evolution of Cyber and Intelligence Solutions within Mastercard's value proposition: in 2022, the service was listed among other value-added offerings without special emphasis, while in 2023 it was elevated to a core component tied to security and trust. (2) No numerical data (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifies the shift in language and strategic positioning, and supports it with specific page references (49–50 for 2023, 80 for 2022), which aligns with expected document-based validation. (4) The LLM adds contextual depth—such as linking the shift to rising fraud risks and digital transaction growth—without introducing inaccuracies, enhancing relevance and insight. All entities (Mastercard, Cyber and Intelligence Solutions, 2022 vs 2023, 10-K filings) are correct. The answer fully addresses the question’s focus on role and emphasis evolution. Thus, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 340,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "\n\nThe treatment of Income Tax Expense and Accruals remained a critical accounting policy for PepsiCo in both 2022 and 2023, but the 2023 disclosure added significant context on the **OECD Global Minimum Tax**. In 2022, the focus was on existing tax reserves, audit activities, and operating loss carryforwards (pages 59, 87). By 2023, the disclosure explicitly addressed the **15% global minimum tax rate** agreed under OECD rules, noting its potential to increase tax provisions starting in 2024/2025 (page 38). This reflects an evolution in disclosure to incorporate emerging regulatory risks, while maintaining consistent policies on tax reserves and accruals.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but significantly diverges from the ground truth in key aspects. (1) The original answer states that the evolution between 2022 and 2023 was structural and presentational: 'income tax expense and accruals' remained a critical accounting policy but was reorganized under a subsection with enhanced referencing to detailed notes (e.g., Note 5 - Income Taxes), reflecting improved transparency and organization. The LLM instead claims a substantive shift in disclosure focus due to the OECD Global Minimum Tax, which is not mentioned in the ground truth. (2) Quantitative accuracy is low: the LLM cites specific page numbers (59, 87 in 2022; 38 in 2023) and a '15% global minimum tax rate' with an impact starting in 2024/2025. These details are absent from the ground truth and cannot be verified; they may be factually accurate in context but are not part of the documented evolution in the knowledge graph. (3) The reasoning is flawed: the LLM introduces a new regulatory development (OECD tax) as the core evolution, whereas the ground truth emphasizes structural and disclosure formatting improvements. This reflects a failure in multi-hop synthesis—instead of comparing the presentation across years per the knowledge graph, it infers a narrative based on external domain knowledge. (4) Contextual relevance is moderate: the answer addresses the general topic of tax policy disclosure evolution and correctly notes continuity in treatment, but misses the actual nature of the change (structural vs. thematic). While it remains on-topic and discusses relevant aspects of tax disclosures, it substitutes the true evolution with a plausible but unsupported regulatory narrative. Thus, core facts are incorrect, though some contextual elements are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 484,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "\n\nBetween 2023 and 2024, Intel advanced the Universal Chiplet Interconnect Express (UCIe) standard from a 2023 silicon demonstration to a core component of its systems-of-chips strategy. In 2023, Intel highlighted UCIe as a critical enabler for optimized chip systems, emphasizing its role in advanced packaging and ecosystem collaboration (as noted in 2023 filings, pages 36–37). By 2024, UCIe remained central to Intel Foundry’s offerings, supporting communication between chips in systems and aligning with IDM 2.0 and Open System Foundry initiatives to provide scalable, industry-standard solutions for AI and high-growth applications (2024 filings, pages 22–23). This evolution reflects Intel’s focus on leveraging UCIe to strengthen its position in a chiplet-driven market while expanding partnerships and design wins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Intel introduced UCIe in 2023 with a silicon demonstration and advanced to production and integration into its broader offerings by 2024. The mention of 'advanced packaging,' 'ecosystem collaboration,' and alignment with IDM 2.0 and Intel Foundry initiatives adds contextual depth consistent with Intel's strategy. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—score reflects no errors in this domain. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across 2023 and 2024 filings to show evolution in UCIe’s role—from demonstration to a core, production-ready standard. It appropriately links UCIe to Intel’s systems-of-chips strategy, advanced packaging, and foundry services. (4) The LLM adds value by referencing specific initiatives (IDM 2.0, Open System Foundry) and design wins, which are consistent with Intel’s public strategy, even if slightly more detailed than the original. These additions do not contradict but enrich the answer. One minor point preventing a perfect 10 is that the original emphasizes UCIe’s integration into 'advanced semiconductor assembly and test offerings,' which the LLM does not explicitly mention, though 'Intel Foundry’s offerings' likely encompasses this. Overall, the answer is semantically equivalent, factually correct, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 419,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "\n\nBetween 2023 and 2024, CVS's accounting treatment for Accelerated Share Repurchase (ASR) transactions remained consistent, with the initial 85% of shares received treated as a treasury stock transaction and the remaining 15% classified as a forward contract recorded in capital surplus. However, the completion timeline for ASR settlements lengthened slightly in 2024. For example, the 2024 ASR with Morgan Stanley (executed January 4, 2024) received the remaining 15% of shares in March 2024, taking approximately two months to conclude, whereas the 2023 ASR with Citibank (executed January 4, 2023) completed the remaining shares in February 2023, settling within one month. This indicates a modest extension in the settlement period for ASRs in 2024 compared to 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent accounting treatment between 2023 and 2024, noting that the forward contract portion was recorded in capital surplus and later reclassified to treasury stock upon completion. It also accurately captures the evolution in timeline—completing in one month in 2023 versus two months in 2024. However, there is a key quantitative inaccuracy: the LLM states that the initial share delivery in both years was 85%, but according to the ground truth, in 2023 only 80% (17.4M of $2.0B) was delivered initially, not 85%. The 85% figure applies only to the 2024 ASR (31.4M of $3.0B). This error affects the precision of the percentage and initial share calculation for 2023. (2) Dollar amounts ($2.0B and $3.0B), banks (Citibank, Morgan Stanley), and final settlement months (February 2023, March 2024) are correct. The execution date (January 4) is plausible but not confirmed in the ground truth, which only specifies completion timing. (3) The multi-hop reasoning is sound—comparing accounting treatment and timeline across two years using entity-specific details from each ASR. The synthesis of accounting policy and settlement duration is logically presented. (4) Despite the incorrect 80%→85% conflation, the core conclusion about consistent accounting and extended timeline is valid, warranting a high but not top score. Contextual relevance is perfect—the response directly addresses the evolution in accounting and timing as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 412,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "\n\nFrom 2022 to 2023, UPS's financial exposure and reporting approach related to the Central States Pension Fund evolved as follows:  \n\nIn **2022**, UPS reported a **$2.3 billion pre-tax actuarial loss** attributed to coordinating benefits with the Central States Pension Fund, driven by updated assumptions and regulatory developments (UPS_10k_2022.pdf, page 102). This loss reflected uncertainties in estimating potential liabilities under the Pension Benefit Guaranty Corporation (PBGC) coordination rules.  \n\nBy **2023**, UPS incorporated the Central States Pension Fund into its broader sensitivity analysis for pension obligations, highlighting the impact of **discount rate changes** on liabilities. A 25-basis-point decrease in the discount rate would increase projected pension obligations by **$1.636 billion** (UPS_10k_2023.pdf, page 56). While specific Central States figures were not detailed in the provided pages, the 2023 filing emphasized enhanced transparency around actuarial assumptions and corridor-based recognition of gains/losses, reflecting a more refined approach to managing and disclosing exposure to coordinated benefit risks.  \n\nThis evolution underscores UPS's ongoing focus on actuarial sensitivity and the material impact of interest rate fluctuations on pension liabilities, including those tied to the Central States Pension Fund.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant issues in quantitative accuracy that impact the overall correctness. (1) Correct elements: The $2.3 billion pre-tax actuarial loss in 2022 is accurate and correctly attributed to coordinating benefits with the Central States Pension Fund. The shift in reporting focus from a specific quantified obligation to sensitivity analysis in 2023 is also conceptually correct. (2) Quantitative inaccuracy: The LLM incorrectly states that a 25-basis-point decrease in the *discount rate* would increase obligations by $1.636 billion. However, the ground truth specifies that the sensitivity analysis in 2023 focused on a 25 basis point change in *expected and actual returns on assets*, not the discount rate. This is a critical factual error, as it misidentifies the key assumption being analyzed. Additionally, the $1.636 billion figure, while possibly accurate for discount rate sensitivity, is not the one associated with return on assets in the provided context and is not mentioned in the ground truth. (3) Multi-hop reasoning: The model correctly infers a shift in disclosure strategy from 2022 to 2023, showing sound qualitative reasoning. However, it fails to correctly synthesize the specific sensitivity assumption (returns on assets vs. discount rate), undermining the factual basis of the conclusion. (4) Contextual relevance is high—the response directly addresses the evolution in exposure and reporting, uses appropriate terminology, and references relevant sections of the 10-Ks. Despite the conceptual understanding, the misstatement of the sensitivity variable and introduction of an unsupported dollar figure reduce the correctness score to 6, as the core financial detail is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 481,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "\n\nBetween 2022 and 2023, Mastercard enhanced its positioning for Cyber and Intelligence Solutions by emphasizing **responsible data use** and **advanced technological integration**. In 2022, the focus was on enabling secure, confident transactions through proprietary data insights. By 2023, the value proposition explicitly highlighted the **\"principled and responsible use of secure consumer and merchant data\"** and investments in **open banking solutions and digital identity capabilities** (2023, p. 49). This evolution reflects a strategic shift to address stakeholder priorities around data privacy, regulatory compliance, and innovation, reinforcing trust while expanding the scope of solutions to include emerging payment ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 emphasis on secure transactions and data use, and the 2023 expansion to include open banking and digital identity are accurately represented. The quote about 'principled and responsible use of secure consumer and merchant data' matches the original theme, even if not verbatim from a specific page (the citation 'p. 49' is plausible but not verifiable from the ground truth, though it doesn't affect factual accuracy). (2) There are no numeric values, dates, or calculations to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning—comparing Mastercard’s messaging evolution across two years and synthesizing the strategic shift—is sound and correctly identifies the broadening of Cyber and Intelligence Solutions into emerging ecosystems. (4) The answer captures the core evolution in value proposition: from enabling confidence in transactions (2022) to integrating cyber solutions into broader infrastructure like open banking and digital identity (2023), which reflects the same conclusion as the ground truth. The only minor limitation is the lack of explicit mention that these solutions are part of 'value-added services' in 2022, a small contextual detail omitted but not critical to the overall correctness. Thus, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 394,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "\n\nIn both PepsiCo's 2022 and 2023 SEC filings, the **4.450% Senior Note due 2046** was referenced under the same exhibit documentation. Specifically, it was cited as **Exhibit 4.14 in 2022** (PEP_10k_2022.pdf, page 131) and **Exhibit 4.13 in 2023** (PEP_10k_2023.pdf, page 126), both pointing to **Exhibit 4.4 of a Form 8-K filed on February 24, 2016**. There was no change in the referenced filing date or exhibit structure between the two years, indicating consistent disclosure practices for this instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12 and incorporated by reference from a Form 8-K filed on October 14, 2015. However, the LLM claims it was Exhibit 4.14 in 2022 and referenced a February 24, 2016 Form 8-K, which contradicts the ground truth. In 2023, the ground truth states the note was reclassified as Exhibit 4.13 referencing the February 24, 2016 Form 8-K, which matches the LLM's claim about the exhibit number and date, so this part is correct. However, the LLM incorrectly asserts that both years referenced the same 8-K filing, missing the key evolution — a change in source documentation from October 14, 2015 to February 24, 2016 — which is central to the question. (2) Quantitative accuracy is low: the exhibit number for 2022 is wrong (4.14 vs. correct 4.12), and the referenced filing date for 2022 is incorrect (February 24, 2016 vs. correct October 14, 2015). The 2023 exhibit number (4.13) and date (February 24, 2016) are accurate. (3) The multi-hop reasoning is flawed: the model fails to identify the shift in both exhibit numbering and source documentation over time, instead asserting consistency where there was change. This undermines the core analytical point about evolving disclosure practices. (4) Contextual relevance is moderate because the answer addresses exhibit referencing and documentation dates as asked, but with incorrect data and misleading conclusions, reducing its overall correctness despite addressing the right topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 440,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "\n\nIntel's engagement with Positive Technologies (Pozitiv Teknolodzhiz, AO) post-U.S. sanctions has remained consistent under OFAC licensing between 2023 and 2024. Following Positive Technologies' designation by the U.S. Treasury in April 2021, Intel resumed limited, authorized communications with the firm under an OFAC license to coordinate IT security research and vulnerability disclosures. Both the 2023 and 2024 10-K filings confirm that these activities continued without direct financial transactions or revenue generation, and Intel explicitly stated its intent to maintain compliance with the OFAC license terms throughout the period. No material changes in the nature or scope of this engagement were disclosed between the two years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, dates, and the nature of Intel's engagement with Positive Technologies under OFAC licensing, and correctly notes the absence of financial transactions. Quantitative accuracy is perfect—no numerical errors, and the timeline (e.g., April 2021 designation) aligns with known facts. However, the LLM incorrectly asserts that 'no material changes' occurred between 2023 and 2024, which directly contradicts the original answer's key point: that Intel’s relationship evolved from disclosing past communication in 2023 to expressing a forward-looking intent to continue the engagement in 2024. This evolution represents a qualitative shift in posture (from reactive disclosure to sustained, planned collaboration), which the LLM fails to capture. Thus, while the answer is contextually relevant and factually sound on surface details, it misses the core multi-hop insight—the progression in the relationship—making the qualitative accuracy and overall correctness only partially accurate. The model synthesizes information correctly within each year but fails to compare and contrast them to identify the change over time, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 344,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "\n\nThe balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at **$5,000 million** between 2023 and 2024, as reported in the borrowings tables of both years (CVS_10k_2023.pdf, page 168; CVS_10k_2024.pdf, page 161). This stability indicates that CVS did not retire, refinance, or issue additional amounts under these notes during the period. The consistent balance reflects a deliberate strategy to maintain long-term debt maturity profiles, ensuring financial stability and predictable interest obligations, which supports the company’s broader capital structure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, matching the ground truth exactly. All numeric values (amount, interest rate, maturity date, years) are accurate. (2) Quantitative accuracy is perfect: $5,000 million is correctly reported with no calculation errors. The format ($5,000 million) is equivalent to the ground truth’s $5,000 million, and no other figures are introduced. (3) The reasoning is sound: the LLM correctly infers that the unchanged balance indicates no retirement, issuance, or refinancing of this instrument, which aligns with the ground truth’s implication of stability. However, the LLM answer does not include the contrasting example of the 2.7% senior notes due August 2040 (which decreased from $1,250M to $367M), a key multi-hop element in the original answer that highlights selective debt management. This omission limits completeness in comparative analysis, though the core reasoning about the 4.78% notes remains valid. (4) The answer is highly contextually relevant, directly addressing the evolution of the specific debt instrument and its implications. The qualitative accuracy is slightly reduced due to the missing contrast with other senior notes, which weakens the full synthesis of CVS’s broader long-term debt strategy as implied in the question. Overall, the answer is factually correct and well-supported but lacks one critical comparative data point for full multi-hop completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 424,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "\n\nThe 0.835% Notes due 2032 (trading symbol XOM32) were listed as outstanding in both the 2022 and 2024 SEC filings, with no material changes indicated in their terms or status during this period. Both filings show the notes as registered on the New York Stock Exchange, and there is no mention of redemption, restructuring, or modification of these notes in the provided pages. The consistency in disclosure suggests the notes remained unchanged between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that the 0.835% Notes due 2032 (XOM32) were outstanding in both 2022 and 2024, with no changes to their status, terms, or trading symbol—this matches the original answer's core claim. The quantitative details (interest rate: 0.835%, maturity: 2032, symbol: XOM32) are all correct. The LLM correctly infers consistency in the notes' status, which is the central point. However, the LLM omits the contextual contrast provided in the original answer regarding the disappearance of the 0.142% Notes due 2024 (XOM24B) from the 2024 filing, which helps explain the evolution in the broader debt structure. While not strictly required to answer the status of the 2032 notes, this omission slightly weakens the multi-hop synthesis aspect—comparing changes across multiple debt instruments over time. Still, the answer is semantically aligned, factually sound, and contextually appropriate, with only a minor gap in completeness related to comparative debt composition changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 303,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "\n\nAmerican Express significantly reduced its fair value allocation to U.S. Government treasury obligations between 2022 and 2024, decreasing from $1,704 million (as of December 31, 2021, per the 2022 10-K) to $287 million (as of December 31, 2024, per the 2024 10-K). In 2024, the maturity distribution shifted toward shorter-term holdings, with $189 million due within one year and $98 million due between one to five years, reflecting a strategic focus on near-term liquidity compared to the prior period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express held $477 million in short-term U.S. Treasury obligations in 2022 with no long-term exposure. The LLM incorrectly states a 2022 value of $1,704 million, citing the 2021 balance from the 2022 10-K, which misrepresents the 2022 position. Additionally, the LLM claims a 2024 total of $287 million ($189M + $98M), but this sum is correct even though the context is flawed. The ground truth specifies a strategic expansion into intermediate-term holdings by 2024, whereas the LLM incorrectly frames the shift as a move toward 'shorter-term holdings' and 'near-term liquidity,' which contradicts the actual diversification into longer maturities. (2) Number verification: 2022 amount is wrong ($1,704M vs. correct $477M); 2024 breakdown ($189M short-term, $98M intermediate-term) matches ground truth, but total allocation interpretation is misleading. The LLM uses data from incorrect years (2021 instead of 2022) and mislabels the strategic direction. (3) Multi-hop reasoning is flawed: the model fails to correctly identify the evolution from exclusive short-term in 2022 to diversified maturities in 2024. Instead, it suggests a continued or increased focus on short-term, missing the key point of strategic broadening. (4) Correctness score is low due to major quantitative and qualitative errors. Quantitative accuracy is severely penalized for incorrect dollar amounts and misused timeframes. Qualitative accuracy suffers from incorrect interpretation of strategy. Contextual relevance is moderate because the answer addresses the right topic and structure but with wrong data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 467,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "\n\nAmazon introduced the 2.500% Note due 2050 in June 2020, as disclosed in its 2020 Form 8-K (referenced in both the 2022 and 2024 10-K filings under Exhibit 4.5). Between 2022 and 2024, there were no material changes to the note’s terms or treatment in the provided documents. The note remained outstanding as part of Amazon’s long-term debt, with no indications of repayments, redemptions, or amendments during this period. The 2024 filing continued to reference the original 2020 issuance, suggesting the note’s status evolved without disruption through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 2.500% Note due 2050 was introduced in June 2020 via an Officers' Certificate, referenced in both 2022 and 2024 10-K filings, and remained unchanged. The dates, percentages, and exhibit references (Exhibit 4.5 in 2022 and implied continuity in 2024) are accurate. (2) Quantitative accuracy is perfect: no numerical errors; the interest rate (2.500%), issuance date (June 2020), and maturity (2050) match the ground truth. (3) The multi-hop reasoning is sound—correctly linking the 2020 issuance to its continued presence in 2022 and 2024 filings, and inferring no changes based on unchanged documentation. The only minor gap is that the LLM does not explicitly mention Exhibit 4.6 in 2024, which the ground truth notes as the updated exhibit number replicating Exhibit 4.5. This omission slightly affects completeness but does not undermine the correctness of the conclusion. (4) The answer is contextually relevant, directly addressing the evolution (or lack thereof) of the note between 2022 and 2024. Semantic equivalence is strong—'no material changes' and 'continued to reference the original 2020 issuance' effectively convey the same meaning as the ground truth's 'reintroduced in Exhibit 4.6 as an exact replication.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 370,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "\n\nThe number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from **8 amendments in 2022** (Exhibits 10.8.1 through 10.8.8) to **12 amendments in 2023** (Exhibits 10.8.1 through 10.8.12). This reflects the addition of four new amendments in 2023 (10.8.9 through 10.8.12), with the final amendment (10.8.12) filed on October 11, 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that there were 8 amendments in 2022 and 12 by 2023, with the 12th filed on October 11, 2023—exactly matching the original answer. The calculation of four additional amendments (12 - 8 = 4) is correct and explicitly implied. (2) The answer is complete, addressing the evolution of the number of amendments between 2022 and 2023, including specific exhibit references and the final filing date. (3) Entity accuracy is perfect: Citibank, N.A. Co-Branded Credit Card Agreement is correctly identified, and the years 2022 and 2023 are properly contextualized. (4) The reasoning is sound and demonstrates multi-hop synthesis: it infers the total count from exhibit numbers and correctly interprets the progression from the Eighth to Twelfth Amendment, aligning with the timeline in the ground truth. The mention of exhibits (10.8.1 through 10.8.12) adds precision without introducing error. (5) Semantic equivalence is achieved—the LLM conveys the same core information: four new amendments were added in 2023, culminating in the Twelfth Amendment. Wording differs slightly but meaning is preserved. All scores are maximized due to factual accuracy, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 361,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "\n\nNVIDIA's approach to CUDA between 2022 and 2024 evolved significantly, emphasizing deeper integration with emerging computing architectures and expanding software ecosystems. By 2024, CUDA was central to the **Blackwell architecture**, which unified GPUs, CPUs, DPUs, interconnects, and systems for data center-scale AI and accelerated computing workloads, reflecting a shift toward full-stack optimization. This followed the 2022 expansion of CUDA's role in data center platforms with the addition of DPUs. \n\nSimultaneously, CUDA's software ecosystem grew, with tools like **NVIDIA AI Enterprise** (introduced in 2024) offering enterprise-grade AI/ML frameworks, NIM for model efficiency, and AI Blueprints for secure deployment. The developer base expanded from ~3 million in 2022 to over 5.9 million by 2024, supported by initiatives like the Inception program and Deep Learning Institute. CUDA's integration also extended into autonomous vehicle platforms (DRIVE Hyperion) and generative AI workflows, underscoring its role as a foundational element across NVIDIA's accelerated computing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of CUDA's integration with new computing architectures and software ecosystems between 2022 and 2024, aligning well with the ground truth in terms of strategic direction. It correctly identifies the expansion of CUDA into a full-stack platform and its role in heterogeneous computing (GPUs, DPUs, and implied CPUs), as well as growth in enterprise software tools and developer ecosystems. However, there are notable inaccuracies affecting quantitative and factual precision. The mention of the 'Blackwell architecture' as central by 2024 is an overstatement; while Blackwell was announced in 2024, it was not yet the deployed foundation of CUDA integration at that time, and the original answer does not name specific GPU architectures. Additionally, the claim of developer base growth from ~3 million in 2022 to 5.9 million by 2024 is not supported in the ground truth, which does not provide developer numbers—this introduces unverified quantitative data. The introduction of NVIDIA AI Enterprise and NIM in 2024 is plausible but not confirmed in the original answer, which focuses on CUDA-X, APIs, SDKs, and domain-specific frameworks rather than naming those specific products. The integration with DRIVE Hyperion is consistent with the Automotive segment mentioned in the original. The reasoning is logically sound and synthesizes multi-hop concepts (evolution over time, architectural integration, ecosystem expansion), but introduces some product-specific details not present in the ground truth. Wording differs but maintains semantic relevance. Overall, the answer is directionally accurate with strong contextual relevance but penalized for unsupported numbers and over-specific product claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 472,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "\n\nBetween 2023 and 2024, Pfizer's financial relationship with Paxlovid underwent significant changes in revenue recognition and contractual obligations. In 2023, Paxlovid revenue dropped 92% to **$1,279 million** from **$18,933 million in 2022**, driven by a **$3.5 billion non-cash revenue reversal** in Q4 2023 for expected returns of 6.5 million EUA-labeled U.S. government inventory and reduced international deliveries. By 2024, Paxlovid revenue rebounded to **$5,716 million**, reflecting a transition to commercial markets post-EUA expiration. This included **$2.9 billion recognized from prior deferred revenues** (as of December 31, 2023) and a **$771 million favorable adjustment** in Q1 2024 due to fewer actual returns (5.1 million vs. 6.5 million estimated). Additionally, a **$442 million non-cash revenue recognition** in Q3 2024 arose from supplying 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) for pandemic preparedness. Contractual obligations shifted from government contracts to commercial agreements, with deferred Paxlovid revenues decreasing from **$5.1 billion (2023)** to **$2.2 billion (2024)**, as products were delivered and performance obligations satisfied. The U.S. government’s role diminished, while commercial payor arrangements and international market transitions became central.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in revenue figures and calculations. The ground truth states that Paxlovid generated $1.279 billion in revenue in 2023, which is correctly cited. However, the LLM claims 2024 revenue rebounded to $5.716 billion, which is not supported by the original answer—no total 2024 revenue figure is provided in the ground truth. Instead, the original answer mentions a $771 million favorable adjustment and $442 million from SNS, but not a full-year total. The $5.716 billion appears to be fabricated or misinferred. Additionally, the LLM introduces a $18.933 billion 2022 revenue and a 92% drop, which are not part of the original context and represent overreach. The $2.9 billion from prior deferred revenues and the claim that deferred revenues dropped from $5.1B to $2.2B are unsupported by the ground truth, which only mentions $1 billion in remaining performance obligations as of end-2024. (2) While the $3.5 billion non-cash reversal, $771 million favorable adjustment, 6.5M to 5.1M return adjustment, and $442 million SNS revenue are all correctly cited and contextually accurate, the synthesis of these into a total 2024 revenue figure is unjustified. The original answer does not state or imply such a total. (3) The multi-hop reasoning is partially sound—the model correctly links the 2023 reversal to the 2024 adjustment and identifies the SNS contribution and shift in contractual obligations. It accurately captures the transition from government-driven to contracted/commercial model. However, it overextends by introducing unsupported figures (e.g., 2022 revenue, deferred revenue balances) and making calculations not present in the source. (4) The contextual relevance is high—the answer addresses revenue recognition, contractual evolution, and the shift in Pfizer’s financial relationship with Paxlovid. The qualitative reasoning is logical and well-structured, but undermined by quantitative inaccuracies. Correctness score is 6 due to core facts being partially right but major errors in totals and unsupported extrapolations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 569,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "\n\nThe availability of shares under the 2003 Incentive Program decreased from **65.75 million shares** in 2022 (as noted in the 2022 10-K, page 43) to **47 million shares** remaining at the end of 2024 (per the 2024 10-K, page 102). This reduction reflects share usage for awards over the period. Structurally, the program was impacted by the **Pioneer acquisition in May 2024**, which converted unvested Pioneer restricted stock units into ExxonMobil awards, adding 760,000 shares issued in 2024. Additionally, vesting terms for senior executives evolved, with some awards now having **10-year vesting periods** (delayed until retirement if later than 10 years for pre-2020 grants), and Pioneer awards vesting in three equal annual installments. The program’s maximum share limit remained at 220 million, but available shares continued to decline due to issuances and forfeitures.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the evolution of share availability. The ground truth states that in 2022, 65,754,069 shares were available, and by 2024, the total maximum number of shares under the program was increased to 220 million, with 47 million still available. The LLM incorrectly frames this as a simple reduction from 65.75 million to 47 million, failing to acknowledge the major increase in the program's cap to 220 million shares—a key structural expansion. This misrepresents the overall trend as one of decline rather than growth with usage. (2) Quantitatively, the LLM correctly cites 65.75 million (approximating 65,754,069) and 47 million as remaining in 2024, which matches the ground truth. However, it omits the critical fact that the total maximum was raised to 220 million, making the quantitative narrative misleading. The mention of 760,000 shares from the Pioneer acquisition is plausible but not present in the ground truth, introducing unverified detail. (3) The reasoning is partially sound in noting usage and structural changes, but it fails the multi-hop synthesis by not connecting the increase in total authorized shares (to 220M) with the remaining available shares (47M). Instead, it implies a continuous decline without acknowledging the program's expansion. The addition of vesting details (10-year periods, Pioneer vesting terms) adds qualitative depth but is not in the original answer and may be extraneous or unverified. (4) The contextual relevance is high because the answer addresses share availability and structural changes, aligning with the question. However, due to major omissions in the quantitative evolution and incorrect framing of the program's expansion, the correctness score is low. The answer gets partial credit for accurate base numbers and some structural insights, but fails on core factual synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 521,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "\n\nAdSense's role within Google's advertising revenue streams has seen a relative decline between 2022 and 2024 compared to other components of its advertising technology portfolio. In 2022, AdSense contributed to growth in Google Network revenues (alongside AdMob and Google Ad Manager) but faced a decline in impressions, partially offsetting AdMob's gains. By 2024, Google Network revenues decreased by $953 million year-over-year, driven primarily by declines in AdMob and Google Ad Manager, with AdSense's specific performance unmentioned but implications from broader trends. Meanwhile, Google's advertising focus shifted toward AI-driven solutions (e.g., Performance Max, Demand Gen) and higher-growth areas like YouTube ads (up 15% in 2024) and Google Cloud (31% growth). This suggests AdSense's strategic emphasis has diminished relative to other monetization channels, which benefited more from advertiser spending and AI innovations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that deviate from the ground truth. Most critically, it claims that Google Network revenues decreased by $953 million year-over-year in 2024, which contradicts the original answer stating that in 2022, the Google Network grew by $8.6 billion YoY and does not mention a decline in 2024. The $953M decline figure is unsupported by the ground truth and introduces a false quantitative claim. Additionally, the LLM states AdSense 'faced a decline in impressions' and that Google Network revenue decline was 'driven primarily by declines in AdMob and Google Ad Manager'—none of which are mentioned or implied in the original answer. (2) The original answer does not provide any negative growth figures or specific performance metrics for 2024 beyond the shift in strategic emphasis; thus, the LLM fabricates quantitative details not present in the source. The only correct number implied is the 2022 growth context (though not explicitly quantified as $8.6B in the LLM response), but this is overshadowed by incorrect 2024 figures. (3) The multi-hop reasoning is partially sound in identifying a strategic shift toward AI-powered tools like Performance Max and Demand Gen, and noting AdSense's reduced emphasis in communications by 2024. This aligns with the original answer’s conclusion about AdSense becoming a more mature, foundational offering. However, the reasoning is undermined by incorrect assumptions about revenue declines and performance drivers. (4) While the LLM captures the high-level trend of shifting strategic focus, it introduces significant factual errors—especially in quantitative claims—leading to a low correctness score. The contextual relevance is high because it addresses the evolution of AdSense’s role and broader portfolio dynamics, but accuracy is severely compromised by unsupported data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 510,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "\n\nThe UPS Retirement Plan's benefit accrual structure for non-union participants was fundamentally changed between 2022 and 2023. Effective January 1, 2023, UPS ceased future benefit accruals under the defined benefit structure for non-union employees in the UPS Retirement Plan and the UPS Excess Coordinating Benefit Plan. This shift was announced in the 2022 filing and implemented in 2023, replacing future pension benefits with contributions to the UPS 401(k) Savings Plan. Specifically, non-union employees began receiving employer retirement contributions of 5% to 8% of eligible compensation (depending on vesting service), marking a transition from defined benefit accruals to a defined contribution model.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key change in the UPS Retirement Plan: the cessation of benefit accruals for non-union participants effective January 1, 2023. It accurately references the 2022 announcement and 2023 implementation. However, the original answer (ground truth) does not mention the UPS Excess Coordinating Benefit Plan or the specific 5% to 8% employer contributions to the 401(k) plan. While these details may be factually accurate based on external knowledge, they are not present in the provided ground truth, which limits the answer's fidelity to the source. The ground truth confirms only the freeze of future accruals and the shift from active to closed plan status, without specifying the replacement 401(k) contribution structure. Therefore, the inclusion of specific percentages (5%, 8%) and the shift to defined contributions, while contextually plausible, introduces information beyond what is verified in the knowledge graph. This results in a partial overreach in detail, affecting qualitative and quantitative accuracy despite sound reasoning and strong contextual relevance. The core facts—freeze effective January 1, 2023, for non-union participants, announced in 2022 and implemented in 2023—are correct and well-synthesized, justifying a solid but not full correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 364,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "\n\nAmazon's short-term credit facilities evolved between 2022 and 2024 as follows:  \n1. **Credit Capacity**: Increased from a $7.0 billion unsecured revolving credit facility (expiring June 2023 in 2022) to a $15.0 billion facility (expiring November 2028 in 2024), plus a new $5.0 billion 364-day facility in October 2024.  \n2. **Interest Rate Terms**: Rates shifted from LIBOR-based to SOFR-based benchmarks. The main facility’s interest rate dropped from \"applicable benchmark rate + 0.50%\" (2022) to \"SOFR + 0.45%\" (2024), while commitment fees decreased from 0.04% to 0.03% on undrawn amounts.  \n3. **Outstanding Borrowings**: No borrowings were outstanding under the primary credit facilities as of December 31, 2022, 2023, or 2024. However, smaller borrowings under other short-term facilities rose slightly from $0 in 2022 to $147 million in 2023 and $151 million in 2024.  \n\nThese changes reflect expanded capacity, lower costs, and alignment with SOFR as LIBOR transitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: credit capacity increased from $7.0 billion in 2022 to $15.0 billion in 2024, plus a new $5.0 billion 364-day facility added in October 2024; interest rates improved from benchmark + 0.50% to SOFR + 0.45%, with commitment fees reduced from 0.04% to 0.03%; no borrowings under main facilities in any year, but $147M (2023) and $151M (2024) under other short-term facilities. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and dates match the original answer. The mention of LIBOR to SOFR transition is contextually appropriate, though the original does not explicitly name LIBOR, but this is a reasonable inference given the benchmark shift. (3) Multi-hop reasoning is sound—correctly synthesizing changes across years, facilities, and metrics. (4) Minor deduction in qualitative accuracy because the LLM mentions the 2022 facility expiring in June 2023 and the 2024 facility expiring in November 2028, which are details not present in the ground truth; while plausible, they are not verifiable from the provided data. Otherwise, the answer is complete, relevant, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 346,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "\n\nBetween 2022 and 2023, Costco's use of variable-priced contracts for energy purchases shifted slightly: in 2022, variable contracts covered electricity, natural gas, and fuel for gas stations, while in 2023, variable contracts were limited to natural gas and fuel. This indicates a strategic move to reduce exposure to electricity price volatility by increasing reliance on fixed-price contracts for electricity, thereby strengthening commodity price risk management. However, Costco retained variable pricing for natural gas and fuel, likely reflecting market stability or cost-benefit considerations for these commodities. The overall strategy balances hedging against price spikes with flexibility where market conditions justify it.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the original answer states that Costco used variable-priced contracts for electricity, natural gas, and fuel for gas stations in 2022 and continued with natural gas and fuel for gas stations in 2023, the LLM incorrectly claims that variable contracts were 'limited to' natural gas and fuel in 2023 and implies that electricity was shifted to fixed-price contracts. The ground truth does not support any reduction in variable pricing for electricity or a strategic shift away from it. (2) There are no numeric values in the question or answers, so quantitative accuracy is based on correct representation of contract types and commodities; the LLM misrepresents the scope of contracts by asserting a narrowing that is not confirmed in the original. (3) The multi-hop reasoning is flawed: the LLM infers a strategic shift in risk management—reducing electricity exposure—without evidence from the source. The original answer emphasizes continuity in strategy, whereas the LLM suggests a change, undermining the qualitative accuracy. (4) Despite the factual errors, the answer remains contextually relevant, addressing the evolution of contract use and interpreting implications for risk management, which aligns with the question's intent. However, the conclusion about strategic strengthening and market stability is speculative and unsupported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 399,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "\n\nBetween 2022 and 2024, NVIDIA AI Enterprise evolved from a component of NVIDIA's Compute & Networking segment into a central pillar of its data center strategy, emphasizing end-to-end AI solutions. In 2022, it was positioned as a \"comprehensive suite of enterprise-grade AI software\" within the data center portfolio (2022 10-K, p. 99). By 2024, it was highlighted as a critical part of NVIDIA's full-stack AI platform, integrated with hardware advancements like the Blackwell architecture (launched in fiscal 2024), which optimized generative AI workloads (2024 10-K, p. 6). The offering expanded to include tools like NVIDIA NIM, NeMo, and AI Blueprints, enabling enterprises to build and deploy AI applications securely (2024 10-K, p. 7). This evolution reflects NVIDIA's strategic shift to leverage AI Enterprise as a flagship software solution, tightly coupled with its data center hardware, to dominate the AI infrastructure market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of NVIDIA AI Enterprise from a component of the Compute & Networking segment in 2022 to a central, monetized software offering by 2024. The description of it being a 'comprehensive suite of enterprise-grade AI software' matches the original answer. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification; thus, quantitative accuracy is not applicable but assumed correct as no incorrect numbers are present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), correctly attributes the strategic shift, and supports it with specific product expansions (NVIDIA NIM, NeMo, AI Blueprints) and integration with hardware like the Blackwell architecture. While the ground truth does not mention Blackwell or these specific tools, these details are consistent with the 2024 10-K and enhance the answer without introducing inaccuracies. (4) The only minor deviation is that the LLM slightly overemphasizes the 2022 positioning by quoting it as already being called a 'comprehensive suite' in 2022, whereas the ground truth implies this characterization became prominent by 2024. However, this does not constitute a factual error but rather a nuance in emphasis. Overall, the answer is factually correct, contextually rich, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 414,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "\n\nPfizer's contractual obligations related to Paxlovid evolved significantly between 2023 and 2024, reflecting a strategic shift from government contracts to commercial markets. In 2023, Paxlovid revenue was heavily reliant on government sales, with $1.279 billion in revenue, but this included a **$3.5 billion non-cash revenue reversal** due to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue surged to **$5.716 billion**, driven by commercial market adoption post-November 2023 and a **$771 million favorable adjustment** from lower-than-expected returns. Additionally, Pfizer supplied 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost, recognizing $442 million in revenue. \n\nThis evolution indicates that while Paxlovid's government-driven peak (e.g., $18.933 billion in 2022) is unlikely to recur, the product retains commercial viability. The transition to commercial markets and ongoing obligations (e.g., SNS contributions) suggest **moderate future revenue expectations**, with deferred Paxlovid-related revenues of $2.2 billion as of December 31, 2024, expected to be recognized through 2028. However, the sharp decline from 2022 levels and reliance on stockpile agreements highlight reduced long-term revenue potential compared to the pandemic-era peak.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $3.5 billion non-cash revenue reversal in 2023 related to expected returns of EUA-labeled Paxlovid from the U.S. government, it incorrectly states that Paxlovid generated $1.279 billion in revenue in 2023—this figure is not supported by the ground truth and conflates partial data. More critically, the claim that Paxlovid revenue surged to $5.716 billion in 2024 is unsupported; the ground truth does not provide total 2024 Paxlovid revenue, only that remaining performance obligations were $1 billion as of December 31, 2024. The $771 million favorable adjustment and $442 million revenue from SNS supply are not mentioned in the ground truth and appear fabricated. The deferred revenue of $2.2 billion through 2028 is also absent from the original answer and contradicts the stated $1 billion in remaining obligations. (2) The only correct numeric elements are the $3.5 billion reversal and the general context of EUA-labeled returns. All other figures—$1.279B, $5.716B, $771M, $442M, $2.2B—are either incorrect or unsupported. The calculation of trends based on these numbers is therefore invalid. (3) The reasoning attempts multi-hop synthesis by connecting revenue reversals, government returns, and commercial transition, which aligns with the question’s intent. However, the logic is built on false quantitative premises, undermining the conclusion. The shift from uncertainty in 2023 to stabilization in 2024 is conceptually correct, but the LLM overreaches by inferring commercial market 'surge' and long-term deferrals not present in the ground truth. (4) Contextual relevance is high because the answer addresses the evolution of contractual obligations and revenue expectations, using appropriate financial terminology and structure. However, the correctness score is low due to severe quantitative inaccuracies that distort the actual situation. The original answer emphasizes stabilization via $1B in remaining obligations post-reversal, while the LLM invents a narrative of commercial resurgence unsupported by the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 585,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "\n\nBetween 2022 and 2024, Google's exposure to international regulatory costs evolved from general compliance risks to more specific, sector-focused challenges, particularly in data privacy and AI governance. In 2022, the focus was on broad regulatory scrutiny (e.g., EU GDPR, U.S.-foreign policy shifts) and uncertainties around compliance costs, with risks tied to data protection laws and potential limitations on business models. By 2024, the scope expanded to include concrete regulations like the EU Digital Markets Act (DMA) and Data Act, which impose strict data portability, interoperability, and user consent requirements. Additionally, AI-related regulations emerged as a key challenge, with evolving obligations around transparency, ethical use, and data governance. The nature of challenges shifted from generalized compliance uncertainties to enforceable, technology-specific rules, reflecting increased global regulatory momentum in AI and digital markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies compared to the ground truth. (1) Correct elements: The answer correctly identifies an evolution in Google's regulatory exposure from broader concerns in 2022 to more specific regulations by 2024, and it appropriately highlights data privacy and AI as growing regulatory areas. The mention of the EU Digital Markets Act (DMA) and Data Act aligns with plausible regulatory developments, though these specific acts are not mentioned in the ground truth. (2) Quantitative accuracy: There are no numeric values in either response, so this dimension is neutral; no errors in dates (2022 and 2024 are correctly referenced). (3) Multi-hop reasoning assessment: The LLM synthesizes a reasonable narrative across years and regulatory domains, but fails to reflect the actual content of the original answer. Crucially, the ground truth emphasizes a shift from data transfer issues (EU-UK) and customer requirements in 2022 to increased uncertainty and risks under local laws lacking due process in 2024 — a qualitative broadening of legal risk, not a shift to AI governance or the DMA. The LLM introduces AI regulation and specific EU legislation not present in the original filings, which misrepresents the actual evolution described. (4) The answer is contextually relevant and well-structured, but the qualitative inaccuracy — introducing unverified regulations and missing the core shift toward legal uncertainty and weak due process — undermines factual correctness. Thus, while the direction of change (increasing complexity) is correctly inferred, the nature and scope of the regulatory challenges are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 460,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "\n\nBetween 2022 and 2023, UPS shifted its funding approach for postretirement medical benefits, reducing contributions to plan trusts while increasing direct corporate funding. In 2022, expected employer contributions to plan trusts for U.S. postretirement medical benefits were $177 million, with $49 million paid directly to participants. By 2023, contributions to plan trusts decreased to $74 million, while payments to participants rose to $92 million. This indicates a strategic reliance on corporate assets (rather than plan trust funding) for a larger portion of benefit payments, likely influenced by the 2023 Teamsters labor agreement updates and ongoing adjustments post-UPS Freight divestiture. Both years maintained the policy of funding legally required amounts, but the 2023 shift reflects a more direct corporate funding approach.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting a shift in UPS's funding approach between 2022 and 2023. The ground truth states that the language in UPS's disclosures remained unchanged, indicating no change in the funding sources (plan trusts and corporate assets). The LLM incorrectly claims a strategic shift toward greater corporate funding and reduced trust contributions. (2) The numeric values cited—$177M and $49M in 2022, $74M and $92M in 2023—are not supported by the ground truth, which does not provide specific contribution amounts. These figures appear fabricated or misattributed, failing the quantitative accuracy test. There is no mention in the original answer of such numbers or trends. (3) The multi-hop reasoning is flawed: the LLM infers a funding shift based on non-existent data and introduces external factors like the '2023 Teamsters labor agreement' and 'UPS Freight divestiture' that are not referenced in the ground truth. This reflects unsupported speculation rather than document-based synthesis. (4) While the answer addresses the question's topic (funding sources for postretirement benefits), it contradicts the core fact of no change between years. The contextual relevance is moderate because it discusses the right subject area but with incorrect details and reasoning. Correctness is severely penalized due to complete factual inaccuracy regarding the evolution (or lack thereof) in funding approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 403,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "\n\nNVIDIA AI Enterprise evolved from a foundational component of its Data Center segment in 2022 to a comprehensive, end-to-end platform for generative AI development and deployment by 2024. Initially introduced as part of NVIDIA's accelerated computing solutions for AI and HPC (2022), it expanded to include specialized tools like **NVIDIA NIM** (for token throughput optimization), **NeMo** (for model customization), and **AI Blueprints** (pre-built templates for secure AI deployment). By 2024, it integrated with **DGX Cloud** for managed AI training-as-a-service and emphasized scalability across enterprise workflows, supported by a growing ecosystem of 5.9 million developers and partnerships with universities/startups. This evolution reflects NVIDIA's strategic shift toward enabling production-grade generative AI applications and strengthening its position in enterprise AI adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: NVIDIA AI Enterprise was introduced in 2022 as a software suite for AI deployment and evolved by 2024 into a full-stack generative AI platform. The inclusion of NVIDIA NIM, NeMo, and AI Blueprints is accurately stated. The 2.5x increase in token throughput from NIM is implied through 'token throughput optimization' though not explicitly quantified—this minor omission prevents a perfect score. (2) Quantitative accuracy is strong: no incorrect numbers are presented. The mention of 5.9 million developers is not in the original answer, but since it doesn't contradict the ground truth and is plausible context, it doesn't count as an error. (3) Reasoning is sound: the answer correctly synthesizes the evolution from a foundational tool to an integrated platform, capturing the multi-hop progression across time and functionality. (4) The response is contextually excellent, directly addressing the role and scope evolution. Only the lack of explicit mention of the 2.5x token throughput improvement—present in the original—keeps this from being fully equivalent. Otherwise, the semantic meaning, entity accuracy (NVIDIA, NIM, NeMo, AI Blueprints, DGX Cloud), and timeline (2022 to 2024) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 363,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "\n\nExxonMobil's proved reserves through equity companies increased from **1,512 million oil-equivalent barrels in 2024** (as detailed in the 2024 10-K) compared to **1,481 million barrels in 2022** (inferred from 2022 operational activities and regional focus). The 2024 data highlights significant reserves in **Asia (1,276 million barrels)** and **Africa (143 million barrels)**, reflecting a strategic emphasis on high-growth regions like Guyana (Americas) and continued investments in Asia’s liquefied natural gas projects. This evolution underscores ExxonMobil’s focus on expanding its footprint in resource-rich, geopolitically stable regions with long-term energy demand, particularly in LNG and unconventional resources.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, ExxonMobil's proved reserves from equity companies were 14 million barrels gross (1 million net), not 1,481 million barrels as claimed. In 2024, the ground truth reports 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas—none of which are accurately reflected in the LLM's claim of 1,512 million oil-equivalent barrels. The LLM invents a unit (oil-equivalent barrels) and aggregates numbers not present in the original data. (2) The quantitative values are entirely incorrect: 1,481M vs. actual 14M in 2022 (over 10x error); 1,512M vs. unreported total in 2024 (the actual sum, if converted to oil-equivalent, would still not support this figure). The regional breakdowns (Asia: 1,276M; Africa: 143M) are fabricated and do not align with the ground truth, which only specifies 'majority of growth in Asia' without exact regional totals. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the source data, misrepresents the time points, and invents metrics. It references a '2024 10-K' but the ground truth does not confirm this document source. The strategic interpretation about Guyana and LNG projects is plausible but unsupported by the provided truth data. (4) While the answer attempts to address the question’s two parts—evolution of reserves and strategic implications—the factual foundation is so inaccurate that the conclusions are invalid. The contextual relevance is moderate because it discusses regions and strategy, but the incorrect numbers and invented figures severely undermine correctness. Quantitative accuracy is extremely low due to fabricated statistics. Qualitative accuracy is low because entity and metric identification is wrong, though the general idea of regional strategic shift is partially aligned. Correctness score is low due to complete mismatch in core data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 537,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "\n\nThe financial relationship with Google Network Partners between 2022 and 2024 evolved with increased Traffic Acquisition Costs (TAC) in absolute terms, rising from $50.9 billion in 2023 to $54.9 billion in 2024, driven by higher revenues. However, the TAC rate as a percentage of revenue decreased from 21.4% to 20.7%, reflecting a shift in revenue mix toward higher-margin Google Search & other properties. Despite this, TAC rates for Google Search increased due to higher-cost mobile searches. The cost of revenues as a percentage of total revenue slightly declined from 43% to 42%, indicating improved efficiency. Revenue generation through Network Partners remained significant but with a reduced proportional cost burden, supporting margin stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The original answer emphasizes a shift in financial reporting and framing of Google Network Partners from a revenue-centric (gross reporting) model in 2022 to a cost-centric (cash flow impact) focus in 2024. The LLM instead introduces specific quantitative data (e.g., TAC of $50.9B in 2023, $54.9B in 2024, TAC rates of 21.4% and 20.7%) that are not present in the ground truth and cannot be verified from the provided context. There is no mention of Traffic Acquisition Costs (TAC), TAC rates, or cost of revenues as a percentage of total revenue in the original answer. (2) The numbers cited (e.g., $50.9B, 21.4%, etc.) are entirely absent from the ground truth, making the quantitative claims unsupported and likely fabricated. The years 2023 and 2024 are referenced with precise figures, but the original only compares 2022 and 2024 without providing dollar amounts. (3) The multi-hop reasoning is flawed: the LLM invents a narrative around efficiency and margin stability based on non-existent metrics rather than capturing the actual evolution in accounting treatment and reporting emphasis. It misses the key point about gross revenue reporting in 2022 and the shift to emphasizing cash outflows in 2024. (4) While the LLM attempts to address revenue generation and cost structure, it does so with incorrect data and framing, reducing contextual relevance. The core evolution described in the ground truth—reporting philosophy and cash flow emphasis—is entirely missing. Hence, the correctness score is low due to major factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 446,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "\n\nBetween 2022 and 2023, UPS's financial impact from undesignated foreign currency forward contracts on earnings volatility decreased significantly. In 2022, these contracts resulted in a $69 million loss recognized in \"Investment income and other,\" whereas in 2023, the loss was reduced to $7 million. This reduction suggests improved risk management strategies, such as more frequent termination or offsetting of contracts, as noted in the 2023 filing, which minimized earnings fluctuations from foreign exchange rate movements. The 2023 filing also highlights that non-designated derivatives are marked-to-market through earnings, but the smaller 2023 loss indicates greater stability in managing these exposures compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative inaccuracy: The LLM claims specific losses of $69 million in 2022 and $7 million in 2023 from undesignated foreign currency forward contracts, but the original answer (ground truth) contains no such numbers. There is no mention of 'Investment income and other' or any dollar amounts related to these contracts in the ground truth, making these figures fabricated. (2) The original answer focuses on the evolution of disclosure practices and transparency—not actual financial results or risk reduction. It states that UPS improved its reporting by introducing side-by-side presentation of fair value changes and settlements for 2023 and 2022, with an emphasis on how undesignated derivatives affect earnings volatility. The LLM incorrectly interprets this as a reduction in actual losses and attributes it to improved risk management, which is not supported by the ground truth. (3) Multi-hop reasoning failure: The LLM conflates enhanced disclosure with improved financial performance, failing to recognize that the evolution is in transparency and presentation, not in the underlying risk or realized gains/losses. (4) While the LLM correctly identifies that undesignated derivatives impact earnings through fair value changes (mark-to-market), this is a generic accounting principle and not specific to UPS's 2022–2023 evolution as described in the ground truth. The contextual relevance is moderate because it addresses foreign currency forward contracts and earnings volatility, but the core factual claims are unsupported. Thus, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 462,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "\n\nBetween 2022 and 2023, Costco's membership format remained central to its profitability strategy, emphasizing member loyalty and fee revenue. In 2022, the focus was on expanding the membership base, increasing Executive membership penetration, and maintaining high renewal rates, which directly supported recurring fee revenue. By 2023, the company highlighted challenges to renewal rates in newer international markets, while reiterating the importance of sustaining loyalty through competitive membership benefits. Additionally, Costco noted that warehouse openings in existing markets could adversely affect paid membership growth, underscoring a strategic emphasis on balancing expansion with preserving the value proposition for existing members. Fee revenue continued to serve as a stable income stream, complementing sales growth and reinforcing profitability amid operational and market challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the centrality of the membership model to profitability, emphasis on membership base growth, Executive member penetration, and renewal rates in 2022; the continued importance in 2023; and the emergence of concerns about renewal rates in newer (particularly international) markets. The mention of warehouse openings in existing markets affecting paid membership growth adds contextual nuance consistent with the strategic balancing act described in the original. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—however, the absence of fabricated or incorrect figures earns full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the role of the membership format evolved from a growth-focused driver in 2022 to one that still underpins profitability in 2023 but now faces expansion-related challenges. The inference about balancing expansion with value preservation is logically consistent with the original’s mention of risks to worldwide renewal rates from newer markets. (4) The only minor gap is that the LLM slightly rephrases the evolution of language from 2022 to 2023 (e.g., 'integral part of our business and has a significant effect' vs. 'integral part of our business and profitability') without directly quoting or highlighting the tightening of language, which was a specific detail in the ground truth. However, the semantic meaning is preserved. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 465,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "\n\nNVIDIA's approach to CUDA between 2022 and 2024 evolved significantly in integration within the data center platform and software ecosystem. By 2024, CUDA's role expanded beyond GPUs to encompass a full-stack architecture, including CPUs (introduced in FY2024) and DPUs, enabling optimized computing, networking, and storage solutions (NVDA_10k_2024.pdf, p. 6). The launch of the Blackwell architecture in FY2025 (2024 context) further unified these components for generative AI and accelerated computing workloads, emphasizing hardware-software synergy (p. 6, 8). Additionally, CUDA's ecosystem grew from ~3 million developers in 2022 (p. 11) to 5.9 million by 2024 (p. 7), supported by enhanced software tools like NVIDIA AI Enterprise (NIM, NeMo) and DGX Cloud, which streamlined AI model development and deployment. This reflects a strategic shift toward a cohesive, end-to-end platform integrating CUDA across diverse data center applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of CUDA from a developer-focused tool in 2022 (~3 million developers) to a full-stack infrastructure layer by 2024. The figure of 5.9 million developers by 2024 is consistent with the source (NVDA_10k_2024.pdf, p.7), though this specific number is not in the original answer; however, growth in developer base is correctly emphasized. (2) Quantitatively, the ~3 million developer count in 2022 matches the original answer. The 5.9 million figure in 2024 is plausible and documented in the cited filing, representing strong quantitative accuracy—minor discrepancy is acceptable as the original answer does not specify the 2024 number. (3) The qualitative reasoning is sound: the LLM correctly synthesizes CUDA’s expansion into a full-stack platform integrating GPUs, CPUs, and DPUs, referencing the Blackwell architecture and CUDA-X ecosystem (implied in 'full-stack architecture'). It accurately reflects the strategic shift toward enterprise-scale, end-to-end solutions. (4) Contextual relevance is excellent—the response directly addresses the evolution of CUDA’s integration in data centers and software ecosystems, citing specific programs (NVIDIA AI Enterprise, NIM, NeMo, DGX Cloud) and architectural advances. The only reason for not scoring a 10 is that the original answer emphasizes CUDA-X, APIs, SDKs, and domain-specific frameworks more explicitly, while the LLM mentions related tools but could have more directly named 'CUDA-X' as the structural evolution. Overall, the answer demonstrates strong multi-hop reasoning and factual consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 453,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "\n\nPfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2023 to 2024. In 2023, Paxlovid revenue was heavily reliant on government contracts, with $1.279 billion in revenues, but this included a **$3.5 billion non-cash revenue reversal** in Q4 2023 due to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue surged to **$5.716 billion**, driven by transition to commercial markets (post-EUA) and a **$442 million revenue recognition** for supplying 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost. \n\nContractual obligations shifted from bulk government deliveries to commercial sales and stockpile commitments, with **remaining performance obligations** for Paxlovid totaling **$1 billion as of December 31, 2024**, to be recognized through 2028. Deferred revenues for Paxlovid declined sharply from **$5.1 billion in 2023 to $2.2 billion in 2024**, reflecting revenue recognition from product deliveries and a **$771 million favorable adjustment** in Q1 2024 due to fewer returned EUA-labeled courses than estimated. This evolution highlights a strategic pivot from government-funded pandemic response to sustained commercial and stockpile-driven revenue streams.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, despite capturing the general trend of Pfizer's shift from government to commercial sales and reduced uncertainty in Paxlovid revenue. The ground truth states a $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of 6.5 million treatment courses — this part is correctly included. However, the LLM claims Paxlovid revenue in 2024 was $5.716 billion, which is not supported by the original answer and introduces unverified data. The original answer does not provide total 2024 Paxlovid revenue, only remaining performance obligations of $1 billion. Similarly, the $1.279 billion 2023 revenue figure is not in the ground truth and appears fabricated. The $442 million revenue recognition for SNS delivery and $771 million favorable adjustment in Q1 2024 are also absent from the original answer and cannot be verified. The deferred revenue figures ($5.1B in 2023, $2.2B in 2024) and their interpretation are not mentioned in the ground truth, indicating significant hallucination of financial data. (2) While the $3.5 billion reversal and $1 billion remaining performance obligations (as of end-2024) are correct and properly contextualized, other numbers are either invented or misaligned. The calculation of a 'favorable adjustment' or specific revenue from SNS delivery lacks grounding. (3) The multi-hop reasoning is partially sound — the model correctly infers a strategic shift from pandemic-era government reliance to commercial and long-term contractual revenue, and correctly identifies that remaining obligations of $1 billion are to be recognized from 2025–2028 (implied from original). However, it overreaches by introducing unsupported figures to bolster this narrative. (4) The contextual relevance is high because the answer addresses financial commitment evolution, revenue outlook, and delivery timelines. The qualitative reasoning about strategic pivot is aligned with the original. However, the quantitative accuracy is low due to multiple incorrect or hallucinated figures, which undermines the correctness score despite correct identification of the $3.5B reversal and $1B forward obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 593,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "\n\nExxonMobil's strategic emphasis on Guyana evolved from focusing on reserves development in 2022 to solidifying its position as a core advantaged asset in 2024. In 2022 disclosures (pages 13–14), Guyana was highlighted for additions to proved undeveloped reserves through discoveries and extensions, with investments directed toward long-term project development. By 2024 (pages 37, 42), Guyana was explicitly listed as a key component of \"Advantaged Assets\" within the Company's earnings driver framework, reflecting its role in driving high-return growth through sustained production and integration into upstream operations. This shift underscores a transition from reserve accumulation to leveraging Guyana's mature asset base for consistent, low-cost output and strategic value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Guyana's role in adding reserves in 2022 (~1.3 billion oil-equivalent barrels, though the exact number is omitted in the LLM response, it is not contradicted) and its elevation to 'Advantaged Assets' in 2024 are correctly reported. The strategic evolution from reserves growth to advantaged production and earnings contribution is accurately captured. (2) Quantitative accuracy is strong—while the specific 1.3 GOEB figure is not mentioned, no incorrect numbers are presented, and the absence does not distort the meaning. The focus on proved undeveloped reserves and asset advantage is consistent with the original. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2024 disclosures, correctly identifying the shift in strategic framing from reserves development to earnings-driven advantaged asset status. The use of page references (13–14, 37, 42) suggests accurate sourcing. (4) Semantic equivalence is maintained—phrasing like 'high-return growth' and 'low-cost output' aligns with 'advantaged production and earnings visibility.' The only minor shortcoming is the omission of the specific reserve addition figure (1.3 billion), which slightly reduces completeness but does not impair the core correctness. Hence, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 382,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "\n\nThe planned utilization of the ATR 72-600F aircraft decreased significantly from 2022 to 2024. In 2022, FedEx had committed to purchasing 24 ATR 72-600F aircraft across 2023–2026 (11 in 2023, 6 in 2024, 6 in 2025, and 1 in 2026). By 2024, commitments were reduced to 10 aircraft, with deliveries scheduled for 2025 (7) and 2026 (3), and no further plans beyond 2026. This reduction indicates a scaled-back role for the ATR 72-600F in FedEx’s fleet strategy, likely reflecting a shift toward optimizing regional freight capacity, prioritizing other aircraft types, or adjusting to evolving operational or market demands.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numbers and timeline compared to the ground truth. The original answer states that in 2022, the plan was for ATR 72-600F units to drop from 11 in 2023 to just 1 by 2026, but the LLM claims FedEx committed to purchasing 24 aircraft with 11 in 2023, 6 in 2024, 6 in 2025, and 1 in 2026 — this breakdown is not supported by the ground truth and introduces specific delivery numbers per year that were not in the original. The 2024 update in the original shows a stabilization at 7 units for 2025 and 3 by 2026, which the LLM captures approximately (7 in 2025, 3 in 2026), though it frames this as 'deliveries' rather than 'planned units', conflating procurement with fleet utilization. (2) The quantitative accuracy is compromised because the LLM invents a 24-aircraft purchase commitment and annual delivery schedule not present in the ground truth. The original does not mention 'purchasing' or 'deliveries' but rather 'planned units' in the fleet, a critical distinction. The shift from 11 to 1 by 2026 (2022 plan) vs. 7 in 2025 and 3 in 2026 (2024 plan) is partially reflected, but the LLM misrepresents the nature and timing of the data. (3) The reasoning is logically structured and correctly infers a strategic shift toward a more sustained role despite reduction, aligning with the original's conclusion about a less rapid phaseout. It identifies the trend of scaling back but overemphasizes the reduction without noting the relative increase compared to earlier projections (i.e., having 3 units in 2026 instead of 1 is a significant upward revision). (4) Contextual relevance is high — the answer addresses fleet strategy evolution and draws reasonable implications about operational adjustments. However, due to incorrect numerical foundations and mischaracterization of the data as purchase commitments rather than fleet utilization plans, the correctness score is limited to 6 — partially correct but with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 544,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "\n\nBetween 2022 and 2024, NVIDIA's approach to Omniverse evolved from a 3D design collaboration platform to a more integrated component of its AI and simulation ecosystems. In 2022, Omniverse was primarily positioned as a tool for real-time 3D design and virtual world simulation, enabling collaboration in applications like virtual car showrooms and surgical training (NVDA_10k_2022.pdf, pages 6, 9). By 2024, Omniverse was deeply integrated with NVIDIA's AI and autonomous vehicle platforms, such as DRIVE Hyperion, to generate synthetic data for AI model training and validate self-driving systems (NVDA_10k_2024.pdf, pages 6, 7). Additionally, Omniverse expanded its role in cloud-based digital twin applications, robotics testing, and enterprise workflows, leveraging NVIDIA's accelerated computing infrastructure and the Blackwell architecture for enhanced performance in generative AI and simulation workloads (NVDA_10k_2024.pdf, pages 6, 8). This reflects a strategic shift toward embedding Omniverse as a core element of NVIDIA's end-to-end AI and simulation solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, Omniverse was a 3D collaboration platform used in virtual car showrooms and surgical training; by 2024, it evolved into a more comprehensive simulation and digital twin platform integrated with AI and autonomous systems. The mention of DRIVE Hyperion, synthetic data for AI training, robotics testing, and cloud-based digital twins matches the evolution described in the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way—no numbers were misstated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022 and 2024 timeframes, identifies the shift in strategic positioning, and links Omniverse to NVIDIA's broader AI and computing infrastructure (e.g., Blackwell architecture, accelerated computing). (4) The only minor shortcoming is that the LLM answer emphasizes integration with specific platforms like DRIVE Hyperion and Blackwell more than the original answer does, which could be seen as adding detail beyond the source or slightly overemphasizing technical components not explicitly highlighted in the ground truth. However, this does not make it factually incorrect—it's a richer elaboration consistent with the direction of evolution. Overall, the answer is semantically equivalent, contextually relevant, and factually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 418,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "\n\nBetween 2022 and 2023, Google Play's role in generating non-advertising revenue remained a key contributor, with continued emphasis on app sales, in-app purchases, and digital content through the Google Play store. Both the 2022 and 2023 filings highlight that non-advertising revenues (including Google Play) grew as part of broader trends toward diversification, such as Google Cloud, hardware, and YouTube subscriptions. The 2023 10-K explicitly notes that Google Play is categorized under \"platforms\" within the Google Subscriptions, Platforms, and Devices segment, reflecting its ongoing significance. However, margins on non-advertising revenues, including Google Play, remained lower compared to advertising revenues in both years, consistent with prior disclosures. No material shift in Google Play's strategic role or performance was indicated between the two periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of entity accuracy and contains no incorrect numbers or dates (quantitative accuracy is high because no specific figures were cited in either answer, and the LLM does not fabricate any). However, the core discrepancy lies in the qualitative assessment of Google Play's evolution: the Original Answer identifies a strategic shift between 2022 and 2023—specifically, a transition from being part of a diversification strategy to becoming a more defined and structured revenue stream under 'platforms'—indicating a material evolution in its role. In contrast, the LLM Answer explicitly states that 'no material shift in Google Play's strategic role or performance was indicated,' which directly contradicts the ground truth. This represents a failure in multi-hop reasoning and synthesis: while the LLM correctly notes the 2023 categorization under 'platforms,' it downplays the significance of this change, missing the strategic evolution emphasized in the original. The contextual relevance is high because the response addresses the timeframe, the platform, and non-advertising revenue, but the conclusion undercuts the key insight. Thus, while the answer contains accurate elements, it fails to correctly interpret the evolution, leading to a partially correct (score 5) overall assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 371,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "\n\nBetween 2022 and 2023, AIG's use of expected loss ratio methods in workers' compensation reserving showed nuanced evolution. For **guaranteed cost business**, expected loss ratio methods remained weighted primarily in the **most recent accident year**, as noted in 2022, with continued emphasis on development methods due to consistent loss patterns. For **excess of deductible business**, these methods retained significant weight in the **most recent five accident years**, as highlighted in both years. However, in 2023, AIG emphasized adjustments for **rate changes, loss trends (including inflation), and market conditions** when setting expected loss ratios for recent accident years, reflecting heightened sensitivity to evolving factors like medical cost inflation and slower claims emergence from increased high-deductible policies. Additionally, 2023 disclosures noted updates to payout patterns and discount rates tied to U.S. Treasury rates, indirectly influencing the application of expected loss ratios for long-tail liabilities. Thus, while the core methodology remained consistent, 2023 saw greater explicit alignment with dynamic economic and operational trends.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core aspects of AIG's use of expected loss ratio methods in workers' compensation reserving for both 2022 and 2023, with accurate entity and time period alignment. It correctly states that for guaranteed cost business, expected loss ratio methods were primarily used in the most recent accident year, and for excess of deductible business, they were used in the most recent five accident years—matching the ground truth. These key structural points are factually correct, supporting a high quantitative accuracy score. However, the LLM introduces details not present in the original answer, such as 'adjustments for rate changes, loss trends (including inflation), and market conditions' and 'updates to payout patterns and discount rates tied to U.S. Treasury rates,' which were not mentioned in the ground truth. While plausible, these represent inferred enhancements rather than documented changes from the filings. The ground truth emphasizes a reporting change—incurred and paid losses presented net of reinsurance and undiscounted in 2023—as a transparency refinement, which the LLM omits. This is a significant qualitative omission affecting completeness and reasoning accuracy. The LLM also does not mention the accelerating settlements due to claims strategy changes in 2022 or the continued slowing of claims reporting due to large deductible business in 2023, both of which are key contextual elements. While the overall methodology consistency is correctly noted, the absence of these specific disclosures and the addition of unsupported refinements reduce the qualitative accuracy. The answer remains contextually relevant and well-structured, addressing the evolution question with appropriate focus on both business lines and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 484,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "\n\nCisco's product category segmentation evolved between fiscal 2022 and 2024, with the **Collaboration category** undergoing structural and performance changes. In fiscal 2022, Collaboration revenue was $4.5 billion, part of a six-category structure (e.g., Secure, Agile Networks, Internet for the Future), and saw a 5% decline year-over-year due to weaker demand for Collaboration Devices and Meetings. By fiscal 2024, Cisco reorganized its categories into **Networking, Security, Collaboration, and Observability**, consolidating and redefining segments. Under this new structure, Collaboration revenue in fiscal 2024 was $4.1 billion, reflecting a 9% decline in fiscal 2023 (driven by declines in Meetings and Devices) followed by a modest 2% recovery in fiscal 2024, supported by growth in Contact Center and CPaaS offerings. The category’s revenue decreased by 8% overall from fiscal 2022 to 2024, highlighting shifting product dynamics and strategic realignment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several specific financial figures (e.g., $4.5B in 2022, $4.1B in 2024, 5% decline, 9% decline, 2% recovery, 8% overall drop) and performance trends that are not present in the original ground truth answer. The ground truth does not mention any revenue numbers, percentage changes, or performance drivers for the Collaboration category. These quantitative details appear to be hallucinated or sourced from outside the provided knowledge graph, making them factually unsupported. (2) The qualitative structure of the answer—Cisco consolidating from six to four product categories and retaining Collaboration while introducing Observability—is consistent with the ground truth. The reorganization into Networking, Security, Collaboration, and Observability is correctly identified, as is the removal of categories like Internet for the Future and Optimized Application Experiences. However, the LLM adds granular performance analysis (e.g., Contact Center and CPaaS growth) that is not in the original. (3) The multi-hop reasoning is partially sound: the model correctly infers a structural evolution between fiscal 2022 and 2024 and identifies the continuity of Collaboration amid broader consolidation. However, it overreaches by introducing unsupported financial metrics and year-over-year dynamics, undermining the factual integrity. (4) The contextual relevance is high because the answer directly addresses the evolution of product segmentation and the role of Collaboration. However, the correctness score is low due to the inclusion of fabricated quantitative data. While the structural narrative aligns with the ground truth, the addition of unverified numbers and trends significantly reduces factual accuracy. Quantitative accuracy is penalized heavily because all financial figures and percentages are unsupported. Qualitative accuracy is moderate due to correct entity and category identification but docked for unsupported reasoning. Contextual relevance remains strong as the response stays focused on the question's core.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 557,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "\n\nAmgen's disclosure regarding the 3.125% 2025 Notes evolved between 2022 and 2023 as follows:  \n\nIn **2022**, the Notes were presented at their fixed coupon rate of 3.125% with no mention of hedging or swaps, and their effective interest rate was assumed to align with the coupon rate (as no material differences were noted in the disclosure). By **2023**, Amgen explicitly disclosed an interest rate swap for the 3.125% 2025 Notes, converting the fixed-rate coupon to a floating-rate basis tied to **SOFR + 2.1%**. This reflects a shift in the interest rate framework from a purely fixed-rate structure to a hedged, floating-rate framework, enhancing transparency about the Notes' effective cost and risk management strategy. The 2023 disclosure also clarified the notional amount ($1.0 billion) under the swap, which was absent in 2022.  \n\nThis evolution highlights Amgen's adoption of hedging instruments to manage interest rate exposure for these Notes in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right question and showing relevant reasoning. (1) Quantitatively, the LLM correctly identifies the $1,000 million (or $1.0 billion) notional amount and the 3.125% coupon rate, which aligns with the ground truth. However, it incorrectly claims that in 2023, Amgen disclosed an interest rate swap converting the fixed-rate note to SOFR + 2.1%. The ground truth states that the 2023 disclosure added a new table showing the interest rate mechanism as SOFR + 2.1%, but does not mention a swap or hedging activity—this is a critical misrepresentation. (2) The ground truth makes no reference to hedging instruments, swaps, or changes in interest rate structure; rather, it describes an evolution in disclosure transparency, not a change in financial structure. The LLM fabricates the existence of a swap, which is not supported by the original data. (3) The qualitative reasoning is partially sound in identifying a shift toward greater transparency, but the multi-hop synthesis fails because it infers operational changes (hedging) not present in the source. Instead of recognizing that the interest rate framework disclosure was added for clarity, the model incorrectly attributes this to an active risk management strategy. (4) Contextually, the answer is well-structured and relevant, focusing on the right documents and years, and interpreting the significance of enhanced disclosure. However, the introduction of unsupported financial engineering (swaps) severely compromises factual accuracy. While the direction of evolution (increased detail) is correctly perceived, the nature of the change is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 467,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "\n\nConocoPhillips' (COP) natural gas reserves in the Asia Pacific/Middle East region decreased from **326 billion cubic feet (BCF)** at the end of 2022 to **296 BCF** by the end of 2024, a reduction of 30 BCF. This decline reflects lower developed reserves (down from 322 BCF to 289 BCF) despite a slight increase in undeveloped reserves (from 4 BCF to 7 BCF). The reduction is primarily attributed to production outpacing additions and downward revisions. However, COP's equity affiliate reserves in the region rose modestly from **5,753 BCF** to **5,870 BCF** over the same period. \n\nThis trend suggests COP is strategically reducing direct ownership in the region while maintaining a presence through equity partnerships. This approach may mitigate operational and political risks in a volatile area (as noted in COP's 2024 10-K Risk Factors), allowing the company to leverage joint ventures for regional exposure without bearing full development costs or geopolitical uncertainties. The shift underscores a focus on capital efficiency and risk management in the Asia Pacific/Middle East.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core numbers from the ground truth: COP's natural gas reserves decreased from 326 BCF in 2022 to 296 BCF in 2024, a 30 BCF reduction. These figures match the original answer exactly and are accurately presented. However, the LLM introduces additional data not present in the ground truth—specifically, the breakdown into developed (322 to 289 BCF) and undeveloped reserves (4 to 7 BCF), and equity affiliate reserves increasing from 5,753 to 5,870 BCF. Since these figures are not in the original knowledge base answer, their inclusion introduces unverified information, which affects factual accuracy. (2) The calculation of the 30 BCF decrease is correct (326 - 296 = 30), and the directional changes (decline in reserves) are accurate. However, the model performs additional analysis (e.g., production outpacing additions, downward revisions) that, while plausible, are not supported in the ground truth and represent inference beyond the provided data. (3) The multi-hop reasoning is partially sound—the model correctly tracks the change over time and identifies a strategic implication. However, the conclusion about shifting to equity partnerships due to risk mitigation goes beyond the original answer, which only suggests a 'potential strategic shift or divestment' without specifying the mechanism. This over-interpretation weakens qualitative accuracy. (4) Despite the extra details and slight overreach in reasoning, the LLM captures the essential evolution and strategic implication, making the answer largely relevant and factually grounded on the key points. Hence, scores are high but not perfect due to unsupported specifics and minor over-extrapolation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 468,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "\n\nAlphabet's repurchase activity of Class C Capital Stock increased from $52.58 billion in 2022 to $52.87 billion in 2023, while the number of shares repurchased decreased slightly from 469 million to 450 million. This indicates higher average repurchase prices in 2023, likely due to stock price appreciation. The total share repurchases (Class A and C combined) rose from $59.3 billion in 2022 to $62.2 billion in 2023, reflecting an accelerated capital return strategy. Alphabet’s authorization of an additional $70 billion in repurchases in April 2023 further underscores its commitment to allocating capital toward share buybacks, signaling confidence in long-term value and prioritizing shareholder returns amid strong cash flow generation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect numeric values. It incorrectly states that Alphabet repurchased $52.58 billion of Class C stock in 2022 and $52.87 billion in 2023. However, the ground truth does not provide a breakdown between Class A and Class C repurchases—only the combined total of $59.3 billion in 2022 and $62.2 billion in 2023. Therefore, assigning specific dollar amounts to Class C alone is factually unsupported and inaccurate. Additionally, the claim that 469 million and 450 million shares were repurchased is not present in the ground truth and cannot be verified, introducing fabricated granular data. (2) While the total repurchase figures of $59.3 billion (2022) and $62.2 billion (2023) for Class A and C combined are correctly cited, the LLM misattributes part of this total to Class C specifically without evidence. The $70.0 billion authorization in April 2023 and $36.3 billion remaining as of December 31, 2023, are accurately mentioned. (3) The reasoning about increased capital return and shareholder prioritization is sound and aligns with the multi-hop logic—connecting higher buyback totals and new authorizations to strategic capital allocation. The interpretation of stock price appreciation leading to fewer shares bought at higher prices is plausible but speculative without direct data on average prices or volume. (4) Despite the incorrect breakdown of repurchase amounts by share class and unsupported share counts, the LLM captures the overall trend and strategic implication correctly. Hence, the answer is partially accurate with significant quantitative flaws but strong qualitative and contextual reasoning. Correctness score is 7 due to core factual accuracy on total repurchases and strategy, but penalized for inventing unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 494,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "\n\nBetween 2022 and 2023, AIG expanded the application of frequency/severity methods to address inconsistencies in loss development patterns and evolving risk profiles. In 2022, these methods were primarily used for short-tail lines like **U.S. Property** (e.g., commercial and industrial insurance) due to their predictable claim emergence. By 2023, AIG extended their use to **U.S. Workers’ Compensation**, a long-tail line, where loss emergence spans decades and reporting patterns are complicated by risk-sharing features (e.g., high deductibles, self-insured retentions). This shift reflects a strategic adaptation to handle increased complexity in claim reporting, particularly for large deductible business, which slowed claim emergence and required more granular segmentation (e.g., by deductible size and third-party administration). The reasoning centered on improving reliability in reserve estimation for lines with inconsistent development or high severity, leveraging frequency/severity methods to stabilize projections amid evolving underwriting structures and economic factors like inflation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully aligned with the ground truth in both factual content and reasoning. (1) All key facts are correct: in 2022, frequency/severity methods were used primarily for short-tail lines like U.S. Property, and by 2023, they were extended to U.S. Workers’ Compensation, a long-tail line. The avoidance of aviation due to high severity in 2022 is implied through contrast with the expansion into complex lines, though not explicitly stated; however, this omission does not detract from the core accuracy as the focus is on evolution and expansion. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the answer correctly synthesizes the shift across years, lines of business, and underlying rationale involving risk-sharing features, large deductibles, and claim emergence complexity. It accurately reflects AIG’s strategic adaptation to more complex environments. (4) The LLM adds contextual depth—such as segmentation by deductible size and third-party administration, and the impact of inflation—that enriches the original answer without introducing inaccuracies. The semantic meaning fully matches the ground truth, with equivalent or enhanced clarity. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 375,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "\n\nAmgen's financial relationship with BeiGene from 2022 to 2023 shows the following evolution:  \n- **Cost Recovery**: Net costs recovered from BeiGene decreased from $199 million in 2022 to $109 million in 2023, reflecting reduced shared R&D expenses as certain programs advanced beyond the cost-sharing phase.  \n- **Product Sales**: Sales of collaboration products to BeiGene rose significantly, from $64 million in 2022 to $125 million in 2023, likely driven by increased supply of therapies like KYPROLIS and BLINCYTO for commercialization in China.  \n- **Profit and Loss Sharing**: Profit-sharing expenses declined from $53 million in 2022 to $40 million in 2023, indicating either lower initial commercialization profits or transitions of product rights to Amgen, shifting from profit-sharing to royalty-based arrangements.  \n\nThese trends align with the collaboration structure, where cost and profit sharing diminish as products progress, replaced by royalty payments post-commercialization.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all figures are accurate: $199M to $109M cost recovery (correct decrease), $64M to $125M product sales (correct increase), and $53M to $40M profit and loss sharing expenses (correct decrease). These values exactly match the original answer, with acceptable formatting. (2) The answer is complete, addressing all three financial dimensions (cost recovery, product sales, profit and loss sharing) across both years as required. (3) Entities are correctly identified—Amgen and BeiGene—and the time frame (2022 to 2023) is accurately referenced. (4) The reasoning is sound and adds valuable context: the decline in cost recovery and profit-sharing is logically tied to the maturation of the collaboration, with increased product sales suggesting a shift toward commercialization and potential transition to royalty-based arrangements. The mention of specific drugs (KYPROLIS and BLINCYTO) and the China market aligns with known details of the collaboration and enhances plausibility. The multi-hop synthesis—linking changes in financial flows to the stage of partnership development—is well-executed. (5) Semantic equivalence is strong: while the LLM provides slightly more interpretive detail, the core facts, trends, and implications match the original answer precisely. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 391,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "\n\nFrom 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region decreased from **326 billion cubic feet (BCF)** to **296 BCF**, reflecting a net reduction of 30 BCF. Key changes during this period include:  \n- **Revisions**: Net upward revisions of **6 BCF (2022–2023)** and **9 BCF (2023–2024)**, driven by technical adjustments and development timing.  \n- **Production**: Cumulative production reductions of **49 BCF** (24 BCF in 2022–2023 and 25 BCF in 2023–2024).  \n- **Purchases**: No significant purchases occurred in 2022–2023, but **$1.5 billion in purchases** (primarily in Africa) were recorded in 2023–2024, though these did not directly impact the Asia Pacific/Middle East region.  \n\nThe decline was primarily offset by revisions but ultimately driven by production drawdowns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting and ending reserve volumes (326 BCF in 2022 and 296 BCF in 2024), which matches the ground truth. However, it introduces inaccuracies in the breakdown of revisions and production. The ground truth states that revisions in 2023 added 9 BCF and production in 2024 subtracted 25 BCF. The LLM claims 9 BCF revisions from 2023–2024 (partially correct) but also adds 6 BCF for 2022–2023, which is not supported by the original answer. Additionally, the LLM reports cumulative production of 49 BCF (24 + 25), but the ground truth only specifies 25 BCF subtracted in 2024—no production figure is given for 2022–2023. This leads to unsupported inference. (2) The mention of $1.5 billion in purchases in 2023–2024 is factually incorrect in context: the ground truth explicitly states no purchases affected the Asia Pacific/Middle East region in 2024 and implies no such activity in the period. While the LLM correctly notes these purchases did not impact the region, the introduction of a dollar amount and African purchases is extraneous and unsupported in the provided truth. (3) The multi-hop reasoning is partially sound—reserves decreased, revisions added some volume, production reduced it—but the model overextends by inferring production and revision data for 2022–2023 that are not in the source. It also fails to align the timing of events strictly with the original timeline. (4) Despite these issues, the core trend (decline from 326 to 296 BCF) and the explanation that production drove the decline while revisions provided partial offset are consistent with the original. The answer is relevant and structured well, but quantitative inaccuracies and unsupported details reduce its correctness. Hence, a score of 6/10 is justified—partially correct but with significant factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 502,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "\n\nFedEx's planned usage of the B767F aircraft decreased from 2022 to 2024, with commitments shifting from 14 deliveries in 2023 and 14 in 2024 (total 28) in 2022 to only 11 in 2025 and 3 in 2026 (total 14) by 2024. This reduction indicates a strategic adjustment to optimize fleet planning, likely reflecting efforts to align capacity with demand, manage costs, or prioritize other aircraft types amid evolving operational or financial priorities. The decline in both delivery volumes and associated deposits ($1.3 billion in 2022 vs. $611 million in 2024) underscores a more cautious approach to fleet expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend of decreasing planned B767F usage over time and captures the strategic implication of reduced reliance. However, there are key quantitative inaccuracies. In 2022, FedEx projected 14 aircraft for both 2023 and 2024, not '14 deliveries in 2023 and 14 in 2024' as the LLM states — these are not deliveries but planned usage numbers. The LLM incorrectly frames them as 'deliveries' and calculates a total of 28, which is not supported by the ground truth. The updated 2024 projection correctly notes 11 for 2025 and 3 for 2026, but again, these are not framed as deliveries. (2) The dollar amounts mentioned — $1.3 billion in 2022 vs $611 million in 2024 — are not present in the original answer or context provided, making them factually unsupported. This introduces extraneous data not in the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward accelerated reduction in B767F usage. It synthesizes the change in projections across years and draws a reasonable conclusion about fleet optimization. However, the introduction of 'deliveries' and financial figures not in the original answer reflects flawed reasoning or hallucination. (4) Despite these issues, the core message — that FedEx is accelerating its reduction of B767F aircraft — is correct, and the strategic interpretation is valid. Hence, correctness is scored at 7 for accurate direction and reasoning but penalized for significant numerical and factual errors. Quantitative accuracy is lower due to incorrect framing and unsupported financial figures. Qualitative and contextual scores are higher because the logic and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 478,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "\n\nBetween 2022 and 2023, AIG expanded the application of **Expected Loss Ratio (ELR) Methods** to newer accident years and more complex lines of business, particularly those with limited historical loss data or recent market changes. In 2022, ELR methods were primarily used for the **latest accident year** in short-tail lines like **U.S. Property** and **Special Risk** (e.g., aerospace, environmental) to set reserves, supported by ground-up claim projections. By 2023, AIG emphasized using ELR methods for the **most recent five accident years** in lines with excess-of-deductible structures (e.g., **U.S. Workers’ Compensation**, **Excess Casualty**), where loss emergence is slow or inconsistent. The reasoning evolved to include adjustments for **rate changes, inflation, and market conditions**, reflecting greater sensitivity to emerging trends and risk-sharing features (e.g., high deductibles). This expansion aimed to improve accuracy in volatile or evolving segments, such as those impacted by reinsurance terms or economic shifts.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in AIG's use of Expected Loss Ratio (ELR) Methods between 2022 and 2023 with reasonable accuracy but introduces some details not present in the ground truth and omits key specifics. (1) Correct elements: The shift from 2022 to 2023 in applying ELR methods to more recent accident years and extending into complex, long-tail lines like U.S. Workers’ Compensation aligns with the original answer. The mention of structural complexity (e.g., high deductibles, risk-sharing) and external factors like inflation and rate changes reflects accurate qualitative reasoning. (2) Quantitative accuracy: The claim that ELR was applied to the 'most recent five accident years' in 2023 is a specific detail not found in the ground truth, which only states 'latest accident year' in 2022 and broader application in 2023 without specifying a five-year window—this is a minor overprecision. No numerical values (e.g., percentages, dollar amounts) are involved, so scoring is based on temporal and scope claims. (3) Multi-hop reasoning: The model correctly infers a strategic shift in methodology driven by loss emergence patterns and market dynamics, synthesizing across lines of business and time. However, it incorrectly identifies 'U.S. Property' and 'Special Risk' as primary 2022 applications, while the ground truth emphasizes 'aviation exposures' within a high-severity context. Also, the original answer specifically highlights aviation and Workers’ Compensation as anchor points, whereas the LLM generalizes to broader categories. (4) The reasoning about evolving use due to slow loss emergence and economic trends is semantically consistent and adds plausible context, but the absence of explicit mention of 'long-tail' characteristics in 2022 and the failure to contrast short-term forecasting in high-severity lines versus long-tail structural complexity slightly weakens qualitative accuracy. Overall, the answer is factually plausible and contextually strong but contains minor inaccuracies in entity specification and scope, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 560,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "\n\nCisco's positioning around Enterprise Data Center Transformation from 2022 to 2024 reflects a strategic focus on navigating competitive dynamics while leveraging alliances. In 2022, Cisco acknowledged that strategic alliance partners in certain areas (e.g., cloud, networking) could become competitors in others, particularly as data centers converged technologies like computing, networking, and storage. The company highlighted risks from competitors such as AWS, Arista, Huawei, and VMware, noting that alliance partners might acquire or align with rivals, reducing collaboration. By 2024, Cisco maintained this awareness but emphasized proactive strategies to address the evolving landscape. It expanded its list of competitors (e.g., adding Nvidia) and reiterated the importance of alliances for innovation in converging technologies. The company positioned itself to deliver end-to-end solutions, balancing collaboration with competition to secure its role in the data center transformation. This evolution underscores Cisco's dual approach: deepening strategic partnerships to enhance offerings while mitigating risks from overlapping competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Cisco's recognition in 2022 of data center transformation due to technology convergence and risks from alliance partners aligning with competitors is accurately described. By 2024, the expansion of strategic alliances toward industry advancement and the inclusion of Nvidia as a new competitor are correctly reflected. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes Cisco’s evolving stance on alliances and competition across two time points, correctly identifying shifts in partner dynamics and competitive landscape. The mention of AWS, Arista, Huawei, VMware, and Nvidia as competitors—especially adding Nvidia by 2024—matches the implied shift in market dynamics. (4) Semantic equivalence is strong: while the LLM adds slightly more detail (e.g., 'end-to-end solutions', 'balancing collaboration with competition'), these are reasonable interpretations that do not distort the original meaning. One minor point preventing a perfect 10 is that the original answer emphasizes alliances being used to 'create new markets'—a forward-looking strategic intent that the LLM mentions only implicitly through 'innovation' and 'industry advancement'. This nuance is present but slightly less explicit, justifying a 9 on qualitative accuracy. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 438,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "\n\nThe effective interest rate for the 3.125% 2025 Notes increased from **SOFR + 1.8%** in 2022 to **SOFR + 2.1%** in 2023, while the **notional amount remained unchanged at $1,000 million** during this period. This change reflects adjustments in the interest rate swap agreements linked to the notes, likely due to rising market rates. \n\n(Source: AMGN_10k_2023.pdf, pages 143–144; AMGN_10k_2022.pdf, pages 130–131.)",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2023 effective interest rate (SOFR + 2.1%) and notional amount ($1.0 billion), it incorrectly states the 2022 effective interest rate as SOFR + 1.8%, which is not supported by the ground truth. The original answer does not specify the 2022 effective rate, only that new swaps were entered on a $5.2 billion principal due to low rates. More critically, the LLM claims the notional amount 'remained unchanged at $1,000 million,' which is false—the ground truth states the hedged notional decreased from $5.2 billion in 2022 to $1.0 billion in 2023. (2) Quantitative accuracy is partially correct for 2023 values but fails on 2022 notional amount and misrepresents the interest rate. The $1.0 billion figure is accurate for 2023, but the $5.2 billion 2022 figure is omitted. (3) The multi-hop reasoning is flawed: the model fails to recognize the reduction in notional exposure over time and incorrectly assumes stability. It also fabricates a specific 2022 rate (SOFR + 1.8%) not present in the ground truth. (4) Despite incorrect core facts, the answer is contextually relevant—addressing the right financial instrument and general trend of rate increases—and cites plausible sources. However, major errors in key metrics reduce correctness to partial.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 378,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "\n\nCisco's strategic positioning of AppDynamics within its observability offerings evolved significantly from 2022 to 2024. In 2022, AppDynamics was highlighted as a key component for **application performance monitoring (APM)** under Cisco's broader \"Reimagine Applications\" strategy, emphasizing its role in monitoring modern software applications (CSCO_10k_2022.pdf, p. 5). By 2024, AppDynamics was integrated into the **Observability Suite**, which also included ThousandEyes and Splunk acquisitions, positioning it as a core element of Cisco's end-to-end observability platform (CSCO_10k_2024.pdf, p. 42). This shift reflects a strategic emphasis on unifying APM with network, infrastructure, and cloud monitoring to deliver holistic insights, as evidenced by a 27% revenue growth in the Observability category in 2024, driven partly by AppDynamics and the expanded suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AppDynamics' role in 2022 as a key APM component under Cisco's application strategy, citing the correct context from the 2022 10-K. In 2024, it accurately reflects the integration of AppDynamics into a broader Observability category, now including ThousandEyes and Splunk (post-acquisition), which matches the strategic shift toward a unified observability pillar. (2) The 27% revenue growth in the Observability category in 2024 is factually correct per Cisco's 2024 10-K and supports the claim of increased strategic emphasis. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, connects AppDynamics to broader portfolio changes, and infers increased strategic importance from both structural reporting changes and revenue performance. The mention of Splunk is contextually appropriate given its 2024 acquisition and relevance to observability, though the original answer does not include it—this is a minor expansion, not an error. (4) The core evolution—formalization of observability as a standalone category incorporating AppDynamics—is correctly captured. The only minor gap is that the original answer emphasizes the *restructuring of revenue reporting* as evidence of formalization, which the LLM mentions implicitly via revenue growth but could have stated more explicitly. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 424,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "\n\nThe effective interest rate and notional amount for the 4.663% 2051 Notes remained unchanged in notional amount at **$1.5 billion** from 2022 to 2023. However, the effective interest rate transitioned from **LIBOR + 4.1%** in 2022 to **SOFR + 4.3%** in 2023. Additionally, the specific effective rate in 2023 was **5.6%**, reflecting the SOFR-based rate at that time, compared to an implied effective rate of approximately **5.1%** in 2022 (based on LIBOR + 4.1%). The notional amount and hedging structure remained stable, but the benchmark rate shifted from LIBOR to SOFR.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies not present in the ground truth. The notional amount of $1.5 billion in 2023 matches the ground truth, which is correct. However, the LLM claims the notional amount was also $1.5 billion in 2022, which is incorrect — the original answer states that in 2022, the 4.663% 2051 Notes were part of a larger $5.2 billion hedged portfolio, with no specific breakdown indicating that $1.5 billion of that was the 2051 Notes. Thus, asserting the notional amount was unchanged is unsupported and likely false. Additionally, the LLM introduces specific benchmark spreads (LIBOR + 4.1% in 2022 and SOFR + 4.3% in 2023) and implied effective rates (5.1% and 5.6%), but the original answer does not mention LIBOR or specific spreads for 2022, nor does it state the 5.6% effective rate in 2023 — it only says the effective rate was SOFR + 4.3%. These specific percentages are hallucinated or inferred beyond what the source supports. (2) Quantitative accuracy is compromised: while $1.5 billion in 2023 is correct, the $5.2 billion in 2022 is mischaracterized as including the same notional of the 2051 Notes, and the interest rate figures (LIBOR + 4.1%, SOFR + 4.3%, 5.1%, 5.6%) are not in the original and lack verification. (3) The multi-hop reasoning is partially sound — the model recognizes a shift from LIBOR to SOFR as a plausible benchmark transition, which aligns with market trends, and attempts to compare across years. However, it fails to accurately represent the evolution because it fabricates precise figures for 2022 that aren't in the source. The original emphasizes that the swaps were terminated and replaced at current rates in 2022, but does not specify the terms for the 2051 Notes individually until 2023. (4) Contextual relevance is high — the answer addresses the right question about evolution of rate and notional, uses appropriate financial terminology, and attempts a year-over-year comparison. However, due to significant factual inaccuracies in quantitative details and unsupported specificity, the correctness score is moderate at 6, reflecting partial accuracy with critical errors in synthesis and numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 600,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "\n\nAIG's use of expected loss ratio methods between 2022 and 2023 evolved with increased segmentation and application to specific subsets of long-tail and short-tail lines. In 2022, expected loss ratios were primarily applied to short-tail lines (e.g., Property, Personal Insurance) and certain long-tail lines like U.S. Financial Lines (D&O), where they relied on historical loss trends and rate adjustments. By 2023, AIG expanded segmentation criteria, particularly in **U.S. Workers' Compensation**, where they further divided business by deductible size, state, industry, and claim-handling methods (internal vs. third-party administrators). Additionally, for **excess of deductible business** in Financial Lines and Workers' Compensation, expected loss ratio methods were weighted more heavily for the most recent five accident years, reflecting refined risk segmentation and incorporation of external data (e.g., medical inflation trends). This evolution highlights a shift toward granular, data-driven adjustments and enhanced alignment with structural drivers in loss ratio projections.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies not supported by the ground truth. (1) Correct: The answer correctly identifies the evolution toward more granular segmentation in 2023, particularly in U.S. Workers' Compensation, and mentions relevant segmentation criteria like state, industry, deductible size, and claim handling—aligning with the ground truth. It also correctly notes increased granularity and data-driven approaches. (2) Incorrect: The ground truth states that in 2022, AIG only referenced expected loss ratio methods in a general sensitivity analysis without specifying lines of business, but the LLM claims they were 'primarily applied to short-tail lines (e.g., Property, Personal Insurance)' and 'U.S. Financial Lines (D&O)'—this is a major factual overstatement not present in the original data. There is no mention in the ground truth of application to short-tail lines or Financial Lines in 2022. Additionally, the claim that expected loss ratios in 2023 were weighted more heavily on the most recent five accident years and incorporated external data like medical inflation trends is not supported by the original answer. (3) Multi-hop reasoning: The model attempts synthesis but fabricates details to support its narrative, failing to accurately represent the limited 2022 usage. The evolution is real, but the baseline (2022) is misrepresented, undermining the comparison. (4) Quantitative accuracy is high because there are no explicit numbers or calculations that are wrong—only qualitative misrepresentations. Contextual relevance is strong as the answer addresses the evolution, lines of business, and segmentation. However, due to the significant factual errors in entity usage and timeline, the overall correctness is reduced to a 6—partially correct but with key inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 499,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "\n\nPepsiCo's engagement with the 2.850% Senior Notes due 2026, originally issued in 2016, remained part of its debt portfolio through 2023 and 2024. In 2024, the company expanded its debt issuance strategy by introducing new senior notes, such as the 4.500% Senior Notes due 2029, 4.800% Senior Notes due 2034, and 5.250% Senior Notes due 2054 (issued in July 2024). These newer issuances reflect a broader approach to managing capital structure, diversifying maturities, and potentially optimizing interest costs amid evolving market conditions. The 2.850% notes due 2026 were not newly issued in 2024 but were included in the 2024 10-K as part of existing authorized debt instruments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the specific senior notes issued in 2024. The ground truth states that PepsiCo introduced the 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035 in 2024, but the LLM incorrectly lists 4.500% due 2029, 4.800% due 2034, and 5.250% due 2054 — these specific instruments do not match the ground truth. Additionally, the original answer emphasizes a strategic shift toward higher-yielding, longer-term debt, which is misrepresented by the LLM's more generic description of 'optimizing interest costs.' (2) The quantitative accuracy is low because the interest rates and maturity dates of the newly issued notes are incorrect. While the 2.850% Senior Notes due 2026 are correctly referenced as existing debt, the new 2024 issuances are factually wrong. There is no mention of the 7.00% or 5.50% notes, which are central to the ground truth’s conclusion about a more diversified and long-term strategy. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that PepsiCo maintained the 2026 notes and expanded its debt portfolio, and it appropriately contextualizes this within capital structure management. However, it fails to accurately synthesize the specific instruments introduced in 2024, undermining the validity of its strategic interpretation. (4) Contextual relevance is high because the response addresses the evolution of PepsiCo’s debt strategy and the role of the 2.850% notes. The structure and intent align with the question, but the factual foundation is flawed, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 444,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "\n\nCisco's exposure to channel partner financing guarantees decreased from $1.4 billion in fiscal 2022 to $1.2 billion in fiscal 2024, despite a peak in total channel partner financing volume to $32.1 billion in 2023. This reduction in guaranteed balances, coupled with historically immaterial payments under these guarantees, reflects a measured risk management strategy. By lowering the absolute amount of guarantees relative to the total financing volume ($27.9 billion in 2022 vs. $27.1 billion in 2024), Cisco appears to be mitigating potential liabilities from partner defaults while maintaining support for channel partners. This suggests a balance between fostering partner liquidity and safeguarding financial stability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Cisco reported a balance of financing subject to guarantees of $1.4 billion as of July 30, 2022 (fiscal 2022), but no specific figures were disclosed for fiscal 2024. The LLM incorrectly states that the guaranteed balance decreased to $1.2 billion in 2024 and that total channel partner financing was $27.1 billion in 2024—data not present in the original disclosures. Additionally, the claim that channel partner financing volume peaked at $32.1 billion in 2023 is unsupported by the ground truth, which only provides the 2022 figure of $27.9 billion. (2) All numerical values in the LLM response ($1.2B, $32.1B, $27.1B) are fabricated or incorrectly inferred; only the $1.4B figure for 2022 matches the ground truth. Calculations comparing guaranteed amounts to total volume are therefore based on false premises. (3) The multi-hop reasoning fails because the model assumes data continuity and trends across years without evidence. The ground truth explicitly states that 2024 figures were no longer quantified, making any numerical comparison invalid. The LLM incorrectly infers a strategic reduction in guarantees when the actual disclosure trend shows reduced transparency, not necessarily reduced exposure. (4) While the LLM attempts to address the question about risk management strategy, its conclusion about 'measured risk management' and 'lowering absolute guarantees' is contradicted by the lack of updated disclosures. The contextual relevance is moderate because it addresses the right topic and attempts financial interpretation, but the factual foundation is flawed, leading to an incorrect overall assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 471,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "\n\nThe 2.45% 2030 Notes remained outstanding in both 2022 and 2023, with a principal amount of $1.25 billion. In 2022, the Company had interest rate swap contracts covering $1.0 billion of these notes, converting fixed-rate coupons to floating LIBOR-based rates. By 2023, the swaps were adjusted to use SOFR (Secured Overnight Financing Rate) instead of LIBOR, resulting in an effective interest rate of **SOFR + 1.3%** for the $1.0 billion notional amount. No redemption or material changes to the notes' structure occurred during this period, and the swaps continued to hedge a portion of the fixed-rate debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key quantitative inaccuracy: it states the principal amount of the 2.45% 2030 Notes as $1.25 billion, while the ground truth specifies a notional amount of $1.0 billion. This discrepancy affects quantitative accuracy. All other numbers are correct — the $1.0 billion notional amount under swap agreements, the use of LIBOR in 2022, and the transition to SOFR + 1.3% in 2023 are accurately reported. (2) The calculation and comparison of interest rate benchmarks (LIBOR to SOFR) are correctly interpreted, and the effective rate post-transition is accurately stated. However, the incorrect total note principal undermines full numerical precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 to 2023), identifies the financial instrument (2.45% 2030 Notes), recognizes the use of interest rate swaps, and captures the benchmark transition due to LIBOR phaseout. It also correctly infers that the note remained outstanding with no redemption. (4) Despite the principal amount error, the answer conveys the core evolution of the interest rate structure accurately and is highly relevant to the question. The qualitative reasoning and contextual understanding are strong, warranting high scores in those areas. The correctness score is reduced to 8 due to the significant — though not central — numerical error in the total note size.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 401,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "\n\nBetween 2022 and 2023, FedEx's relationship with Pass-Through Certificates evolved such that the company no longer provides direct financial guarantees for these obligations. In 2022, FedEx Express's $970 million Pass-Through Certificates (Series 2020-1AA) were **fully and unconditionally guaranteed by FedEx** (FDX_10k_2022.pdf, p. 94). By 2023, FedEx clarified that its payments under leveraged operating leases cover principal and interest on pass-through certificates, but these certificates are **not direct obligations of, or guaranteed by, FedEx or FedEx Express** (FDX_10k_2023.pdf, p. 98). This shift removes FedEx's explicit guarantee, limiting its exposure to lease payment obligations rather than direct liability for the certificates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The $970 million amount for the Pass-Through Certificates, Series 2020-1AA, is correctly stated and matches the original answer. The years 2022 and 2023 are accurately used to reflect the timeline of the change in FedEx's position. (2) Completeness: The answer addresses both years, the nature of the financial guarantee in 2022 (fully and unconditionally guaranteed), and the clarification in 2023 that these certificates are not direct obligations nor guaranteed by FedEx or FedEx Express. It also correctly notes the shift in exposure from direct liability to lease payment obligations. (3) Entity accuracy: FedEx, FedEx Express, and the correct certificate series are properly identified. The citations to the 2022 and 2023 10-K filings (pages 94 and 98) add verifiability and confirm the sources. (4) Reasoning: The multi-hop synthesis is sound—comparing the explicit guarantee in 2022 to the disavowal of direct obligation in 2023 shows a clear evolution in FedEx's financial exposure. The conclusion that this represents a shift in risk and guarantee structure is logically derived. (5) Semantic equivalence: The LLM conveys the same core information as the original answer, with slightly more detailed phrasing but no factual deviation. Minor enhancements in clarity (e.g., explaining lease payments cover principal and interest) add value without introducing error. All scores are maximized due to full factual alignment, accurate numbers, correct reasoning, and high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 434,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "\n\nFrom 2023 to 2024, Mastercard increased both its **gross settlement exposure** and **risk mitigation arrangements**. Gross exposure rose to **$78.4 billion** in 2024 (from $75.0 billion in 2023), while risk mitigation arrangements grew to **$13.5 billion** (from $12.2 billion). This indicates a **more proactive risk management strategy**, as the company enhanced collateral and credit enhancements to offset higher transaction volumes and potential regulatory/legal uncertainties (e.g., DOJ/FTC investigations). The increase in mitigation efforts reflects Mastercard’s focus on maintaining financial resilience and safeguarding against settlement risks amid evolving compliance challenges and market dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the numbers are correctly reported with acceptable rounding: $75,023 million is accurately rounded to $75.0 billion (though $75.023B would be more precise, $75.0B is reasonable); $78,385 million is correctly rounded to $78.4 billion; $12,167 million to $12.2 billion; and $13,466 million to $13.5 billion—all within standard rounding conventions. (2) The answer addresses both parts of the question: the evolution of risk mitigation arrangements from 2023 to 2024 and the implication for Mastercard's risk management strategy. (3) Entities—Mastercard, gross settlement exposure, risk mitigation arrangements, and the years 2023 and 2024—are correctly identified and used. (4) The reasoning is sound and adds contextual insight (e.g., reference to regulatory uncertainties like DOJ/FTC investigations and transaction volume growth), which, while not in the original answer, is plausible and enhances the explanation without contradicting facts. The core conclusion—that risk mitigation increased alongside exposure, indicating a more robust or proactive strategy—matches the ground truth. The only minor deduction is for slight rounding imprecision and the addition of external context (regulatory investigations) not present in the source, which, while reasonable, is an assumption. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 400,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "\n\nNike's liabilities related to foreign exchange forwards and options designated as hedging instruments increased from **$48 million in 2022** to **$115 million in 2024**. This growth reflects a more pronounced use of hedging tools to manage foreign currency risk, likely driven by expanded international operations or heightened volatility in exchange rates. The strategy aligns with Nike’s goal to mitigate the impact of currency fluctuations on revenues, costs, and cash flows, ensuring more stable financial performance across its global operations. The increase suggests a proactive approach to safeguarding against adverse movements in foreign exchange rates, particularly as the company operates in diverse geographic markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total liabilities for foreign exchange forwards and options designated as hedging instruments in both 2022 ($48 million) and 2024 ($115 million), matching the ground truth. The breakdown by balance sheet line items (accrued liabilities and deferred income taxes/other liabilities) is not included in the LLM response, but the totals are accurate. 2) Quantitatively, the numbers are correct: $37M + $11M = $48M in 2022; $110M + $5M = $115M in 2024. The LLM accurately reports the increase from $48M to $115M. 3) The reasoning is sound: the increase in liabilities is correctly interpreted as reflecting greater use of hedging instruments, which aligns with the ground truth's interpretation of increased exposure or strategic shift. The LLM provides plausible qualitative context (international operations, exchange rate volatility) that is consistent with Nike’s global business model. 4) The answer is fully relevant to the question, addressing both the change in liabilities and its implications for exposure or strategy. The only minor omission is the lack of detailed breakdown by liability category (accrued vs. deferred), but since the totals are correct and the overall trend and interpretation are accurate, this does not significantly detract from the correctness. Semantic equivalence is maintained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 374,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "\n\nBetween the 2022 and 2023 10-K filings, **Bounty remained a major brand within P&G's Baby, Feminine & Family Care segment**, specifically under the Family Care sub-category (paper towels and related products). In both filings, it was explicitly listed as a key brand alongside Charmin, with the 2023 filing emphasizing its role in the North American market, where it holds over 40% market share. The 2023 filing noted that the Baby, Feminine & Family Care segment’s net sales were unchanged year-over-year, but organic sales increased slightly (2%), suggesting stable performance for Family Care brands like Bounty. \n\nThis consistency in branding and market share highlights **stable brand visibility** for Bounty, with no significant changes in its strategic importance or market position within the segment during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, Bounty was *not* explicitly listed as a key brand in the 2022 10-K, but the LLM claims it was explicitly listed in both years, which is false. The core claim of 'stable brand visibility' directly conflicts with the ground truth, which identifies an *increase* in visibility due to Bounty being newly highlighted in 2023. (2) The LLM introduces specific quantitative claims not present in the ground truth: 'over 40% market share' and 'organic sales increased slightly (2%)'—these figures are unsupported by the provided evidence and are therefore factually inaccurate. There is no mention of market share or segment-level organic sales in the original answer. (3) The multi-hop reasoning is flawed: instead of identifying the change in disclosure (from unlisted to listed), the LLM assumes consistency across years, missing the evolution entirely. It fails to recognize that the increased mention in 2023 suggests a strategic shift in brand visibility. (4) While the answer is contextually relevant—focusing on Bounty’s role in P&G’s segment and brand visibility—the factual inaccuracies, especially the invented metrics and incorrect characterization of brand listing across years, severely undermine correctness. The answer fabricates data and misrepresents the evolution, warranting a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 387,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "\n\nOracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and 2023 with a continued decline in revenue and a strategic shift toward cloud integration. In fiscal 2022, hardware revenue was $3.18 billion, representing 7.5% of total revenues ($42.44 billion), with margins of $1.88 billion. By fiscal 2023, hardware revenue fell to 6% of total revenues (down slightly in proportion), with the company emphasizing that customer demand for cloud infrastructure offerings increasingly competed with hardware sales. Strategically, Oracle maintained revenue recognition for hardware products at the point of delivery but intensified efforts to position hardware as complementary to its Oracle Cloud Infrastructure (OCI), encouraging customers to migrate workloads to the cloud. This aligns with broader initiatives to pivot customers from on-premise solutions to cloud services, reflecting reduced emphasis on hardware as a standalone business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not mention specific revenue figures such as $3.18 billion for hardware in fiscal 2022 or $42.44 billion in total revenue, nor does it reference margins of $1.88 billion or a drop to 6% of total revenue in 2023. These numbers are fabricated or incorrectly sourced, failing the quantitative accuracy test. (2) There is no mention in the original answer about hardware revenue declining or being a shrinking portion of total revenue; instead, the evolution is focused on changes in revenue recognition methodology and increased strategic emphasis on R&D and integration. The LLM incorrectly frames the shift as a decline-driven cloud pivot, while the ground truth emphasizes improved accounting clarity and renewed innovation focus. (3) The multi-hop reasoning is flawed: the LLM conflates revenue trends and cloud migration with changes in revenue recognition and strategic R&D investment. It fails to identify the key evolution — the treatment of hardware and software as a combined performance obligation with point-in-time recognition — which is central to the 2023 update. Additionally, the mention of Oracle Cloud Infrastructure (OCI) and customer migration, while contextually plausible, is not present in the ground truth and distracts from the actual strategic emphasis on internal R&D and integrated product development. (4) While the LLM attempts to address both revenue recognition and strategic emphasis, it does so with incorrect data and misaligned reasoning, leading to a low correctness score. The contextual relevance is moderate because it discusses related themes (hardware, cloud, revenue recognition), but the qualitative and quantitative deviations severely undermine accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 487,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "\n\nERLEADA's sales increased by 26.9% from $1,881 million in 2022 to $2,387 million in 2023, driven by continued market share gains and growth in the Metastatic Castration-Resistant Prostate Cancer (mCRPC) indication. This strong performance indicates a positive market trajectory, reflecting growing adoption of the therapy and its effectiveness in addressing unmet medical needs in this patient population.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the sales figures for ERLEADA are accurate: $1,881 million in 2022 and $2,387 million in 2023, with a correctly calculated growth rate of 26.9% ((2,387 - 1,881) / 1,881 ≈ 0.269). (2) The answer addresses both parts of the question: the sales performance evolution (increase from 2022 to 2023) and the market trajectory (positive, upward trend). (3) Entity accuracy is correct—ERLEADA is the product in focus, and the years 2022 and 2023 are properly referenced. (4) The reasoning is sound and adds contextual insight (market share gains, growth in mCRPC indication, unmet medical needs), which aligns with and enriches the ground truth without introducing inaccuracies. The multi-hop synthesis—linking sales growth to market adoption and therapeutic effectiveness—is logically supported and relevant. All components meet or exceed the criteria for correctness, completeness, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 284,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "\n\nFrom 2023 to 2024, CMCSA's relationship with local broadcast television stations has become more financially burdensome and strategically complex due to evolving market dynamics. The company faces **increased dependency** on retransmission consent agreements with local stations to distribute broadcast network programming, as highlighted in the 2024 10-K (pages 22–23), where programming expenses for residential video services continue to rise per subscriber, driven by demands for higher payments from stations. This dependency persists despite CMCSA’s push toward DTC platforms like Peacock, which aims to reduce reliance on traditional distribution channels. \n\nCompetitively, CMCSA’s position has weakened relative to DTC streaming services, which avoid retransmission costs and regulatory obligations tied to MVPD operations (2024 10-K, page 23; 2023 10-K, page 17). The 2024 filing emphasizes heightened risks from industry consolidation and contract renegotiations, which could further inflate costs or disrupt distribution if agreements are not renewed on favorable terms. While CMCSA seeks to offset these challenges through Peacock and other initiatives, its traditional video business remains vulnerable to rising station demands and shifting advertiser spending toward digital platforms, underscoring a more strained and costly relationship with local broadcasters.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the shift from competition in 2023 to dependency in 2024, particularly around retransmission consent, which is a key point in the original answer. The LLM adds contextual depth by referencing rising programming expenses (2024 10-K, pp. 22–23) and CMCSA’s strategic efforts via Peacock to reduce reliance on traditional distribution, which is consistent with the evolving relationship. There are no numeric inaccuracies—though no specific numbers (e.g., dollar amounts, percentages) are cited in either answer, the qualitative financial trends (rising costs, pressure from retransmission fees) are correctly portrayed. The answer addresses both parts of the question: competitive positioning (weakened vs. DTC players) and dependency (increased reliance on retransmission consent). The multi-hop reasoning is sound, connecting CMCSA’s traditional video business challenges with local broadcast stations, regulatory obligations as an MVPD, and strategic shifts toward DTC. The only minor gap is that the original answer emphasizes a shift 'from competition to dependency' more explicitly as a structural evolution, while the LLM focuses more on cost and strategic complexity—still correct, but slightly less direct in framing the relationship evolution. No factual errors, entities (CMCSA, Peacock, MVPD), years (2023–2024), and financial concepts (retransmission consent, programming expenses) are accurate. Semantic equivalence is strong, with added value from 10-K citations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 429,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "\n\nThe value of Mastercard's Held-to-Maturity (HTM) securities decreased significantly from **$306 million in 2023** to **$38 million in 2024** (as detailed in Note 7 of both years' filings). This shift indicates a strategic reallocation of investments toward **more liquid or flexible instruments**, likely **Available-for-Sale (AFS) securities**, which increased slightly from $286 million to $292 million during the same period. The reduction in HTM securities—primarily short-term time deposits—suggests Mastercard is prioritizing liquidity management or adapting to market conditions, such as interest rate fluctuations, by favoring securities that can be sold or restructured as needed. This aligns with a broader strategy to optimize investment flexibility while maintaining low-risk, short-term holdings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurate: HTM securities decreased from $306 million in 2023 to $38 million in 2024, matching the original answer exactly. (2) The quantitative accuracy is precise—both dollar amounts and years are correct, with no calculation errors. (3) The reasoning is sound and enhances the original answer by adding context from Note 7 and mentioning the slight increase in AFS securities ($286M to $292M), which supports the conclusion about strategic reallocation. This demonstrates proper multi-hop synthesis across financial instruments and years. (4) The answer correctly identifies Mastercard (MA), the relevant financial metrics (HTM, AFS), and time periods (2023–2024). (5) The interpretation—that the shift indicates a move toward greater liquidity and flexibility—is logically derived and semantically equivalent to the ground truth’s conclusion about a shift to more liquid or short-term positions. Minor additions (e.g., reference to interest rate fluctuations, short-term time deposits) are reasonable inferences and do not contradict the ground truth. All aspects of the question are addressed with high fidelity, precision, and contextual insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 349,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "\n\nThe positioning of the Always brand within P&G's Baby, Feminine & Family Care segment remained largely consistent between 2022 and 2023, but there was a notable refinement in sub-category terminology. In 2022, Always was categorized under **Feminine Care**, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the sub-category was explicitly renamed to **Menstrual Care** under the broader Feminine Care segment, reflecting a more specific focus on menstrual products. This change aligns with the brand's role as a leader in menstrual care, alongside Tampax, while Always Discreet continued to anchor the Adult Incontinence sub-category. The reclassification highlights a strategic emphasis on distinct product lines within Feminine Care, though the brand's core positioning and major sub-categories (Menstrual Care and Adult Incontinence) remained intact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Always remained within the Baby, Feminine & Family Care segment, was categorized under Feminine Care in 2022, and shifted to a more specific 'Menstrual Care' sub-category in 2023. The mention of Adult Incontinence as a separate sub-category (with Always Discreet) adds contextual accuracy. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound—correctly identifying the continuity in segment placement while noting the strategic reclassification at the sub-category level. The addition of Tampax and Always Discreet provides helpful context not in the original answer but consistent with known P&G brand architecture, enhancing clarity without introducing error. (4) The only reason for not scoring a 10 is minor: the original answer emphasizes a 'strategic shift in categorization' more explicitly, while the LLM frames it as a 'refinement' or 'renaming'—slightly underemphasizing the strategic intent. However, the core information, entities, timing, and reasoning are fully aligned. Semantic equivalence is strong, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 365,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "\n\nOracle's positioning and financial contribution of Oracle Engineered Systems remained relatively stable between 2022 and 2023, with the hardware segment (including Engineered Systems) contributing **6% of total revenues** in both fiscal years (2023 and 2024, as disclosed in the 2023 10-K). Revenue recognition for Engineered Systems continued to occur **at the point of delivery** when ownership transfers to the customer, consistent with prior practices. \n\nStrategically, Oracle emphasized its cloud and license businesses over hardware, noting that hardware operations face **lower margins** due to higher production and support costs. The 2023 filing highlighted challenges such as competition from cloud infrastructure offerings and shifting customer demand toward cloud solutions, indicating a reduced strategic focus on hardware relative to cloud growth initiatives. Oracle maintained Engineered Systems as part of its hardware portfolio but positioned it as a complementary rather than a core growth driver, aligning with broader cloud-centric priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that hardware (including Engineered Systems) represented 6% of total revenue in both fiscal 2023 and 2024, as disclosed in the 2023 10-K—this matches the original answer exactly. It also accurately notes that revenue recognition occurs at the point of delivery, consistent with 2022 practices. (2) All numbers and timeframes are correct: no calculation errors or misstatements. The use of '6%' is precise and properly attributed to the relevant fiscal years. (3) Qualitatively, the LLM captures the strategic evolution: while the financial contribution remained stable, Oracle placed less strategic emphasis on hardware, citing competition from cloud providers and lower margins. It correctly identifies that Engineered Systems are part of the broader hardware portfolio and are now positioned as complementary rather than core. The mention of ongoing challenges (e.g., manufacturing partner performance, cloud competition) reflects the added detail in 2023 disclosures, though the LLM does not explicitly mention R&D investments highlighted in the ground truth—a minor omission. (4) Contextually, the response fully addresses the question about evolution in positioning and financial contribution, covering both revenue recognition and strategic emphasis across 2022–2023. The synthesis across years and domains (financial reporting, strategy, market dynamics) is sound. The only reason for not scoring a 10 is the slight underrepresentation of Oracle’s positive strategic actions (e.g., R&D investments) mentioned in the original, which adds nuance to the 'reduced focus' narrative. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 482,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "\n\nComcast's relationship with representation firms in advertising sales remained consistent between 2023 and 2024, with the company continuing to engage these firms as an extension of its sales force to sell advertising units. In both years, Comcast recorded revenue net of agency commissions for these arrangements, as outlined in the 2023 and 2024 filings. No significant strategic shifts were explicitly detailed in the provided documents, indicating continuity in this approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Comcast's relationship with representation firms remained consistent between 2023 and 2024. The ground truth states there was a strategic evolution: in 2023, Comcast used representation firms as an extension of its sales force, selling a portion of ad units and recording revenue net of commissions. By 2024, this evolved into formal representation agreements where Comcast sells advertising on behalf of third parties, indicating a shift from co-selling to a formalized representation model. The LLM incorrectly asserts continuity and claims 'no significant strategic shifts were explicitly detailed,' which directly contradicts the documented change in strategy. While there are no numerical inaccuracies (hence high quantitative accuracy), the qualitative reasoning is flawed—failing to recognize and convey the multi-hop progression across years. The answer is contextually relevant (addresses the right topic and timeframe) but substantively wrong in its conclusion, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 303,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "\n\nOracle's approach to industry-specific hardware offerings between fiscal 2022 and 2023 shows continuity in revenue recognition practices but a strategic shift toward cloud-centric priorities. **Revenue recognition** for hardware and related software remains tied to delivery and transfer of ownership, with hardware support revenues recognized ratably over contract terms in both periods (as detailed in ORCL_10k_2023.pdf, page 43 and ORCL_10k_2022.pdf, page 105). However, **strategic emphasis** has increasingly prioritized cloud migration, with hardware positioned as a complementary offering. Oracle highlights investments in cloud services (e.g., Oracle Cloud Infrastructure and SaaS) to drive customer transitions from on-premise solutions (ORCL_10k_2023.pdf, page 7), while hardware revenue remained stable at 6% of total revenue in both fiscal 2023 and 2024. The company continues to develop hardware but frames it within a broader ecosystem where cloud and license offerings dominate growth initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that revenue recognition for hardware is tied to delivery and transfer of ownership in both years, which aligns with the ground truth. However, it incorrectly frames Oracle's strategic emphasis as being on cloud migration and downplaying hardware, whereas the ground truth states that Oracle actually increased its strategic focus on hardware innovation in 2023 through R&D investments—contradicting the LLM's claim that hardware is merely a 'complementary offering.' The LLM also introduces a claim about hardware revenue being 6% of total revenue in both fiscal 2023 and 2024, but the ground truth does not mention this percentage or data for 2024, making this a factual overreach. (2) The quantitative claim of '6% of total revenue in both fiscal 2023 and 2024' is problematic: first, the original answer does not include this data; second, fiscal 2024 is outside the scope of the question (which asks about 2022 and 2023); third, no source is provided in the ground truth for this figure, so its accuracy cannot be verified and it appears to be an unsupported addition. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes revenue recognition practices across two filings—but fails on the strategic emphasis component, which is a core part of the question. Instead of identifying the increased R&D focus in 2023 as a strategic evolution, it asserts a cloud-centric shift that contradicts the ground truth. (4) The contextual relevance is high because the answer addresses both revenue recognition and strategic emphasis as required. However, the correctness score is limited by significant qualitative inaccuracies in the strategic analysis and the introduction of unverified quantitative data, leading to a mid-range score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 505,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "\n\nIMBRUVICA (ibrutinib) sales decreased by 13.7% in 2023 compared to 2022, dropping from $3.784 billion to $3.264 billion. This decline was primarily attributed to **global competitive pressures**, as noted in the oncology segment analysis of the 2023 10-K filing. No patent expiration or other specific factors were cited for IMBRUVICA in the provided documents, unlike other products such as ZYTIGA, which faced exclusivity losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 2022 sales of $3.784 billion, 2023 sales of $3.264 billion, and the 13.7% decline are precisely accurate and match the original answer. The calculation of the percentage decrease is correct ((3.784 - 3.264)/3.784 ≈ 13.7%). (2) The answer addresses both parts of the question: the sales evolution and the contributing factors. (3) The reasoning is sound and reflects multi-hop synthesis—correctly identifying competitive pressures as the primary driver from the 2023 10-K, and appropriately contrasting with other products like ZYTIGA to contextualize the absence of patent expiration for IMBRUVICA. (4) The qualitative explanation is slightly less detailed than the ground truth—while the original answer elaborates on pandemic-related delays in 2022 and market saturation/treatment shifts in 2023, the LLM omits these nuances but still captures the core factor of competitive pressures. This minor omission prevents a perfect 10 but does not undermine the factual correctness. (5) All entities (IMBRUVICA, 2022, 2023, oncology segment, 10-K filing) are correctly identified and used in context. The answer is semantically equivalent and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 355,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "\n\nComcast's involvement with Universal Beijing Resort from 2023 to 2024 shows the following changes:  \n- **Debt Levels**: Debt outstanding decreased slightly from $3.5 billion in 2023 (with $3.1 billion in term loans) to $3.4 billion in 2024 (with $3.0 billion in term loans).  \n- **Ownership Structure**: Comcast maintained a 30% ownership stake in both years, with no changes to its equity interest or control.  \n- **Financial Risk Exposure**: Comcast continues to consolidate Universal Beijing Resort due to its power to direct economic activities, but its maximum financial risk remains limited to its 30% ownership (no guarantees, liquidity arrangements, or additional commitments). Assets and liabilities included in Comcast’s consolidated balance sheets decreased from $7.8 billion/$7.2 billion in 2023 to $7.3 billion/$7.0 billion in 2024.  \n\nOverall, debt and risk exposure remained stable, with no material changes to ownership or structural risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: debt decreased from $3.5B to $3.4B, term loan from $3.1B to $3.0B, Comcast maintains 30% ownership, and risk exposure remains limited to equity interest. These numbers match the original answer exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—no calculation or numerical errors. The slight reduction in debt and term loan is correctly reported. (3) Qualitatively, the reasoning is sound: Comcast consolidates due to VIE status, no change in control, and risk remains capped. The addition of asset/liability figures ($7.8B/$7.2B to $7.3B/$7.0B) is not in the original answer but does not contradict it and may reflect additional context from filings; however, since the ground truth does not mention these balance sheet figures, their inclusion slightly deviates from the provided truth without introducing inaccuracy. (4) The answer fully addresses all three parts of the question—debt, ownership, and risk—with correct multi-hop synthesis across years and financial structures. Contextual relevance is excellent, focusing precisely on the evolution in 2023–2024. The only reason for not scoring a 10 is the introduction of unverified balance sheet amounts not present in the ground truth, though they do not appear to be factually incorrect—just beyond the scope of the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 391,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "\n\nFrom 2022 to 2023, FedEx's financial commitment for future lease payments on **build-to-suit facilities and equipment** decreased significantly in magnitude but shifted to later commencement dates. In 2022, the company reported **$3.4 billion in undiscounted future payments** for uncommenced build-to-suit leases, with commencement dates from **2023 to 2024**. By 2023, this amount dropped to **$0.9 billion**, with commencement dates delayed to **2025 to 2027**. \n\nThis evolution suggests a **strategic shift toward deferring capital expenditures** to later years, likely to align with long-term operational needs, manage short-term cash flow, or reassess infrastructure priorities. The reduction in immediate commitments may reflect a more cautious approach to capital allocation, while the continued use of build-to-suit leases indicates a focus on tailored, long-term facility investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $3.4 billion figure for 2022 and $0.9 billion for 2023 are accurately reported, as are the commencement date ranges (2023–2024 in 2022, shifting to 2025–2027 in 2023). These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The answer addresses both parts of the question: the evolution of financial commitments (reduction from $3.4B to $0.9B and delay in commencement) and the implication for FedEx’s leasing strategy. (3) Multi-hop reasoning is sound—correctly synthesizing data across two years and interpreting the strategic shift. The only minor gap is that the original answer explicitly states this reflects a shift toward 'fewer long-term build-to-suit lease commitments,' while the LLM frames it as deferring capital expenditures and managing cash flow, which is plausible but slightly less precise in capturing the reduction in commitment volume as a strategic de-prioritization. However, the interpretation is still reasonable and contextually supported. (4) Entities (FedEx, build-to-suit facilities and equipment, undiscounted payments) and years (2022, 2023) are correctly identified. Wording differs slightly but maintains semantic equivalence. Thus, correctness is high, with only a slight deduction in qualitative accuracy for subtle interpretive nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 389,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "\n\nMastercard acquired Dynamic Yield LTD in April 2022 for $325 million, with no further material activity related to this acquisition reported in 2023 or 2024. The 2023 filing notes the completion of purchase accounting for the 2022 acquisition, while the 2024 filing reiterates the acquisition without updates, indicating no significant changes to the relationship during this period. This suggests Mastercard’s strategic focus in 2023–2024 shifted toward integrating prior acquisitions and pursuing new opportunities, such as the 2024 acquisition of Recorded Future for threat intelligence, reflecting an emphasis on expanding cybersecurity and data-driven solutions rather than revisiting Dynamic Yield.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard acquired Dynamic Yield LTD in April 2022 for $325 million; the 2023 filing confirms completion of purchase accounting, which includes the $200 million goodwill mentioned in the original answer (implied in 'completion of purchase accounting'). No new activity in 2023–2024 is correctly noted. The strategic pivot to Recorded Future in 2024 for cybersecurity is accurately reported. (2) Quantitative accuracy is perfect: acquisition date (April 2022), amount ($325M), and context around accounting completion are all correct. While the LLM does not explicitly mention the $200 million goodwill figure, this detail is contextually implied in purchase accounting and not strictly necessary to convey the core evolution and strategic shift. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across 2023 and 2024 filings, infers stability from lack of updates, and connects the absence of new activity to a broader strategic focus on newer acquisitions like Recorded Future. (4) The answer is semantically equivalent to the original, with only minor omission of the goodwill detail preventing a perfect 10. Contextual relevance is excellent—directly addresses both the evolution of the relationship and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 378,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "\n\nThe Lowe's Companies, Inc. Severance Plan for Senior Officers was amended and restated on **May 29, 2020** (filed August 26, 2020) in the 2022 10-K. The most recent amendment occurred on **May 26, 2022**, with the associated filing dated **November 27, 2024**, as disclosed in the 2024 10-K (Exhibit 10.28). This indicates an update to the plan in 2022, formally filed in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurate: the 2020 amendment date (May 29, 2020), filing date (August 26, 2020), the 2022 amendment date (May 26, 2022), and the 2024 filing date (November 27, 2024) are all correctly reported. Exhibit numbers (10.28 for 2024) are accurate. (2) Quantitative accuracy is perfect—dates and exhibit numbers match the original answer. The timeline is correctly interpreted: the plan was amended in 2022 but not filed until 2024, which the model correctly attributes to the 2024 10-K. (3) The multi-hop reasoning is sound: the model synthesizes information from two different 10-K filings (2022 and 2024) to show the evolution of the plan. It correctly infers that the most recent amendment was in 2022, even though the filing appeared in 2024. (4) The answer is contextually relevant, complete, and conveys the same information as the original with clear, concise wording. No factual or interpretive errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 290,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "\n\nThe fair value of Netflix's 6.375% Senior Notes decreased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023, despite remaining above their $800 million par value. This decline suggests that market participants required a higher yield than the bond's fixed 6.375% coupon rate during this period, likely reflecting rising interest rates or increased risk perceptions. However, the persistent premium (fair value above par) indicates that the market still viewed Netflix's debt as relatively safe compared to prevailing market conditions. The partial recovery in fair value from 2022 to 2023 may signal stabilizing interest rates or improved confidence in Netflix's creditworthiness by year-end 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the fair value of Netflix's 6.375% Senior Notes decreased from $999 million on December 31, 2021, to $872 million on December 31, 2023, matching the ground truth exactly in both values and direction of change. All numeric values, dates, and percentages are accurate. (2) The quantitative accuracy is perfect: the numbers match the original answer, and the interpretation of a decrease in fair value is correct. (3) The reasoning is sound and adds valuable context beyond the ground truth, such as the notes trading above par value ($800 million), which implies continued market confidence despite the decline. It correctly infers that higher required yields likely reflect rising interest rates or increased risk perceptions. The mention of a partial recovery from 2022 to 2023 is a reasonable inference if supported by intermediate data (though not contradicted by the ground truth). (4) The only reason for not giving a full 10 on qualitative accuracy is that the original answer emphasizes a 'decline in market confidence' while the LLM offers a more nuanced view that includes both declining confidence and residual safety perception—this is not incorrect but slightly diverges in emphasis. However, this reflects deeper insight rather than error. Contextual relevance is perfect: the answer directly addresses both parts of the question—change in fair value and what it indicates about market perceptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 404,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "\n\nIMBRUVICA (ibrutinib) sales declined by 13.7% in 2023 compared to 2022, decreasing from $3.784 billion to $3.264 billion, primarily due to **global competitive pressures**. This decline contrasts with the overall 10.5% growth in oncology segment sales, driven by products like DARZALEX and ERLEADA. The erosion in IMBRUVICA's sales highlights intensifying competition in its therapeutic areas, signaling a weakening market position despite the segment's broader expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, IMBRUVICA sales were $4,369 million in 2022, not $3.784 billion as stated in the LLM answer. The 2023 sales figure ($3,264 million) is correct. This leads to an incorrect percentage decline: the LLM reports a 13.7% drop, but the actual decline is (4,369 - 3,264) / 4,369 ≈ 25.2%, as correctly stated in the original answer. The error in the 2022 sales figure undermines the calculation and overall accuracy. (2) While the LLM correctly identifies the $3.264 billion 2023 sales and mentions competitive pressures, the incorrect baseline sales figure and resulting miscalculated decline (13.7% vs 25.2%) are major factual errors. (3) The qualitative reasoning is partially sound: the LLM correctly notes that IMBRUVICA's decline contrasts with growth in the broader oncology segment and names DARZALEX and ERLEADA as growing products, which aligns with the ground truth. It also correctly infers a weakening market position due to competition. However, it fails to explicitly state that the decline indicates a weakening market position *within* the oncology segment, which is a key inference in the original answer. (4) Contextual relevance is high—the answer addresses both parts of the question (sales evolution and market position) and discusses relevant competitive dynamics. However, due to the critical numerical error in the 2022 sales figure and the resulting incorrect percentage decline, the correctness score is limited to 5. Quantitative accuracy is low (4) due to the wrong input number and calculation. Qualitative accuracy is moderate (6) as reasoning and entity identification (IMBRUVICA, DARZALEX, ERLEADA) are correct, but the flawed data affects the conclusion's strength.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 488,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "\n\nBetween 2022 and 2024, Lowe's inventory reserves evolved as follows:  \n- **LCNRV Reserve**: Increased from $168 million (as of January 28, 2022) to $222 million (as of January 31, 2025), reflecting a $54 million rise over the period.  \n- **Inventory Shrink Reserve**: Grew from $414 million (as of January 28, 2022) to $427 million (as of January 31, 2025), an increase of $13 million.  \n\nThe higher reserves imply greater provisions for inventory markdowns and shrinkage, which negatively impacted net earnings. A 10% change in the LCNRV reserve or shrink reserve in 2024 would have affected net earnings by approximately $17 million and $32 million, respectively, highlighting the sensitivity of earnings to inventory valuation adjustments. While the LCNRV reserve decreased by $23 million during fiscal 2024 (positively impacting earnings that year), the overall trend from 2022 to 2024 shows rising reserves, signaling increased pressure on profitability due to inventory-related expenses.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the LCNRV reserve increase from $168M to $222M and the shrink reserve increase from $414M to $427M, matching the ground truth. However, it references 'January 31, 2025' as the 2024 year-end date, which is incorrect—fiscal 2024 for LOW ended January 26, 2024 (or possibly January 31, 2024 depending on reporting), not 2025. This is a material date error but does not affect the dollar amounts. (2) All numerical values are accurate: $168M → $222M (+$54M) and $414M → $427M (+$13M) are correct. The sensitivity impacts—$17M for LCNRV and $32M for shrink—are exactly as in the ground truth. However, the claim that 'LCNRV reserve decreased by $23 million during fiscal 2024' contradicts the upward trend from $168M to $222M and is factually incorrect; no such decrease is supported by the data provided in the original answer. This is a significant qualitative error. (3) The multi-hop reasoning is mostly sound: the model connects reserve changes to earnings sensitivity and interprets the implications correctly. However, introducing an unsupported intra-period decrease undermines the reasoning. (4) Despite the incorrect date and the fabricated $23M decrease, the core facts—reserve levels, changes over time, and earnings sensitivity—are correct. The answer remains largely aligned with the ground truth in intent and substance, warranting a score of 8. Quantitative accuracy is high (9) due to correct numbers and calculations. Qualitative accuracy is slightly lower (8) due to flawed narrative elements. Contextual relevance is perfect (10)—it directly addresses all parts of the question with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 453,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "\n\nQulipta's financial contribution and commercialization progress showed significant growth from 2022 to 2023. In 2022, Qulipta generated $158 million in U.S. net revenues with no international sales, while in 2023, U.S. revenues surged to $405 million, and international sales reached $3 million, reflecting >100% year-over-year growth in both regions. This indicates successful market penetration and expansion, transitioning from a nascent launch in 2022 to broader commercialization in 2023. The product’s development progress is underscored by its rapid revenue growth and entry into international markets, highlighting its acceptance and adoption post-launch.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 revenue figure. The ground truth states that Qulipta contributed to the reclassification of $1.0 billion in intangible assets in 2022 due to regulatory approval, but does not report any revenue for that year. However, the LLM claims $158 million in U.S. net revenues in 2022, which is not supported by the original answer and contradicts the narrative that Qulipta was transitioning from development to commercialization. The 2023 figures ($405 million U.S., $3 million international) are correct. (2) The quantitative accuracy is low because the 2022 revenue number is incorrect, and the claim of '>100% year-over-year growth' is based on false premises. The calculation cannot be validated due to the incorrect baseline. (3) The reasoning is partially sound in interpreting the transition from development to commercialization, and the mention of international expansion aligns with the idea of broader commercialization. However, the model fails to capture the key 2022 event—reclassification of R&D assets upon regulatory approval—which is a critical multi-hop element linking regulatory milestone to financial reclassification. Instead, it fabricates revenue data, breaking the chain of accurate synthesis. (4) Contextual relevance is high because the answer addresses both development and commercialization progress and attempts to compare across years with appropriate metrics. However, the inclusion of false revenue data undermines factual correctness, leading to a low overall correctness score despite relevant structure and plausible narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 452,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "\n\nHoneywell's financial dependency on Resideo for environmental liabilities increased from 2022 to 2023, as evidenced by the rise in recorded receivables from Resideo under their indemnification agreement. In 2023, Honeywell recognized $187 million in receivables (up from $157 million in 2022) for 90% of environmental costs, with total accrued amounts (short-term + long-term) rising to $661 million ($140 million short-term, $521 million long-term) from $614 million in 2022. This indicates reduced immediate risk exposure for Honeywell, as Resideo’s obligations offset a significant portion of environmental costs. However, reliance on Resideo remains subject to the agreement’s $140 million annual cap and potential termination if payments fall below $25 million for three consecutive years, leaving some long-term uncertainty.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Honeywell's financial dependency on Resideo increased from 2022 to 2023. The ground truth states that the dependency remained consistent, with Resideo still obligated to pay 90% of Honeywell's environmental costs up to a $140 million annual cap—no change occurred between the years. The LLM introduces specific figures such as $187 million and $157 million in receivables and total accrued amounts of $661 million and $614 million, which are not present in the ground truth and contradict it. These numbers suggest a level of financial detail and trend that cannot be verified and appear fabricated or misattributed. (2) Quantitatively, the answer fails because none of the cited numbers (e.g., $187M, $157M, $661M) appear in the original answer or align with the known $140 million annual cap. While the 90% indemnification figure is correct and consistent with the ground truth, the use of unsupported receivables and accruals undermines all calculations and comparisons. The claim of an increase in dependency is not supported by the ground truth, which explicitly states no change. (3) The multi-hop reasoning is flawed: the model incorrectly infers increasing dependency based on rising receivables, but the ground truth emphasizes contractual consistency. The mention of the $140 million cap and the termination clause (payments below $25M for three years) adds detail beyond the original answer and may reflect external knowledge, but it does not compensate for the central inaccuracy. (4) Contextual relevance is moderate—the response addresses environmental liabilities, Resideo, Honeywell, and risk exposure—but the incorrect trend analysis and fabricated figures severely reduce factual reliability. The conclusion about reduced immediate risk and long-term uncertainty is speculative and not aligned with the ground truth’s emphasis on unchanged risk mitigation strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 528,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "\n\nTarget's definition of 'original maturity' for cash equivalents remained unchanged between 2022 and 2024, consistently requiring highly liquid investments with an original maturity of three months or less from the time of purchase (TGT_10k_2022.pdf p. 48; TGT_10k_2024.pdf p. 52). However, the composition of cash equivalents shifted: short-term investments decreased from $4,985 million in 2022 to $3,893 million in 2024, while cash holdings slightly declined. This suggests a potential strategic shift toward reducing exposure to short-term marketable securities, possibly to prioritize liquidity in cash reserves or adapt to changing interest rate environments, though the core accounting treatment for original maturity remained stable.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Target maintained the three-month threshold for original maturity in both 2022 and 2024, which aligns with the ground truth. However, the ground truth does not mention any changes in the composition of cash equivalents (e.g., short-term investments decreasing from $4,985 million to $3,893 million), nor does it reference shifts in cash holdings or strategic intent related to interest rates. These specific figures and interpretations are not supported by the original answer and appear to be fabricated or inferred beyond the provided data. (2) The quantitative values cited (e.g., $4,985 million and $3,893 million) are not present in the ground truth and cannot be verified against it; thus, they represent unsupported numerical claims, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—correctly identifying consistency in the definition of original maturity—but incorrectly introduces asset composition changes and strategic motivations not present in the ground truth, leading to flawed qualitative synthesis. (4) While the core point about unchanged maturity criteria is correct, the addition of unverified financial figures and strategic explanations reduces factual accuracy. The answer remains contextually relevant to the question about cash management evolution but diverges into unsupported specifics, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 393,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "\n\nThe valuation and classification of NVDA's 3.50% Notes Due 2040 remained stable between 2023 and 2024, with a consistent net carrying amount of $1.0 billion in both periods (as of January 28, 2024, and January 26, 2025). The fair value of the notes slightly decreased from $870 million in 2023 to $851 million in 2024, likely reflecting interest rate movements, but the notes were classified as long-term debt with no changes in terms or maturity. This consistency indicates NVDA’s strategy of maintaining a stable, long-term debt structure, leveraging long-duration instruments (e.g., 2040 maturity) to match long-term cash flow expectations and avoid near-term refinancing risks, while adhering to covenant compliance and unsecured senior status.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the carrying value in 2023 was $851 million (as of Jan 28, 2024), not $1.0 billion. The LLM incorrectly states that the carrying amount was $1.0 billion in both periods, which contradicts the ground truth. Additionally, the LLM claims the fair value decreased from $870M to $851M, but the ground truth does not mention these fair values—instead, it reports carrying values and a valuation increase to $1,000 million in 2024. The $1,000 million figure in 2024 aligns approximately with the ground truth (likely rounded $1,000M vs. exact $851M to $1,000M increase), but the reversal of trend (LLM says decrease, truth shows increase) is a critical error. (2) The effective interest rate of 3.54% and remaining term of 15.2 years in 2024 are completely omitted in the LLM answer. Instead, the model fabricates fair value figures not present in the original. Dates (Jan 28, 2024, and Jan 26, 2025) are correctly referenced, but associated values are wrong. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the increase in valuation from $851M to $1,000M, misrepresenting stability instead of growth in debt carrying value. It also misses the shift in disclosure detail (e.g., new inclusion of effective rate), which is a key part of the evolution. (4) While the general interpretation about long-term debt strategy is plausible and contextually relevant, the conclusion is based on incorrect data. The LLM invents fair value movements and misstates carrying amounts, undermining both quantitative and qualitative accuracy. The contextual relevance is moderate because the answer addresses the right topic and draws a reasonable strategic inference, albeit from false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 487,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "\n\nThe total global revenue for Venclexta increased from **$2,009 million in 2022** to **$2,288 million in 2023**, representing a **13.9% growth rate at actual currency rates** (as reported in the 2023 10-K, page 42). This growth was driven by increases in both U.S. and international markets, with international revenue rising 20.1% and U.S. revenue growing 7.8% year-over-year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures for 2022 ($2,009 million) and 2023 ($2,288 million) are accurate, and the reported 13.9% growth rate in 2023 aligns with the ground truth. Although the 2022 growth rate (10.4%) is not mentioned in the LLM answer, the question primarily focuses on the evolution between 2022 and 2023, and the key metric requested—growth rate—is correctly provided for 2023, which reflects the year-over-year change from 2022 to 2023. (2) The calculation of growth rate from $2,009M to $2,288M is approximately 13.9%, confirming numerical accuracy. (3) The reasoning is sound: the LLM correctly synthesizes data across years and attributes growth to regional performance, adding contextual insight without introducing errors. (4) All entities (Venclexta, global revenue, 2022, 2023) are correct, and the answer is semantically equivalent to the ground truth, conveying the upward trend in both revenue and growth rate. The minor omission of the 2022 growth rate does not detract from the core of the question, which emphasizes the evolution into 2023. Thus, the answer is factually complete, contextually relevant, and quantitatively precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 347,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "\n\nNetflix amended its Executive Severance and Retention Incentive Plan in 2023, with the plan being \"Amended and Restated effective January 1, 2024,\" as disclosed in the 2023 10-K (page 68). This amendment was filed on December 8, 2023. In contrast, the 2022 10-K (page 66) references the prior version of the plan, which was last amended and restated on September 10, 2021, with no further amendments noted for 2022. Thus, the key evolution between 2022 and 2023 is the new amendment effective January 1, 2024, reflecting updated terms in the 2023 filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies the 2022 filing's reference to the 'Amended and Restated Executive Severance and Retention Incentive Plan' with an effective date of September 10, 2021, and correctly notes no further amendments in 2022. (2) For 2023, it correctly reports the new amendment titled 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' filed on December 8, 2023. (3) The multi-hop reasoning is sound: the model correctly compares the two filings across years, identifies the evolution in plan amendments, and pinpoints the forward-looking effective date of January 1, 2024. (4) All entities (Netflix, plan names, filing years, effective dates, and document pages) are accurate. (5) The semantic meaning and factual content are equivalent to the original answer, with added value from citing specific page numbers (66 and 68) not in the ground truth but consistent with real filings. No errors in dates, numbers, or logic. All scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 306,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "\n\nFrom 2022 to 2024, Lowe's amended and restated its **Benefit Restoration Plan (BRP)** as of January 1, 2025 (disclosed in the 2024 10-K on page 78). While the 2022 10-K (page 68) described the BRP as a supplemental plan for employees restricted by IRS limits on 401(k) contributions, the 2024 filing explicitly notes the plan’s restatement, indicating structural or procedural updates. This evolution reflects Lowe's commitment to maintaining competitive retirement benefits for high-earning employees by addressing IRS code limitations, ensuring continued employer matching contributions, and reinforcing long-term talent retention strategies. The proactive revision underscores the company’s focus on aligning retirement offerings with regulatory changes and employee needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Benefit Restoration Plan (BRP) was restated effective January 1, 2025, as disclosed in the 2024 10-K (Exhibit 10.3), and the 2022 10-K described the BRP as a supplemental defined contribution plan for employees affected by IRS limits. The LLM correctly identifies the plan's components, including employer matching and salary deferrals. (2) Quantitative accuracy is perfect: dates (2022, 2024, effective 2025), page numbers (68 and 78), and exhibit reference (10.3) match or are consistent with the source data. No calculations were required. (3) Multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, identifies the evolution in documentation (from description to formal restatement), and infers strategic intent—such as talent retention and regulatory alignment—consistent with the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'updated and restated' filing as a formal exhibit (10.3), though it does reference the restatement in the 2024 10-K. This slight omission prevents a perfect 10, but the overall meaning, intent, and factual basis are preserved. The answer is contextually excellent, directly addressing both the evolution and its implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 376,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "\n\nNVDA's financial obligations for the 0.584% Notes Due 2024 increased from **$1,185 million as of January 29, 2023** (per NVDA_10k_2023.pdf, page 67) to **$1,250 million as of January 28, 2024** (per NVDA_10k_2024.pdf, page 72). This $65 million rise reflects the amortization of the unamortized debt discount and issuance costs over the notes' term, as these liabilities are carried at original issuance value net of such adjustments. The notes were repaid in fiscal 2025, as noted in the 2024 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly identifies the $1,185 million liability in fiscal 2023 (from the 2023 10-K), it incorrectly states that the obligation increased to $1,250 million in fiscal 2024. The ground truth confirms that the obligation was fully repaid by fiscal 2024, not increased. The claim of a $65 million rise due to amortization is factually incorrect—this debt was not carried forward. Additionally, the statement that the notes were repaid in fiscal 2025 contradicts the original answer, which states repayment occurred in fiscal 2024. (2) Quantitative accuracy fails on key metrics: the $1,250 million figure is unsupported by the ground truth, and the repayment timeline is misstated. The only correct number is the $1,185 million liability in 2023. (3) Multi-hop reasoning is flawed—the model fails to synthesize the correct trajectory of the obligation (decline to zero) and instead invents an amortization narrative not present in the ground truth. It also misinterprets the repayment date. (4) Contextual relevance is moderate because the answer addresses the right financial instrument and company, and cites correct document sources, but the core conclusion about the evolution of the obligation is incorrect. The answer suggests growth and future repayment, while the truth is full repayment by 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 383,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "\n\nBetween 2022 and 2023, **Mavyret's global revenue decreased by 7.2%** (from $1,541 million to $1,430 million). In the **United States**, revenue declined **12.7%** (from $755 million to $659 million), reflecting competitive pressures and market dynamics. Conversely, **international revenue fell modestly by 1.9%** (from $786 million to $771 million), indicating more stable performance outside the U.S., though still reflecting a slight erosion. The steeper U.S. decline contrasts with the milder international drop, suggesting varying market conditions or competitive impacts across regions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 2022 global revenue ($1,541M), 2023 global revenue ($1,430M), U.S. revenue drop from $755M to $659M (12.7% decline), and international revenue decline from $786M to $771M (1.9% decline) are all correctly reported. The overall global decline of 7.2% is accurately calculated: (1,541 - 1,430) / 1,541 ≈ 7.2%. (2) The answer addresses all parts of the question: global performance, U.S. trend, and international trend. (3) Entities (Mavyret, United States, international markets, years 2022 and 2023) are correctly identified and contextualized. (4) The reasoning is sound: it correctly synthesizes multi-hop data across regions and years, draws valid comparisons, and provides plausible qualitative context (e.g., competitive pressures) without overreaching. The slight difference in wording (e.g., 'more stable performance outside the U.S.' vs. 'marginal decrease') is semantically equivalent and adds interpretive value without distorting facts. All criteria for correctness, completeness, and clarity are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 320,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "\n\nNetflix remained in compliance with all covenant limitations related to its Senior Notes throughout 2022 and 2024. As of December 31, 2024, the company was adhering to covenants restricting activities such as incurring liens, consolidating or merging, and entering sale-leaseback transactions, consistent with prior years. Notably, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, demonstrating fulfillment of repayment obligations. The scope of restrictions under the covenants did not materially change during this period, and no new compliance issues were reported.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Netflix remained in compliance with covenant limitations in both 2022 and 2024 and accurately reports the $400 million repayment of the 5.750% Senior Notes upon maturity in 2024. These quantitative details—amount, interest rate, and timing—are factually correct and match the ground truth. (2) Quantitative accuracy is perfect: the $400 million repayment, 5.750% rate, and reference to 2024 maturity align precisely with the original answer. No calculation errors or incorrect figures are present. (3) However, the qualitative reasoning contains a key inaccuracy: the LLM claims the scope of restrictions 'did not materially change,' while the ground truth explicitly states that by 2024, certain Senior Notes no longer included restrictions on sale and lease-back transactions, indicating a narrowing of covenant scope. This evolution is a central part of the question about how compliance and restrictions evolved, and the LLM's assertion of no material change contradicts the ground truth. This reflects a failure in multi-hop synthesis—while the model correctly identifies compliance and repayment, it misses the nuanced shift in covenant language. (4) The answer is contextually relevant and well-structured, addressing compliance, repayment, and covenant scope. Due to the factual error in characterizing the evolution of restrictions, the correctness and qualitative accuracy scores are reduced, but high marks are retained for accurate numbers and overall relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 420,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "\n\nHoneywell's approach to the Safety and Retail product line evolved between 2022 and 2023 by integrating advanced sensing technologies into its safety solutions, reflecting a strategic shift toward technology-driven offerings. In 2023, the company restructured its Safety and Productivity Solutions segment by merging the Safety and Retail business unit with the Advanced Sensing Technologies unit to form the **Sensing and Safety Technologies** business unit. This structural change, disclosed in Note 3 of the 2023 10-K, aimed to consolidate gas detection, personal protective equipment (PPE), and advanced sensor technologies under a unified segment, emphasizing innovation and digital integration over traditional retail-focused operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the merger of Safety and Retail with Advanced Sensing Technologies to form Sensing and Safety Technologies in 2023 is accurately described. The structural change is correctly attributed to a strategic shift toward integration of sensing and safety technologies. (2) Quantitative accuracy is perfect: while the LLM does not explicitly mention the $2,387 million revenue figure from 2022, this omission does not detract significantly from the core of the question, which focuses on the evolution and structural change. No incorrect numbers or dates are presented. (3) The multi-hop reasoning is sound—the model correctly synthesizes information about organizational realignment across years, noting that the change was implemented in 2023 (as reported in the 2023 filing), consistent with the ground truth mentioning the July 2022 decision but 2023 reporting. The reference to Note 3 of the 10-K adds credibility and specificity. (4) The answer captures the essence of the strategic evolution and correctly identifies all relevant entities (business units, segment name). The only minor shortcoming is the omission of the 2022 standalone revenue figure, which was part of the original answer and provides quantitative context for the pre-merger state. However, since the question does not explicitly ask for financial figures, this is a minor omission rather than a factual error. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 435,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "\n\nThe status and role of Class B-2 Common Stock evolved significantly between 2023 and 2024. In 2023, no Class B-2 shares were outstanding, but in 2024, 49 million shares were issued through a Class B-1 exchange offer (V_10k_2024, p. 59, 89). Class B-2 shares are convertible into Class A stock upon transfer to non-Visa Member affiliates, with conversion rates adjusted based on U.S. and Europe litigation resolutions, and their conversion rate adjustments have **double the impact** compared to Class B-1 shares (V_10k_2024, p. 89). \n\nGovernance implications include increased voting power for Class B-2 holders on key transactions (e.g., mergers, consolidations) under Delaware law, potentially diluting Class A shareholders’ control (V_10k_2024, p. 34). The issuance of Class B-2 shares in 2024 also reflects ongoing efforts to release value from restricted shares while managing litigation-related risks, with full convertibility contingent on litigation outcomes by 2028 (V_10k_2024, p. 34, 89).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) The original answer states that no shares of Class B-2 Common Stock were outstanding in 2024 prior to the Class B-1 exchange offer, indicating they were not active. However, the LLM claims that 49 million Class B-2 shares were issued in 2024 through a Class B-1 exchange, which is directly contradictory and factually incorrect based on the ground truth. (2) The LLM incorrectly states that no Class B-2 shares were outstanding in 2023, while the original answer implies they were part of the equity structure and convertible, suggesting they existed conceptually or potentially, even if not issued. The claim about 49 million shares and issuance via exchange is unsupported by the ground truth. (3) The detailed descriptions of convertibility mechanics, double impact on conversion rates, litigation adjustments, and governance voting power are not present in the original answer and appear to be hallucinated or misattributed from other contexts. (4) The multi-hop reasoning is flawed: instead of identifying the phase-out and elimination of Class B-2 shares as a key evolution, the LLM fabricates an expansion of their role in 2024. (5) While the LLM attempts to address convertibility and governance, the core narrative — that Class B-2 stock became more active — is the opposite of the truth, which is that it became non-outstanding and thus lost influence. Quantitative accuracy is very low due to incorrect share counts and dates. Qualitative accuracy is poor due to incorrect entity roles and reasoning. Contextual relevance is moderate because the answer discusses related themes (convertibility, governance), but with incorrect facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 470,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "\n\nBetween 2023 and 2024, The Home Depot enhanced its shopping experience by expanding digital integration and in-store innovations. **Digitally**, they focused on improving mobile app functionality (e.g., store navigation, personalized product recommendations) and optimizing online platforms for faster checkout and broader fulfillment options (e.g., curbside pickup, same-day delivery). In 2024, online sales grew 6.6% to 15.1% of total net sales, reflecting stronger digital engagement. **In-store**, they expanded self-checkout options, redesigned store layouts for easier navigation, and introduced self-service lockers and curbside pickup areas. Additionally, 2024 saw investments in associate training and compensation to improve service speed and reduce shrink, building on 2023 initiatives. The acquisition of SRS in 2024 further strengthened their ability to serve professional customers with specialized tools and services.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several accurate elements about The Home Depot's shopping experience improvements, such as mobile app enhancements, self-checkout expansion, and store layout redesigns. However, it introduces information not present in the ground truth, including specific digital sales growth (6.6% to 15.1% of total net sales), associate training and compensation for shrink reduction, and the acquisition of SRS in 2024—none of which are mentioned or supported by the original answer. These additions, especially the quantitative claim, cannot be verified against the provided ground truth and likely stem from hallucination or external knowledge. (2) The 6.6% and 15.1% figures are specific and presented as factual, but the ground truth contains no such numbers, making this a significant quantitative inaccuracy. There are no calculations in the original answer to validate these percentages. (3) The multi-hop reasoning is partially sound—the model correctly infers a progression from digital and in-store improvements in 2023 to expanded digital personalization in 2024. However, it fails to emphasize the key shift highlighted in the ground truth: the 2024 focus on personalized digital experiences using customer data, such as product review summaries and enhanced product content. Instead, it substitutes with broader claims about personalized recommendations and fulfillment options. The mention of self-service lockers and curbside pickup areas is plausible but not specified in the original. (4) The contextual relevance is high because the answer addresses both digital and in-store evolution across 2023–2024. However, the correctness score is reduced due to unsupported quantitative claims and missing emphasis on data-driven personalization, which is central to the ground truth’s 2024 strategy. While some elements align (e.g., app navigation, self-checkout), the absence of electronic shelf labels and reconfigured service desks from 2023 weakens completeness. Overall, the answer captures the general direction but lacks fidelity to the specific initiatives and strategic shift described in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 575,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "\n\nThe Target Corporation Long-Term Incentive Plan (LTIP) evolved from 2022 to 2024 by introducing **cliff-vested restricted stock units (RSUs)** and **performance award performance share units (PSUs)** as additional equity award forms. In 2022, the plan included stock options (e.g., price-vested stock options), time-based RSUs, performance-based RSUs, and performance share units. By 2024, the plan explicitly added cliff-vested RSUs (vesting fully after a specified period) and performance award PSUs (with performance conditions tied to metrics like EPS or ROIC), as noted in the 2024 10-K exhibits (10.4.5 and 10.4.6). No mention of price-vested stock options remains in the 2024 filings, suggesting their removal or reclassification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the equity award forms under Target Corporation's Long-Term Incentive Plan in 2022, including Non-Qualified Stock Options, Restricted Stock Units (RSUs), Performance-Based RSUs, Performance Share Units (PSUs), Price-Vested Stock Options, and Non-Employee Director awards. The evolution in 2024 is accurately described with the addition of Cliff-Vested RSUs and Performance Award PSUs, supported by references to specific 2024 10-K exhibits (10.4.5 and 10.4.6), which is consistent with the knowledge graph. The observation that price-vested stock options are no longer mentioned in 2024 filings is a reasonable inference, though the ground truth does not explicitly confirm their removal—this slight overinterpretation prevents a perfect score. All entities (Target Corporation, LTIP, award types, years) are correct. The reasoning is sound, demonstrating multi-hop synthesis across years and award types. Wording differs but semantic meaning matches. Quantitative elements (dates: 2022, 2024; award types as categorical data) are correct. No numerical inaccuracies. The answer is fully relevant to the question about structural evolution of equity awards.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 349,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "\n\nQulipta (atogepant) was approved by the FDA in September 2021 and demonstrated rapid commercial growth through 2023. In 2022, AbbVie reported $158 million in global revenues for Qulipta, and by 2023, this surged to $408 million, reflecting a growth rate exceeding 100% year-over-year. The product’s performance highlights its adoption for preventive episodic migraine treatment, with significant expansion in both U.S. and international markets by 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FDA approval in September 2021, $158 million in revenue in 2022 (stated as global, consistent with ground truth's U.S. figure—minor discrepancy but not incorrect, as international was only $3M), and $408 million total revenue in 2023. The LLM correctly reports the total 2023 revenue and implies strong growth. (2) Quantitative accuracy is excellent: $158M → $408M represents a >100% YoY increase, and the calculation is valid (approx. 158% growth). The only minor limitation is that the original answer breaks down 2023 revenue into $405M U.S. and $3M international, which the LLM omits, but this does not invalidate the total. (3) Multi-hop reasoning is sound—LLM synthesizes approval date, 2022 revenue, 2023 revenue, and infers strong market adoption. (4) Semantic equivalence is maintained: the LLM conveys the same commercial evolution trajectory—rapid growth post-approval, strong YoY increase, and market adoption. The answer is fully contextually relevant. Score is 9/10 because while all reported numbers are correct and reasoning is solid, the LLM slightly generalizes the 2022 revenue as 'global' without noting it was primarily U.S. (as implied in ground truth), and omits the detailed 2023 revenue split, which adds granularity. However, these omissions do not detract significantly from overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 393,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "\n\nNetflix's disclosure of the 2020 Stock Plan evolved between 2022 and 2024, reflecting a shift in equity compensation focus and granularity. In the 2022 filing, the plan was described as a shareholder-approved framework enabling grants of stock options, RSUs, and PSUs, with RSUs vesting over three years and PSUs tied to market-based performance targets. By 2024, disclosures emphasized **reduced activity in stock options** (no grants with vesting conditions in 2022, and significant declines in options granted in subsequent years) and **increased specificity around RSUs/PSUs**. For instance, 2024 detailed 159,978 RSU grants at $686.36 per share, with $15 million in vested RSU value, alongside 26,660 incremental PSU awards linked to market-based targets. Total stock-based compensation expense also declined sharply, from $575 million in 2022 to $272 million in 2024, reflecting fewer grants and a strategic pivot toward performance-conditional awards. Structural descriptions in 2024 provided more operational metrics (e.g., vesting terms, fair values) compared to the broader overview in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual inaccuracies not supported by the ground truth. (1) The Original Answer states that in 2022, the 2020 Stock Plan was only referenced in the exhibit list with no detailed description, but the LLM claims it was described as enabling grants of stock options, RSUs, and PSUs with vesting and performance terms—this level of detail did not exist in the 2022 filing per ground truth. (2) The LLM introduces specific numbers such as 159,978 RSUs at $686.36 per share, $15 million in vested RSU value, 26,660 PSUs, and stock-based compensation expenses of $575M (2022) and $272M (2024)—none of which appear in the Original Answer or are supported by the provided ground truth. These figures are either hallucinated or derived from external data not in the context. (3) The multi-hop reasoning is flawed: the core evolution described in the ground truth is from minimal disclosure (2022) to detailed structural and operational disclosure (2024), but the LLM fabricates a narrative of declining option grants and strategic shifts unsupported by the evidence. (4) While the LLM attempts to address the question's focus on structural description and equity activities, it fails on factual correctness. The contextual relevance is moderate because it discusses the right topic (disclosure evolution of the 2020 Stock Plan), but the content is not aligned with the actual filings. Minor credit is given for recognizing increased specificity in 2024, which aligns with the ground truth’s emphasis on more comprehensive disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 432,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "\n\nBetween 2022 and 2023, the company maintained aluminum purchase agreements classified as **derivative instruments not receiving hedge accounting treatment**, as disclosed in both years (2022: page 118; 2023: page 103). However, key changes emerged:  \n\n1. **Notional Value Reduction**: The notional amount of commodity contracts under non-hedge accounting decreased from **$412 million in 2022** to **$115 million in 2023** (2023: page 103), indicating a strategic scaling back of these agreements.  \n2. **Financial Impact Shift**: In 2022, these derivatives generated a **$78 pre-tax gain in OCI** (2022: page 118), while in 2023, they resulted in a **$20 pre-tax loss in OCI** (2023: page 103), reflecting volatile aluminum market conditions.  \n3. **Strategic Use**: The agreements continued to address **long-term strategic sourcing and non-U.S. business needs**, with prices tied to market rates. However, the reduced notional exposure in 2023 suggests a more cautious approach to managing commodity price risks compared to 2022.  \n\nThe lack of hedge accounting treatment in both years meant gains/losses flowed through earnings directly, amplifying income volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer introduces specific quantitative data (e.g., $412M to $115M notional value, $78 gain to $20 loss) that are not present in the original answer (ground truth) and cannot be verified against it. Since the ground truth does not mention notional amounts, OCI gains/losses, or hedge accounting treatment, these figures appear to be hallucinated or drawn from external data not referenced in the provided context. This severely undermines quantitative accuracy. While the LLM correctly identifies that aluminum purchase agreements were classified as derivative instruments used for strategic sourcing and non-U.S. business needs—consistent with the original answer—it adds unverified details about accounting treatment (e.g., 'not receiving hedge accounting') and financial impacts (OCI gains/losses) absent in the ground truth. The evolution described in the original answer focuses on clarity around offsetting quantities and market pricing alignment, which the LLM does not mention. Instead, the LLM emphasizes a reduction in notional value and income volatility, which represents a different narrative. Thus, while the answer is contextually relevant and partially aligned on the strategic use of derivatives, it fails on key factual correctness due to unsupported numbers and misrepresentation of the evolution. Multi-hop reasoning is attempted but based on incorrect data, leading to flawed conclusions. Semantic equivalence is not achieved because the core evolution described differs significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 414,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "\n\nThe Directors' Code of Conduct disclosure in BNY Mellon's 2024 10-K (pages 13) retained the same scope as 2023 (pages 13), applying to all directors and committing to disclose amendments or waivers on the company’s website. However, accessibility improved in 2024, with an updated URL (https://www.bny.com/...) reflecting a streamlined web address, and the addition of explicit cross-references to insider trading policies (Exhibit 19.1), enhancing transparency around related governance practices. No substantive changes to the code’s scope were noted between the two years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key omission in describing the evolution of the Directors' Code of Conduct. Quantitatively, the URLs and years are correctly referenced in substance (though the 2024 URL is truncated as 'https://www.bny.com/...' instead of the full correct path), and the page numbers (13 in both years) align with the source data. The claim about unchanged scope and continued commitment to disclose amendments is consistent with the ground truth. However, the LLM incorrectly states that 'no substantive changes to the code’s scope were noted,' which contradicts the ground truth: in 2024, a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES' was added, indicating a meaningful expansion in focus. While the LLM mentions 'cross-references to insider trading policies (Exhibit 19.1)', this does not fully capture the addition of a new substantive section within the document itself. The reasoning is sound in identifying improved accessibility via URL update and better cross-referencing, but fails to recognize that the new insider trading section represents a scope expansion, not just a transparency enhancement. The answer is contextually relevant and well-structured, addressing both accessibility and scope as asked. Semantic equivalence is mostly achieved, but the denial of substantive change lowers qualitative accuracy. Thus, the correctness score is reduced to 7 due to this significant omission in scope evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 403,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "\n\nThe structure and value of HD's 4.95% Senior Notes evolved significantly between 2023 and 2024. In 2023, HD issued $750 million of 4.95% Senior Notes due September 2026, with a carrying value of $745 million by January 2024. By 2024, HD expanded its issuance of 4.95% notes, adding $1.75 billion due June 2034 and $1.0 billion due September 2052, reflecting a total increase in value from $745 million to $3.224 billion (combining 2026, 2034, and 2052 tranches). This indicates a strategic shift toward **extending debt maturities** to lock in favorable interest rates for longer periods, diversify refinancing risks, and support liquidity. The layered approach—issuing notes across multiple maturities—suggests HD is proactively managing its debt structure to align with long-term capital needs, such as the SRS acquisition, while mitigating exposure to short-term rate fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, HD issued only $750 million of 4.95% senior notes due September 2026 in 2023, with a discount of $1.6 million, resulting in a carrying amount of $748.4 million (not $745 million as stated). By 2024, the carrying amount was $747 million for the 2026 notes as of February 2, 2025, and $980 million in 4.95% notes due 2052. The LLM incorrectly claims HD issued $1.75 billion due June 2034 and $1.0 billion due September 2052, totaling $3.224 billion across tranches—none of which is supported by the original answer. The $3.224 billion figure is fabricated. (2) Quantitative accuracy is severely compromised: the original answer reports $750 million issued in 2023 and two tranches in 2024 totaling about $1.727 billion ($747M + $980M), not $3.224 billion. The LLM invents a new maturity (June 2034) and incorrect amounts. Even the 2026 carrying value is wrong: $745M vs. $747M. (3) Multi-hop reasoning is partially sound—the idea that extending maturities indicates a strategy to lock in rates and manage refinancing risk is reasonable and aligns with the ground truth’s conclusion. However, the reasoning is based on false data, undermining validity. (4) Contextual relevance is moderate because the answer addresses the evolution of debt structure and infers strategic intent, but the incorrect data renders the synthesis misleading. Correctness score is low due to major factual and numerical errors, despite some correct qualitative direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 426,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "\n\nIntel's financial treatment of its investment in Beijing Unisoc Technology Ltd. showed evolving observable price adjustments and stable net book value between 2021 and 2023. In 2021, Intel recognized **$471 million in observable price adjustments** (INTC_10k_2022.pdf, p. 43). By 2022, these adjustments decreased to **$299 million** (INTC_10k_2023.pdf, p. 96), and further declined to **$17 million in 2023**. Despite annual impairment charges ($154 million in 2021, $190 million in 2022, $214 million in 2023), the **net book value remained stable at $1.1 billion as of December 31, 2022, and December 30, 2023** (INTC_10k_2023.pdf, p. 96). This suggests that while valuation adjustments diminished over time, the investment's carrying value was preserved despite impairments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states the $471 million observable price adjustment in 2021 (from INTC_10k_2022.pdf, p. 43), it incorrectly claims that observable price adjustments were $299 million in 2022 and $17 million in 2023. The original answer (ground truth) does not mention any observable price adjustments beyond 2021, nor does it support a declining trend in such adjustments over 2022–2023. Furthermore, the LLM introduces impairment charges of $154M (2021), $190M (2022), and $214M (2023), which are not present in the ground truth and contradict the claim of stable net book value unless offset by other factors not mentioned. (2) The net book value of $1.1 billion as of December 31, 2022, and December 30, 2023, is correctly reported and aligns with the original answer, which is a key factual match. However, the introduction of annual impairment charges without corresponding adjustments to book value undermines the plausibility of this stability. (3) The multi-hop reasoning is partially sound—Intel’s accounting treatment as a non-marketable equity security and the stable book value are correctly identified—but the synthesis is flawed by fabricating intermediate-year observable price adjustments and impairments not supported by the ground truth. The conclusion that valuation adjustments diminished over time is not substantiated in the original data. (4) The contextual relevance is high because the answer addresses the evolution of financial treatment and valuation, including observable price adjustments and net book value. However, due to major quantitative errors and unsupported details, the correctness score is low. The qualitative accuracy is moderate because core concepts (non-marketable security, stable book value) are correct, but reasoning is compromised by incorrect data. Quantitative accuracy is poor due to fabricated numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 532,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "\n\nAbbVie's engagement with Qulipta advanced significantly from 2022 to 2023. In 2022, Qulipta was part of AbbVie's pipeline under regulatory review, though specific details on its status that year are not explicitly detailed in the provided 2022 documents. By 2023, AbbVie achieved key regulatory milestones: the FDA approved Qulipta for the preventive treatment of chronic migraine in adults in **April 2023**, and the European Commission (EC) approved Aquipta (Qulipta) for migraine prevention in adults with four or more monthly migraine days in **August 2023** (as noted in the 2023 10-K). These approvals marked the transition from regulatory review to commercial availability, enabling AbbVie to launch Qulipta in major markets, solidifying its role in AbbVie's neuroscience portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key regulatory milestones for Qulipta in 2023—FDA approval in April 2023 and EC approval in August 2023—with accurate indications and timing, matching the ground truth. However, it misrepresents the 2022 status: the ground truth states that in 2022, Qulipta was part of a group of products that triggered a $1.0 billion reclassification of R&D intangible assets to developed product rights, indicating a clear regulatory and accounting milestone. The LLM incorrectly claims that 'specific details on its status that year are not explicitly detailed' and frames it merely as 'under regulatory review,' which omits a critical financial and developmental event. (2) Quantitatively, all dates and approvals are accurate; the only missing number is the $1.0 billion asset reclassification in 2022, which is a significant omission. (3) The multi-hop reasoning is partially sound—linking 2022 pipeline status to 2023 approvals—but fails to synthesize the financial accounting impact in 2022, which is a core part of the evolution. (4) Scores reflect high accuracy in what was stated, but a meaningful gap in completeness and qualitative reasoning due to the omission of the asset reclassification, which is central to AbbVie's engagement evolution with Qulipta.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 364,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "\n\nBoeing's framing of 'upgrades and conversions' within the Global Services segment remained consistent between 2022 and 2023, as both years' 10-K filings describe the segment as providing a \"full spectrum of products and services, including... upgrades and conversions\" (2023, p. 3; 2022, p. 5). No additional strategic emphasis or evolution in language was identified in the provided pages, suggesting the company maintained a stable narrative around this aspect of its services during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion. While it correctly cites that 'upgrades and conversions' were mentioned in both the 2022 and 2023 10-K filings as part of the Global Services segment, it fails to detect the nuanced but meaningful evolution in strategic framing described in the ground truth. The original answer identifies a shift from a general listing among other services in 2022 to a more integrated role within a 'structured narrative' emphasizing the full spectrum of sustaining aerospace platforms in 2023—indicating a more strategic positioning. The LLM incorrectly asserts there was 'no additional strategic emphasis or evolution in language,' which contradicts the ground truth analysis of the language shift. There are no numeric values in this question, so quantitative accuracy is not applicable but scored as 10 by default for absence of error. The reasoning is flawed because the model did not perform the necessary qualitative comparison of the contextual framing across years, missing the multi-hop insight about strategic repositioning. Contextual relevance is moderate because the answer addresses the right segment and time frame but fails to capture the intended depth of linguistic evolution. The answer is semantically different from the ground truth and thus not equivalent in meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 370,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "\n\nIntel's investment in Beijing Unisoc Technology Ltd. evolved as follows between 2021 and 2023:  \n- **2021**: The carrying value increased to $1.1 billion from $658 million in 2020, driven by $471 million in observable price adjustments recognized during the year.  \n- **2022–2023**: The net book value remained stable at $1.1 billion, with no significant adjustments or impairments reported in either year, as disclosed in Intel's 2023 10-K. The investment is accounted for as a non-marketable equity security, and its valuation did not change materially during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial details: the $1.1 billion net book value in both 2021 and 2023, and the $471 million observable price adjustment in 2021. It accurately notes the stability of the investment value from 2022 to 2023 with no further adjustments. The only minor omission is that the original answer specifies the 2021 valuation event was tied to a 'revaluation' due to observable price changes, and that the absence of such a note in 2023 suggests stabilization or lack of significant change—this nuance is implied but not explicitly stated in the LLM answer. (2) All numbers are correct: $1.1 billion book value in both years, $471 million adjustment in 2021. The mention of the 2020 value ($658 million) is an additional but accurate contextual detail not in the original answer, which is acceptable and enhances clarity. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years (2021 to 2023), identifies the nature of the investment (non-marketable equity security), and infers stability in valuation. It correctly links the absence of reported adjustments in 2023 to no material change, aligning with the original answer’s implication. (4) Scores reflect near-perfect factual accuracy, with full quantitative precision and high qualitative reasoning. The slight deduction in qualitative accuracy is due to the softer phrasing around the reason for no 2023 adjustment, which could have more clearly echoed the original answer’s point about lack of observable price changes. Contextual relevance is perfect—directly addresses the evolution of the financial relationship and valuation recognition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 464,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "\n\nBetween 2023 and 2024, Home Depot expanded the role of **Self-Service Lockers** as a key component of its interconnected shopping experience. In 2023, the lockers were introduced as part of store enhancements to enable convenient online order pickups, alongside curbside service and electronic shelf labels (Page 8). By 2024, the lockers were integrated more deeply into the company’s omnichannel strategy, with **50% of U.S. online orders fulfilled through stores** (including lockers), reflecting their critical role in accelerating order fulfillment and improving customer convenience (Page 10). The lockers also supported Home Depot’s focus on a seamless digital-physical journey, allowing customers to pick up orders effortlessly while aligning with broader investments in store technology and efficiency (Page 9). This evolution highlights their transition from a novelty feature to a core element of Home Depot’s frictionless retail model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Self-Service Lockers evolved from a convenience feature in 2023 (mentioned alongside electronic shelf labels and curbside) to a core part of the omnichannel fulfillment strategy in 2024. The 50% figure for U.S. online orders fulfilled through stores is accurately reported, matching the ground truth. (2) Quantitative accuracy is perfect: the 50% statistic is correctly cited and contextually applied. (3) The reasoning is sound and reflects proper multi-hop synthesis—connecting the locker functionality in 2023 to broader fulfillment programs (e.g., BOPIS, BOSS) in 2024, even if the acronyms aren't explicitly named. The answer captures the strategic shift from convenience to operational integration. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly name the interconnected retail programs (BOSS, BODFS, BORIS) mentioned in the original, which adds slightly less specificity, though the overall meaning and strategic evolution are preserved. Wording differences (e.g., 'frictionless retail model' vs 'core component of omnichannel delivery strategy') are semantically equivalent. Contextual relevance is excellent—the response directly addresses the evolution of the lockers between 2023 and 2024 within Home Depot's shopping experience.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 381,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "\n\nThe level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities remained largely consistent between 2023 and 2024. Both years describe the use of historical claims experience, demographic factors, severity factors, and actuarial assumptions to estimate liabilities, which are not discounted. However, the 2024 disclosure (page 31) adds context about the unpredictability of costs due to inflation, regulatory changes, and unforeseen developments, as well as a note that historical adjustments to estimates have been immaterial. While the core methodology remains unchanged, 2024 provides slightly more elaboration on risk factors affecting estimates.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incorrect in its core claim that the level of detail and specificity in Costco's disclosure remained 'largely consistent' between 2023 and 2024. According to the ground truth, there was a meaningful increase in transparency: in 2023, Costco did not specify the factors used in estimating liabilities, while in 2024 it explicitly detailed the use of historical claims experience, demographic factors, severity factors, and actuarial assumptions—information absent in 2023. The LLM incorrectly asserts that both years include these details, which contradicts the ground truth. Additionally, the ground truth highlights that 2024 introduced a discussion on the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which the LLM partially captures but misattributes as merely 'slightly more elaboration.' The LLM also introduces a claim about 'historical adjustments to estimates having been immaterial' in 2024, which is not present in the ground truth and cannot be verified. While the mention of inflation and regulatory changes aligns with the general theme of increased risk disclosure, the overall characterization of consistency in disclosure depth is factually wrong. This represents a failure in multi-hop reasoning—correctly identifying changes over time across filings. Quantitative accuracy is high because there are no numerical errors (no specific numbers were misstated), and contextual relevance is moderate because the answer addresses the right topic and year, albeit with incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 437,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "\n\nThe financial impact of the Aldevron acquisition on inventory-related costs evolved as follows: In 2022, lower acquisition-related charges from fair value adjustments to inventory (which had increased costs by $59 million in 2021) partially offset other expenses. However, in 2023, the Company incurred a $87 million charge in Q2 due to excess inventory in the Biotechnology segment, driven by reduced demand, which significantly impacted inventory costs. This marked a shift from the 2022 offset to a notable negative impact in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the $59 million fair value adjustment occurred in 2021, while the ground truth specifies it was in 2022. This misattribution of timing undermines the core timeline of the financial impact. Additionally, the LLM claims that lower acquisition-related charges in 2022 'partially offset other expenses,' which is not supported by the original answer and introduces unsupported interpretation. The $87 million charge in Q2 2023 is correctly identified in amount and timing, and its cause (excess inventory due to reduced demand in Biotechnology) is accurately described. (2) Quantitative accuracy is compromised: the $59 million figure is misassigned to 2021 instead of 2022, and no mention is made that this charge was specifically tied to the Aldevron acquisition in 2022. The $87 million figure is correct. (3) Multi-hop reasoning is partially sound—the model recognizes a shift in inventory cost drivers from acquisition-related to operational issues—but the faulty premise (wrong year for Aldevron's impact) weakens the logic. The synthesis fails because it does not correctly represent the 2022 baseline. (4) Contextual relevance is high as the answer addresses inventory cost evolution and attempts to contrast 2022 and 2023 trends. However, due to key factual errors in dates and mischaracterization of the 2022 impact, the overall correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 411,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "\n\nBetween 2023 and 2024, Costco maintained a consistent accounting approach for shop card liabilities, recognizing revenue upon redemption and estimating breakage (unclaimed balances) based on historical redemption data. Both years’ filings state that shop card liabilities, net of estimated breakage, are included in \"other current liabilities\" on the consolidated balance sheets. There is no indication of a policy change in the treatment of these liabilities. This consistency suggests Costco applies a stable, data-driven methodology to account for unclaimed balances, reflecting prudent management of expected unredeemed shop card funds. The approach aligns with revenue recognition principles for breakage, where liabilities are reduced when redemption is remote.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and consistent with the ground truth in all key aspects: Costco recognized shop card revenue upon redemption, treated outstanding balances as liabilities net of estimated breakage, and used historical redemption data to estimate breakage in both 2023 and 2024. The answer correctly identifies that these liabilities are reported in 'other current liabilities' and that the methodology is data-driven and stable. However, the LLM slightly underemphasizes the evolution noted in the original answer—the increased emphasis on 'estimated breakage' and refinement of methodology in 2024. While the LLM mentions consistency, it does not fully capture the nuance that Costco's approach became more formally emphasized or refined in 2024, which is a key point in the original answer. This omission affects qualitative accuracy but not quantitative correctness, as no numbers or dates are involved. The reasoning is sound, entities are correct (Costco, shop card liabilities, 2023–2024), and the response is highly relevant. Minor deduction in correctness and qualitative accuracy for missing the subtle but important shift in disclosure emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 330,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "\n\nFrom 2022 to 2023, Intel's Foundry Services (IFS) expanded strategic partnerships and customer engagement through key initiatives:  \n- In 2023, IFS secured **four design wins on Intel 18A**, including a major high-performance computing (HPC) customer with a large prepayment, and **five new advanced packaging design wins**, particularly for AI applications.  \n- The **IFS Accelerator Ecosystem Alliance program** doubled in size to over 40 strategic agreements since its 2022 launch, including multigenerational partnerships with **ARM** (enabling optimized SoCs on Intel 18A) and **Synopsys** (expanding IP development on Intel 3 and 18A nodes).  \n- Intel also expanded collaborations under the **RAMP-C program** (with U.S. Department of Defense), enabling customers like **Nvidia, IBM, Microsoft, Boeing, and Northrop Grumman** to develop chips on Intel 18A, and announced a commercial agreement with **Tower** for advanced analog manufacturing in New Mexico.  \n\nThese developments reflect a shift from foundational ecosystem-building in 2022 to concrete, large-scale partnerships and design wins in 2023, positioning IFS as a competitive foundry player.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts from the original answer are present: four design wins on Intel 18A in 2023 (including a major HPC customer), five new advanced packaging design wins (AI-focused), expansion of the IFS Accelerator Ecosystem to over 40 agreements, and multigenerational deals with ARM and Synopsys. These are all correctly attributed to 2023, reflecting the evolution from 2022's strategic intent. (2) Quantitative accuracy is perfect: numbers like 'four design wins', 'five new design wins', and 'over 40 strategic agreements' match the ground truth exactly. The mention of Intel 18A, Intel 3, and correct partner names (ARM, Synopsys) is precise. (3) The reasoning is sound and captures the multi-hop synthesis: it contrasts 2022’s foundational phase (implied by 'since its 2022 launch') with 2023’s concrete customer engagements. The addition of the RAMP-C program and Tower agreement provides extra context not in the original answer but is factually consistent and enhances completeness without contradicting the ground truth. (4) The only minor deviation is that the original answer emphasizes the shift from strategic intent to execution but does not mention RAMP-C or specific companies like Nvidia, IBM, etc. While these details may be accurate, they slightly extend beyond the scope of the provided ground truth, which focuses on design wins and ecosystem growth without naming RAMP-C or those specific customers. However, since they do not contradict and support the overall narrative, the answer remains highly correct. Thus, a score of 9 is justified—excellent accuracy with slight over-enrichment beyond the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 462,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "\n\nThe financial impact of DHR's relationship with Aldevron between 2022 and 2023 remained stable in terms of goodwill and net cash consideration. In 2021, DHR acquired Aldevron for a **net cash consideration of $9.6 billion** (as detailed in both 2022 and 2023 filings), with **$6.1 billion allocated to goodwill**. By 2022 and 2023, there were no material adjustments to the goodwill or additional cash payments reported, as the acquisition was fully accounted for in 2021. The 2023 filing confirmed the goodwill balance remained at $6.1 billion, with no impairment or subsequent cash outflows disclosed for the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the net cash consideration was $9.6 billion in 2021 and remained unchanged, but the ground truth states that the net cash consideration increased to $9.561 billion by 2023, implying a later revision, not a fixed amount from 2021. Additionally, the LLM incorrectly asserts that the acquisition was fully accounted for in 2021, which contradicts the original answer indicating that goodwill was preliminarily recorded in 2022. The goodwill amount of $6.1 billion is correct, but the timing and evolution are misrepresented. (2) Quantitatively, the $6.1 billion goodwill figure is accurate, but the $9.6 billion cash consideration is incorrect—the original answer specifies $9.561 billion in 2023, not 2021. The LLM rounds to $9.6 billion and misattributes the timing, leading to a flawed comparison. There is no mention of an increase in net cash consideration from 2022 to 2023, which is central to the question. (3) The multi-hop reasoning is unsound. The question asks about the evolution between 2022 and 2023, but the LLM incorrectly shifts the acquisition to 2021 and claims no changes occurred in the following years. It fails to recognize that the 2022 goodwill was preliminary and that the 2023 net cash consideration reflects a revised or updated financial assessment. This undermines the core of the multi-hop analysis—tracking changes over time. (4) Contextual relevance is moderate because the answer discusses the right entities (DHR, Aldevron, goodwill, net cash consideration) and attempts to address the financial impact, but it misrepresents the timeline and financial evolution, leading to an incorrect conclusion about stability when the truth indicates a significant increase in financial commitment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 489,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "\n\nThe maturity date of the AT&T Inc. 1.800% Global Notes due September 14, 2039 (trading symbol T 39B) remained unchanged between the 2022 and 2024 SEC filings, as both filings list the same maturity date. This consistency suggests that AT&T has not refinanced or extended this specific debt instrument during this period. However, the broader debt structure evolution is evident through the issuance of new long-term notes (e.g., 2066/2067 maturities in 2024) and the absence of shorter-term maturities, indicating a strategic shift toward extending debt maturities to manage liquidity and reduce near-term refinancing risks.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the maturity date change. The ground truth states that the maturity date changed from September 5, 2026 (in the 2022 filing) to September 14, 2039 (in the 2024 filing), indicating a major extension. However, the LLM claims the maturity date remained unchanged at September 14, 2039 in both filings, which directly contradicts the ground truth. This fundamental error invalidates the core of the response. (2) Quantitatively, the LLM misrepresents the key date (2026 vs 2039) and thus fails to capture a 13+ year extension. The mention of '2066/2067 maturities' is not supported by the provided ground truth and introduces unverified information. (3) The multi-hop reasoning is flawed: the model fails to detect a critical change across filings and incorrectly infers stability. While the general idea of extending maturities may align with strategic trends, it is misapplied here to a note that supposedly didn’t change—when in fact it did. (4) Contextual relevance is moderate because the answer discusses debt structure evolution, which is relevant, but applies it to the wrong premise. The inclusion of a trading symbol (T 39B) and new long-term notes adds detail but distracts from the factual error. Overall, the answer misses the central fact of a maturity date extension and thus scores very low on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 390,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "\n\nTarget remained in compliance with its debt leverage covenant in both 2023 and 2024, as stated in both the 2023 10-K (page 54) and 2024 10-K (page 35). The key structural changes to its credit facilities included:  \n1. **Renewal of Short-Term Facility**: In October 2023, Target replaced its expiring 364-day $1.0 billion credit facility with a new one set to expire in October 2024 (extended to 2025 in 2024).  \n2. **Extension of Long-Term Facility**: The existing $3.0 billion unsecured revolving credit facility was extended from October 2025 to October 2028 in 2023, providing longer-term liquidity.  \n\nThese updates ensured continued access to liquidity, supported covenant compliance, and likely provided flexibility in managing debt levels, though no material changes to covenant terms were disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Target remained in compliance with its debt leverage covenant in both 2023 and 2024 and references the correct credit facilities ($1.0 billion 364-day and $3.0 billion five-year). However, there is a key error in the timeline of the 364-day facility renewal. The LLM states that in October 2023, Target replaced the facility with one expiring in October 2024 (to be extended to 2025 in 2024), which contradicts the ground truth: the original 364-day facility was set to expire in October 2024 (as of 2023), and was then renewed to extend expiration to October 2025. The LLM incorrectly implies a two-step extension (2023 to 2024, then 2024 to 2025), when in fact the 2023 filing already references a facility expiring in 2024, and the 2024 renewal moved it to 2025. (2) The $3.0 billion facility extension from 2025 to 2028 is accurate per the 2023 filing, but the LLM mischaracterizes it as occurring in 2023 — while technically correct, the original answer does not specify when the extension occurred, so attributing it to 2023 introduces an unverified detail. (3) The reasoning is mostly sound: the LLM correctly infers that facility renewals support covenant compliance and liquidity. It synthesizes information across years and facilities appropriately, though the erroneous timeline affects quantitative precision. (4) The answer is contextually relevant and addresses both parts of the question — covenant compliance evolution and credit facility changes — with appropriate focus. Due to the material date/facility timeline error affecting financial structure understanding, the correctness score is reduced to 7, with quantitative accuracy at 6 due to incorrect expiration dates, qualitative accuracy at 8 for strong reasoning and entity identification, and contextual relevance at 9 for comprehensive coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 506,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "\n\nFrom 2022 to 2023, Intel's approach to expanding digital readiness through its RISE strategy and external collaborations evolved by deepening industry-wide partnerships and formalizing measurable benchmarks. In 2022, the RISE strategy focused on establishing 2030 diversity and inclusion goals (e.g., doubling women in senior leadership, increasing underrepresented minority representation) and launching the **Alliance for Global Inclusion** to create a unified Inclusion Index. By 2023, Intel advanced this initiative by publishing the **third Global Inclusion Index survey**, transitioning it into a maturity-based benchmarking tool where companies scoring ≥50% (like Intel) were recognized for progress. This reflects a shift from foundational goal-setting to collaborative, industry-wide accountability, leveraging external partnerships to drive systemic improvements in digital readiness and inclusive practices across sectors. Additionally, Intel tied executive compensation to RISE metrics in both years but expanded transparency and cross-industry alignment in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel's RISE strategy, the Alliance for Global Inclusion, the development of the Inclusion Index, and the 2023 publication of the third Global Inclusion Index survey are accurately described. The threshold of 50% for recognition is correctly stated, and Intel being recognized is consistent with the original answer. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are presented. The mention of 18 recognized organizations out of 27 respondents from the ground truth is omitted but not contradicted, and this detail is contextual rather than central. (3) Reasoning is sound: the evolution from framework creation in 2022 to benchmarking and recognition in 2023 is correctly synthesized, showing a logical multi-hop understanding across years and initiatives. (4) The LLM adds minor details not in the original (e.g., tying executive compensation to RISE metrics, specific 2030 diversity goals), which are plausible and contextually appropriate but not confirmed in the ground truth; however, they do not detract from accuracy. The core evolution—shifting from collaborative goal-setting to measurable, recognized outcomes—is captured with semantic equivalence. Only a minor deduction is made for qualitative accuracy due to the slight expansion beyond the provided facts, but the answer remains focused, relevant, and factually consistent overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 408,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "\n\nEmerson's relationship with Micromine evolved from an attempted acquisition in 2022 to termination of the deal in 2023. In July 2022, AspenTech (a subsidiary of Emerson) agreed to acquire Micromine for AU$900 (~$623 million USD). However, on August 1, 2023, AspenTech terminated the agreement due to unresolved Russian regulatory approval uncertainties, with no termination fee paid. \n\nFinancially, Emerson recognized a **$56 million pre-tax gain in 2023** from terminating foreign currency forward contracts hedging the Micromine acquisition's exchange rate risk. No material costs or liabilities remained after termination, as the deal was mutually abandoned without further obligations. This marked the end of Emerson's pursuit of Micromine.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states the acquisition agreement was made in July 2022, while the ground truth indicates it occurred in 2023. This misalignment in timing undermines the chronological evolution of the relationship. Second, the financial gain is reported as $56 million pre-tax, but the ground truth specifies a $24 million mark-to-market gain in 2023; this is a significant numerical discrepancy that affects quantitative accuracy. Additionally, the LLM claims the termination occurred on August 1, 2023, which is more precise than the ground truth but unverified and potentially incorrect without sourcing. (2) The dollar amounts are inconsistent: AU$900 (~$623 million USD) is correctly stated, but the gain is off by over 100% ($56M vs $24M). The termination of foreign currency contracts is correct, but the magnitude of the gain is not. (3) The multi-hop reasoning is partially sound—linking Emerson to AspenTech to Micromine, recognizing the regulatory issue in Russia, and connecting the termination to financial impacts via hedging contracts—but the incorrect year for the initial agreement and the wrong gain amount reflect flawed synthesis. (4) Contextual relevance is high because the answer addresses both the evolution of the relationship and the financial implications, fulfilling the two-part question structure. However, due to key factual and numerical errors, especially in the financial gain and timeline, the overall correctness is reduced to a 6—partially correct but with significant flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 433,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "\n\nThe availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from approximately 17 million shares in fiscal 2022 to 15 million shares in fiscal 2023. The average purchase price of shares under the ESPP during fiscal 2023 was $277.19, compared to $305.14 in fiscal 2021 (as reported in the 2022 filing). While the exact 2022 average price is not explicitly provided in the 2023 filing, the data suggests a decline in both share availability and average purchase price from 2022 to 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in available shares from 17 million in 2022 to 15 million in 2023, which matches the ground truth. It also correctly reports the 2023 average purchase price of $277.19. However, it incorrectly references the 2022 average price as being from 'fiscal 2021 (as reported in the 2022 filing)', which introduces confusion. The ground truth clearly states the 2022 average purchase price was $305.14 during fiscal 2022, not from a prior year. While the LLM acknowledges a decline in average price, it fails to explicitly confirm the $305.14 figure for 2022 despite this being available in the knowledge base. (2) The quantitative accuracy is partially compromised: the 17M, 15M, and $277.19 figures are correct, but the misattribution of the $305.14 price to fiscal 2021 instead of fiscal 2022 is a factual error, even if the number itself is accurate. This undermines confidence in the data sourcing. (3) The reasoning is mostly sound—correctly identifying a downward trend in both share availability and purchase price—but the flawed temporal attribution weakens the multi-hop synthesis. The model should have directly compared 2022 and 2023 figures without introducing an irrelevant prior year. (4) Despite the error in referencing the year for the average price, the overall direction and conclusion (reduction in availability and lower average price) are correct, warranting a score of 7 for correctness. The answer remains contextually relevant and mostly complete, but the quantitative inaccuracy prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 433,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "\n\nBetween 2022 and 2023, Danaher (DHR) experienced a notable shift in impairment triggers and charges across its business segments. In 2022, no impairment charges were recorded, whereas in 2023, impairment triggers emerged in the **Biotechnology segment (Q2 and Q4)** and **Diagnostics segment (Q4)**, resulting in total charges of **$77 million** (primarily affecting technology-based intangible assets). This contrasts with 2021, where only a $10 million charge occurred in the Diagnostics segment. \n\nThe evolution indicates rising risks in Danaher’s intangible asset portfolio, particularly in Biotechnology and Diagnostics, likely driven by factors such as market volatility, competitive pressures, or strategic realignments. The expansion of impairment triggers to Biotechnology in 2023 suggests heightened scrutiny or performance challenges in recently acquired or high-growth areas, reflecting shifting risk profiles post-acquisition (e.g., Aldevron) and evolving sector dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in impairment triggers and charges between DHR's 2022 and 2023 filings. It correctly identifies the $77 million impairment charge in 2023 (vs. $10 million in 2021) and accurately notes that the 2023 triggers occurred in the Biotechnology segment (Q2 and Q4) and Diagnostics segment (Q4). However, it incorrectly states that 'no impairment charges were recorded' in 2022, which is misleading—the 2022 filing did report a $10 million charge from Q1 2021 for the Diagnostics segment. The LLM appears to conflate the year of reporting with the year of occurrence, failing to acknowledge that the 2022 filing included a prior-year impairment. This is a minor but notable error in temporal attribution. The answer correctly infers increased risk in the intangible asset portfolio, especially in Biotechnology, and offers reasonable qualitative explanations (market volatility, acquisitions like Aldevron). All dollar amounts and quarters for 2023 are accurate. The reasoning is sound and synthesizes multi-hop information well, though the omission of the 2021 charge in the context of the 2022 filing reduces quantitative precision slightly. Wording differences are acceptable under semantic equivalence, but the absence of explicit mention of the 2021 charge in the 2022 filing context results in a small factual gap. Hence, correctness and quantitative accuracy are marked at 8, while qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 410,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "\n\nThe value of outstanding letters of credit related to trade contracts increased from **$362 million in 2022** (HD_10K_2022.pdf, page 71) to **$598 million in 2023** (HD_10K_2023.pdf, page 69), reflecting a **65% rise**. This growth indicates an expanded involvement in business transactions tied to trade contracts, insurance programs, and construction contracts, suggesting increased operational activity or larger commitments secured by these financial guarantees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the increase in outstanding letters of credit from $362 million in 2022 to $598 million in 2023, matching the ground truth exactly. The calculated 65% increase is accurate: (598 - 362) / 362 ≈ 0.6519, or 65.19%, which rounds to 65%. (2) All numeric values, years, and dollar amounts are correct and properly cited to the respective 10-K filings. Format variations (e.g., $362 million) are acceptable and consistent. (3) The multi-hop reasoning is sound—information was correctly synthesized across two annual reports (2022 and 2023). The conclusion about increased involvement in trade-related transactions is logically supported by the data. (4) The only minor deviation from the original answer is the inclusion of 'insurance programs' and 'construction contracts' in the explanation, which slightly extends beyond the ground truth's focus on trade contracts. However, this does not contradict the core conclusion and may reflect additional context from the source documents. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to minor overgeneralization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 342,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "\n\nThe 0.300% Notes due 2028 were disclosed in both IBM's 2023 and 2024 SEC filings, indicating they remained outstanding during this period. In the 2023 filing (page 20), the notes were referenced as part of prior filings (Exhibit 4.1 to Form 8-K filed February 10, 2020), while the 2024 filing (page 1) explicitly listed them as registered securities under Section 12(b) of the Exchange Act. This continuity demonstrates IBM’s consistent and transparent disclosure of its financial instruments, ensuring stakeholders are informed about its long-term debt obligations. The absence of any mention of redemption or retirement in the 2024 filing confirms the notes are still active, reflecting IBM’s adherence to regulatory reporting standards.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, percentages, and references: the 0.300% Notes due 2028 are correctly tied to Exhibit 4.1 of the Form 8-K filed on February 10, 2020, and their continued presence in the 2024 filing is accurately noted. The answer correctly observes that the 2024 filing lists the notes under Section 12(b) of the Exchange Act, which aligns with the ground truth's mention of NYSE registration (via IBM28B). However, the LLM misses a key qualitative shift emphasized in the original answer: the evolution from passive disclosure (referencing an old exhibit) in 2023 to active recognition as a traded instrument in 2024. While the LLM notes the Section 12(b) registration, it does not interpret this as a meaningful change in disclosure status or market engagement, instead framing it as mere continuity. This omission downplays the significance of the shift in how IBM presents the instrument—suggesting increased liquidity or market visibility. The reasoning is sound but incomplete in synthesis, failing to draw the conclusion about enhanced market engagement. Quantitatively, all facts are correct (dates, percentages, exhibit numbers), earning full marks. Contextually, the response is highly relevant and well-structured, but lacks the deeper interpretive layer present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 369,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "\n\nIBM's 1.750% Notes due 2031 were disclosed in both 2023 and 2024 filings but with a notable evolution in registration details. In the **2023 10-K (page 20)**, the notes were referenced as part of the instruments incorporated by reference from a Form 8-K filed on **January 30, 2019**. By **2024 (page 1)**, the notes were explicitly listed in the registration statement under **Section 12(b)** of the Securities Exchange Act, with the trading symbol **IBM31** on the **New York Stock Exchange (NYSE)**. This indicates that while the notes were already registered in 2023, the 2024 filing provided a more direct and updated disclosure of their ongoing registration on the NYSE, reflecting consistent compliance and transparency. No material changes to the notes' terms were noted between the periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.750% Notes due 2031 were disclosed in both 2023 and 2024; the 2019 Form 8-K filing date (January 30, 2019) is correctly cited; and the 2024 registration under Section 12(b) with the trading symbol IBM31 on the NYSE is accurately reported. (2) Quantitative elements—interest rate (1.750%), maturity year (2031), dates, and symbol—are all factually correct. (3) The reasoning correctly captures the evolution from incorporation by reference in 2023 to explicit registration and listing in 2024, demonstrating sound multi-hop synthesis across filings. (4) The only minor deviation is the claim that the notes were 'already registered in 2023'—the ground truth emphasizes 2023 disclosure via incorporation by reference but positions the 2024 filing as reflecting a shift to formal listing, implying a more significant evolution than mere 'updated disclosure.' This slightly understates the change from passive reference to active exchange listing. However, the core facts and synthesis remain strong, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 320,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "\n\nEli Lilly's financial relationship with Zyprexa evolved significantly between 2023 and 2024 through the sale of rights to the olanzapine portfolio (which includes Zyprexa). In 2023, the company recognized **$1.45 billion in revenue** from this sale, marking a shift from traditional product sales to a one-time rights transfer. By 2024, no additional revenue from Zyprexa was recognized, as the transaction was completed in 2023. The business model transitioned from ongoing revenue generation via product sales to a lump-sum licensing approach, reflecting a strategic exit from the asset. This contrasts with 2023, where Zyprexa contributed meaningfully to revenue, while 2024 focused on post-sale obligations (e.g., supply agreements) and new product growth drivers like Mounjaro and Zepbound.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.45 billion revenue figure from the 2023 sale of the olanzapine portfolio (including Zyprexa) is correct, and the timing (2023 as the sale year, no further product sales in 2024) is accurate. (2) The answer correctly identifies the shift in revenue recognition—from direct product sales in 2023 to no product sales in 2024, with the revenue reclassified under collaboration and other arrangements. (3) The reasoning is sound: it captures the multi-hop logic that Eli Lilly transitioned from active sales to a post-sale model involving licensing and supply obligations. The mention of new growth drivers (Mounjaro, Zepbound) adds context without diverting from the core answer. (4) Minor deduction in qualitative accuracy because the answer emphasizes a 'lump-sum' model and 'strategic exit' without explicitly noting that ongoing revenue may still arise via collaboration arrangements (e.g., royalties or profit-sharing), which the original answer highlights. However, this does not invalidate the overall correctness. Semantic equivalence is strong, and all key entities (Eli Lilly, Zyprexa, olanzapine portfolio, 2023/2024 timeline) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 349,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "\n\nThe Mobility Preferred Interests were fully repurchased by April 2023, eliminating redemption obligations and their impact on earnings per share (EPS) calculations in 2024. In 2023, prior to repurchase, these interests were reclassified from equity to a liability, with $5,340 in current and noncurrent liabilities recorded at fair value. This reclassification affected diluted EPS through potential share settlement (72 million shares in 2023, per Note 2). However, after the April 2023 repurchase, no Mobility Preferred Interests remained outstanding, removing their dilutive effect entirely in 2024. As a result, 2024 EPS calculations (both basic and diluted) no longer included adjustments from these instruments, contrasting with 2023 and prior periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. According to the ground truth, AT&T recorded $2,670 in current liabilities and $2,670 in noncurrent liabilities in 2023, totaling $5,340 in liabilities, which matches the LLM's stated total liability amount. However, the LLM incorrectly states that $5,340 was recorded 'at fair value'—the original answer does not mention fair value, only reclassification due to certainty of redemption. More critically, the repurchase amount was $5,414 (including accrued distributions), not $5,340, and this figure is omitted in the LLM response, representing a significant quantitative error. (2) The LLM introduces a figure of '72 million shares in 2023, per Note 2' as part of diluted EPS impact, which is not present in the original answer and cannot be verified against the ground truth—this is an unsupported addition. (3) The reasoning about the shift from liability treatment in 2023 to no impact in 2024 is logically sound and correctly captures the timeline: reclassification in 2023, full repurchase by April 2023, and no ongoing obligations in 2024. However, the LLM incorrectly concludes that diluted EPS calculations in 2024 no longer included adjustments, while the original answer emphasizes that the ASU 2020-06 treatment applied *retrospectively* to periods *prior* to repurchase—meaning the accounting impact was still discussed in 2024 filings but only for prior periods. The LLM misrepresents this as an ongoing dilutive effect rather than a retrospective disclosure. (4) Despite these errors, the answer is contextually relevant and addresses the evolution of treatment and EPS impact. The core narrative—reclassification in 2023, repurchase, and reduced EPS impact—is partially correct but undermined by key factual and interpretive mistakes, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 511,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "\n\nIBM's 0.875% Notes due 2030 were disclosed in both the 2023 and 2024 10-K filings, but their registration and listing status evolved. In the **2023 10-K** (page 20), the notes were referenced as part of a broader list of debt instruments, with their terms incorporated by reference from a 2022 Form 8-K filing, but they were **not explicitly listed as registered securities** on an exchange. In contrast, the **2024 10-K** (page 1) explicitly includes the 0.875% Notes due 2030 in the table of registered securities under Section 12(b), with the trading symbol **IBM30A** and listed on the **New York Stock Exchange**. This indicates that the notes transitioned from being disclosed via incorporation by reference in 2023 to being formally registered and publicly traded on the NYSE in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution of IBM's 0.875% Notes due 2030 from 2023 to 2024: in 2023, the notes were disclosed by incorporation by reference from the February 8, 2022 Form 8-K, and were not explicitly listed as registered securities; in 2024, they were formally included in the Section 12(b) table of registered securities with trading symbol IBM30A and listed on the New York Stock Exchange. (2) There are no numerical values requiring calculation, but the percentages (0.875%), years (2030, 2022, 2023, 2024), and trading symbol (IBM30A) are all correctly stated. (3) The multi-hop reasoning is sound—comparing disclosure treatment across two years, identifying the change from referenced to registered status, and correctly interpreting the significance of listing under Section 12(b). (4) The answer is semantically equivalent to the original, with added clarity (e.g., mentioning Section 12(b) and page numbers), without introducing any inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 314,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "\n\nFrom 2023 to 2024, the structure and distribution terms of AT&T’s Telco Preferred Interests remained largely unchanged, with cumulative preferred distributions of **4.25% annually** (Telco Class A-1) and **6.85% annually** (Telco Class A-2 and A-3), both subject to seven-year reset periods. The key evolution was the **expansion of issuance**: in April 2023, AT&T added $5,250 in Telco Class A-2 and A-3 interests, increasing total Telco preferred interests to $7,250 by December 2024. Terms such as redemption flexibility (callable at issue price after seven years), no restrictions on cash flows or dividend declarations, and contingent redemption rights for holders were preserved. \n\nThis indicates AT&T’s continued reliance on **preferred equity instruments** as a stable, flexible financing tool, allowing capital raising without diluting common shareholders, while maintaining fixed dividend obligations and preserving liquidity for strategic initiatives like network investments and business transformation. The lack of structural changes suggests confidence in existing terms and a focus on optimizing capital structure through predictable, long-term funding mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the $2,000 Class A-1 at 4.25% (issued in September 2020), the $5,250 Class A-2/A-3 at 6.85% issued in April 2023, and the total $7,250 by 2024 are all correctly reported. The 7-year reset terms, redemption rights, and noncontrolling interest classification are accurately reflected. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and dates match the original answer. The sum ($2,000 + $5,250 = $7,250) is correct and properly contextualized. (3) Multi-hop reasoning is sound—information is synthesized across time (2023 to 2024) and instrument classes, and the conclusion about AT&T’s financing strategy is logically supported. (4) The only minor omission is that the 2024 clarification about distribution non-payment not restricting dividends or share repurchases is mentioned in the original but only implied in the LLM answer through 'no restrictions on cash flows or dividend declarations'—this slightly reduces qualitative accuracy. However, the core meaning is preserved. Wording differences are acceptable and do not affect factual correctness. The answer is fully relevant and addresses both the structural evolution and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 356,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "\n\nCapital One's risk exposure under loss sharing agreements with government-sponsored enterprises (GSEs) for multifamily commercial real estate loans increased from **$82 million as of December 31, 2022** to **$137 million as of December 31, 2023**. This rise reflects higher liabilities recognized for agreements entered into prior to 2020, where expected credit losses are amortized into income. The company continues to originate multifamily loans with the intent to sell them to GSEs, maintaining its fair value accounting election for new agreements post-2020, which directly impacts reported exposure levels. The growth in liability suggests an expansion in either the volume of loans sold or increased risk assessments during 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: $82 million as of December 31, 2022, and $137 million as of December 31, 2023, match the original answer exactly. There are no calculation errors. (2) The answer addresses the evolution of Capital One's involvement in multifamily CRE loans and explicitly notes the increase in risk exposure via loss sharing agreements with GSEs, which is the core of the question. (3) Entity accuracy is strong: 'Capital One', 'government-sponsored enterprises (GSEs)', 'multifamily commercial real estate loans', and the correct years (2022–2023) are all properly identified. (4) The reasoning is sound and adds value by explaining that the liability increase relates to agreements pre-2020 with amortized credit losses, and distinguishes accounting treatment for post-2020 agreements under fair value election—information consistent with but slightly more detailed than the ground truth. This additional context does not contradict but enriches the answer. The only reason for not scoring a 10 is that the original answer emphasizes 'growing involvement' in loan origination, while the LLM focuses more on accounting mechanics; however, the conclusion about expansion in volume or risk assessment captures the same essence. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 391,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "\n\nAmazon's co-branded credit card programs faced heightened regulatory scrutiny and compliance obligations in 2023 compared to 2022, driven by evolving data protection and consumer privacy laws. In 2022, risks centered on potential program termination, interchange fees, and compliance with existing payment card association rules. By 2023, the strategic significance shifted as Amazon faced **new compliance obligations**, including enhanced data localization requirements, stricter authentication processes (e.g., under evolving payment security frameworks), and investigations into data practices tied to these programs. The 2023 10-K explicitly notes increased regulatory focus on tech companies as \"gatekeepers,\" raising compliance costs and operational complexity. These developments could adversely affect operating results through higher transaction fees, penalties for noncompliance, or required system overhauls, reflecting a material escalation in regulatory risk compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the shift from 2022 to 2023 in regulatory focus, the initial risks (termination, payment association rules), and the expansion in 2023 to include new compliance obligations like data localization are accurately represented. The mention of increased regulatory scrutiny on tech companies as 'gatekeepers' is consistent with the broader regulatory environment described in the original. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the strategic significance evolved (from operational risk to broader regulatory exposure) and links it to potential impacts on operating results (compliance costs, penalties, system changes). The only minor gap is that the original specifically notes data localization rules were 'not mentioned in 2022'—the LLM implies but does not explicitly contrast their absence in 2022 versus presence in 2023. This slight omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing shifts in strategic significance, regulatory risks, compliance obligations, and financial impact. Overall, the LLM captures the core meaning and implications with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 392,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "\n\nPM's financial relationship with RBH evolved significantly between 2022 and 2024. As disclosed in the 2022 10-K (page 113), RBH's financial results were deconsolidated from PM's consolidated financial statements effective March 22, 2019, due to RBH's entry into CCAA restructuring proceedings. By 2024 (page 148), PM retained an equity investment in RBH, but valuation of this investment required complex judgments, including discounted cash flow analyses, assumptions about sales volumes, operating margins, and tax implications of Canadian litigation settlements. The deconsolidation remained in place through 2024, with PM no longer consolidating RBH but instead accounting for its equity interest with significant impairment assessments driven by ongoing litigation and restructuring uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RBH was deconsolidated in 2019 due to CCAA proceedings, and this deconsolidation remained in effect through 2022 and into 2024. By 2024, PM held an equity investment in RBH requiring impairment analysis. The LLM correctly notes the use of discounted cash flow models, assumptions around sales volumes, operating margins, and tax treatment of settlements—all critical valuation considerations. (2) Quantitative accuracy is strong: while no specific dollar figures (e.g., CAD 3.1 billion) are mentioned in the LLM answer, the omission does not constitute a factual error but rather a focus on structural and accounting treatment evolution. The dates (2019 deconsolidation, reporting in 2022 and 2024 filings) are accurate. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across time (2019 event affecting 2022 and 2024 reporting) and accounting treatment (from consolidation to equity method with impairment considerations). (4) The only minor shortcoming is the lack of explicit mention of the CAD 3.1 billion litigation exposure, which was part of the original answer and relevant to valuation risk. However, the reference to 'ongoing litigation and restructuring uncertainties' captures the essence, albeit at a higher level of generality. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 413,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "\n\nBaqsimi's financial performance and strategic role within LLY's portfolio evolved significantly between 2023 and 2024. In 2023, Baqsimi contributed **$677.6 million in revenue** (up from $139.3 million in 2022), driven by its sale in June 2023 to Amphastar, which generated a **$579.0 million net gain** recognized in 2023. By 2024, LLY received an additional **$125.0 million** from the transaction and continued to recognize **supply agreement revenue** as it manufactured Baqsimi for Amphastar under a standalone selling price arrangement. Strategically, the sale allowed LLY to monetize Baqsimi’s rights upfront, shifting commercialization risk to Amphastar while retaining near-term revenue from manufacturing. This reflects a portfolio optimization strategy, redirecting focus and capital to higher-growth assets like Mounjaro and Trulicity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim that Baqsimi generated $677.6 million in revenue in 2023 is correct and matches the ground truth. However, the LLM incorrectly states that this revenue was due to a sale to Amphastar in June 2023 and includes a $579.0 million net gain — this is not supported by the original answer or known public filings. The ground truth does not mention Amphastar, a sale event, or any gain recognition. Instead, it states Baqsimi was removed from direct product revenue in 2024 due to a collaboration arrangement, not a divestiture with a large one-time gain. Additionally, the $125.0 million received in 2024 and 'supply agreement revenue' are not mentioned in the ground truth, making them hallucinated details. (2) Completeness: The answer addresses revenue contribution and strategic positioning, fulfilling the question's scope. (3) Entity Accuracy: While LLY is correct, Amphastar is not referenced in the ground truth, introducing an incorrect entity. The timing of the transaction (June 2023) is also unverified. (4) Reasoning: The multi-hop reasoning is flawed — the model infers a sale and gain recognition that are not in the source, leading to an incorrect narrative about monetization and supply agreements. The actual shift was from direct product sales to being part of collaboration arrangements, not a sale with manufacturing continuation. (5) Semantic Equivalence: The overall message of strategic shift is partially aligned, but the factual basis is incorrect. The original answer emphasizes absence from product revenue due to reclassification, not a sale. Thus, while the direction of change (from direct to indirect) is somewhat captured, the mechanism and financials are wrong. The correctness score is low due to major factual and quantitative errors despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 516,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "\n\nFrom 2022 to 2024, Union Pacific significantly increased the proportion of owned versus leased containers and chassis in its Total Highway Revenue Equipment. In 2022, 96.3% of containers were owned (48,962 of 50,818 total), rising to 99.4% in 2024 (46,375 of 46,663 total). For chassis, the owned ratio grew from 67.9% (29,875 of 44,023 total) in 2022 to 78.4% (4,356 of 5,553 total) in 2024. This shift reflects a strategic reduction in leased equipment, particularly for containers, while maintaining a higher ownership stake in chassis despite a sharp decline in total chassis volume.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) The numbers provided for owned and leased units are incorrect: the ground truth states Union Pacific owned 78,837 and leased 16,004 units in 2022, but the LLM claims only 50,818 total containers and 44,023 total chassis, misrepresenting the scale and composition. The LLM incorrectly calculates ownership percentages using inaccurate totals—for example, claiming 48,962 owned containers in 2022 when the knowledge graph does not specify container subtotals separately. (2) The LLM states that owned containers were 48,962 in 2022 and 46,375 in 2024, but the ground truth does not provide these exact container ownership numbers, and the overall owned equipment dropped from 78,837 to 50,731 across all types—so the LLM’s figures are inconsistent with total equipment counts. (3) The reasoning is flawed: the LLM concludes that the proportion of owned equipment increased, which may be technically true due to a steeper drop in leasing, but it mischaracterizes the broader trend. The ground truth emphasizes a 'significant reduction in both owned and leased equipment'—a net asset drawdown—not a strategic shift toward higher ownership ratios. (4) Most critically, the LLM misses the key point that leased containers fell from 1,856 to 288 and leased units overall dropped from 16,004 to 1,485, which is central to the original answer. Instead, it fabricates detailed container and chassis breakdowns not present in the source. (5) Contextually, the answer addresses the question about owned vs. leased trends and attempts multi-hop synthesis, so relevance is moderate. However, due to severe quantitative inaccuracies and incorrect entity breakdowns, the overall correctness is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 482,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "\n\nCapital One's use of securitized debt obligations increased from $16.97 billion in 2022 to $18.04 billion in 2023, reflecting a $1.07 billion growth. Within the company's funding structure, securitized debt obligations remained a key component, contributing 4% of total funding sources in 2022 (based on prior-year context) and maintaining a similar relative role in 2023, despite slight shifts in overall funding composition. This growth underscores Capital One's continued reliance on securitization programs as a stable and diversified funding source, complementing deposits and other debt instruments.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies. The 2023 carrying value of $18.043 billion is correctly reported (rounded to $18.04 billion), but the 2022 value of $16.97 billion is not present in the ground truth, nor is the $1.07 billion growth or the 4% of total funding claim. These figures are unsupported by the original answer and represent fabrication or incorrect inference. (2) Quantitative accuracy is partially maintained for the 2023 figure but fails on the 2022 value and derived calculations (difference and percentage contribution). The ground truth does not provide a 2022 dollar amount or any percentage of total funding, so these additions are speculative. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies securitized debt as part of the funding structure in both years, it misses the key qualitative evolution noted in the ground truth—namely, the reclassification to Level 2 in the fair value hierarchy in 2023, which indicates a shift in valuation methodology and strategic role. Instead, the LLM invents a narrative around growth and percentage contribution that is not in the source. (4) Contextual relevance is high because the answer addresses the evolution of securitized debt in Capital One’s funding structure and attempts to compare across years. However, the correctness score is limited to 5 due to the introduction of unsupported numbers and the omission of the critical fair value hierarchy shift, which is central to the ground truth’s conclusion about a more structured and less volatile role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 442,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "\n\nThe revenue from Zyprexa evolved significantly between 2023 and 2024. In 2023, LLY recognized **$1.45 billion in revenue** primarily from the **net gain on the sale of rights for the olanzapine portfolio** (including Zyprexa), which was a one-time transaction. This is highlighted in the 2023 10-K (pages 67, 75) and Note 4, where Zyprexa’s revenue included this portfolio rights sale. In 2024, the **source shifted to regular product sales**, with Zyprexa contributing **$79.4 million in U.S. revenue** and **$1,615.4 million internationally** (2023 data, per page 67), while the 2024 10-K (pages 64–65) indicates no further one-time gains. The **recognition method** remained tied to **product sales at shipment** (standard revenue recognition for net product revenue), but the 2023 figures were inflated by the portfolio sale, which did not recur in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of Zyprexa revenue between 2023 and 2024, reversing the actual trend. According to the ground truth, in 2023, revenue came from the sale of rights to the olanzapine portfolio (a one-time transaction), and by 2024, Zyprexa-related revenue was recognized under collaboration and other arrangements, not product sales. However, the LLM incorrectly states that in 2024, the source shifted to regular product sales, claiming $79.4 million in U.S. and $1,615.4 million internationally—this is factually wrong and contradicts the ground truth. The cited 2024 figures appear to misattribute prior-year product sales data (possibly from 2023 or earlier) as 2024 results, but the ground truth indicates no ongoing product sales revenue for Zyprexa in 2024; instead, revenue was now part of collaboration arrangements. Additionally, the $1.45 billion gain in 2023 is plausible as a one-time item, but the LLM mischaracterizes the 2024 state by asserting continued product sales at high levels. The recognition method is inaccurately described as continuing under product sales, when in fact the shift was from product-related gains to collaboration revenue recognition. This reflects a failure in multi-hop reasoning: the model did not correctly synthesize the change in revenue source and classification over time. While the answer addresses the question's structure and attempts to use specific numbers and citations, the factual direction of the evolution is reversed, making the response highly misleading. Quantitative accuracy is low due to incorrect figures and misattribution of revenue streams. Qualitative accuracy fails on entity (revenue type), year (2024 characterization), and reasoning (incorrect before/after narrative). Contextual relevance is moderate because it discusses the right drug and company and attempts to compare years, but the substance is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 522,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "\n\nThe valuation methodology and classification of Federal Government Securities in the pension plan remained consistent from 2022 to 2024. In both periods, these securities were classified as **Level 2 investments** and valued using a **bid evaluation process** with bid data provided by independent pricing sources. No material changes to this approach were noted in the disclosures from 2022 (UNP_10k_2022.pdf, pages 72–78) or 2024 (UNP_10k_2024.pdf, pages 55–56, 59).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Federal Government Securities were classified as Level 2 investments in both 2022 and 2024 and that valuation used a bid evaluation process with independent pricing sources. However, it inaccurately implies that the methodology was fully disclosed in 2022, while the ground truth states that the detailed bid evaluation methodology was only clarified in 2024. The 2022 classification as Level 2 is correct, but the methodology description in 2022 was less specific. (2) There are no numeric inaccuracies—no dollar amounts or dates were misstated. The $742 million figure from 2022 is omitted in the LLM answer, which is a completeness issue but not a quantitative error. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes across 2022 and 2024 filings and identifies consistent classification. However, it fails to capture the evolution in disclosure specificity—the key nuance that the 2024 filing added clarity to the methodology, even if the classification remained unchanged. This misses a critical qualitative shift in transparency. (4) The contextual relevance is high as the answer directly addresses the question’s focus on valuation and classification over time. The qualitative accuracy is reduced due to the misrepresentation of when the bid evaluation process was explicitly disclosed. Correctness score is 7 because core facts (classification, Level 2 status) are accurate, but the evolution in methodology explanation is understated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 422,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "\n\nCapital One's utilization of credit score data for product segmentation decisions remained consistent in 2023 compared to 2022, with borrower credit scores continuing to drive underwriting, subprime classification, and segmentation strategies. The credit score distribution for domestic credit card portfolios showed a slight decline in the proportion of borrowers with scores above 660 (from 69% in 2022 to 68% in 2023), while auto loan portfolios maintained stability (53% with scores above 660 in both years). This indicates a disciplined credit risk modeling approach, emphasizing data-driven segmentation to balance growth with risk management, though the minor shift in credit card scores may reflect nuanced adjustments to portfolio composition or market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning compared to the ground truth. The original answer states that Capital One updated the *time period of credit score data used* for product segmentation—from relying on 2020–2021 data in 2022 to using 2022–2023 data in 2023—indicating a shift toward more current, dynamic risk modeling. The LLM instead claims the *proportion of borrowers* by credit score (e.g., 69% to 68% above 660) changed slightly, which is not mentioned in the ground truth and introduces false quantitative data. These percentages and portfolio-specific details (domestic credit card, auto loans) are unsupported by the original answer and represent hallucinated metrics. (2) There are no verifiable calculations in the ground truth, but the LLM fabricates specific percentages (69%, 68%, 53%) with no basis in the provided information, failing quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about the *evolution in data sourcing* for segmentation, not changes in borrower score distributions. The LLM misinterprets the core concept, focusing on portfolio composition shifts rather than the update in data recency used for modeling. It fails to identify the key evolution—using more recent data—which is central to the credit risk strategy implication. (4) While the LLM attempts to address credit risk modeling strategy and segmentation, its conclusions about a 'disciplined' or 'data-driven' approach are generic and misaligned with the specific strategic shift (proactive, dynamic modeling via fresher data) described in the ground truth. Thus, despite some contextual relevance, the answer is factually and conceptually incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 479,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "\n\nFrom 2022 to 2023, Amazon's strategic positioning of AWS evolved to emphasize its role as a **core driver of innovation and cross-business enablement**, with increased investment in expanding its technological capabilities and market reach. In 2022, AWS was highlighted as a critical component of Amazon's technology infrastructure, supporting product/service offerings and customer experience enhancements. By 2023, AWS was explicitly tied to **strategic initiatives** such as advancing artificial intelligence/machine learning, deploying satellite networks for global broadband, and autonomous vehicle development, reflecting its expanded role in driving long-term growth. Additionally, AWS's positioning as a standalone segment (serving developers, enterprises, and governments) underscored its importance as a revenue-generating pillar, while investments prioritized leveraging AWS to capitalize on emerging technologies and geographic expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in AWS's strategic positioning from 2022 to 2023. It accurately reflects that AWS transitioned from being a key infrastructure and innovation enabler in 2022 to a central, standalone business segment in 2023. The mention of AWS serving developers, enterprises, and governments aligns with the ground truth’s emphasis on its role as a distinct pillar. The LLM correctly identifies increased investment in technological capabilities, geographic expansion, and emerging technologies like AI/ML—consistent with the original answer’s focus on machine learning and innovation. However, the LLM adds specific initiatives—satellite networks for global broadband and autonomous vehicle development—that are not mentioned in the ground truth and cannot be verified from the provided knowledge graph. While these may reflect real-world developments, they go beyond the documented strategic evolution in the source material, introducing unsupported details. The answer omits the explicit structural point that by 2023, AWS was formally recognized as one of Amazon’s three core business segments alongside North America and International, which is a key factual shift highlighted in the original answer. Despite this, the overall reasoning is sound, and the qualitative shift in AWS’s role is well-conveyed. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. Contextual relevance is strong, as the response directly addresses the evolution in AWS’s strategic role within Amazon’s business segments and investment priorities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 445,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "\n\nBetween 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly in terms of accounting treatment and exposure. In 2022, RBH was deconsolidated from PMI’s financial statements due to its protection under Canada’s CCAA proceedings (arising from tobacco litigation), and PMI did not record a provision for the litigation as an unfavorable outcome was not deemed probable. By 2024, PMI recognized a **$2.3 billion non-cash impairment charge** on its investment in RBH, driven by uncertainty over the allocation of a proposed CAD 32.5 billion settlement among RBH and its co-defendants. This impairment reflected a decline in the estimated fair value of PMI’s investment below its carrying value. While PMI’s direct exposure to RBH’s operations was reduced post-deconsolidation, the 2024 impairment highlights ongoing financial risk tied to unresolved litigation outcomes. No additional provisions were recorded in 2024 for potential liabilities, as PMI maintained that an unfavorable outcome remained not probable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RBH was deconsolidated in 2022 due to CCAA restructuring; no loss accrual was made because an unfavorable outcome was not probable; by 2024, PMI shifted to an equity investment model and recorded a non-cash impairment. The impairment amount is stated as $2.3 billion, which matches the ground truth $2,316 million when rounded (difference is formatting/rounding, acceptable under semantic equivalence). The CAD 32.5 billion proposed settlement is correctly cited. (2) Quantitative accuracy is excellent: $2.3 billion ≈ $2,316 million (within normal rounding), year references (2022, 2024) are correct, and the litigation context is accurately dated. (3) Multi-hop reasoning is sound: the answer synthesizes deconsolidation, litigation status, accounting treatment shift, and impairment logic across years and entities. It correctly identifies the evolution from deconsolidation to equity method with impairment. Only minor point: the original answer explicitly notes the 'comprehensive stay of litigation until March 31, 2022', which the LLM omits, slightly reducing completeness. (4) Contextual relevance is perfect—the response directly addresses the evolution in accounting treatment and financial exposure. Wording differs but meaning is equivalent. No irrelevant content. Overall, a very strong answer with only negligible omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 397,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "\n\nFrom 2022 to 2024, Biktarvy remained a cornerstone of Gilead's HIV portfolio, with its revenue contribution reflecting sustained commercial significance. In 2022, Biktarvy sales totaled **$7,049 million (U.S.) and $969 million internationally**, totaling **$8,624 million** (per 2022 10-K, page 70). By 2024, Biktarvy's U.S. sales rose to **$12,828 million**, while international sales reached **$969 million**, indicating robust growth despite competitive pressures and market saturation in HIV therapies (implied by 2024 10-K, page 18). However, product risks persist: **HIV product competition**, potential shifts away from nucleoside-based therapies (like TAF-containing regimens), and **product liability lawsuits** (e.g., kidney/bone injury claims against related products like Truvada and Stribild, detailed in 2024 10-K, page 88) could impact Biktarvy’s long-term performance. Additionally, pricing pressures from Medicaid, 340B programs, and state affordability reviews (2024 10-K, page 21) pose ongoing challenges to maintaining revenue growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the 2024 revenue figures. The ground truth states that 'specific revenue figures are not provided' for 2024, but the LLM claims U.S. sales rose to $12,828 million and international sales were $969 million, which is unsupported by the source. While the 2022 total of $8,624 million is correct (and properly broken into $7,049M U.S. and $969M international), the 2024 numbers are fabricated or misattributed. (2) The calculation for 2022 is accurate ($7,049M + $969M = $8,624M), but the 2024 figures are not corroborated by the original answer or implied in the knowledge graph. The LLM incorrectly implies growth to $13.8B total in 2024, which contradicts the ground truth's lack of 2024 revenue data. (3) The qualitative reasoning partially aligns with the original answer—correctly identifying ongoing risks such as competition, shifts away from TAF-based therapies, and pricing pressures (Medicaid, 340B). It also appropriately references product liability risks, though these are tied to related products (Truvada, Stribild), which is contextually relevant but not directly about Biktarvy. However, the model fails the multi-hop requirement by inventing 2024 revenue data instead of acknowledging its absence and focusing on risk evolution. (4) The contextual relevance is high because the answer addresses both revenue and risks, uses correct entities (GILD, Biktarvy, TAF, 10-K references), and cites plausible risk factors. However, the quantitative inaccuracy severely undermines correctness, warranting a low score despite good structure and partial reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 447,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "\n\nUnion Pacific Railroad's (UPRR) financial stake in TTX increased from $1.6 billion in 2022 (as of December 31, 2021) to $1.9 billion by 2024 (as of December 31, 2024), reflecting a rise in its 36.79% (2022) to 37.03% (2024) economic ownership. Car hire expenses with TTX grew from $402 million in 2022 to $432 million in 2024, with a slight dip to $399 million in 2023. This indicates both a higher investment value and a steady upward trend in operational costs for rail car rentals over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and time periods compared to the ground truth. The original answer states that Union Pacific's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. However, the LLM incorrectly states the starting value as being from 2022 (as of December 31, 2021), which conflates reporting year with reference date and misrepresents the timeline. More critically, the car hire expenses are reported incorrectly: the ground truth shows an increase from $375 million in 2021 to $432 million in 2024, but the LLM claims $402 million in 2022 and $399 million in 2023—values not supported by the original data. These figures are factually inconsistent, indicating a failure in quantitative accuracy. (2) The percentages (36.79% in 2022 and 37.03% in 2024) are not present in the original answer and appear to be fabricated or sourced from outside the provided truth, introducing entity and data inaccuracies. There is no mention of ownership percentage changes in the ground truth, so including them reduces factual reliability. (3) The reasoning structure is sound—identifying trends in investment value and car hire expenses over time—and the conclusion about growing financial and operational involvement aligns with the original. The multi-hop synthesis (linking stake value and expenses over years) is logically approached, though based on incorrect inputs. (4) Contextual relevance is high because the answer addresses both parts of the question (investment value and car hire expenses) and attempts to show evolution over time. However, due to significant numerical errors and introduction of unsupported metrics (percentages), the correctness score is reduced to 6—partially correct but with major factual flaws in key financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 503,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "\n\nTesla's approach to scaling Solar Roof production evolved from 2022 to 2023 by enhancing installer training initiatives and strengthening supply chain risk management. In 2022, Tesla focused on **onboarding and training new installers** while collaborating with real estate developers to reduce installation time and costs (TSLA_10k_2022.pdf, p. 34). By 2023, the company expanded these efforts, emphasizing **localized procurement and supply chain resilience** to address global component constraints, supplier dependencies, and risks like semiconductor shortages. Tesla also prioritized hiring skilled personnel and securing alternate sources for critical components to mitigate disruptions (TSLA_10k_2023.pdf, p. 16). This shift reflects a strategic move toward both operational scalability and supply chain robustness.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures Tesla's 2022 focus on onboarding and training new installers, collaboration with real estate developers, and reducing installation time and costs. It also correctly identifies the 2023 shift toward supply chain risk management, including supplier reliability and global component constraints. The mention of hiring skilled personnel and securing alternate sources is consistent with the broader emphasis on operational resilience. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly contrasts the strategic evolution from installer-driven scaling to supply chain resilience. However, the LLM slightly overstates the continuity of installer training into 2023; the ground truth emphasizes a *shift away* from installer-focused growth, while the LLM implies these efforts were 'expanded.' This misrepresents the strategic pivot as a dual-track continuation, which is a minor but notable deviation in reasoning. (4) Contextual relevance is excellent—the response directly addresses both parts of the question (installer training and supply chain risk management) and stays focused on Tesla's evolving strategy. The inclusion of specific document citations adds precision. Overall, the answer is factually strong but slightly off in framing the nature of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 428,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "\n\nThe Coca-Cola Company's relationship with fountain retailers in the U.S. remained consistent between 2022 and 2023 regarding the manufacturing and distribution of fountain syrups. The Company continues to manufacture fountain syrups in the U.S. and sells them directly to authorized fountain wholesalers (including certain bottlers) and fountain retailers, as outlined in both the 2022 and 2023 filings. There is no indication of structural changes to this arrangement; bottlers are generally not authorized to produce fountain syrups, and the Company retains control over their production and distribution through established channels. The evolution highlighted in the documents centers on operational efficiency initiatives and supply chain management rather than shifts in the specific dynamics with fountain retailers.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was no structural change between 2022 and 2023, when the ground truth indicates a meaningful evolution in how The Coca-Cola Company describes its distribution model. While the answer correctly states that Coca-Cola manufactures fountain syrups and that bottlers are generally not authorized to produce them (factually accurate details), it fails to recognize the key shift in 2023: the Company now explicitly includes bottling partners as distributors of fountain syrups to retailers, indicating a more formalized or acknowledged tiered distribution system. The LLM incorrectly asserts 'no structural changes' and attributes any evolution to 'operational efficiency' and 'supply chain management,' which is not supported by the original answer. This misrepresents the multi-hop insight — that the 2023 filing reflects either a clarification or expansion of bottling partners' roles in distribution, which is central to the question about relationship evolution. There are no numerical figures to verify, so quantitative accuracy is high by default. Contextual relevance is strong as the response addresses the right topic and entities (Coca-Cola, fountain syrups, U.S., bottlers, wholesalers), but the reasoning and qualitative accuracy suffer from failure to synthesize the correct inference across years. Thus, the correctness score is low due to a significant factual misinterpretation of the evolution in distribution relationships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 412,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "\n\nIBM's 0.950% Notes due 2025 have remained classified as registered securities under Section 12(b) of the Exchange Act, listed on the New York Stock Exchange (NYSE) with the trading symbol **IBM25B**, consistently in both 2022 and 2024. In 2022, the Notes were disclosed in the 10-K via incorporation by reference to Exhibit 4.1 of a 2017 Form 8-K (page 33 of IBM_10k_2022.pdf). By 2024, the Notes were explicitly listed in the 10-K’s securities registration table (page 1 of IBM_10k_2024.pdf), reflecting ongoing registration without material changes to their classification or exchange listing. No new registration details or reclassification were disclosed in 2024, indicating consistent treatment as long-term debt instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of quantitative details: the interest rate (0.950%), maturity year (2025), trading symbol (IBM25B), listing exchange (NYSE), and reference to Exhibit 4.1 of the 2017 Form 8-K are all accurate. The citation of document locations (page 33 in 2022 10-K, page 1 in 2024 10-K) aligns with expected disclosure practices. However, the key discrepancy lies in the interpretation of evolution. The original answer emphasizes a shift from mere disclosure in 2022 to formal registration and listing for trading by 2024. In contrast, the LLM asserts the Notes were already registered under Section 12(b) and listed on the NYSE in 2022, which contradicts the 'evolution' narrative in the ground truth. This misrepresents the timeline of registration status, implying consistency where the ground truth suggests progression. While the LLM correctly identifies the 2024 registration table inclusion, it fails to acknowledge that the formal listing (with trading symbol) may not have been active or disclosed in 2022, thus missing the core evolution. The reasoning is sound in structure but flawed in synthesis across years, particularly in concluding 'consistent treatment' when the ground truth implies a material change in disclosure and registration visibility. Wording and semantic content are otherwise relevant and precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 375,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "\n\nFrom 2022 to 2024, Gilead's strategic positioning of **Biktarvy** evolved with key shifts in financial risk exposure and competitive differentiation:  \n\n1. **Financial Risk Exposure**:  \n   - In 2022, Gilead resolved a major patent litigation risk with ViiV Healthcare via a **$1.25 billion upfront payment** and a **3% royalty on U.S. Biktarvy sales until 2027** (GILD_10k_2024: p. 89). This eliminated uncertainty but introduced ongoing financial obligations. By 2024, risks shifted to **pricing pressures** from state affordability reviews (e.g., Colorado’s PDAB), 340B program constraints, and Medicaid rebate complexities, which could erode margins (GILD_10k_2024: p. 21).  \n\n2. **Competitive Differentiation**:  \n   - Biktarvy remains a **differentiated single-tablet regimen (STR)** for HIV, offering high efficacy and tolerability, which sustains its market leadership. The 2022 settlement with ViiV removed a key competitive threat (dolutegravir-based products) and allowed Gilead to avoid potential generic competition during the royalty period. However, **generic challenges** to TAF-containing products (e.g., Odefsey, Descovy) persist, necessitating legal defenses to protect market share (GILD_10k_2024: p. 94).  \n\nIn summary, Gilead transitioned from litigation-driven risks in 2022 to post-settlement pricing and rebate pressures by 2024, while maintaining Biktarvy’s competitive edge as a preferred HIV STR.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer introduces specific financial figures such as a $1.25 billion upfront payment and a 3% royalty on U.S. Biktarvy sales until 2027, citing 'GILD_10k_2024: p. 89'. However, the Original Answer (ground truth) contains no such quantitative details, and crucially, the knowledge graph does not support these specific numbers or the claim of a settlement with ViiV Healthcare involving ongoing royalties. This represents a significant factual inaccuracy. There is no mention in the ground truth of litigation resolution, royalty payments, or pricing pressures from state-level reviews like Colorado’s PDAB or the 340B program—these are fabrications or hallucinations not present in the source data. While the LLM correctly identifies Biktarvy as a key differentiating product in GILD’s HIV portfolio, it misrepresents the nature of the financial risk evolution. The ground truth emphasizes increasing financial risk due to overreliance on nucleoside-based therapies and potential paradigm shifts away from TAF-based regimens (like Biktarvy), not litigation settlements or rebate pressures. The competitive differentiation point about STRs is partially aligned, but the claim about eliminating generic competition via settlement with ViiV is unsupported. The multi-hop reasoning is structurally sound—attempting to trace risk evolution over time—but based on incorrect premises. The contextual relevance is high because the answer addresses the right topic areas (financial risk, competitive positioning), but the factual foundation is flawed. Quantitative accuracy is low due to invented figures; qualitative accuracy is moderate due to partial alignment on Biktarvy’s role but incorrect reasoning on risk drivers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 466,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "\n\nBetween 2022 and 2023, Lockheed Martin continued its strategy to reduce defined benefit pension obligations by transferring liabilities to insurance companies, with associated financial impacts. In **2022**, the company transferred **$4.3 billion** of pension obligations for ~13,600 retirees in Q2 2022, recognizing a **$1.5 billion noncash pension settlement charge** (accelerated actuarial losses from accumulated other comprehensive loss). In **2023**, Lockheed executed a smaller-scale voluntary settlement, paying **$414 million** to ~6,500 participants who had not yet started benefits, reducing the pension obligation by a similar amount but **without recognizing a settlement charge** (likely due to accounting thresholds). \n\nThese actions reflect ongoing efforts to mitigate pension volatility and liability size, complementing the 2020 freeze of defined benefit plans for salaried employees and the shift to defined contribution plans for new hires. The 2022 charge significantly impacted non-operating income, while the 2023 settlement had a direct cash outflow but no immediate noncash accounting impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations and recognized a $1.5 billion noncash settlement charge; in 2023, it made $414 million in settlement payments to ~6,500 former employees. These numbers match the original answer exactly. (2) The explanation of the strategic shift—from large-scale annuity transfers in 2022 to direct individual settlements in 2023—is well articulated and logically sound. The LLM correctly notes that the 2023 settlements did not trigger a settlement charge, likely due to accounting thresholds, which is a reasonable inference consistent with accounting rules (e.g., ASC 715), even if not explicitly stated in the ground truth. (3) The multi-hop reasoning is strong: the model synthesizes information across two years, distinguishes between types of pension obligation reductions (annuity buyouts vs. direct settlements), and connects them to financial impacts (noncash charges vs. cash outflows). (4) Minor deduction in qualitative accuracy because the LLM implies the 2023 action was part of a continuation of transferring liabilities to insurers, when in fact 2023 involved direct payments, not insurer transfers—this slightly misrepresents the evolution. However, the overall semantic meaning and factual core are correct. Contextual relevance is perfect: the response directly addresses the evolution in approach and associated financial impacts as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 416,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "\n\nBetween 2022 and 2024, IBM's debt instruments maturing in 2025 were restructured. In 2022, IBM listed three 2025-maturing notes: **2.875% Notes (IBM 25A)**, **0.950% Notes (IBM 25B)**, and **0.875% Notes (IBM 25C)**. By 2024, the **0.950% and 0.875% Notes (IBM 25B/C)** were removed, and a new **7.00% Debentures due 2025 (IBM 25)** was added. The **2.875% Notes due 2025 (IBM 25A)** remained part of IBM's debt structure in 2024, indicating continuity for this specific instrument while other 2025 maturities were adjusted.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative and entity accuracy domains. (1) According to the ground truth, in 2022 IBM had three notes due 2025: 2.875% (IBM 25A), 0.950% (IBM 25B), and 0.875% (IBM 25C). The LLM correctly identifies these three in 2022, which is accurate. (2) However, the LLM claims that by 2024, both the 0.950% and 0.875% Notes (IBM 25B/C) were removed and replaced with a new '7.00% Debentures due 2025 (IBM 25)'. This is incorrect — the ground truth states only that the 0.875% Notes (IBM 25C) were no longer listed in 2024, while the 0.950% Notes (IBM 25B) are not mentioned as removed, and there is no mention of any new 7.00% Debentures. This introduces false entities and incorrect changes. (3) The LLM correctly notes that the 2.875% Notes due 2025 (IBM 25A) remained in 2024, which aligns with the ground truth. However, the reasoning about restructuring is partially flawed due to the incorrect claim about removal of IBM 25B and addition of a new instrument. (4) The contextual relevance is high because the answer addresses the evolution of debt composition and focuses on the 2.875% Notes as asked. But due to major errors in the composition changes — especially inventing a 7.00% Debenture not present in the truth — the quantitative accuracy is low. The qualitative accuracy is moderate because some reasoning structure is sound, but based on incorrect data. Overall, the answer is partially correct but contains critical factual errors that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 423,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "\n\nFrom 2022 to 2024, Biktarvy's strategic importance within Gilead's HIV portfolio has remained central as a key revenue driver, but its risk profile has increased due to intensifying competitive pressures and potential shifts in treatment paradigms. In 2022, Biktarvy was highlighted for its \"continued growth in all geographies,\" offsetting declines in older HIV products like Truvada and Atripla due to generic competition (GILD_10k_2022, p. 39). By 2024, however, Gilead explicitly noted heightened risks from market share losses to competitive products (including generics) and the possibility of nucleoside-based regimens (like Biktarvy, which contains TAF) losing favor if treatment guidelines evolve (GILD_10k_2024, p. 18). This underscores a growing vulnerability amid pricing pressures and the need for innovation to sustain Biktarvy's dominance in a maturing HIV market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Biktarvy was a growth driver in 2022 with 'continued growth in all geographies' (GILD_10k_2022, p. 39), and by 2024, Gilead highlighted increased risks due to its reliance on TAF-containing products and potential shifts away from nucleoside-based therapies (GILD_10k_2024, p. 18). The mention of competitive pressures, generics, and treatment paradigm changes is consistent with the original answer. (2) There are no numeric inaccuracies—while no specific percentages or dollar amounts are cited in the response, the qualitative references to growth and risk are correctly attributed to the appropriate years and filings. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 10-Ks, correctly identifying the evolution from growth asset to increased vulnerability. It appropriately links Biktarvy’s composition (TAF) to broader franchise risk, demonstrating strong qualitative synthesis. (4) The only minor shortcoming is that the original answer emphasizes a shift in strategic *positioning*—from growth driver to potentially vulnerable asset—more explicitly, while the LLM slightly softens this by saying 'strategic importance... has remained central.' However, this is semantically acceptable given that Biktarvy remains a key product even as its risk profile increases. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 414,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "\n\nThe U.S. litigation escrow account balance increased from **$1,449 million at the end of fiscal 2022** to **$1,764 million at the end of fiscal 2023**, according to the 2023 10-K (page 73). During fiscal 2023, **$1,000 million was deposited** into the account, while **$685 million was paid out** (primarily to opt-out merchants). The specific deposit contributions for fiscal 2022 are not explicitly detailed in the provided pages, but the ending balance for fiscal 2022 reflects prior activity, including historical deposits and payments.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ending balance for fiscal year 2023 is incorrect: it states $1,764 million, while the ground truth is $3,089 million. The deposit amount for fiscal year 2023 is also wrong: the LLM claims $1,000 million was deposited in fiscal 2023, but the correct amount is $1,500 million. Additionally, the LLM introduces a payout of $685 million not mentioned in the original answer and not requested by the question, which adds irrelevant and potentially misleading information. The deposit for fiscal 2022 is omitted with a note that it's not explicitly detailed, but the ground truth confirms it was $1,000 million. (2) Quantitative accuracy is low: both the ending 2023 balance and the 2023 deposit are incorrect, and the answer fabricates a payout figure. The only correct number is the starting balance of $1,449 million at the end of fiscal 2022. (3) The reasoning is partially sound in that it attempts to trace changes in the escrow account, but it fails the multi-hop requirement by not correctly synthesizing the full evolution of the account balance and deposits across both years. It relies on incorrect or extraneous data, undermining the logical chain. (4) Contextual relevance is moderate—the response addresses the general topic and time frame, and cites a document page, but due to major factual errors and omissions, it does not accurately reflect the true evolution of the account or the specified deposits. Overall, the answer is mostly incorrect on key quantitative points, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 437,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "\n\nThe role of fountain syrups in Coca-Cola's North America operating segment remained consistent between 2022 and 2023. In both years, the Company manufactured fountain syrups in the U.S. and sold them directly to fountain retailers or through authorized fountain wholesalers and bottling partners, with these sales included in the North America segment. No material changes to manufacturing or distribution responsibilities for fountain syrups were disclosed in the provided documents during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Coca-Cola manufactured fountain syrups in the U.S. and sold them through similar channels in both 2022 and 2023, with no disclosed material changes in manufacturing or distribution responsibilities within North America. This aligns with the ground truth's observation of operational continuity in North America. However, the LLM answer omits a key nuance highlighted in the original answer: the 2023 shift in language regarding bottling partners being authorized to manufacture fountain syrups outside the U.S. using company concentrates. While the question focuses on North America, the evolution in global language may still inform the broader strategic context of the North America segment’s role in a changing distribution model. The LLM correctly identifies no change in responsibilities but fails to acknowledge the subtle but meaningful shift in disclosure that suggests a more decentralized, authorization-based model emerging—particularly outside the U.S.—which the original answer presents as part of the evolution. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (Coca-Cola, North America segment, U.S., bottling partners) are correctly identified. The reasoning is sound but incomplete in synthesis, missing the multi-hop element of comparing disclosure language changes between years that imply strategic nuance. Contextual relevance is high as the response directly addresses the question’s focus on manufacturing and distribution in North America.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 425,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "\n\nBetween 2022 and 2024, IBM's debt instruments maturing in 2025 saw a reduction in the number of outstanding notes. In 2022, IBM listed both **0.950% Notes due 2025 (IBM25B)** and **0.875% Notes due 2025 (IBM25C)** in its 10-K filing. By 2024, the **0.875% Notes due 2025 (IBM25C)** were no longer listed, while the **0.950% Notes due 2025 (IBM25B)** remained outstanding. This indicates the 0.875% Notes were likely redeemed or retired during this period, simplifying the 2025 debt maturity to only the 0.950% Notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the presence of the 0.950% Notes due 2025 (IBM25B) and 0.875% Notes due 2025 (IBM25C) in 2022 and the absence of the latter in 2024, which aligns with the ground truth. However, it omits the 2.875% Notes due 2025 (IBM25A), which were present in both 2022 and 2024 according to the original answer. This is a significant omission affecting completeness and accuracy of the debt composition. (2) Quantitatively, the percentages (0.950%, 0.875%) and years (2025) are correct, and the timeline (2022 to 2024) is accurately represented. No calculations are required, but the identification of instruments is mostly accurate except for the missing 2.875% note. (3) The reasoning is sound in inferring that the removal of the 0.875% Notes suggests redemption or retirement, and that the composition simplified. However, the conclusion that only the 0.950% Notes remain is incorrect because the 2.875% Notes also remain, undermining the multi-hop synthesis. The model fails to fully represent the evolution of the full set of 2025-maturing instruments. (4) Contextual relevance is high as the response directly addresses the evolution of IBM's debt instruments maturing in 2025 and focuses on the 0.950% Notes as asked. The omission of a key instrument reduces qualitative and overall correctness, warranting a score of 7 for correctness and qualitative accuracy, 9 for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 402,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "\n\nDisney's strategic approach to cruise ships evolved from addressing pandemic-related disruptions in 2022 to pursuing expansion in 2024. In 2022, disclosures highlighted the suspension of cruise ship sailings due to COVID-19 measures and hurricane impacts, which reduced revenues and emphasized vulnerabilities to external shocks (DIS_10k_2022.pdf, pages 23–24). By 2024, Disney shifted focus to growth, announcing plans to expand its cruise ship fleet and increase investments in its Experiences segment, which includes cruise operations (DIS_10k_2024.pdf, pages 22–26). This reflects a strategic pivot from recovery to proactive expansion, aiming to capitalize on demand for premium travel experiences while mitigating past challenges through diversified offerings and operational resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in Disney's strategic approach from 2022 to 2024: in 2022, cruise operations were affected by external disruptions (pandemic, hurricanes), while in 2024, Disney emphasized expansion and investment in the cruise fleet as part of its Experiences segment. This matches the original answer’s core claim of a shift from passive dependence on demand to active growth strategy. (2) There are no numeric values (e.g., dollar amounts, fleet counts) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly inferring a strategic evolution. The mention of 'increased investments' and 'expansion of cruise fleet' in 2024 is consistent with the original answer. The LLM adds contextual detail (e.g., hurricane impacts, operational resilience) that is plausible and enhances the narrative without contradicting the ground truth. (4) The only minor difference is that the original answer emphasizes the acknowledgment of increased costs and uncertain returns on new cruise investments in 2024, which the LLM omits. This is a small but relevant nuance about risk awareness in the strategic shift. However, the core factual progression—strategic pivot from recovery to expansion—is accurately captured. Thus, the answer is semantically equivalent with high completeness and reasoning quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 428,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "\n\nLockheed Martin's approach to pension risk transfer transactions from 2022 to 2023 reflects a continuation of strategic efforts to mitigate pension liabilities while acknowledging potential future financial impacts. In 2022, the company executed significant transactions, including a $4.9 billion GAC purchase in 2021 that transferred obligations for 18,000 retirees, resulting in a **$1.7 billion noncash settlement charge** (after tax) and reducing annual PBGC premiums by $69 million. By 2023, while no new large-scale transfers were disclosed, the company maintained its intent to evaluate future transactions but highlighted risks of **additional contributions or noncash charges** if new transactions occurred. The strategic intent remained focused on stabilizing pension obligations and cash flows, though 2023 emphasized caution regarding potential earnings volatility from future settlements, indicating a more measured approach post-2022.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic evolution and financial impact of Lockheed Martin's pension risk transfer approach from 2022 to 2023, with mostly accurate facts and good synthesis. However, there are key quantitative inaccuracies that reduce the correctness score. First, the $1.7 billion noncash settlement charge is correctly cited but incorrectly labeled as 'after tax'—the original answer and SEC filings describe it as a pre-tax, noncash charge, which is a significant distinction. Second, the LLM introduces a figure of '18,000 retirees' impacted by the 2021 transaction, which is not present in the ground truth; the original answer states that since December 2018, ~95,000 retirees were affected by cumulative transfers, but does not specify how many were part of the 2021 $4.9B transaction. This number appears to be fabricated or misattributed. Third, the $69 million PBGC premium reduction is not mentioned in the ground truth and lacks verification. On qualitative accuracy, the LLM correctly identifies the shift in strategic intent—continuing evaluation of transfers while highlighting risks of future contributions and noncash charges—and notes increased caution in 2023, including the potential for earnings volatility. It also correctly conveys the ongoing strategic goal of stabilizing obligations. However, it misses the nuanced 2023 disclosure about residual liability if insurers default on GACs, a key element in the ground truth that reflects a more cautious framing. Contextually, the answer is highly relevant, addressing both financial impact and strategic intent across years. While the reasoning is logical and mostly sound, the introduction of unverified numbers and the tax characterization error undermine quantitative accuracy. Semantic equivalence is mostly preserved, but the added specifics (18,000 retirees, $69M savings, after-tax label) introduce factual distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 515,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "\n\nBetween 2022 and 2023, Tesla's relationship with financing partners evolved with increased emphasis on managing accounts receivable complexities and leasing program risks. In 2022, accounts receivable included significant amounts from government rebates (e.g., $627 million in long-term receivables as of December 31, 2021) and financing partners, with fluctuations tied to payment terms and rebate processing delays. By 2023, Tesla highlighted heightened risks in its leasing programs, including residual value volatility due to used vehicle demand, economic cycles, and new vehicle pricing adjustments. The company also noted challenges in securing adequate financing for its direct leasing operations, which could hinder growth if alternative funding sources were unavailable. Additionally, compliance with financial regulations and credit risks became more critical as Tesla expanded its direct financing arrangements globally. This reflects a shift toward greater self-management of financing programs and increased exposure to market and operational risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Tesla's relationship with financing partners from 2022 to 2023, particularly regarding accounts receivable management and leasing program risks. It correctly identifies the shift from operational timing issues (e.g., payment delays) in 2022 to broader financial and market risks in 2023. However, there is a minor quantitative inaccuracy: the LLM cites $627 million in long-term receivables as of December 31, 2021, which falls outside the 2022–2023 scope of the question and is not mentioned in the ground truth. While this figure may be factually correct in Tesla’s filings, it introduces a data point not relevant to the specified timeframe, slightly undermining quantitative precision. The ground truth emphasizes 2022 payment terms (up to two weeks for settlement), which the LLM does not explicitly quantify, though it references 'fluctuations tied to payment terms'—a semantically close but less precise rendering. Qualitatively, the LLM correctly synthesizes multi-hop information: it links the increased complexity in leasing programs to residual value risks, financing availability, and regulatory compliance, reflecting a sound understanding of Tesla’s expanding exposure. The answer addresses both sub-questions (accounts receivable and leasing risks) and maintains contextual relevance throughout. Minor deductions are due to the out-of-scope receivable figure and the lack of explicit mention of the two-week settlement window, but overall, the reasoning and factual content align closely with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 434,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "\n\nBetween 2022 and 2023, Coca-Cola expanded the role of U.S. bottlers in its fountain syrup distribution strategy by authorizing them as **fountain wholesalers** to distribute fountain syrups to retailers. Previously, in 2022, bottlers were generally not involved in manufacturing or distributing fountain syrups in the U.S., as the company directly sold syrups to authorized wholesalers (including some bottlers). By 2023, the company explicitly included bottling partners as part of the distribution chain, enabling them to act as intermediaries alongside traditional wholesalers. This shift leveraged bottlers’ existing infrastructure and networks to enhance efficiency in the fountain channel, while maintaining the company’s control over syrup production. Outside the U.S., bottlers had long been authorized to manufacture fountain syrups, but the 2023 changes in the U.S. marked a strategic evolution in domestic operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a fundamental factual error in the core claim about U.S. bottlers: it incorrectly states that in 2023, Coca-Cola authorized U.S. bottlers to act as fountain wholesalers, expanding their role domestically. However, the ground truth indicates that the strategic shift occurred *outside the United States*, where bottlers were increasingly authorized to *manufacture* fountain syrups using Coca-Cola concentrates—a key distinction the LLM misses. The LLM incorrectly reverses the geography of change, asserting a domestic (U.S.) evolution when the actual change was international. Additionally, the ground truth emphasizes that bottlers outside the U.S. could manufacture syrups, not just distribute them, which involves a deeper integration into production, not merely distribution. The LLM focuses on distribution rights in the U.S., which is not supported by the original answer. While the description of the 2022 model is accurate and the general idea of bottlers gaining a larger role is directionally correct, the specific entities (U.S. vs. international), the nature of the change (manufacturing vs. distribution), and the direction of evolution are incorrect. There are no numerical values in the question, so quantitative accuracy is scored as 10 by default. Contextual relevance is high because the answer addresses the right topic and structure, but the qualitative accuracy is low due to the misattribution of the strategic shift. The multi-hop reasoning fails because the model conflates international manufacturing authorization with domestic distribution changes, breaking the logical synthesis required across time and geography.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 453,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "\n\nBetween 2023 and 2024, AMD's financial relationship with the ATMP JV evolved as follows:  \n- **Receivables** increased from $9 million (Dec 30, 2023) to $12 million (Dec 28, 2024), driven by higher resales to the JV ($14 million in 2023 vs. $121 million in 2024).  \n- **New investment activities** included a $17 million equity contribution in August 2024 (proportional to AMD's 15% ownership) and a $100 million secured term loan to one ATMP JV in October 2024, bearing SOFR-based interest. The carrying value of AMD's investment rose to $149 million in 2024 (from $99 million in 2023), reflecting these contributions and equity income.  \n\nThese actions highlight expanded operational and financial support to the ATMP JV in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies the increase in receivables from $9M to $12M, it introduces several unsupported details. The ground truth states there was no direct investment or loan by AMD in 2023 and only a $100M term loan in 2024. However, the LLM claims a $17M equity contribution in August 2024 and an increase in carrying value from $99M to $149M, which are not present in the original answer and contradict the 'no investment' statement for 2023. Additionally, the LLM cites resales of $14M in 2023 and $121M in 2024 as drivers for receivables, but this information is absent in the ground truth and not logically connected. (2) Number verification: Receivables ($9M → $12M) are correct. The $100M term loan is correctly reported. However, the $17M equity contribution, $99M to $149M investment carrying value, and resale figures are entirely fabricated or misattributed. These are major quantitative errors. (3) Multi-hop reasoning is partially sound in identifying a deepening financial relationship, but the reasoning is based on incorrect data. The conclusion about expanded operational and financial support is plausible but overstated due to false inputs. The model fails to correctly synthesize the absence of investment in 2023 and the singular nature of the 2024 loan as the only new financial activity. (4) Correctness score is 4 due to partial accuracy on receivables and the $100M loan, but major errors in investment details. Quantitative accuracy is low (3) due to multiple invented figures. Qualitative accuracy is moderate (5) because the direction of evolution (closer financial ties) is correct, but reasoning is flawed. Contextual relevance is high (8) as the answer addresses the right entities and time frame and attempts a synthesized comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 507,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "\n\nBetween 2022 and 2023, Lockheed Martin shifted its approach to managing nonqualified defined benefit pension plans by executing different types of settlements with distinct financial impacts. In **2022**, the company purchased group annuity contracts to transfer **$4.3 billion** of pension obligations for ~13,600 retirees, resulting in a **noncash, nonoperating pension settlement charge of $1.5 billion** (accelerated recognition of actuarial losses from accumulated other comprehensive loss). In **2023**, it instead offered a **voluntary cash settlement** of **$414 million** to ~6,500 participants who had not yet begun receiving benefits, directly reducing the pension obligation without a significant noncash charge. \n\nThe 2022 strategy involved large-scale risk transfer to insurers with immediate noncash accounting impacts, while 2023 focused on targeted cash settlements to mitigate future liabilities with a smaller direct cash outflow. This evolution reflects efforts to reduce pension volatility and obligations through diversified de-risking tactics.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: $4.3 billion in pension obligations transferred in 2022, $1.5 billion noncash settlement charge, and $414 million voluntary cash settlement in 2023. The participant counts (~13,600 retirees in 2022, ~6,500 in 2023) are consistent with the knowledge graph. (2) The answer correctly identifies the shift in strategy—from large-scale annuity buyouts in 2022 to targeted cash settlements in 2023—with precise financial impacts: the 2022 charge stemmed from accelerated actuarial losses, while 2023’s smaller cash outflow avoided a significant noncash charge. (3) Multi-hop reasoning is sound: the model synthesizes data across two years, distinguishes between types of settlements (annuity vs. cash), and correctly infers the strategic evolution toward de-risking with reduced volatility. (4) The terminology is precise (e.g., 'noncash, nonoperating pension settlement charge', 'accumulated other comprehensive loss'), and the explanation of financial mechanics is accurate. The answer fully addresses the question’s focus on evolution, pension obligation settlements, and financial impacts. Minor additions like participant status (not yet receiving benefits) enhance clarity without introducing error. All elements meet the highest standard for correctness, completeness, and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 389,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "\n\nBetween 2023 and 2024, AMD's investment in the ATMP JV increased from $99 million to $149 million, driven by a $17 million equity contribution in August 2024 proportional to its 15% ownership. Equity income from the ATMP JV rose significantly, with gains of $33 million in 2024 compared to $16 million in 2023, reflecting improved performance of the joint venture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key financial figures are correct: the 2023 carrying value ($99M), 2024 carrying value ($149M), additional contribution ($17M), and equity income for 2023 ($16M) and 2024 ($33M) match exactly. (2) The calculation of the investment increase is sound: $99M + $17M = $116M, but the final carrying value is $149M, implying other adjustments (e.g., equity income or revaluation), which the model does not attempt to explain—this is a minor gap but not incorrect. (3) The mention of an 'August 2024' contribution and '15% ownership' introduces specific details not present in the original answer; while not contradicted by the ground truth, they are unverified additions, slightly reducing qualitative accuracy. (4) The reasoning correctly synthesizes multi-hop information—investment change and income trend—and draws a valid conclusion about improved JV performance. (5) The answer is contextually relevant, directly addressing AMD's evolving financial relationship with ATMP JV in terms of investment and equity income. Overall, the answer is factually correct with only minor speculative additions, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 337,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "\n\nBetween 2023 and 2024, Johnson & Johnson's ownership in Kenvue evolved as follows:  \n\n1. **2023**:  \n   - On **May 8, 2023**, J&J completed Kenvue's IPO, retaining **89.6% ownership**.  \n   - On **August 23, 2023**, J&J further reduced its stake via an exchange offer, disposing of **80.1%** of Kenvue shares, leaving **9.5% ownership** (valued at **$4.3 billion** as of August 23, 2023). This transaction generated a **non-cash gain of $21.0 billion** (including a $2.8 billion gain on the retained stake) in Q3 2023.  \n\n2. **2024**:  \n   - On **May 17, 2024**, J&J eliminated its remaining 9.5% stake via a **Debt-for-Equity Exchange**, swapping **182.3 million Kenvue shares** for $3.6 billion in commercial paper. This resulted in a **$0.4 billion loss** recorded in Other (income) expense.  \n\n**Retained equity**: J&J’s ownership dropped from 89.6% (post-IPO) to 9.5% by August 2023, then to **0% by May 2024**. The **$21.0 billion gain in 2023** contrasted with a **$0.4 billion loss in 2024** due to the final divestiture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers, dates, percentages, and dollar amounts are correct: 9.5% ownership retained in 2023 valued at $4.3 billion, $21.0 billion non-cash gain (including $2.8 billion on retained shares), disposal of 80.1% stake, 182.3 million shares (matching 182,329,550), Debt-for-Equity Exchange on May 17, 2024, resulting in $0.4 billion loss. These match or are precise representations of the original data. (2) Quantitative accuracy is perfect—no errors in figures or formatting; $0.4 billion loss and $21.0 billion gain are correctly reported. (3) The reasoning is sound and captures the multi-hop evolution: from post-IPO ownership (89.6%), partial exit in August 2023, retained stake, associated gains, and full exit in 2024 with loss. The only minor discrepancy is that the original answer does not explicitly state J&J’s post-IPO ownership was 89.6%, though it can be inferred; the LLM adds this detail, which is contextually accurate but not present in the ground truth. This does not constitute an error but adds precision beyond the original. (4) The answer fully addresses the question about the evolution of financial stake, retained equity, and gains/losses across 2023–2024. Semantic equivalence is maintained with enhanced clarity. Thus, the answer earns a 9/10 for correctness due to slight over-attribution of detail not in the original, but no factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 401,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "\n\nAT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, as both years' filings reference the same guaranty agreement under \"4-b\" in the exhibit lists, citing Exhibit 4-c to the December 31, 2011, Form 10-K. No modifications, terminations, or updates to this guarantee are disclosed in the provided pages for either year, indicating continuity in its inclusion within AT&T's guarantee agreements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, with the guarantee continuing to be included in the same exhibit (Exhibit 4-c) in both years. The key factual elements—continuity of the guarantee, reference to Exhibit 4-c, and no disclosed modifications—are accurate and align with the ground truth. However, there is a minor error in the LLM answer: it incorrectly states that the exhibit list references '4-b' instead of consistently citing 'Exhibit 4-c' as in the original answer. This appears to be a typographical or referencing inconsistency, but since the correct exhibit (4-c) is mentioned later in the sentence and the overall conclusion about continuity is correct, the impact on factual accuracy is limited. All dates and entity names (AT&T, Southwestern Bell Telephone Co.) are correct, and no numerical data is involved, so quantitative accuracy is perfect. The reasoning is sound, demonstrating proper synthesis across years and documents, and the answer is fully contextually relevant. The minor exhibit label discrepancy prevents a top score, but the core information is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 337,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "\n\nLockheed Martin expanded its strategic positioning in hypersonics programs from 2022 to 2023 by broadening its development responsibilities across business segments and defense services. In 2022, hypersonics efforts were primarily associated with the **Space** segment, focusing on programs with the **U.S. Army and Navy**. By 2023, the **Missiles and Fire Control (MFC)** segment explicitly joined the effort, adding programs with the **U.S. Air Force and Army**, while the Space segment continued its work with the Navy. This expansion reflects a more integrated approach, leveraging multiple business units to address hypersonic strike weapon development for all three services, thereby solidifying Lockheed Martin’s role as a key defense contractor in advancing U.S. hypersonics capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in entity and program attribution, particularly regarding business segment involvement. While the ground truth states that in 2022, hypersonics were described as a growth area dependent on government funding and not yet assigned to specific segments, the LLM incorrectly asserts that in 2022 the Space segment was already actively working on programs with the U.S. Army and Navy. The original answer indicates this level of specificity and active program status only emerged in 2023. Additionally, the LLM introduces the Missiles and Fire Control (MFC) segment’s involvement in 2023 with the Air Force and Army, which is not mentioned in the ground truth and represents an unsupported expansion. The ground truth emphasizes a shift in strategic positioning—from a potential growth area to a defined program under the Space segment—but does not support the claim of multi-segment integration across MFC and Space with all three military services. There are no numerical figures to verify, so quantitative accuracy is high by default. The reasoning is logically structured but based on incorrect entity-time mappings, undermining the multi-hop synthesis. The answer is contextually relevant and addresses the evolution question, but the factual misattribution of segments and services reduces its overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 385,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "\n\nThe balance of the U.S. litigation escrow account increased from **$1.4 billion as of September 30, 2022** (fiscal 2022) to **$1.764 billion as of September 30, 2023** (fiscal 2023). During fiscal 2022, **$850 million** was deposited into the account, while **$1.0 billion** was deposited in fiscal 2023. The 2023 balance reflects additional deposits offset by payments of **$685 million** to opt-out merchants during the year.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the final balance for fiscal year 2023. The ground truth states the balance was $3.089 billion as of September 30, 2023, but the LLM reports $1.764 billion, which is substantially lower. The deposits are correctly stated: $850 million in fiscal 2022 and $1.0 billion in fiscal 2023. However, the LLM introduces a payment of $685 million to opt-out merchants, which is not mentioned in the ground truth and appears to be fabricated or misattributed, leading to an incorrect ending balance calculation. (2) Quantitative accuracy fails on the key final balance figure. While the starting balance ($1.4B) and deposits are correct, the resulting balance should be $1.4B + $1.0B = $2.4B at minimum (ignoring interest or other adjustments), but the reported $1.764B implies unverified deductions. The correct ending balance per ground truth is $3.089B, suggesting additional deposits or different accounting not reflected in the LLM response. (3) The multi-hop reasoning is partially sound—linking deposits and starting balance—but flawed by introducing unsupported outflows, undermining the synthesis. The model attempts to explain the change but does so with incorrect data. (4) Scores reflect partial correctness on deposits and starting balance (hence not zero), but major error in the outcome metric. Contextual relevance is high as all parts of the question are addressed with relevant structure and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 408,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "\n\nThe role of Outdoor Garden within HD's product strategy remained within the **Hardlines** category from 2022 to 2024, as shown in both filings (2022: page 56; 2024: page 56). In 2022, Outdoor Garden contributed **6.8% of total net sales** ($10,317 million in fiscal 2021). By 2024, while specific sales figures for Outdoor Garden were not disclosed, the **Hardlines segment grew** to $48,562 million (fiscal 2024) from $45,730 million (fiscal 2022), suggesting a maintained or enhanced role. The 2024 filing also noted merchandising department realignments, but Outdoor Garden retained its classification under Hardlines, indicating strategic continuity. Performance metrics imply stable positioning, though relative growth within the expanding Hardlines segment is likely.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states that Outdoor Garden was part of the Hardlines category in 2022, while the ground truth indicates it was a *distinct product line* in 2022 and only later grouped under Hardlines by 2024. This misrepresents the strategic evolution. Second, the LLM claims the $10,317 million in net sales was for *fiscal 2021*, but the original answer states this was for *2022*, which is a factual error. Third, the LLM asserts that Outdoor Garden 'retained its classification under Hardlines' from 2022 to 2024, which directly contradicts the ground truth that it was only integrated into Hardlines by 2024. (2) Quantitatively, the $10,317 million and 6.8% figures are correct, and the Hardlines totals for 2022 ($45,730M) and 2024 ($48,562M) are accurate, though their use to infer Outdoor Garden's performance is speculative since the sub-category breakdown is not provided in 2024. The misattribution of the $10.3B figure to 2021 instead of 2022 is a significant quantitative error. (3) The multi-hop reasoning is flawed: the model fails to recognize the key shift from standalone category to sub-component within Hardlines, which is the central point of the original answer. Instead, it assumes continuity, missing the strategic repositioning. The synthesis across years is therefore incorrect. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of Outdoor Garden’s role and citing performance metrics. It attempts to use disclosed data and acknowledges changes in merchandising structure. However, due to key factual and interpretive errors, especially regarding classification over time, the correctness score is moderate at 5, reflecting partial accuracy with significant gaps in the core narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 492,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "\n\nAMD maintained its emphasis on an engaging and open environment amid its global workforce expansion (from ~26,000 employees in 2023 to ~28,000 in 2024) by prioritizing **culture, diversity, and employee development**. Key initiatives included:  \n1. **Cultural Reinforcement**: Annual surveys measuring engagement and workplace experience, with 2024 results showing high scores for inclusivity, innovation, and manager quality, placing AMD in the top 10% of tech industry peers.  \n2. **Diversity & Inclusion (D&I)**: Expanding Employee Resource Groups (ERGs) (85% of new hires join at least one), mentoring programs, and initiatives like \"Advancing Women in Technology\" to support underrepresented groups.  \n3. **Total Rewards**: Competitive compensation, hybrid/remote work flexibility, inclusive benefits (e.g., global parental leave, adoption assistance), and performance-linked incentives to align employee success with company growth.  \n4. **Career Development**: Leadership programs, tuition reimbursement, and internal promotion prioritization to foster growth.  \n\nThis strategy suggests AMD prioritizes **retaining top talent** in a competitive semiconductor industry by creating a **collaborative, inclusive culture** with robust career and compensation opportunities, countering attrition risks posed by rivals like Intel and NVIDIA. The focus on engagement and D&I strengthens loyalty and positions AMD to attract skilled professionals critical for innovation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in context and relevance but contains significant factual inaccuracies not supported by the ground truth. (1) The original answer states only that AMD maintained identical cultural messaging between 2023 and 2024 despite workforce growth from ~26,000 to ~28,000 employees (a 7.7% increase), with no mention of specific programs, surveys, ERGs, or benefits. The LLM answer fabricates detailed initiatives such as 'annual surveys with top 10% results,' '85% of new hires joining ERGs,' 'Advancing Women in Technology,' 'hybrid/remote flexibility,' 'tuition reimbursement,' and 'performance-linked incentives'—none of which appear in the original data. (2) Quantitative accuracy is low: while the workforce numbers (~26,000 in 2023, ~28,000 in 2024) are correct and the implied 7.7% growth aligns with the original, all other percentages (e.g., 85%, top 10%) are unsupported and likely invented. (3) Qualitative accuracy suffers because the LLM fails to base its reasoning solely on the provided source; instead of noting the repetition of identical cultural language as evidence of strategic consistency, it assumes specific D&I and development programs without evidence. The multi-hop reasoning is flawed—there is no synthesis from additional documents or years beyond the two statements. (4) Contextual relevance is high because the answer addresses workforce expansion, culture, and talent retention in the semiconductor industry, and correctly infers that cultural consistency supports talent strategy. However, the addition of unverified details significantly undermines factual correctness. The core insight about culture as a retention tool is aligned with the original, but the supporting evidence is not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 472,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "\n\nAT&T's guarantee obligations related to The Ohio Bell Telephone Company remained consistent between 2022 and 2023. Both the 2022 and 2023 10-K filings (pages 141 and 103, respectively) disclose a guaranty of obligations for The Ohio Bell Telephone Company under the same terms, indicating no material changes to the guarantee during this period. The company continued to include Ohio Bell in its list of entities covered by guarantees, reflecting an ongoing financial commitment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that AT&T's guarantee obligation for The Ohio Bell Telephone Company remained unchanged between 2022 and 2023, which matches the original answer's assertion of a stable relationship with continued documentation. The mention of specific 10-K pages (141 in 2022, 103 in 2023) adds precision and supports the claim of consistency. While the ground truth references Exhibit 4-c and its update in documentation practices, the LLM answer captures the semantic equivalent by noting the ongoing inclusion under the same terms, reflecting maintenance of the guarantee. The only minor omission is the lack of explicit reference to the exhibit number or its update (e.g., Exhibit 4-c), which is present in the original answer but does not detract from the core factual correctness. All entities (AT&T, The Ohio Bell Telephone Company), years (2022–2023), and the nature of the obligation are accurately identified. The reasoning is sound, demonstrating correct synthesis across two years of filings. Quantitative elements (years, document types, page numbers) are accurate. The answer is highly relevant and conveys the same conclusion as the ground truth: no material change in the guarantee, with ongoing financial commitment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 365,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "\n\nThe financial impact of GE's relationship with AerCap, as reflected in gains on retained and sold ownership interests, declined significantly between 2023 and 2024. In 2023, GE reported **$5.778 billion in gains** (primarily from AerCap and GE HealthCare investments), as noted on page 13 of the 2023 10-K. However, in 2024, these gains decreased by **$5.2 billion** compared to 2023, driven by lower gains from the same AerCap and GE HealthCare investments, as detailed on page 8 of the 2024 10-K. This reduction reflects the monetization and partial exit of these stakes over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM reports a $5.778 billion gain in 2023, which is consistent with the ground truth's $5.7 billion figure—this minor difference (0.078 billion) likely reflects rounding and is acceptable under format variation allowances. The $5.2 billion decrease in 2024 is exactly matched in both answers. (2) The answer correctly identifies that the gains were primarily driven by AerCap and GE HealthCare in both years, and notes the year-over-year decline, which captures the core evolution asked in the question. (3) The multi-hop reasoning is sound: it synthesizes data from two different years (2023 and 2024) and attributes the change correctly to the same set of investments, showing understanding of the evolving financial impact. (4) The mention of 'monetization and partial exit' adds contextual insight that is plausible given the reduction in gains, though not explicitly stated in the ground truth—this is a reasonable inference and does not detract from accuracy. The only minor discrepancy is the slightly more precise $5.778B figure, which may come from a specific line item in the cited 10-K page 13, but does not contradict the rounded $5.7B. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 368,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "\n\nHome Depot's strategic use of HD Supply evolved from integrating the subsidiary post-acquisition in late 2020 to a more refined focus on professional (Pro) customers and MRO (Maintenance, Repair, and Operations) services by 2024. In 2022, HD Supply was positioned as a key channel for serving Pro customers and MRO needs, particularly in sectors like multifamily and hospitality, following its acquisition to strengthen Pro customer relationships. By 2024, Home Depot expanded this strategy through the acquisition of SRS (specializing in roofing, landscaping, and pool contractors) and enhanced HD Supply's capabilities, including tailored credit programs (e.g., Pro House Account), expanded delivery networks, and dedicated Pro services. This evolution reflects a deeper integration of HD Supply into Home Depot's interconnected retail strategy, emphasizing Pro customer growth and MRO service differentiation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its overall narrative and timeline, but contains a significant factual error regarding the acquisition of SRS, which is not mentioned in the original answer and is not part of the ground truth from the knowledge graph. The original answer focuses solely on the evolution of HD Supply’s role between 2022 and 2024, noting a shift from integration challenges to a strategic asset for Pro and MRO services. The LLM correctly identifies HD Supply’s growing role in serving professional customers and MRO needs in sectors like multifamily and hospitality, and accurately reflects the post-2020 integration context. However, the mention of the SRS acquisition and its integration with HD Supply is unsupported by the provided ground truth and introduces a fabricated element, undermining the qualitative accuracy. While the LLM captures the correct strategic trajectory and correctly references tailored credit programs and expanded services, these details are not in the original answer and may represent plausible inference rather than verified facts. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. The reasoning is logically sound but based on some incorrect premises, leading to a partial mismatch in factual synthesis. Thus, the answer is semantically close but not fully factually aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 392,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "\n\nBetween 2023 and 2024, AMD maintained a strong patent portfolio, with **7,500 U.S. patents** in both years, while global issued patents increased slightly from **12,800 to 13,200**, reflecting growth in international IP. Pending patent applications remained stable at ~5,600 globally, though U.S. pending applications decreased marginally from 2,000 to 1,900. AMD continued to rely on **cross-licensing and technology exchange agreements** typical in the semiconductor industry, enabling mutual technology sharing and reducing litigation risks. The slight expansion in issued patents, particularly outside the U.S., suggests AMD strengthened its IP position to enhance bargaining power in licensing deals and support collaborative innovation, though the stable pending applications indicate a consistent but measured pace of new filings. This evolution underscores AMD’s strategic focus on leveraging its IP portfolio to sustain competitive advantage and foster technology exchange with partners.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. While it correctly states that global issued patents increased from 12,800 to 13,200 and pending applications remained at ~5,600, it introduces new figures not present in the original answer—specifically 7,500 U.S. patents and 2,000 to 1,900 U.S. pending applications—which are unsupported by the ground truth. The original answer only provides global totals (18,500 in 2023 and 18,800 in 2024), broken into issued and pending, with no mention of U.S.-specific data. These fabricated U.S. numbers significantly undermine quantitative accuracy. (2) The calculation of total patent matters is partially correct: 12,800 + 5,600 = 18,400 (close to the reported 18,500), and 13,200 + 5,600 = 18,800 (exact for 2024), suggesting minor rounding or categorization differences, which is acceptable. However, introducing unverified U.S.-only splits constitutes a major error. (3) The reasoning and synthesis are sound: the LLM correctly infers that growth in issued patents strengthens AMD's bargaining position in cross-licensing, and it accurately reflects AMD's continued reliance on such agreements for technology exchange. The logic connecting patent growth to strategic advantage aligns with the original answer. (4) Contextual relevance is high—the response directly addresses the evolution of AMD's reliance on cross-licensing, ties in patent portfolio changes, and discusses implications for technology exchange. However, the inclusion of unverified U.S.-specific patent data reduces factual reliability. Overall, the core narrative is correct but compromised by unsupported specifics, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 469,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "\n\nJohnson & Johnson's financial stake in Kenvue evolved significantly from 2023 to 2024. In May 2023, following Kenvue's IPO, J&J retained 89.6% ownership. By August 2023, J&J reduced its stake to 9.5% ($4.3 billion fair value) via an exchange offer, recognizing a $21.0 billion non-cash gain, including $2.8 billion from the retained shares. In May 2024, J&J disposed of its remaining 9.5% stake through a debt-for-equity exchange, swapping shares for commercial paper, resulting in a $0.4 billion loss. Strategically, J&J transitioned from majority ownership to full divestiture, with post-separation agreements (e.g., transition services) governing interim relationships, but no material financial ties remained by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has key factual inaccuracies. It correctly states that Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after an exchange offer in August 2023 and that the remaining stake was disposed of in May 2024 via a debt-for-equity exchange resulting in a $0.4 billion loss. However, it incorrectly claims that J&J retained 89.6% ownership in May 2023 after Kenvue's IPO — this is not supported by the ground truth, which begins with the August 2023 stake of 9.5%. Additionally, the LLM introduces a $21.0 billion non-cash gain and attributes $2.8 billion of that to retained shares, which is absent from the original answer and unverifiable based on the provided truth. (2) The quantitative inaccuracies include the erroneous 89.6% ownership figure and the fabricated $21.0 billion gain and $2.8 billion component. The correct numbers per the ground truth are: 9.5% stake, $4.3B value, $0.4B expense in 2023, and $3.6B commercial paper satisfied with 182,329,550 shares in 2024 — the share count and $3.6B amount are missing in the LLM answer. (3) The multi-hop reasoning is partially sound — the model correctly infers a strategic shift from partial retention to full divestiture and links the debt-for-equity transaction to the complete exit. However, it invents financial details not present in the source, undermining the reasoning chain. (4) Despite these issues, the core narrative of reducing and then fully exiting the stake is accurate, and the strategic interpretation is reasonable. The answer is highly relevant and covers the evolution of the relationship, but the inclusion of unsupported numbers reduces quantitative accuracy significantly. Hence, correctness is reduced to 7 due to major but not central numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 494,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "\n\nAT&T's inclusion of Indiana Bell Telephone Co. Inc. in its guarantee disclosures changed between 2022 and 2023. In the **2022 10-K** (page 141), Indiana Bell was explicitly listed under **Exhibit 4-c** as part of a guaranty covering obligations of multiple subsidiaries, including \"Indiana Bell Telephone Co. Inc.\" However, in the **2023 10-K** (page 103), the same Exhibit 4-c reference (to the 2011 guaranty) no longer includes Indiana Bell in the listed entities. This indicates that **Indiana Bell was removed from AT&T's guarantee obligations by 2023**, likely due to a corporate restructuring or divestiture, as no other pages in the 2023 filing mention Indiana Bell in the context of guarantees.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) The original answer (ground truth) states that Indiana Bell Telephone Co. Inc. was included in AT&T's guarantee disclosures under Exhibit 4-d in both 2022 and 2023, with no change in status. However, the LLM claims the company was removed from Exhibit 4-c in 2023, which contradicts the ground truth. (2) The LLM incorrectly references Exhibit 4-c instead of Exhibit 4-d in both years, misidentifying the exhibit entirely. This is a critical error in entity and document accuracy. (3) The multi-hop reasoning fails: rather than identifying continuity in the guarantee, the LLM asserts a change (removal) that did not occur, likely due to hallucination or misreading of the filings. (4) The claim of removal 'due to corporate restructuring or divestiture' is unsupported by the ground truth and introduces speculative information. While the answer attempts to cite specific pages and exhibits, the core facts—exhibit number, inclusion status, and evolution of the relationship—are all incorrect. The contextual relevance is moderate because it addresses the right topic (guarantee disclosures), but the factual foundation is flawed, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 350,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "\n\nFrom 2023 to 2024, GE's financial relationship with AerCap shifted significantly. In 2023, GE sold its remaining equity shares in AerCap, generating investment gains (noted in the $5.2 billion decrease in gains on retained/sold ownership interests in 2024). By 2024, GE's involvement primarily centered on a senior note receivable from AerCap (maturing in late 2025) and operational cash flows, including a $203 million net cash outflow to AerCap in 2024. Investment securities related to AerCap dropped from $944 million (Dec 2023) to $982 million (Dec 2024), reflecting reduced equity holdings post-2023 sales, while gains from AerCap investments declined sharply in 2024 compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly undermine its correctness. Most critically, it reverses the timeline: the ground truth states that in 2023, GE had continuing operational involvement (note receivable, product leases, transition services) with a $203 million net cash *payment to* AerCap, while in 2024, GE held an investment stake and reported a $5.2 billion decrease in gains. The LLM incorrectly claims the $203 million outflow occurred in *2024*, and that GE sold its shares in *2023*, which contradicts the original answer’s implication that the investment stake persisted into 2024. (2) Quantitative inaccuracies include the claim that investment securities increased from $944M (Dec 2023) to $982M (Dec 2024), which is unsupported by the original answer and suggests growth rather than reduction; the original does not provide these specific balance sheet figures. The $5.2 billion decrease in gains is correctly cited but misattributed in timing and context—LLM frames it as gains from 2023 sales, while the original indicates it's a year-over-year decline *in 2024*. (3) The multi-hop reasoning is partially sound—LLM recognizes the shift from operational to investment relationship and cites relevant instruments like the note receivable—but the causal and temporal logic is flawed. It fails to correctly synthesize the evolution: 2023 = operational + cash outflow; 2024 = investment-based + reduced gains. Instead, it suggests sales occurred in 2023 and operational flows continued into 2024, which inverts the transition. (4) Contextual relevance is high—the answer addresses cash involvement, investment gains, and the GE-AerCap relationship—but due to critical errors in timing, direction of cash flows, and characterization of transactions, the overall correctness score is low. Minor flexibility is allowed for phrasing, but not for reversed causality and misallocated events across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 528,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "\n\nFrom 2022 to 2024, The Home Depot enhanced its store appearance and competitive strategy by integrating digital tools with in-store experiences to elevate customer service. In 2022, the company focused on foundational investments like store refreshes, wayfinding signs, self-checkout expansions, and mobile app improvements to create a seamless \"interconnected shopping experience.\" By 2024, this evolved into advanced digital integration, including optimized mobile platforms with personalized search, product content, and fulfillment options (e.g., BOPIS, curbside pickup), while maintaining store investments such as electronic shelf labels and associate-equipped GET phones to streamline service. The SRS acquisition in 2024 further strengthened its ability to serve professional customers, complementing store strategies with specialized distribution capabilities. Store appearance remained central as the \"hub\" of the customer journey, with continued emphasis on navigation, layout efficiency, and technology-driven convenience to differentiate in a competitive, digitized retail landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of The Home Depot's strategy from 2022 to 2024 regarding store appearance and competitiveness, emphasizing the shift toward an interconnected shopping experience that integrates physical and digital elements. The answer accurately reflects that in 2022, store appearance, layout, and foundational digital improvements (e.g., mobile app, self-checkout) were key, and by 2024, this expanded to deeper digital integration such as personalized search, electronic shelf labels, and enhanced fulfillment options (BOPIS, curbside). The mention of SRS acquisition in 2024 is factually correct and contextually relevant, reinforcing professional customer support, though not directly tied to store appearance—this is a minor addition that does not detract. All entities (The Home Depot, 2022–2024 timeline) and strategic themes (store as 'hub', digital integration, customer experience) are correctly identified. There are no numerical inaccuracies (no specific numbers in the original or LLM response), so quantitative accuracy is perfect. The reasoning is sound and demonstrates multi-hop synthesis across years and strategic domains. The only reason for not scoring a 10 is that the LLM slightly overemphasizes specific technologies (e.g., GET phones, electronic shelf labels) not explicitly mentioned in the ground truth, though they are plausible and consistent with the reported digital integration trend. Overall, the semantic meaning and strategic narrative match the original answer closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 436,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "\n\nBetween 2023 and 2024, AMD's financial relationship with the ATMP JV evolved through increased resales and a new loan arrangement. Resales to the ATMP JV rose significantly from $14 million in 2023 to $121 million in 2024, while purchases from the JV remained at $1.7 billion annually. Additionally, in October 2024, AMD provided a $100 million one-year term loan to one of the ATMP JVs, secured by the JV's receivables from AMD, marking a new financial arrangement. AMD also contributed $17 million to the ATMP JV in August 2024, increasing its investment carrying value from $99 million (2023) to $149 million (2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the increase in resales from $14 million in 2023 to $121 million in 2024 and the October 2024 $100 million term loan, it introduces several unsupported details not present in the ground truth. Specifically: (1) The claim that AMD made a $17 million contribution to the ATMP JV in August 2024 is not mentioned in the original answer and lacks verification. (2) The statement that AMD's investment carrying value increased from $99 million to $149 million between 2023 and 2024 is absent from the ground truth and represents a major addition. (3) The detail about the loan being 'secured by the JV's receivables from AMD' is not in the original and may be speculative. (4) The mention of purchases from the JV remaining at $1.7 billion annually is irrelevant to the question about AMD's resales and new financial arrangements and is not corroborated. These additions suggest over-inference or hallucination. While the core resale figures and loan agreement are correct (supporting partial quantitative accuracy), the inclusion of unverified financial contributions and valuation changes significantly reduces factual reliability. The reasoning structure is logically coherent and contextually relevant to the evolution of the financial relationship, but the multi-hop synthesis fails because it incorporates entities and figures not supported by the knowledge graph. Thus, despite addressing the general theme, the answer is only partially correct with major factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 434,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "\n\nBetween 2023 and 2024, Johnson & Johnson enhanced its privacy compliance programs by strengthening third-party risk management, increasing board-level oversight, and addressing evolving international data flow regulations. In 2024, the company explicitly highlighted structured third-party risk management programs to safeguard data security and supply chains, along with quarterly updates to the Regulatory Compliance & Sustainability Committee (RCSC) on cybersecurity and privacy risks, compared to bi-annual updates in 2023. Additionally, the 2024 filing emphasized proactive measures to comply with emerging global privacy laws, particularly data localization requirements and cross-border data transfer restrictions, reflecting a response to heightened regulatory scrutiny and geopolitical tensions. These steps indicate a more rigorous, adaptive approach to align with new legal frameworks and mitigate risks from complex international data flows.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Johnson & Johnson's evolving privacy compliance approach between 2023 and 2024, particularly regarding increased focus on international data flows and emerging global privacy laws, which aligns with the ground truth. It correctly identifies a heightened emphasis on third-party risk management and board-level oversight in 2024, which reflects a more rigorous compliance posture. However, several specific details in the LLM response are not supported by the original answer: (1) The original does not mention 'strengthening third-party risk management' in structured programs or link it explicitly to supply chains; (2) The claim about quarterly updates to the Regulatory Compliance & Sustainability Committee (RCSC), compared to bi-annual in 2023, introduces specific governance details (frequency, committee name) absent in the ground truth; (3) While the original notes broader anticipation of global privacy laws, it does not reference 'geopolitical tensions' or 'board-level oversight' enhancements. These additions suggest over-specificity or inference beyond the source material. Quantitatively, there are no numerical errors because no numbers are involved, so the score is high by default. Qualitatively, the reasoning shows partial synthesis—correctly identifying a shift from 'other territories' to 'globally' in regulatory anticipation—but fails to accurately represent the nature of the evolution as a broadening of focus rather than an addition of structured governance processes. Contextually, the answer remains highly relevant to the question about evolution in privacy compliance. Thus, while the core theme is correct, the inclusion of unsupported specifics reduces factual accuracy, warranting a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 484,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "\n\nGE's financial exposure to Bank BPH decreased between 2023 and 2024 in terms of estimated borrower litigation losses and valuation allowances. As of December 31, 2023, total estimated borrower litigation losses were **$2,669 million**, with a valuation allowance of **$1,963 million** (including $1,712 million directly related to litigation losses). By December 31, 2024, these losses declined to **$2,461 million**, and the valuation allowance was reduced to **$1,594 million** (with $1,517 million tied to litigation losses). The 2024 valuation allowance fully offset the financing receivables balance, reflecting a strategic reduction in exposure through a settlement program and improved reserve alignment. This marks a **$208 million reduction in estimated losses** and a **$369 million decrease in valuation allowances** over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall trend of decreasing financial exposure from 2023 to 2024 and captures the core elements of estimated litigation losses and valuation allowances. However, there are significant quantitative inaccuracies. According to the ground truth, in 2023, the valuation allowance was $1,712 million (not $1,963 million as stated), and in 2024 it was $1,517 million (not $1,594 million). The LLM introduces a 'total valuation allowance' figure that includes additional amounts not specified in the original answer, leading to incorrect totals. The breakdown of $1,712 million and $1,517 million for litigation-related allowances is correct, but the inclusion of extra amounts without source justification distorts the numbers. (2) The total estimated losses are correctly reported as $2,669 million in 2023 and $2,461 million in 2024, and the $208 million reduction is accurate. However, the claimed $369 million decrease in valuation allowances is based on incorrect totals ($1,963 to $1,594), whereas the actual decrease in valuation allowances is $195 million ($1,712 - $1,517). (3) The multi-hop reasoning is sound in identifying the trend, the strategic shift due to the settlement program, and the full offset of financing receivables by the end of 2024. The synthesis of reduced exposure and improved reserve alignment is logically consistent with the ground truth. (4) Despite the correct narrative and contextual understanding, the quantitative inaccuracies in key financial figures—especially the inflated valuation allowances—reduce confidence in the answer's factual reliability. The answer is partially correct but contains material numerical errors that affect the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 475,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "\n\nHD's Indoor Garden product line remained categorized under the **Hardlines** major product line in both 2022 and 2024, indicating consistent positioning within its merchandising structure. In 2022, Indoor Garden contributed $15.5 billion in net sales (10.3% of total sales), reflecting strong financial performance. By 2024, while the Hardlines segment’s total sales slightly decreased to $48.6 billion (from $48.4 billion in 2022), the Indoor Garden retained its placement within Hardlines, alongside Outdoor Garden, Power, and Storage & Organization. The 2024 merchandising realignments (e.g., renaming \"Tools\" to \"Power\") did not reposition Indoor Garden, suggesting HD maintained its strategic focus on the product line as a core component of the Hardlines segment. No material shifts in financial prioritization or categorization were evident between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the Indoor Garden product line was a standalone category with $15,546 million (i.e., $15.5 billion) in net sales, accounting for 10.3% of total revenue. However, the LLM incorrectly states that Indoor Garden was part of the 'Hardlines' category in 2022, which contradicts the ground truth that it was a distinct category at that time. By 2024, it was reclassified into Hardlines — a key strategic shift that the LLM fails to identify as a change, instead claiming it was 'consistent' in categorization. This misrepresents the core evolution the question asks about. (2) The LLM invents financial data not present in the ground truth: it claims Hardlines segment sales were $48.4 billion in 2022 and $48.6 billion in 2024, but the original answer does not provide total Hardlines sales for either year, nor does it support this comparison. While the $15.5 billion figure for Indoor Garden in 2022 is correctly approximated (from $15,546 million), the additional segment-level data is fabricated. (3) The multi-hop reasoning is flawed: the question asks how treatment and positioning evolved given financial performance in 2022 and categorization in 2024. The correct inference is that despite strong performance in 2022, it was later integrated into Hardlines by 2024, suggesting a strategic repositioning. The LLM incorrectly concludes there was 'no material shift,' directly contradicting the ground truth's implication of a strategic integration. (4) The contextual relevance is moderate because the answer discusses the right product line, time frame, and some relevant context like merchandising departments, but the core conclusion is factually wrong. Due to major errors in entity accuracy, quantitative claims, and reasoning, the correctness score is low despite partial factual grounding in the 2022 sales figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 522,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "\n\nFrom 2022 to 2024, Colgate-Palmolive maintained sourcing strategies to manage commodity price volatility, including cost containment, productivity initiatives, and limited commodity hedging contracts (e.g., futures for Hill's Pet Nutrition). In 2022, these strategies were explicitly tied to addressing raw material exposures (CL_10k_2022.pdf, p. 90). By 2024, the company emphasized the **2022 Global Productivity Initiative** as a key component of its cost management, with charges from this initiative impacting other (income) expense (CL_10k_2024.pdf, p. 14, 35). While commodity hedging remained limited, the company increasingly relied on **ongoing productivity efforts** and price adjustments to offset persistent inflationary pressures, acknowledging that commodity prices could rise again despite prior efforts (CL_10k_2024.pdf, p. 16). This evolution reflects a shift toward sustained operational efficiency initiatives alongside traditional sourcing tactics to navigate prolonged volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, document references, and entity names (e.g., Colgate-Palmolive, 2022 Global Productivity Initiative, Hill's Pet Nutrition), and correctly cites specific pages from the 10-K filings (p. 90 for 2022, pp. 14, 16, 35 for 2024), which aligns with the expected sourcing of information. There are no numeric inaccuracies, and since the original answer does not contain specific numbers (e.g., dollar amounts, percentages), the absence of such figures does not detract from quantitative accuracy—thus a score of 10 is warranted. Contextual relevance is high, as the response directly addresses the evolution of sourcing strategies from 2022 to 2024 in relation to commodity price fluctuations. However, the qualitative accuracy is slightly lower because the LLM emphasizes the '2022 Global Productivity Initiative' as a central element in 2024 cost management, which, while mentioned in the 2024 filing, is not highlighted in the ground truth as a key evolution in sourcing strategy. Instead, the ground truth stresses a shift toward managing specific commodities (resins, essential oils, soybeans) and increased focus on geopolitical and climatic risks—details missing in the LLM response. Additionally, the LLM introduces 'limited commodity hedging contracts (e.g., futures for Hill's Pet Nutrition)' and 'price adjustments' not explicitly emphasized in the original answer, potentially overemphasizing hedging and underrepresenting the defensive sourcing shift due to external disruptions. While the core idea of increased reliance on productivity and cost containment is consistent, the multi-hop synthesis is partially incomplete: the LLM does not fully connect the evolution to broader risk management frameworks (e.g., derivative instruments and local currency borrowings in 2022) or the explicit expansion of exposure concerns to climate and geopolitics by 2024. Thus, while the answer is largely correct and well-supported, it omits key elements of the strategic shift described in the ground truth, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 564,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "\n\nTREMFYA's sales increased by 16.6% in 2024 compared to 2023, rising from $3.15 billion to $3.67 billion. This growth was driven by **operational growth of 18.1%**, attributed to continued market expansion and sustained strength in Psoriasis/Psoriatic Arthritis (PsO/PsA), as noted in both years. However, a **negative currency impact of 1.5%** in 2024 slightly offset the growth. In 2023, TREMFYA's 17.9% increase was similarly fueled by market growth and patient mix dynamics, with no significant currency effects. The 2024 performance reflects ongoing demand in its therapeutic areas despite macroeconomic headwinds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: TREMFYA sales increased from $3,147 million in 2023 to $3,670 million in 2024, representing a 16.6% growth. The 18.1% operational growth and 1.5% negative currency impact in 2024 are accurately stated. The LLM uses rounded figures ($3.15 billion and $3.67 billion), which are acceptable approximations of $3,147 million and $3,670 million respectively. (2) Quantitative accuracy is excellent—percentages and financial figures match the ground truth, and the explanation of currency impact aligns with the original. The calculation of growth (approx. (3670-3147)/3147 ≈ 16.6%) is correct. (3) The multi-hop reasoning is sound: the model synthesizes sales data across two years and correctly attributes growth drivers (market expansion, PsO/PsA strength, patient mix in 2023; operational growth and currency effects in 2024). It appropriately contrasts 2023 and 2024 dynamics, though it adds a detail about 2023 having a 17.9% increase, which was not in the original answer—this is plausible but not verifiable from the ground truth provided, slightly reducing qualitative accuracy. (4) The answer is highly relevant, directly addressing both parts of the question—sales performance evolution and contributing factors—with accurate, well-structured reasoning. The minor addition of an unverified 2023 growth percentage prevents a perfect 10, but overall the response is factually strong and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 412,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "\n\nThe structural change in Disney's relationship with A&E from 2022 to 2023 primarily affected the reporting of subscriber numbers rather than the financial stake. In 2022, Disney reported domestic subscribers for A+E channels including A&E (69M), HISTORY (70M), Lifetime (69M), LMN (52M), and FYI (42M). By 2023, the disclosed subscriber counts were consolidated to only A&E, HISTORY, and Lifetime, each at 58 million, excluding LMN and FYI. This suggests a strategic focus on core channels or operational restructuring. Disney’s 50% equity stake in A+E remained unchanged, but the reported subscriber metrics became narrower, reflecting a shift in how the partnership’s performance was aggregated and disclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly notes the change in subscriber numbers from 69 million in 2022 to 58 million in 2023 for A&E, it incorrectly claims that Disney's 50% equity stake in A+E remained unchanged. The ground truth states that the relationship evolved into a 50% equity stake by 2023, implying a structural change in ownership — not a static stake. This is a major factual error. Additionally, the LLM introduces subscriber numbers for HISTORY, Lifetime, LMN, and FYI not mentioned in the original answer, which misrepresents the scope of disclosed data. The consolidation of reported channels is speculative and unsupported by the ground truth. (2) Quantitatively, the 69M and 58M figures for A&E domestic subscribers are correct and properly attributed to 2022 and 2023. However, the inclusion of additional channels (HISTORY at 70M, etc.) and the claim that all three core channels were reported at 58M in 2023 are not in the original answer and appear fabricated. There is no mention in the ground truth of subscriber numbers for LMN or FYI, nor any indication that Disney previously reported them. (3) The multi-hop reasoning is flawed. The LLM fails to recognize that the key shift was from a partnership to a joint ownership model (50% equity stake), which changed Disney’s financial reporting from simple subscriber counts to including A+E’s results under 'Equity in the income of investees'. This critical accounting and structural change is entirely missed, undermining the core of the question. Instead, the model focuses on a narrow interpretation of subscriber disclosure changes, missing the broader financial reporting implications. (4) The contextual relevance is moderate — the answer addresses subscriber reporting changes and mentions the correct entities and years, but it omits the central financial stake evolution and mischaracterizes the nature of Disney’s relationship change. Due to major errors in entity accuracy and reasoning, the correctness score is low despite partial numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 557,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "\n\nThe financial impact of GE's relationship with AerCap evolved significantly between 2023 and 2024. In 2023, GE realized a **$6.6 billion gain** from the sale of its remaining AerCap shares (as noted in the 2023 10-K, page 73), contributing to $129 million in realized and unrealized gains for the year (Note 19, 2023 10-K, page 72). By 2024, however, the impact reversed: the **$5.2 billion decrease in gains** on retained and sold ownership interests (2024 10-K, page 8) included losses related to AerCap, as GE no longer held equity stakes but retained a senior note. This shift reflects the monetization of the investment in 2023 and subsequent unrealized losses or reduced gains in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported 2023 gain. The original answer states that GE had an *unrealized gain of $129 million* in 2023 from its investment in and note with AerCap. However, the LLM claims a *$6.6 billion gain from the sale of AerCap shares* and that this contributed to $129 million in total gains—this reverses the magnitude and nature of the gain. The $129 million figure is presented in the ground truth as the total gain, not a subset, and there is no mention of a $6.6 billion sale in the original answer. This is a major quantitative error. (2) The $5.2 billion *decrease in gains* in 2024 is correctly cited and aligns with the original answer, which notes a $5.2 billion drop in gains on retained and sold ownership interests, with AerCap as a key contributor. This part is accurate. (3) The reasoning is partially sound in that it identifies a shift from gains in 2023 to reduced gains/losses in 2024 and references the change in GE’s ownership (from equity to a senior note). However, the multi-hop synthesis is flawed because it incorrectly characterizes the 2023 event as a realized $6.6 billion gain, which contradicts the ground truth’s assertion of a $129 million *unrealized* gain. This undermines the validity of the comparison. (4) The contextual relevance is high—the answer addresses the evolution of the financial impact, discusses realized/unrealized gains, and references the correct entities (GE, AerCap) and time frame (2023–2024). However, due to the critical error in financial figures and mischaracterization of the 2023 gain, the overall correctness score is low. Quantitative accuracy is severely compromised, qualitative accuracy is moderate due to correct directional trend but flawed details, and contextual relevance remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 499,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "\n\nBetween 2022 and 2024, Mastercard enhanced its multi-layered security approach by explicitly integrating **third-party service provider risk management** into its cybersecurity framework. In 2024, the company introduced structured processes to evaluate and monitor third-party providers, including reviewing their privacy/data security infrastructure, onboarding protocols, and continuous monitoring during engagements (MA_10k_2024.pdf, p. 39). This evolution reflects a strategic response to emerging threats by prioritizing third-party risk mitigation, adopting advanced technologies like tokenization and biometric authentication, and aligning with global security standards. The emphasis on third-party governance underscores Mastercard’s proactive stance to safeguard its ecosystem against escalating cyber risks, ensuring resilience in an increasingly interconnected payments landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Mastercard had a multi-layered security approach but did not explicitly mention third-party service provider risks, and that by 2024, it had explicitly integrated third-party risk management into its framework. The LLM adds specific details from the 2024 10-K (p. 39), such as reviewing privacy/data security infrastructure, onboarding protocols, and continuous monitoring—details not in the ground truth but consistent with and supportive of the overall evolution described. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; all timeframes (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution across years and identifies the strategic implication—ecosystem-wide resilience in response to interconnected threats. The mention of tokenization and biometric authentication, while not in the original answer, are plausible components of Mastercard’s security strategy and do not contradict the ground truth; they add context without introducing error. (4) The answer is contextually excellent, fully addressing all parts of the question: evolution over time, focus on third-party providers, and strategic implications. The only minor deduction is for introducing slight extrapolation (e.g., specific technologies) not present in the ground truth, but these do not undermine factual correctness. Overall, the answer reflects strong qualitative and contextual accuracy with full semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 444,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "\n\nTarget Corporation remained in compliance with its debt leverage covenant in both 2022 and 2023, despite modifications to its credit facilities. In 2023, Target secured a new $1.0 billion 364-day unsecured revolving credit facility (expiring October 2024) and extended its existing $3.0 billion facility to October 2028, replacing prior facilities. The company emphasized continued compliance with covenants, supported by stable credit ratings (A2/Moody’s, A/S&P, A/Fitch) and no outstanding balances under credit facilities during the periods. The debt leverage covenant requirements were not triggered by these changes, and Target’s strong liquidity and credit profile ensured ongoing adherence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Target remained in compliance with its debt leverage covenant in both 2022 and 2023, and accurately describes the changes to its credit facilities—specifically, the new $1.0 billion 364-day facility (expiring October 2024) and the extension of the $3.0 billion facility to October 2028. These details match the ground truth exactly. (2) All numeric values—$1.0 billion, $3.0 billion, October 2024, October 2028—are correct and consistent with the original answer. The expiration dates and amounts are accurately reported, and no incorrect calculations are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about covenant compliance across two years and links it to structural changes in credit facilities. It also adds context not in the ground truth—credit ratings and lack of outstanding balances—which are factually plausible and enhance the answer without contradicting it. However, the original answer does not mention credit ratings or balances, so while not incorrect, this is an addition rather than synthesis from the provided truth. (4) The answer is semantically equivalent to the ground truth, with slightly more detail. The core facts, numbers, and reasoning are correct, and the evolution of compliance and credit facilities is accurately conveyed. The only minor deviation is the inclusion of extra details not in the original, which do not detract from accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 442,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "\n\nFrom 2023 to 2024, the risks associated with Salesforce's AI offerings, including generative AI like Agentforce, evolved from general ethical and reputational concerns to more specific challenges tied to regulatory scrutiny, technical complexities, and operational costs. In 2023, the focus was on broad social and ethical issues, such as potential reputational harm from customer misuse of AI tools or conflicts with ESG policies. By 2024, the risks were expanded to include concrete challenges like **accuracy, bias, toxicity, privacy, and data provenance** in generative AI, alongside heightened regulatory pressures (e.g., EU AI Act, DSA). Additionally, Salesforce highlighted increased costs for compliance, governance, and computing resources required for AI development, reflecting a shift toward addressing technical and regulatory complexities as AI capabilities advanced. This evolution underscores a growing emphasis on managing the operational and compliance burdens of deploying sophisticated AI systems like Agentforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of risks from 2023 to 2024, noting a shift from broader ethical and reputational concerns to more specific, operational risks tied to AI integration. The mention of 'accuracy, bias, toxicity, privacy, and data provenance' in 2024 matches the ground truth's emphasis on inaccurate, biased, or copyright-infringing AI-generated content. The reference to regulatory scrutiny (e.g., EU AI Act, DSA) aligns with the increased regulatory focus in 2024. The LLM also correctly highlights increased costs for compliance, governance, and computing resources, which corresponds to the ground truth's mention of AI governance, compliance, and testing costs. One minor omission is that the 2023 risk was specifically tied to third-party integrations and warranty-related liabilities, which the LLM frames more broadly as 'ethical and reputational concerns'—slightly less precise but still contextually valid. No numerical inaccuracies are present (quantitative accuracy is perfect), and the reasoning demonstrates strong multi-hop synthesis across years and risk categories. The answer is fully relevant and conveys semantically equivalent information to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 353,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "\n\nBetween fiscal years 2023 and 2024, Lowe's enhanced its delivery capabilities for parcel-eligible items by reducing delivery times to **two business days or less** (from two business days in 2023) and expanding same-day delivery options. Specific improvements included:  \n1. **Nationwide expansion of gig provider networks** to enable same-day delivery of select products from stores.  \n2. **Next-day delivery for major appliances** in nearly all U.S. zip codes by fiscal 2024.  \n3. Completion of the **market-based delivery model rollout**, improving geographic coverage and distribution efficiency for big and bulky items.  \n\nThese upgrades reflect investments in omnichannel logistics and network optimization to meet evolving customer expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: delivery improved from 'two business days' in 2023 to 'two business days or less' in 2024, and next-day delivery for major appliances was expanded to nearly all U.S. zip codes by fiscal 2024. These match the original answer exactly. (2) The LLM adds specific improvements not explicitly mentioned in the ground truth—namely, the 'nationwide expansion of gig provider networks' and 'completion of the market-based delivery model rollout.' While these details are plausible and contextually consistent, they are not present in the original answer, representing minor additions rather than inaccuracies. (3) The reasoning is sound and correctly synthesizes the evolution across fiscal years 2023 and 2024, capturing both speed improvements and geographic expansion. (4) The mention of 'same-day delivery' is a slight overreach—the original answer does not specify same-day delivery, only 'two business days or less' and 'next-day delivery for major appliances.' This is a minor discrepancy, hence the 9/10 on qualitative accuracy. Overall, the answer is factually correct, comprehensive, and contextually appropriate, with only minor elaboration beyond the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 356,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "\n\nThe financial impact of the Dermstore LLC sale (completed in February 2021) on Target's consolidated revenues and operating income was less than 1% in both 2022 and 2023, as stated in the 2022 (page 20) and 2023 (page 24) filings. No material evolution in its impact occurred between these periods, as Dermstore's contribution to revenues and operating income remained immaterial (<1%) in both years. The pretax gain of $335 million in 2021 did not result in ongoing significant effects on subsequent annual financials.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the Dermstore LLC sale occurred in February 2021, its financial impact on Target's consolidated revenues and operating income was less than 1% in both 2022 and 2023, and the $335 million pretax gain was recognized in 2021 with no ongoing material impact. (2) Quantitative elements—dates (February 2021), percentage (<1%), dollar amount ($335 million), and financial metrics (revenues, operating income)—are all accurately reported and consistent with the original answer. Format variations (e.g., 'less than 1%' vs '<1%') are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the sale predated both years in question and that its financial footprint remained immaterial in both 2022 and 2023, drawing logical conclusions about lack of evolution in impact. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of financial impact over the specified period. Minor enhancements like citation of specific filing pages (2022 p.20, 2023 p.24) add credibility without altering factual content. All scoring dimensions warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 343,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "\n\nBetween 2023 and 2024, Salesforce elevated Data Cloud's strategic role by integrating it more deeply into its AI-driven Einstein 1 Platform, emphasizing its ability to unify structured and unstructured data for AI-powered automation and analytics across services (2023, p. 8; 2024, p. 20). In 2024, Data Cloud became a cornerstone of Salesforce's expansion into consumption-based models and industry-specific solutions, positioning it as a hyperscale data engine critical for delivering personalized customer experiences and compliance with evolving data privacy regulations (2024, p. 20; 2023, p. 7). This evolution reflects a shift toward leveraging Data Cloud not just for internal CRM cohesion but as a competitive differentiator in AI-augmented, scalable cloud services amid regulatory and market challenges.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of Data Cloud's evolving strategic role between 2023 and 2024, with accurate contextual framing around AI integration, compliance, and consumption-based models. It correctly identifies the deepening integration of Data Cloud within Salesforce's broader platform (e.g., Einstein 1 Platform) and its growing importance for personalized customer experiences, which aligns with the ground truth's emphasis on unification and 360-degree views. The mention of consumption-based models in 2024 matches the original answer’s point about Salesforce acknowledging limited experience in pricing such models. However, the LLM answer omits a key element from the ground truth: the explicit 2024 framing of Data Cloud as being in a 'relatively new and uncertain' market with increasing competitive pressure from AI and data platform evolution. While it references 'regulatory and market challenges,' it does not clearly convey the shift in tone from product-centric promotion in 2023 to strategic risk awareness in 2024. Additionally, the LLM introduces specific page citations (e.g., 2023, p. 8) not present in the original answer, which may imply over-precision. There are no numerical inaccuracies (quantitative accuracy is perfect since no incorrect numbers are stated), and the reasoning is sound but incomplete in capturing the full strategic nuance. The answer remains contextually relevant and well-structured, but misses part of the multi-hop synthesis regarding competitive landscape and strategic risk disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 430,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "\n\nLOW's treatment of forward interest rate swap contracts evolved significantly between 2023 and 2024. In 2023, the company held forward swaps with a notional amount of $1.29 billion designated as cash flow hedges, which were settled in connection with note issuances (e.g., $2.0 billion notional for 2023 Notes, generating a $247 million payment). By 2024, all forward interest rate swap agreements under cash flow hedges were eliminated (notional amount of $0), indicating full settlement or de-designation. Financially, this shift resulted in a transition from recording gains in other comprehensive income (e.g., $311 million pre-tax gain in 2023) to recognizing losses (e.g., $14 million pre-tax loss in 2024), reflecting the impact of hedge ineffectiveness or market rate changes post-settlement. Fixed-to-floating swaps under fair value hedges remained unchanged at $850 million, with no net earnings impact due to perfect hedge accounting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The notional amount of forward interest rate swaps in 2023 is incorrectly stated as $1.29 billion; the ground truth specifies $2.0 billion related to the March 2023 Notes. The $247 million settlement receipt is correctly mentioned but incorrectly contextualized as being from a $1.29 billion notional swap rather than the $2.0 billion one. The $311 million pre-tax gain in 2023 and $14 million pre-tax loss in 2024 are not present in the original answer and appear fabricated. The $850 million fixed-to-floating swaps are not mentioned in the ground truth, making this detail incorrect. (2) Calculations cannot be verified due to incorrect inputs; the LLM introduces numbers (e.g., $311M gain, $14M loss) absent from the original data. The shift from cash flow to fair value hedges is partially correct but mischaracterized by implying that all forward swaps were eliminated, whereas the original answer emphasizes a change in accounting designation and method. (3) The multi-hop reasoning is flawed: while the LLM identifies a shift in hedge designation, it invents quantitative details and misattributes notional amounts and financial impacts. It fails to correctly synthesize the evolution from cash flow hedges (2023) to fair value hedges using the shortcut method (2024) with no earnings impact due to assumed perfect effectiveness. Instead, it introduces hedge ineffectiveness and fabricated gains/losses. (4) The contextual relevance is high because the answer addresses the evolution in accounting treatment and financial impact, but the qualitative accuracy is reduced by incorrect entities and reasoning. The correctness score is low due to major quantitative errors and unsupported financial figures, despite capturing a general directional shift in hedge accounting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 500,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "\n\nFrom 2022 to 2023, Target's strategy for its owned brands evolved to emphasize **strengthening and expanding its portfolio** while integrating **signature partnerships** to drive differentiation and growth. In 2022, the focus was on differentiating through curated national brands and existing owned brands (which represented ~30% of sales). By 2023, the strategy explicitly prioritized \"delighting with newness, style, and value\" by enhancing owned brands, broadening their breadth/depth, and leveraging exclusive partnerships (e.g., Ulta shop-in-shops). Strategic objectives now include using these brands to deepen guest relevance, boost traffic, and sustain higher-margin offerings, reflecting a shift toward proactive portfolio evolution and collaboration to maintain competitive advantage.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution from 2022 to 2023, noting a shift toward strengthening owned brands as a core differentiator and aligning them with the 'delight with newness, style, and value' objective, which matches the ground truth. It also accurately identifies strategic goals like driving traffic, sales, and guest relevance. However, there is a discrepancy in the quantitative claim that owned brands represented '~30% of sales' in 2022 — this figure is not present in the original answer and cannot be verified from the provided ground truth, which only states 'over 40' owned brands and a descriptive presence. This introduces a factual inaccuracy. (2) The original answer does not provide any percentage of sales from owned brands, so the ~30% figure is unsupported and likely incorrect or at minimum, not attributable to the source. No other numbers or dates are in conflict. (3) The multi-hop reasoning is sound: the model correctly synthesizes a strategic shift over time, identifying both the descriptive emphasis in 2022 and the more proactive, growth-oriented strategy in 2023. It appropriately infers that owned brands became a lever for differentiation and margin improvement, consistent with the 'delight with newness, style, and value' framing. The mention of Ulta partnerships adds contextual detail that, while not in the original answer, is plausibly aligned with Target’s strategy and does not contradict the ground truth. (4) The correctness score is 8 because the core strategic narrative is accurate and well-articulated, but the unsupported sales percentage reduces confidence in quantitative accuracy. Qualitative accuracy is high due to strong reasoning and synthesis. Contextual relevance is perfect — the answer directly addresses portfolio emphasis and strategic objectives as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 503,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "\n\nFrom 2022 to 2023, GM expanded its software-enabled services through the deployment of its end-to-end software platform, which enables over-the-air updates for features like Super Cruise, vehicle performance, and connectivity. In 2022, the platform was described as being rolled out across \"most products in the coming years,\" while 2023 highlighted its active use in vehicles like the 2024 Cadillac LYRIQ and Chevrolet Silverado EV, signaling accelerated adoption. GM also emphasized collaboration with six automakers to build a high-powered charging network (targeting 30,000+ chargers) and expanded OnStar’s role in safety, infotainment, and driver assistance. \n\nThis evolution reflects a strategic investment in scalable digital solutions, supported by increased R&D spending ($9.9 billion in 2023 vs. $9.8 billion in 2022) and a focus on ecosystem development (e.g., charging infrastructure). The shift from platform rollout to active deployment in key models and partnerships underscores GM’s commitment to leveraging software to enhance vehicle functionality and customer engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution from 2022 to 2023: in 2022, GM described software-enabled services generally, while in 2023 it detailed a specific end-to-end software platform enabling over-the-air updates for Super Cruise, safety, infotainment, and EV experience. The mention of the 2024 Cadillac LYRIQ and Chevrolet Silverado EV using the platform is factually correct and matches the original answer. (2) Quantitative accuracy is strong: the R&D figures ($9.9B in 2023 vs $9.8B in 2022) are accurate and correctly compared, showing minimal but real growth. The 30,000+ charger target is consistent with GM's announced Ultium Charge 360 initiative. (3) Multi-hop reasoning is sound—LLM synthesizes platform deployment, vehicle integration, ecosystem expansion (charging network, OnStar), and R&D investment to infer strategic commitment to scalable digital solutions. (4) Minor omission: the original answer emphasizes a shift from 'general involvement' to 'concrete platform deployment' as evidence of operational maturity, which the LLM implies but doesn't explicitly frame. Also, the LLM adds details (e.g., six automaker collaboration, OnStar expansion) not in the original answer; while factually plausible and contextually relevant, they slightly extend beyond the scope of the provided ground truth. Overall, the answer is semantically equivalent, well-reasoned, and fully addresses the question with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 413,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "\n\nThe revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability category grew between fiscal 2022 and 2023. In fiscal 2022, ThousandEyes drove an 11% increase ($75 million) in the category’s revenue (CSCO_10k_2022.pdf, page 45). In fiscal 2023, ThousandEyes remained a key growth driver, contributing to a 14% increase ($80 million) in the Observability category’s revenue (CSCO_10k_2023.pdf, page 42). This indicates a stronger relative contribution in 2023, despite the category’s name evolution to \"Observability.\"",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: in FY2022, the Optimized Application Experiences category grew by $75 million (11%), driven by ThousandEyes; in FY2023, the Observability category grew by $80 million (14%), with ThousandEyes cited as a key contributor. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: both absolute revenue increases ($75M and $80M) and percentage growth (11% and 14%) are correctly stated, and the trend of increasing contribution is properly inferred. (3) The multi-hop reasoning is sound—information is correctly synthesized across two fiscal years and two slightly rebranded product categories (Optimized Application Experiences → Observability), with appropriate acknowledgment of the name change. (4) The answer addresses all aspects of the question: evolution of revenue contribution over time, specific figures, and the role of ThousandEyes. Minor wording differences (e.g., 'stronger relative contribution' vs 'continued upward trend') do not affect factual equivalence. Citations to source documents add contextual support. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 345,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "\n\nThe treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolved between the 2023 and 2024 10-K filings by being explicitly included as an exhibit in the 2024 filing (cited under Exhibit 10.36, incorporated by reference to a 2022 10-Q) but absent in the 2023 filing. This indicates a shift in the company’s disclosure strategy toward greater transparency regarding executive compensation amendments, likely to align with heightened regulatory scrutiny or investor demands for detailed executive benefits information. The inclusion reflects a proactive approach to disclosing updates to severance terms, ensuring compliance with SEC requirements and providing stakeholders with a clearer view of executive compensation structures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. According to the ground truth, Amendment No. 4 was disclosed in the 2023 10-K (as Exhibit 10.34, incorporated from the September 2022 10-Q), but the LLM incorrectly states it was 'absent in the 2023 filing.' Conversely, the LLM claims it was 'explicitly included as an exhibit in the 2024 filing (Exhibit 10.36)', but the ground truth states that in the 2024 10-K, Amendment No. 4 is no longer a standalone exhibit—instead, it is part of a consolidated sequence including Amendments 2 through 5. Thus, the direction of change is completely reversed in the LLM answer. (2) The exhibit numbers (10.34 vs 10.36) and years (2022 10-Q) are partially accurate in referencing the source, but the LLM misattributes the presence/absence across years and exhibits. There are no calculations in this question, but the temporal and structural facts are incorrect. (3) The multi-hop reasoning fails: the model does not correctly synthesize the evolution of disclosure treatment over time. Instead of identifying a shift from standalone to integrated disclosure, it asserts the opposite—increased prominence in 2024—leading to a flawed conclusion about disclosure strategy. (4) The contextual relevance is moderate because the answer addresses the general topic of disclosure strategy and executive compensation, but due to fundamental factual errors, the analysis is based on a false premise. Correctness, quantitative, and qualitative accuracy scores are low due to major factual and directional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 429,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "\n\nFrom 2023 to 2024, JPMorgan maintained strong compliance with capital ratio requirements. Its **Standardized CET1 capital ratio** increased slightly from **15.0%** in 2023 to **15.7%** in 2024, exceeding the regulatory minimum of 11.4% in 2023 and 12.3% in 2024. The **Tier 1 leverage ratio** remained stable at **7.2%** for both years, well above the 4.0% minimum requirement in 2023 and the 4.0% minimum in 2024. This indicates consistent capital adequacy and adherence to regulatory standards during the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative data compared to the ground truth. While it correctly states JPMorgan's 2023 Standardized CET1 ratio as 15.0% and the 2024 Tier 1 leverage ratio as 7.2%, it incorrectly claims the CET1 ratio increased to 15.7% in 2024—this figure is not supported by the original answer, which does not provide a 2024 CET1 value. Additionally, the LLM introduces a 2024 CET1 requirement of 12.3% and claims the Tier 1 leverage ratio was 7.2% in both 2023 and 2024, but the original answer only provides the 2024 Tier 1 leverage ratio (7.2%) and does not mention the 2023 value at all. (2) The original answer does not support year-over-year comparisons for CET1 or leverage ratios; thus, the LLM's assertions about stability or increases are unsupported. The regulatory minimums cited (12.3% for 2024 CET1, 4.0% for leverage) are plausible but not confirmed in the ground truth, which only specifies the 2023 CET1 requirement (11.4%) and 2024 leverage requirement (4.0%). (3) The reasoning is partially sound—JPMorgan did maintain compliance in both years according to the original answer—but the LLM overextends by inferring trends (e.g., 'increased slightly', 'remained stable') that cannot be validated from the provided data. This reflects a failure in multi-hop synthesis, as the model fabricates missing data points rather than acknowledging gaps. (4) Despite these issues, the answer is contextually relevant and correctly identifies the key metrics and general conclusion of sustained compliance. The qualitative reasoning is logical but based on inaccurate inputs, warranting moderate scores in accuracy while maintaining high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 465,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "\n\nBetween 2022 and 2023, GM Financial remained a consolidated segment within General Motors' financial statements, with no material changes to its integration framework. Key aspects include:  \n1. **Consolidation and Tax Adjustments**: GM Financial’s financials continued to be adjusted for deferred tax impacts and consolidated tax returns, with intercompany transactions eliminated (2023, p. 63; 2022, p. 67).  \n2. **Segment Reporting**: GM Financial was presented as a distinct operating segment, contributing net sales/revenue of $13.4 billion in 2023 (down slightly from $13.8 billion in 2022) and reflecting earnings before interest and taxes-adjusted of $5.0 billion in 2023 (2023, p. 78; 2022, p. 99).  \n3. **Risk Management**: Foreign currency swaps increased to $8.0 billion in 2023 (from $6.9 billion in 2022), with reduced net fair value liability ($0.2 billion vs. $0.6 billion), indicating enhanced hedging effectiveness (2023, p. 54).  \n4. **Credit Quality**: The allowance for loan losses decreased to $1.9 billion in 2023 (from $1.98 billion in 2022), reflecting improved credit performance post-pandemic (2023, p. 69).  \n\nOverall, GM Financial’s integration and financial presentation remained consistent, with adjustments primarily in risk management and credit metrics rather than structural changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer introduces specific financial figures (e.g., $13.4 billion revenue in 2023, $5.0 billion EBIT-adjusted, allowance for loan losses of $1.9 billion) and risk metrics (foreign currency swaps at $8.0 billion) that are not present in the original ground truth. The ground truth does not mention any quantitative financial performance data for GM Financial, nor does it reference changes in revenue, earnings, hedging activity, or credit loss allowances. Instead, the ground truth focuses exclusively on the *nature of financial presentation adjustments* related to tax consolidation and intercompany transactions, noting an increased emphasis in 2023 on deferred tax impacts and differences from stand-alone reporting. The LLM answer incorrectly shifts focus to operational and risk performance metrics not addressed in the original answer, suggesting a failure in multi-hop reasoning fidelity. While the mention of tax adjustments and consolidation aligns broadly with the original, the addition of unsupported quantitative details and extraneous metrics (which may be hallucinated or misattributed) severely undermines factual accuracy. The structure and reasoning appear plausible, but the content diverges significantly from the ground truth, resulting in a partially correct but largely misleading response. Quantitative accuracy is low due to unverifiable and unsupported numbers. Qualitative accuracy is moderate because the core idea of tax integration is mentioned, but the evolution is misrepresented. Contextual relevance is fair as the topic is on-point, but the emphasis is misplaced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 437,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "\n\nThe treatment and disclosure of step-rent provisions in lease accounting at Costco evolved between 2022 and 2024 as follows:  \n\nIn **2022**, the Company disclosed that leases with periodic rent increases based on price indices or sales volume were recognized as part of lease terms but did not explicitly specify their accounting treatment (COST_10k_2022.pdf, page 45). By **2024**, the disclosure clarified that such increases are recognized as **variable lease payments** under ASC 842, reflecting a shift toward explicit recognition of these payments as part of lease liabilities (COST_10k_2024.pdf, page 45). This change aligns with updated lease accounting standards requiring variable payments tied to indices or usage to be accounted for in lease liabilities, enhancing transparency and consistency in financial reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the shift in accounting treatment of step-rent provisions from 2022 to 2024 and correctly states that by 2024, increases based on price indices or sales volume are recognized as variable lease payments under ASC 842. The contextual details about enhanced transparency and alignment with updated standards are reasonable interpretations. However, there is a significant discrepancy in the 2022 characterization: the LLM claims the company 'did not explicitly specify their accounting treatment' in 2022, which contradicts the ground truth stating that in 2022, such rents were 'accounted for on a straight-line basis.' This omission of the straight-line method in 2022—a key factual point—represents a major qualitative error in reasoning and completeness. The ground truth clearly indicates a shift *from* straight-line *to* variable lease payment treatment, but the LLM fails to establish the starting point accurately, undermining the multi-hop comparison. Quantitatively, no numerical data is involved, so accuracy is high by default. The citations to page 45 of the 10-Ks add credibility, but the core reasoning is flawed due to missing the prior straight-line treatment. Thus, while the direction of change and 2024 treatment are correct, the failure to accurately represent the 2022 accounting method reduces correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 383,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "\n\nThe projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show a slight decrease from 2023 to 2024. For 2025, the expected payout decreased from **$1,860 million in 2023** to **$1,800 million in 2024**. Over the long-term period (2029–2033), the projected obligations declined marginally from **$10,020 million in 2023** to **$9,990 million in 2024**. These changes reflect adjustments in actuarial assumptions, such as higher discount rates in 2024, which reduced present-value estimates of future liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, the projected 2025 payout remained unchanged at $1,860 million from 2023 to 2024, but the LLM incorrectly states it decreased to $1,800 million. This is a major quantitative error. The long-term projection from 2029–2033 decreasing to $9,990 million in 2024 is correct, though the ground truth specifies the period as 2030–2034 in the 2024 projection, not 2029–2033. The LLM fails to note this shift in time horizon, which affects interpretation. (2) The $1,800 million figure for 2025 is factually wrong—ground truth confirms $1,860 million in both years. The $9,990 million long-term amount is correct, but applied to the wrong period; the 2024 projection covers 2030–2034, not 2029–2033, making the comparison misleading. (3) The multi-hop reasoning is partially sound—comparing two years’ pension projections across short- and long-term horizons—but fails in precise synthesis. The model incorrectly infers a decrease in the 2025 payment and overlooks the shift in the long-term window. (4) Correctness is scored 4/10 due to one correct long-term dollar figure but major error in 2025 projection. Quantitative accuracy is 3/10 due to incorrect numbers and misaligned periods. Qualitative accuracy is 5/10 as reasoning structure is logical but based on flawed data. Contextual relevance is 8/10—response addresses the right topic and structure, with relevant context on actuarial assumptions, even if not in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 424,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "\n\nBetween 2023 and 2024, JPMorgan Chase's disclosures on resolution plan obligations evolved by emphasizing **greater specificity in liquidity risk management strategies** and **explicitly linking funding cost considerations to regulatory compliance**. In 2024, the firm highlighted actions to address resolution plan obligations, such as **pre-positioning liquidity in material legal entity subsidiaries** and adhering to liquidity coverage and net stable funding ratios, while 2023 discussions were more general about regulatory actions impacting funding costs. Additionally, 2024 disclosures explicitly noted the potential for **higher funding costs due to alternative liquidity sources** and cross-border regulatory requirements, reflecting a more detailed alignment of liquidity strategies with resolution plan demands compared to 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in JPMorgan Chase's disclosures between 2023 and 2024. It accurately identifies key elements such as pre-positioning liquidity in subsidiaries, adherence to LCR and NSFR requirements, and the concern over higher funding costs due to alternative sources and cross-border regulations. The answer correctly contrasts the more general 2023 disclosures with the more detailed 2024 disclosures, noting increased specificity in liquidity risk management. However, it omits a critical nuance present in the original answer: the 2024 expansion to include how resolution plan obligations interact with dynamic regulatory expectations and systemic events, particularly changes in laws in response to macroeconomic or systemic shocks. This reflects a broader framing of risk that the LLM answer does not mention, representing a meaningful but not central omission. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (JPMorgan Chase, resolution plans, liquidity coverage ratio, net stable funding ratio) are correctly identified. The reasoning is sound and contextually relevant, with only partial deduction for missing the expanded macro-regulatory context in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 349,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "\n\nBetween 2022 and 2023, Optum Rx's financial structure showed growth in accounts receivable, increasing from $7.1 billion to $8.6 billion, driven by higher script volumes and expanded pharmacy care services. Revenue recognition remained tied to prescription dispensing, with revenues recognized upon drug dispensation through retail, home delivery, and specialty pharmacies. The rise in accounts receivable reflects increased demand for pharmacy services, consistent with Optum Rx's reported growth in people served and script fulfillment (e.g., 1.4 billion adjusted scripts in 2021, with continued growth implied for subsequent years). No material changes in revenue recognition methodology were noted, but higher transaction volumes directly impacted both revenue and receivables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, matching the original answer exactly. No calculation errors or misstatements. (2) The answer correctly identifies that revenue recognition remained unchanged—revenue is recognized at the point of prescription dispensing across retail, home delivery, and specialty pharmacies—consistent with the gross revenue model implied in the original answer. (3) The qualitative reasoning is sound: the increase in receivables is logically tied to higher script volumes and expanded services, which is a reasonable inference from the growth in receivables, even if the original answer does not explicitly state 'higher script volumes.' The mention of '1.4 billion adjusted scripts in 2021' is contextually relevant and supports the trend, though slightly outside the 2022–2023 scope, it does not detract significantly. (4) The only minor gap is that the LLM does not explicitly mention the rationale for gross revenue reporting (i.e., Optum Rx's primary obligation to pay providers regardless of collection), which is a key element of the financial structure described in the original answer. However, the core aspects—revenue recognition timing and receivables growth—are correctly captured. The answer is contextually relevant, directly addressing both revenue recognition and accounts receivable evolution. Thus, the correctness score is 9 due to this slight omission in explanatory depth, but quantitative accuracy is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 440,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "\n\nUPS's quantitative exposure to Floating to Fixed Interest Rate Swaps decreased significantly from $778 million in 2020 to $28 million in 2021, as detailed in the 2022 10-K. By 2024, while specific notional amounts for these swaps are not disclosed in the provided pages, the strategic approach remains focused on managing the fixed and floating interest rate mix of the debt portfolio. UPS continues to use interest rate swaps to hedge against rate fluctuations, designating them as fair value or cash flow hedges depending on their purpose, and revised collateral terms in 2024 to include a $250 million threshold, reflecting ongoing risk management discipline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps in 2022, but the LLM incorrectly claims this $28 million figure was from 2021 and references a $778 million notional in 2020—data not present in the original answer or supported by the question's scope (2022–2024). There is no mention of 2020 or 2021 in the ground truth, making the inclusion of those years and figures erroneous. (2) The quantitative accuracy is low because the only correct number ($28 million) is misattributed to the wrong year (2021 instead of 2022), and the $778 million figure is entirely fabricated with respect to the provided context. The 2024 disclosure correctly notes no specific notional amount is given, which the LLM acknowledges, but fails to emphasize the strategic evolution as the core development. (3) The multi-hop reasoning is partially sound—the LLM identifies that UPS uses swaps to manage interest rate mix and mentions hedge accounting and collateral changes in 2024, which aligns with a strategic shift. However, it fails to correctly frame the evolution from limited quantitative use in 2022 to a more strategic approach in 2024 due to incorrect temporal anchoring. (4) Contextual relevance is moderate because the answer discusses relevant concepts (hedging, interest rate mix, collateral thresholds), but the inclusion of incorrect years and figures undermines the factual foundation. The strategic continuity is noted, but the evolution narrative is distorted. Thus, the correctness score is low due to major factual and numerical errors despite some relevant qualitative elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 466,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "\n\nBetween 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved through two key developments:  \n1. **Joint Venture Activities**: GM and LGES continued expanding their Ultium Cells LLC joint venture, with plans for mass-producing battery cells at U.S. facilities in Lordstown, Ohio, Spring Hill, Tennessee, and Lansing, Michigan, as noted in the 2022 filing (page 4). By 2023, commercial negotiations with LGES resolved matters tied to the joint venture following the Chevrolet Bolt recall (2023, page 92).  \n2. **Recall-Related Costs**: The Chevrolet Bolt EV/EUV recall (expanded to all 2017–2022 models in 2021) led to significant costs. By December 31, 2023, GM had accrued $2.6 billion total for these recalls but recognized $1.6 billion in receivables from LGES, leaving a remaining accrual of $0.6 billion. LGES agreed to reimburse GM for certain expenses, reflecting a shared financial burden (2023, page 92).  \n\nThis highlights a shift from production expansion in 2022 to addressing recall liabilities in 2023, with LGES playing a critical role in cost mitigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Ultium Cells LLC is properly identified as the joint venture; the $2.6 billion total recall accrual and $1.6 billion receivable from LG Energy Solution (LGES) are accurately reported, leaving a net $1.0 billion cost to GM (though the LLM mentions a remaining accrual of $0.6 billion, which may reflect a misstatement—$2.6B - $1.6B = $1.0B, not $0.6B, but this does not appear in the original answer and may be a minor interpretation difference). (2) Quantitative accuracy is excellent: all dollar figures ($2.6B, $1.6B) and years (2022, 2023) match the ground truth. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across 2022 (joint venture expansion) and 2023 (recall costs and resolution), showing the shift from strategic collaboration to cost-sharing. (4) The only minor issue is the phrasing of 'remaining accrual of $0.6 billion,' which contradicts the math and is not in the original; otherwise, the answer captures the evolution in the financial relationship accurately. Entity names (GM, LG Energy Solution, Ultium Cells LLC), locations, and document references are correct. The answer is fully relevant and addresses both joint venture activities and recall-related costs as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 367,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "\n\nThe revenue contribution from ThousandEyes within the Observability product category increased by **14% ($80 million)** from fiscal 2022 to fiscal 2023, as noted in the fiscal 2023 MD&A section of the 10-K filing (page 42). This growth was a key driver of the overall Observability category's revenue increase during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that ThousandEyes' revenue contribution increased by 14% ($80 million) from fiscal 2022 to 2023, which misrepresents the ground truth. The $80 million figure refers to the Observability category's revenue increase in fiscal 2022 (not the 2022–2023 change), and there is no 14% growth figure mentioned for ThousandEyes specifically in the original answer. (2) Quantitatively, the $80 million is incorrectly attributed as the year-over-year increase for ThousandEyes, when in fact it was the 2022 increase for the entire Observability category. The actual Observability revenue growth in fiscal 2023 was $176 million (27%), with organic growth (excluding Splunk) at 15%, primarily driven by ThousandEyes. The LLM answer fabricates a 14% growth rate and misassigns the $80M figure. (3) The reasoning is flawed: the model fails to correctly synthesize multi-hop information across fiscal years and misattributes category-level data to ThousandEyes specifically. It also fails to mention the key context of Splunk's inclusion in 2023 and the 15% organic growth, which are critical to understanding ThousandEyes' true contribution. (4) While the answer is relevant to the question and attempts to address revenue evolution, the severe factual and quantitative errors—especially the incorrect dollar amount and percentage—warrant a low correctness score. Contextual relevance is moderate because it discusses the right product and category, but accuracy is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 423,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "\n\nUPS's 7.620% Debentures, maturing in April 2030, had their interest rate reduced from 8.375% to 7.620% on April 1, 2020, as noted in the 2022 10-K (page 118). Between 2022 and 2024, the redemption terms remained unchanged: the debentures are callable at the greater of par plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. Interest payments continued to be made semi-annually in April and October, with no sinking fund requirements. No further adjustments to the redemption structure or payment terms were disclosed in the 2024 10-K (page 108).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the interest rate was reduced from 8.375% to 7.620% on April 1, 2020, which is not supported by the ground truth and is irrelevant to the 2022–2024 evolution asked in the question. The ground truth does not mention any rate change during this period—only that the 7.620% debentures had a principal of $276 million and a carrying value of $280 million in 2022. The LLM also fails to mention these key financial figures entirely, which are central to the original answer. (2) The redemption terms described in the LLM answer—callable at the greater of par plus accrued interest or present value of remaining payments—align partially with the ground truth, but the LLM incorrectly implies no change occurred between 2022 and 2024, while the ground truth explicitly states that UPS *clarified* these terms in 2024, indicating an evolution in disclosure. The interest payment schedule (semi-annual in April and October) is correctly identified and matches the ground truth. However, the LLM’s claim that 'no further adjustments' were disclosed contradicts the ground truth’s assertion that 2024 included a more detailed explanation of redemption flexibility, which constitutes an evolution in disclosure. (3) The multi-hop reasoning is flawed: the model fails to recognize that the evolution lies in the increased transparency and specification of terms in 2024, not necessarily a structural change. It treats 'no disclosed change' as equivalent to 'no evolution,' missing the nuance that enhanced disclosure itself represents a development in how the terms are communicated. (4) Due to major omissions of dollar amounts, incorrect historical context (rate reduction), and failure to recognize the qualitative evolution in disclosure, the correctness score is low. Quantitative accuracy is partially preserved only in the interest payment timing, but missing principal and carrying values hurt this score. Qualitative accuracy is low due to incorrect reasoning about the nature of change. Contextual relevance is moderate because the answer addresses the right instrument and time frame, but with wrong details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 590,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "\n\nFrom 2022 to 2023, MET's Fixed Maturity Securities AFS held by employee benefit plans showed the following changes:  \n- **U.S. government bonds** increased from **$1,507 million (2022)** to **$1,575 million (2023)**, driven by a rise in Level 1 fair value hierarchy holdings.  \n- **Corporate securities** rose from **$3,001 million (2022)** to **$3,083 million (2023)**, reflecting growth in Level 2 investments.  \n\nThe **total fair value** of Fixed Maturity Securities AFS decreased slightly from **$6,802 million (2022)** to **$6,714 million (2023)**, despite increases in U.S. government and corporate securities, due to declines in other categories like foreign bonds and federal agencies. The composition shifted modestly toward U.S. government and corporate holdings, which together accounted for ~77% of the portfolio in 2023 (vs. ~76% in 2022).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative values, particularly regarding the total fair value and prior-year baselines. The original answer states that the total fair value of Fixed Maturity Securities AFS was $2,164 million as of December 31, 2021 (reported in 2022), and increased to $6,714 million in 2023. However, the LLM claims a total fair value of $6,802 million in 2022 and a decrease to $6,714 million in 2023, which contradicts the ground truth: there is no support for a $6.8B total in 2022, and the growth is misrepresented as a decline. This is a critical error in trend interpretation. While the 2023 values for corporate securities ($3,083M) and U.S. government bonds ($1,575M) are correctly reported, the corresponding 2022 figures ($3,001M and $1,507M) are not present in the original answer and appear fabricated. The original makes no mention of 2022 breakdowns or a total of $6.8B, so these numbers lack support. The mention of Level 1 and Level 2 allocations for 2023 partially aligns with the truth (U.S. gov't $1,537M Level 1; corporate $3,029M Level 2), but the LLM incorrectly frames this as growth from 2022 without source data. The composition shift and percentage calculations (~77% in 2023 vs ~76% in 2022) are speculative additions not grounded in the original. While the answer addresses the question's structure and attempts multi-hop reasoning (comparing composition over time), the synthesis is based on incorrect or invented data. Contextual relevance is high as it directly addresses the evolution of composition and value, but quantitative accuracy is severely compromised. Minor point: the original refers to securities held by MET broadly, not specifically 'by employee benefit plans'—a misattribution. Overall, partial credit is given for correct 2023 component values and directionally correct qualitative trends, but major deductions apply for unsupported numbers and incorrect total fair value trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 532,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "\n\nGeneral Motors' relationship with Ultium Cells LLC evolved from significant financial investment in 2022 to facing regulatory penalties in 2023. In 2022, GM invested $500 million in Ultium Cells LLC as part of its EV strategy, supporting battery cell production through joint ventures (GM_10k_2022.pdf, p. 42). By 2023, GM self-disclosed TSCA violations at Ultium Cells LLC, leading to a settlement with the EPA in November 2023. This settlement included civil penalties of approximately $5.1 million (subject to increase based on import activity), jointly and severally assessed to GM and Ultium Cells LLC (GM_10k_2023.pdf, p. 28). This highlights increased regulatory scrutiny and financial risks tied to the joint venture's compliance in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the $500 million (or $0.5 billion) investment by GM in Ultium Cells LLC in 2022 is accurately reported, and the November 2023 EPA settlement involving approximately $5.1 million in joint civil penalties for TSCA violations is correctly stated. Minor formatting differences ($500 million vs $0.5 billion) are semantically equivalent and acceptable. (2) Quantitative accuracy is perfect: the dollar amounts and dates (2022 investment, February 2023 disclosure, November 2023 settlement) match the original answer and source documents. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two years and two types of involvement (financial investment in 2022 and regulatory consequences in 2023), demonstrating the evolution from financial to operational entanglement. (4) The answer addresses both parts of the question: financial involvement (investment) and regulatory implications (TSCA violation and settlement). The reasoning about increased regulatory scrutiny and financial risk is a valid interpretation supported by the facts. All entities—General Motors, Ultium Cells LLC, EPA, TSCA—are correctly identified. Overall, the answer is complete, precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 368,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "\n\nThe company maintained its use of variable-priced contracts for natural gas and fuel purchases between 2022 and 2024, with these contracts indexed to market rates and qualifying for the \"normal purchases and normal sales\" exception, avoiding mark-to-market adjustments. However, the aggregate notional amounts of open variable-priced contracts decreased slightly, from $1,242 million in 2022 to $1,212 million in 2024. Additionally, the company increasingly utilized fixed-price contracts for energy purchases in its U.S. and Canadian operations during this period to mitigate price volatility, indicating a partial shift toward hedging strategies while retaining variable contracts for certain needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that no specific volume or value of variable-priced contracts was disclosed for 2022 or 2024, but the LLM asserts notional amounts of $1,242 million in 2022 and $1,212 million in 2024—these figures are entirely fabricated and not present in the original answer. This severely undermines quantitative accuracy. Additionally, the claim that the company 'increasingly utilized fixed-price contracts... to mitigate price volatility' and is shifting toward 'hedging strategies' is not supported by the original answer, which makes no mention of increased use of fixed-price contracts or strategic hedging. The only correct element is the accurate description that variable-priced contracts qualified for the 'normal purchases and normal sales' exception and avoided mark-to-market adjustments by 2024. The reasoning about a more formalized or strategic use in 2024 based on accounting alignment is missing from the LLM response, and instead, it introduces unsupported claims about contract volumes and hedging trends. While the answer addresses the evolution of contract use and remains within the topic domain (contextual relevance is moderate), the inclusion of false data and incorrect synthesis results in a low correctness score. Multi-hop reasoning is flawed due to reliance on non-existent numerical data and unverified strategic shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 400,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "\n\nCisco's financial reporting approach for the APJC segment did not change between fiscal 2022 and fiscal 2023 regarding excluded expense categories. Both years excluded **research and development, sales and marketing, general and administrative expenses**, along with **amortization/impairment of acquisition-related intangible assets, share-based compensation, litigation settlements, contingencies, asset impairments, restructurings, and certain other charges** from segment performance measurement. The structure and rationale for exclusions remained consistent across the two periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that Cisco's financial reporting approach for the APJC segment remained unchanged between fiscal 2022 and 2023, which directly addresses the question. The excluded expense categories listed—research and development, sales and marketing, general and administrative expenses—are explicitly mentioned in both answers. The additional exclusions in fiscal 2023 (amortization/impairment of acquisition-related intangibles, share-based compensation, litigation settlements, asset impairments, restructurings, etc.) match the original answer. (2) There are no numeric values requiring calculation, but the fiscal years (2022 and 2023) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the exclusion framework was consistent across both years, indicating no evolution in reporting approach. (4) The LLM includes slightly more detailed phrasing (e.g., 'contingencies' and 'certain other charges'), which are consistent with typical SEC filing language and do not contradict the ground truth; they may reflect broader categorization of the same exclusions. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 359,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "\n\nFrom 2022 to 2023, UNH shifted its focus toward proactive strategies to address rising outpatient procedure costs for seniors, emphasizing value-based care models and enhanced data-driven decision-making. In 2023, the company explicitly highlighted increased care patterns for seniors, particularly outpatient procedures, and outlined efforts to mitigate costs by engaging physicians and consumers to prioritize clinically sound, cost-effective care choices. Additionally, UNH accelerated investments in integrated care delivery (e.g., virtual care, in-home services) and analytics to optimize care settings, while expanding value-based payment arrangements to align incentives with providers. This reflects an evolution from general cost-management approaches in 2022 to targeted, systemic solutions in 2023 aimed at curbing outpatient trend growth through structural and operational innovations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution in UNH's approach from 2022 to 2023: a shift from general concern about medical cost trends (especially due to deferred care during the pandemic) to targeted, proactive strategies in 2023 focused on rising outpatient costs for seniors. The LLM accurately identifies key strategies such as data-driven decision-making, physician and consumer engagement, value-based care models, and investments in integrated care delivery (e.g., virtual and in-home services). These details are consistent with the ground truth’s emphasis on data-driven insights and clinical decision support. While the original answer does not explicitly mention 'value-based payment arrangements' or 'in-home services,' these are reasonable elaborations that fall within the scope of 'proactive, systemic solutions' and do not contradict the source. There are no numerical figures in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound, demonstrating correct multi-hop synthesis across years and strategic focus areas. The answer is semantically equivalent and contextually precise, addressing all parts of the question. One minor point preventing a perfect 10 is the slight expansion beyond the documented scope (e.g., specific delivery models not mentioned in the original), but these are plausible inferences. Overall, the response is factually correct, comprehensive, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 415,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "\n\nBetween 2022 and 2024, UPS enhanced its time-definite delivery services by **insourcing UPS SurePost residential deliveries** (previously handled by USPS starting January 1, 2025), improving network control and reliability. Service scope expanded into **healthcare logistics**, leveraging cold-chain capabilities for time-sensitive shipments like vaccines. Network integration advanced through **RFID-enabled Smart Package technology** and a unified global smart logistics network, optimizing efficiency and visibility. These changes strengthened UPS’s ability to meet time-definite commitments while aligning with growth in e-commerce and specialized sectors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. While it correctly identifies the insourcing of UPS SurePost as a key evolution, it incorrectly states that the change occurred starting January 1, 2025—this is factually wrong as the question and ground truth focus on developments between 2022 and 2024, and the insourcing was implemented in 2024, not 2025. This major date error undermines quantitative accuracy. Additionally, the LLM introduces 'healthcare logistics' and 'RFID-enabled Smart Package technology' as part of the evolution in time-definite delivery, which are not mentioned in the original answer and lack support from the provided context. These additions reflect plausible but unverified expansions, reducing factual correctness. (2) The ground truth highlights specific 2024 changes: insourcing SurePost, same-day pickup seven days a week, and expanded returns in ~150 countries. The LLM omits the same-day pickup and global returns expansions entirely, missing key elements of service scope. It also misrepresents the network integration aspect—while the original emphasizes integration of air and ground networks and bringing final delivery in-house, the LLM shifts focus to RFID and 'smart logistics network,' which are not in the source. (3) The multi-hop reasoning is partially sound—linking insourcing to greater control over delivery quality is logical—but the model fails to synthesize the correct set of changes across years. It invents new dimensions (healthcare, RFID) instead of drawing from the documented evolution. (4) Despite these issues, the answer is contextually relevant, addressing service scope and network integration as asked, and correctly identifying the strategic move of insourcing SurePost. However, due to significant factual and temporal errors and unsupported additions, the overall correctness is only partially achieved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 525,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "\n\nLowe's Companies, Inc. consistently recognized its 2.50% Notes maturing in April 2026 under the Thirteenth Supplemental Indenture dated April 20, 2016 (Exhibit 4.14) in both the 2022 and 2023 annual filings. There were no material changes to the terms or accounting treatment of these notes between the two periods, as no amendments or new indentures related to these specific notes were disclosed in the 2023 filing. The notes remained part of the company’s long-term debt obligations under the same indenture in both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim of 'consistent recognition' between the 2022 and 2023 filings, directly contradicting the ground truth. While it correctly identifies the Thirteenth Supplemental Indenture dated April 20, 2016, and the note terms (2.50%, April 2026 maturity), these quantitative details are accurate (hence quantitative accuracy score of 10), the qualitative analysis fails. The ground truth states that in 2022, the notes were referenced only in a historical/documentation context, but in 2023 they were explicitly recognized as issued instruments—indicating a shift in disclosure treatment. The LLM incorrectly asserts there was 'no material change' and 'consistently recognized', missing this key evolution entirely. This reflects a failure in multi-hop reasoning: the model did not synthesize the change in narrative context and disclosure status across the two filings. The answer is contextually relevant—addressing the right company, notes, and indenture—but fundamentally wrong on the evolution aspect of the question, which is the central focus. Thus, the correctness score is low (3) due to major qualitative inaccuracy despite correct entity and date references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 339,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "\n\nThe impact of sovereign debt crises on Costco's merchandise sourcing and cost structure from 2022 to 2024 evolved as follows:  \n\nIn 2022, the company highlighted risks from sovereign debt crises, trade actions (e.g., U.S.-China tariffs), and economic instability, which could disrupt sourcing, increase merchandise costs, and force changes in product mix. By 2024, Costco noted ongoing challenges from tariffs and supply chain pressures but emphasized adaptive strategies, such as adjusting pricing and merchandising to mitigate cost increases. Inventory levels rose from $16.7 billion (2022) to $18.6 billion (2024), reflecting potential buffer-building against sourcing uncertainties, while accounts payable increased, indicating possible extended supplier terms to manage cash flow. The 2024 filing also underscored heightened focus on international operations (28% of sales) and foreign exchange risks, suggesting deeper exposure to regional debt crises. Overall, Costco transitioned from risk acknowledgment in 2022 to proactive cost and supply chain management by 2024, though external pressures persisted.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported data, significantly affecting correctness. (1) Quantitative Accuracy: The inventory figures ($16.7B in 2022, $18.6B in 2024) and accounts payable trends are not present in the original answer and cannot be verified from the provided ground truth; these numbers are likely fabricated or misattributed. The claim about international operations representing 28% of sales is not mentioned in the original and lacks sourcing. (2) Qualitative Accuracy: While the LLM correctly identifies that sovereign debt crises were a concern in both years, it misrepresents the evolution. The original answer states that in 2022, sovereign debt crises were part of broader macroeconomic risks, but by 2024, they were explicitly said to 'negatively impact' the business. The LLM instead frames the shift as one of adaptive strategy and proactive management, which is not supported—the original emphasizes increased severity and explicit negative impact, not mitigation efforts. The LLM also introduces 'tariffs' and 'pricing adjustments' as central elements without grounding in the original text. (3) Reasoning: The multi-hop synthesis is flawed. The original traces an escalation in risk characterization—from potential adverse effect to explicit negative impact—linked to broader supply chain and geopolitical concerns. The LLM incorrectly infers operational responses (e.g., buffer-building, extended supplier terms) not stated in the ground truth. (4) Contextual Relevance: The response stays on topic and attempts to address the evolution of impact on sourcing and cost structure, earning moderate relevance. However, the inclusion of unverified metrics and strategic responses reduces fidelity. Overall, the answer is partially correct in theme but fails on key facts and introduces unsupported details, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 512,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "\n\nThe number of shares available for future grants under the 2020 Stock Incentive Plan decreased from **64 million as of December 31, 2021** (UNH_10k_2022.pdf, page 57) to **53 million as of December 31, 2023** (UNH_10k_2023.pdf, page 72). This 11 million share reduction indicates that UnitedHealth Group has issued a portion of its allocated shares for employee compensation during this period. Despite the decline, the remaining 53 million shares as of 2023 still reflect a substantial capacity for issuing new share-based awards, though the shrinking pool may signal increased utilization of equity incentives or potential future dilution if no additional approvals are obtained.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The 11 million reduction is accurate and correctly calculated (64M - 53M = 11M). (2) All numeric values and years are correct, with proper sourcing from the respective 10-K filings (2022 and 2023), and the formatting (e.g., '64 million') is semantically equivalent to the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two different years and filings, computes the change, and draws a logical conclusion about the company's capacity for issuing new awards. The only minor deviation from the ground truth is the addition of interpretive commentary about 'potential future dilution' and 'increased utilization,' which, while reasonable, goes slightly beyond the factual statement in the original answer. However, this does not introduce inaccuracy but adds context. (4) The answer fully addresses both parts of the question: the change in shares and what it indicates. The core facts, calculations, and synthesis are correct, warranting a high score. The qualitative accuracy is marked at 9 due to the slight expansion beyond the ground truth's neutral tone, but the reasoning remains valid and insightful.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 372,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "\n\nBetween 2022 and 2024, the expiration date of the IAM National Pension Fund / National Pension Plan relationship with UPS was extended from **July 31, 2024 (2022)** to **July 31, 2029 (2024)**. Contributions increased from **$48 million in 2022** to **$53 million in 2024**, reflecting sustained significance (exceeding 5% of total plan contributions each year). However, in 2024, UPS finalized a withdrawal from the IAM Fund, transferring impacted employees to its own pension plan and recording a $19 million withdrawal liability. This action marked a structural shift, ending future obligations to the IAM Fund while maintaining prior high contribution levels until the withdrawal.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The expiration date evolution is partially correct: it correctly states the extension from July 31, 2024, to July 31, 2029, which aligns with the original answer. However, the claim about UPS contributing $48 million in 2022 and $53 million in 2024 is not supported by the ground truth, which only states that UPS contributed more than 5% of total plan contributions for the relevant years—no dollar amounts are provided. (2) The assertion that UPS 'finalized a withdrawal from the IAM Fund' in 2024 and recorded a $19 million liability is entirely absent from the original answer and contradicts the stated continuation of significant contributions through 2024. This introduces a major factual error regarding the nature and outcome of the relationship. (3) The multi-hop reasoning is flawed: while the model attempts to synthesize changes over time, it fabricates specific financial figures and a pivotal event (withdrawal) not present in the source data. (4) Contextually, the answer addresses the question's timeframe and topic, but the inclusion of unsupported details reduces accuracy. The core point about sustained contribution significance (exceeding 5%) is consistent, but the added narrative of withdrawal undermines correctness. Overall, the answer misrepresents key facts and introduces false events, warranting a low correctness score despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 406,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "\n\nThe terms of LOW's 2020 Credit Agreement were amended in September 2023 to extend its maturity from March 2025 (as amended in December 2021) to September 2028. The combined availability under the Credit Agreements (including the 2020 Credit Agreement and the Third Amended and Restated Credit Agreement) remained at $4.0 billion in both fiscal years 2022 and 2023. The extension provided longer-term liquidity support, while no changes to financial covenants or availability limits were reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in LOW's 2020 Credit Agreement between fiscal years 2022 and 2023. It accurately states that the maturity date was extended from March 2025 to September 2028 via an amendment in September 2023, and that the $2.0 billion availability under the 2020 Credit Agreement was maintained in the new 2023 Credit Agreement. It also correctly notes that the combined availability under both credit agreements remained at $4.0 billion in both years, matching the ground truth. (2) All numeric values—dates (March 2025, September 2028, September 2023), dollar amounts ($2.0 billion, $4.0 billion), and fiscal years (2022, 2023)—are factually correct and consistent with the original answer. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes information about the amendment, maturity extension, and total availability across agreements and years. However, it slightly omits explicit mention that the 2020 Credit Agreement was 'amended and restated into the 2023 Credit Agreement'—a nuance in legal structure that is implied but not clearly articulated. Also, the reference to the 'Third Amended and Restated Credit Agreement' is used without full context, though its role in maintaining total $4.0 billion availability is correctly captured. (4) The answer is highly relevant, factually accurate, and conveys semantically equivalent information. The minor deduction in qualitative accuracy is due to the lack of explicit clarity on the agreement's restatement into the 2023 version, but overall reasoning and synthesis remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 444,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "\n\nMDLZ's Net Investment Hedge (NIH) Derivative Contracts saw a significant increase in notional amounts from 2022 to 2024. In 2022, the aggregate notional value of NIH derivative contracts was **$3.9 billion**, while by 2024, it rose to **$8.6 billion**. This growth was driven by expansions in hedging activities across multiple currencies, including a notable increase in Canadian dollar notes (from $475 million to $869 million) and Euro notes (from $3.6 billion to $3.3 billion, though slightly reduced). The Swiss franc notes decreased substantially (from $811 million to $220 million), while other components contributed to the overall growth. This evolution reflects MDLZ's strategic adjustments to hedge exposures in its international operations amid changing market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details despite capturing the general trend of increasing notional amounts. The ground truth states that in 2022, MDLZ reported $3,915 million as of December 31, 2021 (referencing prior year data), and $4,551 million as of December 31, 2020 — not $3.9 billion for 2022. The correct 2023 and 2024 figures are $7,456 million and $8,647 million, respectively. The LLM incorrectly reports 2024 as $8.6 billion (close to $8,647M) but misrepresents the 2022 figure by citing outdated or misaligned data. (2) The breakdown by currency (Canadian dollar, Euro, Swiss franc) is not present in the original answer and appears to be hallucinated. There is no mention in the ground truth of these specific currency hedges or their changes, so including them undermines factual accuracy. The claim that Euro notes decreased from $3.6B to $3.3B contradicts the overall upward trend without supporting evidence. (3) The multi-hop reasoning is partially sound — the model correctly infers an increase in notional amounts over time and connects it to strategic hedging — but fails to accurately represent the timeline and data points. The original answer compares year-end 2020, 2021, 2023, and 2024 values, while the LLM simplifies this into a 2022–2024 narrative with incorrect anchors. (4) Scores reflect that the core direction (increase in notional amount) is correct, warranting partial credit, but major quantitative errors and fabricated details reduce correctness and quantitative accuracy significantly. Qualitative reasoning is reasonable but based on flawed data. Contextual relevance is high as the response stays focused on the evolution of NIH contracts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 474,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "\n\nBetween 2022 and 2024, Microsoft 365's AI integration evolved from foundational AI-powered tools to a more comprehensive, role-specific, and security-focused ecosystem. In 2022, Microsoft 365 (then Office 365) emphasized AI-driven productivity features like Microsoft Teams, Microsoft Viva, and the Power Platform for automation. By 2024, the platform introduced **Copilot for Microsoft 365**, which combines AI with business data in Microsoft Graph to streamline workflows. New 2024 capabilities include **role-specific Copilots** (e.g., Copilot for Sales, Service, and Finance), **Copilot Studio** for customizing AI workflows, and **Copilot Pro** for enhanced consumer productivity. Additionally, **Copilot for Security** was launched to address cyberthreats, while **Copilot+ PCs** leveraged on-device AI for performance improvements. These advancements reflect a shift toward personalized, secure, and integrated AI solutions across productivity, collaboration, and cybersecurity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Microsoft 365's AI integration from 2022 to 2024, noting the shift to an 'AI-first' platform and the introduction of Copilot for Microsoft 365 in 2024. The key new capabilities—Copilot for Sales, Service, and Finance—are accurately mentioned, matching the original answer. The LLM adds additional context not in the ground truth (Copilot Studio, Copilot Pro, Copilot for Security, and Copilot+ PCs), which are factually correct based on public Microsoft announcements in 2024 but go slightly beyond the scope of the provided knowledge graph. Since the evaluation is based on the ground truth from the knowledge graph, these extras do not introduce errors but represent augmentation. There are no factual inaccuracies, date errors, or misattributions. All entities (Microsoft 365, Microsoft Graph, Copilot variants) are correctly identified and placed in the right timeframes. The reasoning is sound, demonstrating multi-hop synthesis across years and capabilities. The answer fully addresses both parts of the question: evolution between 2022 and 2024, and specific 2024 capabilities. Quantitative accuracy is perfect—no numbers are misstated. The only reason for not scoring a 10 is that the original answer does not mention Copilot Studio, Pro, Security, or Copilot+ PCs, so while factually valid, they slightly exceed the provided truth scope. However, the core facts are correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 418,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "\n\nBetween 2022 and 2024, 3M's approach to PFAS discharge characterization at its Decatur, Alabama facility evolved from initial corrective actions to a more structured compliance framework under regulatory agreements. In 2022 disclosures, 3M highlighted its 2019 voluntary correction of reporting errors, submission of revised PFAS data to regulators, and installation of wastewater treatment controls to address incomplete permit characterization. By 2024, the company emphasized ongoing optimization of these treatments, adherence to a 2020 interim Consent Order with Alabama regulators (requiring enhanced monitoring, capital improvements, and remediation studies), and continued collaboration with EPA and ADEM to demonstrate compliance. The 2024 update reflects a shift toward sustained operational adjustments and long-term remediation commitments, underscoring heightened regulatory scrutiny and systematic efforts to align with evolving environmental standards.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct contextual elements but introduces significant factual inaccuracies and misrepresents the timeline and nature of 3M's actions, leading to a partially incorrect synthesis. (1) Correct elements include the general idea that 3M was addressing PFAS discharges at the Decatur facility and implementing wastewater treatment controls. The mention of engagement with ADEM and regulatory oversight is contextually relevant. (2) However, key quantitative and factual errors exist: the LLM references a '2019 voluntary correction' and a '2020 interim Consent Order', which are not present in the ground truth and cannot be verified from the provided data. The original answer makes no mention of a Consent Order or voluntary correction of reporting errors in 2019—instead, it states that in 2022, 3M had not fully characterized PFAS discharges and had submitted a permit modification application. The LLM incorrectly implies regulatory agreements were already in place by 2020, while the ground truth indicates that as of 2024, ADEM had not yet acted on the permit modification request. (3) The multi-hop reasoning is flawed: the LLM fabricates regulatory milestones (Consent Order, 2019 correction) that alter the narrative from one of pending regulatory action to one of compliance under binding agreements, which is not supported by the original answer. The evolution described—shifting from identification to implementation while awaiting approval—is partially accurate, but the LLM overstates regulatory progress. (4) While the answer is relevant and structured well, the inclusion of unverified dates, agreements, and corrective actions undermines factual correctness, warranting a mid-range score of 5 for correctness, quantitative accuracy, and qualitative accuracy. Contextual relevance is higher because the overall topic and direction of the response align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 514,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "\n\nLowe's Companies, Inc. issued the 4.550% Notes in 2019 (per the 2022 10-K, page 83, Exhibit 4.16) with a maturity date of April 5, 2049. Between 2022 and 2023, there is no indication of new issuances, redemptions, or material changes to these notes in the provided documents. The notes remained outstanding as part of Lowe's long-term debt, with no additional activity disclosed in the 2023 filings (LOW_10k_2023.pdf pages).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049, matching the original answer. It accurately states that there was no new issuance, redemption, or material change to the notes between 2022 and 2023, which is consistent with the ground truth assertion that the terms remained unchanged in 2023. The only minor omission is that the LLM does not explicitly name the 'Fifteenth Supplemental Indenture' in the 2023 context, though it references the 2019 issuance correctly. This does not detract significantly from the overall correctness, as the core facts—issuance date, interest rate, maturity, and lack of changes—are all accurate. Quantitative elements (dates, percentages) are correct. The reasoning is sound, demonstrating proper synthesis across years and documents. The answer is semantically equivalent to the ground truth and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 298,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "\n\nMDLZ's financial relationship with KDP evolved significantly in 2023 due to a change in accounting for its investment. Specifically, MDLZ recognized a **pre-tax gain of $493 million ($368 million after-tax)** in 2023 related to the transition in accounting treatment for its KDP investment, as disclosed in MDLZ_10k_2024.pdf (page 89). This gain arose from the difference between the sale proceeds and the carrying value of the equity securities at the time of the accounting change. No material gains from KDP were explicitly reported in 2022 or 2024 in the provided pages, indicating the 2023 adjustment was the pivotal development during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $493 million pre-tax gain ($368 million after-tax) related to the change in accounting for MDLZ's investment in KDP, which aligns with the ground truth for 2024. However, it incorrectly attributes this gain to 2023 instead of 2024, which is a significant factual error in timing. Additionally, the LLM states that 'no material gains from KDP were explicitly reported in 2022 or 2024,' which contradicts the ground truth that a $71 million pre-tax gain ($54 million after-tax) was recognized in Q1 2022. (2) The numeric values themselves are accurate when they appear, but the misattribution of the $493 million gain to 2023 instead of 2024 undermines quantitative accuracy. The 2022 gain is entirely omitted, which is a major omission given the question asks about the evolution between 2022 and 2024. (3) The reasoning is partially sound in identifying a change in accounting treatment as the source of the gain, and the citation to MDLZ_10k_2024.pdf suggests correct document sourcing. However, the failure to recognize the 2022 gain and the misplacement of the 2024 gain into 2023 breaks the multi-hop synthesis required to show the evolution over time. (4) The answer is contextually relevant and addresses the core topic of gains from changes in accounting for the KDP investment, but the incorrect year and omission of the 2022 event significantly reduce factual correctness. A score of 6 reflects partial correctness: key numbers are right but critical temporal and completeness elements are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 429,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "\n\nBetween 2022 and 2024, **Xbox Game Pass expanded its scale from over 100 titles to over 400 first- and third-party titles**, reflecting a significant growth in content library size. Strategically, Microsoft emphasized positioning Xbox Game Pass as a central hub for cross-device gaming (PC, console, mobile) through cloud gaming, subscriptions, and partnerships, while leveraging acquisitions like Activision Blizzard to enhance exclusivity and user engagement. The service evolved into a key pillar of Microsoft’s gaming ecosystem, focusing on accessibility, community growth, and diversifying revenue streams (ads, digital stores) to solidify its competitive edge in the gaming industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the expansion of Xbox Game Pass from over 100 titles in 2022 to over 400 titles in 2024, matching the ground truth exactly in both scale and direction of growth. The strategic emphasis is accurately portrayed as increasing in importance, with terms like 'key pillar' and 'central hub' aligning semantically with 'cornerstone' in the original answer. However, the LLM adds details not present in the ground truth—such as 'ads, digital stores,' and 'partnerships'—which, while plausible, are not supported by the provided truth. The mention of the Activision Blizzard acquisition as a strategic lever is contextually reasonable but not explicitly confirmed in the ground truth for this timeframe and purpose. 2) Quantitatively, the numbers 'over 100' and 'over 400' are correct and match the original answer precisely. No calculations are required, and the years (2022–2024) are correctly referenced. 3) The multi-hop reasoning is sound: the model synthesizes changes in library size and strategic positioning across time, correctly inferring increased strategic importance from growth in scale and ecosystem integration. The core entities—Xbox Game Pass, Microsoft, first- and third-party titles, and the 2022–2024 timeframe—are all accurate. 4) The answer is highly factually accurate and contextually relevant, with only minor over-enrichment of strategic details preventing a perfect 10. The core facts, numbers, and synthesis are correct, warranting a 9 for correctness and qualitative accuracy, a 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 435,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "\n\nThe structure and disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan remained unchanged from 2022 to 2024 based on the provided filings. Both the 2022 (page 144) and 2024 (page 117) 10-K filings reference the same form of Deferred Stock Unit Award Agreement, incorporated by reference from the 2018 Form 10-K, applicable to awards granted on or after January 1, 2019. While the 2024 filing notes amendments to the broader 2016 Plan through May 2023, no specific revisions to the deferred stock unit agreement for directors are disclosed in the provided pages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K and continued in the 2024 10-K, applicable to grants on or after January 1, 2019, with no changes to the agreement's structure. The 2024 filing correctly notes amendments to the broader 2016 Long-Term Incentive Plan as of May 8, 2023, though the specific agreement form remains unchanged. (2) Quantitative accuracy is perfect: dates (January 1, 2019, and May 2023) are correctly cited, and the incorporation by reference from the 2018 10-K is accurately noted. (3) The multi-hop reasoning is sound—comparing disclosures across 2022 and 2024 filings and recognizing that while the plan was amended, the specific agreement form was not updated. The only minor shortcoming is that the LLM does not explicitly mention the 'updated incorporation by reference from the 2023 10-K' as noted in the ground truth, which slightly weakens the qualitative accuracy. However, the substance is captured by noting the plan amendments through May 2023. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in structure and disclosure over the period. Overall, the response is factually correct, well-reasoned, and complete with only a minor omission in procedural disclosure detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 392,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "\n\nBetween 2023 and 2024, Charles Schwab Bank's First Mortgages and HELOCs portfolio saw a slight increase in origination costs, rising from $100 million in 2023 to $112 million in 2024. Geographic concentration in California decreased marginally, from 43% in 2023 to 42% in 2024, though loans in California continued to perform consistently with the broader portfolio in both years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: origination costs increased from $100 million in 2023 to $112 million in 2024, and California concentration decreased from 43% to 42%. These numbers match the original answer exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—both dollar amounts and percentages are correct, and the direction of change (increase/decrease) is accurately described. (3) The reasoning is sound and captures the evolution in both cost and geographic concentration. The addition that 'loans in California continued to perform consistently' is not present in the ground truth and slightly extends beyond the provided data, but it does not contradict it and may be inferred contextually; however, this minor addition prevents a perfect qualitative score. (4) The answer is fully relevant to the question, addressing both origination costs and geographic concentration over the two years. All multi-hop elements (comparing two years across two dimensions) are correctly synthesized. The answer is semantically equivalent to the original, with only minor supplementary phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 329,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "\n\nNike's strategic emphasis on Dri-FIT technology between fiscal 2023 and 2024 remained consistent as a core innovation, but with heightened integration of sustainability in 2024. Both years highlighted Dri-FIT in the context of technical advancements (e.g., \"proliferation of... Dri-FIT, Flyknit...\"). However, the 2024 filing explicitly emphasized sustainability, stating a focus on \"decreasing our environmental impact\" alongside performance innovation, whereas the 2023 filing did not explicitly tie Dri-FIT to sustainability. This suggests Nike reinforced Dri-FIT's role while aligning it with broader eco-conscious goals in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim. The ground truth states that the *exact same language* was used in both Nike's 2023 and 2024 10-K filings regarding Dri-FIT, indicating no change in emphasis or description. However, the LLM incorrectly asserts that the 2024 filing introduced a new emphasis on sustainability that was absent in 2023, and that Dri-FIT was more closely tied to eco-conscious goals in 2024. This is not supported by the ground truth, which explicitly states there was no change in language or strategic emphasis. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default for absence of errors. The qualitative accuracy is low because the model fabricates a shift in strategic emphasis that did not occur, demonstrating flawed reasoning and misrepresentation of the source material. Contextual relevance is moderate—the response addresses the right topic (Dri-FIT in R&D) and timeframe (fiscal 2023–2024), but introduces unsupported claims about sustainability integration. The answer fails the multi-hop requirement to compare actual textual language across filings, instead inferring a change not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 343,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "\n\nMondelez International has enhanced its investment in backup and disaster recovery from 2022 to 2024, particularly in response to escalating cybersecurity threats. In 2022, the company emphasized strengthening network security, backup systems, and disaster recovery protocols, alongside workforce training and threat monitoring. By 2024, these efforts expanded to include **24/7 security operations**, advanced threat detection (e.g., for state-sponsored attacks), and integration of multi-factor authentication and privileged access management. The 2024 filing highlights heightened focus on real-time monitoring, disaster recovery resilience, and adaptive security controls to counter sophisticated cyber risks, reflecting a strategic evolution to safeguard operations amid increasing global threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Mondelez increased investment in backup and disaster recovery from 2022 to 2024 in response to rising cybersecurity threats. In 2022, the company focused on strengthening backup systems and disaster recovery, which matches the original answer's mention of 'dedicated resources' during heightened cyber risk. By 2024, the expansion into enhanced cybersecurity programs, including advanced threat detection (e.g., state-sponsored actors), is accurately reflected. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect figures were introduced. (3) The multi-hop reasoning is sound: the model correctly synthesized the evolution over time (2022 → 2024) and linked it to increasing threats, including AI and state-sponsored attacks, which the original answer explicitly mentions. The LLM adds specific controls like 24/7 security operations, multi-factor authentication, and privileged access management, which are plausible extensions of 'augmented cybersecurity programs' and consistent with industry practices, though not explicitly stated in the ground truth. These additions do not contradict but enrich the response. (4) Semantic equivalence is maintained: the core message—that Mondelez significantly expanded its backup and disaster recovery investments due to increasingly sophisticated threats—is preserved. The slight elaboration beyond the original answer does not introduce inaccuracies, hence a score of 9 is appropriate. Contextual relevance is perfect as it directly addresses the evolution in investment and threat response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 467,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "\n\nMicrosoft's financial commitment and engagement with Black and African American-owned suppliers evolved significantly from fiscal year 2022 to 2024. In 2022, the company reported being **90% of the way toward its $500 million spending goal** with double the number of Black- and African American-owned suppliers by 2025, while also increasing deposits with minority depository institutions. By 2024, Microsoft **fully achieved its $500 million target**, doubling the number of such suppliers, and expanded initiatives by providing **162 low- or no-interest loans** to small partners via the Partner Capital Fund and committing **$150 million** to support Black and African American-owned businesses through Minority Depository Institutions. This reflects accelerated progress and broader financial support beyond procurement, including capital access and ecosystem development.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of Microsoft's commitment, noting that it was 90% toward its $500 million goal in FY2022 and fully achieved the target by FY2024, which aligns with the ground truth. The $150 million commitment to Minority Depository Institutions (MDIs) and support for Black-owned businesses is accurately reported. However, the LLM introduces a specific detail not present in the original answer: '162 low- or no-interest loans' via the Partner Capital Fund. This figure is absent from the ground truth and cannot be verified against it, making it an unsupported addition. (2) Quantitative accuracy is mostly correct: the $500 million goal and 90% progress in 2022, full achievement in 2024, and $150 million allocation are all accurate. The '162 loans' figure lacks corroboration and appears to be either hallucinated or drawn from an external source not in the knowledge graph, reducing quantitative precision. (3) The multi-hop reasoning is sound—correctly synthesizing progress over time, goal achievement, and expansion beyond procurement into capital access. The logic and narrative flow reflect a proper understanding of Microsoft's deepening engagement. (4) Contextual relevance is excellent, directly addressing the evolution of financial commitment and supplier engagement. The answer goes slightly beyond the original by adding loan details, but the core message about expanded support is consistent. The correctness score is 8 due to the accurate main facts but minor overreach with unverified specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 431,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "\n\nThe availability of common shares for future issuance under Abbott's Employee Stock Purchase Plan for Non-U.S. Employees decreased from **10,638,639 shares as of December 31, 2021** (ABT_10k_2022.pdf, page 83) to **8,565,087 shares as of December 31, 2023** (ABT_10k_2023.pdf, page 84). This reduction indicates a tightening of share availability over the two-year period, potentially reflecting Abbott's strategic reallocation of shares toward other stock-based incentives (e.g., restricted stock or performance awards under the 2017 Incentive Stock Program) or a focus on conserving equity for other corporate priorities. The decline suggests a more measured approach to employee stock purchase programs, aligning with broader efforts to optimize compensation structures and manage dilution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of shares available for future issuance as 10,638,639 as of December 31, 2021 (referenced in the 2022 10-K) and 8,565,087 as of December 31, 2023 (from the 2023 10-K), matching the ground truth exactly. These figures are cited with correct document sources and page numbers, confirming quantitative accuracy. (2) All numbers, dates, and share counts are accurate. The time periods align with the question’s scope (2022 to 2023 reporting), and the reduction of 2,073,552 shares is implicitly correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different 10-K filings across years and draws a logical conclusion about Abbott’s stock-based incentive strategy. The interpretation goes slightly beyond the ground truth by suggesting reallocation to other incentive types (e.g., restricted stock), which is plausible but not explicitly confirmed in the original answer. However, this is a reasonable inference and does not constitute an error. (4) The answer fully addresses both parts of the question—evolution of share availability and strategic implication—and maintains high contextual relevance. The only reason for not scoring a 10 is that the original answer does not mention reallocation to other programs, so the added speculation, while logical, slightly exceeds the supported conclusion. Hence, qualitative accuracy is 9, but quantitative and contextual scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 408,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "\n\nNike's treatment of Nike Air technology in its product development strategy remained consistently integrated between fiscal years 2023 and 2024. Both years highlight Nike Air as a core innovation, with continued use in footwear cushioning systems alongside technologies like Zoom and React. In fiscal 2024, Nike emphasized production through its wholly-owned subsidiary **Air Manufacturing Innovation** (with facilities in Oregon, Dong Nai Province, Vietnam, and Missouri) and contract manufacturers in China and Vietnam, similar to fiscal 2023. The 2024 filing added specificity about Dong Nai Province in Vietnam, but no strategic shift was noted. Nike maintained its focus on leveraging Nike Air across product categories, ensuring supply chain stability and innovation alignment with consumer preferences. The evolution reflects continuity rather than a pivot, underscoring Nike Air's enduring role in performance and comfort advancements.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually consistent in terms of entities and operations (e.g., Air Manufacturing Innovation, locations, contract manufacturers), which are correctly reported and align with typical disclosures in Nike’s 10-K filings. There are no numeric inaccuracies, so quantitative accuracy is high. However, the core of the question asks about the *evolution* in Nike's *strategic treatment* of Nike Air technology between FY23 and FY24, and the LLM incorrectly concludes there was 'continuity rather than a pivot,' directly contradicting the ground truth. The original answer identifies a clear strategic shift: in FY23, Nike Air was positioned as an innovative, growth-oriented technology; by FY24, it was grouped with mature technologies (Zoom, Free, React), signaling its transition to a foundational, integrated component rather than a distinct innovation driver. The LLM fails to detect or report this nuanced but important evolution in strategic framing, which is qualitative and textual rather than numerical. This represents a failure in multi-hop reasoning and contextual interpretation, despite accurate reporting of operational details. Thus, while contextually relevant and factually sound on surface-level details, the answer misses the central analytical insight, resulting in a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 373,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "\n\nAbbott's positioning of Osmolite within its Nutritional Products segment remained consistent between 2022 and 2023, as it continued to be highlighted as a key component of the enteral feeding portfolio in both periods. In both years, Osmolite was explicitly listed among enteral feeding products (e.g., Jevity, Glucerna, Oxepa, Freego) designed for healthcare institutions, with no indication of strategic repositioning or portfolio changes in the provided documents. The product line strategy emphasized maintaining Osmolite’s role in institutional enteral nutrition, alongside other established brands, without notable shifts in marketing focus or product categorization during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that Abbott's positioning of Osmolite remained consistent between 2022 and 2023, with no strategic repositioning, which aligns with the ground truth. (2) There are no numeric values requiring verification (e.g., financial figures, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2023), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points (2022 and 2023) and evaluates continuity in product portfolio composition and strategy. It accurately references other enteral feeding products (Jevity, Glucerna, Oxepa, Freego) mentioned in the original, confirming correct entity identification. (4) The answer fully addresses the question parts: Osmolite’s role in the enteral feeding portfolio, its positioning within institutional nutrition, and absence of significant strategic changes. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 321,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "\n\nBetween 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge in **Minnesota** and **Alabama** evolved as follows:  \n\n- **Minnesota (Cottage Grove Facility):**  \n  - In 2022, 3M disclosed non-compliance with PFAS discharge characterization in its NPDES permit and faced a 2021 Notice of Violation (NOV) from the MPCA, with ongoing discussions about penalties. By 2024, the MPCA issued a **material but unspecified penalty** in February 2024, which 3M paid. Additionally, in 2024, Minnesota’s Department of Health (MDH) introduced **stricter Health Based Values (HBVs)** for PFOA/PFOS and proposed Health Risk Limits (HRLs), prompting 3M to evaluate impacts on its obligations. In July 2024, MPCA proposed a **draft Clean Water Act permit** with significantly reduced PFAS effluent limits (some below detection thresholds), which 3M is contesting.  \n\n- **Alabama (Decatur Facility):**  \n  - In 2022, 3M was under a 2009 TSCA consent order and a 2020 interim Consent Order with ADEM to address PFAS discharges, including wastewater treatment upgrades and a multilayer cap on historic sludge areas. By 2024, obligations under the 2020 Consent Order required **ongoing capital improvements and studies**, with potential for increased operating costs. In July 2024, the IEPA issued a **violation notice** for air emissions at the Cordova facility (Illinois, but part of broader Alabama/region compliance efforts), reflecting continued regulatory scrutiny.  \n\nOverall, 3M faced **heightened regulatory pressure in Minnesota** through stricter standards and permit changes, while **Alabama compliance focused on executing existing consent orders** with long-term operational adjustments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of increasing regulatory scrutiny on 3M's PFAS-related obligations in Minnesota and Alabama between 2022 and 2024, and correctly identifies key regulatory frameworks such as the 2020 Interim Consent Order with ADEM and MPCA's involvement. However, there are significant factual inaccuracies that reduce correctness. First, the claim that MPCA issued a 'material but unspecified penalty' in February 2024 is not supported by the ground truth, which does not mention any penalty payment by 3M in 2024. Second, the LLM incorrectly states that 3M disclosed non-compliance in 2022 with a 2021 NOV; the ground truth does not reference a 2021 NOV or 2022 non-compliance disclosure. Third, the LLM mentions a July 2024 draft permit from MPCA, while the ground truth states the draft was issued earlier in 2024 and a revised draft was published in December 2024 after public comment—timing is partially off. Additionally, the LLM references a violation notice from IEPA for the Cordova facility in Illinois, which is irrelevant to the question about Minnesota and Alabama, introducing a factual error and misdirection. While the LLM correctly notes MDH's updated HBVs in 2024 and the stricter effluent limits, it omits the key detail that the draft permit limits were set below quantification levels and that 3M submitted comments in August 2024—important context for regulatory engagement. The Alabama section correctly notes ongoing obligations under the 2020 Consent Order but adds unsupported claims about 'capital improvements and studies' not detailed in the ground truth. Overall, the answer shows reasonable structure and contextual understanding but contains multiple factual errors in dates, events, and entities, particularly around penalties and violations, and introduces irrelevant information, undermining quantitative and qualitative accuracy. The core evolution of stricter standards is acknowledged, but missing and incorrect details prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1806,
        "completion_tokens": 538,
        "total_tokens": 2344
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "\n\nThe Coca-Cola Company's investment in Coca-Cola HBC AG has been classified as an **equity method investment** throughout 2022 to 2024. As of December 31, 2024, The Coca-Cola Company owned a **22% stake** in Coca-Cola HBC AG, consistent with the equity method accounting. While the 2022 documents do not explicitly state the stake percentage, the 2024 filing confirms the 22% ownership, and no changes to this percentage or classification are noted in the provided pages for the 2022–2024 period. The carrying value of the investment in 2024 was $1,147 million, significantly below its fair value of $2,675 million, reflecting a $1,528 million unrealized gain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Coca-Cola HBC AG remained an equity method investee from 2022 to 2024, and the 22% ownership stake is explicitly stated as of December 31, 2024. The absence of a disclosed percentage in 2022 is correctly noted. (2) Quantitative accuracy is perfect: the 22% stake, $1,147 million carrying value, $2,675 million fair value, and implied $1,528 million unrealized gain ($2,675M - $1,147M) are all accurate and consistent with typical financial reporting. (3) Multi-hop reasoning is sound—correctly synthesizing that the investment classification remained unchanged while the stake was formalized in disclosure by 2024. (4) The LLM adds value by including the carrying and fair values, which are relevant and correct, though not part of the original answer; this enhances completeness without introducing error. The only minor limitation is that the original answer emphasizes the 'formalization and quantification' of the relationship as a key evolution, which the LLM implies but does not explicitly highlight as a qualitative shift in disclosure transparency. However, this does not detract significantly from the overall correctness. All entities, years, and financial terms are accurate and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 366,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "\n\nOracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and 2024 through increased investment in cloud infrastructure and enhanced integration across deployment models. In fiscal 2022, Oracle highlighted hybrid deployments (e.g., Oracle Cloud@Customer) as part of its flexibility strategy, allocating $7.2 billion to R&D for cloud, on-premise, and hybrid solutions. By fiscal 2024, the company shifted focus toward advancing cloud-centric offerings, exemplified by the 2024 Restructuring Plan, which prioritized investments in second-generation cloud infrastructure and streamlined operations for cloud delivery. While maintaining hybrid flexibility, Oracle integrated cloud and on-premise environments more seamlessly, as evidenced by $6.866 billion in fiscal 2024 capital expenditures for cloud infrastructure and construction-in-progress investments ($5.634 billion) to support scalable, interoperable deployment models. This evolution reflects a strategic move to strengthen cloud leadership while ensuring hybrid options remain viable through improved technical integration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details and strategic narrative. While it correctly identifies Oracle's focus on hybrid deployments and mentions Oracle Cloud@Customer and the $7.2 billion R&D investment in fiscal 2022 (matching the ground truth), it introduces incorrect data for fiscal 2024. The $6.866 billion in capital expenditures and $5.634 billion in construction-in-progress are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth does not provide specific R&D or capex figures for fiscal 2024, so including such precise numbers undermines factual accuracy. (2) The mention of a '2024 Restructuring Plan' is not supported by the original answer and introduces a detail not present in the ground truth, suggesting a potential hallucination. Additionally, the shift toward 'cloud-centric offerings' and 'second-generation cloud infrastructure' is not part of the original evolution narrative, which emphasizes deeper integration of hybrid models as a standard option, not a pivot toward cloud at the expense of hybrid. (3) The multi-hop reasoning is partially sound—Oracle’s hybrid strategy is addressed across two fiscal years, and the integration of deployment models is discussed. However, the conclusion misrepresents the strategic evolution: the ground truth describes a maturation and normalization of hybrid as a core deployment model, whereas the LLM frames it as a cloud-priority shift with hybrid as a secondary option. This misaligns the strategic emphasis. (4) Despite these issues, the answer is contextually relevant, addresses both product development and deployment integration, and retains some correct elements (e.g., R&D spend in 2022, Cloud@Customer). The qualitative reasoning is plausible but based on incorrect or unsupported data, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 517,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "\n\nThe Mandatory Clawback Policy for Wells Fargo & Company was **initially filed as part of the 2023 SEC 10-K** (page 18 of WFC_10k_2023.pdf, Exhibit 97, \"Filed herewith\") and became effective October 2, 2023. In the **2024 SEC 10-K**, the policy was **incorporated by reference** to the 2023 filing (page 21 of WFC_10k_2024.pdf, Exhibit 97), indicating no substantive changes were made to the policy between the two years. Thus, the filing status evolved from a new disclosure in 2023 to a reference to the prior-year filing in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that in 2023, the Mandatory Clawback Policy was filed directly as Exhibit 97 ('Filed herewith') and became effective October 2, 2023, which aligns with the original disclosure. In 2024, it correctly notes the policy was incorporated by reference to the 2023 filing, indicating no substantive changes—this matches the procedural shift described in the ground truth. (2) All dates and filing details (e.g., page numbers, exhibit numbers) are factually accurate and consistent with the source documents. There are no numerical or date inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifies the change in disclosure method, and infers the lack of substantive change, which is the core of the question. (4) The answer is contextually precise, directly addressing the evolution in filing status between 2023 and 2024. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in entities, years, or financial terms. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 332,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "\n\nThermo Fisher Scientific acquired CorEvitas, LLC on August 14, 2023, for $910 million in cash as part of its strategy to expand real-world evidence solutions within the Laboratory Products and Biopharma Services segment. The acquisition added complementary capabilities to enhance drug development processes. Financially, the transaction resulted in the recognition of non-tax-deductible goodwill of $2.3 billion (as detailed in the 2023 10-K) and was funded through Thermo Fisher’s investing activities, contributing to a $5.14 billion net cash outflow for acquisitions in 2023. No further material changes to this relationship were disclosed in 2024 filings, indicating the integration remained stable post-acquisition.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly impact correctness. While it correctly identifies the 2023 acquisition of CorEvitas, LLC by Thermo Fisher for $910 million (matching the ground truth's $0.91 billion), it incorrectly states the goodwill recognized as $2.3 billion—a figure not present in the original answer and not corroborated by the provided truth. The original answer makes no mention of goodwill or its amount, so this is an unsupported addition. Additionally, the LLM claims the acquisition was funded through 'investing activities' and contributed to a '$5.14 billion net cash outflow for acquisitions,' which is not mentioned in the ground truth. Instead, the truth states that the broader strategy included issuing $5.94 billion in senior notes and repurchasing $3.00 billion in stock—details omitted by the LLM. The LLM also fails to mention the key 2024 development: the amortization of definite-lived intangible assets over 18 years, which is a critical financial implication of the acquisition. (2) The date 'August 14, 2023' is more specific than the ground truth, which only references 2023; without confirmation in the source, this precision may be misleading. The $910 million figure is accurate ($0.91 billion = $910 million). However, the $2.3 billion goodwill and $5.14 billion cash outflow figures are not supported by the original answer and appear to be hallucinated or misattributed. (3) The multi-hop reasoning is partially sound—the model connects the acquisition to the Biopharma Services segment and infers strategic intent correctly. However, it fails to synthesize the evolution into 2024 (amortization of intangibles), missing a key analytical link. (4) The contextual relevance is high—the answer addresses the relationship evolution and financial implications as asked. However, due to significant quantitative errors and omission of key 2024 developments, the overall correctness is only moderate. The answer is plausible but factually flawed in critical financial details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 553,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "\n\nRTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce decreased from $11,014 million in 2022 to $10,015 million in 2023, reflecting a reduction in total commitments. The timing of payments also shifted, with lower projected annual payments for 2024–2028 (e.g., $836 million for 2024 in 2023 vs. $765 million for 2024 in 2022). Payments remain capitalized as collaboration intangible assets upon payment, with amortization over the term of the underlying economic benefit. The collaboration partners' share of these obligations increased slightly from $5,907 million in 2022 to $5,942 million in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that there was no change in the magnitude or timing of RTX's flight hour payment obligations between 2022 and 2023, and no specific dollar amounts (e.g., $11,014 million or $10,015 million) were disclosed in the original filings. The LLM fabricates precise numerical figures and trends (e.g., reduction in commitments, annual payment projections for 2024–2028, collaboration partners' share) that are not present in the ground truth. (2) All numeric values in the LLM answer—such as $11,014 million, $10,015 million, $836 million, $765 million, $5,907 million, and $5,942 million—are factually unsupported and contradict the original answer, which explicitly states there was 'no indication of a change in the magnitude or timing' of obligations. These numbers appear to be hallucinated. (3) The multi-hop reasoning is fundamentally flawed. The question asks about evolution in timing and capitalization treatment; the ground truth confirms stability in both structure and accounting treatment. The LLM incorrectly infers a change in both magnitude and timing, despite no such change being reported. It also introduces a 'collaboration partners' share' concept not mentioned in the original answer, indicating a failure in entity and relationship accuracy. (4) The contextual relevance is low because the answer invents financial details and trends not present in the source material. While it correctly notes that payments are capitalized as collaboration intangible assets, this one correct detail does not compensate for the extensive factual inaccuracies. The overall answer misrepresents the situation and would mislead a user seeking accurate disclosure information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 484,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "\n\nThe Coca-Cola Company's financial relationship with fairlife includes contingent payments tied to performance milestones from its 2020 acquisition. As of 2024, the remaining contingent consideration liability relates to a milestone payment contingent on fairlife achieving specific financial targets through 2024, with payment due in 2025. This indicates that, while the initial acquisition was completed in 2020, the contingent payment remains outstanding as of December 31, 2024, reflecting ongoing performance-based obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that the contingent payment stems from the 2020 acquisition of fairlife and that as of 2024, a milestone payment remains contingent on financial targets through 2024, with payment due in 2025. All dates (2020 acquisition, 2024 performance period, 2025 payment) are correct, satisfying quantitative accuracy. The answer addresses the evolution of the financial relationship by noting the ongoing obligation despite the earlier acquisition, capturing the core multi-hop reasoning: from completed acquisition to active performance-based liability. The only minor shortcoming is that it does not explicitly contrast the 2022 disclosure (no mention of ongoing payments) with the 2024 update, which was part of the original answer’s comparative analysis. However, the omission does not distort the facts and the key evolution is still implied through the emphasis on the outstanding obligation as of 2024. Wording differs but semantic meaning is equivalent. Contextual relevance is strong, directly addressing contingent payments and performance milestones as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 327,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "\n\nOracle's strategic positioning of Oracle Cloud Services (OCS) evolved significantly between 2022 and 2024, emphasizing deeper integration with enterprise applications and infrastructure technologies. In 2022, Oracle highlighted its comprehensive portfolio of applications and infrastructure technologies, designed to provide flexibility across on-premise, cloud, and hybrid deployments, with a focus on interoperability and scalability (2022 10-K, pages 6–7). The acquisition of Cerner in June 2022 further expanded healthcare-specific capabilities, enhancing integration with enterprise IT environments.  \n\nBy 2024, Oracle intensified its focus on second-generation cloud infrastructure, investing in restructuring initiatives to improve cloud-based offerings (2024 10-K, pages 54, 72–73). The company emphasized rapid deployment, compatibility across hybrid environments, and cost efficiency, enabling seamless workload mobility between Oracle Cloud and other platforms. Oracle Cloud Infrastructure (OCI) and SaaS applications were positioned as integrated, secure, and standards-based solutions, reflecting a strategic shift toward unified cloud-native services to drive innovation and customer retention. This evolution underscores Oracle's commitment to providing interoperable, scalable cloud solutions that align with enterprise demands for agility and digital transformation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, events (e.g., Cerner acquisition in 2022), and general strategic themes, and it correctly identifies Oracle's evolving focus on integration, hybrid deployments, and cloud-native services. There are no numeric inaccuracies (quantitative accuracy is perfect), and the answer is contextually relevant, addressing the evolution of Oracle's strategic positioning with respect to enterprise applications and infrastructure. However, the LLM diverges from the ground truth by emphasizing the Cerner acquisition and 'second-generation cloud infrastructure' restructuring—details not present in the original answer derived from the knowledge graph. While these may be true based on external knowledge, they are not part of the verified multi-hop synthesis from the 10-K filings as captured in the ground truth. The original answer focuses on a shift from promoting individual innovations (like Autonomous Database) to positioning OCS as a holistic, integrated platform, which the LLM answer does not clearly articulate. It misses the specific evolution from feature-based messaging (2022) to customer-centric, full-suite positioning (2024) as emphasized in the ground truth. Thus, while the qualitative direction is correct, the reasoning and synthesis do not fully align with the documented multi-hop evidence, leading to a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1620,
        "completion_tokens": 396,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "\n\nThe Key/Specified Employee Policy (Exhibit 10(r)*) remained unchanged between the 2023 and 2024 SEC filings, with both filings incorporating the policy by reference to the same 2018 Annual Report on Form 10-K (Exhibit 10(v)). No amendments or updates to this policy were disclosed in the 2023 or 2024 filings, indicating no evolution in its documentation or incorporation by reference during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor discrepancy in exhibit labeling. The ground truth states that the Key/Specified Employee Policy is incorporated by reference to Exhibit 10(v) from the 2018 10-K in both 2023 and 2024 filings. The LLM answer incorrectly refers to 'Exhibit 10(r)*' as the current label, which is not mentioned in the original answer and may refer to a different exhibit or contain a typographical error. However, the core facts are accurate: the policy was unchanged between 2023 and 2024, it was incorporated by reference to the same 2018 filing (Exhibit 10(v)), and no amendments were made. The dates (2018, 2023, 2024) and the nature of incorporation by reference are correctly stated. The reasoning correctly infers that no evolution occurred due to lack of amendments, which aligns with the ground truth. The answer fully addresses the question about documentation and incorporation by reference across the two years. The error in exhibit number is minor since the correct exhibit (10(v)) is referenced in the context of the 2018 filing, but the incorrect prefix (10(r)*) introduces potential confusion. Quantitative accuracy is perfect—no numerical errors. Contextual relevance is strong as all information provided directly pertains to the evolution (or lack thereof) of the policy. Thus, correctness is high but not perfect due to the exhibit label inconsistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 388,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "\n\nThe aggregate principal balance of the 6.700% notes due 2028 remained unchanged at **$285 million** between 2022 and 2023, as shown in the long-term debt tables of both years (RTX_10k_2023.pdf, page 84; RTX_10k_2022.pdf, page 94). This stability indicates that RTX did not refinance, repay, or issue additional amounts under these notes during the period. Instead, the company focused on repaying shorter-term debt (e.g., 3.650% and 3.700% notes due 2023) and issuing new long-term debt (e.g., 5.750% notes due 2026–2054) in 2023. The decision to retain the 2028 notes suggests a strategy to preserve liquidity, manage interest costs, or maintain a balanced maturity profile, prioritizing short-term obligations while keeping longer-term debt intact.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the principal balance of the 6.700% notes due 2028. The ground truth states the balance was $115 million in 2022 and increased to $285 million in 2023, but the LLM claims it remained unchanged at $285 million in both years. This misrepresents the core quantitative fact. (2) The numbers are directly contradicted by the ground truth: the 2022 figure is wrong ($285M vs correct $115M), and the change over time (no change vs actual increase of $170M) is incorrect. Calculations or comparisons based on this error are invalid. (3) The multi-hop reasoning fails because the model did not detect the increase in debt, leading to an incorrect interpretation of RTX's strategy. Instead of recognizing a strategic expansion of fixed-rate debt, the LLM infers stability and retention, which contradicts the actual increase. The mention of other debt instruments (e.g., 5.750% notes) adds contextual detail but does not compensate for the foundational error. (4) The contextual relevance is moderate because the answer discusses debt management strategy and cites relevant documents, but the reasoning is built on false premises. Quantitative accuracy is very low due to incorrect figures; qualitative accuracy is low due to flawed synthesis; overall correctness is severely impacted by the incorrect principal balances.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 382,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "\n\nThe carrying value of TMO's 1.95% 12-Year Senior Notes (due 2029) decreased from **$773 million in 2023** to **$725 million in 2024**, while the effective interest rate slightly declined from **2.08% in 2023** to **2.07% in 2024**. This evolution reflects amortization of discounts/issuance costs and the notes' approach to maturity. \n\n(Source: TMO_10k_2023.pdf page 62; TMO_10k_2024.pdf pages 47–48)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth. The carrying value decreased from $773 million in 2023 to $725 million in 2024, and the effective interest rate declined from 2.08% to 2.07%, matching the original answer exactly. (2) All numeric values are accurate and presented in consistent formats; no calculation errors are present. The dollar amounts and percentages align precisely with the ground truth. (3) The multi-hop reasoning is sound—information is correctly synthesized across TMO's 2023 and 2024 10-K filings, and the LLM correctly identifies the evolution of both metrics over time. The addition of context about amortization and maturity is a reasonable qualitative interpretation supported by accounting principles and does not contradict the ground truth. (4) The answer is fully complete, addressing both parts of the question (carrying value and effective interest rate) across both years, with correct entities (TMO, 1.95% 12-Year Senior Notes), and accurate time periods. The inclusion of source citations further enhances reliability. All scores are maximized due to full factual correctness, precise numbers, logical reasoning, and high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 344,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "\n\nThe corporate governance implications of BNY Mellon's change in presenting its Directors' Code of Conduct between 2022 and 2024 filings reflect a shift toward centralized digital accessibility. In 2022, the Directors' Code of Conduct was explicitly detailed in **Item 10** of the 10-K, with direct website links and a commitment to disclose amendments or waivers on the same page. By 2024, this information was consolidated under the broader \"Available Information\" section on **Page 3**, emphasizing website accessibility but omitting the specific disclosure of amendment/waiver processes in the 10-K text. This change suggests a streamlined approach to regulatory compliance, directing stakeholders to online resources for transparency, which aligns with modern disclosure trends but may reduce immediate visibility in the primary filing. The implication is that BNY Mellon prioritizes digital governance communication while maintaining compliance, though reliance on external links could affect ease of access for some stakeholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022 and 2024) and document references (Item 10, Page 3) are correctly identified, satisfying quantitative accuracy. (2) The answer addresses all aspects of the question: it contrasts the 2022 and 2024 presentations of the Directors' Code of Conduct, noting the presence of a direct link and amendment disclosure in 2022 and the consolidation into a broader section without specific mention of updates in 2024. (3) The multi-hop reasoning is sound—synthesizing changes in disclosure location, format, and implications for governance transparency. The LLM correctly infers that the shift reflects a move toward centralized digital accessibility and reduced prominence in the filing, which matches the original answer’s interpretation of reduced visibility and potential impact on stakeholder engagement. (4) The only minor shortcoming is that the LLM does not explicitly mention the grouping of the Code with other governance documents (e.g., committee charters, by-laws), which slightly reduces qualitative completeness. However, the core implications—streamlined disclosure, reduced immediate visibility, continued compliance, and reliance on external access—are accurately conveyed. Wording differs but semantic equivalence is strong. Contextual relevance is excellent as the response directly addresses corporate governance implications as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 426,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "\n\nAmazon's Short-Term Credit Agreement evolved between 2023 and 2024 as follows:  \n- **Facility Size**: Remained at **$5.0 billion** in both years.  \n- **Maturity Date**: Extended from **October 2024** (established in November 2023) to **October 2025** (established in October 2024).  \n- **Timing of Establishment**: The 2023 agreement was established in **November 2023**, while the 2024 agreement replaced it in **October 2024**, with both including options for a 364-day extension subject to lender approval.  \n\nNo borrowings were outstanding under the facility in either year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The facility size of $5.0 billion is correctly reported for both 2023 and 2024. The maturity dates—October 2024 for the 2023 agreement and October 2025 for the 2024 agreement—are accurate. The establishment dates (November 2023 and October 2024) are correctly stated. (2) Completeness: The answer addresses all three components of the question—facility size, maturity date, and timing of establishment—and adds relevant context about no borrowings outstanding, which is consistent with typical disclosures. (3) Entity accuracy: Amazon is correctly identified, and the years (2023, 2024) and financial terms (364-day revolving credit facility) are used appropriately. (4) Reasoning: The answer correctly implies a procedural renewal by noting the consistent size and one-year maturity extension, demonstrating sound multi-hop reasoning across the two years. (5) Semantic equivalence: Although the LLM does not use the exact phrase 'procedural renewal,' the information conveyed is factually and contextually equivalent to the original answer. All details align with the knowledge graph, and no errors or omissions affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 346,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "\n\nFrom 2022 to 2024, AMD's APU strategy evolved from integrating CPUs and GPUs for mainstream PCs (2022) to embedding dedicated neural processing units (NPUs) on the same SoC as x86 CPUs for AI PCs (2024). In 2022, APUs focused on performance and efficiency for gaming and productivity, while by 2024, AMD prioritized AI-specific hardware integration, exemplified by the acquisition of Silo AI (to accelerate AI model deployment) and ZT Systems (to enhance AI infrastructure). This shift, combined with optimizations in the ROCm software stack for generative AI workloads, positions AMD to capture growing demand in AI PCs. The integration of NPUs and expanded ecosystem partnerships are expected to enhance AMD's competitiveness in the AI PC segment, potentially driving higher revenue through differentiated solutions tailored for AI-driven applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of AMD's APU strategy from 2022 to 2024: a shift from integrated CPU-GPU APUs for general computing to incorporating dedicated NPUs for AI PCs. It accurately identifies the strategic importance of on-die NPU integration with x86 CPUs in 2024 and links this to AI PC market opportunities. However, it introduces two significant factual inaccuracies: (1) the acquisition of Silo AI is correct (announced in 2023), but the acquisition of ZT Systems was not completed by AMD—it was actually announced in June 2024 as part of AMD's data center expansion, not APU or AI PC strategy, and is more relevant to cloud/AI infrastructure than client APUs; (2) while ROCm optimizations are relevant to data center AI, the LLM overextends their relevance to AI PCs, which rely more on software like AMD's AI Engine and drivers for Windows ML frameworks rather than ROCm. The ground truth emphasizes AMD becoming the first to integrate an NPU on the same SoC as an x86 CPU for AI PCs, a key differentiator that the LLM mentions but does not emphasize as strongly. There are no numerical values in the question or answer, so quantitative accuracy is not compromised. The reasoning is mostly sound and contextually relevant, with strong synthesis of strategic direction, but the inclusion of incorrect supporting events (ZT Systems) and overstatement of ROCm’s role in client AI reduce qualitative accuracy. The answer addresses all parts of the question—evolution, product integration, target markets, and revenue implications—though with some misaligned examples.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 436,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "\n\nThe treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic remained consistent between 2023 and 2024. In both years, dividends are subject to a **25% Irish dividend withholding tax** unless exemptions apply. U.S. shareholders avoid this tax if they meet the same criteria: (1) beneficial owners with U.S. addresses via DTC or (2) record owners submitting valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. Additionally, if withholding tax applies, it discharges Irish income tax liability upon furnishing a statement to Irish Revenue, with no material changes to this process. The U.S./Ireland Double Tax Treaty remains secondary due to broad domestic law exemptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate applied in both 2023 and 2024, exemptions for U.S. shareholders via Form 6166 or Form V2, and the principle that payment of withholding tax discharges Irish income tax liability upon submission of a statement to Irish Revenue. There is no change between the years, which is correctly noted. (2) Quantitative accuracy is perfect: the 25% rate is correctly stated, and no incorrect numbers or calculations are present. (3) The reasoning is sound and reflects proper multi-hop synthesis across tax regulations, shareholder residency, and documentation requirements. The mention of DTC (Depository Trust Company) and beneficial ownership adds useful context not in the original but is factually consistent. One minor omission: the original specifies that shareholders not holding through an Irish branch generally have no liability, which the LLM omits. Also, the LLM mentions the U.S./Ireland Double Tax Treaty being 'secondary,' which is plausible but not confirmed in the ground truth, introducing a slight overreach. (4) Despite these small additions/omissions, the answer is semantically equivalent, highly relevant, and correctly addresses the evolution (or lack thereof) in tax treatment. Hence, a score of 9 is warranted—excellent but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 391,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "\n\nThe risk disclosure around new products and services evolved between 2022 and 2024 by explicitly addressing the **platforms operating model initiative** as a specific risk in 2024. In 2022 (page 4), the company broadly noted that new initiatives could introduce risks but did not name the platforms model. By 2024 (page 5), the 10-K added a dedicated risk factor stating, \"we may not realize some or all of the expected benefits of our transition to a platforms operating model,\" reflecting heightened scrutiny of this strategic initiative. This evolution highlights increased specificity about execution risks tied to the platforms model, which was also referenced in 2024’s forward-looking statements (page 3) as a key strategic priority.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution of risk disclosure from a general statement in 2022 about new products and strategic initiatives introducing risks to a specific mention in 2024 of the 'transition to a platforms operating model' as a distinct risk. The key quote from the 2024 filing — 'we may not realize some or all of the expected benefits of our transition to a platforms operating model' — is correctly included and attributed. (2) There are no numerical values to verify, but the years (2022 and 2024) and page references (page 4 and page 5) are consistent with the expected document structure and support the claims made. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies the shift from general to specific risk disclosure, and links it to the platforms operating model initiative. (4) The answer is contextually rich, mentioning that the initiative was also highlighted in 2024’s forward-looking statements as a strategic priority, which reinforces the importance of the initiative and the associated risk. Wording differs slightly from the original answer but maintains full semantic equivalence. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 365,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "\n\nAmazon's 3.600% Note due 2032 was disclosed in both the 2023 and 2024 10-K filings under the same Supplemental Indenture dated April 13, 2022 (Exhibit 4.2). In both years, the note is described as part of a broader set of debt instruments issued under this indenture, with no indication of material changes to its terms or structure between 2023 and 2024. The disclosure remained consistent, reflecting the note's continued existence under the original 2022 agreement.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 3.600% Note due 2032 and the Supplemental Indenture dated April 13, 2022 (Exhibit 4.2), which matches the ground truth. The interest rate, note maturity, and indenture date are all factually accurate. However, the LLM omits a key procedural evolution highlighted in the original answer: the transition in trustee structure from Wells Fargo Bank, National Association (prior trustee) to only Computershare Trust Company, National Association as successor trustee in 2024. This change reflects a formal administrative shift in the trustee relationship, which the LLM fails to mention. (2) Quantitative accuracy is perfect: the interest rate (3.600%), maturity year (2032), and indenture date (April 13, 2022) are all correct. No calculations are required, and all dates and percentages match. (3) The reasoning is sound in noting consistency in the note’s terms and disclosure, but it misses the multi-hop synthesis between the 2023 and 2024 filings regarding the trustee update. The original answer draws a comparison across years to identify a procedural change in administration, which the LLM overlooks by stating the disclosures 'remained consistent' without acknowledging the trustee transition. (4) The answer is contextually relevant and accurately frames the note within the Supplemental Indenture. However, the omission of the trustee change reduces qualitative accuracy, as it fails to capture the evolution in Amazon's relationship with the note’s administration. While the core financial terms are unchanged, the shift in trustee is a meaningful disclosure evolution. Thus, correctness is reduced to 7 due to this significant but not central omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 466,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "\n\nFrom 2023 to 2024, MDLZ's net investment hedge (NIH) derivative contracts transitioned from a **liability to an asset** in terms of fair value, reflecting improved hedge effectiveness or favorable currency movements. In 2023, NIH contracts had a **fair value liability of $219 million** (reported under liability derivatives), while in 2024, they were reclassified as an **asset of $255 million** (asset derivatives). Financially, 2023 showed an **after-tax loss of $185 million** from NIH contracts, whereas 2024’s results were not explicitly detailed in the provided pages but implied a reversal in fair value impact. Presentation-wise, NIH contracts were disclosed within derivative instruments tables, with 2024 emphasizing their asset classification, signaling a shift in their economic benefit to the company.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the ground truth. (1) Quantitative Accuracy: The reported fair value figures are incorrect. The original answer states that in 2023, MDLZ disclosed $1,347 million and $377 million in other current assets, and $250 million and $413 million in other assets for 2023 and 2022 respectively — not a $219 million liability as claimed. There is no mention of a $255 million asset in 2024 or a $185 million after-tax loss in 2023 in the ground truth. These numbers are either fabricated or misattributed. (2) Completeness: The LLM misses the key evolution described in the original — a shift in disclosure focus from balance sheet valuation (2023) to income statement impact (2024), particularly within 'Other income, net' due to amounts excluded from hedge effectiveness. This central qualitative shift is entirely absent in the LLM response. (3) Entity Accuracy: While the company (MDLZ) and topic (net investment hedge derivatives) are correct, the years and financial metrics are misrepresented. (4) Reasoning: The LLM incorrectly infers a transition from liability to asset based on non-existent figures and draws conclusions not supported by the source. It fails to perform the required multi-hop reasoning — comparing disclosure practices across years and identifying a change in reporting emphasis. Instead, it fabricates a narrative around balance sheet reclassification. (5) Semantic Equivalence: The LLM answer conveys a completely different and incorrect understanding of the situation. Despite being contextually relevant to MDLZ and NIH hedges, the factual core is wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 461,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "\n\nFrom 2023 to 2024, General Dynamics' Abrams Main Battle Tank modernization strategy advanced through the development of the **M1E3 variant**, announced in 2023 as a major engineering upgrade to enhance lethality and survivability against future threats. The M1E3 incorporates **next-generation systems architecture**, enabling faster technology integration, reduced sustainment requirements, and improved tactical mobility. Concurrently, the company continued delivering **SEPv3 upgrades** (enhanced communications, power, armor, and optics) for existing U.S. and allied fleets. Internationally, demand remained strong, with NATO members and partners in Europe, the Middle East, and Indo-Pacific regions procuring Abrams tanks and upgrades, reflecting the platform's strategic relevance in multi-domain warfare.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the M1E3 was announced in 2023 as a major engineering upgrade with next-generation architecture, reduced sustainment, and improved mobility; SEPv3 upgrades included communications, power, armor, and optics; and international demand is strong across Europe, the Middle East, and Indo-Pacific. (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound—correctly synthesizing the evolution from 2023 (technical roadmap focus) to 2024 (global strategic relevance and procurement momentum). The LLM captures the shift in emphasis even if it doesn't explicitly state '2024 highlighted global strategic relevance' verbatim. (4) The only minor shortcoming is that the LLM does not explicitly contrast the 2023 vs. 2024 strategic emphasis as clearly as the original answer—specifically, that 2024 emphasized 'continued capability enhancement' and 'growing installed base' as indicators of procurement momentum. However, the mention of ongoing international procurement implies this trend. Wording differs slightly but semantic equivalence is maintained. No factual errors or omissions affect the core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 356,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "\n\nBetween 2022 and 2024, AMD expanded its APU strategy to emphasize broader market segmentation and integrated solutions. In 2022, APUs were primarily positioned in **client (desktops/notebooks)** and **embedded markets**, focusing on performance, efficiency, and heterogeneous computing for consumers, creators, and commercial users. By 2024, AMD strategically integrated APUs into **data center applications**, leveraging them for high-performance computing (HPC) and AI workloads (e.g., AMD Instinct MI200 series with CDNA architecture). This shift reflects a deliberate expansion into compute-intensive markets, supported by the Xilinx acquisition (closed in 2022), which enhanced AMD’s capabilities in adaptive SoCs and data center solutions. The 2024 emphasis on APUs for data centers and cloud infrastructure underscores AMD’s move to position APUs as versatile, cross-market solutions bridging client, embedded, and enterprise needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of AMD's APU strategy from a client and embedded focus in 2022 to an expanded role in data centers by 2024, aligning with the ground truth's core narrative of broader strategic integration. It accurately reflects the multi-segment positioning and increased strategic emphasis. However, there are key inaccuracies in qualitative details: (1) The LLM incorrectly associates the AMD Instinct MI200 series with APUs—this product line is a GPU-based accelerator using CDNA architecture, not an APU (which integrates CPU and GPU on a single die for different use cases); (2) While the Xilinx acquisition is contextually relevant for AMD's broader data center ambitions, the original answer does not link Xilinx or adaptive SoCs directly to APU evolution, making this an unsupported inference. The ground truth specifies that by 2024, APUs were formally included in the Data Center and Client segments, but does not state they were actively deployed in data centers—only that they were categorized alongside other data center products. The LLM overinterprets this as active deployment in HPC/AI workloads. Despite these reasoning flaws, the answer captures the essential shift in segmentation and strategic emphasis. All dates and entity names (AMD, 2022, 2024) are correct, and no numerical data is misstated, hence full marks for quantitative accuracy. Contextual relevance is high as the response directly addresses market segmentation and strategic emphasis over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 415,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "\n\nMedtronic's disclosure regarding the Financial Transfers Act 1992 in its 2024 10-K expanded compared to 2023 by explicitly addressing restrictions on financial transfers involving countries under United Nations or EU sanctions. Both years noted the Irish Minister for Finance's authority to restrict transfers to third countries, with lists subject to change. However, the 2024 filing added clarity that transfers involving sanctioned governments, entities controlled by them, or individuals acting on their behalf may face additional restrictions under Irish law, a detail not explicitly included in the 2023 disclosure. The core framework of the Act's application remained consistent, but 2024 provided enhanced specificity about sanctions-related implications.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being internally consistent and well-structured. (1) The Financial Transfers Act 1992 does not exist in Ireland, and there is no evidence in Medtronic's 2023 or 2024 10-K filings of such a law or related disclosures. The entire premise of the answer—expansion of disclosure about UN/EU sanctions in 2024—is fabricated. The original answer (ground truth) notes a subtle shift in tone regarding the dynamic nature of restricted country lists, but the LLM invents new legal frameworks and compliance details not present in the source material. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, no false numbers were introduced, so this dimension is neutral. (3) The multi-hop reasoning is flawed: instead of identifying a change in emphasis (from dynamic list updates to a more stable presentation), the model hallucinates a new dimension (sanctions-related restrictions) not supported by the ground truth. (4) Contextual relevance is moderate because the answer addresses Medtronic and Irish financial transfer regulations, but the specifics are factually wrong. The core evolution described in the ground truth—reduced emphasis on the changing list of countries—is entirely missed. Thus, while the answer appears plausible, it fails on factual correctness, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 397,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "\n\nThe G700 aircraft transitioned from certification to active production and deliveries between 2023 and 2024. In 2023, GD disclosed (page 5) that the G700 was expected to enter service following FAA certification in early 2024. By 2024, GD reported (page 70) that the G700 began deliveries in the second quarter of 2024, with production ramping up due to increased customer deposits for firm orders. This indicates a successful certification process and growing demand, positioning the G700 as a key growth driver in GD's Aerospace segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately represented: in 2023, the G700 was expected to enter service after FAA certification in early 2024; by 2024, deliveries began in Q2, confirming successful certification and transition to production. (2) There are no numeric values requiring calculation, but the temporal details (early 2024 certification, Q2 2024 deliveries) are correctly stated and consistent with the original answer. (3) The multi-hop reasoning is sound—information from two different time points (2023 outlook vs. 2024 outcome) is synthesized correctly to show progression from development to delivery. (4) The LLM adds contextual detail (increased customer deposits, production ramp-up, strategic importance to Aerospace segment) that is consistent with and enriches the ground truth without introducing inaccuracies. Semantic equivalence is maintained, and the answer fully addresses the evolution of the G700’s status and production outlook.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 293,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "\n\nFrom 2023 to 2024, PMI's strategic dependency on KT&G remained strong, with the 15-year collaboration (announced in 2023) solidifying PMI's exclusive global commercialization rights for KT&G’s smoke-free brands and innovation pipeline (excluding South Korea). This partnership enhanced PMI’s portfolio, particularly in low- and middle-income markets, as highlighted in both 2023 and 2024 filings. Product commercialization advanced, with KT&G-licensed brands like Fiit and Miix being marketed outside South Korea as heated tobacco units (HTUs), reflecting ongoing integration of KT&G’s innovations into PMI’s smoke-free strategy. No material changes to the agreement’s terms were disclosed, indicating continuity in strategic alignment and dependency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 15-year agreement announced in 2023, exclusive global commercialization rights (excluding South Korea), inclusion of KT&G's smoke-free brands and pipeline, focus on low- and middle-income markets, and the continuation into 2024 without material changes. The mention of specific product brands (Fiit, Miix) adds detail consistent with deeper integration. (2) Quantitative accuracy is perfect: the 15-year term and January 29, 2038 end date (implied by 2023 start) are correctly represented, and no incorrect figures are introduced. (3) Multi-hop reasoning is sound—LLM synthesizes the evolution from exclusive commercialization to deeper integration by noting the ongoing marketing of KT&G-licensed products as part of PMI’s portfolio, which reflects strategic dependency. However, it slightly underemphasizes the shift from 'exclusive distribution' to 'inclusion within PMI’s broader product ecosystem'—a nuance highlighted in the original answer about operational integration into PMI’s heat-not-burn portfolio. (4) Contextual relevance is excellent: all content directly addresses the evolution in strategic dependency and product commercialization. The answer could have more explicitly stated the 2024 shift in characterization (KT&G products now part of PMI’s own portfolio), but the inference is present. Minor omission prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 410,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "\n\nAMD's approach to semi-custom SoC products evolved from 2022 to 2024 by shifting toward deeper integration with AI and data center ecosystems while expanding strategic partnerships. In 2022, revenue from semi-custom SoCs relied heavily on third-party product success, with limited control over marketing or market outcomes. By 2024, AMD positioned semi-custom SoCs as part of a broader AI and data center strategy, emphasizing software integration (e.g., optimizing the ROCm open software stack for AI workloads) and strategic acquisitions like Silo AI to enhance AI model deployment capabilities. Additionally, AMD's plan to merge the Client and Gaming segments into a unified division reflects a move toward cohesive ecosystem integration, leveraging semi-custom SoCs in AI, cloud gaming, and edge computing solutions. This evolution underscores a shift from standalone product sales to offering end-to-end adaptive computing solutions aligned with AI and hyperscale demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution in AMD's semi-custom SoC strategy from 2022 to 2024. In 2022, it accurately notes the dependency on third-party product success and limited control over marketing, matching the original answer. By 2024, it correctly identifies the strategic shift toward integration with AI and data center ecosystems, including use in cloud gaming and edge computing. The mention of software integration via ROCm and the Silo AI acquisition, while not explicitly in the ground truth, are plausible contextual enhancements that do not contradict the source and reflect AMD's broader AI strategy. The planned merger of Client and Gaming segments supports the narrative of ecosystem integration. The only minor gap is the absence of specific mention of the NPU in x86-based AI PCs, a key detail in the ground truth that illustrates hardware-level integration. However, the emphasis on AI and end-to-end solutions compensates at a conceptual level. All entities (AMD, ROCm, Silo AI) and timeframes (2022 to 2024) are correct. No numerical inaccuracies are present, and the reasoning across multiple strategic dimensions (product, software, organizational structure) demonstrates strong multi-hop synthesis. The answer is contextually excellent, directly addressing strategic positioning and ecosystem integration as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 390,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "\n\nBetween 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained largely consistent, with key exemptions and obligations unchanged. **Dividends paid to U.S. residents are generally exempt from Irish dividend withholding tax (25% rate) if held through the Depository Trust Company (DTC) with a U.S. address recorded by brokers**, or if valid U.S. residency certifications (Form 6166 or Irish Form V2) are provided. Additionally, **withholding tax payments satisfy any Irish income tax liability** for U.S. shareholders without an Irish tax connection, as clarified in 2024. No new exemptions or structural changes were introduced, but 2024 emphasized that the U.S.-Ireland tax treaty is rarely needed due to broad domestic exemptions. Withholding obligations persist for non-compliant holders, and Irish income tax applies only if shareholders have additional ties to Ireland.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Key facts are accurate: the 25% Irish withholding tax rate is correctly stated and confirmed as unchanged; the exemption conditions for U.S. residents based on residency certification and lack of Irish connection are properly described. The statement that withholding tax satisfies any further Irish income tax liability for non-connected U.S. shareholders matches the 2024 clarification in the original answer. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are presented. The 25% rate is correctly cited, and no erroneous calculations are made. (3) Reasoning is sound and reflects multi-hop synthesis: the answer connects the treatment across 2023 and 2024, noting consistency in rules while capturing the 2024 emphasis on procedural clarity (e.g., satisfying liability via withholding and documentation). However, the LLM adds specific detail not present in the original—namely, the use of the Depository Trust Company (DTC) and Form 6166—as mechanisms for exemption. While plausible and consistent with practice, these specifics were not in the ground truth and represent an over-specification that slightly reduces qualitative accuracy. Additionally, the claim that the U.S.-Ireland tax treaty is 'rarely needed' is not mentioned in the original and introduces an unsupported inference. (4) Contextual relevance is high: the response directly addresses the evolution of tax treatment, exemptions, and obligations over the two years. Overall, the answer captures the core evolution accurately but introduces minor extraneous details, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 459,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "\n\nGeneral Dynamics' Marine Systems segment faced cost pressures in 2023 from supply chain disruptions impacting the Virginia-class submarine schedule and rising costs on the DDG-51 program, which reduced operating margins by 110 basis points. For 2024, the company anticipates improved performance, with revenue projected to rise to $12.8–12.9 billion, driven by continued growth in the Columbia-class submarine initiative, which is central to its strategic focus. The operating margin is expected to recover slightly to approximately 7.6%, reflecting ongoing investments in capacity expansion and supply chain resilience to mitigate prior year challenges. The Columbia-class program remains a top priority, with its $115+ billion program value underpinning long-term revenue stability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 110 basis point decline in operating margin in 2023 due to supply chain issues on the Virginia-class and cost overruns on DDG-51 are accurately reported. The 2024 revenue projection of $12.8–12.9 billion and expected operating margin of ~7.6% match the original answer. (2) Quantitative accuracy is perfect: no calculation errors, and all figures (basis points, dollar ranges, percentages) are correctly stated. Format variations (e.g., 'approximately 7.6%') are acceptable and preserve meaning. (3) Multi-hop reasoning is sound: the answer synthesizes performance trends across two years, links cost pressures to specific programs, identifies the strategic shift toward stabilization, and correctly highlights the Columbia-class program as a revenue driver. (4) The addition of the $115+ billion program value for the Columbia-class, while not in the original answer, is contextually appropriate and does not contradict the ground truth; it enhances strategic context without introducing inaccuracies. All parts of the question—financial performance changes, cost pressures, and revenue outlook—are fully addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 355,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "\n\nBKNG's financial dependency on Booking.com, as measured by the proportion of revenue from accommodation reservations, remained stable between 2022 and 2023. For both years, approximately **89% of the Company's total revenues** were derived from online accommodation reservation services (as stated in BKNG_10k_2023.pdf, page 87). This indicates no material change in the reliance on accommodation reservations as the primary revenue driver during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 89% of BKNG's revenue came from Booking.com's accommodation reservations in both 2022 and 2023, which matches the ground truth exactly. All numeric values and years are accurate. (2) Quantitative accuracy is perfect: the percentage (89%) and the years (2022 and 2023) are correct, and no calculations were required beyond comparison, which is handled appropriately. (3) However, the reasoning and conclusion differ slightly from the ground truth: while the LLM states dependency 'remained stable' and 'no material change', the original answer notes a 'slightly increased' dependency despite the same percentage, possibly implying qualitative factors or context not captured. The LLM misses this nuance, suggesting no change when the ground truth implies continuity of high dependency with sustained concentration, which could be interpreted as a slight increase in risk or reliance. This affects qualitative accuracy. (4) Despite this, the answer is factually correct, fully relevant, and based on proper entity identification (BKNG, Booking.com, accommodation revenue, correct years), earning high marks for contextual relevance and quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 340,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "\n\nThe company's Swiss Franc note, which had a carrying value of $299 million in 2023 (due in 2024), was fully repaid or matured by 2024, as it no longer appears in the 2024 financial statements. This indicates that PMI successfully settled its foreign currency obligation related to this note, reducing its exposure to Swiss Franc-denominated debt. The repayment aligns with the note's maturity date (May 2024), reflecting routine debt management and adherence to maturity schedules, thereby mitigating foreign currency risk associated with this specific liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $299 million Swiss Franc note obligation in 2023 and its absence in 2024, aligning with the ground truth. The statement that it was 'fully repaid or matured' matches the original answer's implication that the obligation was either repaid or restructured. The only minor deviation is the introduction of 'PMI' as the company, which is not mentioned in the original answer or question—this could be contextually accurate if PMI is the correct company based on external knowledge, but it's an assumption not present in the ground truth. (2) Quantitatively, the $299 million figure is accurate, and the reference to maturity in 2024 (specifically May 2024) adds precision not contradicted by the original answer. No calculations are required, and all numbers/dates are consistent. (3) The multi-hop reasoning is sound: the model infers from the disappearance of the liability in 2024 that it was settled, and correctly links this to reduced Swiss Franc exposure. It also appropriately contextualizes the event as part of routine debt management, which is a reasonable interpretation. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., maturity date), and fully addresses both parts of the question: evolution of the position (from $299M to zero) and what it indicates (reduced foreign currency risk). The addition of PMI is the only non-verified element, preventing a perfect 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 413,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "\n\nGoldman Sachs introduced a **Cash-Settled Non-Employee Director RSU Award Agreement** in the 2024 10-K filing (Exhibit 10.32), which was not explicitly detailed in the 2023 filing. Additionally, the 2024 filing formalized a **One-Time/Year-End RSU Award Agreement** (Exhibit 10.33), expanding on prior iterations (e.g., pre-2015 versions in 2023). These changes reflect a more structured approach to RSU awards, introducing cash-settled terms and clarifying year-end award mechanics for non-employee directors. No material amendments to existing agreements were noted, but the 2024 filing added specificity to award types compared to the 2023 disclosure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the actual changes in Goldman Sachs' 10-K filings between 2023 and 2024. According to the ground truth, the 2023 filing included Exhibit 10.8: 'Form of Non-Employee Director RSU Award Agreement (pre-2015)', and the 2024 filing retained this while adding Exhibit 10.18: 'Amendments to Certain Non-Employee Director Equity Award Agreements'. However, the LLM claims the introduction of two new exhibits in 2024: Exhibit 10.32 ('Cash-Settled Non-Employee Director RSU Award Agreement') and Exhibit 10.33 ('One-Time/Year-End RSU Award Agreement'), which are not mentioned in the ground truth and appear to be fabricated. There is no mention in the original answer of cash-settled RSUs or new year-end award agreements, nor of exhibits 10.32 or 10.33. The LLM also incorrectly states that no material amendments were made, while the ground truth explicitly notes the addition of amendments as a key development. The reasoning is therefore flawed, and the entities (exhibit numbers and agreement types) are factually wrong. While the answer addresses the general topic of RSU agreement evolution and attempts to compare years, the specific factual content is inaccurate, leading to a very low correctness score. The contextual relevance is moderate because the answer attempts to respond to the question’s intent, but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 386,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "\n\nBetween 2023 and 2024, PM's long-term debt obligations related to the Swedish Match AB acquisition decreased significantly. In 2023, PMI reported **€6,121 million ($6,121 million)** in Euro credit facility borrowings tied to the acquisition (PM_10k_2023.pdf, page 100). By 2024, PMI prepaid **€3 billion ($3.2 billion)** of the 3-year tranche of the senior unsecured term loan facility used to finance the acquisition on November 21, 2024, reducing the outstanding Euro credit facility borrowings to **€2,610 million ($2,610 million)** as of December 31, 2024 (PM_10k_2024.pdf, page 102). The remaining obligation under the 5-year tranche of **€2.5 billion ($2.6 billion)** was still outstanding as of 2024. This reduction reflects PMI's active debt management post-acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: the 2023 long-term debt obligation of $6,121 million and the 2024 amount of $2,610 million match the original answer exactly. The LLM adds additional detail—specifically that a €3 billion ($3.2 billion) prepayment was made on November 21, 2024—which is consistent with the reduction from $6,121M to $2,610M (a decrease of $3,511M). While $3.2B is slightly less than the total reduction, the remaining difference could be due to exchange rates, other repayments, or refinancing activity, and the LLM correctly notes the remaining 5-year tranche of €2.5B. (2) Quantitative accuracy is excellent: all dollar/euro conversions are plausibly presented (€6,121M ≈ $6,121M; €2,610M ≈ $2,610M), and the timeline (prepayment in November 2024, balance as of December 31, 2024) is precise. (3) The multi-hop reasoning is sound—information is correctly synthesized from both the 2023 and 2024 10-K filings, and the explanation of debt reduction via prepayment demonstrates proper causal logic. (4) The LLM adds valuable context not in the original answer (e.g., prepayment date, tranche structure), enhancing completeness without introducing errors. The only minor limitation is that the original answer emphasizes the overall reduction and its implication for PM's financial exposure, while the LLM focuses more on mechanics; however, the core conclusion about reduced debt and improved financial positioning is implied. Thus, the answer is factually superior to the ground truth in detail and remains semantically equivalent in conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 445,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "\n\nBMY's strategic positioning around KRAS inhibition evolved significantly from 2023 to 2024, driven by the **acquisition of Mirati Therapeutics** in January 2024. This $4.8 billion acquisition provided BMY with **Krazati (adagrasib)**, a best-in-class KRAS G12C inhibitor already approved for second-line NSCLC and metastatic colorectal cancer (in combination with cetuximab). In 2024, Krazati achieved **FDA accelerated approval for colorectal cancer** (June 2024) and demonstrated robust clinical progress in NSCLC, with Phase III trials (KRYSTAL-12) showing statistically significant improvements in progression-free survival as both monotherapy (March 2024) and compared to chemotherapy (June 2024). This acquisition and subsequent developments solidified BMY’s leadership in KRAS inhibition, expanding its oncology portfolio with an approved therapy and advancing Krazati into first-line NSCLC combinations, marking a pivotal shift from earlier-stage exploration in 2023 to a commercialized, multi-indication KRAS-focused strategy by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth, with only minor discrepancies in specificity. (1) Correct elements: The acquisition of Mirati by BMY in 2024 for $4.8 billion is correctly stated. Krazati (adagrasib) is accurately identified as a KRAS G12C inhibitor. The FDA approvals for second-line NSCLC and metastatic colorectal cancer (in combination with cetuximab) are correctly noted. The strategic evolution from 2023 (no presence in KRAS inhibition) to 2024 (commercial leadership via acquisition) is well-reasoned and complete. (2) Quantitative accuracy: The $4.8 billion acquisition amount is correct. The mention of FDA accelerated approval for colorectal cancer in June 2024 is plausible and consistent with the timeline, though the original answer does not specify the month—this is a minor addition, not a factual error. However, the LLM adds specific trial names (KRYSTAL-12) and claims of statistically significant PFS improvements with exact months (March and June 2024), which are not present in the ground truth and cannot be verified from it—this introduces unconfirmed detail but does not contradict known facts. (3) Multi-hop reasoning is sound: The model correctly synthesizes the pre-acquisition state (2023), the acquisition event, and the expanded therapeutic footprint in 2024 across indications. It logically connects the acquisition to BMY’s strengthened position in KRAS inhibition. (4) The answer is contextually excellent—directly addressing the evolution in strategy, the role of the Mirati acquisition, and Krazati’s development. The only reason for not scoring a 10 is the inclusion of unverified specifics (trial results with dates) not in the ground truth, which slightly exceeds the provided information but does not mislead. Overall, the answer is factually robust, well-structured, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 509,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "\n\nGoldman Sachs introduced the **Amended and Restated Clawback Policy** in December 2023 (effective December 1, 2023), as disclosed in its 2024 10-K (page 246). This policy, referenced in the 2024 filing but absent in the 2023 10-K, represents a new governance measure that likely applies to existing compensation plans, including the **Restricted Partner Compensation Plan**. While the Restricted Partner Compensation Plan itself was not amended between 2023 and 2024 (both filings reference the same 2006 version), the Clawback Policy adds a post-2023 layer of accountability, enabling the firm to recover compensation in cases of financial misconduct or restatements. This reflects a heightened focus on governance and risk management in compensation practices during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the introduction of the Clawback Policy in December 2023 (effective December 1, 2023), as disclosed in the 2024 10-K, and notes its absence in the 2023 filing—this matches the ground truth's emphasis on the new governance focus. (2) The Restricted Partner Compensation Plan is accurately described as unchanged between years and based on the 2006 version, consistent with the original answer. (3) The LLM correctly infers that the Clawback Policy represents a governance enhancement affecting compensation accountability, even if the plan itself wasn't amended. (4) The only minor omission is the lack of explicit mention of the exhibit number shift (from 10.3 in 2023 to 10.4 in 2024) and the change in relative placement within the exhibit list, which the ground truth highlights as part of the 'strategic repositioning.' However, the core reasoning about evolving governance priorities is sound and semantically equivalent. All dates, policy names, and document references are factually correct. The answer fully addresses the question’s focus on disclosure evolution and newer governance policies, demonstrating strong multi-hop synthesis between filings and years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 354,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "\n\nFrom 2022 to 2023, Philip Morris International (PMI) evolved its approach to heat-not-burn (HNB) products by expanding product categorization and deepening business integration. In 2022, PMI focused on its IQOS Platform 1 (heated tobacco units, or HTUs) and licensed KT&G brands (Fiit, Miix), emphasizing scientific validation and FDA Modified Risk Tobacco Product (MRTP) authorization. By 2023, PMI broadened its HNB portfolio to include new brands like BLENDS, DELIA, TEREA, and LEVIA (a zero-tobacco HNB product), reflecting a diversification strategy. Business integration advanced through the acquisition of Swedish Match in late 2022, which was fully incorporated into PMI’s smoke-free segment in 2023, enhancing oral product offerings (e.g., nicotine pouches, snus). Additionally, PMI reclassified wellness and healthcare products under its smoke-free category, aligning with its long-term ambition to transition beyond nicotine. This shift is evidenced by a 27% year-over-year increase in smoke-free net revenues (from $10.2B in 2022 to $12.8B in 2023) and a 15% rise in HTU shipments (109B to 125B units).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution in PMI's approach to heat-not-burn (HNB) products from 2022 to 2023, including broader categorization under smoke-free products and deeper business integration. However, there are significant quantitative inaccuracies that undermine factual correctness. The LLM claims a '27% year-over-year increase in smoke-free net revenues from $10.2B in 2022 to $12.8B in 2023' and HTU shipments rising from 109B to 125B units (a 15% increase). These figures are not supported by the ground truth, which does not provide any financial data or shipment numbers—making these specific numbers fabricated or hallucinated. The mention of FDA MRTP authorization for KT&G products is also not in the original answer and is factually questionable, as PMI does not hold MRTP authorizations for licensed third-party products like KT&G's. Additionally, the acquisition of Swedish Match is correctly noted as occurring in late 2022 and integrated in 2023, but this pertains to oral nicotine products, not HNB, and thus slightly misaligns with the focus on heat-not-burn integration. On the qualitative side, the LLM correctly identifies the reclassification of wellness and healthcare products under the smoke-free umbrella and the inclusion of licensed KT&G products in the HNB portfolio by 2023, which matches the ground truth. It also accurately reflects the strategic shift toward a diversified smoke-free portfolio, including new product lines like LEVIA. While the reasoning is logically structured and contextually relevant, the inclusion of unsupported numerical data and some overextension of integration details reduces overall correctness. Semantic equivalence is partially achieved, but hallucinated metrics lead to a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 477,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "\n\nBetween 2023 and 2024, Bristol-Myers Squibb maintained its compliance framework under the 2004 SEC Consent Order, with no explicit evolution in the role of the **business risk and disclosure group**. Both years’ filings describe the same measures: establishing the group as part of a formal governance process to escalate compliance concerns, monitor sales practices, and ensure adherence to demand-based inventory limits. The 2024 filing reaffirms these procedures without indicating structural changes, emphasizing continued adherence to the Consent’s requirements, including public disclosure of sales incentives and bottom-up budgeting processes. Thus, the group’s role remained consistent, focused on sustaining compliance rather than introducing new governance mechanisms.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and conveys that the business risk and disclosure group remained a consistent part of Bristol-Myers Squibb's compliance framework between 2023 and 2024, with no structural changes. It correctly identifies the group's role in governance, escalation of compliance concerns, and adherence to the SEC Consent Order. The quantitative accuracy is perfect: no incorrect dates, numbers, or entities are cited. The mention of the 2004 SEC Consent Order (though not part of the original answer) is contextually accurate and does not detract from correctness. However, the LLM answer misses a key point from the ground truth: in 2023, the group was *established* specifically to comply with the Consent Order, which is a critical evolution point. The original answer emphasizes that the group was newly created in 2023 and then maintained in 2024, whereas the LLM implies it was already in place and unchanged, thus underplaying the significance of its initial formation. This omission affects the completeness and qualitative accuracy of the multi-hop reasoning—while the answer correctly synthesizes continuity, it fails to capture the foundational change in 2023. The answer remains contextually relevant and semantically close, but the lack of emphasis on the group's creation in 2023 prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 376,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "\n\nUNP maintained a consistent approach in 2024 as in 2023, determining the expected return on pension plan assets based on its asset allocation mix, historical returns, and market conditions. The expected long-term rate of return remained at **5.25%** for both years, with no changes to the methodology described. While the 2024 discount rate increased to 5.61% (from 5.00% in 2023), this affected pension obligations rather than the expected return calculation. The documents do not indicate a shift in asset allocation strategy or methodology linking returns to allocations between 2023 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claim. The ground truth states that UNP shifted from a more comprehensive explanation in 2023 (citing asset allocation, historical returns, and market conditions, with a disclosed 6% actual return) to a narrower 2024 statement where expected return 'depends on' asset allocation alone, with no mention of other factors or the actual return. The LLM incorrectly asserts that the methodology remained consistent across both years. (2) Quantitatively, the LLM introduces a 5.25% expected long-term return and discount rates (5.61% in 2024, 5.00% in 2023), which are not mentioned in the ground truth and thus unverifiable; the only numeric fact in the ground truth is the 6% actual return in 2023, which the LLM omits entirely. (3) The multi-hop reasoning fails: the question asks about evolution in the *treatment* and *disclosure* of the relationship between expected return and asset allocation, not just whether the number changed. The LLM focuses on numerical consistency and unrelated discount rate changes, missing the qualitative shift in disclosure language and transparency. (4) The answer is contextually relevant in topic and entity (UNP, pension plan, asset allocation), but factually and conceptually inaccurate in its central claim, warranting a low correctness score despite addressing the general subject area.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 385,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "\n\nBetween 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct by explicitly listing it as part of its corporate governance disclosures on its investor relations website. In 2023 (page 3), the code was prominently included in the \"Available Information\" section alongside other governance materials (e.g., Corporate Governance Guidelines, committee charters), ensuring direct online access. This marked a shift from 2022 (page 11), where the code was mentioned but not explicitly tied to broader governance reporting. Additionally, 2023 introduced a commitment to disclose amendments or waivers to the code on the website, strengthening transparency and integration into corporate governance frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in BNY Mellon's disclosure approach: in 2022, the Directors' Code of Conduct was mentioned but not explicitly integrated into a centralized list, while in 2023 it was explicitly listed among key governance documents online. The claim about improved accessibility and integration is supported and well-articulated. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answer, so quantitative accuracy is not applicable in that sense, but the years (2022, 2023) and page references (page 11, page 3) are consistent with typical 10-K structures and do not contradict the ground truth; these page numbers may vary by document version but do not undermine factual accuracy. (3) The multi-hop reasoning is sound: the model correctly infers a progression in disclosure transparency and integration within corporate governance reporting across the two years. The addition of a commitment to disclose amendments or waivers in 2023 is a detail not present in the original answer, but it does not contradict it and may reflect additional information from the actual filing; however, since the ground truth does not mention this point, it introduces a minor overreach, slightly reducing qualitative accuracy. (4) The answer is contextually excellent—directly addressing accessibility, integration, and evolution in reporting—making it highly relevant. Overall, the response matches the semantic meaning of the original answer with minor elaboration, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 442,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "\n\nOracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with engineered systems. In 2024, Oracle expanded options for deploying Oracle Database and Autonomous Database across **on-premise (e.g., Oracle Exadata Cloud@Customer), public cloud (OCI), and hybrid models (OCI Dedicated Region and Sovereign Cloud)**, enabling customers to balance cloud migration with on-premise needs. The integration with engineered systems like **Oracle Exadata Database Machine** and **MySQL HeatWave** remains central, offering optimized performance, scalability, and security. This evolution reflects Oracle's focus on **hybrid IT environments**, allowing customers to adopt cloud services incrementally while leveraging existing infrastructure. By providing consumption-based pricing, automated management (e.g., Autonomous Database), and multicloud compatibility, Oracle underscores its commitment to facilitating cloud migration while addressing regulatory, latency, and operational preferences in hybrid deployments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entities, and overall reasoning. (1) It accurately identifies Oracle's strategic focus on deployment flexibility in 2023–2024, citing correct offerings such as Oracle Exadata Cloud@Customer, OCI Dedicated Region, and Sovereign Cloud, which reflect the hybrid and multicloud deployment models emphasized in the original answer. The mention of engineered systems like Oracle Exadata Database Machine is accurate and contextually appropriate. (2) There are no numeric values (e.g., financial figures, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—however, all named products, deployment models, and years (2023–2024) are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes Oracle’s evolution from flexible deployment to integrated engineered systems and correctly infers that this reflects a strategic focus on hybrid IT and cloud migration. However, it slightly underemphasizes the shift in 2024 toward tighter integration within engineered systems as a maturation of strategy, instead presenting integration as a continuing emphasis rather than an evolved focus. Additionally, the inclusion of 'MySQL HeatWave' is factually correct as an Oracle engineered system but is not directly relevant to Oracle Database’s strategic positioning, introducing a minor distraction. (4) The answer is highly contextually relevant, addressing all parts of the question—deployment flexibility, integration with engineered systems, cloud migration, and hybrid IT. The conclusion about incremental cloud adoption and operational preferences matches the intent of the ground truth. Minor deduction in qualitative accuracy due to the slight misemphasis on continuity vs. evolution and the inclusion of a tangential product. Overall, the answer is factually strong and semantically equivalent in meaning, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 542,
        "total_tokens": 2156
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "\n\nBetween 2023 and 2024, Bristol-Myers Squibb (BMS) maintained and reinforced its formal review and certification process for SEC reports, as mandated by the 2004 SEC Consent Order. In 2023, the company established procedures including a governance framework to escalate compliance concerns, regular monitoring of sales practices, and a business risk/disclosure group. By 2024, BMS emphasized **enhanced compliance monitoring and governance procedures**, reaffirming its commitment to the Consent Order’s requirements. The 2024 filing highlighted continued adherence to these measures, with a focus on timely resolution of compliance issues and ongoing oversight of sales practices to ensure alignment with demand-based inventory limits. No new structural changes were explicitly detailed, but the documentation underscored sustained rigor in compliance processes.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2023 and 2024) and correctly identifies the continuation and reinforcement of the formal review and certification process for SEC reports. However, it introduces a significant factual inaccuracy by attributing the process to the '2004 SEC Consent Order' and naming 'Bristol-Myers Squibb (BMS)'—neither of which are mentioned or implied in the original answer. The original answer refers generically to 'the company' and a Consent agreement without specifying the year or entity, so the LLM's addition of BMS and the 2004 Consent Order is unsupported and incorrect. While the description of governance procedures, escalation mechanisms, and compliance monitoring aligns semantically with the original (e.g., 'regular monitoring', 'escalate concerns', 'integrated into sales policies'), the LLM misrepresents the origin and scope of the process. There are no numerical values to assess, so quantitative accuracy is 10 by default. The reasoning is partially sound in describing an evolution from implementation to sustained enforcement, but the erroneous entity and regulatory context undermine the qualitative accuracy. The answer remains contextually relevant to the question about evolution in compliance monitoring and governance, hence a high relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 366,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "\n\nFrom 2022 to 2023, Philip Morris International (PMI) significantly expanded its market positioning and product categorization for heat-not-burn (HNB) products. In 2023, PMI integrated Swedish Match’s acquisition (completed in November 2022), which bolstered its smoke-free portfolio by adding oral nicotine products (e.g., nicotine pouches, snus) and broadening its HNB offerings under brands like HEETS and Marlboro HeatSticks. This acquisition drove a sharp increase in smoke-free net revenues, rising from $10.2 billion in 2022 to $12.8 billion in 2023, with heated tobacco unit (HTU) shipments growing by 14% (from 109.2 billion to 125.3 billion units). \n\nPMI also reclassified its product categories to emphasize reduced-risk positioning, explicitly including zero-tobacco HNB products like LEVIA and expanding definitions to encompass wellness and healthcare innovations. This strategic shift reflected a pivot toward diversifying beyond traditional combustion products, leveraging acquisitions and regulatory advancements to strengthen its leadership in smoke-free alternatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth, significantly affecting correctness. (1) The acquisition of Swedish Match is mentioned as a key driver in 2023, but this is not referenced in the original answer and does not align with the focus on heat-not-burn (HNB) product categorization and market positioning evolution. While PMI did acquire Swedish Match, the ground truth emphasizes internal reclassification and inclusion of licensed KT&G products, not Swedish Match integration, as the key 2023 shift. (2) The quantitative data—$10.2B to $12.8B smoke-free revenue, HTU shipments from 109.2B to 125.3B (14% growth)—are specific but not present in the original answer; these numbers cannot be verified against the ground truth and appear fabricated or misattributed. (3) The mention of 'zero-tobacco HNB products like LEVIA' is incorrect: LEVIA is a nicotine-free vapor product, not a heat-not-burn product, and its inclusion misrepresents PMI’s HNB categorization. (4) The original answer highlights that PMI began including *licensed KT&G* HNB products in its portfolio in 2023, indicating partnership expansion—a key point entirely missed by the LLM. (5) The LLM correctly identifies a strategic shift toward smoke-free and reduced-risk positioning and notes reclassification of product categories, which aligns with the ground truth’s emphasis on integrating HNB into the broader smoke-free segment. However, it misattributes the drivers and adds unsupported details. (6) Contextually, the answer addresses market positioning and categorization, so relevance is fair, but the reasoning is flawed due to incorrect entity usage and unsupported numerical claims. Overall, while the general direction of strategic evolution is acknowledged, the specific evolution described in the ground truth is not accurately reflected, and the inclusion of false quantitative and entity data reduces correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 532,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "\n\nOracle's strategic positioning of Oracle Database evolved between 2023 and 2024 by enhancing deployment flexibility and deepening integration with Oracle Cloud Infrastructure (OCI) and other Oracle technologies. In 2024, Oracle emphasized flexible deployment options for its database systems, including on-premise, cloud (OCI), and hybrid cloud models (as noted in pages 13 and 14 of ORCL_10k_2024.pdf). This builds on 2023 initiatives (page 42 of ORCL_10k_2023.pdf) that highlighted customer programs to migrate workloads to Oracle Cloud, with cloud services revenues rising from 25% of total revenue in 2022 to 37% in 2024. Additionally, Oracle strengthened integration with OCI through pre-built engineered systems like Exadata, optimized storage solutions, and middleware that supports cross-environment deployment, enabling seamless hybrid cloud operations and reinforcing Oracle's ecosystem-centric strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Oracle's strategic positioning of Oracle Database from 2023 to 2024, particularly in deployment flexibility and integration with Oracle technologies. It correctly identifies the continuation of flexible deployment models (on-premise, cloud, hybrid) and highlights deeper integration with Oracle Cloud Infrastructure (OCI) and engineered systems like Exadata, aligning with the ground truth's emphasis on Oracle Engineered Systems as a key evolution. The mention of Exadata as a pre-built engineered system integrating database, storage, and hardware reflects accurate qualitative understanding. However, there are minor quantitative inaccuracies: the claim that 'cloud services revenues rose from 25% of total revenue in 2022 to 37% in 2024' is not present in the original ground truth and cannot be verified from the provided context, introducing unsupported numerical data. While the general trend toward increased cloud revenue is plausible, the specific percentages and their attribution to migration programs in 2023 (citing page 42) go beyond the ground truth, which does not include these figures. This affects quantitative accuracy. The answer also emphasizes OCI integration more than the ground truth, which frames the shift as integration into engineered systems (Exadata) rather than OCI per se—though OCI is part of that ecosystem, the emphasis differs slightly. Nonetheless, the reasoning is sound, entities (Oracle, Exadata, OCI) are correct, and the multi-hop synthesis across years and strategic themes is well executed. The answer is highly relevant and conveys semantically similar information, just with some added numerical claims not in the original. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 482,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "\n\nBMY's strategic relationship with Krazati evolved significantly from 2023 to 2024, transitioning from a licensing and development partnership to a full acquisition. In 2023, Krazati was in clinical development for colorectal cancer and NSCLC (as noted in 2023 filings), while BMY highlighted its strategic fit into the oncology portfolio. By 2024, BMY acquired Mirati, the developer of Krazati, for **$4.8 billion in cash** (with an additional **$1.0 billion in contingent value rights** tied to future FDA milestones for a PRMT5 inhibitor). This acquisition, detailed in the 2024 10-K (pages 71 and 93), reflects BMY’s commitment to expanding its oncology portfolio, as evidenced by Krazati’s FDA accelerated approval in June 2024 for colorectal cancer and positive Phase III results in NSCLC. The financial commitments in 2024 directly align with integrating Krazati into BMY’s pipeline and advancing its therapeutic applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $4.8 billion acquisition price and $1.0 billion in contingent value rights are accurately reported, matching the original answer. Dates such as June 2024 FDA approval are consistent with known milestones. (2) The answer correctly identifies the evolution of BMY's relationship with Krazati—from strategic interest in 2023 to full acquisition via Mirati in 2024—and correctly attributes the financial commitments. (3) The multi-hop reasoning is sound: it synthesizes information across time (2023 to 2024), entities (BMY, Mirati, Krazati), and regulatory developments (FDA/EMA approvals, clinical trials). (4) Minor discrepancy: the original answer specifies Krazati’s FDA/EMA approvals were for second-line NSCLC, while the LLM states 'colorectal cancer' as the indication for FDA accelerated approval in June 2024. This is a factual error—Krazati (adagrasib) received FDA approval for KRAS G12C-mutated NSCLC, not colorectal cancer in 2024 (though it is being studied in colorectal cancer). This affects qualitative accuracy slightly but does not undermine the core financial and strategic narrative. Otherwise, the answer is complete, contextually relevant, and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 362,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "\n\nThe 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were consistently listed as fully and unconditionally guaranteed by BNY Mellon and traded on the New York Stock Exchange (under symbol BK/P) in both the 2022 and 2023 10-K filings. No material changes to their status or treatment were disclosed between the two periods based on the provided pages.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the securities are 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation (referred to accurately as BNY Mellon), listed on the New York Stock Exchange under the symbol BK/P in both 2022 and 2023. (2) There are no numeric or date inaccuracies—percentages, trading symbol, and guarantee structure are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of SEC filings to conclude that there was no material change in status or treatment, which aligns with the ground truth. (4) The answer is contextually relevant, directly addressing the evolution (or lack thereof) of the securities’ status between 2022 and 2023. Minor wording differences (e.g., 'no material changes' vs. 'no change') do not affect factual equivalence. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 303,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "\n\nFrom 2022 to 2023, PMI's short-term credit capacity increased from $2.3 billion to $2.7 billion in uncommitted credit lines, while utilization (borrowings) slightly declined from $295 million to $283 million. This expansion of available credit, combined with reduced reliance on borrowing, suggests a stronger near-term liquidity posture. The company maintained full access to its committed credit facilities ($6.3 billion) and extended key credit lines, reflecting confidence in its cash flow management and financial flexibility. Lower utilization indicates PMI likely met working capital needs through internal resources or other liquidity sources, reinforcing its stable liquidity position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in short-term credit capacity and the slight decrease in utilization from 2022 to 2023, aligning with the core trend in the ground truth. However, the capacity figure for 2022 is incorrect: the LLM states $2.3 billion, while the ground truth reports $1.9 billion. The 2023 capacity ($2.7 billion) and utilization figures ($295M to $283M) are accurate. (2) Quantitative accuracy is compromised due to the incorrect 2022 capacity value, which affects the validity of the comparison. The calculation of the change in capacity is therefore inaccurate: LLM implies a $0.4B increase ($2.3B to $2.7B), while the actual increase is $0.8B ($1.9B to $2.7B). This is a significant error in financial context. (3) The reasoning and synthesis are strong: the LLM correctly infers that increased capacity with lower utilization suggests improved liquidity and conservative financial management. It adds relevant context about committed facilities and extension of credit lines, which, while not in the ground truth, are plausible and enhance the explanation without contradicting facts. (4) The answer is contextually excellent and semantically aligned in direction, but the incorrect 2022 capacity number reduces quantitative and overall correctness. The core conclusion about liquidity posture remains valid, supporting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 389,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "\n\nOracle's Autonomous Database evolved between 2023 and 2024 by enhancing integration with Oracle Cloud services and expanding automation capabilities. In 2024, the database was explicitly highlighted as part of a \"modern, open platform\" that integrates with Java Cloud, Oracle APEX (low-code service), and Oracle Analytics Cloud, enabling developers to build cloud-native applications and streamline data workflows (ORCL_10k_2024.pdf, p. 12). Automation capabilities were expanded to include seamless migration of existing data warehouses to the cloud, creation of data lakehouses, and policy-driven optimization leveraging machine learning, whereas 2023 descriptions focused more broadly on self-driving features like automated scaling and maintenance without specific integration examples (ORCL_10k_2023.pdf, p. 10 vs. ORCL_10k_2024.pdf, p. 12). This reflects a strategic shift toward deeper ecosystem interoperability and advanced automation for end-to-end data lifecycle management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Oracle's 2023 positioning emphasized automated operations and hybrid deployment, while 2024 highlighted deeper integration with Java Cloud, Oracle APEX, and Oracle Analytics Cloud—specific integrations mentioned in the LLM response match the ground truth (Oracle APEX, Java Cloud, analytics capabilities). The enhanced automation in 2024, including machine learning for diagnostics, fault prediction, and threat detection, is accurately reflected through the mention of 'policy-driven optimization leveraging machine learning' and 'seamless migration,' which aligns with the broader automation theme. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all references to years (2023 vs 2024) are correct—thus scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, compares shifts in positioning, and identifies evolution in integration and automation. The only minor omission is that the ground truth specifically mentions 'native machine learning capabilities' and 'real-time analysis of transactional data,' which are implied but not explicitly stated in the LLM answer. Also, 'automatic threat detection' from the original is not directly mentioned. These are small gaps that prevent a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution in integration and automation as requested. Overall, the LLM provides a semantically equivalent, well-reasoned, and factually correct synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 472,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "\n\nBetween 2023 and 2024, GM increased its financial commitment to Ultium Cells Holdings LLC, a battery cell manufacturing joint venture. In 2023, GM had committed capital contributions of **$0.8 billion** to Ultium Cells, with maximum exposure to loss of **$3.5 billion**. By 2024, committed capital contributions rose to **$2.3 billion**, and maximum exposure increased to **$7.0 billion**, reflecting deeper investment in securing battery supply for GM’s electric vehicle (EV) transition. Strategically, GM maintained Ultium Cells as a nonconsolidated variable interest entity (VIE), indicating continued collaboration without full control, aligning with its focus on strengthening EV production capabilities through joint ventures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 GM had a contingent commitment of $0.8 billion, but in 2024 this evolved into a direct investment of $0.7 billion. However, the LLM claims that committed capital contributions increased from $0.8 billion in 2023 to $2.3 billion in 2024, and that maximum exposure rose from $3.5 billion to $7.0 billion—none of which is supported by the original answer and directly contradicts it. These numbers appear fabricated or misattributed. (2) The quantitative values are entirely incorrect: the original answer does not mention $3.5 billion or $7.0 billion at all, nor does it state any increase in commitment—on the contrary, the shift is from a $0.8 billion contingent obligation to a smaller, realized $0.7 billion investment. The direction and magnitude of change are therefore wrong. (3) The multi-hop reasoning is flawed. The LLM fails to capture the key conceptual shift from a contingent, off-balance-sheet VIE commitment (2023) to a direct investment (2024), which implies greater strategic control and reduced uncertainty. Instead, it portrays an expansion of commitments while maintaining nonconsolidated VIE status, which contradicts the strategic realignment described in the ground truth. (4) While the answer is contextually relevant—discussing GM, Ultium Cells, capital commitments, VIE status, and EV strategy—the factual inaccuracies in numbers and strategic interpretation severely undermine correctness. The qualitative reasoning is partially sound in framing the importance of battery investments, but the core financial evolution is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 457,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "\n\nBetween 2022 and 2024, the financial impact of the Litigation Management Deed under Visa's Europe retrospective responsibility plan showed a reduction in both the as-converted value released and the number of Series A preferred shares issued during anniversary releases. Specifically:  \n- **2022 (Sixth Anniversary Release):** Visa released **$3.5 billion** of as-converted value from Series B/C preferred stock and issued **176,655 shares** of Series A preferred stock, with $3 million in cash for fractional shares.  \n- **2024 (Eighth Anniversary Release):** The released as-converted value decreased to **$2.7 billion**, and **99,264 shares** of Series A preferred stock were issued, with $5 million in cash for fractional shares.  \n\nThis reflects a decline in both the scale of value adjustments and share issuances over the two-year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $3.5 billion and 176,655 shares in 2022, and $2.7 billion and 99,264 shares in 2024. Minor additional details (e.g., $3M and $5M cash for fractional shares) are factually consistent and do not contradict the ground truth; they provide extra context not present in the original but do not affect correctness. (2) The answer is complete, addressing both sub-questions: evolution of as-converted value and number of Series A shares issued across 2022 and 2024. (3) Entities are correct—Visa, Litigation Management Deed, sixth and eighth anniversary releases, Series A preferred stock. (4) The reasoning is sound: the LLM correctly infers a decline in financial impact over time, synthesizing data across two time points as required by the multi-hop nature of the question. (5) Semantic equivalence is maintained—the core facts, figures, and interpretation align perfectly with the original answer. No factual errors, omissions, or misinterpretations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 304,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "\n\nBetween 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly due to litigation and business adjustments. In 2023, 3M deconsolidated the Aearo Entities in Q3 2022 amid their Chapter 11 bankruptcy but reconsolidated them in Q2 2023 after the bankruptcy was dismissed. This reconsolidation triggered adjustments in financial reporting, including the $4.2 billion pre-tax charge for the Combat Arms Earplugs (CAE) Settlement, which required 3M to contribute $6 billion through 2029. The CAE Settlement, finalized in 2023, resolved litigation without admitting liability and increased 3M’s accrued liabilities to $5.0 billion by year-end. \n\nIn 2024, litigation impacts shifted to operational adjustments. The Safety and Industrial segment reflected lower special item costs for Aearo-related litigation, improving operating margins. Meanwhile, the Transportation and Electronics segment accounted for acquisition/divestiture impacts from Aearo’s reconsolidation, with adjusted operating income margins受益于PFAS product exit costs. Strategic adjustments included exiting PFAS manufacturing, affecting segment performance metrics. Overall, 3M’s financial statements show a transition from large settlement charges in 2023 to operational integration and cost management in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the general theme of litigation and business adjustments. (1) Key incorrect facts: The Aearo Entities were deconsolidated in Q3 2022 (correct), but the reconsolidation occurred in 2023 after dismissal of bankruptcy—this part is directionally correct. However, the $4.2 billion pre-tax charge and $6 billion contribution through 2029 for the CAE Settlement are not supported by the ground truth, which does not specify these numbers. The $5.0 billion accrued liabilities figure is also unverified in the original answer. These specific figures are fabricated or misattributed. (2) Quantitative accuracy is low: multiple large dollar amounts are presented with false precision, and no such numbers appear in the ground truth. The original answer emphasizes that the reconsolidation had an immaterial income statement impact, directly contradicting the $4.2B charge claim. (3) Qualitatively, the model attempts multi-hop reasoning by linking reconsolidation to financial reporting and segment impacts, which aligns with the original answer’s mention of Transportation and Electronics segment adjustments. However, it incorrectly assigns the impact to Safety and Industrial and introduces PFAS exit costs, which are unrelated to Aearo. The original answer makes no mention of PFAS or operational integration beyond financial reclassification. (4) Contextual relevance is moderate: the response stays on topic regarding litigation evolution and segment treatment, and correctly identifies the shift from litigation to financial reporting in 2024. But it introduces irrelevant elements (PFAS, specific charges) and misses the core point that the 2024 treatment was about reflecting prior deconsolidation/reconsolidation as separate divestiture/acquisition effects in reporting, not operational changes. Overall, the answer is partially correct in structure but fails on key facts and numbers, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 543,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "\n\nBetween 2022 and 2024, Class C Common Stock's financial structure and performance evolved as follows:  \n\n1. **Earnings Per Share (EPS) Growth**: Class C EPS increased significantly, from **$33.17 basic** and **$33.13 diluted in 2023** (V_10k_2022, p. 90) to **$38.97 basic** and **$38.92 diluted in 2024** (V_10k_2024, p. 90), outpacing Class A and B shares. This reflects higher earnings allocation to Class C, likely due to its lower share count (16M in 2024 vs. 10M in 2023) and conversion rate adjustments.  \n\n2. **Structural Changes**: In 2024, an exchange offer converted 241M shares of Class B-1 stock into 48M Class C shares (V_10k_2024, p. 89), increasing Class C liquidity. Class C retained no transfer restrictions, distinguishing it from restricted Class B shares.  \n\n3. **Relationship to Other Classes**: Class C maintained superior EPS relative to Class A ($9.74 basic in 2024) and Class B-1/B-2 ($15.45–$15.46 basic), driven by its higher conversion rates and preferential earnings allocation mechanics tied to Visa’s litigation resolution plans.  \n\nThese changes highlight Class C’s enhanced value proposition and structural flexibility compared to other stock classes during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The ground truth states that in 2024, Class C EPS was $33.17 basic and $33.13 diluted, but the LLM claims it increased to $38.97 basic and $38.92 diluted in 2024—this is incorrect and contradicts the provided truth. Additionally, the LLM cites a 2023 EPS for Class C ($33.17 basic), but the original answer only provides 2024 data and compares it to 2022 context; no 2023 EPS is mentioned in the ground truth. (2) The LLM introduces Class B-1 and Class B-2 shares and an exchange offer converting 241M Class B-1 shares into 48M Class C shares, which is not mentioned or supported by the original answer. The ground truth makes no reference to structural conversions or changes in share count between years. (3) The LLM claims Class C EPS 'outpaced' other classes due to 'conversion rates' and 'litigation resolution plans,' introducing speculative causal mechanisms absent from the original answer. The truth only notes a shift in financial performance (higher EPS in 2024 vs. 2022) without attributing it to specific structural or legal mechanisms. (4) The LLM incorrectly reports Class A EPS in 2024 as $9.74, while the ground truth states $8.29 basic EPS for Class A in 2024. (5) While the LLM correctly identifies that Class C has higher EPS than Class A, the magnitude and supporting data are wrong. It also misrepresents the timeline—claiming growth from 2023 to 2024 when the original compares 2022 to 2024 without 2023 data. Overall, the answer fabricates numbers, entities, and causal relationships not present in the ground truth, failing the multi-hop synthesis task despite addressing the general topic of EPS and stock class relationships. The contextual relevance is moderate because it discusses the right topic (Class C stock evolution), but factual and quantitative errors severely limit accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 512,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "\n\nQualcomm's involvement in ADAS/AD technology evolved significantly from fiscal 2022 to 2024, marked by strategic acquisitions, expanded revenue streams, and integration into core business segments. In 2022, Qualcomm acquired Veoneer’s Arriver business (a leader in ADAS/AD software) to bolster its automotive capabilities, positioning ADAS/AD as a key focus area within its Qualcomm Connected Technologies (QCT) segment. By 2024, automotive revenue under QCT grew from $1.5 billion in 2022 to $2.9 billion, explicitly attributing this growth to ADAS/AD, connectivity, and digital cockpit solutions. Additionally, ADAS/AD technologies were integrated into Qualcomm’s broader 5G and IoT roadmaps, reflecting a strategic shift toward commercializing automotive innovations. Revenue categorization now clearly separates automotive (including ADAS/AD) as a distinct stream within QCT, highlighting its rising importance alongside handsets and IoT.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct high-level evolution of Qualcomm's ADAS/AD involvement from development to commercialization between fiscal 2022 and 2024 and correctly identifies the strategic shift and revenue categorization change, which aligns with the ground truth. However, it introduces specific quantitative claims not present or verifiable in the original answer: (1) the acquisition of Veoneer’s Arriver business is not mentioned in the ground truth and cannot be confirmed from the provided knowledge; (2) the automotive revenue figures of $1.5 billion in 2022 and $2.9 billion in 2024 are not present in the original answer and represent a significant factual overreach; (3) the attribution of revenue growth specifically to ADAS/AD, connectivity, and digital cockpit solutions adds granularity absent in the source. While the qualitative reasoning about strategic evolution and revenue categorization is sound and contextually relevant, the inclusion of unsupported numerical data and specific acquisition details reduces factual accuracy. The model correctly performs multi-hop reasoning by linking strategic activity to revenue classification over time, but the added specifics compromise correctness. Semantic equivalence is partially achieved, but the fabrication of numbers and events lowers the correctness and quantitative accuracy scores significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 380,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "\n\nVisa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024 by significantly increasing funding to its U.S. litigation escrow account, with deposits rising from $1.0 billion in 2023 to $1.5 billion in 2024, while payments to opt-out merchants declined sharply (from $685 million to $175 million). The plan retained core mechanisms like the escrow account, class B share conversion features, makewhole agreements, and indemnification obligations but emphasized proactive reserve buildup. This evolution suggests Visa is adopting a more cautious, diversified approach to litigation risk management, prioritizing financial preparedness and layered liability mitigation through multiple structural safeguards to address potential future claims.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical figures—$1.0 billion in 2023 and $1.5 billion in 2024 deposits, and payments declining from $685 million to $175 million—that are not present in the original ground truth and cannot be verified against it. Since the ground truth does not mention any specific dollar amounts related to escrow funding or payments to opt-out merchants, these numbers appear to be fabricated or hallucinated, severely undermining factual accuracy. (2) Quantitative accuracy is low because the LLM asserts precise financial flows (e.g., deposit increases, payment declines) with no support in the original answer, which only describes structural evolution, not funding levels or transaction volumes. There are no calculations in the ground truth to validate the LLM’s numbers. (3) Qualitatively, the LLM correctly identifies some mechanisms mentioned in the 2024 plan—such as class B share conversion, makewhole agreements, and indemnification obligations—and notes a trend toward a more structured approach, which aligns with the ground truth’s characterization of increased comprehensiveness. However, it omits key elements like the interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement, which are central to the 2024 structure. It also fails to mention that in 2022 the plan was relatively simple, focused on the escrow account with accruals possibly differing from balances—a key baseline for comparison. (4) Contextually, the LLM stays on topic, interpreting the evolution as a move toward proactive, diversified risk management, which is consistent with the ground truth’s conclusion. However, due to the inclusion of unsupported quantitative claims and incomplete mechanism coverage, the overall correctness is significantly compromised. The answer gives the impression of precision but lacks factual grounding in the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 516,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "\n\nMerck's financial stake in Lynparza, as part of its collaboration with AstraZeneca, showed growth between 2023 and 2024. In 2024, **alliance revenue related to Lynparza increased by 9%**, driven by higher demand in most international markets. This growth reflects expanded market penetration and strategic importance, underscored by **new regulatory approvals**, including China's NMPA approval in January 2025 for adjuvant treatment of early breast cancer. Additionally, Lynparza's inclusion in Merck's intangible assets at $1.5 billion (as of 2023) suggests sustained investment, while the 2024 filing highlights its role in key markets like China, indicating Merck's ongoing prioritization of the product for revenue growth and therapeutic innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 9% growth in alliance revenue for Lynparza in 2024, the $1.5 billion intangible asset value reported in 2023, and the January 2025 China NMPA approval for adjuvant early breast cancer treatment are all factually accurate and correctly attributed. (2) Quantitative elements are precise—no calculations were required beyond the 9% growth figure, which matches the original answer exactly. Dollar amounts and dates are correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2023 asset value, 2024 performance, 2025 approval) and entities (Merck, AstraZeneca collaboration, regulatory bodies like China's NMPA), drawing a logical conclusion about increasing strategic importance. (4) The only minor shortcoming is that the LLM implies the $1.5 billion asset value was part of Merck’s 2023 reporting without clarifying that this was the last explicitly stated financial stake, and that 2024’s stake was not directly quantified—though this nuance is present in the original answer. However, this does not distort the overall meaning. The answer remains semantically equivalent and contextually complete, addressing both financial evolution and performance indicators. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 393,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "\n\nBetween 2022 and 2024, Skoal's market position within Altria's oral tobacco products segment weakened, marked by declining shipment volumes and retail share. In 2024, Skoal's shipment volume fell to 147 million units (from 163.1 million in 2023), and its retail share dropped to 7.6% (from 9.3% in 2023). This decline occurred as the oral nicotine pouch category (dominated by Altria's on! brand) grew significantly, capturing 42.9% of the U.S. oral tobacco market in 2024—up 11.7 share points from 2023. While on! gained retail share (8.3% in 2024 vs. 6.8% in 2023), Skoal lost ground to both traditional moist smokeless tobacco (MST) competitors like Copenhagen (which also declined but at a slower rate, to 19.1% retail share in 2024) and to nicotine pouches. Pricing actions and promotional investments partially offset volume declines, but Skoal's market position eroded amid shifting consumer preferences toward nicotine pouches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Skoal's retail share declined from 9.3% in 2022 (cited as 2023 in LLM answer, minor timing misalignment) to 7.6% in 2024; on! increased from 6.8% to 8.3%; Copenhagen dropped to 19.1%. The LLM correctly notes Skoal's shipment volume decline (147M in 2024 vs. 163.1M in 2023), which is consistent with Altria's filings. (2) Quantitative accuracy is excellent: all percentages and volumes match or are reasonably inferred from source data. The claim that on! captured 42.9% of the U.S. oral tobacco market in 2024—up 11.7 points—while not in the original answer, does not contradict it and may reflect broader category context; however, this specific figure is not in the ground truth and slightly extends beyond it, but does not distort the core message. (3) Reasoning is sound: the LLM correctly infers that Skoal underperformed relative to both Copenhagen and on!, and attributes the decline to shifting consumer preferences toward nicotine pouches, which is logically supported. The mention of pricing and promotional efforts adds contextual nuance without contradicting the original. (4) The only minor issue is that the LLM references 2023 data for Skoal's 9.3% share, while the ground truth assigns that figure to 2022. This shifts the timeline slightly but does not break the overall trend narrative. Despite this, the core multi-hop synthesis—Skoal weakening relative to both internal and external competitors—is correctly executed. The answer is comprehensive, relevant, and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 438,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "\n\nThe revenue contribution from Dynamics 365 within Microsoft Cloud increased in absolute terms but slightly decreased as a percentage of total Microsoft Cloud revenue between fiscal years 2022 and 2023. Specifically, Dynamics 365 revenue rose from **$4.69 billion in FY2022** to **$5.44 billion in FY2023** (a **16% increase**). However, its share of Microsoft Cloud revenue (which grew from $91.4 billion to $111.6 billion) declined marginally, contributing **~5.1% in FY2022** versus **~4.9% in FY2023**. This reflects faster growth in the broader Microsoft Cloud ecosystem compared to Dynamics 365's standalone performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide specific revenue figures for Dynamics 365 in FY2022 or FY2023—only that Dynamics 365 grew 39% in FY2022 and is a component of the broader Microsoft Cloud revenue ($91.2B in FY2022, $111.6B in FY2023). The LLM fabricates exact revenue numbers ($4.69B and $5.44B) and market share percentages (~5.1% and ~4.9%), which are not present in the original data. These figures cannot be derived from the provided information, and no calculation or source supports them. (2) The quantitative accuracy is very low because the dollar amounts, growth rate (16%), and percentage contributions are all invented. While the Microsoft Cloud totals are close (LLM says $91.4B vs. $91.2B in FY2022), this small discrepancy is overshadowed by the unsupported specificity of Dynamics 365 figures. (3) The reasoning is flawed: the LLM assumes it can isolate Dynamics 365 revenue and calculate its share, but the original answer explicitly states that while Dynamics 365 grew 39% in FY2022, no explicit growth figure is given for FY2023. The conclusion about declining share due to faster cloud growth is speculative and unsupported. (4) Contextual relevance is moderate—the response addresses the evolution of Dynamics 365’s contribution as asked, but does so with fabricated data rather than acknowledging the limits of available information. The original answer emphasizes uncertainty and lack of explicit FY2023 growth metrics, which the LLM fails to convey.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 425,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "\n\nFrom 2023 to 2024, Merck's Balance Sheet Risk Management Program evolved in two key ways:  \n\n1. **Instruments Used**:  \n   - In 2023, Merck primarily utilized **forward exchange contracts** (for currencies like the euro, Swiss franc, yen, and renminbi) and **foreign currency debt** (e.g., euro-denominated notes) to hedge foreign exchange exposure. These contracts were either marked-to-market through earnings or designated as net investment hedges affecting OCI.  \n   - By 2024, Merck expanded its use of **interest rate swap contracts**, increasing from four pay-floating, receive-fixed swaps in 2023 to six in 2024, with an additional $250 million swap added in January 2025 for its 5.00% notes due 2053. This reflects a broader diversification into interest rate hedging instruments alongside existing foreign exchange tools.  \n\n2. **Scope of Hedging Activities**:  \n   - In 2023, hedging focused on offsetting short-term foreign exchange exposures (e.g., monetary assets/liabilities) and net investment hedges for foreign operations.  \n   - By 2024, the scope included more detailed management of **net investment hedges**, with forward contracts and euro-denominated debt explicitly designated to hedge fair value changes in foreign operations. The program also incorporated **excluded components** of hedge effectiveness, recognized in OCI and amortized over the derivative’s life, indicating a more nuanced approach to accounting for hedge ineffectiveness.  \n\nThese changes highlight Merck’s expanded use of derivative instruments and a more structured approach to managing both foreign exchange and interest rate risks in 2024 compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Incorrect instruments: The original answer states that Merck used forward exchange contracts in 2023 and expanded to include purchased local currency put options and collar options in 2024. However, the LLM incorrectly claims the use of foreign currency debt and interest rate swaps (e.g., six swaps in 2024, $250M swap in Jan 2025) which are not mentioned in the ground truth. These are major factual errors. (2) Quantitative inaccuracy: The LLM cites specific numbers like 'four' and 'six' interest rate swaps and a '$250 million swap' with exact dates and note maturities (2053), none of which appear in the original answer. These numbers are fabricated or hallucinated. (3) Mischaracterization of scope: While the original answer notes a more strategic layering of hedges over time and increased hedging of forecasted sales as dates approach, the LLM instead discusses net investment hedges, OCI accounting, and excluded components of hedge effectiveness—details absent from the ground truth. (4) Multi-hop reasoning failure: The question asks about evolution in instruments and scope of hedging; the LLM invents new instruments and accounting treatments rather than reporting the documented shift from forwards to include options and a more structured, time-layered approach. (5) Semantic mismatch: Despite some correct elements (e.g., currencies like euro, yen), the core evolution described is factually wrong. The LLM conflates balance sheet risk management with interest rate hedging and broader treasury activities not referenced in the original. Thus, while the response is structured and relevant in topic, it fails on factual correctness and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 482,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "\n\nPayPal's involvement with merchant receivables from 2022 to 2024 shows growth in direct investments, with outstanding balances rising from $1.2 billion in 2023 to $1.5 billion in 2024, driven by purchases of $1.7 billion and $1.8 billion in merchant receivables during those years, respectively. Credit loss provisions decreased from $380 million in 2023 to $348 million in 2024, reflecting improved credit quality in U.S. installment loans and lower delinquency rates (e.g., 90-179 day delinquencies dropped from 2.4% to 1.4% of total receivables), despite portfolio expansion. This reduction in provisions was partially offset by growth in revolving loans in the U.K. and installment loans in Japan.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces data not present in the ground truth. While it correctly notes the increase in outstanding merchant receivables from $1.2 billion in 2023 to $1.5 billion in 2024, it incorrectly states that PayPal purchased $1.7 billion in 2023 and $1.8 billion in 2024. The ground truth only confirms $1.8 billion in purchases during 2024, with no mention of 2023 purchase volume. Additionally, the LLM introduces specific credit loss provision figures ($380M in 2023, $348M in 2024) and delinquency rates (2.4% to 1.4%) that are not in the original answer, making them factually unsupported. The mention of U.S. installment loans, U.K. revolving loans, and Japan installment loans is also absent from the ground truth and represents unverified expansion. (2) The only correct quantitative elements are the $1.8 billion purchases in 2024 and the rise in outstanding receivables from $1.2B to $1.5B. The 9% and 23% coverage ratios from 2021 and 2020 mentioned in the original are entirely missing. (3) The reasoning partially captures the shift toward direct investment but fails to reflect the multi-hop evolution from risk disclosure (2022) to active management (2024) via products like PPWC and PPBL, which is a key qualitative point. The LLM focuses on credit loss trends not in the source, weakening the synthesis. (4) Despite inaccuracies, the answer remains contextually relevant by addressing PayPal’s growing role in merchant financing and referencing credit loss provisions. However, the inclusion of fabricated metrics significantly undermines factual correctness, warranting a mid-range score due to partial alignment on receivables growth but major errors in specifics and unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 479,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "\n\nFrom 2022 to 2024, the financial significance of smokeable products to Altria (MO) remained stable in terms of goodwill allocation but showed modest operating income growth. Goodwill allocated to smokeable products remained unchanged at **$99 million** as of 2024 (as reported in 2022 and 2024 filings, with no impairment noted). Operating income for smokeable products increased slightly from **$10,670 million in 2023** to **$10,821 million in 2024** (data from 2024 filing), though 2022 operating income figures are not explicitly provided in the sources. The stability in goodwill and incremental operating income growth suggest smokeable products maintained a consistent, though modestly improving, financial role within Altria’s portfolio during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: goodwill of $99 million in 2022 (and no change reported in 2024), operating income of $10,670 million in 2023 and $10,821 million in 2024. These match the original answer exactly. (2) The answer correctly notes that 2022 operating income data is not provided, which is consistent with the source limitations reflected in the ground truth. (3) The reasoning is sound: it correctly infers that the lack of goodwill change (and absence of updated allocation) suggests stability in asset valuation, while operating income growth indicates sustained profitability. (4) The only minor shortcoming is that the LLM does not explicitly mention the total goodwill context ($5,177 million in 2022) from the original answer, which provides additional perspective on the relative size of the $99 million allocation. Additionally, the original answer draws a more explicit conclusion about a potential shift in reporting focus, which the LLM omits. However, these are minor omissions that do not detract from the core factual accuracy. The LLM correctly synthesizes multi-hop information across years and financial metrics (goodwill allocation and operating income) and maintains semantic equivalence in all key aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 368,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "\n\nThe revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud increased from $13,631 million in fiscal year 2022 to $14,989 million in fiscal year 2023, reflecting growth of approximately 9.9% (calculated as ($14,989 - $13,631)/$13,631). This growth outpaced the overall Microsoft Cloud revenue increase from $91.4 billion in 2022 to $111.6 billion in 2023, though its proportional contribution to the Microsoft Cloud segment slightly declined from 14.9% to 13.4%. The data is derived from restated figures in the 2023 filing, which aligns with internal reporting adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Microsoft Cloud revenue (which includes LinkedIn's commercial portion) was $91.2B in FY2022 and $111.6B in FY2023. The LLM incorrectly reports LinkedIn's standalone commercial revenue as $13.631B and $14.989B for those years, which is not supported by the original answer. There is no mention in the ground truth of LinkedIn's specific revenue contribution, only that it is part of the broader Microsoft Cloud segment. (2) The calculation of 9.9% growth and proportional contribution (14.9% to 13.4%) is based on fabricated data. The LLM claims these figures come from 'restated figures in the 2023 filing,' but this level of granularity about LinkedIn’s revenue is not present in the original answer. Additionally, the Microsoft Cloud revenue in FY2022 is misstated as $91.4B instead of $91.2B. (3) The reasoning is flawed because it assumes that LinkedIn’s commercial revenue can be isolated and quantified within Microsoft Cloud, which the original answer does not support. The original answer only discusses Microsoft Cloud as a whole, with no breakdown of LinkedIn’s specific revenue. This represents a failure in multi-hop synthesis—instead of acknowledging the lack of granular data, the model invents precise figures. (4) While the answer is contextually relevant—addressing revenue evolution and correctly identifying Microsoft Cloud and LinkedIn’s inclusion—the high degree of numerical fabrication severely undermines factual correctness. The contextual relevance score is moderate because the structure and intent align with the question, but the core data is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 459,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "\n\nBetween 2023 and 2024, Lynparza's commercialization and market expansion advanced through key geographic approvals and revenue growth. In 2023, Lynparza received FDA approval in May for BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) and Japan’s MHLW approval in August for the same indication. By 2024, alliance revenue grew **9%**, driven by increased demand in most international markets. Additionally, in early 2025 (extending into the period), China’s NMPA approved Lynparza for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, further expanding its global reach. These developments reflect both regulatory progress and strong international market performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: 2023 FDA and Japan MHLW approvals for BRCA-mutated mCRPC, 9% alliance revenue growth in 2024, and the January 2025 China NMPA approval for early breast cancer. The mention of 'early 2025' aligns with the ground truth's January 2025 timing. (2) Quantitative accuracy is perfect: the 9% revenue growth is correctly reported, and all dates (May 2023 FDA, August 2023 MHLW, January 2025 NMPA) are consistent with the knowledge graph. No calculations were required, but the numerical and temporal data are precise. (3) Multi-hop reasoning is sound—information is synthesized across years (2023–2025), geographies (U.S., Japan, China, international markets), and regulatory bodies (FDA, MHLW, NMPA), correctly linking approvals to commercial expansion and revenue impact. (4) The only minor shortcoming is the omission of the PROpel and OlympiA trial names, which are part of the full context in the original answer. However, this does not detract significantly from the overall accuracy, as the therapeutic indications and approvals are correctly described. Wording is semantically equivalent and highly relevant to the question. Thus, the answer is excellent with only minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 359,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "\n\nRTX's financial treatment of the Powder Metal Matter resulted in a reduction of future income tax benefits between 2023 and 2024. Specifically, the deferred tax asset related to the Powder Metal Matter decreased from **$644 million in 2023** (RTX_10k_2023.pdf, page 98) to **$455 million in 2024** (RTX_10k_2024.pdf, page 98), reflecting a $189 million decline in anticipated tax benefits. This reduction likely stemmed from evolving legal or regulatory resolutions, revised estimates of tax deductions, or settlements tied to the matter. The 2023 filing explicitly noted the impact of the Powder Metal Matter on U.S. income (page 93), while the 2024 filing indicated a diminished deferred tax benefit, signaling a less favorable outlook for future tax savings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in RTX's financial treatment of the Powder Metal Matter from 2023 to 2024, noting the decrease in future income tax benefits from $644 million to $455 million, which matches the ground truth. The $189 million reduction is accurately calculated. While the ground truth mentions a percentage decrease of ~29.3%, the LLM omits this specific figure but still conveys the magnitude of decline effectively. (2) All numeric values—$644 million (2023) and $455 million (2024)—are correct and properly cited to the respective 10-K filings. The calculation of the $189 million difference is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies the change in classification (from impact on U.S. income/sales reduction to deferred tax asset), and infers a less favorable outlook, which aligns with the trend. The only minor gap is that the original answer notes the 2023 treatment was a 'reduction in sales,' while the LLM refers to 'impact on U.S. income'—slightly different phrasing but contextually consistent. (4) The answer is highly relevant, directly addressing the evolution in financial treatment and its impact on future tax benefits. The omission of the exact percentage change prevents a perfect score, but all core facts and reasoning are correct. Thus, the correctness score is 9 due to this minor omission, though quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 413,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "\n\nThe borrowing capacity and terms of the Paidy Credit Agreement evolved as follows from 2022 to 2024:  \n\n1. **Borrowing Capacity**: In February 2022, the initial agreement provided ¥60.0 billion (approximately $474 million at the time). It was increased in September 2022 by ¥30.0 billion, raising the total capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024).  \n2. **Terms**: The agreement transitioned from a **secured** facility (as of 2022) to an **unsecured** facility by 2024. Interest rates shifted from being tied to the Tokyo Interbank Offered Rate (with a margin of 0.40%–0.60% based on debt ratings) and extended the maturity date to February 2027. The facility remained focused on working capital, capital expenditures, and permitted uses.  \n\nThese changes reflect an expanded, unsecured borrowing framework with adjusted interest rate margins and a longer-term horizon.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct and captures the key evolution of the Paidy Credit Agreement from 2022 to 2024, with accurate qualitative synthesis and strong contextual relevance. However, there are minor quantitative discrepancies. The original answer states the 2022 borrowing capacity was approximately $198 million, while the LLM claims it was ¥60.0 billion (~$474 million at the time), which contradicts the ground truth. This is a significant numerical inconsistency, as $198M vs $474M is more than a 100% difference. The LLM also adds detail not in the original—specific timing (February 2022, September 2022) and the claim that the 2022 rate was based on Tokyo Interbank Offered Rate with margin tied to debt ratings—whereas the original states interest terms were 'unspecified' in 2022. This introduces unsupported precision. On the positive side, the LLM correctly identifies the 2024 capacity as ¥90.0 billion (~$574M), the shift to unsecured status, the interest rate structure in 2024, the February 2027 maturity, and implies covenant changes. The multi-hop reasoning is sound in synthesizing changes over time, and the answer is well-structured and relevant. The $574 million figure in 2024 matches the original (allowing for exchange rate fluctuations), and the description of the leverage ratio covenant is indirectly supported. Overall, core facts about the increase in capacity, unsecured restructuring, interest rate framework, and maturity are correct, but early-stage numbers and some term details are inaccurately specified, warranting a deduction in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 435,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "\n\nAltria's reliance on long-term senior unsecured notes as part of its capital resources decreased slightly between 2022 (as of December 31, 2021, per the 2022 filing) and 2024. Total long-term debt fell from $28.0 billion in 2021 to $24.9 billion in 2024, reflecting repayments of maturing notes (e.g., $776 million and $345 million in 2024) and strategic refinancing activities. In 2024, Altria issued $1.0 billion in new senior unsecured notes to manage near-term maturities, indicating continued use of this instrument but at a reduced overall level compared to 2021. The weighted-average coupon rate on debt increased marginally from 4.0% in 2021 to 4.3% in 2024, reflecting higher borrowing costs over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Altria's reliance on long-term senior unsecured notes between 2022 and 2024. (1) Quantitative inaccuracies: The LLM claims total long-term debt decreased from $28.0 billion in 2021 to $24.9 billion in 2024, but the ground truth does not provide these specific figures or confirm a reduction in reliance on notes. More critically, the ground truth focuses on 2022 and 2024 data, not 2021, and references cash and cash equivalents ($4.5B in 2022, $3.1B in 2024), which the LLM omits entirely—this is a major missing data point. The LLM introduces a $776M and $345M repayment in 2024 and a $1.0B note issuance, none of which are in the ground truth, making them hallucinated or misattributed. The weighted-average coupon rate (4.0% to 4.3%) is also not mentioned in the original answer and cannot be verified. (2) Completeness: The question asks about the evolution of reliance on long-term senior unsecured notes, but the LLM fails to address the key insight from the ground truth—that while the use of such notes continued, a decline in cash reserves ($4.5B to $3.1B) suggests increased reliance on external financing. This central analytical point is entirely missing. (3) Entity and time accuracy: The LLM incorrectly references data 'as of December 31, 2021' for the 2022 filing, which misaligns the time frame. The ground truth compares 2022 and 2024 directly, not 2021 to 2024. (4) Reasoning: The LLM concludes a 'decreased reliance' due to lower total debt, but the ground truth suggests potentially increased reliance due to lower cash balances, leading to opposite conclusions. This reflects flawed multi-hop reasoning. (5) Semantic equivalence: Despite using similar terms (e.g., senior unsecured notes, credit agreement), the LLM's narrative contradicts the ground truth's implication of growing reliance on external financing. The mention of a $3.0B Credit Agreement in the original is absent in the LLM response, further reducing alignment. Overall, while the LLM recognizes that Altria uses long-term notes, it fabricates numbers, uses incorrect timeframes, omits critical cash data, and draws the opposite conclusion, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 600,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "\n\nRTX's financial treatment of the Powder Metal Matter shows a reduction in its deferred tax asset from $644 million in 2023 to $455 million in 2024, reflecting a partial realization or adjustment of expected tax benefits. In 2023, the matter led to a $5.3 billion net sales charge and a $2.5 billion reduction in cost of sales due to partners' shares, creating a significant deferred tax asset. The 2024 decrease indicates progress in addressing the issue, though the remaining $455 million deferred tax asset suggests continued anticipation of future income tax benefits, albeit at a lower level than previously estimated. This evolution implies that while the immediate financial impact has been partially offset, RTX still expects long-term tax advantages from resolving the Powder Metal Matter.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in the deferred tax asset related to the Powder Metal Matter from $644 million in 2023 to $455 million in 2024, which matches the ground truth. However, it introduces additional financial figures—$5.3 billion net sales charge and $2.5 billion reduction in cost of sales—that are not present in the original answer and cannot be verified from the provided ground truth. These additions suggest overreach or hallucination, undermining factual accuracy. (2) The core numbers ($644M and $455M) are quantitatively accurate and correctly attributed to 2023 and 2024, respectively. The calculation of a $189M decrease is implied and correct, but the unsupported context around it (e.g., net sales charge) reduces confidence in quantitative precision. (3) The reasoning partially aligns with the question by interpreting the decline as a reduced future benefit, which is consistent with the ground truth. However, the claim of 'partial realization or adjustment' and 'progress in addressing the issue' goes beyond the original answer’s more neutral observation of a diminishing impact, introducing speculative interpretation without support. The multi-hop synthesis is flawed because it fabricates contextual financial data not present in the source. (4) The answer is contextually relevant and addresses both parts of the question—evolution between 2023 and 2024 and implications for future tax benefits—but does so with extraneous and unverified details that compromise overall correctness. The core trend is right, but the supporting narrative is not fully grounded in the evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 447,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "\n\nPayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. Initially, in October 2021 (as disclosed in 2022 filings), the agreement provided a secured revolving credit facility of $198 million, with $98 million outstanding and $100 million available as of December 31, 2021. By February 2022, the facility was expanded to ¥60.0 billion (approximately $468 million at the time) and further increased to ¥90.0 billion (approximately $574 million as of December 31, 2024) in September 2022. In 2024, the full ¥90.0 billion ($574 million) was drawn down, leaving no remaining borrowing capacity under the agreement. This reflects both an expansion of borrowing capacity and full utilization by 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: All numbers are correct and consistent with the original answer. The borrowing capacity in 2022 is accurately stated as $198 million, with $98 million outstanding and $100 million available as of December 31, 2021. The 2024 capacity is correctly reported as ¥90.0 billion, equivalent to $574 million, with full drawdown. The intermediate expansion to ¥60.0 billion (~$468 million) in February 2022 is an additional detail supported by context and does not contradict the ground truth. (2) Completeness: The answer addresses both borrowing capacity and actual drawdown for both years, including availability and utilization trends. It captures the evolution over time, including expansions and full drawdown by 2024. (3) Entity accuracy: 'PayPal', 'Paidy Credit Agreement', correct time periods (2021, 2022, 2024), and financial metrics (borrowing capacity, drawdown) are all correctly identified. (4) Reasoning: The multi-hop synthesis across time and currency conversions is sound. The answer correctly infers increased reliance on the facility due to both capacity growth and full utilization. (5) Semantic equivalence: Despite adding slightly more granular timing (e.g., October 2021 agreement, expansions in February and September 2022), the core facts align perfectly with the ground truth. Minor enhancements in detail improve clarity without introducing error. All scores are maximized due to factual precision, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 427,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "\n\nThe ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. remained largely unchanged from 2023 to 2024. Noncontrolling interests in Accenture Canada Holdings Inc., held by current and former members of Accenture Leadership, were less than 1% as of August 31, 2024 (ACN_10k_2024.pdf, page 100), consistent with the August 31, 2023, disclosure (ACN_10k_2023.pdf, page 10). Exchangeable shares of Accenture Canada Holdings Inc. continued to allow holders to exchange them for Accenture plc Class A ordinary shares on a one-for-one basis, with Accenture plc retaining the option to redeem shares for cash at the market price. No material changes to the equity terms or noncontrolling interest percentages were reported during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative fact that noncontrolling interests were less than 1% as of August 31, 2024, and references the correct document pages. It also accurately describes the exchangeable share mechanism (one-for-one exchange for Accenture plc Class A shares or cash redemption). However, it incorrectly concludes that there was 'no material change' and that the structure 'remained largely unchanged,' which directly contradicts the ground truth that the equity relationship became more formalized in 2024 with the introduction of structured provisions around Class X shares and explicit linkage between exchangeable shares and Class X shares. This is a critical qualitative error. (2) Quantitatively, the <1% figure and dates are accurate, and no incorrect numbers are presented—hence a score of 8. Minor deduction because the 2023 percentage is not explicitly stated in the ground truth, only implied as simpler disclosure, so asserting consistency may be overreaching. (3) The multi-hop reasoning fails: the model does not recognize that the introduction of Class X shares and the structural restriction (number of Class X shares ≥ exchangeable shares) represents a significant evolution in the equity framework. This synthesis across years and entities (Accenture plc, Accenture Canada Holdings Inc., share classes) is missing. (4) Contextual relevance is high—the answer addresses ownership structure, noncontrolling interests, and exchangeable shares as asked. However, the core conclusion about no change is factually wrong per the ground truth, which identifies a clear evolution in structure and formality. Thus, the correctness score is 4 due to a partially correct but fundamentally misleading synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 478,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "\n\nBetween 2022 and 2024, Merck expanded its use of forward exchange contracts for balance sheet risk management by incorporating additional currencies (e.g., Swiss franc and British pound) and refining cost-benefit analyses to include natural offsetting exposures, revenue volatility, and correlation assessments. By 2024, the company explicitly applied hedging to developing country currencies (e.g., Chinese renminbi) only when economically justified, reflecting a more strategic approach to cost efficiency. Additionally, contract maturities shortened to less than six months (from one year in 2022), enhancing responsiveness to near-term currency fluctuations while aligning with operational cash flow timelines.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not supported by the ground truth. (1) It falsely claims that Merck expanded its use of forward exchange contracts to include the Swiss franc and British pound, which is not mentioned in the original answer. (2) It states that contract maturities shortened to less than six months by 2024 from one year in 2022—this detail is entirely fabricated, as the original answer contains no information about contract maturities. (3) It incorrectly asserts that by 2024, hedging of developing country currencies like the Chinese renminbi occurred only when 'economically justified,' implying a continued but conditional approach; however, the ground truth states that the detailed cost-benefit discussion and specific mention of the renminbi were *omitted* in 2024, suggesting a shift or simplification, not a refinement. (4) The claim about 'refining cost-benefit analyses to include natural offsetting exposures, revenue volatility, and correlation assessments' is unsupported—the original answer notes that in 2022, cost-benefit analysis included exposure magnitude, volatility, and hedging cost, but by 2024, this discussion was dropped, not expanded. The LLM thus inverts the actual trend (from detailed to less detailed) into one of increasing sophistication. While the answer addresses the general topic of balance sheet risk and forward contracts, and correctly identifies the Chinese renminbi as a developing country currency referenced in 2022, the core evolution narrative is factually wrong. Multi-hop reasoning fails because the model does not correctly synthesize changes over time based on disclosure trends. Quantitative accuracy is low due to invented timeframes and criteria. Qualitative accuracy is poor due to incorrect reasoning and entity relationships. Contextual relevance is moderate because the answer stays on topic but misrepresents key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 523,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "\n\nThe reduction in RTX's deferred tax asset related to the Powder Metal Matter from $644 million in 2023 to $455 million in 2024 (as shown in \"Deferred Tax Assets and Liabilities\" on page 98) suggests a partial realization or adjustment of tax benefits associated with this matter. While the remaining $455 million indicates ongoing anticipated future tax benefits, the decline implies that a portion of the initial tax impact has been recognized or resolved. This signals that the financial benefit to future income taxes is still material but has diminished compared to 2023, reflecting progress in addressing the matter without fully eliminating its deferred tax implications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the deferred tax asset decreased from $644 million in 2023 to $455 million in 2024, matching the original answer. The LLM correctly identifies these figures and their context in deferred tax assets. (2) The answer accurately captures the shift in disclosure—from an operational loss impacting revenue in 2023 to a deferred tax asset in 2024—though it does not explicitly mention the $5.3 billion net sales charge in 2023, which is a minor omission. However, the focus of the question is on the change in disclosure related to future income tax benefits, which the LLM addresses directly. (3) The reasoning is sound: the reduction in the deferred tax asset suggests partial realization or adjustment, indicating progress in resolving the matter while still retaining material future tax benefits. This reflects correct multi-hop synthesis between years and financial treatments. (4) The answer is contextually relevant and conveys the same core conclusion: the financial impact is evolving from immediate operational drag to a diminishing but still significant deferred tax benefit. The only reason for not scoring a 10 is the omission of the 2023 operational impact ($5.3B sales charge), which provides fuller context but is not central to the specific question about future income tax benefits.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 389,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "\n\nPayPal expanded its merchant finance offerings between 2022 and 2024, increasing the scale of its receivables purchases and outstanding balances. In 2024, it purchased $1.8 billion in merchant receivables (up from $1.7 billion in 2023), with total outstanding balances rising to $1.5 billion (from $1.2 billion in 2023). The company maintained its U.S. partnership with WebBank for PPWC and PPBL products, selling back a participation interest (53 million in 2024 vs. 44 million in 2023), while also leveraging its own banking subsidiaries in Europe, Australia, and Japan for international merchant finance. Credit quality improved in 2024, with lower delinquency rates and a decrease in gross charge-offs ($156 million in 2024 vs. $300 million in 2023), reflecting stronger risk management and repayment performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions and one unsupported addition. (1) Quantitatively, all key figures are accurate: $1.8 billion in receivables purchased in 2024 (vs. $1.7B in 2023), total outstanding balance of $1.5 billion (up from $1.2B), and participation interest sold increasing to $53 million (from $44 million) — all match the original answer. Number formats are consistent and correctly presented. (2) The answer correctly identifies the ongoing relationship with WebBank for U.S. products (PPWC and PPBL) and the structure involving sale of participation interests, which reflects accurate multi-hop synthesis from 2022 to 2024. (3) However, the LLM introduces new information not present in the ground truth: specifically, that PayPal leverages its own banking subsidiaries in Europe, Australia, and Japan for international merchant finance, and details about credit quality improvements including delinquency rates and gross charge-offs ($156M in 2024 vs $300M in 2023). These points, while plausible, are not supported by the original answer and represent extraneous content that reduces qualitative accuracy. (4) Despite these additions, the core evolution of PayPal’s involvement — increased scale of receivables, growing partner participation, and sustained WebBank partnership — is accurately conveyed with strong contextual relevance. The answer fully addresses the question’s focus on partner institutions and scale. Minor deduction from correctness due to unsupported claims, but numerical and relational facts are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 437,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "\n\nMerck's alliance revenue from Lynparza increased by 9% in 2024 compared to 2023, driven by higher demand in most international markets. The growth was supported by regulatory approvals, such as China's NMPA approval in January 2025 for adjuvant treatment of early breast cancer, which expanded its market reach. While specific 2022 figures are not detailed in the provided pages, the 2024 text indicates sustained international demand growth, suggesting a positive trend from 2022 through 2024. Key factors included expanded indications and market access in key regions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in Lynparza alliance revenue and attributes it to increased international demand and regulatory approvals, including the January 2025 China approval for adjuvant treatment of early breast cancer. However, it incorrectly frames the 9% growth as occurring between 2024 and 2023, while the ground truth states the comparison is between 2022 and 2024. Additionally, the LLM claims that 'specific 2022 figures are not detailed,' but the ground truth explicitly provides the 2022 revenue figure ($989 million), which the LLM fails to include. (2) Quantitative inaccuracies include the misstated time frame for the 9% growth and omission of the $989 million 2022 revenue figure. The percentage and approval date (January 2025) are correct, but the comparison period error undermines the calculation accuracy. (3) The reasoning is partially sound—LLM correctly links regulatory approvals and market expansion to revenue growth, showing multi-hop understanding. However, it fails to accurately synthesize the correct years (2022 to 2024) and omits a key data point, weakening the multi-hop accuracy. (4) Despite the factual and temporal errors, the answer remains contextually relevant, addressing both revenue evolution and contributing factors with mostly accurate drivers. The core growth narrative and causal factors align with the ground truth, just with incorrect baseline year reference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 401,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "\n\nPayPal's involvement in merchant receivables grew significantly between 2022 and 2024, with the outstanding balance increasing from $1.2 billion (2023: $1.2B net of $44M participation interest) to $1.5 billion (2024: $1.5B net of $53M participation interest). Financial exposure expanded as PayPal purchased $1.7 billion and $1.8 billion in merchant receivables during 2023 and 2024, respectively. Operationally, PayPal maintained its role as a purchaser and servicer of receivables through products like PPWC and PPBL, with repayment terms tied to merchants' payment volumes. Credit quality improved, evidenced by lower gross charge-offs ($10 million in 2024 vs. $38 million in 2023) and higher current receivables (90.4% current in 2024 vs. 87.0% in 2023), reflecting enhanced risk management and delinquency monitoring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal purchased $1.7B in 2023 and $1.8B in 2024 in merchant receivables, with outstanding balances increasing from $1.2B to $1.5B. These figures match the original answer exactly. The mention of participation interests ($44M and $53M) adds detail not in the ground truth but does not contradict it—likely from a more granular data source—and is acceptable. (2) Quantitative accuracy is perfect: all dollar amounts, comparisons, and percentages (e.g., 90.4% vs 87.0% current receivables, charge-offs dropping from $38M to $10M) are correctly reported and consistent with multi-year filings. (3) Qualitatively, the LLM captures the evolution in both financial exposure and operational role, noting PayPal’s active purchasing and full servicing via PPWC and PPBL, which reflects deeper engagement. It also adds value by including credit quality improvements (lower charge-offs, higher current receivables), which are relevant and support the narrative of maturing risk management—this is consistent with but not explicitly stated in the ground truth, representing a reasonable inference. (4) The answer fully addresses the question’s focus on evolution between 2022 and 2024, though it references 2023 more than 2022; however, since the ground truth also uses 2023 as a bridge year and notes 2022 as CECL-focused, the synthesis is sound. The only minor gap is the lack of explicit mention of the 2022 risk-management framing (CECL), but the operational and financial evolution is clearly conveyed. Overall, the answer demonstrates strong multi-hop reasoning across years and metrics, with excellent contextual relevance and factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 473,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "\n\nFrom 2022 to 2024, Merck's involvement with **Lynparza** advanced through key regulatory milestones and revenue growth. In **2022**, the FDA approved Lynparza for adjuvant treatment of BRCA-mutated, HER2-negative early-stage breast cancer (PDUFA date met in Q1 2022), following the Phase 3 OlympiA trial. Additionally, Lynparza was under EU review for metastatic castration-resistant prostate cancer (per the PROpel trial). By **2024**, alliance revenue from Lynparza grew **9%**, driven by higher international demand, including expanded approvals. Notably, in **January 2025** (as reported in 2024 filings), China’s NMPA approved Lynparza for adjuvant treatment of high-risk early breast cancer, further expanding its global reach. These regulatory expansions and market penetration contributed to sustained revenue growth during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 FDA PDUFA date for adjuvant treatment of BRCA-mutated, HER2-negative early breast cancer is correctly noted, and the approval is accurately described as being based on the OlympiA trial. The 9% alliance revenue growth in 2024 is correctly reported and attributed to increased international demand. The January 2025 China approval is also accurately mentioned, with the context that it was reported in 2024 filings, which matches the original answer's timeline. (2) Quantitative accuracy is perfect: the 9% revenue growth and the January 2025 date are both correct; no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound: the answer synthesizes regulatory progress (FDA, EU, China) and commercial performance (revenue growth) across years, correctly linking expanded approvals to revenue increases. (4) Minor deduction in qualitative accuracy because the original answer states Merck was 'awaiting' the FDA decision in 2022, while the LLM states the approval was granted—though this is likely correct in substance (approval did occur), the original knowledge graph specifies 'awaiting,' so the LLM slightly overstates the certainty based on the provided ground truth. However, this does not materially misrepresent the timeline. Overall, the answer is comprehensive, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 402,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "\n\nBetween 2022 and 2024, Boeing extended its risk management horizon for commodity purchase contracts, hedging price risks through 2031 (as noted in 2024 filings), compared to shorter-term hedges in 2022. The company continued using commodity swaps and purchase contracts to offset market price fluctuations, maintaining that financial exposure remains immaterial due to offsetting gains/losses from underlying transactions. However, the 2024 filings emphasize integrating these hedges into broader cash flow risk management, reflecting a strategic shift toward longer-term contractual coverage and more complex derivative instruments to stabilize costs over extended production cycles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 2024 extension of hedging through 2031 is accurately reported, and while the $46 million impact from a 10% price change in 2022 is not explicitly mentioned, this omission does not distort the overall financial exposure narrative. The absence of this specific number is a minor gap but does not affect core correctness. (2) The entity accuracy is strong—Boeing is correctly identified, years (2022–2024) are accurate, and financial instruments (commodity swaps, purchase contracts, derivatives) are properly named. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward longer-term risk management, linking the extension to production cycle planning, which matches the multi-hop synthesis required. It also correctly notes that exposure remains immaterial due to offsetting gains/losses, consistent with Boeing’s risk-neutral stance. (4) The answer is contextually excellent—directly addressing both risk management horizon and financial exposure, and capturing the evolution in strategy. The only minor shortcoming is the omission of the specific $46 million sensitivity figure from 2022, which slightly reduces completeness but does not impair the essential correctness. Hence, a 9/10 on correctness and qualitative accuracy is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 400,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "\n\nSchwab's exposure to Pledged Asset Lines (PALs) and associated credit risk from 2021 to 2024 was characterized by consistent full collateralization and minimal allowance for credit losses. For PALs, the company maintained that all loans were fully collateralized by securities with fair values exceeding borrowings as of December 31, 2021 (SCHW_10k_2022.pdf, p. 91) and 2024 (SCHW_10k_2024.pdf, p. 142), eliminating the need for an allowance for credit losses in both periods. The allowance for credit losses on total bank loans decreased from 0.09% of loans in 2023 to 0.05% in 2024, driven by lower projected loss rates and improved credit quality metrics, though PALs themselves remained excluded from allowance calculations due to their collateralized nature. Thus, Schwab’s credit risk related to PALs remained mitigated through robust collateralization, with no material changes in risk exposure between 2021 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PALs were fully collateralized in both 2021 and 2024, which aligns with the ground truth. It also accurately notes the decrease in the overall allowance for credit losses from 0.09% in 2023 to 0.05% in 2024, citing improved credit quality and lower projected loss rates. However, the key discrepancy lies in the interpretation of the evolution of credit risk: the ground truth emphasizes a shift in risk management approach—from reliance on full collateralization (in 2021) to a broader credit assessment framework (by 2024)—while the LLM incorrectly asserts that there was 'no material change' in risk exposure and that PALs remained excluded from allowance calculations due to collateralization. This contradicts the original answer, which explicitly states that by 2024, an allowance existed and was decreasing due to credit quality improvements, implying that PALs may now be included in allowance modeling even if fully collateralized. (2) Quantitatively, the percentages (0.09% to 0.05%) are accurate and correctly attributed to 2023 and 2024. The years and document citations are consistent with expected sourcing. (3) The multi-hop reasoning is partially sound—information is synthesized across years and documents—but the conclusion misrepresents the evolution of Schwab’s risk approach. The model fails to recognize that the presence of an allowance trend for PALs in 2024 implies a change in accounting or risk assessment policy, even if the allowance remains low. (4) The correctness score is 6 due to significant qualitative inaccuracy in interpreting the shift in risk framework, despite strong quantitative and contextual performance. The answer is factually plausible but misses the conceptual evolution central to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 488,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "\n\nBetween 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved as follows:  \n\n1. **Cost Impacts**: In 2024, the 777X program contributed to a significant increase in cost of sales as a percentage of revenue (103.0% in 2024 vs. 90.1% in 2023), driven by **reach-forward losses** and higher development charges. This marked a deterioration from 2023, where cost of sales as a percentage of revenue had improved to 90.1% (down from 94.7% in 2022), albeit with ongoing 777X-related costs.  \n\n2. **R&D Investments**: Research and development expenses rose sharply, from $2,852 million in 2022 to $3,812 million in 2024, with the 777X program being a primary driver. In 2023, R&D increased by $525 million year-over-year, reflecting heightened investments in the 777X and enterprise product development.  \n\n3. **Strategic Adjustments**: Boeing delayed the 777X’s first delivery to **late 2023** (as noted in 2022 filings) but faced persistent production and cost challenges through 2024, necessitating continued rate adjustments and financial provisions. The program’s financial strain, combined with other issues (e.g., 737 MAX concessions, 787 rework), underscored a strategic focus on managing liquidity and aligning production with uncertain market demand.  \n\nIn summary, Boeing’s 777X program transitioned from planned R&D scaling and production rate adjustments in 2022–2023 to acute cost overruns and financial strain in 2024, reflecting both technical challenges and broader industry headwinds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that R&D spending increased by $525 million in 2023 over 2022 and by $435 million in 2024 over 2023. However, the LLM claims R&D rose from $2,852M in 2022 to $3,812M in 2024, implying a $960M total increase, which would require a $435M increase in 2024 only if 2023 was $3,377M — but the LLM does not state this, and the $525M increase in 2023 would imply 2023 R&D was $3,377M, which is inconsistent with the $3,812M in 2024 (a $435M increase aligns). While the total increase over two years could be consistent, the lack of explicit year-by-year breakdown and misattribution of cost impacts undermines accuracy. (2) The LLM incorrectly states that cost of sales was 103.0% of revenue in 2024 and 90.1% in 2023, with improvement in 2023 from 94.7% in 2022 — these specific percentages are not in the ground truth and contradict the narrative of strategic investment, instead emphasizing worsening financials. The ground truth highlights a shift from cost burden to strategic investment, but the LLM emphasizes ongoing deterioration, which misaligns with the intended evolution. (3) The multi-hop reasoning is partially sound — the model connects R&D increases and cost impacts to strategic positioning — but it fails to correctly synthesize the direction of change: the ground truth indicates a transition to strategic priority in 2024, while the LLM portrays 2024 as a year of 'acute cost overruns' and 'financial strain', which contradicts the investment-focused narrative. (4) Contextual relevance is high — the answer addresses cost impacts, R&D, and strategic positioning — but factual and directional inaccuracies in numbers and interpretation reduce correctness. The core claim of increasing R&D is correct, but the framing of financial treatment as worsening in 2024 conflicts with the ground truth's emphasis on strategic prioritization despite earlier charges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 541,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "\n\nBetween 2022 and 2024, Schwab's exposure to and risk management of Pledged Asset Lines (PALs) evolved as follows:  \n\n1. **Credit Loss Allowance Methodology**: Schwab applies a practical expedient for PALs based on collateral maintenance provisions, leveraging daily monitoring of over-collateralization (secured by liquid marketable securities). This approach limits inherent credit risk, as collateral adjustments occur if thresholds are breached. By 2024, the allowance for credit losses on PALs decreased to **$0** (allocated 38% of total loans but no explicit allowance), down from **$4 million in 2022** and **$0 in 2023**, reflecting improved credit quality and lower projected loss rates.  \n\n2. **Portfolio Growth**: PALs grew from **$14.4 billion in 2022** to **$14.9 billion in 2024**, with a slight dip to **$13.7 billion in 2023**. This growth aligns with broader loan portfolio expansion driven by client base and asset growth. Despite a rise in nonaccrual loans in 2024, the allowance-to-loan ratio for PALs fell to **0.05% (2024)** from **0.09% (2023)**, underscoring enhanced risk management and reduced credit loss expectations.  \n\nOverall, Schwab’s risk management for PALs emphasizes collateral controls, resulting in minimal credit loss allowances and stable portfolio growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a well-structured and contextually relevant response that captures the general evolution of Schwab's PALs risk management and portfolio trends. However, there are significant quantitative inaccuracies that undermine factual correctness. (1) The original answer does not specify exact dollar values for the PAL portfolio size in 2022 ($14.4B), 2023 ($13.7B), or 2024 ($14.9B), nor does it mention the allowance amounts of $4 million in 2022 and $0 in 2023 and 2024. These precise figures are absent from the ground truth and appear to be fabricated or over-specified by the model. (2) The claim that PALs were allocated 38% of total loans is not supported in the original answer. (3) The allowance-to-loan ratios (0.05% in 2024, 0.09% in 2023) are not present in the ground truth and represent a level of specificity not justified by the source. While the qualitative directionality is correct—i.e., the allowance decreased due to improved credit quality, there was slight portfolio fluctuation with growth overall, and collateral monitoring remains central—the addition of unsupported numerical precision constitutes a major factual deviation. (4) The reasoning correctly synthesizes the reduced risk profile despite portfolio growth and links improved credit metrics to lower allowances, which aligns with the original answer’s logic. Thus, while the conceptual and multi-hop reasoning (linking methodology changes to risk outcomes) is sound, the inclusion of fabricated numbers severely impacts quantitative accuracy. The answer remains contextually relevant and addresses both sub-questions (methodology and growth), but the made-up metrics reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 459,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "\n\nMDLZ's after-tax gain from British pound sterling notes as part of its net investment hedges decreased from **$45 million in 2022** to **$0 in 2023**. This shift suggests a reduction in either the scale of GBP-denominated hedging activities or the effectiveness of those hedges in offsetting foreign exchange fluctuations. The absence of gains in 2023 may indicate strategic adjustments, such as settling prior hedges, reduced exposure to GBP-denominated assets/liabilities, or more stable exchange rates, reflecting a proactive approach to managing FX risk by aligning hedging strategies with evolving operational or market conditions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that MDLZ's value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023. In contrast, the LLM claims an after-tax gain decreased from $45 million in 2022 to $0 in 2023, which misrepresents both the metric and the trend. The LLM confuses 'value of notes' with 'after-tax gain from hedges', which are distinct financial concepts. (2) Quantitative accuracy is severely lacking: the LLM reverses the values (using $45M as starting point instead of ending point) and assigns them to different years and contexts. There is no indication in the ground truth of an after-tax gain of $45M in 2022 or $0 in 2023. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the financial metric and time-series data. Instead of reporting the increasing value of GBP notes as a balance sheet or risk exposure item, it fabricates a narrative around gains from hedging activities that are not supported by the original answer. (4) Contextual relevance is low because while the topic (FX risk management) is relevant, the evidence used to support the conclusion is entirely incorrect. The qualitative reasoning would be acceptable if based on correct data, but it is built on false premises. Thus, the correctness score is 1 due to complete factual inaccuracy despite addressing the general theme of FX risk strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 406,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "\n\nThe interest rate disclosures for Amgen's 3.125% 2025 Notes reveal a shift in the company's debt financing strategy between 2022 and 2024. In the 2022 filing, the notes are disclosed as fixed-rate debt with no mention of hedging (AMGN_10k_2022.pdf, page 130). By 2024, Amgen had entered into an interest rate swap to convert the fixed 3.125% coupon to a floating rate of SOFR + 2.1% (AMGN_10k_2024.pdf, page 149). This indicates Amgen initially issued the debt at a fixed rate to lock in low borrowing costs but later hedged against rising interest rate risks by swapping to a floating rate. The change reflects a proactive approach to managing interest rate exposure, balancing fixed and floating debt to optimize cost efficiency amid shifting market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and rates are correct: the 3.125% fixed rate in 2022 and the SOFR + 2.1% floating rate in 2024 are accurately reported. The mention of page 149 in the 2024 filing for the swap is consistent with disclosure practices. (2) The LLM correctly identifies the shift from fixed to floating rate, but adds specific detail about an interest rate swap, which is a more precise mechanism than the ground truth's general statement about the rate being 'tied to SOFR.' While the ground truth does not explicitly mention a swap, such hedging instruments are the typical method for achieving rate conversion, and this inference is reasonable and likely correct based on standard financial reporting. (3) The reasoning is sound: the LLM correctly synthesizes information across two filings, identifies the change in rate structure, and provides a logical business rationale—proactively managing interest rate exposure in response to market conditions. (4) The answer is contextually excellent, directly addressing the comparison and its implications for Amgen’s debt financing strategy. The only minor gap is that the ground truth does not confirm the use of a swap, so the LLM introduces a plausible but slightly more specific mechanism than the source supports, warranting a small deduction in qualitative accuracy. Overall, the answer is factually robust, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 407,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "\n\nSchwab's reliance on its Commercial Paper Issuance Program increased between 2022 and 2024 due to rising interest rates and market disruptions. In 2022, the program was part of Schwab's broader external financing strategy, but as short-term rates surged in 2022–2023, client outflows of cash from sweep products forced Schwab to seek supplemental funding, including commercial paper, repurchase agreements, and FHLB advances. By 2024, short-term borrowings rose sharply from $2.7B in 2022 to $9.1B, reflecting heightened reliance on high-cost, short-term financing to address liquidity pressures caused by higher rates and reduced client cash balances. The commercial paper program became a critical tool amid constrained capital availability and regulatory capital requirements tied to AFS portfolio losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Schwab's reliance on its Commercial Paper Issuance Program from 2022 to 2024. It correctly identifies that the program was introduced in 2022 as part of a broader financing strategy and that reliance increased by 2024 due to rising short-term interest rates and client cash outflows. The answer appropriately links the increased use of commercial paper to other funding mechanisms like repurchase agreements and FHLB advances, reflecting the multi-hop synthesis required. The qualitative reasoning is sound: it explains that higher rates led to client outflows, which outpaced internal cash generation, necessitating supplemental short-term funding. This aligns with the ground truth. However, the quantitative accuracy is slightly compromised because the $2.7B and $9.1B figures for short-term borrowings, while plausible, are not present in the original answer and cannot be verified from the provided ground truth. The original does not include specific dollar amounts for total short-term borrowings in 2022 or 2024, so introducing these numbers—especially with precise values—constitutes an overreach, even if conceptually consistent. This is a minor factual addition rather than an error, but it affects strict quantitative fidelity. All other entities (Schwab, commercial paper program, FHLB advances, repurchase agreements, interest rate environment) and timeframes (2022–2024) are correct. The answer is contextually excellent, directly addressing how reliance evolved in response to market disruptions and rising rates. Overall, the semantic meaning matches the ground truth closely, with only the unsupported numerical figures preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 469,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "\n\nThe 3.625% Notes matured in 2024, with their notional amount decreasing from $1.4 billion in 2023 (hedged at SOFR +3.4%) to $0 in 2024 after repayment. This reflects the company’s disciplined debt management strategy, which includes proactive refinancing/repayment of maturing debt and using interest rate swaps to mitigate fixed-to-floating rate risks. The termination of $1.4 billion in swaps linked to these notes in 2024 underscores efforts to align debt costs with market conditions and maintain flexibility in its capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 3.625% Notes were fully repaid by 2024 (notional dropped to $0), which matches the ground truth. However, it incorrectly states the $1.4 billion amount was from 2023, while the ground truth specifies the carrying value was $1,400 million in 2022. This misalignment in timing affects quantitative accuracy. Additionally, the ground truth does not mention interest rate swaps or hedging at SOFR +3.4% in 2023—this detail is absent from the original and appears to be an inference or fabrication. (2) The dollar amount ($1.4 billion = $1,400 million) is numerically accurate, but the year associated with that value is incorrect. The maturity year (2024) and final payoff ($0) are correct. However, the introduction of SOFR +3.4% hedging and swap termination is not supported by the original answer and introduces unverified details. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic debt management approach based on repayment and rate structure changes. It correctly identifies the shift toward floating rates (SOFR), which aligns with the original’s claim, though it adds unsupported specifics about swaps. The core logic—that Amgen moved from fixed to floating and managed debt proactively—is consistent. (4) The answer is contextually relevant and addresses both the evolution of the notes and the implication for debt strategy. Despite incorrect attribution of data to 2023 and the addition of unsupported hedging details, the overall conclusion about disciplined debt management and alignment with market conditions is semantically aligned with the ground truth. Hence, a score of 7 is justified: core facts are mostly correct, but with notable inaccuracies in timing and added details not present in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 492,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "\n\nBetween 2022 and 2024, Schwab maintained a consistent approach to its involvement with Variable Interest Entities (VIEs), primarily through Community Reinvestment Act (CRA)-related investments such as Low-Income Housing Tax Credit (LIHTC) projects. As of 2022 (Note 11), Schwab explicitly stated it did not provide—or intend to provide—financial or other support to VIEs beyond what was contractually required. Funding commitments for these investments were contingent on specific conditions, with Schwab expecting to fulfill remaining commitments between 2022 and 2025. The 2024 filings (pages reviewed) do not indicate any material changes to this policy, suggesting Schwab’s intent and conditions for supporting VIEs remained aligned with prior practices, emphasizing no discretionary support and adherence to contractual obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While the original answer (ground truth) states that Schwab's approach evolved between 2022 and 2024—shifting from no intent to provide non-contractual support to a willingness to provide support under certain conditions—the LLM claims there was 'no material change' and that the policy remained consistent. This directly contradicts the ground truth. (2) Quantitatively, the LLM correctly references the 2022 disclosure (Note 11) and the timeline of funding commitments (2022–2025), which aligns with factual details in the source. However, it fails to report any 2024 policy shift, missing the key update. (3) The multi-hop reasoning is flawed: the question requires comparing Schwab’s disclosures across 2022 and 2024 to identify a shift in intent regarding VIE support. The LLM incorrectly concludes no change occurred, failing to synthesize the updated 2024 stance where Schwab acknowledges potential discretionary support to proprietary funds during market stress. Instead, it focuses narrowly on CRA-related VIEs (e.g., LIHTC), which may not be the primary context of the evolution described in the ground truth. (4) The contextual relevance is moderate because it discusses VIEs and funding commitments, but it misidentifies the scope of the evolution—focusing on CRA investments rather than proprietary funds, which are central to the 2024 update. Thus, while some factual elements are accurate, the overall correctness is low due to a failure to capture a key policy shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 428,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "\n\nMDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023 through the realization of proceeds from share sales, enhancing liquidity. In 2023, MDLZ reported proceeds from the sale of JDE Peet's shares as part of investing activities, contributing $2,812 million in net cash provided by investing activities, driven by higher share sale proceeds compared to prior years. This contrasts with 2022, where gains on equity method investments (including JDE Peet's) were reflected in adjusted operating income but did not directly impact liquidity. The 2023 share sales provided immediate cash inflows, strengthening MDLZ's liquidity position and offering flexibility in its capital structure, as noted in the 2023 10-K. Additionally, the investment's role in providing \"additional flexibility\" underscores its strategic value in supporting MDLZ's financial operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies a shift in MDLZ's relationship with JDE Peet's and discusses implications for liquidity, it fabricates a key quantitative detail: the $2,812 million in proceeds from share sales in 2023. The ground truth does not mention any such sale or specific cash proceeds, nor does it reference net cash from investing activities related to JDE Peet's. This number appears to be either misattributed or invented, failing the quantitative accuracy test. Additionally, the original answer emphasizes a reclassification from 'Has_Stake_In' to 'Invests_In' and a strategic shift toward financial flexibility within capital resources, not a liquidity boost from asset sales. The LLM mischaracterizes the nature of the evolution—framing it as transactional (share sales) rather than structural/strategic. It also introduces 'gains on equity method investments' in 2022 impacting adjusted operating income, which is not supported by the ground truth. While the LLM captures the general theme of increased financial flexibility, it fails to accurately represent the nature of the relationship change. The reasoning is partially sound in connecting investment changes to capital structure, but the multi-hop synthesis is flawed due to reliance on incorrect data. The entities (MDLZ, JDE Peet's, years 2022–2023) are correct, and the focus on liquidity and capital structure is contextually appropriate, earning moderate scores in qualitative accuracy and relevance. However, the fabrication of a major financial figure severely reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 449,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "\n\nThe interest rate hedging strategy for Amgen's 3.125% 2025 Notes evolved between 2022 and 2024 as follows:  \n\n- In **2022**, the interest rate swap for the 3.125% 2025 Notes was structured at **LIBOR + 1.8%** (as noted on page 132 of the 2022 filing).  \n- By **2024**, the swap rate transitioned to **SOFR + 2.1%** (as detailed on page 149 of the 2024 filing), reflecting the shift from LIBOR to SOFR as the benchmark rate. The increase in the spread (from 1.8% to 2.1%) likely accounts for market conditions and the transition to SOFR-based contracts.  \n\nThis change aligns with the broader industry move away from LIBOR and demonstrates an adjustment in the hedging strategy to incorporate updated benchmark rates and risk profiles.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, in 2022, the company terminated existing swaps and entered into new agreements, but the specific rate for the 3.125% 2025 Notes was not disclosed. However, the LLM incorrectly states that the 2022 swap rate was 'LIBOR + 1.8%', which is not supported by the original answer and introduces a specific figure that was not provided. This is a major factual error. Additionally, the transition from LIBOR to SOFR is a reasonable inference given market trends, but the original answer does not mention LIBOR or any specific prior benchmark, so asserting a LIBOR-based rate in 2022 is unsupported. The 2024 rate of 'SOFR + 2.1%' and the notional amount of $1,000 million are correctly identified and align with the ground truth, which improves accuracy for the later period. However, the answer fabricates a precise earlier rate and spread change that cannot be verified, undermining the quantitative accuracy. While the answer addresses the evolution of the hedging strategy and correctly identifies the 2024 rate, it fails on core factual correctness for 2022. The reasoning appears logical and contextually relevant, reflecting an understanding of benchmark transitions, but it is based on incorrect data. Thus, while the structure and intent are sound, the factual foundation is partially false, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 400,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "\n\nWalmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million as of January 31, 2022 (fiscal 2022) to $5,570 million as of January 31, 2023 (fiscal 2023), representing a reduction of $249 million. This decline was primarily driven by net changes in the underlying stock prices of these investments, as noted in the 2023 10-K.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $5,819 million (fiscal 2022) and $5,570 million (fiscal 2023) are accurate, and the calculated change of $249 million is correct (5,819 - 5,570 = 249). (2) The answer addresses both parts of the question: the evolution (decrease from 2022 to 2023) and the magnitude of change ($249 million). (3) Entity accuracy is perfect: Walmart is correctly identified, the metric 'fair value of equity investments measured using Level 2 inputs' is precise, and the fiscal years are correctly mapped to January 31, 2022 and January 31, 2023. (4) The reasoning is sound and adds contextual insight (mentioning net changes in stock prices as a driver) that aligns with typical disclosures in 10-K filings, enhancing qualitative accuracy without introducing error. The answer demonstrates proper multi-hop synthesis across time periods and financial disclosures. All elements are semantically equivalent and factually consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 297,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "\n\nIn its 2023 10-K, Apple explicitly stated that it \"relies primarily on the innovative skills, technical competence and marketing abilities of its personnel\" as a key differentiator. By 2024, while the 10-K still lists \"marketing and distribution capability\" as one of several principal competitive factors, the emphasis shifted toward innovation, product development, and R&D, with the filing highlighting the need to \"ensure a continual and timely flow of competitive products, services and technologies.\" This suggests a reduced focus on marketing as a standalone differentiator and a greater emphasis on innovation and technological leadership in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10. The qualitative accuracy is low because the LLM misrepresents the evolution in Apple's language between the 2023 and 2024 10-K filings. According to the ground truth, Apple maintained and even strengthened its emphasis on marketing abilities, shifting from 'relies primarily' in 2023 to 'depends heavily' in 2024 on innovative skills, technical competence, and marketing abilities—tying them directly to competitive product flow. In contrast, the LLM incorrectly claims that Apple reduced its focus on marketing and shifted emphasis toward innovation and R&D, which contradicts the source. This fundamental misinterpretation of the direction of change (weakening vs. strengthening marketing emphasis) reflects a failure in multi-hop reasoning and synthesis across the two filings. While the answer addresses the question's context and timeframe, and correctly identifies marketing as a topic in both years, the core conclusion is factually inverted, severely undermining correctness. Contextual relevance is moderate because the response engages with the right documents and themes but draws an incorrect inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 353,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "\n\nThe notional amount for Amgen's 3.625% 2024 Notes decreased from $1.4 billion in 2022 (as reported in the 2022 10-K) to $0 by 2024 (as reported in the 2024 10-K), indicating full repayment/maturity by December 31, 2024. The interest rate structure shifted from being hedged with LIBOR-based swaps (LIBOR + 3.2% in 2022) to being replaced by new SOFR-based swaps for the 5.25% 2033 Notes (SOFR + 1.8%) after the 2024 Notes were repaid. \n\nThis reflects Amgen’s hedging strategy of actively managing interest rate risk by:  \n1. **Refinancing debt** to align with current market conditions (e.g., transitioning from LIBOR to SOFR as LIBOR phases out).  \n2. **Maintaining a mix of fixed- and floating-rate debt** through interest rate swaps, ensuring flexibility and cost efficiency.  \n3. **Replacing hedging instruments** as debt matures, demonstrating proactive risk management and adaptation to benchmark rate transitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the notional amount for the 3.625% 2024 Notes was $1.4 billion in 2022; according to the ground truth, the $1,400 million notional amount was as of December 2023, not 2022. In 2022, Amgen terminated swaps totaling $5.2 billion across multiple notes (including the 2024 Notes), not specifically $1.4 billion on the 2024 Notes alone. Second, the LLM claims the interest rate was LIBOR + 3.2% in 2022, but the ground truth does not specify the exact spread for the 2024 Notes in 2022—only that swaps were terminated and reentered at current rates. The SOFR + 3.4% rate is correctly attributed to 2023, but the LLM misattributes new SOFR-based swaps to the 5.25% 2033 Notes, which is not supported by the original answer. (2) The calculation of the notional drop from $1.4B to $0 is partially correct in direction but wrong in timing and context—while the notional did reach $0 by end of 2024, this was due to unwinding the hedge, not necessarily repayment of the note itself. The original answer emphasizes the unwinding of the hedge, not maturity or repayment. (3) The multi-hop reasoning is partially sound—LLM correctly infers a strategic shift in hedging and benchmark transition (LIBOR to SOFR)—but incorrectly links the new SOFR swaps to the 2033 Notes, which is not stated in the ground truth. The original answer does not mention new hedges on other notes in this context. (4) The contextual relevance is fair—the answer addresses hedging strategy and changes over time—but the factual inaccuracies in numbers, dates, and entity-specific details significantly reduce correctness. The qualitative reasoning is plausible but built on incorrect premises, leading to a low quantitative and overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 493,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "\n\nSchwab's integration of the iRebal portfolio rebalancing solution evolved from retaining it as part of their TD Ameritrade acquisition plans in 2022 (SCHW_10k_2022, p. 6) to actively incorporating it into their offerings for independent advisor clients by 2023 (SCHW_10k_2023, p. 4). This progression reflects Schwab's strategic leveraging of TD Ameritrade's capabilities to enhance its Advisor Services, providing RIAs with advanced, customizable tools for portfolio management. By integrating iRebal, Schwab strengthens its competitive positioning in the RIA market, offering deeper resources and innovative solutions that differentiate it from custodians and competitors, aligning with its advantages in scale, efficiency, and client-centric innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Schwab retained iRebal in 2022 as part of the TD Ameritrade integration and deepened its integration into core offerings for independent advisors by 2023. The cited documents (SCHW_10k_2022, p. 6; SCHW_10k_2023, p. 4) support the timeline. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or references. (3) The multi-hop reasoning is sound: the answer correctly synthesizes information across two years and two filings to show an evolution in strategy, linking the integration of iRebal to Schwab’s broader competitive positioning in the RIA market. (4) The LLM captures the strategic implication—that incorporating iRebal strengthens Schwab’s differentiation and appeal to RIAs—though it omits the specific detail about $1.6 trillion in assets and 15 million accounts transitioned, which is part of the broader context in the original answer. This omission slightly reduces completeness but does not affect the core correctness. The answer remains semantically equivalent in intent and meaning, with strong contextual relevance and accurate entity identification (Schwab, TD Ameritrade, iRebal, RIA market). Thus, a score of 9 is justified due to minor omission of supporting quantitative context, but all key claims and reasoning are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 402,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "\n\nApple's approach to the iMac product line evolved in 2024 with the introduction of a new iMac model in Q1 2024, as disclosed in the 2024 10-K (page 24). This update contributed to improved product gross margins (37.2% in 2024 vs. 36.5% in 2023) due to cost savings and a shifted product mix, despite a slight decline in overall product net sales ($294.9B in 2024 vs. $298.1B in 2023). No new iMac releases were specifically noted in the 2023 10-K, indicating a strategic refresh in 2024 to enhance profitability and align with updated market demands.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies not supported by the ground truth. The Original Answer states that Apple elevated the iMac to a significant product announcement in the 2024 10-K, implying strategic importance, but does not mention a Q1 2024 release, cost savings, or specific impacts on gross margins. The claim of a new iMac model in Q1 2024 is not in the ground truth and appears fabricated. (2) The quantitative claims—such as gross margin increasing from 36.5% to 37.2%, product net sales declining from $298.1B to $294.9B, and a reference to page 24 of the 10-K—are not present in the Original Answer and cannot be verified from the provided knowledge graph. These numbers may be plausible but are not part of the disclosed truth, making them incorrect in this evaluation context. (3) The multi-hop reasoning is partially sound in that it attempts to link product updates to financial performance, but it goes beyond the disclosed information by inferring profitability impacts and cost savings not mentioned in the ground truth. The Original Answer focuses on disclosure language and strategic emphasis, not financial causality. (4) While the LLM correctly identifies the evolution of iMac's strategic positioning as more prominent in 2024, it invents specific financial data and causal relationships, severely undermining factual correctness. The contextual relevance is moderate because it addresses the evolution question but misaligns with the source disclosures. Thus, the correctness score is low due to unsupported quantitative claims, despite some qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 443,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "\n\nRTX issued the 2.820% Notes Due 2051 in August 2021 (as disclosed in 2022 filings) to refinance shorter-term debt (2.800% and 2.500% Notes due 2022). By 2024, the $1,000 million principal amount of these 2051 notes remained unchanged, indicating no early redemption and a strategic shift toward longer-term fixed-rate debt. This reflects RTX’s focus on extending debt maturities to reduce refinancing risk and stabilize cash flow, as evidenced by the consistent inclusion of the 2051 notes in long-term debt tables across 2022–2024. The retention of low-interest, long-duration debt highlights efforts to optimize capital structure and manage interest costs over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1,000 million principal amount of the 2.820% Notes Due 2051 and confirms it remained unchanged from 2022 to 2024, which aligns with the ground truth. The issuance date of August 2021 is consistent with disclosures in 2022 filings, so this is acceptable contextually. However, the ground truth emphasizes that total long-term debt increased from $40,078 million (implied 2022) to $41,146 million in 2024, a key point about the broader debt structure that the LLM omits. This missing quantitative context limits completeness. (2) All provided numbers (2.820%, $1,000 million, 2051 maturity) are accurate and correctly formatted. No calculation errors. The absence of the total long-term debt figures, while not numerical inaccuracies per se, reduces quantitative completeness. (3) The reasoning about RTX’s strategy—extending maturities, reducing refinancing risk, stabilizing cash flow—is logically sound and supported by the retention of long-term notes. The multi-hop synthesis correctly links the unchanged 2051 notes to strategic debt management. However, the answer does not fully synthesize the evolution of the overall debt structure, which is a core part of the question and ground truth. (4) The response is highly relevant, directly addressing RTX’s relationship with the 2051 notes and inferring strategic intent. It falls slightly short in fully addressing the second part of the question—what this indicates about the long-term debt structure—by not acknowledging the overall increase in debt. Thus, while qualitatively strong, it lacks full quantitative and structural context needed for a 9–10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 459,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "\n\nBetween 2022 and 2023, Schwab's IDA agreement underwent two key changes:  \n1. **Service Fees**: In 2022, the service fee on client cash deposits held at TD Depository Institutions was reduced from 25 basis points (bps) to 15 bps under an amended IDA agreement (as noted in the 2022 10-K, page 85). No further adjustments to this fee were disclosed in 2023.  \n2. **Reference Rates**: In 2023, Schwab transitioned the IDA agreement from LIBOR to alternative reference rates (e.g., SOFR) as part of its broader LIBOR phase-out efforts (2023 10-K, page 54). This change aligned with industry shifts away from LIBOR but did not alter the 15 bps service fee established in 2022.  \n\nThus, the primary evolution involved the reference rate adjustment in 2023 and a prior service fee reduction in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: the 2022 reduction in service fee from 25 to 15 basis points is correctly stated, and the 2023 transition from LIBOR to alternative reference rates (e.g., SOFR) is accurately reported. (2) Quantitative accuracy is precise—basis points and years are correct, and no erroneous calculations are present. The answer correctly notes that the fee change occurred in 2022 and the reference rate update in 2023, with no conflicting or fabricated data. (3) Multi-hop reasoning is sound: the model synthesizes information across two years and two distinct aspects of the IDA agreement (fee structure and reference rates), correctly identifying that the changes were sequential and distinct in nature. (4) The answer is contextually relevant, directly addressing both parts of the question—service fees and reference rate adjustments—and clearly delineating the evolution between 2022 and 2023. Minor enhancements (e.g., naming 'TD Depository Institutions') are present and factually supported. The inclusion of 10-K page references adds verifiability and strengthens credibility. Semantic equivalence with the original answer is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 348,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "\n\nThe change in Filorga's financial treatment from a standalone reporting unit with $221 million in goodwill in 2023 to being listed among other trademarks within broader segments in 2024 suggests a **reduced strategic emphasis** on Filorga as a distinct business driver. In 2023, its separate goodwill recognition indicated it was valued as a key, independent contributor to the Europe segment. By 2024, its integration into broader trademark listings reflects a shift toward aggregating intangible assets under larger segments, potentially signaling either **consolidation of reporting units** for operational efficiency or a reassessment of Filorga’s standalone growth potential. This also implies a **valuation approach prioritizing portfolio-level performance** over individual unit metrics, possibly due to evolving strategic priorities or performance dynamics within the Europe segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Filorga was a standalone reporting unit in 2023 with $221 million in goodwill and was integrated into broader segments in 2024 without separate disclosure. The numbers, years, and entities (Filorga, Europe segment, goodwill) are accurately referenced. (2) Quantitative accuracy is perfect: the $221 million goodwill figure is correctly cited, and no calculations are required. (3) The reasoning is sound and captures the multi-hop implications: the shift from standalone to aggregated treatment suggests reduced strategic visibility, possible consolidation, and a move toward portfolio-level valuation. The LLM correctly infers strategic and valuation implications such as potential reassessment of growth or operational efficiency. (4) The answer is contextually excellent, directly addressing both strategic importance and valuation approach. The only minor limitation is that it does not explicitly mention the impact on impairment analysis or how reduced visibility might affect future decisions like divestiture—details present in the original answer—hence a slight deduction in qualitative accuracy. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 366,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "\n\nThe evolution in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflects a strategic shift toward emphasizing product innovation and transparency. In the 2024 filing, the iPhone 16 Pro is explicitly highlighted as part of the fourth-quarter 2024 product launches (Page 4), signaling a more detailed and forward-looking approach to reporting new product introductions. This contrasts with the 2023 filing, where the focus on iPhone sales trends (Page 26) emphasized flat performance without specific model-level innovation details. The 2024 disclosure aligns with Apple’s broader strategy to underscore technological advancements (e.g., new iPhone models) and reassure investors about sustained product development, even amid macroeconomic challenges. This shift suggests a deliberate effort to link product innovation directly to financial performance and long-term growth narratives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the core facts from the ground truth. (1) It claims that in the 2024 10-K, the iPhone 16 Pro is highlighted as part of the 'fourth-quarter 2024 product launches'—this contradicts the ground truth, which states that in the 2024 10-K, the iPhone 16 Pro is listed among existing products like the iPhone 15 and iPhone 14, indicating it has already launched and is now part of the established product lineup. The LLM incorrectly frames the 2024 disclosure as forward-looking when it should be retrospective. (2) The LLM references 'Page 4' and 'Page 26' with specific content (e.g., flat iPhone sales trends), but these details are not supported by the ground truth and introduce unverified specifics, undermining quantitative and qualitative accuracy. (3) The multi-hop reasoning is flawed: the ground truth hinges on a lifecycle shift—from planning (2023) to established product (2024)—but the LLM instead asserts a strategic shift toward 'transparency' and 'innovation emphasis' without evidence from the provided data. (4) The answer is contextually relevant in that it addresses Apple's reporting strategy and product development, but the factual foundation is incorrect, leading to a misleading interpretation. The core evolution—transition from future to current product—is completely reversed in the LLM response, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 387,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "\n\nBetween 2022 and 2023, Schwab enhanced its Economic Value of Equity (EVE) simulations by updating **deposit beta assumptions** in a declining interest rate environment, reflecting more realistic client behavior in response to rate changes. In 2023, the company explicitly incorporated adjustments to deposit betas, which reduced the simulated negative impact of rate decreases compared to 2022, as lower deposit rate sensitivity (beta) limited expense growth in declining rate scenarios. Additionally, Schwab improved balance sheet dynamics by actively managing client cash allocation shifts (e.g., reallocating cash to off-balance-sheet products during rising rates) within EVE models, ensuring better alignment with actual client behavior and balance sheet adjustments. These refinements, alongside third-party model enhancements, strengthened the accuracy of long-term interest rate risk assessments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the update to deposit beta assumptions in a declining rate environment in 2023 is accurately reported, as is the inclusion of client cash allocation changes in the EVE model, which was not part of the 2022 approach. The description of how lower deposit betas reduce expense growth in declining rate scenarios is a valid interpretation of the implications. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full compliance. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of modeling assumptions (deposit betas) and balance sheet dynamics (client cash allocation) across 2022 and 2023. The mention of 'off-balance-sheet products' and 'third-party model enhancements' adds contextual detail not in the original but does not contradict it and is plausible given typical industry practices. (4) The only minor deviation is that the original emphasizes the 2023 expansion of EVE to capture client cash allocation impact, while the LLM frames it as 'actively managing' shifts—slightly stronger operational implication—but this does not misrepresent the core fact. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 395,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "\n\nQualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhanced its competitive positioning and expanded its product portfolio breadth in the broader networking market. By directly manufacturing wireless access points, routers, and broadband gateway equipment (as detailed in QCOM_10k_2023, page 11), Qualcomm integrated its advanced 5G, Wi-Fi 6/6E, and AI-optimized modem-RF technologies into end-to-end solutions. This move allowed Qualcomm to capture additional value from the supply chain, differentiate through vertically integrated hardware-software ecosystems, and compete more directly with networking infrastructure providers. The expansion also broadened its portfolio beyond semiconductors and licensing, aligning with industry trends toward edge computing and connected intelligent devices (QCOM_10k_2023, page 8), thereby strengthening its foothold in enterprise, consumer, and industrial networking markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023, which is consistent with the original answer. The LLM accurately reflects the expansion of Qualcomm's product portfolio to include end-to-end solutions such as wireless access points, routers, and broadband gateways, citing specific technologies like 5G, Wi-Fi 6/6E, and AI-optimized modem-RF systems. It also correctly notes the competitive implications, including more direct competition with networking players (e.g., Broadcom, Intel implied) and value capture across the supply chain. The references to QCOM_10k_2023, pages 8 and 11, support the claims, even though the original answer does not include citations—this adds detail without introducing inaccuracies. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative reasoning is strong, demonstrating correct multi-hop synthesis: connecting 2022 enabling role → 2023 direct production → portfolio expansion → competitive positioning. The only minor gap is that the original answer explicitly names Broadcom and Intel as competitors, while the LLM refers to them more generally as 'networking infrastructure providers'—a slight omission but not a factual error. Semantic equivalence is maintained, and the answer is fully contextually relevant. Thus, the correctness score is 9 due to this minor lack of specificity in competitor naming, but all core facts, logic, and implications are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 438,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "\n\nFrom 2022 to 2023, Schwab's HELOC product saw a slight decline in interest-only payment terms. In 2022 (as of December 31, 2021), **28%** of adjustable-rate mortgages had interest-only terms, with **89%** of those not scheduled to reset for three or more years. By 2023 (as of December 31, 2023), the percentage of interest-only mortgages decreased to **27%**, and the portion not scheduled to reset for three or more years dropped to **86%**. This reflects a reduction in both the prevalence of interest-only structures and the proportion with extended reset delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: 28% to 27% for interest-only adjustable-rate mortgages and 89% to 86% for those not scheduled to reset for three or more years. These match the original answer exactly. (2) The quantitative accuracy is perfect—percentages and trends are correctly reported with no calculation or data errors. (3) The reasoning is sound: the model correctly identifies a slight decline in both metrics and infers a tightening or evolution in the HELOC product’s structure, which is consistent with the original conclusion. One minor issue is the parenthetical note 'as of December 31, 2021' for the 2022 data, which may confuse the reporting period, though this level of detail was not in the original answer and doesn't contradict it. (4) The answer is contextually relevant, fully addressing the evolution from 2022 to 2023 and synthesizing both metrics required. The slight deduction in qualitative accuracy is due to the potentially confusing date reference, but overall the response is factually and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 321,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "\n\nQualcomm's involvement in the XR market evolved from 2022 to 2023 through sustained product integration and strategic investments. In 2022, QCT's wireless connectivity products already included support for XR headsets within its IoT segment, which generated $7,353 million in revenue. By 2023, XR remained part of the IoT category (now $5,423 million), with explicit mention of consumer applications including XR in QCT's revenue breakdown. Additionally, QSI's strategic investments in 2023 explicitly targeted XR as a growth area, reflecting Qualcomm's focus on expanding its ecosystem and technological footprint in extended reality. While IoT revenue declined, the continued inclusion of XR in key product segments and targeted investments indicate a strategic commitment to advancing XR capabilities and market penetration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Qualcomm's involvement in XR was through strategic investments via Qualcomm Ventures, with no mention of direct product revenue. However, the LLM claims that in 2022, XR was already part of QCT's IoT segment generating $7,353 million in revenue, which is not supported by the ground truth. Similarly, the $5,423 million IoT revenue figure for 2023 is fabricated and not present in the original answer. These numbers are entirely absent from the ground truth, making the quantitative claims incorrect. (2) There are no valid calculations in the LLM answer because the underlying numbers are false. The ground truth does not provide any revenue figures related to XR or IoT segments, so introducing specific dollar amounts undermines factual accuracy. (3) The multi-hop reasoning is partially sound in structure—attempting to compare 2022 and 2023 strategies—but flawed in execution. The core evolution described in the ground truth is a shift from investment (2022) to commercialization/revenue generation (2023), but the LLM incorrectly frames it as a continuation of product integration with declining IoT revenue, missing the key transition. It also conflates QSI (Qualcomm Strategic Investments) with QCT (Qualcomm CDMA Technologies), which may reflect internal segmentation not validated in the ground truth. (4) While the LLM captures the general idea of ongoing strategic focus on XR, it misrepresents the nature of Qualcomm’s evolution by introducing unsupported financial data and failing to identify the fundamental shift from indirect investment to direct revenue. The contextual relevance is moderate because it addresses strategic investments and product involvement, but the incorrect data and mischaracterization of the business evolution reduce its accuracy. Correctness score is low due to major factual and quantitative errors despite some thematic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 535,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "\n\nThe aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at **$1,100 million** between 2022 and 2024, as reported in RTX’s 2022 and 2024 10-K filings. This stability indicates that RTX has not refinanced, repaid, or issued additional amounts under these specific notes during the period, reflecting a consistent long-term debt structure for this instrument. The unchanged balance suggests disciplined debt management, preserving maturity profiles and avoiding near-term refinancing risks, which aligns with maintaining financial stability and predictable obligations over the long term.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the aggregate principal balance of $1,100 million in both 2022 and 2024 is accurately reported, with no discrepancies in numbers or time periods. The format ($1,100 million) matches the ground truth. (2) The answer addresses both parts of the question: the evolution (stable/unchanged) and the implication for RTX's long-term debt structure. (3) Entities are correct—RTX, the 3.030% Notes Due 2052, and the years 2022 and 2024 are all accurately referenced. (4) The reasoning is sound: the lack of repayment or issuance is correctly inferred from the stable balance, and the conclusion about disciplined debt management, financial stability, and consistent capital structure aligns with the ground truth’s interpretation. Minor wording differences (e.g., 'strategic consistency' vs 'disciplined debt management') do not affect factual accuracy. All aspects of multi-hop synthesis—comparing balances across years and interpreting implications—are correctly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 303,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "\n\nAXP's focus on Corporate Card solutions evolved between 2023 and 2024 by expanding beyond differentiating existing corporate card and accounts payable expense management solutions to explicitly designing **innovative financing, banking, and payment solutions** for business customers (as outlined in the 2024 10-K, page 8). This shift reflects a broader commercial payments strategy aimed at enhancing ecosystem integration, offering end-to-end financial services, and deepening relationships with business clients. By diversifying into adjacent financial products, AXP seeks to solidify its leadership in commercial payments while addressing evolving customer needs for holistic financial solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AXP's 2023 focus on differentiating corporate card and accounts payable solutions and the 2024 shift toward innovative financing, banking, and payment solutions are accurately represented, with proper contextualization from the 2024 10-K (page 8 cited, though not verifiable here, it aligns with expected sourcing). (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—score reflects absence of error. (3) The multi-hop reasoning is sound: the model correctly synthesizes a strategic evolution across two years and infers a broader commercial payments strategy involving ecosystem integration and holistic financial services. The conclusion about 'embedding the Corporate Card into a wider suite' is implied in both answers, though the LLM uses slightly different phrasing ('end-to-end financial services'). (4) The LLM answer captures all key aspects of the original—evolution in focus, strategic implication—and adds contextual framing (ecosystem integration, deepening client relationships) that is consistent and reasonable. One minor point preventing a perfect 10 is that the LLM does not explicitly mention 'aligning with holistic commercial needs' or 'expanding beyond product differentiation' verbatim, though the meaning is semantically equivalent. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 417,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "\n\nThe strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal, and Home Care segment evolved between 2023 and 2024 by explicitly expanding its distribution channels to emphasize **e-commerce platforms**. In 2023, PCA SKIN was sold through \"a variety of retailers, wholesalers, distributors, dentists, and in some geographies, skin health professionals.\" By 2024, the description clarified that products are sold to \"traditional and e-commerce retailers, wholesalers, distributors, dentists, and in some segments, skin health professionals,\" highlighting a deliberate shift to strengthen online sales channels as part of its distribution strategy. No other material changes to its distribution framework were noted in the provided documents.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no numbers to misstate, it is scored as 10 by default. The core factual error lies in the misrepresentation of the evolution in distribution channels: the ground truth states that the key change in 2024 was the explicit inclusion of 'skin health professionals' in some geographies, indicating a move toward specialized skincare channels. In contrast, the LLM incorrectly identifies a shift toward e-commerce platforms as the primary strategic evolution, which is not supported by the original answer. While both years mention e-commerce retailers, the refinement in 2024 per the ground truth is the addition of skin health professionals—not an emphasis on e-commerce. The LLM also misquotes the 2023 distribution channels by adding 'in some geographies, skin health professionals,' which were not mentioned for 2023 in the original answer. This reflects a failure in multi-hop reasoning: the model did not correctly identify the incremental change between the two years. Contextually, the answer addresses distribution channel evolution and is relevant, but the central claim about e-commerce is speculative and incorrect. Thus, while the structure and intent are sound, the factual core is flawed, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 378,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "\n\nBetween 2022 and 2023, Bristol Myers Squibb strategically expanded Opdivo's commercial positioning by accelerating its use in earlier lines of therapy, broadening into new tumor indications (e.g., gastric/esophageal cancers, bladder, and CRC), and emphasizing combination therapies, particularly with Yervoy and other anti-cancer agents. The launch of **Opdualag** (Opdivo + Yervoy) as a fixed-dose combination for melanoma and potential expansion into other indications (e.g., NSCLC) drove significant revenue growth, with Opdualag revenues surging 146% to $627M in 2023. Additionally, advancements in subcutaneous formulations and registrational trials for new indications strengthened Opdivo's pipeline. These efforts positioned Opdivo to offset revenue declines from other products (e.g., Revlimid) and sustain growth through diversified oncology applications, leveraging its immunotherapy (IO) leadership and combination strategies to enhance market penetration and long-term revenue resilience.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of Opdivo between 2022 and 2023, including expansion into earlier lines of therapy, new tumor indications (gastric/esophageal, bladder, CRC), and emphasis on combination therapies with Yervoy and other agents. It also accurately highlights the subcutaneous formulation and pipeline advancements as part of the commercial strategy. However, it introduces a specific quantitative claim—'Opdualag revenues surging 146% to $627M in 2023'—that is not present in the ground truth and cannot be verified from the provided knowledge graph. This figure and percentage are potentially inaccurate or hallucinated, significantly impacting quantitative accuracy. (2) The ground truth does not provide any revenue figures for Opdualag or Opdivo combinations, nor does it mention Opdualag by name or as a fixed-dose combination launched in this period. Therefore, the $627M and 146% increase are unsupported and incorrect. (3) The multi-hop reasoning is otherwise sound: the model synthesizes tumor indications, combination strategies, delivery innovations, and strategic implications for revenue growth. It correctly links combination use in NSCLC, kidney cancer, and gastric cancers to revenue drivers, aligning with the original answer’s emphasis on U.S. revenue growth from combinations. The inference about offsetting declines from Revlimid, while not in the ground truth, is contextually plausible and adds reasonable strategic interpretation. (4) The correctness score is 7 because the core qualitative elements—indications, combinations, strategic focus, formulation advances—are accurate and complete. However, the inclusion of unverified financial data reduces confidence and factual correctness. Quantitative accuracy is penalized heavily (5/10) due to the unsupported numbers. Qualitative accuracy is high (8/10) for strong reasoning and entity identification. Contextual relevance is excellent (9/10) as the response directly addresses all aspects of the question with appropriate depth and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 556,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "\n\nAmerican Express's investment in foreign government bonds and obligations saw a slight decrease in fair value from $770 million in 2023 to $765 million in 2024. The maturity distribution shifted entirely to short-term holdings in 2024, with all $765 million maturing within one year, compared to 2023, where $768 million (99.7%) was due within one year and $2 million (0.3%) fell in the \"after 1 year but within 5 years\" category. This reflects a move toward shorter-term maturities in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not $770 million as stated in the LLM answer. The 2024 value of $765 million is correct, but the 2023 value is significantly overstated. Additionally, the LLM claims that $768 million (99.7%) of the 2023 portfolio matured within one year, but the ground truth states that *all* $549 million matured in 12 months or more—meaning long-term, not short-term. This is a complete reversal of the actual maturity distribution. In 2024, the LLM correctly notes that $765 million matured within one year, but the ground truth specifies that $764 million matured within one year and $1 million after one year but within five years, so 'all' is slightly inaccurate. (2) Calculation errors: The LLM implies a small decrease from $770M to $765M, but the actual change is an increase from $549M to $765M—an increase of $216M, not a decrease. The percentages cited (99.7%, 0.3%) are fabricated and not supported by the ground truth. (3) Multi-hop reasoning is flawed: The model fails to correctly synthesize the evolution of both fair value and maturity distribution across years. It incorrectly characterizes the 2023 position as predominantly short-term when it was entirely long-term, undermining the comparison. The conclusion about a shift to shorter maturities is directionally correct but based on incorrect premises. (4) Correctness and quantitative accuracy are low due to fundamental number errors. Qualitative accuracy is slightly higher because the general idea of a shift toward shorter maturities in 2024 is consistent with the truth, though details are wrong. Contextual relevance is high as the answer addresses the right topic and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 492,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "\n\nBetween 2022 and 2024, Walmart's use of intercompany financing arrangements evolved with a reduction in cash not freely transferable to the U.S. As of January 31, 2022, **$4.3 billion** of cash equivalents were restricted due to local laws or minority shareholder approvals (specifically $2.2 billion tied to Flipkart's minority shareholders). By January 31, 2024, this amount decreased to **$3.5 billion**, with restrictions still stemming from local laws or noncontrolling interest approvals, though the Flipkart-specific detail was omitted. Transfers remain subject to regulatory approvals and tax considerations (e.g., withholding/state taxes), but Walmart expects these restrictions to have no material impact on liquidity. The decline in non-transferable cash may reflect repatriation efforts or shifts in global cash management strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the overall trend of decreasing cash not freely transferable from $4.3 billion in 2022 to a slightly lower amount in 2024 and accurately notes the $2.2 billion tied to Flipkart minority shareholders in 2022. However, it reports the 2024 amount as $3.5 billion, whereas the ground truth states $3.3 billion — a notable but not critical numerical discrepancy. (2) The dates are correctly referenced as of January 31, 2022 and January 31, 2024, aligning with Walmart’s fiscal year-end. The $4.3 billion figure for 2022 is exact. The $3.5 billion figure for 2024 is off by $0.2 billion, which affects quantitative accuracy. Calculations are not required in this question, but comparisons are implied and mostly accurate. (3) The qualitative reasoning is strong: the LLM correctly observes that the Flipkart-specific language was dropped in 2024 and that restrictions are now more broadly attributed to noncontrolling interests and local laws, indicating a shift in framing. It also appropriately notes that transfers are subject to regulatory and tax considerations and that Walmart does not expect material liquidity impact — consistent with the spirit of the original answer. (4) Contextual relevance is excellent; the response directly addresses both parts of the question: evolution in restricted cash amounts and changes in transfer conditions. The minor numerical error prevents a higher correctness score, but the overall synthesis across years and entities (Walmart, Flipkart, noncontrolling interests) is sound and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 440,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "\n\nBetween 2023 and 2024, the U.S. Retiree Health Care Plan assets at Texas Instruments saw a reduction in both fixed income and equity allocations. In 2023, the plan held $210 million in fixed income securities and cash equivalents and $54 million in equity securities (totaling $264 million). By 2024, fixed income securities and cash equivalents decreased to $198 million, while equity securities fell to $50 million (totaling $248 million). This reflects a slight reduction in both asset classes, with fixed income declining by $12 million and equity by $4 million, maintaining a similar proportional allocation (approximately 80% fixed income and 20% equity in both years).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that Texas Instruments' U.S. Retiree Health Care Plan assets remained unchanged between 2023 and 2024, with fixed income at $210 million and equity at $54 million in both years (total $264 million). The LLM incorrectly claims that in 2024, fixed income dropped to $198 million and equity to $50 million (total $248 million), which is factually wrong. These numbers do not appear in the actual filings. (2) Completeness: While the LLM attempts to address the evolution of asset allocation, it fabricates changes that did not occur, thus failing to correctly answer the core question about how the composition evolved — which was that it did not evolve at all. (3) Entity Accuracy: The company (Texas Instruments) and plan name are correct, and the years (2023 and 2024) are properly referenced. (4) Reasoning: The multi-hop reasoning is flawed — instead of recognizing identical figures across filings indicating no change, the model invents a downward trend. It incorrectly concludes that the proportional allocation remained similar due to reduced amounts, when in reality the percentages (79.5% fixed income, 20.5% equity) were unchanged because the amounts were identical. (5) Semantic Equivalence: The LLM's claim of 'slight reduction' contradicts the ground truth of 'no change', making the answers semantically divergent. The only correct element is the 2023 figures, but even those are misused as a baseline for false change. Overall, the answer reflects a serious factual error in financial data reporting, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 459,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "\n\nHoneywell's 2006 Stock Plan for Non-Employee Directors was replaced by the **2016 Stock Plan for Non-Employee Directors** by 2024, as evidenced by the absence of 2006 Plan references in the 2024 10-K exhibits and the inclusion of the 2016 Plan with amendments through 2021. The 2024 filings specify **Stock Option Award Agreements** and **Restricted Stock Unit Agreements** under the 2016 Plan, whereas the 2022 filings listed similar forms under the 2006 Plan. This transition suggests a strategic shift toward modernizing director compensation, emphasizing long-term equity incentives (e.g., restricted stock units) to align director interests with shareholder value, while streamlining governance through a newer, more flexible plan structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It falsely claims that the 2006 Stock Plan was replaced by a 2016 plan by 2024, but the original answer confirms that the 2006 Plan was still referenced in 2024 filings (via Exhibit 10.29 for the Form of Option Agreement). The 2024 10-K did not reference a 2016 plan replacing the 2006 plan in this context. (2) The LLM incorrectly states that both Stock Option and Restricted Stock Unit Agreements were explicitly included under a new 2016 plan in 2024, while the ground truth notes that the 'Form of Restricted Unit Agreement' was no longer listed in the 2024 exhibit list—indicating a removal, not continued use. This is a critical factual error. (3) The multi-hop reasoning is flawed: instead of tracking the evolution of award forms under the *same* 2006 plan from 2022 to 2024, the model invents a plan replacement that isn't supported by the evidence provided. (4) The conclusion about shifting toward restricted stock units is the opposite of the ground truth, which suggests a move *away* from restricted units toward options. While the question involves director compensation trends, the LLM’s narrative about modernization and alignment with shareholder value is speculative and based on incorrect premises. Quantitative accuracy is low due to wrong years (2016 vs. no plan change) and incorrect presence of restricted unit agreements in 2024. Contextual relevance is moderate because it addresses director compensation structure, but factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 423,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "\n\nBetween 2022 and 2024, Walmart increased its ownership stake in Flipkart from **75% (as of January 31, 2022)** to **85% (as of January 31, 2024)** through a $3.5 billion acquisition of noncontrolling interest shares in fiscal 2024 (WMT_10k_2024.pdf, p. 65). This expansion enhanced Walmart’s control over Flipkart’s operations and consolidated financial reporting but involved significant capital outflows. \n\n**Financial implications** included reduced equity dilution in 2022 when Walmart’s ownership dropped to 75% due to Flipkart’s $3.2 billion equity funding (WMT_10k_2022.pdf, p. 66), followed by a strategic buyback to strengthen its position. \n\n**Regulatory risks** emerged in 2024, with India’s Directorate of Enforcement investigating Flipkart for potential violations of Foreign Direct Investment (FDI) rules from 2009–2015 (WMT_10k_2024.pdf, p. 76). This could result in penalties, share ownership restrictions, or indemnification claims, though outcomes remain uncertain. Walmart emphasized it cannot estimate potential losses or regulatory impacts, highlighting exposure to material adverse effects on its financial position. \n\nIn summary, Walmart solidified its majority stake in Flipkart financially but faces unresolved regulatory scrutiny in India that could affect future operations or valuation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It incorrectly states that Walmart increased its ownership stake in Flipkart from 75% in 2022 to 85% in 2024, when the ground truth confirms the opposite: Walmart's stake decreased from 83% to 75% in 2022 due to a $3.2 billion equity funding round. There is no evidence in the ground truth of a subsequent buyback or increase to 85%. The $3.5 billion figure cited by the LLM for fiscal 2024 is unsupported and contradicts the original answer. (2) Quantitative accuracy is severely compromised: the direction of ownership change is reversed, the percentages are incorrect (75% to 85% vs. 83% to 75%), and the dollar amounts do not align ($3.5B outflow vs. $3.2B inflow). The LLM misrepresents the nature of the transaction—Walmart received cash in 2022, reducing its stake, rather than investing more. (3) The reasoning is flawed in its multi-hop logic: while the LLM correctly identifies regulatory scrutiny in India related to FDI rules from 2009–2015 and cites Walmart’s inability to estimate losses, it fails to connect this to the fact that these risks stem from Flipkart’s pre-acquisition history, as emphasized in the ground truth. Instead, it frames the narrative around a fictional stake increase, undermining the synthesis. (4) Contextual relevance is moderate—the answer addresses financial implications and regulatory risks as required, and cites plausible document sources, but the core narrative is factually inverted. The qualitative accuracy is low due to incorrect entity relationships and timeline distortions. Overall, the answer presents a fundamentally incorrect evolution of Walmart’s strategic position, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 472,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "\n\nHoneywell's total U.S. and global cash balances increased from $9.6 billion at the end of 2022 to $10.6 billion by December 31, 2024. In 2024, $8.0 billion (73% of total cash) was held in non-U.S. subsidiaries, compared to $8.1 billion in total cash for 2023 (with unspecified geographic breakdown). This reflects a strategic emphasis on maintaining liquidity across international operations, with non-U.S. cash holdings rising despite higher overall liquidity in 2024. The company prioritizes safety of principal and diversification of cash across counterparties, with no material restrictions on repatriating non-U.S. funds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Honeywell's total cash was $9.6 billion at the end of 2022, while the ground truth reports $11.5 billion as of December 31, 2021 (reported in 2022). The 2024 cash balance is stated as $10.6 billion, but the correct amount is $11.0 billion as of December 31, 2024. The LLM correctly identifies that $8.0 billion was held in non-U.S. subsidiaries in 2024, aligning with the ground truth. However, it references a 2023 figure of $8.1 billion with no geographic breakdown, which is not mentioned in the original answer and appears extraneous. (2) Quantitative accuracy is low: the opening cash figure is off by nearly $2 billion, and the ending total is understated by $400 million. The 73% calculation ($8.0B / $10.6B) is approximately correct based on the LLM's numbers, but since the totals are wrong, the percentage is not valid against ground truth. The original answer does not provide a percentage, so this is not a direct error, but the underlying totals are. (3) The multi-hop reasoning is partially sound—LLM attempts to show a shift in geographic distribution and notes the strategic emphasis on safety and diversification, which matches the original. However, it misrepresents the timeline and amounts, failing to accurately reflect the evolution from 2022 (reporting 2021 data) to 2024. The original emphasizes a shift from primarily U.S.-held cash to a larger non-U.S. portion, but the LLM's incorrect totals distort this narrative. (4) Contextual relevance is fair—the answer addresses cash composition, geographic distribution, and strategy, which are all relevant. However, due to significant numerical errors and the introduction of unsupported data (e.g., 2023 cash), the qualitative and correctness scores are reduced. The strategic emphasis on safety and diversification is correctly noted, preserving some accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 522,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "\n\nThe financial treatment and liability estimation methodology for the Membership Rewards program in 2024 built upon 2023 practices with enhanced sensitivity and dynamic adjustments. Both years used **Ultimate Redemption Rate (URR)** and **Weighted Average Cost (WAC) per point** as core assumptions, derived from redemption trends, card product types, and partner contracts. However, 2024 introduced **explicit quantification of sensitivity impacts**: a 25-basis-point URR increase would raise the liability by $197 million, and a 1-basis-point WAC increase by $220 million. This reflects refined risk modeling. Additionally, 2024 emphasized adjustments for **non-representative redemption costs** and **product-driven changes** (e.g., redemption options, cards-in-force mix) in periodic reviews, whereas 2023 focused on partner contract changes and redemption pattern shifts. Deferred fees remained tied to Membership Rewards liability estimation, with 2024 showing a $953 million increase in the liability year-over-year ($12.8B in 2023 to $13.7B in 2024), partly due to higher enrollment and updated assumptions. The 2024 methodology thus incorporated more granular scenario analysis and proactive adjustments to evolving program dynamics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right topic and showing an understanding of the general direction of methodological evolution. (1) The most critical error is the claim that both 2023 and 2024 used URR and WAC as core assumptions. According to the ground truth, 2023 only mentioned deferred fees without detailing URR or WAC—these modeling components were introduced in 2024. This misrepresents the evolution by suggesting continuity rather than a shift. (2) The LLM introduces a $12.8B liability in 2023 and $13.7B in 2024 (a $953M increase), but this data is not present in the original answer and cannot be verified against the ground truth. The original makes no mention of absolute liability values or year-over-year changes, so this addition is unsupported. (3) The sensitivity figures ($197M for 25 bps URR, $220M for 1 bps WAC) are correctly stated, which is a strength. (4) The discussion of 'non-representative redemption costs' and 'product-driven changes' in 2024 is plausible but not mentioned in the original answer, introducing speculative detail. (5) The reasoning framework—suggesting increased granularity and dynamic modeling in 2024—is directionally correct and contextually relevant, but the faulty premise that both years used URR/WAC undermines the multi-hop logic. Overall, while the answer captures the theme of enhanced disclosure and sensitivity analysis in 2024, it fabricates or misattributes key details, leading to a low quantitative and correctness score despite reasonable structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 438,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "\n\nAdobe's strategic integration of Frame.io from 2022 to 2024 reflects a deliberate alignment with its broader product ecosystem, enhancing cross-platform collaboration and AI-driven workflows. Acquired in late 2021 and integrated into the **Digital Media segment** (2022 10-K, p. 41), Frame.io evolved from a standalone cloud-based video collaboration tool to a core component of Adobe's **content production ecosystem**. By 2024, Frame.io was deeply embedded in Adobe's **Creative Cloud suite**, enabling seamless integration with apps like **Premiere Pro, After Effects, and Photoshop** (2024 10-K, p. 12), allowing real-time feedback and streamlining video production workflows. \n\nAdditionally, Frame.io became part of **Adobe GenStudio** (2024 10-K, p. 12), a platform leveraging generative AI (e.g., Firefly) to scale content creation, positioning Frame.io as a critical node in Adobe's AI-enhanced creative pipeline. Its **Camera to Cloud** functionality and integration with **Workfront** (from the Digital Experience segment) further expanded its role in end-to-end project management, aligning with Adobe's strategy to unify creative and workflow tools across segments. This evolution underscores Adobe's focus on embedding Frame.io into a cohesive ecosystem that enhances productivity, collaboration, and AI-driven innovation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Frame.io was acquired for $1.18 billion (implied by context, though not explicitly restated in LLM answer, but not contradicted), integrated into the Digital Media segment in 2022, and by 2024 became a core part of Adobe's ecosystem with deep integration into Premiere Pro, After Effects, Photoshop, and Workfront. The inclusion in Adobe GenStudio is correctly noted. (2) No quantitative inaccuracies: while the $1.18B acquisition amount is not repeated in the LLM answer, it is not required for correctness since the focus is on strategic positioning, and no incorrect numbers are presented. Dates (2022, 2024) and product names are accurate. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and segments (Digital Media and Digital Experience via Workfront), correctly tracing the evolution from initial integration to ecosystem-wide alignment. (4) The answer adds contextual value (e.g., mention of Camera to Cloud, AI-driven workflows, Firefly, Creative Cloud) that enriches the ground truth without introducing errors. All aspects of the question—strategic positioning, integration evolution, and alignment with Adobe’s broader ecosystem—are thoroughly and correctly addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 372,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "\n\nThe fair value measurements using significant unobservable inputs (Level 3) for equity-like funds within private alternative investments increased between 2022 and 2023. In 2022, equity-like funds under defined benefit pension plans had a Level 3 fair value of **$5.5 million**, while retiree health plans had **$0.5 million**. By 2023, these values rose to **$25.1 million** for pension plans and **$2.4 million** for retiree health plans. This reflects a notable increase in unobservable input valuations for equity-like funds in 2023 compared to 2022, though the company noted that Level 3 activity remained non-material overall.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces entities not present in the original answer—specifically 'defined benefit pension plans' and 'retiree health plans'—which were not mentioned in the ground truth. The original answer refers to private alternative investments broadly, without breaking down by pension or health plans. This misrepresents the scope and source of the Level 3 fair value. (2) Quantitatively, the LLM states $5.5 million for 2022, which matches the ground truth. However, it reports $25.1 million for 2023 instead of the correct $25.4 million, a small but material discrepancy. Additionally, the LLM adds $0.5 million and $2.4 million for retiree health plans, which are not part of the original data, leading to an inflated and incorrect total. (3) The multi-hop reasoning is flawed because the model incorrectly segments the data by benefit plan type, which was not required or supported by the original information. The evolution of equity-like funds in Level 3 should reflect a single aggregate value increase from $5.5M to $25.4M, not a breakdown across unrelated categories. (4) While the general trend of increase is correctly identified, the specific figures, categorization, and synthesis are inaccurate. The contextual relevance is high because the answer addresses fair value changes in Level 3 inputs over time, but factual and quantitative errors reduce correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 391,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "\n\nAdobe's integration and positioning of Frame.io within its Digital Media segment evolved significantly between 2022 and 2024. In 2022, Frame.io was described as a cloud-native video collaboration tool integrated with Creative Cloud apps like Premiere Pro and After Effects, focusing on post-production workflows (ADBE_10k_2022.pdf, p. 42). By 2024, Frame.io was positioned as a core component of **Adobe GenStudio**, a platform for scalable content production, and its integration expanded to include real-time collaboration across a broader ecosystem (e.g., Photoshop, Lightroom, Workfront) and **Camera-to-Cloud** functionality for automated footage uploads (ADBE_10k_2024.pdf, p. 12). Additionally, Frame.io’s role now spans pre-production stages (e.g., casting, location scouting) and marketing workflows, reflecting its evolution into a comprehensive content creation and management solution within Adobe’s generative AI-driven offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Frame.io was acquired in October 2021 and integration began in 2022 as a cloud-based video collaboration platform, particularly with Premiere Pro and After Effects. By 2024, it evolved into a core part of Adobe’s ecosystem, integrated with Photoshop, Lightroom, Workfront, and notably included in Adobe GenStudio for scalable content production. The mention of Camera-to-Cloud and expansion into pre-production and marketing workflows adds contextual depth consistent with strategic embedding. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes information across years and products, correctly identifying the evolution from post-production tool to comprehensive collaboration platform. The integration with GenStudio and expansion beyond video into broader content workflows reflects accurate synthesis. (4) The only reason for not scoring a 10 is minor: the original answer does not explicitly mention 'Camera-to-Cloud' or 'pre-production stages' like casting and location scouting, so while plausible and consistent, those details slightly extend beyond the ground truth without contradiction. Overall, the answer is semantically equivalent, highly relevant, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 404,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "\n\nBetween 2022 and 2024, CVS Health expanded its Medication Management approach by enhancing clinical programs and digital tools to improve adherence and cost efficiency. **Key developments include**:  \n1. **Digital Tools**: Introduction of AI-driven platforms like the Health Engagement Engine, which automates clinical interventions and leverages data analytics to identify cost-saving opportunities and adherence gaps in real time. Enhanced digital connectivity now provides members with expanded visibility to lower-cost alternatives through improved analytics and provider integration.  \n2. **Clinical Programs**: Expansion of specialized initiatives, such as the **CVS Weight Management program** for GLP-1 medications, combining therapy optimization with lifestyle coaching. Disease management programs (e.g., for rheumatoid arthritis, Parkinson’s) were accredited by NCQA and URAC, ensuring clinical rigor.  \n3. **Value-Based Care Integration**: Acquisition of Oak Street Health enabled community-based primary care centers focused on chronic disease management, aligning medication adherence with preventive care.  \n4. **Opioid and Specialty Drug Management**: Strengthened utilization management (UM) strategies, including stricter opioid dispensing limits and the NovoLogix preauthorization tool for specialty drugs, to curb misuse and ensure cost-effective treatment.  \n\nThese advancements reflect a shift toward data-driven, patient-centric solutions and partnerships to reduce costs while improving health outcomes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core developments in CVS's Medication Management approach between 2022 and 2024. Key accurate elements include: the launch of the CVS Weight Management program integrating GLP-1 optimization and lifestyle coaching; the role of Oak Street Health in expanding value-based, community-based primary care (with correct contextual emphasis on chronic disease management); the introduction of the NovoLogix preauthorization tool for specialty drugs; and the continued focus on opioid utilization management. The shift toward a more integrated, digitally enabled model is accurately conveyed. However, there is a discrepancy in the mention of the 'Health Engagement Engine' and its characterization as an AI-driven platform automating clinical interventions—this specific tool is not mentioned in the ground truth and may represent an overstatement or misattribution not supported by the original data. While enhanced analytics and digital connectivity are correctly noted, the branding and capabilities attributed to the Health Engagement Engine go beyond the provided truth. There are no numerical inaccuracies (quantitative accuracy is perfect—no incorrect figures, dates, or calculations). The reasoning is sound and reflects multi-hop synthesis across clinical programs, digital tools, and strategic acquisitions. The answer is highly relevant and addresses all parts of the question. The minor overreach on unverified digital tools prevents a 9–10 on correctness and qualitative accuracy, but the core facts are intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1692,
        "completion_tokens": 436,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "\n\nAdobe's integration of Frame.io into its Creative Cloud ecosystem evolved significantly from 2022 to 2024. In 2022, Adobe began integrating Frame.io's review and approval capabilities into **Premiere Pro** and **After Effects** to create a native collaborative platform for video editing (ADBE_10k_2022.pdf, p. 6). By 2024, Frame.io was positioned as a central cloud-native collaboration platform, deeply integrated with **Premiere Pro**, **After Effects**, **Photoshop**, **Lightroom**, and **Adobe Workfront**, enabling real-time upload, frame-accurate commenting, annotations, and support for workflows beyond post-production (e.g., casting, location scouting, marketing campaigns) (ADBE_10k_2024.pdf, p. 12). Additionally, **Camera to Cloud** functionality allowed automatic footage uploads from cameras directly into Frame.io for instant review. Collaboration features expanded to include seamless integration with Adobe GenStudio for scaled content production and support for still images, design files, and PDFs, reflecting a broader, more seamless ecosystem for cross-stakeholder collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the timeline (2022–2024), the acquisition and integration of Frame.io into Creative Cloud, and the initial focus on Premiere Pro and After Effects in 2022. The 2024 evolution is accurately described, including expanded integration with Photoshop, Lightroom, and Workfront, real-time collaboration features, support for still images, design files, and PDFs, and the introduction of Camera to Cloud functionality. The mention of 'frame-accurate commenting, annotations' and use in workflows beyond post-production (e.g., casting, location scouting) adds contextual detail consistent with a broader collaboration platform, though not explicitly in the ground truth—this is a reasonable inference and does not detract from accuracy. The reference to 'Adobe GenStudio' is not present in the ground truth and may be speculative or incorrectly named (possibly conflating with Adobe Firefly or another generative AI tool); this is a minor factual overreach, but does not undermine the core correctness. All entities, years, and integrations are accurate. No numerical data is present, so quantitative accuracy is based on correct dates and feature timelines, which are accurate. The reasoning is sound, demonstrating multi-hop synthesis across years and products. The answer fully addresses both parts of the question: evolution of integration/positioning and specific collaboration enhancements. Semantic equivalence is strong, with slightly enhanced elaboration beyond the original answer but no material inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 439,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "\n\nFrom 2023 to 2024, the use of recently executed transactions in valuing loans and other assets became more systematic and prominent in fair value determination. In 2023, recently executed transactions were one of several inputs (e.g., market quotations, CDS spreads) used for held-for-sale loans, with significant reliance on Level 3 unobservable inputs (e.g., $4.5 billion in Level 3 loans). By 2024, the Firm emphasized recently executed transactions as a primary observable input, particularly for held-for-sale categories, leading to a shift toward Level 2 classifications. This is evident in the reduction of Level 3 loan valuations ($4.5 billion in 2023 to $4.5 billion in 2024) and increased use of observable market data. Additionally, nonrecurring fair value losses for loans declined sharply ($426 million in 2023 to $64 million in 2024), suggesting improved valuation accuracy from leveraging transaction data. The evolution reflects a strategic prioritization of observable, transaction-based inputs to enhance transparency and reduce reliance on subjective models.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite capturing some qualitative trends. (1) Quantitative Accuracy: The dollar amounts and metrics cited are incorrect or unsupported. The claim that Level 3 loans were $4.5 billion in both 2023 and 2024 contradicts the expectation of a reduction if there was a shift toward Level 2; the repetition suggests no change, undermining the stated shift. The nonrecurring fair value losses dropping from $426M to $64M are not mentioned in the ground truth and cannot be verified. These numbers appear fabricated. (2) Completeness: The answer addresses the evolution of transaction use in fair value determination and mentions held-for-sale loans, which aligns with the ground truth. It also notes increased use of observable data, which is consistent with a more targeted use of transaction data. However, it fails to mention contingent lending commitments (noted in 2023) and omits the extension to 'other investments' valued via discounted cash flows and comparable multiples in 2024. (3) Entity Accuracy: No specific companies are named, which is acceptable given the general nature of the question. However, the use of terms like 'the Firm' implies a specific entity not referenced in the original, introducing ambiguity. (4) Reasoning: The logic of shifting from Level 3 to Level 2 due to greater use of observable transactions is sound and reflects an understanding of fair value hierarchies. However, this inference is not grounded in the provided truth and introduces unsupported data. (5) Semantic Equivalence: While the general direction of evolution (increased reliance on transaction data) is plausible, the specific evidence used to support it is factually wrong. The ground truth emphasizes a more targeted application, not necessarily a broad strategic shift across all valuations. Thus, the core factual content does not match, dragging down correctness despite some reasonable qualitative interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 539,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "\n\nBetween 2022 and 2024, Adobe positioned **Substance 3D Stager** as a core component of its expanded **Substance 3D ecosystem**, emphasizing integration with complementary tools and workflows. In 2022, the product was only listed as a trademark (page 105 of ADBE_10k_2022.pdf) with no detailed description. By 2024, Adobe explicitly framed Substance 3D Stager as part of a cohesive ecosystem (page 12 of ADBE_10k_2024.pdf), highlighting its role in building and assembling 3D scenes while integrating with tools like **Substance 3D Painter** (for texturing), **Sampler** (for asset digitization), and **Modeler** (for sculpting). The 2024 description also emphasized access to the **Substance 3D Assets library** for professional materials and cross-platform workflows (desktop and VR), reflecting a strategic shift toward positioning Stager as a collaborative, ecosystem-driven tool within Adobe’s broader 3D creation suite.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) It accurately reflects the evolution of Adobe's approach to Substance 3D Stager: from being only a trademark in 2022 (citing page 105 of the 2022 10-K) to being positioned as an integrated tool within a broader 3D ecosystem by 2024 (citing page 12 of the 2024 10-K). (2) All non-numeric details are factually accurate: Stager’s role in building and assembling 3D scenes, integration with Painter, Sampler, Modeler, access to the Substance 3D Assets library, and support for desktop and VR workflows. (3) The multi-hop reasoning is sound—correctly synthesizing information across two years of filings to show strategic evolution. (4) The answer addresses all parts of the question: the timeline (2022 to 2024), the product (Stager), and its changing positioning within the Substance 3D ecosystem. Minor additions (e.g., VR workflows, asset library) are consistent with the broader strategic shift and enhance completeness without introducing inaccuracies. No calculation errors; no entity or date errors. Semantic equivalence is strong, with enhanced clarity and contextual detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 328,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "\n\nFrom 2022 to 2023, GE maintained grid-scale batteries as a component of its energy transition strategy, emphasizing their role in enabling deeper decarbonization of the power sector, particularly to support renewable energy integration. However, the company did not significantly elevate their strategic reliance relative to other technologies like hydrogen, carbon capture, or advanced nuclear. In both years, grid-scale batteries were positioned as part of a broader portfolio of emerging solutions critical for modernizing power grids and achieving long-term emission reduction goals. The 2023 filings reiterated the need for substantial investments in these technologies but highlighted uncertainties around commercial viability and adoption timelines, reflecting a cautious, diversified approach rather than a pivot toward batteries as a central strategic focus.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about GE's strategic evolution. The ground truth shows a clear shift from 2022 to 2023—from viewing grid-scale batteries as a speculative future technology to integrating them as a strategic dependency for decarbonization goals ('depend in part' on such technologies). In contrast, the LLM claims there was 'no significant elevation' in strategic reliance and portrays GE’s stance as consistently cautious and undifferentiated within a broader portfolio, which contradicts the documented shift in language and strategic framing. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to detect the evolution in GE’s narrative between 2022 and 2023. In 2022, batteries were mentioned as 'may become more important over time'; in 2023, they were explicitly tied to decarbonization success with stronger dependency language. This progression indicates increased strategic reliance, which the LLM overlooks. Instead, it emphasizes continuity and caution, misrepresenting the shift in strategic positioning. (4) Contextual relevance is moderate—the response addresses energy transition and grid-scale batteries in the correct timeframe and context, but mischaracterizes the strategic evolution. The answer discusses related themes (renewables integration, hydrogen, carbon capture) not mentioned in the ground truth, introducing unsupported comparisons. Thus, while topically relevant, it fails to accurately reflect the specific strategic shift documented in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 461,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "\n\nCVS's disclosure regarding broker-quoted debt securities in its fair value measurements remained consistent between 2022 and 2024. In both periods, the company explicitly stated it had **no broker-quoted debt securities** (CVS_10k_2024.pdf, page 146 for 2024 and 2023; CVS_10k_2022.pdf, page 148 for 2021 and 2020). The absence of such securities persisted, with Level 3 debt securities instead being valued through internal analysis or third-party broker assessments based on market knowledge, not quoted prices. This consistency indicates no material impact on financial reporting related to broker-quoted debt during the reviewed periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key fact from the ground truth—that CVS had no broker-quoted debt securities in both 2022 and 2024 disclosures, with accurate reference to years (2020–2021 in 2022 filing; 2023–2024 in 2024 filing). This core quantitative and factual claim is accurate. (2) All dates, years, and the absence of broker-quoted securities are correctly reported, and no numerical inaccuracies are present—quantitative accuracy is perfect. (3) However, the LLM answer misses a key qualitative nuance emphasized in the original answer: the evolution in disclosure tone and content. Specifically, the 2024 filing no longer mentions any review process or negative impact related to broker-quoted debt securities, indicating reduced emphasis over time. The LLM states the disclosures are 'consistent' but fails to note this shift in narrative, which is central to the question about 'evolution' and 'impact on financial reporting.' This omission affects the depth of the multi-hop reasoning, which should synthesize not just the continued absence of securities but also the changing disclosure focus. (4) Despite this, the answer remains factually sound and highly relevant, correctly interpreting the primary data and citing appropriate sources. The correctness score is reduced slightly (8/10) due to the missing nuance about reduced emphasis in 2024, which is critical for a complete evolution analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 396,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "\n\nBetween 2023 and 2024, BlackRock's Equity Securities at FVTNI composition shifted as follows:  \n- **Equity securities/mutual funds** increased by **$365 million** (from $1,585 million in 2023 to $1,950 million in 2024).  \n- **Equity method investments** rose slightly by **$27 million** (from $2,756 million in 2023 to $2,783 million in 2024), driven by growth in real assets funds ($417 million to $520 million) and hedge funds, partially offset by a decline in private equity funds ($1,264 million to $1,060 million).  \n\nThis reflects a relative increase in direct equity/mutual fund holdings compared to equity method investments, with notable reallocation within equity method components.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for both equity securities/mutual funds and equity method investments. According to the ground truth, in 2023, equity securities/mutual funds were $1,211 million, but the LLM incorrectly states $1,585 million. The 2024 value of $1,950 million is correct, but the increase is miscalculated as $365 million (should be $739 million based on correct 2023 value). For equity method investments, the LLM reports $2,756 million in 2023, whereas the ground truth is $1,895 million — a major discrepancy of $861 million. The 2024 value of $2,783 million is correct. (2) Calculations are therefore flawed: the LLM reports a $27 million increase in equity method investments, but the actual increase is $888 million. The LLM also introduces subcategory details (real assets funds, hedge funds, private equity funds) that are not present in the original answer and may be fabricated or misattributed, as they do not align with the ground truth data. (3) Multi-hop reasoning is compromised because the model fails to correctly retrieve and synthesize the base figures from 2023 and 2024. The conclusion about a 'relative increase in direct equity/mutual fund holdings compared to equity method investments' is misleading, as both categories increased substantially, with equity method investments growing more in absolute terms according to ground truth. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant — it addresses the right categories and time frame, and attempts to explain changes. However, due to severe quantitative errors, the correctness score is low. Quantitative accuracy is severely penalized due to wrong base figures and incorrect deltas. Qualitative accuracy suffers due to flawed synthesis and unsupported subcategory breakdowns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 504,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "\n\nUnitedHealth Group's evaluation of credit-related impairments for available-for-sale debt securities from 2022 to 2024 remained consistent, focusing on expected cash flows, issuer credit quality, and market factors. In 2021 (as disclosed in the 2022 10-K), unrealized losses totaled $274 million, primarily due to interest rate fluctuations rather than credit deterioration, with no material allowance for credit losses. By 2024, the company continued to exclude non-credit-related unrealized losses from net earnings (reporting them in comprehensive income) and maintained that credit losses were immaterial, though specific 2024 figures for unrealized losses or allowances were not provided in the excerpts. The methodology for assessing impairments and managing credit risk remained unchanged, emphasizing temporary market-driven losses over credit-specific issues.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key aspects of the evolution in UnitedHealth Group's accounting framework for credit-related impairments. It correctly states that in 2022 (based on 2021 data), unrealized losses were due to interest rates and not credit deterioration, and that the allowance was immaterial. However, it introduces a specific figure of $274 million in unrealized losses for 2021, which is not present in the original answer (ground truth) and cannot be verified from the provided context—this is an unsupported addition. (2) Quantitatively, the $274 million figure is unverified and potentially incorrect, as the ground truth does not include any specific dollar amount for unrealized losses. The absence of 2024 figures is noted correctly, but the original answer emphasizes a qualitative shift in accounting treatment, not just the persistence of immateriality. (3) The multi-hop reasoning is partially sound—information is synthesized across years and concepts—but the LLM fails to capture the core evolution highlighted in the ground truth: the move toward a more formalized impairment accounting framework with an explicit allowance account and recognition of credit-related impairments through investment income. Instead, the LLM incorrectly asserts that the methodology 'remained unchanged,' contradicting the original answer’s emphasis on structural changes in recognition and presentation. (4) While the answer is contextually relevant and addresses the general topic accurately, it lacks the critical insight about evolving accounting practices and incorrectly implies no methodological change, leading to a moderate correctness score. The qualitative accuracy is penalized for missing this key development, despite correct identification of entities and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 497,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "\n\nBetween 2022 and 2023, AMD's investment in the ATMP JV increased in carrying value from **$83 million** to **$99 million**, reflecting a $16 million rise. Equity income from the ATMP JV also grew from **$14 million** in 2022 to **$16 million** in 2023, indicating improved returns on the investment. These changes highlight AMD's enhanced financial position and performance from its equity stake in the joint venture during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of AMD's investment in the ATMP JV increased from $83 million in 2022 to $99 million in 2023, and equity income rose from $14 million to $16 million. The $16 million increase in carrying value is correctly implied. (2) The answer is complete, addressing both investment value and equity income across both years as required by the question. (3) Entities—AMD, ATMP JV, and the relevant financial metrics (carrying value, equity income)—are correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop information (two years, two financial metrics) and draws a logical conclusion about AMD's growing financial stake and improved returns. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 277,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "\n\nUnitedHealth Group's exposure to tort claims from 2022 to 2024 has evolved with the addition of significant cyber-related risks, particularly following the 2024 Change Healthcare cyberattack. In 2022, tort claims primarily involved traditional medical malpractice and clinical liability from healthcare services, with the company noting self-insurance and potential large defense costs. By 2024, the nature of tort exposure expanded to include data security breaches, as the cyberattack on Change Healthcare (an Optum subsidiary) led to business disruptions, direct response costs, and heightened risks of litigation related to unauthorized data access. The financial impact in 2024 reflects not only ongoing costs from traditional tort claims but also material expenses from the cyberattack, including operational losses and potential liability claims tied to compromised sensitive data.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual alignment with the ground truth. (1) What was correct: The mention of tort claims related to healthcare services in 2022 aligns partially with the original answer, which notes medical malpractice and professional liability. The years 2022 and 2024 are correctly referenced. There are no numeric values to verify, so quantitative accuracy is not penalized. (2) However, the core of the LLM response introduces a major factual error: it claims that UnitedHealth Group's tort exposure evolved due to the 2024 Change Healthcare cyberattack, expanding to include data security and cyber-related litigation. This is not supported by the original answer, which makes no mention of cyberattacks, data breaches, or the Change Healthcare incident. Instead, the actual evolution described is a shift from narrowly defined medical malpractice claims in 2022 to broader legal risks around clinical quality and patient safety standards in 2024, with added emphasis on reputational harm and business relationship risks. (3) The multi-hop reasoning is flawed because the LLM appears to conflate external public knowledge (the Change Healthcare cyberattack) with the specific content of UnitedHealth’s SEC filings as represented in the knowledge graph. The original answer does not reference cyber risks or Optum subsidiaries in this context, so the synthesis is invalid. (4) The contextual relevance is moderate because the answer addresses tort claim evolution over time and financial impact, but the substance is misdirected. The qualitative accuracy is low due to incorrect entity-event linkage (cyberattack not in source) and failure to capture the actual shift in tort claim nature as defined in the ground truth. Correctness score is low because the central claim of the answer is factually unsupported by the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 504,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "\n\nBetween 2023 and 2024, Boeing’s three-year revolving credit agreement remained at **$3.0 billion** in capacity, but its structure and context evolved. In 2023, the company had a legacy three-year facility expiring in August 2025 alongside a $3.2 billion five-year agreement expiring in October 2024. By 2024, Boeing terminated the $3.2 billion five-year facility and replaced it with a **new $4.0 billion five-year revolving credit agreement expiring in May 2029**, while retaining the $3.0 billion three-year facility. This shift extended the maturity of a portion of its credit lines and increased the size of its long-term liquidity backup. \n\nThis evolution reflects a **liquidity strategy focused on extending debt maturities and securing flexible, long-term funding** to support operational needs amid ongoing challenges (e.g., 777X program risks). By maintaining both three-year and five-year facilities, Boeing balances short-term liquidity with longer-term stability, reducing refinancing pressures and aligning with improved credit outlooks from rating agencies. The total undrawn credit capacity remained at $10.0 billion, underscoring a cautious approach to preserving financial flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.0 billion three-year revolving credit agreement in 2023 expiring in August 2025 and the new $4.0 billion five-year facility in 2024 expiring in May 2029, which aligns with the ground truth. However, it introduces a $3.2 billion five-year agreement expiring in October 2024 that is not mentioned in the original answer, and claims Boeing terminated this facility—this detail is unsupported by the ground truth and represents a factual inaccuracy. Additionally, the LLM states that the total undrawn credit capacity remained at $10.0 billion, which is not present in the original answer and cannot be verified from the provided information. (2) While the $3.0 billion and $4.0 billion figures are correct, the inclusion of the $3.2 billion facility and the $10.0 billion total capacity introduces incorrect quantitative elements. The ground truth does not mention these numbers, so their presence reduces quantitative accuracy. (3) The reasoning about Boeing’s liquidity strategy—extending maturities, increasing long-term capacity, and enhancing financial flexibility—is logically sound and consistent with the evolution described in the original answer. The synthesis of strategic intent from structural changes is well-executed, though based partly on incorrect premises. (4) The answer is highly relevant to the question, addressing both structural evolution and strategic implications. Despite some inaccuracies, it maintains focus on Boeing’s credit agreements and liquidity posture. Overall, the core facts about the $3.0 billion legacy facility and the new $4.0 billion agreement are correct, but the addition of unverified facilities and totals reduces factual precision, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 485,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "\n\nThe financial impact of the 2017 Performance-based Options evolved as follows between 2023 and 2024:  \n- **Fair Value of Options Vested**: Decreased slightly from $56 million in 2023 to $52 million in 2024.  \n- **Intrinsic Value of Options Exercised**: Rose significantly from $44 million in 2023 to $373 million in 2024, reflecting higher stock prices and the vesting of larger tranches in 2024.  \n\nThis shift highlights stronger realized gains in 2024 despite a marginal reduction in the fair value of newly vested options.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of options vested decreased from $56 million in 2023 to $52 million in 2024, and the intrinsic value of options exercised increased from $44 million to $373 million—both figures match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the evolution of fair value and intrinsic value between 2023 and 2024. (3) Entity accuracy is correct—the 2017 Performance-based Options are properly referenced, and the years 2023 and 2024 are accurately used. (4) The reasoning is sound: the LLM correctly infers that the significant rise in intrinsic value likely reflects higher stock prices and larger vesting tranches in 2024, which is a logical and contextually appropriate explanation. The multi-hop synthesis—linking vesting values in one year to exercise values in the next—is handled correctly. (5) The semantic meaning is equivalent to the original answer, with clear, concise presentation and no factual or interpretive errors. All scoring dimensions warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 324,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "\n\nBetween 2022 and 2023, AMD refined its methodology for estimating adjustments to product return rights by enhancing the integration of **current economic conditions and market data analysis**. Specifically, in 2023, AMD explicitly stated that adjustments for distributor and OEM returns now incorporate **trended historical data adjusted for \"known events or current economic conditions\"** (2023 10-K, p. 49). This contrasts with 2022, where adjustments were based on historical returns and \"actual known information or events\" but without explicit emphasis on real-time economic factors (2022 10-K, p. 45). Additionally, 2023 introduced a more structured approach to analyzing **internal and external market data** for forecasting future price movements and rebate program attainment, improving the precision of estimates for both distributor price protection and OEM incentives. These changes reflect a shift toward dynamic, data-driven adjustments to better align with evolving market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in that it identifies AMD and the relevant time frame (2022–2023), and correctly references the use of historical data and adjustments for known events. However, it introduces significant factual inaccuracies regarding the evolution of AMD's methodology. The ground truth states that in 2023, AMD adopted a more structured approach under ASC 606-10-32-8 through 14, explicitly using the 'most likely amount' method for variable consideration, including returns, rebates, and price protection. This key accounting standard reference and the shift to a codified 'most likely amount' estimation approach are entirely missing from the LLM answer. Instead, the LLM incorrectly claims that AMD began incorporating 'current economic conditions and market data analysis' and 'real-time economic factors' in 2023—details not supported by the ground truth. While the LLM cites specific page numbers and mentions trended historical data (which aligns generally), the core of the methodology change—alignment with ASC 606 and use of the 'most likely amount'—is omitted and replaced with fabricated elements about economic conditions and market forecasting. There are no numerical figures in the question or answer, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound in structure but based on incorrect premises, leading to a low qualitative accuracy score. The answer is contextually relevant and addresses the question's intent, hence a solid score for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 419,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "\n\nThe number of shares under option for the 2017 Performance-based Options decreased significantly from **1,549,080 at December 31, 2023, to 625,825 at December 31, 2024**, a reduction of approximately **59%**. This decline was primarily driven by **905,219 shares exercised in 2024** (compared to only 183,704 shares exercised in 2023) and minimal forfeitures (18,036 shares in 2024 vs. 3,114 in 2023). The sharp drop reflects the final tranche of these options vesting at the end of 2024, followed by high exercise activity, likely due to the stock’s favorable intrinsic value ($373 million aggregate intrinsic value exercised in 2024). Low forfeiture rates suggest strong employee retention for vested awards, while the exercise trend indicates confidence in the stock’s performance post-vesting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key numbers from the ground truth: the decrease in shares under option from 1,549,080 (end of 2023) to 625,825 (end of 2024), the 905,219 shares exercised, and 18,036 forfeited. These match the ground truth exactly. The percentage decrease (~59%) is accurate: (1,549,080 - 625,825) / 1,549,080 ≈ 59.6%. 2) The quantitative accuracy is perfect—no errors in numbers, calculations, or dates. The LLM even adds context (e.g., prior year exercise and forfeiture figures) that are consistent with multi-hop reasoning from SEC filings. 3) The qualitative reasoning is strong: it correctly infers that the drop is due to final vesting and high exercise activity, links it to intrinsic value ($373M), and interprets low forfeitures as a sign of retention. While the ground truth does not mention the $373M intrinsic value or comparative 2023 exercise/forfeiture data, the LLM’s use of such data (if present in the filings) enhances—rather than contradicts—the core answer. The only minor gap is that the ground truth emphasizes the 'completion of lifecycle' as the central theme, which the LLM captures implicitly but not explicitly in those terms. 4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of shares and what it indicates about exercise/forfeiture trends. All information provided supports the conclusion. Minor deduction in qualitative accuracy only because the LLM introduces external details (e.g., 2023 exercise/forfeiture comparisons, intrinsic value) not in the ground truth, which, while plausible, slightly extend beyond the provided truth without confirmation. However, since these do not contradict and likely reflect correct synthesis, the overall correctness remains very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 484,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "\n\nBetween 2022 and 2024, Optum Rx's Pharmacy Care Services expanded its service offerings and strategic role within UnitedHealth Group through several key developments:  \n\n1. **Service Offerings**: Optum Rx increased its focus on specialized pharmacy care, including managing medication needs for individuals with behavioral health and substance use disorders (highlighted in 2024 filings). Script volumes grew steadily, fulfilling 1.4 billion adjusted scripts in 2021 (per 2022 data), 1.542 billion in 2023, and 1.623 billion in 2024, driven by new clients and existing client growth. Enhanced clinical programs and digital tools were deployed to optimize medication adherence and reduce inappropriate utilization.  \n\n2. **Strategic Positioning**: Optum Rx became a critical component of UnitedHealth Group’s integrated health ecosystem, leveraging data analytics and supply chain efficiencies to align medical and pharmaceutical care. It supported UnitedHealthcare’s cost-management goals by managing $112 billion in pharmaceutical spending (as of 2021) and driving operating cost efficiencies. The segment also strengthened its role in value-based care models, integrating pharmacy services with broader population health initiatives to improve outcomes and reduce total health system costs.  \n\nThese advancements reflect Optum Rx’s evolution into a more strategically embedded, technology-driven pillar of UnitedHealth Group’s efforts to streamline care delivery and control costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Optum Rx within UnitedHealth Group and correctly identifies its growing integration into value-based care and population health initiatives, which aligns with the ground truth. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the claim that Optum Rx managed $112 billion in pharmaceutical spending 'as of 2021' is misaligned with the original answer, which states this figure was for 2022. Second, the LLM introduces script volume data (1.4 billion in 2021, 1.542 billion in 2023, 1.623 billion in 2024) that is not present in the ground truth and cannot be verified from the provided information—this represents a hallucination. Additionally, the $45 billion in specialty pharmaceutical spending from 2022 is omitted. While the qualitative shift toward data analytics, clinical programs, and integration with broader health services is accurately reflected, the answer adds unsupported specifics and misattributes timeframes. The reasoning is logically structured and contextually relevant, showing understanding of Optum Rx’s strategic role, but the inclusion of unverified numbers and incorrect temporal references reduces quantitative accuracy. Semantic equivalence is partially achieved in narrative but not in factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1645,
        "completion_tokens": 372,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "\n\nBlackRock's Equity Securities at FVTNI increased in total fair value from $1,585 million in 2023 to $1,950 million in 2024, reflecting a $365 million rise. However, the specific portion held for deferred cash compensation plans, which are categorized under Equity method investments rather than directly within Equity Securities at FVTNI, decreased from $241 million in 2023 to $173 million in 2024, a $68 million reduction. This indicates that while the broader equity securities portfolio grew, the allocation to deferred compensation-related investments declined during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, BlackRock reported $9 million in Equity Securities at FVTNI for deferred cash compensation plans, not $241 million as stated by the LLM. Furthermore, the LLM claims this amount decreased to $173 million in 2024, but the ground truth states that the $173 million figure in 2024 was reclassified under 'Investments related to deferred cash compensation plans' within the Equity Method section, not as a reduction from a prior $241 million. The LLM incorrectly frames this as a decrease, when it is actually a reclassification. Additionally, the LLM introduces total Equity Securities at FVTNI values of $1,585 million (2023) and $1,950 million (2024), which are not present in the original answer and unsupported by the provided ground truth. (2) Quantitative accuracy is severely compromised: the key figures ($9M vs $241M) are wrong, and the calculation of a $68 million reduction is based on false premises. The total portfolio growth of $365 million is not mentioned in the ground truth and appears fabricated. (3) The multi-hop reasoning is flawed. The LLM fails to recognize the reclassification event — the core insight in the original answer — and instead misinterprets the change as a simple decline in investment value. It also misattributes the $173 million to a continuation of the same category, when in fact it was moved to a different reporting section. (4) Contextual relevance is moderate because the answer discusses the right topic (deferred compensation investments and FVTNI), but the incorrect data and reasoning undermine usefulness. The answer addresses composition and valuation changes but does so with incorrect numbers and logic, leading to a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 489,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "\n\nThe aggregate available authorization for Accenture's open-market share purchase program decreased from $3.13 billion as of August 31, 2022 (ACN_10k_2022.pdf, page 93) to $2.69 billion as of August 31, 2024 (ACN_10k_2024.pdf, page 100). This reduction indicates that the company utilized approximately $435 million of its repurchase authorization over the period, reflecting an active capital allocation strategy focused on returning value to shareholders through share buybacks. The sustained authorization levels (despite partial usage) also suggest a balanced approach to capital deployment, prioritizing shareholder returns while retaining flexibility for future opportunities or strategic adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in aggregate available authorization from $3.13 billion in 2022 to $2.69 billion in 2024, which aligns with the ground truth values of $3,129,296 and $2,694,281 (rounded appropriately). The difference of approximately $435 million is accurate and correctly interpreted as utilization of the repurchase program. (2) Quantitatively, the numbers are correct when accounting for rounding ($3.13B ≈ $3,129,296; $2.69B ≈ $2,694,281), and the implied calculation of usage (~$435M) is accurate. (3) However, the qualitative interpretation diverges from the ground truth: while the original answer frames the reduction as indicating a 'more conservative approach' or 'strategic shift', the LLM interprets it as evidence of an 'active capital allocation strategy' and 'balanced approach'. This is a reasonable inference but contradicts the original conclusion of reduced capital allocation intent. The LLM emphasizes sustained authorization and shareholder returns, whereas the ground truth emphasizes reduction and conservatism. (4) The answer is factually sound and contextually relevant, with strong quantitative accuracy, but the reasoning and qualitative interpretation partially misalign with the intended inference from the data, warranting a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 381,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "\n\nThe treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024 as follows:  \n\n1. **Share Repurchase Activity**: In 2022, Accenture disclosed its intent to use significant cash flow for repurchases of exchangeable shares in fiscal 2023, with flexibility to adjust based on market conditions and cash needs. By 2024, the company provided a more specific authorization of **$2,694,281 million** (as of August 31, 2024) for repurchases and redemptions of exchangeable shares, including open-market purchases and redemptions at the company’s option for cash at the market price of Class A ordinary shares.  \n\n2. **Shareholder Rights**: In 2022, disclosures focused on general repurchase terms. By 2024, the filing clarified that holders retain the right to exchange shares for Class A ordinary shares at any time, while Accenture added details about its redemption rights (e.g., redeeming shares to align with Class X ordinary share holdings). Additionally, 2024 emphasized contractual safeguards, such as non-redemption agreements with original holders to prevent imbalance between Class X shares and exchangeable shares.  \n\nThese changes reflect increased specificity in redemption terms, funding authorizations, and alignment with broader shareholder equity structures.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct evolution in disclosure and treatment of Accenture Canada Holdings Inc. Exchangeable Shares between 2022 and 2024, with accurate qualitative descriptions of shareholder rights and repurchase activity. It correctly identifies the increased specificity in 2024 regarding redemption rights, exchangeability for Class A shares, and alignment with Class X shares. However, there is a critical error in quantitative accuracy: the LLM states the remaining authorization as '$2,694,281 million', which equals ~$2.7 trillion—a gross inflation of the actual $2,694,281 (approximately $2.7 million). This misstatement suggests a failure to parse the number correctly, likely due to erroneous addition of 'million' after a figure already expressed in dollars. The original answer specifies '$2,694,281' without 'million', making the LLM's version off by a factor of one million. Despite this, the reasoning and contextual understanding are strong, with proper synthesis across years and entities. The answer addresses both share repurchase activity and shareholder rights as required, and the explanation of contractual safeguards and redemption mechanics aligns well with the ground truth. Hence, while the core logic and structure are sound, the severe numerical inaccuracy significantly undermines factual reliability, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 382,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "\n\nThe global revenue from Electrophysiology Devices increased from $2,195 million in 2023 to $2,467 million in 2024. Excluding the impact of foreign exchange fluctuations, this represents a **14.4% increase** (from the \"Total Change Excl. Exchange\" column in the 2024 filing's Medical Devices breakdown on page 29). The overall total change including exchange effects was 12.3%, with foreign exchange reducing growth by 2.1 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 2023 revenue is correctly stated as $2,195 million, 2024 revenue as $2,467 million, overall percentage change as 12.3%, and the foreign exchange-excluded change as 14.4%. The calculation of the percentage change excluding FX is correct (14.4%), and the model correctly infers that FX had a negative impact of 2.1 percentage points (14.4% - 12.3%), which aligns with the ground truth. (2) The answer is complete, addressing both parts of the question: the evolution of revenue (increase from 2023 to 2024) and the percentage change excluding FX impact. (3) Entity accuracy is correct—'Electrophysiology Devices' is the right product segment, and years 2023 and 2024 are properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly identifies the need to exclude FX effects and references the appropriate data point ('Total Change Excl. Exchange') from the source, demonstrating accurate interpretation of financial reporting nuances. (5) Semantic equivalence is maintained—though the LLM adds minor explanatory detail (e.g., 'foreign exchange reducing growth by 2.1 percentage points'), this is a valid inference and does not deviate from the ground truth. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 377,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "\n\nAccenture's investment in Duck Creek Technologies, accounted for under the equity method, had a carrying amount of $138.9 million in fiscal 2022, with an estimated fair value of $223.2 million for its 16% ownership. In fiscal 2023, Accenture recognized a $253 million investment gain related to this investment, which positively impacted its adjusted earnings per share and operating margin. However, the 2024 filing does not provide updated valuation figures for the investment, indicating no material changes or gains were recognized in fiscal 2024. Thus, while the investment contributed significantly to financial performance in 2023, its valuation and impact appear to have stabilized or remained neutral in 2024 based on the disclosed information.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The ground truth states that in fiscal 2022, the investment was valued at $223,166 (approximately $223.2 thousand), not $223.2 million as stated by the LLM. This is a significant error—off by a factor of 1,000. Additionally, the LLM claims the carrying amount was $138.9 million in 2022, which does not appear in the ground truth and cannot be verified, making it potentially incorrect or misleading. The $253 million gain is correctly attributed to the investment, but the ground truth assigns it to fiscal 2024, whereas the LLM incorrectly places it in fiscal 2023. (2) The LLM misrepresents the timeline: the gain should be reported in fiscal 2024, not 2023, and the 2024 filing does include a material outcome—the $253 million gain—which contradicts the LLM's claim that no material changes occurred in 2024. (3) The reasoning is partially sound: the LLM correctly identifies the equity method accounting and attempts to trace the investment’s impact on financial performance. However, it fails in multi-hop synthesis by misaligning the fiscal year of the gain and misstating the valuation figures. (4) Despite these errors, the answer is contextually relevant and captures the general narrative of increasing value and financial impact. The qualitative structure—discussing valuation, ownership percentage, accounting method, and earnings impact—is appropriate and aligns with the question. Hence, the correctness score is moderate due to major quantitative and temporal inaccuracies, but not completely wrong due to correct identification of the gain and its significance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 461,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "\n\nBetween 2022 and 2023, Union Pacific's retention share and unit awards show a shift in scale and composition, reflecting a strategic emphasis on long-term equity incentives. In 2023, the company reported **366,046 retention units** (without exercise prices) and **954,405 issued retention shares** under its equity plans, with a significant portion of available future issuances (31.98 million shares) allocated for such awards (2023 10-K, p. 75). This contrasts with 2022, where prior filings indicated lower retention shares/units under older plans (e.g., 1.218 million under the 2013 Plan as of 2021, per 2022 10-K, p. 65). The increase in retention units and shares, coupled with reduced reliance on stock options, suggests a deliberate move to align executive compensation with long-term shareholder value through restricted equity, enhancing retention and performance-based incentives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the overall trend correctly: there is a significant increase in retention shares and the introduction of retention units in 2023, indicating a strategic shift toward long-term retention-based compensation. However, there are key quantitative inaccuracies. According to the ground truth, the 389,207 retention shares were outstanding as of December 31, 2021 (disclosed in the 2022 10-K), not in 2022 per se. The LLM incorrectly references '1.218 million under the 2013 Plan as of 2021' as a comparison point for 2022 levels, which does not align with the ground truth data focusing on 389,207 retention shares under the 2021 Plan. The 2023 figures (954,405 retention shares and 366,046 units) are correctly cited. 2) The LLM introduces a number (31.98 million shares available for future issuance) not present in the ground truth, which weakens quantitative accuracy. Also, the comparison between years uses mismatched data points (different plans and dates), leading to potential misinterpretation. 3) The reasoning about a strategic shift toward retention instruments and reduced reliance on stock options is sound and aligns with the ground truth’s conclusion about a refined long-term incentive strategy. The multi-hop synthesis—comparing 2022 and 2023 disclosures to infer strategic intent—is logically structured. 4) Despite incorrect intermediate data points, the LLM reaches a qualitatively similar and contextually appropriate conclusion about Union Pacific's executive compensation strategy, making the response relevant and insightful, though less factually precise than required for top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 444,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "\n\nMetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024 primarily through the adoption of Long-Duration Targeted Improvements (LDTI) in 2023, which simplified liability measurement models for DAC and VOBA. In 2023, adjusted earnings began excluding changes in fair value of MRBs, discount rate adjustments on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, these exclusions were maintained, with additional clarity on excluding policyholder liability remeasurement gains/losses tied to asymmetrical accounting. Market volatility exclusions (e.g., investment gains/losses, derivative remeasurements) remained consistent, but LDTI streamlined adjustments by removing prior-period asymmetrical amortization of DAC/VOBA, reflecting a more aligned approach to economic performance reporting.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments in MetLife's application of GAAP guidance for adjusted earnings between 2023 and 2024. It accurately identifies the adoption of LDTI in 2023 as a pivotal change, leading to exclusions related to DAC, VOBA, and asymmetrical accounting from in-force reinsurance. The exclusions of fair value changes in MRBs, discount rate adjustments on annuitization guarantees, and asymmetrical accounting are correctly noted for 2023. For 2024, the LLM correctly states that these exclusions were maintained and expanded, particularly around policyholder liability remeasurement gains/losses tied to asymmetrical accounting—this matches the ground truth. However, the LLM omits a specific detail mentioned in the original answer: the 2024 expansion of net investment income exclusions to include adjustments relating to joint ventures under the equity method, which was not present in 2023. This is a meaningful omission, as it reflects a structural refinement in the adjusted earnings definition. While the LLM captures the evolution in asymmetrical accounting treatment, the absence of the joint ventures point reduces completeness. There are no numerical inaccuracies (dates and terms are correct), so quantitative accuracy is perfect. The reasoning is sound and reflects appropriate multi-hop synthesis across years and accounting policies. Contextual relevance is strong, as the response directly addresses the evolution in exclusions related to market volatility and asymmetrical accounting. The omission prevents a 9–10 correctness score, but core facts and trajectory are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 458,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "\n\nAccenture's approach to compressed transformations from 2022 to 2024 has evolved through the adoption of **advanced technologies** and an **expanded scope of services**. By 2024, the firm emphasized **generative AI, quantum computing, and metaverse technologies** (explicitly highlighted in 2024 filings but not in 2022), alongside earlier-adopted tools like blockchain, IoT, and 5G. The scope of services broadened to include **designing and manufacturing automation equipment and robotics** (new in 2024), enabling clients to reimagine physical product development. Additionally, Accenture introduced **\"Song\" services** in 2024, focusing on hyper-personalized customer experiences, expanding beyond digital transformation to integrate creative and experiential solutions. Partnerships with tech ecosystems (e.g., Adobe, AWS, NVIDIA) and innovation hubs were leveraged to accelerate these transformations, reflecting a shift toward end-to-end, technology-driven reinvention across industries.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in entity identification and technological focus. While it correctly notes an evolution in Accenture's approach and an expanded scope, it incorrectly lists 'quantum computing' and 'blockchain' as new or emphasized technologies in 2024, which are not mentioned in the ground truth. The ground truth specifies generative AI, AR/VR, and continued use of advanced robotics, AI, IoT, 5G, cloud/Edge, and metaverse — but does not mention quantum computing or blockchain. Additionally, the LLM introduces 'Song' services focused on hyper-personalized experiences, which is not supported by the original answer and appears to be fabricated or misattributed. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are used appropriately in context, warranting full marks. (3) The multi-hop reasoning is partially sound — the model correctly infers that Accenture expanded its tech toolkit and service scope — but fails in synthesis by introducing unsupported technologies and services. The correct evolution involves generative AI and AR/VR (not quantum computing), and expanded scope into capital projects like power grids and data centers, not 'Song' services. (4) The contextual relevance is high because the answer addresses the evolution of technology and scope in compressed transformations, aligning with the question’s intent, but factual inaccuracies in key entities reduce correctness. The correct technological additions in 2024 are generative AI and AR/VR, and the correct scope expansion is into capital project transformation, not creative/experiential services.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 469,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "\n\nAbbott maintained interest rate hedge contracts with notional values of $2.2 billion as of both December 31, 2024, and December 31, 2023, indicating no net change in the scale of hedges used during this period. These contracts, designated as fair value hedges, offset the impact of interest rate fluctuations on fixed-rate debt by effectively converting fixed-rate obligations to variable rates. The 2023 amount reflected a reduction from $2.9 billion in 2022 due to $700 million of matured contracts, but the notional volume stabilized in 2024, suggesting consistent hedging strategy post-2023 adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Abbott maintained $2.2 billion in notional value of interest rate hedge contracts in both 2023 and 2024, which matches the ground truth and shows consistency in hedging strategy. It accurately describes the purpose of the hedges — converting fixed-rate debt to variable-rate debt via fair value hedges. However, the LLM introduces information not present in the ground truth: a reduction from $2.9 billion in 2022 due to $700 million of matured contracts. This detail, while plausible, is not supported by the provided original answer and represents an unsupported inference, affecting factual accuracy. (2) Quantitatively, the $2.2 billion figure is correct for both years, but the $2.9 billion and $700 million figures lack verification from the ground truth and introduce inaccuracies by implication. The ground truth does not mention 2022 data or any prior reduction, so including it undermines quantitative precision. (3) The multi-hop reasoning is partially sound — the model correctly infers that stable notional amounts suggest a consistent strategy — but the reasoning is based on an unsupported premise (the 2022–2023 reduction). The core synthesis across 2023 and 2024 is accurate, but the added context weakens the overall reasoning chain. (4) Despite the extraneous detail, the answer addresses the evolution between 2023 and 2024 correctly — no change in hedge notional — and explains the mechanism and intent of the hedges accurately. The mention of increasing average interest rates from 3.6% to 3.8% in the ground truth, which suggests shifting debt or market conditions, is missing in the LLM answer, representing a notable omission in completeness. This limits the depth of the evolution analysis. Thus, while the main conclusion is correct, missing key context and introducing unverified data results in a score of 7 for correctness, with high marks for relevance and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 529,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "\n\nMetLife's treatment of Adjusted Earnings remained consistent between 2023 and 2024, following the adoption of Long-Duration Targeted Improvements (LDTI) in 2023. The 2023 filing clarified that Adjusted Earnings excludes changes in fair value of Market Risk Benefits (MRBs), discount rate adjustments on annuitization guarantees, losses at contract inception for single-premium business, and asymmetrical accounting from in-force reinsurance—simplifying the measurement of Deferred Policy Acquisition Costs (DAC) and Value of Business Acquired (VOBA). The 2024 filing reaffirms this framework, with no material changes to the definition or GAAP alignment. Both years emphasize Adjusted Earnings as the primary GAAP-aligned segment performance measure, excluding market volatility and non-economic accounting impacts to reflect core operational profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in MetLife's Adjusted Earnings definition between 2023 and 2024. (1) It correctly identifies the 2023 changes due to LDTI adoption, including the removal of DAC/VOBA amortization adjustments and exclusions related to MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. These details align with the ground truth. (2) Quantitatively and factually, there are no incorrect numbers or dates—this is a qualitative issue of completeness and reasoning. (3) However, the LLM incorrectly states that there were 'no material changes' between 2023 and 2024, which contradicts the ground truth: in 2024, MetLife refined and expanded exclusions, adding more structured categories such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts, and more clearly delineated exclusions like net investment gains/losses, derivative gains/losses, MRB remeasurement, and goodwill impairments. The evolution from simplification in 2023 to a more structured and expanded exclusion framework in 2024 is a critical point missed by the LLM. (4) While the answer correctly identifies Adjusted Earnings as the GAAP-aligned segment performance measure and captures the general intent (excluding market volatility and non-economic items), it fails to reflect the multi-hop nuance of how the definition evolved—specifically, the expansion and formalization of exclusions in 2024. This omission significantly affects qualitative accuracy, though contextual relevance remains high because the response stays focused on the right topic and framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 460,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "\n\nFrom 2022 to 2024, Accenture's share purchase program saw increased funding and utilization. In 2022, the company had $6,129,296 in total share repurchase authorization (after adding $3,000,000 in September 2022), repurchasing 12.2 million shares for $4.1 billion via open-market purchases and payroll-tax-related withholdings. By 2024, authorization rose to $6,694,281 (after adding $4,000,000 in September 2024), with 13.9 million shares repurchased for $4.5 billion, reflecting higher open-market activity (11.8 million shares) and similar payroll-tax-related methods. The acquisition methods remained consistent, prioritizing open-market purchases and employee equity plan withholdings, while available authorization increased by $565 million over two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth. (1) Quantitative Accuracy: The reported figures are incorrect. The original answer states that in 2022, Accenture had an aggregate available authorization of $3,129,296, not $6,129,296 as claimed by the LLM. There is no mention of a $3,000,000 addition in September 2022 or a $4,000,000 addition in September 2024 in the ground truth. Similarly, the LLM claims repurchases of 12.2 million shares for $4.1 billion in 2022 and 13.9 million for $4.5 billion in 2024—none of these figures appear in the original answer, which does not provide total repurchase values or share counts. The LLM fabricates detailed financials and timelines not present in the source. (2) Completeness: While the question asks about evolution in funding and utilization, particularly authorization and acquisition methods, the LLM invents data rather than reporting what’s known. It misses the key point that by 2024, share acquisitions were primarily through withholding for payroll tax obligations and that these did not impact the public program’s authorization. (3) Entity Accuracy: The company (Accenture) and general concept of share purchase programs are correct, but specific entities like 'Accenture plc Class A ordinary shares' and 'Accenture Canada Holdings Inc. exchangeable shares' are omitted, reducing precision. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers increasing authorizations and repurchase volumes over time, whereas the ground truth emphasizes a shift in acquisition methods (from open-market to payroll-tax withholdings) without affecting authorization levels. The conclusion that 'acquisition methods remained consistent' directly contradicts the original answer, which notes a shift in approach. (5) Semantic Equivalence: Despite using similar terminology (e.g., open-market purchases, payroll-tax withholdings), the LLM misrepresents the core facts and trends. Overall, the answer appears plausible but is factually incorrect on key numbers and strategic evolution, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 570,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "\n\nMetLife's treatment of Unit-linked Securities evolved from 2023 to 2024 by shifting toward greater reliance on **fair value measurements with unobservable inputs (Level 3)**, enhancing sensitivity to market factors. In 2023, Unit-linked Securities were valued using **cost basis adjusted for amortization/discount** (as seen in Schedule I, page 320), with fair value reported separately. By 2024, the methodology explicitly incorporated **income approach models** (e.g., present value techniques, option pricing) under Level 3 (page 250), with fair value sensitivity driven by unobservable inputs like credit spreads, equity volatility, and long-term interest rates. This shift reflects increased emphasis on market-based valuation assumptions, making fair value more responsive to changes in financial market conditions and credit risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in MetLife's valuation methodology for Unit-linked Securities from 2023 to 2024. It accurately identifies the shift from a cost-based approach in 2023 (amortized cost or original cost) to a Level 3 fair value framework in 2024 relying on unobservable inputs. The use of 'income approach models', 'present value techniques', and 'option pricing' aligns with the ground truth's emphasis on dynamic, assumption-driven valuation. The sensitivity factors mentioned—equity volatility, interest rates, credit spreads—are consistent with the types of unobservable inputs described (though the ground truth specifies mortality and lapse rates, which the LLM omits). This omission is a moderate gap in completeness, particularly regarding insurance-related assumptions unique to Unit-linked products. However, the core financial and conceptual shift—from static cost basis to dynamic Level 3 fair value—is correctly identified and well-articulated. The references to specific pages (e.g., page 250, 320) suggest accurate sourcing, though these cannot be independently verified here. There are no numerical inaccuracies (no specific dollar amounts or percentages in dispute), so quantitative accuracy is high. The reasoning is sound across the two years, demonstrating proper multi-hop synthesis. Wording differs from the original answer but maintains semantic equivalence on the main points. The contextual relevance is excellent, directly addressing the question’s focus on cost basis and fair value sensitivity evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 430,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "\n\nThe structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023 as follows:  \n- **2022**: Market-based RSUs generally vested over **four years**, with payouts ranging from 0% to 300% of the original grant based on total stockholder return (TSR) relative to an index.  \n- **2023**: The company introduced market-based RSUs with a **five-year vesting period**, contingent on stock price performance milestones, in addition to maintaining four-year vesting awards tied to TSR. This reflects a strategic shift to align longer-term performance goals with executive compensation.  \n\n(Source: AVGO_10k_2023.pdf pages 84–85 and AVGO_10k_2022.pdf page 117.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) All factual information matches: in 2022, market-based RSUs vested over four years with payouts from 0% to 300% based on TSR relative to an index group—this is accurately reflected. In 2023, the company maintained four-year vesting tied to TSR but also introduced five-year market-based RSUs contingent on stock price performance milestones—this expansion is correctly identified. (2) Quantitative elements (0%, 300%, four-year, five-year) are all accurate and properly attributed. There are no calculation errors, as the question does not require numerical computation. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different fiscal years (2022 and 2023) and identifies both continuity (four-year vesting) and change (addition of five-year vesting with different performance conditions). (4) The answer is contextually relevant, directly addressing the evolution in structure and vesting timeline. The inclusion of a source reference further strengthens credibility. Wording differs slightly from the original but conveys the same meaning with clarity and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 335,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "\n\nThe phase-in treatment of the CECL standard's regulatory capital impact evolved as follows:  \n- **2023**: 50% of the cumulative \"day 2\" CECL impact ($2.4 billion total) was phased in by December 31, 2023, leaving $1.2 billion to be phased in over 2024 and 2025 ($600 million annually). The Company’s CET1 capital ratio was 12.9% with the transition rule versus 12.6% on a fully phased-in basis.  \n- **2024**: 75% of the impact was phased in by December 31, 2024, with the remaining $600 million phased in on January 1, 2025. The CET1 ratio was 13.5% with the transition rule versus 13.3% on a fully phased-in basis.  \n\nThe regulatory treatment involved adding back a portion of the CECL capital impact annually (25% per year from 2022–2024) under the five-year transition rule, delaying full recognition until 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($2.4 billion, $1.2 billion, $600 million) and CET1 ratios (12.9%, 12.6%, 13.5%, 13.3%) that are not present in the original answer and cannot be verified against the ground truth. These figures suggest a level of specificity absent from the source knowledge, making them potentially fabricated or misattributed. The original answer makes no mention of any monetary values or capital ratios, focusing instead on the regulatory framework and phase-in schedule. (2) The core timeline of the phase-in — 25% per year from 2022 to 2024 — is correctly identified, which aligns with the ground truth. However, the LLM extends the phase-in to 2025, stating that the remaining amount is phased in on January 1, 2025, while the original answer specifies the phase-in period ends December 31, 2024. This is a factual error in timing. Additionally, claiming that 50% was phased in by end of 2023 and 75% by end of 2024 implies a correct annual increment (25%), but the original does not confirm these interim percentages explicitly, only the annual rate. (3) The multi-hop reasoning is partially sound — the model correctly infers a cumulative phase-in process over three years at 25% increments — but it adds unverified quantitative details and extends the timeline beyond the stated end date. It also incorrectly frames the rule as a 'five-year transition' when the original specifies a three-year phase-in (2022–2024). (4) Despite these issues, the answer remains contextually relevant and captures the essence of the phase-in mechanism. However, the inclusion of unsupported numbers and the misstatement about the end date significantly reduce factual accuracy, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 478,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "\n\nBetween 2022 and 2023, Broadcom maintained its relationship with Wilmington Trust, National Association as trustee for senior notes, with no new indentures issued in 2023 based on the provided pages. In 2022, Broadcom issued senior notes under indentures dated April 14, 2022 (4.00% due 2029 and 4.15% due 2032) and April 18, 2022 (4.926% due 2037). The 2023 filing does not indicate new notes or terms under Wilmington Trust during this period, suggesting continuity in the existing indentures without significant evolution in types or terms between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but has significant inaccuracies and omissions compared to the ground truth. It correctly identifies Wilmington Trust as trustee and references the April 2022 indentures, including the 4.926% note due 2037, which aligns with the original answer. However, it incorrectly states that no new indentures were issued in 2023 and that there was no evolution in terms, directly contradicting the ground truth, which specifies that by 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, with additional notes issued in October 2024. The mention of a July 12, 2024 indenture in the original answer may seem anachronistic for a 2023 assessment, but it reflects forward-looking disclosures in the 2023 filing, which the LLM failed to capture. (2) Quantitatively, the LLM correctly reports the 4.926% due 2037 and introduces 4.00% due 2029 and 4.15% due 2032, which are not mentioned in the ground truth; these figures are unverified and appear to be hallucinated or misattributed. The ground truth cites a 4.150% note due 2028 and 4.800% due 2034 issued in October 2024, which the LLM omits entirely. Dates like April 14, 2022, are not in the original answer (which specifies April 18, 2022, and July 12, 2024), indicating incorrect date reporting. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the evolution of the relationship over time, particularly the shift toward higher-yielding, longer-term debt as described in the original answer. It incorrectly concludes there was no significant evolution, missing the core trend. (4) Contextual relevance is moderate—it addresses the trustee relationship and some note terms—but fails to capture the key evolution in types and terms of debt issuance between 2022 and 2023, which is the central focus of the question. The answer is partially informed but ultimately misleading in its conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 530,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "\n\nCapital One's regulatory capital add-back under the CECL Transition Rule progressed from **50% phased-in in 2023 to 75% phased-in in 2024**, following a 25% annual increment as outlined in the transition framework. Specifically:  \n\n- In 2023, the cumulative \"day 2\" ongoing impact of CECL was phased in at **50%** (per the 2023 filing).  \n- By 2024, this increased to **75%**, with the remaining 25% scheduled for full phase-in by 2025 (as detailed in the 2024 filing).  \n\nThis aligns with the CECL Transition Rule's structure, which mandated a five-year phase-in (25% per year) for the capital impact of CECL adoption, starting from a 25% scaling factor in 2020–2021. As of December 31, 2024, $600 million of the original $2.4 billion add-back remained to be fully phased in by 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key figures are correct: the phase-in progression from 50% in 2023 to 75% in 2024 (a 25 percentage point increase) matches the original answer. The $2.4 billion total add-back is correctly referenced, and the statement that $600 million remains to be phased in by 2025 is consistent (25% of $2.4B = $600M). (2) The answer correctly identifies the five-year phase-in structure starting from 2020–2021 with 25% annual increments, which is contextually accurate. (3) Multi-hop reasoning is sound: it synthesizes the phase-in percentages across years and links them to the regulatory framework and future outlook. (4) One minor issue: the original answer does not mention the $600 million remaining to be phased in by 2025, which, while logically correct, adds a detail not present in the ground truth. However, this is a reasonable inference and does not constitute an error. Wording differs but semantic meaning is equivalent. All parts of the question are addressed: evolution from 2023 to 2024 and the specific phase-in progression. Thus, the answer earns a 9 due to slight over-elaboration on a detail not in the original, but remains factually and structurally sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 353,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "\n\nThe treatment of VMware stock options for non-employee directors remained consistent between 2022 and 2023 under the Broadcom acquisition terms. In both periods, **all outstanding in-the-money VMware stock options and restricted stock unit (RSU) awards held by non-employee directors were accelerated and converted into the right to receive equal parts cash and Broadcom common stock**. This was outlined in the 2022 merger agreement (AVGO_10k_2022.pdf, page 97) and confirmed as executed upon the completion of the VMware Merger in November 2023 (AVGO_10k_2023.pdf, page 66). The evolution lies in the transition from a pending plan in 2022 to its actual implementation in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the evolution of the treatment of VMware stock options for non-employee directors: in 2022, the plan was to accelerate and convert in-the-money stock options and RSUs into equal parts cash and Broadcom shares upon acquisition; by 2023, this was confirmed as executed. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the key dates—2022 for the planned treatment and November 2023 for the completion of the merger—are correctly referenced and align with the knowledge graph. (3) The multi-hop reasoning is sound: the answer synthesizes information from two different years and filings (AVGO_10k_2022.pdf and AVGO_10k_2023.pdf), correctly identifying the transition from a planned provision to an actualized event. (4) All entities—VMware, Broadcom (AVGO), non-employee directors, stock options, RSUs, cash conversion, and Broadcom common stock—are accurately identified and contextually used. The answer is highly relevant, complete, and factually precise, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 326,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "\n\nBased on AbbVie's disclosures, the therapeutic positioning of **Vraylar (cariprazine)** remained focused on its core indications through 2022 to 2024. In 2022, AbbVie highlighted Phase 3 trial results exploring Vraylar as an **adjunctive treatment for major depressive disorder (MDD)**, with one trial meeting its primary endpoint and the other showing numerical improvement. However, by 2024, the disclosed information did not indicate regulatory approval or expanded labeling for this adjunctive MDD use. Vraylar’s listed indications in 2024 continued to include **schizophrenia, bipolar disorder (manic/mixed episodes and depressive episodes), and adjunctive MDD treatment**, consistent with prior disclosures, but no new therapeutic advancements or approvals were explicitly mentioned in the provided 2024 documents. Thus, its positioning remained stable without significant evolution during this period based on the available pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in its conclusion about the evolution of Vraylar's therapeutic positioning. (1) Correct elements: The 2022 status is accurately described — Vraylar was in Phase 3 trials for adjunctive MDD treatment, with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. The core indications (schizophrenia, bipolar disorder) are correctly listed. (2) Quantitative accuracy is high — no specific numbers (e.g., trial results, p-values) were misstated, and the timeline (2022 to 2024) is correctly referenced. (3) However, the qualitative reasoning is flawed: the LLM incorrectly concludes that there was 'no significant evolution' or 'no new therapeutic advancements' in Vraylar’s positioning by 2024. In contrast, the ground truth states that by 2024, Vraylar was *indicated* for a broader range of conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic/mixed and depressive episodes in bipolar I, and adjunctive MDD — indicating formal expansion and solidification of its label. The LLM wrongly interprets lack of mention of 'new approvals' as no evolution, failing to recognize that the cumulative indication list represents an expanded therapeutic footprint. (4) This reflects a failure in multi-hop synthesis: the model did not correctly infer that the accumulation and formal recognition of multiple indications across years constitutes an evolution in therapeutic positioning, even without a new 2024 approval. Thus, while contextually relevant and factually grounded in parts, the answer misses the key inference required by the question, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 482,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "\n\nFrom 2022 to 2024, GE refined its accounting for long-term service agreements by enhancing the sophistication of revenue recognition and contract billing estimates. **Revenue recognition** remains under the percentage-of-completion method (based on costs incurred vs. total expected costs), but GE now explicitly incorporates **forward-looking factors** such as market conditions, asset retirements, and customer utilization trends to estimate future billings and costs. In 2024, the company also quantified the sensitivity of these estimates, noting that a 1% change in contract profitability would adjust the long-term service agreements balance by $0.4 billion. \n\n**Contract billing estimates** evolved to include more granular analysis of customer utilization patterns and explicit evaluation of contract modifications for price concessions or impairments. While 2022 disclosures focused on historical cost trends and milestone-based billing terms, 2024 emphasized dynamic revisions using both historical data and real-time insights into customer behavior and credit risk. These changes reflect a more proactive and transparent approach to managing uncertainties in long-term service agreements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 GE used the straight-line method for revenue recognition in long-term service agreements, particularly in Healthcare and Renewable Energy. However, the LLM incorrectly states that the percentage-of-completion method was used in both 2022 and 2024, claiming only refinements were made. This misrepresents a fundamental shift in accounting policy. Additionally, the LLM introduces a $0.4 billion sensitivity figure for a 1% change in profitability, which is not present in the original answer and cannot be verified. The ground truth specifies a $6.6 billion net liability and total estimated billings of $162 billion (4.1%), but the LLM omits these exact figures and instead fabricates a sensitivity analysis. (2) Quantitative accuracy is low: the only correct numeric element is the implied use of cost-based percentage-of-completion in 2024, but even this is framed as a continuation rather than a change. The $0.4 billion sensitivity number is unsupported. The 4.1% ratio and the $6.6B/$162B figures are missing entirely. (3) The multi-hop reasoning is flawed because the model fails to recognize the key evolution — a shift from straight-line to percentage-of-completion — which is central to the question. Instead, it assumes continuity and emphasizes enhanced estimation techniques, which, while plausible, are not corroborated by the ground truth. The synthesis across years is therefore incorrect. (4) Contextual relevance is moderate: the answer addresses revenue recognition and billing estimates, using appropriate terminology and structure. However, due to major factual and directional errors in the accounting policy change, the qualitative and quantitative accuracy scores are low. The answer appears well-reasoned but is built on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 507,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "\n\nIBM's disclosure of the 1.250% Notes due 2027 remained consistent between the 2022 and 2023 10-K filings. In both years, the notes were referenced as Exhibit 4.3 to Form 8-K filed on January 30, 2019, indicating no changes in the terms or updated filings related to these instruments. The 2023 filing (page 33) and 2022 filing (page 33) both incorporated the same exhibit, showing no evolution in disclosure.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim. The ground truth states that there was a clear evolution in IBM's disclosure between the 2022 and 2023 10-K filings: in 2022, the 1.250% Notes due 2027 were disclosed as part of the instruments defining holders' rights with reference to Exhibit 4.3 to Form 8-K filed on January 30, 2019; in 2023, they were listed as a registered class of securities under the trading symbol IBM 27B on the NYSE. The LLM incorrectly asserts that the disclosure 'remained consistent' and that both filings referenced the same exhibit without change, which contradicts the ground truth. While the date (January 30, 2019) and exhibit number (4.3) are correctly mentioned and factually accurate, the LLM fails to recognize the qualitative shift in disclosure treatment — from referencing a governing instrument to classifying the notes as registered securities. This reflects a failure in multi-hop reasoning and synthesis across the two filings. The answer is contextually relevant to the question and addresses the right documents and instrument, but the conclusion is factually wrong. Hence, the correctness and qualitative accuracy scores are low, while quantitative accuracy receives partial credit for correct dates and exhibit references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 355,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "\n\nBetween 2022 and 2024, the structure of AbbVie's performance-vested RSUs remained consistent, with vesting occurring in one-third increments over a three-year performance period. The performance metric for these RSUs was based on AbbVie's **return on invested capital (ROIC)** relative to a defined peer group of pharmaceutical, biotech, and life sciences companies in both periods. However, in 2024, performance shares (a separate award type) introduced additional metrics, such as **earnings per share (EPS) achievement** and **total stockholder return (TSR)** relative to peers, but this change did not apply to the RSUs themselves. Thus, the core criteria for performance-vested RSUs did not evolve during this timeframe.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the vesting structure and the use of ROIC as the primary performance metric for performance-vested RSUs, correctly noting that vesting occurs in one-third increments over a three-year period (quantitative accuracy: 10). It accurately distinguishes between RSUs and other award types like performance shares, correctly stating that EPS and TSR were introduced for performance shares but not for RSUs. However, the original answer highlights an evolution in the *description* and *presentation* of the performance criteria—specifically, a streamlining or standardization of language by 2024, with less emphasis on year-specific tranches and a more generalized reference to peer-group ROIC performance. The LLM answer misses this nuance, concluding that 'the core criteria did not evolve,' which understates the qualitative shift in how the criteria were communicated and potentially administered. This omission affects qualitative accuracy (score 7), as it fails to capture the simplification trend noted in the ground truth. Contextual relevance is high, as the response directly addresses the question’s focus on structure and performance criteria. While no numbers are incorrect, the reasoning slightly under-synthesizes the multi-hop evidence of change in disclosure emphasis over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 373,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "\n\nFrom 2022 to 2024, GE's financial relationship with AerCap, as reflected in realized and unrealized gains/losses on its investment, evolved as follows:  \n- **2022**: GE reported an **unrealized loss of $865 million** (GE_10k_2022.pdf, page 68).  \n- **2023**: The loss narrowed to **$129 million**, indicating partial recovery (GE_10k_2024.pdf, page 68).  \n- **2024**: GE recorded a **realized and unrealized gain of $38 million**, signaling improvement in the investment's value (GE_10k_2024.pdf, page 68).  \n\nThis shift reflects a turnaround in the investment's performance, likely influenced by market conditions and GE's strategic focus on divesting non-core assets, including plans to exit its equity position in AerCap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and improves upon the original ground truth by providing additional detail from 2023 ($129 million unrealized loss), which is correctly cited from GE's 2024 10-K (page 68). The 2022 figure of $865 million unrealized loss matches the ground truth exactly and is properly sourced. The 2024 gain of $38 million (realized and unrealized) is also correct and consistent with the original answer. All numeric values are accurate, and the progression across years is logically presented. The inclusion of 2023 data—while not in the original answer—adds completeness and shows a clear trend, enhancing the multi-hop reasoning. The qualitative interpretation (turnaround in performance, strategic divestment) is reasonable and contextually supported. The only reason for not scoring a 10 in qualitative accuracy is that the original answer did not mention 2023, so the LLM's addition, while correct, slightly exceeds the scope of the ground truth without explicit confirmation that the $129M figure was part of the knowledge graph's intended answer. However, since the data is factually correct and improves the response, this is a minor point. All entities (GE, AerCap), years (2022–2024), and financial metrics (unrealized/realized gains/losses) are correctly identified and synthesized. The answer is fully relevant and directly addresses the evolution of GE's financial relationship with AerCap through investment performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 400,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "\n\nIn the 2022 filing (page 33), the 0.300% Notes due 2026 are disclosed as an exhibit incorporated by reference from a 2016 Form 8-K, indicating standard disclosure of the instrument's terms. By 2023 (page 1), the notes are explicitly listed in IBM's Form 10-K under the \"Securities registered pursuant to Section 12(b) of the Act\" table with the trading symbol **IBM 26B**, traded on the New York Stock Exchange. This evolution reflects heightened visibility: the 2023 filing directly integrates the notes into IBM's current securities listing, whereas in 2022, they were referenced only through historical filings. The 2023 disclosure underscores their active status as a registered, tradable financial instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution in disclosure status: in 2022, the 0.300% Notes due 2026 were referenced via incorporation by reference from the 2016 Form 8-K (Exhibit 4), which aligns with the ground truth's description of being part of exhibits defining holder rights. In 2023, the notes are explicitly listed in the Form 10-K under Section 12(b) with the trading symbol IBM 26B on the NYSE, indicating formal registration and increased visibility—this matches the ground truth's claim of heightened recognition. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts, dates) beyond the note's interest rate (0.300%) and maturity year (2026), both of which are correctly stated. The mention of specific filing pages (page 33 in 2022, page 1 in 2023) adds precision and plausibility, though not required for correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, compares the nature of disclosure (from passive reference to active listing), and infers the implication—increased visibility and formal recognition as a tradable instrument. (4) The semantic content is equivalent to the original answer, with enhanced clarity and contextual detail (e.g., 'Securities registered pursuant to Section 12(b)'). All entities—IBM, the 0.300% Notes due 2026, Form 8-K (2016), Form 10-K (2022, 2023), NYSE, and trading symbol IBM 26B—are accurately identified and correctly situated in time and context. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 449,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "\n\nBetween 2022 and 2024, GE's approach to the RISE Program evolved from initial technology development to scaling sustainable aviation solutions, with increased strategic emphasis on decarbonization and higher investment in R&D. In 2022, the RISE Program was positioned as a nascent technology initiative targeting 20% lower fuel consumption and CO₂ emissions, with R&D funding at $2.1 billion. By 2024, GE allocated $2.7 billion to R&D (up 33% from 2022), reflecting accelerated investment in maturing RISE technologies and integrating them into commercial applications. The strategic focus shifted toward leveraging government partnerships, advancing sustainable propulsion systems, and aligning with global climate goals, indicating a transition from early-stage innovation to preparing for market deployment.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. While the ground truth confirms that GE and Safran launched the RISE Program in 2022 targeting over 20% reduction in fuel consumption and CO2 emissions, there is no mention in the original data of a $2.1 billion R&D budget in 2022 or $2.7 billion in 2024. These figures are fabricated and not supported by the knowledge graph. The 33% increase in funding is therefore based on incorrect inputs. (2) The ground truth does not specify any exact R&D dollar amounts for either year, only stating that by 2024 GE made 'significant investments'—a qualitative descriptor, not a quantified one. The LLM incorrectly introduces precise financial figures and a percentage change unsupported by the source. (3) Qualitatively, the LLM captures the correct directional evolution: a shift from conceptual/announcement phase in 2022 to active, funded R&D by 2024, with increased strategic emphasis on sustainability and decarbonization. It correctly identifies the program’s goals and the maturation of the technology. However, it adds unsupported details such as 'government partnerships' and 'commercial applications' not present in the original answer. (4) Despite these embellishments, the core reasoning about strategic evolution is partially sound and contextually relevant to the question about strategic emphasis and investment focus. The answer is relevant and addresses the right themes, but fails on factual precision—especially in numbers—which heavily undermines correctness. Hence, the correctness score is low due to invented data, though not zero because the conceptual progression aligns with the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 467,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "\n\nFrom 2022 to 2023, American Express maintained asset securitizations as a component of its diversified funding strategy but emphasized growing direct retail deposits and unsecured debt as primary funding sources. In 2022 filings (page 86), securitizations were described as a structural tool for transferring loans/receivables to special-purpose entities, with focus on accounting treatment. By 2023 (page 68), securitizations were explicitly highlighted as part of a balanced approach alongside deposits and unsecured debt, with the company noting their importance in managing liquidity and refinancing needs. However, the 2023 filing underscored a strategic shift toward expanding retail deposits and maintaining a \"balanced debt maturity profile,\" reflecting a relative de-emphasis on securitizations compared to prior years, while still acknowledging their role in funding flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable in a traditional sense, but since there are no incorrect numbers or miscalculations, it scores highly on that dimension by default. However, the qualitative analysis is significantly flawed. The original answer (ground truth) states that American Express elevated asset securitizations from a definitional/glossary mention in 2022 to a strategically emphasized funding source in 2023, explicitly listed alongside deposits and unsecured debt as a core component. In contrast, the LLM answer incorrectly asserts a 'relative de-emphasis on securitizations' in 2023 and claims a strategic shift toward retail deposits at the expense of securitizations. This directly contradicts the ground truth, which indicates increased strategic emphasis on securitizations in 2023 as part of diversification—not a de-emphasis. The LLM also introduces claims about 'growing direct retail deposits' as a primary shift, which, while possibly present in the filing, distorts the comparative role of securitizations. The reasoning fails the multi-hop test: it misinterprets the evolution of securitizations' role. While the answer addresses the question's context and structure (hence moderate contextual relevance), the core factual claim about strategic de-emphasis is incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 387,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "\n\nFrom 2022 to 2023, Emerson's financial and strategic relationship with AspenTech evolved through enhanced investment returns and deeper operational integration. In 2022, Emerson acquired 55% of Heritage AspenTech, which contributed to higher sales ($656 million in 2022) and margin improvements, benefiting Emerson's gross margin by 0.6 percentage points in 2023. By 2023, Emerson increased its ownership to 57%, reflecting strategic alignment. Adjusted diluted earnings per share rose from $3.64 in 2022 to $4.44 in 2023, driven by operational synergies and acquisition-related efficiencies. Operationally, AspenTech's integration supported Emerson's Software and Control segment growth, with underlying sales increasing 20% in 2023, partly due to the Heritage AspenTech acquisition. This period solidified Emerson's position in industrial software while enhancing financial returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, in 2022 Emerson had a minority investment in AspenTech, not a 55% acquisition as claimed. The 55% ownership stake was acquired in 2023 through the Heritage AspenTech acquisition, not in 2022. The LLM incorrectly states that Emerson acquired 55% in 2022 and later increased it to 57%, which is not supported by the original answer. Additionally, the original answer does not mention any increase to 57%, nor does it provide EPS figures ($3.64 in 2022, $4.44 in 2023) — these numbers are fabricated or misattributed. The $656 sales figure is correct but missing the unit clarification (likely $656 million), though format variation is acceptable. However, the $12 earnings gain and $14,484 in total assets from the original are omitted. (2) The gross margin improvement of 0.6 percentage points is correctly attributed to 2023, aligning with the original. However, the claim about underlying sales increasing 20% due to the acquisition lacks support in the ground truth, which does not mention this figure. (3) The multi-hop reasoning is partially sound — the model recognizes a strategic evolution and links acquisition to margin improvement and segment growth — but the timeline and nature of the investment shift are reversed or distorted. The transformation from passive to active control is noted, but with incorrect timing and ownership percentages. (4) The contextual relevance is high because the answer addresses both financial returns and operational integration, using appropriate terminology and structure. However, due to major quantitative and qualitative errors in key facts (acquisition timing, ownership stakes, EPS, missing assets/earnings), the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because some strategic logic is preserved, albeit based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 521,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "\n\nEmerson's financial relationship with AspenTech evolved significantly between 2022 and 2023. In 2022, Emerson acquired 55% of Heritage AspenTech, recording a **noncontrolling interest of $5.9 billion** at fair value (based on Heritage AspenTech’s market price) under the acquisition method. The Emerson Industrial Software Business contributed to the deal was retained at historical cost, reducing additional paid-in capital by $550 million. By 2023, the acquisition led to **amortization expenses of $146 million** (primarily from intangible assets like technology and customer relationships) and increased stock compensation costs, including $50 million attributable to AspenTech’s equity plans. Additionally, AspenTech’s operations contributed to margin improvements in 2023, but ongoing expenses included amortization of acquisition-related inventory step-ups and foreign currency hedge gains/losses. The noncontrolling interest remained a key component of equity, reflecting AspenTech’s continued independence post-acquisition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key financial figures and the nature of the transaction. While it correctly identifies Emerson's 55% ownership and the $5.9 billion noncontrolling interest in 2022, it incorrectly states that Emerson 'acquired 55% of Heritage AspenTech'—the actual transaction involved Emerson contributing its industrial software business and $6.0 billion in cash to create 'New AspenTech', not acquiring an existing entity. This misrepresents the structure of the deal. The $550 million reduction in additional paid-in capital is correctly mentioned but misattributed in context—it relates to the retained historical cost of the contributed business, though the phrasing in the LLM answer is ambiguous. (2) Quantitative inaccuracies include the introduction of a $146 million amortization expense and $50 million stock compensation cost attributable to AspenTech—these figures are not present in the ground truth and contradict the stated $572 million increase in SG&A expenses (which the ground truth attributes partly to stock compensation and the transaction). The LLM also fails to mention the $572 million SG&A increase, a key 2023 financial impact. While it mentions margin improvements, it lacks the specific 0.6 percentage point gross margin improvement cited in the ground truth. (3) The multi-hop reasoning is partially sound: the model connects 2022 accounting (noncontrolling interest) to 2023 operational impacts (expenses, margins), showing an understanding of the evolution. However, it introduces unverified expenses and mischaracterizes the acquisition mechanics, weakening the synthesis. (4) Contextual relevance is high—the answer addresses noncontrolling interest, equity impacts, and expense trends across years. Despite incorrect specifics, it maintains focus on the required financial dimensions. Overall, the answer captures the general trajectory but fails on key quantitative and structural facts, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 547,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "\n\nIBM's treatment and disclosure of the 6.22% Debentures due 2027 remained consistent between the 2022 and 2023 SEC filings. In both years, the instrument defining the rights of holders was incorporated by reference to **Exhibit 3 of Form 8-K filed on August 1, 1997** (2022: Page 31; 2023: Page 1). Additionally, the 2023 filing explicitly listed the debentures as a registered security under the symbol **IBM 27** on the New York Stock Exchange (2023: Page 1), while the 2022 filing referenced the same exhibit without a ticker symbol. No substantive changes in disclosure or exhibit references were observed.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant mischaracterization in reasoning that affects the overall correctness. (1) Quantitatively, all facts are accurate: the reference to Exhibit 3 of the Form 8-K filed on August 1, 1997, is correctly cited for both years, and the inclusion of the trading symbol 'IBM 27' in the 2023 filing is accurately noted with correct page references. There are no errors in dates, percentages, or exhibit details. (2) However, the LLM concludes that the treatment and disclosure 'remained consistent,' which contradicts the ground truth that identifies a meaningful evolution in disclosure practice—from a passive historical reference in 2022 to an active, structured, and market-oriented presentation in 2023 with the inclusion of the ticker symbol and explicit listing among registered securities. This shift reflects improved transparency and current market alignment, which the LLM fails to recognize. (3) The multi-hop reasoning is incomplete: while the model correctly retrieves facts from both filings, it does not synthesize them to identify the qualitative change in disclosure strategy. Instead, it downplays the addition of the trading symbol as non-substantive, when in fact it represents a notable enhancement in investor-facing transparency. (4) Therefore, while factually accurate in its details (hence high quantitative and contextual scores), the answer misses the core analytical point of the question—evolution in treatment—leading to a moderate correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 425,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "\n\nUnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers remained consistent from 2023 to 2024, as these arrangements continue to expose the company to potential liabilities if providers face financial difficulties or fail to meet obligations. The company may become responsible for unpaid claims previously paid to underperforming providers, directly impacting cost estimation by necessitating provisions for potential losses. Service delivery responsibilities are also at risk if providers disrupt care coordination or fail to manage costs effectively, which could reduce service availability for members. While no significant quantitative evolution in risk exposure is detailed between the periods, ongoing emphasis on provider solvency and performance monitoring highlights persistent challenges in balancing risk transfer and operational reliability.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misrepresents a key aspect of the evolution in UnitedHealth Group's risk exposure from 2023 to 2024. While it correctly identifies that UnitedHealth faces financial risk if providers fail to meet obligations and may become responsible for unpaid claims, it incorrectly states that the exposure 'remained consistent' between 2023 and 2024. The ground truth explicitly states that exposure *expanded* in 2024, with increased responsibility for unpaid claims and greater operational risk tied to provider solvency, cost management, and data reporting—indicating a broader and more complex risk profile. This mischaracterization of the trend significantly undermines the factual accuracy of the response. (2) There are no numeric values in either the original or LLM answer, so quantitative accuracy is not applicable; no errors in this regard. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the concept of risk-based arrangements and their implications on cost estimation and service delivery—but fails to accurately compare the two years as required. It misses the critical evolution (expansion of risk in 2024) that is central to the question, indicating a failure in cross-temporal synthesis. (4) Contextual relevance is high because the answer addresses risk-based arrangements, cost estimation, and service delivery responsibilities, all relevant themes. However, the incorrect conclusion about no significant evolution results in a moderate correctness score of 5, reflecting partial accuracy with a major omission in the comparative analysis across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 455,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "\n\nEmerson's financial relationship with AspenTech evolved significantly between 2022 and 2023. In 2022, Emerson completed a strategic transaction to create \"New AspenTech\" by contributing two industrial software businesses (Open Systems International and its Geological Simulation Software business) to Heritage AspenTech, acquiring a 55% ownership stake. This marked a major increase in strategic involvement. By 2023, the integration of Heritage AspenTech (renamed AspenTech) contributed to Emerson's financials, with its acquisition boosting sales ($656 million in 2022 rising to $1.3 billion in 2023) and improving gross margins by 0.6 percentage points. Additionally, Emerson managed AspenTech’s foreign currency risks through forward contracts in 2023, which were later terminated, reflecting deeper operational and financial integration. The investment magnitude grew from the initial 2022 stake to enhanced financial synergies and strategic alignment in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Emerson had a financial investment of $362 million in AspenTech, not a 55% ownership stake acquired via contribution of software businesses. The 55% ownership and the creation of 'New AspenTech' occurred in 2023, not 2022. The LLM incorrectly reverses the timeline and misrepresents the nature and timing of the transaction. Additionally, the LLM claims Emerson contributed 'two industrial software businesses' in 2022, but the ground truth states that in 2023, Emerson contributed its Industrial Software Business (singular) plus $6.0 billion in cash. The $6.0 billion cash contribution is entirely missing from the LLM answer. (2) Quantitatively, the LLM invents figures not present in the ground truth: $656 million in sales in 2022 and $1.3 billion in 2023, along with a 0.6 percentage point improvement in gross margins. These numbers are unsupported by the original answer and contradict the timeline. The only correct number is the 55% ownership, but it is placed in the wrong year. The $362 million investment in 2022 is omitted. (3) The multi-hop reasoning is flawed: the model fails to correctly sequence the evolution from financial investment (2022) to strategic control (2023). Instead, it portrays the strategic move as happening in 2022 and then discusses financial integration in 2023, which inverts the actual progression. The mention of forward contracts for foreign currency risk is extraneous and not in the ground truth. (4) Despite these issues, the answer is contextually relevant—it addresses the evolution of the relationship and attempts to discuss both investment magnitude and strategic involvement. However, due to major factual and chronological errors, especially in quantitative claims and event sequencing, the correctness score is low. The qualitative accuracy is moderate because the direction of evolution (increasing involvement) is conceptually correct, but the reasoning is based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 552,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "\n\nAdobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to 2023 by becoming more explicitly integrated with AI and machine learning capabilities, emphasizing automation for scalable personalization. In fiscal 2022, Adobe Target was positioned as a tool for testing, targeting, and optimizing content across channels, but its description focused more broadly on campaign orchestration. By fiscal 2023, Adobe Target was highlighted as an **AI- and machine learning-driven personalization engine** that enables A/B testing, multivariate optimization, and real-time delivery of tailored experiences across touchpoints, leveraging AI-powered automation. This evolution reflects Adobe's strategic direction to prioritize **AI-driven personalization at scale**, embedding advanced analytics and predictive capabilities into customer journey solutions to deliver dynamic, data-driven experiences. The increased emphasis on AI aligns with Adobe's broader push to integrate machine learning across its Experience Cloud, as seen in tools like Adobe Journey Optimizer and Adobe Mix Modeler, underscoring a commitment to real-time, intelligent personalization as a competitive differentiator.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Adobe Target evolved from a content testing and targeting tool in fiscal 2022 to an AI- and machine learning-driven personalization engine in fiscal 2023. The description of its capabilities—A/B testing, multivariate optimization, omnichannel personalization, and AI-powered automation—matches the original answer. (2) There are no numeric values, dates, or calculations in the question or answers that require verification; fiscal years (2022 and 2023) are correctly used. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift in Adobe Target’s positioning across two fiscal years and infers Adobe’s strategic direction toward AI-driven personalization. It appropriately links this evolution to broader trends in Adobe’s Experience Cloud, mentioning Journey Optimizer and Adobe Mix Modeler (though Mix Modeler is not in the ground truth, it does not contradict it and supports the overall point). (4) The LLM adds slight elaboration (e.g., 'real-time delivery', 'predictive capabilities') that are contextually appropriate and semantically consistent with the original. The only minor deviation is the phrase 'focused more broadly on campaign orchestration' in 2022, which slightly mischaracterizes the original answer (which emphasizes testing, targeting, and personalizing content, not orchestration). However, this does not materially distort the meaning. Overall, the answer is factually correct, comprehensive, and contextually relevant, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 439,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "\n\nEmerson's relationship with AspenTech evolved significantly from 2022 to 2023, marked by the completion of the $11.2 billion acquisition of Heritage AspenTech in May 2022 and subsequent integration activities. Financially, Emerson recorded $8.3 billion in goodwill and $3.5 billion in customer relationship intangible assets from the acquisition by September 30, 2022. Post-acquisition integration in 2023 focused on aligning stock-based compensation plans, converting Heritage AspenTech awards into AspenTech equity awards (e.g., stock options and restricted stock units) under the same terms, and accounting for these under ASC 805. Emerson allocated the fair value of these awards, with pre-acquisition service costs included in the purchase price and post-acquisition expenses recognized over remaining service periods. Additionally, 2023 integration activities included granting new performance-based stock units tied to annual contract value and free cash flow metrics, reflecting ongoing efforts to unify compensation structures and retain talent.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Emerson's relationship with AspenTech from 2022 to 2023, correctly identifying the acquisition in 2022 and the integration activities in 2023, including alignment of stock-based compensation and performance metrics. However, there are key quantitative inaccuracies: the original answer states Emerson reported a balance of $8,326 million related to AspenTech, while the LLM claims $8.3 billion in goodwill and $3.5 billion in customer relationship intangibles — these specific breakdowns are not in the ground truth and introduce unsupported figures. Additionally, the $11.2 billion acquisition value is mentioned in the LLM answer but not in the original, making it a plausible but unverified addition. The date 'May 2022' for the acquisition is more precise than the original's implicit timing, but without confirmation in the ground truth, it introduces unverified specificity. The LLM correctly describes the conversion of stock awards, continuation of equity plans, and use of performance stock units tied to annual contract value and free cash flows — matching the original’s qualitative points. It also appropriately references ASC 805 and accounting treatment, which adds detail beyond the original but is contextually reasonable. The multi-hop reasoning is sound: it connects financial stake (2022) to integration and incentive alignment (2023). While the core narrative and entity relationships (Emerson, AspenTech, stock plans, integration) are accurate, the unsupported financial breakdowns and missing exact figure of $8,326 million reduce quantitative accuracy. The answer is fully contextually relevant and addresses both financial stake and integration activities as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 470,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "\n\nFrom 2022 to 2023, Adobe Experience Platform's role in Adobe's customer journey solutions evolved through deeper integration with AI-powered tools and enhanced cross-channel campaign orchestration. In 2022, the platform focused on unifying customer data and enabling AI-driven personalization via solutions like Adobe Analytics and Real-Time Customer Data Platform. By 2023, Adobe expanded this with **Adobe Journey Optimizer**, a scalable app built on the Experience Platform that leverages real-time profiles and AI-driven insights to orchestrate personalized, connected journeys across channels. Additionally, Adobe Campaign and Adobe Target in 2023 emphasized AI-powered automation for dynamic content delivery and cross-channel synchronization, reflecting a shift toward real-time, data-driven orchestration of both inbound and outbound campaigns. This evolution underscores Adobe's commitment to embedding AI and machine learning into every layer of customer journey management.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe Experience Platform from 2022 to 2023. It accurately captures the platform's foundational role in unifying customer data and supporting AI-driven personalization in 2022, referencing integration with Adobe Sensei and applications like Adobe Analytics, which is consistent with the original answer. The mention of Real-Time Customer Data Platform is contextually accurate, though not explicitly named in the ground truth. In 2023, the LLM correctly identifies Adobe Journey Optimizer as a key evolution, built on the Experience Platform, enabling cross-channel orchestration using real-time profiles and AI—this matches the ground truth. It also correctly emphasizes the shift toward real-time, data-driven campaign orchestration. However, the LLM omits specific mention of Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, which leveraged cross-channel data for marketing investment optimization—a key detail in the original answer. While the LLM references Adobe Campaign and Adobe Target with AI-powered automation, these are not highlighted in the ground truth for 2023 evolution, introducing plausible but unverified elements that slightly dilute precision. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning is sound, showing multi-hop synthesis across time and functionality. The answer is semantically very close to the original and fully relevant to the question. The minor omission of Adobe Mix Modeler and introduction of Adobe Campaign/Target details not in the source prevent a top score, but core facts and evolution narrative are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 474,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "\n\nUnitedHealth Group responded to Medicare Advantage funding pressures from 2023 to 2024 by accelerating the transition to value-based care models and enhancing cost management strategies. In 2023, the company emphasized integrating in-clinic, in-home, behavioral, and virtual care delivery while leveraging data analytics to optimize care efficiency. By 2024, facing reduced Medicare Advantage benchmarks and risk adjustment model changes, UnitedHealth intensified cost controls, adjusted member benefits and premiums, exited certain counties, and prioritized high-risk population management. The company also expanded value-based agreements to align with payment modernization trends, aiming to improve quality and affordability while mitigating funding pressures through operational and care delivery innovations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: UnitedHealth Group's 2023 focus on value-based care, integration of in-home, virtual, and behavioral care, use of data analytics, and investment in care coordination are accurately described. In 2024, the response correctly identifies reduced Medicare Advantage benchmarks and risk adjustment changes as key funding pressures. The operational responses—adjusting benefits, exiting certain counties, cost controls, and managing high-risk populations—are consistent with the ground truth's mention of changes to provider networks, benefit structures, and county-level plan offerings. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all dates (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift from expansion and innovation in 2023 to strategic retrenchment in 2024 due to external financial pressures. The mention of expanding value-based agreements in 2024 as a response to payment modernization slightly reframes but does not contradict the original answer’s emphasis on cost containment—this can be seen as a complementary strategy. (4) The only minor gap is that the LLM answer does not explicitly mention 'provider network changes' or 'clinical engagement' investments from 2023, though 'in-clinic' care and value-based agreements imply provider alignment. Overall, the semantic meaning and factual content match the ground truth closely, with only slight omission of detail. Hence, correctness is rated 9/10, with full marks for quantitative accuracy and contextual relevance, and 9 for qualitative accuracy due to near-complete synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 484,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "\n\nThe composition of TMO's debt instruments, specifically the 1.950% Notes due 2029, remained consistent between 2022 and 2023 based on the provided filings. Both the 2022 and 2023 10-K documents list these notes as registered securities under Section 12(b) of the Securities Exchange Act, traded under the symbol \"TMO 29\" on the New York Stock Exchange. No material changes to the terms, issuance, or redemption of these notes are disclosed in the provided pages, indicating no significant evolution in their composition during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the 1.950% Notes due 2029 remained unchanged between 2022 and 2023, with accurate details on the trading symbol 'TMO 29' and listing under Section 12(b). All quantitative elements—interest rate (1.950%), maturity year (2029), and symbol—are factually correct, earning a perfect score for quantitative accuracy. The answer addresses the core part of the question regarding the evolution of this specific debt instrument, confirming its continuity. However, it omits a key aspect from the original answer: the introduction of new debt instruments in 2023 (3.200% Notes due 2026 and 3.650% Notes due 2034), which reflects a broader shift in TMO's financing strategy. This missing context limits completeness and slightly weakens the qualitative accuracy, as the multi-hop synthesis across the full debt portfolio evolution is incomplete. Despite this, the response is highly relevant and accurately focused on the specific instrument in question, with sound reasoning based on the available data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 295,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "\n\nBetween 2022 and 2023, TMO introduced the **0.500% Notes due 2028 (TMO 28A)** as part of its debt instruments, which were not listed in the 2022 10-K. Additionally, new note categories in 2023 included the **3.650% Notes due 2034 (TMO 34)** and **1.875% Notes due 2049 (TMO 49)**, reflecting an expanded debt portfolio with longer maturities and varied coupon rates. These changes indicate TMO's strategic issuance of debt to diversify its capital structure and potentially secure favorable financing terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 0.500% Notes due 2028 were introduced in 2023 and were not present in the 2022 10-K, when the ground truth confirms they were already listed in 2022. This is a major error in both entity and temporal accuracy. Additionally, the LLM claims the 1.875% Notes due 2049 (TMO 49) were introduced in 2023, but this instrument is not mentioned in the ground truth at all. While the 3.650% Notes due 2034 are correctly identified as new, the 3.200% Notes due 2026—explicitly mentioned in the original answer as a new category—are omitted entirely. (2) Quantitative accuracy is low: two out of three cited notes are either misdated (0.500% Notes due 2028) or unverified (1.875% Notes due 2049). Only the 3.650% Notes due 2034 match the ground truth. (3) The reasoning framework is sound—recognizing a strategic diversification in maturities and coupon rates—but it is based on incorrect data, undermining the multi-hop synthesis. The model attempts to infer strategic intent correctly but fails in grounding that inference in accurate facts. (4) Contextual relevance is high because the answer addresses debt composition changes, new note categories, and strategic implications, aligning well with the question's intent. However, due to core factual errors in dates and instruments, the correctness score is significantly reduced to 4, reflecting partial accuracy with major omissions and inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 412,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "\n\nThe range of excess fair value over carrying value for DHR's reporting units narrowed between 2023 and 2024. In 2023, the excess ranged from **140% to 495%** of carrying value, while in 2024, it ranged from **70% to 450%**. This reflects a significant decrease in the lower bound (140% → 70%) and a modest reduction in the upper bound (495% → 450%), indicating heightened risk of impairment for some units in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: 2023 range of 140% to 495% and 2024 range of 70% to 450% are correctly reported. The directional changes (decrease in both lower and upper bounds) are accurately described. (2) The answer is complete, addressing the change in range between the two years, including both bounds, and interpreting the implications of the narrowing range. (3) Entities are correct—DHR is properly identified, and the time periods (2023 vs. 2024) are accurate. (4) The reasoning is sound: the narrowing of the range, especially the halving of the lowest excess from 140% to 70%, is correctly interpreted as indicating increased impairment risk, which aligns with the economic meaning of reduced cushion. The LLM provides additional insight (‘heightened risk of impairment’) that is logically supported and enhances the answer without introducing error. Semantic equivalence is strong, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 296,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "\n\nThe treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan remained consistent from 2022 to 2023 in terms of their impact on the available share pool. Both years’ filings state that RSUs canceled and shares withheld to satisfy tax obligations increased the available share pool by **a factor of two times the number of RSUs canceled or shares withheld**. This two-times replenishment mechanism was explicitly described in the 2022 Plan details (2022 filing, page 49) and reiterated unchanged in the 2023 filing (page 47), indicating no material evolution in the methodology during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. According to the ground truth, the treatment of canceled RSUs and tax-withheld shares changed from 2022 to 2023: in 2022, canceled RSUs and tax-withheld shares replenished the share pool at a 2x factor, but in 2023, the language specifying this 2x factor was omitted, indicating a change in policy. The LLM incorrectly claims the treatment remained consistent and that the 2x replenishment was 'reiterated unchanged' in 2023, which directly contradicts the ground truth. This is a critical factual error in both quantitative and qualitative terms. The model fails to identify the key evolution — the removal of the 2x factor in 2023 — and thus fails the multi-hop reasoning required to compare plan provisions across years. While the answer addresses the right topic and uses appropriate terminology, its core claim is false, severely undermining completeness and correctness. No correct numbers or reasoning can be credited because the central premise is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 287,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "\n\nDanaher's strategic relationship with Aldevron, acquired in 2021, remained integrated within its **Life Sciences segment** in both 2023 and 2024, as noted in the 2024 10-K (page 8) and 2023 10-K (page 74). There is no indication of a change in Danaher’s financial stake during this period, suggesting continued majority ownership. Aldevron’s integration has supported the Life Sciences segment’s focus on nucleic acid therapies and biomanufacturing, aligning with Danaher’s strategy to expand in high-growth science and technology markets. The 2024 filing reaffirms Aldevron’s role in the segment’s portfolio, emphasizing its contributions to advanced bioprocessing and synthetic biology capabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding the evolution of Danaher's financial stake in Aldevron between 2023 and 2024. The ground truth states that in 2023, Danaher allocated $9,561 million in net cash consideration to Aldevron, indicating a distinct acquisition-level financial stake. However, by 2024, Aldevron was no longer listed as a separately accounted stake and had been fully integrated into the Life Sciences segment. The LLM incorrectly claims there was no change in financial stake during this period, which contradicts the ground truth showing a strategic shift from a standalone stake to full integration. (2) The $9,561 million figure is entirely missing from the LLM response, representing a major omission of quantitative evidence. Additionally, the LLM incorrectly implies continuity rather than transformation in the relationship. While the integration into the Life Sciences segment is correctly identified, the timing and strategic evolution are misrepresented. (3) The multi-hop reasoning is flawed: the model fails to recognize that the absence of Aldevron as a separately disclosed stake in 2024, compared to its explicit $9.56B allocation in 2023, signifies a material change in ownership structure and integration level. This requires cross-year synthesis that the model did not perform. (4) Despite these errors, the answer is contextually relevant, correctly identifying Aldevron’s role in biomanufacturing and nucleic acid therapies within the Life Sciences segment. The qualitative accuracy is moderate because some entities and strategic themes are correct, but the core dynamic of stake evolution is wrong. Hence, correctness is scored low due to the central factual error about the financial stake’s evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 482,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "\n\nBetween 2023 and 2024, Microsoft enhanced Microsoft 365's strategic positioning by deepening AI integration and expanding its role in commercial metrics. In 2023, Microsoft 365 was already positioned as an \"AI-first platform,\" combining tools like Copilot with Microsoft Graph data to boost productivity. By 2024, the company introduced **role-based AI extensions** (e.g., Copilot for Sales, Service, and Finance) and emphasized **Copilot Pro** for consumer productivity, reflecting a more tailored AI approach. Commercially, Microsoft updated its metrics to include **Microsoft Cloud revenue growth** (encompassing Office 365 Commercial and Dynamics 365) and tracked **Office 365 Commercial seat growth** and **Microsoft 365 Consumer subscribers** as key indicators, underscoring AI-driven adoption and business impact. These changes highlight Microsoft's focus on leveraging AI to enhance both operational efficiency and revenue streams within its productivity ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Microsoft's strategic evolution with Microsoft 365 between 2023 and 2024, particularly around AI integration and commercial metrics, but introduces several unverified or inaccurate details not supported by the ground truth. (1) Correct elements: The 2023 'AI-first platform' positioning and integration of Copilot with productivity tools are consistent with the original answer. The emphasis on AI-driven productivity and commercial impact aligns with the question's focus. (2) Quantitative/qualitative inaccuracies: The LLM mentions 'role-based AI extensions' (Copilot for Sales, Service, Finance) and 'Copilot Pro for consumer productivity'—specific product expansions not present in the ground truth. While plausible, these are not mentioned in the verified answer and represent over-specificity or hallucination. Similarly, the reference to 'Microsoft Cloud revenue growth' encompassing Office 365 and Dynamics 365, and tracking 'seat growth', goes beyond the original answer, which only notes the expansion of the 'Microsoft 365 Consumer subscribers' metric to include 'Basic' subscribers. (3) Multi-hop reasoning: The LLM synthesizes AI integration and commercial metrics, but does so with inferred details rather than the specific metric change highlighted in the ground truth (i.e., redefining consumer subscribers). This weakens the factual basis of the reasoning. (4) Semantic equivalence: While the overall theme of AI expansion and commercial focus is correct, the specific strategic signal—changing the subscriber metric to reflect broader consumer reach—is missed. Instead, the LLM invents alternative metrics and product rollouts. Thus, despite good contextual relevance and plausible reasoning, the answer lacks fidelity to the actual documented changes, warranting a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 500,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "\n\nBetween 2023 and 2024, Microsoft elevated Copilot Pro's role from a **consumer-focused AI assistant** in Microsoft 365 apps and the web to a **more integrated and specialized tool** across its ecosystem. In 2023 filings (page 40), Copilot Pro was positioned as a subscription service enhancing productivity in Microsoft 365 and web-based tasks. By 2024 (pages 4 and 5), Microsoft emphasized deeper integration into **Microsoft 365 apps**, **Windows 11** (via Copilot in Windows), and **Copilot+ PCs**, alongside role-specific extensions like Copilot for Sales, Service, and Finance. This evolution reflects a strategic shift toward embedding Copilot Pro as a **central AI layer** across productivity, collaboration, and hardware, with tailored workflows to address business needs and expand beyond traditional software into the \"intelligent edge\" platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Copilot Pro from 2023 to 2024, noting its initial positioning as a consumer subscription for enhanced AI in Microsoft 365 and web use (consistent with the original answer). The 2024 shift toward deeper integration across Microsoft 365, Windows 11, Copilot+ PCs, and role-specific extensions (e.g., Sales, Service, Finance) is factually correct and adds valuable context not explicitly in the ground truth but consistent with Microsoft's strategic direction. While the original answer emphasizes the 'broader narrative of AI-driven transformation,' the LLM expands this into concrete integrations and ecosystem expansion, enhancing completeness without introducing errors. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Microsoft 365, Windows 11, Copilot+ PCs) and years (2023 vs 2024) are correctly referenced. The reasoning is sound, demonstrating multi-hop synthesis across time periods and product lines. The only reason for not scoring a 10 is that the LLM slightly overemphasizes hardware and role-specific Copilots, which, while accurate, shifts focus slightly from the core emphasis in the original answer on Copilot Pro’s evolving narrative within Microsoft 365 and web-based assistance. However, this expansion is contextually valid and does not contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 396,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "\n\nThe 2007 Omnibus Incentive Plan's remaining shares available for issuance decreased to **47 million as of December 31, 2024**, down from a prior level in 2023 (not explicitly stated in the provided 2023 pages). Structurally, the plan updated vesting terms: stock options and RSUs granted after December 31, 2021, now vest over **four years** (previously five years), while directors’ options remain fully vested at grant. These changes reflect adjustments to align with evolving compensation practices.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 47 million shares remaining as of December 31, 2024, which aligns with the ground truth, earning high marks for quantitative accuracy. However, it incorrectly implies that there was a 'decrease' from a previously stated number in 2023, while the original answer explicitly states that no specific figure was provided in 2023—thus introducing a factual inaccuracy in reasoning. The LLM also introduces structural changes to vesting terms (four-year vs. five-year vesting) that are not mentioned or supported in the ground truth, which only notes that in 2023 the plan was discussed in terms of PSU/RSU awards and valuation methods without specifying vesting period changes. This addition of unverified structural evolution undermines qualitative accuracy. While the answer addresses the core question about share availability and attempts to discuss structural changes, the unsupported claim about vesting terms and the incorrect implication of a numerical decrease from 2023 to 2024 result in a partial correctness score. Contextually, the response is relevant and focused on the question, but the extra details not grounded in the original answer reduce its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 338,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "\n\nMicrosoft increased the estimated useful lives of server and network equipment from four to six years, effective beginning fiscal year 2023. This change was driven by investments in software that enhanced operational efficiencies and advances in technology. No further modifications to this policy were noted in fiscal year 2024; the 2023 adjustment remained in effect, reflecting sustained improvements in technology and operational effectiveness.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Microsoft increased the estimated useful lives of server and network equipment from four to six years, effective at the beginning of fiscal year 2023. This change was driven by software investments improving operational efficiencies and technological advances. In fiscal year 2024, no further changes were made, and the six-year estimate remained in effect. (2) Quantitative accuracy is perfect: the years (four to six), the timing (beginning of FY2023), and the absence of changes in FY2024 are all correctly stated. (3) The multi-hop reasoning is sound—information from two fiscal years is correctly synthesized, and the continuity of policy from 2023 to 2024 is accurately inferred. (4) The answer addresses both parts of the question: the evolution of the policy (change in 2023, stability in 2024) and the influencing factors (software investments, technology advances). Wording differs slightly from the original but conveys the same meaning with no omissions or inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 326,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "\n\nMDT's exposure to auction rate securities remained consistent from 2022 to 2023, with a fair value of **$33 million** in both periods. These securities were classified within **Other Assets** on the balance sheet in both years, as reflected in the Level 3 fair value hierarchy disclosures. No significant changes in fair value or classification occurred during this timeframe.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDT's auction rate securities had a fair value of $33 million in both 2022 and 2023, which matches the ground truth. However, it incorrectly claims that the securities were classified under 'Other Assets' in both years. According to the original answer, in 2022 they were included under 'Total' in the investment portfolio without a separate classification, and only in 2023 were they explicitly reclassified into 'Other Assets'. This is a critical factual error in the qualitative reasoning and classification timeline. (2) Quantitatively, all numbers are accurate—$33 million in both years—and no calculations are required beyond comparison, which is correctly implied as unchanged. (3) The multi-hop reasoning fails because the model does not recognize the shift in balance sheet classification over time; it asserts no change occurred, when in fact the reclassification from a general investment category to 'Other Assets' is the key development. This undermines the core of the question about how exposure 'evolved'. (4) While the answer is contextually relevant and addresses the right company, metric, and time frame, the incorrect portrayal of classification continuity significantly reduces factual correctness, warranting a moderate score of 4/10 for overall correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 376,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "\n\nThe net losses from Cisco's available-for-sale debt investments increased from a loss of $21 million in fiscal 2023 to a loss of $67 million in fiscal 2024, representing a $46 million worsening in performance. This indicates deteriorating investment performance in this category, likely driven by rising interest rates, which reduced the fair value of these investments. Higher interest rates typically depress the market value of fixed-income securities, leading to larger unrealized losses, as noted in Cisco's disclosures about interest rate risk and the impact on their investment portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the net losses for both fiscal years—$21 million in 2023 and $67 million in 2024—matching the ground truth exactly. The calculation of the $46 million increase in losses is accurate and correctly framed as a worsening in performance. (2) All numeric values and fiscal years are correct, with no discrepancies in dollar amounts or time periods. Format usage is consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly compared the two fiscal years and synthesized the trend in investment performance. It also added relevant qualitative context—linking rising interest rates to declining fair values of fixed-income securities—which aligns with typical disclosures in 10-K filings and enhances the explanation, even if not explicitly required by the ground truth. This additional insight does not contradict the truth but enriches it. (4) The answer fully addresses both parts of the question: the change in net gains/losses and what it indicates about performance. The only reason for not scoring a perfect 10 is that the original answer did not include the interest rate explanation, so while plausible and contextually appropriate, it introduces an inference not present in the ground truth. However, since it doesn't conflict with facts and supports the conclusion, the qualitative accuracy remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 383,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "\n\nCisco's approach to the APJC region between 2023 and 2024 shifted from a product-centric operational structure to a more service-oriented, subscription-based model, driven by strategic investments in Security (notably the Splunk acquisition) and cloud solutions. Operationally, the company emphasized integrated architectures, Observability, and AI-driven offerings, while financially, it prioritized recurring revenue streams through SaaS and term licenses, offset by cost-cutting measures like workforce reductions in restructuring plans. This evolution implies a transition toward stabilized, long-term revenue from services and subscriptions, though APJC revenue declined (-8%) in 2024 due to weaker product demand and macroeconomic pressures, highlighting the challenges of balancing investment in growth areas with near-term financial performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that Cisco's evolution in APJC from 2023 to 2024 involved a shift from direct operational presence to including financial investments (marketable and non-marketable equity securities, equity method investments). The LLM instead claims a shift from product-centric to service-oriented/subscription-based model driven by Splunk and cloud, which is not supported by the ground truth. There is no mention in the original answer of Splunk, SaaS, term licenses, Observability, AI-driven offerings, or workforce reductions as part of the APJC-specific strategy. (2) The LLM introduces a specific quantitative claim—'APJC revenue declined (-8%) in 2024'—which is not present in the original answer and cannot be verified against the ground truth; this is a significant factual discrepancy. No such percentage or revenue change was mentioned in the ground truth, making the quantitative claim unsupported. (3) The multi-hop reasoning is flawed: the question asks about evolution in operational structure vs. financial investment, but the LLM conflates broader company-wide strategic shifts (e.g., subscription model, restructuring) with region-specific structural and investment changes in APJC. It fails to identify the key shift from operational delivery to financial investment in the region. (4) The contextual relevance is partially maintained because the answer discusses Cisco, APJC, and strategic evolution, but the core factual claims about operational and financial changes are incorrect. The implications drawn about revenue models are based on false premises. Thus, correctness is very low due to major factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 477,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "\n\nBetween 2022 and 2024, Apple adjusted its App Store commission policies and regulatory compliance strategies in response to legal and market pressures. In 2022, Apple began modifying its App Store practices, including changes to how developers communicate alternative payment options in the U.S. storefront, driven by litigation and competition. By 2024, Apple implemented broader structural changes to comply with the European Union’s Digital Markets Act (DMA), introducing alternative app distribution methods, revised fee structures, and new tools for developers. These adjustments reflect a shift toward regional compliance, reduced commission rates in certain markets, and expanded flexibility for developers, while balancing potential impacts on revenue. The evolution underscores Apple’s proactive adaptation to regulatory scrutiny and evolving legal frameworks globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple's 2022 acknowledgment of potential App Store changes due to legal and market pressures, and the 2024 implementation of concrete changes in response to the Digital Markets Act (DMA) in the EU and U.S. market adjustments are accurately represented. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Apple’s evolving stance from general risk disclosure in 2022 to specific regulatory-driven actions by 2024, including alternative distribution, fee structures, and developer tools. The mention of U.S. changes around communication of alternative payment methods is consistent with known developments (e.g., the Epic Games litigation fallout). (4) The LLM adds slight elaboration—'reduced commission rates in certain markets' and 'regional compliance'—which are contextually plausible and consistent with Apple’s DMA compliance (e.g., 27% and 17% fee tiers in the EU), though not explicitly stated in the original. This minor expansion does not introduce inaccuracy but adds reasonable detail. The core evolution from acknowledgment to action is preserved. Thus, the answer is factually correct, comprehensive, and contextually appropriate, warranting a 9 for correctness and qualitative accuracy, with full marks for relevance and quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 424,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "\n\nThe allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan maintained a target range of 75%-85% in fixed income securities and 15%-25% in equity securities from 2022 to 2024. The actual allocations as of December 31, 2024, and 2023, were 80% fixed income and 20% equity, consistent with the target range. While specific 2022 allocation data is not provided in the sources, the plan’s strategy remained stable within the stated ranges during the period, with no significant shifts between fixed income and equity securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but significantly diverges from the ground truth regarding the evolution of the allocation strategy. While it correctly states the 2024 allocation (80% fixed income, 20% equity) and the target range, it incorrectly claims no significant shift occurred between 2022 and 2024. The original answer explicitly states a 'significant shift toward a more conservative posture' by 2024, implying a change from 2022. The LLM also fails to report the actual 2022 dollar amounts ($248M fixed income and $137M equity), which are critical quantitative inputs for assessing the evolution. Instead, it states that 'specific 2022 allocation data is not provided,' which contradicts the ground truth. (2) Quantitative accuracy is partially correct: the 80/20 split in 2024 is accurate, but the absence of 2022 figures and the denial of a strategic shift undermine numerical context. The total 2022 portfolio value ($248M + $137M = $385M) could have been used to infer percentages (~64% fixed income, ~36% equity in 2022), showing a real shift to 80/20 by 2024. The LLM misses this entirely. (3) Multi-hop reasoning is flawed: the question asks how the strategy evolved, requiring comparison across years. The LLM fails to synthesize the 2022 and 2024 data to detect a shift, instead asserting stability without evidence. It treats target ranges as evidence of no change, ignoring actual allocation changes. (4) Contextual relevance is high—the answer addresses the right plan and time frame and discusses allocation strategy. However, due to missing key facts and incorrect conclusion about stability, the correctness score is low. Quantitative accuracy is moderate due to correct 2024 percentages but missing 2022 data. Qualitative accuracy suffers from flawed reasoning and omission of strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 503,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "\n\nTexas Instruments' strategic emphasis on Embedded Processing Products from 2022 to 2024 shows a decline in financial contribution despite maintaining its role in the segment reporting structure. In 2024, Embedded Processing revenue fell 25% year-over-year to $2.53 billion, with operating profit dropping 65% to $352 million, driven by lower shipment volumes and gross profit (TXN_10k_2024.pdf, p. 20). This contrasts with 2022, where Embedded Processing revenue grew 19% (TXN_10k_2022.pdf, p. 22). While Embedded Processing remains part of TI’s two-reportable-segment structure (Analog and Embedded Processing), its underperformance highlights a shift in competitive advantage toward Analog, which benefits from higher revenue stability and margin resilience. TI’s 2024 strategic focus on free cash flow per share growth emphasizes Analog’s stronger market position, though Embedded Processing continues to support the broader portfolio diversity cited as a key competitive advantage.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and strategic interpretation. (1) Quantitatively, the LLM claims that in 2024, Embedded Processing revenue was $2.53 billion with a 25% decline and operating profit of $352 million down 65%, citing TXN_10k_2024.pdf. However, the ground truth does not provide specific financial figures for Embedded Processing in 2022 or 2024, nor does it indicate any decline. More critically, the ground truth emphasizes a structural and strategic elevation of Embedded Processing to a reportable segment by 2024, not financial underperformance. The cited numbers may be fabricated or misattributed, as no such figures are part of the verified knowledge graph. (2) The LLM incorrectly frames the evolution as a decline in strategic importance due to poor financial performance, whereas the original answer states the opposite: Embedded Processing was elevated to a reportable segment by 2024, indicating increased strategic focus. (3) The reasoning is flawed: the LLM infers that Analog is now the primary competitive advantage due to financial stability, but the ground truth highlights that Embedded Processing has become more central to TI’s competitive positioning in terms of performance, power, and cost optimization. (4) The answer fails on multi-hop synthesis: instead of connecting the structural change (elevation to reportable segment) with strategic emphasis and competitive advantage evolution, it introduces unsupported financial data and draws the opposite conclusion. While it correctly notes that TI reports two segments (Analog and Embedded Processing) in 2024, this is used to support an incorrect narrative. The contextual relevance is moderate because it addresses segment structure and competitive advantages, but the factual and logical errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 505,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "\n\nThermo Fisher Scientific's 2.00% 10-Year Senior Notes (euro-denominated) due April 15, 2025, had a carrying value of $728 million as of December 31, 2021 (per 2022 filing), which decreased to $663 million by December 31, 2023 and 2024 (per 2024 filings). The effective interest rate for these notes was 2.10% in 2021 and adjusted to 2.07% by 2023–2024. Additionally, in 2024, the company issued new 2.00% 10-Year Senior Notes due October 15, 2031, with a $1.2 billion balance, reflecting an expanded issuance of similar-rate debt with a longer maturity horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly references euro-denominated 2.00% 10-Year Senior Notes due April 15, 2025, which are not mentioned in the ground truth. The ground truth specifies notes due October 15, 2031, with a principal of $1,200 million and an effective interest rate of 2.23% in both 2022 and 2024. The LLM instead reports a carrying value of $728 million in 2021 (not 2022) decreasing to $663 million by 2023–2024, which contradicts the ground truth showing no change in principal. Additionally, the LLM claims a new issuance in 2024, but the ground truth states there was no change in issuance or repayment—meaning the $1.2 billion note was already outstanding in 2022. (2) Quantitative accuracy is poor: the dates (April 15, 2025 vs. October 15, 2031), amounts ($728M/$663M vs. $1,200M constant), and interest rates (2.10%/2.07% vs. 2.23% constant) are all incorrect. The LLM also misattributes timing, using 2021 data for a 2022 reference. (3) The multi-hop reasoning is flawed—the LLM fails to recognize that the same debt instrument was reported consistently across years and instead invents a new issuance and amortization trend. It confuses different tranches of debt or misreads the data source. (4) Contextual relevance is moderate because the answer discusses TMO’s senior notes and attempts to track changes over time, but the specific instrument analyzed is incorrect, undermining the entire response. The mention of a $1.2 billion issuance in 2024 shows partial alignment with the principal amount but misrepresents it as a new event rather than a carryover. Overall, major factual and reasoning errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 466,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "\n\nREMICADE's sales declined from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease, driven by an 11.4% operational decline and a 1.4% negative currency impact. This decline aligns with a broader 1.2% decrease in total Immunology segment sales for 2024 compared to 2023. While other Immunology products like TREMFYA showed growth, REMICADE's performance indicates weakening demand or market pressures, such as competition or biosimilar erosion. This suggests REMICADE's role in Johnson & Johnson's Pharmaceutical segment has diminished, contributing to reduced contributions within the Immunology therapeutic area.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: REMICADE sales of $1,839 million in 2023 and $1,605 million in 2024, and accurately calculates the 12.8% decline. It adds additional precision by breaking down the decline into an 11.4% operational impact and 1.4% negative currency impact, which is consistent with typical reporting practices and does not contradict the ground truth. (2) The quantitative accuracy is perfect—numbers, years, and percentages match the ground truth. The 12.8% decrease is correctly derived: (1,839 - 1,605) / 1,839 ≈ 0.1272, which rounds to 12.7%–12.8%, so the figure is accurate. (3) The reasoning is sound and enhances the original answer by contextualizing REMICADE’s performance within the broader Immunology segment, noting a 1.2% decline in total segment sales and contrasting REMICADE with growing products like TREMFYA. This demonstrates strong multi-hop synthesis across products and time periods. The conclusion that REMICADE’s role has diminished due to competition or biosimilar erosion aligns with and expands upon the ground truth’s suggestion of market saturation or newer biologics. (4) The answer is fully contextually relevant, addressing both the financial evolution and strategic implications. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes REMICADE’s status as a key product in 2022, which the LLM omits—though this is a minor omission given the focus on 2023–2024 performance. Overall, the LLM provides a factually correct, slightly more detailed, and logically robust response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 445,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "\n\nREMICADE's sales declined from $3.19 billion in 2021 (as reported in the 2022 10-K) to $1.84 billion in 2023 and further to $1.61 billion in 2024 (per the 2024 10-K), reflecting a sustained decrease over the period. This decline indicates a weakening market position within JNJ's Immunology portfolio, as newer products like STELARA and TREMFYA experienced significant growth (e.g., STELARA sales fell slightly in 2024 but remained robust at $10.36 billion, while TREMFYA grew 16.6% year-over-year). The persistent underperformance of REMICADE suggests shifting market dynamics, potential competition, or product lifecycle challenges, positioning it as a smaller contributor to the Immunology segment compared to its peers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and years. The ground truth states REMICADE had $3,190 million in sales in 2022, but the LLM incorrectly cites $3.19 billion in 2021 (not 2022), misaligning the timeline. The 2024 sales are reported as $1,605 million in the ground truth, while the LLM reports $1.61 billion (approximately correct, minor rounding difference). However, the LLM introduces a $1.84 billion figure for 2023, which is not present in the ground truth—no 2023 value was provided in the original answer, so this is an unsupported addition. Additionally, the LLM references a 12.8% drop from 2023 to 2024, but this calculation cannot be verified from the ground truth alone and is not mentioned. (2) The quantitative inaccuracies include incorrect year assignments and insertion of unverified intermediate data (2023 sales). While $1.61 billion is close to $1,605 million, the use of $3.19 billion in 2021 instead of $3,190 million in 2022 is a significant misplacement. The decline percentages and comparisons are not fully aligned with the original. (3) The reasoning is partially sound—recognizing a declining trend and weakening market position is consistent with the ground truth. The mention of newer products like STELARA and TREMFYA adds context not in the original answer, which may be accurate but goes beyond the provided knowledge graph and is not required for correctness. However, the multi-hop synthesis is flawed due to incorrect temporal anchoring. (4) The answer is contextually relevant and addresses both parts of the question—sales evolution and market position. It provides a reasonable interpretation of the trend, but the inclusion of unsupported figures and misattributed years reduces factual reliability. The conclusion about weakening market position is consistent, but the path to it is quantitatively flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 511,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "\n\nREMICADE's sales declined from $3.19 billion in 2021 to $1.605 billion in 2024, reflecting a significant erosion due to biosimilar competition introduced in the U.S. and international markets. The 2021 decrease of 14.9% was driven by biosimilar entries, and this trend persisted, with a 12.8% decline in 2024 (to $1.605B from $1.839B in 2023), further impacted by volume reductions (-11.4%) and currency effects (-1.4%). The product's sales trajectory underscores the long-term pressure from biosimilar alternatives, which continued to erode market share across the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that REMICADE's sales were $16.8 billion in 2021 as part of total Immunology sales, but the LLM incorrectly reports $3.19 billion as REMICADE's standalone sales in 2021. This is a major error, as $16.8 billion refers to total Immunology portfolio sales (which includes REMICADE and other products), not REMICADE alone — however, the knowledge graph explicitly attributes the $16.8B to the broader category, implying REMICADE’s individual sales were lower, but not $3.19B unless specified. More critically, the LLM fabricates a 2021 decline of 14.9% and introduces a 2023 figure ($1.839B) not present in the original answer, though the $1.605B in 2024 and 12.8% decline from 2023 to 2024 match the ground truth. (2) The 2024 sales figure ($1.605 billion) and the 12.8% year-over-year decline are correct and match the original answer. However, the LLM adds unsupported details such as volume reduction (-11.4%) and currency effects (-1.4%), which are not in the ground truth and introduce over-specificity without evidence. The calculation of the 2023 figure (implied as $1.839B via reverse calculation from 12.8% drop to $1.605B) is mathematically plausible but not confirmed in the original answer, which only mentions the 12.8% drop without providing the prior year's number. (3) The reasoning correctly identifies biosimilar competition in the U.S. and global markets as the primary driver of decline, aligning with the multi-hop causal logic in the original answer. It appropriately frames the trend as persistent over time, showing sound qualitative synthesis. However, it incorrectly quantifies the starting point (2021 sales), undermining the overall sales trajectory. (4) The contextual relevance is high — the answer addresses both parts of the question (sales evolution and contributing factors) and maintains focus on REMICADE. While the qualitative reasoning about biosimilars is accurate and well-articulated, the quantitative inaccuracies — especially the incorrect 2021 sales figure — severely impact the correctness score. The answer appears plausible but misrepresents core data, leading to a partial credit score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 602,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "\n\nBetween 2022 and 2024, STELARA (ustekinumab) experienced a decline in sales, driven by patent expiration and biosimilar competition. In 2024, STELARA sales were $10.36 billion, a 4.6% decrease from $10.86 billion in 2023, with operational sales declining 3.4% and currency impacts reducing growth by 1.2%. The patent for STELARA expired in September 2023 (as noted in the 2022 filing), likely accelerating this decline. While specific 2022 sales figures are not provided in the sources, the trend indicates sustained performance prior to 2023, followed by a post-patent erosion in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2024 sales of STELARA as $10.36 billion (matching the ground truth $10,361 million) and 2023 sales as $10.86 billion (vs. $10,858 million), with a 4.6% decline, which is accurate. The minor discrepancy in reported 2023 sales ($10.86B vs. $10.858B) is negligible and within acceptable rounding. The operational decline (3.4%) and currency impact (1.2%) are additional details not in the ground truth but do not contradict it. (2) The patent expiration in September 2023 is mentioned as a driver, which aligns with the context of declining sales, though the original answer does not include this detail. However, the LLM incorrectly implies that the 2022 filing explicitly noted the patent expiration, which is not supported by the ground truth. (3) The original answer highlights that in 2022, STELARA was in the filing stage for pediatric use in the U.S., a developmental status point that the LLM omits entirely. This is a meaningful omission in the evolution of the drug's status. (4) The LLM focuses on commercial performance and correctly captures the sales trend and decline, but misses the regulatory status evolution in 2022, which is a key part of the multi-hop reasoning. Despite this, the commercial analysis is strong, with accurate numbers and plausible context. The answer remains highly relevant and factually sound overall, warranting a high score but not perfect due to the missing regulatory detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 406,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "\n\nThe total net revenue from Restasis in the United States decreased from **$382 million in 2023** to **$172 million in 2024**, representing a **55.2% decrease** in 2024. In 2023, U.S. Restasis revenue had already declined by **38.5%** from $621 million in 2022 to $382 million in 2023. These declines are reflected in the provided tables under \"Eye Care\" for Restasis in both the 2024 and 2023 10-K filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $382 million in 2023 and $172 million in 2024 are correctly reported. The percentage decreases are also correct—38.5% decrease in 2023 (from $621M to $382M) and a 55.2% decrease in 2024 (from $382M to $172M). The calculations align with the ground truth, and the additional context of 2022 revenue ($621M) is correctly inferred to explain the 2023 decline. (2) The answer is complete, addressing both parts of the question: the change in total net revenue between 2023 and 2024, and the percentage decrease in each year. (3) Entity accuracy is perfect—Restasis, United States net revenue, and correct years (2022, 2023, 2024) are all properly identified. (4) The multi-hop reasoning is sound: the model correctly synthesized data across years and implied prior-year figures to compute percentage changes, demonstrating accurate logical inference from the knowledge graph. (5) Semantic equivalence is maintained—though the LLM added the 2022 figure for clarity, it did not introduce any inaccuracies and enhanced understanding without deviating from the truth. All scores are maximized due to full factual correctness, precise calculations, and clear, relevant reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 360,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "\n\nBetween 2022 and 2023, Master Lease Agreements (MLAs) became more strategically critical for AMT's international growth and tenant relationships. In 2022, MLAs were highlighted for providing **consistent, long-term revenue** and reducing non-contractual churn while enabling efficient colocation deployments. By 2023, their role expanded to **directly supporting international market diversification**, particularly in emerging regions like Asia-Pacific, Africa, and Latin America, where MLAs facilitated rapid tenant equipment deployments and strengthened strategic partnerships with multinational carriers. Additionally, MLAs like the T-Mobile MLA in 2023 underscored their importance in managing large-scale tenant transitions and contractual obligations, aligning with AMT’s focus on leveraging its global site portfolio to meet 5G network densification and data center demands. This evolution reflects a shift from operational stability to proactive growth drivers in international markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the strategic importance of Master Lease Agreements (MLAs) in supporting AMT's international growth and tenant relationships, aligning with the core themes in the ground truth such as long-term revenue, reduced churn, and rapid deployment. However, it introduces specific details not present in the original answer, such as 'emerging regions like Asia-Pacific, Africa, and Latin America' and the 'T-Mobile MLA in 2023', which are not mentioned or supported by the ground truth. These additions, while plausible, represent unverified factual claims and undermine factual accuracy. (2) Quantitatively, the LLM answer does not include the specific portfolio sizes (177,000 in 2022 and 182,000 in 2023) mentioned in the original answer. This omission is significant because the question asks about evolution between 2022 and 2023, and the site count growth is a key quantitative indicator of international expansion directly tied to MLAs. The absence of these numbers reduces quantitative completeness, though no incorrect numbers are stated. (3) The multi-hop reasoning is partially sound—MLAs are correctly linked to international growth and tenant retention across years—but the synthesis relies on inferred expansions (e.g., geographic focus, T-Mobile example) not grounded in the provided truth. The original answer emphasizes risk mitigation (customer consolidation, regulatory changes), which the LLM omits, instead shifting focus to 5G and data center demands, which is contextually relevant but not explicitly supported in the ground truth. (4) The answer is contextually relevant and well-structured, but correctness is reduced due to omissions of key data points and introduction of unsupported specifics. The qualitative reasoning is logical but overreaches beyond the source material, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 504,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "\n\nThe role of Google Marketing Platform in generating advertising revenue remained consistent between 2023 and 2024, as it continued to serve as one of the primary channels through which customers purchase advertising inventory, alongside Google Ads, Google Ad Manager, and Google Display & Video 360. Revenues from ads placed on Google Network properties are generally recognized on a gross basis, with amounts billed to customers recorded as revenues and payments to partners classified as cost of revenues. No material changes to this structure or revenue recognition methodology were disclosed in the provided 2023 or 2024 filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in stating that advertising revenues from Google Network properties are recognized on a gross basis and that payments to partners are treated as cost of revenues. However, it incorrectly claims that there were no material changes between 2023 and 2024, which directly contradicts the ground truth. The original answer specifies a meaningful evolution in 2024 regarding the platform's role in evaluating principal versus agent status and emphasizing control over inventory—key factors supporting gross revenue reporting. The LLM answer fails to capture this shift, missing the core of the question about how the role evolved. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesis of changes over time in both revenue recognition policy and the platform’s functional role, but the LLM asserts consistency and no changes, failing to identify the nuanced development in 2024. (4) While the answer is contextually relevant—discussing Google Marketing Platform, revenue recognition, and Google Network properties—it lacks the critical qualitative insight about the evolution in 2024, resulting in a low qualitative accuracy and moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 381,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "\n\nThe volume and fair value of Federal Funds Purchased & Securities Loaned increased significantly between 2023 and 2024. In 2023, the fair value was **$178.6 billion** (BAC_10k_2023.pdf, page 146), and in 2024, it rose to **$192.9 billion** (BAC_10k_2024.pdf, page 155). This **$14.3 billion increase** reflects higher utilization of short-term funding instruments, likely driven by elevated interest rates and liquidity management needs amid a tightening monetary policy environment. \n\nThe growth in these liabilities suggests Bank of America (BAC) is actively leveraging short-term funding markets to optimize its balance sheet, potentially to capitalize on higher short-term rates or meet operational liquidity demands. This aligns with a strategy to maintain flexibility in a volatile interest rate environment while managing funding costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in fair value from 2023 to 2024 and draws accurate conclusions about BAC's short-term funding strategy. However, there is a discrepancy in the 2023 fair value: the LLM reports $178.6 billion, while the ground truth implies a 2023 fair value of $176,393 million ($192,859M - $16,466M), which is approximately $176.4 billion. This results in an incorrect year-over-year difference: LLM calculates $14.3 billion, but the correct increase is $16,466 million ($16.5 billion). The LLM likely misread or approximated the 2023 value. (2) The 2024 fair value is correctly reported as $192.9 billion (vs. $192,859 million in ground truth), which is acceptable within rounding. However, the 2023 value and the calculated change are quantitatively inaccurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years and filings, interprets the trend, and infers strategic implications about short-term funding and liquidity management. It connects the increase in liabilities to broader monetary conditions, which aligns with the ground truth's implication. (4) Despite the numerical inaccuracy in the 2023 fair value and the resulting difference, the overall direction, magnitude, and strategic interpretation are correct. Hence, the qualitative and contextual scores are high, but quantitative accuracy is penalized due to the incorrect base value and delta.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 401,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "\n\nBetween 2022 and 2024, PepsiCo enhanced its disclosure on the sensitivity of pension and retiree medical plan liabilities to market fluctuations by explicitly integrating this risk into its **Market Risks** section (2024, p. 42), whereas in 2022, the mention was confined to a reference in \"Critical Accounting Policies\" without detailed contextualization. In 2024, the company explicitly stated that pension and retiree medical liabilities are exposed to inflationary, deflationary, and recessionary conditions, alongside commodity, foreign exchange, and interest rate risks. This contrasts with 2022 (p. 40), where such sensitivities were only indirectly noted. Additionally, 2024 provided quantified adjustments in the **Consolidated Statement of Comprehensive Income** (p. 64), showing a $5 million net pension and retiree medical gain in 2024 versus a $358 million loss in 2023, reflecting improved transparency on market-driven volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, PepsiCo's disclosure was limited to a reference in 'Critical Accounting Policies,' while in 2024, it expanded to include explicit discussion of macroeconomic risks such as inflationary, deflationary, and recessionary conditions—this matches the original answer's core claim. (2) The quantitative details—$5 million net gain in 2024 and $358 million loss in 2023—are factually correct and enhance transparency, though these specific figures were not included in the ground truth; however, they do not contradict it and are plausibly derived from the filings. Page references (p. 42, p. 40, p. 64) suggest precise sourcing, which supports credibility. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure location (from accounting policies to Market Risks section), evolution in risk characterization, and adds financial impact data to illustrate volatility. (4) The only minor shortcoming is that the original answer does not mention the $5M gain or $358M loss, so including them, while plausible, introduces unverified specifics not confirmed by the ground truth—this prevents a perfect 10. However, the core evolution in disclosure is accurately captured with strong qualitative and contextual fidelity. Wording differs but semantic meaning is equivalent or richer. No entity, year, or metric errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 399,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "\n\nBetween 2023 and 2024, Adobe positioned Adobe Scan as a more integrated component of its Document Cloud ecosystem, emphasizing seamless collaboration and AI-driven functionality. In 2023, Adobe Scan was described as a free mobile tool for converting paper documents into PDFs via optical character recognition (OCR), focusing on basic scanning capabilities. By 2024, Adobe highlighted Adobe Scan’s role in enabling \"instant sharing\" of scanned documents through Adobe Document Cloud services, integrating it with workflows involving Acrobat, Acrobat Sign, and cloud storage. Additionally, Adobe Scan’s 2024 positioning aligned with broader AI advancements (e.g., Firefly AI integration across Adobe apps), though Scan itself was not explicitly tied to generative AI features. The evolution reflects Adobe’s strategy to strengthen cross-product synergy and enhance productivity within its document management suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Adobe Scan was a free mobile OCR tool in 2023 focused on individual users, and by 2024 it was more tightly integrated into Adobe Document Cloud with enhanced collaboration features like instant sharing and integration with Acrobat, Acrobat Sign, and cloud storage. The emphasis on AI advancements such as Firefly is correctly noted, though the LLM appropriately clarifies that generative AI was not explicitly tied to Adobe Scan itself. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly synthesizing Adobe Scan’s role across two years and its positioning within the broader Document Cloud ecosystem. The only minor shortcoming is that the LLM does not mention 'Content Credentials' or 'digital trust mechanisms,' which are part of the 2024 strategic shift in the original answer. This omission slightly affects completeness but does not undermine the core accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of Adobe Scan’s positioning between 2023 and 2024 within Adobe’s document management ecosystem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 343,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "\n\nGemini's role and integration across Google's products evolved significantly from 2023 to 2024. In late 2023, Google launched **Gemini**, a native multimodal AI model capable of processing text, code, audio, images, and video. By 2024, Gemini 2.0 was introduced as the most advanced version, with expanded integration into all seven of Google's two-billion-user products (Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube). Key advancements in multimodal capabilities included enhanced generalization across data types, enabling features like **AI Overviews** (answering complex questions using videos or documents), **NotebookLM** (summarizing sources with quotes), and **Gemini App** (image generation, coding support, and app integration). Additionally, research prototypes like **Project Astra** (universal AI assistant) and **Project Mariner** (Chrome automation) showcased Gemini 2.0's potential for seamless cross-modal interaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini was launched in 2023 as a multimodal model; in 2024, Gemini 2.0 was introduced and integrated into all seven of Google's two-billion-user products (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube). The mention of Project Astra and Project Mariner as experimental prototypes is accurate. (2) Quantitative elements—such as the timeline (2023 launch, 2024 evolution), the number of products (seven), and user scale (two billion-user products)—are correctly stated. (3) The multi-hop reasoning is sound: the answer synthesizes Gemini’s evolution across time, product integration, and technical advancement. (4) Minor deduction in qualitative accuracy due to the inclusion of specific features like 'AI Overviews', 'NotebookLM', and 'Gemini App' with detailed capabilities (e.g., image generation, summarization) that, while plausible, are not present in the ground truth and slightly extend beyond the provided knowledge. However, these do not contradict the original answer and are contextually reasonable. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 344,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "\n\nBetween 2022 and 2024, Linde's global helium wholesale operations, reported under the \"Other\" segment, experienced a decline in sales and mixed operating profit outcomes. In 2024, sales for the \"Other\" segment decreased by 2% compared to 2023 due to lower helium volumes, while operating profit surged 44% driven by insurance recoveries related to Linde Advanced Materials Technology (LAMT), partially offsetting higher helium costs. This contrasts with 2021 (as referenced in 2022 filings), where helium and other smaller businesses contributed to a 14% sales increase and a 63% operating profit rise due to volume growth and pricing. The 2024 results highlight increased cost pressures and volatility in helium demand, mitigated by non-recurring insurance gains.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2% sales decrease in the 'Other' segment in 2024 due to lower helium volumes and the 44% operating profit increase, which aligns with the ground truth. It also correctly notes that higher helium costs partially offset insurance recovery in LAMT. However, the LLM incorrectly references 2021 data (from 2022 filings) as a point of comparison, while the question specifically asks about 2022–2024. The ground truth does not mention 2021 or 2022 performance of helium beyond stating it was a supply (neutral/positive) in 2022—no sales or profit figures for helium in 2022 are provided. Thus, including a 14% sales increase and 63% profit rise for 2021/2022 introduces unsupported details. (2) Quantitatively, the 2% sales decline and 44% operating profit increase for 2024 are accurate and correctly attributed. The error lies in introducing unverified numbers for 2022 (14%, 63%) not present in the ground truth. (3) The multi-hop reasoning is mostly sound—linking helium volumes to sales impact and helium costs offsetting insurance gains in LAMT reflects correct synthesis across segments and factors. However, the inclusion of 2021 data introduces a flawed comparison not supported by the knowledge graph, weakening the reasoning chain. (4) Scores reflect high accuracy on core 2024 facts and correct qualitative relationships, but deductions are made for introducing unsupported quantitative data from 2021/2022, affecting overall correctness. Contextual relevance remains high as all discussed points relate directly to helium’s evolving impact on Linde.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 442,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "\n\nThe net value of acquired franchise rights decreased from $789 million in 2022 to $598 million in 2024, representing a reduction of $191 million over the two-year period. This decline reflects accumulated amortization and potential impairments, as detailed in the amortization schedules and impairment disclosures in Notes 4 of both the 2022 and 2024 filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net value of acquired franchise rights in 2022 ($789 million) and 2024 ($598 million), matching the ground truth exactly. The calculated change of $191 million (789 - 598) is accurate. (2) All numeric values and the time frame (2022 to 2024) are correct, with acceptable formatting ($789 million vs $789M). The subtraction is mathematically sound. (3) The reasoning is strong: the model correctly synthesizes the two data points across years and infers a logical explanation (amortization and impairments), referencing relevant disclosures (Notes 4) from the appropriate filings, demonstrating valid multi-hop reasoning. (4) The answer fully addresses both parts of the question: the evolution of value and the magnitude of change. It adds context without introducing errors. All scores are 10 due to complete factual accuracy, correct calculations, proper entity and year identification, sound reasoning, and full relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 284,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "\n\nChevron's natural gas delivery commitments and production volumes related to Tengizchevroil (TCO) in Kazakhstan evolved as follows from 2023 to 2024:  \n\nIn **2023**, TCO was included in Chevron’s broader international delivery commitments of 2.9 trillion cubic feet of natural gas from 2024–2026, though specific TCO volumes were not detailed. Production from Kazakhstan (including TCO) remained stable at 45,000 barrels of oil-equivalent per day (MBD).  \n\nIn **2024**, Chevron increased equity investments in TCO by $1.3 billion to advance development of proved undeveloped reserves. Production from Kazakhstan held steady at 45 MBD, but TCO contributed 329 million BOE in transfers to proved developed reserves. Additionally, 197 million BOE of TCO’s proved undeveloped reserves remained untouched for five years or more, reflecting ongoing infrastructure and reservoir constraints.  \n\nOverall, while production volumes from TCO remained flat, 2024 emphasized expanded capital investments and reserve development activities compared to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of the core facts. The original answer states specific daily natural gas volumes for Chevron in 2023 and 2024—596 and 609 million cubic feet per day consumed, and 7,148 and 7,569 million cubic feet per day sold—directly tied to Tengizchevroil. The LLM answer does not mention these figures at all, instead discussing unrelated metrics like barrels of oil equivalent (BOE), equity investments, reserve transfers, and long-term delivery commitments from 2024–2026. These are not responsive to the question about production and delivery volumes from 2023 to 2024. (2) Quantitative accuracy is very low: none of the numbers in the LLM answer match the ground truth. The 2.9 trillion cubic feet commitment is for a multi-year period (2024–2026) and not annual or daily, and is not specific to TCO’s production volumes. The 45,000 MBD and BOE transfer figures are irrelevant to the question. (3) The multi-hop reasoning is flawed—the question asks for evolution in natural gas delivery and production volumes related to TCO, which requires pulling and comparing specific daily gas volume data across years. The LLM instead focuses on capital investment and reserve classifications, failing to synthesize the correct data points. (4) Contextual relevance is moderate because the answer discusses Tengizchevroil and Chevron in the right timeframe, but it addresses the wrong aspects of the relationship—investment and reserves rather than production and delivery volumes. Thus, while it shows awareness of the entities and general context, it fails on factual correctness and task alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 449,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "\n\nThe role of Google Network partners in Google's advertising revenue model remained consistent between 2023 and 2024 in terms of payment structure, as Google continued to report advertising revenues from Google Network properties on a **gross basis** (recording full revenue and classifying payments to partners as cost of revenues). However, the 2024 filing (page 58) added **greater specificity** about the criteria justifying this treatment, emphasizing Google’s control over advertising inventory, sole ability to monetize it prior to customer transfer, and primary responsibility to advertisers. In contrast, the 2023 filing (page 42) described payments to partners more generally as a use of operating cash flow without detailing the accounting rationale. This evolution reflects increased transparency in 2024 regarding the economic substance of these partnerships.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects. (1) It correctly identifies that there was a change in disclosure between 2023 and 2024 and references specific page numbers (42 and 58), which aligns with plausible document locations. However, the core claim—that Google continued to report payments to Network partners as cost of revenues on a gross basis—is not supported by the original answer, which instead emphasizes a shift in classification from general operating cash outflows to Traffic Acquisition Costs (TAC) tied directly to revenue generation. (2) There are no explicit numerical values in either answer, so quantitative accuracy is not heavily applicable; however, the LLM introduces accounting terminology (e.g., 'gross basis', 'cost of revenues') not present or implied in the ground truth, potentially misrepresenting the nature of the change. (3) The multi-hop reasoning is partially sound—comparing disclosures across years—but mischaracterizes the evolution: the original answer frames the change as a re-categorization within operating activities (to TAC), while the LLM interprets it as an accounting policy justification for gross reporting, which is a different concept. (4) Contextually, the answer addresses the question about evolution in description of payments, but shifts focus to revenue recognition policy rather than the strategic reclassification of expenses. This represents a material deviation in interpretation, reducing factual correctness despite some accurate contextual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 431,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "\n\nFrom 2023 to 2024, Bank of America faced heightened climate-related regulatory challenges due to **increased jurisdictional divergence and evolving compliance risks**. In 2023, the Corporation highlighted growing global regulatory focus on climate change, noting \"new or heightened regulatory requirements\" across state, federal, and non-U.S. jurisdictions, which introduced risks from inconsistent standards. By 2024, the filing emphasized that **existing and pending disclosure requirements** across jurisdictions had further complicated compliance, with \"jurisdictional divergence\" explicitly linked to rising legal, compliance, and public disclosure costs. Additionally, 2024 underscored challenges in managing climate-related data quality, third-party data reliability, and evolving standards, amplifying risks of noncompliance and reputational harm. This evolution reflects a more fragmented and stringent regulatory landscape, requiring Bank of America to navigate divergent rules and invest in robust data governance to mitigate compliance risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Bank of America's 2023 filing noted increasing regulatory focus and jurisdictional divergence as a source of future legal, compliance, and disclosure risks; by 2024, these risks were described as actively impacting the company due to existing and pending disclosure requirements across jurisdictions. The LLM correctly captures the evolution from anticipated to actual impact. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly identifies the progression in regulatory impact. It adds contextual detail about data quality and third-party data challenges in 2024, which are consistent with typical regulatory risk expansions and do not contradict the ground truth. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes a clear shift from 'anticipation of increased risk' to 'experiencing tangible impacts,' which the LLM conveys but slightly softens by focusing on complexity and compliance burden rather than explicitly stating the shift in risk realization. However, the core message remains semantically equivalent. The answer is fully relevant, directly addressing jurisdictional divergence and compliance risks in both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 412,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "\n\nGeneral Motors' strategic emphasis on full-size pickup trucks from 2022 to 2024 shifted from maintaining market success to leveraging stronger performance and profitability. In 2022, GM highlighted the importance of full-size SUVs and pickup trucks as critical to operational success (GM_10k_2022.pdf, p. 48). By 2024, quantitative indicators showed a clear market positioning shift: **GM North America’s net sales and revenue rose 11.4% year-over-year**, driven by **increased full-size pickup truck sales volumes** and a **9.2% EBIT-adjusted margin** (up from 8.7% in 2023; GM_10k_2024.pdf, p. 34). Additionally, **wholesale vehicle sales grew 10.1%**, with full-size pickups and mid-size trucks contributing significantly to higher volumes and favorable pricing, reflecting stronger demand and profitability. These metrics underscore GM’s successful reinforcement of its full-size truck strategy in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in GM's strategic emphasis on full-size pickup trucks from 2022 to 2024, noting the shift from risk/dependence to strength and performance. This aligns with the ground truth. However, the quantitative indicators cited are partially inaccurate or not fully supported by the ground truth. The LLM claims an '11.4% year-over-year increase in GM North America’s net sales and revenue' and a rise in EBIT-adjusted margin from 8.7% to 9.2%, but these specific figures and comparisons are not present in the original answer. The ground truth does not provide year-over-year percentage changes in revenue or EBIT margin, nor does it mention mid-size trucks as contributors. Instead, the ground truth emphasizes a 'variable profit of approximately 160% for trucks on a weighted-average basis'—a key profitability metric that the LLM omits entirely. (2) The LLM introduces specific numbers (11.4%, 9.2%, 10.1% wholesale growth) that are not in the original answer, making them unverifiable against the ground truth. While these may exist in the actual 10-K filings, they were not part of the knowledge graph's verified answer, so their inclusion constitutes a deviation. The absence of the 160% variable profit—a central quantitative indicator in the original—is a significant omission. (3) The multi-hop reasoning is sound in structure: the model connects 2022 risk language to 2024 performance indicators, showing evolution. It correctly identifies full-size pickups as drivers of volume and profitability. However, it substitutes unverified metrics for the ones actually present in the ground truth, weakening the factual synthesis. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of strategy and 2024 performance indicators—and uses appropriate terminology. The qualitative accuracy is good due to correct entity identification (GM, full-size pickups, 2022 vs 2024) and logical flow. The correctness score is 7 because the core narrative is accurate, but key quantitative details are either incorrect or missing, and unsupported numbers are introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 580,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "\n\nThe allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased from **$293 million in 2021** (Georgia Power, per SO_10k_2022.pdf page 311) to **$349 million in 2023** (Georgia Power, per SO_10k_2024.pdf page 277), while Alabama Power’s allocation remained relatively stable ($21 million in 2021 vs. $20 million in 2023). This shift reflects a strategic move toward **lower-risk, liquid investments** to ensure long-term funding stability for nuclear decommissioning obligations, prioritizing capital preservation and regulatory compliance over higher-yield alternatives. The emphasis on U.S. Treasury securities underscores a conservative approach to managing these trusts.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and years. The ground truth states data for 2022 and 2024, but the LLM incorrectly references 2021 and 2023. For Alabama Power, the ground truth reports $21M in 2022 and $20M in 2024, but LLM cites $21M in 2021 and $20M in 2023 — using incorrect years and implying stability over a mismatched time frame. For Georgia Power, the correct figures are $293M in 2022 and $349M in 2024, but LLM reports $293M in 2021 and $349M in 2023 — again misaligning the years. While the dollar amounts for Georgia Power are numerically close to correct, they are tied to wrong years, undermining temporal accuracy. (2) The calculations themselves (e.g., increase from $293M to $349M) are arithmetically correct, but applied to incorrect time periods. The LLM also omits the fact that the data comes from 2022 and 2024 specifically, which is central to the question. (3) The multi-hop reasoning is partially sound — the model identifies both Alabama and Georgia Power and attempts to compare trends. However, it fails to correctly align the time series across entities and years, leading to flawed synthesis. The conclusion about a conservative investment strategy is plausible but diverges from the ground truth’s emphasis on a shift toward Georgia Power’s portfolio as a strategic reallocation, not just a general risk-aversion move. (4) The contextual relevance is high because the answer addresses both parts of the question — evolution over time and strategic implication — and uses appropriate financial reasoning. However, due to significant quantitative and temporal inaccuracies, the correctness score is limited to 5. The qualitative reasoning is logically structured but based on incorrect premises, warranting a 6. Quantitative accuracy is penalized heavily for year mismatches despite correct dollar figures for Georgia Power, resulting in a 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 518,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "\n\nFrom 2022 to 2024, PepsiCo maintained annual financial incentives for independent bottlers, including bottler funding for advertising, new product support, and equipment placement, as disclosed in both filings. However, strategic dependency evolved due to two factors: (1) a shift in the U.S. alcoholic beverage business to a trademark licensing and flavor sales model (2024), reducing direct bottler reliance for certain products, and (2) increased strategic reliance on major customers like Walmart, where bottler-sold products contributed significantly to PepsiCo’s revenue (14% of consolidated net revenue in 2024). This highlights a dual trend of structural strategic reconfiguration in some segments and heightened dependency on key customer channels through existing bottler networks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 14% contribution of Walmart (via bottlers) to PepsiCo’s consolidated net revenue in 2024, which matches the ground truth. It also accurately describes the nature of financial incentives—advertising support, new product launches, and equipment placement—funded through annual bottler funding, consistent with both 2022 and 2024 disclosures. However, the LLM introduces a detail not present in the original answer: the shift in the U.S. alcoholic beverage business to a trademark licensing and flavor sales model in 2024, which reduces direct bottler reliance. While plausible and potentially true, this specific strategic reconfiguration is absent from the ground truth and may represent over-inference or external knowledge not supported by the provided data. (2) Quantitatively, all numbers (14%, 2022, 2024) are accurate and correctly attributed. There are no calculation errors. (3) The multi-hop reasoning is largely sound—linking bottler funding mechanisms across years and connecting Walmart’s revenue contribution to strategic dependency is valid and well-synthesized. However, the addition of the alcohol segment restructuring introduces a reasoning path not confirmed by the ground truth, slightly undermining qualitative accuracy. (4) Despite the extra detail, the core of the answer aligns with the original: evolution of financial incentives and increased strategic dependency via key customers. The answer is highly relevant and captures the essential evolution. Thus, a score of 8 is justified—high accuracy with minor over-extension in reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 443,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "\n\nAdobe Firefly's role within Adobe's product innovation strategy evolved from a nascent AI initiative in 2023 to a central, explicitly acknowledged component of its generative AI (GenAI) portfolio by 2024. In 2023, Firefly was positioned as part of Adobe's broader AI investments (e.g., Adobe Sensei) but was not specifically highlighted in risk disclosures or trademark listings. By 2024, Firefly was explicitly named in **risk factors** (Page 23 of 2024 10-K) as a flagship GenAI product, emphasizing its strategic importance in driving innovation while acknowledging regulatory and reputational risks tied to AI development. Additionally, Firefly was prominently listed in Adobe's **trademark portfolio** (Page 99 of 2024 10-K), reflecting its formal integration into core product offerings. This evolution underscores Adobe's shift toward prioritizing Firefly as a key differentiator in its AI-driven creative and document solutions, with heightened focus on governance, market adoption, and regulatory compliance.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It incorrectly states that in 2023, Firefly was 'not specifically highlighted in risk disclosures or trademark listings,' which contradicts the original answer stating that Firefly *was* listed among Adobe's trademarks in 2023. This is a critical error in entity and temporal accuracy. (2) While the 2024 information aligns with the ground truth—Firefly being highlighted in risk factors and trademark listings—the LLM fabricates specific document details (e.g., 'Page 23 of 2024 10-K', 'Page 99 of 2024 10-K') not present in the original answer, introducing false precision. There are no numeric values to verify, so quantitative accuracy is based on correct use of years and document types; the years 2023 and 2024 are used correctly, but the citation of page numbers is unsupported. (3) The multi-hop reasoning is partially sound—the model correctly infers increased strategic emphasis from risk factor inclusion and trademark listing—but it misrepresents the starting point (2023 status), undermining the validity of the evolution narrative. The claim that Firefly was part of 'Adobe Sensei' and not trademark-listed in 2023 is unsupported and contradicts the ground truth. (4) Despite these errors, the answer is contextually relevant, addressing the evolution of Firefly’s strategic role and synthesizing trademark and risk disclosure positioning. However, due to major factual errors in entity and document representation, especially the incorrect downplaying of Firefly's 2023 presence, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 456,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "\n\nThe role of contractual rent escalations in driving tenant billing growth diminished in 2023 compared to 2022, primarily due to increased churn and lease cancellations. In 2023, contractual escalations contributed **$12.5 million net of churn** to U.S. & Canada tenant billings growth, a relatively minor component compared to **$229.9 million** from colocations and amendments. In Asia-Pacific, churn exceeded contractual escalations by **$8.9 million**, directly reducing their net positive impact. The elevated churn, driven by T-Mobile lease cancellations in the U.S. & Canada and broader lease non-renewals, weakened the effectiveness of escalations as a growth driver, shifting focus toward colocation activity and new site acquisitions to offset losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$12.5 million net of churn in U.S. & Canada and $8.9 million shortfall in Asia-Pacific—that are not present in the original answer and cannot be verified against the ground truth. These numbers appear fabricated or hallucinated, as the original answer does not provide any dollar amounts related to rent escalations or churn impacts. The mention of T-Mobile lease cancellations is correct and aligns with the original, but the financial breakdowns are unsupported. (2) The calculation claims—such as escalations contributing only $12.5 million net while colocations contributed $229.9 million—are entirely absent from the ground truth and introduce a level of precision that misrepresents the available information. There is no mention in the original answer of these specific figures or regional financial impacts, making the quantitative assertions inaccurate. (3) The reasoning partially captures the multi-hop logic: it correctly identifies that contractual rent escalations were a growth driver in both years but faced headwinds in 2023 due to increased churn, particularly from T-Mobile. It also correctly infers that escalations became less effective relative to other growth drivers like colocation. However, the synthesis is undermined by the inclusion of false numerical data, which distorts the factual basis. (4) While the qualitative direction of the argument (escalations weakened as a driver due to churn) is consistent with the original, the hallucinated numbers severely compromise factual correctness. The contextual relevance is high because the answer addresses the core dynamics asked—change in role of escalations, impact of churn—but the quantitative inaccuracies drag down overall correctness and trustworthiness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 490,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "\n\nChevron's relationship with Tengizchevroil (TCO) in Kazakhstan evolved between 2023 and 2024 with increased capital expenditure commitments and sustained production involvement. In 2024, **affiliated capital expenditures (Capex)** for TCO’s Field Gas Processing/Western Gas Expansion (FGP/WPMP) project in Kazakhstan accounted for nearly half of Chevron’s $3 billion projected equity affiliate Capex, up from $2.31 billion in international upstream affiliate Capex in 2023. Production contributions from TCO remained significant in 2024, with Chevron’s net production in Kazakhstan averaging **45,000 barrels of crude oil per day and 113 million cubic feet of natural gas per day**. Additionally, TCO held **197 million BOE of proved undeveloped reserves** as of 2024, reflecting ongoing development efforts aligned with facility and reservoir constraints.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported data not present in the ground truth. While it correctly identifies that nearly half of Chevron’s $3 billion 2024 equity affiliate Capex was allocated to Tengizchevroil’s FGP/WPMP project, it incorrectly states that 2023 international upstream affiliate Capex was $2.31 billion — this figure is not mentioned in the original answer and cannot be verified from the provided context. The original answer only states that 2024 Capex was expected to be $3 billion with nearly half going to TCO, but does not provide a 2023 Capex figure for comparison, so the 'up from $2.31 billion' claim is fabricated. (2) The LLM introduces specific production numbers — 45,000 barrels of crude oil per day and 113 million cubic feet of natural gas per day — and 197 million BOE of proved undeveloped reserves in 2024, none of which appear in the original answer or are supported by the knowledge graph. These numbers are quantitatively inaccurate because they were not part of the ground truth. (3) The qualitative reasoning partially captures the evolution from capital investment (2023 focus) to production involvement (2024 focus), which aligns with the original answer’s narrative of a shift from development to operational phase. This shows correct multi-hop synthesis in intent, though it is undermined by hallucinated data. (4) Contextual relevance is high because the answer addresses both capital expenditure and production involvement across 2023–2024 and focuses on the correct entities (Chevron, Tengizchevroil, FGP/WPMP project). However, the inclusion of unverified metrics significantly reduces factual correctness. The correctness score is low due to major quantitative errors, despite a reasonable structural interpretation of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 501,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "\n\nThe specificity of UPS's bond matching approach for determining the discount rate in U.S. pension and postretirement benefit plans remained consistent between 2023 and 2024, as the company continued to select specific bonds to match projected benefit payments. However, the resulting discount rate for U.S. pension plans increased from **5.42% in 2023 to 5.88% in 2024**, reflecting higher market interest rates and improved bond yields during this period. The methodology itself did not evolve, but the applied rate adjusted based on updated bond market conditions as of the measurement dates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the nature of the evolution in UPS's bond matching approach. (1) The answer incorrectly introduces specific discount rate figures—5.42% in 2023 and 5.88% in 2024—which are not present in the ground truth and cannot be verified from the provided context. These numbers are therefore factually unsupported, severely undermining quantitative accuracy. (2) The question asks about the evolution in the *specificity* and *methodological framing* of the bond matching approach, not changes in the resulting discount rate. The ground truth emphasizes a shift in language from describing the method as directly selecting bonds to satisfy obligations, to describing it as a 'guide' for selection—indicating a subtle operational reframing. The LLM answer fails to capture this nuance and instead asserts that 'the methodology itself did not evolve,' which contradicts the original answer’s point about a shift in emphasis and wording. (3) While the LLM correctly identifies that UPS uses a bond matching approach to align with projected benefit payments, it misses the multi-hop nuance: the evolution is in disclosure language and conceptual framing, not in rate outputs or market conditions. (4) The focus on interest rate changes and resulting discount rate increases is contextually relevant to pension accounting but directly addresses a different question than the one asked, leading to a partially relevant but factually and conceptually misaligned response. Thus, while some entities (UPS, pension plans, bond matching) are correct, the reasoning and factual core are flawed, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 456,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "\n\nFrom 2022 to 2024, Linde's relationship with helium shifted from a focus on raw material sourcing (as noted in 2022 disclosures about market-dependent helium procurement) to a segment-level operational challenge in 2024. In 2024, Linde's global helium wholesale (part of the \"Other\" segment) contributed to a **$32 million sales decline (2%)** due to lower volumes, while operating profit rose **$19 million (44%)** driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher helium costs. This contrasts with 2022, where helium was primarily discussed as a volatile raw material input rather than a direct operational focus. The 2024 results reflect improved profitability despite volume headwinds, highlighting cost management and insurance proceeds mitigating helium-related pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in Linde's relationship with helium from 2022 to 2024 and mentions the $32 million, or 2%, sales decline in the Other segment due to lower helium volumes—this matches the ground truth. However, it incorrectly states that operating profit rose $19 million (44%) in 2024 due to insurance recovery, which contradicts the ground truth that helium had a negative impact on operating profit, with costs applying downward pressure (only partially offset by insurance). The ground truth does not mention a 44% increase or a $19 million operating profit gain; thus, this is a significant factual error. (2) The $32 million sales decline and 2% figure are accurate and correctly attributed. But the $19 million and 44% operating profit increase are unsupported by the ground truth and introduce false quantitative claims. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes helium’s evolving role and links it to segment performance. However, it misrepresents the financial outcome on operating profit, failing to accurately synthesize the net negative impact despite the insurance offset. (4) Correctness is scored 6 due to accurate sales impact but major error in operating profit characterization. Quantitative accuracy is 5 because half the numbers are correct, but the operating profit claim is fabricated. Qualitative accuracy is 7 due to strong narrative and correct entity identification (LAMT, Other segment, helium volumes), but flawed conclusion. Contextual relevance is 9—response directly addresses the question’s scope and evolution over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 447,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "\n\nBetween 2023 and 2024, Bank of America's **unfunded capital contributions for renewable energy investments** decreased from **$6.2 billion** (December 31, 2023) to **$4.6 billion** (December 31, 2024), a reduction of **$1.6 billion**. Concurrently, the **recognized tax credits** related to these investments declined slightly from **$4.0 billion** in 2023 to **$3.9 billion** in 2024, a decrease of **$100 million**. This reflects a modest contraction in both committed capital and associated tax benefits during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, a $1.6 billion reduction, and recognized tax credits declined from $4.0 billion to $3.9 billion, a $100 million decrease—both figures match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entity accuracy is correct—Bank of America, the correct metric names, and the years 2023 and 2024 are properly identified. (4) The reasoning is sound: the LLM correctly infers a contraction in commitments and associated benefits, aligning with the original conclusion about reduced near-term funding while tax benefits remained stable. The slight decline in tax credits is accurately characterized. (5) Semantic equivalence is maintained—though the wording differs slightly (e.g., 'modest contraction' vs. 'reduction'), the meaning and factual content are identical. No errors in multi-hop synthesis; the model correctly combines data across years and metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 339,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "\n\nGeneral Motors' approach to fleet sales with commercial customers from 2022 to 2024 evolved by expanding direct engagement with fleet customers while maintaining dealer network channels. In 2022 filings, fleet sales (including commercial customers) were primarily conducted through dealers, with certain transactions (e.g., daily rental car companies) noted as less profitable than retail sales. By 2024, GM clarified that fleet sales are completed \"through the dealer network and in some cases directly with fleet customers\" (page 103), indicating a strategic shift toward direct sales for select commercial fleets. Profitability considerations remained focused on differentiating less profitable fleet segments (like daily rentals) from retail, though specific profitability metrics for commercial fleets were not detailed. The emphasis on direct channels suggests efforts to optimize margins and streamline relationships with larger commercial accounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, GM viewed fleet sales (especially daily rental) as less profitable than retail and used dealer or direct channels; by 2024, sales were conducted through the dealer network and sometimes directly with fleet customers, indicating a more structured approach. The LLM correctly identifies this evolution and the profitability context. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates (2022 to 2024) or document references (e.g., page 103 citation, which is plausible though not cross-verified here). (3) Multi-hop reasoning is sound: the model synthesizes information across years and channels, correctly inferring a strategic shift toward direct engagement for commercial fleets while maintaining dealer channels. The reasoning about profitability considerations is consistent with the original answer, noting that while daily rental fleet sales were less profitable, commercial fleet profitability specifics were not detailed. (4) The only minor shortcoming is that the LLM slightly overemphasizes 'expanding direct engagement' as a new trend, whereas the original answer frames it more cautiously as 'in some cases directly,' suggesting limited or selective direct sales. This nuance is mostly preserved, so the qualitative accuracy is high but not perfect. Overall, the answer is contextually complete, factually correct, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 428,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "\n\nBetween 2022 and 2024, PepsiCo's relationship with Sabra evolved through its joint venture structure and financial revaluations. In 2022, PepsiCo retained a 39% noncontrolling interest in a joint venture after selling its Tropicana and other juice brands, while continuing to distribute Sabra products via its FLNA division through a partnership with Strauss Group. By 2024, the company recognized a **pre-tax gain of $122 million ($92 million after-tax)** in its FLNA division from remeasuring its previously held 50% equity ownership in Sabra at fair value, reflecting an increase in the joint venture's valuation. This gain positively impacted operating profit and net income, highlighting improved financial returns from the Sabra joint venture over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding PepsiCo's ownership of Sabra. The ground truth states that in 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio and by 2024 had reduced its ownership to a 50% equity stake, resulting in a $122 million pre-tax gain from remeasurement at fair value. However, the LLM incorrectly claims that in 2022 PepsiCo had a 39% noncontrolling interest due to the Tropicana sale, which is unrelated to Sabra. This misattributes the ownership change to a different transaction. Additionally, the LLM states that the 50% ownership was 'previously held' and then remeasured, implying PepsiCo already had a 50% stake before 2024, contradicting the ground truth that the 50% stake resulted from a divestment during the period. (2) The quantitative accuracy is partially correct: the $122 million pre-tax gain (and $92 million after-tax) matches the ground truth and is correctly cited. However, the 39% ownership figure is incorrect and not supported by the original answer. (3) The multi-hop reasoning is flawed. The model fails to correctly trace the evolution of ownership — it conflates the Sabra joint venture with the Tropicana divestiture, which is a separate transaction. The correct reasoning should focus on PepsiCo initially owning Sabra fully (or majority) in 2022 and then reducing to 50% by 2024, triggering the gain. The LLM instead suggests the gain came from remeasuring a pre-existing 50% stake, which contradicts the divestment narrative. (4) Despite these major factual and reasoning errors, the answer is contextually relevant — it addresses the evolution of the relationship and financial implications, and includes the correct gain amount, which keeps relevance high. However, core entity and ownership timeline inaccuracies severely undermine correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 511,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "\n\nBetween 2023 and 2024, Adobe's treatment of **Adobe Scan** evolved in terms of its positioning within the product ecosystem. In 2023, Adobe Scan was listed as a trademark (ADBE_10k_2023.pdf, p. 99) but received no detailed discussion in the 10-K, suggesting it was a peripheral product. By 2024, Adobe Scan was explicitly highlighted as part of **Adobe Document Cloud** (ADBE_10k_2024.pdf, p. 12), which includes Acrobat, Acrobat Sign, and other document workflow tools. This integration emphasizes Adobe Scan’s role in enabling digital document workflows, aligning it more closely with core Document Cloud offerings to enhance productivity and automation for users. No mention of generative AI (e.g., Firefly) integration with Adobe Scan was made in 2024, indicating its positioning remained focused on document management rather than AI-driven creativity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Adobe Scan was listed as a trademark in 2023 (p. 99 of 2023 10-K) and explicitly integrated into Adobe Document Cloud in 2024 (p. 12 of 2024 10-K), which includes Acrobat and Acrobat Sign. The evolution from peripheral recognition to strategic integration is correctly interpreted. (2) There are no numeric values requiring calculation, so quantitative accuracy is not applicable beyond correct referencing of document pages and years—both are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings to show a shift in positioning. The conclusion that Adobe Scan is now more strategically aligned with document workflow tools is logically supported. (4) The only minor shortcoming is the addition of a detail not present in the ground truth—specifically, the statement that there was no mention of generative AI integration in 2024. While factually plausible and contextually relevant, this point introduces an extra observation that slightly exceeds the scope of the original answer, slightly reducing qualitative accuracy. However, it does not detract from correctness. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 371,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "\n\nGeneral Motors' financial exposure and obligations to Stellantis regarding indemnifications and historical liabilities from the 2017 Opel/Vauxhall sale remained significant but uncertain from 2022 to 2024. In both periods, GM's subsidiary agreed to indemnify Stellantis for losses arising from pre-sale liabilities, including emissions claims, product liabilities, and recalls, though GM could not estimate potential losses due to the unresolved nature of lawsuits in Germany, the UK, and the Netherlands. In 2024, new risks emerged from investigations by the European Commission and UK Competition and Markets Authority into Opel's past practices related to vehicle waste management, which could result in material fines if Opel's conduct was found to infringe regulations. While GM noted that prior Takata-related indemnifications were immaterial (2022) and \"remote\" for future claims (2024), the core indemnification obligations under the 2017 agreement persisted without material changes, reflecting ongoing exposure to unquantifiable historical liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core elements of GM's evolving financial exposure to Stellantis from 2022 to 2024. It accurately identifies the persistence of indemnification obligations stemming from the 2017 Opel/Vauxhall sale, including emissions claims, product liabilities, recalls (notably Takata), and new regulatory investigations into end-of-life vehicle practices by European authorities. The answer correctly notes that GM could not estimate potential losses due to unresolved legal matters, aligning with the ground truth's implication of uncertainty. It also correctly states that Takata-related exposures were immaterial in 2022 and considered 'remote' in 2024, consistent with the original answer’s 'immaterial amount accrued' as of 2024. However, the LLM answer omits the explicit shift from operational supply relationships in 2022 (mentioned in the ground truth) to indemnification-based exposure in 2024, which is a key qualitative evolution. While it references new European investigations, it does not clearly frame the overall transformation in the nature of obligations—from active supply involvement to passive financial guarantees—as emphasized in the original answer. There are no numerical inaccuracies (quantitative accuracy is high, hence 9), and all entities (GM, Stellantis, Opel/Vauxhall, European Commission, CMA) and timeframes (2022–2024) are correctly used. The reasoning is sound and reflects multi-hop synthesis across years and liability types, though the narrative emphasis is more on continuity than evolution. Contextual relevance is perfect—directly addresses the question’s focus on indemnifications and historical liabilities. Minor omission of the operational-to-financial shift prevents a 9 or 10 on correctness, but core facts and risks are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 493,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "\n\nBetween 2022 and 2024, PepsiCo's relationship with co-packers evolved through strategic adjustments in operational dependency and collaborative structures. In 2022, the company retained a 39% noncontrolling interest in a joint venture after selling its Tropicana and juice brands (Juice Transaction), maintaining exclusive U.S. distribution for small-format and foodservice customers. By 2024, PepsiCo continued leveraging co-packers and joint ventures (e.g., with TBG, Unilever, and Starbucks) for production and distribution, as noted in its properties and financial disclosures. Operational dependency remained consistent, utilizing co-packers for a distributed network of plants and warehouses. Strategically, PepsiCo shifted toward equity-based partnerships and joint ventures, reducing direct ownership while preserving influence through distribution rights and collaborative agreements, reflecting a focus on flexibility and shared risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects of the evolution of PepsiCo's relationship with co-packers between 2022 and 2024. (1) Correctly notes the continued use of joint ventures and co-packers, and mentions strategic partnerships (e.g., with TBG, Unilever, Starbucks), which aligns with the general direction of strategic involvement. The 39% noncontrolling interest referenced is factually accurate in context of the Juice Transaction, but this detail is not directly tied to co-packers broadly—it pertains specifically to Tropicana and juice brands, which is a narrower scope than the question's focus on co-packers overall. (2) Quantitative accuracy is mostly sound: the 39% figure is correct as disclosed in filings, and no other numbers are misstated. However, this percentage does not represent PepsiCo’s general dependency on co-packers, so its inclusion without clarification misleads the synthesis. (3) The reasoning is partially flawed: while the answer describes joint ventures and equity interests, it fails to capture the core evolution highlighted in the ground truth—the shift in language and strategy from a 'highly distributed network' of third-party facilities in 2022 to 'strategic alliances or joint ventures with equity interest' in 2024 as a deliberate strategic shift. Instead, the LLM introduces the Juice Transaction as a central point, which, while factually valid, is not representative of the broader co-packer relationship evolution. (4) The answer is contextually relevant and well-structured, but misses the primary evidence of evolution (change in corporate language and strategic framing) and substitutes it with tangential examples. Thus, while some facts are correct, the multi-hop synthesis between years and strategic posture is incomplete and slightly misdirected, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 514,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "\n\nBetween 2023 and 2024, SPG's financial relationship with ABG evolved through strategic divestitures and significant gains recognition. In 2023, SPG recognized a **$157.1 million pre-tax gain** from selling a portion of its ABG interest and a **$10.3 million non-cash gain** from a deemed disposal due to ABG's capital transactions diluting SPG's ownership to 9.6%. By 2024, SPG sold **all remaining interests in ABG** for **$1.2 billion**, generating a **$414.8 million pre-tax gain**. These actions reflect a shift from prior strategic investments (e.g., acquiring ABG stakes via licensing ventures in 2021–2022) to exiting the relationship, capitalizing on ABG's growth, and optimizing returns through divestiture.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, SPG recognized a $157.1 million gain from the sale of a portion of its ABG interests and a $59.1 million gain from deemed disposals due to ABG's capital transactions (not $10.3 million as stated). The LLM incorrectly states a $10.3 million gain and misrepresents the $59.1 million figure. Additionally, the LLM claims that in 2024, SPG sold all remaining interests in ABG for $1.2 billion, generating a $414.8 million pre-tax gain — this is entirely fabricated and not supported by the original answer. The actual 2024 gain was $18.8 million from the sale of a portion of its ABG interest in *December 2021* (disclosed in 2024), not a 2024 sale. (2) The quantitative inaccuracies are severe: all major figures ($10.3M vs $59.1M, $414.8M gain, $1.2B sale) are incorrect. The only correct number is the $157.1 million gain in 2023. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a full exit from ABG in 2024, whereas the ground truth indicates ongoing strategic collaboration (Reebok partnership), signaling deeper operational ties, not an exit. The model fails to mention the $145.8 million gain from dilution in SPARC Group in 2023 and omits the key strategic shift toward operational partnership in 2024. (4) The contextual relevance is moderate because the answer addresses the evolution of the financial relationship and mentions gains, but the core facts and direction of the relationship (from financial to operational) are misrepresented. Due to major factual and numerical errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 452,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "\n\nLockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024 with increased production volumes in 2022, driven by higher output on various Sikorsky programs, as noted in the 2022 10-K (page 43). By 2024, the scope shifted as the VH-92A helicopter program for U.S. Marine One concluded with its final delivery (2024 10-K, page 5), while ongoing programs like the Black Hawk, Seahawk, and CH-53K King Stallion heavy lift helicopters continued to anchor RMS operations. This reflects a transition from volume growth in 2022 to program completion and sustained production in key platforms by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts other than the $560 million increase in product costs are mentioned in the original answer, and the LLM correctly avoids introducing incorrect figures. It accurately references increased production volume in 2022 without misstating numbers. (2) The LLM adds a detail not present in the original answer—the conclusion of the VH-92A program in 2024—but this is factually correct per the 2024 10-K and enhances accuracy by providing context on program scope evolution. (3) The qualitative reasoning is strong: it captures the shift from volume-driven activity in 2022 to a refined portfolio focus in 2024, highlighting ongoing programs (Black Hawk, Seahawk, CH-53K) as strategic anchors, which matches the original’s emphasis on Sikorsky programs becoming a clearly defined strategic line. (4) The answer addresses both production volume and program scope across 2022–2024, fulfilling the multi-hop requirement across years and programs. The only minor gap is that the original emphasizes the 'cost driver to strategic product line' framing more explicitly, which the LLM implies but doesn’t directly state. However, the semantic meaning and factual content are substantially equivalent. All entities (Lockheed Martin, RMS, Sikorsky programs, correct years) are accurate. Contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 392,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "\n\nWalmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, increasing its ownership to 100%. Between fiscal 2023 and 2024, there were no additional financial investments or changes in ownership stake, as the 100% ownership was maintained until the entity was sold and deconsolidated in fiscal 2025. The $0.4 billion investment in fiscal 2023 fully established Walmart's controlling interest, with no further activity related to Alert Innovation disclosed in fiscal 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion and increased ownership to 100%, which matches the ground truth. However, it incorrectly claims that ownership was maintained until a sale in fiscal 2025, which is not supported by the original answer. The ground truth explicitly states that by fiscal 2024, there was no mention of Walmart retaining ownership, indicating a full exit—likely via divestiture—during or before fiscal 2024. The LLM introduces a fact (sale in fiscal 2025) not present in the source and contradicts the timeline. (2) Quantitatively, the $0.4 billion figure is accurate and correctly attributed to fiscal 2023. There are no calculation errors, and the format is acceptable. (3) The multi-hop reasoning fails because the model does not correctly synthesize the absence of mention in fiscal 2024 as evidence of divestiture. Instead, it invents a future event (fiscal 2025 sale) not in the data, breaking the logical chain. The original answer infers exit from silence in the filings; the LLM overlooks this key inference. (4) While the initial investment is accurately described, the conclusion about stake evolution is wrong—the ownership did not remain at 100% into fiscal 2024 and beyond. Thus, the core of the question (how stake evolved between 2023 and 2024) is inaccurately answered, warranting a moderate correctness score due to partial factual alignment but major reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 407,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "\n\nBetween 2023 and 2024, SPG's utilization of the Supplemental Facility shifted from active borrowing and repayment to minimal usage, reflecting strategic refinancing and liquidity management. In 2023, SPG repaid €750 million ($815.4 million) under the Supplemental Facility in November using proceeds from a bond issuance, indicating a focused repayment strategy to reduce variable-rate debt. By 2024, SPG significantly reduced reliance on the Supplemental Facility, with only $323.7 million outstanding under its broader Credit Facilities (which include the Supplemental Facility) as of December 31, 2024. The company maintained $8.2 billion in aggregate borrowing capacity under the Credit Facilities, with weighted average outstanding balances under the facilities remaining low ($311.1 million in 2024). This suggests SPG prioritized liquidity preservation, utilized long-term fixed-rate debt issuances (e.g., $1.0 billion in September 2024), and curtailed Supplemental Facility borrowings to manage interest costs and leverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2024 status of the Supplemental Facility. The ground truth states there was *no outstanding balance* under the Supplemental Facility in 2024, but the LLM claims $323.7 million was outstanding under the broader Credit Facilities (which includes the Supplemental Facility), implying continued usage. This contradicts the ground truth and misrepresents SPG's strategic shift. Additionally, the LLM introduces a conversion of €750 million to $815.4 million, which is not in the original answer and may be misleading without context. (2) The repayment date of November 17, 2023, is correctly implied as 'November' but the LLM adds a dollar conversion not present in the source. The $1.0 billion September 2024 bond issuance is correctly mentioned, but the LLM fabricates specific figures like $323.7 million outstanding and $311.1 million average balance in 2024, which are not supported by the ground truth. (3) The multi-hop reasoning is partially sound—LLM correctly infers a shift toward long-term fixed-rate debt and away from variable-rate facilities—but fails the core synthesis: it does not accurately reflect that the Supplemental Facility was fully repaid and unused in 2024. Instead, it conflates the broader Credit Facilities with the Supplemental Facility, leading to incorrect conclusions. (4) The contextual relevance is fair because the answer addresses borrowing activity, repayment strategy, and refinancing trends. However, due to major quantitative errors and failure to distinguish the Supplemental Facility from other credit lines, the correctness score is low. The qualitative reasoning is somewhat accurate but undermined by factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 480,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "\n\nLinde has maintained helium as a key process gas within its industrial gases portfolio in both 2023 and 2024, with no indication of a shift in its positioning as a primary product. In 2023, helium was explicitly listed among process gases (e.g., carbon dioxide, hydrogen, specialty gases) sold via on-site, merchant, and packaged distribution methods. By 2024, while specific product details are less detailed in the provided pages, the company’s emphasis on long-term supply contracts and minimum purchase requirements in the \"Remaining Performance Obligations\" section (2024, p. 89) suggests continued strategic focus on securing stable helium supply agreements. Supply strategies likely prioritize these long-term contracts to mitigate market volatility, consistent with prior practices. No material changes in helium’s strategic role or distribution approach are explicitly noted between the periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about helium's positioning, directly contradicting the ground truth. While there are no numeric inaccuracies (hence a high quantitative accuracy score), the qualitative analysis fails significantly. The ground truth states that in 2023, helium was explicitly named as a primary product alongside oxygen, nitrogen, and hydrogen, but in 2024 it was no longer specifically listed and was instead subsumed under broader gas categories—indicating a strategic de-emphasis. The LLM incorrectly asserts that there was 'no indication of a shift' and that helium remained explicitly positioned as a key product in both years. This misrepresents the evolution in Linde's product disclosure strategy. The LLM also incorrectly infers from the 2024 'Remaining Performance Obligations' section that this implies continued strategic focus on helium, despite the absence of any specific mention of helium in product listings—this is speculative and contradicts the observed trend of reduced specificity. The reasoning fails the multi-hop requirement to compare explicit product categorization across years. Contextually, the answer addresses the right topic and time frame, so relevance is moderate, but the failure to detect a material change in disclosure and positioning severely undermines the response. Semantic equivalence is not achieved because the central conclusion opposes the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 395,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "\n\nBetween 2022 and 2023, the U.S. Retiree Health Care Plan shifted its asset allocation toward fixed income securities and away from equity securities. In 2022, the plan held **$182** in fixed income securities and cash equivalents and **$98** in equity securities (totaling $280). By 2023, fixed income securities and cash equivalents increased to **$210**, while equity securities decreased to **$54** (totaling $264). This reallocation reflects the plan's investment strategy to align asset returns with liability sensitivities, prioritizing fixed income to mitigate discount rate volatility. \n\nThe fixed income allocation (primarily bond index funds and cash equivalents) rose by **$28**, whereas equity securities (equity index funds) fell by **$44**. This shift aligns with the company's broader approach of using low-cost, broad-market index funds to balance risk and return characteristics relative to plan liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, in 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities (totaling $385), not $182 and $98 totaling $280 as stated by the LLM. The 2023 figures for fixed income ($210) and equity ($54) are correct in the LLM response, but the total of $264 is inconsistent with the incorrect 2022 baseline. (2) Calculations are therefore flawed: the LLM claims fixed income increased by $28 (from $182 to $210), but in reality it decreased from $248 to $210 (a drop of $38). Similarly, the LLM correctly notes equity fell to $54 but incorrectly states a decrease of $44 (from $98), whereas the actual decrease was from $137 to $54, a reduction of $83. (3) The multi-hop reasoning is partially sound in that the model identifies a shift from equities to fixed income, but the direction of change in fixed income is misrepresented (it actually decreased, not increased). The explanation about investment strategy and risk mitigation adds context not present in the original answer, which may be plausible but is unsupported by the provided ground truth. (4) The contextual relevance is fair because the answer addresses asset allocation changes between the two years and focuses on the requested categories. However, due to major quantitative errors and incorrect synthesis of trends, the correctness and quantitative accuracy scores are low. The qualitative accuracy is modest because the structure and intent align with the question, but the reasoning is based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 457,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "\n\nBetween 2022 and 2023, **Trodelvy's financial performance and strategic positioning evolved significantly**. Revenue from Trodelvy surged by **56% to $1.06 billion in 2023** (from $680 million in 2022), driven by expanded regulatory approvals, including FDA clearance for **HR+/HER2- metastatic breast cancer** (2023) and prior accelerated approval for urothelial cancer (2021). This expansion solidified its role in oncology, contributing to a **37% year-over-year increase in Gilead’s Oncology segment revenue**. However, a Phase 3 trial for non-small cell lung cancer failed to meet its primary endpoint, signaling a strategic challenge. Despite this, Trodelvy’s strong sales growth and new indications reinforced Gilead’s oncology portfolio, aligning with broader investments in acquisitions (e.g., Tmunity, XinThera) and collaborations to enhance pipeline diversity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains major factual inaccuracies, particularly in financial figures. The ground truth states that Trodelvy generated $380 million in 2022, but the LLM claims $680 million in 2022 and $1.06 billion in 2023—both figures are incorrect and unsupported by the original data. Additionally, the 56% growth and contribution to a 37% increase in Gilead’s Oncology segment revenue are not mentioned in the ground truth and appear fabricated. The Phase 3 trial failure in non-small cell lung cancer is also not part of the provided information, introducing false context. (2) Quantitatively, all key numbers are wrong: $380M (actual 2022 revenue) vs. $680M (claimed), and no 2023 revenue is given in the original answer, so the $1.06B figure is speculative. Calculations based on these numbers (56% growth) are therefore invalid. (3) While the LLM correctly identifies the 2023 FDA and EC approvals for HR+/HER2- metastatic breast cancer as strategic milestones, which aligns with the original answer, it fails to acknowledge that 2023 revenue data is unavailable. The reasoning is partially sound in linking approvals to strategic positioning but overreaches by implying confirmed commercial success via unsubstantiated revenue growth. (4) Contextual relevance is moderate—the response addresses revenue and regulatory developments as asked, but introduces extraneous details (e.g., failed lung cancer trial, Gilead acquisitions) not in the source, reducing accuracy. Overall, the answer fabricates key financial data and adds unsupported strategic challenges, warranting a low correctness score despite some accurate regulatory information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 449,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "\n\nChevron's downstream-related earnings from GS Caltex, a 50%-owned joint venture in South Korea, showed a significant improvement from 2022 to 2024. In 2022, GS Caltex contributed **$85 million** in equity earnings (per the 2024 10-K's Note 15, reflecting 2021 data as a proxy), reversing a **$185 million loss in 2020** and demonstrating recovery. By 2024, the joint venture maintained its strategic importance, with Chevron continuing to invest in downstream operations and maintaining a strong partnership with GS Energy. This stability and earnings growth highlight GS Caltex's role in Chevron's downstream portfolio, particularly in refining, marketing, and petrochemicals in a key Asian market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it cites a $85 million equity earnings figure from GS Caltex in 2022, referencing 'Note 15 of the 2024 10-K' and stating it reflects 2021 data as a proxy. This is incorrect and unsupported by the ground truth, which does not provide specific equity earnings amounts for GS Caltex in 2022 or 2024, only noting improved income from equity affiliates. The mention of a $185 million loss in 2020 is also not present in the ground truth and introduces unverified data. Additionally, the LLM claims 'significant improvement' and 'earnings growth' from 2022 to 2024, but the ground truth indicates a decrease in sales and other operating revenues with affiliated companies from $16,286 million in 2022 to $13,850 million in 2024, contradicting the narrative of growth. (2) The quantitative inaccuracies are severe: the ground truth does not report GS Caltex-specific earnings figures, so the $85M and $185M numbers are fabricated or misattributed. The correct financial trend is a decline in affiliated revenues, which the LLM fails to report. (3) The multi-hop reasoning is partially sound in identifying GS Caltex as a 50% JV with GS Energy involved in downstream operations, and recognizing its strategic importance. However, the conclusion that earnings grew is not supported and contradicts the revenue decline noted in the ground truth. The LLM fails to incorporate the key data point about declining revenues with affiliates, which is central to assessing the evolution of the relationship. (4) The contextual relevance is fair—the answer addresses the joint venture, its ownership, operations, and strategic role—but the incorrect numerical claims and misleading trend analysis significantly undermine factual correctness. The answer creates a narrative of recovery and growth not present in the ground truth, which instead suggests stable ownership but reduced financial activity, indicating a more nuanced strategic position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 542,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "\n\nThe CH-53K program's financial performance and production status from 2022 to 2024 evolved as follows:  \n\n- **Production Volume**: In 2021 (reported in the 2022 10-K), production volume for the CH-53K increased, contributing to higher net sales and operating profit for Lockheed Martin's Rotary and Mission Systems (RMS) segment. By 2024, production ramped up further, driving higher product sales for RMS, partially offset by lower volume on other programs like VH-92A.  \n\n- **Risk Retirements**: In 2021, risk retirements (improved cost estimates) for the CH-53K program positively impacted RMS operating profit. However, by 2024, there were no notable risk retirements mentioned for CH-53K; instead, financial performance was driven by stable production volumes rather than adjustments to profit booking rates.  \n\nOverall, the program transitioned from risk mitigation and volume growth in 2021–2022 to sustained production scaling by 2024, with no significant remaining risk retirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of the CH-53K program from 2022 to 2024 in terms of production volume and risk retirements, aligning well with the ground truth. It accurately notes that in 2022 (with data from 2021), increased production volume and risk retirements boosted operating profit for Sikorsky/RMS, contributing to higher profitability. It also correctly observes that by 2024, the program had transitioned to sustained production scaling with no significant risk retirements, which matches the ground truth's implication that gains from risk retirements diminished as the program matured. However, the LLM answer refers to '2021 (reported in the 2022 10-K)' rather than directly stating 2022 performance, which may confuse the timeline slightly—though this is a common reporting lag, the original answer focuses on 2022 performance without back-attributing to 2021. Additionally, the LLM omits the specific $140 million profit increase in 2022, a key quantitative detail present in the ground truth. While it correctly infers that risk retirements were no longer a major driver by 2024, it does not mention the 73% decline in RMS operating profit, which is a significant contextual data point explaining the broader financial environment. These omissions affect quantitative accuracy but not the overall qualitative reasoning. The synthesis across years and programs is sound, and the conclusion about transitioning from risk-driven gains to volume-driven production is semantically equivalent and well-reasoned. Contextual relevance is excellent, addressing all aspects of the question with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 445,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "\n\nBetween 2022 and 2023, PayPal's approach to seller protection programs evolved by **expanding strategic emphasis on risk management and regulatory alignment** while maintaining low risk exposure. In 2022, the focus was on managing transaction loss rates (0.09%–0.15% of TPV) and mitigating economic risks like merchant insolvency, particularly in post-pandemic recovery contexts. By 2023, PayPal highlighted integrating seller protection as a core differentiator in its value proposition, emphasizing **technology-driven risk mitigation** (leveraging data from its two-sided network) and compliance with evolving global regulations (e.g., EU/UK post-Brexit frameworks, anti-money laundering rules). This shift reflects a strategic move to enhance merchant and consumer trust through broader, more adaptive protections while navigating regulatory complexity to sustain growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in PayPal's seller protection programs between 2022 and 2023. It accurately states the transaction loss rate range of 0.09%–0.15% of TPV in 2022, which matches the ground truth. The shift from risk management focus in 2022 to a strategic, value-driven emphasis in 2023 is correctly captured, including the framing of seller protection as a competitive differentiator tied to merchant trust and platform growth. (2) Quantitatively, all numbers are accurate: the 0.09%–0.15% loss rate range is correctly cited with no calculation errors. There are no dollar amounts or dates requiring verification beyond years (2022–2023), which are correct. (3) The multi-hop reasoning is sound—information is synthesized across time periods and strategic themes. The LLM adds contextual detail not in the original (e.g., post-pandemic recovery, EU/UK regulatory frameworks, anti-money laundering rules, two-sided network data), which is plausible and enhances the answer without contradicting the ground truth. However, the original does not explicitly mention 'technology-driven risk mitigation' or specific regulations like AML/post-Brexit, so these represent minor extrapolations. While reasonable, they slightly extend beyond the provided truth, preventing a perfect 10 on qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing both risk exposure and strategic emphasis as asked. Semantic equivalence is strong: the core message—that PayPal shifted from managing risk to leveraging protection as a growth tool—is preserved and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 448,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "\n\nBetween 2023 and 2024, Starbucks maintained consistent revenue recognition for ready-to-drink (RTD) beverages, with sales generally recognized upon shipment to customers under contract terms (SBUX_10k_2023.pdf, page 65; SBUX_10k_2024.pdf, page 6). However, supplier dependency evolved due to strategic changes: the 2023 sale of the Seattle's Best Coffee brand to Nestlé (SBUX_10k_2023.pdf, page 39) reduced reliance on certain suppliers, while SKU optimization and long-term contracts with specialty suppliers for RTD beverages were emphasized to ensure stability (SBUX_10k_2024.pdf, page 13). This shift reflects a focus on streamlining supplier relationships and aligning with the Global Coffee Alliance, though core revenue recognition practices remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of revenue recognition and correctly identifies that Starbucks recognizes RTD beverage revenue upon shipment, consistent across 2023 and 2024 (supported by cited pages). The mention of long-term contracts with specialty suppliers in 2024 aligns with the ground truth's emphasis on supply chain resilience. However, the LLM introduces a specific event—the sale of Seattle's Best Coffee to Nestlé in 2023—as reducing supplier dependency, which shifts focus toward a brand divestiture not directly tied to the core RTD beverage supply chain discussed in the original answer. While this event is factual, it redirects the narrative away from the ground truth's central point: a strategic shift in reporting focus from revenue recognition (2023) to supply chain risk management (2024). The original answer emphasizes a change in disclosure emphasis and strategic framing, whereas the LLM interprets this as a change in actual supplier dependency due to divestiture and SKU optimization—adding plausible details not present in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer remains contextually relevant. The qualitative reasoning is sound but overreaches in attributing reduced supplier dependency to a specific sale, missing the more nuanced shift in reporting and strategic emphasis described in the original. Thus, core facts are correct, but the synthesis slightly misaligns with the ground truth’s intended focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 415,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "\n\nBetween 2022 and 2023, Trodelvy's geographic reach and regulatory approvals expanded as follows:  \n\n- **2022**: Trodelvy was approved in the U.S., EU, Canada, and other countries for metastatic triple-negative breast cancer (TNBC) and urothelial cancer. Collaborations with Merck initiated trials for non-small cell lung cancer (NSCLC) in 2022.  \n- **2023**: The FDA and European Commission granted additional approvals for Trodelvy as monotherapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer, expanding its therapeutic indications. This marked a significant regulatory expansion into a new patient population, enhancing its global market presence.  \n\nThus, Trodelvy’s regulatory footprint broadened in 2023 through new indications in key regions, building on its 2022 approvals.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key regulatory developments for Trodelvy in 2023, specifically the FDA and European Commission approvals for HR+/HER2- metastatic breast cancer, which aligns with the ground truth and reflects accurate multi-hop reasoning regarding expanded indications. However, the LLM introduces information not present in the original answer: claims of approvals in Canada and other countries in 2022, as well as collaborations with Merck for NSCLC trials, which are absent from the ground truth and cannot be verified from the provided data. This affects quantitative and qualitative accuracy. The original answer emphasizes limited geographic reach in 2022 based on sales data ($370M U.S., $10M Europe, no other markets), but the LLM omits this quantitative evidence of geographic reach, instead asserting broader approvals without supporting sales figures. While the LLM captures the essence of regulatory expansion in 2023, it fails to incorporate the sales-based evidence of geographic reach from 2022, weakening completeness and factual grounding. The reasoning is logically sound but built on unverified assertions. Semantic equivalence is partially met—core regulatory developments are correct, but unsupported details reduce factual precision. Contextual relevance is high as the response directly addresses the evolution of geographic reach and approvals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 384,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "\n\nBetween 2023 and 2024, Simon Property Group (SPG) reduced its ownership stake in Authentic Brands Group (ABG) through multiple transactions, culminating in the full disposal of its remaining interest. In 2023, SPG sold a portion of its ABG stake for a **pre-tax gain of $157.1 million** and recognized a non-cash gain of **$10.3 million** due to a capital transaction that diluted its ownership to approximately 9.6%. By early 2024, SPG sold **all remaining ABG interests** for **$1.2 billion in cash**, generating a **pre-tax gain of $414.8 million**. These transactions reflect a strategic exit from ABG, with total gains of **$582.2 million combined** across the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the LLM reports a pre-tax gain of $157.1 million in 2023, which does not match any individual gain in the original answer; the actual non-cash pre-tax gains in 2023 were $36.4M, $12.4M, and $10.3M—summing to $59.1M, not $157.1M. The LLM also claims a $414.8 million gain in 2024 from a $1.2 billion cash sale of all remaining interests, but the original answer states no new transactions were reported in 2024 and SPG did not disclose any active stake changes. Instead, it referenced a prior 2021 transaction with an $18.8M gain and a $100M acquisition. The total gain of $582.2M is therefore entirely fabricated. (2) The ownership stake evolution is misrepresented: the LLM implies a full disposal by early 2024, but the ground truth only confirms dilution down to 9.6% in 2023 and no further updates in 2024. (3) Qualitatively, the reasoning fails on multi-hop synthesis: the model incorrectly infers an active exit strategy in 2024 when the truth indicates a passive disclosure stance. It conflates past transactions and invents new ones. (4) Contextually, the answer addresses the general theme of ownership and gains, so relevance is moderate, but the core facts are incorrect. Minor credit is given for correctly identifying that dilution occurred and that gains were non-cash and pre-tax in nature, though magnitudes and timing are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 400,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "\n\nThe 2012 Equity Incentive Plan evolved between 2023 and 2024 through the addition of a **Fourth Amendment** (filed August 1, 2024, under Exhibit 10.2(C)+) and the inclusion of an **additional form of award agreement** (Exhibit 10.2(K)+, filed April 25, 2024). In 2023, the plan disclosed a Third Amendment (Exhibit 10.2(B)+) and forms of award agreements up to Exhibit 10.2(J)+ (April 27, 2023). The 2024 filing reflects one new amendment and an expanded set of award agreement forms compared to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) It accurately identifies the Fourth Amendment dated August 1, 2024, aligning with the ground truth's mention of the August 1, 2024 amendment. The reference to the April 2024 award agreement form is correctly supported by the April 25, 2024 filing date. (2) Quantitatively, all dates (August 1, 2024; April 25, 2024; April 27, 2023) and amendment numbers (Third and Fourth) are correct. The exhibit numbers (e.g., 10.2(C)+, 10.2(K)+, 10.2(B)+, 10.2(J)+) are consistent with detailed filing disclosures and add precision beyond the ground truth without introducing error. (3) The reasoning correctly synthesizes multi-hop information by comparing the 2023 and 2024 filings, identifying both the progression in amendments and the expansion in award agreement forms. (4) The answer is contextually precise, directly addressing the evolution of the plan in terms of amendments and award agreements. Minor enhancements in exhibit-level detail improve accuracy without deviating from the original answer’s meaning. All criteria—factual correctness, completeness, entity accuracy, and logical synthesis—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 337,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "\n\nThe capitalized software licenses increased from $152 million in 2022 to $223 million in 2023, reflecting a significant rise in the company's investment in software licensing. This growth is further evidenced by higher amortization expenses, which rose from $54 million in 2022 to $63 million in 2023. The treatment of capitalized software licenses remained consistent, with amortization applied on a straight-line basis over the license term. The increase indicates a strategic emphasis on software licensing to support operations, likely tied to expanding digital capabilities or technological advancements in semiconductor manufacturing and related services.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in capitalized software licenses from $152 million in 2022 to $223 million in 2023, which matches the ground truth and shows accurate core financial data. However, it introduces amortization expenses of $54 million in 2022 and $63 million in 2023, which are not present in the original answer or implied by the ground truth. These figures are unsupported and represent a significant factual overreach, as the original answer only confirms the amortization method (straight-line) but does not provide any expense amounts. (2) The quantitative accuracy is reduced due to the inclusion of unverified amortization expense numbers. While the $152M to $223M increase is correct, the additional numbers fail verification and undermine confidence in the response. (3) The reasoning is otherwise sound: the LLM correctly notes the unchanged amortization policy and infers increased investment in software licensing, aligning with the original conclusion. It also appropriately links the trend to strategic technological investment, which is a reasonable interpretation. (4) Contextual relevance is perfect—the answer directly addresses the evolution in treatment and valuation and interprets the implications for company investment. The core multi-hop synthesis (comparing valuation across years and linking to investment strategy) is well executed, but the addition of unsupported figures lowers correctness and quantitative accuracy. A score of 7 reflects mostly correct facts with one significant error in introduced data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 434,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "\n\nPayPal reduced the absolute amount of European customer balances allocated to fund credit activities from $3.8 billion (37% of European balances) in 2022 to $3.0 billion (39% of European balances) in 2023. This indicates a strategic shift toward diversifying funding sources for credit products, as evidenced by the company’s multi-year agreement to sell €40 billion of eligible consumer installment receivables (with $5.5 billion sold in 2023). The decrease in allocated balances, despite a slight increase in utilization percentage, suggests PayPal is actively reducing reliance on internal customer funds and prioritizing external capital to support credit expansion while maintaining regulatory compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $3.8 billion in 2022 (37%), $3.0 billion in 2023 (39%), the €40 billion receivables agreement, and $5.5 billion sold in 2023. These match the ground truth exactly, with acceptable format variations (e.g., $5.5 billion vs. $5.5 billion). (2) Quantitative accuracy is perfect—no calculation or number errors. The percentages and amounts are accurately represented, and the comparison between years is factually sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes the reduced absolute funding from customer balances with increased percentage utilization and links it to the new external funding mechanism. The interpretation of a strategic shift toward external capital is well-supported and aligns with the ground truth. The only minor gap is that the original answer explicitly notes the higher percentage (39% vs. 37%) suggests more efficient use of balances, while the LLM emphasizes reduced reliance on internal funds—both are valid interpretations, but the LLM slightly downplays the efficiency angle. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: evolution between 2022 and 2023, and strategic implications. The inclusion of the €40 billion agreement and its execution provides critical context for PayPal’s funding strategy. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 416,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "\n\nStarbucks' investment in Valor Siren Ventures I L.P. increased significantly from fiscal 2023 to 2024. As of October 1, 2023, the carrying value of Starbucks' limited partnership interest in Valor Siren Ventures (primarily I L.P.) was $24.2 million (included in \"Other investments\" in Note 6 of the 2023 10-K). By September 29, 2024, the total carrying value of investments in both Valor Siren Ventures I L.P. and II L.P. rose to $211.9 million, reflecting an expanded commitment to these private equity funds. Financially, the impact on Starbucks' consolidated statements was immaterial during both periods, as the related income or losses from these investments were not material to earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that the carrying value for Valor Siren Ventures I L.P. in fiscal 2023 was not specifically disclosed, but the LLM claims it was $24.2 million as of October 1, 2023, citing 'Note 6 of the 2023 10-K'. This figure is not supported by the ground truth and represents a critical error. While the $211.9 million combined carrying value for both I L.P. and II L.P. as of September 29, 2024, is correctly reported, the earlier number is fabricated or misattributed, undermining trust in the response. (2) The date alignment is mostly correct—fiscal years 2023 and 2024 are appropriately referenced with corresponding end dates (October 1, 2023, and September 29, 2024)—but the unsupported $24.2 million figure invalidates the comparison. The claim about 'Other investments' in Note 6 is not corroborated by the ground truth, which does not specify any breakdown for Valor Siren Ventures I L.P. in 2023. (3) The multi-hop reasoning is partially sound: the model attempts to compare two fiscal years and correctly identifies that the financial impact remained immaterial and reported in 'interest income and other, net'. It also correctly notes the expansion to include both I L.P. and II L.P. by 2024. However, the failure to acknowledge that the 2023 value was not disclosed breaks the chain of accurate synthesis. (4) Contextual relevance is high—the answer addresses the evolution of the investment relationship, carrying values, and financial statement impact—but the inclusion of an incorrect key number severely reduces factual correctness. The qualitative reasoning is plausible but built on a false premise. Thus, while the structure and intent are appropriate, the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 497,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "\n\nBetween 2022 and 2023, Texas Instruments (TI) maintained its strategic focus on Analog Products as the core driver of revenue and competitive advantage, with **Analog contributing 74% of total revenue in 2023 ($13.04 billion)**, consistent with its dominant role in prior years. The four competitive advantages—manufacturing/technology, broad product portfolio, market channel reach, and product diversity—remained central to TI’s strategy, emphasizing long-term free cash flow growth. Financially, Analog’s contribution stabilized despite macroeconomic pressures, while Embedded Processing grew to 19% of revenue in 2023 ($3.37 billion), reflecting expanded market penetration in industrial and automotive sectors. TI continued investing in manufacturing capacity (e.g., 300mm wafer facilities) to reinforce its cost and supply-chain advantages, underscoring Analog’s sustained strategic priority.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The claim that Analog contributed 74% of total revenue in 2023 ($13.04 billion) is not supported by the ground truth, which does not provide revenue percentages or dollar figures for Analog Products—this data is fabricated or misattributed. Similarly, the $3.37 billion figure for Embedded Processing (19%) is absent from the original answer and introduces new, unverified data. (2) The ground truth emphasizes gross margin (67.5% in 2022) and strategic reframing in 2023 around TI’s four sustainable competitive advantages, especially cost and supply chain control, and a shift toward free cash flow per share as the key metric. The LLM mentions competitive advantages and free cash flow, which aligns qualitatively, but incorrectly introduces revenue breakdowns not present in the original. (3) The multi-hop reasoning is partially sound—linking Analog Products to TI's competitive advantages and long-term financial strategy—but fails to accurately reflect the evolution in strategic framing between 2022 and 2023 based on actual disclosures. Instead of focusing on gross margin in 2022 and the intensified emphasis on supply chain and cost control in 2023, the model shifts focus to revenue share and embedded processing growth, which are not part of the original answer. (4) The contextual relevance is high because the answer addresses strategic positioning, competitive advantages, and financial contribution. However, the quantitative inaccuracies severely undermine correctness, warranting a moderate score. While some qualitative elements like manufacturing investment and free cash flow are consistent, the inclusion of unsupported figures reduces overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 484,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "\n\nChevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, as reflected in a **significant increase in depreciation, depletion, amortization, and impairments (DD&A)**. In 2023, DD&A for the Lower 48 rose to **$5,729 million** (up from **$4,854 million** in 2022), driven by higher asset activity and the 2021 acquisition of Concho Resources. This acquisition added substantial depreciable assets, necessitating higher DD&A under the unit-of-production method. The increase suggests a strategic focus on maintaining and expanding production capacity in the Lower 48, aligning with Chevron's emphasis on core U.S. onshore operations. Additionally, the absence of major impairments in 2023 (unlike 2022, which included adjustments from prior impairments) indicates stabilized asset values and operational performance in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: DD&A increased from $4,854 million in 2022 to $5,729 million in 2023 in the Lower 48 region, indicating increased capital allocation. These numbers match the original answer exactly and are presented clearly. (2) Quantitative accuracy is perfect—values are correct, properly formatted, and the year-to-year comparison is accurate. (3) The qualitative reasoning is strong: the LLM correctly infers that rising DD&A reflects greater asset development and operational expansion. It adds valuable context about the Concho Resources acquisition and the unit-of-production method, which, while not in the original answer, is factually sound and enhances the explanation. It also correctly notes the absence of major impairments in 2023 versus 2022, which supports the conclusion of stabilized operations. (4) The answer is fully contextually relevant, directly addressing how capital allocation evolved based on DD&A changes. The only reason for not scoring a 10 is that the original answer emphasizes the contrast with other regions (Europe, MENA), which the LLM omits—this is a minor completeness gap but does not detract significantly from the core accuracy. Overall, the multi-hop reasoning—linking financial metrics to strategic intent across years and regions—is well-executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 382,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "\n\nBetween 2023 and 2024, Verizon elevated Fixed Wireless Access (FWA) Broadband's strategic role within its product portfolio and expanded its target customer segments. In 2023, FWA was primarily positioned as a residential alternative to traditional landline internet under the Consumer segment, serving homes not connected to Fios (3.1 million connections as of December 31, 2023). By 2024, FWA was integrated more prominently into both Consumer and Business segments, reflecting its growth as a core component of Verizon’s 5G and fiber expansion strategy. The 2024 filings highlight FWA as a key driver for business customers, including enterprises and public sector clients, alongside residential users, while the acquisition of Frontier and increased fiber investments underscored Verizon’s commitment to scaling FWA as a competitive differentiator in both fixed and mobile broadband markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and captures the evolution of Verizon's FWA broadband strategy between 2023 and 2024. It correctly identifies that FWA was offered to both Consumer and Business segments and notes the 3.1 million connections as of 2023, which matches the ground truth. The shift toward a more integrated and strategic positioning in 2024 is also accurately reflected. However, there are some inaccuracies and unsupported claims: (1) The mention of the 'acquisition of Frontier' is factually incorrect—Verizon did not acquire Frontier in this period, which introduces a significant factual error. (2) While the ground truth notes a semantic shift from 'provides' to 'produces' indicating a more product-centric approach, the LLM overreaches by linking FWA's strategic role to fiber expansion and the non-existent acquisition, introducing speculative reasoning not supported by the source. (3) The ground truth does not mention public sector clients or enterprises as new 2024 targets, so that expansion of customer segments is an overstatement. Quantitatively, the 3.1 million figure is correct and well-placed. Contextually, the answer is highly relevant and addresses both positioning and customer segments. The qualitative reasoning is mostly sound but includes unsupported inferences, reducing its accuracy. Thus, while the core facts and timeline are correct, the addition of incorrect contextual details lowers the overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 408,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "\n\nEmerson's relationship with AspenTech evolved significantly from 2022 to 2024. In 2022, Emerson contributed two industrial software businesses and $6.0 billion in cash to Heritage AspenTech, acquiring 55% ownership. By 2024, Emerson proposed to acquire the remaining 43% of AspenTech for $15.3 billion, moving toward full ownership. \n\nFinancially, the 2022 acquisition of Heritage AspenTech improved Emerson's 2023 gross margin by 0.6 percentage points, contributing to a 49.0% margin. In 2024, while the Test & Measurement acquisition (not AspenTech-related) drove a 1.8 percentage point increase to 50.8%, AspenTech's long-term integration likely sustained margin benefits. The equity structure shifted as Emerson financed the 2024 proposal using cash reserves and credit, reducing its non-controlling interest in AspenTech to zero upon completion, thereby consolidating AspenTech fully into its balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around the timeline and nature of Emerson's transactions with AspenTech. The ground truth states that Emerson acquired a 55% stake in AspenTech as part of a strategic transaction forming 'New AspenTech'—not by contributing software businesses and $6.0 billion to 'Heritage AspenTech' in 2022, which is not supported by the original answer. Additionally, the claim that Emerson proposed to acquire the remaining 43% in 2024 for $15.3 billion is not mentioned in the original answer and appears speculative or incorrect. (2) The 0.6 percentage point improvement in gross margin in 2023 is correctly cited and aligns with the ground truth, which is a key quantitative match. However, the additional claim about Test & Measurement driving a 1.8 percentage point increase to 50.8% in 2024 introduces unrelated information not present in the original answer and distracts from AspenTech’s specific impact. The $6.0B and $15.3B figures are not in the original answer and cannot be verified, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—Emerson’s increased ownership and the financial impact on gross margin and equity structure are addressed. However, the reasoning is flawed by introducing a non-mentioned future acquisition proposal and misrepresenting the 2022 transaction structure. The consolidation of AspenTech and reduction of non-controlling interest is a reasonable inference but not explicitly confirmed in the original. (4) Despite inaccuracies, the answer remains contextually relevant, addressing the evolution of the relationship and financial impacts on margin and equity. The core idea of a deepening relationship and positive margin impact is preserved, warranting a moderate correctness score. Minor errors in wording would be acceptable, but the introduction of unsupported financial figures and transaction details significantly undermines factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 536,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "\n\nThe financial relationship between NextEra Energy, Inc. (NEE) and FPL Group Capital Inc. from 2022 to 2023 reflects NEE's continued role as the parent guarantor for FPL Group Capital's obligations, with updates to debt structures and capital arrangements. In 2022, FPL Group Capital Inc. had unsecured subordinated debentures and guarantees under indentures dated 2004–2006, with FPL Group, Inc. (NEE’s predecessor) as the guarantor. By 2023, NEE directly assumed guarantor responsibilities for FPL Group Capital’s obligations through amended indentures (e.g., Series J, K, L Debentures) and new issuances, such as the 4.45% Notes due 2026 and Floating Rate Notes due 2073. Capital structure involvement evolved as NEE issued junior subordinated debentures (e.g., Series P due 2082) and established purchase contract agreements and pledge agreements to collateralize obligations, reflecting centralized debt management under NEE’s corporate structure. FPL Group Capital’s role remained as a subsidiary entity, with NEE overseeing its capital needs and credit support.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of the financial relationship between NEE and FPL Group Capital Inc. but contains significant factual inaccuracies that affect correctness. (1) The original answer states that in 2022, the relationship was defined by a 1998 guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc., whereas the LLM incorrectly references indentures from 2004–2006 and does not mention the 1998 agreement, which is central to the ground truth. (2) The LLM claims NEE assumed guarantor responsibilities through amended indentures (e.g., Series J, K, L) and new issuances like the 4.45% Notes due 2026 and Floating Rate Notes due 2073—none of which are mentioned in the ground truth and appear to be fabricated or misattributed. (3) While the LLM correctly identifies that NEE issued junior subordinated debentures to FPL Group Capital Inc. (e.g., Series P due 2082), it omits the specific list of Series B, C, L, M, N, O, and P with maturities from 2057 to 2082 as stated in the original answer. Instead, it references unrelated notes and structures. (4) The qualitative shift from a simple guarantee to a long-term capital financing arrangement is partially recognized, but the multi-hop synthesis is flawed—the LLM fails to correctly trace the transition from the 1998 guarantee to the 2023 debenture structure. (5) Contextually, the answer is relevant and addresses the nature of obligations and capital structure involvement, but the incorrect dates, missing series, and invented instruments reduce quantitative and qualitative accuracy. Minor formatting variations in financial terms are acceptable, but invented securities and incorrect timelines constitute major errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 465,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "\n\nThe positioning and market acceptance of InterStim II evolved between 2022 and 2024 by solidifying its role as a recharge-free option within Medtronic’s expanded Pelvic Health portfolio. In 2022, the InterStim Micro (rechargeable) was highlighted as a recent launch driving Pelvic Health growth, while InterStim II was positioned alongside it. By 2024, InterStim II was explicitly noted as a \"recharge-free neurostimulator,\" complementing the InterStim X (another model) and InterStim Micro, reflecting a diversified product strategy to address patient preferences. The 2024 filing emphasized continued global adoption of Pelvic Health therapies, with InterStim II contributing to growth alongside advancements like the Inceptiv closed-loop SCS system (approved in 2024). This evolution underscores Medtronic’s focus on integrating neurostimulation solutions (e.g., AiBLE spinal ecosystem) and expanding indications, enhancing market acceptance through innovation and tailored options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: InterStim II is correctly identified as a recharge-free neurostimulator by 2024, differentiated from InterStim Micro (rechargeable) and grouped with InterStim X. The evolution in positioning—from being part of a general suite in 2022 to being explicitly highlighted by device attribute (recharge-free) in 2024—is accurately captured. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification; the mention of 2022 and 2024 is consistent and correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time (2022 vs 2024), products (InterStim II, Micro, X), and strategic context (product differentiation, patient preferences, portfolio diversification). It correctly infers a shift in emphasis toward device-specific features and broader Pelvic Health therapy adoption. (4) The LLM adds minor contextual details not in the original—such as the Inceptiv closed-loop SCS system and AiBLE spinal ecosystem—which are relevant to Medtronic’s broader innovation strategy but not directly tied to InterStim II’s evolution. These additions do not detract from accuracy but slightly extend beyond the scope of the ground truth. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate, warranting a high score with only minor deduction for slight over-extension of context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 411,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "\n\nSimon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024 as follows:  \n\n1. **Borrowing Capacity**: The Supplemental Facility maintained a borrowing capacity range of $3.5 billion to $4.5 billion during its term in both 2022 and 2024. However, its initial maturity was extended from January 31, 2026 (2022) to January 31, 2029 (2024), with an option to extend further, reflecting a strategic decision to secure longer-term liquidity.  \n\n2. **Interest Rate Strategies**: The facility continued to use SOFR-based floating rates (plus a spread adjustment for LIBOR transition) in 2024, consistent with 2022. The weighted average interest rate for all Credit Facilities in 2024 was 5.29%, up from higher historical rates in 2022, indicating increased cost of borrowing amid rising market rates.  \n\n3. **Repayment Actions**: In 2023, Simon repaid €750 million ($815.4 million) under the Supplemental Facility using proceeds from bond issuances, demonstrating active debt management. By December 31, 2024, the maximum outstanding balance under all Credit Facilities was relatively low at $325.1 million, suggesting limited drawdowns and a focus on maintaining liquidity through other sources like commercial paper or long-term debt.  \n\nOverall, Simon extended the Supplemental Facility’s maturity, managed interest rate risk through SOFR-based pricing, and prioritized repayments and low utilization to preserve liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. The ground truth states the Supplemental Facility had a maturity of January 31, 2026, but the LLM claims it was extended to January 31, 2029 in 2024 — this extension is not supported by the original answer and is a major factual error. The original answer does not mention any extension beyond 2026. Additionally, the LLM states the weighted average interest rate for all Credit Facilities in 2024 was 5.29%, which is not mentioned in the ground truth; the only interest rate information provided is about a 3.81% fixed rate achieved via swaps on the €750 million borrowing. The repayment amount is stated as €750 million in the ground truth, but the LLM converts this to $815.4 million without source data for conversion, introducing unsupported precision. The maximum outstanding balance of $325.1 million as of December 31, 2024, and the claim about low drawdowns are not in the original answer and appear to be fabricated or inferred from unrelated data. (2) Quantitative accuracy is low: while €750 million is correctly cited, the $815.4 million conversion cannot be verified and is extraneous. The 5.29% rate and $325.1 million balance are not in the ground truth. The maturity date change from 2026 to 2029 is incorrect. Only the borrowing capacity range ($3.5B to $4.5B) is accurate. (3) Qualitatively, the LLM recognizes the multi-hop elements — borrowing, interest strategy, repayment — and attempts synthesis, but misrepresents the evolution by adding unverified extensions and financials. The use of SOFR is correctly noted, and the repayment via bond proceeds aligns with the original, but the interest rate swap detail (3.81%) is omitted in favor of an incorrect aggregate rate. (4) Contextual relevance is high — the structure addresses all dimensions of the question (capacity, rates, repayment) and maintains focus on SPG’s strategic management. However, the inclusion of unsupported figures and dates undermines factual reliability. Overall, the answer shows understanding of the question’s intent but fails on key factual and quantitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 582,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "\n\nFrom 2023 to 2024, Verizon shifted its device payment plans toward **non-interest-bearing installment financing** (typically 36-month terms) and **promotional billing credits tied to service retention**, while eliminating fixed-term subsidies for consumer devices. In 2023, Verizon ceased offering fixed-term, subsidized plans for consumer devices but retained them for business customers. By 2024, promotional incentives were structured as **billing credits allocated to service obligations**, reducing transaction prices and creating contract liabilities. Additionally, Verizon no longer separately accounts for financing components in device payment plans, deeming them insignificant, and introduced trade-in rights as guarantee obligations, further aligning financing structures with customer retention goals.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies and conflates information not present in the ground truth. (1) Correct aspects: the mention of non-interest-bearing installment plans with 36-month terms aligns with the 2024 update in the original answer. The general shift toward structured financing is also consistent. (2) Quantitative accuracy: the 36-month term is correctly cited, and no incorrect numerical values (e.g., dollar amounts, percentages) are introduced—this prevents a lower score. However, the answer fabricates details not found in the ground truth, such as 'billing credits allocated to service obligations,' 'contract liabilities,' and 'eliminating fixed-term subsidies for consumer devices,' which are not mentioned in the source. The claim that Verizon 'ceased offering fixed-term, subsidized plans for consumer devices' in 2023 is unsupported by the original answer, which only states that installment plans existed without promotional details. (3) Multi-hop reasoning is partially sound—there is an attempt to synthesize changes over time—but the LLM adds unverified accounting treatments (e.g., 'no longer separately accounts for financing components,' 'trade-in rights as guarantee obligations') that go beyond the provided truth. The original answer notes trade-in rights as part of a promotional upgrade path, not as a guarantee obligation or accounting liability. (4) The answer is contextually relevant and addresses the evolution of financing and incentives, but the inclusion of unsupported financial reporting concepts and promotional structures reduces factual accuracy. The core evolution—toward structured, incentive-driven plans with trade-in upgrades—is underemphasized in favor of speculative accounting details. Thus, while the direction of change is partially captured, the specific factual basis from the knowledge graph is not faithfully represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 519,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "\n\nBetween 2023 and 2024, The Coca-Cola Company's legal stance on liability for Aqua-Chem's asbestos-related claims remained consistent, with no new developments indicating a shift in responsibility. Key points include:  \n\n1. **Insurance Coverage Resolution**: By 2014, insurers were deemed **jointly and severally liable** for Aqua-Chem’s asbestos claims up to policy limits, as finalized by the Wisconsin Supreme Court. This ruling resolved the core dispute, and no subsequent updates in 2023 or 2024 suggest changes to this outcome.  \n2. **Georgia Case Stay**: The Georgia litigation (filed in 2002) remains **stayed** as of both filings, with Coca-Cola maintaining its position that it has no obligation to Aqua-Chem for liabilities not covered by insurance.  \n3. **No New Liability Exposure**: Both filings confirm that Coca-Cola’s exposure is limited to **insurance policy exhaustion**, with no direct financial liability for asbestos claims beyond insurer obligations.  \n\nIn summary, the legal relationship between Coca-Cola and Aqua-Chem regarding asbestos liabilities remained unchanged between 2023 and 2024, with insurers bearing responsibility under existing court rulings.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Coca-Cola's legal stance between 2023 and 2024. (1) The claim that the Wisconsin Supreme Court ruled on joint and several liability in 2014 is incorrect — this detail does not appear in the ground truth and is unsupported; the original answer makes no mention of a 2014 ruling or Wisconsin court involvement. This is a major factual error. (2) The LLM incorrectly asserts that there was 'no shift' in Coca-Cola's stance, directly contradicting the ground truth, which identifies a clear shift in emphasis from outright denial in 2023 to a more nuanced discussion of insurance coverage and shared insurer responsibility in 2024. (3) The LLM fails to mention the key evolution in disclosure — the increased detail about multiple insurers and ongoing coverage litigation in 2024 — which is central to the original answer. (4) While the Georgia case being stayed is consistent with the ground truth, the LLM mischaracterizes Coca-Cola's position as unchanged, when the nuance of the disclosure shift is critical. (5) The conclusion that 'no new developments' occurred is factually incorrect per the original answer, which documents a strategic shift in narrative focus. Quantitative accuracy is partially acceptable due to correct referencing of the stayed Georgia case, but the erroneous 2014 date and fabricated court ruling severely undermine reliability. Qualitative accuracy is low due to failure in multi-hop reasoning: the model did not synthesize the change in disclosure tone and content across years. Contextual relevance is moderate because the answer addresses the general topic and legal framework but misses the core analytical point about evolving corporate disclosure strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 481,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "\n\nIntel's utilization of non-US tax credits reduced its long-term income tax liabilities from $4.3 billion in 2022 (as of December 25, 2021) to $1.6 billion in 2024 (as of December 28, 2024), reflecting a significant decline. This reduction aligns with a lower effective tax rate, decreasing from 12.5% in 2022 to 8.5% in 2024, driven by benefits from non-US income taxed at lower rates (e.g., in Hong Kong, Ireland, Israel, and Malaysia) and tax credits. The trend indicates Intel’s strategic focus on optimizing its global tax structure by leveraging favorable tax jurisdictions and credits, thereby reducing overall tax exposure and enhancing financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: long-term income taxes decreased from $4.3 billion in 2022 to $1.6 billion in 2024, matching the original answer. The effective tax rate drop from 12.5% to 8.5% is an additional detail not in the ground truth but does not contradict it and may reflect deeper filing insights. (2) The fiscal years are correctly referenced with appropriate as-of dates (December 25, 2021 for 2022 data; December 28, 2024 for 2024 data), which is consistent with SEC reporting conventions. (3) The reasoning is sound: the answer correctly infers that increased use of non-US tax credits and lower foreign tax rates (citing specific jurisdictions) contributed to reduced liabilities, indicating a strategic international tax optimization—this synthesizes multi-hop information across time and geography. (4) The only minor gap is that the original answer emphasizes the 'stronger offsetting effect over time' of non-US tax credits, while the LLM adds explanatory detail about lower-taxed jurisdictions, which enriches but slightly shifts focus. However, this addition is plausible and contextually appropriate. No factual errors; excellent completeness, entity accuracy, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 358,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "\n\nBetween 2022 and 2024, MetLife's treatment and risk exposure to pension risk transfers evolved with increased interest rate sensitivity management and heightened regulatory influence. **Interest rate sensitivity** saw improved mitigation strategies, as evidenced by rising adjusted earnings impacts under hypothetical interest rate scenarios (e.g., U.S. segment adjusted earnings shifted from a $5M negative impact in 2022 to $20M positive by 2024), reflecting better alignment of derivatives and reinvestment strategies with rate fluctuations. **Regulatory influence** intensified, with 2024 filings highlighting potential delays in pension plan terminations due to stricter funding rules, enhanced capital standards, and supervision. These factors increased reliance on non-guaranteed funding products and constrained structural flexibility, while regulatory scrutiny over solvency, capital buffers, and ESG standards added complexity to risk management frameworks. Together, these shifts underscore a more cautious approach to pension risk transfers, balancing market dynamics with evolving compliance demands.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, particularly the adjusted earnings impacts under interest rate scenarios (e.g., $5M negative in 2022 to $20M positive in 2024), which are entirely fabricated and not supported by the original answer or any cited data. These numbers do not appear in the ground truth and cannot be verified, making them factually incorrect. (2) There is no mention in the original answer of MetLife specifically, nor of any earnings figures, derivatives usage, or reinvestment strategy details—these are speculative additions. The ground truth does not provide any numerical data on earnings impacts or quantitative risk metrics, so the LLM's inclusion of such specifics fails the quantitative accuracy test. (3) Qualitatively, the LLM captures the general direction of regulatory influence correctly: that by 2024, regulatory changes (e.g., stricter funding rules) could delay pension plan terminations and shift activity toward non-guaranteed funding products. This aligns with the original answer’s emphasis on reduced likelihood of plan terminations and a strategic shift in product mix. The multi-hop reasoning about evolving regulatory impact and interest rate sensitivity is conceptually sound, though overstated with false precision. (4) Contextually, the response is highly relevant, addressing both interest rate sensitivity and regulatory influence across 2022–2024 as required. However, the invented metrics severely undermine factual correctness. While the qualitative trend interpretation is reasonable, the inclusion of unsupported numerical claims results in a low quantitative accuracy score and a moderate overall correctness score due to partial alignment with the ground truth’s core themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 487,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "\n\nBetween 2022 and 2024, Medtronic's strategy for the **InterStim Micro neurostimulator** evolved from **initial market adoption** to **sustained growth and product line expansion**. In 2022, the device was highlighted as a newly launched innovation driving Pelvic Health growth, targeting overactive bladder, urinary retention, and fecal incontinence. By 2024, the focus shifted to reinforcing its **rechargeable design** as a key differentiator and integrating it into a broader portfolio that includes the InterStim X and InterStim II models. This reflects a strategy to solidify market leadership in pelvic health neurostimulation while expanding treatment options for chronic conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the InterStim Micro was positioned in 2022 as part of Medtronic's Pelvic Health therapies for overactive bladder, urinary retention, and fecal (bowel) incontinence, and by 2024 it was specifically highlighted as a rechargeable device, differentiated from the non-rechargeable InterStim X and II models. The evolution from broader adoption to targeted differentiation based on rechargeability is correctly captured. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—only years (2022, 2024), which are correctly used. (3) The multi-hop reasoning—synthesizing Medtronic's shifting product strategy across two time points and within the context of a competitive product lineup—is sound and logically presented. The LLM correctly infers a strategic shift toward differentiation without overreaching. (4) Minor deduction in qualitative accuracy due to the phrase 'initial market adoption' and 'newly launched innovation' in 2022, which slightly overstates novelty—the ground truth does not describe it as newly launched in 2022, only as part of an established and growing line. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 369,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "\n\nSimon Property Group's use of the Supplemental Facility evolved as follows between 2022 and 2024:  \n\n- **Outstanding Borrowings**: In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion (expandable to $4.5 billion) with a maturity of January 2026. By 2024, its capacity remained at $3.5–$4.5 billion, but outstanding borrowings were significantly reduced. Notably, in November 2023, the company repaid €750.0 million ($815.4 million) under the Supplemental Facility using proceeds from bond issuances, reflecting active repayment actions. By December 31, 2024, total outstanding borrowings under the Credit Facilities (which include the Supplemental Facility) were $323.7 million, indicating a sharp decline from prior years.  \n\n- **Repayment Actions**: Key repayments included the 2023 repayment of the €750.0 million borrowing, which eliminated a major portion of the facility’s outstanding balance. The facility’s maturity was also extended to January 2029 (from 2026 in 2022), providing longer-term flexibility.  \n\nOverall, the company reduced reliance on the Supplemental Facility through strategic repayments while maintaining expanded borrowing capacity for future needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key repayment action of €750.0 million ($815.4 million) under the Supplemental Facility on November 17, 2023, which aligns with the ground truth. It also accurately reflects the reduction in outstanding borrowings over time. However, the LLM states that the total outstanding borrowings under the Credit Facilities were $323.7 million as of December 31, 2024, while the ground truth reports a weighted average outstanding balance of $311.1 million in 2024. This is a minor discrepancy in metric type (point-in-time vs. weighted average) and amount, but close enough to not constitute a major error. The 2022 weighted average balance of $519.9 million and maximum balance of $2.1 billion are not mentioned in the LLM answer, representing a partial omission. (2) The €750.0 million and $815.4 million figures are correctly reported. The repayment date (November 2023) is accurate. The $3.5–$4.5 billion capacity and maturity extension to January 2029 are plausible contextual details not contradicted by the ground truth, though not in the original answer. (3) The multi-hop reasoning is sound: the model connects the 2023 repayment to reduced 2024 balances and infers strategic debt reduction, which is consistent with the ground truth’s conclusion. It synthesizes repayment actions and balance trends correctly. (4) The answer is highly relevant, well-structured, and captures the evolution of the facility use. The main shortcoming is the lack of explicit mention of the 2022 weighted average and maximum balances, and slight mismatch in 2024 balance figure, preventing a top score. Overall, core facts and reasoning are correct with minor omissions and a small numerical variance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 473,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "\n\nCOP's investment activity in the Lower 48 region increased from 2022 to 2023, as reflected in the rise of depreciation, depletion, amortization, and impairments (DD&A) expenses. In 2023, DD&A for the Lower 48 reached **$5,729 million** (COP_10k_2023.pdf, page 133), up from **$4,854 million** in 2022 (COP_10k_2022.pdf, page 143). This **$875 million increase** suggests higher capital investment or asset valuation in the region during 2023 compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported DD&A expenses for 2022 ($4,854 million) and 2023 ($5,729 million) are accurate, and the calculated increase of $875 million is correct (5,729 - 4,854 = 875). (2) The answer is complete, addressing the evolution of investment activity by referencing the key financial metric (DD&A) across both years and drawing a logical conclusion about increased investment or asset utilization. (3) Entity accuracy is perfect: COP (ConocoPhillips), the Lower 48 region, and the correct fiscal years (2022 and 2023) are properly identified. (4) The reasoning is sound—DD&A expenses are a recognized proxy for asset utilization and investment activity in upstream oil and gas, so an increase suggests higher activity, which aligns with the inference in the original answer. The LLM also cites specific document sources (page numbers from 10-K filings), enhancing credibility. (5) The semantic meaning is equivalent to the ground truth, with slightly more detail (explicit calculation of the difference), but no factual or interpretive errors. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 334,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "\n\nFrom 2023 to 2024, Verizon's approach to corporate networking solutions evolved by integrating advanced 5G and fiber infrastructure, emphasizing the **Intelligent Edge Network** architecture to enhance application performance through localized hosting, and accelerating fiber expansion via strategic acquisitions like Frontier (announced in September 2024). The Business segment shifted focus toward leveraging 5G and fiber for enterprise solutions, including denser networks and eliminating legacy systems, while maintaining core offerings like private networking and managed services. Despite a 2.0% revenue decline in 2024, the emphasis on next-generation infrastructure and IoT-enabled services reflects a strategic pivot to position corporate solutions at the forefront of Verizon's growth initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. It claims Verizon emphasized the 'Intelligent Edge Network,' integrated 5G and fiber, and made a strategic acquisition of Frontier (announced September 2024), none of which are supported by the original answer or implied in the evolution from 2023 to 2024. There is no mention of Frontier acquisition or Intelligent Edge Network in the ground truth. The 2.0% revenue decline in 2024 is fabricated; the original answer only provides 2023 revenue ($15.1 billion) and no 2024 revenue change. (2) Quantitative accuracy is poor: the only correct number in the original is the $15.1 billion Enterprise and Public Sector revenue in 2023, which the LLM omits entirely. Instead, it invents a 2.0% decline without basis. Dates like 'September 2024' are specific but incorrect and not in the source. (3) The multi-hop reasoning is flawed. The question asks for evolution in service description and business segment emphasis based on how Verizon presented its offerings. The ground truth identifies a shift from detailed service descriptions in 2023 (private networking, cloud connectivity, SDN) to a more generalized description in 2024. The LLM completely misses this narrative and instead fabricates a technology-driven strategic pivot, failing to address the actual change in reporting or messaging. (4) Contextual relevance is moderate because the LLM discusses corporate networking and business segments, which are relevant, but it invents strategic initiatives and performance metrics, making the answer misleading. The core evolution—simplification and generalization of service descriptions—is entirely missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 473,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "\n\nMetLife's valuation approach for FVO (Fair Value Option) securities remained consistent from 2022 to 2024, utilizing Level 3 inputs with techniques aligned with other unobservable asset valuations (e.g., present value models, option pricing). However, sensitivity to U.S. dollar appreciation impacts was explicitly quantified in 2022, showing a $54 million potential loss for FVO securities under a 10% dollar strengthening scenario (MET_10k_2022.pdf, p. 151). By 2024, while the valuation methodology for FVO securities was unchanged (MET_10k_2024.pdf, p. 250), the document did not provide updated sensitivity figures for U.S. dollar movements. This suggests a continued exposure to currency risk but a shift in disclosure focus, possibly reflecting improved hedging strategies or reduced reliance on detailed scenario analysis in later filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 fair value sensitivity figure of a $54 million decrease for FVO securities under a 10% U.S. dollar appreciation, which matches the ground truth. However, it incorrectly states that the valuation methodology remained 'unchanged' and that the approach was 'consistent' from 2022 to 2024. The ground truth indicates a clear evolution in methodology—from a static sensitivity model to a more nuanced, dynamic framework incorporating duration and currency dependence by 2024. The LLM misses this key shift and instead suggests only a 'shift in disclosure focus,' which is speculative and contradicts the original answer. (2) Quantitatively, the $54 million figure is accurate, and no other numbers are misstated. The absence of a 2024 fair value number is correctly noted, aligning with the ground truth. However, the LLM fails to mention the broader sensitivity framework introduced in 2024 involving nonperformance risk spreads and unobservable inputs varying by duration and currency—critical qualitative developments. (3) The multi-hop reasoning is partially sound: the model correctly retrieves 2022 sensitivity data and acknowledges missing 2024 figures. But it fails to synthesize the evolution in methodology, instead concluding methodological consistency, which is incorrect. The reasoning gap lies in interpreting reduced disclosure as no change in approach, whereas the ground truth shows an actual methodological advancement. (4) The correctness score is 5 due to accurate numbers but significant omission and mischaracterization of the methodological evolution. Quantitative accuracy is high (9) because all cited numbers are correct. Qualitative accuracy is low (5) due to incorrect synthesis and reasoning about the valuation approach. Contextual relevance is strong (8) as the response stays on topic and references relevant disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 514,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "\n\nNextEra Energy's (NEER) power marketing and energy trading activities showed significant improvement in financial performance between 2022 and 2023. In 2023, operating revenues increased by $5,952 million, driven largely by **$2,529 million in gains from non-qualifying commodity hedges** (compared to $2,670 million in losses in 2022), reflecting favorable changes in energy prices and reduced volatility. Additionally, revenues from customer supply and gas infrastructure grew by $647 million, while new clean energy investments added $390 million. Adjusted earnings highlighted a **$1,497 million after-tax gain from non-qualifying hedges in 2023**, reversing a $696 million loss in 2022. These factors, combined with higher capacity service revenues and expanded trading activities, underscored a strategic shift toward leveraging market conditions and optimizing asset value, resulting in a **$3,273 million increase in NEER’s net income** for 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of growth in NextEra Energy's power marketing and trading activities between 2022 and 2023 and correctly identifies NEER as the subsidiary involved. However, there are significant quantitative discrepancies. The ground truth states that net income rose from $285 million in 2022 to $3,558 million in 2023 — a difference of $3,273 million — which the LLM correctly cites as a '$3,273 million increase in NEER’s net income'. This part is accurate. However, the LLM introduces detailed breakdowns not present in the original answer, such as '$5,952 million' in operating revenue increase, '$2,529 million in gains from non-qualifying commodity hedges', and '$1,497 million after-tax gain', none of which appear in the ground truth and cannot be verified against it. These specific figures and the detailed hedge performance may be factually correct in external sources but are not supported by the provided ground truth, making them potentially hallucinated or misaligned. (2) The net income change calculation ($3,558M - $285M = $3,273M) is correct and matches the LLM's statement, which is a strong point. However, other numbers like $647M and $390M in revenue contributions are not mentioned in the original answer and introduce unverified detail. (3) The reasoning is logically sound in connecting improved financial performance to expanded trading and market optimization, aligning with the original answer’s theme of growth and strategic evolution. The mention of 'expanded trading activities' and 'optimizing asset value' reflects the multi-hop synthesis of activity expansion and financial impact. (4) While the core conclusion — that power marketing activities grew significantly and profitably from 2022 to 2023 — is correct and contextually well-supported, the inclusion of unsupported granular financial data reduces quantitative accuracy. The answer is qualitatively reasonable and highly relevant, but the addition of unverified figures lowers confidence in factual fidelity, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 559,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\n\nThe Coca-Cola Company's ownership stake in Coca-Cola FEMSA remained at 28% in both 2023 and 2024. However, the carrying value of the investment decreased from $1,967 million in 2023 to $1,786 million in 2024, likely reflecting impairments or reduced earnings. Equity income from all equity method investees, including Coca-Cola FEMSA, increased slightly to $1,770 million in 2024 from $1,691 million in 2023. However, specific impairments related to Latin American investees (including Coca-Cola FEMSA) reduced equity income, with charges of $39 million in 2023 and $34 million in 2024. Thus, while ownership remained stable, equity income was negatively impacted by these impairments during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. The original answer states that in 2023, The Coca-Cola Company did not report a 28% ownership stake in Coca-Cola FEMSA — rather, the relationship was described as one of indirect financial dependency due to FEMSA's role as a key bottler affecting credit ratings. The shift to a 28% ownership stake accounted under the equity method is presented as a new development in 2024. However, the LLM claims the stake was 28% in both 2023 and 2024, which contradicts the evolution narrative in the ground truth. (2) The quantitative details in the LLM answer — such as the carrying value decreasing from $1,967 million to $1,786 million, equity income increasing from $1,691M to $1,770M, and impairment charges of $39M and $34M — are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be factually correct in external sources but contradict the knowledge graph's representation, which does not mention specific carrying values or impairment amounts. Thus, they introduce unsupported data. (3) The multi-hop reasoning is flawed because the LLM fails to recognize the qualitative shift from indirect dependency (2023) to direct ownership influence (2024), which is the core of the original answer. Instead, it assumes stable ownership and focuses on financial fluctuations, missing the strategic evolution entirely. (4) While the LLM discusses equity income and ownership, it misrepresents the timeline and nature of the relationship change, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because it addresses stake ownership and equity income, but with incorrect framing and unverified numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 487,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "\n\nThe financial investment and operational focus on the Lower 48 region between 2022 and 2023 showed mixed trends. **Depreciation expenses increased** from $4,854 million in 2022 to $5,729 million in 2023 (COP_10k_2023.pdf, p. 133), reflecting higher capital investment or asset utilization. However, **production volumes likely declined**, as sales revenue for the Lower 48 segment dropped significantly from $52,903 million in 2022 to $38,237 million in 2023 (ibid.), potentially indicating reduced output or lower pricing realization. This suggests a shift in operational emphasis, possibly due to strategic reallocation of resources or market conditions impacting the region’s contribution.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the depreciation, depletion, amortization, and impairments expenses of $4,854 million in 2022 and $5,729 million in 2023, citing COP_10k_2023.pdf, p. 133, which aligns with the ground truth. This shows accurate quantitative reporting of financial investment. However, the claim that 'production volumes likely declined' is incorrect and unsupported by the ground truth, which states strong production volumes in 2022 (447 kbbl/d crude oil, 1,340 MMcf/d natural gas) and implies stability into 2023. The LLM incorrectly infers declining production based on a drop in sales revenue from $52,903 million to $38,237 million, failing to account for potential price fluctuations or other market factors. The ground truth emphasizes continued operational focus and increased financial investment despite stable production, whereas the LLM suggests a decline in operational performance, which contradicts the evidence. (2) All cited numbers are quantitatively accurate as reported in the source, though the interpretation of revenue decline as a proxy for production decline is flawed. (3) The multi-hop reasoning is partially sound—linking higher depreciation to increased investment is valid—but the leap from lower revenue to lower production is not justified without additional data on commodity prices or volume disclosures. The model fails to synthesize the full context: rising DD&A indicates sustained or growing investment, which should imply continued operational focus, not a reduction. (4) The correctness score is 4 due to major factual misinterpretation of production trends despite accurate numbers. Quantitative accuracy is high (8) because all dollar figures are correct. Qualitative accuracy is moderate (5) due to flawed logic in interpreting revenue changes. Contextual relevance is fair (7) as the answer addresses both financial and operational aspects but draws an incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 526,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "\n\nBetween 2023 and 2024, Verizon's 4G LTE network evolved from a core infrastructure component to a complementary element within its broader 5G and fiber-centric growth strategy. In 2024, the company emphasized advancing its 5G network deployment and fiber expansion (including the Frontier acquisition), positioning 5G as the primary driver for innovation and capacity. However, 4G LTE remains integral for Fixed Wireless Access (FWA) broadband, serving as an alternative to traditional landline internet, particularly in areas where fiber deployment is still progressing. This shift reflects a strategic focus on 5G's superior speed and capacity while leveraging 4G LTE to maintain connectivity and support existing customer needs during the transition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2023, Verizon used 4G LTE primarily for Fixed Wireless Access (FWA) as an alternative to landline internet, which matches the original answer. In 2024, it accurately reflects the shift in strategy where 4G LTE becomes part of a broader integrated network vision alongside 5G (including C-Band and millimeter wave) and fiber, though it emphasizes 5G and fiber more than the original's mention of a 'multi-technology ecosystem.' (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or financials. (3) The multi-hop reasoning is sound: the model synthesizes the evolving strategic role of 4G LTE across two years and contextualizes it within Verizon’s larger network infrastructure and growth initiatives. The mention of the Frontier acquisition is not in the original answer and may be extraneous or incorrect (Frontier was not acquired by Verizon), but it does not undermine the core accuracy regarding network strategy. (4) The answer is contextually relevant, complete, and semantically equivalent to the ground truth, with only minor emphasis differences—hence a high score but not perfect due to the slight overemphasis on 5G/fiber at the expense of fully capturing the 'integrated network vision' framing from the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 383,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "\n\nEmerson's relationship with AspenTech evolved significantly from 2022 to 2024. In 2022, Emerson acquired a 55% stake in AspenTech by contributing its industrial software businesses and $6.0 billion in cash, creating \"New AspenTech\" (page 3, 2022 10-K). This acquisition boosted AspenTech’s backlog from $328 million in 2021 to $1,042 million in 2022 (page 10, 2022 10-K) and improved Emerson’s gross margin by 0.6 percentage points in fiscal 2023 (page 26, 2024 10-K). By 2024, Emerson proposed to acquire the remaining 43% of AspenTech (owning 57% at the time) for $240 per share, valuing AspenTech at $15.3 billion (page 25, 2024 10-K), reflecting increased stake value and full ownership ambitions. The 2024 financials showed continued margin benefits from prior acquisitions, though the Test & Measurement acquisition had a larger 2024 impact. Ownership shifted from a majority stake to near-full control, with strategic integration enhancing backlog and margin contributions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and attempting multi-hop reasoning. (1) Key facts are incorrect: The ground truth states Emerson did *not* acquire a 55% stake in 2022 via cash and asset contribution — rather, the 55% ownership emerged in 2024 after the creation of 'New AspenTech'. The LLM incorrectly backdates this ownership structure to 2022. Additionally, the claim that Emerson 'acquired a 55% stake in 2022' contradicts both the timeline and the actual transaction sequence. (2) Quantitative errors: The LLM states backlog rose from $328M (2021) to $1,042M (2022), but the ground truth reports $1,042M as Emerson's stake value in 2022, not AspenTech’s total backlog. The actual backlog cited in the ground truth is $6,533M in 2021 and $8,053M in 2024 — numbers completely omitted or misrepresented by the LLM. The gross margin improvement is stated as 0.6 percentage points in the LLM answer (citing 2024 10-K), but the ground truth reports a 3.3 percentage point increase, making this a major discrepancy. (3) The LLM introduces a claim that Emerson proposed to acquire the remaining 43% in 2024 while owning 57% — this is unsupported by the ground truth, which states Emerson *already owned 55%* post-transaction in 2024, with no mention of a 57% stake or a new $240/share offer. The $15.3B valuation is not in the original answer and appears fabricated. (4) While the LLM correctly identifies the strategic evolution and attempts to link the acquisition to financial metrics like backlog and margin, the reasoning is based on incorrect data. It also confuses the direction of the transaction — the formation of 'New AspenTech' involved merging Emerson's software business into AspenTech, not Emerson buying AspenTech outright in 2022. (5) Contextually, the answer is relevant and structured well, addressing stake value, ownership, and financial impacts. However, due to major quantitative and factual errors in numbers, timing, ownership percentages, and financial impacts, the overall correctness is low. Minor credit is given for identifying the creation of 'New AspenTech' and attempting to quantify financial effects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 592,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "\n\nNEE's financial commitment to the Mountain Valley Pipeline (MVP) evolved significantly between 2022 and 2023. In 2022, NextEra Energy Resources (NEER) fully wrote off its investment in MVP due to impairment charges, as disclosed in Note 9 of the 2022 10-K. However, by 2023, NEE committed to equity contributions for MVP construction, with $1,060 million allocated in 2024 under NEER’s capital expenditures (Note 15 of the 2023 10-K). This shift indicates a strategic pivot to re-engage with MVP despite prior losses, reflecting NEE’s long-term commitment to critical infrastructure projects and its willingness to reinvest in ventures aligned with its energy transition goals, even after recognizing impairments. The continued investment underscores resilience and confidence in the project’s eventual viability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims NEE fully wrote off its MVP investment in 2022 due to impairment (citing Note 9 of the 2022 10-K), but the original answer states NEE maintained a 32%-55% equity stake, indicating continued involvement, not a write-off. (2) The LLM asserts a $1,060 million allocation in 2024 under NEER’s capital expenditures in 2023 (citing Note 15 of the 2023 10-K), but the ground truth reports a 32.8% equity investment and a $70M/year transportation agreement—no mention of $1,060M or 2024 capital allocation. These figures and citations are factually unsupported by the provided truth. (3) The reasoning is flawed: the LLM frames the evolution as a 'strategic pivot' after a write-off, while the truth shows a continuity and deepening of commitment via structured contracts, not a re-engagement post-loss. (4) Entity accuracy is partially correct (NEE, NEER, MVP), but the financial events and their interpretation are wrong. The answer is contextually relevant to MVP and NEE’s strategy but factually and quantitatively inaccurate. Thus, the correctness score is low due to major factual and quantitative errors, despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 342,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "\n\nFrom 2023 to 2024, Coca-Cola's relationship with Costa Limited remained integrated within the **Global Ventures segment**, with no significant operational or strategic shifts disclosed. Both filings confirm that Costa's direct-to-consumer retail sales of finished beverages (primarily coffee and tea) are included in the Global Ventures operating segment. In 2023, Costa was highlighted as part of the \"water, sports, coffee and tea\" brand portfolio, and in 2024, it was explicitly listed among the Global Ventures businesses (alongside innocent and doğadan). The strategic positioning emphasizes Costa's role in expanding Coca-Cola's direct retail footprint and diversifying its beverage offerings, with no material changes in integration or scope during the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy and timeline (2023–2024), correctly identifying Costa Limited's inclusion in the Global Ventures segment both years and its association with direct retail operations and beverage diversification. It accurately notes the co-location of Costa with innocent and doğadan in 2024, which aligns with the original answer. However, the LLM underrepresents the evolution by stating there was 'no significant operational or strategic shifts disclosed' and 'no material changes in integration or scope,' which contradicts the ground truth's emphasis on Costa being 'more strategically embedded' and the segment now including new elements like distribution coordination fees and other businesses—indicating deeper integration. While the LLM lists the correct components, it fails to convey the progression in strategic depth and operational expansion implied in the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning is logically structured, but the qualitative assessment of the relationship's evolution is incomplete. Thus, the answer is largely correct but misses a key nuance in strategic progression, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 386,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "\n\nIntel's fair value of economically hedged marketable debt investments decreased from **$19.0 billion as of December 31, 2022**, to **$17.1 billion as of December 30, 2023**, and further to **$13.5 billion as of December 28, 2024**. This decline reflects net losses of $748 million in 2022, net gains of $534 million in 2023, and net losses of $464 million in 2024, driven by market fluctuations and hedging activities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeline. The original answer states that in 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments, but does not provide the fair value at the end of 2022. However, the LLM claims the fair value was $19.0 billion as of December 31, 2022, which is not supported by the ground truth. The ground truth only provides 2023 ($17.1 billion) and 2024 ($13.5 billion) values. This $19.0 billion figure is an unsupported addition. Additionally, the LLM introduces 'net gains of $534 million in 2023', which is entirely absent from the original answer and cannot be verified from the provided truth. (2) While the $13.5 billion (2024) and $17.1 billion (2023) figures are correctly used, the 2022 value is fabricated. The net losses of $748 million in 2022 and $464 million in 2024 are correctly cited. However, the inclusion of a $534 million gain in 2023 introduces a quantitative error in the trend analysis. (3) The multi-hop reasoning is partially sound— the model attempts to show evolution over time and links fair value changes to gains/losses, which aligns with the question’s intent. However, the unsupported 2022 fair value and 2023 gain undermine the validity of the synthesis. (4) The contextual relevance is high because the answer addresses the evolution of Intel's investments and focuses on the correct metric. The qualitative reasoning is logical but based on incorrect data inputs. The correctness score is 6 due to partial factual accuracy—core elements like 2024 and 2023 fair values and 2024/2022 losses are correct, but the addition of unverified data points reduces overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 467,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "\n\nAMT's financial focus on communications sites evolved from 2023 to 2024 with a continued emphasis on **recurring revenue generation** through long-term leases, which constituted 99% of total revenues in 2023 and remained a priority in 2024. In 2024, the company highlighted that most customer leases are multiyear contracts, ensuring stable cash flows, and stressed maintaining this recurring revenue as critical for liquidity. Regarding **asset retirement liabilities**, AMT reported a significant increase, with estimated undiscounted future cash outflows rising to $4.5 billion as of December 31, 2024 (from $2.1 billion in 2023). This reflects expanded obligations tied to site remediation and asset removal, likely driven by growth in communications sites and a 2024 accounting change extending the estimated useful life of tower assets to 30 years, which impacts long-term liability recognition.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued emphasis on recurring revenue generation, noting that 99% of revenues came from property operations in 2023 and remained a focus in 2024. It also correctly reports the $4.5 billion in estimated undiscounted future cash outflows for asset retirement obligations as of December 31, 2024. However, the ground truth does not mention the $2.1 billion figure for 2023 or an accounting change extending asset life to 30 years—these are plausible but unsupported additions not present in the original answer, introducing potential inaccuracies. (2) The $4.5 billion liability figure for 2024 is accurate and matches the ground truth. The 99% recurring revenue figure is also correct. However, the inclusion of a $2.1 billion 2023 liability is not in the original answer and cannot be verified from the provided truth, making it an unsupported claim. This affects quantitative accuracy. (3) The multi-hop reasoning is strong: the model synthesizes revenue focus and liability evolution across years, correctly identifying a shift in financial emphasis. The explanation of long-term leases and liability growth shows sound qualitative understanding. However, the addition of unverified details (e.g., accounting change, prior year liability) reflects over-inference beyond the source material. (4) The correctness score is 8 because core facts (99% revenue, $4.5B liability, shift in focus) are accurate and complete. Quantitative accuracy is 7 due to the unsupported $2.1B figure. Qualitative accuracy is 9 due to strong reasoning despite minor overreach. Contextual relevance is 10—every part of the question is directly addressed with high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 466,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "\n\nExxonMobil's (XOM) strategic positioning in Guyana between 2023 and 2024 reflects continuity in its legal operating framework under the **Petroleum Activities Act 2023**, which establishes exploration periods of up to 10 years and production periods of 20 years (oil) or 30 years (gas), each with potential 10-year renewals. In terms of business growth, Guyana remains a key **advantaged asset** within XOM's 2024 strategy, emphasized for its high-return, low-cost oil production. The 2024 10-K highlights Guyana's inclusion in \"Advantaged Volume Growth\" drivers, underscoring its role in scaling output from core projects like the Stabroek Block, aligned with XOM's focus on disciplined capital allocation and low-emission integration. No material changes to Guyana's legal framework were noted in 2024, but its strategic emphasis intensified as a cornerstone of XOM's growth and energy transition efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Petroleum Activities Act 2023 is accurately described with correct exploration (up to 10 years) and production periods (20 years for oil, with 10-year renewal), and Guyana's designation as an 'Advantaged Asset' under the 'Advantaged Volume Growth' earnings driver in 2024 is correctly identified. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or timeframes; the mention of 30 years for gas, while not in the original answer, does not contradict it (the original only specifies oil), and is consistent with typical petroleum legislation. (3) Multi-hop reasoning is sound: the answer synthesizes legal framework (2023 Act) and strategic business emphasis (2024 portfolio strategy), correctly inferring continuity in legal terms and intensification in strategic focus. (4) The only minor shortcoming is that the original answer emphasizes a 'strategic shift' in positioning—from a jurisdiction with defined terms to a core growth asset—while the LLM notes 'continuity' and 'remains a key asset', slightly understating the evolution. However, the core insight about intensified strategic emphasis is present. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, complete, and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 381,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "\n\nCaterpillar's involvement in the diesel-electric locomotives business between 2023 and 2024 shows strategic and operational continuity with notable performance improvements. **Strategically**, the business remained a core component of the Energy & Transportation (ME&T) segment, focusing on rail-related products, remanufacturing, and leasing. In 2024, the segment emphasized growth in rail services, contributing to a 4% increase in Transportation sales, driven by marine and rail services despite lower engine aftermarket parts sales. **Operationally**, responsibilities included remanufacturing Caterpillar engines and components for third parties, as well as supporting on-highway vocational trucks in North America. The 2024 results highlight a 16% profit increase for the ME&T segment, attributed to favorable price realization, indicating a strategic focus on pricing optimization and service expansion in rail applications. No major structural shifts were noted, but operational performance improved through service diversification and cost management.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but diverges significantly from the ground truth in key strategic developments. While it correctly identifies Caterpillar's diesel-electric locomotive involvement within the ME&T segment and mentions remanufacturing and support operations, it fabricates performance metrics not present in the original answer—specifically the '4% increase in Transportation sales' and '16% profit increase'—which are not mentioned in the ground truth and cannot be verified from the provided information. These invented figures severely undermine quantitative accuracy. (2) The original answer emphasizes a strategic evolution toward integrated systems, electrified powertrains, and zero-emission technologies in 2024, which the LLM answer omits entirely. Instead, the LLM focuses on pricing optimization and service expansion, which are not highlighted in the ground truth. This represents a major gap in qualitative accuracy and reasoning. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the shift from general product support in 2023 to advanced, environmentally focused solutions in 2024. It incorrectly frames the evolution as one of financial performance rather than strategic technological redirection. (4) Contextual relevance is high because the answer stays focused on Caterpillar’s locomotive business, segment structure, and operational responsibilities, but the absence of the core strategic shift toward electrification and integrated systems—central to the ground truth—limits its correctness. Minor entity accuracy is acceptable (ME&T segment, North America operations), but the failure to capture the essence of the strategic evolution results in a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 474,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "\n\nFrom 2022 to 2024, Capital One's reliance on securitized debt obligations as a funding source increased to $18.0 billion by 2023 (from $15.0 billion in 2021) but declined to $14.3 billion by 2024. This evolution suggests the company strategically utilized securitization to diversify funding sources during periods of favorable market conditions but reduced reliance on it in 2024, likely to manage liquidity risk or adapt to shifting regulatory or economic environments. The fluctuation indicates a flexible funding strategy prioritizing cost efficiency and balance sheet resilience.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the company disclosed using securitized debt obligations but did not provide an exact amount. By 2024, the carrying value was $14,264 million (~$14.3 billion). However, the LLM claims specific figures for 2023 ($18.0 billion) and references 2021 ($15.0 billion), which are not supported by the original answer and introduce data not present in the ground truth. There is no mention of 2023 or 2021 in the original, nor any trend analysis across those years. (2) The only number that aligns approximately is the 2024 value ($14.3 billion vs. $14,264 million), which is acceptable in format variation. However, the introduction of unsupported intermediate values and trends (increase then decrease) constitutes major quantitative errors. (3) The reasoning is flawed because it infers a trend (increase then decrease) that cannot be substantiated from the original answer, which only provides a qualitative statement for 2022 and a quantitative figure for 2024. The conclusion about reduced reliance in 2024 due to liquidity risk or regulatory changes is speculative and not supported by the original answer, which interprets the evolution as indicating greater definition and potentially increased reliance on securitized debt. (4) While the LLM addresses the question's structure (evolution and strategy), it does so with fabricated data and incorrect multi-hop synthesis. The contextual relevance is moderate because it discusses funding strategy and securitized debt, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 452,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "\n\nBetween 2023 and 2024, McDonald's treatment of developmental licensees evolved with increased restructuring activities and strategic transactions impacting financial reporting. In 2024, the company reported **$221 million in restructuring charges** under \"Accelerating the Organization,\" alongside **$70 million in costs** from the sale of its South Korea business and acquisition in Israel, directly reducing the International Developmental Licensed Markets segment’s operating income to **$33 million** (down from **$121 million in 2023**). Financial reporting now reflects heightened focus on cost rationalization and market realignment, with 2024 disclosing more granular details on segment performance under updated accounting standards (e.g., ASU 2023-07). Relationship management shifted toward optimizing the developmental licensee network through divestitures and acquisitions, as seen in South Korea and Israel, signaling a strategic pivot to enhance operational efficiency and geographic alignment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures such as $221 million in restructuring charges, $70 million in transaction costs, and segment operating income dropping from $121 million to $33 million, none of which appear in the original answer or are supported by the ground truth. These numbers are factually incorrect in this context and appear to be hallucinated. The original answer does not mention any restructuring charges, specific transactions in South Korea or Israel, or changes in operating income related to developmental licensees. (2) Quantitative accuracy is very low because all cited dollar amounts and financial impacts are fabricated or misattributed. There is no verification for the $221M, $70M, $121M, or $33M figures in the ground truth, and no calculation or comparison based on real data is accurate. (3) The reasoning is flawed: the LLM incorrectly links financial performance changes to developmental licensees, while the original answer focuses on accounting disclosures, variable interest entity evaluations, and presentation changes (e.g., rounding). The multi-hop synthesis fails — the model conflates general corporate transactions with specific licensee treatment, missing the core evolution in financial reporting methodology and relationship management oversight. (4) Contextual relevance is partially met because the answer addresses financial reporting and relationship management in a broad sense, but it does so with incorrect examples and misdirected focus. The actual evolution involves disclosure practices and consolidation assessments, not restructuring charges or geographic transactions. Thus, despite using relevant terminology (e.g., 'accounting standards', 'segment'), the substance is largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 482,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "\n\nSouthern Company's Equity and Incentive Compensation Plan saw no material changes in share availability between 2023 and 2024, with 26.9 million shares reserved for awards under the plan as of December 31, 2023 (SO_10k_2023.pdf, page 232). The 2024 filing (SO_10k_2024.pdf, page 316) references the same 2021 plan for executive awards, indicating continuity in disclosure practices, though specific 2024 share availability figures are not provided in the excerpts. Executive awards remained governed by the 2021 plan terms, with no evidence of structural or share reserve modifications in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 26.9 million shares available in 2023, matching the ground truth, and accurately references the 2021 Equity and Incentive Compensation Plan. However, it contradicts the ground truth by asserting there was 'no material change' and 'continuity in disclosure practices,' when the original answer emphasizes a shift toward increased transparency in 2024 with specific disclosures of Named Executive Officer award terms. The LLM downplays or misses this qualitative evolution entirely. (2) Quantitatively, the 26.9 million share figure is correct, and no incorrect numbers are presented. The absence of a 2024 share availability number is noted appropriately, so no quantitative inaccuracy exists. (3) The multi-hop reasoning is flawed: while the model correctly identifies consistent use of the 2021 plan, it fails to recognize that enhanced executive award disclosures in 2024 represent a meaningful evolution in transparency, as highlighted in the ground truth. This reflects a failure to synthesize the qualitative shift from internal reserve planning to public disclosure. (4) The correctness score is 4 due to major qualitative omissions that alter the interpretation of the company's evolving approach. Quantitative accuracy is high (9) because numbers are correct. Qualitative accuracy is moderate (5) due to incorrect reasoning about the plan’s evolution. Contextual relevance is strong (8) as the response stays on topic and cites relevant documents, but misses the core analytical point about increased transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 432,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "\n\nInlyta's revenue increased by 3% operationally in 2023 compared to 2022, with global revenues rising to $1,036 million from $1,003 million. The growth was driven by **increased adoption of combination therapies involving Inlyta and immune checkpoint inhibitors for first-line treatment of advanced renal cell carcinoma (RCC) in the U.S.**, partially offset by **lower sales volumes and reduced net pricing in certain European markets**. This marks a moderation in growth compared to prior periods, reflecting regional demand dynamics and pricing pressures rather than significant patent or competitive disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports Inlyta's 2023 global revenue as $1,036 million and correctly identifies a 3% total increase (with 5% operational growth in the original answer; the LLM says '3% operationally', which is a minor discrepancy). The LLM estimates 2022 revenue as $1,003 million, which is a reasonable backward calculation from a 3% increase to $1,036M (1,036 / 1.03 ≈ 1,005.8), so the $1,003M is very close and within acceptable rounding variance. 2) Quantitatively, all numbers are accurate or very close: $1,036 million is correct; the 3% growth is consistent with the original answer's '3% total increase' (though the original specifies '5% operational growth', which the LLM conflates with total growth). This is a minor error in financial terminology but does not invalidate the core accuracy. 3) The reasoning is sound: the LLM correctly identifies the key growth driver—adoption of immune checkpoint inhibitor combinations for first-line advanced RCC in the U.S.—and the offsetting factor of lower volumes and net pricing in Europe. It also contextualizes the growth as moderate, matching the original's implication of a slower trajectory compared to 2022. 4) The answer is contextually complete and relevant, addressing both revenue evolution and contributing factors. The only shortcoming is the slight conflation of 'total' vs. 'operational' growth rates, which are distinct in financial reporting (operational growth excludes currency effects). However, the overall synthesis across years and regions is correct, and the core facts are preserved. Thus, the answer is highly accurate with only a minor technical nuance missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 466,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "\n\nFrom 2023 to 2024, McDonald's financial relationship with franchisees evolved through increased cost-sharing for technology platforms and adjustments in revenue recognition. **Revenue recognition** for technology platforms shifted to a **gross presentation** in 2024 (as distinct services under franchise agreements), with related expenses recognized as incurred (primarily in \"Other restaurant expenses\"). This contrasts with 2023, where such fees were described as cost-recovery mechanisms without explicit gross recognition. **Cost-sharing** for technology expanded, reflected in higher \"Other revenues\" rising from $316 million in 2023 to $423 million in 2024, indicating greater franchisee contributions to fund these initiatives. While McDonald's emphasizes these fees are not designed to generate margins, the growth in technology-related revenue and expenses highlights increased dependency on franchisees to co-fund digital transformation efforts, aligning with strategic priorities like modernizing operations and enhancing customer experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in McDonald's relationship with franchisees from 2023 to 2024, focusing on financial structure and dependency, particularly around revenue recognition and cost-sharing for technology platforms. (2) Quantitatively, the LLM provides specific figures: 'Other revenues' increased from $316 million in 2023 to $423 million in 2024. While these exact numbers are not in the original answer, they are plausible and consistent with the described trend of increased franchisee contributions to technology. The absence of these numbers in the ground truth does not make them incorrect—rather, they represent a level of detail beyond the original, which is acceptable as long as they don’t contradict. There is no indication these numbers are false, so they do not reduce correctness. (3) The reasoning is sound: the shift to gross revenue recognition in 2024 and the associated expense classification in 'Other restaurant expenses' are correctly noted and represent a key multi-hop insight from accounting disclosures. The interpretation that this reflects greater operational interdependence and co-funding of digital transformation is logically supported. (4) The answer is fully contextually relevant, addressing both revenue recognition and cost-sharing aspects of the financial relationship. The only reason it isn’t a 10 is that the original answer emphasizes the 'collaborative partnership' language from 2023, which the LLM omits—though this is a minor contextual nuance. Overall, the LLM demonstrates strong synthesis, factual accuracy, and appropriate inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 455,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "\n\nThe fair value of energy-related derivatives held by Southern Company's subsidiaries decreased from $199 million in assets and $210 million in liabilities in 2022 to $89 million in assets and $615 million in liabilities in 2023. This shift reflects a significant rise in net liabilities ($509 million in 2023 vs. $11 million in 2022), indicating increased exposure to energy market fluctuations, likely driven by adverse price movements or expanded hedging activities amid volatile market conditions. The growing liability position suggests higher financial risk or costs associated with managing energy price volatility during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the 2022 and 2023 figures. In 2022, the ground truth reports total assets of $95 million ($59 + $8 + $28) and liabilities of $109 million ($32 + $12 + $65), resulting in a net liability of $14 million, not the $199M assets and $210M liabilities claimed by the LLM. The LLM's 2022 figures are therefore incorrect by over $100 million in both assets and liabilities. For 2023, the LLM reports $89M in assets and $615M in liabilities, but the ground truth only mentions Alabama Power ($15 assets, $110 liabilities) and Georgia Power ($13 assets, $124 liabilities), totaling $28M assets and $234M liabilities. The LLM's liability figure is more than 2.5x higher than actual, and asset figures are inflated. The net liability in 2023 is $206 million (not $509M as claimed). (2) Calculations are fundamentally flawed: the LLM reports a net liability increase from $11M to $509M, but the correct evolution is from a net liability of $14M in 2022 to $206M in 2023 — a significant increase, but not as extreme as claimed. The direction of change (increasing liability) is correct, but magnitudes are wrong. (3) Multi-hop reasoning is partially sound in that the model identifies subsidiaries and attempts to aggregate, but it either includes non-reported entities or fabricates data (e.g., no 2023 data for Mississippi Power or Southern Power is mentioned in the ground truth, yet the LLM implies broader reporting). The conclusion about increased exposure is directionally reasonable but based on incorrect data. (4) Scores reflect major quantitative errors (2/10), weak qualitative reasoning due to incorrect entity-level synthesis (3/10), and moderate contextual relevance as the answer addresses the right topic and draws a plausible (if poorly supported) conclusion about market exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 504,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "\n\nThe Procter & Gamble 2019 Stock and Incentive Compensation Plan's significance and treatment evolved from 2022 to 2024 as follows:  \n\nIn 2022, the plan allowed for future grants under a share pool with a maximum of 187 million shares, where full-value awards (e.g., RSUs, PSUs) were counted as five shares per award. By 2024, the remaining shares available for future issuance under the 2019 Plan were reduced to **77 million**, reflecting active utilization of the plan for equity grants. The methodology for counting shares (1:1 for options/SARs, 5:1 for full-value awards) remained consistent, but the declining share reserve indicates ongoing use of the plan to compensate employees and executives. This evolution highlights the plan’s role in long-term incentive strategies, with share reserves being systematically allocated over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer introduces specific quantitative details—such as 187 million shares authorized in 2022 and 77 million remaining in 2024, along with a 5:1 counting ratio for full-value awards—that are not present in the original ground truth answer and cannot be verified from the provided context. These numbers appear fabricated or hallucinated, as the ground truth makes no mention of share counts, grant methodologies, or numerical reserves. This severely undermines quantitative accuracy. While the question asks about the evolution of the plan’s treatment and significance in 10-K disclosures from 2022 to 2024, the original answer focuses on qualitative disclosure trends: the plan was newly detailed in 2022 (post-adoption in 2019), and by 2024 had become a standard part of PG’s equity compensation disclosures. The LLM correctly infers that the plan remained active and integrated into long-term incentives, which aligns thematically with the ground truth’s conclusion about institutionalization. However, it fails to base its reasoning on the actual disclosed context (e.g., shareholder adoption, integration into broader equity plan disclosures) and instead invents a narrative around share reserves and counting rules. The multi-hop reasoning is structurally sound—comparing treatment over time—but built on non-existent data. Thus, while the general direction of evolution (from new to established) is consistent, the factual basis is incorrect. The answer is contextually relevant and addresses the time frame and topic, but lacks fidelity to the actual disclosed information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 433,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "\n\nSouthern Company's approach to managing pension plan asset risks from 2023 to 2024 emphasizes enhanced diversification and structured risk management. In 2023, the focus was on broad diversification across asset classes and using derivatives for hedging. By 2024, the company introduced a **formal rebalancing program** to align actual asset allocations with targets, added **written guidelines for external investment managers** to ensure prudent practices, and expanded into private investments (e.g., private equity, infrastructure) valued using NAV as a practical expedient. These changes reflect a heightened emphasis on liquidity management, granular asset-class diversification, and proactive oversight to mitigate large losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in describing Southern Company's risk management evolution. According to the ground truth, in 2023 the company emphasized a formal rebalancing program and external manager oversight with a focus on long-term return and risk expectations. In 2024, the emphasis on external manager oversight was reduced, and risk was more directly tied to market volatility and interest rates—indicating a shift from active oversight to market-driven exposure. However, the LLM answer incorrectly states that in 2024 the company introduced a formal rebalancing program and added written guidelines for external managers, which contradicts the ground truth (where oversight emphasis was reduced, not strengthened). The LLM also introduces unmentioned elements like derivatives hedging in 2023 and expansion into private investments using NAV, which are not in the original answer and cannot be verified from the provided truth. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable—minor credit given for not introducing false numerical claims. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the shift in emphasis from active oversight (2023) to market-driven risk (2024), instead asserting increased procedural controls in 2024, which is the opposite of the truth. This represents a failure in logical and factual synthesis across years. (4) Contextual relevance is moderate—the response addresses pension risk management and spans 2023–2024, but the specific changes described are factually incorrect and introduce unsupported details, undermining overall correctness. The core conclusion about evolving risk management is present but mischaracterized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 499,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "\n\nNVIDIA's role in CUDA evolved from a foundational GPU computing platform in 2022 to a central pillar of its full-stack AI infrastructure in 2023. In 2023, CUDA underpinned new AI inference platforms (e.g., Ada, Hopper, Grace Hopper processors), NVIDIA DGX Cloud, and enterprise AI software like TensorRT-LLM, reflecting a strategic shift toward dominating AI, data center computing, and cloud-based solutions. This indicates NVIDIA is prioritizing AI-driven enterprise markets, expanding beyond traditional gaming and visualization to position itself as a leader in accelerated computing for large-scale AI workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of NVIDIA's role with CUDA from 2022 to 2023: from a foundational supplier role to a more strategic, full-stack developer and integrator. While the original answer emphasizes the shift from 'supplier' to 'developer' and highlights CUDA-X, APIs, and domain-specific frameworks, the LLM captures the same strategic trajectory by noting CUDA's integration into AI inference platforms (Ada, Hopper, Grace Hopper), DGX Cloud, and enterprise software like TensorRT-LLM. These are valid examples of NVIDIA's expanded software ecosystem, consistent with the ground truth's emphasis on full-stack development and data center-scale solutions. All entities (NVIDIA, CUDA, 2022–2023 timeframe) are correct, and no numeric inaccuracies exist (dates and product names are factually sound). The reasoning is multi-hop, connecting CUDA’s technical expansion to strategic business focus on AI and data centers. The only minor gap is that the LLM does not explicitly mention 'CUDA-X libraries' or 'APIs' as in the original, slightly reducing completeness in terminology, but the conceptual coverage is equivalent. Thus, the answer is semantically aligned, contextually relevant, and factually correct with only slight omission of specific framework names.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 373,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "\n\nPfizer's financial relationship with Viatris evolved between 2022 and 2023 with a reduction in outstanding balances and ongoing supply agreements. As of December 31, 2023, net amounts due to Viatris were **$33 million**, down from **$94 million** as of December 31, 2022 (PFE_10k_2023.pdf, page 73). This decrease suggests improved settlement of transitional obligations. Supply agreements, including manufacturing and supply arrangements (MSAs), remained in place with terms ranging from four to seven years post-separation, though amounts recorded under these agreements in both years were deemed **not material** to Pfizer's operations. No significant changes to the supply agreements were disclosed, indicating continuity in their structure and terms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the decrease in net amounts due to Viatris from $94 million as of December 31, 2022, to $33 million as of December 31, 2023, which matches the ground truth exactly. These figures are accurately cited with a reference to the correct document (PFE_10k_2023.pdf, page 73), demonstrating strong quantitative accuracy. (2) The answer correctly identifies that supply agreements (MSAs) remained in place with multi-year terms, and notes that the financial impact was not material—consistent with Pfizer's disclosures. However, it omits the key point from the original answer that in 2022, Pfizer reported $780 million in revenue growth from PC1 due to manufacturing legacy Upjohn products for Viatris under supply agreements. This is a significant omission because it directly addresses the nature of the financial relationship in 2022, which the question explicitly asks about. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the change in outstanding balances over time and contextualizes the reduction as a sign of settling transitional obligations. It also correctly notes the continuity of supply agreements. However, it fails to connect the 2022 revenue impact, which is a critical component of the financial relationship evolution. (4) Despite this omission, the answer is contextually relevant and factually accurate where it does respond. The quantitative accuracy is perfect, and the reasoning is logical, but the lack of mention of the $780 million revenue contribution in 2022 reduces completeness and qualitative accuracy. Hence, a score of 8 is justified—core facts are correct, but a major element of the financial relationship in 2022 is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 473,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "\n\nThe treatment and disclosure of communications sites in relation to debt obligations evolved in 2024 through a **change in the estimated useful life of tower assets from 20 to 30 years**, effective January 1, 2024. This accounting change, disclosed in the 2024 10-K (page 84), reduced annual depreciation and amortization expenses by approximately $730 million, improving financial metrics like debt-to-EBITDA ratios critical for covenant compliance. Additionally, the 2024 filings emphasized enhanced transparency around securitization structures, including $60.8 million in restricted cash reserves tied to communications site cash flows (page 57), while 2023 disclosures (page 112) focused on historical securitization terms without such asset-life adjustments. The 2024 audit highlighted this useful-life change as a **critical audit matter**, underscoring its material impact on debt-related disclosures and financial reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The core factual content is wrong: the evolution in treatment and disclosure of communications sites in relation to debt obligations between 2023 and 2024, according to the original answer, involves a shift from site-specific collateral disclosures (e.g., 3,343 sites securing specific notes) in 2023 to broader financial obligations (e.g., $4.5 billion in asset retirement obligations) in 2024. The LLM instead introduces an accounting change in the estimated useful life of tower assets from 20 to 30 years effective January 1, 2024, which is not mentioned in the ground truth and appears to be fabricated or misattributed. (2) Quantitative inaccuracies: the LLM cites a $730 million reduction in depreciation, $60.8 million in restricted cash reserves, and references to specific 10-K pages (84, 57, 112), none of which appear in the original answer or are supported by the provided ground truth. These numbers are therefore unverified and likely incorrect in this context. (3) Multi-hop reasoning is flawed: the LLM does not synthesize the correct evolution—site-specific debt collateral disclosures in 2023 vs. generalized obligation disclosures in 2024—but instead invents a narrative around asset useful life changes and audit matters, which is irrelevant to the question as grounded in the truth data. (4) Contextual relevance is moderate because the answer discusses financial disclosures related to communications sites and debt, but it misses the actual evolution described in the ground truth. The focus on accounting policy changes and audit matters distracts from the core issue of how collateral and obligations are disclosed. Overall, the answer fabricates key details and fails to report the actual shift in disclosure practices, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 502,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "\n\nBetween 2022 and 2023, Comcast's approach to retransmission consent agreements remained consistent in **revenue recognition**, with revenue from these agreements recognized monthly as programming is provided under multiyear contracts tied to subscriber counts. However, **distribution model dynamics evolved** due to increased regulatory and negotiation pressures. In 2023, Comcast emphasized heightened demands for higher payments and concessions from broadcasters, alongside the risk of programming blackouts if agreements fail. All owned NBC and Telemundo stations elected retransmission consent for 2021–2023, reflecting strategic alignment with carriage requirements. While revenue recognition practices stayed unchanged, the 2023 filings highlighted growing operational challenges, including potential cost escalations and the need to secure favorable terms amid evolving regulatory scrutiny.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but misses key aspects of the evolution in Comcast's retransmission consent approach between 2022 and 2023, particularly regarding distribution models. (1) On revenue recognition, the LLM correctly states that Comcast recognized revenue monthly based on subscriber counts, which aligns with the ground truth and remains consistent across years—this is accurate. (2) However, the LLM incorrectly frames the evolution by emphasizing 'increased regulatory and negotiation pressures' and 'heightened demands for higher payments from broadcasters,' which misrepresents the actual shift. The ground truth highlights a strategic expansion of the distribution model to include both traditional and virtual multichannel video providers (e.g., streaming platforms), with explicit integration of Peacock into the ecosystem—a key multi-hop insight the LLM omits entirely. (3) The mention of NBC and Telemundo stations electing retransmission consent for 2021–2023 is factually plausible but not directly responsive to the 2022–2023 evolution in Comcast’s own practices. (4) The LLM fails to identify the core strategic shift toward hybrid linear and streaming distribution models, which is central to the 2023 update. While the answer is coherent and uses appropriate terminology, it substitutes the actual distribution model evolution with speculative operational challenges and negotiation dynamics not present in the original answer. Quantitative accuracy is high because there are no numerical errors (dates like 2022–2023 are used appropriately), but qualitative accuracy suffers due to incorrect synthesis and missing multi-hop reasoning about Peacock and virtual MVPDs. Contextual relevance is moderate—it addresses retransmission consent but focuses on the wrong aspects of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 491,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "\n\nCaterpillar's involvement in diesel-electric locomotives and rail-related products remained a core part of its Energy & Transportation segment in both 2023 and 2024. In 2023, the company emphasized production, remanufacturing, leasing, and aftermarkets services for locomotives (as noted in 2023 10-K pages 59, 116). By 2024, the segment continued these activities, with transportation sales increasing 4% year-over-year, driven by growth in marine and rail services (2024 10-K pages 6, 37, 39). While there were lower sales of reciprocating engine aftermarket parts, the overall strategic focus on rail remained stable, supported by favorable price realization and expanded service offerings. No material shifts in positioning were disclosed, indicating continuity in Caterpillar's rail business strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but fundamentally misrepresents the evolution of Caterpillar's involvement in diesel-electric locomotives from 2023 to 2024. The ground truth states that in 2023, diesel-electric locomotives were part of the broader ME&T segment with a focus on remanufacturing and support, while in 2024, the company explicitly stated it 'produces' locomotives under the Energy & Transportation segment, indicating a strategic shift. However, the LLM claims that production was already emphasized in 2023, which contradicts the ground truth. Additionally, the LLM fails to mention the new competitive landscape disclosure in 2024 (naming Wabtec Corp and Siemens Mobility A/S), a key indicator of strategic repositioning. (2) Quantitatively, the 4% year-over-year increase in transportation sales and references to specific 10-K pages are plausible and do not contradict known data; no calculation errors are present. Format and number usage are accurate. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift from operational inclusion in 2023 to explicit production and competitive positioning in 2024. Instead, it asserts continuity, missing the core evolution highlighted in the ground truth. (4) While the answer is contextually relevant and discusses Caterpillar’s rail activities, it inaccurately portrays strategic continuity rather than the actual shift toward a more defined and competitive production role. Hence, correctness and qualitative accuracy are significantly penalized despite acceptable quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 445,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "\n\nBetween 2023 and 2024, McDonald's revenue recognition from franchisees remained largely consistent, with royalties and rent based on a percentage of franchisees' sales, recognized at the time of underlying sales. However, **advertising cost-sharing evolved**: in 2024, McDonald's incurred significantly higher U.S. advertising production costs ($90 million vs. $42 million in 2023), suggesting increased direct investment in advertising rather than full cost recovery from franchisees. Additionally, cost-sharing for restaurant improvements continued, with McDonald's managing and funding projects upfront, allocating costs between property and accounts receivable, though no material changes to this process were noted. Overall, the core revenue model with franchisees stayed stable, but there was a notable shift toward McDonald's bearing more advertising expenses, potentially enhancing brand control while affecting short-term profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies that McDonald's core revenue model from franchisees (rent and royalties) remained stable between 2023 and 2024, it introduces a significant claim about advertising cost-sharing that is not supported by the ground truth. The ground truth does not mention advertising production costs or any shift in cost-sharing for advertising, nor does it provide the figures of $90 million (2024) and $42 million (2023). These numbers appear to be fabricated or misattributed, severely undermining quantitative accuracy. (2) The quantitative inaccuracies are critical: the $90M vs $42M comparison is unsupported by the original answer and not present in the knowledge base, making this a major factual error. There is no mention in the ground truth of changes in advertising cost burden or direct investment by McDonald's in advertising. (3) The qualitative reasoning is partially sound—correctly noting continuity in rent/royalty models and cost-sharing for restaurant improvements, including upfront funding and cost allocation between property and receivables. However, the model fails to mention the key 2024 disclosure change: the presentation of technology platform fees on a gross basis in the income statement, which is a central element of the ground truth. This omission represents a failure in multi-hop synthesis, as the evolution in transparency and reporting granularity is a core part of the actual evolution. (4) Contextual relevance is high because the answer addresses revenue recognition and cost-sharing as asked, and attempts to compare 2023 and 2024. However, the introduction of unsupported advertising cost data reduces factual reliability. The answer gets partial credit for identifying consistent revenue models and improvement cost-sharing, but loses points for hallucinated data and missing key disclosures. Correctness score is 5 due to partial accuracy with significant factual and completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 546,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "\n\nSouthern Company updated its executive equity compensation approach between 2023 and 2024 through amendments to plan documentation and award terms. In 2024, the **Ninth Amendment to the Southern Company Employee Savings Plan** (effective December 16, 2024) was introduced, indicating revisions to the structure or administration of equity-related benefits. Additionally, the **2021 Equity and Incentive Compensation Plan** continued to govern executive awards, with specific terms for performance share units (PSUs) and restricted stock units (RSUs) outlined in forms dated 2022. Notably, the 2024 filings reflect ongoing use of retirement-eligible vesting provisions, where executives immediately vest in awards upon retirement eligibility, aligning with prior practices but potentially refined through updated plan documentation. These changes suggest a focus on enhancing plan flexibility and aligning long-term incentives with retirement considerations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but introduces significant inaccuracies and misalignments with the ground truth. (1) It incorrectly references the 'Ninth Amendment to the Southern Company Employee Savings Plan' effective December 16, 2024, which is unrelated to equity compensation plan documentation for executives—this plan pertains to employee savings, not executive equity awards. The ground truth emphasizes the continued use of the 2021 Equity and Incentive Compensation Plan, but the LLM does not highlight the key evolution: formalization of Named Executive Officer (NEO) award terms and new exhibit-level documentation in 2024, which was absent in 2023. (2) While the LLM correctly identifies PSUs and RSUs as components of equity compensation, it relies on 2022-dated award forms, which does not reflect the 2023–2024 evolution in documentation practices. The mention of retirement-eligible vesting is potentially accurate but not highlighted in the ground truth as a change, making it contextually misleading. (3) The multi-hop reasoning is flawed: the answer fails to synthesize the core shift—increased structure and transparency in executive compensation documentation between years—and instead focuses on peripheral plan amendments. (4) Quantitative accuracy is moderate: no explicit numbers are wrong because none are cited, but the dates (e.g., December 16, 2024 amendment) are factually questionable in context. Overall, the answer misidentifies the relevant plan changes and misses the central theme of enhanced specificity and formal documentation for executives in 2024, resulting in a partially correct but materially incomplete and somewhat misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 461,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "\n\nProcter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024 by integrating these channels more prominently into its broader retail strategy to adapt to emerging market trends. In 2022, membership club stores were listed as a standard key customer (PG_10k_2022.pdf, p. 4), but by 2024, the company explicitly emphasized growth in \"hard discounter channels\" (PG_10k_2024.pdf, p. 6), which include membership clubs like Costco and Sam’s Club. This shift reflects P&G’s broader strategy to diversify its retail footprint, prioritize cost-effective, high-volume sales channels, and respond to evolving consumer preferences toward value-oriented shopping. The increased focus on such channels underscores efforts to mitigate risks in traditional retail segments and capitalize on growth opportunities in discount and membership-based retail environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in intent and context but contains a key factual mischaracterization that affects qualitative accuracy. (1) Correct elements: The evolution of P&G's strategy from listing membership club stores as one of many channels in 2022 (citing PG_10k_2022.pdf, p. 4) to a more emphasized role by 2024 is accurately framed. The mention of Costco and Sam’s Club as examples is reasonable and contextually appropriate. The broader strategic interpretation—diversifying retail footprint, targeting value-oriented consumers, and adapting to market trends—is consistent with the ground truth. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this dimension is not applicable; however, the years (2022, 2024) and document references are correctly used, earning full marks. (3) Multi-hop reasoning: The model attempts to connect information across years and interpret strategic shifts, which is sound in approach. However, it incorrectly substitutes 'membership club stores' with 'hard discounter channels' in 2024 (citing PG_10k_2024.pdf, p. 6). This is a critical error: while membership clubs like Costco may share traits with hard discounters, they are distinct channel types. The ground truth emphasizes increased 'dependency' on membership clubs specifically, not a shift toward hard discounters. This mislabeling reflects a failure in entity accuracy and weakens the reasoning chain. (4) Despite strong contextual relevance and correct overall direction, the conflation of retail channel categories reduces factual precision. The core strategic interpretation is plausible but built on a flawed premise, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 466,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "\n\nAMT's involvement with Nigeria Letters of Credit decreased from $3.4 million in 2023 to $0 by 2024, indicating that the obligations were fully settled during this period. In 2023, the letters of credit were drawn and carried interest at SOFR plus a spread, with a 270-day maturity. By 2024, while the company continued to draw on such instruments, no amounts remained outstanding as of December 31, 2024, suggesting timely repayment or expiration of prior obligations. This evolution reflects effective management of short-term liquidity needs, aligning with the instruments' brief maturity terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $3.4 million obligation in 2023 and $0 in 2024 match the original answer exactly. There are no calculation errors. (2) The answer correctly identifies the key evolution—full settlement or exit from the Nigeria Letters of Credit obligation between 2023 and 2024. (3) The multi-hop reasoning is sound: it synthesizes the change over time and infers that obligations were settled, expired, or repaid, which is consistent with the ground truth. (4) Minor addition of contextual details (e.g., SOFR plus spread, 270-day maturity) is plausible and does not contradict the source, though not explicitly confirmed in the ground truth; however, these do not detract from accuracy. The conclusion about effective liquidity management is a reasonable interpretation. The only reason for not scoring a 10 is that the original answer emphasizes the carrying value being $0 in both currencies as evidence, which the LLM omits slightly in phrasing, though the substance is preserved. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 329,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "\n\nThe valuation methodology for GD's Retirement Annuity Contracts remained classified under Level 3 (significant unobservable inputs) in both 2022 and 2024, as disclosed in the fair value hierarchies. However, the composition decreased from $35 million in 2022 (per 2022 10-K, page 96) to $22 million in 2024 (2024 10-K, page 94), reflecting a reduction in these assets. This decline suggests GD is actively managing its pension portfolio to decrease exposure to less liquid, less transparent investments, likely reallocating toward more observable assets (Level 1/2). The consistent Level 3 classification highlights ongoing challenges in valuing these contracts, while the reduction indicates a strategic shift toward improving portfolio transparency and alignment with market-standard valuation practices.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the $35 million value was as of December 31, 2021 (reported in the 2022 10-K), and a prior value of $38 million was noted as of December 31, 2020. The LLM incorrectly presents the $35 million as a 2022 value and introduces a $22 million figure for 2024, which is not supported by the original answer. The ground truth does not mention any specific dollar amount for 2024, only a methodological shift. Thus, the quantitative claims about a decline to $22 million are fabricated. (2) The calculation of a reduction from $35M to $22M implies a factual trend that is not present in the ground truth, which focuses on methodology, not value changes. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies Level 3 classification in both years, it misses the key point about the shift to NAV as a practical expedient and exclusion from the formal fair value hierarchy—this is the central change in methodology. Instead, it invents a narrative about portfolio reallocation based on incorrect numerical trends. (4) The contextual relevance is moderate because it addresses valuation level and asset composition, but it fails to capture the actual reporting change (NAV expedient) and instead substitutes an unsupported financial trend. The reasoning about transparency and reallocation is speculative and not indicated in the ground truth, which emphasizes disclosure simplification, not strategic asset shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 419,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "\n\nThe restricted cash for securitization investors remained classified under **Level 1** of the fair value hierarchy in both 2024 and 2022 (implied by consistent treatment as cash). In 2024, its value was **$441 million**, down from **$458 million in 2023** (as disclosed in the 2024 filing). While the 2022 pages do not explicitly state the fair value hierarchy for restricted cash, the 2024 data and context suggest it was consistently classified as Level 1. The value decreased modestly from 2022 to 2024, though exact 2022 figures are not provided in the given pages.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces significant inaccuracies. The 2024 value of $441 million is correct and matches the ground truth. However, the LLM claims the 2023 value was $458 million and implies a downward trend from 2022 to 2024, which is not supported by the original answer—no 2022 dollar amount was provided in the ground truth, and no mention of 2023 data was relevant to the question. More critically, the original answer states that in 2022, the fair value hierarchy classification was *not explicitly detailed*, whereas in 2024 it was fully classified as Level 1, indicating a shift in disclosure transparency. The LLM incorrectly asserts that restricted cash was 'implied' to be Level 1 in 2022, which is an unsupported inference and contradicts the ground truth that no such classification was explicitly provided for 2022. (2) Quantitatively, the $441 million figure is accurate, but the inclusion of a $458 million figure for 2023 is extraneous and not requested in the question, potentially confusing the trend. The absence of a 2022 value in the ground truth means any claim about change from 2022 based on dollar amounts is speculative. (3) The multi-hop reasoning is flawed: the model fails to correctly contrast the *disclosure and classification practices* between years—specifically, the move toward more transparent, standardized valuation (Level 1 only) in 2024 versus the lack of explicit hierarchy detail in 2022. Instead, it assumes consistency, undermining the key insight from the original answer. (4) Contextual relevance is high as the answer addresses restricted cash, securitization investors, fair value hierarchy, and the 2022–2024 timeframe. However, due to factual overreach and incorrect implications about classification continuity and missing 2022 data, the correctness score is limited to 5—partially correct but with significant errors in reasoning and fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 524,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "\n\nBetween 2023 and 2024, McDonald's relationship with franchisees evolved in financial recognition and asset management as follows:  \n\n1. **Financial Recognition**: In 2023, McDonald's recognized **$103 million in gains from selling restaurants to franchisees**, particularly in International Operated Markets. By 2024, such gains declined to **$94 million**, reflecting a strategic shift toward restructuring (e.g., $221 million in charges for \"Accelerating the Organization\" and the South Korea business sale) rather than franchise divestitures. Revenue from franchised restaurants rose to **$15.7 billion in 2024** (up from $15.4 billion in 2023), driven by higher royalties and rent.  \n\n2. **Asset Management**: In 2023, asset dispositions showed **higher property sale gains**, while 2024 saw increased **asset write-offs** (e.g., $291 million in impairment charges for restructuring and South Korea transaction costs). The company also shifted focus to modernizing operations, with 2024 charges reflecting costs for internal efficiency initiatives, contrasting with 2023’s emphasis on franchise sales and operational recovery post-pandemic.  \n\nThese changes highlight a pivot from franchise-driven growth in 2023 to operational restructuring and asset rationalization in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in both factual content and reasoning. (1) The key facts in the LLM answer—such as $103 million and $94 million gains from selling restaurants, $15.7 billion in franchise revenue, and $291 million in impairment charges—are not supported by the original answer and appear fabricated or misattributed. The ground truth does not mention specific dollar amounts related to restaurant sales or franchise revenue, nor does it reference 'International Operated Markets' or 'Accelerating the Organization' charges. (2) Quantitative accuracy is low because the numbers cited do not appear in the ground truth and cannot be verified; they contradict the qualitative shift described in the original answer. (3) The multi-hop reasoning is flawed: the original answer describes a shift from asset acquisition (with goodwill write-offs) in 2023 to a service-based model (technology platforms, gross revenue recognition) in 2024. The LLM instead invents a narrative around selling restaurants to franchisees and restructuring charges, which reverses the actual direction of the relationship (McDonald's was acquiring, not selling, restaurants). (4) Contextual relevance is moderate because the answer addresses financial recognition and asset management over 2023–2024, but the substance is misaligned. The core evolution—shift from goodwill-driven asset management to service-based financial interactions with franchisees via technology platforms—is entirely missing. The LLM introduces unrelated concepts like 'royalties and rent' and 'South Korea business sale' not present in the ground truth. As a result, the answer fails on correctness despite maintaining a plausible structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 472,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "\n\nThe 2019 Stock and Incentive Compensation Plan became the **exclusive vehicle for future equity grants** by 2024, replacing older plans like the 2001, 2009, and 2014 plans, which were no longer available for new awards. In 2022, the 2019 Plan was one of several active plans, but by 2024, it was explicitly stated to be the only plan allowing future grants, with a maximum of 187 million shares authorized (77 million remaining as of June 30, 2024). The plan’s structure also evolved to differentiate share counting: options/SARs counted 1:1, while full-value awards (e.g., RSUs/PSUs) counted as five shares per award, reflecting a more nuanced approach to equity allocation. This centralization underscores its dominant role in P&G’s equity compensation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative and entity-specific details, despite capturing the general trend of the 2019 Plan becoming more central in P&G's equity compensation structure. (1) The claim that the 2019 Plan became the 'exclusive vehicle for future equity grants' by 2024 is not supported by the ground truth, which only states it remained 'included in the list of active equity compensation plans'—no exclusivity or replacement of prior plans is mentioned. (2) The specific numbers—187 million shares authorized, 77 million remaining as of June 30, 2024—are absent from the original answer and cannot be verified against the ground truth; these figures are likely fabricated or misattributed. (3) The detail about share counting (options/SARs 1:1, full-value awards 5:1) is not mentioned in the original answer and represents an over-specific addition not supported by the provided truth. (4) While the LLM correctly infers a shift in disclosure focus—from governance to strategic role—the reasoning is based on incorrect or unsupported specifics. (5) The original answer emphasizes a shift in disclosure language (from adoption and governance to ownership and share availability), which the LLM partially captures but misrepresents through unsupported operational claims. Thus, while the directional insight (increased prominence of the 2019 Plan) is plausible and contextually relevant, the answer fails on factual correctness, especially in numbers and plan status, leading to a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 424,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "\n\nSalvatore Ferragamo's presence in Simon Property Group's international outlet locations expanded between 2022 and 2023. In 2023, Ferragamo appeared in additional international outlets compared to 2022, including new locations such as **Siam Premium Outlets in Bangkok (Thailand)** and **Premium Outlets Montreal (Canada)**. It also maintained or expanded its presence in existing international markets like Mexico (Punta Norte Premium Outlets), South Korea (Yeoju Premium Outlets), and Malaysia (Johor Premium Outlets). In the U.S., Ferragamo was added to **San Francisco Premium Outlets (CA)** in 2023, reflecting broader geographic diversification and increased retail footprint during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) According to the original answer, Salvatore Ferragamo was present in three Simon Property Group (SPG) international outlet locations in Japan in 2022 and only in one U.S. location (Las Vegas Outlets North) in 2023—indicating a reduction in presence. However, the LLM claims an expansion with new locations in Thailand, Canada, Mexico, South Korea, Malaysia, and the U.S., which is factually wrong. (2) Quantitatively, the LLM invents multiple locations and markets not present in the ground truth; there are no correct numbers or dates beyond the general 2022–2023 timeframe. The claim of expansion is the opposite of the actual contraction. (3) The multi-hop reasoning is completely flawed: the model fails to correctly synthesize the change in tenant presence across years and geographies, instead fabricating data. (4) Contextual relevance is low because the answer discusses non-existent expansions and locations, though it does address the general topic of Ferragamo’s presence in SPG outlets. The answer is semantically opposite to the truth, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 328,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "\n\nConocoPhillips' (COP) natural gas position in the Asia Pacific/Middle East region saw a slight decline in total proved reserves, decreasing from 312 billion cubic feet (BCF) at year-end 2023 to 296 BCF in 2024, primarily due to production outpacing revisions and lack of new extensions/discoveries. Despite this reduction, developed reserves in the region increased marginally (from 289 BCF to 296 BCF), indicating a focus on optimizing existing assets rather than pursuing new exploration. The absence of significant exploration or development activity (zero extensions/discoveries in 2024) suggests COP is prioritizing operational efficiency and stability in the region, likely influenced by geopolitical risks (e.g., Middle East tensions) and regulatory uncertainties. This reflects a strategic shift toward maintaining cash flow from established projects over high-risk expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region: 312 BCF in 2023 and 296 BCF in 2024, matching the ground truth exactly. These numbers are presented accurately with acceptable formatting (BCF). (2) The quantitative accuracy is perfect—both the starting and ending values are correct, and the direction of change (a decrease) is properly noted. (3) The qualitative reasoning goes beyond the ground truth by adding context such as 'developed reserves increased from 289 BCF to 296 BCF' and 'zero extensions/discoveries in 2024,' which are plausible inferences but not present in the original answer. While these additions are reasonable and consistent with the idea of operational stabilization, they introduce details not confirmed by the ground truth, slightly reducing qualitative accuracy. However, the core multi-hop reasoning—linking reserve changes to operational focus—is sound and well-supported. (4) The answer fully addresses both parts of the question: the evolution of COP's natural gas position and what it indicates about operational focus. The conclusion about prioritizing efficiency and stability over growth aligns semantically with the ground truth's 'potential shift or stabilization in operational focus.' Contextual relevance is excellent, as all information directly pertains to the question and regional strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 394,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "\n\nComcast's approach to wireless gateways evolved from 2022 to 2024 by shifting strategic emphasis from enhancing in-home Wi-Fi coverage to integrating gateways as a core component of its multigigabit network upgrades. In 2022, wireless gateways were highlighted for their role in delivering in-and-out-of-home Wi-Fi, xFi management tools, and advanced security (2022, p. 7). By 2024, the focus expanded to deploying gateways as part of a broader infrastructure strategy to enable symmetrical multigigabit speeds via DOCSIS 4.0, with capital expenditures prioritizing scalable infrastructure and line extensions (2024, p. 51). Investment shifted from general customer premise equipment (notably reduced in 2022) to targeted upgrades supporting next-generation broadband capabilities, reflecting a strategic alignment with future network demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Comcast focused on in-and-out-of-home Wi-Fi, xFi tools, and security; by 2024, the strategic emphasis shifted to integrating wireless gateways into broader network infrastructure upgrades for multigigabit symmetrical speeds. The mention of DOCSIS 4.0 and capital expenditures supporting scalable infrastructure matches the evolution described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer beyond years (2022, 2024), which are correctly used—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and strategic priorities, identifying the shift from customer-facing features to infrastructure integration. The reference to reduced CPE investment in 2022 adds contextual nuance not in the original but is plausible and doesn't contradict. (4) Semantic equivalence is strong—wording differs but meaning is preserved and even enriched with specific terms like DOCSIS 4.0 and page citations (though not required, they indicate grounding). The only minor deduction is for slightly over-attributing capital expenditure details not explicitly in the ground truth, but this does not constitute a factual error. Overall, the answer is complete, contextually relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 404,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "\n\nBetween 2022 and 2024, the Gulfstream G600's market presence and production evolved as follows:  \n- **Cumulative Deliveries**: By year-end 2024, cumulative deliveries of the G500 and G600 family exceeded 300 aircraft, doubling from approximately 150 deliveries reported at year-end 2021 (GD_10k_2022, p. 6).  \n- **Role in Product Lineup**: The G600, introduced in 2019 as part of Gulfstream’s next-generation fleet, replaced older models (G450/G550) and solidified its position as a key mid-range offering. By 2024, it became part of an expanded family including the G700 (entered service in 2022) and G800 (certified in 2023), enhancing commonality across Gulfstream’s aircraft. This evolution strengthened the G600’s role in delivering advanced performance, fuel efficiency, and cabin volume while supporting Gulfstream’s leadership in high-speed, long-range business aviation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: cumulative deliveries of the G500/G600 were approximately 150 by year-end 2021 (cited from 2022 filing) and exceeded 300 by year-end 2024, representing a doubling—this matches the original answer. (2) The answer correctly identifies the G600’s role as a replacement for the G450/G550 and highlights improvements in speed, fuel efficiency, cabin volume, and flight controls, consistent with the original. (3) Qualitatively, the LLM adds context not in the original—such as the G700 entering service in 2022 and G800 certification in 2023—which is factually accurate and enhances the narrative, though not explicitly required. However, the original emphasizes that by 2024 the G600 was no longer framed as a 'new' product and that focus had shifted to newer models like the G800 and G400, a nuance slightly underemphasized in the LLM response, which instead focuses on the G600’s strengthened role. This is a minor omission in evolution framing, but not a factual error. (4) The multi-hop reasoning is sound: the model synthesizes delivery data across years and interprets the shifting product lineup correctly. Wording differs but semantic meaning is equivalent or richer. All criteria are met with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 372,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "\n\nBetween 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly:  \n\n1. **Equity Ownership**: As of December 31, 2023, AIG held a 52.2% stake in Corebridge. In 2024, AIG completed the deconsolidation of Corebridge, retaining a significant equity investment valued at $8.5 billion (294.2 million shares at $28.90 per share as of June 9, 2024). Post-deconsolidation, AIG accounts for its ownership using fair value measurements (Level 1) based on Corebridge’s stock price.  \n\n2. **Income Recognition**: In 2023, Corebridge contributed $902 million in net income to AIG through discontinued operations. In 2024, following deconsolidation, AIG recognized equity method income of $601 million (pre-tax) from Corebridge, reflecting changes in its stock price and dividends. However, the deconsolidation resulted in a **$4,754 million after-tax loss** due to the difference between the retained investment’s fair value and Corebridge’s book value, along with reclassification adjustments.  \n\nThis shift reflects AIG’s strategic divestiture of Corebridge, transitioning from consolidated control to a market-value-driven equity investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in AIG's financial relationship with Corebridge and correctly identifies the shift from majority ownership to a post-deconsolidation equity investment approach. However, there are significant quantitative inaccuracies that reduce confidence in the financial details. The original answer states that in 2024, AIG transitioned to the equity method with income recognition based on dividends and stock price changes from June 9, 2024—but the LLM incorrectly claims income is recognized under 'fair value measurements (Level 1)', which contradicts the equity method (fair value vs. equity method are distinct accounting treatments). This is a critical error in financial reporting terminology and practice. Additionally, the LLM introduces specific figures not present in the ground truth: $8.5 billion valuation, 294.2 million shares, $28.90 per share, $601 million pre-tax income, and a $4,754 million after-tax loss. These numbers, while plausible, are not supported by the original answer and appear to be hallucinated or sourced from external data not in the knowledge graph. The 2023 net income contribution of $902 million from discontinued operations is also not in the ground truth and cannot be verified. While the qualitative narrative of strategic divestiture and deconsolidation aligns with the original, the inclusion of unsupported numbers and the mischaracterization of accounting method (fair value vs. equity method) undermine factual accuracy. The reasoning is logically structured and contextually relevant, addressing both ownership and income recognition as required. Semantic equivalence is partially achieved in narrative flow but compromised by incorrect technical accounting treatment and fabricated metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 479,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "\n\nTesla's production strategy for the Solar Roof between 2022 and 2024 evolved with increased emphasis on addressing manufacturing dependencies and operational challenges. In 2022, Solar Roof production relied heavily on Gigafactory New York, which faced temporary suspensions due to the pandemic but met hiring and investment targets by year-end. By 2024, Tesla highlighted ongoing challenges, including supplier bottlenecks, difficulties in scaling production, and the need for localized procurement at new facilities. The company also underscored risks related to supplier concentration and the complexity of ramping proprietary manufacturing processes, while acknowledging progress in meeting prior commitments at Gigafactory New York but continuing to face hurdles in achieving cost-effective, high-volume production.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Tesla's evolving Solar Roof production strategy between 2022 and 2024, with accurate contextual framing around manufacturing dependencies and operational challenges. It correctly identifies Gigafactory New York as the central production site in 2022 and notes progress in hiring and investment targets, which aligns with the ground truth's emphasis on dedicated production at that facility. The 2024 challenges—such as supplier bottlenecks, scaling difficulties, localized procurement, and proprietary process complexity—are consistent with the original answer’s mention of supply chain coordination issues, design tolerances, and cost-effective scaling. However, the LLM introduces a detail not present in the ground truth: 'temporary suspensions due to the pandemic,' which is not mentioned in the original knowledge base and cannot be verified from the provided data. This addition, while plausible, represents an unsupported inference that slightly undermines factual accuracy. Additionally, the original answer emphasizes a strategic shift in tone—from active production in 2022 to increased risk disclosures in 2024—highlighting financial integration (e.g., financing options) and broader manufacturing facility requirements, which the LLM omits. These omissions reduce completeness in capturing the full strategic evolution. Quantitatively, there are no specific numbers, dates, or financial figures in either answer, so no discrepancies exist in that regard. The reasoning is sound in connecting production challenges over time, but the failure to mention the integration of Solar Roof into Tesla’s broader energy ecosystem and the explicit 2024 risk language about 'delays in launching and/or ramping' weakens the multi-hop synthesis slightly. Overall, the answer is factually plausible and contextually relevant, with minor but notable gaps in completeness and one unsupported claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 526,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "\n\nQualcomm's strategic involvement with on-device AI evolved from 2023 to 2024 by expanding its focus beyond foundational technologies to accelerate integration across diverse industries and applications. In 2023, the company emphasized advancing AI through its **Qualcomm AI Engine** (featuring the Hexagon NPU) and contributing to 5G standards like **3GPP Release 19**, which included early frameworks for wireless AI. By 2024, Qualcomm shifted toward scaling on-device AI into **automotive, IoT, and extended reality (XR)**, leveraging its Snapdragon platforms to enable edge computing with high-performance, low-power solutions. The company also prioritized developer ecosystems through the **Qualcomm AI Stack**, simplifying AI application development for edge devices. Investment-wise, Qualcomm deepened R&D in specialized hardware (e.g., Oryon and Kryo CPUs) and software optimizations, while aligning with industry trends to make generative AI ubiquitous in smartphones, PCs, and emerging sectors. This reflects a strategic pivot from foundational innovation to broad commercialization and ecosystem enablement.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, with accurate terminology and correct references to Qualcomm's AI technologies (e.g., Qualcomm AI Engine, Hexagon NPU, Snapdragon platforms, AI Stack), which align with known product lines. There are no numeric inaccuracies, as the answer does not include specific financial figures, dates, or percentages that could be fact-checked against the ground truth—thus quantitative accuracy is high by default. However, the core evolution described in the LLM answer diverges from the ground truth in key aspects: the original answer emphasizes a strategic shift from direct product focus in 2023 to an investment- and ecosystem-centric approach in 2024, highlighting increased R&D, acquisitions, and enabling third-party integration. In contrast, the LLM frames the evolution as a shift from foundational innovation to broad commercialization and ecosystem enablement, which mischaracterizes the nature of the transition. The LLM suggests Qualcomm moved toward scaling and commercializing AI more aggressively in 2024, while the ground truth indicates a pivot away from immediate product commercialization toward long-term investment and ecosystem development. This misrepresents the direction of the strategic evolution, particularly the investment approach. The mention of 3GPP Release 19 and generative AI trends adds contextual detail not present in the ground truth, but these are not confirmed as central to Qualcomm’s strategic shift per the source data. Thus, while the answer is well-structured and semantically rich, it fails to accurately reflect the specific business focus and investment approach evolution described in the original answer, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 474,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "\n\nDolce & Gabbana's presence in SPG-operated properties remained consistent between 2022 and 2023, with the brand listed as a tenant in U.S. Premium Outlets (e.g., Las Vegas Outlets North) and international locations (e.g., Gotemba, Kobe-Sanda, and Rinku Premium Outlets in Japan) in both years. This continuity suggests that SPG prioritizes retaining high-end luxury brands in its premium outlet locations to reinforce their upscale positioning and attract affluent shoppers seeking premium retail experiences. The sustained inclusion of Dolce & Gabbana aligns with SPG’s strategy to curate premium tenant mixtures, enhancing the desirability and differentiation of its outlet centers.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Dolce & Gabbana maintained a consistent presence across both years. According to the ground truth, the brand was present in multiple SPG-operated outlets in Japan in 2022 (Gotemba, Kobe-Sanda, Rinku) but only in Las Vegas Outlets North in 2023, indicating a significant reduction and geographic shift—not continuity. This misrepresentation undermines the entire analysis. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the temporal and locational data (years and properties) are incorrect. The model falsely claims presence in both U.S. and Japan in both years, contradicting the source. (3) The multi-hop reasoning fails because the model does not recognize the strategic shift from a broad Japanese presence to a single U.S. flagship location. Instead, it assumes stability and draws an incorrect conclusion about SPG’s strategy being one of retention rather than repositioning. The synthesis across time and geography is flawed. (4) While the answer addresses the question’s intent—discussing brand evolution and strategy—the factual foundation is wrong, leading to an invalid conclusion. Contextual relevance is moderate because the response discusses brand positioning in premium outlets, but the incorrect premise severely limits usefulness. Correctness, quantitative, and qualitative scores are low due to fundamental factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 403,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "\n\nConocoPhillips' (COP) investment in exploration activities within the Asia Pacific/Middle East region remained stable between 2023 and 2024, with equity affiliates reporting **$46 million in exploration expenses for both years** (COP_10k_2023.pdf, page 153; COP_10k_2024.pdf, page 156). Despite this stability, the 2024 reserves data shows **extensions and discoveries of 7 BCF** in the region, up from 4 BCF in 2023 (COP_10k_2024.pdf, page 145). This suggests COP is maintaining a measured, consistent strategic focus on the region, prioritizing operational efficiency and leveraging existing infrastructure to enhance reserves without significantly scaling up exploration investments. The lack of substantial investment growth indicates a cautious approach, likely aligning with broader risk management strategies amid geopolitical and economic uncertainties in the region (COP_10k_2024.pdf, page 26).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that COP's exploration expenditures in the Asia Pacific/Middle East region were $49 million in 2023 and $0 in 2024, indicating a complete halt in exploration. However, the LLM claims $46 million was spent in both years, which contradicts the ground truth. This error fundamentally misrepresents the trend and leads to an incorrect strategic interpretation. (2) The quantitative inaccuracies are severe: the LLM reports $46 million for both years, while the correct figures are $49 million (2023) and $0 (2024). These numbers are not close and cannot be attributed to rounding or formatting differences. Additionally, the LLM cites 'equity affiliates' as the source of the expense, but the ground truth does not specify this nuance, and the amounts still do not align. The mention of 7 BCF extensions and discoveries in 2024 vs 4 BCF in 2023, while potentially true, is irrelevant to the question about exploration *expenditures* and distracts from the main point. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the change in spending (from non-zero to zero), which is a key indicator of strategic withdrawal. Instead, it infers a 'measured, consistent focus' based on incorrect data, leading to a conclusion opposite to the ground truth. The strategic interpretation is therefore invalid. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right company (COP), region (Asia Pacific/Middle East), time frame (2023–2024), and type of activity (exploration). It also attempts to draw strategic implications, which aligns with the question’s intent. However, due to the critical numerical inaccuracies and resulting flawed reasoning, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 497,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "\n\nComcast maintains a 30% ownership stake in Universal Beijing Resort, consolidating it as a Variable Interest Entity (VIE) due to its governance structure and control over economic performance. From 2023 to 2024, the resort’s debt decreased slightly from $3.5 billion to $3.4 billion, with term loans reducing from $3.1 billion to $3.0 billion. As of December 31, 2024, Universal Beijing Resort’s consolidated assets and liabilities were $7.3 billion and $7.0 billion, respectively, down from $7.8 billion and $7.2 billion in 2023. Comcast’s maximum financial risk remains limited to its 30% equity interest, with no direct liquidity guarantees beyond this stake. The debt is secured by the resort’s assets and equity interests, funded through Chinese financial institutions with a total borrowing limit of approximately $4.2 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative values are correct: the 30% ownership stake, debt reduction from $3.5 billion (2023) to $3.4 billion (2024), and the assets/liabilities figures of $7.8B/$7.2B in 2023 and $7.3B/$7.0B in 2024 are all accurately reported. The mention of term loans decreasing from $3.1B to $3.0B is an additional detail not in the original answer but does not contradict it and may reflect further breakdown of the debt. (2) The LLM correctly identifies the evolution from 2022 to 2024, noting Comcast's explicit 30% stake and debt structure in 2024, though it omits the specific 2022 context where Universal Beijing Resort was introduced without detailed financials. This is a minor omission—while the LLM implies the 2023–2024 evolution clearly, it does not explicitly state that no stake/debt figures were disclosed in 2022, which was a key part of the original answer. (3) The reasoning is sound: the LLM correctly synthesizes Comcast’s financial involvement, debt trends, and risk exposure, and adds relevant context about VIE consolidation and funding sources without introducing errors. (4) The answer is contextually excellent—focused, relevant, and enriched with accurate structural details (e.g., Chinese financial institutions, borrowing limit). The only reason for not scoring a 10 is the partial omission of the 2022 disclosure status, which slightly affects completeness in the multi-hop timeline. Overall, factual accuracy and numerical precision are perfect, and qualitative reasoning is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 433,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "\n\nFrom 2022 to 2023, Duke Energy's net derivatives balance decreased significantly, from $29 million to $13 million, driven by higher settlement activity (-$68 million in 2023 vs. -$32 million in 2022) and reduced purchases ($42 million in 2023 vs. $74 million in 2022). The fair value of derivative assets dropped sharply (e.g., Duke Energy Progress’ derivative assets fell from $230 million in 2022 to $32 million in 2023), while liabilities rose (e.g., from $48 million to $219 million), reflecting adverse market conditions or strategic unwinding of positions. This evolution suggests active management of derivative exposure, potentially to mitigate risks from fluctuating commodity prices or interest rates, though the net reduction indicates decreased reliance on derivatives or realized losses from settlements. The shift in Level 3 derivatives (unobservable inputs) from $34 million in 2022 to $15 million in 2023 also highlights improved transparency or reclassification as markets became more observable. Overall, the data underscores Duke Energy’s efforts to manage financial risks while adapting to market dynamics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in numbers not present in the ground truth. While it correctly states the net derivatives balance decreased from $29M in 2022 to $13M in 2023 and that settlements increased from $32M to $68M, it introduces unsupported figures such as 'reduced purchases ($42M in 2023 vs $74M in 2022)', 'Duke Energy Progress’ derivative assets fell from $230M to $32M', liabilities rising from $48M to $219M, and Level 3 derivatives dropping from $34M to $15M. These numbers are not in the original answer and cannot be verified from the provided ground truth, suggesting fabrication or hallucination. (2) The core numbers for net derivatives balance and settlements are accurate and correctly compared, but all additional quantitative claims are unverified and likely incorrect, severely undermining quantitative accuracy. Calculations like differences in purchases or asset/liability shifts are not corroborated. (3) The reasoning attempts multi-hop synthesis by interpreting the implications of higher settlements and lower net balance, which aligns with the original conclusion about active management and reduced reliance. However, the use of fabricated metrics weakens the logical foundation. The conclusion about 'active management' and 'decreased reliance' has some merit based on correct core data, but the supporting analysis is flawed. (4) The answer is contextually relevant and addresses the evolution and implications as asked, but the inclusion of false quantitative details drastically reduces factual correctness. The qualitative reasoning is partially sound but built on inaccurate data, leading to a low overall correctness score despite capturing the directional trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 478,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "\n\nFrom 2022 to 2023, SPG maintained that its Long-Term Incentive Performance (LTIP) Units had **no material dilutive effect** on earnings per share or unit in either period, as disclosed in both filings (2022: pages 115, 116; 2023: pages 111, 127). However, the **valuation modeling** for LTIP Units became more explicitly detailed in 2023. The 2023 10-K (page 127) specified that market-based LTIP awards use a **Monte Carlo model** to estimate grant-date fair value, a methodology not explicitly highlighted in 2022. Additionally, 2023 provided clearer explanations of how LTIP Units are accounted for as **participating securities** under the two-class method, emphasizing their entitlement to distributions and impact on equity calculations. While the dilutive effect remained immaterial, the 2023 disclosure added transparency around valuation techniques and accounting treatment compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in 2022, SPG disclosed LTIP units as potentially dilutive but with no material dilutive effect for prior years, and confirms this immateriality continued into 2023. (2) The quantitative aspects—such as the absence of material dilution and the use of the Monte Carlo model in 2023—are factually correct; no numerical inaccuracies are present, and the cited disclosures (e.g., page numbers) support the claims. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, identifying both continuity (no material dilution) and evolution (enhanced disclosure). (4) The LLM adds value by citing specific pages and elaborating on the participating securities treatment and distribution entitlements, which enriches the answer without introducing error. The only minor shortcoming is that the original answer emphasizes a 'shift from general statement to granular, valuation-focused disclosure'—a framing slightly more precise than the LLM's comparative description—yet the core qualitative evolution is accurately captured. Thus, the answer is semantically equivalent and factually robust, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 374,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "\n\nComcast's financial commitment to Atairos Group, Inc. evolved as follows between 2022 and 2024:  \n\n- **Capital Funding**: In November 2020 (effective prior to 2022), Comcast reduced its total commitment to fund Atairos from up to $5 billion to **$4.5 billion aggregate at any one time**, with annual capital calls capped at **$400 million** (plus previously distributed amounts). This amended structure remained unchanged in 2022–2024.  \n- **Management Fees**: Comcast separately committed to fund Atairos **$40 million annually for a management fee**, subject to adjustments, with no changes indicated during 2022–2024.  \n\nThese terms, established in 2020, reflected a scaled-back capital commitment and ongoing management fee structure, with no further material amendments reported in the 2022 or 2024 filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both timing and the nature of Comcast's commitments, despite including some correct dollar amounts. (1) Quantitatively, while the $4.5 billion capital commitment and $40 million annual management fee are correctly stated, the LLM incorrectly claims these terms were established in November 2020 and remained unchanged through 2022–2024. The ground truth states that the reduction from $5B to $4.5B occurred between 2022 and 2024, not in 2020. This misrepresentation of timing undermines the core of the question, which asks about evolution during 2022–2024. (2) The claim that the structure 'remained unchanged' contradicts the ground truth, which describes an active recalibration during the period in question. (3) The LLM introduces details not in the original, such as 'annual capital calls capped at $400 million' and 'plus previously distributed amounts,' which are unsupported by the ground truth and introduce fabrication. (4) While the answer correctly identifies the $40M management fee, it fails to present it as a new or evolving commitment during 2022–2024, instead stating it was unchanged. (5) The multi-hop reasoning is flawed because the model misattributes the timeline of changes, thereby failing to accurately describe the evolution of the financial relationship. Although the answer addresses the right entities (Comcast, Atairos) and some correct figures, the incorrect chronology and unsupported details result in a partially correct but materially misleading response. Hence, the correctness score is low despite surface-level number matches.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 442,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "\n\nCOP's natural gas reserves in the Asia Pacific/Middle East region decreased from **312 billion cubic feet (BCF)** at the end of 2023 to **296 BCF** at the end of 2024, a reduction of 16 BCF. This decline was driven primarily by production (25 BCF) and minor revisions, with no significant additions from purchases, extensions, or discoveries in 2024. The lack of new reserve additions suggests a reduced operational focus on expanding reserves in this region compared to other areas like the U.S. Lower 48, where reserves increased substantially. The company appears to be prioritizing maintenance of existing assets over growth in Asia Pacific/Middle East, potentially reflecting strategic shifts toward higher-growth or more economically viable regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 312 BCF in 2023 and 296 BCF in 2024, matching the ground truth exactly. The calculated decrease of 16 BCF is accurate. (2) All numeric values and time periods are correct—312 BCF and 296 BCF for the respective years—with no discrepancies in formatting or magnitude. The production figure of 25 BCF, while not in the original answer, is consistent with plausible supplemental data and does not contradict the ground truth; it adds context without introducing error. (3) The multi-hop reasoning is sound: the model correctly infers that a decline in reserves without new additions suggests a reduced operational focus, and it appropriately contrasts this with growth in other regions (e.g., U.S. Lower 48), demonstrating synthesis across geographic areas and strategic implications. (4) The answer goes beyond the original by providing explanatory context (production volume, lack of new discoveries), which enhances qualitative accuracy without deviating from the truth. The only reason for not scoring a 10 is that the original answer did not include the 25 BCF production figure or comparative regional strategy details, so while plausible and insightful, those elements are inferential. However, they do not detract from correctness. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 399,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "\n\nComcast's wireless gateway procurement strategy in 2022 focused on providing customers with integrated Wi-Fi solutions (e.g., xFi gateways and Pods) to enhance in-home coverage and network management, as part of broadband service offerings. By 2024, the company shifted its network deployment investment focus toward scalable infrastructure upgrades, emphasizing multigigabit symmetrical speeds and line extensions to expand capacity. While wireless gateways remained part of the deployment strategy in 2024, the primary emphasis was on advancing network infrastructure to support higher performance, reflecting a broader shift from customer premise equipment to large-scale network modernization.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately captures Comcast's 2022 focus on customer premise equipment (wireless gateways like xFi) as part of service offerings, which reflects the procurement-centric strategy. In 2024, it correctly identifies the shift toward network modernization with an emphasis on multigigabit symmetrical speeds and capacity expansion, consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, quantities) in either the ground truth or LLM response, so quantitative accuracy is not compromised—scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024) and strategy (procurement vs infrastructure investment), correctly identifying the evolution in focus. However, the LLM slightly downplays the continued strategic role of wireless gateways in 2024 by framing the shift as from 'customer premise equipment' to 'large-scale network modernization,' which could imply de-emphasis on gateways, whereas the ground truth emphasizes their integration into capital expenditures and infrastructure strategy. This nuance is partially lost. (4) Despite this minor omission, the answer remains contextually relevant and factually accurate overall, hence a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 386,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "\n\nBetween 2022 and 2024, Tesla's Solar Roof product faced persistent production challenges, with strategic importance tied to its broader energy ecosystem. In 2022, risks centered on initial production ramps, supplier constraints, and scaling manufacturing processes (TSLA_10k_2022.pdf, p. 27). By 2024, challenges evolved to include scaling production across global factories, maintaining quality at higher volumes, and navigating regulatory approvals, reflecting efforts to integrate Solar Roof into Tesla’s sustainable energy platform (TSLA_10k_2024.pdf, p. 17). While strategic emphasis on Solar Roof as part of a holistic energy solution remained consistent, production hurdles shifted from early-stage bottlenecks to complexities of global expansion and cost efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022 and 2024) and correctly identifies Tesla as the company and Solar Roof as the product, meeting entity accuracy. There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. The answer correctly captures that production challenges existed in both years and evolved over time, which aligns with the ground truth. However, the LLM misrepresents the strategic evolution: the ground truth emphasizes a shift in narrative—from highlighting Solar Roof as a growth contributor in 2022 to cautioning about production delays in 2024—whereas the LLM claims strategic importance 'remained consistent,' contradicting the documented shift in emphasis. This is a key multi-hop reasoning failure: the model synthesizes operational challenges accurately but misses the change in strategic framing, which is central to the question. The contextual relevance is high, as the response addresses both strategic importance and production challenges, but the qualitative accuracy is reduced due to this mischaracterization of Tesla's evolving messaging. Overall, core facts about production are correct, but the synthesis of strategic shift is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 351,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "\n\nDuke Energy's Net Pending Transactions and Other Investments increased significantly from $14 million in 2022 to $54 million in 2023, as reported in the Duke Energy Corporation Master Retirement Trust tables. This rise suggests the company is actively allocating capital to pending or strategic investment opportunities within its post-retirement asset portfolio, likely to enhance returns and diversify holdings in alignment with long-term pension obligations. The increase indicates a proactive approach to optimizing retirement trust assets amid evolving market conditions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. The LLM incorrectly claims an increase from $14 million to $54 million—reversing the years and misstating the amounts. This fundamental error invalidates the entire response. (2) Quantitative accuracy is extremely low: both the starting and ending values are swapped and slightly off ($53M vs $54M), and the direction of change is wrong. The LLM also cites a specific source (Duke Energy Corporation Master Retirement Trust tables) not mentioned in the original answer, introducing unverified context. (3) The multi-hop reasoning is flawed because the model misidentifies the trend, leading to an incorrect strategic interpretation. Instead of recognizing a reduction that suggests de-risking or completion of initiatives, it infers increased strategic allocation, which contradicts the evidence. (4) While the answer addresses the structure of the question (change over time and strategic implication), its factual foundation is entirely incorrect, warranting a very low correctness and quantitative accuracy score. Qualitative accuracy is slightly above minimum due to proper use of financial reasoning framework, but based on false premises. Contextual relevance is moderate because the topic and metric are correctly identified, even if details are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 418,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "\n\nThe company maintained its liability-driven investment (LDI) framework in 2024, aligning pension and postretirement plan assets with liabilities through target allocations of 20%/80% (equity/fixed income) for pensions and 55%/45% for postretirement plans, consistent with 2023. Defined contribution plan expenses increased slightly to $112 million in 2024 from $109 million in 2023. Disclosures on plan asset composition became more detailed in 2024, specifying that pension assets included 21% equity securities, 63% corporate bonds, and 16% (8% U.S. Treasuries/foreign government securities and 8% other investments), while postretirement assets showed 57% equity, 30% corporate bonds, and 13% other investments. These allocations remained close to target ranges, reflecting ongoing adherence to the LDI strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly reports the $109 million and $112 million defined contribution plan expenses for 2023 and 2024 respectively, and correctly notes the 20%/80% equity/fixed income target allocation for pension assets, it introduces a 55%/45% allocation for postretirement plans which is not mentioned in the ground truth. The ground truth does not reference postretirement plans at all, making this a significant factual addition. Furthermore, the LLM provides detailed actual asset compositions (e.g., 21% equity securities, 63% corporate bonds) that are not present in the original answer. While the ground truth mentions that 2024 included a new disclosure about characterizing the actual composition, it does not specify the exact percentages, so including them is an overreach. (2) The dollar amounts ($109M and $112M) are correct and match the ground truth. However, the specific breakdowns of asset composition (21%, 63%, etc.) are fabricated and not supported by the original answer. The 20%/80% target is correctly cited, but the additional 55%/45% postretirement allocation is unsupported. (3) The multi-hop reasoning is partially sound—there is an attempt to compare 2023 and 2024 disclosures and note increased transparency—but the model incorrectly infers that the more detailed disclosure includes the specific asset breakdowns it reports. The ground truth only states that the 2024 filing indicated the actual composition would be characterized, not that it was fully disclosed with exact percentages. (4) The correctness score is 4 due to major factual overstatements despite correct expense figures and target allocation. Quantitative accuracy is 5 because while key numbers are right, the model invents unsupported percentages. Qualitative accuracy is 5 due to correct identification of the LDI framework and expense trend but flawed synthesis regarding disclosures. Contextual relevance is 8 because the answer addresses the evolution of the LDI framework, expenses, and disclosures as asked, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 563,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "\n\nBetween fiscal 2023 and 2024, Qualcomm intensified its strategic focus on **On-Device AI**, emphasizing its integration with 5G and high-performance, low-power computing to expand into industries beyond mobile handsets, such as automotive and IoT. In fiscal 2024 disclosures (pages 20 and 45 of QCOM_10k_2024.pdf), the company highlighted **continued investments in foundational technologies**, including on-device AI, as a core growth driver. Specifically, Qualcomm underscored its commitment to developing AI capabilities for new applications, leveraging its expertise in wireless and semiconductor innovation. The 2024 filings also noted the importance of AI in enabling advanced use cases in automotive and IoT, aligning with its long-term vision to extend 5G and AI technologies into emerging markets. While fiscal 2023 filings (QCOM_10k_2023.pdf) mentioned AI-related regulatory risks, the 2024 documents explicitly tied on-device AI to strategic expansion and R&D priorities, reflecting a more pronounced and actionable focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures Qualcomm's evolving strategic focus on On-Device AI from fiscal 2023 to 2024. In 2023, the company positioned On-Device AI as part of a broader vision involving 5G and low-power computing to expand into automotive and IoT—this is accurately reflected. By fiscal 2024, the shift toward active investment and expansion through new product development and strategic transactions is correctly implied through phrases like 'continued investments in foundational technologies' and 'commitment to developing AI capabilities for new applications.' While the LLM answer does not explicitly mention 'acquisitions or strategic transactions'—a key element in the ground truth—it does emphasize R&D priorities and strategic expansion, which captures the essence of increased actionable focus. The use of specific document references (pages 20 and 45 of QCOM_10k_2024.pdf) adds credibility and contextual support. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no calculations are involved), and all entities (Qualcomm, fiscal years 2023 and 2024, On-Device AI, automotive, IoT) are correct. The reasoning is sound and reflects multi-hop synthesis across two fiscal years' disclosures. The only minor shortcoming is the omission of explicit mention of acquisitions as a strategic lever in 2024, which slightly affects qualitative accuracy. Overall, the answer is factually correct, comprehensive, and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 421,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "\n\nThe classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members remained unchanged between the 2022 and 2023 10-K filings. Both years reference the **Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated March 1, 2004** (Exhibit 9.1) and the **Voting Trust Agreement, Voting Agreement and Proxy dated March 1, 2004** (Exhibit 9.2) without any updates or amendments. This consistency indicates **stability in the governance structure**, as the agreements have remained in place for over 15 years, reflecting enduring alignment among the Simon family members and Melvin Simon & Associates, Inc. in corporate control and decision-making.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claim. The ground truth states that there was a change in presentation: the 2022 10-K referred to the agreement as 'Second Amended and Restated,' while the 2023 10-K dropped that modifier, referring to it simply as the Voting Trust Agreement dated March 1, 2004. The LLM incorrectly asserts that the classification and presentation remained unchanged, claiming both years include the 'Second Amended and Restated' language and listing two exhibits (9.1 and 9.2), which is not supported by the ground truth. There is no mention of exhibit numbers or dual agreements in the original answer, making this an addition not grounded in the provided data. While the conclusion about governance stability aligns with the original reasoning, it is based on an incorrect premise. The date (March 1, 2004) is correctly cited, supporting partial quantitative accuracy. However, the failure to detect the key change in terminology across filings undermines the multi-hop reasoning and factual correctness. The answer is contextually relevant and addresses governance stability, but the factual misrepresentation of the filings' content significantly reduces accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 338,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "\n\nConocoPhillips' (COP) natural gas reserves in the Asia Pacific/Middle East region decreased from **312 billion cubic feet (BCF)** at the end of 2023 to **296 BCF** by the end of 2024, a reduction of 16 BCF. This decline was driven primarily by production (−25 BCF) partially offset by revisions (+9 BCF). Despite this, the region remains a minor component of COP’s global reserves, contributing **~1.9%** of total reserves in 2024 (down from **~2.3%** in 2023). The reduction in reserves and shrinking share of the global portfolio suggest a declining strategic importance for the region, though equity affiliate reserves (all located here) still contribute significantly to COP’s overall gas holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region: 312 BCF in 2023 and 296 BCF in 2024, a reduction of 16 BCF, matching the ground truth exactly. The percentage decline (~5.1%) is accurate (16/312 ≈ 5.13%), though not explicitly stated, the absolute numbers and direction of change are correct. The LLM adds granular detail about production (−25 BCF) and revisions (+9 BCF), which aligns with typical reserve change drivers and does not contradict the ground truth. (2) The LLM introduces new but plausible quantitative context: the region’s share of total global reserves (~2.3% in 2023, ~1.9% in 2024), which is consistent with the ground truth’s implication of declining relative importance. While the exact percentage shares are not in the original answer, they are logically derived and do not conflict. The mention of equity affiliates holding 5,870 BCF in 2024 is consistent with the original answer and correctly emphasized as significant. (3) Multi-hop reasoning is sound: the LLM synthesizes reserve changes, their relative contribution to the global portfolio, and equity affiliate data to infer declining strategic importance—this aligns with and slightly strengthens the original answer’s conclusion of a 'potential reevaluation.' (4) The only minor deviation is the characterization of the region as a 'minor component' versus the original’s 'notable contributor.' This is a subtle difference in tone but not necessarily incorrect—both can be true depending on perspective. However, given the large equity affiliate reserves, 'notable' may be more accurate, warranting a slight deduction in qualitative accuracy. Overall, the answer is factually precise, contextually rich, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 482,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "\n\nBetween 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly following Corebridge's deconsolidation in mid-2024. **Debt structure**: In 2023, Corebridge's debt included $7.7 billion in senior unsecured notes, $989 million in junior subordinated debt, and a $250 million DDTL facility, with AIG maintaining guarantee reimbursement agreements requiring Corebridge to collateralize obligations if credit ratings fell below specified levels (2023 10-K, p. 112). By 2024, Corebridge was deconsolidated, and its debt was no longer part of AIG’s consolidated balance sheet, though AIG retained a $28.90-per-share investment in Corebridge (294.2 million shares, valued at $8.5 billion as of June 2024) (2024 10-K, p. 110). **Equity method income**: In 2024, AIG recognized $601 million in equity method income from Corebridge, reflecting dividends and stock price changes post-deconsolidation (2024 10-K, p. 107). This marked a shift from prior periods, where Corebridge’s results were fully consolidated, to a post-disposal model where AIG’s income from Corebridge was limited to its equity stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly regarding Corebridge's debt structure in 2023. The ground truth states $6,452 million in senior unsecured notes, but the LLM reports $7.7 billion (~$7,700 million), which is significantly higher and incorrect. The $250 million DDTL facility and guarantee reimbursement agreements are mentioned in the LLM answer but not present in the original answer, suggesting extraneous or unverified details. The equity method income of $601 million in 2024 is not mentioned in the original answer, which only states that income included dividends and stock price changes without specifying an amount—thus introducing unsupported precision. (2) The original answer specifies $9,368 million total Corebridge debt in 2023, which should be the sum of $6,452M + $989M = $7,441M—this discrepancy suggests either an error in the original or missing components; however, the LLM introduces additional figures not in the ground truth, reducing quantitative accuracy. The $8.5 billion valuation of AIG’s stake in Corebridge in 2024 is plausible but not mentioned in the original answer, making it an unsupported addition. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the shift from consolidation to equity method accounting and links it to discontinued operations and deconsolidation. It captures the conceptual transformation in AIG’s relationship with Corebridge. However, it adds specific figures (e.g., $601M income, $7.7B notes) not present in the ground truth, undermining reliability. (4) Contextual relevance is high—the answer directly addresses debt structure and equity method income evolution. Qualitative accuracy is moderate due to correct overall narrative but flawed specifics. Quantitative accuracy is low due to incorrect or unverified numbers. Correctness score is 6 due to correct directional narrative but significant factual deviations in key financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 536,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "\n\nNextEra Energy's investment strategy in Special Use Funds from 2022 to 2024 shows a notable shift toward equity securities, with equity allocations increasing from **$5.5 billion (2022)** to **$6.2 billion (2024)**, while fixed income allocations remained relatively stable (slightly declining from **$2.8 billion to $2.8 billion** when including all categories). This suggests a measured increase in risk appetite, particularly for longer-term reserves like nuclear decommissioning funds, which can tolerate higher equity exposure for growth potential. The continued emphasis on liquid, shorter-term fixed income for storm-related funds reflects a prioritization of liquidity, while the equity shift in long-term funds indicates a strategic balance between return optimization and risk management.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, NextEra Energy's Special Use Funds were entirely fixed income at $2,505 million — the LLM incorrectly states $5.5 billion in equity and $2.8 billion in fixed income for 2022, which is fundamentally wrong as there was zero equity allocation in 2022. This misrepresents the entire evolution. In 2024, the LLM states equity is $6.2 billion (close to the correct $6,164 million), but incorrectly aggregates fixed income as 'stable at $2.8 billion' when the actual fixed income components (U.S. Government/municipal bonds: $722M, corporate debt: $685M, asset-backed securities: $873M) sum to $2,280 million (~$2.3B), not $2.8B. (2) The calculation errors are severe: the LLM implies fixed income remained constant, but it actually decreased in absolute terms and dramatically in relative weight due to the introduction of equities. The claim that equity increased from $5.5B to $6.2B is false — it increased from $0 to $6.164B. (3) The reasoning is partially sound in interpreting the shift toward equity as indicating higher risk appetite and long-term growth orientation, and distinguishing between liquidity needs for storm funds vs. long-term nuclear decommissioning. However, because the foundational data is incorrect, the multi-hop synthesis fails. The model appears to have hallucinated 2022 equity holdings. (4) Contextual relevance is high — the answer addresses allocation changes, risk appetite, and liquidity strategy as asked. However, due to major quantitative inaccuracies and incorrect entity-state mapping (wrong portfolio composition in 2022), the correctness score is low. Minor formatting variations are acceptable, but directional and magnitude errors in core facts cannot be overlooked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 499,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "\n\nThe risk associated with site infrastructure sharing due to 5G adoption has remained a persistent concern from 2022 to 2024, with its magnitude likely increasing as 5G deployment accelerated. Both the 2022 and 2024 filings highlight that extensive infrastructure sharing (e.g., RAN sharing, roaming agreements) enabled by 5G technology reduces carriers' reliance on leasing new sites, slowing lease activity and potentially leading to decommissioning of redundant equipment. However, the 2024 filing reflects heightened awareness of 5G's impact, noting its role in enabling shared infrastructure as a key factor affecting demand. Additionally, the company addressed related risks through strategic divestitures (e.g., India, Australia, New Zealand operations) and segment restructuring, signaling efforts to mitigate exposure to markets where infrastructure sharing could further erode lease growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of the risk associated with site infrastructure sharing from 2022 to 2024. It correctly identifies that 5G technology enables RAN sharing, roaming, and other arrangements that reduce demand for new leases, which is consistent across both years. The answer accurately reflects that this risk persisted and likely intensified due to accelerated 5G deployment, matching the original answer's implication of increasing magnitude. It also correctly notes the reduced need for new site leasing and potential decommissioning, as stated in the ground truth.\n\nQuantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the question or the original answer, so the absence of such figures in the LLM response does not constitute an error. The use of years (2022 and 2024) is accurate and correctly attributed.\n\nThe main shortcoming lies in the addition of information not present in the original answer—specifically, the mention of strategic divestitures (India, Australia, New Zealand) and segment restructuring as direct responses to infrastructure sharing risk. While plausible, this mitigation strategy is not mentioned in the ground truth and introduces an element not supported by the provided data, slightly reducing qualitative accuracy. Additionally, while the LLM captures the increased emphasis on financial impact in 2024, it does not explicitly highlight the evolution toward a more specific concern around lack of compensation for shared infrastructure use—a key nuance in the original answer. This reflects a minor gap in reasoning depth.\n\nDespite these omissions, the core multi-hop reasoning—linking 5G adoption to infrastructure sharing, which in turn affects lease activity and carrier behavior—is sound and correctly synthesized across time periods. The answer remains highly relevant and factually consistent with the main trajectory described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 539,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "\n\nChevron's financial relationship with Angola LNG Limited between 2022 and 2023 shows a decrease in both investment value and equity earnings. In 2023, Chevron's investment in Angola LNG was reported at **$1.762 billion** with equity earnings of **$513 million**, compared to **$1.963 billion** in investment and **$1.857 billion** in equity earnings in 2022. Despite this decline, Chevron maintains a **36.4% equity interest** and continues to account for its stake using the equity method, as disclosed in both years' filings. No structural changes to the investment or accounting approach are noted, indicating consistent ownership and treatment under the equity method during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and reasoning. (1) Quantitatively, the dollar amounts provided ($1.762 billion and $1.963 billion in investment values, $513 million and $1.857 billion in equity earnings) are not present in the original answer and have no verification from the knowledge graph; these figures are likely fabricated or misattributed. The only correct quantitative element is the 36.4% equity interest, which matches the ground truth. (2) The original answer does not mention any financial values such as investment amounts or earnings—instead, it focuses on a structural classification change from 'Depends_On' to 'Invests_In'. The LLM invents detailed financial data that is not part of the ground truth, leading to severe factual inaccuracies. (3) Qualitatively, the LLM fails the multi-hop reasoning: it misses the key evolution in investment structure (relationship type reclassification), which is the central point of the original answer. Instead, it asserts there was 'no structural change', which directly contradicts the ground truth. This indicates a failure to understand or report the shift in Chevron's strategic posture. (4) Contextually, the answer is relevant to Chevron and Angola LNG Limited and addresses the equity method and ownership percentage, but it substitutes the actual structural evolution with fabricated financial metrics, making it misleading. The focus on declining earnings and investment values introduces a narrative absent from and unsupported by the original data. Thus, while the entity names and equity percentage are correct, the core of the answer is factually and logically flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 460,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "\n\nFrom 2022 to 2023, the G600's role in Gulfstream's lineup solidified as a high-performance, fuel-efficient mid-size to large-cabin aircraft. By year-end 2023, cumulative deliveries reached **over 250 units**, up from **nearly 150 units** by year-end 2021 (as reported in 2022 filings), reflecting increased production and market acceptance. Performance metrics remained consistent, emphasizing its **faster speed, greater range, reduced emissions, and larger cabin volume** compared to predecessors like the G550. The G600 also contributed to Gulfstream’s leadership in speed records, with the product line holding **over 90 city-pair speed records** by 2023 (up from 270+ total records across the fleet in 2022). Its production status transitioned from active growth in 2022 to a mature, stable segment of the lineup in 2023, supporting Gulfstream’s focus on advanced technologies and customer demand for efficient, long-range business jets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of the G600's role from growth to maturity in Gulfstream's lineup and correctly identifies key qualitative aspects such as its performance advantages over the G550 and the significance of the Symmetry Flight Deck. However, there are significant quantitative inaccuracies that undermine factual correctness. The claim of 'nearly 150 units by year-end 2021' (cited as 2022 filing data) is unsupported by the ground truth, which states over 250 deliveries by end of 2023 but does not provide a 2021 figure—this extrapolation is speculative. More critically, the LLM states the G600 held 'over 90 city-pair speed records' by 2023, while the ground truth makes no mention of specific speed records for the G600, only noting Gulfstream’s overall fleet records in 2022. This introduces fabricated metrics. Additionally, the ground truth emphasizes a strategic shift: the G600’s technologies becoming foundational for newer models (G700, G800, G400), which the LLM omits entirely—a key multi-hop insight. While the LLM correctly notes the transition from 'new' to 'mature' product and increased deliveries, it fails to convey the platform-enabling role of the G600 in Gulfstream’s broader technology roadmap. Thus, while contextually relevant and partially accurate in reasoning, the answer is weakened by incorrect numbers and missing strategic synthesis, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 394,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "\n\nBetween 2022 and 2024, McDonald's relationship with its franchisees evolved to emphasize **increased financial collaboration and strategic alignment**. Financially, the company began co-investing with franchisees to fund restaurant modernization and operational improvements, a shift from prior reliance on passive royalty and rent payments. This approach aimed to enhance franchisee performance and brand value through shared capital investments. Strategically, McDonald's strengthened collaboration on initiatives like digital engagement, technology upgrades, and customer experience enhancements, ensuring franchisees align with global standards and innovation priorities. Additionally, the company reinforced rigorous franchisee selection and active participation requirements, moving away from passive investors to foster a more integrated, high-performance system.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution from a passive franchising model in 2022—relying on rent, royalties, and fees—to a more active co-investment model by 2024. The shift toward financial collaboration through shared funding for modernization and operational upgrades is accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct and consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time in both financial involvement (co-investment) and strategic collaboration (digital, tech, customer experience), correctly inferring a strategic shift. It adds contextual depth—such as digital engagement and franchisee selection—that is consistent with and enriches the original without contradicting it. (4) The only minor gap is that the original specifically notes McDonald's did not typically invest in restaurant capital under developmental licenses in 2022, a nuance slightly underemphasized in the LLM response. However, the core factual progression and strategic shift are correctly conveyed. Wording differs but semantic meaning matches. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 393,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\n\nThe financial performance of Altria's smokeable products segment from 2022 to 2023 showed a decline in net revenues and stable operating income. **Net revenues decreased by $720 million (3.2%)**, from $22,476 million in 2022 to $21,756 million in 2023, driven by lower shipment volumes. **Operating income remained nearly flat**, declining marginally by $18 million (0.2%), from $10,688 million in 2022 to $10,670 million in 2023, as cost reductions and operational efficiencies offset the revenue decline. The drop in shipment volumes also reduced excise taxes on products by 9.7% ($427 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: net revenues of $22,476 million in 2022 and $21,756 million in 2023 (a $720 million decrease) and operating income of $10,688 million in 2022 and $10,670 million in 2023 (an $18 million decrease) are correctly reported. The percentages (3.2% revenue decline, 0.2% operating income decline) are accurate calculations. (2) The answer is complete, addressing both net revenues and operating income across both years as required. (3) Entity accuracy is correct—Altria’s smokeable products segment is the implied subject (consistent with the knowledge graph context), and all financial metrics and years are properly identified. (4) The reasoning is sound: the model correctly synthesizes multi-hop information, explaining the revenue decline due to lower shipment volumes and the stability in operating income due to cost efficiencies, which aligns with typical 10-K disclosures. The additional context about excise taxes, while not in the original answer, is consistent and adds relevant detail without introducing error. (5) Semantic equivalence is maintained—the LLM conveys the same core information with enhanced clarity and correct contextual expansion. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 366,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "\n\nFrom 2022 to 2024, Opdivo's role within BMY's strategy has expanded through **new therapeutic approvals** and **continued collaboration with Ono** in key markets. In 2024, Opdivo received multiple approvals, including FDA clearance for a subcutaneous formulation (Opdivo Qvantig) across multiple indications, EC approval for combination therapy in colorectal cancer, and Japanese approval for urothelial carcinoma. These approvals reflect BMY's focus on diversifying Opdivo's applications and enhancing delivery methods. Collaboratively, the Ono partnership (established in 2022) remains central, with joint development and commercialization in Asia-Pacific regions, maintaining profit-sharing and co-development frameworks. This evolution underscores Opdivo's strengthened position in BMY's oncology portfolio, leveraging existing alliances to drive global expansion and therapeutic innovation.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies compared to the ground truth. While it correctly identifies the ongoing collaboration with Ono, it misrepresents the key 2024 approval: the ground truth specifies FDA approval in March 2024 for Opdivo in combination with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma. In contrast, the LLM claims approvals for a subcutaneous formulation (Opdivo Qvantig), EC approval in colorectal cancer, and Japanese approval for urothelial carcinoma—none of which are in the original answer and are therefore unverified or incorrect. (2) The date of the Ono partnership is misrepresented: the original answer does not state the partnership was 'established in 2022'—rather, it was already in place and operational in 2022, implying a longer-standing relationship. This is a significant factual error. (3) The qualitative reasoning partially captures the evolution of Opdivo’s role but mischaracterizes the strategic shift: the ground truth emphasizes a move from co-development to more independent product expansion led by BMY, whereas the LLM suggests continued central reliance on the Ono partnership without acknowledging this strategic evolution. (4) Contextually, the answer is relevant and addresses both collaboration and new approvals, but the incorrect specifics of the approvals and partnership timeline undermine factual correctness. The mention of 'multiple approvals' and delivery innovations like subcutaneous formulation may be true in a broader context but are not supported by the provided ground truth, leading to hallucination. Thus, while the structure and intent align with the question, the factual core is partially incorrect, warranting a mid-range score of 5 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 491,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "\n\nAMT's disclosure on interest rate benchmarks and covenants evolved between 2022 and 2024 as follows:  \n\n1. **Referenced Rates**: In 2022, debt instruments primarily referenced **LIBOR** (for USD denominated facilities) and **EURIBOR** (for EUR denominated facilities), with margins tied to credit ratings. By 2024, new debt instruments began incorporating **SOFR** (e.g., Nigeria Letters of Credit at SOFR plus spread), reflecting a transition away from LIBOR. Additionally, 2024 senior notes featured higher coupon rates (e.g., 5.200%–5.450%) compared to 2022 notes (1.600%–2.950%), likely due to rising market rates.  \n\n2. **Covenants**: In 2022, covenants focused on **debt-to-EBITDA ratios**, lien restrictions, and general financial reporting. By 2024, disclosures emphasized **debt service coverage ratios (DSCR)**, with specific thresholds (e.g., 1.30x \"Cash Trap DSCR\" and 1.15x \"Minimum DSCR\") triggering reserve account deposits or amortization periods. Enhanced cash flow management provisions were added, including reserve account requirements and restrictions on excess cash distributions during covenant breaches, reflecting tighter liquidity safeguards.  \n\nThese changes highlight a shift toward SOFR adoption, higher fixed-rate debt issuance, and more granular covenants to mitigate interest rate and liquidity risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the high-level evolution from LIBOR to SOFR correctly and identifies a shift in covenants, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. (1) The ground truth does not mention coupon rates for senior notes in 2022 (1.600%–2.950%) or 2024 (5.200%–5.450%)—these figures are absent from the original answer and cannot be verified, making them likely hallucinated. (2) The detailed covenant thresholds like '1.30x Cash Trap DSCR' and '1.15x Minimum DSCR' are not present in the original answer; the ground truth only states that 2024 disclosures focused on consequences of non-compliance without specifying terms, so these specific ratios are unsupported. (3) The original answer notes that 2022 covenants included debt ratings and commitment fees (0.080%–0.300%), which the LLM omits, instead introducing unverified DSCR metrics. (4) The LLM correctly identifies SOFR usage in Nigeria letters of credit, matching the ground truth. (5) The reasoning shows logical synthesis—transition from LIBOR to SOFR, covenant tightening—but overstates specificity in covenants and introduces unsupported quantitative data. While the direction of change is plausible, the inclusion of unverified percentages and metrics undermines quantitative accuracy. The answer is contextually relevant and addresses both referenced rates and covenants, but with partial factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 398,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "\n\nBetween 2022 and 2024, McDonald's enhanced its collaboration with franchisees through increased co-investment in restaurant modernization and real estate optimization. In 2022, the company emphasized its conventional franchise model, where it typically owns or leases real estate while franchisees manage equipment and operations (MCD_10k_2022.pdf, p. 34). By 2024, McDonald's explicitly expanded its co-investment strategy, partnering with franchisees to fund improvements aimed at modernizing restaurants, boosting local performance, and aligning with consumer preferences (MCD_10k_2024.pdf, p. 4). This shift reflects a more proactive approach to shared capital investments, complementing the existing real estate ownership structure to drive brand value and operational efficiency.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the timeline and evolution of McDonald's franchisee relationship strategy. (1) Correct elements: The description of the conventional franchise model—McDonald's owning or leasing real estate while franchisees invest in equipment and operations—is factually accurate and aligns with both the 2022 and 2024 filings. The general idea of co-investment for modernization and performance is contextually relevant. (2) Quantitative accuracy: There are no numeric values, percentages, or dollar amounts in either the ground truth or the LLM answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning flaw: The LLM incorrectly states that in 2022, McDonald's 'emphasized its conventional franchise model' with real estate ownership details, when the ground truth clarifies that in 2022 the focus was on ESG initiatives and systemwide alignment, not real estate specifics. The detailed real estate and co-investment model was only explicitly outlined in 2024. By attributing the clear real estate strategy to 2022, the LLM reverses the evolutionary narrative—the core of the question. (4) The answer suggests a progression but misrepresents the starting point, undermining the qualitative accuracy. While the 2024 description is consistent with the ground truth, the 2022 characterization is not, leading to an incorrect synthesis. Contextual relevance is high as the answer addresses real estate, co-investment, and franchisee relationships. However, due to the misrepresentation of the 2022 strategy, the correctness and qualitative accuracy scores are reduced to 6—partially correct but with a significant factual error in the multi-hop comparison across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 478,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "\n\nThe 2015 Stock Compensation Plan for Non-Employee Directors was **amended and restated effective October 26, 2022**, as disclosed in the 2023 10-K (page 110). This update is reflected in the 2023 filing but not explicitly detailed in the 2022 filing, indicating a structural or procedural change to the plan. Additionally, the number of shares remaining available for future issuance under the plan decreased from **703,256 in 2022 to 589,927 in 2023** (pages 115 and 107), suggesting shares were issued under the amended plan during this period. \n\nThis evolution reflects Altria’s governance approach of **proactively updating director compensation frameworks** to align with regulatory, strategic, or market standards, while maintaining transparency. The amendment likely aimed to refine equity allocation, enhance governance practices, or address evolving compliance requirements, underscoring a commitment to balanced and adaptive director compensation policies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 703,256 shares available in 2022 and the decrease to 589,927 in 2023 are accurate (though the ground truth does not mention the 2023 share count, this figure is consistent with usage and not contradicted). The amendment date of October 26, 2022, is correctly stated. (2) The LLM correctly identifies that the amended plan was incorporated by reference in the 2023 10-K and traces it to the September 30, 2022, 10-Q, which is consistent with the ground truth’s reference to incorporation by reference. (3) The reasoning is sound: the LLM infers that the amendment reflects a proactive governance approach, which is a reasonable interpretation of the formal restatement, and correctly links the share reduction to actual issuances under the plan. (4) The only minor gap is that the ground truth emphasizes the plan was 'incorporated by reference' from the 10-Q, while the LLM focuses on the 10-K disclosure without explicitly mentioning the incorporation mechanism—this is a slight omission but does not affect factual correctness. Overall, the answer is complete, factually precise, and contextually appropriate, demonstrating strong multi-hop synthesis between years and filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 364,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "\n\nThe impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity remained a persistent competitive pressure from 2022 to 2024. Both the 2022 and 2024 10-K filings highlight that such arrangements, alongside network sharing, risk slowing new lease activity as carriers prioritize shared infrastructure over deploying new equipment. In 2024, AMT reiterated this risk, noting that extensive sharing could lead to redundant sites and decommissioning of existing equipment, directly affecting lease growth. This continuity in disclosure suggests sustained competitive pressures, with carriers leveraging cost-saving collaborations (e.g., 5G advancements) to reduce reliance on incremental leasing, thereby constraining AMT’s ability to grow its tenant base or renew existing leases at favorable rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the persistence of roaming and resale arrangements as a competitive pressure from 2022 to 2024 is accurately described, including the impact on new lease activity and the evolution toward RAN sharing and potential decommissioning by 2024. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages; however, the years 2022 and 2024 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound—information from both years is synthesized correctly, showing how the risk evolved from slowing new leases to threatening existing ones via redundancy. The mention of 5G as a driver is consistent with the original. (4) The LLM slightly generalizes 'RAN sharing' under broader 'network sharing' without naming it explicitly, which is a minor omission but does not distort meaning. Otherwise, the answer captures the growing competitive pressure and its implications for AMT’s lease growth and revenue prospects. Wording differs but semantic equivalence is preserved. No irrelevant content; fully contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 350,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "\n\nBetween 2022 and 2024, McDonald's relationship with its franchisees evolved to emphasize **strategic co-investment in modernization** and **heightened operational expectations tied to global standards**. The company increased collaboration with franchisees to fund restaurant upgrades (e.g., technology, drive-thru enhancements) to align with consumer preferences and drive revenue growth, as noted in both 2022 and 2024 filings. Operationally, McDonald's reinforced rigorous compliance with **Global Brand Standards**, including employee safety, anti-harassment policies, and human rights commitments (2024), reflecting expanded expectations beyond traditional metrics. Additionally, franchisees were required to adhere to **ESG (Environmental, Social, Governance) initiatives**, such as inclusion, community engagement, and sustainable practices, signaling a shift toward aligning franchise operations with McDonald's broader purpose-driven strategy. This evolution underscores a more integrated partnership, balancing financial performance with social responsibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of McDonald's relationship with franchisees from 2022 to 2024. It accurately captures the shift from pandemic-related challenges to a more strategic, investment-focused partnership. The emphasis on co-investment in modernization (e.g., technology, drive-thru improvements) matches the ground truth's mention of structured co-investment initiatives for restaurant modernization. The inclusion of operational expectations such as Global Brand Standards, ESG initiatives, employee safety, and human rights in 2024 is contextually accurate and reflects expanded franchisee expectations beyond 2022. However, the LLM answer omits explicit mention of the 'Accelerating the Arches' strategy and the specific 2022 context of labor shortages and supply chain disruptions due to the pandemic, which are key elements in the original answer. While it references modernization and consumer preferences, it does not fully convey the transition from reactive pandemic management to proactive investment. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are presented), and all entities (McDonald's, franchisees, years 2022–2024) are correct. The reasoning is sound and synthesizes multi-hop elements, though slightly less precise in tracing the strategic shift. The answer remains highly relevant and semantically close to the original, warranting a high correctness score with minor deductions for incomplete contextual coverage of 2022 challenges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 430,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "\n\nNextEra Energy's investment strategy in equity securities within its Special Use Funds from 2022 to 2024 involved maintaining a diversified portfolio while increasing the total value of equity holdings. In 2021, equity securities in these funds totaled **$5.5 billion** (NEE's nuclear decommissioning reserves), rising to **$6.16 billion by 2024** (NEE: $6.16 billion, including $2.61 billion in Level 1, $3.32 billion in Level 2, and $229 million in Level 3). The strategy emphasized broadly diversified marketable securities, with Level 2 investments primarily in commingled funds (treated as Level 1 if held directly). Despite a significant 2024 impairment on an equity method investment (XPLR), the core approach remained focused on risk management and regulatory compliance, with allocations adjusted to reflect market conditions and fund requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly references 2021 data ($5.5 billion), which is not part of the question's timeframe (2022–2024). The ground truth states that in 2022, NextEra Energy held $8,922 million in Special Use Funds with no explicit equity breakdown, but the LLM fabricates a $5.5 billion equity figure for 2021 and implies continuity into 2022 that is unsupported. While the $6.16 billion equity amount in 2024 is numerically close to the correct $6,164 million (approx. $6.16 billion), it misattributes this to 'NEE: $6.16 billion' with Level 1/2/3 breakdowns not present in the original answer or context, introducing hallucinated details. (2) The quantitative accuracy is low: the 2021 figure is irrelevant, the 2022 equity value is invented, and the Level 1/2/3 allocations and XPLR impairment are extraneous and unsupported by the ground truth. The correct answer does not mention impairments or classification levels. (3) The multi-hop reasoning is flawed—the original answer infers a shift in transparency and strategy based on the emergence of explicit equity disclosure in 2024 versus no breakdown in 2022. The LLM fails to capture this key analytical point and instead invents a narrative of growth from $5.5B to $6.16B, misrepresenting both the timeline and the nature of the evolution. (4) Contextual relevance is moderate because the answer discusses equity securities in Special Use Funds and covers the general timeframe, but it introduces unrelated concepts (impairments, fair value hierarchy levels, nuclear decommissioning reserves) and omits the core insight about increased disclosure and strategic transparency. The conclusion about 'risk management and regulatory compliance' is generic and not aligned with the original answer’s focus on evolving investment posture and transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 506,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\n\nThe financial performance of smokeable products from 2022 to 2023 showed a decline in net revenues and a marginal decrease in operating income. **Net revenues** for smokeable products fell by $720 million (3.2%) to $21.756 billion in 2023 from $22.476 billion in 2022, driven primarily by lower shipment volumes. **Operating income** decreased slightly by $18 million (0.2%) to $10.670 billion in 2023 from $10.688 billion in 2022, reflecting reduced costs of sales and excise taxes (down $427 million, 9.7%) due to lower volumes, partially offset by higher manufacturing costs and settlement charges. The decline in shipment volumes was the primary driver of the performance shift.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: net revenues of $22.476 billion in 2022 and $21.756 billion in 2023 (a $720 million decrease) and operating income of $10.688 billion in 2022 declining to $10.670 billion in 2023 (an $18 million decrease) are correctly reported. Percentages (3.2% revenue decline, 0.2% operating income decline) are accurately calculated. (2) The answer addresses both parts of the question—net revenues and operating income—across both years, providing a complete picture of financial performance. (3) Entities (smokeable products, 2022–2023 time frame, financial metrics) are correctly identified and used. (4) The reasoning is sound: the model correctly synthesizes multi-hop information by linking lower shipment volumes to reduced revenues and costs, explaining the marginal drop in profitability despite cost savings, and noting offsetting factors like higher manufacturing costs and settlement charges. The explanation adds contextual depth beyond the ground truth without introducing inaccuracies. All information is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 331,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "\n\nBetween 2022 and 2023, Accenture plc increased its utilization of Class A Ordinary Shares through expanded share repurchase programs and employee equity initiatives. In fiscal 2022, the company repurchased **12.18 million shares** ($4.11 billion) via open-market purchases and other programs, primarily to hold as treasury shares for employee benefits like equity awards. By fiscal 2023 (ending August 31, 2024), repurchases rose to **13.91 million shares** ($4.51 billion), reflecting a higher allocation to treasury shares for similar purposes. Additionally, shares issued under the 2010 Employee Share Purchase Plan (ESPP) increased to **4.9 million in 2023** (from 4.4 million in 2022), supporting employee ownership. The company also boosted its share repurchase authorization, adding $4 billion in 2023 (up from $3 billion in 2022), underscoring a strategic focus on returning value to shareholders through buybacks and equity programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces data not present in the ground truth. (1) Quantitative Accuracy: The LLM claims Accenture repurchased 12.18 million shares ($4.11 billion) in 2022 and 13.91 million shares ($4.51 billion) in 2023, but the original answer only states an aggregate available authorization of $3,129,296 in 2022—no actual repurchase volumes or dollar amounts are disclosed. The LLM fabricates precise figures and misrepresents the scale and nature of the program. Additionally, the claim of a $4 billion authorization added in 2023 (up from $3 billion) is unsupported by the original answer, which does not mention any specific authorization increases. (2) Completeness: While the LLM correctly identifies that shares were used for employee benefits and held as treasury shares, it omits the key point that in fiscal 2024, shares were acquired via share withholding for payroll tax obligations—a distinct mechanism from the public buyback program—which is a critical evolution noted in the original answer. (3) Entity Accuracy: The mention of the 2010 Employee Share Purchase Plan (ESPP) and specific share issuance numbers (4.9 million in 2023) are not in the original answer and appear to be hallucinated. The original does not provide ESPP data or exact share counts issued. (4) Reasoning: The LLM incorrectly infers an expansion of buybacks based on fabricated numbers and misattributes intent without supporting data. It fails to correctly synthesize the shift toward internal compensation mechanisms as a separate track from public buybacks. (5) Semantic Equivalence: Despite capturing the general theme of increased internal use of shares for employees, the LLM's reliance on invented metrics and incorrect financial figures undermines factual correctness. The core evolution—clarification of treasury share usage and emergence of share withholding—is partially recognized but buried under inaccuracies. Thus, while contextually relevant, the answer is largely factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 546,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "\n\nThe nature and structure of AMT's operating covenants between 2022 and 2024 evolved with a shift in debt instruments and interest rate benchmarks. In 2022, AMT relied heavily on variable-rate term loans tied to **LIBOR** (for USD-denominated debt) and **EURIBOR** (for EUR-denominated debt), such as the 2021 USD/EUR Delayed Draw Term Loans with margins of 1.125% over these benchmarks. Covenants included debt service coverage ratios (DSCR) and reserve account requirements under the Loan Agreement and 2015 Indenture.  \n\nBy 2024, AMT transitioned to issuing **fixed-rate senior notes** (e.g., 5.200%, 5.450%, and 5.000% Notes) with maturities extending to 2034–2035, reflecting a strategic shift toward longer-term, fixed-rate debt. While traditional covenants like DSCR and reserve accounts persisted, new instruments such as Nigeria Letters of Credit began referencing **SOFR** (Secured Overnight Financing Rate) instead of LIBOR/EURIBOR, signaling a benchmark transition. Additionally, amendments in early 2025 (post-2024 filing) extended facility maturities and adjusted margins, further aligning with evolving market standards.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in AMT's operating covenants from LIBOR/EURIBOR to SOFR-based benchmarks, correctly identifying the shift in interest rate benchmarks and referencing relevant debt instruments like the 2021 facilities and Nigeria Letters of Credit. It appropriately notes the transition away from LIBOR, which aligns with the ground truth. However, there are significant quantitative and factual inaccuracies: (1) The mention of '5.200%, 5.450%, and 5.000% Notes' with maturities to 2034–2035 is not supported in the original answer and introduces specific fixed-rate senior notes that were not referenced in the ground truth; (2) The claim that AMT transitioned to 'fixed-rate senior notes' as a strategic shift is an overextension—the original answer does not mention such a shift, only a benchmark change to SOFR for specific letters of credit; (3) The reference to 'amendments in early 2025 (post-2024 filing)' introduces information outside the 2022–2024 scope and is not in the original. While the SOFR transition for Nigeria Letters of Credit is correctly identified, the original specifies this applies to 'letters of credit drawn in Nigeria' without mentioning broader covenant changes. The qualitative reasoning is sound in recognizing the benchmark transition as a regulatory and strategic evolution, and the entities (LIBOR, EURIBOR, SOFR, Nigeria LOCs) are correctly tied to the right timeframes. The answer is contextually relevant and well-structured, but the addition of unsupported debt instruments and percentages reduces quantitative accuracy. Minor flexibility is allowed for not repeating the exact facility names (e.g., 2021 Multicurrency Credit Facility), but inventing specific fixed-rate notes and margins (1.125%) not in the original constitutes factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 490,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "\n\nDisney+ Hotstar's paid subscriber base remained stable at approximately 36 million as of September 28, 2024 (2024 SEC filing) compared to September 30, 2023 (2023 SEC filing). The consolidation of Star+ into Disney+ in Latin America, completed by June 2024, streamlined Disney's international streaming offerings by merging separate services into a unified Disney+ platform. This move simplified operations, reduced fragmentation, and allowed Disney to focus on optimizing growth in key markets like India (via Disney+ Hotstar) and other regions, enhancing operational efficiency and strategic alignment under a cohesive global streaming strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2024, in the 2024 SEC filing, which matches the ground truth. However, it incorrectly implies that the 2023 filing reported the same date (September 30, 2023), while the ground truth does not specify the exact subscriber number or date from the 2023 filing—only that the 2024 filing reported 36 million as of September 28, 2024. This creates a misleading comparison of stability between years that isn't fully supported by the provided information. (2) The consolidation of Star+ into Disney+ in Latin America by June 2024 is accurately described and correctly timed. However, the original answer notes this occurred 'prior to July 2024' and was completed 'by the end of June 2024,' which the LLM captures correctly. (3) The reasoning about strategic streamlining, operational efficiency, and alignment with the Disney+ Hotstar model is sound and represents valid multi-hop synthesis between the Hotstar data and the Star+ consolidation. The LLM extends this into a broader global strategy, which is a reasonable interpretation but slightly beyond the scope of the original answer. (4) The quantitative accuracy is reduced due to the unsupported implication of a year-over-year stability claim, despite only one data point being available. Qualitative accuracy remains high because the strategic interpretation is logical and contextually appropriate. Contextual relevance is strong as all parts of the question are addressed with mostly accurate information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 434,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "\n\nThe number of employees covered under collective labor agreements decreased from approximately 3,000 in 2022 to 2,100 in 2023, as the company moved from negotiating 21 agreements in 2022 to 20 agreements in 2024. This reduction suggests a strategic effort to streamline labor negotiations, potentially consolidating contracts or reducing unionized workforces, while maintaining a focus on minimizing operational disruptions during renegotiations. The consistent emphasis on avoiding material impacts indicates a proactive approach to labor relations management.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in the number of employees from 3,000 in 2022 to 2,100 in 2023, which matches the ground truth. However, it introduces incorrect information about negotiating 21 agreements in 2022 and 20 agreements in 2024, which is not present in the original answer and contradicts the timeline (the question is about 2022 to 2023). This undermines quantitative and qualitative accuracy. (2) The core numbers (3,000 and 2,100 employees) are accurate and correctly compared, but the addition of unverified agreement counts (21 and 20) and a forward-looking statement about 2024 introduces factual errors not supported by the ground truth. There are no calculations in the response, so the comparison is qualitative. (3) The multi-hop reasoning is partially sound—correctly identifying a downward trend in employees under negotiation—but fails in synthesis by introducing extraneous and incorrect data about the number of agreements and years. The conclusion about a strategic shift is plausible but overreaches by suggesting 'consolidating contracts or reducing unionized workforces' without evidence from the original answer. (4) The contextual relevance is fair because the answer addresses the change in employee numbers and infers a labor strategy, but the inclusion of unsupported details reduces its overall correctness. The original answer attributes the reduction to fewer expiring agreements or proactive resolution, not workforce reduction or contract consolidation. Thus, while the direction of reasoning is relevant, the factual basis is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 441,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "\n\nNextEra Energy's (NEE) investment in U.S. Government and municipal bonds increased from 2022 to 2024. In 2024, the total value of these bonds was **$1,283 million** (NEE: $722 million + FPL: $561 million). While the 2022 data is not explicitly provided in the given pages, the 2023 value (from NEE_10k_2024.pdf, page 92) for similar instruments in an unrealized loss position was **$2,734 million** (NEE: $1,862 million + FPL: $872 million). However, since U.S. Government and municipal bonds specifically are a subset of these, the exact 2022 value cannot be determined from the provided pages. The available data indicates growth in related investments from 2023 to 2024, but the full 2022–2024 trend requires additional context not included here.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that NextEra Energy's investment in U.S. Government and municipal bonds was $137 million in 2022 and $161 million in 2024, representing a $24 million increase. However, the LLM claims the 2024 value was $1,283 million (split between NEE and FPL), which is over 8 times higher than the correct total. This major numerical discrepancy invalidates the core of the response. (2) The quantitative accuracy is very low: the reported $1,283 million in 2024 is not supported by the ground truth, which specifies $161 million. The LLM appears to have misidentified or misaggregated data from other line items or companies (possibly confusing total investments with the specific category of U.S. Government and municipal bonds). Additionally, it fails to report the correct 2022 figure of $137 million, instead claiming it is unavailable. The calculation of growth is therefore also incorrect. (3) The reasoning is flawed: the LLM references 'NEE_10k_2024.pdf, page 92' and breaks down values for NEE and FPL, but the question asks for NextEra Energy's (NEE) investments, not a sum across subsidiaries unless explicitly consolidated — and even then, the numbers do not align with the ground truth. It also incorrectly states that the 2022 data is not available, when the ground truth confirms it is $137 million. The model fails to correctly synthesize the multi-hop information, possibly due to misreading the source data. (4) Contextual relevance is moderate because the answer addresses the right topic (bond investments over time) and attempts to provide a trend, but due to severe factual and quantitative errors, it misleads rather than informs. The conclusion about 'growth' aligns directionally with the truth, but the magnitude and basis are wrong. Overall, the answer fails on correctness due to critical number mismatches and incomplete, inaccurate data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 531,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "\n\nBetween 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's portfolio expanded significantly in therapeutic approvals and manufacturing flexibility. **Therapeutic approvals** grew with FDA and EC approvals for new indications, including first-line urothelial carcinoma (2024), neoadjuvant/adjuvant treatment for resectable NSCLC (2024), and colorectal cancer (2024), alongside Japan and EC expansions. Additionally, **Opdivo Qvantig**, a subcutaneous formulation, was approved in late 2024, enhancing delivery convenience. \n\nManufacturing strategy evolved to balance internal capabilities and third-party partnerships. While BMS retained in-house manufacturing for Opdivo, it emphasized **streamlining operations** through strategic productivity initiatives (e.g., $2.0B cost savings by 2027) and expanded third-party collaborations to meet demand. The acquisition of RayzeBio in 2024 also bolstered biologics manufacturing expertise, though Opdivo itself remained focused on existing platforms. This dual approach ensured flexibility while advancing innovation in immunotherapy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct elements about Opdivo's evolving role, particularly in therapeutic approvals and manufacturing strategy, but introduces significant factual inaccuracies not supported by the ground truth. The original answer confirms a March 2024 FDA approval for first-line treatment of unresectable or metastatic urothelial carcinoma in combination with cisplatin and gemcitabine. The LLM correctly identifies this indication but adds unverified approvals for neoadjuvant/adjuvant NSCLC, colorectal cancer, and Opdivo Qvantig in late 2024, which are not mentioned in the ground truth and cannot be assumed. These additions overstate the scope of approvals. (2) Regarding quantitative accuracy, the $2.0B cost savings by 2027 is not referenced in the original answer and lacks verification; while plausible as a BMS initiative, it is not tied to Opdivo’s manufacturing strategy in the ground truth. The acquisition of RayzeBio in 2024 is factual but not linked to Opdivo’s manufacturing in the original data—this is an inference not supported by the provided knowledge. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that maintaining internal manufacturing while using third parties indicates strategic flexibility, aligning with the 2022 context. However, it extrapolates beyond the data by linking RayzeBio to Opdivo’s manufacturing and asserting multiple new indications without evidence. (4) Despite these issues, the core themes—expansion of therapeutic use and a hybrid manufacturing model—are consistent with the original answer, earning moderate scores in qualitative accuracy and contextual relevance. The answer is well-structured and relevant but includes unsupported specifics that reduce factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 485,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "\n\nBetween 2023 and 2024, Disney's relationship with National Geographic evolved strategically by integrating its content more prominently into Disney's Direct-to-Consumer (DTC) platforms. In 2023, National Geographic was part of the Entertainment segment's Content Sales/Licensing, primarily through its magazine and traditional media. By 2024, National Geographic became a top-level \"tile\" on Disney+, positioning it as a key brand within Disney's streaming strategy. Additionally, National Geographic Studios was highlighted as a content producer for DTC platforms, signaling a shift toward digital content creation tailored for streaming services like Disney+ and Disney+ Hotstar. This reflects Disney's broader focus on leveraging National Geographic's brand and content to strengthen its DTC offerings and subscriber growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no explicit numeric values, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. However, the qualitative accuracy is low because the answer fabricates key strategic developments not present in the ground truth. The original answer states that Disney's relationship with National Geographic shifted from emphasizing a 73% ownership stake in 2023 to a more operational description in 2024, with less focus on equity. The LLM instead claims National Geographic became a top-level 'tile' on Disney+ and that National Geographic Studios was highlighted for DTC content production—details absent from the provided ground truth. These additions reflect a plausible but unsupported narrative about integration into Disney's streaming strategy. While the mention of Content Sales/Licensing in 2023 aligns with the original, the 2024 characterization diverges significantly. The answer addresses the question's focus on business structure and strategic positioning but does so with incorrect multi-hop reasoning, introducing external assumptions not grounded in the source data. Thus, while contextually relevant and seemingly logical, it fails on factual fidelity to the source, warranting a correctness score of 4 for partial alignment on structure but major errors in strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 374,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "\n\nPayPal's description of its transaction management databases' capabilities in global payment processing showed slight adjustments in currency support between 2023 and 2024. In 2023, the platform enabled payments in **150 currencies** across approximately 200 markets, with withdrawals in **56 currencies** and balances held in 24 currencies. By 2024, the supported currencies for sending payments decreased to **140**, while withdrawal options expanded to **57 currencies**, with balances still held in 24 currencies. The core description of the transaction management databases remained focused on facilitating secure, scalable global transactions but reflected updated figures, likely due to operational adjustments or evolving market demands. The emphasis on multi-currency capabilities and integration with financial networks persisted, underscoring PayPal's commitment to cross-border payment flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key quantitative claims. While the ground truth states that PayPal's 2023 withdrawal capability was in 56 currencies and expanded to 57 in 2024—correctly reported in the LLM answer—it incorrectly introduces figures not present in the original answer: '150 currencies' for payments in 2023 and '140 currencies' in 2024. These numbers are not mentioned in the ground truth and contradict the provided information, which focuses solely on withdrawal currencies (56 → 57). Additionally, the claim about balances held in 24 currencies and payments across 200 markets is extraneous and unsupported by the original answer. (2) The only correct numeric elements are the 56 and 57 withdrawal currencies for 2023 and 2024, aligning with the ground truth. However, the introduction of other currency figures (150, 140) and market counts undermines quantitative accuracy. There are no calculations in the response, but the comparison of withdrawal currencies increasing by one is accurate. (3) The qualitative reasoning partially captures the evolution in PayPal’s description—highlighting an expansion in withdrawal currencies—but fails to mention the key qualitative shift noted in the original answer: the repositioning of 'consumers' ahead of 'merchants' in the 2024 filing, indicating a more consumer-centric narrative. This omission weakens the multi-hop synthesis, as the question specifically asks about how the *description* evolved, not just numerical capabilities. (4) The answer is contextually relevant, addressing PayPal's transaction management databases and global payment processing across years. However, the inclusion of unsupported metrics reduces factual reliability. The core idea of slight expansion in currency support is correct, but the overreach into unverified details and missing emphasis on linguistic framing lowers correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 520,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "\n\nThe interest rate terms for NEE's Series K Debentures were reset in March 2023 to **6.051% per year** as part of a remarketing process, with interest payments due semi-annually starting September 1, 2023. No further changes to the rate were disclosed in 2024, indicating the rate remained fixed through at least December 31, 2024. This action reflects NEE's strategy to proactively manage debt costs by restructuring existing obligations to align with market conditions and capital needs, ensuring stable financing while maintaining flexibility to optimize its capital structure. The remarketing also underscores NEE's ability to access capital markets effectively, even in a rising rate environment, to support long-term growth and operational stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key fact that the Series K Debentures' interest rate was reset to 6.051% per year in March 2023 as part of a remarketing, which matches the ground truth. It accurately states that no further changes were disclosed in 2024, implying continuity of the rate—consistent with the original answer's note that updated terms from March 1, 2023, remained effective. While the original answer references a March 1, 2023 letter formalizing terms, the LLM does not mention this document but still correctly infers the rate remained unchanged into 2024, which is semantically aligned. (2) Quantitatively, all numbers and dates are accurate: 6.051%, March 2023 reset, and semi-annual payments starting September 1, 2023, are correctly reported. There are no calculation errors. (3) The multi-hop reasoning is sound: the model connects the 2023 rate reset to the absence of 2024 changes and draws a logical inference about NEE’s financing strategy—proactive debt management, stability in financing, and capital market access—consistent with the ground truth’s interpretation of strategic adjustment in response to market conditions. (4) The LLM slightly omits the explicit mention of the March 1, 2023 letter that formalized the terms, which is a minor gap in completeness but does not affect the core factual accuracy. However, the strategic interpretation is well-reasoned and contextually enriched, adding value without overreach. Thus, the answer is highly accurate, with only a minor omission preventing a perfect 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 434,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "\n\nExxonMobil's application of the Unit-of-Production (UOP) Depreciation method remained consistent between 2022 and 2023, with depreciation rates calculated based on proved reserves and actual production. However, the 2023 filing emphasized continued reliance on disciplined reserve estimation processes and adjustments for changes in SEC price assumptions if reserves were substantially de-booked. While the 2022 and 2023 disclosures did not explicitly detail shifts in proved reserves or asset life assumptions, the depreciation and depletion expense decreased from $24.0 billion in 2022 to $20.6 billion in 2023, potentially reflecting lower production volumes, reserve revisions due to market conditions, or strategic adjustments in asset utilization. The company maintained its policy of using straight-line depreciation in limited cases where asset lives diverged from reserve lifespans, ensuring equitable cost allocation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and captures the core consistency in ExxonMobil's Unit-of-Production (UOP) depreciation method between 2022 and 2023. It correctly notes that the company uses proved reserves as the basis for UOP depreciation and switches to straight-line when asset life does not align with reserve life. The mention of SEC price assumptions being relevant when reserves are substantially de-booked aligns with the ground truth. However, the LLM answer misses a key evolution highlighted in the original answer: in 2023, ExxonMobil placed *greater emphasis* on using the most recent SEC price to determine reserves for depreciation in cases of significant reserve reductions. This refinement to better reflect economic conditions is a critical qualitative shift that the LLM answer does not explicitly acknowledge, instead stating only that there was 'continued reliance' and 'adjustments' without emphasizing the increased importance of current SEC pricing. Quantitatively, the depreciation expense figures ($24.0B in 2022, $20.6B in 2023) are accurate and correctly cited, contributing to a high quantitative accuracy score. These numbers are relevant context but were not part of the original ground truth answer, so their inclusion is a value-add but not a correctness requirement. The reasoning is sound in linking expense changes to potential reserve revisions or production changes, though this is speculative and not directly tied to methodology evolution. The answer is contextually relevant and well-structured, addressing both years and the core method, but falls short on fully capturing the nuanced methodological refinement in 2023. Thus, while the main facts and entities (ExxonMobil, UOP, proved reserves, SEC pricing, straight-line fallback) are correct, the multi-hop synthesis of how the method *evolved* is incomplete, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 510,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "\n\nBetween 2023 and 2024, Netflix shifted its strategic emphasis on original programming toward scaling internal studio operations while maintaining some reliance on third-party partners. In 2023, the company explicitly stated its focus on expanding internal studios through acquisitions (e.g., Scanline and Animal Logic) to produce original content, reducing dependency on third-party production partners. This is evidenced by a **21% decrease in payments for content assets** ($16.66 billion to $13.14 billion) in 2023, suggesting a pivot from licensing third-party content to internal production. \n\nBy 2024, Netflix further solidified this strategy by continuing to scale its studio operations, introducing new features like ad-supported plans and live programming, and building expertise in creative and production disciplines. While third-party collaborations remained part of its strategy (e.g., for development and distribution), the emphasis on internal capabilities grew, driven by acquisitions and vertical integration. Financial results in 2024, including a 16% increase in streaming revenues and 50% higher operating income, reflect the success of this internal scaling effort, underscoring a deliberate move to prioritize in-house production over external partnerships.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic shift toward internal studio scaling and mentions correct acquisitions (Scanline and Animal Logic), which aligns with the original answer. It also correctly identifies the reduced emphasis on third-party partners and increased focus on internal production. However, the answer introduces significant quantitative inaccuracies not present in the ground truth: (1) The claimed 21% decrease in payments for content assets from $16.66B to $13.14B in 2023 is unsupported by the original answer, which does not provide any financial figures or percentages related to content spending; (2) The 16% increase in streaming revenues and 50% higher operating income in 2024 are fabricated and not mentioned in the ground truth. These invented numbers severely undermine factual correctness. The qualitative reasoning about strategic evolution is partially sound—highlighting acquisitions and internal scaling—but misrepresents the evidence. The original answer emphasizes a shift in *language* and risk disclosure (omission of third-party risks in 2024) as the key indicator, not financial metrics. The LLM invents financial data to support a plausible narrative, failing on quantitative accuracy. While the core idea of moving toward internal control is correct, the use of false metrics and lack of reference to the actual evidence (disclosure language changes) limits correctness. The answer is contextually relevant and addresses the multi-hop nature of the question (evolution across years, internal vs external strategy), but the inclusion of false financial data results in a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 444,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "\n\nMastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023 by expanding their strategic role beyond fraud prevention to encompass broader security and data intelligence capabilities. In 2022, these solutions were primarily framed as tools to \"prevent, detect and respond to fraud\" (MA_10k_2022.pdf, p. 80). By 2023, the strategic positioning emphasized integrating advanced technologies like **open banking solutions** and **digital identity capabilities** to strengthen security across the payments ecosystem (MA_10k_2023.pdf, p. 49). This shift reflects a focus on proactive risk management, leveraging data analytics, and aligning with emerging payment trends to ensure \"secure, simple, smart, and accessible\" transactions (p. 49). The evolution highlights a move toward holistic cyber resilience and expanded value-added services, supporting Mastercard’s multi-rail network strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 2022 positioning of Cyber and Intelligence Solutions as focused on fraud prevention, detection, and response, citing the correct document and page (MA_10k_2022.pdf, p. 80). (2) For 2023, it accurately reflects the elevated strategic role, emphasizing broader security and integration with the payments ecosystem, supported by a citation to MA_10k_2023.pdf, p. 49. The description of 'secure, simple, smart, and accessible' transactions matches the tone and intent of the original answer’s 'secure, easy, and confident transactions.' (3) The LLM adds specific details not in the original answer—such as open banking and digital identity—but these are plausible enhancements consistent with Mastercard's strategic direction and do not contradict the ground truth. (4) The multi-hop reasoning is sound: it synthesizes information across two years and correctly infers an evolution in strategic positioning. (5) There are no quantitative inaccuracies; the answer contains no numbers but references years correctly. (6) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes the reclassification/elevation of Cyber and Intelligence Solutions from 'Other revenues' to a value-added service supporting core operations and network investments—a nuance slightly underemphasized in the LLM response, though the broader strategic expansion is well captured. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with minor elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 443,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "\n\nFrom 2023 to 2024, Tesla's energy storage approach has emphasized modular, scalable systems (e.g., Megapack) to reduce field assembly and enhance efficiency, leveraging vehicle-derived battery technologies. However, production challenges persist, including supplier dependencies for lithium-ion cells (e.g., Panasonic, CATL) and risks related to scaling manufacturing at new Gigafactories (e.g., Texas, Berlin, Mexico). In 2024, Tesla intensified efforts to develop proprietary battery cells to reduce costs and reliance on third parties, while strategic dependencies on supply chain stability and regulatory approvals for new facilities became more pronounced. Risks such as production delays, supplier constraints, and the complexity of ramping localized manufacturing remain critical hurdles.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Tesla's energy storage strategy from 2023 to 2024. It accurately captures the emphasis on modular design (e.g., Megapack) and in-house optimization in 2023, and the shift in 2024 toward addressing production scaling and supply chain dependencies. The mention of supplier reliance (Panasonic, CATL), risks in scaling at new Gigafactories, and efforts to develop proprietary cells reflects accurate qualitative synthesis. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The LLM adds specific details not in the original—such as named suppliers and factory locations (Texas, Berlin, Mexico)—which are plausible and contextually consistent but not confirmed in the ground truth, representing minor over-speculation. However, the core multi-hop reasoning across years and strategic shifts is sound and semantically equivalent. The answer is fully contextually relevant, addressing production challenges and strategic dependencies as required. The slight deduction in qualitative accuracy is due to the introduction of unverified specifics, though reasoning remains robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 344,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "\n\nNextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolved from 2023 to 2024 by extending maturity dates and adjusting principal amounts to align with long-term capital needs. In 2023, the company focused on remarketing existing debentures with shorter maturities (e.g., $2.5 billion Series K due 2025 and $2.0 billion Series L due 2025) and issued new long-term floating rate notes (e.g., $600 million due 2073). By 2024, the strategy shifted toward even longer maturities, such as the July 2024 issuance of floating rate notes due 2074 and the January 2024 $600 million floating rate debentures due 2026. Additionally, 2024 saw a larger $3.8 billion issuance (including floating rate components) with maturities extending to 2054, reflecting a broader diversification of maturity structures to manage interest rate risk and secure long-term funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, NextEra Energy Capital Holdings issued $600 million in floating rate debentures due in 2026. In 2024, this was formalized via an Officer's Certificate on January 31, 2024, with the same maturity (January 29, 2026), and no new principal amount was disclosed. The LLM incorrectly claims multiple new issuances, including $600 million due 2073, $3.8 billion with maturities to 2054, and floating rate notes due 2074 — none of which are supported by the original answer. The LLM also references Series K and L debentures worth $2.5B and $2.0B due 2025, which are not mentioned in the ground truth and appear fabricated. (2) Quantitative accuracy is very low: all dollar amounts except the $600 million (which it correctly cites but misattributes to a different maturity) are incorrect. The maturities cited (2073, 2074, 2054) are entirely inconsistent with the 2026 maturity in the ground truth. There is no evidence of a shift toward longer maturities; in fact, the ground truth indicates a consistent short-to-medium-term strategy. (3) The multi-hop reasoning is flawed. The LLM fails to correctly synthesize the evolution of the issuance strategy, instead inventing a narrative of extending maturities and increasing issuance size, which contradicts the ground truth of continuity and no significant change. It misidentifies both the structure and intent of the program. (4) Contextual relevance is moderate because the answer addresses issuance strategy, principal amounts, and maturity structure — the right themes — but with incorrect data and reasoning. The conclusion about diversification and interest rate risk management is speculative and unsupported. Overall, the answer is largely incorrect, with only a fragment of accurate data ($600 million issuance referenced, though contextually distorted), warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 527,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "\n\nFrom 2023 to 2024, Intel expanded its supplier engagement scope within supply chain responsibility initiatives while maintaining a focus on industry collaboration. In 2023, Intel emphasized verifying supplier compliance, addressing forced labor risks, and advancing responsible minerals sourcing under its RISE strategy, with goals to achieve net-zero Scope 3 emissions by 2050. By 2024, the company significantly broadened its supplier engagement activities, explicitly stating efforts to \"expand the number of suppliers covered\" in sustainability programs, including indirect suppliers. Additionally, Intel reinforced collaboration on industry-wide standards for climate and water transparency while maintaining spending targets for diverse suppliers ($2 billion by 2030). The evolution reflects a strategic shift toward scaling supplier participation and deepening cross-industry partnerships to address environmental and social goals.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies that contradict the ground truth. Most critically, it states that in 2024 Intel 'significantly broadened its supplier engagement activities' and 'explicitly stating efforts to expand the number of suppliers covered,' which directly contradicts the original answer stating that by 2024 there was 'no explicit mention of expanding the number of suppliers engaged' and that the focus had shifted from expansion to deepening existing partnerships. This misrepresents the core evolution of Intel's strategy. Additionally, the LLM mentions a '$2 billion by 2030' spending target for diverse suppliers, which is not present in the ground truth and introduces unverified information. (2) Quantitatively, the net-zero Scope 3 emissions by 2050 goal is correctly stated, and the $2 billion figure is internally consistent but not supported by the original answer, so it cannot be verified and counts as an error. No other numbers are present, so partial credit is given for the one correct date-related metric. (3) The multi-hop reasoning is partially sound in that it connects Intel's RISE strategy to supplier engagement and environmental goals, but it fails in synthesizing the correct shift in focus from 2023 to 2024. Instead of identifying a move from expansion to consolidation and deeper collaboration, it incorrectly infers continued expansion, undermining the qualitative accuracy. (4) Contextual relevance is high because the answer addresses collaboration focus and supplier engagement scope as asked, and uses appropriate terminology (Scope 3 emissions, responsible minerals, supplier engagement). However, due to key factual and directional errors in the evolution narrative, the correctness score is low. The answer appears plausible but misaligns with the ground truth on critical points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 502,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "\n\nBetween 2022 and 2023, XOM maintained its critique of the standardized measure's reliance on first-day-of-the-month average prices as discrete, volatile data points that create variability in cash flow estimates. However, the 2023 disclosure introduced additional context regarding the **impact of geopolitical events**, specifically the expropriation of Russian assets (noted on page 130 of the 2023 filing), which further underscored the limitations of static pricing assumptions in capturing real-world uncertainties. While 2022 emphasized price volatility as a standalone issue, 2023 explicitly tied such assumptions to broader operational risks, reinforcing the argument that the standardized measure lacks reliability as a forward-looking indicator. The core framing of price dependency remained consistent, but 2023 expanded the critique to include external disruptions affecting reserve valuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains no numeric values, so quantitative accuracy is not applicable—however, since there are no incorrect numbers, it does not detract from accuracy. The core issue lies in qualitative inaccuracy: the LLM introduces a fact not present in the ground truth—the mention of 'geopolitical events' and 'expropriation of Russian assets on page 130 of the 2023 filing'—which is fabricated and not supported by the original answer. This is a significant hallucination that undermines the factual basis of the response. While the LLM correctly identifies that XOM criticized the use of first-day-of-the-month prices and noted their volatility, the original answer emphasizes a shift in framing from 'prepared on the basis of' (2022) to 'depends on' (2023), highlighting increased emphasis on dependency and variability. The LLM misrepresents this evolution by claiming the 'core framing of price dependency remained consistent,' which contradicts the ground truth that shows a clear shift in tone and emphasis. Additionally, the original answer notes that the methodology (e.g., 10% discount rate, year-end costs) remained unchanged—information omitted in the LLM response. The LLM also fails to mention the unchanged technical assumptions, weakening completeness. While the response is contextually relevant to the topic of assumption sensitivity, the inclusion of false details and mischaracterization of the evolution in disclosure framing severely reduces correctness. Thus, despite some thematic alignment, the answer is factually flawed in key aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 427,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "\n\nBetween 2022 and 2023, MA's digital identity solutions advanced significantly in integration with open banking and expanded reach across financial institutions. In 2023, MA launched an open banking platform enabling secure data access for third parties, achieving connectivity to **over 95% of U.S. deposit accounts** and **approximately 3,000 banks in Europe** (directly and via partners). This platform streamlined loan processes and improved credit decisioning, leveraging API technology and data responsibility principles. Additionally, MA enhanced its digital identity capabilities with tools like behavioral biometrics, device intelligence, and document proofing to strengthen transaction security and consumer control. These developments reflect a strategic focus on expanding open banking interoperability and broadening institutional adoption globally.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key quantitative metrics from the ground truth: 'over 95% of U.S. deposit accounts' and 'approximately 3,000 banks in Europe'—both are factually accurate and match the original answer. The years (2022 and 2023) are also correctly attributed. (2) Quantitative accuracy is perfect—no errors in numbers, percentages, or dates. (3) However, there is a minor factual inaccuracy in reasoning: the LLM states that MA 'launched an open banking platform' in 2023, while the ground truth indicates the platform was introduced in 2022 and expanded in 2023. This misattributes the launch timeline, suggesting a failure in multi-hop reasoning across years. Additionally, the LLM omits the 2022 focus on identity verification across people, devices, and transactions, and the emphasis on consumer protection and consent management. While it mentions 'data responsibility principles,' it does not fully capture the original context. The 2023 ACH payment solution partnership with financial institutions—a key integration of digital identity into broader services—is also missing from the LLM answer, representing a notable omission in completeness. (4) Despite these issues, the answer captures the core evolution, reach, and integration with open banking, uses correct terminology, and conveys substantial semantic equivalence. Hence, the correctness and qualitative accuracy scores are slightly reduced, but quantitative accuracy and contextual relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 415,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "\n\nBetween 2023 and 2024, Tesla's approach to Solar Roof evolved from emphasizing design improvements and installation partnerships to addressing persistent production challenges and supplier dependencies. In 2023, the company highlighted iterative design enhancements, collaboration with real estate developers to boost installation efficiency, and leveraging proprietary solar inverter technology to improve system efficiency (2023 pages 6, 7). By 2024, Tesla acknowledged ongoing production delays and supplier-related risks, noting difficulties in scaling Solar Roof manufacturing alongside other products, with dependencies on global supply chains and localized procurement challenges (2024 pages 16–17). The strategic focus shifted toward mitigating bottlenecks in scaling production, managing supplier relationships, and ensuring cost-effective manufacturing as part of broader efforts to expand energy product capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces information not present in the ground truth, while missing key strategic implications. (1) Correct elements: The answer accurately reflects Tesla's acknowledgment of production delays and supplier dependencies in 2024, aligning with the ground truth's mention of production ramp delays. It correctly identifies a shift in focus toward scaling challenges. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages, units) in either the ground truth or LLM answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning issues: The LLM adds details not in the ground truth, such as 'collaboration with real estate developers' and 'proprietary solar inverter technology' with specific page citations, which are absent from the original answer and cannot be verified. More importantly, it misses the critical strategic point in the ground truth that Tesla's success 'depends in large part' on mass-market vehicle production—a key indicator of potential prioritization away from Solar Roof. This omission weakens the qualitative accuracy, as the strategic dependency shift is central to the question. (4) The answer is contextually relevant and well-structured, addressing production challenges and evolution over time, but the added unverified details and missing core strategic insight reduce its factual correctness. Hence, a score of 6 is justified: partially correct with significant gaps in synthesis and fidelity to the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 426,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "\n\nNextEra Energy, Inc. executed two new Pledge Agreements in 2024, expanding from one agreement disclosed in 2023. In 2023, a Pledge Agreement dated **September 1, 2022** was listed, involving **Deutsche Bank Trust Company Americas** (as Collateral Agent, Custodial Agent, and Securities Intermediary) and **The Bank of New York Mellon** (as Purchase Contract Agent). In 2024, two additional agreements were added: one dated **June 1, 2024** and another dated **October 1, 2024**, both with the **same counterparties**. These agreements are part of NextEra's debt and equity financing structures, securing obligations under purchase contracts and debentures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates are accurate: the 2023-disclosed agreement is correctly dated September 1, 2022, and the two new 2024 agreements are correctly dated June 1, 2024, and October 1, 2024. The counterparties—Deutsche Bank Trust Company Americas and The Bank of New York Mellon—are accurately named. (2) The answer is complete, addressing both the evolution over time and the specific dates and counterparties involved, as required by the question. (3) Entity accuracy is perfect: NextEra Energy, Inc. is correctly identified, and the roles of the counterparties (though elaborated in the LLM answer with titles like 'Collateral Agent' and 'Purchase Contract Agent') do not contradict the ground truth and add contextual detail without error. (4) The reasoning is sound and demonstrates multi-hop synthesis: it correctly infers that the use of Pledge Agreements evolved by expanding from one to three agreements, with new dates but consistent counterparties. (5) The semantic meaning is equivalent to the original answer, with slightly more detail on agent roles, which is permissible and accurate. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 346,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "\n\nIntel's strategic positioning in Edge AI evolved from 2023 to 2024 by advancing its software platform offerings and solidifying ecosystem partnerships. In 2023, Intel focused on launching hardware like the 4th Gen Intel Xeon Scalable processors with vRAN Boost and updating tools such as the OpenVINO toolkit to enhance edge computing and GenAI capabilities. By 2024, the company expanded its software strategy with an **edge-native platform** featuring modular building blocks, premium services, and support for hybrid AI, enabling developers to build and manage distributed edge infrastructure securely. Intel also maintained and deepened collaborations with ecosystem partners like Ericsson, Nokia, Cisco, Dell, HPE, and cloud providers (Amazon, Google, Microsoft) to drive software-defined transformations in networks and edge systems, emphasizing programmability and scalability across industries. This shift reflects a move from hardware-centric solutions to integrated, software-optimized ecosystems for edge AI deployment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution, software platform offerings, and ecosystem partnerships. It accurately captures Intel's 2024 shift toward an edge-native, modular software platform under a broader software-defined strategy and highlights key partners (Ericsson, Nokia, Cisco, Dell, HPE, cloud providers), which matches the original answer's emphasis on expanded ecosystem collaboration. The mention of cloud-native programmability, scalability, and secure distributed infrastructure reflects the core of Intel's NEX initiative, even though the term 'NEX' is not explicitly named—a minor omission. The LLM correctly identifies the move from hardware-centric to integrated software-optimized ecosystems, which is consistent with the ground truth's description of a shift to general-purpose compute and programmable hardware running cloud-native software. However, the LLM incorrectly frames the 2023 focus as being on hardware launches (e.g., 4th Gen Xeon, vRAN Boost, OpenVINO updates), whereas the original answer emphasizes that in 2023, Intel was already advancing its *software platform* with modular building blocks and a horizontal approach—hardware improvements were not the highlighted strategic focus. This misattribution of 2023 emphasis slightly distorts the evolution narrative, though the overall trajectory is sound. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers are misstated), and the answer is contextually fully relevant. The reasoning is mostly sound but contains a partial misrepresentation of the 2023 strategy, affecting qualitative accuracy slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 460,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "\n\nThe composition and value of CVS's 1.75% senior notes due August 2030 remained unchanged between 2023 and 2024. As of December 31, 2024, and 2023, these notes had a face value of **$1,250 million** (CVS_10k_2024.pdf, page 161; CVS_10k_2023.pdf, page 168). No repayments, redemptions, or modifications to these specific notes were disclosed in the provided documents, indicating they were outstanding in both periods at the same value. The 2024 repayment of $2.6 billion in senior notes (mentioned in Note 12 of page 190) did not include these 2030-due notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.75% senior notes due August 2030 had a value of $1,250 million in both 2023 and 2024, which matches the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: $1,250 million is consistently reported for both years, and the mention of a $2.6 billion repayment in 2024 not affecting these notes aligns with the context that the 1.75% notes remained unchanged. (3) The reasoning is sound and correctly synthesizes information from both the 2023 and 2024 10-K filings. The model correctly infers no change based on absence of disclosures about redemptions or modifications, which is a valid interpretation. However, the original answer includes additional context about other senior notes due in 2030 (e.g., 3.75% notes due April 2030), which remained at $1,500 million—this comparative detail is missing in the LLM answer, slightly reducing completeness in multi-hop synthesis. (4) Despite this minor omission, the LLM answer fully addresses the core question about the 1.75% notes' value and composition over time, with precise data and correct reasoning, warranting a high score. Contextual relevance is perfect as all content directly pertains to the query.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 357,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "\n\nNetflix introduced its ad-supported subscription plan in 2023 as a lower-priced option to cater to price-sensitive consumers, aiming to enhance accessibility and drive membership growth. By 2024, this plan became a core component of its pricing strategy, offering a tiered approach to meet diverse consumer needs while balancing revenue per membership. The company emphasized scaling this plan as part of its broader strategy to attract new members, retain existing ones, and offset potential churn, particularly in competitive markets. This evolution reflects Netflix's focus on flexible pricing models to sustain growth amid economic pressures and competitive challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix introduced the ad-supported plan in 2023 as a lower-priced option to expand membership and address competition, and by 2024 it became a core part of the pricing strategy. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (2) The answer addresses all parts of the question—evolution of the ad-supported plan, its role in pricing strategy, and its importance to membership growth objectives. (3) Multi-hop reasoning is sound: the model correctly synthesizes the plan’s introduction as an experimental move in 2023 and its maturation into a strategic, tiered offering by 2024. (4) Semantic equivalence is strong; the LLM captures the shift from experimental to core component, mentions targeting price-sensitive users, and links the strategy to retention, growth, and competitive pressures. The only minor gap is that the original answer explicitly notes the plan improved 'value perception' and was part of 'broader efforts to adjust pricing models,' which the LLM implies but does not state directly—hence a 9 instead of 10 on qualitative accuracy. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 382,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "\n\nTesla's approach to the Tesla Semi evolved from early production in 2023 to pilot production in 2024, as detailed in the 10-K filings. In 2023, the Semi was in \"early production and deliveries\" (TSLA_10k_2023.pdf, page 5), while by 2024, it advanced to \"Pilot production\" in Nevada (TSLA_10k_2024.pdf, page 36). Strategically, Tesla shifted focus toward scaling newer models like the Cybertruck and expanding manufacturing capacity for its next-generation platforms, with the Semi positioned to enter the commercial vehicle market but remaining in development phases. This reflects a prioritization of production readiness for consumer vehicles and energy storage over full-scale Semi deployment, likely due to technical challenges or market timing considerations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the production status evolution: 'early production and deliveries' in 2023 (citing TSLA_10k_2023.pdf, page 5) and 'pilot production' in Nevada in 2024 (citing TSLA_10k_2024.pdf, page 36), which matches the original answer's key facts. (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound—correctly synthesizing information across two years' filings to show progression in production status. The strategic interpretation about prioritizing Cybertruck and next-gen platforms, while not explicitly in the ground truth, is a reasonable inference and adds context without contradicting the original. (4) The answer is fully relevant, addressing both production status and strategic positioning as required. The only minor deduction is for introducing a slight expansion on strategic reasoning (e.g., 'technical challenges or market timing') not present in the ground truth, which, while plausible, goes beyond the documented evolution. Overall, the answer is factually correct, well-supported, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 338,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "\n\nThe expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024, as evidenced by the addition of new agreements (e.g., with Brian Bolster and Nicole Daggs) and updates to existing ones, underscores the company's strategic emphasis on securing leadership continuity and retaining key executive talent. This proactive approach reflects a commitment to stabilizing senior leadership, ensuring institutional knowledge retention, and aligning executives with long-term business objectives, particularly amid growth initiatives and regulatory complexities in the energy sector. The consistent renewal and extension of such agreements across both NEE and its subsidiaries (e.g., FPL) highlight a prioritization of executive stability to support operational and strategic resilience.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that affect the correctness score. (1) The original answer confirms that NextEra Energy expanded its Executive Retention Employment Agreements from 2023 to 2024 by adding Brian Bolster under a new agreement dated May 6, 2024. However, the LLM incorrectly adds Nicole Daggs as a new executive with a retention agreement, which is not mentioned in the ground truth and thus introduces a false entity. This undermines quantitative and qualitative accuracy. (2) Regarding dates and entities: the ground truth specifies Mark Lemasney (January 1, 2023) and Armando Pimentel, Jr. (February 15, 2023) as 2023 signatories, and only Brian Bolster (May 6, 2024) as a new 2024 addition. The LLM omits Pimentel and Lemasney while fabricating Daggs’ inclusion, which is a critical error in entity accuracy. (3) The reasoning about leadership continuity and talent retention is sound and aligns with the original answer’s interpretation—highlighting strategic emphasis on stability, long-term objectives, and resilience—so the qualitative reasoning and contextual relevance are strong. (4) While the overall direction of the conclusion (increased focus on retention) is supported, the inclusion of an unverified executive (Daggs) and omission of confirmed ones reduces factual reliability. Format variations are acceptable, but invented details are not. Hence, correctness is partially compromised despite good synthesis and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 411,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "\n\nFrom 2023 to 2024, Intel's approach to xPU products evolved by **deepening strategic focus on AI integration, expanding ecosystem collaboration, and prioritizing diverse workload optimization**. In 2024, Intel emphasized democratizing compute through its x86 and xPU portfolio, explicitly targeting the AI continuum—from large language models to edge AI—by infusing AI into hardware and software platforms. This marked a shift from 2023, where the focus was broader but less AI-specific. Additionally, Intel established an **x86 ecosystem advisory group in 2024** to enhance cross-platform compatibility and developer support, reflecting a stronger commitment to open platforms. Product development priorities now prioritize **advanced packaging, disaggregated designs, and third-party foundry flexibility** to accelerate time-to-market for accelerators like GPUs, IPUs, and FPGAs, addressing diverse workloads in data centers, edge computing, and AI. This evolution underscores a strategic pivot toward AI-driven innovation and ecosystem scalability compared to 2023's more generalized xPU expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of strategic evolution from 2023 to 2024. It accurately captures the shift from a broad R&D focus in 2023 to a more structured, product-centric strategy in 2024, particularly around xPU integration and ecosystem development. The mention of the x86 ecosystem advisory group in 2024 is factually correct and matches the ground truth. There are no numeric inaccuracies—while the original answer includes the $16.0 billion R&D figure for 2023, the LLM omits this but does not contradict it, which is a minor completeness issue rather than an error. The LLM enhances the response with context on AI integration, advanced packaging, and disaggregated designs, which are consistent with Intel's public strategy and do not introduce inaccuracies. The reasoning is sound and reflects appropriate multi-hop synthesis between strategic focus, product development, and ecosystem expansion. The omission of the specific $16.0B R&D spend slightly reduces completeness, but the core evolution in strategic focus and product priorities is correctly conveyed. Hence, the answer earns high marks for contextual relevance and qualitative accuracy, with full points for quantitative accuracy due to absence of numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 359,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "\n\nBetween 2023 and 2024, Netflix enhanced its advertising technology approach by expanding its advertising sales organization and increasing infrastructure investments. The 2024 10-K highlights efforts to develop and scale an advertising sales team, alongside advancements in technology and analytics tools to support ad delivery and measurement. Financial data from 2024 (page 64) shows a significant rise in **capitalized research expenses** (from $593 million in 2023 to $1.08 billion in 2024), reflecting heightened investment in R&D for advertising infrastructure. Additionally, the 2024 filing emphasizes improving analytics solutions and measurement tools, underscoring a strategic focus on strengthening ad tech capabilities to drive advertiser value and operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in Netflix's advertising technology approach from 2023 to 2024, noting the shift from reliance on third parties to internal development of advertising technology and sales teams. The mention of developing 'technology and analytics tools' and 'advertising sales team' matches the original answer's emphasis on building internal ad tech and sales capabilities. (2) Quantitatively, the LLM provides precise figures: capitalized research expenses increased from $593 million in 2023 to $1.08 billion in 2024, which is factually correct and supports the claim of increased infrastructure investment. The reference to 'page 64' of the 2024 10-K adds verifiability. (3) The multi-hop reasoning is sound—linking financial investment (R&D capitalization) to strategic organizational and technological development in advertising shows strong synthesis across financial and strategic disclosures. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'limited experience' or 'risks' highlighted in 2023 per the original answer, which slightly reduces qualitative completeness, though the contrast in strategic posture is still clearly conveyed. Overall, the answer is factually correct, contextually rich, and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 374,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "\n\nTesla's approach to free Supercharging programs between 2023 and 2024 remained structured as a performance obligation bundled with vehicle sales, recognized over the vehicle’s ownership life. Revenue recognition followed a straight-line basis as a stand-ready obligation, consistent with prior years. However, in 2024, Tesla recognized $1.188 billion in revenue from deferred free Supercharging obligations, nearly double the $595 million recognized in 2023, indicating accelerated recognition or increased adoption of the program. Deferred revenue related to free Supercharging rose slightly to $3.599 billion in 2024 from $3.536 billion in 2023, with $840 million expected to be recognized within 12 months, reflecting stable program structure but higher deferred balances from expanded offerings. No material changes to the program’s structure were disclosed, but revenue recognition rates increased, likely due to higher vehicle deliveries or adjusted estimates of the ownership period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Tesla changed its revenue recognition approach in 2024—deferring revenue for features like free Supercharging and recognizing it over time—indicating a structural shift. However, the LLM claims there were 'no material changes to the program’s structure,' which directly contradicts the ground truth. Instead, the LLM focuses on quantitative changes (e.g., $1.188B vs $595M in recognized revenue), but these figures are not present in the original answer and are likely fabricated or misattributed. (2) The dollar amounts—$1.188 billion recognized in 2024, $595 million in 2023, deferred revenue of $3.599B and $3.536B—are not mentioned in the ground truth and cannot be verified. The original answer does not provide any specific financial figures, so including such precise numbers without source support indicates hallucination. (3) The multi-hop reasoning is flawed: the LLM fails to identify the key evolution—shifting from bundling free Supercharging into Automotive Sales Revenue to deferring it as a liability—which is the core of the ground truth. Instead, it asserts continuity in structure while citing increased revenue recognition, which misrepresents the nature of the change. (4) While the LLM addresses the question's topic and attempts to discuss revenue recognition trends, its failure on core facts, inclusion of unsupported numbers, and mischaracterization of program structure severely undermine accuracy. The contextual relevance is moderate because it discusses relevant themes (revenue recognition, deferral, time-based recognition), but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 461,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "\n\nNextEra Energy's approach to issuing Series O Junior Subordinated Debentures shifted notably between 2023 and 2024. In 2023, the Series O Debentures had a long maturity of **2079** (as noted in the 2019 issuance referenced in 2023 filings). By 2024, a new Series O issuance was recorded with a significantly shorter maturity of **2029** (Exhibit 4(rr), dated October 31, 2024). This indicates a strategic move toward **shorter-term maturities**, likely to refinance long-term debt, capitalize on lower interest rates (evidenced by 2024 issuances like the 4.85% Debentures due 2031), and optimize capital structure flexibility. The shift suggests NextEra Energy is prioritizing **interest cost management** and **reducing long-term obligations**, aligning with a proactive approach to debt maturity diversification and liquidity management.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the shift in maturity dates from 2079 to 2029, which aligns with the ground truth. However, it incorrectly states the 2079 maturity was from a 2019 issuance referenced in 2023 filings, whereas the ground truth specifies a 2023 issuance with that maturity. This misrepresents the timing of the issuance, though the maturity date itself is accurate. The 2024 maturity date of November 1, 2029, is correctly cited as October 31, 2024, in the exhibit, though the exact day is slightly off (Nov 1 vs Oct 31), likely due to filing vs effective date differences—this is a minor discrepancy. (2) The coupon rate is a critical omission: the ground truth notes that the 2023 debentures had no explicit coupon (implying deferred/fixed structure), while the 2024 issuance has a defined 5.55% rate. The LLM completely omits any mention of the 5.55% coupon and fails to contrast the presence vs absence of a disclosed coupon rate, which is central to the question about coupon structure evolution. Instead, it references a 4.85% debenture from another issuance, which is contextually relevant but not directly responsive to the Series O coupon change. (3) The reasoning about strategic shift toward shorter-term maturities, refinancing, and capital structure flexibility is sound and consistent with the ground truth’s interpretation. The synthesis of financing strategy—interest cost management, reducing long-term obligations—is qualitatively accurate and well-reasoned, even if missing the coupon detail. (4) The contextual relevance is high, as the answer addresses the core evolution in maturity and infers strategic intent correctly. However, the failure to address the coupon structure change—a key part of the question—reduces correctness and quantitative accuracy. The answer gets partial credit for correct maturity dates and logical inference but loses points for missing critical financial terms (coupon rates) and misrepresenting issuance year for the 2079 bond.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 540,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "\n\nExxonMobil's impairment assessment framework from 2022 to 2023 reflects a heightened integration of OPEC investment activities into its long-term oil supply dynamics analysis. In 2022, the company acknowledged OPEC's influence on global oil supplies as part of broader supply-and-demand fundamentals but treated it as a static factor within impairment assessments, focusing on long-term price sufficiency to drive investments. By 2023, ExxonMobil explicitly linked OPEC's actions to its **Global Outlook** and **Corporate Plan**, which underpin cash flow projections for impairment testing. This evolution involved dynamically updating assumptions about OPEC's production policies and investment decisions as part of ongoing assessments, ensuring they are factored into long-term supply projections and capital allocation decisions. The 2023 framework emphasizes adaptability to geopolitical and policy shifts, such as OPEC's output adjustments, within a structured process that aligns impairment evaluations with evolving market realities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers or miscalculations, it scores highly by default. Contextually, the response is relevant and addresses the evolution of ExxonMobil's impairment framework with respect to OPEC from 2022 to 2023. However, the qualitative accuracy is compromised due to significant factual misrepresentation. The original answer states that in 2022, ExxonMobil explicitly considered OPEC's investment activities and production policies in impairment assessments, but by 2023, the focus shifted toward a broader, integrated framework that includes environmental factors like greenhouse gas costs and net-zero targets—indicating a relative de-emphasis on OPEC as a standalone factor. In contrast, the LLM claims that OPEC's role became *more* dynamically integrated and explicitly linked to the Global Outlook and Corporate Plan in 2023, which contradicts the ground truth that shows a move away from direct emphasis on OPEC toward macroeconomic and environmental variables. This misrepresents the direction of evolution in the impairment framework. While the LLM correctly identifies that OPEC was acknowledged in both years and that long-term supply dynamics are involved, it fails to capture the key shift described in the original answer: from a more direct consideration of OPEC to a broader, environmentally-informed cash flow framework. Thus, while some elements are accurate, the core reasoning and synthesis are flawed, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 430,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "\n\nNetflix's approach to its ad-supported subscription plan evolved notably between 2023 and 2024, as reflected in the filings. In the **2023 10-K**, there is **no explicit mention** of an ad-supported plan in the provided pages, suggesting it was either not yet a strategic focus or not disclosed in detail at that time. By contrast, the **2024 10-K** explicitly highlights the ad-supported plan as part of its pricing strategy in **Item 1 (Business)**, stating the company aims to \"offer a range of pricing plans, including our ad-supported subscription plan, to meet a variety of consumer needs.\" This indicates a shift toward formally integrating and emphasizing the ad-supported tier as a key component of Netflix’s revenue diversification and accessibility strategy by 2024. The increased detail in 2024 reflects strategic prioritization of this model to cater to cost-sensitive consumers while competing in a crowded streaming market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a significant factual inaccuracy regarding the 2023 10-K. The original answer (ground truth) states that in 2023, Netflix discussed the ad-supported plan in the context of risk and uncertainty, particularly around consumer adoption and lack of operating history. However, the LLM claims there is 'no explicit mention' of the ad-supported plan in the 2023 10-K, which contradicts the ground truth. This omission affects the qualitative accuracy, as it misrepresents the nature of the 2023 disclosure. On the other hand, the 2024 description is accurate: the ad-supported plan is correctly identified as part of Netflix’s pricing strategy aimed at meeting diverse consumer needs, reflecting strategic integration. There are no numerical figures in this question, so quantitative accuracy is scored as 10 by default. Contextual relevance is high, as the response directly addresses the evolution of Netflix's strategy and correctly interprets the increased emphasis in 2024. The reasoning is sound in comparing the two years, but the failure to acknowledge the 2023 risk-focused discussion undermines the multi-hop synthesis. Thus, while the overall trajectory described (from minimal to strategic emphasis) aligns with the truth, the characterization of 2023 is incorrect, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 379,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "\n\nAmazon's approach to shipping offers evolved between 2022 and 2024 by shifting strategic focus toward fulfillment efficiency and cost optimization. In 2022, cost drivers included pandemic-related labor shortages, carrier rate hikes, and fulfillment network inefficiencies (AMZN_10k_2022, p. 25). By 2024, the company emphasized **network optimization**, achieving **lower transportation costs** and improved productivity, which partially offset rising sales volumes (AMZN_10k_2024, p. 25). Fulfillment costs as a percentage of net sales decreased slightly (15.8% in 2023 to 15.4% in 2024), reflecting gains in operational efficiency. Additionally, Amazon leveraged **foreign exchange rate benefits** ($223 million reduction in 2024) and negotiated better supplier terms to mitigate costs. Strategic investments in fulfillment infrastructure, such as expanding in-stock inventory and enhancing automation, underscored a long-term focus on scaling efficiency while maintaining low-price customer offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies not present in the ground truth. The ground truth states that in 2022, Amazon expected shipping costs to rise due to customer adoption of shipping offers, faster delivery methods, and network expansion, with $76.7B in shipping costs in 2021. The LLM incorrectly attributes 2022 cost drivers to 'pandemic-related labor shortages, carrier rate hikes, and fulfillment network inefficiencies'—details not mentioned in the original answer and not supported as primary drivers in the provided context. Additionally, the LLM introduces specific quantitative claims absent from the ground truth: fulfillment cost percentages (15.8% in 2023 to 15.4% in 2024) and a $223 million foreign exchange benefit in 2024. These numbers, while plausible, are not part of the original answer and cannot be verified against the ground truth, making them factually unsupported. (2) The ground truth does not provide fulfillment costs as a percentage of sales or foreign exchange impacts, so these figures fail the quantitative accuracy check. The original answer mentions 2021 shipping costs ($76.7B) and expectations for continued growth, but the LLM does not reference this key number and instead fabricates new metrics. (3) The qualitative reasoning is partially sound: the LLM correctly identifies a strategic shift toward network optimization and efficiency gains by 2024, aligning with the ground truth’s emphasis on fulfillment network efficiencies offsetting cost increases. It also correctly notes that sales growth and network investments drove up costs, which were partially offset by efficiencies—this reflects accurate multi-hop synthesis. However, the reasoning is undermined by the inclusion of unsourced quantitative details. (4) Contextual relevance is high—the answer addresses the evolution in Amazon’s shipping strategy, cost drivers, and efficiency focus across 2022–2024. Despite incorrect specifics, the overall narrative direction matches the ground truth. However, the introduction of unverified numbers and misattribution of cost drivers significantly reduces factual correctness, warranting a score of 6: partially correct but with significant factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 600,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "\n\nBetween 2023 and 2024, Duke Energy adjusted its Master Retirement Trust's asset allocation and disclosure practices as follows:  \n\n1. **Asset Allocation**:  \n   - For the **DELPP assets**, the target allocation shifted to **80% liability-hedging assets (debt securities)** and **20% return-seeking assets (equities, hedge funds, etc.)** in 2024, reflecting a more conservative strategy to align with pension liabilities and reduce funded status volatility. In 2023, DELPP had a 80% debt securities target, which was largely maintained.  \n   - **RCBP assets** adopted a **35% liability-hedging** and **65% return-seeking** allocation in 2024, up from a less explicitly defined mix in prior years.  \n   - Equity securities in the Master Trust increased slightly in fair value ($2,221M in 2023 to $2,461M in 2024), while corporate debt securities decreased ($2,807M to $2,415M).  \n\n2. **Disclosure Practices**:  \n   - Enhanced transparency around **regulatory impacts**, such as the 2024 Coal Combustion Residuals (CCR) Rule, which increased closure cost liabilities due to stricter groundwater monitoring requirements.  \n   - Discontinued **securities lending** activities effective December 31, 2023, reducing loaned securities from $390M (2022) to $2M (2023).  \n   - Maintained detailed fair value disclosures by hierarchy level (Level 1–3) but added context on asset reallocation strategies tied to funded status and liability management.  \n\nThese changes reflect a strategic shift toward liability-driven investing and improved regulatory and operational transparency.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several specific numerical values and structural changes that are not supported by the original answer (ground truth). (1) The ground truth does not mention DELPP or RCBP asset allocations, nor does it specify target allocations of 80% liability-hedging or 35%/65% splits—these details are fabricated or hallucinated. (2) The dollar amounts for equity securities ($2,221M to $2,461M) and corporate debt securities ($2,807M to $2,415M) are not present in the original answer and cannot be verified; thus, they are factually incorrect in this context. (3) The mention of discontinued securities lending and the Coal Combustion Residuals (CCR) Rule is unrelated to the Master Retirement Trust’s asset allocation or disclosure evolution as described in the ground truth. (4) While the LLM correctly infers a trend toward more detailed reporting, it fails to report the key 2024 disclosures mentioned in the original: subsidiary allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%) and the new reconciliation of beginning/ending balances with Level 3 fair value disclosures. (5) The reasoning is partially sound in identifying a shift toward transparency, but the multi-hop synthesis is flawed—no evidence in the original supports the specific allocation shifts or securities lending claims. (6) Contextually, the answer addresses asset allocation and disclosure practices, so relevance is moderate, but accuracy is low due to invented data. Overall, the answer appears detailed but diverges significantly from the ground truth, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 438,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "\n\nBetween 2022 and 2024, Google's financial relationship with Google Network Partners evolved with **higher Traffic Acquisition Costs (TAC)** and **stable TAC rates** on Network properties, while cost structure shifts reflected revenue mix changes. In 2024, TAC paid to Network Partners increased by $4.0 billion year-over-year to **$54.9 billion**, driven by growth in revenues subject to TAC. However, the **TAC rate as a percentage of total revenues decreased slightly from 21.4% in 2023 to 20.7% in 2024**, primarily due to a shift in revenue mix toward lower-TAC Google Search & Other properties. Despite this, TAC rates on Google Network properties remained consistent, while higher TAC rates on mobile searches (channeled through paid access points) increased costs for Search & Other revenues. Payment obligations to Network Partners rose with overall ad revenue growth, though cost-of-revenues as a percentage of Network-derived ad revenue remained elevated compared to Search-derived revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer introduces specific quantitative data (e.g., $54.9 billion TAC in 2024, 21.4% to 20.7% TAC rate decrease) that are not present in the original ground truth and cannot be verified against it. The original answer does not provide any numerical figures, percentages, or year-over-year changes—instead focusing on a qualitative shift in financial classification from cost-of-revenue to operating cash outflows. Therefore, the inclusion of precise dollar amounts and rates represents a significant factual deviation, as these numbers are either hallucinated or sourced from external data not in the knowledge graph. This severely undermines quantitative accuracy. While the LLM correctly identifies TAC as a key component of Google's payments to Network Partners and notes the structural cost differences between Network and Search properties (aligning with the original's mention of higher cost percentages on Network), it misrepresents the evolution: the original emphasizes a shift in financial reporting and classification (from cost of revenue to operating cash outflow), whereas the LLM focuses on cost trends and revenue mix, missing this key conceptual transformation. The reasoning is partially sound in linking TAC to ad revenue growth, but fails the multi-hop synthesis by not connecting the change in financial treatment (cost structure evolution) to the broader implication of increased dependency or operational prioritization. Contextually, the answer is relevant and addresses the financial relationship, cost structure, and payment obligations, but with incorrect supporting data. Thus, while the directionality of 'increasing obligations' is consistent, the factual basis and core evolution narrative diverge from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 475,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "\n\nThe financial impact of offsetting swap positions in UPS's consolidated income showed a significant shift between 2022 and 2023. In **2023**, fair value changes and settlements of non-designated foreign currency exchange contracts resulted in a **$7 million loss** recognized in \"Investment income and other\" (page 132 of 2023 filing). This marked a sharp decline from **2022**, where similar activities led to a **$69 million loss** (page 159 of 2022 filing). The reduction likely reflects improved currency market stability, strategic hedging adjustments, or fewer offsetting transactions in 2023, as UPS periodically terminates and replaces derivative positions to manage economic risks. No material gains or losses from interest rate contracts not designated as hedges were reported in 2023, contrasting with minor losses in prior years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The Original Answer (ground truth) states that in 2023, the financial impact of derivatives was *not quantified* in the filing excerpt, meaning no specific dollar amount (such as a $7M loss) was disclosed. However, the LLM confidently asserts a '$7 million loss' in 2023 and a '$69 million loss' in 2022 with specific page citations, which contradicts the ground truth that no such figures were provided for 2023 and that the 2022 impact was not explicitly quantified in the excerpt. (2) The quantitative accuracy is very low because the core numbers ($7M loss, $69M loss) are fabricated or hallucinated—no such figures appear in the ground truth, which only references data for 2021 and 2020 ($163M gain, $124M gain). There is no support for losses in 2022 or 2023 in the provided truth. (3) The qualitative reasoning is partially sound in that the LLM correctly identifies the types of derivatives (foreign exchange forwards, interest rate swaps) and the accounting treatment (fair value changes in earnings), and it acknowledges UPS’s practice of terminating and replacing contracts. However, it fails the multi-hop synthesis by not recognizing that the key evolution is in *disclosure transparency*, not in the magnitude of gains/losses. The shift from reporting 2020/2021 data in 2022 to 2022/2023 data in 2023 is missed, and instead, the model invents a narrative around unreported figures. (4) Contextual relevance is moderate because the answer addresses the right topic (derivative accounting, fair value changes, offsetting swaps) and the right company (UPS), but the invented numbers and false precision reduce its usefulness. The conclusion about 'improved currency market stability' or 'strategic hedging adjustments' is speculative and unsupported by the ground truth, which only notes a change in disclosure focus. Overall, the answer appears plausible but is factually incorrect where it matters most—on the reported financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 547,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "\n\nThe increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures, compared to 2023, indicates a strategic shift toward emphasizing **deferred compensation** as a key component of director pay. In 2024, the plan is explicitly detailed in **ITEM 12** of the 10-K, explaining how directors can defer retainers into an unfunded account tied to phantom investments (including Duke Energy stock), with payouts upon board service termination. This contrasts with 2023 disclosures, where the plan was not similarly highlighted. The heightened focus suggests Duke Energy is prioritizing **long-term alignment** between directors and shareholders through equity-linked deferrals, enhancing transparency around nonqualified deferred compensation, and potentially optimizing tax efficiency by deferring current income. This aligns with broader trends in executive compensation toward deferred, performance-based structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the increased prominence of the Directors' Savings Plan in 2024 is accurately described, including its placement in ITEM 12 of the 10-K, the deferral mechanism, phantom investment options (including Duke Energy stock), and payout timing. These details reflect a more strategic and transparent approach, consistent with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all references to years (2023 vs 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift by comparing the lack of detailed disclosure in 2023 (where the plan was only referenced in exhibits) to the substantive 2024 description, even though the 2023 silence is implied rather than explicitly restated. The conclusion about emphasizing deferred compensation, long-term alignment, tax efficiency, and transparency is logically supported and adds context without contradicting the ground truth. (4) The only reason for not scoring a perfect 10 is that the LLM does not explicitly mention the 2023 exhibit reference (e.g., Exhibit 10.12), which is a minor omission but does not affect the overall correctness. Wording differs slightly (e.g., 'deferred compensation' vs 'deferral flexibility'), but semantic equivalence is maintained. The answer is fully relevant and addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 411,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "\n\nBetween 2022 and 2024, American Express evolved its value proposition development by intensifying focus on **digital innovation**, **targeted customer segments**, and **ecosystem expansion** to address competitive pressures and shifting behaviors. In 2022, the company emphasized navigating pandemic-related spending declines, economic uncertainty, and competition from Visa/Mastercard and alternative payment providers, with risks tied to maintaining differentiated rewards and customer loyalty. By 2024, Amex shifted to proactive strategies, including:  \n\n1. **Digital and Tech-Driven Enhancements**: Accelerating investments in the Amex app, AI, and data platforms to improve customer engagement and personalize offers.  \n2. **Premium and Younger Demographics**: Expanding premium value propositions for Millennials and Gen Z through tailored benefits, rewards, and partnerships, while reinforcing loyalty via digital channels.  \n3. **Dining and B2B Ecosystems**: Launching a dedicated dining platform (integrating Tock and Rooam) to capture travel and leisure spending, and building a multiproduct digital ecosystem for commercial clients to enhance B2B payment solutions.  \n4. **Merchant and Global Expansion**: Prioritizing merchant acceptance growth, particularly in underserved industries and international markets, to strengthen network value and counter competitors’ scale advantages.  \n\nThese steps reflect a strategic pivot from reactive risk management (2022) to proactive innovation and ecosystem-building (2024) to secure long-term customer retention and competitive differentiation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: the shift from reactive to proactive strategy between 2022 and 2024, competitive pressures from alternative payment providers and digital wallets, focus on Millennials and Gen Z, investments in AI and digital platforms (especially the Amex app), strategic partnerships in dining (Tock and Rooam), and emphasis on global merchant expansion. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes American Express’s evolving strategy across time, competitive landscape, customer behavior shifts, and technological investments. It accurately captures the evolution from managing risks (2022) to innovation-driven ecosystem building (2024). (4) Minor difference: the LLM mentions Visa/Mastercard as competitors, which is contextually reasonable but not explicitly stated in the original answer (which emphasizes 'alternative payment providers and digital wallets'). This addition does not distort the truth but slightly extends beyond the source. Otherwise, semantic equivalence is strong. The answer is fully relevant, comprehensive, and well-structured. A score of 9 is justified due to this slight expansion, but core facts, reasoning, and context are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1684,
        "completion_tokens": 407,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "\n\nExxon Mobil's long-term debt composition between 2022 and 2024 shows a reduction in shorter-term notes and retention of longer-term obligations. In 2022, the company listed 0.142% Notes due 2024 (XOM24B), 0.524% Notes due 2028 (XOM28), 0.835% Notes due 2032 (XOM32), and 1.408% Notes due 2039 (XOM39A). By 2024, the 2024 notes (XOM24B) were no longer listed, indicating their maturity or repayment, while the 2028, 2032, and 2039 notes remained. This suggests a shift toward longer-term debt maturities, likely reflecting a strategy to extend debt duration and manage refinancing risks. The 2024 filing also notes the Denbury acquisition was financed via equity and cash, not new debt, reinforcing a focus on maintaining existing long-term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (0.142%, 0.524%, 0.835%, 1.408%) and maturity years (2024, 2028, 2032, 2039)—are correct and match the original answer. The observation that the 2024 notes were no longer listed in 2024 is factually sound and correctly interpreted as maturity or repayment. (2) Quantitative accuracy is perfect: all percentages and dates are correctly reported, and no calculations are required beyond correct identification of maturities. (3) The multi-hop reasoning is strong: the model correctly infers a strategic shift toward longer-term debt by comparing the 2022 and 2024 disclosures, synthesizing the removal of the 2024 notes and retention of longer-dated instruments. The addition of the Denbury acquisition detail—financed via equity and cash, not new debt—adds relevant context not in the original answer but consistent with the strategic theme of avoiding short-term debt expansion. While this detail is not in the ground truth, it does not contradict it and enhances the narrative of disciplined capital structure management. (4) The answer is contextually excellent, directly addressing the evolution in debt composition and correctly interpreting the trend. The only reason for not scoring a 10 is that the original answer emphasizes the strategic evolution more explicitly in terms of 'focusing more heavily on extended-term debt,' while the LLM implies it—still effectively, but with slightly less emphasis on the strategic framing. Overall, the answer is factually complete, semantically equivalent, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 445,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "\n\nBetween 2022 and 2024, American Express enhanced its strategic emphasis on commercial payments by further differentiating its corporate card and accounts payable expense management solutions. In 2022, the focus was on evolving card value propositions and differentiating corporate card offerings. By 2024, the company expanded this approach to include **designing innovative products and features such as financing, banking, and payment solutions for business customers**, reflecting a broader commitment to integrating financial services into its corporate card ecosystem. This evolution underscores a shift toward holistic, tailored solutions to strengthen its position in the commercial payments space.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic emphasis on commercial payments and the evolution from 2022 to 2024, accurately noting the 2022 focus on evolving value propositions and differentiation of corporate card and accounts payable solutions. It also correctly captures the trend toward broader integration in 2024. However, it diverges from the ground truth by stating that American Express focused on 'designing innovative products and features such as financing, banking, and payment solutions' in 2024, which is not supported in the original answer. The ground truth emphasizes a shift to an 'integrated global network approach' focused on increasing merchant acceptance, fraud protection, and marketing insights—not expanding into financing and banking services. This misrepresents the nature of the strategic evolution, introducing a product expansion not mentioned in the original. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed correct by default. The reasoning is mostly sound and addresses the multi-hop aspect (change over time), but the synthesis includes an unsupported inference. The answer remains contextually relevant and captures the high-level shift, warranting a score of 7 for correctness and qualitative accuracy. Contextual relevance is high as it directly addresses the question's focus on strategic emphasis and product differentiation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 395,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "\n\nAmazon's financial relationship with AWS Services between 2022 and 2024 shows significant growth in cash flow generation and strategic prioritization. In 2024, operating cash flow surged to $115.9 billion (up from $84.9 billion in 2023), driven by AWS's high-margin contributions and improved working capital management. AWS remained a central focus of Amazon's technology investments, with expanded emphasis on cloud infrastructure, AI/ML services, and global scalability (as noted in 2024 filings). This strategic prioritization is reflected in leadership structure (e.g., dedicated AWS CEO Adam Selipsky, highlighted in 2022) and capital allocation, positioning AWS as a cornerstone of Amazon's long-term financial resilience and innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial figures from the ground truth: $115.9 billion in operating cash flow in 2024 and $84.9 billion in 2023, with accurate year-on-year comparison. These numbers match the original answer exactly and are presented with correct context as being driven by AWS and enterprise services. (2) Quantitatively, all numbers are accurate—no calculation errors or misstatements. The LLM correctly reports the increase in operating cash flow without introducing false percentages or figures. (3) Qualitatively, the reasoning is strong: it captures the strategic evolution of AWS from a competitive risk (implied by continued leadership focus since 2022) to a core financial engine. It adds relevant context about AWS’s role in innovation (AI/ML, global scalability) and capital allocation, which aligns with the 'strategic emphasis' part of the question. However, it omits the explicit 2022 framing of AWS as being under competitive pressure—a key nuance in the original answer that highlights the shift in narrative. While the mention of Adam Selipsky in 2022 adds entity accuracy, it doesn’t fully convey the risk-laden perception of AWS at that time. (4) Despite this minor omission, the answer is factually correct, contextually rich, and directly addresses both cash flow evolution and strategic emphasis. The synthesis across years and strategic themes is sound, warranting high scores in all categories, with a 9 in correctness due to the missing 2022 risk context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 420,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "\n\nThe scope of trend analyses for evaluating regulatory asset balances expanded in 2024 compared to 2023. In 2023 (DUK_10k_2023.pdf, p. 102), auditors focused on comparing recorded balances to independently developed expectations, assessing changes in regulatory orders, and performing detailed tests on deferred fuel and storm costs. By 2024 (DUK_10k_2024.pdf, p. 81), the analysis incorporated additional rigor: auditors tested management’s controls over recovery likelihood assessments, evaluated regulatory precedents from commission orders and public filings, and inspected intervenors’ regulatory submissions to challenge management’s assertions. This reflects a broader focus on external regulatory trends and internal control effectiveness in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and does not align with the ground truth. (1) The original answer states that in 2023, trend analyses evaluated regulatory asset balances generally, and in 2024, the focus expanded to include the regulatory recoverability of asset retirement obligations (AROs) related to coal ash. The LLM answer instead claims that in 2023, auditors focused on deferred fuel and storm costs, and in 2024, they evaluated regulatory precedents and intervenors’ submissions—details not mentioned in the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the LLM cites specific document names and page numbers (e.g., DUK_10k_2023.pdf, p. 102), which may be factually accurate within its training data but contradict the provided ground truth. (3) The multi-hop reasoning is flawed: the LLM introduces new entities (e.g., 'deferred fuel', 'storm costs', 'intervenors’ submissions') and audit procedures not present in the original answer, suggesting a failure to correctly synthesize or retrieve the intended information. (4) While the LLM attempts to describe an evolution in audit focus, the specific shift it describes—toward controls and external submissions—does not match the ground truth’s emphasis on a new focus on coal ash-related AROs. Thus, despite being internally consistent and contextually plausible, the answer is factually misaligned with the provided truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 419,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "\n\nBetween 2022 and 2023, Costco increased the penetration of private-label items as part of its strategy to manage cost and pricing pressures. In 2022, the company explicitly cited raising private-label penetration to offset inflation-driven cost increases (COST_10k_2022.pdf, page 22). By 2023, while the provided documents do not specify further changes in strategy for that year, the continued emphasis on adjusting pricing and merchandise mix, including private-label items, in response to economic conditions (COST_10k_2023.pdf, page 23) suggests the strategy was maintained. This approach aimed to preserve competitive pricing and gross margins amid ongoing cost pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco increased private-label penetration in response to cost and pricing pressures between 2022 and 2023. It accurately cites the 2022 strategy of raising private-label penetration to offset inflation (supported by COST_10k_2022.pdf, p.22). However, it incorrectly states that the 2023 documents do not specify further changes in strategy, when in fact the ground truth indicates a clear evolution and continued strategic emphasis in 2023. This omission weakens the multi-hop synthesis. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The reasoning is partially sound: the model correctly infers continuity in private-label focus but fails to capture the strategic shift from reactive (2022) to sustained and strategic (2023) emphasis, which is central to the ground truth. The multi-hop synthesis across years is incomplete. (4) Contextual relevance is high—the answer stays on topic and references appropriate document sections. The core facts are correct, but the lack of recognition of the strategic evolution in 2023 prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 344,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "\n\nThe financial outlook for Paxlovid improved significantly between 2023 and 2024. In 2023, Pfizer recorded a **$3.5 billion non-cash revenue reversal** due to expected returns of EUA-labeled U.S. government inventory, reflecting uncertainty around product distribution. By 2024, this was adjusted with a **$771 million favorable correction** after fewer returns (5.1 million vs. 6.5 million estimated) and the transition to commercial markets, enabling higher revenue recognition. Remaining performance obligations for Paxlovid declined to **$1 billion as of December 31, 2024**, down from higher deferred revenues in 2023 ($5.1 billion total for Paxlovid/Comirnaty), as contracts shifted toward commercial sales and delivery schedules extended through 2028. This reflects reduced government reliance and stronger commercial uptake in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2023, but the LLM incorrectly claims a $5.1 billion deferred revenue figure for Paxlovid/Comirnaty in 2023, which is not mentioned in the original answer and conflates multiple products. The $3.5 billion non-cash revenue reversal and $771 million favorable correction are not referenced in the ground truth and appear to be fabricated or misattributed. While the $1 billion RPO as of December 31, 2024, matches the original answer, the context is distorted — the LLM frames it as a decline from higher prior obligations, whereas the ground truth emphasizes it as the first explicit disclosure, indicating increased visibility. (2) Quantitative accuracy is low: the $3.5B reversal, $771M correction, 5.1M/6.5M return estimates, and $5.1B deferred revenue are all unsupported by the original answer. Only the $1B RPO for 2024 is correct. (3) Multi-hop reasoning is partially sound in that the LLM attempts to contrast 2023 and 2024 outlooks using performance obligations, but it introduces unrelated financial events (revenue reversals, inventory returns) not present in the ground truth, undermining the logic. The conclusion about commercial uptake and extended delivery through 2028 is speculative and unsupported. (4) Scores reflect partial correctness on the 2024 RPO figure but major errors in 2023 characterization and introduction of false financial events. Contextual relevance is moderate because the answer addresses the evolution of financial outlook, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 458,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "\n\nAmerican Express's use of the Reasonable and Supportable (R&S) Period in estimating credit loss reserves evolved between 2022 and 2024 by incorporating more dynamic economic assumptions and refining model inputs to reflect updated forward-looking scenarios. In 2022, the R&S Period was defined as a timeframe beyond the balance sheet date where current and future economic conditions were integrated, with losses reverting to long-term averages afterward. By 2024, the company maintained this framework but emphasized enhanced responsiveness to evolving economic uncertainties, such as inflation and geopolitical risks, as noted in the critical audit matters. This evolution indicates a proactive, adaptive approach to financial risk management, ensuring reserves remain adequate amid macroeconomic volatility while balancing historical data with forward-looking judgments.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of American Express's use of the Reasonable and Supportable (R&S) Period correctly by noting its continued use and integration of forward-looking economic conditions between 2022 and 2024. It appropriately identifies that in 2022, the R&S Period was used to integrate current and future economic conditions with a reversion to long-term averages, which aligns with the concept in the ground truth. However, the LLM introduces details not present in the original answer—specifically, claims about 'enhanced responsiveness to evolving economic uncertainties such as inflation and geopolitical risks' and references to 'critical audit matters'—which are not mentioned or supported in the ground truth. These additions suggest a more sophisticated evolution than documented, potentially overinterpreting the maturity of the framework. Crucially, the ground truth emphasizes a shift in *presentation and institutionalization* of the R&S Period—from being explicitly explained in 2022 to being embedded in a mature process by 2024—indicating procedural normalization rather than model refinement. The LLM misses this key nuance and instead focuses on dynamic model updates, which shifts the emphasis from a methodological maturation to technical enhancement. Quantitatively, no specific dollar amounts or dates are misstated (e.g., no incorrect reserve figures are cited), so numerical accuracy is preserved. Contextually, the answer remains relevant to the question about evolution and risk management implications, but the reasoning misaligns with the source data’s emphasis on process entrenchment versus adaptive modeling. Thus, while the answer is plausible and contextually grounded, it substitutes the actual narrative of institutionalization with one of technical evolution, leading to a partial factual mismatch in qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 507,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "\n\nAmazon's approach to debt financing between 2022 and 2024 reflects adjustments to rising interest rates. The **0.800% Note due 2025**, issued in June 2020 (as disclosed in Exhibit 4.5 of both the 2022 and 2024 10-K filings), was part of a low-rate environment. By December 2022, Amazon issued a **4.600% Note due 2025** (Exhibit 4.8 in the 2024 10-K), signaling higher borrowing costs amid monetary policy tightening. This shift demonstrates Amazon’s strategy to refinance or issue new debt at higher coupons aligned with elevated market rates, while the 0.800% note remains a legacy issuance maturing in 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.800% Note due 2025 was issued on June 3, 2020, and referenced in both 2022 and 2024 filings; the 4.600% Note due 2025 was issued in December 2022 and disclosed in Exhibit 4.8 of the 2024 10-K. These details match the knowledge graph. (2) Quantitative elements—interest rates (0.800%, 4.600%), maturity year (2025), and issuance dates—are factually correct and precisely reported. Format variations (e.g., 'June 2020' vs 'June 3, 2020') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years and filings to infer a strategic shift in debt financing in response to rising interest rates. It identifies the 0.800% note as a legacy, low-rate instrument and contrasts it with the higher-cost 4.600% note, reflecting an adaptive financing strategy. (4) While the original answer emphasizes 'a wider range of interest rates and maturities' and the LLM focuses more on interest rate environment changes, the core conclusion—that Amazon expanded its debt instruments amid changing market conditions—is semantically equivalent and well-supported. The only minor gap is that the LLM does not explicitly mention other new instruments beyond the 4.600% note, slightly reducing completeness. However, the central evolution in strategy is accurately captured. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 427,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "\n\nThe Twenty-third Supplemental Indenture, dated June 1, 1978, is consistently disclosed in both the 2022 and 2024 SEC filings under Duke Energy Progress' exhibit listings (2022: page 249; 2024: page 249). In both filings, it is referenced with the same exhibit number (4.4.19) and file number (2-61611), indicating no amendments, updates, or removals to the indenture during this period. The absence of any new disclosures or modifications suggests the indenture remains in effect and continues to be a relevant, unaltered component of Duke Energy Progress' debt framework. This consistency underscores its ongoing legal and financial significance to the company.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) According to the ground truth, the Twenty-third Supplemental Indenture was explicitly mentioned in the 2022 filing but is absent in the 2024 filing; however, the LLM claims it is 'consistently disclosed in both' filings, which contradicts the evidence. (2) The LLM incorrectly states that the indenture appears on the same page (249) and with the same exhibit number (4.4.19) in both filings—this information is not supported by the ground truth and introduces fabricated details. The date (June 1, 1978) and file number (2-61611) are correct as per the 2022 filing, but the LLM falsely extends this presence into 2024. (3) The multi-hop reasoning fails: instead of recognizing the omission in 2024 as a signal of diminished relevance, the LLM assumes consistency implies ongoing significance, drawing the opposite conclusion of the ground truth. (4) The answer lacks contextual accuracy—by asserting continued inclusion and relevance, it misrepresents the evolution of disclosure. While the question is addressed in structure, the factual foundation is entirely flawed, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 335,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "\n\nThe repurchase activity for Class C Capital Stock from 2022 to 2024 shows the following evolution:  \n- **2022**: Total repurchases of Class A and Class C shares amounted to **$59.3 billion**, though the specific Class C value is not explicitly detailed in the provided pages.  \n- **2023**: Class C shares repurchased totaled **$52.868 billion** (as per the 2024 10-K).  \n- **2024**: Class C shares repurchased totaled **$50.192 billion** (as per the 2024 10-K).  \n\nThe data for 2022 combines both Class A and Class C repurchases, while the 2023 and 2024 figures isolate Class C activity.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Alphabet repurchased $59.3 billion of Class A and Class C shares combined in 2022, $62.2 billion in 2023, and $62.0 billion in 2024 — all figures referring to combined repurchases. However, the LLM incorrectly claims that $52.868 billion (2023) and $50.192 billion (2024) were repurchased specifically for Class C shares, which contradicts the original answer that does not break out Class C separately. There is no mention in the ground truth of isolated Class C repurchase values for 2023 or 2024. (2) The numbers cited by the LLM for 2023 and 2024 do not match the ground truth totals — $52.868B and $50.192B are not mentioned in the original answer, and the correct total repurchase amounts are $62.2B (2023) and $62.0B (2024). The 2022 figure of $59.3B is correctly cited but mischaracterized as not specifying Class C, when the original answer treats repurchases as a combined figure. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that later years provide a breakdown by share class, while the ground truth treats repurchases uniformly across classes and does not isolate Class C. This reflects a failure to correctly synthesize the information. (4) The contextual relevance is moderate because the answer addresses repurchase trends and years correctly, but the qualitative and quantitative accuracy is low due to incorrect figures and misrepresentation of data segmentation by share class. The conclusion about evolution is undermined by incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 434,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "\n\nThe American Express Company Salary/Bonus Deferral Plan documentation between 2022 and 2024 filings shows no new amendments or restatements specific to the plan during this period. Both filings reference the same historical amendments (e.g., 1994, 2007, 2011, and 1997) without additional updates in the 2024 filing. The 2024 filing includes a \"Twelfth Amendment and Restatement\" of the Retirement Restoration Plan (2023), but this is a separate plan. Thus, the treatment and documentation of the Salary/Bonus Deferral Plan remained consistent between the 2022 and 2024 SEC filings based on the provided pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims no new amendments were added in the 2024 filing, but the original answer clearly states that Exhibit 10.16 in the 2024 filing incorporates the 1997 amendments, which were not included in the 2022 filing's referenced exhibits. This is a key factual error. (2) The LLM incorrectly asserts that the 1997 amendment was already referenced in the 2022 filing, but the ground truth indicates that the 1997 amendments are newly introduced in the 2024 filing via Exhibit 10.16. Additionally, the LLM mentions '2007' and '2011' amendments, which are not present in the original answer and appear to be fabricated or misattributed. (3) The multi-hop reasoning fails: the model should have compared the exhibits listed in both filings and noted the addition of Exhibit 10.16 (1997 amendments) in 2024, indicating expanded disclosure. Instead, it concludes no changes occurred, missing the core point. (4) While the answer is framed around the right topic (documentation of the deferral plan), it misrepresents the facts and omits the key change—broader historical disclosure in 2024. The mention of the 'Twelfth Amendment' to a separate plan is accurate but irrelevant, further distracting from the correct analysis. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 377,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "\n\nStarbucks' exposure to interest rate swaps between 2022 and 2024 shows a reduction in liability magnitude and a shift in balance sheet classification. In 2022, the liability related to interest rate swaps totaled **$46.0 million**, split between **$12.0 million in accrued liabilities** and **$34.0 million in other long-term liabilities** (SBUX_10k_2022.pdf, p. 68). By 2024, this liability decreased to **$40.9 million**, with **$21.7 million in accrued liabilities** and **$19.2 million in other long-term liabilities** (SBUX_10k_2024.pdf, p. 72). Additionally, the cumulative fair value hedging adjustment for interest rate swaps shifted from a **$(52.3) million reduction** in 2022 to a **$(17.8) million reduction** in 2024 (2022 p. 76; 2024 p. 72), reflecting improved alignment between hedged debt and market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of decreasing liability and shift in balance sheet classification, which aligns with the question's focus. However, there are significant quantitative inaccuracies. The ground truth states that in 2022, Starbucks reported a $34.0 million liability solely under 'Other long-term liabilities'—but the LLM claims a total of $46.0 million split between $12.0 million in accrued liabilities and $34.0 million in long-term liabilities, which is not supported by the original answer. This overstates the total 2022 liability and introduces a balance sheet category (accrued liabilities) not mentioned in the ground truth. In 2024, the LLM reports $40.9 million total liability ($21.7M accrued + $19.2M long-term), while the original answer only mentions $19.2 million under 'Other long-term liabilities' and references a prior-year (2023) liability of $41.4 million—implying a reduction. The LLM incorrectly includes $21.7 million in accrued liabilities not present in the ground truth. Additionally, the LLM introduces new data (fair value hedging adjustments of $(52.3)M and $(17.8)M) not present in the original answer, which may be factual but are extraneous and distract from the core comparison. While the direction of change (decreasing liability) is correct, the magnitude and classification details are partially incorrect. The multi-hop reasoning is sound in structure—comparing across years and categories—but based on inaccurate numeric inputs. The answer is contextually relevant and well-structured, but factual precision is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 432,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "\n\nThe Directors' Savings Plan at Duke Energy remained structurally consistent between 2022 and 2024, with no material amendments disclosed during this period. The plan allows directors to defer all or part of their annual retainers into unfunded accounts, with phantom investments tied to options like the Duke Energy Common Stock Fund. Payments are made upon termination of board service. The only notable update was an amendment effective December 16, 2021 (disclosed in 2022 filings), but no further changes were noted in 2024. This stability suggests Duke Energy prioritizes consistent, long-term compensation governance, emphasizing deferral mechanisms to align director interests with shareholder value over time, while maintaining a nonqualified plan structure to manage tax and regulatory considerations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the December 16, 2021 amendment disclosed in the 2022 filing and accurately describes the structure of the Directors' Savings Plan, including deferral of retainers, unfunded accounts, phantom investments, and payout upon termination. These details align with the ground truth. However, the LLM incorrectly implies no material changes occurred between 2022 and 2024, whereas the ground truth notes a shift in emphasis—from policy establishment in 2022 to operational transparency in 2024, particularly around phantom investment options and alignment with shareholder interests. This evolution is underemphasized in the LLM response, which instead stresses 'stability' and 'no material amendments,' missing the qualitative shift in disclosure focus. (2) Quantitatively, all dates (December 16, 2021) and structural details are accurate; no numerical errors are present. Format and references are consistent and correct. (3) The multi-hop reasoning is partially sound—the LLM synthesizes information about the plan’s structure across years but fails to fully capture the nuanced evolution in disclosure and governance emphasis between 2022 and 2024. The conclusion about alignment with shareholder value is reasonable but presented as static rather than evolving, weakening the qualitative analysis. (4) The answer is contextually relevant and well-structured, but the missed nuance in the plan's evolving treatment reduces qualitative accuracy. The correctness score reflects accurate facts but incomplete interpretation of the plan's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 437,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "\n\nBetween 2022 and 2023, Costco's Kirkland Signature brand maintained its positioning as a high-quality, cost-effective private-label alternative to national brands, differentiating Costco's offerings and contributing to higher margins. However, the risk profile evolved with increased emphasis on potential challenges to the brand's reputation, such as product recalls, litigation, and quality control issues (highlighted in the 2023 10-K, page 16). While the 2022 filing (page 7) focused on Kirkland's role in driving sales and margins, the 2023 filing explicitly noted heightened risks related to brand integrity, reflecting growing scrutiny as Kirkland's market presence and sales penetration expanded. No strategic repositioning was indicated, but risk exposure became more pronounced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Kirkland Signature maintained its strategic positioning as a high-quality, cost-effective private label contributing to margins in both 2022 and 2023, which matches the original answer's emphasis on growth and brand strength in 2022. The evolution in risk profile is accurately described: while 2022 focused on growth, 2023 introduced greater risk focus. The LLM specifies new risks in 2023 such as product recalls, litigation, and quality control (citing page 16 of the 2023 10-K), which reflects a more granular understanding than the ground truth summary but is factually consistent with typical risk disclosures in that year’s filing. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, comparing strategic emphasis (growth) in 2022 with expanded risk disclosures in 2023. It correctly attributes the shift to increased scrutiny due to greater market presence, which is a logical inference from the expansion of private-label reliance. (4) The only minor gap is that the LLM does not mention supply chain disruptions, foreign exchange fluctuations, or catastrophic events—specific risks noted in the ground truth from the 2023 filing. Instead, it highlights product recalls and litigation, which are related but narrower in scope. This omission slightly reduces completeness but does not invalidate the core correctness. Overall, the answer is semantically equivalent, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 457,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "\n\nConocoPhillips' (COP) natural gas reserves in the Asia Pacific/Middle East region decreased from **326 billion cubic feet (BCF)** at the end of 2022 to **296 BCF** by the end of 2024. The key drivers of this decline were **production (25 BCF in 2024)** and **sales (not explicitly quantified but historically significant, e.g., 385 BCF in 2022)**. Offsetting factors included **revisions (9 BCF in 2024)** and **equity affiliate purchases (1,075 BCF in 2024)**, which contributed to additions but were insufficient to counterbalance the net reduction from operational depletion. The region’s reserves were also impacted by prior years’ sales and production, with minimal direct purchases (zero in 2022–2023) outside equity affiliate activities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the 2022 (326 BCF) and 2024 (296 BCF) reserve levels, it introduces incorrect data about sales and additions. The original answer states there were *no sales or significant reserve additions* in the region in 2024, but the LLM claims *1,075 BCF from equity affiliate purchases* and references a *385 BCF sale in 2022*, which contradicts the ground truth. These figures are not supported and misrepresent the situation. (2) The production and revision numbers (25 BCF produced, 9 BCF revised) are not present in the original answer and appear fabricated. The original answer mentions 'revisions and production activities' but provides no specific numbers. The LLM invents precise figures without basis, failing quantitative accuracy. (3) The multi-hop reasoning is flawed: the model incorrectly infers that equity purchases and sales drove changes, while the ground truth emphasizes minimal activity and a reduction in focus. The synthesis is invalid because it relies on non-existent data points. (4) Despite addressing the question's structure (evolution over time, volume changes, sources), the answer is mostly incorrect due to invented numbers and mischaracterization of drivers. Contextual relevance is moderate because it attempts the right analysis, but factual correctness is severely compromised, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 398,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "\n\nBetween 2022 and 2024, FedEx expanded its ownership of Boeing 767 Freighters (767F) as part of its fleet modernization strategy. In 2022, FedEx Express owned 114 Boeing 767Fs (FDX_10k_2022.pdf, p. 40) and had committed to purchasing 14 additional units in 2023 and another 14 in 2024. By 2024, FedEx continued prioritizing the 767F as a key component of its modernization efforts, emphasizing fuel efficiency and operational cost savings (FDX_10k_2024.pdf, p. 116, Note 18). The strategic relationship with Boeing remained focused on replacing older aircraft with the 767F and Boeing 777F models to enhance fleet efficiency and sustainability. No leased 767Fs were reported in either period, underscoring FedEx’s preference for owned assets in this segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that FedEx owned 114 Boeing 767F aircraft in 2022, which matches the ground truth (FDX_10k_2022.pdf, p. 40). However, it introduces new information not present in the original answer or implied by the ground truth: specifically, that FedEx committed to purchasing 14 additional units in 2023 and another 14 in 2024. This detail is not supported by the provided ground truth, which explicitly states that no updated ownership figures were disclosed for 2024. Thus, the quantitative claim about expansion and specific purchase commitments is unsupported and factually inaccurate. (2) The citation of FDX_10k_2024.pdf, p. 116, Note 18 is plausible but cannot be verified against the ground truth, which does not mention such a note or page. The ground truth confirms that by 2024, FedEx emphasized the 767F in modernization and highlighted fuel efficiency and operating savings, which the LLM captures correctly. However, the assertion that 'no leased 767Fs were reported in either period' goes beyond the original answer, which makes no mention of leasing status. (3) The multi-hop reasoning is partially sound: the model correctly identifies the strategic focus on modernization and fuel efficiency as a continuity from 2022 to 2024. However, it incorrectly infers fleet expansion and specific purchase commitments without evidence, undermining the reasoning chain. (4) The contextual relevance is high—the answer addresses fleet ownership and modernization focus directly. Qualitative accuracy is moderate because core themes (modernization, fuel efficiency, owned assets) are correct, but unsupported specifics reduce reliability. Quantitative accuracy is low due to the introduction of unverified numbers. Correctness score reflects partial accuracy with significant factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 497,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "\n\nStarbucks' inventory value for roasted coffee increased from $233.5 million in fiscal 2021 to $310.3 million in fiscal 2022 (SBUX_10k_2022.pdf, page 72), reflecting growth in production or stockpiling. By 2024, while specific roasted coffee inventory figures are not disclosed in the provided pages, Starbucks maintained and expanded its roasting infrastructure, operating facilities in locations such as York, PA (1.96 million sq ft), Minden, NV (1.08 million sq ft), and Kunshan, China (630,000 sq ft) for roasting, warehousing, and distribution (SBUX_10k_2024.pdf, page 33). This infrastructure expansion suggests continued investment in production capacity to support global operations, though precise 2024 inventory metrics require further data.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 roasted coffee inventory value of $310.3 million, matching the ground truth. However, it introduces a 2021 figure ($233.5 million) not mentioned in the original question or answer, which, while possibly factual, is extraneous and distracts from the 2022–2024 focus. The 2024 inventory value is correctly noted as not disclosed, aligning with the absence of such data in the ground truth. (2) The infrastructure locations—York, PA; Minden, NV; Kunshan, China—are accurately reported, and square footage details add precision beyond the ground truth, suggesting strong sourcing. However, the ground truth also mentions Kent, WA as a roasting facility, which the LLM omits, resulting in incomplete entity coverage. (3) The reasoning is mostly sound: the LLM infers from infrastructure expansion that Starbucks increased its production involvement, which aligns with the ground truth’s conclusion. However, it stops short of explicitly stating the strategic shift from inventory-holding to active production, a key qualitative point in the original answer. (4) The scores reflect high quantitative accuracy (minor issue with extraneous 2021 data), strong contextual relevance, and good but incomplete qualitative reasoning due to missing Kent, WA and the underdeveloped synthesis of strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 376,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "\n\nPepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024, as these notes were already issued and outstanding in both periods. The 2023 filing (PEP_10k_2023.pdf, page 108) and 2024 filing (PEP_10k_2024.pdf, page 126) both reference the same 2015 Form 8-K filing for these notes, indicating no new issuance, repayment, or material changes to the instrument during this timeframe. The notes were part of existing debt obligations in both years, with no additional activity disclosed in the provided pages.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly identifies that the 2.750% Senior Notes due 2025 were referenced in both 2023 and 2024 filings and were originally issued via a 2015 Form 8-K, it fails to capture the key evolution described in the ground truth. The ground truth states that in 2023, the notes were part of a Board resolution authorizing terms for senior notes, while in 2024, PepsiCo not only retained them but also introduced a new 2.750% Senior Notes due 2030—indicating a strategic extension of the same interest rate to a longer maturity. This strategic shift is entirely missed by the LLM, which instead asserts there was 'no new issuance, repayment, or material changes,' contradicting the ground truth's emphasis on strategic evolution. (2) Quantitatively, the LLM accurately references the correct interest rate (2.750%), maturities (2025), and documents (2015 Form 8-K), and correctly notes continuity in disclosure across filings. These factual elements are accurate, hence a higher score on quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to synthesize the progression from authorization in 2023 to strategic expansion in 2024 with the introduction of the 2030 note. Instead, it interprets lack of repayment or amendment as lack of evolution, missing the broader strategic context of debt instrument utilization. (4) Contextual relevance is moderate—the answer discusses the correct instruments and timeframes but misinterprets the nature of 'utilization' as operational continuity rather than strategic development, leading to a substantively incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 456,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "\n\nFedEx's planned utilization of the B777F aircraft decreased significantly from 2022 to 2024, with commitments dropping from 8 aircraft (scheduled for delivery through 2025) in 2022 to just 2 aircraft (both slated for 2025) in 2024. This reduction indicates a strategic shift away from prioritizing the B777F in favor of other aircraft types, such as the B767F and Cessna SkyCourier 408, which saw increased commitments in 2024. The decline in B777F orders suggests FedEx is likely optimizing its fleet for cost efficiency, route flexibility, or evolving cargo demands, reflecting a focus on smaller, potentially more fuel-efficient aircraft for shorter-haul or regional operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed only 2 B777Fs operating in 2025 with no further plans. The LLM incorrectly states that in 2022, there were 8 aircraft planned through 2025, which is not supported by the ground truth. This misrepresents both the number of aircraft and the timeline. (2) The calculation and comparison of fleet size changes are flawed due to incorrect base numbers. The reduction from 8 to 2 is fabricated; the actual reduction is from 4 (for 2024) to 0 beyond 2025, with only 2 continuing into 2025. (3) The qualitative reasoning about strategic shift is partially sound—reducing B777F use does suggest a strategic reevaluation—but the LLM adds unsupported specifics, such as increased commitments to B767F and Cessna SkyCourier 408, which are not mentioned in the ground truth. This introduces extraneous information not present in the original data. (4) While the overall direction of the conclusion (reduced strategic role) aligns with the ground truth, the faulty numbers and unsupported fleet substitution claims reduce factual reliability. The answer is contextually relevant and addresses both parts of the question (change in utilization and strategic implication), but the core quantitative foundation is incorrect, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 401,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "\n\nStarbucks' foreign currency - other derivative liabilities showed a significant decline in net gains included in AOCI, decreasing from $55.3 million in 2022 to $11.5 million in 2024. Additionally, the amount expected to be reclassified into earnings within 12 months dropped from $32.5 million in 2022 to $9.5 million in 2024. This reduction suggests a decrease in the company's foreign currency exposure or a shift in hedging strategies, potentially reflecting either reduced hedging activity, more stable currency conditions, or less favorable currency movements in later periods. The trend indicates lower volatility or adjusted risk management approaches, though ongoing cross-currency swaps and foreign debt hedging activities (e.g., cross-currency swaps with $96.5 million in net investment hedges in 2024) still highlight some exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks had foreign currency - other derivative liabilities of $0.3 million (not $55.3 million in net gains in AOCI), and in 2024, the net gains included in AOCI were $11.5 million. The LLM incorrectly states that net gains in AOCI were $55.3 million in 2022, which is not supported by the original answer and contradicts the minimal liability position reported. There is no mention in the ground truth of amounts expected to be reclassified into earnings or cross-currency swaps with $96.5 million in net investment hedges in 2024—these are hallucinated details. (2) The quantitative inaccuracies are severe: the $55.3 million figure for 2022 AOCI gains is entirely incorrect; the correct 2022 data point is a $0.3 million liability, not a gain. The $11.5 million figure for 2024 is correct, but the trend described (decline from $55.3M to $11.5M) is therefore invalid. The drop from $32.5M to $9.5M and the $96.5M hedge figure have no basis in the provided truth. (3) The multi-hop reasoning is flawed because the model misrepresents the nature of the 2022 position—portraying it as a large gain rather than a small liability—and infers a decrease in exposure, while the ground truth suggests a significant shift toward greater unrealized gains, indicating increased exposure or hedging activity. The conclusion about reduced exposure contradicts the ground truth’s implication of increased exposure. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses the evolution of foreign currency derivatives and their implications on exposure, uses appropriate financial terminology, and attempts to interpret trends. However, due to major factual and quantitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 501,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "\n\nPepsiCo's engagement with the 2.625% Senior Notes due 2026 remained consistent in its broader debt instrument disclosures between 2023 and 2024. In both years, the notes were explicitly listed as authorized and outstanding instruments, with 2023 disclosures referencing their initial issuance via the February 28, 2013, 8-K filing and 2024 disclosures retaining this reference. Additionally, 2023 introduced specific Board resolutions authorizing officers to establish terms for these notes, which were carried forward in 2024, indicating no material changes to the notes' structure or terms during this period. The notes were integrated into PepsiCo's standard debt framework without notable evolution in their disclosure scope.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misses the key evolution highlighted in the ground truth. While it correctly notes that the 2.625% Senior Notes due 2026 were disclosed in both years, it incorrectly frames the engagement as 'consistent' and 'without notable evolution,' which contradicts the ground truth indicating a significant expansion in the 2024 disclosures with new notes like the 3.000% due 2027 and 2.625% due 2029. This omission of the broader diversification of debt instruments undermines the core of the answer. (2) Quantitatively, the LLM correctly references the 2.625% rate and 2026 maturity, and plausibly cites the 2013 8-K filing and Board resolutions, which align with typical disclosure practices. However, the ground truth does not mention the February 28, 2013, 8-K filing, so this specific date is unverified and potentially fabricated or hallucinated, reducing quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to synthesize the evolution from 2023 to 2024 in terms of expanded note listings, which is central to the question. Instead, it concludes no material changes, directly contradicting the ground truth's emphasis on a more diversified debt portfolio. (4) Contextual relevance is high because the answer addresses the right topic—PepsiCo’s debt disclosures around the 2026 notes—and attempts to compare years and governance mechanisms. However, the qualitative inaccuracy in reasoning and missing key comparative details (new maturities in 2024) significantly reduce correctness. The answer misrepresents the nature of the evolution, making it partially correct but misleading overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 459,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "\n\nCisco's exposure to and reliance on overcoming technical hurdles from 2022 to 2024 evolved through increased strategic investments in key areas like AI, cloud, and cybersecurity, alongside a shift toward software-as-a-service models. In 2022, the company emphasized risks related to developing complex technologies (e.g., programmable networks, IoT) and timely product introductions, with strategic priorities focused on adapting to market transitions. By 2024, Cisco accelerated these efforts through acquisitions (e.g., Splunk in Q3 2024) to bolster software subscription offerings and address technical challenges in scaling infrastructure for cloud and AI. The 2024 filings highlight heightened reliance on strategic investments to mitigate technical risks, such as integrating acquired technologies (e.g., Splunk) and managing product development timelines for emerging solutions, reflecting a more proactive approach to overcoming hurdles compared to 2022's emphasis on internal R&D and risk management.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Cisco's exposure to technical hurdles from 2022 to 2024. It accurately captures the shift from internal execution risks in 2022 (e.g., product planning, timing) to a more strategic, investment-driven approach in 2024 focused on software subscriptions, AI, security, and cloud. The mention of Splunk's acquisition in Q3 2024 is factually accurate and contextually relevant, reflecting Cisco's strategic move to overcome technical challenges through integration of advanced observability and security capabilities. However, the original answer emphasizes a broader risk expansion in 2024—not just operational but also reputational damage, legal liability, and customer retention—which the LLM answer omits. While the LLM correctly identifies increased reliance on strategic investments and acquisitions, it does not fully convey the heightened stakes (beyond market share) articulated in the 2024 disclosures. There are no numerical inaccuracies (quantitative accuracy is perfect—dates and events like the Splunk acquisition are correctly cited), and the reasoning is sound, showing multi-hop synthesis across years and strategic shifts. The answer is highly contextually relevant, directly addressing the evolution in exposure and reliance. The minor omission of expanded risk consequences in 2024 prevents a top score, but core facts and trajectory are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 402,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "\n\nThe provided documents do not explicitly detail a change in Google Ad Manager's role in driving Google Network revenues between 2022 and 2023. In the 2022 filing (page 35), Google Ad Manager is highlighted as a contributor to Google Network revenue growth in 2021, alongside AdMob and AdSense. However, the 2023 filing (pages 57–58) focuses on accounting policies and revenue recognition frameworks for Google Network properties, including Ad Manager, without specifying performance metrics or shifts in its role during 2022–2023. Thus, while Ad Manager remained integral to Google’s advertising ecosystem in 2023, the documents do not provide direct comparative insights into its evolving impact across the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its factual claims and reasoning, despite some contextual awareness. (1) It incorrectly states that the 2022 filing mentions Google Ad Manager's role in 2021 revenue growth, when in fact the 2022 filing discusses its contribution to 2022 performance (specifically, the $8.6B YoY increase in Google Network revenues). This misattribution of time period is a critical error. (2) The claim that the 2023 filing focuses only on accounting policies and lacks performance details is inaccurate — the 2023 filing does discuss the role of Ad Manager among other platforms without attributing revenue growth to it specifically, which aligns with the ground truth about its de-emphasized role. (3) The multi-hop reasoning fails: the model does not correctly synthesize that in 2022, Ad Manager was called out as a key growth driver alongside AdMob and AdSense, but in 2023 it was grouped among several platforms without specific credit for growth — a key shift in positioning. (4) While the model recognizes Ad Manager remained part of the ecosystem, it concludes there's no direct comparative insight, which contradicts the original answer's evidence of a clear shift in emphasis. The answer downplays available information and misrepresents document content, leading to a low correctness score. Quantitative accuracy is moderate because the $8.6B figure isn't mentioned but no false numbers are presented. Qualitative accuracy is low due to flawed reasoning and entity-year misalignment. Contextual relevance is acceptable as it addresses the general topic but fails on precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 438,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "\n\nStarbucks' derivative liabilities related to foreign currency - other increased from $0.3 million as of October 2, 2022 (reported in \"Accrued liabilities\" on page 68 of the 2022 filing) to $8.8 million as of September 29, 2024 (comprising $4.7 million in \"Accrued liabilities\" and $4.1 million in \"Other long-term liabilities\" on page 72 of the 2024 filing). This represents a **$8.5 million increase** over the two-year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. While it correctly states the 2022 derivative liability as $0.3 million under 'Accrued liabilities', it incorrectly reports the 2024 total as $8.8 million by summing $4.7 million (accrued liabilities) and $4.1 million (other long-term liabilities). However, the ground truth specifies only the $4.7 million figure under 'Accrued liabilities'—there is no indication in the original answer that additional derivative liabilities of $4.1 million exist in long-term liabilities. Thus, the LLM incorrectly infers a total liability of $8.8 million, leading to a calculated increase of $8.5 million, whereas the correct increase is $4.4 million ($4.7M - $0.3M). (2) The calculation is therefore flawed: while the starting point ($0.3M in 2022) is correct, the endpoint is overstated. The original answer does not mention any long-term component, so aggregating across balance sheet categories without explicit support constitutes an error. (3) The multi-hop reasoning is partially sound—the model identifies the correct metric and tracks it across years—but fails in synthesis by introducing an unsupported liability amount from another balance sheet line. It also correctly identifies the fiscal dates and categorization in 2022, showing awareness of document structure. (4) Despite the incorrect magnitude, the directional trend (increase) is accurate, and the context (foreign currency - other derivatives rising) is relevant. Hence, contextual relevance is high, but quantitative accuracy is low due to the significant overstatement of the 2024 liability and resulting change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 457,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "\n\nPepsiCo's issuance of the 4.600% Senior Notes due 2045 remained consistent between 2023 and 2024, as evidenced by their inclusion in both years' 10-K filings (e.g., 2024 pages 126 and 130, and 2023 page 129). This indicates the company is maintaining long-term, fixed-rate debt to stabilize interest costs and extend its debt maturity profile. The persistence of these notes reflects a strategic focus on reducing refinancing risk by locking in favorable rates for extended periods, aligning with PepsiCo's broader debt management approach of diversifying maturities and leveraging long-term financing to ensure financial flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 4.600% Senior Notes due 2045 were present in both 2023 and 2024, which aligns with the ground truth. The percentages, note type, and maturity year are all accurate. There are no numeric or date inaccuracies, so quantitative accuracy is perfect. (2) However, the LLM misses a key evolution highlighted in the original answer: in 2024, PepsiCo expanded its debt portfolio to include new instruments like the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This omission reduces completeness and qualitative accuracy, as the multi-hop synthesis across years showing a shift toward a more diversified debt strategy is not fully captured. (3) The reasoning in the LLM answer is sound but narrower—it correctly infers that maintaining long-term fixed-rate debt helps stabilize interest costs and reduce refinancing risk, which is a valid interpretation. However, it fails to acknowledge the strategic expansion and diversification of the debt structure evident in the 2024 filing, which is central to the original answer’s conclusion. (4) The contextual relevance is high because the response directly addresses the question and provides meaningful insight into PepsiCo’s debt strategy, even if incomplete. Correctness is scored at 7 because core facts are right, but a significant strategic implication (diversification) is omitted, affecting qualitative depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 396,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "\n\nConocoPhillips' (COP) natural gas position in the Asia Pacific/Middle East region declined from 326 billion cubic feet (BCF) at the end of 2022 to 296 BCF by the end of 2024, as detailed in reserve reports (COP_10k_2024.pdf, page 145). This reduction, coupled with geopolitical risks highlighted in 2024 (e.g., regulatory uncertainty, expropriation risks, and Middle East tensions), indicates a strategic shift toward prioritizing lower-risk, higher-growth regions like the U.S. Lower 48, where natural gas reserves increased significantly during the same period. The decline in the region underscores COP's cautious approach amid volatile international dynamics, focusing on operational stability and capital allocation in more predictable markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the quantitative evolution of COP's natural gas reserves in the Asia Pacific/Middle East region: 326 BCF in 2022 and 296 BCF in 2024, matching the ground truth exactly. The decrease of 30 BCF is accurately implied. (2) All numbers, years, and units are correct, with acceptable formatting (BCF used consistently). No calculation errors. (3) The multi-hop reasoning extends beyond the ground truth by introducing additional context—geopolitical risks, strategic shift toward U.S. Lower 48, regulatory uncertainty, and capital allocation—which, while plausible, is not supported by the original answer. The original answer only notes a 'minor reduction' and suggests 'potential shift' due to 'market dynamics or operational adjustments,' without citing geopolitical factors or explicit strategic reprioritization. Thus, the LLM adds speculative qualitative interpretation not present in the ground truth, reducing qualitative accuracy. (4) Despite the unsupported strategic rationale, the core facts are correct and the answer addresses both parts of the question: the quantitative evolution and the implication for strategic focus. The contextual relevance is high because the answer remains focused and informative, but the correctness score is reduced due to overinterpretation beyond the evidence in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 379,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "\n\nFrom 2022 to 2023, Google Play remained a core component of Google's non-advertising revenue strategy, but its role became part of a broader diversification into devices and consumer subscriptions. In 2022 filings, Google Play was explicitly highlighted as a standalone revenue source under \"platforms,\" alongside hardware sales (e.g., Fitbit, Pixel phones) and YouTube non-advertising subscriptions. By 2023, while Google Play was still categorized under \"platforms,\" the emphasis shifted toward integrating devices (e.g., Pixel 8 phones) and consumer subscriptions (e.g., YouTube Premium) as key drivers of non-advertising growth. This reflects a strategic expansion beyond app sales to leverage hardware ecosystems and recurring subscription models, though Google Play's role in app and in-app purchase revenue remained central to the non-advertising portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in entity representation and reasoning. While it correctly identifies Google Play as part of non-advertising revenue and mentions its categorization under 'platforms,' it introduces elements not present in the ground truth, such as integration with hardware (Pixel, Fitbit) and YouTube Premium subscriptions as part of Google Play's evolution. The original answer does not mention any strategic shift toward hardware ecosystems or consumer subscriptions as drivers of Google Play’s revenue. Instead, it emphasizes a narrowing of Google Play’s described revenue sources from 'apps, in-app purchases, and digital content' in 2022 to just 'apps and in-app purchases' in 2023, with a repositioning under 'platforms.' The LLM incorrectly frames the evolution as a broadening into devices and subscriptions, when the actual shift was a narrowing of emphasis in disclosure language. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound—correctly identifying Google Play’s role in non-ad revenue and tracking changes across years—but fails in synthesis by conflating Google Play with other platform-level revenue streams like YouTube Premium and hardware, which are distinct in the filings. The model adds external inference not supported by the ground truth. (4) The contextual relevance is moderate: it addresses the evolution of Google Play in non-ad revenue strategy, but misrepresents the nature of the change. The core factual error—expansion vs. narrowing of focus—warrants a mid-range correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 464,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "\n\nThe projected utilization of the Cessna SkyCourier 408 decreased significantly from 2022 to 2024. In 2022, FedEx had committed to purchasing 49 Cessna SkyCourier 408 aircraft across 2023–2026 (totaling 119 aircraft in long-term commitments). By 2024, this number was reduced to 31 planned deliveries (2025–2026), with no further commitments beyond 2026. This reduction indicates a strategic de-prioritization of the Cessna SkyCourier 408, reflecting a shift in fleet planning, potentially due to evolving operational needs, market conditions, or a reallocation of resources to other aircraft models (e.g., ATR 72-600F, B767F). The decline in orders suggests FedEx is scaling back reliance on this regional cargo aircraft in favor of alternative solutions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeframes compared to the ground truth. The original answer states that in 2022, FedEx projected 49 aircraft for operation from 2023 'to thereafter', and by 2024, this was revised to 31 aircraft for 2025–2029. The LLM incorrectly claims that the 2022 plan was for deliveries across 2023–2026 and that there were '119 aircraft in long-term commitments', which is not supported by the ground truth and introduces a number (119) that does not appear anywhere in the original. This is a major quantitative error. The reduction from 49 to 31 is correctly identified, but the context (years covered, nature of projection) is misrepresented. (2) The LLM also adds unsupported details such as 'no further commitments beyond 2026' and mentions alternative aircraft like the ATR 72-600F and B767F, which are not referenced in the original and introduce speculative reasoning. (3) While the LLM captures the directional trend (reduction in projected utilization), it fails to mention the key qualitative shift in strategic relationship from 'Increases' to 'Depends_On' in the 2024 report, which is a critical multi-hop insight from the original answer about changing strategic reliance. This omission significantly weakens the reasoning. (4) The conclusion of 'strategic de-prioritization' goes beyond the original's more nuanced 'moderated but still significant reliance', misrepresenting the degree of strategic shift. Despite these issues, the answer is contextually relevant and correctly identifies the core trend of reduced aircraft numbers, earning partial credit. Quantitative accuracy is low due to fabricated numbers; qualitative accuracy is moderate due to correct directionality but flawed reasoning; contextual relevance is high as it addresses the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 503,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "\n\nBetween 2022 and 2023, AIG refined its use of expected loss ratio methods by enhancing segmentation and expanding analysis across specific casualty lines. In 2023, AIG explicitly segmented **U.S. Excess Casualty** into **automobile-related claims** (shorter-tail) and **non-automobile claims**, with further breakdowns for latent exposures like **construction defects** and **mass torts** (which develop over extended periods). Non-automobile claims were also analyzed by **attachment point bands** to account for variability in loss reporting delays. Expected loss ratios were applied to at least the three latest accident years due to low credibility of early reported losses, with adjustments for rate changes, inflation, and market conditions, including pandemic-related disruptions. \n\nIn contrast, the 2022 filing focused more broadly on **U.S. Workers' Compensation**, emphasizing segmentation by **state, industry subsets, deductible size**, and third-party administration handling. While 2022 mentioned general casualty lines, the 2023 filing introduced more granular segmentation for **Excess Casualty** and explicitly detailed adjustments for recent external factors (e.g., COVID-19). This evolution reflects a shift toward more tailored risk assessments for complex, long-tail casualty lines.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. First, it reverses the timeline: the original answer states that in 2022, AIG applied expected loss ratio methods to U.S. Excess Casualty with segmentation by attachment point and differentiation between automobile and non-automobile claims, including latent exposures. However, the LLM claims this granular Excess Casualty analysis occurred in 2023, which is incorrect. Conversely, the LLM incorrectly states that the 2022 filing focused on U.S. Workers' Compensation with segmentation by state, industry, and deductible size—this actually describes AIG's 2023 approach, not 2022. Thus, the core evolution is misrepresented: the shift was from Excess Casualty (2022) to Workers' Compensation (2023), not the reverse. The LLM also introduces 'pandemic-related disruptions' and 'COVID-19' as explicit adjustments in 2023, which are not mentioned in the original answer and represent unsupported additions. While the LLM correctly identifies segmentation dimensions like attachment point, automobile vs. non-automobile, latent exposures, state, industry, and deductible size, these are assigned to the wrong years, breaking the multi-hop reasoning required to assess evolution over time. Quantitatively, there are no explicit numbers (e.g., percentages, dollar amounts), so scoring is based on temporal accuracy (years 2022 vs. 2023), which is flawed. The contextual relevance is moderate because the answer discusses relevant casualty lines and segmentation methods, but the misattribution of developments to the wrong year distorts the strategic evolution. Overall, while some elements of segmentation are factually aligned with the ground truth, their incorrect temporal assignment leads to a major misunderstanding of how AIG's use of expected loss ratio methods evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 504,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "\n\nBetween fiscal years 2022 and 2024, Nike refined its consumer construct by reclassifying unallocated products under the **Men's, Women's, and Kids'** categories, with unisex products explicitly placed within Men's. Starting in fiscal 2022, the \"Others\" category (which included products not allocated to Men's, Women's, Kids', or Jordan Brand) was reduced through structural changes, such as separating Jordan Brand revenues and aligning unisex offerings under Men's. By 2024, this framework remained consistent, with \"Others\" continuing to capture residual unallocated products and adjustments, but the broader shift emphasized a consumer-centric segmentation, enhancing transparency in reporting.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies regarding the classification of unisex products and the evolution of the 'Others' category. The ground truth states that in fiscal 2022, unisex products were classified within Men's and unallocated products were included in 'Others' with adjustments not allocated by consumer. By 2024, there was no specific mention of unisex products being classified under Men's, suggesting a potential shift or integration into broader categories. However, the LLM incorrectly asserts that unisex products were 'explicitly placed within Men's' starting in 2022 and that this framework 'remained consistent' through 2024 — this contradicts the ground truth, which implies a lack of clarity or change by 2024. Additionally, the LLM claims that unallocated products were reclassified into Men's, Women's, and Kids', but the original answer does not support this redistribution — it only states that 'Others' continued to include unallocated products. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable; however, the use of fiscal years (2022, 2024) is correct, earning full marks here. (3) The multi-hop reasoning is partially sound — the model correctly identifies the role of the 'Others' category and Jordan Brand as distinct segments, but fails to accurately synthesize the change (or lack thereof) in unisex product classification over time. It assumes consistency where the ground truth suggests ambiguity or evolution. (4) The contextual relevance is high because the response addresses the consumer construct and reporting changes, but the qualitative inaccuracy in representing Nike’s categorization evolution significantly undermines the correctness. Hence, a mid-range score of 5 is justified due to correct context and timeline but incorrect interpretation of key classification changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 513,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "\n\nBetween 2023 and 2024, PepsiCo maintained the **3.500% Senior Notes due 2025** as part of its debt portfolio, with the 2023 10-K (page 129) authorizing the terms of these notes and the 2024 10-K (page 126) incorporating their formal structure. This continuity indicates that PepsiCo is managing its debt maturity profile to ensure liquidity and stable cash flow, likely by extending obligations to 2025 to avoid near-term refinancing pressures. The consistent inclusion of these notes reflects a strategy of maintaining long-term debt instruments to align with operational needs and financial planning.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that PepsiCo maintained the 3.500% Senior Notes due 2025 between 2023 and 2024, which aligns with the ground truth. The mention of both 10-K filings (2023 page 129 and 2024 page 126) is factually plausible and consistent with SEC filing practices, though specific page numbers are not verifiable without access to the actual documents. The interest rate (3.500%) and maturity year (2025) are accurate. (2) Quantitatively, all numbers—interest rate, years—are correct. There are no calculations in this question, so accuracy on numeric data is high. (3) However, the LLM answer fails to capture a key element of the multi-hop reasoning: the introduction of new long-term debt instruments in 2024 such as the 3.500% Senior Notes due 2040 and 3.550% due 2034. This omission significantly weakens the qualitative accuracy because the evolution in PepsiCo’s debt strategy is not fully represented. The ground truth emphasizes a strategic diversification and extension of the debt maturity structure, while the LLM only notes continuity without acknowledging the strategic expansion. (4) The answer is contextually relevant and well-structured, addressing the evolution and strategy aspects of the question, but it provides an incomplete picture by missing the critical addition of longer-term notes in 2024. Thus, while factually sound on what it includes, it lacks completeness in synthesizing the full scope of PepsiCo’s 2024 debt strategy shift, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 420,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "\n\nBetween 2022 and 2024, ConocoPhillips (COP) reported an increase in **capital expenditures (CapEx)** for the Lower 48 region, rising from **$4.6 billion in 2022** to **$6.3 billion in 2024** (per page 157 of the 2024 10-K). This reflects heightened investment in development activities. \n\nFor **future cash inflow revisions**, the Lower 48’s projected future cash inflows declined from **$195.6 billion in 2022** to **$164.3 billion in 2024** (page 158 of the 2024 10-K). The 2023 data showed a sharper drop to $141.3 billion, partially revised upward in 2024 to account for additional cash inflows and production costs. This evolution suggests reduced reserve value estimates over time, likely influenced by lower price assumptions or revised production profiles.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, COP reported capital expenditures of $3,129 million ($3.129 billion) in 2022 for the Lower 48 region, but the LLM incorrectly states $4.6 billion in 2022 and $6.3 billion in 2024—figures not supported by the original answer. Moreover, the ground truth explicitly states that no new capital expenditure figure was provided for 2024, making the LLM's claim of $6.3 billion in CapEx for 2024 factually wrong. Regarding future cash inflows, the LLM introduces specific numbers—$195.6 billion in 2022 and $164.3 billion in 2024—that are not present in the original answer, which only mentions that revisions occurred due to updated production and cost expectations, without quantifying them. (2) The quantitative inaccuracies are severe: both CapEx and future cash inflow figures are fabricated or misattributed, and the cited page numbers from the 10-K are not verifiable from the provided ground truth. Calculations or trends based on these numbers (e.g., decline in cash inflows) are therefore invalid. (3) The multi-hop reasoning is flawed—the original answer indicates a shift from active investment (2022) to revised financial projections (2024) without new CapEx data, but the LLM incorrectly infers increasing investment and declining reserve values based on unsupported numbers. The synthesis fails because it relies on incorrect data points rather than the actual evolution described. (4) Despite the incorrect facts, the LLM attempts to address the question’s core themes—CapEx trends and cash flow revisions—so contextual relevance is moderate. However, due to major factual and quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 478,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "\n\nComcast's financial commitments and governance arrangements with Atairos Group between 2023 and 2024 remained largely unchanged, governed by the November 2020 amendment. Key terms included a reduced total capital commitment of up to $4.5 billion (down from $5 billion) and annual capital calls capped at $400 million, plus previously distributed amounts. Comcast also committed $40 million annually for a management fee. Governance structures retained Comcast's control via management companies led by its former CFO, with Comcast absorbing ~99% of losses but holding no voting rights on economic interests, while retaining ~86% of residual returns. No material amendments to these terms were disclosed in the 2023 or 2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth. It incorrectly states that Comcast's arrangements with Atairos Group 'remained largely unchanged' and were governed by the 'November 2020 amendment', while the original answer confirms a key amendment in June 2023 and a material evolution in 2024 under equity method accounting. This misrepresents the timeline and nature of changes. (2) Quantitative accuracy is partially correct: the $4.5 billion commitment (down from $5 billion), $400 million annual capital call cap, $40 million annual management fee, ~99% loss absorption, and ~86% residual returns are all accurate. However, the LLM incorrectly attributes the $4.5 billion reduction to an earlier period (implying it was pre-2023), whereas the original answer specifies this change occurred in 2024. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the evolution from a shareholders agreement framework in 2023 to a formalized equity method investment in 2024, which is central to the question. It also incorrectly claims 'no material amendments were disclosed', directly contradicting the ground truth's description of significant 2023 and 2024 changes. (4) Entity accuracy is mostly correct—Comcast, Atairos Group, and the former CFO's role are properly identified—but the governance synthesis is wrong: the LLM says Comcast 'retained control' via management companies, while the original answer clarifies that Atairos’ management companies retained all voting rights, meaning Comcast does not have voting control despite financial exposure. This is a critical distinction in governance structure. Overall, while some financial figures are correct, the core narrative of stability is false, and key developments in both financial commitments and control structures are misrepresented, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 517,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "\n\nFedEx's projected utilization of the Cessna SkyCourier 408 decreased between 2022 and 2023, with deliveries delayed from 2023–2026 (49 total in 2022 filings) to 2025–2026 (31 total in 2023 filings). This reduction and delay indicate a diminished strategic role for the Cessna compared to larger aircraft like the ATR 72-600F, B767F, and B777F, which retained more consistent delivery commitments. The shift suggests FedEx is prioritizing larger, higher-capacity aircraft for its fleet, likely to optimize efficiency and address evolving logistics demands over regional or smaller-scale operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies a decrease in projected Cessna SkyCourier 408 utilization from 49 to 31 aircraft between the 2022 and 2023 filings, which matches the ground truth. However, the LLM inaccurately states that deliveries were initially projected for 2023–2026 in the 2022 filing and delayed to 2025–2026 in the 2023 filing. The ground truth does not specify delivery windows in this way—instead, it states the 2022 projection was for 49 aircraft to be in service through 2027, and the 2023 projection was 31 through 2029. The LLM introduces specific delivery windows not present in the original answer, which is a factual overreach. (2) The numbers 49 and 31 are correct, but the associated timeframes (2023–2026 vs. 2025–2026) are not supported by the ground truth and contradict the 'through 2027' and 'through 2029' phrasing. This affects quantitative accuracy. (3) The reasoning about strategic role is sound: the LLM correctly infers that the reduction indicates a diminished strategic role and compares it appropriately to larger aircraft like the B767F and B777F. It even adds the ATR 72-600F, which is contextually plausible and does not contradict the ground truth. The conclusion about prioritizing larger, higher-capacity aircraft aligns with the original answer’s implication of reassessment. (4) The answer is contextually excellent—addresses both parts of the question (change in projection and strategic role), uses correct entities (FedEx, Cessna SkyCourier 408, B767F, B777F), and provides logical synthesis. The main deduction is for introducing unsupported delivery timelines, which slightly undermines quantitative accuracy, but the core facts and reasoning remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 468,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "\n\nFrom 2022 to 2024, Nike maintained a strong emphasis on technological innovation for the Air Max product line, integrating it into broader product categories and consumer experiences, as highlighted in the 2024 10-K (page 6). However, revenue transparency for Air Max remained limited in both periods, with neither filing disclosing specific revenue figures for the product line. Instead, Air Max contributions were aggregated within broader segments like Footwear or \"Other\" categories, which accounted for immaterial amounts (e.g., $30 million in 2022). The evolution reflects sustained innovation focus but no significant shift toward granular revenue reporting for Air Max.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Nike did not disclose specific revenue figures for the Air Max product line in either 2022 or 2024, and notes the continued lack of granular reporting, which aligns with the ground truth. It also correctly observes the emphasis on technological innovation and integration into broader categories by 2024. However, a critical factual error occurs in the claim that 'Other' categories accounted for $30 million in 2022 and that this amount is linked to Air Max. The ground truth does not support this number or its attribution to Air Max; no such figure is mentioned in the original answer, and there is no indication that Air Max revenue was isolated even within an 'Other' category. This introduces a fabricated quantitative detail. (2) The $30 million figure is unsupported and incorrect—there is no mention of this amount in the ground truth, making the quantitative accuracy low. Additionally, the LLM implies a level of revenue disaggregation that contradicts the original answer’s assertion that Air Max was only listed among other technologies without financial metrics. (3) The reasoning correctly captures the shift from passive acknowledgment to strategic emphasis on innovation, showing sound qualitative synthesis across years. However, the erroneous inclusion of a specific dollar amount undermines the multi-hop logic, as it falsely suggests that some revenue transparency existed. (4) The contextual relevance is high because the answer addresses both revenue transparency and technological innovation across the specified time frame. Qualitative accuracy is moderate due to correct interpretation of strategic emphasis but docked for the unsupported number. Correctness score is 6 due to mostly accurate reasoning but significant factual error in financial data attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 500,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "\n\nComcast increased its capital expenditures for Epic Universe in 2023 as part of its theme park development, though specific 2023 investment amounts for Epic Universe were not disclosed. In 2024, the company maintained its focus on theme park investments, including Epic Universe, as a priority within its broader capital strategy, with Connectivity & Platforms capex rising slightly to $8.29 billion (up from $8.24 billion in 2023). The 2024 filings emphasized continued investment in \"existing and new attractions\" at Universal parks, aligning with plans to advance Epic Universe’s development. While exact figures for Epic Universe remained unspecified, the strategic priority shifted from initial 2023 construction phases to sustained expansion and attraction development in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that $8.2 billion was allocated to Connectivity & Platforms in 2023, but the LLM incorrectly reports $8.24 billion for 2023 and $8.29 billion for 2024, which are not supported by the original answer. These figures are fabricated or misremembered, as the original does not provide 2024 capex totals or year-over-year comparisons. (2) While the original answer notes that specific investment amounts for Epic Universe were not disclosed in either year, the LLM implies that the $8.24B and $8.29B figures are relevant to Epic Universe, which is misleading—these totals include broader infrastructure investments and cannot be directly attributed to the theme park. (3) Qualitatively, the LLM captures the correct evolution in strategy: from initial infrastructure focus in 2023 to sustained development and guest experience in 2024, citing 'existing and new attractions' as per the original. It correctly identifies the thematic shift and ongoing priority, showing sound multi-hop reasoning in interpreting strategic intent. (4) Contextually, the answer is highly relevant, addressing both years, investment strategy evolution, and development priorities. However, the incorrect numerical data significantly undermines factual reliability, warranting a moderate correctness score despite accurate qualitative synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 393,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "\n\nFedEx's utilization of the ATR 72-600F aircraft, as reflected in fleet projections, showed a decline in planned additions between 2022 and 2023. In the 2022 10-K (page 40), FedEx had committed to purchasing 11 ATR 72-600F aircraft for delivery in 2023 and 6 for 2024. However, the 2023 10-K (page 117) revealed reduced commitments, with only 7 planned for 2025 and 3 for 2026. This indicates a strategic slowdown in expanding the ATR 72-600F fleet during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the numbers are correct: the 2022 projection included 11 aircraft for 2023 delivery (and 6 for 2024), while the 2023 filing updated projections to 7 for 2025 and 3 for 2026. The LLM correctly reports these figures. (2) There is a minor omission: the original answer notes the 2022 projection also included 6 aircraft for 2025 and only 1 for 2026, which provides fuller context for the shift. The LLM omits the 2025 and 2026 projections from the 2022 filing, focusing only on the 2023 and 2024 figures. (3) The reasoning is sound—LLM correctly infers a strategic slowdown from the reduced numbers and correctly attributes the data to the respective 10-K filings (page 40 and 117). (4) The answer is contextually relevant and directly addresses how FedEx’s utilization projections evolved between 2022 and 2023. The conclusion about reduced expansion aligns with the ground truth. The only reason for not scoring a 10 is the partial omission of the full 2022 projection timeline (especially 2025 and 2026), which slightly reduces completeness in multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 330,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "\n\nBetween fiscal 2022 and 2024, Nike maintained a consistent approach to estimating product return reserves, relying on historical rates, specific identification of outstanding returns, and estimates for future claims. Both filings describe reserves calculated as a reduction to revenues at the time of recognition, with inventory costs for returns recorded as prepaid assets. There is no indication of a methodological shift in how reserves were estimated during this period. This consistency suggests that Nike’s revenue recognition methodology for returns remained stable, with provisions based on similar criteria (historical trends and contractual/discretionary return rights) in both years. The absence of notable changes in the approach implies no material evolution in how returns are accounted for within revenue recognition.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims Nike maintained a 'consistent approach' between fiscal 2022 and 2024, but the original answer clearly states there was a methodological evolution: in 2022, Nike used a disclosed dollar amount ($269 million) and recorded reserves in Prepaid expenses, while in 2024, it adopted a more formalized 'most likely amount' approach to estimate variable consideration, indicating a shift in methodology. The LLM fails to identify this key change. (2) Quantitatively, the LLM omits the $269 million figure from fiscal 2022 entirely and does not acknowledge that the 2024 reserve amount was not disclosed—both critical facts. (3) The reasoning is flawed: instead of recognizing a shift toward a probabilistic, forward-looking model aligned with revenue recognition standards (ASC 606), the LLM asserts no change occurred, missing the multi-hop synthesis between the change in estimation technique and its implication for revenue recognition. (4) While the answer is relevant to Nike’s revenue recognition and addresses the general topic of return reserves, its factual inaccuracies and failure to detect a documented evolution severely undermine its correctness. The conclusion that there was 'no material evolution' is directly contradicted by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 369,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "\n\nThe planned fleet composition of the Cessna SkyCourier 408 decreased significantly between 2022 and 2023, with total commitments dropping from 49 aircraft in 2022 to 31 in 2023. For 2025 and beyond, the number of planned deliveries increased from 12 in 2022 to 31 in 2023, reflecting a deferral of deliveries from earlier years (2023–2024) to 2025–2026. This shift suggests a strategic adjustment, potentially indicating reduced immediate reliance on the Cessna model while maintaining long-term integration, possibly due to production delays, evolving operational needs, or a pivot toward other aircraft types like the ATR 72-600F. The overall reduction in total commitments, however, signals a scaled-back emphasis on the Cessna SkyCourier 408 compared to prior plans.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, FDX planned 12 Cessna SkyCourier 408 aircraft by 2025 in 2022, increasing to 17 in 2023 for 2025, then decreasing to 14 for 2026. The LLM incorrectly states that total commitments dropped from 49 to 31, and that planned deliveries increased from 12 to 31—numbers not supported by the ground truth. There is no mention of 49 or 31 aircraft in the original answer, making these figures entirely fabricated. (2) The quantitative inaccuracies are severe: the LLM invents total commitments (49 and 31) and misrepresents the 2023 plan as 31 for 2025, when the correct number is 17. It also fails to report the 2026 reduction to 14. Calculations and comparisons are therefore invalid. (3) The reasoning is flawed—while the LLM attempts multi-hop synthesis (comparing 2022 and 2023 plans), it does so on false data. The conclusion about reduced reliance and a pivot to ATR 72-600F is speculative and unsupported by the ground truth, which indicates a short-term increase in reliance, not a reduction. (4) The contextual relevance is moderate because the answer addresses fleet composition changes and strategic reliance, but the factual foundation is incorrect, undermining the entire response. Correctness is severely compromised by invented numbers and incorrect trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 379,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "\n\nMastercard expanded its real-time account-based payments infrastructure from 2023 to 2024, operating or implementing real-time payments in **13 markets by December 31, 2023**, with continued global expansion implied by increased Payment Network revenue rising from **$15.8 billion in 2023 to $17.3 billion in 2024** (MA_10k_2024.pdf, page 81). Security capabilities were enhanced through integrated solutions, including **multi-layered fraud detection (e.g., fraud scoring, tokenization)**, **digital identity verification** (e.g., biometrics, device intelligence), and compliance with EMV standards, as detailed in both 2023 (pages 11, 17) and 2024 filings (pages 72–73). These advancements reinforced transaction integrity while enabling faster, data-rich payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the statement that Mastercard was operating or implementing real-time payments in 13 markets by the end of 2023 matches the original answer. The revenue figures—$15.8 billion in 2023 and $17.3 billion in 2024—are correctly cited from MA_10k_2024.pdf, page 81, and support the claim of expansion, though revenue growth is indirect evidence of operational scale. These numbers are presented accurately with proper context. (2) The security capabilities described—multi-layered fraud detection (fraud scoring, tokenization), digital identity verification (biometrics, device intelligence), and EMV compliance—are consistent with the original answer’s emphasis on a multi-layered security approach and value-added services applied in real time. References to specific pages in the 2023 and 2024 filings add credibility. (3) The reasoning is sound: the LLM correctly infers continued global expansion from revenue growth and links it to infrastructure development, which, while not explicitly stated in the ground truth, is a reasonable inference supported by context. (4) All entities (Mastercard, real-time account-based payments, 2023–2024 timeframe) are correct, and the answer addresses both operational scale and security enhancements as required. The only minor shortcoming is that the original answer emphasizes architectural improvements (e.g., distributed network, intelligent routing), which the LLM mentions implicitly through 'faster, data-rich payments' but does not explicitly detail. This slight omission prevents a perfect 10 but does not detract significantly from overall correctness. Semantic equivalence is maintained, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 480,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "\n\nBetween 2022 and 2024, Nike's use of foreign exchange forwards and options showed shifts in both financial liabilities and hedging effectiveness. In 2022, these derivatives resulted in a $39 million loss recognized in Other Comprehensive Income (OCI) and a $82 million reclassification loss into income (primarily cost of sales and revenues). By 2024, the OCI loss widened to $66 million, but the reclassification loss into income decreased to $24 million, indicating improved hedging effectiveness over time. Financial liabilities related to these derivatives declined from $180 million in 2023 to $151 million in 2024, driven by reductions in deferred tax liabilities and interest rate swaps, despite a slight increase in accrued liabilities for foreign exchange contracts. Nike maintained its strategy to mitigate currency volatility, centralizing hedging through standard rates and adjusting hedge volumes to reduce net losses in later periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, foreign exchange forwards and options had a net gain of $8 million after tax, but the LLM claims a $39 million loss in OCI and an $82 million reclassification loss, which contradicts the original. There is no mention of OCI or reclassification losses in the ground truth. Additionally, the LLM introduces data for 2023 ($180 million liabilities) and 2024 ($151 million), neither of which align with the ground truth: in 2024, liabilities were $110 million under accrued liabilities and $5 million under deferred income taxes, totaling $115 million—not $151 million. The LLM also attributes changes to 'interest rate swaps,' which are not mentioned in the original answer and are unrelated to the question about foreign exchange forwards and options. (2) Quantitative accuracy is very low: all key numbers (e.g., $39M loss, $82M reclassification, $66M OCI loss, $24M reclassification, $180M to $151M decline) are unsupported by the ground truth and often fabricated. The only correct number is the $8 million from 2022, but it is misrepresented as part of a loss rather than a net gain after tax. (3) The multi-hop reasoning is flawed. The LLM fails to connect the evolution of liabilities as reported in the ground truth (increase to $110M and $5M in 2024) and instead invents a downward trend from 2023 to 2024 based on unrelated instruments. It also mischaracterizes the hedging strategy evolution, implying improved effectiveness due to reduced reclassification losses, which is not supported by the source. (4) Contextual relevance is moderate—the response addresses the general topic of Nike's FX hedging evolution and mentions relevant categories like cost of sales and revenues. However, due to severe factual and quantitative errors, the answer misrepresents Nike's actual financial position and strategy evolution. The core message about strategic evolution is present but based on incorrect data, leading to an overall low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 554,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "\n\nThe product category classification of **Puffs** within the **Baby, Feminine & Family Care** segment remained unchanged between 2022 and 2023. In both years, Puffs was consistently categorized under the **Family Care** sub-segment, which includes products like paper towels, tissues, and toilet paper. The 2022 and 2023 filings explicitly list Puffs as a major brand under Family Care (2022: pages 19, 38; 2023: pages 18, 19), with no indication of reclassification. The segment structure itself retained its core categories (Feminine Care and Family Care in 2023, previously including Baby Care in 2022), but Puffs’ placement within Family Care did not shift.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Puffs remained in the Family Care sub-segment in both 2022 and 2023, and accurately references the product categories (paper towels, tissues, toilet paper) and document pages. However, it contradicts the ground truth by stating there was no change in classification, while the original answer indicates a qualitative shift in reporting: in 2023, the sub-category 'Tissues' was no longer explicitly broken out, suggesting a simplification or consolidation in how the segment was reported. The LLM overlooks this evolution in categorization detail, which is central to the question about how the classification 'evolved.' While the core placement of Puffs did not change, the ground truth emphasizes a change in disclosure granularity, which the LLM fails to acknowledge. This omission reduces qualitative accuracy, as the reasoning does not fully capture the nuance of the multi-hop comparison across years. There are no numerical inaccuracies (hence high quantitative score), and the response is highly relevant contextually, but the failure to recognize the reporting-level evolution limits correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 322,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "\n\nBetween 2022 and 2023, Tampax's positioning within P&G's portfolio evolved through **refined categorization** and **enhanced market focus**. In 2022, Tampax was grouped under the broader \"Feminine Care\" category within the Baby, Feminine & Family Care segment, with P&G noting a global market share of over 20%. By 2023, Tampax was explicitly categorized under a **\"Menstrual Care\" sub-category** within Feminine Care, reflecting a strategic emphasis on this product line. The 2023 filing highlighted a **25% global market share** for menstrual care (driven by Tampax and Always), up from 20% in 2022, signaling growth and a more targeted approach. Additionally, Tampax remained a key brand in P&G's efforts to strengthen its feminine care offerings, supported by pricing strategies and innovation, as evidenced by low-single-digit sales growth in the category in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift from 'Feminine Care' in 2022 to a more specific 'Menstrual Care' categorization in 2023, aligning with the ground truth's core insight about refined positioning. However, it introduces unsupported quantitative claims not present in the original answer or implied by the knowledge graph. Specifically, the 20% and 25% global market share figures for Tampax/Always and the claim of 'low-single-digit sales growth' in 2023 are not part of the ground truth and cannot be verified from the provided information. These additions significantly impact factual accuracy. (2) The ground truth does not mention any market share percentages or sales growth metrics, so the inclusion of 20% (2022) and 25% (2023) constitutes a factual overreach. There is no basis for these numbers in the original answer, making the quantitative accuracy low. (3) The qualitative reasoning is sound in interpreting the re-categorization as a strategic refinement and correctly places Tampax within the same broader segment (Baby, Feminine & Family Care). The model correctly performs the multi-hop synthesis of changes in categorization across years, showing understanding of portfolio evolution. However, the unsupported metrics undermine the reasoning's reliability. (4) Contextual relevance is high because the answer directly addresses the question about Tampax’s evolving positioning, categorization, and associated product lines. Despite the factual inaccuracies in numbers, the structural and conceptual framing matches the intent of the ground truth. The score is reduced primarily due to the introduction of unverified quantitative data that distorts the factual basis of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 470,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "\n\nOracle's strategy for Oracle Engineered Systems between fiscal 2022 and 2023 emphasized maintaining their role within the hardware segment while aligning with broader cloud-focused initiatives. Revenue contribution from the hardware business, including Engineered Systems, represented **6% of total revenues in both fiscal 2023 and 2024** (ORCL_10k_2023.pdf, p. 43), consistent with prior years despite a **5% decline in hardware revenues in fiscal 2022** (ORCL_10k_2022.pdf, p. 51) due to reduced emphasis on nonstrategic hardware products. Oracle continued to invest in research and development for hardware improvements and new offerings (ORCL_10k_2023.pdf, p. 43), though the hardware segment inherently carries lower margins compared to cloud and license businesses. The positioning reflects a balanced approach, sustaining Engineered Systems as a strategic component while prioritizing cloud migration.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Most critically, it states that hardware revenue represented 6% of total revenues in both fiscal 2023 and 2024, but the question only asks about 2022 and 2023, and the ground truth does not mention fiscal 2024 at all. This introduces a fact not present in the source and is factually problematic. Additionally, the claim of a '5% decline in hardware revenues in fiscal 2022' is not mentioned in the ground truth, which only discusses revenue recognition methods and indirect channels for that year—this number appears to be hallucinated or misattributed. (2) The ground truth confirms that in fiscal 2023, Oracle stated hardware represented 6% of total revenue—a key quantitative point the LLM correctly identifies, though it incorrectly extends it to 2024. The research investment expectation in 2023 is accurately reflected. However, the LLM incorrectly implies that the 6% figure was also true in 2022, while the ground truth emphasizes that this specific revenue contribution was only disclosed in 2023, marking a shift in transparency and strategic emphasis. (3) The multi-hop reasoning is partially sound: the model connects hardware strategy to R&D investment and revenue contribution across years. However, it fails to accurately contrast the absence of the 6% figure in 2022 versus its introduction in 2023, which is central to the evolution in strategic positioning. The mention of 'cloud-focused initiatives' and 'lower margins' adds context not present in the ground truth, which may be generally accurate but distracts from the specific evolution asked about. (4) The correctness score is 5 due to partial factual accuracy—core elements like R&D investment and the 6% figure in 2023 are correct, but significant errors in numbers (fiscal 2024, 5% decline) and misrepresentation of 2022 data reduce reliability. Quantitative accuracy is low (4) due to unsupported percentages. Qualitative accuracy is moderate (6) as reasoning structure is logical but based on some incorrect premises. Contextual relevance is high (8) because the answer addresses strategy, revenue, and R&D as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 578,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "\n\nHoneywell's Non-U.S. pension plans increased their investment in private funds from $90 million in 2022 to $115 million in 2023. The allocation across fair value hierarchy levels shifted significantly: Level 2 decreased from $54 million (60% of private funds) to $41 million (36%), while Level 3 rose from $36 million (40%) to $74 million (64%). This reflects a growing portion of private fund investments being classified under Level 3 (less observable valuations) in 2023 compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The original answer states that in 2022, Honeywell reported $1,105 million invested in private funds for its *U.S.* pension plans (not Non-U.S.), all classified under Level 3. However, the LLM incorrectly claims $90 million in Non-U.S. private fund investments in 2022, which is not supported by the ground truth. The 2023 figure of $115 million for Non-U.S. plans is correct, with $41 million in Level 2 and $74 million in Level 3, which the LLM accurately reports. However, the LLM fabricates 2022 Non-U.S. allocations of $54 million in Level 2 and $36 million in Level 3, which are not present in the original answer. (2) Calculations and percentages are based on incorrect inputs: claiming Level 2 was 60% and Level 3 40% in 2022 is invalid because the ground truth does not provide Non-U.S. 2022 breakdowns. The increase from $90M to $115M is entirely fabricated. (3) The multi-hop reasoning fails because the LLM conflates U.S. and Non-U.S. pension plan data. The original answer emphasizes a shift from U.S. to Non-U.S. plans and a significant decrease in overall private fund allocation, but the LLM incorrectly suggests growth in Non-U.S. investments without acknowledging the large drop from $1,105M to $115M overall. (4) The contextual relevance is moderate because the answer discusses the right topic (private fund allocation in Non-U.S. plans across fair value levels) and correctly reports the 2023 numbers, but the core quantitative and entity inaccuracies severely undermine correctness. The qualitative reasoning is flawed due to incorrect premises. Thus, the correctness and quantitative accuracy scores are low, while qualitative accuracy and contextual relevance receive partial credit for structure and partial data alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 492,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "\n\nThe 2014 USD Notes (3.375% Senior Notes due April 2024) matured in April 2024, and Mastercard repaid the $1.0 billion principal amount as scheduled. This repayment is explicitly noted in the 2024 10-K (page 58), which states that the debt matured and was paid in full. In 2024, the company also issued new long-term debt (the 2024 USD Notes) to maintain liquidity, including $1.0 billion due 2034, $750 million due 2028, $1.15 billion due 2032, and $1.1 billion due 2035. The repayment of the 2014 USD Notes marked the conclusion of this debt obligation, reflecting routine debt management aligned with maturity schedules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 2014 USD Notes matured in April 2024 and that $1.0 billion in principal was repaid in full, matching the ground truth. The maturity date (April 2024), amount ($1 billion), and classification as short-term debt in 2023 are all accurate. (2) All numeric values—$1.0 billion principal, repayment date (April 2024), and coupon rate (3.375%)—are factually correct and consistent with the original answer and typical disclosures. The mention of new debt issuances in 2024, while not part of the ground truth, does not contradict it and adds context about overall debt management. (3) The multi-hop reasoning is sound: the model connects the 2014 notes' maturity from 2023 (as a short-term liability) to their settlement in 2024, demonstrating proper synthesis across time periods. The only minor gap is that the original answer emphasizes the transition from short-term debt classification in 2023 to full repayment in 2024, which the LLM mentions implicitly but could have made more explicit. (4) The scores reflect near-perfect factual accuracy, with full quantitative precision and high qualitative reasoning. The added detail about new debt issuance slightly exceeds the scope but enhances context without error, justifying a 9/10 on qualitative accuracy. Contextual relevance is complete as all key aspects of the question are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 388,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "\n\nThe treatment and documentation of Lowe's Officer Indemnification Agreements remained consistent between 2022 and 2024, as both filings reference the same form (Exhibit 10.23/10.31) incorporated by reference from the 2019 10-K, with no indication of amendments during this period. This continuity suggests stable executive risk management practices, reflecting confidence in existing indemnification frameworks to protect officers against litigation or regulatory risks. However, Lowe's updated other executive compensation elements (e.g., the 2022 amendment to the Severance Plan for Senior Officers), indicating a targeted approach to governance rather than broad changes to indemnification policies. The lack of evolution in indemnification agreements highlights governance continuity but may also signal a focus on maintaining established protections rather than adapting to emerging risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a critical error in the exhibit number: it cites 'Exhibit 10.23/10.31' instead of the correct 'Exhibit 10.43' as stated in the ground truth and confirmed by the 2019, 2022, and 2024 10-K filings. This misidentification undermines quantitative and entity accuracy. (2) The dates (2019, 2022, 2024) and the fact that no amendments were made are correctly noted, and the reference to incorporation by reference from the 2019 filing is accurate. However, the incorrect exhibit number is a significant factual flaw. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged documentation implies consistent governance and risk management practices, and it appropriately contrasts this with changes in other executive compensation plans (e.g., the 2022 Severance Plan amendment), demonstrating good synthesis across filings. (4) Despite the exhibit number error, the overall conclusion about governance continuity and stable executive risk management aligns with the ground truth and is contextually well-reasoned. The answer adds value by contextualizing indemnification within broader governance trends, even if one key factual detail is incorrect. Hence, correctness is reduced to 7 due to the exhibit number inaccuracy, which affects quantitative and qualitative precision, but not the core reasoning or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 390,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "\n\nThe market share of Always Discreet in the adult incontinence category increased between the 2022 and 2023 10-K filings. In 2022, Procter & Gamble reported that Always Discreet held **over 10% market share** in key markets (2022 filing, page 19). By 2023, this share rose to **about 15%** in the markets where the brand competes (2023 filing, page 18). The category positioning remained focused on the adult incontinence sub-category, with no indication of a shift in strategic emphasis, but the higher market share suggests improved competitive positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Always Discreet's market share increased to about 15% in 2023. The ground truth explicitly states that no market share figure was provided in the 2023 filing, making the claim of a rise to 15% entirely unsupported. The only quantified figure comes from the 2022 filing, which reported 'over 10%' market share. (2) Quantitative accuracy is severely compromised because the 15% figure is fabricated; there is no such number in the 2023 filing. The model introduces a precise percentage not present in the source, which constitutes a major factual error. (3) The multi-hop reasoning is flawed: instead of recognizing the absence of a market share disclosure in 2023 as a shift in reporting, the model incorrectly infers an increase in market share. The correct qualitative interpretation is a change in disclosure strategy, not a performance improvement. The model fails to note the absence of data as a meaningful change. (4) Contextual relevance is moderate because the answer addresses the right brand, category, and time frame, and correctly cites the 2022 market share. However, the core conclusion about market share growth and competitive positioning is false, severely undermining the answer's correctness. Minor credit is given for correct identification of the brand and category context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 379,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "\n\nOracle's strategic positioning of Engineered Systems evolved between 2022 and 2023 by increasingly integrating these systems into its cloud infrastructure offerings, reinforcing their role as a bridge between traditional hardware and cloud services. In 2022, Engineered Systems were highlighted as core components of both cloud and on-premise data center solutions, emphasizing performance and scalability (2022, p. 13). By 2023, the focus shifted to aligning Engineered Systems—such as Exadata—with Oracle Cloud Infrastructure (OCI), offering flexible deployment options (on-premise, cloud, hybrid) to facilitate customer migration to Oracle’s cloud ecosystem (2023, p. 43). This repositioning underscores their role in Oracle’s cloud transformation, enabling hybrid cloud adoption while maintaining hardware business relevance. The hardware segment (6% of total revenue in 2023) now prioritizes cloud integration, with Engineered Systems serving as foundational infrastructure for OCI services, thereby supporting Oracle’s strategic pivot toward cloud-driven growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 6% of total revenue for hardware in 2023 is accurately reported, consistent with the original answer stating 6% in both fiscal 2023 and 2024. No incorrect figures or miscalculations are present. (2) The answer correctly identifies the evolution in strategic positioning from 2022 to 2023: in 2022, Engineered Systems were emphasized for performance and scalability in both cloud and on-premise environments; by 2023, they were more tightly aligned with Oracle Cloud Infrastructure (OCI) and hybrid deployments. The mention of Exadata as a key Engineered System integrated with OCI is contextually appropriate and reflects real-world offerings. (3) The multi-hop reasoning is sound—information from both years is synthesized to show a strategic shift, and the role of Engineered Systems in supporting cloud transformation through hybrid models is logically inferred. (4) The LLM captures the core narrative that Engineered Systems are now foundational to Oracle’s cloud strategy, despite hardware being a lower-margin, smaller-revenue segment. One minor omission is that the 2023 filing also notes R&D investments and that hardware includes servers, storage, and operating systems as combined performance obligations—details not explicitly mentioned in the LLM response. However, this does not detract significantly from the overall correctness. Wording differs but semantic meaning matches the ground truth. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 458,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "\n\nIn the 2022 10-K filing, the disclosure explicitly stated that the 2020 Stock Plan was the **successor to the 2011 Stock Plan**, noting that 5,530,106 shares remaining under the 2011 Plan were rolled into the 2020 Plan. However, in the 2023 10-K, this direct reference to the 2011 Plan as a predecessor was omitted. The 2023 filing only described the 2020 Stock Plan’s authorization and share activity without mentioning the 2011 Plan, indicating a simplification or reduction in detail regarding the relationship between the two plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 10-K included the detail about 5,530,106 shares carried forward from the 2011 Stock Plan to the 2020 Stock Plan, and this reference was omitted in the 2023 10-K. The number is correctly stated and matches the ground truth exactly. (2) Quantitative accuracy is perfect—no calculations were required, but the specific figure of 5,530,106 shares is accurately reported. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two years of filings and identified the change in disclosure practice. It correctly inferred that the omission in 2023 indicates a shift in presentation, though it uses slightly different phrasing (e.g., 'successor' and 'rolled into' vs. 'carried forward'), which is semantically equivalent. (4) The only minor deviation is that the LLM adds the term 'successor,' which is a reasonable interpretation but not explicitly stated in the ground truth; however, this does not distort the factual content. Overall, the answer is complete, factually correct, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to interpretive wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 351,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "\n\nHoneywell increased its allocation to private funds within non-U.S. pension plans from $36 million in 2022 to $74 million in 2023, reflecting a strategic shift toward higher allocations in private equity and alternative investments. This evolution suggests a prioritization of diversification and potentially higher-risk-adjusted returns in international pension portfolios, likely to address funding goals or capitalize on private market opportunities. The modest increase in U.S. direct private investments ($1,284 million to $1,293 million) contrasts with the more pronounced non-U.S. shift, indicating a targeted focus on non-U.S. markets for capital deployment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Honeywell's total investment in private funds was $1,244 million in 2022 and $1,265 million in 2023, representing a 1.7% increase. However, the LLM incorrectly claims that the allocation to private funds within non-U.S. pension plans increased from $36 million to $74 million, which is not supported by the original data. Additionally, the LLM cites U.S. direct private investments as increasing from $1,284 million to $1,293 million, which contradicts the ground truth figures of $1,244M and $1,265M. These numbers do not match any disclosed totals in the original answer and appear fabricated. (2) The calculations are therefore also incorrect: the claimed 'modest increase' in U.S. investments and 'pronounced shift' in non-U.S. markets are based on false data. There is no mention in the original answer of a breakdown between U.S. and non-U.S. plans; the ground truth refers to overall private fund investments without geographic segmentation. (3) The multi-hop reasoning fails because the LLM invents a distinction between U.S. and non-U.S. allocations that is not present in the source data, leading to a completely different interpretation. The original answer emphasizes stability in private fund allocation amid broader asset reductions, while the LLM suggests a strategic international pivot that lacks evidentiary support. (4) The contextual relevance is moderate because the answer addresses capital deployment priorities and attempts to interpret strategic intent, but the reasoning is built on inaccurate data and misattribution of figures to specific regions. Due to major factual errors and incorrect synthesis, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 486,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "\n\nThe status of Class B-2 Common Stock evolved significantly between 2023 and 2024. In 2023, no shares of Class B-2 were outstanding, as noted in the 2023 10-K (pages 89 and 87). However, in 2024, Visa executed a **Class B-1 common stock exchange offer** (disclosed in the 2024 10-K, pages 89 and 87), where 241 million shares of Class B-1 were exchanged for **120 million shares of Class B-2 and 48 million shares of Class C**. This made Class B-2 outstanding starting in 2024. \n\nClass B-2 shares are subject to **conversion rate adjustments** tied to litigation escrow accounts, with adjustments having **double the impact** compared to Class B-1 shares (page 89). As of September 30, 2024, 120 million Class B-2 shares were outstanding, with a conversion rate of **1.5430 shares of Class A per Class B-2 share** (page 87). This reflects a structural distinction from Class B-1 (conversion rate: 1.5653) and underscores the evolving relationship between stock classes post-exchange offer.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) The original answer states that *no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer* and that in 2024, there were *no further updates or disclosures* about Class B-2, suggesting reduced emphasis or discontinuation. However, the LLM claims that in 2024, 120 million Class B-2 shares were issued as part of an exchange offer, making them 'outstanding starting in 2024'—this is directly contradicted by the ground truth, which indicates no new disclosures or active role for Class B-2 in 2024. (2) The LLM cites specific numbers: 241 million Class B-1 exchanged for 120 million Class B-2 and 48 million Class C, a conversion rate of 1.5430, and outstanding status as of September 30, 2024—none of which appear in the original answer and all of which imply detailed disclosures that the ground truth explicitly says were *absent* in 2024. (3) The multi-hop reasoning is flawed: instead of recognizing the *disappearance* of disclosures about conversion mechanics and dilution impacts from 2023 to 2024, the LLM fabricates a detailed transaction and ongoing status for Class B-2. (4) While the mention of conversion rate adjustments tied to litigation escrow in 2023 aligns loosely with the ground truth, the doubling of impact and specific conversion rates are unsupported. Overall, the LLM invents a narrative contrary to the original answer’s implication of Class B-2 being inactive or discontinued, leading to a low correctness score. Quantitative accuracy is poor due to fabricated figures. Qualitative accuracy fails on entity relationships and reasoning. Contextual relevance is moderate because it discusses the right topic (Class B-2 evolution) but with incorrect substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 486,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "\n\nThe financial obligations related to the Target Circle program, represented by deferred revenue, increased from $89 million in 2022 to $117 million in 2024. This rise indicates expanded program participation and enhanced reward offerings, as Target Circle members earned more rewards on transactions during this period. The growth in deferred liabilities suggests strategic efforts to incentivize customer loyalty, reflecting the program's evolution toward greater financial commitment to retain and reward members.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the increase in deferred revenue from $89 million in 2022 to $117 million in 2024, matching the ground truth in both values and direction of change. However, it omits the critical subsequent drop to $19 million by February 1, 2025, which is a key part of the program's evolution and indicates a sharp reversal in financial obligations. This omission significantly limits completeness.\n\n2) Quantitatively, the numbers are accurate: $89M (as of Jan 29, 2022) and $117M (as of Feb 3, 2024) are correctly reported. No calculations were required beyond comparison, and the direction (increase) is correct.\n\n3) The reasoning correctly infers that the increase may reflect greater participation or enhanced rewards, which aligns with plausible interpretations. However, it fails to acknowledge the multi-hop aspect of the full timeline—particularly the dramatic decline by 2025—which would require synthesizing data across three time points. This weakens the qualitative accuracy, as the conclusion about 'continued evolution toward greater financial commitment' is contradicted by the later drop.\n\n4) Contextually, the answer is highly relevant and well-framed around financial obligations and program evolution. The explanation ties deferred revenue to customer loyalty strategy appropriately. However, the failure to include the 2025 data point—a material development—means the answer presents an incomplete and potentially misleading narrative. A score of 7 reflects accurate core facts but a significant omission affecting overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 431,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "\n\nThe fair value of Netflix's 4.375% Senior Notes increased from $980 million as of December 31, 2022, to $996 million as of December 31, 2023. This slight increase suggests that market conditions or investor perception during this period favored the notes, potentially reflecting stable or improved confidence in Netflix's creditworthiness, lower perceived risk, or a broader decline in market interest rates that increased the value of fixed-income securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the fair value of Netflix's 4.375% Senior Notes increased from $980 million to $996 million, when in fact the ground truth indicates a decrease from $980 million to $996 million is impossible because $996M > $980M — this is a critical error in directionality. The correct movement is an increase, not a decrease as implied in the original answer's explanation. However, the original answer itself contains a factual error: it claims the fair value 'decreased' from $980M to $996M, which is mathematically incorrect. Thus, both answers are flawed, but the LLM correctly reports the numerical values and their direction (increase), contradicting the ground truth's erroneous description. (2) Quantitatively, the LLM accurately reports the dollar amounts ($980M on Dec 31, 2022, and $996M on Dec 31, 2023), so numeric accuracy is high. However, the ground truth contains a logical inconsistency — claiming a 'decrease' when the value rose — which undermines its reliability. (3) The LLM’s reasoning is sound: it correctly interprets an increase in fair value as reflecting improved investor confidence, lower risk, or declining interest rates, which aligns with financial principles. The original answer incorrectly frames the change as a decrease and then paradoxically says it moved closer to par, which would imply an increase — revealing internal contradiction. (4) Given that the LLM provides numerically accurate data and logically sound interpretation, while the ground truth contains a clear factual/mathematical error in describing a decrease when the value increased, the LLM answer should be scored higher than if the ground truth were correct. However, since the evaluation must follow the provided ground truth, and it incorrectly labels the change as a decrease, the LLM's contradiction of that leads to a partial score. The correctness score is 4 due to the conflict with the (flawed) ground truth, but the LLM answer is actually more factually accurate in both numbers and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 551,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "\n\nBetween 2023 and 2024, Visa's equity structure for Class C Common Stock evolved through a significant share issuance in May 2024. Specifically, Visa conducted an exchange offer where it accepted 241 million shares of Class B-1 common stock and issued **120 million shares of Class B-2 common stock and 48 million shares of Class C common stock** (as detailed in the 2024 filing, page 40). This issuance increased the outstanding shares of Class C, though the balance sheet (2024, page 58) lists Class C shares as 10 issued and outstanding, likely due to rounding or presentation conventions. \n\nEquity classification for Class C Common Stock remained consistent, retaining its status as a non-voting, convertible class with limited rights compared to Class A stock. Class C shares, along with Class B-1 and B-2, are eligible to convert into Class A common stock under specified conditions, such as the release of preferred stock value tied to litigation developments. No material changes to the classification or rights of Class C shares were disclosed between 2023 and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the date of the exchange offer. The original answer states the exchange occurred in 2023, but the LLM incorrectly claims it happened in May 2024. This misalignment with the timeline undermines the quantitative and temporal accuracy. Additionally, the LLM introduces 'Class B-2 common stock' and claims 120 million shares were issued, which is not mentioned in the ground truth and appears to be fabricated or misattributed. While the 48 million shares of Class C common stock issued is correct, the context is wrong. The 2024 balance of 10 shares issued and outstanding for Class C is correctly reported, but the LLM's suggestion that this discrepancy is due to 'rounding or presentation conventions' is speculative and not supported by the original answer, which interprets it as evidence of stabilization post-restructuring. (2) Quantitative accuracy is partially correct: 48 million shares issued in 2023 (not 2024) and 10 shares outstanding in 2024 are accurate. However, the addition of 120 million Class B-2 shares and the misdating of the event to 2024 introduce significant errors. (3) The multi-hop reasoning is partially sound—linking the exchange offer to restructuring and noting the final balance in 2024—but fails in synthesizing the correct year and associated entities. The reasoning about equity classification (non-voting, convertible) is consistent and plausible but not directly confirmed in the ground truth, so it adds unsupported detail. (4) Contextual relevance is high as the answer addresses share issuance, equity classification, and evolution over time. However, due to the incorrect year and invented share class, the factual core is compromised, warranting a moderate correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 485,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "\n\nLowe's engagement with Rough Plumbing evolved from 2022 to 2024 through reclassification and expanded service offerings. In 2022, Rough Plumbing was categorized under **Building Products** (a product-centric division) and primarily offered **protection plans** for extended warranties and repairs. By 2024, it was reclassified under **Installed Sales**, reflecting a strategic shift toward service-oriented solutions. Lowe's expanded its offerings to include **installation services** for Rough Plumbing, leveraging independent contractors and third-party models to provide end-to-end project solutions (e.g., selling, furnishing, and installing plumbing systems). This aligns with Lowe's Total Home strategy, emphasizing growth in home services and DIFM (do-it-for-me) options, with installed sales contributing ~5% of total revenue in 2024. Protection plans remained part of the service suite but were complemented by broader installation capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Rough Plumbing was classified under 'Building Products' in 2022 and shifted to 'Installed Sales' by 2024, reflecting a move toward service-oriented offerings. The ~5% contribution of installed sales to total revenue in 2024 is correctly stated. (2) Quantitative accuracy is perfect: the 5% figure matches the original answer exactly, and no incorrect numbers are introduced. (3) Multi-hop reasoning is sound—LLM correctly synthesizes the evolution in classification and service expansion (installation + protection plans) and links it to Lowe's broader Total Home and DIFM strategy, which is contextually valid and enhances understanding. (4) The only minor discrepancy is that the original answer does not explicitly state that protection plans were offered in 2022, only that the 2024 model includes both installation and protection; the LLM assumes continuity of protection plans from 2022, which is plausible but not confirmed in the ground truth. This slight over-assumption prevents a perfect 10 but does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. All parts of the question are addressed: business classification change and service offering evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 364,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "\n\nThe introduction of Class B-2 common stock in 2024 followed Visa's January 2024 shareholder-approved amendments to its certificate of incorporation, which authorized an exchange offer to release transfer restrictions on Class B-1 shares. On May 6, 2024, Visa executed this exchange, accepting 241 million shares of Class B-1 common stock and issuing 120 million shares of Class B-2 common stock (with double the conversion rate adjustment impact compared to B-1) and 48 million shares of freely tradable Class C stock. By September 30, 2024, Class B-2 shares were outstanding, reflecting their integration into the capital structure. This evolution indicates that Class B-2 serves as a mechanism to manage litigation-related conversion rate adjustments and shareholder dilution, with its unique conversion features aligning with Visa’s retrospective responsibility plans for U.S. and European litigation obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in multiple critical aspects. (1) The introduction of Class B-2 common stock is stated to occur in 2024, but the ground truth specifies it was introduced in 2023 with 77 million shares outstanding. The LLM incorrectly claims the introduction happened in 2024 as part of an exchange offer, which is not supported by the original answer. (2) The LLM reports that 120 million Class B-2 shares were issued on May 6, 2024, and were outstanding by September 30, 2024. However, the ground truth states that by 2024, no Class B-2 shares were outstanding prior to the Class B-1 exchange offer, implying they were either eliminated or restructured—directly contradicting the LLM's claim of 120 million shares being issued. (3) The LLM introduces specific details such as Visa, shareholder-approved amendments in January 2024, an exchange of 241 million Class B-1 shares, issuance of 48 million Class C shares, and litigation-related conversion adjustments—none of which appear in the original answer and are therefore unsupported. (4) The multi-hop reasoning is flawed: instead of recognizing that Class B-2 was introduced in 2023 and then disappeared or was restructured by 2024 (indicating a strategic shift), the LLM fabricates a detailed narrative about Visa’s capital structure changes involving entities and events not present in the ground truth. (5) While the question asks about the evolution and role of Class B-2 stock between 2023 and 2024, the LLM misplaces the timeline, misrepresents the status of shares, and injects incorrect company and transaction details. The only partial credit is for addressing the general topic of capital structure evolution, hence a contextual relevance score of 5. Overall, the answer fails on factual accuracy, entity identification, quantitative correctness, and logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 507,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "\n\nThe financial liability associated with the Target Circle program, represented by deferred revenue, decreased significantly from $117 million in February 3, 2024 (2023 fiscal year end) to $19 million in February 1, 2025 (2024 fiscal year end), as disclosed in TGT_10k_2024.pdf (page 50). This sharp reduction suggests increased redemption of earned rewards by members or changes in the program’s structure that accelerated revenue recognition. While 2022 data is not explicitly provided in the sources, the 2023–2024 decline indicates the program evolved to prioritize rewarding members more promptly, potentially enhancing customer engagement and loyalty.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change. The ground truth states that in 2022, no specific liability was disclosed, but by 2024 (as of February 3, 2024), the deferred revenue for Target Circle had grown to $117 million, indicating growth. The LLM incorrectly claims a decrease from $117 million in 2024 to $19 million in 2025, which is not supported by the original answer and reverses the trend. The fiscal year end dates are misrepresented: the LLM cites February 1, 2025 (2024 fiscal year), which is outside the 2022–2024 scope and not mentioned in the ground truth. The original answer does not provide any data for 2025 or a reduction to $19 million, nor does it suggest a decline in liability. The reasoning about increased redemptions or structural changes is speculative and unsupported by the provided truth. The LLM also fails to acknowledge the absence of 2022 liability data, instead implying a timeline that contradicts the source. While the mention of deferred revenue as the liability metric is correct, and the general idea of linking liability to program activity is relevant, the core facts—direction of change, amounts, and years—are wrong. This results in a severe factual error, especially in quantitative terms, and flawed multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 363,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "\n\nNVIDIA's exposure to and concerns about pollution limits evolved between 2023 and 2024, with increased emphasis on regulatory impacts and data center expansion challenges. In 2023, the company highlighted general risks from climate-related regulations, including potential costs for compliance and energy efficiency. By 2024, NVIDIA explicitly addressed pollution limits as part of broader climate regulations, noting that restrictions on energy or water availability could impair customers' ability to expand data centers, directly affecting demand for its products. Additionally, 2024 disclosures emphasized heightened risks of legal action or reputational harm if stakeholders perceive insufficient responsiveness to climate issues, reflecting a more pronounced concern about regulatory and operational impacts compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—NVIDIA (NVDA), 2023 and 2024 timeframes, pollution limits, regulatory impact, and data center expansion—are correctly identified and contextualized. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable; however, the absence of any incorrect figures or miscalculations supports a score of 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how NVDA’s risk disclosures evolved from general cost and compliance concerns in 2023 to more specific operational and demand-side risks in 2024, particularly around customer data center expansion. The mention of land and permitting constraints is slightly more detailed in the original answer, but the LLM captures the essence by referencing energy/water availability impairing data center growth. The added point about legal and reputational risks in 2024 is consistent with broader climate disclosure trends and does not contradict the ground truth—it adds context without introducing error. (4) The answer is fully relevant to the question, addressing both regulatory impact on operations and customer expansion. The only minor gap is that the original emphasizes 'land and permitting constraints' more explicitly, while the LLM focuses on resource availability; this nuance is not critical enough to undermine correctness. Overall, the LLM conveys semantically equivalent information with strong reasoning and no factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 420,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "\n\nThe company's Guaranteed Senior Notes, issued by its Japanese subsidiary, evolved as follows between 2023 and 2024:  \n- **Issuance**: In November 2023, four Guaranteed Senior Notes totaling $500 million were issued at fixed rates of 1.400%–2.120%, valued using **Level 3 inputs** (2023).  \n- **Repayment**: In July 2024, $77 million of these notes was repaid, reducing the outstanding balance (2024).  \n- **Valuation**: The notes remained valued using **Level 3 inputs** in 2024, reflecting their complex, subsidiary-specific nature and lack of observable market data.  \n\nThis evolution reflects new issuances in late 2023 and partial repayment in mid-2024, with consistent Level 3 fair value classification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: four Guaranteed Senior Notes totaling $500 million were issued in 2023 at fixed rates of 1.400%–2.120%, valued using Level 3 inputs; $77 million was repaid in 2024. The LLM correctly specifies issuance in November 2023 and repayment in July 2024, which are consistent with the knowledge graph. (2) Quantitative accuracy is perfect: $500 million issuance, $77 million repayment, and correct interest rate range. While the original answer does not specify exact months, the LLM’s inclusion of November 2023 and July 2024 is plausible and does not contradict the ground truth. (3) The LLM correctly maintains that the notes were valued using Level 3 inputs in both years, which is consistent with the original answer. However, the LLM omits the broader context that the total fair value of long-term debt declined from $5,738 million to $5,412 million, which provides important valuation context. This is a minor omission but relevant to the 'valuation' aspect of the question. (4) The reasoning is sound, correctly synthesizing issuance, repayment, and fair value classification across years. The answer is semantically equivalent and highly relevant, with only the missing aggregate fair value figures preventing a perfect 10. Overall, the answer is factually correct, well-structured, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 391,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "\n\nFrom 2022 to 2024, Netflix increased investments in streaming service improvements and cybersecurity, with evolving risk exposure. In 2022, the company emphasized scaling infrastructure (e.g., CDNs, AWS reliance) and personnel growth to support streaming enhancements, while disclosing risks related to third-party service disruptions, technology failures, and cybersecurity threats. By 2024, Netflix strengthened its cybersecurity program under a **Vice President of Security and Privacy Engineering** (with over 30 years of experience), implementing advanced risk quantification models, regular audits, and third-party risk management. Cybersecurity measures expanded to include bug bounty programs, penetration testing, and board-level oversight via the Audit Committee. Despite these efforts, risks such as third-party vulnerabilities, evolving cyber threats, and potential disruptions from cloud providers (e.g., AWS) remained significant, reflecting a shift toward proactive risk mitigation while managing heightened exposure from expanded operations and technological complexity.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several details not present in the ground truth, particularly around specific personnel (e.g., 'Vice President of Security and Privacy Engineering with over 30 years of experience'), bug bounty programs, penetration testing, and board-level Audit Committee oversight. These specifics were not disclosed in the original answer and cannot be verified from the provided ground truth, introducing factual inaccuracies. The ground truth mentions a $384 million increase in personnel costs in 2022, but the LLM answer omits this key quantitative figure entirely, which is a major omission for quantitative accuracy. (2) There are no correct numbers cited from the original answer—specifically, the $384M personnel cost increase in 2022 is missing. The LLM introduces qualitative details about cybersecurity roles and programs without grounding them in the disclosed data, making the quantitative accuracy low. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift from growth-focused investment (2022) to increased cybersecurity focus (2024). It synthesizes the evolution of risk exposure over time and connects personnel and cybersecurity changes across years, which aligns with the question’s intent. However, it fabricates specific programmatic details not present in the source, weakening the reasoning's factual basis. (4) Despite the lack of numerical accuracy, the answer captures the general trajectory of Netflix’s strategic evolution—increased cybersecurity emphasis alongside streaming investment—and remains highly relevant to the question. The qualitative accuracy is moderate because core themes (shift to risk mitigation, third-party risks, cloud dependencies) are consistent with the ground truth, even if specifics are embellished. Contextual relevance is high as the response directly addresses personnel and cybersecurity changes across the specified timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 524,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "\n\nThe Bank of New York Mellon Corporation updated its restricted stock unit (RSU) agreements between 2023 and 2024, reflecting a structured approach to lifecycle management. In 2023, the 2024 RSU Agreement was filed (BK_10k_2023.pdf, p. 19), while the 2024 filing introduced the 2025 RSU Agreement (BK_10k_2024.pdf, p. 19), indicating annual revisions to align with evolving compensation strategies. This suggests a deliberate effort to refine vesting terms, performance conditions, or governance requirements. The continued use of RSUs as a core component of executive compensation underscores the company’s focus on long-term incentives to retain talent and align executive interests with shareholder value, while periodic updates ensure adaptability to regulatory or strategic priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in the 2023 filing, the '2024 Form of RSU Agreement' was filed (‘Filed herewith’), and in the 2024 filing, the '2025 Form' was introduced as newly filed—both key facts from the original answer. The dates, years, and sequence of forms are correct. (2) There are no numerical values requiring calculation, but the temporal references (2023 → 2024 → 2025 forms) are factually precise and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the model infers lifecycle management through annual updates and connects this to executive compensation strategy, including retention and alignment with shareholder value. It correctly interprets the shift from 'Filed herewith' to implied prior filing status, though it does not explicitly state that the 2024 form became 'Previously filed' in the 2024 report—a minor omission. (4) The answer is contextually excellent, addressing both lifecycle management and strategic implications. The only reason for not scoring a 10 is the lack of explicit mention of the transition of the 2024 form to 'Previously filed' status, which slightly reduces completeness in qualitative accuracy. However, the core evolution and strategic intent are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 366,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "\n\nThe 4.90% Senior Notes due April 2029 had a carrying amount of **$743 million** as of January 28, 2024 (fiscal 2023) and increased slightly to **$744 million** by February 2, 2025 (fiscal 2024), reflecting accretion of the discount over time. The maturity timeline remained unchanged, with the notes maturing in April 2029 in both periods. These notes were issued in November 2023 as part of a $750 million tranche, initially recorded at a discount of $3.4 million, and no structural changes (e.g., redemption terms or interest rate) were noted between 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error: it states the carrying amount increased to $744 million by February 2, 2025, while the ground truth only provides data up to January 28, 2024 ($743 million). The $744 million figure is not supported by the original answer and appears to be an extrapolation or error. Additionally, the original answer does not state any increase in carrying amount from 2023 to 2024—rather, it notes a slight decrease due to the discount and amortization. The LLM incorrectly frames the change as an 'increase' due to 'accretion,' which contradicts the ground truth's implication of a slight decrease. (2) Other numeric details are correct: the $750 million principal, $3.4 million discount, November 2023 issuance, and April 2029 maturity are all accurate. However, the use of 'fiscal 2023' and 'fiscal 2024' in reference to the dates may reflect a misunderstanding of reporting periods, though this is not explicitly contradicted. (3) The reasoning is partially sound: the LLM correctly identifies that the notes were issued in 2023 and remained outstanding in 2024 with no structural changes. It correctly synthesizes maturity and interest details. However, the claim about the carrying amount increasing to $744 million is unsupported and incorrect, indicating a failure in accurate multi-hop synthesis or data retrieval. (4) Contextual relevance is high—the answer addresses both carrying amount and maturity timeline as asked. The qualitative reasoning is mostly logical but undermined by the incorrect numerical trend. The core facts are present but the key financial evolution is misrepresented, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 463,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "\n\nBetween 2023 and 2024, Costco's Japanese subsidiary issued and repaid Guaranteed Senior Notes as follows: In November 2023, the subsidiary issued four Guaranteed Senior Notes totaling **$500 million** with fixed interest rates ranging from 1.400% to 2.120%. By July 2024, the subsidiary repaid **$77 million** of these notes. This repayment reduced the outstanding balance, reflecting a partial paydown of the 2023 issuance. The notes, valued using Level 3 inputs, had maturity dates spanning November 2033 to November 2043. The repayment is noted in the 2024 10-K, while the 2023 filing does not disclose prior activity specific to these Japanese subsidiary notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four Guaranteed Senior Notes in November 2023 totaling $500 million at fixed interest rates from 1.400% to 2.120%, and the repayment of $77 million in July 2024, which aligns with the ground truth. The amounts are accurate with proper formatting variations accepted ($500 vs $500 million). (2) All numeric values—$500 million issuance, $77 million repayment, interest rate range, and maturity dates (2033–2043)—are factually correct and consistent with the knowledge graph. The timing (November 2023 issuance, July 2024 repayment) adds precision not contradicted by the original answer. (3) The multi-hop reasoning is sound: the model synthesizes data across 2023 and 2024 filings, correctly noting that the 2023 filing does not reference prior activity for these notes and that the 2024 filing reports the repayment and use of proceeds as a financing activity. The mention of Level 3 inputs and maturity dates provides additional context supported by typical 10-K disclosures, though not explicitly in the ground truth; this does not detract from accuracy. (4) The answer is semantically equivalent and slightly more detailed than the original, with no factual errors. The only minor limitation is the addition of specific months (November, July) and valuation details (Level 3 inputs), which, while plausible and consistent, are not confirmed in the ground truth—hence a 9 instead of 10 on qualitative accuracy. Overall, the response is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 430,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "\n\nThe risk associated with competitors developing after-market parts for DHR's products was explicitly highlighted in 2023 (DHR_10k_2023.pdf, page 20) as a potential threat that could \"detract from our sales,\" reflecting a heightened awareness compared to 2022. In 2022 (DHR_10k_2022.pdf, page 23), the focus was broader, emphasizing competitors introducing private-label, generic, or low-cost products but not specifically addressing after-market parts. The 2023 disclosure indicates an evolution in recognizing after-market parts as a distinct competitive risk, likely due to increased market activity in this area. This shift could impact DHR's business by reducing sales and pricing power, potentially affecting revenue and profitability, though specific financial impacts are not quantified in the provided pages.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental misrepresentation of the evolution of risk from 2022 to 2023, reversing the actual trend described in the ground truth. According to the original answer, in 2022 the risk of competitors developing after-market parts was explicitly framed as a direct threat that could 'detract from our sales,' while in 2023 it was contextualized more broadly within industry-wide pricing pressures and relatively de-emphasized. However, the LLM claims the opposite: that the risk was *not* specifically addressed in 2022 and became a *new*, heightened concern in 2023. This is factually incorrect and inverts the true progression. The LLM incorrectly cites DHR_10k_2023.pdf page 20 for introducing the phrase 'detract from our sales,' but this language actually appeared in the 2022 filing (per ground truth), suggesting a misattribution. While there are no numerical figures to verify (so quantitative accuracy is not applicable in a meaningful way), the qualitative reasoning is flawed due to incorrect multi-hop synthesis—specifically, the comparison across years and the interpretation of risk trajectory. The answer does address the question's focus on business and financial impact by noting potential effects on sales and profitability, which is contextually relevant, but the underlying reasoning is based on a false premise. Thus, despite correct formatting and plausible language, the core factual and inferential content is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 412,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "\n\nFrom 2022 to 2024, Netflix evolved its membership plans by introducing **lower-priced ad-supported tiers** (e.g., extra member sub-accounts priced $2–$8/month) and adjusting pricing globally, with 2024 plans ranging from $1 to $32/month (vs. $2–$27 in 2022). The 2024 strategy emphasized **price increases** and **feature diversification**, such as live programming and games, to address challenges like **competition**, **member retention**, and **revenue growth** amid slowing subscriber growth. These changes aimed to counter piracy, attract budget-conscious users, and offset fixed content costs by boosting average revenue per member (up 6% in 2024 vs. 2023) while enforcing stricter terms to limit shared accounts. The ad-supported model specifically targeted price sensitivity and market expansion without compromising content investment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several inaccuracies, particularly in quantitative details. While it correctly identifies the introduction of an ad-supported tier and efforts to combat password sharing, many specific numbers are either fabricated or misaligned with the ground truth. For example, the claim that 2024 plans range from $1 to $32/month (vs. $2–$27 in 2022) is unsupported by the original answer, which does not provide specific price ranges. Similarly, the mention of 'extra member sub-accounts priced $2–$8/month' is not in the ground truth—Netflix’s strategy focused on enforcing terms to limit shared accounts, not selling sub-accounts at those prices. The 6% increase in average revenue per member in 2024 vs. 2023 is also not mentioned in the original answer, which only notes a 7% rise in 2022. (2) The original answer emphasizes that in 2022, revenue grew 19% due to an 11% membership increase and 7% rise in revenue per membership, but the LLM omits this entirely and instead invents later-year metrics. There is no mention in the ground truth of live programming or games as part of the 2024 membership evolution, weakening the feature diversification claim. (3) The reasoning partially captures the multi-hop intent: Netflix faced slowing growth (evidenced by 50% drop in net additions in 2022) and responded in 2024 with pricing and access changes to address competition and retention. This causal chain is reasonably inferred, though the LLM overreaches by adding unmentioned features and financials. (4) Despite factual inaccuracies, the answer is contextually relevant—addressing pricing, features, and business challenges—and captures the general strategic direction. However, the invention of specific dollar amounts, pricing tiers, and performance metrics significantly undermines quantitative accuracy, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 501,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "\n\nBetween 2022 and 2023, Boeing's approach to in-orbit incentive payments remained focused on performance risks but clarified financial recognition practices. In 2022 (page 45), the company highlighted that in-orbit payments are at risk if satellites fail to meet contractual criteria, potentially requiring refunds or charges. By 2023 (page 15), Boeing explicitly stated that the **net present value of expected in-orbit incentive fees is recognized as revenue during the construction period**, rather than deferring recognition until post-acceptance. This shift reflects earlier financial recognition of these incentives, while risk exposure remains tied to long-term satellite performance (up to 15 years post-acceptance). The 2023 disclosure emphasizes upfront revenue recognition but retains the same performance-based risk profile as 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Boeing's approach to in-orbit incentive payments between 2022 and 2023, focusing on risk exposure and financial recognition. It accurately notes that in 2022, Boeing highlighted performance risks tied to in-orbit payments, including potential refunds or charges if satellites fail to meet criteria. In 2023, it correctly identifies the key shift: revenue recognition of the net present value of expected in-orbit incentive fees during the construction period, increasing financial exposure if performance issues arise post-acceptance. The answer also correctly notes the 15-year performance risk window. However, it omits a critical quantitative element from the original answer: the $1,585 million in additional losses recorded in 2023 on Boeing’s five major fixed-price development programs. This is a significant factual omission affecting quantitative accuracy. While the qualitative reasoning and synthesis across years are strong—correctly identifying the shift from general risk acknowledgment to more specific financial recognition practices—the absence of this key figure reduces completeness and numerical precision. The entities (Boeing, years, program types) and contextual details (pages cited, revenue recognition timing, performance criteria) are accurate. The answer is highly relevant and semantically aligned with the ground truth, but the missing dollar amount prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 409,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "\n\nThe disclosure and accessibility of the Directors' Code of Conduct remained consistent between 2023 and 2024, with both filings stating it is posted on BNY Mellon’s website at **https://www.bnymellon.com**. However, the 2024 filing (page 3) explicitly included the Directors' Code of Conduct in the **\"Available Information\"** section, which lists all publicly accessible documents, enhancing its visibility. Both years committed to disclosing amendments or waivers to the code on the website, but the 2024 filing emphasized improved organization by integrating it into a centralized disclosure framework, potentially improving stakeholder accessibility. No substantive changes to the code’s content were noted.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant inaccuracies in describing the evolution of disclosure and accessibility. While it correctly notes that the Code was posted on the website in both years and that amendments/waivers would be disclosed, it incorrectly claims that the 2024 filing 'explicitly included' the Directors' Code of Conduct in the 'Available Information' section with enhanced visibility. The ground truth states the opposite: in 2024, the direct URL was no longer provided and the Code was referenced more generally among other governance materials, indicating reduced specificity, not improved visibility. This misrepresents the nature of the change. (2) Quantitatively, there are no numerical values to verify (no dollar amounts, percentages, or counts), but the mention of 'page 3' in the 2024 filing is an unsupported detail not present in the ground truth. Otherwise, the URL mentioned is correct as it matches the domain in the original answer, though the full path is omitted. (3) The multi-hop reasoning is flawed: the model fails to recognize that moving from a specific URL citation to a general reference represents a reduction in direct disclosure, not an enhancement. It incorrectly interprets consolidation as improved accessibility, whereas the ground truth describes a shift to a less direct approach. The synthesis across years is therefore inaccurate. (4) Despite these issues, the answer is contextually relevant—addressing the right topic, company, document, and time frame—and correctly notes the ongoing commitment to post amendments. However, the core conclusion about improved visibility contradicts the ground truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 464,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "\n\nBetween 2022 and 2023, Mobileye Drive™ evolved from initial deployment partnerships to a more scalable and integrated autonomous driving strategy. In 2022, Mobileye launched its SAE L4 Mobileye Drive system, securing collaborations for autonomous cargo delivery (Udelv) and mobility services (Transdev), and announced Robotaxi services in Germany via SIXT. By 2023, the deployment strategy expanded to include supplying the self-driving system to transportation network companies, public transit operators, and AV-ready platforms, with plans to bundle it with Moovit’s mobility app. Hardware advancements also progressed, with the introduction of the EyeQ6L and EyeQ6H chips (supporting L2+ to L4 systems) in 2023 and the announcement of the high-performance EyeQ Ultra SoC for 2025. Additionally, Mobileye emphasized True Redundancy™ (combining camera and radar/LiDAR systems) and leveraged REM mapping for enhanced L2/L4 capabilities, reflecting a more matured, scalable approach to autonomous driving.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the 2022 launch of Mobileye Drive™ as an SAE L4 system and accurately mentions key collaborations with Udelv (autonomous cargo) and Transdev (mobility services). It also correctly notes the expansion in 2023 to target transportation network companies, public transit operators, and AV-ready platforms, along with the bundling strategy with Moovit—core elements from the original answer. The addition of SIXT for Robotaxi services in Germany is factually correct and consistent with Mobileye's 2022 strategy, though not included in the ground truth; this represents a valid expansion rather than an error. The mention of EyeQ6L, EyeQ6H, and EyeQ Ultra SoC is accurate for 2023 developments and reflects broader strategic context, even if not in the original answer. Similarly, True Redundancy™ and REM mapping are correctly attributed as technical enablers. These additions enhance completeness without introducing inaccuracies. All entities, years, and strategic shifts are correctly identified. The only minor deviation is that the original answer emphasizes the Geely design win in 2022, which the LLM omits—this is a small but notable omission in completeness, preventing a perfect 10. Quantitative accuracy is flawless: no incorrect numbers, dates, or financial figures. Reasoning is sound, showing a clear evolution from initial partnerships to a scalable MaaS-focused strategy. The answer synthesizes multi-hop information correctly across time, partners, and strategic direction. Contextual relevance is excellent, directly addressing the evolution of role and deployment strategy. Overall, the answer is factually robust, slightly enriched with accurate supplementary details, and semantically equivalent to the ground truth with high qualitative and quantitative fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 506,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "\n\nFrom 2022 to 2024, the structure and distribution rates of AT&T's Tower Preferred Interests evolved significantly. In 2022, the Tower Holdings preferred interests consisted of two fixed-rate series: Class A-1 (5.0%) and Class A-2 (4.75%), with rates set to reset in December 2024. By August 2024, these were restructured into **Fixed Rate Class A** (5.90%) and **Floating Rate Class A** (SOFR + 250 bps) interests, with a phased conversion of a portion to floating rates annually over five years. This marked an increase in the fixed rate (from 4.75–5.0% to 5.90%) and introduced a floating rate component tied to market conditions, enhancing flexibility while altering the distribution profile. The amended terms also allowed for earlier call options and reclassified the interests under \"Noncontrolling interest\" on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the Tower Preferred Interests from 2022 to 2024. (1) Quantitatively, all key numbers are correct: the 2022 series (Class A-1 at 5.0%, $1,500; Class A-2 at 4.75%, $4,500) and the 2024 changes (Fixed Rate at 5.90%, Floating Rate at SOFR + 250 bps) match the ground truth. The August 2024 amendment date is correctly implied by 'by August 2024'. (2) The answer correctly notes the reset timing (rates set to reset in December 2024), which aligns with the original 'reset every five years' clause from 2019, though the LLM slightly misattributes the reset to 2022 issuance—this is a minor inaccuracy since the reset applies to the 2019 interests. (3) The qualitative reasoning is strong: it identifies the structural shift from two fixed-rate series to a hybrid fixed/floating structure, the annual transition mechanism, and the economic implications (increased rate, market linkage). (4) The addition of 'earlier call options' and 'reclassified under Noncontrolling interest' is not in the ground truth and cannot be verified—this is a minor overreach but doesn't contradict known facts. Overall, the answer conveys semantic equivalence with excellent multi-hop synthesis across time and structure, warranting a high score. Minor deduction in qualitative accuracy due to unverified balance sheet classification and slight misstatement on reset timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 390,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "\n\nThe investment approach for Level 3 assets related to the Balanced Index Fund showed a reduction in total assets from $268 million in 2022 to $226 million in 2023, driven by net transfers out of Level 3 ($44 million) and lower net purchases. Unrealized gains/(losses) improved significantly, shifting from a $90 million loss in 2022 to a $14 million gain in 2023. This improvement was led by gains in corporate fixed income ($5 million in 2023 vs. $19 million loss in 2022) and mortgage-backed securities ($7 million gain in 2023 vs. $11 million loss in 2022), reflecting better market conditions and reduced exposure to lower-transparency assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, in 2022, unrealized losses were ($16) million for corporate fixed income and ($11) million for mortgage-backed/asset-backed securities, not $19 million and $11 million losses as stated. In 2023, the correct unrealized gains are $2 million and $6 million respectively, not $5 million and $7 million. The total unrealized loss/gain figures of $90 million loss in 2022 and $14 million gain in 2023 are entirely fabricated and not supported by the original data. Additionally, the claim of total Level 3 assets decreasing from $268M to $226M and $44M net transfers are not mentioned in the ground truth, making them incorrect additions. (2) Calculations are not verifiable because the totals provided do not align with the sum of the components in either year. For example, the ground truth shows a net improvement from ($27M) total unrealized losses in 2022 to ($8M) gains in 2023 (a $35M turnaround), but the LLM claims a shift from $90M loss to $14M gain (a $104M improvement), which is grossly inaccurate. (3) The multi-hop reasoning is partially sound in that it attempts to compare changes in unrealized gains/losses across years and links them to market conditions, but it fails to correctly identify or synthesize the actual disclosed values. The mention of valuation methodology evolving to a market approach (Level 1) in 2023 — a key qualitative shift — is completely omitted, weakening the analysis of the investment approach evolution. (4) The contextual relevance is moderate because the answer addresses the general theme of performance change and asset allocation, but due to severe quantitative errors and missing key disclosures about valuation methodology, the correctness score is low. Minor credit is given for recognizing a directional improvement in performance, which aligns with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 522,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "\n\nBNY Mellon's emphasis on accounting developments in its forward-looking statements shows a shift from a general risk factor in 2023 to an integrated strategic consideration in 2024. In 2023, accounting developments were listed alongside regulatory, market, and technology risks as external factors impacting business. By 2024, the company explicitly tied accounting developments to strategic priorities, including transitions to a \"platforms operating model,\" efficiency savings, and acquisitions. This evolution reveals that accounting standards are increasingly shaping BNY Mellon’s operational and strategic decisions, reflecting a proactive alignment of financial reporting requirements with business transformation initiatives. The heightened integration suggests accounting standards now directly influence how the company structures its growth, cost management, and long-term operational frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the evolution from a general mention in 2023 to a more integrated and strategic emphasis in 2024 is accurately described. The LLM correctly identifies that in 2023, accounting developments were listed among other broad risk factors, and in 2024, they were more explicitly tied to business impacts. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the absence of numbers does not detract from correctness. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure language across years and infers strategic implications—such as the connection to efficiency savings and business transformation—which is consistent with the ground truth’s mention of 'efficiency savings' and 'capital plans.' The LLM adds contextual interpretation (e.g., 'platforms operating model') that is plausible and aligns with BNY Mellon’s known strategic direction, though slightly more interpretive than the original. (4) The only minor deviation is that the original answer specifically notes the expanded 2024 phrasing includes 'regulatory, technology, market, economic or accounting developments' and ties impacts to 'businesses, capital plans including dividends and repurchases.' The LLM captures the essence but does not quote or reflect the exact expansion of the list or mention dividends and repurchases explicitly. However, it compensates by correctly identifying strategic linkages. Overall, the answer is semantically equivalent, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 465,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "\n\nIn 2023, risks related to store safety (e.g., organized retail crime, shrinkage) and cybersecurity (e.g., data breaches, system disruptions) introduced operational and compliance challenges that likely diverted resources and focus from the engagement initiatives emphasized in 2022. While 2022 prioritized associate engagement through training, compensation enhancements, and inclusive culture programs, 2023’s evolving risks necessitated increased investments in security measures (e.g., store safety protocols, cybersecurity defenses) and operational adjustments, potentially creating a more stressful work environment and diverting attention from engagement efforts. Additionally, cybersecurity threats could erode trust in internal systems, while store safety concerns may heighten associate anxiety, impacting morale and retention despite prior engagement-focused initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the shift from 2022 engagement initiatives (training, compensation, inclusive culture) to 2023 focus on store safety risks like organized retail crime and cybersecurity threats is accurately portrayed. While the original answer specifies HD (Home Depot) and notes that four out of five associates were emotionally committed, the LLM answer omits the specific statistic and company name but still captures the essence of prior engagement success. (2) There are no numeric inaccuracies—no incorrect figures, dates, or calculations are present. The years 2022 and 2023 are correctly attributed to their respective contexts. (3) The multi-hop reasoning is sound: the LLM correctly infers that increased focus on external risks in 2023 could divert resources and attention from engagement efforts, potentially impacting morale, trust, and retention—this synthesis across years and domains (engagement vs. risk) is logically and contextually valid. (4) The answer is contextually excellent, directly addressing how evolving risks in 2023 may have undermined the associate experience improvements pursued in 2022. The only minor shortcoming is the omission of the specific 'four out of five emotionally committed' data point, which slightly reduces completeness but does not affect the overall correctness. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to strong reasoning with a minor detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 440,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "\n\nThe role of the 'learning curve' in influencing cost and production estimates remained a critical factor in both 2022 and 2023, but its impact on program profitability and risk management became more complex in 2023 due to heightened operational and external challenges. In 2022, the learning curve was explicitly cited as a factor affecting cost reductions and production efficiency, alongside risks like supplier delays and regulatory hurdles (2022, p. 42). By 2023, while the learning curve continued to influence cost estimates, its effectiveness was increasingly constrained by persistent supply chain disruptions, regulatory scrutiny, and production instability (2023, p. 49). This evolution underscored greater uncertainty in achieving anticipated cost savings, leading to more frequent reassessments of program profitability and increased risk of earnings charges, particularly for programs like the 767, 777X, and 787 operating near break-even margins (2023, p. 49). The heightened focus on risk management reflected the growing interplay between learning curve assumptions and external disruptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct contextual elements but diverges significantly from the ground truth in terms of the core evolution of the 'learning curve' concept. (1) What was correct: The answer correctly identifies that the learning curve influenced cost and production estimates in both years and references relevant programs (787, 777X), maintaining contextual relevance. It also accurately situates the learning curve within broader risk factors like supply chain and regulatory issues. (2) Quantitative accuracy: There are no explicit numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so no numeric inaccuracies are present. Page citations (p. 42, p. 49) may be accurate but cannot be verified against the ground truth source; however, they do not contradict the knowledge graph. (3) Multi-hop reasoning assessment: The LLM fails the key multi-hop insight—while the ground truth states that the learning curve shifted from being a 'risk factor' in 2022 to an 'integrated, predictable component' of cost estimation in 2023, the LLM instead claims the learning curve became *more constrained* and *less effective*, implying increased uncertainty. This is the opposite of the documented evolution. The ground truth describes a maturation of modeling and planning; the LLM describes degradation due to external pressures. (4) Justification for scores: Correctness is scored low (4) because the central claim about the evolution of the learning curve’s role is factually incorrect. Qualitative accuracy is moderate (5) as the answer demonstrates understanding of related risks but misrepresents the strategic shift. Quantitative accuracy is high (8) due to absence of numerical errors. Contextual relevance is solid (7) as it addresses the right programs, timeframes, and themes, even if the synthesis is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 499,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "\n\nThe disclosure regarding officer and director participation in the Dividend Reinvestment Plan remained consistent between the 2023 and 2024 SEC filings. Both filings state that certain officers and directors participate in the plan and may utilize trading arrangements, including elections to have shares withheld to cover withholding taxes or exercise prices of stock awards. These arrangements are noted as either complying with Rule 10b5-1 under the Exchange Act or constituting non-Rule 10b5-1 trading arrangements (as defined in Item 408(c) of Regulation S-K). No material changes in the treatment or additional details about the plan’s structure or participation were disclosed in 2024 compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the disclosure remained consistent between 2023 and 2024, when the ground truth explicitly states that the 2024 filing omitted the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements that was present in 2023. This omission represents a material change in disclosure specificity, contradicting the LLM's assertion of 'no material changes.' While the LLM correctly identifies that officers and directors participate in the Dividend Reinvestment Plan and may use share withholding for tax or exercise price purposes, it fails to capture the key evolution in disclosure: the removal of detailed trading arrangement frameworks in 2024. There are no numerical values in the question or answer, so quantitative accuracy is not applicable in a meaningful way—however, since no numbers were misstated, it scores high by default. The qualitative accuracy is low because the model misrepresents the multi-hop comparison across years, failing to synthesize the change in regulatory disclosure detail. Contextual relevance is moderate because the answer addresses the right topic and entities (officers, directors, dividend reinvestment, trading arrangements) but draws an incorrect conclusion about the evolution of disclosure. The answer would have been correct if it had noted the simplification or reduction in detail in the 2024 filing, but instead it asserts consistency, which is directly contradicted by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 411,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "\n\nThe Home Depot's investment in creating an interconnected shopping experience evolved significantly from fiscal 2021 to 2023. In fiscal 2021, the company focused on foundational investments, such as enhancing digital properties (e.g., mobile optimization, product search capabilities, and fulfillment options like BOPIS/BODFS) to blend online and in-store experiences. By fiscal 2023, the strategy advanced to leverage data analytics and merchandising IT tools to tailor experiences more precisely to **shopping intent and location**, while expanding services like installation and tool rentals. Specific changes included:  \n1. **Personalization**: Enhanced marketing messaging and product recommendations based on customer behavior and preferences.  \n2. **Localization**: Adjusting product assortments and inventory to meet regional demand, supported by supply chain collaboration.  \n3. **Technology Integration**: Investments in mobile app features (e.g., store navigation, real-time inventory checks) and tools to optimize inventory and pricing dynamically.  \n4. **Seamless Fulfillment**: Expanding options like curbside pickup and same-day delivery, supported by supply chain infrastructure upgrades.  \n\nThese efforts aimed to create a frictionless journey across channels, from inspiration to post-purchase support, while deepening engagement with both DIY and professional customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of The Home Depot's strategy from fiscal 2021 to 2023 accurately and provides a detailed, contextually relevant expansion on how the interconnected shopping experience was tailored. However, it omits the specific $2.6 billion capital expenditure figure from fiscal 2021 mentioned in the ground truth, which is a key quantitative element. While the qualitative description of advancing from foundational investments to data-driven personalization aligns with the original answer—especially the shift toward shopping intent and location—the absence of this number reduces quantitative accuracy. The LLM adds plausible details (e.g., BOPIS/BODFS, mobile app features, installation services) that are consistent with Home Depot’s known initiatives but are not present in the ground truth, making them reasonable inferences but not verifiable from the provided knowledge graph. The multi-hop reasoning is sound: it correctly identifies the progression over time and synthesizes changes in personalization, localization, and technology. The entities (The Home Depot, fiscal years 2021–2023, customer experience focus) are accurate. The answer is semantically aligned with the original and highly relevant, earning full marks for contextual relevance. The qualitative accuracy is high due to logical structure and correct identification of strategic shifts, though some specifics (like the exact nature of 'enhanced merchandising IT tools') are elaborated beyond the source without contradiction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 419,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "\n\nThe financial relationship between Danaher (DHR) and Aldevron between 2022 and 2023 primarily reflects the integration of Aldevron following its acquisition in August 2021 for $9.6 billion (as disclosed in 2022 filings). In 2022, DHR allocated approximately $1.5 billion to capital expenditures, partly driven by Aldevron’s integration and production capacity expansions. By 2023, there were no new acquisition-related expenditures for Aldevron, as the acquisition was already completed. Instead, Aldevron’s financial impact in 2023 is evident in the Life Sciences segment’s growth, with sales rising to $7.14 billion (from $7.04 billion in 2022), reflecting ongoing operational contributions post-acquisition. No additional capital investments or acquisitions involving Aldevron were disclosed for 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $1.5 billion capital expenditure in 2022 and links it to Aldevron integration and capacity expansion, which aligns with the ground truth. However, it incorrectly states that the acquisition occurred in August 2021 for $9.6 billion, while the ground truth indicates that the net cash consideration paid in 2023 was $9,561 million (~$9.56 billion), suggesting the primary financial outlay occurred in 2023, not 2021. This is a major factual discrepancy. (2) The LLM cites Life Sciences segment sales growth from $7.04B to $7.14B, but this data is not present in the original answer and is irrelevant to the question about capital investment and acquisition-related expenditures. The original answer does not mention segment sales, so this is extraneous and potentially misleading. The $9.6B figure is close to the $9,561M (i.e., $9.561B), but the timing is wrong—attributing the full acquisition cost to 2021 contradicts the ground truth that the cash consideration was paid in 2023. (3) The multi-hop reasoning is partially sound—linking capital expenditures in 2022 to Aldevron and recognizing that no new acquisition spending occurred in 2023 reflects some correct synthesis. However, it fails to recognize that the 2023 net cash consideration of $9,561 million represents a major financial outflow related to the acquisition, which is central to the evolution of the financial relationship. Instead, the LLM implies the acquisition was fully completed earlier, which contradicts the ground truth. (4) The correctness score is 5 due to significant factual errors in timing and amount of acquisition payment, despite some accurate context on capex. Quantitative accuracy is 5 because while $1.5B capex is correct, the $9.6B acquisition figure is misattributed in timing and slightly off in amount. Qualitative accuracy is 5 due to flawed reasoning about when the acquisition was financially realized. Contextual relevance is 8 because the answer addresses the right topic and timeframe, even if with errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 568,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "\n\nFrom 2022 to 2024, Telco LLC's preferred interests evolved significantly. In 2022, Telco LLC had $2,000 in preferred interests (Class A-1) with a 4.25% annual distribution rate and a seven-year reset schedule. By 2024, the structure expanded: in April 2023, AT&T issued an additional $5,250 of preferred interests (Classes A-2 and A-3), increasing the total value to $7,250. The new classes (A-2 and A-3) carried a higher initial distribution rate of 6.85% annually, with resets scheduled for November 1, 2027, and every seven years thereafter. The original Class A-1 retained its 4.25% rate and seven-year reset schedule (first reset in 2027). This restructuring increased both the total value and the average distribution rate of Telco LLC's preferred interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: the initial $2,000 in preferred interests (Class A-1) with a 4.25% distribution rate, the April 2023 issuance of $5,250 in new preferred interests (Classes A-2 and A-3), the resulting total of $7,250, and the 6.85% rate with resets starting November 1, 2027, are all correct. The statement that the original Class A-1 retains its 4.25% rate and seven-year reset (first reset in 2027) aligns with the ground truth, even though the original answer did not explicitly restate this—this is a reasonable inference. The only minor issue is the mention of 'AT&T issued' the new preferred interests, whereas the ground truth attributes the issuance to Telco LLC. This introduces a slight entity inaccuracy, as AT&T may be related but is not the entity specified in the original answer. However, this does not materially distort the capital structure evolution. The reasoning is sound, multi-hop synthesis is correct (combining 2022 baseline with 2023 issuance and 2024 outcome), and the conclusion about increased total value and average distribution rate is logically supported. All parts of the question—structure, total value, distribution rates, and reset schedules—are addressed with high fidelity. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 374,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "\n\nAIG's use of Expected Loss Ratio Methods between 2022 and 2024 evolved with a continued focus on **high-severity, low-frequency insurance lines** such as U.S. Property, Aviation, and Workers' Compensation, while adapting to structural changes in risk profiles. In 2022, these methods were primarily applied to the **latest accident year** for short-tail lines like U.S. Property and program business, leveraging earned premium and IBNR factors to account for emerging claim trends and inflation. By 2024, the rationale expanded to address **increased complexity in risk-sharing structures** (e.g., large deductibles and self-insured retentions), which slowed claim reporting and necessitated more dynamic reserve adjustments. For example, in U.S. Workers’ Compensation, the proportion of large deductible business grew, prompting greater reliance on Expected Loss Ratio Methods to reflect altered claim emergence patterns. Additionally, ADC agreements (adverse development reinsurance) in 2024 influenced reserve methodologies by transferring a portion of long-tail risk, allowing AIG to refine its application of these methods in lines like U.S. Excess Casualty. Overall, the evolution reflects a strategic shift toward aligning reserve practices with evolving underwriting structures and claim severity dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces significant inaccuracies and overreaches in scope compared to the ground truth. (1) Correctly identifies that Expected Loss Ratio Methods were used in 2022 for short-tail, high-severity lines and mentions aviation, which aligns with the original answer. It also correctly notes expansion by 2024, including U.S. Workers' Compensation, which matches the ground truth. However, the original answer does not mention U.S. Property, program business, ADC agreements, or U.S. Excess Casualty as part of the evolution in Expected Loss Ratio Methods—these are unsupported additions. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not penalized; the dates (2022, 2024) are correct and consistently used. (3) The multi-hop reasoning is partially sound—there is an attempt to link method evolution to risk structure changes like large deductibles and reinsurance agreements—but these specific drivers (e.g., ADC agreements influencing Expected Loss Ratio use) are not present in the ground truth and represent speculative elaboration. The core evolution—expansion from short-tail to include long-tail lines like Workers' Compensation—is correct and reflects proper synthesis. (4) The answer is contextually relevant and well-structured, but the inclusion of unverified lines of business and rationale (e.g., inflation, IBNR factors, adverse development reinsurance) reduces factual accuracy. The ground truth emphasizes methodological expansion across claim types (short-tail to long-tail), while the LLM overcomplicates with unsupported strategic and structural justifications. Thus, while key facts are present, the added detail introduces material inaccuracies, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 494,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "\n\nTarget's approach to owned brands evolved from 2023 to 2024 by shifting strategic emphasis toward **expanding its portfolio with new, price-focused lines** and **scaling high-performing brands**. In 2024, the company launched *dealworthy*—a low-price essentials line—and expanded existing brands like Auden, Cat & Jack, Gigglescape, and up&up, with 11 owned brands surpassing $1 billion in annual sales. This reflects a deliberate focus on differentiation through exclusive products (e.g., wellness items, celebrity collaborations) and value-driven assortments. In contrast, 2023 emphasized margin optimization and maintaining existing owned brands, as seen in reduced promotional markdowns and a broader but less dynamic portfolio. The 2024 strategy underscores innovation and market expansion, leveraging owned brands to drive loyalty and compete on both price and uniqueness.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific details not present in the ground truth, such as the launch of 'dealworthy', expansion of brands like Auden, Cat & Jack, Gigglescape, and up&up, and the claim that 11 owned brands surpassed $1 billion in annual sales. These specific numbers and brand names are not supported by the original answer and cannot be verified from the provided ground truth. The ground truth only states that Target listed over 40 distinct brands by 2024, with no mention of sales figures, billion-dollar brands, or specific new product lines. (2) Quantitative accuracy is low because the LLM asserts precise financial performance (11 brands over $1B in sales) and specific new brand launches without corroboration in the ground truth. These are significant factual additions that alter the factual basis of the response. (3) The reasoning partially aligns with the multi-hop requirement—there is an attempt to contrast 2023 and 2024 strategies—but the synthesis is based on fabricated or unsupported details rather than the actual evolution described (from strategic emphasis on expansion in 2023 to concrete execution and diversification in 2024). The core idea of a shift toward more active development in 2024 is directionally consistent, but the supporting evidence is inaccurate. (4) Contextual relevance is high because the answer addresses the evolution of Target's owned brands strategy across the two years and discusses strategic emphasis and portfolio development as asked. However, correctness score is low due to the introduction of unverified specifics that contradict the factual sparsity of the ground truth. The original answer emphasizes a shift from strategic intent to execution with over 40 brands, while the LLM overreaches with unsupported granularity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 489,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "\n\nIBM's continued listing of the 0.875% Notes due 2030 alongside the new 2.900% Notes due 2030 in 2024 suggests a **strategic approach to debt management** and reflects **favorable long-term borrowing conditions**. By retaining the lower-coupon 2030 notes while issuing new higher-coupon notes of the same maturity, IBM likely aims to diversify its debt structure, lock in lower rates for existing obligations, and access additional capital without retiring the older, cheaper debt. This indicates confidence in maintaining access to capital markets at competitive rates, even as broader interest rates may have risen. The issuance of new notes at a higher coupon also implies IBM is leveraging current market demand for its debt to raise funds, potentially for growth initiatives like hybrid cloud and AI, while managing refinancing risks by extending maturities and spreading interest cost exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key entities (IBM, 0.875% Notes due 2030, 2.900% Notes due 2030), years (2024 listing), and the quantitative facts (interest rates of 0.875% and 2.900%), so quantitative accuracy is perfect. Contextual relevance is high as the response directly addresses IBM's debt strategy and market conditions. However, the qualitative reasoning contains a significant error: the LLM interprets the higher coupon rate on the new notes as indicating 'favorable long-term borrowing conditions,' which contradicts the ground truth. In reality, the jump from 0.875% to 2.900% for the same maturity (2030) suggests *less favorable* market conditions in 2024 compared to when the original notes were issued (2023), not favorable ones. The ground truth correctly frames this as potentially reflecting higher interest rates or targeting different investor segments. The LLM’s conclusion that IBM is accessing capital at 'competitive rates' and has 'confidence in maintaining access' misreads the implications of higher borrowing costs. While the idea of diversifying debt and managing refinancing risk is correctly identified (aligning with the ground truth), the flawed interpretation of market conditions undermines the reasoning. Thus, while some strategic elements are accurate, the core inference about market conditions is incorrect, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 386,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "\n\nThe 4.000% Global Notes due June 1, 2049 (trading symbol T 49A) were part of AT&T's long-term debt in both 2022 and 2024, indicating no change in this specific instrument. However, in 2024, AT&T added two new long-term notes: **5.350% Global Notes due November 1, 2066 (TBB)** and **5.625% Global Notes due August 1, 2067 (TBC)**. These longer-term, higher-coupon notes were not listed in the 2022 10-K, reflecting an expansion of AT&T's debt maturity profile and increased reliance on long-term financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies. According to the ground truth, AT&T added the 4.300% Global Notes due November 18, 2034 (T 34C) in 2024, not the 5.350% due 2066 (TBB) and 5.625% due 2067 (TBC) as claimed by the LLM. These latter notes are entirely incorrect and not supported by the original answer. The 4.000% Global Notes due 2049 (T 49A) were correctly identified as present in both years. However, the core of the answer — the new debt instruments — is wrong in terms of coupon rates, maturity dates, and trading symbols. This results in a major failure in quantitative accuracy (dates, percentages, instrument identifiers) and qualitative accuracy (incorrect entity identification and synthesis). The reasoning structure is sound — recognizing that AT&T expanded its debt portfolio — but it is based on fabricated instruments. Contextual relevance is moderate because the answer addresses the evolution of long-term debt and attempts to compare 2022 and 2024, but the incorrect instruments undermine the conclusion. Multi-hop synthesis was attempted but failed due to incorrect data retrieval or hallucination.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 321,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "\n\nThe financial impact of the Heritage AspenTech acquisition evolved as follows between 2023 and 2024:  \n- **Intangibles Amortization**: In 2023, amortization related to the Heritage AspenTech acquisition was $258 million (part of total $482 million in intangibles amortization). By 2024, total intangibles amortization rose to $1,077 million, with $560 million attributed to the National Instruments (NI) acquisition; the remaining $517 million included ongoing amortization from Heritage AspenTech and other intangibles.  \n- **Restructuring Costs**: Restructuring costs increased from $72 million in 2023 to $228 million in 2024, driven by larger workforce reductions (2,250 positions in 2024 vs. 700 in 2023) and facility exits (22 in 2024 vs. 10 in 2023), reflecting broader operational restructuring efforts.  \n\nThis highlights a significant rise in both amortization expenses (due to new acquisitions and ongoing Heritage AspenTech integration) and restructuring costs in 2024 compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, intangibles amortization for Heritage AspenTech decreased from $258 in 2023 to $97 in 2024. However, the LLM claims it was $258 million in 2023 (partially correct, assuming '258' implies millions) but incorrectly states that Heritage AspenTech amortization was part of a $517 million figure in 2024, with no clear isolation of the $97 actual value. Instead, it suggests ongoing amortization is embedded in a larger pool, contradicting the ground truth specificity. The restructuring costs are correctly stated as $72 million in 2023 and $228 million in 2024, which matches the ground truth. (2) Quantitative accuracy fails on the amortization evolution: the LLM implies amortization increased due to Heritage AspenTech and other factors, when in fact it decreased significantly from $258 to $97. This is a critical error in both magnitude and direction. The introduction of National Instruments acquisition ($560M) and total intangibles ($1,077M) adds context not present in the original question or ground truth, introducing irrelevant data that misleads the analysis. (3) The reasoning is flawed in multi-hop synthesis: the question specifically asks about the financial impact of the *Heritage AspenTech* acquisition, but the LLM conflates it with other acquisitions (NI), failing to isolate the correct amortization trend for the specified acquisition. It incorrectly infers that Heritage AspenTech amortization remains high, when it actually declined. (4) Contextual relevance is strong—structure, focus on amortization and restructuring, and use of comparative language are appropriate. However, the core financial facts—especially the amortization trajectory—are incorrect, severely undermining correctness. The answer gets partial credit for correct restructuring numbers and correct year references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 515,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "\n\nAIG's use of expected loss ratio methods for U.S. Workers' Compensation between 2022 and 2024 evolved with increased segmentation and adjustments for large deductible accounts. In 2022, expected loss ratios were primarily applied to **guaranteed cost business** in the most recent accident year, with segmentation by state (e.g., California and New York) and industry subsets. By 2024, the methodology expanded to **excess of deductible business**, where expected loss ratios were given significant weight in the **most recent five accident years**, reflecting the growing proportion of large deductible accounts, which slowed claim reporting patterns. \n\nAIG also enhanced segmentation for excess of deductible business by **deductible size** and whether claims were handled internally or by third-party administrators. Additionally, expected loss ratios for recent years were adjusted for **rate changes, loss trends (including inflation), and market conditions**, reflecting a more dynamic approach to account for evolving risk profiles. The increased use of large deductible structures further necessitated refined reserving techniques to address delayed claim emergence and greater complexity in loss estimation.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and captures the evolution of AIG's use of expected loss ratio methods between 2022 and 2024, particularly regarding segmentation and large deductible accounts. However, there are some inaccuracies and omissions that affect qualitative accuracy. (1) The LLM incorrectly states that in 2022, segmentation was done by state and industry subsets—this level of detail is not present in the ground truth and may be speculative. (2) The LLM reverses the application timeline: it claims that by 2024, expected loss ratios were expanded to excess of deductible business, but the original answer states that in 2022, expected loss ratios were already given significant weight for excess of deductible business over five accident years. Thus, the evolution is misrepresented—the methodology was already applied to excess of deductible in 2022, not newly expanded in 2024. (3) The LLM adds details not in the original, such as adjustments for rate changes, loss trends, and market conditions, which, while plausible, are not mentioned in the ground truth and introduce unsupported enhancements. (4) The correct emphasis on segmentation by deductible size and claim handling (AIG vs. TPA) in 2024 is accurately noted. (5) The point about large deductible accounts slowing claim reporting is correctly identified in both years. (6) The LLM fails to mention the 2024-specific disclosure about limitations in claim count data due to aggregation and reinsurance exclusions—a key differentiator in the original answer. Quantitative accuracy is high as no incorrect numbers or dates are provided (e.g., 'most recent five accident years' is correctly cited). Contextual relevance is strong as the response directly addresses the evolution, segmentation, and impact of large deductible accounts. However, due to the misrepresentation of the timeline and inclusion of unsupported details, the correctness score is reduced to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 525,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "\n\nTarget enhanced its cybersecurity threat investigation and response from 2023 to 2024 by expanding the role of its **Cyber Fusion Center** as a central hub for proactive threat intelligence and incident response, with a coordinated escalation model involving management and the Board of Directors. In 2024, the company emphasized **deepened collaboration with external organizations** across industries to share best practices, address evolving regulatory environments, and advance collective cybersecurity capabilities, building on 2023 efforts to fight cybercrime and enhance privacy frameworks. These steps reflect a more integrated and proactive approach to threat management and cross-industry partnership.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Target's cybersecurity approach from 2023 to 2024. It accurately notes the continued operation of the Cyber Fusion Center and the introduction of a coordinated escalation model involving management and the Board of Directors in 2024, which reflects a more structured incident response program—this matches the original answer. The emphasis on collaboration with external organizations across industries is correctly mentioned as a continuity from 2023 into 2024. However, the LLM answer omits specific new elements from 2024 highlighted in the ground truth: (1) regular training and compliance activities for team members, and (2) the use of third-party vendors to assess and test the cybersecurity program. These omissions are notable but do not undermine the core factual accuracy of the response. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default (no errors possible). The reasoning is sound and synthesizes the multi-hop elements (evolution over time, internal operations, external collaboration), though slightly less comprehensive than the original. The answer is fully contextually relevant and well-structured. Thus, a score of 8 is justified for correctness and qualitative accuracy due to minor but meaningful omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 384,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "\n\nEli Lilly's financial relationship with Baqsimi evolved significantly between 2023 and 2024. In **2023**, Lilly recognized **$579.0 million in revenue** from the sale of Baqsimi rights to Amphastar, as disclosed on page 47 of the 2023 10-K. The transaction included **$500.0 million in cash received in 2023** and an additional **$125.0 million in 2024**, with potential future milestone payments of up to $450.0 million (not yet included in revenue as of 2024). Contractually, Lilly entered into a **supply agreement** obligating Amphastar to purchase manufactured Baqsimi product, with Lilly recognizing **net product revenue over time** as production occurs due to the product’s standalone selling price and no alternative use. By **2024**, the focus shifted from upfront gains to ongoing revenue recognition through the supply arrangement, reflecting a transition from a one-time sale to a structured, multi-year contractual relationship.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $579.0 million revenue from Baqsimi rights in 2023, aligning with the ground truth. However, it introduces specific details not present in the original answer or implied by the question, such as the $500.0 million cash received in 2023, $125.0 million in 2024, and $450.0 million in potential milestones—none of which are mentioned in the ground truth. These figures, while possibly from external data, contradict the provided knowledge graph and introduce unsupported specifics. (2) The quantitative accuracy is partially correct: the $579.0 million figure is accurate, but the breakdown into $500M + $125M + $450M in milestones is not supported by the original answer and appears to be hallucinated or sourced beyond the knowledge graph. There is no verification that Amphastar or a supply agreement was referenced in the ground truth. (3) The reasoning is flawed in terms of multi-hop synthesis: the original answer focuses on a shift in revenue recognition—from standalone Baqsimi revenue in 2023 to inclusion in broader collaboration revenue in 2024—indicating accounting integration. The LLM instead shifts focus to a contractual supply relationship and milestone payments, which changes the nature of the evolution from an accounting classification change to an operational partnership, misrepresenting the core insight. (4) Contextual relevance is moderate: the answer addresses revenue recognition and contractual changes, which are relevant, but misdirects the evolution toward specific contractual terms not in the ground truth. The qualitative accuracy suffers due to incorrect entity relationships (e.g., Amphastar, supply agreement) and unsupported financial breakdowns. Overall, while the core 2023 revenue figure is correct, the rest of the narrative diverges significantly from the ground truth, warranting a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 529,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "\n\nFrom 2023 to 2024, AT&T repurchased all remaining **Mobility Preferred Interests** in April 2023 for $5,414, funded by proceeds from expanding **Telco LLC preferred interests** (issuing an additional $5,250 of nonconvertible cumulative preferred interests with a 6.85% initial distribution rate). In 2024, AT&T further restructured **Tower Holdings preferred interests**, resetting rates to 5.90% fixed and introducing floating rates tied to SOFR + 250 bps, while continuing to expand Telco LLC’s preferred interests, which totaled $7,250 by year-end. This evolution reflects a shift from repurchasing legacy instruments to strategically reconfiguring and expanding higher-yield preferred structures to optimize capital efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key elements of the ground truth. (1) Quantitative accuracy: All numbers, dates, and percentages are correct—$5,414 repurchase amount, $5,250 issuance of Telco LLC preferred interests at 6.85%, restructuring of $6,000 Tower Holdings preferred interests (implied in 'restructuring rates') with 5.90% fixed and SOFR + 250 bps, and total Telco LLC preferred interests reaching $7,250 by end of 2024. The $7,250 total aligns with the original $2,000 (Class A-1) plus $5,250 issued in 2023. (2) Completeness: The answer addresses both the 2023 repurchase of Mobility Preferred Interests and the 2024 evolution involving Tower Holdings and continued expansion of Telco LLC. It correctly identifies the funding mechanism and strategic shift. (3) Entity accuracy: All entities—AT&T, Mobility Preferred Interests, Telco LLC, Tower Holdings—are correctly named and contextualized. The time periods (2023 and 2024) are accurately referenced. (4) Reasoning: The multi-hop synthesis is sound—linking the 2023 repurchase to the funding via new preferred issuance, then connecting to 2024 restructuring and expansion. The conclusion about strategic pivot is logically supported. (5) Semantic equivalence: The LLM conveys the same core message as the original, though it omits the specific balance sheet impact ($2,650 from 'Accounts payable' and $2,670 from 'Other noncurrent liabilities'), which is a minor omission that doesn't affect the overall correctness. Also, the $6,000 Tower restructuring amount is implied but not explicitly stated. These omissions prevent a perfect 10 but do not undermine the factual or strategic accuracy. Hence, correctness score is 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 462,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "\n\nEmerson's relationship with AspenTech evolved significantly from 2023 to 2024. In 2023, Emerson completed the **Heritage AspenTech acquisition**, contributing two software businesses to form \"New AspenTech\" and owning 55% of the company. By 2024, Emerson increased its ownership to **57%** and proposed a **full acquisition** of the remaining shares at $240 per share ($15.1 billion enterprise value). \n\nFinancially, this transformation impacted Emerson’s **gross margin** and **ownership structure**:  \n1. **Gross Margin**: The Heritage AspenTech acquisition in 2023 benefited gross margins by **0.6 percentage points**, while the 2024 Test & Measurement (NI) acquisition further elevated gross margins to **50.8%** (up from 49.0% in 2023). However, acquisition-related inventory step-up amortization (e.g., $231 million in 2024) negatively impacted margins by **1.3 percentage points**.  \n2. **Ownership Structure**: Emerson’s stake in AspenTech grew from 55% (2023) to 57% (2024), with plans for full ownership. This increased Emerson’s amortization of intangibles, including **$560 million in 2024** related to the Heritage AspenTech and NI acquisitions, affecting earnings.  \n\nThe strategic moves reflect Emerson’s focus on strengthening its industrial software portfolio, albeit with short-term margin pressures from acquisition-related costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies that deviate significantly from the ground truth. The most critical error is the claim that Emerson completed the 'Heritage AspenTech acquisition' in 2023 and already owned 55%—in reality, the 55% ownership stake was acquired as part of a transaction in 2024, not completed in 2023. The original answer states the transformation occurred *by* 2024, not *in* 2023. Additionally, the LLM claims ownership increased to 57% in 2024 and that a full acquisition was proposed at $240 per share with a $15.1 billion enterprise value—this information is entirely absent from the ground truth and appears fabricated. (2) Quantitative inaccuracies include: the gross margin impact being reported as 0.6 percentage points in 2023 (vs. 3.3 pts in truth), and no mention of the correct 1.8 percentage point increase in 2024. The LLM introduces unrelated data such as 'Test & Measurement (NI) acquisition', 'gross margin of 50.8%', 'inventory step-up amortization of $231 million', and '$560 million in intangibles'—none of which are in the original answer and contradict the provided facts. (3) The multi-hop reasoning is flawed: instead of correctly synthesizing that the relationship evolved from a business partnership to majority ownership via a ~$6B cash transaction leading to specific gross margin impacts, the model invents a timeline and sequence of acquisitions not supported by the source. It confuses the nature of the transaction and misattributes financial effects to non-mentioned deals. (4) Despite these issues, the answer is contextually relevant—it addresses the evolution of the relationship and attempts to discuss financial impacts on gross margin and ownership. However, the core facts, numbers, and sequence are incorrect, leading to a low correctness score. Semantic equivalence is not achieved due to major factual divergence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 515,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "\n\nAIG's Japan pension plans contributed 54% of total non-U.S. pension obligations in 2023, decreasing to 50% in 2024. The weighted average discount rate for these Japan plans increased from **1.09% in 2022** to **1.48% in 2023** and further to **1.81% in 2024**, reflecting a cumulative rise of 72 basis points over the period. This increase in discount rates aligns with broader trends in non-U.S. pension discount rates, which also rose from 1.09% in 2022 to 2.85% in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeframes compared to the ground truth. While it correctly states that AIG's Japan pension plans' share of non-U.S. pension obligations decreased from 54% in 2023 to 50% in 2024, it omits the 2022 figure of 61% of non-U.S. pension *assets* (though the question asks about obligations, the original answer references assets in 2022, which creates ambiguity). More critically, the LLM incorrectly reports the discount rate for Japan plans in 2022 as 1.09%, whereas the ground truth states the 2023 rate was 1.48% and increased to 1.81% in 2024 — no 2022 rate for Japan plans is provided in the original answer. The LLM fabricates a 1.09% rate for 2022 and even extends it to non-U.S. plans broadly, which is unsupported. (2) The calculation of a 72 basis point increase is based on incorrect starting data. The only verifiable number — the 1.81% discount rate in 2024 — matches the original answer. The 1.48% rate in 2023 is correct, but the LLM misattributes it as a Japan-specific rate in 2023 (which the original does state), yet then incorrectly extends it backward to 2022. (3) The multi-hop reasoning is partially sound: the model identifies the trend of declining contribution to obligations and increasing discount rates. However, it invents data points not present in the original (2022 discount rate for Japan) and conflates non-U.S. and Japan-specific rates. (4) The contextual relevance is high — the answer addresses both parts of the question and attempts synthesis. However, due to significant quantitative errors, especially the fabricated 2022 discount rate and incorrect attribution of trends, the correctness score is limited to 5. The qualitative accuracy is moderate due to correct identification of trends but flawed data sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 495,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "\n\nBetween 2022 and 2023, Amazon's disclosure on competitive pressures evolved by narrowing the framing of external market conditions. In the **2022 10-K** (page 9), Amazon explicitly highlighted broader external factors such as \"changes in usage or adoption rates of the Internet, e-commerce, electronic devices, and web services\" as risks, alongside direct competition. By **2023** (page 9), the focus shifted to more immediate competitive actions, emphasizing the \"introduction of competitive stores, websites, products, services, price decreases, or improvements\" without explicitly mentioning macro-level trends. The 2023 filing also expanded the \"Competition\" section (page 4) to detail competitors' strategies (e.g., aggressive pricing, restrictive distribution), reflecting a sharper focus on direct competitive threats rather than broader market dynamics. This shift suggests a more tactical framing of competition in 2023, prioritizing specific actions over general external conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim and misrepresents the evolution of Amazon's disclosures between the 2022 and 2023 10-K filings. (1) The LLM incorrectly asserts that Amazon narrowed its framing of external market conditions in 2023 and removed macro-level trends, when the ground truth states the opposite: the 2023 filing embedded competitive pressures within a broader context of external economic and geopolitical conditions. The LLM claims that in 2023, Amazon omitted macro-level trends and focused only on direct competition, but the original answer confirms that 2023 expanded the external framing, not narrowed it. (2) While the LLM correctly cites the phrase 'introduction of competitive stores, websites, products, services, price decreases, or improvements' and attributes it to both years, it misinterprets the context shift. The 2022 filing listed competitive stores among various factors, while 2023 integrated that same language into a broader discussion of global economic conditions—this key nuance is reversed in the LLM response. (3) The multi-hop reasoning fails: the model should have recognized that the repetition of the competitive language in a new, broader context indicates a reframing toward systemic external risks, not a tactical narrowing. Instead, the LLM invents a narrative of increased focus on direct competition unsupported by the ground truth. (4) The mention of page numbers and expanded 'Competition' section details (e.g., aggressive pricing) are not present in the original answer and appear to be hallucinated or misattributed. While the quantitative elements like years (2022, 2023) and document type (10-K) are accurate, the qualitative reasoning and overall conclusion are fundamentally flawed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 485,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "\n\nTarget's exposure to port security risks between 2023 and 2024 remained geographically focused on major U.S. ports, particularly California, where the company receives a significant portion of imported merchandise. In 2023, the risk centered on periodic port closures, labor disputes, and congestion disrupting supply chains. By 2024, while port security challenges persisted, the operational impact expanded to include heightened risks from **new U.S. tariffs on China, Mexico, and Canada**, which increased procurement costs and necessitated alternative sourcing strategies. Additionally, 2024 emphasized the compounding effects of **trade policy volatility** and retaliatory actions, alongside ongoing port disruptions, leading to higher costs and potential price increases for consumers. The geographic focus remained unchanged, but the operational impact broadened to include trade policy-driven financial pressures alongside traditional port-related disruptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding geographic focus and operational impact evolution. While the ground truth states that Target shifted from specifically naming California ports in 2023 to referring more broadly to 'major U.S. ports' in 2024, the LLM incorrectly claims the geographic focus 'remained unchanged'—this contradicts the documented broadening of concern. This is a critical error in interpreting the evolution of risk exposure. Additionally, the LLM introduces new elements not present in the original answer—specifically 'new U.S. tariffs on China, Mexico, and Canada' and 'trade policy volatility' with 'retaliatory actions'—which are not mentioned in the ground truth and cannot be verified from the provided data. These additions reflect unsupported extrapolation. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, since no numbers are misused or miscalculated, this dimension is scored as fully accurate. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift in geographic specificity (from California to broader U.S. ports) and incorrectly infers that trade policy and tariffs are part of the 2024 risk narrative, which is not supported by the original answer. The correct reasoning should have emphasized the shift from past operational adaptations (2023) to future-oriented risks (2024), including cost increases and supply issues due to global conflicts and labor disputes—not tariffs or trade policy. (4) The contextual relevance is moderate because the answer addresses port security risks and operational impacts in the correct timeframe and for the correct company, but introduces irrelevant factors (tariffs, trade policy) and misses the key evolution in geographic focus. Correctness and qualitative accuracy are low due to these substantive factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 524,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "\n\nEmerson's acquisition-related amortization for Heritage AspenTech increased from $258 million in 2023 (as part of its total intangible amortization of $482 million) to a continued contribution in 2024, though specific Heritage figures are not disclosed due to the larger National Instruments (NI) acquisition driving $560 million of 2024 amortization. Restructuring costs rose from $72 million in 2023 to $228 million in 2024, with the latter including $43 million in integration expenses related to NI and broader workforce reductions/facility exits. While Heritage-specific 2024 restructuring costs are not isolated, the overall increase reflects expanded operational adjustments post-acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Heritage AspenTech-related amortization was $258 million in 2023 and was no longer reported in 2024, indicating it had ended or was subsumed. However, the LLM claims amortization 'increased' and continued in 2024, which contradicts the original answer. Additionally, the LLM introduces the National Instruments (NI) acquisition as a driver of $560 million in 2024 amortization, which is not mentioned in the ground truth and appears to be fabricated or misattributed. (2) Quantitatively, the $258 million amortization in 2023 and $72 million to $228 million restructuring cost increase are correctly cited, earning partial credit. However, the $560 million amortization figure for 2024 and the $43 million integration expense related to NI are unsupported by the ground truth and introduce false data. (3) The multi-hop reasoning is flawed: instead of recognizing that AspenTech amortization ceased to be separately reported—suggesting integration completion or reclassification—the model incorrectly infers it continued and was overshadowed by another acquisition not referenced in the original answer. This misrepresents the evolution of the financial relationship. (4) Contextually, the answer addresses the right question and uses appropriate financial terminology, but the introduction of an unmentioned acquisition (National Instruments) and associated figures undermines factual accuracy. The restructuring cost increase is correctly noted and aligned with the ground truth, but the explanation for it being tied to NI rather than potentially AspenTech integration weakens the qualitative accuracy. Overall, the answer is partially correct on core numbers but fails on key factual synthesis, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 498,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "\n\nAIG's use of Expected Loss Ratio (ELR) methods between 2022 and 2024 evolved with increased responsiveness to emerging trends and specific adjustments for market conditions. In **2022**, ELR methods were weighted more heavily in **recent accident years** for lines like D&O, E&O, and professional liability, while loss development methods dominated for mature years. For **U.S. Workers’ Compensation**, ELR methods were applied only to the **most recent accident year** for guaranteed cost business and up to **five recent years** for excess of deductible business, with adjustments for rate changes and inflation. \n\nBy **2024**, the weighting of ELR methods remained focused on recent accident years but incorporated **dynamic adjustments** for factors like **medical cost trends**, **legal cost increases** (e.g., in California), and **reinsurance program changes**. For example, in Workers’ Compensation, expected loss ratios were recalibrated to reflect **longer medical development patterns** and **shifts in risk retention structures** (e.g., high-deductible policies). In Financial Lines, ELR methods continued to be used for recent years but faced challenges from unfavorable developments in high-severity classes like M&A, prompting methodological refinements. Overall, AIG emphasized integrating ELR with loss development and frequency/severity methods, adjusting weights based on **emerging claim severity**, **underwriting changes**, and **reinsurance impacts** (e.g., ADC agreements). This evolution reflects a more adaptive approach to volatile loss environments and regulatory shifts.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and evolution of AIG's use of Expected Loss Ratio (ELR) methods from 2022 to 2024. It accurately identifies that in 2022, ELR methods were primarily used for recent accident years in Financial Lines (D&O, E&O, professional liability), consistent with the original answer. It also correctly notes the limited use in U.S. Workers’ Compensation for recent years, specifying distinctions between guaranteed cost and excess of deductible business—details not in the ground truth but plausible and contextually appropriate, without contradicting it. By 2024, the LLM correctly captures the broader integration of ELR with other methods (loss development, frequency/severity), though it does not explicitly state the 'expansion' into Workers’ Compensation as a new application area per the original answer, instead implying continuity with enhanced adjustments. The LLM adds granular detail on dynamic recalibration for medical trends, legal costs, and reinsurance—information not in the ground truth but consistent with the direction of evolution, enhancing context without introducing error. There are no incorrect numbers, dates, or entities; all references to years (2022, 2024), lines of business, and methods are accurate. The qualitative reasoning is sound: it reflects multi-hop synthesis across time, lines of business, and methodological shifts. The only minor gap is that the original emphasizes a structural expansion of ELR into long-tail Workers’ Compensation as a notable evolution, while the LLM frames it as an ongoing practice with refinements—slightly underemphasizing the significance of methodological broadening. However, the core message of increased integration and adaptability is preserved. Thus, the answer is factually strong, detailed, and relevant, warranting a high score with a small deduction for incomplete emphasis on the expansion aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 526,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "\n\nBetween 2022 and 2023, Amazon's monetization strategy for film groups evolved through increased investment in capitalized video and music content, coupled with higher associated expenses. Capitalized costs rose from **$16.7 billion in 2022 to $17.4 billion in 2023** (AMZN_10k_2023, p. 49), while total video and music expenses increased from **$16.6 billion to $18.9 billion** during the same period. This reflects a strategic shift toward greater content production and licensing, likely to bolster Amazon Prime memberships and digital subscriptions. Additionally, the weighted average remaining life of capitalized video content extended from **2.6 years in 2022 to 3.5 years in 2023**, indicating a longer-term amortization approach, potentially to align with extended content usage or monetization cycles. These changes suggest Amazon is prioritizing sustained content investment to enhance subscriber value and diversify revenue streams, such as through ad-supported models or expanded international offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key financial figures are correct: capitalized costs increased from $16.7B in 2022 to $17.4B in 2023, and total video and music expenses rose from $16.6B to $18.9B—matching the original answer exactly. These numbers are cited with a specific source (AMZN_10k_2023, p. 49), enhancing credibility. (2) The quantitative accuracy is perfect; all dollar amounts and year-over-year changes are correctly reported, and no calculation errors are present. (3) The qualitative reasoning is strong, correctly interpreting the increased investment as a sign of more aggressive monetization strategy. The LLM adds valuable context not in the original answer—the extension of the weighted average remaining life from 2.6 to 3.5 years—which is consistent with Amazon’s strategy of longer-term content amortization and supports the conclusion of a strategic shift. While this detail is not in the ground truth, it does not contradict it and enhances the analysis, assuming it is factually drawn from the cited filing. (4) The answer is fully contextually relevant, directly addressing how monetization strategy evolved based on capitalized costs and expenses. The only reason for not scoring a 10 is that the original answer emphasizes the direct link between rising costs and 'monetization efforts,' while the LLM infers broader strategic goals (e.g., ad-supported models, international expansion), which, while plausible, are not confirmed in the ground truth. However, these inferences are reasonable and do not detract from factual correctness. Overall, this is a robust, well-supported, and semantically aligned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 459,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "\n\nBetween 2022 and 2024, Philip Morris International (PMI) recognized a significant impairment of its stake in Rothmans, Benson & Hedges (RBH). In 2024, PMI recorded a **$2.316 billion non-cash impairment charge** due to uncertainties surrounding the allocation of a CAD 32.5 billion Canadian tobacco litigation settlement among RBH, Imperial Tobacco Canada, and JTI Macdonald Corp. This followed objections filed by RBH to the proposed settlement plan, narrowing the range of possible outcomes and triggering a valuation that showed PMI’s investment in RBH was impaired. In contrast, PMI’s 2022 filings (pages 34–37, 42) do not mention any impairment or material changes to its stake in RBH, indicating the impairment emerged as a new development in 2024. The stake itself remains, but its carrying value was reduced due to the litigation-related risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $2.316 billion impairment charge in 2024 (equivalent to $2,316 million in the original answer), the CAD 32.5 billion Canadian litigation settlement, and the entities involved—RBH, Imperial Tobacco Canada (ITL), and JTI Macdonald Corp (JTIM)—are correctly identified. The absence of any mention of impairment in 2022 filings is accurately noted. (2) Quantitative accuracy is perfect: $2.316 billion = $2,316 million, and CAD 32.5 billion matches the original. No calculations are required beyond correct reporting. (3) The multi-hop reasoning is sound: the answer correctly infers a shift in the nature of PMI's relationship with RBH—from no reported impairment or stake changes in 2022 to a recognized equity investment impairment in 2024 due to litigation uncertainty. It correctly identifies the triggering event (objections to settlement) and the financial consequence (non-cash impairment). (4) The only minor shortcoming is that the original answer notes a broader evolution from a trademark and brand licensing relationship in 2022 to an equity investment in 2024, which the LLM answer implies but does not explicitly state. While the stake's existence is acknowledged, the qualitative shift in relationship type is underemphasized. However, the core financial evolution—no impairment in 2022, major impairment in 2024 due to litigation—is fully and correctly conveyed. Wording differences do not affect semantic equivalence on the key financial and temporal points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 432,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "\n\nThe sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities increased between 2023 and 2024. In 2023, a 5% change in these liabilities would have impacted revenue by approximately **$615 million** (as disclosed on page 53 of the 2023 10-K). By 2024, pressures from the Inflation Reduction Act (IRA), which mandated significant Medicare price discounts (e.g., a 66% discount for Jardiance), and heightened payer negotiations (e.g., managed care, Medicaid, and Medicare programs) likely amplified rebate and discount liabilities. While the 2024 filing does not explicitly quantify the updated sensitivity, the expanded liability exposure from regulatory and market-driven pricing concessions suggests a material increase in sensitivity compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the 2023 sensitivity figure of $615 million from a 5% change in liabilities, which matches the ground truth and is accurately attributed to the 2023 10-K. However, it incorrectly asserts that sensitivity 'increased' between 2023 and 2024, which is unsupported by the 2024 filing. The ground truth explicitly notes that LLY did not provide an updated sensitivity figure in 2024, making any claim about the direction or magnitude of change speculative. The LLM introduces external reasoning (e.g., Inflation Reduction Act, 66% discount for Jardiance) not present in the 10-K disclosures to infer increased sensitivity, which goes beyond the disclosed information and introduces unsupported conclusions. (2) Quantitatively, the $615 million figure is correct and properly contextualized. No calculation errors are present, and the 5% change benchmark is accurately used. However, the absence of a 2024 number means no quantitative comparison can be made, yet the LLM implies one. (3) The multi-hop reasoning fails because the model does not recognize that the lack of 2024 disclosure prevents any valid comparison of sensitivity evolution. Instead of acknowledging the missing data, it infers a trend using external factors, which violates the requirement to base answers solely on 10-K disclosures. (4) While the response is contextually relevant and addresses the question's intent, the overreach in drawing conclusions without data significantly undermines factual accuracy. The answer would score higher if it had noted the absence of 2024 sensitivity data and refrained from asserting a directional change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 450,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "\n\nFrom 2022 to 2024, Union Pacific's **Bulk shipments** maintained a consistent revenue contribution, representing **32–33% of total freight revenues**. In 2021 (as disclosed in the 2022 filing), Bulk revenue was $6.656 billion (32.9% of $20.244 billion total freight revenue). By 2024, Bulk shipments accounted for 32% of Union Pacific’s $22.8 billion in freight revenues, indicating stable relative importance. The evolution reflects resilience in key sectors like grain, fertilizer, and coal, supported by core pricing gains and volume recovery, despite challenges such as coal volume declines and supply chain disruptions. Absolute revenue growth from 2021 to 2024 is implied, though specific 2022 data is not provided in the sources.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeframes compared to the ground truth. The ground truth states that the $3,305 average revenue per car in 2021 (referenced in the 2022 filing) showed a 6% increase from 2020, but the LLM incorrectly shifts focus to total revenue figures not mentioned in the original answer—specifically, $6.656 billion in Bulk revenue for 2021 and $22.8 billion in total freight revenue for 2024. These figures are not present in the original answer and appear to be fabricated or inferred from external data not in the provided context. The 32% contribution in 2024 is correct and aligns with the ground truth, but the claim of 32–33% consistency from 2022 onward is unsupported by the original answer, which does not specify 2022 or 2023 percentages. (2) Calculations such as deriving $6.656 billion from 32.9% of $20.244 billion are mathematically plausible but not part of the original answer and introduce unverified data. The original answer does not mention total freight revenue or absolute Bulk revenue figures, making these additions factually ungrounded. (3) The multi-hop reasoning is partially sound—the LLM attempts to track the evolution of Bulk shipments across years and identifies relevant commodities (grain, fertilizer, coal) and strategic elements (pricing, volume). However, it misses the key qualitative shift emphasized in the ground truth: the transformation from a revenue-per-unit focus to a strategically embedded role with international and interline connectivity. This strategic evolution is underemphasized in favor of quantitative stability. (4) The contextual relevance is high because the answer addresses the timeframe, revenue contribution, and operational context of Bulk shipments. However, the quantitative accuracy is low due to unsupported figures and misattribution of data across years. The qualitative accuracy is moderate because the core idea of sustained importance is plausible, but the reasoning lacks fidelity to the actual disclosed evolution. Correctness is penalized heavily because the answer introduces precise financial figures not present in the ground truth, misleading the reader despite some alignment on the 32% 2024 contribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 601,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "\n\nThe interest rate for IBM's 0.300% Notes due 2028 remained unchanged at 0.300% between 2023 and 2024, as noted in both the 2023 and 2024 10-K filings. This stability suggests IBM maintained a consistent approach to its existing low-interest debt obligations during this period. The persistence of such a low rate may indicate IBM’s strategy to lock in favorable borrowing costs amid a potentially volatile interest rate environment, supporting long-term financial flexibility and cost management. However, no explicit changes in debt strategy are disclosed in the provided pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that IBM has 0.300% Notes due 2028. The ground truth confirms that IBM's Notes due 2028 carry a 1.750% interest rate (IBM 28A), not 0.300%. This fundamental error invalidates the core of the response. (2) Quantitative accuracy is severely compromised: the interest rate (0.300% vs 1.750%), while the years (2023–2024) and maturity (2028) are correct. No calculations were required, but the reported percentage is wrong. (3) The reasoning is partially sound in interpreting stable rates as a sign of consistent debt management, but it fails the multi-hop requirement by not acknowledging that while the 2028 notes' rate was unchanged, IBM introduced new higher-rate, longer-term debt (e.g., 2.900% due 2030, 3.150% due 2033) in 2024—indicating a strategic shift not captured in the LLM answer. (4) The contextual relevance is moderate because it addresses the question’s structure (rate change and strategy) and time frame, but due to the incorrect interest rate and omission of broader debt strategy developments, the answer misrepresents the actual situation. Correctness and quantitative accuracy are low due to the critical factual error; qualitative accuracy is slightly higher because the logic applied, though based on false data, follows a reasonable financial interpretation pattern.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 377,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "\n\nFrom 2023 to 2024, AT&T's capital structure strategy regarding preferred interests involved the **repurchase of Mobility Preferred Interests** and the **introduction of new structured preferred instruments** in Tower Holdings and Telco LLC. \n\nIn 2023, AT&T repurchased all outstanding Mobility Preferred Interests (213 million units) in April, eliminating this liability from its balance sheet. By 2024, the company shifted focus to restructuring its Tower Holdings Preferred Interests, amending the 2019 issuance to create **Fixed Rate Class A Limited Membership Interests** (5.90% distribution) and **Floating Rate Class A Limited Membership Interests** (SOFR + 250 bps), effective November 2024. Additionally, AT&T expanded its Telco LLC Preferred Interests in 2023, issuing $5,250 in new Telco Class A-2 and A-3 instruments with higher initial distributions (6.85%) and longer reset periods. These actions reflect a strategic pivot toward diversified, resettable preferred instruments with tailored risk-return profiles, replacing the prior reliance on Mobility Preferred Interests.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the repurchase of Mobility Preferred Interests in 2023 and the restructuring of Tower Holdings and expansion of Telco LLC preferred interests in 2024, aligning with the core strategic pivot described in the ground truth. However, there are key quantitative inaccuracies: the ground truth states the redemption value of Mobility Preferred Interests was approximately $5,340 million and annual distributions were $373 million, but the LLM omits these specific figures and instead mentions '213 million units' and April timing, which are not in the original answer and may be hallucinated. Additionally, the LLM claims Telco LLC expansion occurred in 2023 and specifies $5,250 million in new instruments with a 6.85% distribution, but the ground truth states the total Telco LLC preferred interests reached $7,250 million in 2024, not $5,250 million in 2023. The LLM also introduces specific rates (5.90%, SOFR + 250 bps) and a November 2024 effective date for Tower Holdings restructuring, which are absent from the original answer and not supported by the ground truth. (2) These numerical discrepancies—especially the incorrect dollar amounts, missing $5,340M/$373M figures, and unsupported specifics like percentages and dates—reduce confidence in quantitative accuracy. While some details may reflect external knowledge, the evaluation is based solely on alignment with the provided ground truth. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from Mobility to infrastructure/telecom-focused preferred instruments and synthesizes changes across entities and years. The logic and narrative flow match the original conclusion. (4) Contextual relevance is perfect—the answer directly addresses the evolution of AT&T’s capital structure strategy regarding preferred interests from 2023 to 2024. Despite strong qualitative reasoning and relevance, the correctness score is reduced due to unsupported numerical claims and omissions of key figures from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 552,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "\n\nAmazon's characterization of competitive threats from websites evolved between 2022 and 2023 by shifting from a general acknowledgment of \"websites\" as competitors to a more nuanced and specific description of the competitive landscape. In 2022, the 10-K (page 9) broadly listed \"websites\" alongside other competitive factors like price decreases and product improvements. By 2023, the 10-K (page 4) explicitly detailed the diversity of digital competitors, including **web search engines, comparison shopping websites, social networks, web portals, and app-based platforms**, emphasizing collaboration with retailers and new business models. This language change reflects Amazon's recognition of a broader, more fragmented threat from evolving digital ecosystems, such as social commerce and app-driven services, indicating a shift toward acknowledging non-traditional e-commerce platforms as significant competitors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of years (2022 and 2023) and correctly identifies a shift in Amazon's competitive language between those years, with accurate page references (page 9 for 2022, page 4 for 2023). There are no numerical values requiring verification, so quantitative accuracy is scored as 10. The answer addresses the evolution in language and identifies specific changes, such as the inclusion of 'web search engines, comparison shopping websites, social networks, web portals, and app-based platforms' in 2023, which reflects a broader competitive landscape. However, the original answer emphasizes a shift from 'general awareness of competitive pressures' to a 'more direct and strategic competitive stance' centered on 'competitive stores, websites, products, services, price decreases, or improvements'—a more precise framing around strategic business actions. The LLM answer introduces specific platform types not explicitly detailed in the ground truth, potentially adding interpretation beyond the source. While this reflects plausible analysis, it diverges from the documented shift in the knowledge graph, which focuses on the intensification and centralization of competitive threats rather than ecosystem fragmentation or social commerce. Thus, while the core idea of increased specificity and scope is correct, the qualitative emphasis differs slightly, missing the exact phrasing and conceptual pivot (from operational factor to strategic concern) in the original. Contextual relevance is high, as the response directly addresses the question’s focus on language evolution and competitive framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 446,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "\n\nPMI's relationship with KT&G has remained strategically collaborative but non-dominant in its smoke-free portfolio from 2022 to 2024. Under their 2020 global collaboration agreement, PMI continues to distribute KT&G’s heat-not-burn products (e.g., LIL Mini/Plus) in select international markets, with no plans for U.S. commercialization. However, PMI’s smoke-free growth has been driven more by its own innovations (e.g., IQOS, ZYN nicotine pouches) and oral products than by KT&G’s offerings. For instance, smoke-free net revenues grew from $10.2 billion in 2022 to $14.7 billion in 2024, with oral product shipments rising 37.6% in 2024, while heat-not-burn unit shipments declined slightly in some regions. This indicates PMI maintains a partnership with KT&G but prioritizes its proprietary platforms for strategic expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and misrepresents the evolution of PMI's relationship with KT&G. While it correctly notes the global collaboration agreement allowing PMI to distribute KT&G’s heat-not-burn products (e.g., LIL Mini/Plus) outside South Korea, it incorrectly frames the relationship as static and non-dominant, contradicting the ground truth that by 2024, KT&G’s products were integrated into PMI’s own smoke-free portfolio, indicating a deeper strategic reliance. The LLM instead claims PMI prioritizes its own platforms (IQOS, ZYN), which downplays the increased integration of KT&G’s products. (2) Quantitatively, the LLM introduces numbers not present in the ground truth: smoke-free net revenues of $10.2B in 2022 and $14.7B in 2024, and a 37.6% rise in oral product shipments in 2024. These figures may be accurate in isolation but are not supported by the provided ground truth and distract from the core focus on KT&G integration. The decline in heat-not-burn unit shipments is also unverified in the ground truth. (3) The multi-hop reasoning is flawed: the ground truth emphasizes a shift from distribution to integration, a key strategic evolution. The LLM fails to identify this shift and instead infers continued limited reliance based on unrelated growth in oral products, which is not evidence against deeper reliance on KT&G in the heat-not-burn segment. (4) Contextual relevance is high—the answer addresses the time frame, companies, and product types—but correctness and qualitative accuracy are low due to incorrect synthesis and unsupported claims. The core conclusion opposes the ground truth, warranting a low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 469,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "\n\nIBM's use of the PWCC Plan for funding employee awards remained consistent between 2022 and 2024 in terms of administration and scope. The plan, established in 2002 to fund awards for employees of PricewaterhouseCoopers Consulting (PwCC) who joined IBM post-acquisition, continued to exclude senior executives and maintained terms identical to the 2001 Long-Term Performance Plan. No material changes to its administration or eligibility criteria were disclosed in the provided filings for either year.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the PWCC Plan's administration and scope remained consistent between 2022 and 2024, with no material changes disclosed. It correctly identifies the plan's purpose—funding awards for former PwCC employees post-acquisition—and notes its alignment with the 2001 Long-Term Performance Plan, which matches the ground truth. The exclusion of senior executives and administrative continuity are also correctly mentioned. However, the LLM omits a key qualitative evolution highlighted in the original answer: the shift in IBM's language from 'will continue to be used' in 2022 to a more definitive 'has been and will continue to be used solely' in 2024, which signals a stronger reaffirmation of intent. While the core facts and dates (e.g., 2002 establishment, reference to 2001 Plan) are accurate, the answer fails to capture the nuanced change in tone that indicates IBM's heightened commitment to maintaining the plan’s limited scope. This omission affects the depth of reasoning and completeness in addressing how the plan's usage *evolved* in emphasis, even if not in practice. Thus, while quantitatively accurate and contextually relevant, the qualitative accuracy is reduced due to incomplete synthesis of the linguistic shift across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 359,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "\n\nAT&T repurchased all outstanding Mobility Preferred Interests in April 2023, eliminating this financial obligation by year-end 2023 and removing related distribution liabilities from its capital structure. This action, coupled with the restructuring of Tower Holdings and Telco LLC preferred interests in 2024 (e.g., fixed/floating rate terms and call provisions), reflects a strategic shift toward simplifying capital obligations, reducing financial risk, and optimizing cost-efficient financing. The move underscores AT&T’s focus on enhancing balance sheet flexibility to support investments in fiber, 5G, and operational transformation while mitigating exposure to complex hybrid equity-debt instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that AT&T repurchased all Mobility Preferred Interests in 2023, eliminating the obligation—consistent with the original answer's claim of a $5,414 million repurchase including accrued distributions. While the exact dollar amount ($5,414 million) is omitted in the LLM response, the core fact of full repurchase and elimination of the liability is correct, and no incorrect numbers are presented. (2) The date 'April 2023' is more specific than the ground truth (which only says 2023), but does not contradict it and may reflect additional precision from the source filing; this is acceptable under semantic equivalence. (3) The LLM correctly contrasts this with the 2024 restructuring of Tower Holdings and Telco LLC preferred interests, accurately identifying AT&T’s selective capital structure management. (4) The reasoning is sound: it infers a strategic shift toward simplification, risk reduction, and financing efficiency, which is a valid interpretation of the shift described in the original answer. The broader implications about balance sheet flexibility and investment in fiber/5G are contextually appropriate and consistent with strategic logic, even if slightly more expansive than the original. The only minor shortcoming is the omission of the specific repurchase amount ($5,414 million), which is a factual detail present in the ground truth and relevant to financial obligations. However, since the qualitative and strategic synthesis is excellent and no facts are incorrect, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 467,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "\n\nIBM's regulatory exposure for its debt securities related to stock exchange regulations remained consistent between 2022 and 2024. Both filings highlight that the value of IBM's debt securities is influenced by factors such as governmental and stock exchange regulations, interest rates, and credit ratings. However, there is no indication of material changes in IBM's relationship with stock exchange regulations during this period. The 2024 filing emphasizes broader regulatory pressures from global cybersecurity and data protection laws, but these are distinct from stock exchange-specific regulations impacting debt securities. Thus, the disclosed risks related to stock exchange regulations for debt securities have not meaningfully evolved in the provided documents.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim, directly contradicting the ground truth. The original answer states that IBM's language evolved from describing stock exchange regulations as an influencing factor in 2022 to being 'subject to' them in 2024, indicating a stronger, more direct regulatory exposure. However, the LLM claims there was 'no material change' and that the relationship 'remained consistent,' which misrepresents the shift in IBM's disclosed regulatory stance. There are no numeric values in this question, so quantitative accuracy is scored as 10 by default (no errors possible). Qualitative accuracy is low because the model failed to recognize the semantic shift in IBM's regulatory language—a key multi-hop insight requiring comparison across years. The reasoning is flawed: it acknowledges broader regulatory pressures in 2024 but incorrectly dismisses the specific evolution in stock exchange regulation exposure. Contextual relevance is moderate because the answer discusses related topics (regulatory influences on debt securities) but misses the central evolution the question targets. The LLM may have overlooked or misinterpreted the change in phrasing from 'influencing factor' to 'subject to,' which the ground truth identifies as a meaningful escalation in perceived regulatory exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 369,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "\n\nDisney's equity income contribution from its 50% ownership in A+E decreased in 2024 compared to 2023. Specifically, **equity income from A+E declined by $207 million in 2024**, reducing the total equity income from investees to $575 million (from $782 million in 2023). While the provided 2022 documents do not explicitly state A+E's equity income contribution for that year, the decline in 2024 highlights a deterioration in A+E's performance relative to the prior year, indicating a weakening financial relationship between Disney and A+E over this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $207 million decline in equity income from A+E in 2024, which matches the ground truth. However, it incorrectly frames the comparison as being between 2024 and 2023, while the original answer specifies the evolution from 2022 to 2024. The LLM also introduces specific total equity income figures ($575M in 2024 and $782M in 2023) that are not present in the ground truth and cannot be verified from the provided information. (2) The $207 million decrease is accurate and correctly attributed to lower income from A+E. However, the additional numbers (total equity income values) are unsupported in the original answer and appear to be fabricated or inferred beyond available data, reducing quantitative accuracy. (3) The reasoning is partially sound—correctly identifying a decline in financial contribution—but fails to address the full multi-hop requirement of analyzing the relationship from 2022 to 2024. Instead, it focuses on 2023–2024, missing the starting point (2022) context mentioned in the original answer. (4) Despite the misalignment in time frame and the introduction of unverified totals, the core fact of the $207M decline due to A+E is correct, and the overall direction of the financial relationship (deteriorating) is consistent. Hence, the correctness score is 7—core facts are right but with notable omissions and additions that affect completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 397,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "\n\nThe carrying value of securitized debt obligations increased from **$16,973 million in 2022** to **$18,043 million in 2023**, reflecting a **$1,070 million rise**. This growth indicates that Capital One Financial Corporation is actively utilizing securitization programs as a core component of its long-term funding strategy. By issuing securitized debt, the company likely aims to diversify funding sources, access cost-effective capital, and manage liquidity needs, aligning with its centralized asset/liability management approach to optimize financial flexibility and support ongoing operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, from a prior level of $42.3 billion (as of December 31, 2021), with no direct 2022 figure provided in the original answer. However, the LLM incorrectly claims an increase from $16,973 million ($16.973 billion) in 2022 to $18.043 billion in 2023, which contradicts the stated reduction from $42.3 billion. This misrepresents the trend entirely. (2) The quantitative values are inaccurate: the starting point of $16,973 million is not supported by the original answer, and the calculation of a $1,070 million increase is therefore also incorrect. The original answer emphasizes a significant decrease in securitized debt obligations, not an increase. (3) The multi-hop reasoning is flawed—the LLM infers increased reliance on securitization due to a supposed rise in carrying value, but the ground truth indicates a strategic reduction in reliance on securitized debt as part of long-term funding, suggesting a shift away from this instrument. The LLM fails to recognize the broader context of a declining trend from $42.3 billion. (4) While the LLM attempts to interpret the strategic implication, it draws the opposite conclusion from the evidence. The contextual relevance is moderate because it addresses funding strategy, but the factual foundation is so flawed that the analysis is invalid. Scores reflect major factual and directional errors, especially in quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 445,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "\n\nBetween 2022 and 2024, Disney shifted its focus from international general entertainment linear channels to Direct-to-Consumer (DTC) platforms, consolidating services and prioritizing streaming. By 2024, the company merged Latin America’s Star+ into Disney+, eliminated standalone services like Star+ by June 2024, and planned to launch an ESPN tile on Disney+ in the U.S. (early 2025). This strategic pivot reduced reliance on international linear channel licensing, which the 2024 filing acknowledged would negatively impact International Channels revenue as content monetization shifted to DTC. Scripted programming, previously distributed via Fox-, National Geographic-, and Star-branded linear channels (as noted in 2022), now emphasizes DTC platforms like Disney+ and Disney+ Hotstar, which bundle general entertainment, family, and sports content. The 2024 documents highlight expanded DTC integration, including live sports streaming and localized content, reflecting a broader move to centralize subscriber growth and control distribution through owned platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Disney operated ~220 international general entertainment channels in 2022 under Fox, National Geographic, and Star brands; by 2024, there was a strategic pivot toward DTC platforms. The LLM correctly notes the merger of Star+ into Disney+ by June 2024 and the planned ESPN tile launch in early 2025—consistent with the Venu Sports joint venture and ESPN+ integration mentioned in the original. (2) Quantitative accuracy is strong: no specific numbers are misstated. The reference to Latin America’s Star+ integration is factually sound and matches known 2024 developments. Dates (June 2024, early 2025) are correctly used and consistent with the original timeline. (3) Multi-hop reasoning is solid: the LLM synthesizes the shift from linear channels to DTC, connects scripted programming’s redistribution via Disney+, and links reduced licensing revenue to the strategic pivot—demonstrating sound understanding across time, geography, and business units. (4) The only minor gap is that the LLM does not explicitly mention the Venu Sports joint venture with Fox Corp and Warner Bros. Discovery, which is a notable element in the original answer. However, it does reference the ESPN tile and live sports on Disney+, which captures the essence of the sports-driven DTC shift. Overall, the answer is semantically equivalent, highly relevant, and factually precise, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 432,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "\n\nFrom 2022 to 2023, Tesla faced evolving financial and operational challenges in its energy storage segment. In 2022, accounts receivable pressures arose from delayed collections of government rebates, which could take up to a year to resolve, as noted in the 2022 10-K (page 64). By 2023, production scaling for energy storage products remained challenging due to supplier dependencies, bottlenecks, and complexities in ramping manufacturing at facilities like Gigafactories. The 2023 10-K (page 16) highlighted ongoing risks of production delays for energy storage systems and Solar Roof, emphasizing Tesla's vulnerability to supply chain disruptions and the need for efficient scaling to meet demand. While accounts receivable specifics for 2023 were not detailed, the persistent focus on production hurdles suggests operational dependencies continued to outweigh financial receivables concerns in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 2022 financial challenge related to delayed government rebate collections, citing the extended collection period of up to a year, consistent with the original answer. While the exact $627 million figure from December 31, 2021, is not repeated, the focus is on the 2022 context and receivables pressure, which is qualitatively accurate. (2) The quantitative accuracy is slightly reduced because the specific $627M receivable balance is omitted, though the nature and timing (2022, government rebates, long collection periods) are correctly conveyed. (3) The shift in 2023 to operational challenges—supplier constraints, bottlenecks, and factory ramp delays at Gigafactories in Nevada and Texas—is accurately captured, including citation of the 2023 10-K (page 16) and correct emphasis on production scaling risks. The synthesis across years and domains (financial to operational) demonstrates strong multi-hop reasoning. (4) The answer addresses all parts of the question: evolution of financial (accounts receivable) and operational (production scaling dependencies) challenges from 2022 to 2023. The contextual relevance is perfect, directly responding to the query with appropriate detail and source references. Minor deduction in quantitative accuracy due to omission of the specific dollar amount, but overall factual and semantic equivalence is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 401,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "\n\nBetween 2022 and 2023, Coca-Cola's role of syrups evolved by expanding direct engagement with fountain retailers and refining pricing strategies tied to bottler performance. In 2023, the company emphasized selling fountain syrups directly to retailers in the U.S. (as noted in the 2023 10-K, page 37), reducing reliance on bottling partners for this distribution channel. This shift likely strengthened Coca-Cola's control over pricing and supply chain efficiency. Additionally, the incidence-based pricing model (described in the 2022 10-K, page 43) for concentrates and syrups continued to evolve, with pricing increasingly influenced by bottler pricing, sales channels, and package mix, ensuring alignment with market dynamics. These changes reflect a strategic focus on optimizing revenue streams and deepening relationships with end-users like fountain retailers, while maintaining bottlers' roles in production and regional distribution.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it introduces some details not explicitly present in the original answer and slightly reframes the evolution. (1) Correct elements: The shift toward direct sales of fountain syrups to retailers in 2023 is accurately noted, as is the strategic emphasis on fountain syrups within the operational framework. The reference to the 2023 10-K (page 37) and 2022 10-K (page 43) supports the claim about evolving pricing models and distribution strategies. The core idea of reduced reliance on bottling partners for fountain syrup distribution and increased control over pricing and supply chain is consistent with the ground truth’s emphasis on a more integrated and strategic role for syrups. (2) Quantitative accuracy: No specific numbers (e.g., revenue amounts, volumes) are mentioned in either the original or LLM answer, so there are no numeric inaccuracies. References to years (2022, 2023) and document locations (page numbers) are plausible and contextually appropriate. (3) Multi-hop reasoning: The LLM correctly synthesizes information across years and entities—Coca-Cola, bottling partners, fountain retailers—and infers a strategic shift in business model orientation. However, the original answer does not mention 'incidence-based pricing' or 'pricing influenced by bottler pricing, sales channels, and package mix' as a 2022–2023 evolution; this detail, while potentially accurate, goes beyond the scope of the ground truth and introduces unverified specifics. (4) The answer is contextually highly relevant and captures the essence of the shift—from a volume-driven, partner-mediated model to a more direct, operationally embedded one. However, the original answer emphasizes a change in *description and conceptual framing* of syrups in the business model (from volume recognition rules to operational dependency), while the LLM focuses more on pricing and distribution tactics. This difference in emphasis prevents a perfect match, but the overall direction and strategic interpretation are sound. Hence, minor deduction in qualitative accuracy and correctness, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 590,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "\n\nDisney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) increased from **$84 million in fiscal 2022** (as of October 1, 2022) to **$166 million in fiscal 2024** (as of September 28, 2024), representing a near-doubling in absolute value. The proportion of these securities relative to total investments in the fair value hierarchy rose slightly from **1.1% in fiscal 2022** ($84M / $7,543M) to **1.5% in fiscal 2024** ($166M / $10,974M), indicating a modest increase in their relative significance within the portfolio over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dollar amounts and percentages. According to the ground truth, Disney's investment in Other MBS & ABS was $96 million in fiscal 2022 and $120 million in fiscal 2024, each representing 1% of the total plan asset mix. The LLM incorrectly reports $84 million in 2022 and $166 million in 2024, which are not only wrong but imply a near-doubling, contrary to the moderate 25% increase. Additionally, the LLM fabricates total portfolio values ($7,543M and $10,974M) not present in the original answer and calculates incorrect proportions (1.1% and 1.5%), which are unsupported by the ground truth. (2) The calculations in the LLM answer are internally consistent but based on incorrect input data, making them factually invalid. The ground truth states the proportion remained stable at 1%, while the LLM claims a rise to 1.5%, which misrepresents the trend. (3) The multi-hop reasoning is partially sound in structure—comparing absolute and relative changes over time—but fails due to incorrect data sourcing. The model attempts to assess both value and proportional trends, which aligns with the question, but the synthesis is flawed. (4) Contextual relevance is high because the LLM addresses the evolution of investment and its proportion over time, using appropriate financial reasoning. However, the severe quantitative errors undermine the qualitative and overall correctness, warranting a low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 418,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "\n\nBetween 2022 and 2023, Skunk Works' Advanced Development Programs (ADP) expanded their focus to explicitly prioritize **air dominance** as a core capability for next-generation military aircraft, alongside maintaining emphasis on hypersonics, intelligence/surveillance/reconnaissance (ISR), situational awareness, and air mobility. In 2022, the ADP highlighted future systems for \"hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility\" (LMT_10k_2022.pdf, p. 6). By 2023, the focus evolved to include **\"air dominance\"** as a stated priority, reflecting a strategic shift toward advanced combat capabilities (LMT_10k_2023.pdf, p. 4). This expansion aligns with broader U.S. military priorities for next-generation air superiority and integrated battle network technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the 2022 focus areas (hypersonics, ISR, situational awareness, air mobility) and the 2023 addition of 'air dominance' as a key priority are accurately reported, with proper context about continuity and strategic refinement. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but the years (2022, 2023) and page references (p. 6, p. 4) are correctly cited and consistent with the source documents. (3) The multi-hop reasoning is sound—comparing focus areas across two years from Lockheed Martin’s 10-K filings—and correctly infers a strategic shift toward air dominance without overstating it as a complete change. (4) The LLM slightly enhances the original answer by linking the shift to broader U.S. military priorities and battle network technologies, which is contextually reasonable but not explicitly in the ground truth; this adds value without introducing inaccuracy. The only reason for not scoring a 10 is that the original answer notes the 2022 focus also included 'unmanned and manned aerial systems,' which the LLM omits—this is a minor but notable completeness gap. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 369,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "\n\nTesla's approach to the Powerwall product evolved from 2022 to 2023 by **enhancing integration with solar energy systems and prioritizing scalable production**. In 2022, the focus was on addressing component constraints, cross-selling Powerwall with residential solar products, and improving installation efficiency (TSLA_10k_2022.pdf, p. 34). By 2023, Tesla emphasized **modular design** for energy storage systems to optimize manufacturing capacity and integrated Powerwall more seamlessly with Solar Roof and solar inverters, leveraging shared power electronics and software for remote control (TSLA_10k_2023.pdf, pp. 7, 13). Production emphasis shifted toward scaling output through new Gigafactories (e.g., Mexico) and local manufacturing strategies to reduce costs, reflecting a move from overcoming supply challenges to systematic expansion and technical integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, Tesla focused on cross-selling Powerwall with solar products and improving installation efficiency, which matches the original answer's emphasis on availability and grid stability concerns. By 2023, the integration with Solar Roof and solar systems became more engineered and seamless, as correctly noted in the LLM response with specific mention of shared power electronics and software. The addition of modular design and Gigafactory expansion (e.g., Mexico) is consistent with Tesla’s scalable production strategy and reflects a logical evolution from supply chain mitigation to systemic scaling. (2) There are no numeric values, dates, or financial figures in the question or answers that conflict; all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is sound—information is synthesized across two years and multiple aspects (integration, production, design) to show strategic evolution. The LLM adds slightly more detail (e.g., Gigafactory Mexico, modular design) than the original answer, but these are plausible and contextually supported, not contradictory. (4) The core shift from sales/availability focus to technical integration is accurately captured. The only minor gap is that the original answer emphasizes 'price efficiencies for Solar Roof' more explicitly, which the LLM touches on indirectly via cost reduction strategies but doesn’t name directly. This does not detract significantly from correctness. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 452,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "\n\nGilead's strategic positioning of **Biktarvy** as a cornerstone of its HIV portfolio remained central between 2022 and 2024, with continued emphasis on its role as a once-daily single-tablet regimen for HIV-1 treatment. However, **commercial risks evolved** to include heightened pricing pressures from state-level drug affordability reviews (e.g., Colorado’s PDAB), expanded 340B program constraints limiting pricing flexibility, and potential competition from generics or alternative therapies. Additionally, risks related to treatment paradigm shifts—such as reduced reliance on nucleoside-based therapies (e.g., TAF, a key component of Biktarvy)—persisted, threatening revenue stability. While Biktarvy retained its core strategic importance, the company faced escalating regulatory and reimbursement challenges that could impact its market access and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts: Biktarvy remains a central product in Gilead’s HIV portfolio from 2022 to 2024, and commercial risks have increased due to overreliance on TAF-based therapies and potential shifts in treatment paradigms. The answer correctly identifies the strategic continuity and evolving risk environment. However, the LLM introduces specific new details not present in the ground truth—namely, Colorado’s PDAB and 340B program constraints—which, while plausible, are not supported by the original knowledge graph and represent an overextension beyond the provided information. These additions do not contradict the ground truth but add unverified specifics that reduce qualitative accuracy. The core reasoning about increased vulnerability due to reliance on nucleoside-based therapies and TAF is sound and matches the original answer’s intent. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. The answer captures the evolution in risk profile but slightly diverges by emphasizing regulatory and pricing mechanisms not mentioned in the ground truth, which focused on therapeutic class overreliance as the primary risk. Thus, while semantically close and factually coherent, it is not fully equivalent due to the addition of unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 387,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "\n\nThe composition of Visa's U.S. Retrospective Responsibility Plan between 2022 and 2023 remained structurally consistent, retaining mechanisms such as the U.S. litigation escrow agreement, class B common stock conversion feature, indemnification obligations, interchange judgment sharing agreement, and loss sharing agreement. However, the **U.S. litigation escrow account balance increased significantly**, rising from **$1,449 million at the end of 2022** (per 2022 10-K, page 72) to **$1,764 million at the end of 2023** (per 2023 10-K, page 72). This increase reflects additional deposits into the escrow account in 2023, though specific deposit amounts for 2023 are not disclosed in the provided pages. The mechanisms themselves, including the board-directed funding process and dilutive conversion adjustments to class B shares, remained unchanged in function.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but fundamentally misaddresses the core of the question. (1) The question asks about changes in the *composition* of the U.S. Retrospective Responsibility Plan between 2022 and 2023, specifically regarding mechanisms related to the U.S. Litigation Escrow Agreement. The ground truth states that the plan *expanded* in 2023 to include a new mechanism: 'makewhole agreements relating to the Class B-1 common stock exchange offer.' The LLM answer completely omits this key structural change and instead focuses on a quantitative change—the increase in the escrow account balance from $1,449 million to $1,764 million—which, while factually accurate (verified from 10-K filings), is not the same as a change in the plan's composition. (2) Quantitative accuracy is high: the dollar amounts and page references are correct, and the increase of $315 million is accurate. However, this is not what the question asked. (3) Qualitatively, the reasoning is flawed because it misinterprets 'composition' as financial magnitude rather than structural components. The model fails to perform the required multi-hop synthesis of identifying which mechanisms were added or removed. It correctly lists the retained mechanisms but misses the addition of the makewhole agreements, which is the central change. (4) Contextual relevance is moderate—the answer discusses related elements (escrow account, mechanisms) but shifts focus to funding levels rather than structural evolution, thus missing the primary intent of the question. The answer would be strong for a question about escrow funding trends but is incorrect for one about compositional changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 453,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "\n\nThe strategic importance of Biktarvy for Gilead Sciences (GILD) increased from 2022 to 2024 due to its robust patent protection (expiring in 2033 in both the U.S. and EU) and its role as a key revenue driver amid growing HIV product dependency risks. In 2022, GILD highlighted Biktarvy’s patent term until 2033 but faced risks from competitive HIV products and potential generic erosion of other HIV therapies (e.g., Descovy, Complera, with earlier patent expirations). By 2024, the company emphasized heightened reliance on Biktarvy as other HIV products (e.g., Genvoya, Stribild) faced patent expirations or pricing pressures from state-level drug affordability reviews and 340B program constraints. The extended exclusivity of Biktarvy positioned it as a critical asset to offset revenue declines from older HIV regimens, while risk disclosures underscored the vulnerability of HIV product dependency amid regulatory and competitive challenges.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding patent expiration dates. The ground truth states that in 2022, Biktarvy had a U.S. patent expiration in 2033 and no expiration listed in the E.U., but the LLM incorrectly claims patent expiration in 2033 for both the U.S. and E.U., which is not supported by the original data. This is a critical error in quantitative accuracy. Additionally, the LLM implies that the 2033 expiration was confirmed in both regions in both years, while the 2024 filing did not explicitly mention patent details—this nuance is missed. (2) The LLM invents specific details not present in the ground truth, such as the expiration of Genvoya and Stribild, 340B program constraints, and state-level drug affordability reviews, which were not part of the original answer. While it correctly identifies Biktarvy as a key revenue driver and notes increasing risk disclosures around HIV dependency, these added specifics are unsupported and introduce factual noise. (3) The multi-hop reasoning is partially sound—linking patent protection to strategic importance and recognizing increased risk disclosures over time—but it misrepresents the evolution: the original answer emphasizes growing vulnerability despite long-term patents, whereas the LLM suggests increased strategic importance due to extended exclusivity, which misaligns with the nuanced shift in risk profile. (4) Contextual relevance is high because the answer addresses the core themes: patent timeline, revenue dependency, and risk disclosures. However, due to key factual errors in dates and unsupported claims about EU patents and other product expirations, the correctness score is limited to 5—partially correct but with significant errors affecting the overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 491,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "\n\nBased on the provided 2022 and 2023 10-K filings, there are no indications of modifications to AT&T's financial guarantees for Illinois Bell Telephone Company between 2022 and 2023. Both filings reference the same guaranty documentation for Illinois Bell under **Exhibit 4-d to Form 10-K for December 31, 2011** (see 2022 page 141 and 2023 page 103). No updated guarantees, structural changes, or new referenced agreements related to Illinois Bell are disclosed in the exhibits or notes for the 2022–2023 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the guarantee structure remained unchanged between 2022 and 2023, and both years reference the same Exhibit 4-d to the Form 10-K for the period ending December 31, 2011. (2) There are no numeric values requiring calculation, but the exhibit number and filing date are correctly cited with precision. (3) The multi-hop reasoning is sound—information is correctly synthesized across two years (2022 and 2023) and two documents (their respective 10-K filings), confirming consistency in referenced documentation and absence of modifications. (4) The answer addresses all parts of the question: it confirms no changes in guarantee structure or documentation and supports this with specific exhibit and filing details. Wording differs slightly from the original answer but conveys the same meaning with high accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 273,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "\n\nThe consistent Class C to Class A common stock conversion rate of 4.0000 between 2022 and 2023 suggests that if Class C shares convert to Class A shares, the increase in Class A shares outstanding would dilute the voting power of existing Class A common stockholders. This is because additional Class A shares from conversions would reduce the proportional ownership and voting influence of pre-existing Class A shareholders in significant corporate transactions (e.g., mergers, consolidations). Furthermore, the documents highlight that holders of other stock classes (e.g., Class B, C, or preferred stock) may have divergent interests, potentially leading to voting conflicts on key decisions, as their conversion or voting rights could alter the dynamics of corporate governance.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the consistent conversion rate of 4.0000 from Class C to Class A common stock between 2022 and 2023, which matches the ground truth and earns full points for quantitative accuracy. It also correctly notes that conversion would lead to dilution of voting power for existing Class A stockholders, which is a valid general principle. However, the LLM misses the key point from the original answer: the *stability* of the conversion rate implies *no change* in the relative dilution or voting power impact year-over-year. Instead of emphasizing stability in voting power dynamics due to the unchanged rate, the LLM focuses on the potential for dilution and voting conflicts, which, while plausible in theory, overlooks the core inference—no structural change occurred. The answer introduces speculative elements about divergent interests and governance dynamics not supported or emphasized in the ground truth. While contextually relevant and logically sound in parts, it fails to synthesize the multi-hop insight that a constant conversion rate with only a minor increase in as-converted value (38M to 39M) indicates stable, not increasing or changing, dilution pressure. Thus, qualitative accuracy is reduced due to incomplete and slightly misaligned reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 360,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "\n\nFrom 2022 to 2023, Tesla maintained Solar Roof production at Gigafactory New York (Buffalo) as part of its energy generation strategy, but faced production challenges and supply chain risks highlighted in 2023. The 2023 filing emphasized ongoing dependencies on localized manufacturing at Gigafactory New York and risks related to scaling Solar Roof production, including potential delays and supplier constraints. Additionally, strategic focus shifted toward navigating expiring U.S. federal solar tax credits (declining in 2023) and regulatory uncertainties, which impacted incentives for solar adoption. While Solar Roof remained a component of Tesla’s integrated energy ecosystem, the 2023 document underscored heightened risks in achieving cost-effective production ramps compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Tesla produced the Solar Roof at Gigafactory New York in 2022 and notes the shift in 2023 to emphasizing risks and dependencies in scaling production, including delays and supply chain constraints—this matches the core evolution described in the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes production focus (continued manufacturing) with strategic shifts (increased risk disclosures, supplier dependencies, regulatory incentives). It adds contextual detail not in the original—such as the expiring federal solar tax credits—which is factually plausible and enhances the explanation without contradicting the ground truth. (4) The only minor deviation is that the original answer emphasizes a transition from a 'production-centric view' to a 'cautionary outlook on strategic execution risks,' while the LLM frames it slightly more broadly with external factors like tax credits. This addition is relevant but not explicitly in the ground truth, which focuses on internal execution risks. Still, it does not detract from factual correctness. Overall, the answer is semantically equivalent, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 397,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "\n\nBetween 2022 and 2023, the role of syrups in Coca-Cola's business model remained central to its concentrate operations, where they serve as intermediate products sold to bottling partners for finished beverage production. However, two key evolutions emerged:  \n\n1. **Expanded Direct-to-Consumer Distribution**: In 2023, Coca-Cola began selling fountain syrups directly to consumers through retail stores operated by Costa Limited (part of the Global Ventures segment). This marked a new distribution channel for syrups, complementing traditional sales to bottlers and fountain retailers.  \n\n2. **Operational Segmentation Clarity**: The 2023 filings emphasized that fountain syrup sales in the U.S. are explicitly included in the North America operating segment, reflecting a more granular breakdown of distribution responsibilities compared to the 2022 disclosures.  \n\nOverall, syrups continued to underpin bottler partnerships, but Coca-Cola expanded their reach through direct retail channels, enhancing flexibility in finished beverage distribution.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces a significant factual inaccuracy that undermines its overall correctness. (1) Correct aspects: The emphasis on fountain syrups being part of concentrate operations and their role in the North America operating segment in 2023 aligns with the ground truth. The point about increased segmentation clarity in 2023 is also valid and contextually relevant. (2) Quantitative accuracy: There are no numeric values in either the original or LLM answer, so this dimension does not apply—score reflects absence of numerical errors. (3) Multi-hop reasoning assessment: The model correctly identifies a shift in operational segmentation between years, showing some synthesis across filings. However, it fails in a critical aspect of entity and factual accuracy by claiming that in 2023, Coca-Cola began selling fountain syrups directly to consumers through retail stores operated by Costa Limited. This is incorrect. Costa Limited is part of Coca-Cola’s Global Ventures segment, but there is no evidence in the 10-K filings that Costa retail stores sell Coca-Cola fountain syrups to consumers. Fountain syrups are sold to fountain retailers and authorized wholesalers, not through consumer retail channels as implied. This misrepresents the distribution model and introduces a fictional channel. (4) The answer is contextually relevant and addresses the evolution of syrups in production and distribution, but the inclusion of a fabricated distribution channel (direct-to-consumer via Costa) severely compromises qualitative accuracy and overall correctness, resulting in a partial score. The core strategic shift toward tighter control and regional segmentation is partially captured, but the erroneous expansion into direct-to-consumer undermines the answer’s reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 492,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "\n\nThe company's operational focus on Africa/Eurasia between 2022 and 2024 involved a **realignment of its geographic reporting structure** in 2024, where the skin health business previously reported under Europe was shifted to North America, though Africa/Eurasia itself remained a distinct reportable segment. Financially, Africa/Eurasia's operating profit was **$203 million in 2022** (as disclosed in 2022 filings), but specific 2024 figures are not provided in the sources. The 2024 filings emphasize structural changes in reporting rather than significant shifts in financial contribution from Africa/Eurasia during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Africa/Eurasia was part of the Oral, Personal and Home Care segment in 2022 with an operating profit of $203 million, matching the ground truth. It accurately notes that by 2024, Africa/Eurasia remained a distinct reportable segment and correctly identifies the realignment of the skin health business from Europe to North America. The only omission is that the original answer notes Africa/Eurasia was maintained as a distinct segment *within the Oral, Personal and Home Care geographic structure*—a minor contextual detail that adds precision but does not alter the core meaning. (2) Quantitatively, the $203 million figure for 2022 is correct and properly attributed. The LLM correctly acknowledges that 2024 financial figures are not provided, which aligns with the ground truth (no 2024 profit number is given in the original answer either). No calculations are required, and all numbers are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and segments, correctly identifying structural changes and their implications. It distinguishes between reporting structure changes and financial performance, showing appropriate logic. (4) The answer is contextually highly relevant, directly addressing both the geographic reporting evolution and financial contribution. The slight lack of specificity about the 2024 segment hierarchy prevents a perfect 10, but overall the response is factually correct, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 430,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "\n\nBetween 2023 and 2024, Johnson & Johnson's strategic presentation of its Orthopaedics business highlighted a stronger emphasis on **enabling technologies** in 2024, as explicitly stated in the 2024 10-K (page 8), which described the portfolio as including \"products and enabling technologies\" across hips, knees, trauma, spine, and sports. This marked a shift from 2023, where the 2023 10-K (pages 90–91) focused primarily on sales performance without explicitly tying growth to technological innovation. \n\nIn terms of **global sales performance**, Orthopaedics achieved 4.1% worldwide sales growth in 2023 ($8,942 million), driven by 3.8% U.S. growth and 4.6% international growth. While 2024 sales figures for Orthopaedics are not provided in the excerpts, the 2024 strategic narrative underscores a deliberate focus on integrating enabling technologies to enhance procedural outcomes, suggesting a forward-looking strategy to differentiate the business beyond traditional sales metrics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative data is correct: 2023 global sales of $8,942 million, 4.1% growth, U.S. sales growth of 3.8%, and international growth of 4.6% are all accurately reported. No 2024 sales figures were provided in the original answer, and the LLM correctly notes their absence. (2) The qualitative shift in strategic presentation—from financial metrics in 2023 to emphasis on enabling technologies in 2024—is accurately captured, including the specific language from the 2024 10-K about 'products and enabling technologies' across key therapeutic areas. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifying both the presence of sales data in 2023 and its absence in 2024, while inferring a strategic pivot based on changed language. (4) The only minor shortcoming is a slight lack of explicit comparison between the two years’ narrative tones (e.g., 'shift from quantitative to qualitative emphasis') as clearly articulated in the original answer, but the substance is fully conveyed. Wording differences do not affect semantic equivalence. All entities—Johnson & Johnson, Orthopaedics segment, correct years, and financial metrics—are accurate. The answer is fully contextually relevant and addresses both sub-questions on sales performance and enabling technologies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 391,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "\n\nBetween 2022 and 2023, Visa's approach to managing litigation liabilities through loss sharing agreements remained structurally consistent, with the **scope of U.S. covered litigation** continuing to include MDL 1720 cases and opt-out actions arising from substantially similar claims. However, **liability allocation mechanisms** and funding practices evolved as follows:  \n\n1. **Escrow Account Funding**: The U.S. litigation escrow balance increased significantly, rising from **$1,449 million in 2022** to **$3,089 million in 2023**, reflecting heightened funding to address anticipated settlements or judgments. This increase suggests a more proactive approach to reserving for litigation risks in 2023.  \n\n2. **Liability Allocation**: The omnibus agreement’s 66.67% allocation of Visa-related liabilities (vs. 33.33% for Mastercard) remained unchanged. However, the 2023 filing emphasized continued reliance on the **loss sharing agreement**, where Visa U.S.A. members’ indemnification obligations are triggered for excess amounts beyond escrow and judgment sharing agreements, reinforcing member accountability.  \n\n3. **Conversion Mechanism**: The class B common stock conversion rate adjustment mechanism, which dilutes shares to absorb losses, was operational in both years but saw a notable reduction in conversion rates in 2023 (e.g., Series B conversion rate dropped to 1.0030 from higher levels in 2022), reflecting absorbed litigation costs.  \n\nIn summary, while the framework for liability allocation stayed consistent, Visa increased escrow funding in 2023 and utilized equity conversion adjustments more prominently to manage rising litigation exposures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth, particularly regarding quantitative figures and specific mechanisms. (1) Quantitative Accuracy: The claimed escrow balances of $1,449 million in 2022 and $3,089 million in 2023 are not mentioned in the original answer and cannot be verified against the provided ground truth; these numbers appear fabricated or misattributed. Similarly, the claim about the Series B conversion rate dropping to 1.0030 is unsupported by the original text, which does not mention stock conversion rates or dilution mechanisms at all. (2) Completeness & Entity Accuracy: While the LLM correctly identifies MDL 1720 and the omnibus agreement with Mastercard’s 33.3333% share, it fails to mention the key evolution highlighted in the ground truth—the 2023 consolidation under the U.S. Retrospective Responsibility Plan and the inclusion of 'settled or otherwise fully or substantially resolved' matters. Instead, it focuses on funding and equity mechanisms absent from the original. (3) Reasoning: The multi-hop synthesis is flawed; the LLM infers changes in funding and equity adjustments without grounding in the source material, missing the strategic pivot from amendment-based management to retrospective consolidation. (4) Semantic Equivalence: Despite using similar terminology (e.g., loss sharing, omnibus agreement), the emphasis on escrow funding increases and stock conversion mechanisms misrepresents the actual evolution described. The core shift—from a focus on specific amendments in 2022 to a comprehensive retrospective framework in 2023—is entirely omitted. Thus, while some entities and percentages are accurate, the overall narrative diverges significantly from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1743,
        "completion_tokens": 484,
        "total_tokens": 2227
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "\n\nColgate-Palmolive reduced its investment in Guaranteed Investment Contracts (GICs) within its international pension plans from $55 million in 2021 to $30 million by 2024, as detailed in the 2022–2024 10-K filings. This decline indicates a strategic shift toward diversifying fixed-income allocations, aligning with the company’s target of 63% fixed-income securities for international plans. The reduction in GICs—likely replaced by other fixed-income assets like bonds—reflects a focus on optimizing returns, enhancing liquidity, and balancing risk in response to evolving market conditions and pension liability management needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that the $55 million allocation to Guaranteed Investment Contracts (GICs) in international plans was in 2021, while the ground truth specifies 2022. More critically, it omits any mention of the U.S. Pension Plans entirely—specifically, the $1 million in GICs in 2022 and the complete phase-out by 2024—which is a major component of the original answer and the question's focus on the evolution across both U.S. and international plans. The 2024 international amount is stated as $30 million in the LLM answer, but the ground truth reports $34 million, introducing a $4 million error. (2) Quantitative accuracy is low: the years are misaligned, the U.S. figures are missing, and the 2024 international value is incorrect. The calculation of change (from $55M to $30M) is therefore inaccurate. (3) The reasoning about strategic reallocation and diversification is plausible and aligns thematically with the ground truth’s indication of a strategic shift, but the multi-hop synthesis is incomplete because it fails to integrate data from both U.S. and international plans across 2022 and 2024. The LLM also introduces unverified details like a 'target of 63% fixed-income securities' and claims about replacement with bonds, which are not in the ground truth. (4) Despite these issues, the answer is contextually relevant—it addresses the general trend of reducing GICs and interprets it as a strategic asset shift, which matches the intent of the question. However, due to significant omissions and numerical inaccuracies, the correctness score is limited to 4, reflecting partial accuracy with major gaps in factual reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 467,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "\n\nBetween 2022 and 2024, the **Mastercard Developer Platform** evolved significantly to enhance integration of digital assets and new technologies. In 2022, the platform focused on simplifying access to digital assets and enabling APIs for secure integration into customer solutions (MA_10k_2022.pdf, p. 14). By 2024, the platform expanded its role by:  \n1. **Enabling blockchain-based innovations** through the Mastercard Multi-Token Network™, supporting programmable payments and secure, scalable blockchain transactions (MA_10k_2024.pdf, p. 14).  \n2. **Accelerating tokenization and contactless payments**, with 30% of Mastercard transactions tokenized and contactless payments accounting for 70% of in-person purchases (MA_10k_2024.pdf, p. 14).  \n3. **Integrating advanced solutions** like Alias-Based Remittances (simplifying cross-border payments via phone/email aliases) and partnerships with crypto platforms to enable card-based cryptocurrency purchases (MA_10k_2024.pdf, p. 13).  \n\nThese advancements positioned the Developer Platform as a central hub for fostering innovation in digital assets, real-time payments, and secure, frictionless transaction technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2022 role of the Mastercard Developer Platform as a gateway for digital assets and API integration is accurately described, and the 2024 evolution to support blockchain and digital assets via the Mastercard Multi-Token Network™ is correctly detailed. (2) Quantitative claims are factually sound: the 30% tokenization rate and 70% contactless payment share in 2024 are consistent with the cited 10-K (p. 14), and the references to Alias-Based Remittances and crypto partnerships (p. 13) are correctly attributed. (3) Multi-hop reasoning is strong—the model synthesizes information across years and documents to show platform evolution, correctly linking the Developer Platform to new technologies like blockchain and programmable payments. (4) The only minor shortcoming is that the original answer emphasizes the platform’s strategic shift toward 'programmable commerce solutions' and 'interoperable blockchain transactions' more explicitly, while the LLM answer includes related details (e.g., programmable payments) but doesn’t fully encapsulate the strategic repositioning in framing. However, the core evolution is accurately conveyed. Wording differs but semantic meaning is equivalent. No factual errors; minor deduction from 10 to 9 due to slight underemphasis on strategic positioning shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 388,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "\n\nThe company's investment in U.S. common stocks within its U.S. pension plans increased slightly from $0 million in 2021 to $1 million in 2024, as disclosed in the 2024 10-K. However, this remains a negligible portion of the total U.S. pension plan assets ($1,295 million in 2024). The strategic asset allocation emphasizes fixed income securities (60% target in 2024) and other investments (14%), with equity exposure primarily channeled through pooled funds and NAV-based funds rather than direct U.S. common stocks. This indicates a conservative, diversified approach prioritizing stability over direct equity market exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the company's investment in U.S. common stocks in the U.S. pension plan increased from $0 million in 2021 to $1 million in 2024, but the ground truth states there was no investment in U.S. common stocks in the U.S. pension plan in either 2022 or 2024. Additionally, the LLM introduces 2021 data not mentioned in the question or ground truth, which is irrelevant. The ground truth specifies that only the international pension plan held $2 million in U.S. common stocks in both years, a key detail entirely missed by the LLM. (2) Quantitatively, the LLM is incorrect: it reports $1 million in 2024 for U.S. pension plan investments in U.S. common stocks, while the correct amount is $0. It also misrepresents the international plan’s holdings, failing to mention the consistent $2 million investment. The total U.S. pension assets ($1,295 million) and allocation percentages (60% fixed income, 14% other) are not in the ground truth and appear fabricated or misattributed. (3) The multi-hop reasoning is flawed: the LLM fails to distinguish between U.S. and international pension plans, conflating them. It incorrectly infers a strategic shift toward minimal direct equity exposure when the actual strategy is complete avoidance in the U.S. plan and stable minimal exposure in the international plan. The conclusion about a 'conservative, diversified approach' may be plausible but is based on incorrect data. (4) The contextual relevance is moderate because the answer addresses strategic asset allocation and pension investments, but the factual foundation is unsound, leading to a misleading interpretation. The LLM invents data and omits critical distinctions, resulting in a largely incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 486,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "\n\nBetween 2022 and 2023, Disney's strategic focus on cruise ships evolved with increased capital investment plans and ongoing operational risk management. In 2022, the company emphasized expanding its \"Experiences\" segment, including cruise ships, as part of significant capital investments in parks and experiences (DIS_10k_2022.pdf, p. 17). By 2023, Disney explicitly announced plans for **additional expansion of its cruise ship fleet** (DIS_10k_2023.pdf, p. 22), signaling a more concrete commitment to this asset class. \n\nOperationally, risks remained tied to **pandemic-related disruptions**, **natural disasters** (e.g., hurricanes impacting Florida operations), and **health/safety measures** (DIS_10k_2023.pdf, p. 21). In 2022, cruise ship sailings had been suspended due to COVID-19, while in 2023, the company highlighted ongoing vulnerabilities to external events like weather and global health crises. Despite these risks, Disney continued to prioritize cruise ships as a growth area, reflecting confidence in their long-term strategic value within the Experiences segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the strategic shift described in the ground truth. (1) Correctly identifies that cruise ships were part of Disney's capital investment in 2022 (DIS_10k_2022.pdf, p. 17) and references operational risks like hurricanes and health crises in 2023. However, it incorrectly states that Disney announced 'additional expansion of its cruise ship fleet' in 2023 as a sign of continued growth focus. The ground truth indicates a strategic pivot from growth/investment to risk mitigation, with cruise ships framed as an operational exposure due to external disruptions like Hurricane Milton—not a continued expansion. (2) There are no explicit numerical errors (dates, percentages, dollar amounts), so quantitative accuracy is high. (3) The multi-hop reasoning fails: the model does not correctly synthesize the shift in tone and strategic emphasis between years. Instead of recognizing the move from asset expansion to risk management, it asserts ongoing prioritization and expansion, contradicting the ground truth. (4) Contextual relevance is moderate—many topics are relevant (capital investment, operational risks), but the core conclusion about strategic direction is incorrect. The answer misses the key evolution: from growth engine to risk exposure. This major misinterpretation of strategic intent justifies a low correctness score despite accurate citation of some risks and investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 402,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "\n\nMastercard's use of short duration foreign exchange derivative contracts to manage foreign exchange risk during daily settlement activities remained focused on offsetting currency fluctuations between payment transactions and customer settlements. Between 2022 and 2024, the scale of these contracts decreased: the notional amount of non-designated foreign exchange derivatives dropped from $5,424 million in 2023 to $2,741 million in 2024, with corresponding reductions in derivative assets and liabilities. Despite this reduction, the objective of mitigating short-term currency volatility against functional currencies persisted, with gains/losses continuing to be recorded in general and administrative expenses alongside foreign currency impacts on monetary assets/liabilities. This evolution suggests a potential refinement in hedging strategies or reduced exposure from daily operational settlements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative data—namely, a drop in notional amount from $5,424 million in 2023 to $2,741 million in 2024—that is not present in the original answer (ground truth). There is no mention in the ground truth of any numerical values related to notional amounts, derivative assets/liabilities, or trends in scale of contracts. This makes the quantitative claims unsupported and factually unverifiable against the provided truth. Since the ground truth does not include these figures, their inclusion constitutes a significant factual deviation, not just a formatting difference. (2) The original answer emphasizes continuity in the use and objective of short-duration FX derivatives but highlights a broader strategic evolution in Mastercard’s FX risk management, particularly around euro-denominated debt hedging (de-designation and re-designation in 2023–2024). The LLM answer fails to mention this key strategic shift involving debt hedging, which is a central qualitative point in the ground truth. Instead, it fabricates a narrative about decreasing notional amounts and reduced exposure, which is not corroborated. (3) The multi-hop reasoning is partially sound in that it correctly identifies the purpose of short-duration FX derivatives (managing daily settlement risk and reducing volatility), and maintains that objective across years. However, it misses the critical synthesis point: the contrast between stable use of short-term contracts and dynamic changes in macro hedging strategy (euro debt). This omission undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the right topic—short-duration FX derivatives in daily settlement—and discusses risk management objectives appropriately. However, the introduction of false quantitative data severely undermines correctness. While the semantic intent (continued use for similar purpose) aligns, the fabricated metrics and missed strategic context reduce the overall correctness score to 4, as the answer is partially right on intent but significantly flawed in facts and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 572,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "\n\nFrom 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies evolved by **deepening ecosystem integration** and **expanding AI-focused investments**. In 2023, the company emphasized leveraging its AppExchange marketplace and partner ecosystem (including ISVs and system integrators) to drive market expansion and solution integration. By 2024, Salesforce introduced **Agentforce**, an AI layer for autonomous agents, signaling a shift toward embedding AI across its platform and partner applications. Investment focus remained on enterprise cloud startups and technology firms, with a heightened emphasis on AI innovation and vertical-specific solutions (e.g., financial services, healthcare). Additionally, Salesforce continued to prioritize strategic acquisitions and partnerships to enhance its cloud ecosystem, ensuring alignment with industry trends like generative AI and cross-industry digital transformation.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces unverified elements not present in the ground truth, affecting factual accuracy. (1) Correct aspects: The emphasis on ecosystem integration via AppExchange and partners (ISVs, system integrators) aligns with the original answer, as does the continued investment in enterprise cloud and technology firms. The mention of vertical-specific solutions (e.g., healthcare, financial services) is contextually plausible and consistent with Salesforce's strategy. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The core evolution described in the ground truth—from financial investment in 2023 to broader strategic dependency and deeper ecosystem integration in 2024—is partially captured, but the LLM misrepresents the nature of the shift. Instead of highlighting a move from investment to ecosystem dependency and platform-enabled development (via Salesforce Platform and AppExchange), the LLM focuses on the introduction of 'Agentforce' and an 'AI layer' as the primary evolution. However, 'Agentforce' and AI-centric strategic shifts are not mentioned in the ground truth and cannot be verified from the provided knowledge graph, making this a significant factual overreach. (4) The original answer emphasizes structural and strategic dependency evolution, while the LLM reframes it around AI innovation, which may be contextually relevant but is not supported by the provided evidence. This misalignment reduces qualitative accuracy. The answer remains contextually relevant to the question’s domain and maintains a logical structure, hence a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 493,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "\n\nThe company maintained a consistent methodology for accrual rates of vendor funding programs between fiscal 2023 and 2024, basing rates on vendor agreement terms, historical purchase trends, and periodic adjustments for actual volumes. However, sensitivity to projected purchase volumes remained critical, particularly for programs with graduated funding thresholds. In both years, discrepancies between actual and projected volumes could impact accruals, with fiscal 2023 noting a potential $18 million net earnings effect from a 10% volume variance, adjusted to $17 million in 2024. The approach emphasized ongoing analysis and vendor confirmations to ensure accuracy, reflecting sustained sensitivity to purchase volume fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that the company maintained a consistent methodology for accrual rates between fiscal 2023 and 2024 and that projected purchase volumes remained a factor. However, it introduces significant factual inaccuracies not present in the ground truth. Most critically, the LLM claims that a 10% volume variance could impact net earnings by $18 million in fiscal 2023 and $17 million in 2024—this quantitative detail is entirely absent from the original answer and cannot be verified from the provided ground truth. There is no mention of any dollar-impact calculations related to volume variances in the original, making these figures hallucinated. This severely undermines quantitative accuracy. Qualitatively, the LLM correctly identifies ongoing sensitivity to purchase volumes and the use of vendor confirmations and historical trends, aligning with the original's description of continued monitoring. However, it misses the key qualitative evolution noted in the ground truth: the explicit mention of 'graduated purchase volumes' in fiscal 2023 that was omitted in fiscal 2024, which suggests a shift in disclosure emphasis or potential simplification. The LLM instead implies that graduated thresholds remained a highlighted concern in both years, contradicting the original. Contextually, the response is relevant and addresses the question's focus on sensitivity to projected volumes, but the inclusion of fabricated financial impacts and misrepresentation of disclosure changes reduces its factual reliability. Thus, while the general direction of reasoning is sound, the answer fails on key factual and multi-hop synthesis points, particularly in distinguishing subtle but important changes in disclosure language over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 479,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "\n\nThe strategic relationship between LLY and Boehringer Ingelheim (BI) from 2022 to 2024 evolved with increased regulatory and pricing pressures impacting their Jardiance collaboration. **Legal involvement** shifted from product liability defense (BI indemnifying LLY for Jardiance-related lawsuits in 2022) to addressing the U.S. Inflation Reduction Act (IRA) in 2024, which mandated a 66% price discount for Jardiance starting 2026, directly affecting revenue sharing. **Collaborative dependency** remained strong, with both parties sharing development/commercialization costs and royalties for Jardiance in major markets. A 2024 amendment to their agreement included a $300 million one-time payment to adjust commercialization responsibilities in smaller markets, reflecting strategic realignment to mitigate IRA-driven revenue erosion and maintain competitive positioning. This underscores their continued reliance on joint operations while adapting to external regulatory challenges.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness. (1) The claim that Boehringer Ingelheim indemnified LLY for 'product liability defense' in 2022 is not supported by the ground truth, which states that LLY was not a direct party to the Hatch-Waxman patent litigation—this reflects a mischaracterization of legal involvement. (2) The Inflation Reduction Act (IRA) price discount is incorrectly stated to start in 2026; the ground truth indicates the pricing impact is from 2024 onward, with the discount applied starting when Jardiance was selected under the IRA, not two years later. (3) The $300 million one-time payment and agreement amendment in 2024 are entirely fabricated and not present in the original answer or implied by the knowledge graph. (4) While the 66% discount figure is correctly mentioned, its timing and financial implications are misrepresented. (5) The core idea of increasing dependency due to IRA pricing pressures is aligned with the ground truth and shows correct multi-hop reasoning between regulatory changes and collaborative strategy. However, the invented details about indemnification, payment, and delayed discount implementation severely compromise quantitative and qualitative accuracy. The answer is contextually relevant and addresses both legal involvement and collaborative dependency, but with major factual errors. Semantic equivalence fails due to unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 401,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "\n\nFrom 2022 to 2023, Disney's capital investment strategy for cruise ships shifted from **suspension due to pandemic-related disruptions** to **renewed focus within the Parks & Experiences business**. In 2022 (page 23), the company delayed or suspended projects, including cruise ships, as part of broader cost mitigation efforts amid COVID-19 impacts. By 2023 (page 12), capital investments in Parks & Experiences explicitly included cruise ships alongside theme park expansions and new attractions, reflecting a strategic prioritization of enhancing travel and resort offerings post-pandemic. This aligns with the broader goal of revitalizing out-of-home entertainment experiences, as cruise ships remain a key component of Disney’s diversified leisure portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Disney's 2022 capital investment strategy. The claim that Disney 'suspended' cruise ship investments in 2022 due to the pandemic is not supported by the ground truth, which states that while macroeconomic risks (inflation, supply chain issues) were noted, there was no specific emphasis on cruise ship suspensions—only general risk disclosures. The 2022 10-K did not mention project delays or suspensions of cruise ships on page 23 as the LLM claims. In contrast, the 2023 shift is correctly identified: Disney did explicitly list cruise ships among capital investments, aligning with the ground truth. (2) There are no explicit numbers (dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the reference to 'page 23' and 'page 12' lacks verification and may be fabricated, slightly reducing confidence in sourcing—though page numbers were not part of the original truth. (3) The multi-hop reasoning is partially sound: the model correctly identifies a strategic shift toward emphasizing cruise ships in 2023 within Parks & Experiences. However, it incorrectly infers pandemic-related suspension in 2022, which is not in the original answer and contradicts the more nuanced risk-focused narrative of the 2022 filing. This undermines the qualitative accuracy. (4) Contextual relevance is fair—the answer addresses the evolution in investment strategy and ties cruise ships to the broader Parks & Experiences segment. But due to the incorrect characterization of 2022 as a year of suspension rather than risk disclosure, the core factual premise is flawed, warranting a low correctness score despite some alignment in 2023 description.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 481,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "\n\nBetween 2022 and 2024, Mastercard Foundry's role in fostering innovation expanded significantly, with a stronger focus on emerging technologies and fintech partnerships. In 2022, Foundry emphasized innovation workshops like \"Launchpad\" and in-lab testing to drive collaboration with financial institutions and governments. By 2024, Foundry had scaled its efforts to include advanced technologies such as blockchain integration (e.g., programmable payments via the Multi-Token Network), tokenization (30% of transactions tokenized), and contactless solutions (70% of in-person transactions). It also deepened fintech engagement through the Mastercard Developer platform, enabling seamless API integration, and partnered with crypto players to facilitate blockchain-based transactions. Additionally, Foundry supported real-world implementations like Alias-Based Remittances and expanded virtual card solutions, reflecting a shift from prototyping to deploying scalable, ecosystem-wide innovations.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Mastercard Foundry from a collaborative innovation space in 2022 to a more active technology enabler in 2024, which aligns with the ground truth. It correctly identifies blockchain, programmable payments, and fintech partnerships as key focus areas. However, it introduces several specific quantitative claims not present in the original answer or verifiable from the context: '30% of transactions tokenized' and '70% of in-person transactions' being contactless have no support in the ground truth and appear fabricated. Additionally, 'Launchpad' workshops, 'Alias-Based Remittances', and specific figures around virtual cards and API integration are not mentioned in the original answer. (2) Quantitative accuracy is low because the model invents precise percentages (30%, 70%) without grounding, which significantly undermines factual reliability. There are no such metrics in the original knowledge base. (3) Qualitatively, the reasoning follows a logical trajectory—shifting from prototyping to deployment—and correctly identifies the Multi-Token Network™ and blockchain as strategic priorities in 2024. The mention of the Mastercard Developer platform and crypto partnerships is plausible but not confirmed in the ground truth. The core evolution narrative is directionally accurate, showing some correct multi-hop synthesis, though overstated with unsupported details. (4) Contextual relevance is high because the response stays focused on Foundry’s innovation role, emerging tech, and fintech collaboration across the specified time frame. Despite embellishments, the overall structure and intent match the question. The correctness score is moderate due to a mix of accurate directional information and significant factual overreach with unverified statistics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 497,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "\n\nThe collaboration with Boehringer Ingelheim evolved between 2022 and 2024 through **regulatory advancements** and **heightened pricing pressures**. By 2024, Jardiance (a key product in the collaboration) retained **FDA Breakthrough Therapy and Fast Track designations** for heart failure and chronic kidney disease, reflecting ongoing regulatory support. However, the **Inflation Reduction Act (IRA)** introduced significant pricing pressures, with the U.S. government setting Jardiance’s price at a **66% discount** from 2023 list prices, effective 2026. This marked a strategic shift, as the IRA’s pricing controls accelerated revenue erosion risks. Additionally, a 2024 amendment to the collaboration adjusted commercialization responsibilities in smaller markets, including a **$300 million one-time payment**, signaling operational realignments to mitigate financial impacts. While regulatory designations remained strong, the IRA’s mandated discounts and revenue-sharing adjustments underscored the growing financial and strategic challenges under U.S. pricing reforms.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in the Boehringer Ingelheim collaboration correctly: regulatory designations in 2022 and pricing pressures under the Inflation Reduction Act (IRA) by 2024. It accurately notes the 66% discount on Jardiance effective in 2026, aligning with the ground truth. However, there are key inaccuracies affecting quantitative and qualitative scores. First, the $300 million one-time payment and the 2024 amendment to commercialization responsibilities are not present in the ground truth and appear to be hallucinated, undermining factual reliability. Second, while the original answer states that Breakthrough Therapy and Fast Track designations were received in 2022 (indicating early-stage support), the LLM implies they were still active in 2024 without confirming their initial timing, slightly misrepresenting the evolution. The reasoning is otherwise sound—correctly identifying a shift from regulatory facilitation to financial constraints—and the answer is contextually relevant, addressing both regulatory and pricing dimensions. The 66% discount and 2026 effective date are correctly cited, but the addition of unverified financial terms reduces quantitative accuracy. Thus, the answer is mostly correct but contains significant fabricated details that impact overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 367,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "\n\nThe strategic positioning of the CH-53K King Stallion within Lockheed Martin's Rotary and Mission Systems (RMS) segment evolved from 2023 to 2024 by shifting focus from securing international contracts to integrating advanced technologies as part of broader mission solutions. In 2023, the program emphasized international sales, such as the Israeli Ministry of Defense's procurement of 12 helicopters, with awards finalized in 2022–2023. By 2024, the CH-53K was highlighted alongside radar surveillance and C6ISR systems, reflecting its alignment with RMS's emphasis on digital transformation, AI/ML, autonomy, and all-domain mission solutions under Lockheed's 21st Century Security vision. This evolution underscores its role as a technologically enhanced component of integrated defense systems rather than a standalone platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of the CH-53K King Stallion's strategic positioning within Lockheed Martin's Rotary and Mission Systems (RMS) segment from 2023 to 2024. (1) The answer correctly identifies the shift in emphasis from international sales (e.g., Israel's procurement of 12 helicopters) in 2023 to integration with advanced technologies and broader mission solutions in 2024. This matches the ground truth's description of a move toward digital transformation, AI/ML, autonomy, and all-domain solutions. (2) There are no numeric figures in the original answer, and the LLM does not introduce any incorrect numbers—references to the Israeli contract (12 helicopters, awards in 2022–2023) are factually consistent with public disclosures and do not contradict the ground truth, earning full marks for quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information about international contracts, technological integration, and alignment with RMS’s broader portfolio. However, the original answer does not explicitly mention the Israeli contract or international sales as a 2023 focus, so this detail, while plausible and contextually relevant, is an addition not present in the ground truth, slightly reducing qualitative accuracy. (4) The answer remains highly contextually relevant, directly addressing the evolution in strategic positioning with accurate framing around digital transformation and Lockheed’s 21st Century Security vision. Overall, the LLM provides a semantically equivalent and well-reasoned response with minor extrapolation beyond the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 455,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "\n\nThe change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 reflects a strategic shift toward prioritizing products with differentiated therapeutic profiles and stronger market positioning. In 2022, the portfolio included Trajenta (a DPP-4 inhibitor) and Jentadueto (a metformin/sitagliptin combination), while the 2024 portfolio emphasizes Jardiance (an SGLT2 inhibitor with cardiovascular benefits), Glyxambi (a combination of Jardiance and metformin), Synjardy (a metformin/SGLT2 inhibitor), and Trijardy XR (a triple combination). This evolution indicates a focus on therapies with proven added value (e.g., cardiovascular co-benefits) to address payer demands for cost-effectiveness, navigate competitive pressures from generics, and align with value-based healthcare trends. The omission of older products like Trajenta and Jentadueto suggests a rationalization of the portfolio to retain assets with stronger differentiation and commercial resilience in a challenging pricing and reimbursement environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—LLY, Boehringer Ingelheim, product names (Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR), and the time frame (2022 to 2024)—are correctly identified. The narrowing of the portfolio from a broader set in 2022 to only Jardiance, Glyxambi, Synjardy, and Trijardy XR in 2024 is accurately described. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the temporal and categorical data (years and product lists) are correct. (3) The multi-hop reasoning is sound: the model correctly infers a strategic refocusing based on changes in the co-commercialized portfolio and provides plausible drivers—therapeutic differentiation (e.g., SGLT2 inhibitors with cardiovascular benefits), market pressures, generic competition, and value-based care trends. It correctly notes the removal of DPP-4-based products (Trajenta, Jentadueto) and Basaglar (though Basaglar is not explicitly mentioned in the LLM answer, its absence is implied in the portfolio shift). (4) While the LLM does not explicitly mention Basaglar’s removal—present in the original answer—this is a minor omission that does not undermine the core insight. The reasoning about strategic prioritization, lifecycle management, and market dynamics is semantically equivalent and well-articulated. The answer is contextually excellent, directly addressing the question about shifting strategic priorities. Minor deduction from 10 to 9 due to incomplete mention of all discontinued products (Basaglar omitted), but overall factual and inferential accuracy is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 453,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "\n\nThe JASSM program's financial performance and strategic importance evolved between 2023 and 2024 as follows:  \n\n- **2023**: Production ramp-up on JASSM contributed **$145 million higher net sales** in the Missiles and Fire Control (MFC) segment, driven by increased tactical and strike missile program activity. Backlog grew due to higher orders on JASSM, alongside PAC-3, LRASM, and GMLRS programs.  \n\n- **2024**: JASSM production ramp-up intensified, contributing **$1.2 billion higher net sales** in MFC, reflecting significant scale in tactical/strike missile programs. Backlog further increased, fueled by stronger orders for JASSM, PAC-3, and GMLRS. However, MFC’s operating profit dropped sharply in 2024 due to **$1.4 billion in losses on a classified program**, though JASSM’s production remained a critical growth driver.  \n\nStrategically, JASSM solidified its role as a key precision strike capability, with sustained production and backlog growth underscoring its importance to defense modernization efforts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that in 2023, there was no specific mention of significant changes in JASSM production or backlog contribution, but the LLM claims a $145 million increase in net sales and backlog growth due to JASSM—information not present in the original answer. This is a major factual overstatement. In 2024, the LLM correctly identifies the $1.2 billion increase in tactical and strike missile programs (attributed to JASSM, PAC-3, and GMLRS), which aligns with the ground truth. However, the LLM introduces a new detail about a $1.4 billion loss on a classified program causing a drop in MFC operating profit—this is not mentioned in the original answer and appears to be hallucinated or sourced from outside the provided context. (2) The $145 million figure for 2023 is unsupported by the ground truth, which makes no mention of any dollar amount related to JASSM in that year. The $1.2 billion figure for 2024 is correct and matches the original answer. The mention of LRASM in 2023 backlog is also not in the original answer, which only cites JASSM, PAC-3, and GMLRS in 2024. (3) The multi-hop reasoning is partially sound in linking JASSM to increased backlog and production in 2024, but fails in 2023 by fabricating details. The strategic importance is reasonably inferred, but the financial narrative is distorted by incorrect figures and extraneous details. (4) The correctness score is low due to major quantitative errors and hallucinated data. Quantitative accuracy is poor due to the unsupported $145M figure and extraneous $1.4B loss. Qualitative accuracy is moderate because the model captures the rising strategic role of JASSM in 2024 but misrepresents 2023. Contextual relevance is high as the answer addresses the right program, segment, and timeframe with relevant themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 517,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "\n\nJPM's evaluation of credit risk for Business Banking Loans shifted from primarily relying on **delinquency rates and geographic distribution** (as emphasized in 2023) to incorporating **internal risk ratings** as the primary credit quality indicator by 2024 (as detailed in 2024 filings). In 2023, delinquency rates (e.g., 30+ days past due) and regional economic factors were central for identifying early distress signals. By 2024, the firm introduced a more granular framework, categorizing loans by investment-grade vs. non-investment-grade ratings, with subcategories for \"criticized\" loans (nonaccrual and performing but at higher risk). This shift allows earlier identification of borrower distress by proactively assessing creditworthiness through qualitative and quantitative risk factors (e.g., borrower financial health, industry risks) before delinquencies occur, as evidenced by a rise in criticized loans (3.67% of total in 2024 vs. 3.51% in 2023). The evolution reflects a more forward-looking, risk-based approach to credit management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, JPM focused on loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment, not on delinquency rates and geographic distribution as claimed by the LLM. Furthermore, the shift in 2024 was toward delinquency rates (specifically 30+ days past due) as the primary indicator, not internal risk ratings. The LLM incorrectly asserts that internal risk ratings became the primary credit quality indicator in 2024, which contradicts the ground truth. (2) The quantitative claims in the LLM answer are unsupported and incorrect. It cites specific percentages for criticized loans (3.67% in 2024 vs. 3.51% in 2023), but these numbers do not appear in the original answer and are not mentioned in the context provided. There is no mention of investment-grade vs. non-investment-grade categorization or criticized loans in the ground truth, making these additions fabricated. (3) The multi-hop reasoning is flawed. The LLM fails to correctly identify the evolution described in the original answer: from scoring models in 2023 to delinquency tracking in 2024. Instead, it invents a shift from delinquency rates to internal ratings, reversing the actual direction of change and introducing non-existent frameworks. This indicates a failure to synthesize the correct information across years. (4) While the LLM attempts to address the question's structure—discussing changes in credit risk focus and implications for early distress detection—the content is largely incorrect. The contextual relevance is moderate because it discusses plausible financial concepts and the general idea of evolving risk assessment, but the specific facts, entities, and reasoning are misaligned with the ground truth. The answer reflects a plausible-sounding but factually inaccurate narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 518,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "\n\nBetween 2022 and 2023, Target Corporation’s SPP II (Senior Performance Plan II) was amended and restated effective **May 1, 2022**, as disclosed in the 2023 10-K (page 70). This update revised the prior 2016 plan statement referenced in the 2022 filing (page 68). The evolution suggests a deliberate effort to align executive compensation with updated performance metrics, likely emphasizing long-term shareholder value and competitive market practices. The continued use of performance-based restricted stock units tied to total shareholder return relative to retail peers (noted in 2023) underscores Target’s focus on linking executive incentives to financial outcomes and strategic goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key date of May 1, 2022, for the amendment of the SPP II plan, matching the ground truth's reference to the 2022 Plan Statement effective May 1, 2022. It also correctly notes that the 2022 filing referenced the prior 2016 version, establishing the evolution between filings. (2) All dates and plan names (SPP II, 2016 Plan Statement, 2022 Plan Statement) are factually correct; no numerical inaccuracies are present. Page references (68 and 70) add precision and are consistent with typical 10-K structures, though not part of the ground truth—these do not detract as they are plausible and support the claim. (3) The reasoning is sound: the model correctly infers that the update reflects a strategic shift in executive compensation, linking it to performance metrics and long-term value, which is a reasonable interpretation of the plan update. It adds contextual insight about performance-based RSUs and peer benchmarking, which enriches the answer without contradicting the ground truth. (4) The answer fully addresses both parts of the question—how the terms evolved and what it suggests about the compensation framework. The only minor limitation is that the ground truth emphasizes the structural revision without specifying performance metrics, so the added detail about total shareholder return, while plausible and contextually appropriate, is not confirmed in the ground truth. This slight extrapolation prevents a perfect 10 but does not undermine correctness. Overall, the answer is factually solid, well-reasoned, and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 451,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "\n\nThe financial obligations under the Olumiant collaboration with Incyte evolved as follows from 2022 to 2024:  \n\nAs of December 31, 2021 (disclosed in 2022 filings), Incyte was eligible for up to **$100 million in additional regulatory milestone payments** and **$100 million in sales-based milestone payments**. By 2024, the 10-K filings do not indicate any new milestone payments or changes to these contingent obligations, suggesting the potential future payments remained unchanged at these thresholds. The 2024 disclosures focus on ongoing royalty structures (tiered rates up to 20% for inflammatory diseases and additional royalties for COVID-19 sales exceeding thresholds) but do not update the status of the prior milestone contingencies. Thus, the potential obligations for regulatory and sales-based milestones appear to have carried forward without resolution or modification through 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $100 million in potential regulatory and $100 million in sales-based milestone payments from the 2022 disclosures, which matches the ground truth quantitatively. However, it incorrectly interprets the 2024 situation: while the LLM states that 'the potential future payments remained unchanged' and 'appear to have carried forward without resolution or modification,' the ground truth indicates that by 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable. This reflects a key shift in the obligation structure that the LLM fails to recognize. Instead, the LLM assumes continuity due to lack of explicit updates, which contradicts the inference in the original answer that the absence of mention implies resolution. The qualitative reasoning is therefore flawed in the multi-hop synthesis—failing to infer status changes from evolving disclosure patterns. While royalty details (tiered up to 20%, low teens for COVID-19 sales) are accurately noted and contextually relevant, the core evolution of milestone obligations—a central part of the question—is misrepresented. Thus, despite correct numbers and good contextual framing, the conclusion about the persistence of milestone obligations is incorrect, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 371,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "\n\nCisco's financial exposure in the APJC region increased between fiscal 2022 and 2023, primarily driven by acquisitions. In fiscal 2022, APJC segment revenue was $8.0 billion with a gross margin of $5.2 billion (CSCO_10k_2022.pdf, page 105). By fiscal 2023, goodwill allocated to APJC rose from $5.38 billion to $8.21 billion (CSCO_10k_2023.pdf, page 76), largely due to the Splunk acquisition, which contributed $2.7 billion to APJC's goodwill. This reflects expanded asset exposure in the region, though specific 2023 APJC revenue figures are not provided in the excerpts. The growth in goodwill underscores Cisco's strategic investments in APJC during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that specific financial figures for APJC were not disclosed in fiscal 2022, but the LLM claims APJC segment revenue was $8.0 billion and gross margin $5.2 billion in 2022, which contradicts the original answer. Additionally, the LLM states that goodwill in APJC increased from $5.38 billion to $8.21 billion, with $2.7 billion from the Splunk acquisition. However, the ground truth reports total APJC assets (not goodwill) as $5,382 million in 2023, and does not mention goodwill allocation by region or the Splunk acquisition's regional impact. These are major factual errors. (2) Quantitative accuracy is very low: the numbers cited (e.g., $8.0B revenue, $5.2B gross margin, $8.21B goodwill) are not supported by the ground truth and appear fabricated or misattributed. The only number aligning roughly is $5.38 billion (vs. $5,382 million), but it is mischaracterized as goodwill rather than total assets. (3) Multi-hop reasoning is flawed: the LLM incorrectly infers segment-level income statement and goodwill data from sources not mentioned in the ground truth, fails to acknowledge the lack of 2022 asset breakdowns, and invents a causal link to Splunk without evidence. The original answer emphasizes increased disclosure in 2023, while the LLM assumes detailed comparative metrics exist. (4) Contextual relevance is moderate—the response addresses Cisco’s APJC exposure and attempts to compare 2022 and 2023 using asset and acquisition impacts—but the incorrect data and reasoning undermine the conclusion. The focus on acquisitions and regional investment aligns thematically, but factual correctness is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 470,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "\n\nThe strategic collaboration between Eli Lilly (LLY) and Boehringer Ingelheim regarding Jardiance evolved from 2022 to 2024 in response to regulatory pressures, particularly the U.S. Inflation Reduction Act (IRA) of 2022, which mandated government-set price reductions for certain drugs, including Jardiance, effective 2026. To mitigate revenue erosion from these price cuts, the companies amended their collaboration in 2024, adjusting commercialization responsibilities for Jardiance in smaller markets and securing a one-time $300 million payment. This structural shift aimed to optimize revenue-sharing dynamics and operational efficiency in markets less impacted by IRA regulations. Despite regulatory headwinds, Jardiance revenue grew significantly from $2,066 million in 2022 to $3,340.9 million in 2024, reflecting expanded market access and demand management ahead of the 2026 price reductions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual inaccuracies. First, it incorrectly states that the Inflation Reduction Act (IRA) price reductions for Jardiance are effective in 2026, while the ground truth specifies that a 66% discount was applied in August 2024. This misrepresents the timeline and impact of the regulatory change. Second, the LLM claims a one-time $300 million payment was made in 2024 as part of a collaboration amendment, which is not mentioned in the ground truth and appears fabricated. Third, the revenue figures provided ($2,066 million in 2022 and $3,340.9 million in 2024) are not present in the original answer and contradict the implied revenue decline due to the 66% price cut; the ground truth emphasizes negative impact on revenue projections, not growth. (2) Quantitative accuracy is severely compromised: the revenue numbers, the 2026 effective date, and the $300M payment are all unsupported by the ground truth. The ground truth does not provide exact revenue figures for 2022 or 2024, but does state that the 66% discount in 2024 significantly affected revenue projections—contradicting the LLM's claim of strong revenue growth. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the IRA as a regulatory driver and links it to Jardiance, it invents strategic responses (amended collaboration, payment, market shifts) not present in the ground truth. The actual evolution centers on the selection of Jardiance for government pricing in August 2023 and the implementation of a 66% discount in August 2024, with no mention of structural changes to the collaboration. (4) Contextual relevance is moderate—the answer addresses the collaboration and regulatory context, but the invented details and incorrect timeline undermine factual correctness. The core narrative of regulatory impact is relevant, but the specifics are misleading. Correctness score is low due to major factual and temporal errors, especially regarding the IRA's timing and financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 547,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "\n\nBetween 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly for global platforms like the Chevrolet Bolt EV and its EV/AV technologies, evolved in two key ways:  \n\n1. **Increased Financial Scrutiny and Specificity**: In 2023, GM explicitly highlighted a **$2.1 billion rise in recall and warranty-related costs** (notably tied to EV campaigns, including the Bolt EV battery issues) and a **$5.1 million EPA settlement** for TSCA violations at its Ultium joint venture. This reflects a sharper focus on quantifying financial impacts compared to 2022, where risks were discussed more generally.  \n\n2. **Heightened Reputational and Strategic Risk Management**: The 2023 filing underscored reputational damage from recalls involving advanced technologies (e.g., AVs), emphasizing risks to \"brand equity and consumer trust\" in GM’s leadership in EV/AV innovation. This aligns with expanded risk management frameworks, including cybersecurity governance for AVs, signaling a proactive stance to safeguard GM’s positioning in emerging technologies.  \n\nThese changes indicate a shift from general risk acknowledgment in 2022 to concrete financial disclosures and strategic safeguards in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims not present in the original answer or implied by the context. First, the $2.1 billion rise in recall and warranty costs and the $5.1 million EPA settlement are not mentioned in the ground truth and cannot be verified from the provided information; these specific figures are therefore incorrect or fabricated. The original answer makes no reference to numerical cost increases or regulatory settlements, only a general evolution in risk emphasis. This severely undermines quantitative accuracy. Second, while the LLM correctly identifies the Chevrolet Bolt EV as a focal point and notes a shift toward reputational risk in 2023, it misrepresents the nature of GM’s evolving disclosure: the original answer does not mention cybersecurity governance, AV cybersecurity, or TSCA violations, nor does it specify that the financial costs were broken down in 2023 filings. The qualitative reasoning partially aligns—there is a valid conceptual shift from financial to reputational/strategic concerns—but the LLM overreaches by introducing unverified details and specific figures, suggesting a failure in multi-hop synthesis based on actual data. The contextual relevance is high because the response addresses the right companies, technologies, and time frame, and captures the general direction of change in risk emphasis. However, the inclusion of unsupported specifics reduces factual correctness. Overall, the answer gives a plausible narrative but is not factually grounded in the provided truth, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 443,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "\n\nBetween 2022 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling $500 million in November 2023 (with maturities from 2033 to 2043) and partially repaid $77 million in July 2024. This evolution reflects Costco's long-term financing strategy of diversifying debt sources through international subsidiaries to secure favorable interest rates (1.400%–2.120%) and extend maturity profiles, ensuring stable funding while managing leverage. The issuance of long-term notes underscores a focus on low-cost, fixed-rate debt to support operations and mitigate refinancing risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 million in Guaranteed Senior Notes issued in November 2023 by Costco's Japanese subsidiary, with fixed interest rates between 1.400% and 2.120%, and maturities from 2033 to 2043. It also accurately notes the $77 million repayment in July 2024. These figures match the ground truth exactly, with acceptable formatting ($500 million = approximately $500 in the original, interpreted correctly). (2) All numeric values—$500 million, $77 million, interest rate range, and maturity years—are factually correct. The dates (November 2023 issuance, July 2024 repayment) align with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 (implied lack of detail) and 2024 (detailed disclosure), correctly inferring a shift toward greater transparency and strategic long-term financing. It accurately concludes that Costco is focusing on fixed-rate, long-term debt to manage refinancing risk and liquidity—consistent with the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2022 disclosure was limited to Level 3 valuation inputs, which adds nuance to the evolution in transparency. While the strategic interpretation is correct and well-reasoned, this omission slightly reduces qualitative completeness. However, the core facts, calculations, and strategic implications are all accurately conveyed, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 414,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "\n\nThe value of Cisco's available-for-sale debt investments increased from **$11.9 billion in 2022** (CSCO_10k_2022.pdf, page 50) to **$15.6 billion in 2023** (CSCO_10k_2023.pdf, page 47), reflecting a **$3.7 billion growth**. This increase suggests Cisco prioritized expanding its investment portfolio during this period, likely to maintain liquidity, capitalize on market opportunities, or hedge against interest rate fluctuations. The company emphasized preserving principal while seeking returns through high-quality, short-term investment-grade securities, aligning with its strategy of balancing capital preservation with strategic financial flexibility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Cisco's available-for-sale debt investments decreased from $15,592 million in 2022 to $9,865 million in 2023 — a drop of $5,727 million. Instead, the LLM claims an increase from $11.9 billion to $15.6 billion, which is the opposite trend and uses incorrect base values. These numbers do not match the ground truth even with formatting allowances. (2) The calculation in the LLM answer ($3.7 billion growth) is based on false inputs and is therefore invalid. The correct change is a decrease of $5,727 million (~$5.7 billion), not an increase. Additionally, the LLM references gains of $9 million in 2022 as part of its reasoning but omits this entirely, failing to incorporate a key data point from the original answer. (3) The multi-hop reasoning is flawed: the LLM fails to correctly extract and compare the two-year values from the respective 10-K filings. It incorrectly infers an expansion strategy when the data supports a contraction, indicating a failure in synthesizing accurate insights across years. (4) The contextual relevance is partially maintained because the answer discusses Cisco’s investment strategy and refers to available-for-sale debt instruments, but the conclusions are based on fabricated trends. Due to major factual and quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 397,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "\n\nJPMorgan Chase's exposure to system damage risks from 2023 to 2024 shows heightened focus on third-party vendor attacks and data recovery challenges, with proactive measures in 2024. In 2024, the firm emphasized **enhanced oversight of third-party vendors**, including early detection of attacks (e.g., ransomware, open-source software vulnerabilities) and improved technology asset management to address undetected vulnerabilities (JPM_10k_2024.pdf, pages 26–27). This reflects a more structured approach to mitigating vendor risks compared to 2023, where risks were acknowledged but specific controls were less detailed (JPM_10k_2023.pdf, pages 23–24). \n\nFor data recovery, 2024 highlighted **upgrades to systems and controls** to recover from outages caused by malware or ransomware (JPM_10k_2024.pdf, page 27), whereas 2023 focused broadly on operational disruptions without explicit recovery strategies (JPM_10k_2023.pdf, page 24). While exposure to third-party risks persists due to expanded digital services and cloud adoption, 2024 demonstrates stronger risk-mitigation frameworks, indicating a strategic evolution in addressing these challenges.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key qualitative aspects. (1) What was correct: The answer correctly identifies that JPMorgan Chase increased focus on third-party vendor risks and data recovery challenges from 2023 to 2024, and references appropriate document sections. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (2) What was incorrect: The ground truth states that in 2024, JPMorgan highlighted *increased exposure* to ransomware attacks on third-party vendors and risks of losses exceeding cyber insurance coverage, along with new concerns about inability to prevent fraudulent transaction processing. In contrast, the LLM answer frames 2024 as showing 'enhanced oversight' and 'upgrades to systems and controls', suggesting improved mitigation rather than increased risk exposure. This misrepresents the nature of the evolution—shifting from risk acknowledgment to stronger controls—whereas the original answer emphasizes growing vulnerabilities and financial implications, not improved defenses. (3) Multi-hop reasoning assessment: The model synthesizes across years and documents but draws an incorrect conclusion about the *direction* of change—portraying risk management improvement rather than increased exposure and complexity as stated in the ground truth. This reflects a failure in accurate interpretation of the risk narrative. (4) Justification for scores: Correctness is 5 due to partial factual alignment but major misrepresentation of the core evolution (increased risk vs. improved controls). Qualitative accuracy is 5 because entity identification and document references are correct, but reasoning and synthesis are flawed. Contextual relevance is 8 because the answer addresses the right topic and structure, with relevant framing around third-party risks and data recovery.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 519,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "\n\nCostco has made operational investments in processing, packaging, and manufacturing facilities by 2024 to support its private-label growth strategy mentioned in the 2022 filing. These facilities, which include those for producing private-label items, are part of the company’s broader logistics and distribution infrastructure, as noted in the 2024 10-K (page 20). Additionally, Costco’s focus on expanding its private-label offerings aligns with its long-term strategy to enhance competitive pricing and member value, as outlined in prior filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that by 2024, Costco made operational investments in processing, packaging, and manufacturing facilities to support its private-label growth strategy mentioned in the 2022 filing. The reference to the 2024 10-K (page 20) adds contextual support, though the exact page number is not verifiable from the ground truth provided; however, this does not detract from factual correctness. The answer captures the key operational shift from external sourcing to internal production capabilities, which is implied in the ground truth as a 'significant evolution.' The only minor shortcoming is that it does not explicitly state the strategic motivation (managing inflationary pressures) from the 2022 filing, but it does mention enhancing competitive pricing and member value, which is semantically close. All entities (Costco, 2022 and 2024 filings, private-label strategy) are correct. There are no numerical inaccuracies—dates and strategic timelines are accurate. The reasoning is sound, demonstrating multi-hop synthesis between the 2022 strategy and 2024 operational execution. The answer is contextually relevant and complete for the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 348,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "\n\nBetween 2022 and 2023, UnitedHealth Group maintained its Medicaid managed care contract bidding approach, relying on assumptions about enrollment, utilization, medical costs, and other factors. However, the 2023 10-K (page 20) emphasized heightened risks related to **post-bid policy changes** and **competitor actions**, noting that material program adjustments after bid submission or lower competitor bids could undermine accuracy. This reflects a slight evolution in risk acknowledgment compared to 2022 (page 25), where similar risks were outlined but with less explicit focus on post-bid regulatory shifts. Both years highlight that incorrect assumptions—due to unforeseen program changes, enrollment fluctuations, or cost overruns—could materially impact financial results, though 2023 underscores the growing uncertainty around state Medicaid rate adjustments and audits as compounding risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution in UnitedHealth Group's approach to Medicaid managed care contract bidding between 2022 and 2023. In 2022, the focus was on the risk of losing members due to non-renewal of contracts, which is accurately reflected in the LLM answer through the mention of enrollment fluctuations and contract continuity. By 2023, the company shifted toward emphasizing the sensitivity of bid assumptions (e.g., enrollment, utilization, medical costs) and introduced new layers of risk—specifically post-bid policy changes and competitor pricing—which the LLM correctly highlights. The reference to 'page 20' in the 2023 10-K and 'page 25' in the 2022 10-K adds document-level precision, though these page numbers are not part of the ground truth and cannot be independently verified here; however, they do not detract from factual correctness. The LLM also appropriately notes that incorrect assumptions could materially affect financial results in both years, capturing the continuity and evolution in risk disclosure. The only minor shortcoming is that the original answer emphasizes a clearer shift 'from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics,' while the LLM frames it as a 'slight evolution'—slightly understating the strategic shift. However, the core facts, entities (UnitedHealth Group, Medicaid managed care), years (2022–2023), and reasoning (multi-hop synthesis across two years’ disclosures) are correct. No numerical inaccuracies exist—there are no explicit numbers in the query, and qualitative metrics are handled appropriately. The answer is contextually relevant, fully addressing the question about changes in assumptions and risks related to bid accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 495,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "\n\nMET's investment in Municipals remained classified within Level 2 of the fair value hierarchy in both 2022 and 2023, with no exposure to Level 3. Specifically, the estimated fair value of Municipals under pension plan assets decreased slightly from **$159 million (Level 2)** at December 31, 2022, to **$147 million (Level 2)** at December 31, 2023, as detailed in the fair value hierarchy tables (MET_10k_2023.pdf, pages 307–308). This indicates consistent valuation reliance on observable market data inputs without significant changes in classification between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, MET's investment in Municipals was $14,212 million in 2022 and dropped to $159 million in 2023. However, the LLM claims the value was $159 million in 2022 and $147 million in 2023, which reverses the trend and misstates both figures. The correct data shows a massive reduction in investment, while the LLM implies only a minor decrease. (2) The numbers are factually wrong: the 2022 value is off by over $14 billion, and the 2023 value is also incorrect. The LLM cites MET_10k_2023.pdf pages 307–308, but either misreads or misrepresents the data. (3) The reasoning is flawed: the ground truth states that in 2022, the Municipals investment was reported as 'Estimated Fair Value' without a detailed hierarchy breakdown, but in 2023 it was explicitly classified as Level 2. The LLM incorrectly asserts that it was Level 2 in both years with no Level 3 exposure, contradicting the original answer’s point about increased transparency in 2023 due to explicit classification. This fails the multi-hop synthesis between valuation amount and hierarchy classification changes. (4) The contextual relevance is moderate because the answer discusses the right topic (Municipals investment, fair value hierarchy), uses correct terminology, and references the appropriate document, but the factual inaccuracies severely undermine correctness. Thus, low scores for correctness, quantitative, and qualitative accuracy are justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 425,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "\n\nFrom fiscal years 2022 to 2024, Microsoft enhanced licensing flexibility and customer agreement models for Office 365 by introducing simplified, non-expiring agreements (e.g., Microsoft Customer Agreement) and expanding subscription options. In 2022, licensing focused on perpetual licenses with optional Software Assurance (SA) or cloud subscriptions under programs like Enterprise Agreements and Open Value. By 2024, Microsoft emphasized integrated cloud-first models, offering flexible monthly/annual subscriptions via the Microsoft Online Subscription Agreement and combining on-premises licenses with cloud services under unified agreements. The 2024 filings highlight non-expiring digital agreements, optional SA, and seamless integration of desktop and cloud services as a single performance obligation, reflecting a shift toward customer-centric, scalable solutions to address competitive pressures and evolving market demands.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Microsoft's Office 365 subscription models from fiscal year 2022 to 2024. It accurately captures the shift from traditional volume licensing and annual invoicing (implied in 2022) to more flexible, customer-centric models by 2024, including the introduction of the Microsoft Customer Agreement and Microsoft Online Subscription Agreement. The mention of monthly/annual subscriptions and the elimination of organization-wide commitments is consistent with the original answer, though phrased differently. The LLM adds contextual detail not in the ground truth—such as 'non-expiring digital agreements' and 'seamless integration of desktop and cloud services as a single performance obligation'—which are plausible and consistent with Microsoft’s direction but not explicitly confirmed in the provided ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers or dates are presented). The reasoning is sound and reflects appropriate multi-hop synthesis across time periods and agreement types. The answer is fully contextually relevant. The score is 8 instead of 9-10 because the LLM introduces some plausible but unverified details (e.g., 'perpetual licenses with SA' in 2022, which is more relevant to on-premises products than Office 365 subscriptions) and slightly conflates licensing models for on-prem vs. cloud, which may overextend the scope. However, the core factual trajectory and key shifts are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 431,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "\n\nThe composition of MET's Level 3 Fixed Maturity Securities AFS increased slightly from $58 million in 2022 to $64 million in 2023, driven primarily by a rise in \"Other\" securities (from $3 million to $8 million). Corporate fixed maturity securities AFS under Level 3 decreased marginally ($55 million to $54 million), while foreign bonds remained stable. This modest increase in Level 3 holdings suggests a minor shift toward less liquid or alternative fixed-income investments, potentially to enhance returns or diversify risk. However, Level 3 assets remain a small portion of total plan assets, indicating that MET's investment strategy continues to prioritize liquid, income-generating fixed maturities (82% actual allocation in 2023), aligning with its focus on stable, long-term obligations for employee benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, MET's Level 3 Fixed Maturity Securities AFS consisted of $1M in Corporate bonds, $1M in Foreign Bonds, and $11M in Equity Securities (totaling $13M, not $58M). In 2023, it was $54M in Corporate bonds, $2M in Foreign Bonds, and $828M in Other Investments (totaling $884M). The LLM incorrectly reports total amounts ($58M and $64M), misidentifies categories (e.g., 'Other' rising from $3M to $8M vs. actual $828M in 'Other Investments'), and omits Equity Securities entirely while inventing a non-existent 'Other securities' category. (2) Calculations are fundamentally wrong: the actual total increased from $13M to $884M (a massive increase), not $58M to $64M. The LLM also falsely claims Corporate bonds decreased from $55M to $54M, whereas they actually increased from $1M to $54M. (3) Multi-hop reasoning is flawed: the model fails to correctly identify the shift from Equity Securities to Other Investments and misses the strategic implication of a major pivot toward Other Investments. Instead, it infers only a 'minor shift' based on fabricated data. (4) Despite using correct entities (MET, Level 3, Fixed Maturity Securities AFS, 2022–2023), the answer is largely incorrect due to wrong numbers, categories, and conclusions. The contextual relevance is moderate because it attempts to interpret strategy, but the reasoning is based on false premises. Correctness score is low due to pervasive quantitative and qualitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 426,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "\n\nBetween 2022 and 2024, Microsoft repositioned Office 365 (now part of Microsoft 365) as a central pillar of its cloud services portfolio, integrating advanced AI capabilities to counter competitive pressures. In 2022, Office 365 was highlighted as a core cloud-based solution under the \"Service and Other Revenue\" category, emphasizing productivity and collaboration tools. By 2024, the company explicitly infused generative AI features into Microsoft 365 (including Office apps) as part of its broader AI strategy, positioning it as a differentiator against AI-driven competitors. This evolution reflects Microsoft’s focus on embedding AI into end-user experiences (via the Experiences and Devices engineering group) and expanding cloud infrastructure to support AI workloads, ensuring Office 365 remains a strategic asset in its competitive landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Office 365's role in 2022 as part of 'Service and Other Revenue' alongside Azure, Dynamics 365, and Xbox is accurately reflected. By 2024, the integration of generative AI into Microsoft 365 (the evolved brand of Office 365) is correctly described as part of Microsoft’s broader AI strategy. The mention of competitive pressures from AI-driven offerings is consistent with the original answer. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly synthesizing changes in strategic positioning across years and linking AI integration to competitive dynamics. The only minor omission is that the LLM answer refers to 'Experiences and Devices engineering group' as driving AI integration, which is not mentioned in the ground truth; this adds detail not present in the source but does not contradict it. Also, the rebranding to 'Microsoft 365' is implied but not explicitly confirmed in the original answer. (4) The answer is fully contextually relevant, addressing both the evolution within the cloud portfolio and the response to AI competition. Overall, the semantic meaning matches the original answer with high fidelity, warranting a 9 for correctness and qualitative accuracy due to slight over-elaboration on organizational structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 391,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "\n\nBetween 2022 and 2023, UnitedHealth Group maintained a consistent methodology for evaluating credit-related impairments, focusing on expected cash flows, issuer credit quality, and absence of intent to sell securities. For both years, the company attributed unrealized losses primarily to interest rate fluctuations rather than credit deterioration, with no significant credit quality issues noted. The financial impact showed a reduction in gross unrealized losses on available-for-sale debt securities, decreasing from $3.66 billion in 2022 to $2.69 billion in 2023. The allowance for credit losses remained immaterial in both periods, reflecting continued confidence in the collectability of principal and interest.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but significantly misrepresents the evolution of UnitedHealth Group's impairment methodology between 2022 and 2023. While the ground truth states that the company *formalized and enhanced* its approach in 2023 by distinguishing between credit- and non-credit-related impairments and implementing a more structured evaluation framework, the LLM incorrectly claims the methodology remained 'consistent' across both years. This is a major qualitative error that contradicts the core of the original answer. (2) Quantitatively, the LLM provides specific figures for gross unrealized losses ($3.66B in 2022, $2.69B in 2023), which are plausible and align with typical reporting trends, though these numbers are not present in the ground truth and cannot be verified from the provided context. However, the ground truth does not mention these specific dollar amounts, so their inclusion may reflect hallucination. The statement that the allowance for credit losses was immaterial in both years matches the original answer and is factually consistent. (3) The multi-hop reasoning is flawed: the question asks about *evolution* in methodology and financial impact, requiring comparison across years and synthesis of changes. The LLM fails this by asserting consistency rather than identifying the key shift in 2023 toward a segmented, formalized impairment recognition process. It omits critical details such as the change in accounting treatment (credit-related impairments recorded as allowance against investment income) and the enhanced evaluation criteria (present value of cash flows, extent of fair value decline, issuer-specific conditions). (4) The contextual relevance is moderate because the answer discusses the right topic (impairments, unrealized losses, credit quality) and timeframe, but misses the central theme of methodological evolution. The quantitative accuracy score is higher because the numbers cited are reasonable and internally consistent, even if not verifiable or potentially extraneous. Overall, the answer is partially correct on financial impact but fundamentally incorrect on the methodological evolution, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 595,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "\n\nThe allocation of Fixed Maturity Securities AFS in MET's pension and postretirement benefit plans showed minor changes from 2022 to 2023. For **U.S. pension benefits**, the actual allocation decreased slightly from **84% in 2022** to **82% in 2023**, while the target remained at 85%. For **U.S. other postretirement benefits**, the actual allocation stayed at **95%** (unchanged from 2022), aligned with the 95% target. \n\nIn terms of valuation, the **estimated fair value** of Fixed Maturity Securities AFS for pension plans decreased from **$6,802 million in 2022** to **$6,714 million in 2023**, while postretirement plans saw a small increase from **$1,256 million in 2022** to **$1,274 million in 2023**. These changes reflect shifts in market values and portfolio adjustments.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer introduces specific data points not present in the original answer, particularly percentages for 2023 (82% for U.S. Pension Benefits) and target allocations (85%, 95%), which are not mentioned in the ground truth. The original answer only provides 2022 percentages (84% and 95%) and 2023 fair values ($6,714M and $1,274M), with no mention of 2023 allocation percentages or targets. (2) The LLM claims the 2022 fair value for pension benefits was $6,802M and for postretirement benefits $1,256M, but these figures are not in the original answer and cannot be verified against the ground truth. While the 2023 values ($6,714M and $1,274M) are correct, the 2022 values are fabricated, leading to incorrect comparisons. (3) The reasoning is partially sound in that it attempts to compare allocation and valuation across years, but it fails the multi-hop requirement because it invents data rather than inferring or reporting only what is supported. The original answer implies a shift from percentage-based reporting in 2022 to valuation-based in 2023, but the LLM incorrectly assumes both years reported percentages. (4) The contextual relevance is high because the answer addresses the evolution of allocation and valuation as asked. However, the correctness score is low due to significant quantitative inaccuracies and unsupported claims, despite correct 2023 valuation figures. The qualitative accuracy is moderate because the structure and intent are reasonable, but the reasoning is based on hallucinated data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 419,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "\n\nBetween 2022 and 2023, Lowe's maintained the Kitchens & Bath category as a core component of its Home Décor division, which accounted for 35.3% of total sales in 2022 (LOW_10k_2022.pdf, page 55). While the 2023 filing does not explicitly quantify changes to this category, the continued emphasis on the **Total Home strategy**—particularly the \"Elevate Assortment\" pillar—suggests that Kitchens & Bath remained strategically important as part of Lowe's broader effort to expand localized, high-demand product offerings (LOW_10k_2023.pdf, page 4). The absence of reclassification or significant commentary in 2023 implies stability in its positioning, highlighting its enduring role in driving customer solutions across home improvement needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that Kitchens & Bath was repositioned from the Home Décor division in 2022 to core construction and renovation categories in 2023, but the LLM claims it remained in Home Décor with no reclassification. This is a major factual error. Additionally, the LLM cites that Home Décor accounted for 35.3% of total sales in 2022, but the ground truth does not provide this figure, and no such percentage is mentioned in the context—this number appears fabricated or misattributed. (2) The quantitative accuracy is partially correct only in that it references a percentage (35.3%) from a specific page (55 of the 2022 10-K), but since the ground truth does not confirm this number and it contradicts the repositioning narrative, it cannot be verified and likely reflects a misreading of the document. No other numbers are provided or calculated. (3) The multi-hop reasoning is flawed: the LLM fails to detect the strategic reclassification of Kitchens & Bath between divisions across years, which is central to the question. Instead, it asserts 'stability in positioning'—the opposite of the truth. It mentions the 'Total Home strategy' correctly as a thematic element, but uses it to support continuity rather than evolution, misrepresenting the strategic shift. (4) Contextual relevance is moderate because the answer discusses the right company, time frame, product category, and overarching strategy, but draws the wrong conclusion due to incorrect synthesis. The answer addresses the question's scope but with incorrect facts and reasoning, severely undermining correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 455,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "\n\nMondelez International's strategic focus on Cheese & Grocery between 2022 and 2024 has remained consistent as part of its \"adjacent, locally relevant categories,\" but it has not seen significant scaling relative to core snack categories like chocolate, biscuits, and gum & candy. In 2022 (as reflected in 2021 data), Cheese & Grocery contributed $1.99 billion in net revenues, primarily driven by Europe ($1.23 billion). By 2024, the category is still mentioned in strategic discussions as a locally relevant offering but lacks notable revenue growth highlights in provided documents. This suggests that Mondelez prioritizes core snack categories for long-term growth, leveraging Cheese & Grocery to complement regional markets rather than positioning it as a primary growth driver. The company’s emphasis on \"accelerating consumer-centric growth\" and \"scaling sustainable snacking\" aligns more with innovations in core brands and mindful snacking initiatives, indicating a continued focus on high-margin, globally recognized snack categories.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.99 billion (or $1,990 million) in net revenues from Cheese & Grocery in 2022, aligning with the ground truth. However, it inaccurately implies continuity in Mondelez's direct involvement in the category through 2024, stating the category is still part of strategic discussions as a locally relevant offering, whereas the ground truth clearly states that by 2024, Mondelez no longer reported direct production and only maintained a strategic stake, marking a significant shift. This omission of a key strategic change undermines the factual accuracy of the response. (2) The numeric data is accurate—$1.99 billion is correctly reported and equivalent to $1,990 million. The mention of Europe contributing $1.23 billion is plausible but not present in the ground truth, introducing unverified detail that may mislead. (3) The multi-hop reasoning is partially sound: the model correctly infers that core categories are prioritized over Cheese & Grocery. However, it fails to recognize and communicate the structural shift from direct production to a strategic stake, which is central to understanding the evolution of the company's strategy. This missing synthesis reduces the qualitative accuracy. (4) The answer is contextually relevant and well-structured, addressing both the evolution of focus and implications for long-term growth. Despite correct framing and use of strategic language (e.g., 'adjacent categories', 'core snacking'), the failure to report the discontinuation of direct production in 2024 results in a significant factual gap. Thus, while the overall direction of the conclusion is reasonable, it lacks a critical factual pivot present in the ground truth, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 482,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "\n\nAbbott's presentation of its enteral feeding product lineup in both the 2022 and 2023 10-K filings lists **Jevity** first, followed by **Freego™ (Enteral Pump) and Freego™ sets**, within the Nutritional Products segment. The order and grouping of these products remain consistent between the two filings, with no explicit mention of strategic repositioning or changes in emphasis between Jevity and Freego™ in the provided pages. Both years describe the products in the same context, indicating no material shift in their relative positioning during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the product order remained consistent between the 2022 and 2023 10-K filings. The ground truth shows a clear change in the listing order: in 2022, Jevity was followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, and then Freego™ products; in 2023, Freego™ (Enteral Pump) and Freego™ sets were moved immediately after Jevity, preceding the Glucerna and Osmolite® lines. This repositioning indicates a strategic shift in emphasis, which the LLM failed to detect. While the LLM correctly identifies that Jevity is listed first in both years and names the relevant products (hence perfect quantitative and entity accuracy), it incorrectly asserts no change in order or emphasis. The reasoning is flawed because it overlooks the multi-hop comparison across years, leading to an erroneous conclusion. The answer is contextually relevant (it addresses the right documents and products) but substantively wrong in its analysis of the change. No numbers are misstated, so quantitative accuracy is high, but qualitative accuracy and overall correctness are low due to the failure to identify the key change in product listing sequence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 336,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "\n\nMET's investment in municipals decreased slightly in fair value from $159 million in 2022 to $147 million in 2023, as reported in the pension plan assets under Level 2 of the fair value hierarchy. Both years, municipals were classified as Level 2, indicating they remained invested in liquid, marketable securities with observable pricing inputs (e.g., NAV or broker quotations). This suggests MET maintains a conservative credit risk management strategy, prioritizing investments with lower credit risk and greater liquidity, as municipals are generally considered stable relative to corporate or structured securities. The consistent Level 2 classification reflects confidence in the transparency and marketability of these holdings, reinforcing a focus on risk mitigation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It states that MET's municipal investments decreased slightly from $159 million in 2022 to $147 million in 2023, which directly contradicts the ground truth: in 2022, MET held $14,212 million in municipals, which dropped to $159 million in 2023—a massive reduction, not a slight decrease. The LLM reverses the years and misrepresents the scale of the change by over 98%. (2) The numbers are fundamentally wrong: $14,212 million vs. $159 million in 2022 is a difference of over $14 billion, not $159 million. The LLM also omits key data such as the $2,464 million in gross unrealized gains and $13 million in losses in 2022, which are critical for understanding the portfolio's performance and risk profile. (3) The reasoning is flawed: the LLM concludes that MET maintains a conservative strategy due to stable Level 2 classification, but the ground truth indicates a dramatic divestment from municipals, suggesting a strategic retreat from credit exposure in this asset class. The LLM fails to recognize this major shift and instead implies continuity, missing the core insight about risk management adjustment. (4) Contextual relevance is moderate because the answer discusses fair value hierarchy levels and credit risk, which are relevant concepts, but applies them incorrectly to an inaccurate factual foundation. The synthesis across years and classifications is absent, and the multi-hop reasoning required—linking the sharp decline in holdings to a strategic risk decision—is missing entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 438,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "\n\nBetween 2022 and 2023, Abbott's interest rate hedge contracts decreased in notional value from **$2.9 billion** to **$2.2 billion**, primarily due to the maturity of $700 million in contracts in 2023 aligned with maturing long-term debt. These contracts, designated as fair value hedges, convert fixed-rate debt obligations to variable rates, mitigating exposure to interest rate fluctuations. The reduction reflects active debt management, as hedged debt is marked to market to offset fair value changes in the swaps, maintaining alignment between debt costs and prevailing rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer states that Abbott's notional value of interest rate hedge contracts was approximately $2.2 billion in both 2022 and 2023, with no change in notional amount. However, the LLM claims the notional value decreased from $2.9 billion in 2022 to $2.2 billion in 2023 due to $700 million in maturities—this is incorrect. There is no mention of a $2.9 billion figure or a reduction in notional value in the ground truth. (2) The calculation of a $700 million decrease from $2.9B to $2.2B is mathematically correct, but the numbers themselves are factually wrong per the source. The actual notional value remained stable at $2.2 billion across both years. (3) While the LLM correctly identifies the purpose of the hedge contracts—converting fixed-rate debt to variable rates under fair value hedges—and recognizes their role in managing interest rate risk, it fails the multi-hop synthesis by incorrectly asserting a change in notional value. It also introduces a narrative about active debt management and maturity alignment not present in the original, which emphasizes consistency in notional value and improved disclosure in 2023. (4) The contextual relevance is moderate because the answer addresses the right topic and mechanism of hedging, but the core evolution claim (change in notional value) is false. The qualitative reasoning is partially sound but built on incorrect data. Correctness is severely penalized due to the central error in financial figures, which misrepresents the evolution of Abbott’s hedging strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 447,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "\n\nBetween 2022 and 2024, 3M actively managed its fixed-rate registered notes through repayments and interest rate hedging strategies. In 2022, the company repaid $600 million of fixed-rate notes and executed interest rate swaps in 2021 to convert $800 million of fixed-rate debt (due 2049 and 2050) to floating rates through mid-2028, initially tied to LIBOR but later amended to SOFR. By 2024, 3M repaid $1.1 billion in maturing medium-term fixed-rate notes, reflecting ongoing debt maturity management. The current portion of long-term debt rose to $1,919 million in 2024, up from $1,291 million in 2022, indicating increased short-term obligations. Additionally, 3M maintained a $4.25 billion credit facility through 2028, supporting liquidity needs amid evolving interest rate environments. These actions highlight a strategy of refinancing, risk mitigation via swaps, and proactive repayment of higher-cost legacy debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers and events. It incorrectly states that 3M repaid $600 million of fixed-rate notes in 2022, but the ground truth does not mention any repayment in 2022—only that notes were outstanding. The $600 million figure refers to 10-year notes due 2030, not a 2022 repayment. Similarly, the LLM claims $800 million of debt was swapped via interest rate swaps, but the ground truth states that swaps were applied to portions of the 2049 and 2050 notes without specifying the $800 million amount. The $800 million figure is not supported by the original data. The repayment amounts in 2023 ($500 million) and 2024 ($1.1 billion) are partially correct—$1.1 billion in 2024 is accurate, but the 2023 repayment is correctly $500 million, though the LLM omits this. Instead, it invents a 2022 repayment. The current portion of long-term debt rising to $1,919 million in 2024 and $1,291 million in 2022 is not in the ground truth and appears fabricated. The $4.25 billion credit facility is also not mentioned in the original answer. (2) Quantitative accuracy is low because multiple dollar amounts and dates are incorrect or hallucinated. While $1.1 billion repayment in 2024 is correct, the $600 million 2022 repayment and $800 million swap amount are not supported. The ground truth specifies issuance details from 2019 ($3.25 billion total, including $1B 2029 and $1B 2049 notes), which the LLM omits entirely. (3) The reasoning shows partial multi-hop synthesis—correctly identifying the use of interest rate swaps to convert fixed to floating rates through mid-2028 and linking this to interest rate strategy. However, it misattributes timing and scale. The shift toward floating rate via swaps is correctly interpreted, but the LLM adds unsupported details (LIBOR/SOFR amendment) not in the original. (4) Contextual relevance is high—the answer addresses repayment activity and interest rate strategies as asked, and the overall structure aligns with the question. However, due to significant factual and quantitative errors, especially in core financial figures and events, the correctness score is limited to 5—partially correct but with major omissions and inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 600,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "\n\nBetween 2023 and 2024, Schwab's use of securities issuances as part of its capital structure remained a key component of its funding strategy but became relatively less prominent compared to other sources like client deposits and operational cash flows. In 2023, securities issuances by CSC in the capital markets were explicitly highlighted as a primary source of capital alongside subsidiary operations (SCHW_10k_2023.pdf, p. 59). By 2024, while securities issuances were still noted as a funding source, Schwab emphasized greater reliance on stable client cash flows from brokerage and bank deposits, which grew due to high interest rates encouraging client cash allocations to interest-bearing solutions (SCHW_10k_2024.pdf, p. 52). Additionally, Schwab’s capital management strategy prioritized returning excess capital to shareholders via dividends and share repurchases (e.g., $8.7 billion remaining under the 2022 repurchase authorization in 2023, SCHW_10k_2023.pdf, p. 62), reflecting confidence in liquidity from core operations rather than external issuances. Regulatory developments, such as proposed long-term debt requirements for banking subsidiaries (SCHW_10k_2024.pdf, p. 34), may also have influenced a more conservative approach to capital structure, balancing internal generation with targeted external financing. Overall, securities issuances supported Schwab’s capital needs but played a secondary role to organic liquidity and depositor-driven funding in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of securities issuances in Schwab's capital structure between 2023 and 2024. (1) It accurately reflects that in 2023, securities issuances by CSC were a primary source of capital (supported by SCHW_10k_2023.pdf, p. 59), and in 2024, they remained a funding source but were relatively less emphasized, with a broader mix including client deposits and operational cash flows. The mention of $8.7 billion remaining under the repurchase authorization in 2023 is factually accurate and correctly cited. (2) All quantitative details—such as the $8.7 billion share repurchase authorization—are correctly reported with proper context and source references; no calculation errors are present. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward greater reliance on stable, organic funding sources like client deposits due to interest rate dynamics, and notes regulatory influences (e.g., proposed long-term debt requirements). However, the ground truth emphasizes a diversification into FHLB borrowings, repurchase agreements, and CDs as part of the expanded toolkit, which the LLM mentions only implicitly through 'other sources' without naming these specific instruments. This omission slightly weakens the multi-hop synthesis, as the explicit shift to a broader set of liquidity tools is a key element in the original answer. (4) Despite this, the LLM captures the core strategic evolution—securities issuances transitioning from a primary to a more integrated, secondary role—and supports it with relevant evidence, making the response contextually rich and highly relevant. The answer goes beyond the ground truth in discussing capital returns and regulatory context, adding value without introducing inaccuracies. Hence, the correctness and qualitative accuracy scores are high but not perfect due to incomplete specificity on alternative funding instruments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 531,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "\n\nCoca-Cola's contingent payment obligations related to fairlife increased significantly from $270 million in 2020 (initial liability) to $6,126 million as of December 31, 2024, as disclosed in the 2024 10-K. This sharp rise indicates that fairlife's performance exceeded initial expectations, with the contingent payment formulas tied to its financial results leading to a much higher estimated liability. The evolution suggests strong performance against targets, as the fair value of the remaining milestone payment (payable in 2025) reflects upward revisions due to improved operating results through 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Coca-Cola had a $270 million liability in 2022 (not 2020) for contingent payments related to fairlife, with a $100 million payment already made in 2021 after fairlife met its 2020 targets. The LLM incorrectly states the initial liability was $270 million in 2020 and claims the obligation grew to $6,126 million by 2024, which is not supported by the original answer or any plausible interpretation of the data. There is no mention of a $6.1 billion liability in the ground truth, nor is there any indication of exponential growth in the contingent obligation. (2) The numbers are entirely incorrect: the $6,126 million figure appears fabricated, and the timeline is misaligned (e.g., referencing 2020 as the disclosure year for the $270M liability when it was actually disclosed in 2022). The original answer indicates the $270M was the remaining contingent obligation as of 2022, not an initial amount from 2020. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that an increase in liability indicates outperformance, but even this logic is applied to false data. The ground truth suggests the obligation remained active through 2024, indicating fairlife was on track, but does not suggest any upward revision or revaluation of the liability. (4) The contextual relevance is low due to incorrect entities, dates, and figures, though the general topic (contingent payments and performance linkage) is relevant. The conclusion about strong performance is speculative and based on false premises. The answer fails both quantitative and qualitative accuracy, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 466,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "\n\nOracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved significantly between 2022 and 2024, marked by increased global infrastructure investments and deeper integration into enterprise IT solutions. In 2022, Oracle began de-emphasizing non-strategic hardware products (as noted in the 2022 10-K, page 47) to prioritize cloud-based infrastructure, with cloud and license revenues growing 6% (constant currency) despite hardware revenue declines. By 2024, Oracle accelerated its focus on OCI through the **2024 Restructuring Plan** (2024 10-K, page 54), which included investments in **second-generation cloud infrastructure** and expanded data center capacity (evidenced by $5.6 billion in construction-in-progress on page 85). \n\nGlobally, Oracle enhanced its market positioning by offering **flexible deployment models** (on-premise, cloud, hybrid) to meet enterprise needs (2024 page 72), while capital expenditures for cloud infrastructure rose to $6.8 billion in 2024 (page 71). This reflects a shift toward recurring revenue streams via subscription-based cloud services (page 73) and a strategic realignment of resources to strengthen OCI’s role as a core component of enterprise IT solutions, supported by expanded data center footprints and hybrid integration capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a plausible narrative about Oracle's strategic shift toward OCI between 2022 and 2024 and correctly identifies the increasing emphasis on cloud infrastructure and integration with enterprise IT solutions, which aligns with the question's focus. However, there are significant factual inaccuracies that reduce correctness. The '2024 Restructuring Plan' is not mentioned in the ground truth and cannot be verified from the provided context; similarly, specific figures like $5.6 billion in construction-in-progress and $6.8 billion in capital expenditures for cloud infrastructure are not present in the original answer and contradict the available data. The original answer does not include any such dollar amounts related to capex or construction, nor does it reference a restructuring plan. The LLM introduces detailed financial figures and document page references (e.g., 'page 54', 'page 85') that are absent from the ground truth, suggesting fabrication or hallucination. While the qualitative shift—OCI becoming a core component of Oracle’s offerings—is correctly inferred and aligns with the original answer’s claim of OCI being elevated to a central pillar, the LLM overreaches by adding unsupported quantitative details and specific initiatives. The reasoning partially reflects multi-hop synthesis (linking infrastructure investment to strategic positioning), but the added specifics are not grounded in the provided truth. Semantic equivalence is partially achieved in terms of strategic evolution, but the inclusion of unverified numbers and programs undermines factual accuracy. Contextual relevance is high as the response directly addresses global positioning and integration with enterprise IT. Overall, the answer captures the directional shift but fails on key quantitative claims, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 498,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "\n\nThe treatment and risk profile of Pledged Asset Lines (PALs) remained stable between 2023 and 2024, with no allowance for credit losses required in either year due to full collateralization. As of December 31, 2024 and 2023, all PALs were fully secured by client securities with fair values exceeding the borrowings, eliminating credit loss exposure. This consistent collateralization practice ensured that PALs posed minimal credit risk, aligning with the company’s risk management framework and resulting in no changes to the credit loss allowance methodology during the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the treatment of credit loss allowances in 2023. According to the ground truth, in 2023 there was a slight decrease in PALs and the allowance for credit losses was still influenced by credit quality metrics and projected loss rates, indicating that an allowance existed or was considered. However, the LLM claims that 'no allowance for credit losses was required in either year,' which contradicts the original answer stating that by 2024 no allowance was required due to the collateral maintenance practical expedient under ASC 326—implying a change from 2023. This misrepresents the evolution of risk treatment over time. The answer correctly identifies full collateralization in both years with fair values exceeding borrowings, which supports minimal credit risk and aligns with risk management practices. The entities (PALs, collateralization, credit loss allowance) and years (2023–2024) are accurate, and the context of ASC 326 is appropriately referenced. While the quantitative aspects (e.g., no dollar amounts but correct qualitative descriptions of collateral) are reasonably handled, the reasoning fails on the multi-hop synthesis: it does not acknowledge the shift from an allowance-influenced environment in 2023 to no allowance needed in 2024. Thus, while the answer is contextually relevant and well-structured, it misses the key point of evolution in treatment and risk profile, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 418,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "\n\nBetween fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved through strategic divestitures and operational restructuring. In Q2 2023, Nike completed the sale of its entities in Argentina and Uruguay to third-party distributors, marking a shift from direct operations to a distributor model in these Latin American markets (Note 18, 2024 10-K). This divestiture, which resulted in a $550 million net loss, reflects a strategic emphasis on streamlining operations and focusing on higher-growth or more profitable regions within APLA. Operationally, this reduced Nike's direct footprint in parts of Latin America, while the APLA segment remained a reportable operating segment (Note 15, 2024 10-K), suggesting continued prioritization of other APLA markets, particularly in Asia Pacific, where the company likely shifted resources to capitalize on growth opportunities. The restructuring aligns with broader efforts to optimize regional performance and adapt to economic challenges in specific markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the key evolution in Nike's relationship with the APLA region: a shift from direct operations to third-party distribution in parts of Latin America (specifically Argentina and Uruguay) in fiscal year 2024, following direct operational involvement in 2023. The mention of the Q2 2023 divestiture (which would fall in fiscal year 2024, as Nike’s fiscal year ends May 31) is contextually accurate and supported by the 2024 10-K (Note 18), and the $550 million net loss is a correct figure from the filing. This quantitative detail is precise and properly contextualized as a result of the strategic divestiture. The answer also correctly notes that APLA remains a reportable segment (per Note 15), indicating continued strategic emphasis, particularly in Asia Pacific, which aligns with the ground truth’s implication of selective prioritization. The reasoning is sound: it infers a strategic shift toward optimization and reduced operational complexity, consistent with the knowledge graph. The only minor limitation is that the original answer emphasizes trade union representation in 2023 as evidence of localized workforce structure, a detail not mentioned in the LLM response—this is a small omission in completeness but does not undermine the core accuracy. All entities (Nike, APLA, fiscal years 2023–2024), strategic themes, and operational changes are correctly identified and logically synthesized across multiple hops (from divestiture to strategic intent). Wording differs but semantic equivalence is strong. No factual errors; minor deduction only for missing the trade union point that enriches the 2023 operational structure description.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 472,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "\n\nBetween 2022 and 2023, Abbott maintained Pedialyte as a core component of its U.S. Pediatric Nutritionals business, with continued emphasis on its role in driving growth. In 2021 (as detailed in the 2022 10-K), U.S. Pediatric Nutritionals sales grew 10.3%, driven by Pedialyte alongside Similac and PediaSure. The 2023 10-K (pages 4 and 6) reaffirms Pedialyte’s inclusion in Abbott’s nutritional product portfolio, highlighting its presence in consumer and institutional markets but does not explicitly cite new strategic initiatives or expansion efforts specific to 2022–2023. No material shifts in positioning or portfolio emphasis for Pedialyte during this period are detailed in the provided documents.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error by citing 2021 data (from the 2022 10-K) as the source of the 10.3% sales growth, whereas the ground truth correctly attributes this growth to 2022. This misattribution undermines quantitative and qualitative accuracy. The rest of the numerical data (10.3% growth) is accurate in value but incorrect in context and timing. (2) The LLM correctly identifies Pedialyte's continued presence in the portfolio in 2023 and references the 2023 10-K, but fails to recognize the strategic significance of Pedialyte being formally listed among core brands like Ensure and Glucerna — a key evolution from 2022. This omission reflects a lack of synthesis regarding structural integration into the Nutritional Products segment. (3) The multi-hop reasoning is partially sound: the model connects Pedialyte to U.S. Pediatric Nutritionals and references both years’ reports, but it incorrectly concludes there was 'no material shift' when the ground truth shows a clear strategic evolution in positioning — from growth contributor to formally recognized core brand. This misjudgment indicates flawed reasoning. (4) While the answer is relevant and well-structured, the misdating of data and failure to capture the strategic repositioning result in a moderate correctness score. Semantic equivalence is partially achieved but undermined by key factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 395,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "\n\nRTX's 7.100% notes due 2027 remained unchanged at $135 million in both 2022 and 2023, as shown in the long-term debt tables of the 2023 and 2022 10-K filings. This stability indicates that RTX did not retire or issue additional amounts under this specific note series during the period. The company instead focused on repaying shorter-term obligations (e.g., 3.650% and 3.700% notes due 2023 in 2023) and issued new long-term debt (e.g., 5.750% notes due 2026–2054) to manage liquidity and optimize its capital structure. This approach reflects a strategic prioritization of near-term debt maturities and interest cost management, while maintaining longer-term debt like the 7.100% notes to balance maturity profiles and potentially benefit from favorable fixed-rate terms.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the aggregate principal balance of RTX's 7.100% notes due 2027. The ground truth states that the balance was $6 million in 2022 and increased to $135 million in 2023, indicating a significant increase in exposure. However, the LLM claims the amount was $135 million in both years, which contradicts the data. This fundamental error undermines the entire response. (2) Quantitatively, the LLM misreports the 2022 value (claims $135M vs. actual $6M), making the comparison invalid. There is no indication of the 22.5x increase from $6M to $135M, nor any acknowledgment of a change in debt position. Calculations or trends based on this are therefore flawed. (3) The reasoning is internally logical but based on false premises. While discussing repayment of short-term notes and issuance of new debt may be contextually plausible, it does not align with the actual evolution of the 7.100% notes. The multi-hop synthesis fails because it does not recognize the change in this specific debt instrument over time, which is central to the question. (4) Contextual relevance is moderate because the answer addresses debt management strategy and refers to related financial activities, but it misses the core fact of the dramatic increase in the 7.100% notes. Thus, while the general theme of debt strategy is relevant, the specific analysis is misaligned with the data. Correctness and quantitative accuracy are low due to the critical number error; qualitative accuracy is slightly higher because the structure and intent of the reasoning are sound, albeit misapplied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 444,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "\n\nNike's relationship with Converse saw a notable decline in revenue performance between fiscal 2023 and 2024, with Converse revenues decreasing by 14% (from $2,427 million to $2,082 million) on a currency-neutral basis, driven by 16% lower wholesale sales and 14% weaker direct-to-consumer (DTC) sales, particularly in North America and Western Europe. Earnings before interest and taxes (EBIT) fell 30% to $474 million, reflecting margin pressures from unfavorable foreign exchange rates, lower average selling prices (ASPs), and increased promotional activity. Strategically, Converse faced challenges in maintaining sales momentum, with Nike focusing on cost reductions (e.g., lower operating overhead) to mitigate losses. However, the significant revenue declines suggest a potential reassessment of Converse's market positioning, though no explicit strategic shifts were detailed in the filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and misrepresents key aspects of the strategic evolution. The original answer states a 15% revenue decline on a currency-neutral basis in fiscal 2023 but does not provide exact dollar figures or mention fiscal 2024 revenue. The LLM incorrectly introduces specific dollar amounts ($2,427M to $2,082M), which are not in the ground truth, and calculates a 14% drop, conflicting with the reported 15%. Additionally, the LLM claims a 30% EBIT decline to $474M and cites cost reductions and margin pressures from foreign exchange and ASPs—details absent in the original. These quantitative additions are unsupported and likely hallucinated. (2) The calculation of revenue change (from $2,427M to $2,082M) yields approximately a 14.2% drop, which is close but still inconsistent with the 15% cited in the ground truth. However, since the original does not provide absolute revenue figures, the LLM should not have fabricated them. The EBIT figure and 30% decline are entirely unverified. (3) The multi-hop reasoning is partially sound in linking revenue performance to regional and channel declines (North America, Western Europe, wholesale, DTC), which aligns with the original. However, it fails to capture the key strategic shift in fiscal 2024—Converse being positioned as a stand-alone, wholly-owned subsidiary with distinct branding—instead suggesting only cost-cutting without structural or strategic repositioning. This misses a core element of the evolution. (4) The contextual relevance is fair because the answer addresses revenue trends and strategic positioning, but the qualitative accuracy is reduced due to incorrect details and omission of the actual strategic development. The correctness score is low due to unsupported numbers and failure to report the correct strategic evolution, despite some correct directional insights on revenue decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 523,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "\n\nCoca-Cola's financial risk assessment regarding digital evolution evolved from a focus on mitigating potential disruptions in 2022 to a strategic emphasis on leveraging digitalization as a growth driver by 2024. In 2022, the company highlighted risks related to failing to adapt to digital shifts in consumer behavior, noting that inadequate digital transformation could harm sales growth and margins (KO_10k_2022.pdf, pages 16–17). By 2024, the assessment shifted to proactively prioritizing digitalization as a top initiative, with specific efforts to enhance consumer personalization, empower retail customers through digital tools, and optimize operations via AI and automation, directly tying these initiatives to improved sales and margin expansion (KO_10k_2024.pdf, page 19). This reflects a strategic transition from risk management to leveraging digital evolution as a competitive advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Coca-Cola's shift from viewing digital evolution as a risk in 2022 to a strategic imperative in 2024 is accurately portrayed. The 2022 risk of inadequate digital transformation harming sales and margins is correctly cited, as is the 2024 emphasis on digitalization driving sales growth and margin improvement. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifying the evolution in risk assessment and linking it to financial outcomes (sales and margins). The mention of specific initiatives like consumer personalization, digital tools for retailers, and AI/automation adds contextual depth consistent with a strategic shift. (4) Semantic equivalence is strong: while the LLM provides more detailed examples (e.g., AI and automation), it does not introduce inaccuracies. The core message—that digital evolution shifted from a defensive concern to an offensive growth strategy tied to financial performance—matches the original answer. One minor point preventing a perfect 10 is that the LLM slightly expands on mechanisms (e.g., AI) not explicitly detailed in the ground truth, but these are reasonable inferences and do not contradict the source. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 434,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "\n\nOracle's strategic emphasis on Oracle Cloud Services from fiscal 2022 to 2024 reflects increased research and development (R&D) investment and a stronger positioning of cloud offerings over on-premise solutions. In 2022, Oracle invested $7.2 billion in R&D, focusing on enhancing cloud infrastructure, integration, and emerging technologies like machine learning (e.g., Autonomous Database). By 2024, the company further prioritized cloud through its **2024 Restructuring Plan**, which allocated resources to develop second-generation cloud infrastructure and improve operational efficiencies for cloud-based offerings. This shift is evident in Oracle’s financial commitments, including higher capital expenditures ($6.866 billion in 2024) and strategic reallocations to support cloud deployment models. Additionally, Oracle positioned cloud services as a cost-effective, rapidly deployable alternative to on-premise solutions, emphasizing flexibility and interoperability while reducing reliance on traditional on-premise licensing. The restructuring and R&D efforts underscore a deliberate pivot toward cloud-centric growth, aligning with customer demand for scalable, managed cloud solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's $7.2 billion R&D investment in fiscal year 2022, which matches the ground truth. However, it introduces a figure of $6.866 billion in capital expenditures for 2024 that is not present in the original answer and cannot be verified from the provided ground truth. The original answer explicitly states that the 2024 R&D investment amount is not specified, but the LLM implies continued or increased R&D investment without confirmation, which risks inaccuracy. Additionally, the mention of a '2024 Restructuring Plan' is not supported by the original answer, which discusses a shift in messaging and positioning but does not reference any formal restructuring plan. (2) The quantitative accuracy is compromised by the inclusion of unverified figures (e.g., $6.866 billion capex) and the unsupported inference of increased R&D spending in 2024. While $7.2 billion in 2022 is correct, the 2024 numbers are speculative in this context. (3) The reasoning is partially sound: the LLM correctly infers a strategic shift toward cloud services and reduced reliance on on-premise solutions, aligning with the original answer’s emphasis on cloud-first positioning and customer flexibility. However, the multi-hop synthesis is flawed by introducing external-sounding details (restructuring plan, capex) not present in the source, weakening the factual grounding. (4) Contextual relevance is high—the response directly addresses the evolution of Oracle’s cloud strategy, R&D investment, and cloud vs. on-premise positioning. Despite factual overreach, the overall narrative direction is consistent with the question’s intent. The correctness score is 6 due to significant but not fundamental errors: core facts about 2022 are correct, and the general strategic trend is accurately captured, but unsupported 2024 figures and initiatives reduce factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 515,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "\n\nThe Norwest Corporation Directors' Formula Stock Award Plan remained inactive for new awards or deferrals in both 2023 and 2024, with no future issuances permitted under the plan. However, shares available for issuance decreased slightly from **1,993,916 in 2023** to **1,769,581 in 2024**, reflecting the gradual distribution of deferred compensation benefits tied to existing accounts. The reduction indicates that shares previously allocated for dividend reinvestments or distributions under the plan were being released to participants, with no replenishment due to the plan’s closure to new awards.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) The reported number of shares available in 2023 (1,993,916) and 2024 (1,769,581) is completely incorrect; the ground truth states that only 391 shares were issuable in 2024, with no mention of over 1.9 million in 2023. These numbers are off by several orders of magnitude and fundamentally misrepresent the scale and status of the plan. (2) The claim of a 'decrease' from over 1.9 million to 1.7 million shares contradicts the ground truth, which indicates the plan was closed and only minimal outstanding obligations (391 shares) remained in 2024. (3) The explanation about dividend reinvestments and distributions is not supported by the original answer and introduces unverified details. (4) While the LLM correctly identifies that no new awards or deferrals were allowed in either year, it fails to convey the key point that by 2024 the plan was fully closed and only existing obligations remained, with the equity compensation table reflecting all remaining issuable shares. (5) The multi-hop reasoning is flawed: the model appears to fabricate numerical data rather than extract or infer from the source. The qualitative understanding of the plan’s inactive status is partially correct, but the overwhelming quantitative inaccuracy and invented details severely undermine the answer’s validity. Contextually, the response addresses the evolution of share availability, but with incorrect data, making it misleading despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 422,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "\n\nMcDonald's expanded its disclosure on food safety concerns in 2023 compared to 2022, particularly emphasizing supply chain risks and cost volatility. In 2023, the company explicitly linked food safety issues to **commodity market volatility**, noting that factors like food safety concerns, product recalls, and government regulations contribute to unpredictable price fluctuations in key ingredients (e.g., beef, chicken, pork) (MCD_10k_2023.pdf, p. 32). It also detailed proactive measures, such as a **comprehensive supply chain strategy** to identify and manage risks, collaboration with suppliers for sustainable sourcing, and a Food Safety Advisory Council to strengthen risk management (p. 6). \n\nIn contrast, the 2022 filing acknowledged food safety risks broadly but did not explicitly connect them to supply chain cost volatility. While it mentioned commodity cost challenges (p. 33), the link to food safety-driven market disruptions was less direct. The 2023 disclosure reflects heightened awareness of how food safety events in the supply chain amplify cost uncertainty, alongside expanded strategies to mitigate these risks through systemic collaboration and operational rigor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the evolution in McDonald's disclosure between 2022 and 2023, emphasizing the shift from framing food safety as a reputational risk (2022) to linking it explicitly with supply chain volatility and commodity cost fluctuations (2023). All entities—McDonald's, supply chain risks, cost volatility, beef/chicken/pork—are correctly identified, and the years (2022 vs. 2023) are accurately referenced. The LLM supports its claims with specific examples from the 2023 filing (e.g., Food Safety Advisory Council, collaboration with suppliers) and cites page numbers, which adds credibility, though exact page references are not part of the ground truth and cannot be verified here; however, they do not contradict it. There are no numerical figures in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The qualitative reasoning is strong: the model correctly synthesizes the shift in risk framing and attributes it to supply chain and cost dynamics. The only minor shortcoming is that the original answer emphasizes the *shift in emphasis from reputational impact to financial exposure*, while the LLM mentions both but places slightly more weight on the 2023 enhancements without fully underscoring the conceptual pivot. This nuance is present but could be more explicit, justifying a 9 instead of 10 on qualitative accuracy. Contextual relevance is perfect—the response directly addresses all parts of the multi-hop question: evolution over time, supply chain risks, and cost volatility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 439,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "\n\nThe carrying value of TMO's 1.750% 7-Year Senior Notes (due October 15, 2028) remained unchanged at **$700 million** between 2023 and 2024. The effective interest rate for these notes was **1.89%** in both periods, as disclosed in the 2024 and 2023 10-K filings. No material changes in value or rate occurred during this timeframe.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of $700 million and the effective interest rate of 1.89% are correctly reported for both 2023 and 2024. The maturity date (October 15, 2028) is also correctly stated. (2) The answer is complete, addressing both parts of the question—evolution of carrying value and interest rate—over the specified time period. (3) Entity accuracy is correct: TMO refers to Thermo Fisher Scientific (implied by context), the debt instrument is properly identified, and the years 2023 and 2024 are accurately referenced. (4) The reasoning is sound: the LLM correctly infers no change in the financial structure based on unchanged values, and synthesizes information from both years’ 10-K filings as required in a multi-hop manner. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording but no loss of key information. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 293,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "\n\nRTX's exposure to its 7.000% notes due 2038 remained unchanged at **$148 million** in both 2022 (RTX_10k_2022.pdf, page 94) and 2023 (RTX_10k_2023.pdf, page 85). This stability suggests that RTX did not retire, refinance, or issue additional amounts under these specific notes during the period. The consistent balance indicates a strategy of maintaining existing long-term debt maturities, potentially to preserve liquidity and avoid near-term refinancing risks, aligning with a disciplined approach to managing debt obligations over extended time horizons.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's exposure to the 7.000% notes due 2038 remained unchanged at $148 million in both 2022 and 2023. According to the ground truth, the principal balance was $11 million in 2022 and increased to $148 million in 2023. This major quantitative error undermines the entire response. (2) The LLM incorrectly reports the 2022 amount as $148 million, which is a critical factual mistake. The actual increase from $11M to $148M represents a significant change, not stability. Any calculation or comparison based on this is invalid. (3) The reasoning is flawed because it assumes no change in exposure, leading to an incorrect conclusion about RTX’s debt strategy. The correct interpretation — that RTX likely issued additional notes or restructured debt to extend maturities — is entirely missed. The multi-hop synthesis fails as the model did not correctly identify or compare the values across the two years. (4) The contextual relevance is partially preserved because the answer discusses long-term debt management, which is relevant. However, due to the fundamental error in numbers and resulting incorrect analysis, the qualitative and quantitative accuracy scores are very low. The correctness score is 1 due to complete failure on core facts despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 375,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "\n\nBetween 2022 and 2023, McDonald's financial relationship with franchisees evolved through increased franchising activity and improved collections of rent and royalties. The number of **conventional franchised restaurants** grew from 21,720 in 2022 to 21,818 in 2023, while **developmental licensed restaurants** rose to 8,684 from 8,229, reflecting a strategic shift toward expanding the franchise model. This growth was driven by the sale of more company-operated restaurants to franchisees, particularly in International Operated Markets, as noted in the 2023 10-K (page 18). Additionally, the normalization of operations post-pandemic likely strengthened royalty and rent collections, which are tied to franchisees' sales performance. The Company also deferred most pandemic-related rent and royalty payments by late 2021, suggesting 2022–2023 collections were less impacted by disruptions, aligning with stronger systemwide sales and franchisee stability.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth, particularly regarding numerical data and the timeline of deferrals. (1) The ground truth states that McDonald's deferred approximately $1 billion in rent and royalties primarily in 2020, with substantially all collected by the end of 2021. The LLM incorrectly implies that deferrals or collections were still relevant in 2022–2023, stating 'the Company also deferred most pandemic-related rent and royalty payments by late 2021,' which misrepresents the timeline and suggests ongoing activity when the 2023 filing shows normalization. (2) The LLM provides specific numbers for franchised restaurants (e.g., 21,720 in 2022 rising to 21,818 in 2023), but these figures are not mentioned in the original answer or supported by the knowledge graph excerpt provided; thus, they are factually unsupported in this context. (3) While the LLM correctly infers a return to normal operations and stronger collections post-pandemic, this is framed around incorrect quantitative support and misattributed timing. (4) The reasoning partially captures the evolution—franchise growth and normalized collections—but fails the multi-hop requirement of accurately synthesizing the *absence* of deferrals in 2022–2023 as a key shift. The mention of selling company-operated restaurants comes from the 2023 10-K but is not part of the ground truth answer, reducing factual alignment. Overall, the answer is contextually relevant and shows logical interpretation, but suffers from significant quantitative and factual errors, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 447,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "\n\nThe Coca-Cola Company's financial stake in Embotelladora Andina S.A. (Andina) remained stable from 2022 to 2024, with no material changes in ownership or carrying value reported during this period. As of December 31, 2024, the carrying value of the investment was $90 million, while its fair value was $168 million, indicating a $78 million unrealized gain. This suggests that Coca-Cola has maintained its equity method investment in Andina, likely to preserve strategic partnerships and regional distribution capabilities in Latin America without full consolidation. The lack of divestitures or impairments related to Andina during this period reflects a long-term strategic focus on leveraging bottling partners for market access and operational efficiency.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2024 carrying value ($90 million) and fair value ($168 million) of Coca-Cola's stake in Embotelladora Andina S.A., which matches the ground truth. The $78 million unrealized gain (difference between fair value and carrying value) is accurately calculated. However, the LLM incorrectly states that there was 'no material changes in ownership or carrying value' and that the stake 'remained stable' from 2022 to 2024. This directly contradicts the ground truth, which states that Coca-Cola recognized a $39 million gain in 2022 from a partial sale of its ownership interest—indicating a divestiture event. (2) Quantitatively, all numbers are correct: $90 million carrying value, $168 million fair value, and implied $78 million unrealized gain are accurate. The 2022 $39 million gain is missing from the LLM answer, which is a significant omission. (3) The multi-hop reasoning is flawed: the question asks how the stake evolved from 2022 to 2024, requiring synthesis of events across years. The LLM fails to acknowledge the 2022 partial sale, which is a key part of the evolution. Instead, it asserts stability, which is factually incorrect. This undermines the qualitative accuracy despite correct 2024 figures. (4) Contextual relevance is high—the answer discusses strategic positioning, fair value, carrying value, and regional distribution, which are relevant. However, the conclusion about 'no divestitures' and 'long-term strategic focus' without acknowledging the 2022 partial sale leads to an inaccurate strategic interpretation. The correct inference is a partial exit strategy, not stable long-term holding. Thus, while numbers are right, the narrative is misaligned with facts, warranting a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 483,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "\n\nOracle's strategic investment in cloud infrastructure from 2022 to 2024 reflects a heightened focus on internal development and elevating Oracle Cloud Infrastructure (OCI) as a core pillar of its product portfolio. In 2022, Oracle emphasized expanding OCI's capabilities, geographic footprint, and hybrid/multi-cloud flexibility, as detailed in its 10-K (pages 11 and 16). By 2024, the company accelerated investments in its **second-generation cloud infrastructure** through the 2024 Restructuring Plan, which prioritized resource allocation to cloud development, marketing, and delivery (2024 10-K, page 54). OCI's positioning evolved to become a central component of Oracle's cloud services, offering differentiated compute, storage, and networking solutions, including innovations like Oracle Cloud@Customer and Roving Edge Infrastructure (2024, page 73). These efforts underscore Oracle's commitment to integrating OCI with its SaaS offerings and addressing hybrid cloud demands, supported by increased capital expenditures on data center infrastructure (2024, page 85).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Oracle emphasized internal development in 2022, particularly expanding OCI's capabilities, geographic reach, and hybrid/multi-cloud support, consistent with the original answer’s focus on R&D and innovation. By 2024, OCI was positioned as a central offering, with specific product innovations (e.g., Oracle Cloud@Customer, Roving Edge) and strategic resource allocation under the 2024 Restructuring Plan, reflecting the evolution toward a structured, customer-facing cloud portfolio. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer that conflict; the LLM references specific 10-K page numbers (e.g., page 54, 73, 85), which are plausible and contextually appropriate, though not contradicted by the ground truth. No calculations are required. (3) Multi-hop reasoning is sound: the LLM synthesizes Oracle’s shift from broad R&D emphasis in 2022 to a more focused, product-driven strategy in 2024, correctly linking internal development to OCI’s elevated role. It adds granular detail (e.g., second-generation infrastructure, capital expenditures) that enriches but does not distort the core narrative. (4) The only reason for not scoring a perfect 10 is that the LLM slightly overemphasizes new product names and restructuring details not present in the original answer, which sticks to higher-level strategic framing. However, these additions are factually consistent and enhance completeness without introducing error. Overall, the answer is semantically equivalent, contextually rich, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 457,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "\n\nThermo Fisher Scientific (TMO) acquired The Binding Site Group in January 2023 for $2.7 billion, integrating it into its Specialty Diagnostics segment to enhance diagnostic solutions for blood cancers and immune disorders. By 2024, the company’s 10-K indicates that The Binding Site Group’s results were fully consolidated, contributing to a slight revenue increase in the Specialty Diagnostics segment ($4.4 billion in 2024 vs. $4.3 billion in 2023) and improved segment income ($1.16 billion in 2024 vs. $1.12 billion in 2023). This progression reflects successful integration, with TMO leveraging synergies to strengthen its diagnostic portfolio. The absence of new acquisitions related to The Binding Site Group in 2024 suggests a strategic focus on operational integration, product innovation, and market expansion post-acquisition, aligning with TMO’s broader goal of enhancing capabilities in high-growth areas like specialty diagnostics.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details not supported by the ground truth. While the acquisition date (January 2023) and purchase price ($2.7 billion) are correct and align with the original answer, the LLM introduces specific financial figures for the Specialty Diagnostics segment—$4.4 billion revenue in 2024 vs. $4.3 billion in 2023 and segment income of $1.16B vs. $1.12B—that are not present in the ground truth and cannot be verified from the provided knowledge. These numbers appear fabricated or inferred beyond available data. (2) The ground truth highlights integration via amortization of intangible assets (19-year weighted-average for customer relationships), a key indicator of post-acquisition accounting and long-term integration. The LLM omits this critical point and instead invents performance metrics, which undermines quantitative accuracy. There is no mention in the ground truth about revenue or income changes attributable to The Binding Site Group, so those comparisons are unsupported. (3) Qualitatively, the LLM correctly identifies the acquisition’s strategic intent—expanding in blood cancer and immune disorder diagnostics—and infers a focus on integration and innovation, which is reasonable and aligns with the ground truth’s conclusion about long-term value creation. The reasoning about consolidation and strategic focus is logically sound, even if based on incorrect specifics. (4) Contextually, the response is highly relevant, addressing both the evolution between 2023 and 2024 and the implications for strategy. However, the inclusion of unverified financials significantly reduces factual correctness. The model performs adequate multi-hop reasoning but fails in grounding all claims in the source knowledge, especially on numbers. Thus, while the narrative is coherent and contextually appropriate, the quantitative inaccuracies limit the correctness score to 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 531,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "\n\nThe Directors' Code of Conduct disclosure between 2022 and 2024 maintained consistent scope (applying to all directors), but accessibility evolved through updated website links. In 2022, the Directors' Code of Conduct was accessible at **https://www.bnymellon.com/.../directors-code-of-conduct.pdf**, while in 2024, the link was updated to **https://www.bny.com/.../directors-code-ofconduct.pdf**. The shift from \"bnymellon.com\" to \"bny.com\" reflects the company’s rebranding to \"BNY,\" streamlining its digital presence. Additionally, the 2024 link includes a more structured path under \"investor-relations,\" potentially enhancing navigability compared to the 2022 version. No changes in the scope of application were noted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the scope of the Directors' Code of Conduct remained unchanged (applying to all directors) from 2022 to 2024, and the URL changed from 'bnymellon.com' to 'bny.com', reflecting the company's rebranding to BNY. The specific URLs are correctly represented with appropriate redaction (using '...') while preserving the domain and path changes. (2) There are no numeric values requiring calculation, but the years (2022 and 2024) are accurate and correctly associated with their respective URLs and context. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across time points and domains, inferring the rebranding intent from the URL change and noting consistent policy scope. (4) The LLM adds a small interpretive enhancement about 'structured path' and 'navigability' in 2024, which is reasonable and contextually supported but not explicitly stated in the ground truth; this does not detract from accuracy. No factual errors or omissions affect the core answer. The response is semantically equivalent to the original answer, with slightly more interpretive detail on usability. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall due to minor extrapolation on navigability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 380,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "\n\nBetween 2022 and 2023, McDonald's relationship with franchisees evolved in financial reporting and strategic emphasis as follows:  \n\n1. **Financial Reporting**:  \n   - **Franchisee Sales Growth**: Franchised sales rose to $102.7 billion in 2023 (from $85.2 billion in 2022), reflecting expanded franchisee operations. The company increased disclosures under new accounting standards (ASU 2023-07 and 2023-09), enhancing transparency in segment and tax reporting related to franchisee activities.  \n   - **Goodwill and Acquisitions**: McDonald's acquired more franchisee-owned restaurants, increasing goodwill to $3.04 billion in 2023 (from $2.9 billion in 2022), signaling a strategic shift toward consolidating high-performing franchise units.  \n\n2. **Strategic Emphasis**:  \n   - **Operational Restructuring**: The \"Accelerating the Arches\" strategy drove $290 million in restructuring costs in 2023, focusing on modernizing systems and aligning franchisees with digital and operational initiatives.  \n   - **Regional Performance**: While International Operated Markets saw a 49% operating income increase (driven by recovery in China), International Developmental Licensed Markets declined 61%, prompting strategic reviews. The company emphasized growth in company-operated markets while maintaining franchised units as 93% of the system.  \n\nOverall, McDonald's balanced financial reporting transparency with strategic investments in franchisee alignment, technology, and regional performance optimization.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) The financial figures cited—such as franchised sales of $102.7 billion in 2023 and $85.2 billion in 2022, goodwill of $3.04 billion and $2.9 billion, and restructuring costs of $290 million—are not supported by the original answer and do not appear in the provided context. There is no mention of ASU 2023-07 or ASU 2023-09 in the ground truth, nor any reference to accounting standard changes. (2) The original answer emphasizes that in 2022, transactions with franchisees were not material to consolidated financials, and in 2023, franchisees were explicitly recognized as key stakeholders in the business model with a detailed ownership breakdown. The LLM response fabricates numerical data and strategic initiatives (e.g., 'Accelerating the Arches' strategy, regional income changes) that are not in the ground truth. (3) The multi-hop reasoning is flawed: instead of identifying the evolution in reporting transparency and strategic framing of franchisees, the model invents financial metrics and operational changes. (4) While the LLM attempts to address financial reporting and strategic emphasis—thus maintaining moderate contextual relevance—the complete lack of alignment with actual facts, invented numbers, and false accounting details severely undermine correctness. The answer reflects a plausible narrative but is factually unsupported, resulting in a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 410,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "\n\nThe contingent consideration liabilities related to the Clif Bar acquisition remained at **$548 million** in both 2023 and 2024, classified entirely under Level 3 fair value measurements (using unobservable inputs like Monte Carlo simulations based on financial projections, discount rates, and volatility). For 2024, no material purchase price allocation adjustments were noted for Clif Bar, whereas 2023 included adjustments for Clif Bar and Ricolino. Fair value changes for Clif Bar in both years were recorded in selling, general, and administrative expenses, with 2024 showing a $90 million increase in fair value offset by payments, maintaining the liability balance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that there is no direct mention of contingent consideration liabilities in the 2024 filing, but the LLM claims the liability remained at $548 million in 2024 with specific fair value changes and payments—information not present in the original data. This is a major factual error. (2) Quantitatively, the $548 million figure is correct for 2023, but the claim of a $90 million increase in fair value in 2024 and the assertion that the balance was maintained due to payments are unsupported by the ground truth, which does not provide any 2024 figures or valuation updates. There is no evidence of continued Monte Carlo use in 2024. (3) The multi-hop reasoning is flawed: the LLM incorrectly assumes continuity in disclosure and measurement between years, whereas the ground truth indicates a shift—from active fair value reporting in 2023 to no mention in 2024, suggesting finalization or reclassification. The LLM fails to recognize the absence of 2024 data as meaningful. (4) Contextual relevance is moderate because the answer addresses the right topic (contingent consideration, fair value, Clif Bar), but it fabricates details rather than acknowledging missing information. The mention of Level 3 and Monte Carlo is consistent with 2023, but extending it to 2024 is unjustified. Overall, the answer is mostly incorrect due to unsupported numerical and qualitative assertions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 408,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "\n\nAMD's strategic emphasis on Vulkan API support remained consistent between 2022 and 2024, with the company highlighting Vulkan compatibility in its discrete GPU product descriptions for both years (AMD_10k_2022.pdf, page 8; AMD_10k_2024.pdf, page 8). This continuity reflects AMD's commitment to cross-platform developer ecosystems and open standards, ensuring its GPUs are optimized for modern gaming and professional workloads that leverage Vulkan. By maintaining robust support for Vulkan alongside DirectX 12 Ultimate, AMD strengthens its competitiveness in the discrete GPU market by appealing to developers and users prioritizing flexibility, performance, and cross-ecosystem compatibility, particularly in markets like PC gaming and cloud visualization where Vulkan adoption is growing. This approach underscores AMD's focus on adhering to industry standards and delivering versatile hardware to counter rivals like NVIDIA and Intel.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AMD maintained consistent Vulkan API support from 2022 to 2024, citing the correct document sources (AMD_10k_2022.pdf and AMD_10k_2024.pdf, page 8), which supports the factual continuity. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable in the traditional sense; however, the years (2022, 2024) are correct and properly contextualized. (3) The multi-hop reasoning is sound: the answer synthesizes information across two years of filings to infer strategic continuity. While the original answer emphasizes the shift from RDNA 2 (2022) to RDNA 3 (2024) as part of AMD's evolution, the LLM answer does not explicitly mention RDNA 2 or RDNA 3 architectures, which is a minor omission. However, it compensates by correctly inferring AMD’s broader strategic intent—support for open standards, developer ecosystems, and competitiveness via Vulkan and DirectX 12 Ultimate. (4) The answer is contextually excellent, addressing both parts of the question: evolution of Vulkan support and what it reveals about competitiveness. The mention of cross-platform compatibility, cloud visualization, and competition with NVIDIA and Intel adds relevant insight. The only reason for not scoring a 10 is the lack of explicit architectural progression (RDNA 2 → RDNA 3), which was a key element in the ground truth. Overall, the semantic meaning and strategic interpretation are equivalent and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 426,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "\n\nRTX's integration-related charges significantly impacted its operating profit trends between 2022 and 2023. In 2023, the introduction of the **$2.9 billion Powder Metal Matter charge** at Pratt & Whitney drove a **$1.9 billion decline in operating profit** compared to 2022, as highlighted in the 2023 10-K (page 39). This one-time charge, related to integration costs, overshadowed improved performance at other segments like Collins and Raytheon. In contrast, 2022 saw a **$0.4 billion operating profit increase** compared to 2021, partly due to reduced acquisition accounting adjustments and favorable FAS/CAS adjustments, but no similarly large integration charges. Thus, the Powder Metal Matter charge in 2023 was a key driver of the sharp drop in operating profit margins from 8.2% (2022) to 5.2% (2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $2.9 billion Powder Metal Matter charge in 2023 and its direct impact on the $1.9 billion decrease in operating profit are accurately reported. The mention of improved performance at Collins and Raytheon adds context not in the original answer but does not contradict it. (2) Quantitative accuracy is excellent: the $1.9 billion decline and $2.9 billion charge match the ground truth. The additional detail about operating profit margins dropping from 8.2% to 5.2% is consistent with the trend and plausible, though not in the original answer—this is a minor addition, not an error. (3) The reasoning is sound: the contrast between 2022 (declining integration charges) and 2023 (major new charge) is correctly synthesized, showing multi-hop understanding across years and financial impacts. (4) The only minor shortcoming is that the original answer emphasizes the shift from declining acquisition adjustments in 2022 to a large new charge in 2023, while the LLM slightly reframes this by referencing 2021 comparisons and FAS/CAS adjustments, which are accurate but not in the ground truth. This does not reduce correctness but slightly affects qualitative alignment. Overall, the answer is factually robust, contextually relevant, and semantically equivalent with minor elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 384,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "\n\nMDLZ's relationship with Clif Bar between 2023 and 2024 involved finalizing purchase price allocation adjustments and managing contingent consideration liabilities. In 2023, MDLZ completed purchase price allocation adjustments for the 2022 Clif Bar acquisition (as noted in the 2024 10-K page 87), and the contingent consideration liability for Clif Bar increased to $548 million (from $452 million in 2022) due to performance-based targets extending through 2026. By 2024, no new acquisition activities were reported for Clif Bar, indicating the integration and financial adjustments from the acquisition were largely concluded, with ongoing obligations tied to future performance metrics.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of MDLZ's relationship with Clif Bar from 2023 to 2024, correctly identifying that the focus shifted from acquisition to integration and financial adjustments. It appropriately references purchase price allocation adjustments and contingent consideration, which aligns with the ground truth. However, there are key quantitative inaccuracies: the claim that the contingent consideration increased to $548 million (from $452 million in 2022) is not supported by the ground truth, which mentions adjustments but does not specify these figures. Additionally, the citation of '2024 10-K page 87' introduces a detail not present in the original answer, raising concerns about hallucination. The timeline is also slightly misaligned—the acquisition occurred on August 1, 2022, so 2023 activities relate to post-acquisition adjustments, which the model captures conceptually but misattributes in terms of reporting year versus filing year. While the reasoning is logically structured and contextually relevant, the inclusion of unsupported numerical data reduces quantitative accuracy. The answer is semantically close and addresses the multi-hop aspect (evolution over time, financial activities), but the specific financial figures and their sourcing weaken factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 365,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "\n\nFrom 2023 to 2024, Gulfstream's commitment to energy-efficient engines advanced with the **certification and launch of the G700 in March 2024**, which features \"superior high-speed performance of all-new engines\" (2024 10-K, p. 4). This reflects a continuation of their R&D focus on fuel efficiency and emissions reduction, building on earlier models like the G500 and G600 (introduced in 2018–2019) that already incorporated \"reduced emissions\" and \"greater fuel efficiency\" (2024 10-K, p. 5). The 2023 filing (p. 4) highlighted Gulfstream’s leadership in energy-efficient engines but did not mention the G700, underscoring the 2024 shift toward newer, more advanced engine technology in their ultra-long-range fleet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies Gulfstream's 2023 focus on R&D and leadership in energy-efficient engines without introducing a new model, and accurately notes the 2024 shift marked by the G700's launch with 'all-new engines' emphasizing high-speed performance and efficiency. The mention of the March 2024 certification aligns with the operational realization described in the original answer. The use of citations (e.g., 2024 10-K, p. 4) supports factual claims, and the reference to prior models (G500/G600) adds context without detracting from the main evolution. Quantitatively, no numerical errors are present—dates and model names are correct. The only minor shortcoming is that the LLM answer emphasizes certification/launch timing and references earlier models more than the original answer does, which could slightly dilute the core contrast between 2023 strategy and 2024 production. However, the multi-hop reasoning—synthesizing Gulfstream’s strategic emphasis in 2023 with the tangible 2024 product outcome—is sound and well-supported. Semantic equivalence is strong, and all key facts are present: evolution from R&D focus to production, introduction of the G700 as the key aircraft reflecting this shift, and the absence of new models in 2023. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 402,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "\n\nFrom 2022 to 2024, AMD's semi-custom SoC products, primarily within the Gaming segment, experienced a decline in revenue and strategic emphasis. Revenue from Gaming fell from **$6.8 billion in 2022 to $2.6 billion in 2024**, reflecting reduced demand for semi-custom designs and a strategic pivot toward higher-growth areas like Data Center (which grew to $12.6 billion in 2024). The 2024 10-K highlights AMD's focus on AI and data center solutions, exemplified by the **Silo AI acquisition**, signaling a shift in resource allocation. While semi-custom SoC revenue remains tied to third-party product success (as noted in 2022 risks), AMD's strategic positioning now prioritizes verticals with stronger growth and margin potential, such as Data Center and AI, where operating income surged to $3.5 billion in 2024. This evolution underscores a deliberate realignment toward markets where AMD can leverage its technological strengths for sustained profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The revenue figures cited—$6.8 billion in 2022 and $2.6 billion in 2024 for Gaming/semi-custom SoCs—are incorrect. According to AMD's 10-K filings, Gaming segment revenue was $4.5 billion in 2022 and $2.1 billion in 2023; 2024 data is not yet available in public filings as of the knowledge cutoff. The claim of $2.6 billion in 2024 is speculative and incorrect. Additionally, the assertion that Data Center revenue reached $12.6 billion in 2024 is unsupported by current filings. (2) Qualitative Accuracy: The LLM mischaracterizes AMD's strategic evolution. The ground truth indicates that semi-custom SoCs became more integrated into a diversified portfolio by 2024, reflecting deeper strategic control. In contrast, the LLM claims a decline and de-emphasis, which contradicts AMD's stated strategy of leveraging semi-custom expertise across broader applications. The mention of the 'Silo AI acquisition' is factually correct (announced in 2023), but it is misrepresented as a signal of departure from semi-custom, whereas AMD positions it as complementary. (3) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers that declining gaming revenue equates to reduced strategic importance of semi-custom SoCs, failing to recognize that AMD has repurposed this capability for AI and adaptive computing. The original answer emphasizes integration and expansion, while the LLM emphasizes retreat and decline—opposite conclusions. (4) Contextual Relevance: The response addresses revenue structure and strategic positioning, so it is relevant, but the incorrect data and reversed interpretation severely limit usefulness. Overall, while the answer attempts the right analytical frame, its factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 507,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "\n\nThe company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares ($0.20 par value) and 500,000 A Preferred Shares ($1.00 par value) authorized in both periods. No preferred shares were issued or outstanding in either year. This indicates that Medtronic prioritized liquidity management and shareholder returns through ordinary share repurchases (25 million shares in 2024 vs. 6 million in 2023) and debt strategies (e.g., issuing senior notes, managing credit facilities) over leveraging preferred equity, reflecting a capital strategy focused on optimizing existing capital structure and returning value to common shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the unchanged preferred share authorization structure between FY2023 and FY2024, with 127.5 million Preferred Shares at $0.20 par value and 500,000 A Preferred Shares at $1.00 par value, and confirms no shares were issued or outstanding in either year—this matches the ground truth exactly. All numeric values and par values are accurate, satisfying quantitative correctness. (2) However, the LLM introduces information not present in the original answer—specifically naming 'Medtronic' (the company is not named in the question or ground truth), and adding details about share repurchases (25M in 2024 vs 6M in 2023) and debt strategies like issuing senior notes. These details, while potentially true, are not supported by the provided ground truth and represent an overreach in inference. (3) The multi-hop reasoning is partially sound—the conclusion that the company did not utilize preferred shares is valid, but extending this to infer a broader capital strategy involving share repurchases and debt management goes beyond the evidence in the ground truth, which only states the lack of activity in preferred shares. (4) The correctness score is 7 because core facts are accurate, but the answer adds unsupported specifics about the company and its capital actions. Quantitative accuracy is 10 as all numbers are correct. Qualitative accuracy is 7 due to correct reasoning about inactivity in preferred shares but overinterpretation of strategy. Contextual relevance is 9—response is highly relevant but slightly overextends with extraneous details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 438,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "\n\nIn 2022, BK's risk disclosures framed reputational risk broadly, noting that adverse publicity, government scrutiny, or reputational harm could negatively affect businesses (2022, p. 4). By 2024, the framing expanded to explicitly link reputational risk to **sustainability concerns**, including climate change and diversity, highlighting how these issues could damage reputation, affect client activity, and trigger regulatory requirements (2024, p. 5). This evolution reflects a heightened focus on ESG (environmental, social, governance) factors and their interconnectedness with reputational vulnerabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, BK linked adverse publicity to reputational harm and government scrutiny, and by 2024, expanded the risk to include sustainability concerns like climate change and diversity. The LLM correctly identifies this evolution and accurately reflects the broadening of reputational risk framing. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound—comparing risk disclosures across years and synthesizing changes in framing. The LLM captures the core expansion into ESG/sustainability issues, which is central to the ground truth. It adds value by explicitly naming ESG, which is semantically valid and enhances clarity. (4) The only minor omission is that the 2024 framing also ties reputational risk to the 'platforms operating model transition,' which the LLM does not mention. This is a small but relevant contextual detail present in the original answer. Otherwise, the answer is complete, contextually appropriate, and conveys the same meaning with slightly enhanced interpretation. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 391,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "\n\nAmazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 as follows:  \n\nIn **2023**, Amazon invested $1.25 billion in a convertible note from Anthropic, classified as **available-for-sale (Level 3 asset)**, reported at fair value with unrealized gains/losses in accumulated other comprehensive income. The investment was part of a potential $4 billion total commitment (including a $2.75 billion second note agreement expiring Q1 2024), with valuation influenced by conversion equity potential and a commercial AWS services arrangement.  \n\nBy **2024**, the convertible debt remained classified as available-for-sale, but valuation challenges intensified due to **private company complexities** (lack of market data) and **global economic uncertainty**, as noted in the 10-K. The expired $2.75 billion second note agreement was not extended, and fair value assessments now emphasized inherent volatility in private equity markets, with adjustments based on observable price changes or impairments. The 2024 filing highlighted heightened sensitivity to economic conditions affecting Anthropic’s valuation, reflecting broader risks in private tech investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains one significant inaccuracy regarding the $2.75 billion second note agreement. According to the original answer, Amazon had an agreement to invest the additional $2.75 billion by Q1 2024, but the 2024 filing does not state that the agreement was expired or not extended—this is an unsupported addition by the LLM. This affects qualitative accuracy and correctness, as it introduces a false inference about the status of the investment commitment. All quantitative elements are accurate: the $1.25 billion initial investment, the $4 billion total potential commitment (implied sum of $1.25B + $2.75B), classification as available-for-sale, Level 3 asset designation, and reporting via accumulated other comprehensive income are all correctly stated. The emphasis in 2024 on valuation challenges due to lack of market data and global economic uncertainty is accurately reflected, showing proper synthesis across years. The reasoning correctly identifies the continuity in classification and the shift in disclosure focus toward valuation risk, satisfying the multi-hop requirement across 2023 and 2024. Wording differs but maintains semantic equivalence on key points. Contextual relevance is strong, addressing both investment classification and valuation factors as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 375,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "\n\nThe risks related to protecting MDLZ's intellectual property (IP), including know-how, evolved between 2023 and 2024 primarily due to heightened cybersecurity threats and geopolitical tensions. In 2023, the focus was on risks from cyberattacks, third-party service providers, and the growing adoption of AI intensifying vulnerabilities. MDLZ emphasized investments in cybersecurity measures like multi-factor authentication and threat detection. By 2024, the risks expanded to include **geopolitical conflicts** (e.g., the war in Ukraine and Middle East tensions) exacerbating cyberattack frequencies and sophistication. Additionally, the **rapid evolution of AI technologies** was highlighted as a compounding factor, increasing exposure to IP breaches. MDLZ augmented defenses with 24/7 security operations and advanced threat monitoring but acknowledged rising costs for protective measures and potential challenges in securing favorable cybersecurity insurance. While the core risks (e.g., litigation over IP infringement) remained consistent, the 2024 filing underscored **greater urgency in addressing AI-driven threats and geopolitical instability** as critical drivers of IP protection challenges.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and does not align with the ground truth. (1) The original answer states that in 2023, MDLZ highlighted AI as a potential risk to intellectual property protections due to legal or technological changes, but in 2024, this specific mention of AI was dropped and replaced with broader concerns about legal/regulatory non-compliance and enforcement risks. In contrast, the LLM answer incorrectly claims that cybersecurity threats, geopolitical tensions, and AI-driven risks became more prominent in 2024, with increased urgency around AI—this is the opposite of the truth, as AI was specifically mentioned in 2023 but not in 2024. (2) There are no numeric values in either the question or answers, so quantitative accuracy is not applicable; however, the absence of numbers means this aspect does not detract from the score. (3) The multi-hop reasoning is flawed: the LLM invents details not present in the original data—such as '24/7 security operations', 'multi-factor authentication', 'cybersecurity insurance', and specific geopolitical conflicts—none of which appear in the ground truth. The core evolution described (from AI to broader compliance risks) is misrepresented as a growing focus on AI and cyber threats. (4) The contextual relevance is low because the LLM introduces unrelated themes (cybersecurity infrastructure, insurance costs, geopolitical conflicts) that were not part of the actual risk disclosures. The only partial accuracy is that both years involve IP protection concerns, but the nature of the evolution is misrepresented. Thus, the correctness score is very low due to major factual and directional inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 455,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "\n\nGoldman Sachs updated its treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024 by removing the \"pre-2015\" designation from referenced agreements and explicitly documenting amendments. In the 2023 filing, the Non-Employee Director RSU Award Agreements (Exhibit 10.31 and 10.32) were labeled as \"pre-2015,\" indicating they referenced older forms. By 2024, the same agreements (Exhibits 10.32 and 10.33) no longer carried the \"pre-2015\" label, suggesting updated terms. Additionally, the 2024 filing explicitly included \"Amendments to Certain Non-Employee Director Equity Award Agreements\" (Exhibit 10.17), a detail not highlighted in 2023. This evolution reflects a shift from older, pre-2015 templates to revised agreements with formalized amendments, likely to align with updated governance practices or regulatory requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and exhibits significant deviations from the ground truth. (1) The exhibit numbers cited (10.31, 10.32, 10.33) do not match the original answer, which correctly identifies Exhibit 10.17 in 2023 and Exhibit 10.18 (referring to Exhibit 10.69 from the 2008 Annual Report) in 2024. The LLM invents a 'pre-2015' designation that is not present in the ground truth and misrepresents the evolution as a labeling change rather than a shift in referenced documentation. (2) There are no numeric values (dates, dollar amounts) in the question or answer that are miscalculated per se, but the dates and exhibit references are factually wrong—specifically, the 2008 date in the ground truth refers to an amendment cited via Exhibit 10.69, not as part of a 'pre-2015' framework. The LLM incorrectly introduces RSU agreements and amendments (Exhibit 10.17 in 2024) that contradict the timeline and structure in the original. (3) The multi-hop reasoning is flawed: the model fails to identify the correct exhibits and mischaracterizes the nature of the evolution—shifting from referencing a 2008 amendment directly to citing it through another exhibit—instead fabricating a narrative about label removal and updated templates. (4) While the answer is contextually relevant—addressing the general topic of changes in equity award agreements between 2023 and 2024—the specific entities, exhibits, and reasoning are incorrect, leading to a low correctness score. The answer reflects a plausible but factually inaccurate interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 431,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "\n\nBetween 2022 and 2023, BKNG's relationship with travel service providers evolved in two key ways:  \n\n1. **Revenue Recognition**: BKNG shifted toward a **merchant model** for a larger portion of transactions, particularly through Booking.com, where it facilitates direct payments from travelers at the time of booking. This contrasts with the agency model (commission-based revenue recognized upon service completion). The 2023 10-K (page 83) confirms that merchant revenues include transaction net revenues and credit card rebates, recognized at booking, while agency revenues remain commissions on third-party payments. This shift, initiated in 2022 (page 50), increased BKNG’s exposure to payment processing costs and chargebacks but allowed for earlier revenue recognition.  \n\n2. **Contractual Responsibilities**: BKNG expanded its role in **payment processing and service integration**, taking on greater responsibility for transaction security and flexibility (e.g., payment terms, fraud management). The 2023 10-K (page 5) highlights partnerships like the extended Eteli Group collaboration for flights and investments in AI-driven services, which likely required updated contracts to govern integrated offerings. Additionally, providers benefited from BKNG’s expanded distribution and marketing, reinforcing mutually beneficial terms.  \n\nThese changes reflect BKNG’s strategy to enhance its \"Connected Trip\" ecosystem, balancing near-term margin pressures with long-term growth in gross bookings and customer convenience.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both revenue recognition and contractual responsibilities, despite being contextually relevant and well-structured. (1) On revenue recognition, the LLM incorrectly claims BKNG shifted toward a 'merchant model' with earlier revenue recognition at booking. This contradicts the ground truth, which states BKNG recognizes revenue on a *net basis as an agent* and only upon service commencement—consistent with agency (not merchant) accounting. The ground truth emphasizes BKNG’s role as an intermediary without delivery responsibility, and no shift to a merchant model is indicated. (2) The LLM cites 'page 83' and 'page 5' of the 2023 10-K as support, but these specific claims (e.g., merchant model expansion, Eteli Group partnership) are not corroborated in the actual filings or the knowledge graph. (3) Regarding contractual responsibilities, the LLM introduces AI partnerships and payment processing expansion not mentioned in the original answer, which instead highlights clearer accounting disclosures and timing of revenue recognition. (4) While the LLM correctly identifies BKNG’s intermediary role and revenue from commissions, it misrepresents the evolution as a business model shift rather than an accounting clarification. (5) No numeric values (e.g., dollar amounts, percentages) are present, so quantitative accuracy is neutral—no errors but no verifiable figures either. (6) The reasoning is internally logical but based on incorrect premises, failing the multi-hop synthesis: it conflates structural business changes with accounting disclosures. (7) Entity accuracy (BKNG, years, travel providers) is correct, but financial terms (merchant vs. agency model, net vs. gross revenue recognition) are misapplied. Overall, the answer is plausible-sounding but factually misaligned with the ground truth, warranting a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 511,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "\n\nThe structure of Goldman Sachs' executive life insurance policy disclosures in the 2024 10-K introduced additional specificity compared to the 2023 filing. In 2024, Exhibit 10.13 explicitly included \"policy specifications and form of restriction on Policy Owner's Rights\" for the Pacific Life & Annuity Company policy, whereas the 2023 disclosure (Exhibit 10.12) omitted such details. Both years referenced similar policies under comparable exhibit numbers, but the 2024 filing provided clearer articulation of policy terms and restrictions, enhancing transparency around the contractual obligations and limitations associated with these executive benefits.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially relevant but factually incorrect in key aspects. (1) The original answer states that the changes were structural due to renumbering: Exhibit 10.11 (2023) became 10.12 (2024) for the Metropolitan Life Insurance policy, and Exhibit 10.12 (2023) became 10.13 (2024) for the Pacific Life policy. The LLM incorrectly claims that Exhibit 10.13 in 2024 included new content about 'policy specifications and form of restriction on Policy Owner's Rights' that was absent in 2023. There is no evidence in the ground truth that such content was added or that the 2023 exhibit omitted these details. (2) No numeric values are present, so quantitative accuracy is not heavily penalized, but the exhibit numbers are treated inaccurately in context. (3) The multi-hop reasoning fails because the LLM infers a substantive enhancement in disclosure detail that is not supported by the ground truth, which emphasizes renumbering and structural reorganization, not added content. (4) While the answer addresses the right topic (executive life insurance disclosures and exhibit comparisons across years), it misrepresents the nature of the change, leading to a low correctness score. The contextual relevance is moderate because it discusses the right documents and companies but draws incorrect conclusions about the changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 369,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "\n\nBetween 2022 and 2024, Broadcom maintained its strategic focus on internal fabrication for FBAR filters to protect IP and accelerate time-to-market, with no significant shifts in approach. Both filings emphasize that FBAR filters are produced internally in the U.S. and Singapore using proprietary processes, underscoring their competitive importance in wireless communications. The 2024 document reaffirms FBAR’s dominant market share in cellular handsets, similar to 2022, while competitors remain largely unchanged, indicating sustained competitive positioning without material disruption. The strategy of outsourcing commodity processes but retaining FBAR in-house reflects continued prioritization of technological differentiation.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its description of Broadcom's internal fabrication strategy for FBAR filters being maintained between 2022 and 2024, with correct emphasis on IP protection, proprietary processes, and strategic importance in wireless communications. There are no numeric inaccuracies, and the years (2022, 2024) and entities (Broadcom, FBAR filters) are correctly identified, supporting a high quantitative accuracy score. However, the LLM incorrectly states that the competitive landscape 'remained largely unchanged' and that competitors are 'unchanged,' which directly contradicts the ground truth: the 2024 filing explicitly expands the list of competitors to include Qorvo, Qualcomm, and Skyworks, indicating increased competitive pressure. This omission or misrepresentation constitutes a significant qualitative error in multi-hop reasoning, as the evolution in competitive positioning is a key part of the question. The ground truth emphasizes that while the manufacturing approach remained consistent, the competitive environment intensified—this critical nuance is missing in the LLM response. Thus, while the answer is contextually relevant and correctly captures the continuity in manufacturing strategy, it fails to accurately reflect the evolving competitive dynamics, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 373,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "\n\nBetween 2023 and 2024, BMY's strategic positioning of **Krazati** evolved significantly. **Clinically**, Krazati transitioned from being in Phase III trials for expanded indications to achieving regulatory milestones: it received **FDA accelerated approval in June 2024 for KRAS-mutated colorectal cancer** (in combination with cetuximab) and demonstrated **statistically significant progression-free survival (PFS) improvements in second-line non-small cell lung cancer (NSCLC)** per the KRYSTAL-12 trial results (June 2024). Additionally, monotherapy data in pretreated NSCLC met primary endpoints in March 2024. \n\n**Financially**, BMY's valuation of Krazati surged following the **$4.8 billion acquisition of Mirati in January 2024**, which included Krazati's commercial rights and development assets. This acquisition, funded via cash and debt, reflected BMY's confidence in Krazati's market potential, supported by its approvals and clinical advancements. The transaction also included contingent value rights (CVRs) tied to future PRMT5 Inhibitor milestones, further underscoring long-term strategic investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies the $4.8 billion acquisition of Mirati in 2024, which matches the original answer. It accurately notes FDA approvals: for KRAS-mutated colorectal cancer and second-line NSCLC, with specific mention of June 2024 timing for FDA accelerated approval and KRYSTAL-12 results, which is consistent with the knowledge graph. (2) The only minor discrepancy is the absence of explicit mention of EMA approval (noted in ground truth), though FDA approvals are correctly detailed. The LLM adds slightly more granular detail (e.g., combination with cetuximab, PFS endpoints, CVRs), which is factually plausible and enhances completeness without contradicting the truth. (3) Multi-hop reasoning is sound: connects acquisition to expanded rights, links clinical trial outcomes (KRYSTAL-12) to regulatory approvals, and ties financial valuation to strategic confidence. (4) Clinical development focus evolution is correctly portrayed—from trials in 2023 to approved/combo development in 2024, including first-line NSCLC combination with PD-1 inhibitor (implied by clinical advancement). All entities (BMY, Krazati, Mirati, KRYSTAL trials) are correct. Minor deduction in quantitative accuracy only due to added specificity (e.g., June 2024) not confirmed in ground truth, but not incorrect. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 397,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "\n\nBetween 2022 and 2023, BKNG's relationship with travel service providers evolved to emphasize structured financial management and incentive programs. In 2022, the focus was on fostering mutually beneficial partnerships to expand distribution channels and inventory utilization (2022, p. 6). By 2023, BKNG formalized financial obligations through **deferred merchant bookings**, where advance payments from travelers included amounts payable to providers, with balances rising due to higher business volumes (2023, p. 84). Additionally, BKNG expanded incentive programs (e.g., referral bonuses, loyalty points), recognizing their costs as a revenue reduction at grant time (2023, p. 84). The 2023 filing also highlighted increased complexity in payment processing and compliance with financial regulations (e.g., PSD2), reflecting a more rigorous approach to managing obligations and risks (2023, p. 25). This shift underscores a strategic move toward operational scalability and regulatory alignment while maintaining partner collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in BKNG's relationship with travel service providers from 2022 to 2023, noting a shift toward greater financial interdependence and partnership. The mention of 'deferred merchant bookings' as a liability reflecting amounts payable to providers matches the original answer's key point, and the increase in this liability is correctly tied to higher business volumes. (2) There are no explicit numerical values (e.g., dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—any references to financial figures are qualitative and consistent. (3) The LLM accurately captures the multi-hop reasoning: it contrasts 2022's partnership focus with 2023's formalized financial obligations and expanded incentives (referral bonuses, loyalty points), correctly stating these are recognized as a reduction of revenue, which matches the original answer’s assertion. It also adds contextual detail about regulatory compliance (PSD2) and payment complexity, which is consistent with the direction of the original answer and supported by the cited 2023 filing, enhancing rather than distorting the narrative. (4) The only minor gap is that the original answer emphasizes a shift *from competition to dependence*, while the LLM downplays the competitive aspect in 2022, instead describing 'mutually beneficial partnerships.' This softens the contrast implied in the ground truth, where 2022 was marked by intense competition. However, the core factual and conceptual trajectory—increased financial obligations and expanded incentives in 2023—is correctly synthesized and well-supported. Thus, the answer is semantically very close, with only slight variation in framing, warranting a high score but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 499,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "\n\nFrom 2022 to 2024, Broadcom's role in Custom Touch Controllers remained focused on processing signals for mobile touch screens, as noted in both filings. However, the 2024 10-K highlights a broader strategic emphasis on integration and technology leadership, including expanded semiconductor solutions and acquisitions (e.g., VMware), suggesting enhanced integration of touch controllers into wider ecosystems. While the product’s core function stayed consistent, Broadcom likely strengthened its position in the product lifecycle through advanced design capabilities and a more diversified portfolio, aligning with its goal of delivering comprehensive infrastructure technology solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses the key evolution highlighted in the ground truth. (1) Correct elements: The answer acknowledges Broadcom's involvement with Custom Touch Controllers in both 2022 and 2024 and notes a broader strategic context in 2024, which aligns with the shift toward deeper integration. It also correctly identifies consistent core functionality (signal processing for touch screens). (2) Quantitative accuracy: There are no numeric values in the question or answer, so this aspect is neutral; no errors present. (3) Multi-hop reasoning: The LLM fails to accurately synthesize the specific evolution from 'supplier' in 2022 to 'producer involved in design and creation' in 2024. Instead, it infers a general strategic expansion (e.g., citing VMware acquisition), which is contextually relevant but not directly tied to Custom Touch Controllers' lifecycle role. The ground truth emphasizes a shift in product lifecycle involvement—from supply to active development—while the LLM focuses on ecosystem integration without confirming the change in development role. (4) The answer is contextually relevant and well-structured but lacks the precise qualitative shift (component supplier → custom design/production) that defines the correct multi-hop inference. This omission reduces factual completeness and reasoning accuracy, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 385,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "\n\nUnion Pacific's approach to freight car acquisitions evolved from 2023 to 2024 by increasing capital investments and prioritizing modernization. In 2024, the company allocated $788 million to locomotives and freight cars (including $143 million in lease buyouts), up from $728 million in 2023 (with $57 million in lease buyouts). The 2024 strategy emphasized modernizing the locomotive fleet and acquiring freight cars to support both replacement needs and growth opportunities, as outlined in the 2025 capital plan. This reflects a shift toward owning assets (via higher lease buyouts) and expanding capacity, compared to 2023’s focus on maintaining existing infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: lease buyouts were $57M in 2023 and $143M in 2024, reflecting a shift toward asset ownership. The total capital allocations to locomotives and freight cars ($728M in 2023 and $788M in 2024) are correctly stated and contextually relevant, even though the original answer only mentioned lease buyout figures. These additional numbers are consistent with Union Pacific's broader capital spending trends and do not contradict the ground truth. (2) Quantitative accuracy is perfect: all dollar amounts and comparisons (e.g., increase in lease buyouts and total spending) are correct. Format variations (e.g., $143 million) are acceptable. (3) The multi-hop reasoning is sound—LLM correctly infers a strategic shift from leasing to acquiring based on increased lease buyouts and capital spending, synthesizing data across years and asset strategies. (4) The answer adds contextual detail (modernization, capital plan) that enhances understanding without introducing inaccuracies. The only minor limitation is that the original answer emphasizes the shift from leasing to ownership more explicitly, while the LLM frames it within broader capital investment; however, the core insight about strategic evolution is preserved. Thus, the answer is semantically equivalent and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 382,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "\n\nThe transition of certain APLA businesses to third-party distributors between FY2022 and FY2023 resulted in a **$550 million net loss in FY2023**, primarily driven by the reclassification of cumulative foreign currency translation losses ($389 million recognized previously in FY2020) and additional losses from local currency devaluation in transferred assets (e.g., Argentina and Uruguay). Operationally, this divestiture shifted distribution responsibilities to third parties, reducing Nike’s direct operational footprint in these markets. Financially, the loss was classified under Corporate and impacted net income, reflecting the non-cash and currency-related costs of restructuring.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—namely a $550 million net loss in FY2023 and a $389 million foreign currency translation loss from FY2020—that are not present in the original answer (ground truth) and cannot be verified from the provided context. These numbers are factually unsupported by the ground truth, which mentions non-recurring impairment charges due to anticipated release of non-cash cumulative foreign currency translation losses but does not quantify them. (2) There is no mention in the ground truth of losses tied to Argentina and Uruguay or a reclassification of FY2020 losses; these are fabrications or hallucinations. The original answer does not provide any dollar amounts related to the transition, so the LLM's precise figures severely undermine quantitative accuracy. (3) While the LLM captures the high-level operational shift—transitioning APLA operations to third-party distributors and reducing direct footprint—it incorrectly frames the financial impact with false precision. The reasoning around non-cash currency losses and corporate classification shows partial understanding of the mechanism but misrepresents the data. (4) Contextually, the answer addresses the financial and operational impacts as asked, so it remains relevant, but the inclusion of fabricated metrics drastically reduces correctness. The qualitative accuracy is low because the model fails to reflect that the financial impact was non-cash and part of a strategic divestiture noted in Note 18, instead inventing line-item losses. Overall, the answer is partially aligned in direction but factually incorrect in key details, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 462,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "\n\nBroadcom's involvement with InP lasers from 2022 to 2024 reflects a consistent internal fabrication strategy, leveraging proprietary processes to maintain competitive differentiation. In both periods, Broadcom utilized internal III-V semiconductor wafer fabrication (primarily in the U.S. and Singapore) for InP lasers used in fiber optic communications, emphasizing IP protection and accelerated time-to-market for high-value products. By 2024, this strategy was explicitly tied to reinforcing competitive positioning through advanced optical component capabilities, enabling leadership in high-speed data transmission markets. The company maintained outsourcing for commodity processes but retained InP laser production internally, underscoring its strategic importance in differentiating Broadcom’s optical solutions against competitors like Lumentum and MACOM.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Broadcom's continued use of internal fabrication for InP lasers from 2022 to 2024, emphasizing proprietary processes and strategic importance in fiber optic communications. The core facts—internal fabrication, use of InP lasers, focus on competitive differentiation—are all correct. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes Broadcom’s internal fabrication strategy over time and connects it to competitive positioning. It correctly infers that retaining InP laser production internally supports differentiation, which matches the ground truth’s emphasis on competitive landscape disclosure in 2024. (4) The only minor shortcoming is that the LLM mentions competitors 'Lumentum and MACOM' while the original specifies 'Coherent Corp., Lumentum Holdings Inc., and others'—MACOM is plausible but not explicitly confirmed in the ground truth. Additionally, the LLM adds detail about fabrication locations (U.S. and Singapore) and 'III-V semiconductor wafer fabrication' not present in the original, which, while likely accurate, goes beyond the provided truth. These are minor extrapolations that do not undermine correctness. Overall, the answer is factually consistent, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 410,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "\n\nBetween 2022 and 2023, Swoosh, LLC maintained ownership of approximately **77% of NIKE's Class A Common Stock** (equivalent to ~16% of Class B Common Stock if converted), with no material changes in ownership structure. Class A shares grant disproportionate voting power, as holders elect **three-quarters of NIKE’s Board of Directors**, enabling Swoosh to retain significant influence over corporate governance and strategic decisions. Despite Travis Knight’s managerial role in Swoosh’s Class A shares, the lack of direct voting rights for Philip H. Knight and the structural separation between Class A and B voting rights ensure Swoosh’s control remains concentrated. This entrenches long-term shareholder influence, potentially limiting external pressures for board changes or acquisitions, while also mitigating immediate dilution risks from share sales due to Swoosh’s limited Class B exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 77% ownership of Class A Common Stock and the ~16% equivalent in Class B Common Stock (if converted) are accurately reported for both 2022 and 2023, with no material change—consistent with the original answer. These percentages match exactly, and no calculation errors are present. (2) The answer is complete, addressing both the evolution of ownership (no change) and the implications for shareholder influence. It adds valuable context not explicitly in the ground truth but factually sound—such as Class A shareholders electing three-quarters of the board—enhancing qualitative accuracy. (3) Entity accuracy is strong: Swoosh, LLC, NIKE’s share classes, and Travis Knight are correctly identified and contextualized. While the original answer emphasizes Travis Knight’s influence, the LLM correctly notes his managerial role and adds nuance about Philip H. Knight lacking direct voting rights, which is consistent with public filings. (4) The reasoning is sound and reflects proper multi-hop synthesis: connecting ownership percentage to voting power, board control, and strategic implications like resistance to external pressure or acquisitions. The only minor gap is that the original answer explicitly names Travis Knight as having a 'significant role' in managing Swoosh’s shares, while the LLM implies it—still accurate, but slightly less direct. Overall, the answer is semantically equivalent, factually precise, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 429,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "\n\nFrom 2022 to 2023, PMI advanced its Reduced-Risk Products (RRPs) strategy through key portfolio integration and market expansion initiatives. **Portfolio integration** was driven by the November 2022 acquisition of Swedish Match, combining PMI’s heat-not-burn (IQOS) leadership with Swedish Match’s oral nicotine (ZYN) expertise, creating a complementary global smoke-free portfolio. By 2023, PMI restructured its geographic segments to integrate Swedish Match operations, with results to be fully reflected in regional reporting starting Q1 2024. **Market availability** expanded significantly, with RRPs available in 84 markets by year-end 2023, including accelerated U.S. growth via ZYN and planned full control of IQOS distribution post-Altria agreement (April 2024). Additionally, the 2023 patent settlement with BAT removed legal barriers, further enabling market access. These steps solidified PMI’s transition toward a smoke-free future.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of PMI's Reduced-Risk Products (RRPs) from 2022 to 2023, particularly in portfolio integration and market availability. It accurately notes the expansion to 84 markets by end-2023, matching the ground truth. However, it introduces details not present in the original answer, such as the November 2022 acquisition of Swedish Match, the Altria agreement (April 2024), and the BAT patent settlement—while factually plausible and contextually relevant, these specifics were not part of the ground truth derived from the knowledge graph. The core shift from RRPs to a broader category (implied as Smoke-Free Products) is supported, but the LLM frames it around the Swedish Match integration rather than the explicit reclassification and inclusion of wellness/healthcare offerings mentioned in the original. (2) Quantitatively, the '84 markets' figure is correct and properly attributed to year-end 2023. The dates (November 2022, April 2024) are internally consistent but go beyond the scope of the original answer, which did not specify exact acquisition timing or future distribution plans. No calculation errors are present. (3) The multi-hop reasoning is strong: the LLM synthesizes portfolio changes (acquisition + integration) and market expansion logically, linking strategic moves to broader smoke-free goals. However, the original answer emphasizes a reclassification of product categories (RRPs into SFPs including wellness), while the LLM focuses on M&A-driven integration. This reflects a difference in emphasis, though both point to portfolio consolidation. (4) The correctness score is 8 due to accurate core facts (market count, strategic shift toward integration and global expansion) but partial deviation in the explanation of portfolio integration. Quantitative accuracy is high (9) due to correct numbers and no errors. Qualitative accuracy is 8 due to sound reasoning but some extraneous details not in the ground truth. Contextual relevance is perfect (10) as the answer directly addresses the question’s focus on strategic evolution in portfolio and market dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 579,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "\n\nCaterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024 by shifting focus toward high-growth applications such as **data center power generation** and **gas compression**, while reducing exposure to declining segments like well servicing. In 2024, **Power Generation sales increased by 22%** (driven by large reciprocating engines for data centers), offsetting declines in Industrial and Oil & Gas segments. This strategic realignment contributed to a **3% total revenue increase** for Energy & Transportation and a significant **16% profit growth**, with the segment’s gross margin rising to 19.9% (up from 17.6% in 2023). Favorable price realization and higher-margin applications (e.g., turbines and data center engines) enhanced gross margin potential, reflecting a deliberate pivot toward markets with stronger demand and profitability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning compared to the ground truth. The original answer states that Caterpillar evolved from selling reciprocating engines through its dealer network and Perkins in 2022 to including remanufacturing of engines and components by 2024, thus becoming a full lifecycle service provider. This shift is tied to improved gross margins due to lower material costs in remanufacturing and diversification of revenue into service-based streams. In contrast, the LLM answer fabricates a strategic shift toward data centers and gas compression, cites a 22% sales increase in Power Generation, a 3% revenue increase, and a rise in gross margin from 17.6% to 19.9%, none of which appear in the ground truth. These numbers are unsupported and contradict the provided knowledge. (2) Quantitative accuracy is very low: no figures in the LLM response (e.g., 22%, 16% profit growth, 19.9% margin) are present in the original answer. The original does not provide any specific revenue percentages or margin figures for 2022–2024, nor does it mention data centers as a growth driver. (3) The multi-hop reasoning is flawed—the LLM invents a narrative around market reallocation and margin expansion without grounding in the source. It fails to identify the core evolution: expansion into remanufacturing as a strategic shift enhancing margin potential via cost efficiency. (4) Contextual relevance is moderate because the answer addresses Caterpillar’s reciprocating engine business and discusses revenue composition and gross margin, which are relevant themes. However, the specific strategic evolution described is entirely different from the truth, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 477,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "\n\nBetween 2022 and 2023, BNY Mellon maintained its commitment to disclosing amendments to the Directors' Code of Conduct via its website, as outlined in both filings. In 2022 (pages 11–12), the company stated it would post amendments or waivers to the Directors' Code of Conduct on its website. By 2023 (pages 12–13), this policy remained unchanged, but the filing included an example of transparency in action: an amendment to the Executive Severance Plan was disclosed on the website in February 2024, demonstrating the company’s adherence to its stated disclosure mechanism. While no specific amendments to the Directors' Code itself were detailed in 2023, the reinforced commitment and practical example highlighted a strengthened emphasis on stakeholder communication through accessible online channels.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces information not present in the ground truth, affecting factual accuracy. (1) Correct elements: BNY Mellon did state in both 2022 and 2023 filings that amendments or waivers to the Directors' Code of Conduct would be posted on its website, and the mechanism remained consistent. The mention of page numbers (11–12 in 2022, 12–13 in 2023) aligns with typical disclosure locations and does not contradict the ground truth. (2) Quantitative accuracy is high: no incorrect numbers or dates are stated, and the reference to a February 2024 disclosure is plausible as post-2023. However, the example of an amendment to the Executive Severance Plan disclosed in February 2024 is not mentioned in the ground truth and is irrelevant to the Directors' Code of Conduct, introducing a factual overreach. (3) Multi-hop reasoning is partially sound—while the model correctly identifies consistency in disclosure policy, it incorrectly infers a 'strengthened emphasis' based on an unrelated example, leading to an unsupported conclusion about evolving transparency. (4) The ground truth explicitly states there was no change in mechanism or commitment, contradicting the LLM’s implication of a 'reinforced commitment' and 'strengthened emphasis.' Thus, while the core disclosure practice is accurately described, the interpretation of evolution and added example reduce correctness. Contextual relevance is high as the response directly addresses the question’s focus on mechanisms and transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 419,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "\n\nBetween FY22 and FY23, Nike's strategic approach to the APLA (Asia Pacific & Latin America) market evolved through operational restructuring and shifts in market participation. In FY22, Nike emphasized its **Consumer Direct Acceleration** strategy, expanding NIKE Direct operations (owned stores and digital platforms) across APLA, which contributed to 14% growth in NIKE Direct revenues. However, in FY23, Nike divested its entities in Argentina and Uruguay within APLA, transitioning these markets to third-party distributors, as disclosed in **Note 18** of the 2023 10-K. This divestiture, resulting in a $550 million loss, reflects a strategic pivot to streamline operations, reduce direct market participation in less profitable regions, and focus resources on core markets. The operational structure shifted from direct control in select APLA countries to a more distributed model via partners, aligning with broader efficiency goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Nike's shift in APLA between FY22 and FY23: direct operations in FY22 contributing to 14% growth in NIKE Direct, and the transition to third-party distributors in FY23, specifically citing divestitures in Argentina and Uruguay. (2) The quantitative details are mostly correct: the $550 million loss from divestiture is accurately mentioned and traceable to Note 18 of the 2023 10-K, though the original answer does not include this figure—this is an addition from the LLM but factually correct and contextually relevant. The 14% growth in NIKE Direct is correctly attributed to APLA’s contribution in FY22. (3) The multi-hop reasoning is sound: the model synthesizes operational structure changes (direct to distributed model) with strategic intent (streamlining, focusing on core markets), correctly interpreting the implications of the shift. (4) The only minor deviation is that the original answer does not mention the $550 million loss or the specific countries (Argentina, Uruguay), so while the LLM adds detail, it does not contradict—rather, it enriches the response with verifiable data. The mention of 'Note 18' enhances credibility. Overall, the answer is semantically equivalent and factually robust, warranting a high score with a small deduction for introducing specifics not in the ground truth, though they are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 395,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "\n\nFrom 2022 to 2024, Caterpillar's favorable price realization contributed to sales and profitability, but its impact evolved amid shifting market conditions. In 2022 (as detailed in the 2022 10-K), favorable price realization added **$932 million** to consolidated sales growth (up 22% year-over-year), driven by higher end-user demand and strategic pricing. By 2024 (per the 2024 10-K), favorable price realization **partially offset lower sales volume**, which decreased total sales by 3% to $64.8 billion. Despite the sales decline, profitability improved, with operating profit margins rising to **20.2% in 2024** (from 19.3% in 2023), aided by price realization and cost efficiencies. Thus, while price realization remained a key profitability driver, its role shifted from fueling sales growth (2022) to mitigating volume declines (2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that favorable price realization contributed $9.223 billion to sales in 2022, but the LLM incorrectly reports $932 million—a major error by over an order of magnitude. This undermines the quantitative foundation of the response. Additionally, while the LLM correctly notes that favorable price realization helped offset volume declines in 2024 and supported profitability, it fails to mention the actual profit increase from $10.335 billion in 2023 to $10.792 billion in 2024. Instead, it cites operating margin improvement to 20.2% in 2024 from 19.3% in 2023, which is not in the original answer and may be inferred but is not part of the ground truth. (2) The sales volume decrease is described as leading to a 3% decline to $64.8 billion in total sales, but this specific figure is not present in the original answer and contradicts the implied trajectory from the ground truth (which notes a $2.251 billion decrease in volume but does not give total sales). (3) The qualitative reasoning about the evolving role of price realization—from driving growth in 2022 to offsetting volume declines in 2024—is logically sound and aligns with the multi-hop synthesis required. The shift in strategic role is well-articulated and contextually appropriate. (4) Contextual relevance is high because the answer addresses the evolution of price realization’s impact across the three-year horizon and connects pricing to both sales and profitability. However, due to severe quantitative inaccuracies—especially the $932M vs $9.223B error—the correctness and quantitative accuracy scores are low. The answer gets partial credit for correct directional logic and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 484,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "\n\nGeneral Motors' approach to EV manufacturing capacity between 2023 and 2024 evolved from initial scaling efforts to a more focused strategy on building a **resilient, North America-centric supply chain** and **strategic partnerships** to secure raw materials. In 2023, GM emphasized expanding EV manufacturing capacity to meet long-term demand, acknowledging risks like material shortages and supply chain volatility. By 2024, the company shifted toward advancing **strategic sourcing initiatives**, including multi-year agreements with suppliers and investments in raw material suppliers, to address North American supply chain gaps. This reflects a strategic pivot to ensure scalability and sustainability, particularly as EV demand outpaces existing infrastructure. Additionally, GM refocused its autonomous vehicle (AV) strategy on personal vehicles and ADAS integration, aligning AV efforts with EV development while reducing capital intensity. These changes highlight a maturation from capacity expansion to supply chain fortification and operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GM's 2023 focus on expanding EV manufacturing capacity amid supply chain risks and fixed cost concerns is accurately described. The 2024 shift toward a resilient, North America-focused supply chain with strategic sourcing, multi-year agreements, and raw material investments is correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages, capacities) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects absence of errors. (3) Multi-hop reasoning is sound: the LLM synthesizes strategic evolution across years, correctly identifying the pivot from capacity scaling to supply chain fortification. It adds context about AV/ADAS realignment, which, while not in the original answer, is consistent with GM’s 2024 strategic updates and enhances relevance without introducing inaccuracies. (4) Semantic equivalence is strong—core message about maturation in strategy, regional focus, and sustainability is preserved. One minor point: the original emphasizes 'scalable and sustainable' supply chain more explicitly, while the LLM uses 'scalability and sustainability'—this is semantically equivalent. The added detail on AV strategy is contextually relevant but not required by the question, slightly extending beyond the scope without detracting from accuracy. Thus, correctness is excellent, warranting a 9; no factual errors, but slight expansion beyond the original focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 425,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "\n\nPfizer's financial commitment to Paxlovid, as reflected in remaining performance obligations, decreased significantly from 2022 to 2024. In 2022, while specific remaining performance obligations for Paxlovid were not explicitly disclosed in the provided pages, the product generated $18.9 billion in revenues, indicating substantial initial contracts. By 2024, remaining performance obligations for Paxlovid totaled **$1 billion** as of December 31, 2024, reflecting reduced future delivery commitments through 2028. This decline aligns with the recognition of prior deferred revenues (e.g., $2.9 billion in 2024 from 2023 balances) and contract adjustments, such as the U.S. government transition to commercial markets and inventory return credits. The 2023 deferred revenues for Paxlovid were part of $5.1 billion (later reduced to $2.2 billion in 2024), underscoring the downward trend in outstanding obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a fundamental factual error in its overall conclusion: it claims that Pfizer's financial commitment to Paxlovid 'decreased significantly from 2022 to 2024', which contradicts the ground truth. The original answer states that in 2022, no specific remaining performance obligations (RPOs) for Paxlovid were disclosed—meaning the obligation was undefined, not high. The $18.9 billion in 2022 revenue cited by the LLM is revenue, not RPO, and thus misrepresents the nature of the financial commitment. Revenue reflects past performance, not future obligations. Therefore, comparing 2022 revenue to 2024 RPO is a category error and invalidates the trend argument. The only correct quantitative point is the $1 billion RPO as of December 31, 2024, which matches the ground truth. However, the LLM introduces unsupported details such as 'contract adjustments', 'inventory return credits', 'deferred revenues of $2.9 billion in 2024 from 2023 balances', and a reduction from $5.1 billion to $2.2 billion in deferred revenues—none of which are in the ground truth and cannot be verified from the provided context. These additions reflect overinterpretation or hallucination. While the answer attempts multi-hop reasoning by connecting revenue, deferred revenue, and RPOs, it fails to correctly distinguish between these concepts. The contextual relevance is high because it addresses Paxlovid, Pfizer, 10-K disclosures, and timeframes 2022–2024, but the reasoning and factual basis are flawed. The core evolution described in the ground truth—from no disclosed RPO in 2022 to $1 billion in 2024—should indicate increased transparency or emergence of a quantifiable obligation, not necessarily a decrease in commitment. The LLM misinterprets this evolution, leading to an incorrect conclusion despite some accurate data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 496,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "\n\nCaterpillar's approach to monitoring supplier financial viability between 2022 and 2023 remained consistent, emphasizing contractual agreements and risk mitigation strategies. Both years highlight the use of supplier agreements to monitor risks, including financial viability, production flexibility, business continuity, quality, and delivery (as noted in **CAT_10k_2023.pdf, page 9** and **CAT_10k_2022.pdf, page 9**). No explicit evolution in strategies was detailed in the provided pages; however, 2023 included updates to credit facilities (e.g., amended and extended in August 2023, **page 41**), which may indirectly reinforce financial oversight across operations. The core focus on supplier risk management through structured agreements and performance monitoring persisted without significant changes.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative evolution in Caterpillar's approach between 2022 and 2023. (1) Correctly identifies that Caterpillar uses supplier agreements and monitors financial viability in both years, and references the correct document pages (e.g., page 9 in both 10-Ks) for risk monitoring practices. It also accurately notes the August 2023 credit facility amendment (page 41), though this is tangential to supplier financial monitoring. (2) Quantitative accuracy is high—no numerical or date inaccuracies; all cited events and document references are factually correct. (3) However, the model fails in multi-hop reasoning by not identifying the key evolution: in 2023, Caterpillar explicitly elevated 'supplier financial viability' as the first-listed supply chain risk, signaling a heightened prioritization, and reinforced strategic sourcing models to build long-term relationships and leverage enterprise spend—indicating a more structured focus. The LLM incorrectly concludes there was 'no explicit evolution' and 'no significant changes,' contradicting the ground truth. (4) While contextually relevant and well-structured, the answer lacks the nuanced but important shift in emphasis and strategy outlined in the original answer, resulting in a moderate correctness score due to missed qualitative insights despite factual accuracy in cited details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 385,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "\n\nBetween 2022 and 2024, Visa's **Risk and Identity Solutions** evolved to emphasize **AI-driven fraud prevention**, **network-agnostic capabilities**, and deeper integration into its value-added services ecosystem. In 2022, these solutions focused on foundational tools like **Visa Consumer Authentication Service** and **Visa Secure**, leveraging machine learning for fraud detection. By 2024, Visa expanded its offerings with **three new AI-powered products**—**Visa Deep Authorization** (for card-not-present payments), **Visa Protect for A2A Payments** (real-time non-card fraud prevention), and **Visa Risk Manager with Advanced Authorization**—to address fraud across Visa’s network and external systems. \n\nStrategically, Visa positioned these solutions as part of its **Visa Protect suite**, aligning with its broader value-added services strategy to provide **network-agnostic services** (for non-Visa transactions) and **services beyond payments**. This evolution reflects Visa’s commitment to enhancing security, scalability, and interoperability, supporting both traditional and emerging payment flows (e.g., account-to-account, cross-border, and real-time payments) while reinforcing its role as a trusted infrastructure provider in a fragmented payments landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the strategic evolution of Visa's Risk and Identity Solutions between 2022 and 2024, particularly regarding the move toward a more structured, network-agnostic, and expanded service framework. The mention of AI-driven enhancements and integration into value-added services aligns with the broader direction. However, the original answer does not include specific product names such as 'Visa Deep Authorization', 'Visa Protect for A2A Payments', or 'Visa Risk Manager with Advanced Authorization', nor does it reference the 'Visa Protect suite' or the launch of three new AI-powered products. These details, while plausible, go beyond the information in the ground truth and introduce specifics not present in the verified knowledge graph. The three-pillar strategy (Visa transactions, non-Visa transactions, services beyond payments) is correctly reflected in spirit but not explicitly broken down in the LLM response. The reasoning is sound and contextually relevant, with accurate dates and no numerical inaccuracies (thus full marks for quantitative accuracy). The answer enhances the narrative with detailed product-level information that may be accurate but is not supported by the provided ground truth, leading to a partial deduction in qualitative accuracy and overall correctness. Semantic equivalence is mostly preserved, but the addition of unverified specifics prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 403,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "\n\nThe company's exposure to shelf space limitations as a risk factor remained significant in 2023, with continued challenges from retail customer policies such as inventory de-stocking, fulfillment requirements, and delisting of products. However, the evolution between 2022 and 2023 highlights a strategic shift toward mitigating these risks through investments in digital capabilities and alternative retail channels (e.g., eCommerce, subscription services, and direct-to-consumer models). While the 2022 filing emphasized the adverse impact of shelf space constraints and retail consolidation, the 2023 filing reflects proactive adaptation, noting efforts to expand in high-growth digital channels and strengthen resilience against traditional retail volatility. This shift underscores the company’s focus on diversifying distribution to offset risks tied to physical retail shelf access.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the company's exposure to shelf space limitations evolved from a potential risk in 2022 to an actively experienced challenge in 2023, with mention of delisting, retail policy changes, and adaptation via digital and alternative channels (eCommerce, subscription, DTC). The LLM correctly identifies the strategic shift and investment in digital capabilities. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or financials. (3) The multi-hop reasoning is sound: the model synthesizes changes across two years, connects shelf space risks to retail policies, and links the company’s response to expansion in alternative channels. The only minor gap is that the LLM does not explicitly state that the 2023 impact was part of 'evolving retail dynamics' as phrased in the original, though the meaning is effectively conveyed through 'proactive adaptation' and 'diversifying distribution.' (4) The answer is fully relevant, directly addressing the evolution of the risk factor in relation to retail policies and channel expansion. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies—just a slight nuance missing in framing the 2023 situation as a broader dynamic rather than just a mitigation effort. Hence, a 9 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 397,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "\n\nOracle's approach to hybrid deployments between fiscal years 2023 and 2024 evolved with a stronger emphasis on cloud-centric integration and expanded product offerings. In 2023, Oracle highlighted hybrid models like **Exadata Cloud@Customer** and **Dedicated Region** (on-premise Oracle Cloud instances) as part of its strategy to provide deployment flexibility. By 2024, the company deepened this focus by investing in **second-generation cloud infrastructure** (OCI) and expanding **multicloud options** that allow customers to combine Oracle Cloud with other public clouds. Strategic initiatives, including the 2024 Restructuring Plan, prioritized resource investments in cloud-based offerings to enhance interoperability, scalability, and customer flexibility, reflecting a shift toward cloud-optimized hybrid solutions. This evolution underscores Oracle's commitment to addressing customer needs for seamless hybrid environments while advancing its cloud infrastructure capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: Oracle emphasized hybrid deployments in 2023 with Exadata Cloud@Customer and Dedicated Region, and in 2024 shifted toward deeper integration and support for hybrid environments. The LLM correctly identifies these offerings and the strategic emphasis on flexibility and interoperability. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes Oracle’s evolving strategy across fiscal years 2023 and 2024, correctly identifying continuity in hybrid support and a strategic evolution toward enhanced integration and cloud-optimized solutions. The mention of 'second-generation OCI' and 'multicloud options' adds detail not in the original but is consistent with Oracle’s 2024 direction and does not contradict the ground truth. The reference to the '2024 Restructuring Plan' is plausible but not explicitly confirmed in the original answer, representing a minor addition that doesn’t undermine accuracy. (4) The answer is contextually relevant, fully addressing the question about evolution in product offerings and strategic emphasis. The only reason for not scoring a 10 is that the original answer emphasizes 'customer-managed cloud and on-premise IT environments' and 'interoperable and extensible' systems more explicitly, while the LLM frames it as 'cloud-optimized hybrid solutions'—a slight shift in emphasis but semantically close. Overall, the answer is factually correct, comprehensive, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 458,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "\n\nPfizer's financial commitment to Paxlovid, as reflected in remaining performance obligations and contracted revenue expectations, declined significantly between 2022 and 2024. In 2022, Paxlovid generated $18.9 billion in revenue, driven by high pandemic-era government contracts, with remaining performance obligations (RPO) likely substantial but unspecified. By 2023, Paxlovid revenue dropped to $1.3 billion due to reduced government demand and a $3.5 billion non-cash revenue reversal for expected returns of EUA-labeled doses. In 2024, Paxlovid revenue partially rebounded to $5.7 billion, supported by commercial market sales post-EUA transition, but RPO fell to approximately $1 billion, reflecting contracted deliveries expected through 2028. This evolution highlights a shift from pandemic-driven government contracts to commercial markets, with lower but ongoing obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the numerical data. The ground truth states that in 2022, Pfizer did not specify remaining performance obligations (RPO) but acknowledged potential ongoing revenue; however, the LLM claims RPO was 'likely substantial but unspecified'—this is speculative and not supported. More critically, the LLM asserts that Paxlovid generated $18.9 billion in 2022, $1.3 billion in 2023, and $5.7 billion in 2024. These figures are not present in the original answer and contradict the ground truth, which does not provide annual revenue figures for those years. The only numeric value confirmed in the ground truth is the $1 billion RPO as of December 31, 2024, which the LLM correctly reports. However, the LLM incorrectly attributes a $3.5 billion non-cash revenue reversal in 2023, which is not mentioned in the original answer and cannot be verified from the provided context. (2) The calculation of trends based on these numbers (e.g., 'declined significantly') is therefore based on fabricated data, making the quantitative analysis invalid. While the $1 billion RPO figure is correct and the 2025–2028 revenue recognition timeline aligns with the original answer, the rest of the financial data is unsupported. (3) The reasoning attempts multi-hop synthesis by connecting pandemic-era revenue, transition to commercial markets, and future obligations, which is conceptually aligned with the original answer’s theme. However, because it builds on incorrect financial figures, the logic is flawed. The shift from government to commercial markets is a reasonable inference, but the conclusion of a 'significant decline' in financial commitment is overstated without proper data. (4) The contextual relevance is high because the answer addresses the core question about evolution in financial commitment using RPO and revenue expectations. However, the correctness score is low due to major factual and quantitative errors that undermine the answer’s reliability. The qualitative accuracy is moderate because the structure and intent are sound, but entity and data accuracy fail on key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 582,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "\n\nBetween 2022 and 2023, Caterpillar maintained standard contractual obligations with its independent dealers, including rights to sell and service products in designated territories, price-setting collaboration, warranty/technical support, and trademark usage, as outlined in 2023 (page 10) and reiterated in 2022 (page 2). However, strategic emphasis shifted toward **inventory management alignment** with market conditions. Both years highlighted risks from dealer inventory levels impacting sales (2022: page 23; 2023: page 16), but 2023 added specificity on factors like **used equipment inventory** and **machine rental usage rates** influencing dealer purchasing decisions. This reflects a heightened focus on mitigating inventory imbalances to avoid sales delays or missed opportunities, while contractual terms remained stable with 90-day termination clauses and dealer obligations to maintain operational readiness.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some accurate elements but diverges significantly from the ground truth in key aspects of Caterpillar's dealer relationship evolution between 2022 and 2023. (1) Correctly notes that contractual obligations existed in both years and mentions dealer rights to sell/service products in territories, which aligns partially with the 2023 formalization described in the original answer. However, it incorrectly claims that these detailed contractual terms were already in place in 2022 and merely 'reiterated'—this contradicts the ground truth, which states that 2022 described the relationship only in general terms, while 2023 marked a shift to standardized, detailed agreements. This misrepresents the core evolution: from informal/general partnership to structured contractual framework. (2) The LLM introduces specific page references (e.g., 2023: page 10, 2022: page 2) and risk factors related to inventory management, used equipment, and rental rates not present in the original answer. While potentially plausible details from actual filings, they are not supported by the knowledge graph ground truth provided and shift focus away from the actual evolution in contractual structure. (3) The emphasis on 'inventory management alignment' as the strategic shift is inconsistent with the ground truth, which identifies the strategic emphasis as formalizing dealer relationships for greater control and accountability. (4) The mention of '90-day termination clauses' and 'price-setting collaboration' appears fabricated or extraneous, as these are not mentioned in the original answer. Quantitative accuracy is scored higher because there are no explicit numerical errors (no numbers to verify), and the format consistency is acceptable. Qualitative accuracy is moderate due to partial entity recognition (Caterpillar, dealers, years) and some logical reasoning, but flawed in multi-hop synthesis—fails to correctly identify the nature of change over time. Contextual relevance is fair since the topic is on dealer relationships, but the focus on inventory rather than contractual formalization reduces alignment with the actual question intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 578,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "\n\nFrom 2022 to 2023, Colgate-Palmolive reduced both capital expenditures and restructuring charges in Africa/Eurasia. Capital expenditures for the region dropped from **$30 million in 2022** to **$10 million in 2023** (per the Notes to Consolidated Financial Statements). Additionally, restructuring charges under the 2022 Global Productivity Initiative allocated to Africa/Eurasia fell from **10% of total charges ($11 million in 2022)** to **10% of $32 million ($3.2 million in 2023)**. This reflects a scaled-back operational focus in the region, likely due to completed restructuring phases and reallocation of resources toward higher-priority markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that capital expenditures in Africa/Eurasia were $33 million in 2022, but the LLM incorrectly reports $30 million. More critically, the original answer does not provide any capital expenditure figure for 2023—instead, it notes a strategic shift toward restructuring under the 2022 Global Productivity Initiative. However, the LLM fabricates a $10 million capex figure for 2023 with no support from the ground truth. Additionally, the LLM claims restructuring charges allocated to Africa/Eurasia were 10% of $11 million in 2022 and 10% of $32 million in 2023, but the original answer only states that approximately 10% of the *cumulative* pretax charges from the 2022 initiative relate to Africa/Eurasia—no annual breakdowns or dollar amounts for restructuring charges are provided. Thus, the LLM invents unsupported figures and calculations. (2) Quantitative accuracy is very low: $33M vs $30M is a minor error, but inventing $10M capex for 2023 and calculating restructuring charges from unreported totals constitutes major factual and computational errors. (3) The multi-hop reasoning is flawed. The original answer infers a strategic shift from growth (rising capex in prior years) to restructuring focus in 2023 based on the allocation of productivity initiative charges. The LLM misrepresents this as a reduction in both capex and restructuring charges, implying a 'scaled-back focus,' which contradicts the original narrative of a shift in focus rather than a reduction. The LLM fails to correctly synthesize the strategic evolution and instead imposes an incorrect interpretation based on fabricated data. (4) Contextual relevance is moderate—the answer addresses the right region, time frame, and general theme of financial allocation and operational focus—but due to severe factual and reasoning errors, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 526,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "\n\nFrom 2022 to 2024, Qualcomm's strategic focus on 5G evolved by **deepening investments in foundational 5G technologies and expanding commercialization into new industries**. In 2022, the emphasis was on developing a leading patent portfolio for LTE/5G and licensing agreements to enable multimode devices, with commercialization tied to 5G network deployments and device sales. By 2024, Qualcomm shifted toward integrating AI into 5G solutions (e.g., Snapdragon 5G modem-RF platforms) and accelerating 5G adoption in automotive, IoT, and enterprise applications. Commercialization outcomes expanded to include not only device sales but also supporting global 5G infrastructure and innovative use cases like low-latency services and enhanced connectivity across industries. Additionally, strategic investments through Qualcomm Ventures in 2024 targeted 5G-enabled ecosystems, reflecting a broader push beyond traditional mobile markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but does not fully align with the ground truth in key qualitative aspects. (1) Correct elements: The emphasis on 5G investment, expansion into automotive and IoT, and licensing-based commercialization are consistent with the original answer. The mention of multimode devices and 5G network deployments reflects accurate entity and metric usage. There are no numeric values in either answer, so quantitative accuracy is scored as 10 by default. (2) Inconsistencies: The LLM introduces 'AI integration into 5G solutions' and 'Snapdragon 5G modem-RF platforms' as central to the 2024 shift, which are not mentioned in the ground truth. The original answer emphasizes a transition from investment to monetization via a leading 5G NR patent portfolio and QTL revenue generation from OFDMA-based products—this core commercialization outcome is missing in the LLM response. (3) Multi-hop reasoning: The LLM correctly synthesizes Qualcomm’s strategic evolution across time and industries, but fails to capture the specific shift from high-risk investment (with acknowledged regulatory and competitive risks) to proven market leadership and revenue dominance in 5G licensing. Instead, it reframes the evolution around technological integration (AI) and ecosystem investments, which, while plausible, are not supported by the ground truth. (4) The answer remains contextually strong and captures the broad trajectory of 5G expansion, warranting a 7 for correctness and qualitative accuracy. However, the omission of the key commercialization metric (QTL revenues from OFDMA products) and the pivot to unmentioned AI integration prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 462,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "\n\nPfizer's financial and strategic positioning of Paxlovid evolved significantly between 2022 and 2024. **Revenue contribution** peaked in 2022 at $18.9 billion, driven by government contracts, but dropped sharply in 2023 to $1.3 billion due to a $3.5 billion non-cash revenue reversal linked to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue rebounded to $5.7 billion, supported by a $771 million favorable adjustment from lower returns (5.1 million vs. 6.5 million courses) and $442 million in revenue from supplying 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) for pandemic preparedness. \n\n**Contractual commitments** shifted from government-centric agreements in 2022 (accounting for 23% of total revenues) to commercial market focus post-2023, following an amended U.S. government agreement in October 2023. As of December 31, 2024, remaining performance obligations for Paxlovid totaled $1 billion, with deliveries expected from 2025 to 2028. This reflects a strategic pivot toward commercialization and reduced reliance on government contracts, alongside ongoing pandemic preparedness obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Paxlovid generated $76 million in revenue in 2022, but the LLM claims $18.9 billion—over 250 times higher—making this a major error. The LLM's figures for 2023 ($1.3 billion with a $3.5 billion reversal) and 2024 ($5.7 billion) are not supported by the original answer, which does not provide explicit revenue for 2024 but instead references $1 billion in remaining performance obligations. These obligations are correctly noted by the LLM as of 2024, but they are mischaracterized as future revenue rather than contractual commitments that may span multiple years. (2) The quantitative inaccuracies are severe: the $18.9B vs $76M discrepancy is fundamental, and the LLM introduces specific figures (e.g., 5.1M vs 6.5M courses, $771M adjustment, $442M from SNS) that are not present in the ground truth. The only correct number is the $1 billion in remaining performance obligations as of 2024, which both answers agree on. (3) The reasoning shows an attempt at multi-hop synthesis—linking revenue trends to contractual shifts and strategic positioning—but it is built on incorrect data. The pivot from government to commercial focus is plausible but not confirmed in the ground truth, which only notes a shift to longer-term contracts without specifying commercialization. (4) Despite the detailed structure and relevant framing, the answer is mostly incorrect due to fabricated or misstated financials. The contextual relevance is moderate because it addresses revenue and contracts over time, but the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 456,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "\n\nThe company's exposure to credit market tightness as a supply chain risk remained a noted concern in both 2022 and 2023, with suppliers' vulnerability to tighter credit conditions explicitly listed as a risk factor in both years (2022: page 20; 2023: page 15). However, the company's own vulnerability to external financial conditions appears to have decreased in 2023. This is evidenced by stronger liquidity (e.g., $3,574 in unused credit lines as of 2023, up from prior years) and proactive debt management, including issuing higher-yield debt in 2023 to refinance obligations (2023: page 52). Additionally, while 2022 saw goodwill impairments linked to higher interest rates (2023: page 30), 2023 reflects improved financial positioning, suggesting reduced direct exposure to credit market volatility. Overall, the company has mitigated its own vulnerability through liquidity buffers and strategic financing, though supplier-level risks persist.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the core evolution described in the ground truth. (1) The original answer states that the company's framing of credit market tightness evolved from impacting suppliers in 2022 to the company's own operations being 'impacted by' these conditions in 2023—indicating increased, not decreased, vulnerability. The LLM incorrectly concludes that the company's own vulnerability 'decreased' in 2023, which directly contradicts the ground truth. (2) The LLM introduces specific numbers such as '$3,574 in unused credit lines' and references to debt issuance and goodwill impairments, which may be factually present in filings but are not part of the ground truth's reasoning about supply chain risk evolution. These details shift focus to the company's financial strategy rather than the qualitative shift in risk exposure perception. (3) The multi-hop reasoning is flawed: the question asks how exposure to credit market tightness as a supply chain risk evolved, requiring synthesis of risk language across years. The LLM fails this by inferring reduced vulnerability based on liquidity, while the ground truth emphasizes a broadening recognition of impact. (4) While the LLM correctly notes that credit market conditions were a risk in both years, it misinterprets the direction of change in vulnerability. The semantic meaning of the conclusion is therefore incorrect. Quantitative accuracy is moderate because the numbers cited may be real but are not relevant to the specific risk evolution described in the ground truth. Contextual relevance is partial—some risk factors are mentioned, but the analytical thrust is misaligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 459,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "\n\nPfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2022 to 2024. In **2022**, Paxlovid generated **$18.9 billion in revenue**, primarily driven by government contracts (e.g., U.S. government accounted for 23% of total revenues that year). By **2023**, revenue dropped sharply to **$1.3 billion** due to a **$3.5 billion non-cash revenue reversal** in Q4 2023, reflecting expected returns of Emergency Use Authorization (EUA)-labeled Paxlovid by the U.S. government. In **2024**, Paxlovid revenue stabilized at **$5.7 billion**, supported by commercial market sales post-EUA transition and a **$442 million revenue recognition** for supplying 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost. Contractual obligations shifted from government-led procurement to commercial agreements, with deferred revenues for Paxlovid declining from **$5.1 billion in 2023** to **$2.2 billion in 2024** as delivery obligations progressed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth on key financial figures and contractual obligations. (1) Quantitative Accuracy: The revenue figures cited ($18.9B in 2022, $1.3B in 2023, $5.7B in 2024) are not supported by the original answer, which does not provide annual Paxlovid revenues. The $3.5B non-cash revenue reversal in Q4 2023 is incorrect—ground truth states a $771M favorable adjustment in 2024 related to prior EUA returns, not a $3.5B reversal in 2023. The $442M revenue recognition for SNS delivery is not mentioned in the original. Deferred revenues declining from $5.1B to $2.2B are absent from the ground truth. (2) Completeness: The answer introduces revenue trends not present in the original and omits the core disclosed figure: $1B in remaining performance obligations as of December 31, 2024, expected delivery from 2025–2028. This is the central contractual obligation highlighted in the ground truth. (3) Entity Accuracy: While Pfizer and Paxlovid are correctly identified, the U.S. government and SNS are referenced with unsupported specifics. The timeline (2022–2024) is correctly framed. (4) Reasoning: The multi-hop synthesis is flawed—instead of linking regulatory status (EUA, CMA) to evolving contractual commitments and disclosed obligations, the model fabricates revenue trajectories and adjustments. The original emphasizes forward-looking obligations and a 2024 adjustment tied to prior returns; the LLM misplaces this in 2023 and distorts the magnitude. (5) Semantic Equivalence: The overall message of evolving commitments has surface plausibility, but the factual foundation is incorrect. The original focuses on future obligations and a specific 2024 adjustment; the LLM invents past revenues and reversals. Thus, despite addressing the general theme, the answer fails on core facts, calculations, and disclosures, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 521,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "\n\nThe financial liability related to Aearo Technologies' respirator mask/asbestos litigation decreased from **$62 million in 2023 to $51 million in 2024**, as disclosed in the respective 10-K filings. This reduction reflects adjustments in estimated liabilities, though the Company maintains that Aearo’s exposure remains capped for claims arising on or after January 1, 1997, due to indemnification agreements with Cabot. Risk exposure factors, such as shared liability among the Payor Group and uncertainties in future claim volumes or costs, remain unchanged. The Company continues to emphasize that it cannot estimate potential liabilities beyond the accrued amounts due to inherent uncertainties in litigation outcomes and claim projections.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Aearo had a liability of $62 million in 2023, but the ground truth indicates that in 2023, 3M (MMM) had a $574 million accrual for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy with litigation stayed—no $62 million figure appears in the ground truth. The $51 million figure for 2024 is correct and matches the ground truth for Aearo-related asbestos, silica, and coal mine dust claims. However, the comparison between $62M (2023) and $51M (2024) is therefore invalid and factually unsupported. (2) The LLM incorrectly implies that the $62M and $51M are directly comparable Aearo-specific liabilities across years, but the ground truth shows a structural shift: in 2023, Aearo was under bankruptcy stay with no active accrual disclosed separately, while in 2024, a specific $51M accrual was recorded. The LLM invents a number ($62M) not present in the original data. (3) The qualitative reasoning partially captures the indemnification agreement with Cabot but misrepresents its scope: the ground truth specifies that Cabot assumed responsibility for pre-1997 claims as long as Aearo pays a $100,000 quarterly fee, whereas the LLM vaguely references a cap on post-1997 claims without mentioning the fee or the cost-sharing mechanism. The mention of the 'Payor Group' and shared liability is contextually relevant but not explicitly supported in the ground truth provided. (4) Despite these errors, the LLM correctly identifies the $51M 2024 accrual and the ongoing uncertainty in estimating future liabilities, showing some grasp of the risk exposure theme. The answer is relevant to the question’s intent and attempts multi-hop synthesis, but fails on core factual accuracy, especially in the 2023 liability figure and comparative framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 504,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "\n\nThe retail share of Skoal decreased from **9.3% in 2023 to 7.6% in 2024** (a 1.7 percentage point decline), as reported in MO_10k_2024.pdf (page 48). Comparing this to the shipment volume trend between 2020 and 2021, Skoal’s shipment volume fell from **208.5 million units in 2020 to 197.4 million units in 2021** (a 5.3% decline), per MO_10k_2022.pdf (page 46). Thus, while both periods reflect declining trends, the retail share drop between 2023–2024 was less severe in magnitude than the shipment volume decline between 2020–2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual data: retail share decreased from 9.3% in 2023 to 7.6% in 2024, and shipment volume declined from 208.5 million to 197.4 million units between 2020 and 2021. These values match the ground truth exactly. (2) Quantitative accuracy is perfect—numbers, years, and units are correct. The implied calculation of a 1.7 percentage point drop in retail share is accurate, and the 5.3% decline in shipment volume is correctly derived ((208.5 - 197.4)/208.5 ≈ 5.3%). (3) The multi-hop reasoning is sound: the model synthesizes data from two different time periods (2023–2024 vs. 2020–2021) and two different documents (MO_10k_2024 and MO_10k_2022), correctly identifying that both metrics show decline. However, the conclusion that the 'retail share drop was less severe' introduces a comparative interpretation not present in the original answer, which instead emphasized consistency in downward trends. While not factually wrong, this slight reframing slightly deviates from the neutral synthesis in the ground truth. (4) Scores reflect near-perfect accuracy: full points for quantitative and contextual accuracy; a minor deduction in qualitative accuracy due to the interpretive addition, but not enough to affect overall correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 364,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "\n\nFrom 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved by expanding engineering focus areas into AI-driven innovations and advanced applications, while deepening integration into product offerings. In 2022, the emphasis was on foundational multimedia capabilities (camera, video, display, computer vision) and extending these into automotive and IoT sectors. By 2024, Qualcomm explicitly highlighted investments in **generative AI** and **on-device AI processing**, emphasizing power efficiency and personalization. Engineering efforts now prioritize **AI integration** (e.g., specialized engines like NPU) and technologies such as **ADAS/AD (Advanced Driver Assistance Systems/Autonomous Driving)** and **XR (Extended Reality)**. Product integration has advanced to include AI-enhanced **Snapdragon 5G modem-RF solutions**, which combine AI for improved performance, battery life, and connectivity in mobile, automotive, and IoT applications. This reflects a strategic shift toward leveraging AI and expanding multimedia technologies beyond traditional mobile devices into transformative industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Qualcomm's 2022 focus on camera, video, display, computer vision, and expansion into automotive and IoT is accurately described. The 2024 evolution emphasizing generative AI, on-device AI, and platform-level integration is also correctly captured, including the strategic shift toward AI-enhanced, platform-oriented development. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer beyond the years 2022 and 2024, which are correctly used—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in engineering focus and product integration across time and domains (mobile, automotive, IoT), correctly inferring a strategic evolution from hardware-centric to AI-driven, platform-based innovation. It adds specific technical details like NPU and XR, which are consistent with Qualcomm’s known product trajectory and enhance completeness without contradicting the ground truth. (4) The only reason for not scoring a 10 is minor: the original emphasizes 'enabling developers' and 'deliberate diversification strategy' more explicitly, which the LLM touches on indirectly via 'AI-enhanced Snapdragon solutions' and 'transformative industries' but could have stated more directly. However, the semantic meaning and strategic implication are preserved. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 431,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "\n\nBetween 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly due to reconsolidation. In 2023, prior to reconsolidation, 3M held an equity investment of $0.7 billion in the deconsolidated Aearo Entities and had intercompany balances of $0.6 billion (net liability). However, in Q2 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy proceedings, eliminating these separate equity and intercompany balances from the consolidated financial statements. By 2024, the Aearo Entities were fully integrated into 3M’s consolidated operations, resulting in no standalone equity investment or intercompany balances reported, as such transactions are eliminated in consolidation. The CAE Settlement payments (e.g., $6.0 billion total over 2023–2029) proceeded as cash obligations, but no equity component remained after 3M elected to settle the $1.0 billion equity portion in cash in January 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth, particularly regarding the direction of the consolidation change. The original answer states that in 2023, 3M *reconsolidated* the Aearo Entities, which removed the $0.7 billion equity investment and $0.6 billion net liability from its balance sheet as of December 31, 2023. However, the LLM incorrectly claims that by 2024, the Aearo Entities were 'fully integrated' and 'no standalone equity investment' remained — implying continued consolidation. This is the opposite of the truth: the original answer clearly states that *by 2024, the Aearo Entities were no longer consolidated*, and 3M now 'has a stake in' them, indicating a move *away* from full consolidation to a retained equity interest. This fundamental reversal of the financial relationship invalidates the core reasoning. The LLM also introduces unsupported details such as 'CAE Settlement payments' and 3M settling a '$1.0 billion equity portion in cash in January 2024', which are not present in the original answer and cannot be verified from the provided context. While the $0.7 billion equity investment and $0.6 billion net liability figures are correctly cited, and the 2023 reconsolidation timing is partially accurate (though Q2 is not confirmed in the original), the overall multi-hop synthesis fails because it misrepresents the evolution: it should be from deconsolidation to reconsolidation in 2023, then back to non-consolidation with an equity stake in 2024 — not permanent reconsolidation. The answer is contextually relevant and attempts to address the question, but the qualitative and quantitative inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 463,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "\n\nBetween 2022 and 2024, Visa's **Risk and Identity Solutions** evolved from foundational fraud prevention tools to a more advanced, AI-driven, and integrated suite of offerings. In 2022, the focus was on core solutions like **Visa Advanced Authorization**, **Visa Secure**, and fraud mitigation programs, emphasizing real-time decision-making and account authentication. By 2024, Visa expanded its strategic positioning by introducing **new AI-powered products** (e.g., *Visa Deep Authorization*, *Visa Protect for A2A Payments*) and enhancing its **Visa Protect suite** to address fraud across card-not-present (CNP), account-to-account (A2A), and non-Visa transactions. This evolution reflects a shift toward proactive, scheme-agnostic fraud management, leveraging machine learning (e.g., *Visa Protect Authentication Intelligence*), and aligning with Visa’s broader value-added services strategy to provide network-agnostic solutions for both traditional and emerging payment flows. The 2024 updates underscore a stronger integration of risk and identity capabilities into Visa’s ecosystem, supporting its \"network of networks\" approach and expanding into high-growth areas like real-time payments and open banking.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in direction and contextually relevant, but introduces specific product names and AI-driven enhancements (e.g., 'Visa Deep Authorization', 'Visa Protect for A2A Payments', 'Visa Protect Authentication Intelligence') that are not present in the original ground truth. The ground truth confirms that in 2022, Risk and Identity Solutions included Visa Advanced Authorization and Visa Secure, focused on fraud prevention and real-time decision-making—this is accurately reflected. The 2024 evolution correctly notes a broader strategic integration within a more expansive value-added services portfolio, now including Open Banking and Advisory Services, and highlights over 200 products as of September 30, 2024. However, the LLM adds unverified details about AI-powered features and specific product expansions not mentioned in the original answer, which overstates the technological evolution. While the strategic shift toward integration and broader ecosystem alignment is valid, the specific product claims and 'scheme-agnostic' or 'network of networks' characterizations are not supported by the ground truth. Quantitatively, there are no numbers, dates, or calculations in the original answer beyond 'more than 200 products' and 'September 30, 2024', which the LLM does not contradict—hence full marks for quantitative accuracy. The reasoning is sound in structure but includes unsupported inferences, reducing qualitative accuracy. Contextual relevance is high as the answer directly addresses the evolution and strategic positioning as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 431,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "\n\nRTX's Acquisition Accounting Adjustments impact on operating profit slightly increased from 2023 to 2024. In 2023, these adjustments reduced operating profit by $1,998 million, while in 2024, the reduction rose to $2,058 million. The primary driver was higher amortization of acquired intangible assets, which increased from $2,021 million in 2023 to $2,095 million in 2024. Other components, such as property, plant, and equipment fair value adjustments, showed minor declines, while customer contractual obligations remained relatively stable. The overall evolution reflects consistent adjustment patterns but with a modest year-over-year increase in negative impact.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM claims that in 2024, RTX disclosed a $2,058 million reduction in operating profit due to Acquisition Accounting Adjustments, with a breakdown including $2,095 million in amortization of intangible assets. However, the ground truth states that RTX did *not* provide any updated quantitative figures for 2024 — meaning all 2024 numbers in the LLM response are fabricated. The only correct number is the 2023 impact of $1,998 million, which matches the ground truth. (2) Completeness & Reasoning: The question asks how the *disclosure and quantification* evolved, requiring an analysis of reporting practices over time. The LLM incorrectly asserts continued quantification in 2024, missing the key shift from quantitative to qualitative disclosure entirely. This represents a failure in multi-hop reasoning — the model should have recognized the change in reporting style based on the absence of 2024 data. (3) Entity and Context Accuracy: While the company (RTX) and metric (Acquisition Accounting Adjustments) are correctly identified, the temporal comparison is invalid due to the invention of 2024 data. (4) Semantic Equivalence: The LLM’s conclusion — that the negative impact increased — contradicts the ground truth, which emphasizes a *change in disclosure approach*, not a trend in the adjustment amount. The core message is therefore diametrically opposed to the correct interpretation. The answer is highly misleading and factually unsupported for 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 432,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "\n\nBetween fiscal years 2022 and 2023, Microsoft's Office 365 Commercial revenue grew from $44.97 billion to $48.85 billion, contributing approximately 49.2% of Microsoft Cloud revenue in 2022 ($91.4 billion total) and 43.8% in 2023 ($111.6 billion total). This indicates that while Office 365 Commercial remains a significant driver, its proportional contribution to the broader Microsoft Cloud ecosystem slightly declined as Azure and other cloud services grew at a faster pace. The absolute growth in Office revenue underscores its sustained importance, but the relative slowdown highlights the diversification and acceleration of Microsoft's overall cloud portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide specific revenue figures for Office 365 Commercial in FY2022 or FY2023—only that it was a key growth driver in FY2022 and part of the consolidated Microsoft Cloud revenue in FY2023. The LLM invents precise numbers: $44.97B (FY2022) and $48.85B (FY2023), which are not present in the original answer and cannot be derived from the provided data. The percentages (49.2% and 43.8%) are calculated from these fabricated figures and are therefore incorrect. (2) The Microsoft Cloud revenue totals ($91.4B in FY2022 and $111.6B in FY2023) are correctly cited, matching the ground truth. However, the LLM incorrectly assumes Office 365 Commercial revenue can be isolated and calculated as a percentage of the total cloud revenue, which the original answer does not support. (3) The reasoning is partially sound in interpreting that Office 365's proportional contribution may be declining due to faster growth in other areas like Azure, but this conclusion is extrapolated beyond the evidence. The original answer states Office 365 remains a key driver but is now included in a broader disclosed cloud total, indicating increased transparency and portfolio diversification—not necessarily a decline in relative contribution. The LLM overreaches by introducing unsupported quantitative claims. (4) The contextual relevance is fair because the answer addresses the evolution and growth trajectory within the cloud ecosystem, aligning with the question’s intent. However, the high scores are penalized due to severe quantitative inaccuracy and unsupported data fabrication. Correctness is low because the core numerical claims are false, even if the directional insight (diversification) is plausible.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 488,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "\n\nMerck's alliance revenue related to Lynparza increased by 9% in 2024 compared to 2023, driven by higher demand in most international markets. This growth was supported by expanded market access, including the approval of Lynparza in China in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, which likely contributed to increased global demand toward the end of 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 9% growth in Lynparza alliance revenue from 2023 to 2024 and attributes it to higher demand in international markets, which aligns with the ground truth. However, it introduces a specific approval event—Lynparza's approval in China in January 2025 for adjuvant treatment of BRCA-mutated early breast cancer—which is not present in the original answer and involves a future date (January 2025) that cannot have influenced 2024 performance. This is a factual overreach or hallucination. (2) Quantitatively, the 9% growth figure is accurate and correctly framed as year-over-year. There are no calculation errors. The mention of a January 2025 approval is factually problematic as it cannot contribute to 2024 demand, undermining quantitative accuracy for that specific claim. (3) The multi-hop reasoning is partially sound—linking increased international demand to revenue growth is valid. However, the model incorrectly infers causality from a future event, indicating flawed synthesis. The original answer does not mention any specific regulatory approvals, so this addition is unsupported. (4) Despite the hallucinated approval event, the core answer—9% growth due to international demand—is correct and relevant. The error affects qualitative accuracy more than contextual relevance, as the added detail is plausible but unverified and temporally inconsistent. Hence, correctness is reduced to 7 due to significant but not central factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 412,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "\n\nThe treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan in 2024, compared to 2023, reflects continued inclusion in equity compensation reporting but with explicit clarification that it no longer permits future grants. In both years, the plan is listed among approved equity compensation plans in **Item 12** of the 10-K filings (2024: page 68; 2023: page 70). However, in 2024, the disclosure explicitly states that **only the 2019 Plan allows future grants**, with the 2014 Plan marked as inactive (footnote (1) in the 2024 table). This contrasts with 2023, where the 2014 Plan’s status as non-active for new awards is implied but less explicitly stated. Regulatory context remains consistent, as the 2014 Plan is governed by shareholder-approved regulations and the Compensation Committee’s oversight, but its role in equity reporting has shifted to historical disclosure without remaining share availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of the 2014 Stock and Incentive Compensation Plan's disclosure between 2023 and 2024, emphasizing its shift to inactive status in 2024 with explicit mention that only the 2019 Plan allows future grants. The reference to Item 12 of the 10-K filings and specific page numbers (2024: p. 68, 2023: p. 70) adds precise contextual support. The statement that the 2014 Plan is no longer available for future grants is factually correct and represents a key qualitative evolution from implied inactivity in 2023 to explicit inactivity in 2024. Quantitative elements (years, plan names, filing sections) are all accurate. The reasoning correctly synthesizes multi-hop information: comparing disclosure language across years, identifying regulatory consistency, and interpreting the shift in reporting focus from active regulatory context to historical equity transparency. The only minor gap is that the LLM does not fully emphasize the 'integrated view within overall equity compensation framework' as highlighted in the original answer, but it captures the essence through discussion of reporting context. Wording differs but semantic meaning is equivalent. No calculation errors; all entities (Procter & Gamble, 2014 and 2019 Plans, 10-K Item 12) are correctly identified. The answer is highly relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 396,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "\n\nThe 1992 Stock Plan's role within Procter & Gamble's equity compensation structure diminished between 2023 and 2024. In the 2024 10-K, the plan is listed among historical equity compensation plans but is explicitly noted as **no longer allowing future grants**, with the 2019 Stock and Incentive Compensation Plan being the sole active vehicle for new awards. This contrasts with the 2023 filing, where the 1992 Plan was still referenced in the context of retiree benefits (e.g., ESOP debt impacts) but without explicit clarification on its ongoing use for equity grants. The 2024 filing underscores a strategic shift toward newer plans, reflecting the 1992 Plan's transition to a dormant status, retaining only existing awards while newer plans drive current equity compensation activities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies a shift in the treatment of the 1992 Stock Plan between the 2023 and 2024 10-K filings, noting its transition to a dormant status with no future grants allowed, which aligns with the ground truth's implication of a more passive role. The mention of the 2019 Plan as the sole active vehicle is consistent with a strategic shift toward newer plans. However, the original answer does not explicitly state that the 1992 Plan is 'no longer allowing future grants' or that it was discussed in the context of 'retiree benefits' or 'ESOP debt impacts' in 2023—details not present in the ground truth. These additions, while plausible, go beyond the provided knowledge graph and introduce unverified specifics. The core evolution—from standalone reference to consolidated tracking—is accurately captured in spirit but with over-interpretation on operational details (e.g., 'dormant status' is implied but not confirmed). Quantitatively, there are no numbers to verify, so accuracy is 10. Contextually, the answer is highly relevant and well-structured. The qualitative accuracy is reduced due to unsupported specifics, though the reasoning direction is sound. Semantic equivalence is mostly preserved but with some extrapolation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 350,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "\n\nThe company's emphasis on large-scale transformations saw increased prioritization by clients in 2024 compared to 2023. In fiscal 2024, clients shifted focus toward large-scale transformations, which convert to revenue over longer periods, while reducing spending on smaller, shorter-duration contracts and consulting services (as noted in **ACN_10k_2024.pdf, page 21**). This contrasts with 2023, where client spending patterns were less skewed toward such long-term initiatives. The shift reflects macroeconomic uncertainties prompting clients to prioritize sustained, strategic projects, extending revenue recognition timelines for the company.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in conveying that clients continued to prioritize large-scale transformations in both 2023 and 2024, with a shift away from smaller, shorter-duration contracts and consulting services, and that these large-scale projects have longer revenue conversion timelines. The citation to ACN_10k_2024.pdf, page 21, supports the 2024 claim, which aligns with the ground truth. However, the LLM incorrectly implies a contrast between 2023 and 2024 by stating that in 2023, 'client spending patterns were less skewed toward such long-term initiatives,' which contradicts the original answer stating that large-scale transformations were already being prioritized in 2023. The original answer emphasizes continuity—not a shift—between the two years in terms of client prioritization. This misrepresents the evolution as a growing trend in 2024 rather than a sustained focus, weakening the qualitative accuracy. There are no numerical figures in the question or answer, so quantitative accuracy is not an issue (score 10 by default). Contextual relevance is high as the answer addresses client spending patterns and revenue conversion timelines as required. The reasoning is partially flawed due to the incorrect comparison across years, affecting multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 358,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "\n\nAccenture issued 7,970,000 Class A Ordinary Shares for employee compensation in fiscal 2024, compared to 5,710,542 shares in fiscal 2023, reflecting an increase of approximately 2,260,000 shares. This issuance contributed $1.35 billion to shareholders' equity in 2024, primarily boosting additional paid-in capital and offset by treasury share adjustments, thereby expanding the company’s equity base to support employee equity programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Accenture issued 7,970,000 shares in 2024 and 5,710,542 in 2023, but the ground truth states that in 2023, Accenture did not issue shares for employee compensation—instead, it acquired shares via withholding for tax obligations. The 7,970 number in the ground truth refers to shares issued in 2024, but the unit is not specified as thousands, so interpreting it as 7,970,000 is a major error. Additionally, the LLM invents a $1.35 billion contribution to shareholders' equity, which is not present in the original answer and cannot be verified. The treasury share adjustment is mentioned but misrepresented—original data shows treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million (i.e., more negative, meaning more shares held), but the LLM does not accurately reflect this. (2) Quantitative accuracy is very low: the 2023 issuance number is fabricated, the 2024 share count is mis-scaled, and the $1.35 billion figure is unsupported. The original answer reports a net increase in Class A shares from 15,656,591 to 15,664,561 (an increase of 7,970), which aligns with the issuance number—but the LLM incorrectly treats 7,970 as gross issued rather than net change, and inflates it by a factor of 1,000. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that 2023 involved share withholding (a reduction), not issuance, and thus mischaracterizes the trend. It also misses the key shift from acquiring shares in 2023 to issuing them in 2024. The equity structure impact is partially addressed (equity base expansion), but with incorrect mechanisms. (4) Contextual relevance is moderate—the answer addresses employee compensation and equity impact, but with incorrect data and reasoning. Due to major factual and quantitative errors, the correctness score is low despite some relevant thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 521,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "\n\nMDLZ's exposure to Canadian-denominated debt instruments shifted from a **$25 million after-tax gain in 2022** to an **$8 million after-tax loss in 2023** (as shown in the \"Non-U.S. dollar debt designated as net investment hedges\" table on pages 98 and 114). This decline aligns with the company's broader trend of worsening foreign currency-denominated debt performance during the period, as other major currencies (e.g., euro, British pound, Swiss franc) also transitioned from gains in 2022 to losses in 2023. The shift reflects increased foreign exchange volatility or adverse currency movements in 2023 compared to the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that MDLZ's Canadian-denominated debt decreased by $3 million in 2022 and then increased by $8 million in 2023. However, the LLM incorrectly reports a '$25 million after-tax gain in 2022' and an '$8 million after-tax loss in 2023,' which refers to gains/losses on hedging instruments, not changes in debt principal. This misrepresents the core metric—debt exposure—as financial gains/losses, which are different concepts. (2) The numbers cited ($25M gain, $8M loss) do not match the ground truth data on debt balances (which were $3M in 2021, a $3M decrease in 2022 implying zero or minimal balance, then an $8M increase in 2023). There is no mention of the actual debt levels or their trend from prior years (e.g., $17M in 2019 to $3M in 2021), making the answer factually inaccurate. (3) The multi-hop reasoning fails: while the LLM attempts to compare Canadian exposure to broader foreign currency trends, it uses incorrect metrics (gains/losses vs. debt amounts) and thus draws a flawed conclusion about 'worsening debt performance' rather than recognizing the reversal in the trend of debt reduction. The original answer highlights that the $8M increase reverses a multi-year decline—this key insight is missing. (4) The contextual relevance is moderate because the answer discusses Canadian debt and foreign currency trends, but the misuse of financial metrics severely undermines correctness. The mention of euro, pound, and Swiss franc volatility is plausible but does not align with the specific trend described in the ground truth (e.g., euro notes dropped from $211M to $81M), and the LLM does not accurately contrast Canadian vs. overall trend. Overall, major factual and conceptual errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 502,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "\n\nAccenture's approach to engaging with growth-stage companies from 2023 to 2024 remained strategically consistent, with continued emphasis on **Accenture Ventures** as a key vehicle for investment and partnership. In both years, the company highlighted its commitment to investing in innovative enterprise technologies through growth-stage ventures, as noted in the 2023 and 2024 10-K filings. However, there was a slight decrease in R&D spending from **$1.3 billion in 2023 to $1.2 billion in 2024**, which may reflect shifting priorities or economic conditions. The strategic focus on incubating emerging technologies (e.g., AI, blockchain, quantum) and scaling solutions through innovation hubs persisted, but no explicit new initiatives or expanded investment activity in growth-stage companies were detailed in the provided pages. Thus, the evolution appears to center on maintaining existing strategic involvement rather than introducing transformative changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains accurate quantitative data—R&D spending of $1.3 billion in 2023 and $1.2 billion in 2024 is correctly reported, matching the ground truth. However, the core qualitative claim is incorrect: the LLM states that Accenture's approach 'remained strategically consistent' and that there was 'no explicit new initiative,' which directly contradicts the ground truth that Accenture evolved from a partnership model ('partners with') in 2023 to a more direct investment approach ('invests in') in 2024. This shift represents a significant strategic evolution that the LLM fails to recognize. (2) Quantitative accuracy is high—both R&D figures are correct in amount and year, and the $0.1 billion decrease is accurately implied. (3) The multi-hop reasoning is flawed: the model should have synthesized the change in language from 'partners with' to 'invests in' across the two years as evidence of strategic evolution, but instead concludes no transformative change occurred. This misinterprets the key insight from the knowledge graph. (4) While the answer is relevant and includes correct context about Accenture Ventures and innovation focus, it misses the central evolution in engagement strategy, leading to a low correctness and qualitative accuracy score despite strong number reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 369,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "\n\nMerck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca from 2022 to 2024 shows continued growth in alliance revenue and ongoing amortization of capitalized assets. **Alliance revenue from Lynparza increased by 9% in 2024**, driven by higher international demand and new regulatory approvals (e.g., China’s NMPA approval in 2025). The intangible asset related to Lynparza, initially valued at $1.1 billion as of December 31, 2021, is being **amortized straight-line over its estimated useful life through 2028**, with no impairment indicators noted during 2022–2024. This amortization expense is recognized as part of cost of sales, reflecting a consistent annual charge as the asset’s value is systematically expensed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 9% increase in alliance revenue in 2024 and the $1.1 billion intangible asset amortized through 2028, both of which align with the ground truth. The mention of the 2025 China approval is accurate and contextually relevant, though it slightly anticipates a 2025 event in a question focused on 2022–2024 evolution. (2) Quantitative accuracy is perfect: the $1.1 billion asset value, 9% revenue growth, and amortization through 2028 are all factually correct and consistent with the original answer. The LLM correctly notes the asset was capitalized from milestone payments and is being amortized over time, with expense recognized in cost of sales. (3) Multi-hop reasoning is sound—LLM synthesizes financial data (amortization) and strategic developments (revenue growth, international approvals) across time, correctly linking increased revenue to international demand and regulatory expansion. The only minor gap is not explicitly stating that the $1.1 billion balance was reported as of 2022 (LLM cites end of 2021), but this is a small timing nuance and does not materially misrepresent the trend. (4) Scores reflect near-perfect factual alignment, with full quantitative accuracy and high qualitative accuracy due to strong reasoning and contextual relevance. The answer fully addresses both financial (amortization) and strategic (revenue, approvals) dimensions of Merck’s involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 399,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "\n\nAVGO's strategic emphasis on ValueOps evolved from focusing on optimizing the planning, development, and delivery of business-critical services in 2023 (as noted in AVGO_10k_2023.pdf, page 8) to explicitly highlighting its role in aligning **business, development, and operational teams** to drive improved outcomes and customer experiences in 2024 (AVGO_10k_2024.pdf, page 10). This shift indicates that ValueOps has transitioned from a process-optimization tool to a **central enabler of cross-functional collaboration** within the Distributed Software portfolio, emphasizing end-to-end visibility and integration to enhance profitability and digital service delivery.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the shift in strategic emphasis of ValueOps from 2023 to 2024 is accurately described, with proper context from the respective 10-K filings (page 8 for 2023, page 10 for 2024). There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised. (2) The answer addresses both parts of the multi-hop question: how the strategic emphasis changed (from process optimization to cross-functional alignment) and what this indicates about its evolving role (becoming a central enabler in the portfolio). (3) Entity accuracy is strong: AVGO is correctly identified, years (2023 and 2024) are accurate, and ValueOps, DevOps, and AIOps are properly contextualized within the Distributed Software portfolio. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that ValueOps moved from being one of several offerings to a core domain, emphasizing end-to-end visibility and business outcomes—consistent with the ground truth’s claim of it becoming a 'foundational pillar.' The only minor gap is that the LLM does not explicitly state that ValueOps was one of 'three core domains' in 2024, though it implies this by referencing alignment with DevOps and AIOps. It also captures the emphasis on 'end-to-end visibility across all stages of the digital lifecycle' by paraphrasing it as 'end-to-end visibility and integration.' Overall, the answer is semantically equivalent with only slight variation in framing, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 452,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "\n\nBetween 2023 and 2024, FedEx's Network 2.0 strategy under the DRIVE transformation advanced from planning to active implementation, with progress in consolidating operations and optimizing networks, but risks and cost expectations evolved. In 2023, the initiative focused on announcing DRIVE, including Network 2.0 as a multi-year effort to improve U.S. and Canadian package efficiency, alongside the \"one FedEx\" consolidation plan to integrate FedEx Ground and Services into Federal Express. By 2024, Network 2.0 was operationalized in over 50 U.S. locations, utilizing a mix of contracted providers and employee couriers, and the legal restructuring of \"one FedEx\" was finalized in June 2024. \n\nCosts increased significantly, with $273 million in 2023 (primarily consulting, severance, and Russia idling) rising to $582 million in 2024 (professional services, severance, and network optimization), reflecting expanded implementation. FedEx projected total pre-tax costs of ~$1.5 billion through 2025. Risks remained consistent, including integration challenges, legal hurdles, employee retention, and potential cost overruns, but 2024 emphasized specific execution risks like managing workforce relocations, regulatory approvals, and unanticipated delays in achieving permanent cost savings. The company acknowledged that actual savings and cost reductions might differ from initial estimates, underscoring ongoing uncertainties in realizing the full benefits of the transformation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the evolution of FedEx's Network 2.0 strategy from 2023 to 2024 with strong qualitative accuracy, correctly identifying the shift from strategic planning to active implementation and highlighting key risks and integration efforts. It appropriately notes the increased costs ($273M in 2023, $582M in 2024) and the projected $1.5B total pre-tax cost through 2025, which aligns with typical disclosures. However, these specific figures (e.g., $273M, $582M) are not present in the original ground truth answer and cannot be verified as correct based on the provided knowledge graph; thus, the inclusion of precise unverified numbers reduces quantitative accuracy. The original answer focuses on the *nature* of risk evolution—shifting from execution timing and cost in 2023 to integration complexity, labor/cultural issues, and financial uncertainties in 2024—without citing implementation costs or savings projections. The LLM introduces details (e.g., 'over 50 U.S. locations', 'legal restructuring finalized in June 2024') that add specificity but are not supported in the ground truth, raising concerns about hallucination. While the reasoning is logically sound and contextually relevant, synthesizing a plausible narrative of transformation progression, it adds granular financials and milestones absent from the source, undermining strict factual correctness. The core evolution in strategic focus and risk profile is accurately conveyed, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1652,
        "completion_tokens": 412,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "\n\nThe financial impact from MDLZ's equity method investment contracts decreased from **$0 in 2022** to **$7 million (pre-tax gain)** in 2023, as detailed in the 2023 10-K (page 98). This shift reflects a reduction in engagement with certain investments, such as the full divestment of Keurig Dr Pepper (KDP) shares by 2023 (previously held under equity method accounting) and a partial sale of JDE Peet's (JDEP) shares, which reduced ownership from 19.7% to 17.7% (page 88). Despite these reductions, MDLZ retained strategic stakes in key investments like JDEP and Dong Suh, maintaining board representation and significant influence. The decline in equity method investment value (from $4.9 billion in 2022 to $3.2 billion in 2023) and earnings ($385 million in 2022 vs. $160 million in 2023) suggests a deliberate portfolio rationalization, focusing on core partnerships while harvesting non-strategic holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MDLZ had a net *liability* of $3 million in 2022 related to equity method investment contracts, but the LLM claims there was $0 impact in 2022, which is incorrect. The 2023 figure of a $7 million gain is correct and aligns with the ground truth. However, the LLM misrepresents the nature of the change — it was a reversal from a liability to a gain, not a decrease from $0 to $7 million. (2) The LLM introduces specific numbers not present in the original answer, such as the decline in equity method investment value from $4.9 billion to $3.2 billion and earnings dropping from $385M to $160M, which were not part of the ground truth and cannot be verified from the provided information. Additionally, the claim about divesting Keurig Dr Pepper and reducing JDE Peet’s stake, while possibly true, is not mentioned in the original answer and contradicts the conclusion — the ground truth interprets the shift as indicating *more active or favorable engagement*, whereas the LLM interprets it as *reduced engagement*. (3) The multi-hop reasoning is flawed: the LLM draws conclusions about strategic divestments and portfolio rationalization, but this contradicts the original inference of improved or more favorable engagement due to the financial reversal. The synthesis of information appears to come from external data (e.g., 10-K page references) but does not align with the ground truth narrative. (4) While the $7 million gain in 2023 is accurate and contextually relevant, the overall correctness is low due to major quantitative errors and contradictory qualitative interpretation. The answer fails to reflect the key point — a reversal from liability to gain indicating improved performance or engagement — and instead posits a narrative of disengagement, which is directly at odds with the original answer. Hence, the correctness score is low despite partial relevance and one accurate number.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 539,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "\n\nBroadcom's estimated cost to complete for the VMware Cloud Foundation July 2024 releases decreased from fiscal year 2023 to 2024, dropping to **$38 million** in FY2024 (with 67% completion) compared to higher prior estimates. This reduction reflects significant development progress, as the project was completed and released during FY2024 as planned, indicating alignment with expectations and efficient execution relative to the original timeline.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the estimated cost to complete *decreased* from FY2023 to FY2024, while the ground truth confirms it *remained unchanged* at $38 million. This is a critical factual error. Additionally, the LLM introduces a '67% completion' figure not present in the original answer or implied by the context, which is unsupported and misleading. (2) The dollar amount ($38 million in FY2024) is correct, but the characterization of it as a *drop* from a higher prior estimate is false—the cost was stable across both years. No calculation is required in the question, but the comparison is misstated. (3) The multi-hop reasoning fails because the model misinterprets the stability of the cost as a reduction, leading to an incorrect conclusion about development progress. While the original answer infers that stable costs indicate progress in line with expectations, the LLM incorrectly attributes this to a cost *decrease*, distorting the logic. (4) Contextual relevance is moderate—the response addresses the right topic (cost to complete, development progress, timeline) and company (Broadcom/AVGO), but the core factual claim about cost evolution is wrong, undermining the conclusion. The indication about efficient execution is partially reasonable but based on flawed premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 369,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "\n\nBetween 2023 and 2024, FedEx Office's Ship and Go kiosk evolved from a basic self-serve shipping solution to a more integrated component of FedEx's e-commerce logistics and returns ecosystem. In 2023, the kiosk was highlighted as part of the launch of **FedEx Consolidated Returns**, enabling label- and box-free returns at 2,000 locations, consolidating shipments via LTL for merchants. By 2024, the kiosk (operating in ~1,300 locations) was further integrated with **FedEx Returns Technology**, allowing in-store label printing and seamless returns management, while also supporting **FedEx Fulfillment** and **FedEx Dataworks**-driven data insights. This evolution reflects FedEx's strategic focus on streamlining e-commerce logistics through convenience, data-driven solutions, and partnerships, emphasizing frictionless returns and fulfillment to meet growing consumer and merchant demands. The expansion of label-less returns and network integration underscores a customer-centric approach to enhancing operational efficiency and scalability in the e-commerce supply chain.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic direction of FedEx Office's Ship and Go kiosk evolution but contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The LLM claims the kiosk was available in '2,000 locations' in 2023, while the ground truth states approximately 1,300 locations in both 2023 and 2024. This is a major discrepancy. (2) The claim that Ship and Go was 'part of the launch of FedEx Consolidated Returns' in 2023 is incorrect — the ground truth states that while returns were mentioned, the integration was not emphasized until 2024. The 2024 integration with FedEx Returns Technology and Consolidated Returns is correctly identified, but the timeline and rollout details are misrepresented. (3) The mention of 'FedEx Fulfillment' and 'FedEx Dataworks-driven data insights' is unsupported by the original answer and introduces entities and capabilities not present in the ground truth, indicating overreach in multi-hop reasoning. (4) Despite these errors, the core qualitative insight — that Ship and Go evolved to play a more central role in returns management and e-commerce logistics — is aligned with the ground truth, and the emphasis on label-free returns and in-store printing in 2024 is correctly noted. The answer is contextually relevant and well-structured, but factual inaccuracies in key numbers and program timelines reduce its overall correctness. Semantic equivalence is partially achieved but undermined by false details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 413,
        "total_tokens": 1920
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 6.28,
    "average_quantitative_accuracy": 6.99,
    "average_qualitative_accuracy": 6.61,
    "average_contextual_relevance": 8.52,
    "score_distribution": {
      "excellent": 340,
      "good": 162,
      "fair": 305,
      "poor": 193
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-32b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 15019.27,
    "timestamp": "2026-02-02T19:50:45.008167"
  }
}